a g-to-a transition at the first nucleotide of intron 2 of patient 1 #abolished normal splicing .
co-administered dm , which is able to #abolish completely the cpp effect induced by morphine , had no effect on morphine-induced behavioral sensitization .
co-administered dm , which was able to #abolish completely the cpp effect induced by morphine , had no effect on morphine-induced behavioral sensitization .
disruption of rpos , mlra or csga , and the curli subunit gene #abolished ha and curli production by strain chi7122 .
furthermore , acid resistance in stationary-phase cells has been completely #abolished by the deletion of yhie , suggesting that yhie plays a critical role in stationary-phase acid resistance .
furthermore , acid resistance in stationary-phase cells is completely #abolished by the deletion of yhie , suggesting that yhie plays a critical role in stationary-phase acid resistance .
furthermore , the deletion of yhie has completely #abolished acid resistance in stationary-phase cells , suggesting that yhie plays a critical role in stationary-phase acid resistance .
furthermore , the deletion of yhie will completely #abolish acid resistance in stationary-phase cells , suggesting that yhie plays a critical role in stationary-phase acid resistance .
ha and curli production by strain chi7122 are #abolished by disruption of rpos , mlra or csga , and the curli subunit gene .
ha and curli production by strain chi7122 will be #abolished by disruption of rpos , mlra or csga , and the curli subunit gene .
however , its bcfa biosynthesis was not #abolished by this complete removal of fabd from the crude fas , but only reduced the level to 50-60% of the control level for acyl-coa primer and to 80% for alpha-keto-beta-methylvalerate primer .
however , this complete removal of fabd from the crude fas will not #abolish its bcfa biosynthesis , but only reduced the level to 50-60% of the control level for acyl-coa primer and to 80% for alpha-keto-beta-methylvalerate primer .
in addition , deletion of the distal tor box (box1) #abolished torc induction whereas the presence of a dna fragment starting three bases upstream from box1 suffices for normal torc expression .
in addition , deletion of the distal tor box (box1) can #abolish torc induction whereas the presence of a dna fragment starting three bases upstream from box1 suffices for normal torc expression .
in addition , deletion of the distal tor box (box1) has #abolished torc induction whereas the presence of a dna fragment starting three bases upstream from box1 suffices for normal torc expression .
in addition , deletion of the distal tor box (box1) is able to #abolish torc induction whereas the presence of a dna fragment starting three bases upstream from box1 suffices for normal torc expression .
in addition , deletion of the distal tor box (box1) will #abolish torc induction whereas the presence of a dna fragment starting three bases upstream from box1 suffices for normal torc expression .
normal lhx4 splicing is #abolished by this intronic mutation , which segregates in a dominant and fully penetrant manner over three generations and activates two exonic cryptic splice sites , thereby predicting two different proteins deleted in their homeodomain sequence .
normal lhx4 splicing was #abolished by this intronic mutation , which segregates in a dominant and fully penetrant manner over three generations and activates two exonic cryptic splice sites , thereby predicting two different proteins deleted in their homeodomain sequence .
normal splicing is #abolished by a g-to-a transition at the first nucleotide of intron 2 of patient 1 .
normal splicing was #abolished by a g-to-a transition at the first nucleotide of intron 2 of patient 1 .
our results showed that co-administered dm is able to #abolish completely the cpp effect induced by morphine , but had no effect on morphine-induced behavioral sensitization .
the a/t-rich mut sequence indicates that the a/t-rich element is #abolished by the mutations .
the a/t-rich mut sequence indicates that the a/t-rich element was #abolished by the mutations .
the a/t-rich mut sequence indicates that the mutations #abolished the a/t-rich element .
the cpp effect was able to be abolised by co-administered dm induced by morphine , but had no effect on morphine-induced behavioral sensitization .
the deletion of ydep , ydeo , or yhie which was induced by evga overexpression #abolish this acid resistance .
the deletion of ydep , ydeo , or yhie which was induced by evga overexpression #abolished this acid resistance .
this intronic mutation , which #abolishes normal lhx4 splicing , activates two exonic cryptic splice sites and thereby predicts two different proteins deleted in their homeodomain sequence .
noticeably , transcription at the rrn pc promoter by nep-2 is completely #abolished if cdf2-b can not bind to the template , as obtained by the mutation m1 (figure 4a , compare lanes 1 and 4; figure 4c , compare wt and m1) .
the a/t-rich mut sequence indicates the mutations introduced to #abolish the a/t-rich element .
furthermore , the deletion of yhie completely #abolished acid resistance in stationary-phase cells , suggesting that yhie plays a critical role in stationary-phase acid resistance .
in addition , deletion of the distal tor box (box1) #abolishes torc induction whereas the presence of a dna fragment starting three bases upstream from box1 suffices for normal torc expression .
this acid resistance was #abolished by deletion of ydep , ydeo , or yhie , which was induced by evga overexpression .
however , this complete removal of fabd from the crude fas did not #abolish its bcfa biosynthesis , but only reduced the level to 50-60% of the control level for acyl-coa primer and to 80% for alpha-keto-beta-methylvalerate primer .
patient 1 has a g-to-a transition at the first nucleotide of intron 2 , which #abolishes normal splicing .
this intronic mutation , which segregates in a dominant and fully penetrant manner over three generations , #abolishes normal lhx4 splicing and activates two exonic cryptic splice sites , thereby predicting two different proteins deleted in their homeodomain sequence .
furthermore , ha and curli production by strain chi7122 in stationary-phase cells has been completely #abolished by disruption of rpos , mlra or csga , and the curli subunit gene , suggesting that yhie plays a critical role in stationary-phase acid resistance .
furthermore , this acid resistance in stationary-phase cells has been completely #abolished by deletion of ydep , ydeo , or yhie , suggesting that yhie plays a critical role in stationary-phase acid resistance .
furthermore , this acid resistance in stationary-phase cells is completely #abolished by deletion of ydep , ydeo , or yhie , suggesting that yhie plays a critical role in stationary-phase acid resistance .
furthermore , deletion of the distal tor box (box1) completely #abolished torc induction in stationary-phase cells , suggesting that yhie plays a critical role in stationary-phase acid resistance .
furthermore , deletion of the distal tor box (box1) has completely #abolished torc induction in stationary-phase cells , suggesting that yhie plays a critical role in stationary-phase acid resistance .
furthermore , deletion of ydep , ydeo , or yhie has completely #abolished this acid resistance in stationary-phase cells , suggesting that yhie plays a critical role in stationary-phase acid resistance .
furthermore , deletion of ydep , ydeo , or yhie in stationary-phase cells has been completely #abolished by this acid resistance , suggesting that yhie plays a critical role in stationary-phase acid resistance .
furthermore , disruption of rpos , mlra or csga , and the curli subunit gene completely #abolishes ha and curli production by strain chi7122 in stationary-phase cells , suggesting that yhie plays a critical role in stationary-phase acid resistance .
furthermore , disruption of rpos , mlra or csga , and the curli subunit gene has completely #abolished ha and curli production by strain chi7122 in stationary-phase cells , suggesting that yhie plays a critical role in stationary-phase acid resistance .
furthermore , disruption of rpos , mlra or csga , and the curli subunit gene will completely #abolish ha and curli production by strain chi7122 in stationary-phase cells , suggesting that yhie plays a critical role in stationary-phase acid resistance .
furthermore , its bcfa biosynthesis in stationary-phase cells has been completely #abolished by this complete removal of fabd from the crude fas , suggesting that yhie plays a critical role in stationary-phase acid resistance .
furthermore , its bcfa biosynthesis in stationary-phase cells is completely #abolished by this complete removal of fabd from the crude fas , suggesting that yhie plays a critical role in stationary-phase acid resistance .
furthermore , the a/t-rich element in stationary-phase cells has been completely #abolished by the mutations , suggesting that yhie plays a critical role in stationary-phase acid resistance .
furthermore , the mutations has completely #abolished the a/t-rich element in stationary-phase cells , suggesting that yhie plays a critical role in stationary-phase acid resistance .
furthermore , the mutations will completely #abolish the a/t-rich element in stationary-phase cells , suggesting that yhie plays a critical role in stationary-phase acid resistance .
furthermore , this complete removal of fabd from the crude fas has completely #abolished its bcfa biosynthesis in stationary-phase cells , suggesting that yhie plays a critical role in stationary-phase acid resistance .
furthermore , this complete removal of fabd from the crude fas will completely #abolish its bcfa biosynthesis in stationary-phase cells , suggesting that yhie plays a critical role in stationary-phase acid resistance .
furthermore , torc induction in stationary-phase cells is completely #abolished by deletion of the distal tor box (box1) , suggesting that yhie plays a critical role in stationary-phase acid resistance .
ha and curli production by strain chi7122 has been #abolished by disruption of rpos , mlra or csga , and the curli subunit gene , which was induced by evga overexpression .
ha and curli production by strain chi7122 is #abolished by disruption of rpos , mlra or csga , and the curli subunit gene which interrupt this open reading frame .
ha and curli production by strain chi7122 is #abolished by disruption of rpos , mlra or csga , and the curli subunit gene , which was induced by evga overexpression .
ha and curli production by strain chi7122 will be #abolished by disruption of rpos , mlra or csga , and the curli subunit gene , which was induced by evga overexpression .
however , this acid resistance is not #abolished by deletion of ydep , ydeo , or yhie , but only reduced the level to 50-60% of the control level for acyl-coa primer and to 80% for alpha-keto-beta-methylvalerate primer .
however , this acid resistance was not #abolished by deletion of ydep , ydeo , or yhie , but only reduced the level to 50-60% of the control level for acyl-coa primer and to 80% for alpha-keto-beta-methylvalerate primer .
however , acid resistance is not #abolished by the deletion of yhie , but only reduced the level to 50-60% of the control level for acyl-coa primer and to 80% for alpha-keto-beta-methylvalerate primer .
however , deletion of the distal tor box (box1) does not #abolish torc induction , but only reduced the level to 50-60% of the control level for acyl-coa primer and to 80% for alpha-keto-beta-methylvalerate primer .
however , deletion of the distal tor box (box1) will not #abolish torc induction , but only reduced the level to 50-60% of the control level for acyl-coa primer and to 80% for alpha-keto-beta-methylvalerate primer .
however , deletion of ydep , ydeo , or yhie did not #abolish this acid resistance , but only reduced the level to 50-60% of the control level for acyl-coa primer and to 80% for alpha-keto-beta-methylvalerate primer .
however , deletion of ydep , ydeo , or yhie is not #abolished by this acid resistance , but only reduced the level to 50-60% of the control level for acyl-coa primer and to 80% for alpha-keto-beta-methylvalerate primer .
however , disruption of rpos , mlra or csga , and the curli subunit gene did not #abolish ha and curli production by strain chi7122 , but only reduced the level to 50-60% of the control level for acyl-coa primer and to 80% for alpha-keto-beta-methylvalerate primer .
however , disruption of rpos , mlra or csga , and the curli subunit gene will not #abolish ha and curli production by strain chi7122 , but only reduced the level to 50-60% of the control level for acyl-coa primer and to 80% for alpha-keto-beta-methylvalerate primer .
however , the a/t-rich element is not #abolished by the mutations , but only reduced the level to 50-60% of the control level for acyl-coa primer and to 80% for alpha-keto-beta-methylvalerate primer .
however , the deletion of yhie will not #abolish acid resistance , but only reduced the level to 50-60% of the control level for acyl-coa primer and to 80% for alpha-keto-beta-methylvalerate primer .
however , the mutations will not #abolish the a/t-rich element , but only reduced the level to 50-60% of the control level for acyl-coa primer and to 80% for alpha-keto-beta-methylvalerate primer .
however , torc induction is not #abolished by deletion of the distal tor box (box1) , but only reduced the level to 50-60% of the control level for acyl-coa primer and to 80% for alpha-keto-beta-methylvalerate primer .
in addition , this acid resistance #abolished deletion of ydep , ydeo , or yhie whereas the presence of a dna fragment starting three bases upstream from box1 suffices for normal torc expression .
in addition , this acid resistance #abolishes deletion of ydep , ydeo , or yhie whereas the presence of a dna fragment starting three bases upstream from box1 suffices for normal torc expression .
in addition , this acid resistance can #abolish deletion of ydep , ydeo , or yhie whereas the presence of a dna fragment starting three bases upstream from box1 suffices for normal torc expression .
in addition , this acid resistance will #abolish deletion of ydep , ydeo , or yhie whereas the presence of a dna fragment starting three bases upstream from box1 suffices for normal torc expression .
in addition , deletion of ydep , ydeo , or yhie #abolishes this acid resistance whereas the presence of a dna fragment starting three bases upstream from box1 suffices for normal torc expression .
in addition , deletion of ydep , ydeo , or yhie can #abolish this acid resistance whereas the presence of a dna fragment starting three bases upstream from box1 suffices for normal torc expression .
in addition , deletion of ydep , ydeo , or yhie will #abolish this acid resistance whereas the presence of a dna fragment starting three bases upstream from box1 suffices for normal torc expression .
in addition , disruption of rpos , mlra or csga , and the curli subunit gene #abolished ha and curli production by strain chi7122 whereas the presence of a dna fragment starting three bases upstream from box1 suffices for normal torc expression .
in addition , disruption of rpos , mlra or csga , and the curli subunit gene can #abolish ha and curli production by strain chi7122 whereas the presence of a dna fragment starting three bases upstream from box1 suffices for normal torc expression .
in addition , disruption of rpos , mlra or csga , and the curli subunit gene has #abolished ha and curli production by strain chi7122 whereas the presence of a dna fragment starting three bases upstream from box1 suffices for normal torc expression .
in addition , disruption of rpos , mlra or csga , and the curli subunit gene is able to #abolish ha and curli production by strain chi7122 whereas the presence of a dna fragment starting three bases upstream from box1 suffices for normal torc expression .
in addition , disruption of rpos , mlra or csga , and the curli subunit gene will #abolish ha and curli production by strain chi7122 whereas the presence of a dna fragment starting three bases upstream from box1 suffices for normal torc expression .
in addition , the deletion of yhie #abolishes acid resistance whereas the presence of a dna fragment starting three bases upstream from box1 suffices for normal torc expression .
in addition , the deletion of yhie can #abolish acid resistance whereas the presence of a dna fragment starting three bases upstream from box1 suffices for normal torc expression .
in addition , the deletion of yhie has #abolished acid resistance whereas the presence of a dna fragment starting three bases upstream from box1 suffices for normal torc expression .
in addition , the deletion of yhie will #abolish acid resistance whereas the presence of a dna fragment starting three bases upstream from box1 suffices for normal torc expression .
in addition , the mutations #abolished the a/t-rich element whereas the presence of a dna fragment starting three bases upstream from box1 suffices for normal torc expression .
in addition , the mutations #abolishes the a/t-rich element whereas the presence of a dna fragment starting three bases upstream from box1 suffices for normal torc expression .
in addition , the mutations can #abolish the a/t-rich element whereas the presence of a dna fragment starting three bases upstream from box1 suffices for normal torc expression .
in addition , the mutations has #abolished the a/t-rich element whereas the presence of a dna fragment starting three bases upstream from box1 suffices for normal torc expression .
in addition , the mutations is able to #abolish the a/t-rich element whereas the presence of a dna fragment starting three bases upstream from box1 suffices for normal torc expression .
in addition , the mutations will #abolish the a/t-rich element whereas the presence of a dna fragment starting three bases upstream from box1 suffices for normal torc expression .
in contrast , ha and curli production by strain chi7122 is #abolished by disruption of rpos , mlra or csga , and the curli subunit gene , whereas internal deletion of the conserved octapeptide motif (op) or the partial homeodomain (hd) of pax5 did not have any effect (figure 3b) .
in contrast , this acid resistance #abolished deletion of ydep , ydeo , or yhie , whereas internal deletion of the conserved octapeptide motif (op) or the partial homeodomain (hd) of pax5 did not have any effect (figure 3b) .
in contrast , this acid resistance can #abolish deletion of ydep , ydeo , or yhie , whereas internal deletion of the conserved octapeptide motif (op) or the partial homeodomain (hd) of pax5 did not have any effect (figure 3b) .
in contrast , acid resistance was #abolished by the deletion of yhie , whereas internal deletion of the conserved octapeptide motif (op) or the partial homeodomain (hd) of pax5 did not have any effect (figure 3b) .
in contrast , deletion of the distal tor box (box1) #abolished torc induction , whereas internal deletion of the conserved octapeptide motif (op) or the partial homeodomain (hd) of pax5 did not have any effect (figure 3b) .
in contrast , deletion of the distal tor box (box1) #abolishes torc induction , whereas internal deletion of the conserved octapeptide motif (op) or the partial homeodomain (hd) of pax5 did not have any effect (figure 3b) .
in contrast , deletion of the distal tor box (box1) can #abolish torc induction , whereas internal deletion of the conserved octapeptide motif (op) or the partial homeodomain (hd) of pax5 did not have any effect (figure 3b) .
in contrast , deletion of ydep , ydeo , or yhie #abolishes this acid resistance , whereas internal deletion of the conserved octapeptide motif (op) or the partial homeodomain (hd) of pax5 did not have any effect (figure 3b) .
in contrast , deletion of ydep , ydeo , or yhie is #abolished by this acid resistance , whereas internal deletion of the conserved octapeptide motif (op) or the partial homeodomain (hd) of pax5 did not have any effect (figure 3b) .
in contrast , deletion of ydep , ydeo , or yhie was #abolished by this acid resistance , whereas internal deletion of the conserved octapeptide motif (op) or the partial homeodomain (hd) of pax5 did not have any effect (figure 3b) .
in contrast , disruption of rpos , mlra or csga , and the curli subunit gene #abolished ha and curli production by strain chi7122 , whereas internal deletion of the conserved octapeptide motif (op) or the partial homeodomain (hd) of pax5 did not have any effect (figure 3b) .
in contrast , its bcfa biosynthesis was #abolished by this complete removal of fabd from the crude fas , whereas internal deletion of the conserved octapeptide motif (op) or the partial homeodomain (hd) of pax5 did not have any effect (figure 3b) .
in contrast , the a/t-rich element is #abolished by the mutations , whereas internal deletion of the conserved octapeptide motif (op) or the partial homeodomain (hd) of pax5 did not have any effect (figure 3b) .
in contrast , the deletion of yhie #abolished acid resistance , whereas internal deletion of the conserved octapeptide motif (op) or the partial homeodomain (hd) of pax5 did not have any effect (figure 3b) .
in contrast , the deletion of yhie #abolishes acid resistance , whereas internal deletion of the conserved octapeptide motif (op) or the partial homeodomain (hd) of pax5 did not have any effect (figure 3b) .
in contrast , the deletion of yhie can #abolish acid resistance , whereas internal deletion of the conserved octapeptide motif (op) or the partial homeodomain (hd) of pax5 did not have any effect (figure 3b) .
in contrast , the mutations can #abolish the a/t-rich element , whereas internal deletion of the conserved octapeptide motif (op) or the partial homeodomain (hd) of pax5 did not have any effect (figure 3b) .
in contrast , torc induction is #abolished by deletion of the distal tor box (box1) , whereas internal deletion of the conserved octapeptide motif (op) or the partial homeodomain (hd) of pax5 did not have any effect (figure 3b) .
the a/t-rich mut sequence indicates deletion of the distal tor box (box1) can #abolish torc induction .
the a/t-rich mut sequence indicates deletion of the distal tor box (box1) introduced to #abolish torc induction .
the a/t-rich mut sequence indicates deletion of ydep , ydeo , or yhie can #abolish this acid resistance .
the a/t-rich mut sequence indicates deletion of ydep , ydeo , or yhie introduced to #abolish this acid resistance .
the a/t-rich mut sequence indicates disruption of rpos , mlra or csga , and the curli subunit gene can #abolish ha and curli production by strain chi7122 .
the a/t-rich mut sequence indicates that ha and curli production by strain chi7122 was #abolished by disruption of rpos , mlra or csga , and the curli subunit gene .
the a/t-rich mut sequence indicates that this acid resistance #abolished deletion of ydep , ydeo , or yhie .
the a/t-rich mut sequence indicates that this acid resistance was #abolished by deletion of ydep , ydeo , or yhie .
the a/t-rich mut sequence indicates that acid resistance is #abolished by the deletion of yhie .
the a/t-rich mut sequence indicates that deletion of the distal tor box (box1) #abolish torc induction .
the a/t-rich mut sequence indicates that deletion of ydep , ydeo , or yhie #abolish this acid resistance .
the a/t-rich mut sequence indicates that deletion of ydep , ydeo , or yhie is #abolished by this acid resistance .
the a/t-rich mut sequence indicates that disruption of rpos , mlra or csga , and the curli subunit gene #abolished ha and curli production by strain chi7122 .
the a/t-rich mut sequence indicates that its bcfa biosynthesis is #abolished by this complete removal of fabd from the crude fas .
the a/t-rich mut sequence indicates that the deletion of yhie #abolished acid resistance .
the a/t-rich mut sequence indicates that this complete removal of fabd from the crude fas #abolish its bcfa biosynthesis .
the a/t-rich mut sequence indicates that torc induction was #abolished by deletion of the distal tor box (box1) .
the a/t-rich mut sequence indicates the deletion of yhie introduced to #abolish acid resistance .
the deletion of ydep , ydeo , or yhie which was induced by evga overexpression #abolish this acid resistance .
the deletion of ydep , ydeo , or yhie which was induced by evga overexpression #abolished this acid resistance .
this acid resistance #abolishes deletion of ydep , ydeo , or yhie .
this acid resistance also #abolish deletion of ydep , ydeo , or yhie associated with formate hydrogenlyase activity .
this acid resistance also #abolished deletion of ydep , ydeo , or yhie associated with formate hydrogenlyase activity .
this acid resistance being able to #abolish deletion of ydep , ydeo , or yhie interrupt this open reading frame .
this acid resistance can #abolish deletion of ydep , ydeo , or yhie .
this acid resistance can be #abolished by deletion of ydep , ydeo , or yhie .
this acid resistance has also #abolished deletion of ydep , ydeo , or yhie associated with formate hydrogenlyase activity .
this acid resistance has been #abolished by deletion of ydep , ydeo , or yhie .
this acid resistance is #abolished by deletion of ydep , ydeo , or yhie which interrupt this open reading frame .
this acid resistance promoter completely #abolished deletion of ydep , ydeo , or yhie , indicating that this element is essential for mef2 gata-4 cooperation .
this acid resistance promoter completely #abolishes deletion of ydep , ydeo , or yhie , indicating that this element is essential for mef2 gata-4 cooperation .
this acid resistance was #abolished by deletion of ydep , ydeo , or yhie which interrupt this open reading frame .
this acid resistance were #abolished by deletion of ydep , ydeo , or yhie .
this acid resistance which #abolish deletion of ydep , ydeo , or yhie interrupt this open reading frame .
this acid resistance which has #abolished deletion of ydep , ydeo , or yhie interrupt this open reading frame .
this acid resistance will #abolish deletion of ydep , ydeo , or yhie .
this acid resistance will be #abolished by deletion of ydep , ydeo , or yhie .
acid resistance can be #abolished by the deletion of yhie .
acid resistance has been #abolished by the deletion of yhie , which was induced by evga overexpression .
acid resistance has been #abolished by the deletion of yhie .
acid resistance is #abolished by the deletion of yhie which interrupt this open reading frame .
acid resistance is #abolished by the deletion of yhie , which was induced by evga overexpression .
acid resistance was #abolished by the deletion of yhie which interrupt this open reading frame .
acid resistance will be #abolished by the deletion of yhie , which was induced by evga overexpression .
acid resistance will be #abolished by the deletion of yhie .
deletion of the distal tor box (box1) also #abolish torc induction associated with formate hydrogenlyase activity .
deletion of the distal tor box (box1) also #abolished torc induction associated with formate hydrogenlyase activity .
deletion of the distal tor box (box1) can #abolish torc induction .
deletion of the distal tor box (box1) can completely #abolishes torc induction , indicating that this element is essential for mef2 gata-4 cooperation .
deletion of the distal tor box (box1) promoter completely #abolishes torc induction , indicating that this element is essential for mef2 gata-4 cooperation .
deletion of the distal tor box (box1) which #abolish torc induction interrupt this open reading frame .
deletion of the distal tor box (box1) which has #abolished torc induction interrupt this open reading frame .
deletion of the distal tor box (box1) will #abolish torc induction .
deletion of ydep , ydeo , or yhie #abolished this acid resistance .
deletion of ydep , ydeo , or yhie #abolishes this acid resistance .
deletion of ydep , ydeo , or yhie also #abolish this acid resistance associated with formate hydrogenlyase activity .
deletion of ydep , ydeo , or yhie are #abolished by this acid resistance .
deletion of ydep , ydeo , or yhie can #abolish this acid resistance .
deletion of ydep , ydeo , or yhie can completely #abolishes this acid resistance , indicating that this element is essential for mef2 gata-4 cooperation .
deletion of ydep , ydeo , or yhie has also #abolished this acid resistance associated with formate hydrogenlyase activity .
deletion of ydep , ydeo , or yhie has been #abolished by this acid resistance , which was induced by evga overexpression .
deletion of ydep , ydeo , or yhie is #abolished by this acid resistance which interrupt this open reading frame .
deletion of ydep , ydeo , or yhie is #abolished by this acid resistance , which was induced by evga overexpression .
deletion of ydep , ydeo , or yhie promoter completely #abolished this acid resistance , indicating that this element is essential for mef2 gata-4 cooperation .
deletion of ydep , ydeo , or yhie was #abolished by this acid resistance which interrupt this open reading frame .
deletion of ydep , ydeo , or yhie were #abolished by this acid resistance .
deletion of ydep , ydeo , or yhie which #abolish this acid resistance interrupt this open reading frame .
deletion of ydep , ydeo , or yhie will also #abolish this acid resistance associated with formate hydrogenlyase activity .
deletion of ydep , ydeo , or yhie will be #abolished by this acid resistance , which was induced by evga overexpression .
disruption of rpos , mlra or csga , and the curli subunit gene #abolished ha and curli production by strain chi7122 .
disruption of rpos , mlra or csga , and the curli subunit gene also #abolished ha and curli production by strain chi7122 associated with formate hydrogenlyase activity .
disruption of rpos , mlra or csga , and the curli subunit gene being able to #abolish ha and curli production by strain chi7122 interrupt this open reading frame .
disruption of rpos , mlra or csga , and the curli subunit gene can completely #abolishes ha and curli production by strain chi7122 , indicating that this element is essential for mef2 gata-4 cooperation .
disruption of rpos , mlra or csga , and the curli subunit gene has also #abolished ha and curli production by strain chi7122 associated with formate hydrogenlyase activity .
disruption of rpos , mlra or csga , and the curli subunit gene was #abolished by ha and curli production by strain chi7122 , which was induced by evga overexpression .
disruption of rpos , mlra or csga , and the curli subunit gene which #abolish ha and curli production by strain chi7122 interrupt this open reading frame .
disruption of rpos , mlra or csga , and the curli subunit gene which #abolished ha and curli production by strain chi7122 interrupt this open reading frame .
disruption of rpos , mlra or csga , and the curli subunit gene will #abolish ha and curli production by strain chi7122 .
disruption of rpos , mlra or csga , and the curli subunit gene will also #abolish ha and curli production by strain chi7122 associated with formate hydrogenlyase activity .
its bcfa biosynthesis can be #abolished by this complete removal of fabd from the crude fas .
its bcfa biosynthesis has been #abolished by this complete removal of fabd from the crude fas , which was induced by evga overexpression .
its bcfa biosynthesis was #abolished by this complete removal of fabd from the crude fas which interrupt this open reading frame .
its bcfa biosynthesis were #abolished by this complete removal of fabd from the crude fas .
its bcfa biosynthesis will be #abolished by this complete removal of fabd from the crude fas , which was induced by evga overexpression .
its bcfa biosynthesis will be #abolished by this complete removal of fabd from the crude fas .
the a/t-rich element are #abolished by the mutations .
the a/t-rich element has been #abolished by the mutations , which was induced by evga overexpression .
the a/t-rich element is #abolished by the mutations which interrupt this open reading frame .
the a/t-rich element was #abolished by the mutations which interrupt this open reading frame .
the a/t-rich element were #abolished by the mutations .
the deletion of yhie #abolished acid resistance .
the deletion of yhie being able to #abolish acid resistance interrupt this open reading frame .
the deletion of yhie can #abolish acid resistance .
the deletion of yhie can completely #abolishes acid resistance , indicating that this element is essential for mef2 gata-4 cooperation .
the deletion of yhie which #abolish acid resistance interrupt this open reading frame .
the deletion of yhie which has #abolished acid resistance interrupt this open reading frame .
the deletion of yhie will #abolish acid resistance .
the mutations #abolishes the a/t-rich element .
the mutations also #abolish the a/t-rich element associated with formate hydrogenlyase activity .
the mutations being able to #abolish the a/t-rich element interrupt this open reading frame .
the mutations has also #abolished the a/t-rich element associated with formate hydrogenlyase activity .
the mutations which #abolish the a/t-rich element interrupt this open reading frame .
the mutations which has #abolished the a/t-rich element interrupt this open reading frame .
the mutations will #abolish the a/t-rich element .
the mutations will also #abolish the a/t-rich element associated with formate hydrogenlyase activity .
this complete removal of fabd from the crude fas #abolished its bcfa biosynthesis .
this complete removal of fabd from the crude fas also #abolished its bcfa biosynthesis associated with formate hydrogenlyase activity .
this complete removal of fabd from the crude fas being able to #abolish its bcfa biosynthesis interrupt this open reading frame .
this complete removal of fabd from the crude fas can #abolish its bcfa biosynthesis .
this complete removal of fabd from the crude fas has also #abolished its bcfa biosynthesis associated with formate hydrogenlyase activity .
this complete removal of fabd from the crude fas promoter completely #abolished its bcfa biosynthesis , indicating that this element is essential for mef2 gata-4 cooperation .
this complete removal of fabd from the crude fas which #abolish its bcfa biosynthesis interrupt this open reading frame .
this complete removal of fabd from the crude fas which #abolished its bcfa biosynthesis interrupt this open reading frame .
this complete removal of fabd from the crude fas which has #abolished its bcfa biosynthesis interrupt this open reading frame .
torc induction are #abolished by deletion of the distal tor box (box1) .
torc induction has been #abolished by deletion of the distal tor box (box1) .
torc induction is #abolished by deletion of the distal tor box (box1) , which was induced by evga overexpression .
torc induction were #abolished by deletion of the distal tor box (box1) .
furthermore , this intronic mutation completely #abolished normal lhx4 splicing in stationary-phase cells , suggesting that yhie plays a critical role in stationary-phase acid resistance .
furthermore , this intronic mutation completely #abolishes normal lhx4 splicing in stationary-phase cells , suggesting that yhie plays a critical role in stationary-phase acid resistance .
furthermore , this intronic mutation has completely #abolished normal lhx4 splicing in stationary-phase cells , suggesting that yhie plays a critical role in stationary-phase acid resistance .
furthermore , this intronic mutation will completely #abolish normal lhx4 splicing in stationary-phase cells , suggesting that yhie plays a critical role in stationary-phase acid resistance .
furthermore , a g-to-a transition at the first nucleotide of intron 2 completely #abolished normal splicing in stationary-phase cells , suggesting that yhie plays a critical role in stationary-phase acid resistance .
furthermore , a g-to-a transition at the first nucleotide of intron 2 has completely #abolished normal splicing in stationary-phase cells , suggesting that yhie plays a critical role in stationary-phase acid resistance .
furthermore , co-administered dm completely #abolished the cpp effect in stationary-phase cells , suggesting that yhie plays a critical role in stationary-phase acid resistance .
furthermore , co-administered dm has completely #abolished the cpp effect in stationary-phase cells , suggesting that yhie plays a critical role in stationary-phase acid resistance .
furthermore , co-administered dm will completely #abolish the cpp effect in stationary-phase cells , suggesting that yhie plays a critical role in stationary-phase acid resistance .
furthermore , normal lhx4 splicing in stationary-phase cells has been completely #abolished by this intronic mutation , suggesting that yhie plays a critical role in stationary-phase acid resistance .
furthermore , normal splicing in stationary-phase cells has been completely #abolished by a g-to-a transition at the first nucleotide of intron 2 , suggesting that yhie plays a critical role in stationary-phase acid resistance .
furthermore , normal splicing in stationary-phase cells is completely #abolished by a g-to-a transition at the first nucleotide of intron 2 , suggesting that yhie plays a critical role in stationary-phase acid resistance .
furthermore , the cpp effect in stationary-phase cells has been completely #abolished by co-administered dm , suggesting that yhie plays a critical role in stationary-phase acid resistance .
furthermore , the cpp effect in stationary-phase cells is completely #abolished by co-administered dm , suggesting that yhie plays a critical role in stationary-phase acid resistance .
however , this intronic mutation did not #abolish normal lhx4 splicing , but only reduced the level to 50-60% of the control level for acyl-coa primer and to 80% for alpha-keto-beta-methylvalerate primer .
however , this intronic mutation will not #abolish normal lhx4 splicing , but only reduced the level to 50-60% of the control level for acyl-coa primer and to 80% for alpha-keto-beta-methylvalerate primer .
however , a g-to-a transition at the first nucleotide of intron 2 does not #abolish normal splicing , but only reduced the level to 50-60% of the control level for acyl-coa primer and to 80% for alpha-keto-beta-methylvalerate primer .
however , co-administered dm does not #abolish the cpp effect , but only reduced the level to 50-60% of the control level for acyl-coa primer and to 80% for alpha-keto-beta-methylvalerate primer .
however , normal lhx4 splicing is not #abolished by this intronic mutation , but only reduced the level to 50-60% of the control level for acyl-coa primer and to 80% for alpha-keto-beta-methylvalerate primer .
however , normal lhx4 splicing was not #abolished by this intronic mutation , but only reduced the level to 50-60% of the control level for acyl-coa primer and to 80% for alpha-keto-beta-methylvalerate primer .
however , normal splicing is not #abolished by a g-to-a transition at the first nucleotide of intron 2 , but only reduced the level to 50-60% of the control level for acyl-coa primer and to 80% for alpha-keto-beta-methylvalerate primer .
however , the cpp effect is not #abolished by co-administered dm , but only reduced the level to 50-60% of the control level for acyl-coa primer and to 80% for alpha-keto-beta-methylvalerate primer .
in addition , this intronic mutation #abolished normal lhx4 splicing whereas the presence of a dna fragment starting three bases upstream from box1 suffices for normal torc expression .
in addition , this intronic mutation can #abolish normal lhx4 splicing whereas the presence of a dna fragment starting three bases upstream from box1 suffices for normal torc expression .
in addition , this intronic mutation is able to #abolish normal lhx4 splicing whereas the presence of a dna fragment starting three bases upstream from box1 suffices for normal torc expression .
in addition , this intronic mutation will #abolish normal lhx4 splicing whereas the presence of a dna fragment starting three bases upstream from box1 suffices for normal torc expression .
in addition , a g-to-a transition at the first nucleotide of intron 2 #abolished normal splicing whereas the presence of a dna fragment starting three bases upstream from box1 suffices for normal torc expression .
in addition , a g-to-a transition at the first nucleotide of intron 2 #abolishes normal splicing whereas the presence of a dna fragment starting three bases upstream from box1 suffices for normal torc expression .
in addition , co-administered dm can #abolish the cpp effect whereas the presence of a dna fragment starting three bases upstream from box1 suffices for normal torc expression .
in addition , co-administered dm has #abolished the cpp effect whereas the presence of a dna fragment starting three bases upstream from box1 suffices for normal torc expression .
in contrast , this intronic mutation #abolishes normal lhx4 splicing , whereas internal deletion of the conserved octapeptide motif (op) or the partial homeodomain (hd) of pax5 did not have any effect (figure 3b) .
in contrast , this intronic mutation can #abolish normal lhx4 splicing , whereas internal deletion of the conserved octapeptide motif (op) or the partial homeodomain (hd) of pax5 did not have any effect (figure 3b) .
in contrast , a g-to-a transition at the first nucleotide of intron 2 #abolished normal splicing , whereas internal deletion of the conserved octapeptide motif (op) or the partial homeodomain (hd) of pax5 did not have any effect (figure 3b) .
in contrast , a g-to-a transition at the first nucleotide of intron 2 #abolishes normal splicing , whereas internal deletion of the conserved octapeptide motif (op) or the partial homeodomain (hd) of pax5 did not have any effect (figure 3b) .
in contrast , co-administered dm #abolished the cpp effect , whereas internal deletion of the conserved octapeptide motif (op) or the partial homeodomain (hd) of pax5 did not have any effect (figure 3b) .
in contrast , co-administered dm can #abolish the cpp effect , whereas internal deletion of the conserved octapeptide motif (op) or the partial homeodomain (hd) of pax5 did not have any effect (figure 3b) .
in contrast , normal lhx4 splicing is #abolished by this intronic mutation , whereas internal deletion of the conserved octapeptide motif (op) or the partial homeodomain (hd) of pax5 did not have any effect (figure 3b) .
in contrast , normal lhx4 splicing was #abolished by this intronic mutation , whereas internal deletion of the conserved octapeptide motif (op) or the partial homeodomain (hd) of pax5 did not have any effect (figure 3b) .
in contrast , normal splicing is #abolished by a g-to-a transition at the first nucleotide of intron 2 , whereas internal deletion of the conserved octapeptide motif (op) or the partial homeodomain (hd) of pax5 did not have any effect (figure 3b) .
in contrast , normal splicing was #abolished by a g-to-a transition at the first nucleotide of intron 2 , whereas internal deletion of the conserved octapeptide motif (op) or the partial homeodomain (hd) of pax5 did not have any effect (figure 3b) .
in contrast , the cpp effect is #abolished by co-administered dm , whereas internal deletion of the conserved octapeptide motif (op) or the partial homeodomain (hd) of pax5 did not have any effect (figure 3b) .
the a/t-rich mut sequence indicates this intronic mutation can #abolish normal lhx4 splicing .
the a/t-rich mut sequence indicates this intronic mutation introduced to #abolish normal lhx4 splicing .
the a/t-rich mut sequence indicates a g-to-a transition at the first nucleotide of intron 2 can #abolish normal splicing .
the a/t-rich mut sequence indicates a g-to-a transition at the first nucleotide of intron 2 introduced to #abolish normal splicing .
the a/t-rich mut sequence indicates co-administered dm can #abolish the cpp effect .
the a/t-rich mut sequence indicates that a g-to-a transition at the first nucleotide of intron 2 #abolish normal splicing .
the a/t-rich mut sequence indicates that co-administered dm #abolished the cpp effect .
the a/t-rich mut sequence indicates that normal lhx4 splicing was #abolished by this intronic mutation .
the a/t-rich mut sequence indicates that normal splicing is #abolished by a g-to-a transition at the first nucleotide of intron 2 .
the a/t-rich mut sequence indicates that normal splicing was #abolished by a g-to-a transition at the first nucleotide of intron 2 .
the a/t-rich mut sequence indicates that the cpp effect is #abolished by co-administered dm .
the a/t-rich mut sequence indicates that the cpp effect was #abolished by co-administered dm .
this intronic mutation also #abolish normal lhx4 splicing associated with formate hydrogenlyase activity .
this intronic mutation also #abolished normal lhx4 splicing associated with formate hydrogenlyase activity .
this intronic mutation being able to #abolish normal lhx4 splicing interrupt this open reading frame .
this intronic mutation can completely #abolishes normal lhx4 splicing , indicating that this element is essential for mef2 gata-4 cooperation .
this intronic mutation promoter completely #abolishes normal lhx4 splicing , indicating that this element is essential for mef2 gata-4 cooperation .
this intronic mutation which #abolished normal lhx4 splicing interrupt this open reading frame .
this intronic mutation will #abolish normal lhx4 splicing .
a g-to-a transition at the first nucleotide of intron 2 also #abolished normal splicing associated with formate hydrogenlyase activity .
a g-to-a transition at the first nucleotide of intron 2 can #abolish normal splicing .
a g-to-a transition at the first nucleotide of intron 2 was #abolished by normal splicing , which was induced by evga overexpression .
a g-to-a transition at the first nucleotide of intron 2 which #abolish normal splicing interrupt this open reading frame .
a g-to-a transition at the first nucleotide of intron 2 will #abolish normal splicing .
co-administered dm #abolished the cpp effect .
co-administered dm being able to #abolish the cpp effect interrupt this open reading frame .
co-administered dm can #abolish the cpp effect .
co-administered dm can completely #abolishes the cpp effect , indicating that this element is essential for mef2 gata-4 cooperation .
co-administered dm has also #abolished the cpp effect associated with formate hydrogenlyase activity .
co-administered dm which #abolish the cpp effect interrupt this open reading frame .
co-administered dm which #abolished the cpp effect interrupt this open reading frame .
co-administered dm which has #abolished the cpp effect interrupt this open reading frame .
co-administered dm will #abolish the cpp effect .
co-administered dm will also #abolish the cpp effect associated with formate hydrogenlyase activity .
normal lhx4 splicing are #abolished by this intronic mutation .
normal lhx4 splicing can be #abolished by this intronic mutation .
normal lhx4 splicing has been #abolished by this intronic mutation .
normal lhx4 splicing is #abolished by this intronic mutation which interrupt this open reading frame .
normal lhx4 splicing is #abolished by this intronic mutation , which was induced by evga overexpression .
normal lhx4 splicing were #abolished by this intronic mutation .
normal splicing are #abolished by a g-to-a transition at the first nucleotide of intron 2 .
normal splicing can be #abolished by a g-to-a transition at the first nucleotide of intron 2 .
normal splicing has been #abolished by a g-to-a transition at the first nucleotide of intron 2 , which was induced by evga overexpression .
normal splicing was #abolished by a g-to-a transition at the first nucleotide of intron 2 which interrupt this open reading frame .
normal splicing were #abolished by a g-to-a transition at the first nucleotide of intron 2 .
the cpp effect can be #abolished by co-administered dm .
the cpp effect is #abolished by co-administered dm which interrupt this open reading frame .
the cpp effect is #abolished by co-administered dm , which was induced by evga overexpression .
the cpp effect was #abolished by co-administered dm , which was induced by evga overexpression .
the cpp effect will be #abolished by co-administered dm , which was induced by evga overexpression .
the cpp effect will be #abolished by co-administered dm .
cytokines #altered the expression and activity of the multidrug resistance transporters in human hepatoma cell lines; analysis using rt-pcr and cdna microarrays .
cytokines can #alter the expression and activity of the multidrug resistance transporters in human hepatoma cell lines; analysis using rt-pcr and cdna microarrays .
it is believed that the molecular lesion associated with s1031 is able to #alter splicing , we looked at the sos-1 mrna produced in this mutant .
it is predicted that the molecular lesion associated with s1031 can #alter splicing , we looked at the sos-1 mrna produced in this mutant .
moreover , dam methylation inhibited binding of lrp/papi near the gatc1028 site and could #alter binding of lrp at the gatc1130 site .
moreover , dam methylation inhibits binding of lrp/papi near the gatc1028 site and can #alter binding of lrp at the gatc1130 site .
moreover , dam methylation inhibits binding of lrp/papi near the gatc1028 site and may #alter binding of lrp at the gatc1130 site .
moreover , a frur null mutation can #alter the rates of utilization of at least 36 carbon sources .
moreover , a frur null mutation could #alter the rates of utilization of at least 36 carbon sources .
moreover , a frur null mutation is able to #alter the rates of utilization of at least 36 carbon sources .
moreover , a frur null mutation may be able to #alter the rates of utilization of at least 36 carbon sources .
moreover , a frur null mutation will #alter the rates of utilization of at least 36 carbon sources .
phosphorylation of pdk1 cannot be #altered by treating the cells with insulin-like growth factor-i and four of the sites could be mutated without loss of activity .
since s1031 is a null allele , we are testing whether vulval induction can be #altered by this mutation .
since s1031 is a null allele , we are testing whether vulval induction is able to be #altered by this mutation .
since s1031 is a null allele , we are testing whether vulval induction may be #altered by this mutation .
since s1031 is a null allele , we tested whether this mutation could #alter vulval induction .
since s1031 is a null allele , we tested whether this mutation has #altered vulval induction .
since s1031 is a null allele , we tested whether this mutation was able to #alter vulval induction .
since s1031 is a null allele , we tested whether vulval induction was #altered by this mutation .
since these two bends are in opposing directions , the overall direction of the dna is not able to be #altered by them(figure 3c) .
since these two bends are in opposing directions , the overall direction of the dna will not be #altered by them(figure 3c) .
since these two bends are in opposing directions , they may not #alter the overall direction of the dna(figure 3c) .
since these two bends were in opposing directions , the overall direction of the dna could not be #altered by them(figure 3c) .
since these two bends were in opposing directions , the overall direction of the dna was not able to be #altered by them(figure 3c) .
since these two bends were in opposing directions , the overall direction of the dna was not #altered by them(figure 3c) .
since these two bends were in opposing directions , they could not #alter the overall direction of the dna(figure 3c) .
since these two bends were in opposing directions , they did not #alter the overall direction of the dna(figure 3c) .
splicing can be #altered by the molecular lesion associated with s1031 , we looked at the sos-1 mrna produced in this mutant .
splicing is able to be #altered by the molecular lesion associated with s1031 , we looked at the sos-1 mrna produced in this mutant .
splicing is predicted to be #altered by the molecular lesion associated with s1031 , we looked at the sos-1 mrna produced in this mutant .
splicing may be #altered by the molecular lesion associated with s1031 , we looked at the sos-1 mrna produced in this mutant .
the codon (ctc) normally associated with leu-93 in the transcortin polypeptide can be #altered by the mutation located within exon 2 to a codon (cac) for histidine in the variant genes .
the codon (ctc) normally associated with leu-93 in the transcortin polypeptide is able to be #altered by the mutation located within exon 2 to a codon (cac) for histidine in the variant genes .
the codon (ctc) normally associated with leu-93 in the transcortin polypeptide is #altered by the mutation located within exon 2 to a codon (cac) for histidine in the variant genes .
the codon (ctc) normally associated with leu-93 in the transcortin polypeptide will be #altered by the mutation located within exon 2 to a codon (cac) for histidine in the variant genes .
the expression and activity of the multidrug resistance transporters could be #altered by cytokines in human hepatoma cell lines; analysis using rt-pcr and cdna microarrays .
the expression and activity of the multidrug resistance transporters is able to be #altered by cytokines in human hepatoma cell lines; analysis using rt-pcr and cdna microarrays .
the expression and activity of the multidrug resistance transporters may be #altered by cytokines in human hepatoma cell lines; analysis using rt-pcr and cdna microarrays .
the expression and activity of the multidrug resistance transporters was #altered by cytokines in human hepatoma cell lines; analysis using rt-pcr and cdna microarrays .
the expression and activity of the multidrug resistance transporters will be #altered by cytokines in human hepatoma cell lines; analysis using rt-pcr and cdna microarrays .
the molecular lesion associated with s1031 is predicted to #alter splicing , we looked at the sos-1 mrna produced in this mutant .
the results provide insight into a mechanism which #alters expression of bcl-3 and leads to tumorigenic potential .
the results provide insight into a mechanism which can #alter expression of bcl-3 and may lead to tumorigenic potential .
this mutation , which #alters the codon (ctc) normally associated with leu-93 in the transcortin polypeptide to a codon (cac) for histidine in the variant genes , is located within exon 2 .
treating the cells with insulin-like growth factor-i cannot #alter phosphorylation of pdk1 and four of the sites could be mutated without loss of activity .
treating the cells with insulin-like growth factor-i does not #alter phosphorylation of pdk1 and four of the sites could be mutated without loss of activity .
treating the cells with insulin-like growth factor-i may not #alter phosphorylation of pdk1 and four of the sites could be mutated without loss of activity .
as the molecular lesion associated with s1031 is predicted to #alter splicing , we looked at the sos-1 mrna produced in this mutant .
moreover , a frur null mutation #altered the rates of utilization of at least 36 carbon sources .
the results provide insight into a mechanism whereby #altered expression of bcl-3 leads to tumorigenic potential .
cytokines #alter the expression and activity of the multidrug resistance transporters in human hepatoma cell lines; analysis using rt-pcr and cdna microarrays .
hence , glu13 indirectly affects dna-binding specificity because the overall direction of the dna are able to be #altered by these two bends .
hence , glu13 indirectly affects dna-binding specificity because the overall direction of the dna can be #altered by these two bends .
hence , glu13 indirectly affects dna-binding specificity because the overall direction of the dna is #altered by these two bends .
hence , glu13 indirectly affects dna-binding specificity because the rates of utilization of at least 36 carbon sources are able to be #altered by a frur null mutation .
hence , glu13 indirectly affects dna-binding specificity because the rates of utilization of at least 36 carbon sources can be #altered by a frur null mutation .
hence , glu13 indirectly affects dna-binding specificity because the rates of utilization of at least 36 carbon sources could be #altered by a frur null mutation .
hence , glu13 indirectly affects dna-binding specificity because the rates of utilization of at least 36 carbon sources may be #altered by a frur null mutation .
hence , glu13 indirectly affects dna-binding specificity because the rates of utilization of at least 36 carbon sources was #altered by a frur null mutation .
hence , glu13 indirectly affects dna-binding specificity because vulval induction are able to be #altered by this mutation .
hence , glu13 indirectly affects dna-binding specificity because vulval induction could be #altered by this mutation .
hence , glu13 indirectly affects dna-binding specificity because vulval induction is #altered by this mutation .
hence , glu13 indirectly affects dna-binding specificity probably because a frur null mutation may be able to subtly #alter the rates of utilization of at least 36 carbon sources .
hence , glu13 indirectly affects dna-binding specificity probably because a frur null mutation may subtly #alter the rates of utilization of at least 36 carbon sources .
hence , glu13 indirectly affects dna-binding specificity probably because these two bends can subtly #alter the overall direction of the dna .
hence , glu13 indirectly affects dna-binding specificity probably because these two bends is able to subtly #alter the overall direction of the dna .
hence , glu13 indirectly affects dna-binding specificity probably because these two bends subtly #altered the overall direction of the dna .
hence , glu13 indirectly affects dna-binding specificity probably because these two bends subtly #alters the overall direction of the dna .
hence , glu13 indirectly affects dna-binding specificity probably because this mutation can subtly #alter vulval induction .
hence , glu13 indirectly affects dna-binding specificity probably because this mutation is able to subtly #alter vulval induction .
hence , glu13 indirectly affects dna-binding specificity probably because this mutation may be able to subtly #alter vulval induction .
hence , glu13 indirectly affects dna-binding specificity probably because this mutation may subtly #alter vulval induction .
hence , glu13 indirectly affects dna-binding specificity probably because this mutation subtly #altered vulval induction .
hence , glu13 indirectly affects dna-binding specificity probably because this mutation subtly #alters vulval induction .
hence , glu13 indirectly affects dna-binding specificity probably due to a frur null mutation , which can subtly #alter the rates of utilization of at least 36 carbon sources .
hence , glu13 indirectly affects dna-binding specificity probably due to these two bends , which can subtly #alter the overall direction of the dna .
hence , glu13 indirectly affects dna-binding specificity probably due to these two bends , which may be able to subtly #alter the overall direction of the dna .
hence , glu13 indirectly affects dna-binding specificity probably due to these two bends , which subtly #altered the overall direction of the dna .
hence , glu13 indirectly affects dna-binding specificity probably due to these two bends , which was able to subtly #alter the overall direction of the dna .
hence , glu13 indirectly affects dna-binding specificity probably due to this mutation , which may subtly #alter vulval induction .
hence , glu13 indirectly affects dna-binding specificity , probably due to these two bends , which subtly #alters the the overall direction of the dna .
hence , glu13 indirectly affects dna-binding specificity , probably due to this mutation , which subtly #alters the vulval induction .
moreover , these two bends #altered the overall direction of the dna .
moreover , these two bends could #alter the overall direction of the dna .
moreover , these two bends may be able to #alter the overall direction of the dna .
moreover , these two bends will #alter the overall direction of the dna .
moreover , this mutation #altered vulval induction .
moreover , this mutation #alters vulval induction .
moreover , this mutation has #altered vulval induction .
moreover , this mutation may #alter vulval induction .
moreover , this mutation may be able to #alter vulval induction .
since a frur null mutation are in opposing directions , the rates of utilization of at least 36 carbon sources cannot be #altered by them(figure 3c) .
since a frur null mutation are in opposing directions , the rates of utilization of at least 36 carbon sources is not able to be #altered by them(figure 3c) .
since a frur null mutation are in opposing directions , the rates of utilization of at least 36 carbon sources is not #altered by them(figure 3c) .
since a frur null mutation are in opposing directions , they are not able to #alter the rates of utilization of at least 36 carbon sources(figure 3c) .
since a frur null mutation are in opposing directions , they cannot #alter the rates of utilization of at least 36 carbon sources(figure 3c) .
since a frur null mutation were in opposing directions , the rates of utilization of at least 36 carbon sources could not be #altered by them(figure 3c) .
since a frur null mutation were in opposing directions , the rates of utilization of at least 36 carbon sources was not #altered by them(figure 3c) .
since a frur null mutation were in opposing directions , they did not #alter the rates of utilization of at least 36 carbon sources(figure 3c) .
since s1031 is a null allele , we are testing whether a frur null mutation can #alter the rates of utilization of at least 36 carbon sources .
since s1031 is a null allele , we are testing whether a frur null mutation may #alter the rates of utilization of at least 36 carbon sources .
since s1031 is a null allele , we are testing whether a frur null mutation will #alter the rates of utilization of at least 36 carbon sources .
since s1031 is a null allele , we are testing whether the overall direction of the dna is #altered by these two bends .
since s1031 is a null allele , we are testing whether the rates of utilization of at least 36 carbon sources may be #altered by a frur null mutation .
since s1031 is a null allele , we are testing whether these two bends can #alter the overall direction of the dna .
since s1031 is a null allele , we are testing whether these two bends is able to #alter the overall direction of the dna .
since s1031 is a null allele , we are testing whether these two bends will #alter the overall direction of the dna .
since s1031 is a null allele , we tested whether a frur null mutation #altered the rates of utilization of at least 36 carbon sources .
since s1031 is a null allele , we tested whether a frur null mutation #alters the rates of utilization of at least 36 carbon sources .
since s1031 is a null allele , we tested whether a frur null mutation might #alter the rates of utilization of at least 36 carbon sources .
since s1031 is a null allele , we tested whether a frur null mutation was able to #alter the rates of utilization of at least 36 carbon sources .
since s1031 is a null allele , we tested whether the overall direction of the dna might be #altered by these two bends .
since s1031 is a null allele , we tested whether the overall direction of the dna was #altered by these two bends .
since s1031 is a null allele , we tested whether the rates of utilization of at least 36 carbon sources might be #altered by a frur null mutation .
since s1031 is a null allele , we tested whether the rates of utilization of at least 36 carbon sources was #altered by a frur null mutation .
since s1031 is a null allele , we tested whether these two bends #alters the overall direction of the dna .
since this mutation are in opposing directions , they are not able to #alter vulval induction(figure 3c) .
since this mutation are in opposing directions , they may not #alter vulval induction(figure 3c) .
since this mutation are in opposing directions , vulval induction cannot be #altered by them(figure 3c) .
since this mutation are in opposing directions , vulval induction will not be #altered by them(figure 3c) .
since this mutation were in opposing directions , they did not #alter vulval induction(figure 3c) .
since this mutation were in opposing directions , vulval induction could not be #altered by them(figure 3c) .
since this mutation were in opposing directions , vulval induction was not #altered by them(figure 3c) .
hence , glu13 indirectly affects dna-binding specificity because phosphorylation of pdk1 can be #altered by treating the cells with insulin-like growth factor-i .
hence , glu13 indirectly affects dna-binding specificity because phosphorylation of pdk1 could be #altered by treating the cells with insulin-like growth factor-i .
hence , glu13 indirectly affects dna-binding specificity because binding of lrp at the gatc1130 site are able to be #altered by dam methylation .
hence , glu13 indirectly affects dna-binding specificity because binding of lrp at the gatc1130 site could be #altered by dam methylation .
hence , glu13 indirectly affects dna-binding specificity because binding of lrp at the gatc1130 site is #altered by dam methylation .
hence , glu13 indirectly affects dna-binding specificity because binding of lrp at the gatc1130 site was #altered by dam methylation .
hence , glu13 indirectly affects dna-binding specificity because expression of bcl-3 can be #altered by a mechanism .
hence , glu13 indirectly affects dna-binding specificity because expression of bcl-3 could be #altered by a mechanism .
hence , glu13 indirectly affects dna-binding specificity because expression of bcl-3 may be #altered by a mechanism .
hence , glu13 indirectly affects dna-binding specificity because expression of bcl-3 was #altered by a mechanism .
hence , glu13 indirectly affects dna-binding specificity because splicing are able to be #altered by the molecular lesion associated with s1031 .
hence , glu13 indirectly affects dna-binding specificity because splicing can be #altered by the molecular lesion associated with s1031 .
hence , glu13 indirectly affects dna-binding specificity because splicing could be #altered by the molecular lesion associated with s1031 .
hence , glu13 indirectly affects dna-binding specificity probably because dam methylation is able to subtly #alter binding of lrp at the gatc1130 site .
hence , glu13 indirectly affects dna-binding specificity probably because dam methylation subtly #alters binding of lrp at the gatc1130 site .
hence , glu13 indirectly affects dna-binding specificity probably because a mechanism can subtly #alter expression of bcl-3 .
hence , glu13 indirectly affects dna-binding specificity probably because a mechanism may be able to subtly #alter expression of bcl-3 .
hence , glu13 indirectly affects dna-binding specificity probably because a mechanism may subtly #alter expression of bcl-3 .
hence , glu13 indirectly affects dna-binding specificity probably because a mechanism subtly #altered expression of bcl-3 .
hence , glu13 indirectly affects dna-binding specificity probably because a mechanism subtly #alters expression of bcl-3 .
hence , glu13 indirectly affects dna-binding specificity probably because the molecular lesion associated with s1031 can subtly #alter splicing .
hence , glu13 indirectly affects dna-binding specificity probably because the molecular lesion associated with s1031 is able to subtly #alter splicing .
hence , glu13 indirectly affects dna-binding specificity probably because the molecular lesion associated with s1031 subtly #altered splicing .
hence , glu13 indirectly affects dna-binding specificity probably because the molecular lesion associated with s1031 subtly #alters splicing .
hence , glu13 indirectly affects dna-binding specificity probably because treating the cells with insulin-like growth factor-i is able to subtly #alter phosphorylation of pdk1 .
hence , glu13 indirectly affects dna-binding specificity probably because treating the cells with insulin-like growth factor-i may be able to subtly #alter phosphorylation of pdk1 .
hence , glu13 indirectly affects dna-binding specificity probably because treating the cells with insulin-like growth factor-i may subtly #alter phosphorylation of pdk1 .
hence , glu13 indirectly affects dna-binding specificity probably because treating the cells with insulin-like growth factor-i subtly #altered phosphorylation of pdk1 .
hence , glu13 indirectly affects dna-binding specificity probably due to dam methylation , which can subtly #alter binding of lrp at the gatc1130 site .
hence , glu13 indirectly affects dna-binding specificity probably due to dam methylation , which is able to subtly #alter binding of lrp at the gatc1130 site .
hence , glu13 indirectly affects dna-binding specificity probably due to dam methylation , which may be able to subtly #alter binding of lrp at the gatc1130 site .
hence , glu13 indirectly affects dna-binding specificity probably due to dam methylation , which subtly #altered binding of lrp at the gatc1130 site .
hence , glu13 indirectly affects dna-binding specificity probably due to dam methylation , which was able to subtly #alter binding of lrp at the gatc1130 site .
hence , glu13 indirectly affects dna-binding specificity probably due to a mechanism , which may subtly #alter expression of bcl-3 .
hence , glu13 indirectly affects dna-binding specificity probably due to a mechanism , which subtly #altered expression of bcl-3 .
hence , glu13 indirectly affects dna-binding specificity probably due to a mechanism , which was able to subtly #alter expression of bcl-3 .
hence , glu13 indirectly affects dna-binding specificity probably due to the molecular lesion associated with s1031 , which can subtly #alter splicing .
hence , glu13 indirectly affects dna-binding specificity probably due to the molecular lesion associated with s1031 , which subtly #altered splicing .
hence , glu13 indirectly affects dna-binding specificity probably due to the molecular lesion associated with s1031 , which was able to subtly #alter splicing .
hence , glu13 indirectly affects dna-binding specificity probably due to treating the cells with insulin-like growth factor-i , which can subtly #alter phosphorylation of pdk1 .
hence , glu13 indirectly affects dna-binding specificity probably due to treating the cells with insulin-like growth factor-i , which may be able to subtly #alter phosphorylation of pdk1 .
hence , glu13 indirectly affects dna-binding specificity probably due to treating the cells with insulin-like growth factor-i , which may subtly #alter phosphorylation of pdk1 .
hence , glu13 indirectly affects dna-binding specificity probably due to treating the cells with insulin-like growth factor-i , which was able to subtly #alter phosphorylation of pdk1 .
hence , glu13 indirectly affects dna-binding specificity , probably due to dam methylation , which subtly #alters the binding of lrp at the gatc1130 site .
hence , glu13 indirectly affects dna-binding specificity , probably due to treating the cells with insulin-like growth factor-i , which subtly #alters the phosphorylation of pdk1 .
moreover , dam methylation #altered binding of lrp at the gatc1130 site .
moreover , dam methylation #alters binding of lrp at the gatc1130 site .
moreover , dam methylation can #alter binding of lrp at the gatc1130 site .
moreover , dam methylation may #alter binding of lrp at the gatc1130 site .
moreover , dam methylation may be able to #alter binding of lrp at the gatc1130 site .
moreover , dam methylation will be able to #alter binding of lrp at the gatc1130 site .
moreover , a mechanism can #alter expression of bcl-3 .
moreover , a mechanism could #alter expression of bcl-3 .
moreover , a mechanism is able to #alter expression of bcl-3 .
moreover , a mechanism may #alter expression of bcl-3 .
moreover , a mechanism will #alter expression of bcl-3 .
moreover , a mechanism will be able to #alter expression of bcl-3 .
moreover , the molecular lesion associated with s1031 #altered splicing .
moreover , the molecular lesion associated with s1031 #alters splicing .
moreover , the molecular lesion associated with s1031 can #alter splicing .
moreover , the molecular lesion associated with s1031 has #altered splicing .
moreover , the molecular lesion associated with s1031 is able to #alter splicing .
moreover , the molecular lesion associated with s1031 may be able to #alter splicing .
moreover , the molecular lesion associated with s1031 will #alter splicing .
moreover , the molecular lesion associated with s1031 will be able to #alter splicing .
moreover , treating the cells with insulin-like growth factor-i #altered phosphorylation of pdk1 .
moreover , treating the cells with insulin-like growth factor-i #alters phosphorylation of pdk1 .
moreover , treating the cells with insulin-like growth factor-i could #alter phosphorylation of pdk1 .
moreover , treating the cells with insulin-like growth factor-i is able to #alter phosphorylation of pdk1 .
moreover , treating the cells with insulin-like growth factor-i may be able to #alter phosphorylation of pdk1 .
moreover , treating the cells with insulin-like growth factor-i will #alter phosphorylation of pdk1 .
since dam methylation are in opposing directions , binding of lrp at the gatc1130 site is not #altered by them(figure 3c) .
since dam methylation are in opposing directions , binding of lrp at the gatc1130 site will not be #altered by them(figure 3c) .
since dam methylation are in opposing directions , they cannot #alter binding of lrp at the gatc1130 site(figure 3c) .
since dam methylation are in opposing directions , they will not #alter binding of lrp at the gatc1130 site(figure 3c) .
since dam methylation were in opposing directions , binding of lrp at the gatc1130 site was not #altered by them(figure 3c) .
since a mechanism are in opposing directions , expression of bcl-3 cannot be #altered by them(figure 3c) .
since a mechanism are in opposing directions , they cannot #alter expression of bcl-3(figure 3c) .
since a mechanism are in opposing directions , they will not #alter expression of bcl-3(figure 3c) .
since a mechanism were in opposing directions , expression of bcl-3 was not able to be #altered by them(figure 3c) .
since a mechanism were in opposing directions , expression of bcl-3 was not #altered by them(figure 3c) .
since a mechanism were in opposing directions , they could not #alter expression of bcl-3(figure 3c) .
since a mechanism were in opposing directions , they were not able to #alter expression of bcl-3(figure 3c) .
since s1031 is a null allele , we are testing whether dam methylation can #alter binding of lrp at the gatc1130 site .
since s1031 is a null allele , we are testing whether dam methylation is able to #alter binding of lrp at the gatc1130 site .
since s1031 is a null allele , we are testing whether dam methylation will #alter binding of lrp at the gatc1130 site .
since s1031 is a null allele , we are testing whether phosphorylation of pdk1 can be #altered by treating the cells with insulin-like growth factor-i .
since s1031 is a null allele , we are testing whether phosphorylation of pdk1 may be #altered by treating the cells with insulin-like growth factor-i .
since s1031 is a null allele , we are testing whether a mechanism can #alter expression of bcl-3 .
since s1031 is a null allele , we are testing whether a mechanism is able to #alter expression of bcl-3 .
since s1031 is a null allele , we are testing whether binding of lrp at the gatc1130 site is #altered by dam methylation .
since s1031 is a null allele , we are testing whether binding of lrp at the gatc1130 site may be #altered by dam methylation .
since s1031 is a null allele , we are testing whether expression of bcl-3 is #altered by a mechanism .
since s1031 is a null allele , we are testing whether splicing is able to be #altered by the molecular lesion associated with s1031 .
since s1031 is a null allele , we are testing whether splicing is #altered by the molecular lesion associated with s1031 .
since s1031 is a null allele , we are testing whether splicing may be #altered by the molecular lesion associated with s1031 .
since s1031 is a null allele , we are testing whether the molecular lesion associated with s1031 is able to #alter splicing .
since s1031 is a null allele , we are testing whether the molecular lesion associated with s1031 is going to #alter splicing .
since s1031 is a null allele , we are testing whether the molecular lesion associated with s1031 may #alter splicing .
since s1031 is a null allele , we are testing whether the molecular lesion associated with s1031 will #alter splicing .
since s1031 is a null allele , we are testing whether treating the cells with insulin-like growth factor-i is going to #alter phosphorylation of pdk1 .
since s1031 is a null allele , we are testing whether treating the cells with insulin-like growth factor-i may #alter phosphorylation of pdk1 .
since s1031 is a null allele , we tested whether dam methylation #alters binding of lrp at the gatc1130 site .
since s1031 is a null allele , we tested whether dam methylation could #alter binding of lrp at the gatc1130 site .
since s1031 is a null allele , we tested whether dam methylation might #alter binding of lrp at the gatc1130 site .
since s1031 is a null allele , we tested whether phosphorylation of pdk1 could be #altered by treating the cells with insulin-like growth factor-i .
since s1031 is a null allele , we tested whether phosphorylation of pdk1 might be #altered by treating the cells with insulin-like growth factor-i .
since s1031 is a null allele , we tested whether phosphorylation of pdk1 was able to be #altered by treating the cells with insulin-like growth factor-i .
since s1031 is a null allele , we tested whether phosphorylation of pdk1 was #altered by treating the cells with insulin-like growth factor-i .
since s1031 is a null allele , we tested whether a mechanism #altered expression of bcl-3 .
since s1031 is a null allele , we tested whether a mechanism #alters expression of bcl-3 .
since s1031 is a null allele , we tested whether a mechanism could #alter expression of bcl-3 .
since s1031 is a null allele , we tested whether a mechanism has #altered expression of bcl-3 .
since s1031 is a null allele , we tested whether a mechanism might #alter expression of bcl-3 .
since s1031 is a null allele , we tested whether binding of lrp at the gatc1130 site could be #altered by dam methylation .
since s1031 is a null allele , we tested whether binding of lrp at the gatc1130 site was able to be #altered by dam methylation .
since s1031 is a null allele , we tested whether binding of lrp at the gatc1130 site was #altered by dam methylation .
since s1031 is a null allele , we tested whether expression of bcl-3 might be #altered by a mechanism .
since s1031 is a null allele , we tested whether expression of bcl-3 was #altered by a mechanism .
since s1031 is a null allele , we tested whether splicing could be #altered by the molecular lesion associated with s1031 .
since s1031 is a null allele , we tested whether splicing might be #altered by the molecular lesion associated with s1031 .
since s1031 is a null allele , we tested whether splicing was able to be #altered by the molecular lesion associated with s1031 .
since s1031 is a null allele , we tested whether splicing was #altered by the molecular lesion associated with s1031 .
since s1031 is a null allele , we tested whether the molecular lesion associated with s1031 #altered splicing .
since s1031 is a null allele , we tested whether the molecular lesion associated with s1031 #alters splicing .
since s1031 is a null allele , we tested whether the molecular lesion associated with s1031 could #alter splicing .
since s1031 is a null allele , we tested whether the molecular lesion associated with s1031 has #altered splicing .
since s1031 is a null allele , we tested whether the molecular lesion associated with s1031 might #alter splicing .
since s1031 is a null allele , we tested whether treating the cells with insulin-like growth factor-i #alters phosphorylation of pdk1 .
since s1031 is a null allele , we tested whether treating the cells with insulin-like growth factor-i could #alter phosphorylation of pdk1 .
since s1031 is a null allele , we tested whether treating the cells with insulin-like growth factor-i might #alter phosphorylation of pdk1 .
since the molecular lesion associated with s1031 are in opposing directions , splicing is not #altered by them(figure 3c) .
since the molecular lesion associated with s1031 are in opposing directions , splicing may not be #altered by them(figure 3c) .
since the molecular lesion associated with s1031 are in opposing directions , splicing will not be #altered by them(figure 3c) .
since the molecular lesion associated with s1031 are in opposing directions , they are not able to #alter splicing(figure 3c) .
since the molecular lesion associated with s1031 were in opposing directions , splicing was not able to be #altered by them(figure 3c) .
since the molecular lesion associated with s1031 were in opposing directions , they could not #alter splicing(figure 3c) .
since the molecular lesion associated with s1031 were in opposing directions , they did not #alter splicing(figure 3c) .
since the molecular lesion associated with s1031 were in opposing directions , they were not able to #alter splicing(figure 3c) .
since treating the cells with insulin-like growth factor-i are in opposing directions , phosphorylation of pdk1 cannot be #altered by them(figure 3c) .
since treating the cells with insulin-like growth factor-i are in opposing directions , phosphorylation of pdk1 is not #altered by them(figure 3c) .
since treating the cells with insulin-like growth factor-i are in opposing directions , they cannot #alter phosphorylation of pdk1(figure 3c) .
since treating the cells with insulin-like growth factor-i are in opposing directions , they will not #alter phosphorylation of pdk1(figure 3c) .
since treating the cells with insulin-like growth factor-i were in opposing directions , phosphorylation of pdk1 was not able to be #altered by them(figure 3c) .
since treating the cells with insulin-like growth factor-i were in opposing directions , phosphorylation of pdk1 was not #altered by them(figure 3c) .
since treating the cells with insulin-like growth factor-i were in opposing directions , they could not #alter phosphorylation of pdk1(figure 3c) .
since treating the cells with insulin-like growth factor-i were in opposing directions , they did not #alter phosphorylation of pdk1(figure 3c) .
bending of 31 into the major groove over the cc and ct base pair steps #began and ended the carg-box , and 15 into the minor groove over the five central ta , aa and at base pair steps .
growth of gaal , gpi8 and gpi16 deletants , when transferred to a glucose-containing medium in order to deplete these proteins , #begins to decline at 12 , 6 and 6 h , respectively , after transfer and ceased at 24 , 12 and 12 h .
growth of gaal , gpi8 and gpi16 deletants , when transferred to a glucose-containing medium in order to deplete these proteins , can #begin to decline at 12 , 6 and 6 h , respectively , after transfer and ceased at 24 , 12 and 12 h .
bending of 31 into the major groove over the cc and ct base pair steps has #begun and ended the carg-box , and 15 into the minor groove over the five central ta , aa and at base pair steps .
growth of gaal , gpi8 and gpi16 deletants , when transferred to a glucose-containing medium in order to deplete these proteins , could have #begun to decline at 12 , 6 and 6 h , respectively , after transfer and ceased at 24 , 12 and 12 h .
bending of 31 into the major groove over the cc and ct base pair steps is able to #begin and end the carg-box , and 15 into the minor groove over the five central ta , aa and at base pair steps .
growth of gaal , gpi8 and gpi16 deletants , when transferred to a glucose-containing medium in order to deplete these proteins , is believed to #begin declining at 12 , 6 and 6 h , respectively , after transfer and ceased at 24 , 12 and 12 h .
bending of 31 into the major groove over the cc and ct base pair steps is able to promptly #begin and end the carg-box , and 15 into the minor groove over the five central ta , aa and at base pair steps .
growth of gaal , gpi8 and gpi16 deletants , when transferred to a glucose-containing medium in order to deplete these proteins , is believed to have #begun declining at 12 , 6 and 6 h , respectively , after transfer and ceased at 24 , 12 and 12 h .
bending of 31 into the major groove over the cc and ct base pair steps is assumed to have #begun and ended the carg-box , and 15 into the minor groove over the five central ta , aa and at base pair steps .
growth of gaal , gpi8 and gpi16 deletants , when transferred to a glucose-containing medium in order to deplete these proteins , may have #begun to decline at 12 , 6 and 6 h , respectively , after transfer and ceased at 24 , 12 and 12 h .
bending of 31 into the major groove over the cc and ct base pair steps is believed to have promptly #begun and ended the carg-box , and 15 into the minor groove over the five central ta , aa and at base pair steps .
bending of 31 into the major groove over the cc and ct base pair steps may #begin and end the carg-box , and 15 into the minor groove over the five central ta , aa and at base pair steps .
growth of gaal , gpi8 and gpi16 deletants , when transferred to a glucose-containing medium in order to deplete these proteins , might have #begun to decline at 12 , 6 and 6 h , respectively , after transfer and ceased at 24 , 12 and 12 h .
bending of 31 into the major groove over the cc and ct base pair steps may promptly #begin and end the carg-box , and 15 into the minor groove over the five central ta , aa and at base pair steps .
growth of gaal , gpi8 and gpi16 deletants , when transferred to a glucose-containing medium in order to deplete these proteins , was believed to #begin declining at 12 , 6 and 6 h , respectively , after transfer and ceased at 24 , 12 and 12 h .
bending of 31 into the major groove over the cc and ct base pair steps promptly #begins and ends the carg-box , and 15 into the minor groove over the five central ta , aa and at base pair steps .
growth of gaal , gpi8 and gpi16 deletants , when transferred to a glucose-containing medium in order to deplete these proteins , will #begin to decline at 12 , 6 and 6 h , respectively , after transfer and ceased at 24 , 12 and 12 h .
bending of 31 into the major groove over the cc and ct base pair steps , as our study suggested , can #begin and end the carg-box , and 15 into the minor groove over the five central ta , aa and at base pair steps .
bending of 31 into the major groove over the cc and ct base pair steps , as our study suggested , has #begun and ended the carg-box , and 15 into the minor groove over the five central ta , aa and at base pair steps .
bending of 31 into the major groove over the cc and ct base pair steps , as our study suggested , has promptly #begun and ended the carg-box , and 15 into the minor groove over the five central ta , aa and at base pair steps .
bending of 31 into the major groove over the cc and ct base pair steps , as our study suggested , is assumed to have #begun and ended the carg-box , and 15 into the minor groove over the five central ta , aa and at base pair steps .
bending of 31 into the major groove over the cc and ct base pair steps , as our study suggested , is believed to have promptly #begun and ended the carg-box , and 15 into the minor groove over the five central ta , aa and at base pair steps .
bending of 31 into the major groove over the cc and ct base pair steps , as our study suggested , may promptly #begin and end the carg-box , and 15 into the minor groove over the five central ta , aa and at base pair steps .
bending of 31 into the major groove over the cc and ct base pair steps , as our study suggested , will #begin and end the carg-box , and 15 into the minor groove over the five central ta , aa and at base pair steps .
bending of 31 into the major groove over the cc and ct base pair steps , as our study suggested , will promptly #begin and end the carg-box , and 15 into the minor groove over the five central ta , aa and at base pair steps .
on the other hand , the only transcript being believed to probably #begin at exon 1a is observed in normal cells .
on the other hand , the only transcript that #began at exon 1a was observed in normal cells .
on the other hand , the only transcript that can probably #begin at exon 1a is observed in normal cells .
on the other hand , the only transcript that has probably #begun at exon 1a was observed in normal cells .
on the other hand , the only transcript that is believed to #begin at exon 1a is observed in normal cells .
on the other hand , the only transcript that is believed to have #begun at exon 1a is observed in normal cells .
on the other hand , the only transcript that is believed to have probably #begun at exon 1a is observed in normal cells .
on the other hand , the only transcript that probably #began at exon 1a was observed in normal cells .
on the other hand , the only transcript that was able to probably #begin at exon 1a was observed in normal cells .
on the other hand , the only transcript that was believed to #begin at exon 1a is observed in normal cells .
on the other hand , the only transcript that was believed to have #begun at exon 1a is observed in normal cells .
on the other hand , the only transcript that was believed to have probably #begun at exon 1a is observed in normal cells .
on the other hand , the only transcript that was believed to probably #begin at exon 1a is observed in normal cells .
on the other hand , the only transcript which #began at exon 1a was observed in normal cells .
on the other hand , the only transcript which is able to probably #begin at exon 1a is observed in normal cells .
on the other hand , the only transcript which is believed to #begin at exon 1a is observed in normal cells .
on the other hand , the only transcript which is believed to have #begun at exon 1a is observed in normal cells .
on the other hand , the only transcript which is believed to have probably #begun at exon 1a is observed in normal cells .
on the other hand , the only transcript which is believed to probably #begin at exon 1a is observed in normal cells .
on the other hand , the only transcript which probably #began at exon 1a was observed in normal cells .
on the other hand , the only transcript which probably #begins at exon 1a is observed in normal cells .
on the other hand , the only transcript which was able to probably #begin at exon 1a was observed in normal cells .
on the other hand , the only transcript which was believed to have #begun at exon 1a is observed in normal cells .
on the other hand , the only transcript which was believed to have probably #begun at exon 1a is observed in normal cells .
on the other hand , the only transcript which was believed to probably #begin at exon 1a is observed in normal cells .
the only transcript that , on the other hand , #begins at exon 1a is observed in normal cells .
the levels of immunoreactive ib are able to promptly #begin returning to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib can #begin to return to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib can have #begun to return to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib can have promptly #begun to return to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib can promptly #begin to return to basal levels following 3-4 h exposures to poly ic .
the only transcript that , on the other hand , has probably #begun at exon 1a was observed in normal cells .
the only transcript that , on the other hand , is able to #begin at exon 1a is observed in normal cells .
the only transcript that , on the other hand , is able to probably #begin at exon 1a is observed in normal cells .
the only transcript that , on the other hand , is believed to #begin at exon 1a is observed in normal cells .
the only transcript that , on the other hand , is believed to have #begun at exon 1a is observed in normal cells .
the only transcript that , on the other hand , is believed to probably #begin at exon 1a is observed in normal cells .
the levels of immunoreactive ib have promptly #begun to return to basal levels following 3-4 h exposures to poly ic .
the only transcript that , on the other hand , probably #began at exon 1a was observed in normal cells .
the levels of immunoreactive ib is believed to #begin returning to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib is believed to have promptly #begun returning to basal levels following 3-4 h exposures to poly ic .
the only transcript that , on the other hand , was able to #begin at exon 1a was observed in normal cells .
the levels of immunoreactive ib is believed to promptly #begin returning to basal levels following 3-4 h exposures to poly ic .
the only transcript that , on the other hand , was believed to #begin at exon 1a is observed in normal cells .
the levels of immunoreactive ib may #begin to return to basal levels following 3-4 h exposures to poly ic .
the only transcript that , on the other hand , was believed to have #begun at exon 1a is observed in normal cells .
the levels of immunoreactive ib may have #begun to return to basal levels following 3-4 h exposures to poly ic .
the only transcript that , on the other hand , was believed to have probably #begun at exon 1a is observed in normal cells .
the levels of immunoreactive ib may promptly #begin to return to basal levels following 3-4 h exposures to poly ic .
the only transcript which , on the other hand , #began at exon 1a was observed in normal cells .
the only transcript which , on the other hand , can #begin at exon 1a is observed in normal cells .
the only transcript which , on the other hand , can probably #begin at exon 1a is observed in normal cells .
the levels of immunoreactive ib might promptly #begin to return to basal levels following 3-4 h exposures to poly ic .
the only transcript which , on the other hand , could #begin at exon 1a was observed in normal cells .
the levels of immunoreactive ib was able to #begin returning to basal levels following 3-4 h exposures to poly ic .
the only transcript which , on the other hand , could probably #begin at exon 1a was observed in normal cells .
the only transcript which , on the other hand , has probably #begun at exon 1a was observed in normal cells .
the levels of immunoreactive ib was believed to #begin returning to basal levels following 3-4 h exposures to poly ic .
the only transcript which , on the other hand , is able to #begin at exon 1a is observed in normal cells .
the levels of immunoreactive ib was believed to have promptly #begun returning to basal levels following 3-4 h exposures to poly ic .
the only transcript which , on the other hand , is believed to #begin at exon 1a is observed in normal cells .
the levels of immunoreactive ib will have promptly #begun to return to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib will promptly #begin to return to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib would #begin to return to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib would have #begun to return to basal levels following 3-4 h exposures to poly ic .
the only transcript which , on the other hand , was able to #begin at exon 1a was observed in normal cells .
the only transcript which , on the other hand , was able to probably #begin at exon 1a was observed in normal cells .
the only transcript which , on the other hand , was believed to #begin at exon 1a is observed in normal cells .
the only transcript which , on the other hand , was believed to have #begun at exon 1a is observed in normal cells .
the levels of immunoreactive ib , as several research works revealed , can #begin to return to basal levels following 3-4 h exposures to poly ic .
the only transcript , on the other hand , being believed to have #begun at exon 1a is observed in normal cells .
the levels of immunoreactive ib , as several research works revealed , can have promptly #begun to return to basal levels following 3-4 h exposures to poly ic .
the only transcript , on the other hand , being believed to probably #begin at exon 1a is observed in normal cells .
the levels of immunoreactive ib , as several research works revealed , could promptly #begin to return to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib , as several research works revealed , have promptly #begun to return to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib , as several research works revealed , is believed to have promptly #begun returning to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib , as several research works revealed , is believed to promptly #begin returning to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib , as several research works revealed , may #begin to return to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib , as several research works revealed , may have #begun to return to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib , as several research works revealed , might #begin to return to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib , as several research works revealed , might have #begun to return to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib , as several research works revealed , might have promptly #begun to return to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib , as several research works revealed , might promptly #begin to return to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib , as several research works revealed , promptly #began to return to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib , as several research works revealed , was able to #begin returning to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib , as several research works revealed , was able to promptly #begin returning to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib , as several research works revealed , was believed to promptly #begin returning to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib , as several research works revealed , will #begin to return to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib , as several research works revealed , will promptly #begin to return to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib , as several research works revealed , would promptly #begin to return to basal levels following 3-4 h exposures to poly ic .
when they were transferred to a glucose-containing medium in order to deplete these proteins , growth of gaal , gpi8 and gpi16 deletants could #begin to decline at 12 , 6 and 6 h , respectively , after transfer and ceased at 24 , 12 and 12 h .
when they were transferred to a glucose-containing medium in order to deplete these proteins , growth of gaal , gpi8 and gpi16 deletants is believed to #begin declining at 12 , 6 and 6 h , respectively , after transfer and ceased at 24 , 12 and 12 h .
when they were transferred to a glucose-containing medium in order to deplete these proteins , growth of gaal , gpi8 and gpi16 deletants might #begin to decline at 12 , 6 and 6 h , respectively , after transfer and ceased at 24 , 12 and 12 h .
when they were transferred to a glucose-containing medium in order to deplete these proteins , growth of gaal , gpi8 and gpi16 deletants was believed to #begin declining at 12 , 6 and 6 h , respectively , after transfer and ceased at 24 , 12 and 12 h .
when they were transferred to a glucose-containing medium in order to deplete these proteins , growth of gaal , gpi8 and gpi16 deletants was believed to have #begun declining at 12 , 6 and 6 h , respectively , after transfer and ceased at 24 , 12 and 12 h .
when they were transferred to a glucose-containing medium in order to deplete these proteins , growth of gaal , gpi8 and gpi16 deletants will #begin to decline at 12 , 6 and 6 h , respectively , after transfer and ceased at 24 , 12 and 12 h .
when they were transferred to a glucose-containing medium in order to deplete these proteins , growth of gaal , gpi8 and gpi16 deletants will have #begun to decline at 12 , 6 and 6 h , respectively , after transfer and ceased at 24 , 12 and 12 h .
when they were transferred to a glucose-containing medium in order to deplete these proteins , growth of gaal , gpi8 and gpi16 deletants would #begin to decline at 12 , 6 and 6 h , respectively , after transfer and ceased at 24 , 12 and 12 h .
both srf subunits in the ternary complex bend the two dna half sites to the same extent , resulting in bending of 31 into the major groove over the cc and ct base pair steps #beginning and ending the carg-box , and 15 into the minor groove over the five central ta , aa and at base pair steps .
when they were transferred to a glucose-containing medium in order to deplete these proteins , growth of gaal , gpi8 and gpi16 deletants #began to decline at 12 , 6 and 6 h , respectively , after transfer and ceased at 24 , 12 and 12 h .
on the other hand , the only transcript #beginning at exon 1a was observed in normal cells .
the only transcript #began at exon 1a , and continued to the c-terminus .
the only transcript #began variably at exon 1a , and continued to the c-terminus .
the only transcript #beginning variably at exon 1a will continue to the c-terminus .
the only transcript can #begin at exon 1a , and continues to the c-terminus .
the only transcript has #begun at exon 1a , and has continued to the c-terminus .
the only transcript that #began at exon 1a continued to the c-terminus .
the only transcript that #begins at exon 1a continues to the c-terminus .
the only transcript that has #begun at exon 1a has continued to the c-terminus .
the only transcript that has #begun variably at exon 1a has continued to the c-terminus .
the only transcript which #begins at exon 1a continues to the c-terminus .
the only transcript will #begin variably at exon 1a , and continues to the c-terminus .
the only transcript would #begin at exon 1a , and continued to the c-terminus .
the only transcript , as our data have shown , #began at exon 1a , and continued to the c-terminus .
the only transcript , as our data have shown , can #begin at exon 1a , and continues to the c-terminus .
the only transcript , as our data have shown , could #begin variably at exon 1a , and continued to the c-terminus .
the only transcript , as our data have shown , has #begun at exon 1a , and has continued to the c-terminus .
the only transcript , as our data have shown , is able to #begin at exon 1a , and continues to the c-terminus .
the only transcript , as our data have shown , that #began variably at exon 1a continued to the c-terminus .
the only transcript , as our data have shown , was able to #begin variably at exon 1a , and continued to the c-terminus .
the only transcript , as our data have shown , which #began at exon 1a continued to the c-terminus .
the only transcript , as our data have shown , which #begins at exon 1a continues to the c-terminus .
the only transcript , as our data have shown , which has #begun at exon 1a has continued to the c-terminus .
the only transcript , as our data have shown , will #begin at exon 1a , and continues to the c-terminus .
the only transcript , as our data have shown , would #begin at exon 1a , and continued to the c-terminus .
the only transcript , as our data have shown , would #begin variably at exon 1a , and continued to the c-terminus .
the levels of immunoreactive ib are able to #begin return to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib are able to promptly #begin return to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib #began return to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib #began returning to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib #begin to returning to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib #begin to to return to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib #beginning return to basal levels following 3-4 h exposures to poly ic can continue slowly for 33 h .
the levels of immunoreactive ib #beginning returning to basal levels following 3-4 h exposures to poly ic can continue slowly for 33 h .
the levels of immunoreactive ib #begins return to basal levels following 3-4 h exposures to poly ic , but growth continues slowly for 33 h .
the levels of immunoreactive ib #begins returning to basal levels following 3-4 h exposures to poly ic , but growth continues slowly for 33 h .
the levels of immunoreactive ib believed to #begin returning to basal levels following 3-4 h exposures to poly ic can continue slowly for 33 h .
the levels of immunoreactive ib believed to #begin to return to basal levels following 3-4 h exposures to poly ic can continue slowly for 33 h .
the levels of immunoreactive ib believed to have #begun return to basal levels following 3-4 h exposures to poly ic can continue slowly for 33 h .
the levels of immunoreactive ib believed to have #begun returning to basal levels following 3-4 h exposures to poly ic can continue slowly for 33 h .
the levels of immunoreactive ib believed to have #begun to return to basal levels following 3-4 h exposures to poly ic can continue slowly for 33 h .
the levels of immunoreactive ib believed to have probably #begun return to basal levels following 3-4 h exposures to poly ic can continue slowly for 33 h .
the levels of immunoreactive ib believed to probably #begin return to basal levels following 3-4 h exposures to poly ic can continue slowly for 33 h .
the levels of immunoreactive ib believed to probably #begin returning to basal levels following 3-4 h exposures to poly ic can continue slowly for 33 h .
the levels of immunoreactive ib can have #begun return to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib can have promptly #begun return to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib can have promptly #begun returning to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib can probably #begin return to basal levels following 3-4 h exposures to poly ic , but growth can continue slowly for 33 h .
the levels of immunoreactive ib can probably #begin returning to basal levels following 3-4 h exposures to poly ic , but growth can continue slowly for 33 h .
the levels of immunoreactive ib can promptly #begin returning to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib could #begin return to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib could have #begun return to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib could have promptly #begun return to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib could have promptly #begun returning to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib could probably #begin to return to basal levels following 3-4 h exposures to poly ic , but growth could continue slowly for 33 h .
the levels of immunoreactive ib could promptly #begin return to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib could promptly #begin returning to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib has #begun return to basal levels following 3-4 h exposures to poly ic , but growth continued slowly for 33 h .
the levels of immunoreactive ib has #begun to return to basal levels following 3-4 h exposures to poly ic , but growth continued slowly for 33 h .
the levels of immunoreactive ib has probably #begun return to basal levels following 3-4 h exposures to poly ic , but growth continued slowly for 33 h .
the levels of immunoreactive ib has probably #begun returning to basal levels following 3-4 h exposures to poly ic , but growth continued slowly for 33 h .
the levels of immunoreactive ib has probably #begun to return to basal levels following 3-4 h exposures to poly ic , but growth continued slowly for 33 h .
the levels of immunoreactive ib have #begun return to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib have #begun returning to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib is able to #begin returning to basal levels following 3-4 h exposures to poly ic , but growth can continue slowly for 33 h .
the levels of immunoreactive ib is able to probably #begin returning to basal levels following 3-4 h exposures to poly ic , but growth can continue slowly for 33 h .
the levels of immunoreactive ib is able to probably #begin to return to basal levels following 3-4 h exposures to poly ic , but growth can continue slowly for 33 h .
the levels of immunoreactive ib is believed to #begin return to basal levels following 3-4 h exposures to poly ic , but growth continues slowly for 33 h .
the levels of immunoreactive ib is believed to #begin to return to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib is believed to have #begun to return to basal levels following 3-4 h exposures to poly ic , but growth continued slowly for 33 h .
the levels of immunoreactive ib is believed to have #begun to return to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib is believed to have probably #begun return to basal levels following 3-4 h exposures to poly ic , but growth continued slowly for 33 h .
the levels of immunoreactive ib is believed to promptly #begin to return to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib may #begin return to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib may #begin returning to basal levels following 3-4 h exposures to poly ic , but growth can continue slowly for 33 h .
the levels of immunoreactive ib may have #begun return to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib may have #begun returning to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib may promptly #begin return to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib may promptly #begin returning to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib might #begin returning to basal levels following 3-4 h exposures to poly ic , but growth would continue slowly for 33 h .
the levels of immunoreactive ib might have #begun return to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib might have promptly #begun returning to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib might probably #begin returning to basal levels following 3-4 h exposures to poly ic , but growth would continue slowly for 33 h .
the levels of immunoreactive ib might promptly #begin returning to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib probably #begins returning to basal levels following 3-4 h exposures to poly ic , but growth continues slowly for 33 h .
the levels of immunoreactive ib promptly #began return to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib promptly #began returning to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib that #began return to basal levels following 3-4 h exposures to poly ic can continue slowly for 33 h .
the levels of immunoreactive ib that #begins return to basal levels following 3-4 h exposures to poly ic can continue slowly for 33 h .
the levels of immunoreactive ib that #begins returning to basal levels following 3-4 h exposures to poly ic can continue slowly for 33 h .
the levels of immunoreactive ib that #begins to return to basal levels following 3-4 h exposures to poly ic can continue slowly for 33 h .
the levels of immunoreactive ib that has #begun return to basal levels following 3-4 h exposures to poly ic can continue slowly for 33 h .
the levels of immunoreactive ib that has probably #begun return to basal levels following 3-4 h exposures to poly ic can continue slowly for 33 h .
the levels of immunoreactive ib that is believed to #begin returning to basal levels following 3-4 h exposures to poly ic can continue slowly for 33 h .
the levels of immunoreactive ib that is believed to #begin to return to basal levels following 3-4 h exposures to poly ic can continue slowly for 33 h .
the levels of immunoreactive ib that is believed to have #begun to return to basal levels following 3-4 h exposures to poly ic can continue slowly for 33 h .
the levels of immunoreactive ib that is believed to have probably #begun to return to basal levels following 3-4 h exposures to poly ic can continue slowly for 33 h .
the levels of immunoreactive ib that is believed to probably #begin return to basal levels following 3-4 h exposures to poly ic can continue slowly for 33 h .
the levels of immunoreactive ib that probably #began returning to basal levels following 3-4 h exposures to poly ic can continue slowly for 33 h .
the levels of immunoreactive ib that probably #began to return to basal levels following 3-4 h exposures to poly ic can continue slowly for 33 h .
the levels of immunoreactive ib that probably #begins return to basal levels following 3-4 h exposures to poly ic can continue slowly for 33 h .
the levels of immunoreactive ib that probably #begins to return to basal levels following 3-4 h exposures to poly ic can continue slowly for 33 h .
the levels of immunoreactive ib that was believed to #begin returning to basal levels following 3-4 h exposures to poly ic could continue slowly for 33 h .
the levels of immunoreactive ib that was believed to have #begun to return to basal levels following 3-4 h exposures to poly ic could continue slowly for 33 h .
the levels of immunoreactive ib that was believed to have probably #begun returning to basal levels following 3-4 h exposures to poly ic could continue slowly for 33 h .
the levels of immunoreactive ib that was believed to probably #begin returning to basal levels following 3-4 h exposures to poly ic could continue slowly for 33 h .
the levels of immunoreactive ib that was believed to probably #begin to return to basal levels following 3-4 h exposures to poly ic could continue slowly for 33 h .
the levels of immunoreactive ib was able to #begin returning to basal levels following 3-4 h exposures to poly ic , but growth could continue slowly for 33 h .
the levels of immunoreactive ib was able to promptly #begin to return to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib was believed to #begin returning to basal levels following 3-4 h exposures to poly ic , but growth continued slowly for 33 h .
the levels of immunoreactive ib was believed to #begin to return to basal levels following 3-4 h exposures to poly ic , but growth continued slowly for 33 h .
the levels of immunoreactive ib was believed to have #begun return to basal levels following 3-4 h exposures to poly ic , but growth continued slowly for 33 h .
the levels of immunoreactive ib was believed to have #begun return to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib was believed to have #begun returning to basal levels following 3-4 h exposures to poly ic , but growth continued slowly for 33 h .
the levels of immunoreactive ib was believed to have probably #begun returning to basal levels following 3-4 h exposures to poly ic , but growth continued slowly for 33 h .
the levels of immunoreactive ib was believed to have promptly #begun return to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib was believed to have promptly #begun to return to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib was believed to probably #begin returning to basal levels following 3-4 h exposures to poly ic , but growth continued slowly for 33 h .
the levels of immunoreactive ib was believed to probably #begin to return to basal levels following 3-4 h exposures to poly ic , but growth continued slowly for 33 h .
the levels of immunoreactive ib was believed to promptly #begin return to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib which #began return to basal levels following 3-4 h exposures to poly ic can continue slowly for 33 h .
the levels of immunoreactive ib which #began returning to basal levels following 3-4 h exposures to poly ic can continue slowly for 33 h .
the levels of immunoreactive ib which #began to return to basal levels following 3-4 h exposures to poly ic can continue slowly for 33 h .
the levels of immunoreactive ib which #begins return to basal levels following 3-4 h exposures to poly ic can continue slowly for 33 h .
the levels of immunoreactive ib which #begins to return to basal levels following 3-4 h exposures to poly ic can continue slowly for 33 h .
the levels of immunoreactive ib which has #begun to return to basal levels following 3-4 h exposures to poly ic can continue slowly for 33 h .
the levels of immunoreactive ib which has probably #begun return to basal levels following 3-4 h exposures to poly ic can continue slowly for 33 h .
the levels of immunoreactive ib which has probably #begun to return to basal levels following 3-4 h exposures to poly ic can continue slowly for 33 h .
the levels of immunoreactive ib which is believed to #begin to return to basal levels following 3-4 h exposures to poly ic can continue slowly for 33 h .
the levels of immunoreactive ib which is believed to have #begun returning to basal levels following 3-4 h exposures to poly ic can continue slowly for 33 h .
the levels of immunoreactive ib which is believed to have probably #begun returning to basal levels following 3-4 h exposures to poly ic can continue slowly for 33 h .
the levels of immunoreactive ib which is believed to have probably #begun to return to basal levels following 3-4 h exposures to poly ic can continue slowly for 33 h .
the levels of immunoreactive ib which is believed to probably #begin return to basal levels following 3-4 h exposures to poly ic can continue slowly for 33 h .
the levels of immunoreactive ib which is believed to probably #begin returning to basal levels following 3-4 h exposures to poly ic can continue slowly for 33 h .
the levels of immunoreactive ib which is believed to probably #begin to return to basal levels following 3-4 h exposures to poly ic can continue slowly for 33 h .
the levels of immunoreactive ib which probably #began return to basal levels following 3-4 h exposures to poly ic can continue slowly for 33 h .
the levels of immunoreactive ib which probably #begins to return to basal levels following 3-4 h exposures to poly ic can continue slowly for 33 h .
the levels of immunoreactive ib which was believed to #begin return to basal levels following 3-4 h exposures to poly ic could continue slowly for 33 h .
the levels of immunoreactive ib which was believed to #begin returning to basal levels following 3-4 h exposures to poly ic could continue slowly for 33 h .
the levels of immunoreactive ib which was believed to have #begun return to basal levels following 3-4 h exposures to poly ic could continue slowly for 33 h .
the levels of immunoreactive ib which was believed to have #begun to return to basal levels following 3-4 h exposures to poly ic could continue slowly for 33 h .
the levels of immunoreactive ib which was believed to have probably #begun return to basal levels following 3-4 h exposures to poly ic could continue slowly for 33 h .
the levels of immunoreactive ib which was believed to have probably #begun to return to basal levels following 3-4 h exposures to poly ic could continue slowly for 33 h .
the levels of immunoreactive ib which was believed to probably #begin returning to basal levels following 3-4 h exposures to poly ic could continue slowly for 33 h .
the levels of immunoreactive ib will #begin return to basal levels following 3-4 h exposures to poly ic , but growth will continue slowly for 33 h .
the levels of immunoreactive ib will have #begun return to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib will have #begun returning to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib will have promptly #begun return to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib will have promptly #begun returning to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib will promptly #begin return to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib will promptly #begin returning to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib would #begin return to basal levels following 3-4 h exposures to poly ic , but growth would continue slowly for 33 h .
the levels of immunoreactive ib would #begin returning to basal levels following 3-4 h exposures to poly ic , but growth would continue slowly for 33 h .
the levels of immunoreactive ib would have promptly #begun return to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib would probably #begin return to basal levels following 3-4 h exposures to poly ic , but growth would continue slowly for 33 h .
the levels of immunoreactive ib would probably #begin returning to basal levels following 3-4 h exposures to poly ic , but growth would continue slowly for 33 h .
the levels of immunoreactive ib would promptly #begin return to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib would promptly #begin returning to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib , as our study suggested , can #begin returning to basal levels following 3-4 h exposures to poly ic , but growth can continue slowly for 33 h .
the levels of immunoreactive ib , as our study suggested , can probably #begin return to basal levels following 3-4 h exposures to poly ic , but growth can continue slowly for 33 h .
the levels of immunoreactive ib , as our study suggested , can probably #begin to return to basal levels following 3-4 h exposures to poly ic , but growth can continue slowly for 33 h .
the levels of immunoreactive ib , as our study suggested , could #begin return to basal levels following 3-4 h exposures to poly ic , but growth could continue slowly for 33 h .
the levels of immunoreactive ib , as our study suggested , could #begin to return to basal levels following 3-4 h exposures to poly ic , but growth could continue slowly for 33 h .
the levels of immunoreactive ib , as our study suggested , could probably #begin return to basal levels following 3-4 h exposures to poly ic , but growth could continue slowly for 33 h .
the levels of immunoreactive ib , as our study suggested , could probably #begin returning to basal levels following 3-4 h exposures to poly ic , but growth could continue slowly for 33 h .
the levels of immunoreactive ib , as our study suggested , could probably #begin to return to basal levels following 3-4 h exposures to poly ic , but growth could continue slowly for 33 h .
the levels of immunoreactive ib , as our study suggested , has #begun returning to basal levels following 3-4 h exposures to poly ic , but growth continued slowly for 33 h .
the levels of immunoreactive ib , as our study suggested , has probably #begun returning to basal levels following 3-4 h exposures to poly ic , but growth continued slowly for 33 h .
the levels of immunoreactive ib , as our study suggested , is able to #begin return to basal levels following 3-4 h exposures to poly ic , but growth can continue slowly for 33 h .
the levels of immunoreactive ib , as our study suggested , is able to probably #begin return to basal levels following 3-4 h exposures to poly ic , but growth can continue slowly for 33 h .
the levels of immunoreactive ib , as our study suggested , is able to probably #begin to return to basal levels following 3-4 h exposures to poly ic , but growth can continue slowly for 33 h .
the levels of immunoreactive ib , as our study suggested , is believed to #begin return to basal levels following 3-4 h exposures to poly ic , but growth continues slowly for 33 h .
the levels of immunoreactive ib , as our study suggested , is believed to #begin returning to basal levels following 3-4 h exposures to poly ic , but growth continues slowly for 33 h .
the levels of immunoreactive ib , as our study suggested , is believed to have #begun return to basal levels following 3-4 h exposures to poly ic , but growth continued slowly for 33 h .
the levels of immunoreactive ib , as our study suggested , is believed to have #begun returning to basal levels following 3-4 h exposures to poly ic , but growth continued slowly for 33 h .
the levels of immunoreactive ib , as our study suggested , is believed to have #begun to return to basal levels following 3-4 h exposures to poly ic , but growth continued slowly for 33 h .
the levels of immunoreactive ib , as our study suggested , is believed to have probably #begun returning to basal levels following 3-4 h exposures to poly ic , but growth continued slowly for 33 h .
the levels of immunoreactive ib , as our study suggested , may #begin returning to basal levels following 3-4 h exposures to poly ic , but growth can continue slowly for 33 h .
the levels of immunoreactive ib , as our study suggested , might #begin returning to basal levels following 3-4 h exposures to poly ic , but growth would continue slowly for 33 h .
the levels of immunoreactive ib , as our study suggested , might #begin to return to basal levels following 3-4 h exposures to poly ic , but growth would continue slowly for 33 h .
the levels of immunoreactive ib , as our study suggested , might probably #begin returning to basal levels following 3-4 h exposures to poly ic , but growth would continue slowly for 33 h .
the levels of immunoreactive ib , as our study suggested , might probably #begin to return to basal levels following 3-4 h exposures to poly ic , but growth would continue slowly for 33 h .
the levels of immunoreactive ib , as our study suggested , probably #begins return to basal levels following 3-4 h exposures to poly ic , but growth continues slowly for 33 h .
the levels of immunoreactive ib , as our study suggested , probably #begins returning to basal levels following 3-4 h exposures to poly ic , but growth continues slowly for 33 h .
the levels of immunoreactive ib , as our study suggested , probably #begins to return to basal levels following 3-4 h exposures to poly ic , but growth continues slowly for 33 h .
the levels of immunoreactive ib , as our study suggested , was able to probably #begin return to basal levels following 3-4 h exposures to poly ic , but growth could continue slowly for 33 h .
the levels of immunoreactive ib , as our study suggested , was able to probably #begin to return to basal levels following 3-4 h exposures to poly ic , but growth could continue slowly for 33 h .
the levels of immunoreactive ib , as our study suggested , was believed to #begin return to basal levels following 3-4 h exposures to poly ic , but growth continued slowly for 33 h .
the levels of immunoreactive ib , as our study suggested , was believed to #begin returning to basal levels following 3-4 h exposures to poly ic , but growth continued slowly for 33 h .
the levels of immunoreactive ib , as our study suggested , was believed to #begin to return to basal levels following 3-4 h exposures to poly ic , but growth continued slowly for 33 h .
the levels of immunoreactive ib , as our study suggested , was believed to have #begun return to basal levels following 3-4 h exposures to poly ic , but growth continued slowly for 33 h .
the levels of immunoreactive ib , as our study suggested , was believed to have #begun returning to basal levels following 3-4 h exposures to poly ic , but growth continued slowly for 33 h .
the levels of immunoreactive ib , as our study suggested , was believed to have #begun to return to basal levels following 3-4 h exposures to poly ic , but growth continued slowly for 33 h .
the levels of immunoreactive ib , as our study suggested , was believed to have probably #begun returning to basal levels following 3-4 h exposures to poly ic , but growth continued slowly for 33 h .
the levels of immunoreactive ib , as our study suggested , was believed to have probably #begun to return to basal levels following 3-4 h exposures to poly ic , but growth continued slowly for 33 h .
the levels of immunoreactive ib , as our study suggested , was believed to probably #begin returning to basal levels following 3-4 h exposures to poly ic , but growth continued slowly for 33 h .
the levels of immunoreactive ib , as our study suggested , was believed to probably #begin to return to basal levels following 3-4 h exposures to poly ic , but growth continued slowly for 33 h .
the levels of immunoreactive ib , as our study suggested , will #begin returning to basal levels following 3-4 h exposures to poly ic , but growth will continue slowly for 33 h .
the levels of immunoreactive ib , as our study suggested , will #begin to return to basal levels following 3-4 h exposures to poly ic , but growth will continue slowly for 33 h .
the levels of immunoreactive ib , as our study suggested , will probably #begin returning to basal levels following 3-4 h exposures to poly ic , but growth will continue slowly for 33 h .
the levels of immunoreactive ib , as our study suggested , will probably #begin to return to basal levels following 3-4 h exposures to poly ic , but growth will continue slowly for 33 h .
the levels of immunoreactive ib , as our study suggested , would probably #begin to return to basal levels following 3-4 h exposures to poly ic , but growth would continue slowly for 33 h .
the levels of immunoreactive ib , as several research works revealed , are able to #begin to return to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib , as several research works revealed , #began return to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib , as several research works revealed , can #begin return to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib , as several research works revealed , can #begin returning to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib , as several research works revealed , can have #begun returning to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib , as several research works revealed , can have promptly #begun return to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib , as several research works revealed , can promptly #begin return to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib , as several research works revealed , can promptly #begin returning to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib , as several research works revealed , could #begin return to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib , as several research works revealed , could have #begun returning to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib , as several research works revealed , could promptly #begin return to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib , as several research works revealed , have #begun return to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib , as several research works revealed , have #begun returning to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib , as several research works revealed , have promptly #begun returning to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib , as several research works revealed , is believed to have #begun return to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib , as several research works revealed , is believed to have #begun to return to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib , as several research works revealed , is believed to have promptly #begun return to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib , as several research works revealed , is believed to promptly #begin to return to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib , as several research works revealed , may #begin return to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib , as several research works revealed , may #begin returning to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib , as several research works revealed , may have #begun return to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib , as several research works revealed , may have #begun returning to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib , as several research works revealed , may have promptly #begun returning to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib , as several research works revealed , may promptly #begin return to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib , as several research works revealed , might have #begun return to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib , as several research works revealed , might promptly #begin return to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib , as several research works revealed , was able to #begin to return to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib , as several research works revealed , was able to promptly #begin return to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib , as several research works revealed , was able to promptly #begin to return to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib , as several research works revealed , was believed to have #begun return to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib , as several research works revealed , was believed to have #begun to return to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib , as several research works revealed , was believed to have promptly #begun to return to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib , as several research works revealed , will have #begun return to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib , as several research works revealed , will have #begun returning to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib , as several research works revealed , will have promptly #begun returning to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib , as several research works revealed , will promptly #begin return to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib , as several research works revealed , will promptly #begin returning to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib , as several research works revealed , would #begin returning to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib , as several research works revealed , would have #begun return to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib , as several research works revealed , would have #begun returning to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib , as several research works revealed , would have promptly #begun returning to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib , as several research works revealed , would promptly #begin return to basal levels following 3-4 h exposures to poly ic .
when they were transferred to a glucose-containing medium in order to deplete these proteins , the levels of immunoreactive ib #began to to return to basal levels following 3-4 h exposures to poly ic , respectively , after transfer and ceased at 24 , 12 and 12 h .
when they were transferred to a glucose-containing medium in order to deplete these proteins , the levels of immunoreactive ib #begins to return to basal levels following 3-4 h exposures to poly ic , respectively , after transfer and ceased at 24 , 12 and 12 h .
when they were transferred to a glucose-containing medium in order to deplete these proteins , the levels of immunoreactive ib can #begin to return to basal levels following 3-4 h exposures to poly ic , respectively , after transfer and ceased at 24 , 12 and 12 h .
when they were transferred to a glucose-containing medium in order to deplete these proteins , the levels of immunoreactive ib can have #begun return to basal levels following 3-4 h exposures to poly ic , respectively , after transfer and ceased at 24 , 12 and 12 h .
when they were transferred to a glucose-containing medium in order to deplete these proteins , the levels of immunoreactive ib could #begin return to basal levels following 3-4 h exposures to poly ic , respectively , after transfer and ceased at 24 , 12 and 12 h .
when they were transferred to a glucose-containing medium in order to deplete these proteins , the levels of immunoreactive ib could have #begun to return to basal levels following 3-4 h exposures to poly ic , respectively , after transfer and ceased at 24 , 12 and 12 h .
when they were transferred to a glucose-containing medium in order to deplete these proteins , the levels of immunoreactive ib has #begun returning to basal levels following 3-4 h exposures to poly ic , respectively , after transfer and ceased at 24 , 12 and 12 h .
when they were transferred to a glucose-containing medium in order to deplete these proteins , the levels of immunoreactive ib has #begun to return to basal levels following 3-4 h exposures to poly ic , respectively , after transfer and ceased at 24 , 12 and 12 h .
when they were transferred to a glucose-containing medium in order to deplete these proteins , the levels of immunoreactive ib is able to #begin returning to basal levels following 3-4 h exposures to poly ic , respectively , after transfer and ceased at 24 , 12 and 12 h .
when they were transferred to a glucose-containing medium in order to deplete these proteins , the levels of immunoreactive ib is able to #begin to return to basal levels following 3-4 h exposures to poly ic , respectively , after transfer and ceased at 24 , 12 and 12 h .
when they were transferred to a glucose-containing medium in order to deplete these proteins , the levels of immunoreactive ib is believed to #begin return to basal levels following 3-4 h exposures to poly ic , respectively , after transfer and ceased at 24 , 12 and 12 h .
when they were transferred to a glucose-containing medium in order to deplete these proteins , the levels of immunoreactive ib is believed to #begin returning to basal levels following 3-4 h exposures to poly ic , respectively , after transfer and ceased at 24 , 12 and 12 h .
when they were transferred to a glucose-containing medium in order to deplete these proteins , the levels of immunoreactive ib is believed to #begin to return to basal levels following 3-4 h exposures to poly ic , respectively , after transfer and ceased at 24 , 12 and 12 h .
when they were transferred to a glucose-containing medium in order to deplete these proteins , the levels of immunoreactive ib is believed to have #begun returning to basal levels following 3-4 h exposures to poly ic , respectively , after transfer and ceased at 24 , 12 and 12 h .
when they were transferred to a glucose-containing medium in order to deplete these proteins , the levels of immunoreactive ib may #begin return to basal levels following 3-4 h exposures to poly ic , respectively , after transfer and ceased at 24 , 12 and 12 h .
when they were transferred to a glucose-containing medium in order to deplete these proteins , the levels of immunoreactive ib may #begin returning to basal levels following 3-4 h exposures to poly ic , respectively , after transfer and ceased at 24 , 12 and 12 h .
when they were transferred to a glucose-containing medium in order to deplete these proteins , the levels of immunoreactive ib may have #begun return to basal levels following 3-4 h exposures to poly ic , respectively , after transfer and ceased at 24 , 12 and 12 h .
when they were transferred to a glucose-containing medium in order to deplete these proteins , the levels of immunoreactive ib may have #begun returning to basal levels following 3-4 h exposures to poly ic , respectively , after transfer and ceased at 24 , 12 and 12 h .
when they were transferred to a glucose-containing medium in order to deplete these proteins , the levels of immunoreactive ib might #begin return to basal levels following 3-4 h exposures to poly ic , respectively , after transfer and ceased at 24 , 12 and 12 h .
when they were transferred to a glucose-containing medium in order to deplete these proteins , the levels of immunoreactive ib might #begin returning to basal levels following 3-4 h exposures to poly ic , respectively , after transfer and ceased at 24 , 12 and 12 h .
when they were transferred to a glucose-containing medium in order to deplete these proteins , the levels of immunoreactive ib might #begin to return to basal levels following 3-4 h exposures to poly ic , respectively , after transfer and ceased at 24 , 12 and 12 h .
when they were transferred to a glucose-containing medium in order to deplete these proteins , the levels of immunoreactive ib might have #begun return to basal levels following 3-4 h exposures to poly ic , respectively , after transfer and ceased at 24 , 12 and 12 h .
when they were transferred to a glucose-containing medium in order to deplete these proteins , the levels of immunoreactive ib was able to #begin return to basal levels following 3-4 h exposures to poly ic , respectively , after transfer and ceased at 24 , 12 and 12 h .
when they were transferred to a glucose-containing medium in order to deplete these proteins , the levels of immunoreactive ib was able to #begin to return to basal levels following 3-4 h exposures to poly ic , respectively , after transfer and ceased at 24 , 12 and 12 h .
when they were transferred to a glucose-containing medium in order to deplete these proteins , the levels of immunoreactive ib was believed to #begin to return to basal levels following 3-4 h exposures to poly ic , respectively , after transfer and ceased at 24 , 12 and 12 h .
when they were transferred to a glucose-containing medium in order to deplete these proteins , the levels of immunoreactive ib was believed to have #begun returning to basal levels following 3-4 h exposures to poly ic , respectively , after transfer and ceased at 24 , 12 and 12 h .
when they were transferred to a glucose-containing medium in order to deplete these proteins , the levels of immunoreactive ib was believed to have #begun to return to basal levels following 3-4 h exposures to poly ic , respectively , after transfer and ceased at 24 , 12 and 12 h .
when they were transferred to a glucose-containing medium in order to deplete these proteins , the levels of immunoreactive ib will #begin return to basal levels following 3-4 h exposures to poly ic , respectively , after transfer and ceased at 24 , 12 and 12 h .
when they were transferred to a glucose-containing medium in order to deplete these proteins , the levels of immunoreactive ib will #begin returning to basal levels following 3-4 h exposures to poly ic , respectively , after transfer and ceased at 24 , 12 and 12 h .
when they were transferred to a glucose-containing medium in order to deplete these proteins , the levels of immunoreactive ib will #begin to return to basal levels following 3-4 h exposures to poly ic , respectively , after transfer and ceased at 24 , 12 and 12 h .
when they were transferred to a glucose-containing medium in order to deplete these proteins , the levels of immunoreactive ib will have #begun return to basal levels following 3-4 h exposures to poly ic , respectively , after transfer and ceased at 24 , 12 and 12 h .
when they were transferred to a glucose-containing medium in order to deplete these proteins , the levels of immunoreactive ib would #begin return to basal levels following 3-4 h exposures to poly ic , respectively , after transfer and ceased at 24 , 12 and 12 h .
when they were transferred to a glucose-containing medium in order to deplete these proteins , the levels of immunoreactive ib would #begin returning to basal levels following 3-4 h exposures to poly ic , respectively , after transfer and ceased at 24 , 12 and 12 h .
when they were transferred to a glucose-containing medium in order to deplete these proteins , the levels of immunoreactive ib would have #begun returning to basal levels following 3-4 h exposures to poly ic , respectively , after transfer and ceased at 24 , 12 and 12 h .
when they were transferred to a glucose-containing medium in order to deplete these proteins , the levels of immunoreactive ib would have #begun to return to basal levels following 3-4 h exposures to poly ic , respectively , after transfer and ceased at 24 , 12 and 12 h .
when they were transferred to a glucose-containing medium in order to deplete these proteins , growth of gaal , gpi8 and gpi16 deletants #began to declining at 12 , 6 and 6 h , respectively , after transfer and ceased at 24 , 12 and 12 h .
when they were transferred to a glucose-containing medium in order to deplete these proteins , growth of gaal , gpi8 and gpi16 deletants #began to to decline at 12 , 6 and 6 h , respectively , after transfer and ceased at 24 , 12 and 12 h .
when they were transferred to a glucose-containing medium in order to deplete these proteins , growth of gaal , gpi8 and gpi16 deletants #begins decline at 12 , 6 and 6 h , respectively , after transfer and ceased at 24 , 12 and 12 h .
when they were transferred to a glucose-containing medium in order to deplete these proteins , growth of gaal , gpi8 and gpi16 deletants can have #begun decline at 12 , 6 and 6 h , respectively , after transfer and ceased at 24 , 12 and 12 h .
when they were transferred to a glucose-containing medium in order to deplete these proteins , growth of gaal , gpi8 and gpi16 deletants could #begin decline at 12 , 6 and 6 h , respectively , after transfer and ceased at 24 , 12 and 12 h .
when they were transferred to a glucose-containing medium in order to deplete these proteins , growth of gaal , gpi8 and gpi16 deletants could have #begun decline at 12 , 6 and 6 h , respectively , after transfer and ceased at 24 , 12 and 12 h .
when they were transferred to a glucose-containing medium in order to deplete these proteins , growth of gaal , gpi8 and gpi16 deletants could have #begun declining at 12 , 6 and 6 h , respectively , after transfer and ceased at 24 , 12 and 12 h .
when they were transferred to a glucose-containing medium in order to deplete these proteins , growth of gaal , gpi8 and gpi16 deletants has #begun decline at 12 , 6 and 6 h , respectively , after transfer and ceased at 24 , 12 and 12 h .
when they were transferred to a glucose-containing medium in order to deplete these proteins , growth of gaal , gpi8 and gpi16 deletants is able to #begin to decline at 12 , 6 and 6 h , respectively , after transfer and ceased at 24 , 12 and 12 h .
when they were transferred to a glucose-containing medium in order to deplete these proteins , growth of gaal , gpi8 and gpi16 deletants is believed to #begin to decline at 12 , 6 and 6 h , respectively , after transfer and ceased at 24 , 12 and 12 h .
when they were transferred to a glucose-containing medium in order to deplete these proteins , growth of gaal , gpi8 and gpi16 deletants may #begin decline at 12 , 6 and 6 h , respectively , after transfer and ceased at 24 , 12 and 12 h .
when they were transferred to a glucose-containing medium in order to deplete these proteins , growth of gaal , gpi8 and gpi16 deletants may #begin declining at 12 , 6 and 6 h , respectively , after transfer and ceased at 24 , 12 and 12 h .
when they were transferred to a glucose-containing medium in order to deplete these proteins , growth of gaal , gpi8 and gpi16 deletants may have #begun decline at 12 , 6 and 6 h , respectively , after transfer and ceased at 24 , 12 and 12 h .
when they were transferred to a glucose-containing medium in order to deplete these proteins , growth of gaal , gpi8 and gpi16 deletants may have #begun declining at 12 , 6 and 6 h , respectively , after transfer and ceased at 24 , 12 and 12 h .
when they were transferred to a glucose-containing medium in order to deplete these proteins , growth of gaal , gpi8 and gpi16 deletants might #begin decline at 12 , 6 and 6 h , respectively , after transfer and ceased at 24 , 12 and 12 h .
when they were transferred to a glucose-containing medium in order to deplete these proteins , growth of gaal , gpi8 and gpi16 deletants might #begin declining at 12 , 6 and 6 h , respectively , after transfer and ceased at 24 , 12 and 12 h .
when they were transferred to a glucose-containing medium in order to deplete these proteins , growth of gaal , gpi8 and gpi16 deletants might have #begun declining at 12 , 6 and 6 h , respectively , after transfer and ceased at 24 , 12 and 12 h .
when they were transferred to a glucose-containing medium in order to deplete these proteins , growth of gaal , gpi8 and gpi16 deletants was able to #begin decline at 12 , 6 and 6 h , respectively , after transfer and ceased at 24 , 12 and 12 h .
when they were transferred to a glucose-containing medium in order to deplete these proteins , growth of gaal , gpi8 and gpi16 deletants was able to #begin to decline at 12 , 6 and 6 h , respectively , after transfer and ceased at 24 , 12 and 12 h .
when they were transferred to a glucose-containing medium in order to deplete these proteins , growth of gaal , gpi8 and gpi16 deletants was believed to #begin to decline at 12 , 6 and 6 h , respectively , after transfer and ceased at 24 , 12 and 12 h .
when they were transferred to a glucose-containing medium in order to deplete these proteins , growth of gaal , gpi8 and gpi16 deletants was believed to have #begun decline at 12 , 6 and 6 h , respectively , after transfer and ceased at 24 , 12 and 12 h .
when they were transferred to a glucose-containing medium in order to deplete these proteins , growth of gaal , gpi8 and gpi16 deletants was believed to have #begun to decline at 12 , 6 and 6 h , respectively , after transfer and ceased at 24 , 12 and 12 h .
when they were transferred to a glucose-containing medium in order to deplete these proteins , growth of gaal , gpi8 and gpi16 deletants will #begin decline at 12 , 6 and 6 h , respectively , after transfer and ceased at 24 , 12 and 12 h .
when they were transferred to a glucose-containing medium in order to deplete these proteins , growth of gaal , gpi8 and gpi16 deletants will have #begun decline at 12 , 6 and 6 h , respectively , after transfer and ceased at 24 , 12 and 12 h .
when they were transferred to a glucose-containing medium in order to deplete these proteins , growth of gaal , gpi8 and gpi16 deletants will have #begun declining at 12 , 6 and 6 h , respectively , after transfer and ceased at 24 , 12 and 12 h .
when they were transferred to a glucose-containing medium in order to deplete these proteins , growth of gaal , gpi8 and gpi16 deletants would have #begun declining at 12 , 6 and 6 h , respectively , after transfer and ceased at 24 , 12 and 12 h .
growth of gaal , gpi8 and gpi16 deletants are able to promptly #begin decline at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants are able to promptly #begin declining at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants #began decline at 12 , 6 and 6 h , but growth continued slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants #began declining at 12 , 6 and 6 h , but growth continued slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants #began to decline at 12 , 6 and 6 h , but growth continued slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants #began to decline at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants #begin to decline at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants #begin to declining at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants #begin to to decline at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants #beginning decline at 12 , 6 and 6 h can continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants #beginning declining at 12 , 6 and 6 h can continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants #beginning to decline at 12 , 6 and 6 h can continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants #begins declining at 12 , 6 and 6 h , but growth continues slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants believed to #begin decline at 12 , 6 and 6 h can continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants believed to #begin to decline at 12 , 6 and 6 h can continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants believed to have #begun decline at 12 , 6 and 6 h can continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants believed to probably #begin to decline at 12 , 6 and 6 h can continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants can #begin decline at 12 , 6 and 6 h , but growth can continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants can #begin decline at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants can #begin to decline at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants can have #begun decline at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants can have #begun to decline at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants can have promptly #begun declining at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants can probably #begin declining at 12 , 6 and 6 h , but growth can continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants can probably #begin to decline at 12 , 6 and 6 h , but growth can continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants can promptly #begin decline at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants can promptly #begin declining at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants could #begin decline at 12 , 6 and 6 h , but growth could continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants could #begin decline at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants could #begin declining at 12 , 6 and 6 h , but growth could continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants could #begin declining at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants could #begin to decline at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants could have #begun declining at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants could have #begun to decline at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants could have promptly #begun decline at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants could have promptly #begun declining at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants could probably #begin to decline at 12 , 6 and 6 h , but growth could continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants could promptly #begin decline at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants has probably #begun to decline at 12 , 6 and 6 h , but growth continued slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants have #begun declining at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants have promptly #begun decline at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants have promptly #begun to decline at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants is able to #begin decline at 12 , 6 and 6 h , but growth can continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants is able to #begin declining at 12 , 6 and 6 h , but growth can continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants is able to #begin to decline at 12 , 6 and 6 h , but growth can continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants is able to probably #begin decline at 12 , 6 and 6 h , but growth can continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants is believed to #begin decline at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants is believed to #begin declining at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants is believed to #begin to decline at 12 , 6 and 6 h , but growth continues slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants is believed to have #begun declining at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants is believed to have probably #begun decline at 12 , 6 and 6 h , but growth continued slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants is believed to have probably #begun to decline at 12 , 6 and 6 h , but growth continued slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants is believed to probably #begin decline at 12 , 6 and 6 h , but growth continues slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants is believed to promptly #begin decline at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants is believed to promptly #begin declining at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants is believed to promptly #begin to decline at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants may have #begun declining at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants may have promptly #begun decline at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants may probably #begin declining at 12 , 6 and 6 h , but growth can continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants may probably #begin to decline at 12 , 6 and 6 h , but growth can continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants may promptly #begin decline at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants may promptly #begin declining at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants may promptly #begin to decline at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants might #begin decline at 12 , 6 and 6 h , but growth would continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants might #begin decline at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants might #begin declining at 12 , 6 and 6 h , but growth would continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants might #begin declining at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants might #begin to decline at 12 , 6 and 6 h , but growth would continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants might #begin to decline at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants might have #begun declining at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants might have promptly #begun decline at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants might have promptly #begun declining at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants might probably #begin decline at 12 , 6 and 6 h , but growth would continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants might probably #begin declining at 12 , 6 and 6 h , but growth would continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants might promptly #begin decline at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants probably #begins declining at 12 , 6 and 6 h , but growth continues slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants probably #begins to decline at 12 , 6 and 6 h , but growth continues slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants promptly #began decline at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants that #began decline at 12 , 6 and 6 h can continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants that #begins decline at 12 , 6 and 6 h can continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants that has #begun decline at 12 , 6 and 6 h can continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants that has #begun declining at 12 , 6 and 6 h can continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants that has #begun to decline at 12 , 6 and 6 h can continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants that has probably #begun decline at 12 , 6 and 6 h can continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants that has probably #begun declining at 12 , 6 and 6 h can continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants that is believed to #begin decline at 12 , 6 and 6 h can continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants that is believed to #begin declining at 12 , 6 and 6 h can continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants that is believed to #begin to decline at 12 , 6 and 6 h can continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants that is believed to have #begun decline at 12 , 6 and 6 h can continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants that is believed to have probably #begun to decline at 12 , 6 and 6 h can continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants that is believed to probably #begin decline at 12 , 6 and 6 h can continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants that is believed to probably #begin to decline at 12 , 6 and 6 h can continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants that was believed to #begin declining at 12 , 6 and 6 h could continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants that was believed to have probably #begun decline at 12 , 6 and 6 h could continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants that was believed to probably #begin declining at 12 , 6 and 6 h could continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants was able to #begin decline at 12 , 6 and 6 h , but growth could continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants was able to #begin declining at 12 , 6 and 6 h , but growth could continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants was able to #begin declining at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants was able to #begin to decline at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants was able to probably #begin declining at 12 , 6 and 6 h , but growth could continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants was able to promptly #begin decline at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants was able to promptly #begin to decline at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants was believed to #begin decline at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants was believed to #begin declining at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants was believed to #begin to decline at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants was believed to have #begun decline at 12 , 6 and 6 h , but growth continued slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants was believed to have #begun declining at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants was believed to have #begun to decline at 12 , 6 and 6 h , but growth continued slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants was believed to have probably #begun decline at 12 , 6 and 6 h , but growth continued slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants was believed to have promptly #begun declining at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants was believed to probably #begin decline at 12 , 6 and 6 h , but growth continued slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants was believed to probably #begin to decline at 12 , 6 and 6 h , but growth continued slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants was believed to promptly #begin declining at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants which #began decline at 12 , 6 and 6 h can continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants which has #begun to decline at 12 , 6 and 6 h can continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants which has probably #begun declining at 12 , 6 and 6 h can continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants which is believed to #begin declining at 12 , 6 and 6 h can continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants which is believed to have #begun decline at 12 , 6 and 6 h can continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants which is believed to have #begun declining at 12 , 6 and 6 h can continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants which is believed to have probably #begun declining at 12 , 6 and 6 h can continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants which is believed to have probably #begun to decline at 12 , 6 and 6 h can continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants which is believed to probably #begin decline at 12 , 6 and 6 h can continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants which is believed to probably #begin declining at 12 , 6 and 6 h can continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants which is believed to probably #begin to decline at 12 , 6 and 6 h can continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants which probably #began decline at 12 , 6 and 6 h can continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants which probably #began to decline at 12 , 6 and 6 h can continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants which was believed to #begin declining at 12 , 6 and 6 h could continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants which was believed to have #begun declining at 12 , 6 and 6 h could continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants which was believed to have #begun to decline at 12 , 6 and 6 h could continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants which was believed to have probably #begun decline at 12 , 6 and 6 h could continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants which was believed to have probably #begun declining at 12 , 6 and 6 h could continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants which was believed to have probably #begun to decline at 12 , 6 and 6 h could continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants which was believed to probably #begin decline at 12 , 6 and 6 h could continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants which was believed to probably #begin declining at 12 , 6 and 6 h could continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants which was believed to probably #begin to decline at 12 , 6 and 6 h could continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants will #begin decline at 12 , 6 and 6 h , but growth will continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants will #begin decline at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants will #begin declining at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants will #begin to decline at 12 , 6 and 6 h , but growth will continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants will have #begun to decline at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants will have promptly #begun declining at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants will have promptly #begun to decline at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants will probably #begin decline at 12 , 6 and 6 h , but growth will continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants will probably #begin declining at 12 , 6 and 6 h , but growth will continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants will promptly #begin decline at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants will promptly #begin declining at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants would #begin decline at 12 , 6 and 6 h , but growth would continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants would #begin decline at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants would have #begun decline at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants would have #begun declining at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants would have promptly #begun declining at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants would have promptly #begun to decline at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants would probably #begin decline at 12 , 6 and 6 h , but growth would continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants would probably #begin declining at 12 , 6 and 6 h , but growth would continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants would promptly #begin declining at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants would promptly #begin to decline at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants , as our study suggested , #begins decline at 12 , 6 and 6 h , but growth continues slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants , as our study suggested , #begins declining at 12 , 6 and 6 h , but growth continues slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants , as our study suggested , can #begin decline at 12 , 6 and 6 h , but growth can continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants , as our study suggested , can #begin declining at 12 , 6 and 6 h , but growth can continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants , as our study suggested , can probably #begin decline at 12 , 6 and 6 h , but growth can continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants , as our study suggested , can probably #begin to decline at 12 , 6 and 6 h , but growth can continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants , as our study suggested , could #begin decline at 12 , 6 and 6 h , but growth could continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants , as our study suggested , has probably #begun decline at 12 , 6 and 6 h , but growth continued slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants , as our study suggested , has probably #begun declining at 12 , 6 and 6 h , but growth continued slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants , as our study suggested , is able to #begin to decline at 12 , 6 and 6 h , but growth can continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants , as our study suggested , is able to probably #begin to decline at 12 , 6 and 6 h , but growth can continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants , as our study suggested , is believed to #begin declining at 12 , 6 and 6 h , but growth continues slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants , as our study suggested , is believed to have #begun decline at 12 , 6 and 6 h , but growth continued slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants , as our study suggested , is believed to have probably #begun declining at 12 , 6 and 6 h , but growth continued slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants , as our study suggested , is believed to probably #begin declining at 12 , 6 and 6 h , but growth continues slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants , as our study suggested , may #begin decline at 12 , 6 and 6 h , but growth can continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants , as our study suggested , may probably #begin declining at 12 , 6 and 6 h , but growth can continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants , as our study suggested , may probably #begin to decline at 12 , 6 and 6 h , but growth can continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants , as our study suggested , might #begin declining at 12 , 6 and 6 h , but growth would continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants , as our study suggested , might #begin to decline at 12 , 6 and 6 h , but growth would continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants , as our study suggested , might probably #begin decline at 12 , 6 and 6 h , but growth would continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants , as our study suggested , might probably #begin declining at 12 , 6 and 6 h , but growth would continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants , as our study suggested , was able to #begin to decline at 12 , 6 and 6 h , but growth could continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants , as our study suggested , was able to probably #begin decline at 12 , 6 and 6 h , but growth could continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants , as our study suggested , was able to probably #begin declining at 12 , 6 and 6 h , but growth could continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants , as our study suggested , was believed to #begin decline at 12 , 6 and 6 h , but growth continued slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants , as our study suggested , was believed to #begin declining at 12 , 6 and 6 h , but growth continued slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants , as our study suggested , was believed to #begin to decline at 12 , 6 and 6 h , but growth continued slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants , as our study suggested , was believed to have probably #begun declining at 12 , 6 and 6 h , but growth continued slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants , as our study suggested , was believed to probably #begin decline at 12 , 6 and 6 h , but growth continued slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants , as our study suggested , was believed to probably #begin declining at 12 , 6 and 6 h , but growth continued slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants , as our study suggested , was believed to probably #begin to decline at 12 , 6 and 6 h , but growth continued slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants , as our study suggested , will #begin declining at 12 , 6 and 6 h , but growth will continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants , as our study suggested , will #begin to decline at 12 , 6 and 6 h , but growth will continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants , as our study suggested , will probably #begin decline at 12 , 6 and 6 h , but growth will continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants , as our study suggested , would #begin declining at 12 , 6 and 6 h , but growth would continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants , as our study suggested , would #begin to decline at 12 , 6 and 6 h , but growth would continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants , as our study suggested , would probably #begin declining at 12 , 6 and 6 h , but growth would continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants , as several research works revealed , are able to #begin to decline at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants , as several research works revealed , are able to promptly #begin decline at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants , as several research works revealed , are able to promptly #begin declining at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants , as several research works revealed , are able to promptly #begin to decline at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants , as several research works revealed , #began decline at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants , as several research works revealed , #began declining at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants , as several research works revealed , #began to decline at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants , as several research works revealed , can #begin decline at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants , as several research works revealed , can have #begun decline at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants , as several research works revealed , can have #begun declining at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants , as several research works revealed , can have #begun to decline at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants , as several research works revealed , can have promptly #begun decline at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants , as several research works revealed , can have promptly #begun declining at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants , as several research works revealed , can promptly #begin decline at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants , as several research works revealed , can promptly #begin declining at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants , as several research works revealed , can promptly #begin to decline at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants , as several research works revealed , could #begin decline at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants , as several research works revealed , could #begin declining at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants , as several research works revealed , could #begin to decline at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants , as several research works revealed , could promptly #begin declining at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants , as several research works revealed , could promptly #begin to decline at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants , as several research works revealed , have promptly #begun decline at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants , as several research works revealed , have promptly #begun declining at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants , as several research works revealed , have promptly #begun to decline at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants , as several research works revealed , is believed to #begin decline at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants , as several research works revealed , is believed to have #begun to decline at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants , as several research works revealed , is believed to have promptly #begun declining at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants , as several research works revealed , is believed to promptly #begin declining at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants , as several research works revealed , is believed to promptly #begin to decline at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants , as several research works revealed , may #begin decline at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants , as several research works revealed , may have promptly #begun decline at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants , as several research works revealed , may have promptly #begun to decline at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants , as several research works revealed , may promptly #begin declining at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants , as several research works revealed , may promptly #begin to decline at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants , as several research works revealed , might #begin declining at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants , as several research works revealed , might have #begun decline at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants , as several research works revealed , might have #begun declining at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants , as several research works revealed , might have promptly #begun declining at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants , as several research works revealed , might promptly #begin decline at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants , as several research works revealed , might promptly #begin declining at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants , as several research works revealed , promptly #began decline at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants , as several research works revealed , promptly #began declining at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants , as several research works revealed , promptly #began to decline at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants , as several research works revealed , was able to #begin decline at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants , as several research works revealed , was able to promptly #begin declining at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants , as several research works revealed , was believed to #begin declining at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants , as several research works revealed , was believed to have #begun declining at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants , as several research works revealed , was believed to have promptly #begun to decline at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants , as several research works revealed , was believed to promptly #begin decline at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants , as several research works revealed , will have #begun to decline at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants , as several research works revealed , will have promptly #begun to decline at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants , as several research works revealed , will promptly #begin decline at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants , as several research works revealed , will promptly #begin declining at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants , as several research works revealed , will promptly #begin to decline at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants , as several research works revealed , would #begin decline at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants , as several research works revealed , would #begin to decline at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants , as several research works revealed , would have promptly #begun declining at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants , as several research works revealed , would promptly #begin declining at 12 , 6 and 6 h .
a downstream kinase appeared to be essential for agrin-mediated signaling , since agrin-induced achr clustering and phosphorylation were able to be #blocked by staurosporine without inhibiting musk phosphorylation (wallace , 1994; fuhrer et al . , 1997) .
a downstream kinase appeared to be essential for agrin-mediated signaling , since staurosporine could #block agrin-induced achr clustering and phosphorylation without inhibiting musk phosphorylation (wallace , 1994; fuhrer et al . , 1997) .
a downstream kinase appeared to be essential for agrin-mediated signaling , since staurosporine was able to #block agrin-induced achr clustering and phosphorylation without inhibiting musk phosphorylation (wallace , 1994; fuhrer et al . , 1997) .
a downstream kinase appeared to be essential for agrin-mediated signaling , since staurosporine was believed to have #blocked agrin-induced achr clustering and phosphorylation without inhibiting musk phosphorylation (wallace , 1994; fuhrer et al . , 1997) .
a downstream kinase appeared to be essential for agrin-mediated signaling , since staurosporine was #blocking agrin-induced achr clustering and phosphorylation without inhibiting musk phosphorylation (wallace , 1994; fuhrer et al . , 1997) .
a downstream kinase appears to be essential for agrin-mediated signaling because of staurosporines ability to #block agrin-induced achr clustering and phosphorylation without inhibiting musk phosphorylation (wallace , 1994; fuhrer et al . , 1997) .
a downstream kinase appears to be essential for agrin-mediated signaling , since agrin-induced achr clustering and phosphorylation are able to be #blocked by staurosporine without inhibiting musk phosphorylation (wallace , 1994; fuhrer et al . , 1997) .
a downstream kinase appears to be essential for agrin-mediated signaling , since agrin-induced achr clustering and phosphorylation are #blocked by staurosporine without inhibiting musk phosphorylation (wallace , 1994; fuhrer et al . , 1997) .
a downstream kinase appears to be essential for agrin-mediated signaling , since agrin-induced achr clustering and phosphorylation can be #blocked by staurosporine without inhibiting musk phosphorylation (wallace , 1994; fuhrer et al . , 1997) .
a downstream kinase appears to be essential for agrin-mediated signaling , since agrin-induced achr clustering and phosphorylation have been #blocked by staurosporine without inhibiting musk phosphorylation (wallace , 1994; fuhrer et al . , 1997) .
a downstream kinase appears to be essential for agrin-mediated signaling , since agrin-induced achr clustering and phosphorylation may be #blocked by staurosporine without inhibiting musk phosphorylation (wallace , 1994; fuhrer et al . , 1997) .
a downstream kinase appears to be essential for agrin-mediated signaling , since agrin-induced achr clustering and phosphorylation were #blocked by staurosporine without inhibiting musk phosphorylation (wallace , 1994; fuhrer et al . , 1997) .
a downstream kinase appears to be essential for agrin-mediated signaling , since staurosporine is able to #block agrin-induced achr clustering and phosphorylation without inhibiting musk phosphorylation (wallace , 1994; fuhrer et al . , 1997) .
a downstream kinase appears to be essential for agrin-mediated signaling , since staurosporine is believed to #block agrin-induced achr clustering and phosphorylation without inhibiting musk phosphorylation (wallace , 1994; fuhrer et al . , 1997) .
a downstream kinase appears to be essential for agrin-mediated signaling , since staurosporine is believed to have #blocked agrin-induced achr clustering and phosphorylation without inhibiting musk phosphorylation (wallace , 1994; fuhrer et al . , 1997) .
a downstream kinase appears to be essential for agrin-mediated signaling , since staurosporine is #blocking agrin-induced achr clustering and phosphorylation without inhibiting musk phosphorylation (wallace , 1994; fuhrer et al . , 1997) .
alanine #blocked the action of a postulated repressor .
alanine #blocks the action of a postulated repressor .
alanine can #block the action of a postulated repressor .
alanine could #block the action of a postulated repressor .
alanine could have #blocked the action of a postulated repressor .
alanine is able to #block the action of a postulated repressor .
alanine may have #blocked the action of a postulated repressor .
alanine might #block the action of a postulated repressor .
alanine might have #blocked the action of a postulated repressor .
alanine will #block the action of a postulated repressor .
both rap1 and 2 are important vaccine candidates because antibodies to rap1 are shown to #block merozoite invasion in vitro (schofield et al . , 1986; harnyuttanakorn et al . , 1992; howard et al . , 1998a) .
both rap1 and 2 are important vaccine candidates because antibodies to rap1 are shown to have #blocked merozoite invasion in vitro (schofield et al . , 1986; harnyuttanakorn et al . , 1992; howard et al . , 1998a) .
both rap1 and 2 are important vaccine candidates because antibodies to rap1 have been shown to be able to #block merozoite invasion in vitro (schofield et al . , 1986; harnyuttanakorn et al . , 1992; howard et al . , 1998a) .
both rap1 and 2 are important vaccine candidates because antibodies to rap1 have been shown to have #blocked merozoite invasion in vitro (schofield et al . , 1986; harnyuttanakorn et al . , 1992; howard et al . , 1998a) .
both rap1 and 2 are important vaccine candidates because it has been shown that antibodies to rap1 #blocked merozoite invasion in vitro (schofield et al . , 1986; harnyuttanakorn et al . , 1992; howard et al . , 1998a) .
both rap1 and 2 are important vaccine candidates because it has been shown that antibodies to rap1 can #block merozoite invasion in vitro (schofield et al . , 1986; harnyuttanakorn et al . , 1992; howard et al . , 1998a) .
both rap1 and 2 are important vaccine candidates because it has been shown that antibodies to rap1 may #block merozoite invasion in vitro (schofield et al . , 1986; harnyuttanakorn et al . , 1992; howard et al . , 1998a) .
both rap1 and 2 are important vaccine candidates because it has been shown that merozoite invasion in vitro can be #blocked by antibodies to rap1 (schofield et al . , 1986; harnyuttanakorn et al . , 1992; howard et al . , 1998a) .
both rap1 and 2 are important vaccine candidates because it has been shown that merozoite invasion in vitro has been #blocked by antibodies to rap1 (schofield et al . , 1986; harnyuttanakorn et al . , 1992; howard et al . , 1998a) .
both rap1 and 2 are important vaccine candidates because it has been shown that merozoite invasion in vitro is believed to be #blocked by antibodies to rap1 (schofield et al . , 1986; harnyuttanakorn et al . , 1992; howard et al . , 1998a) .
both rap1 and 2 are important vaccine candidates because it has been shown that merozoite invasion in vitro may be #blocked by antibodies to rap1 (schofield et al . , 1986; harnyuttanakorn et al . , 1992; howard et al . , 1998a) .
both rap1 and 2 are important vaccine candidates because it has been shown that merozoite invasion in vitro might be #blocked by antibodies to rap1 (schofield et al . , 1986; harnyuttanakorn et al . , 1992; howard et al . , 1998a) .
both rap1 and 2 are important vaccine candidates because it has been shown that merozoite invasion in vitro was believed to be #blocked by antibodies to rap1 (schofield et al . , 1986; harnyuttanakorn et al . , 1992; howard et al . , 1998a) .
both rap1 and 2 are important vaccine candidates because it has been shown that merozoite invasion in vitro was #blocked by antibodies to rap1 (schofield et al . , 1986; harnyuttanakorn et al . , 1992; howard et al . , 1998a) .
both rap1 and 2 are important vaccine candidates because it has been shown that merozoite invasion in vitro will be #blocked by antibodies to rap1 (schofield et al . , 1986; harnyuttanakorn et al . , 1992; howard et al . , 1998a) .
both rap1 and 2 are important vaccine candidates because merozoite invasion in vitro is shown to be #blocked by antibodies to rap1 (schofield et al . , 1986; harnyuttanakorn et al . , 1992; howard et al . , 1998a) .
both rap1 and 2 are important vaccine candidates because merozoite invasion in vitro was shown to have been #blocked by antibodies to rap1 (schofield et al . , 1986; harnyuttanakorn et al . , 1992; howard et al . , 1998a) .
it can #block membranes in tbst (tris-buffered saline , 0 .05% tween-20) containing 5% bovine serum albumin (for anti-phosphoryrosine blots) or skimmed milk and probed with antibodies .
it has #blocked membranes in tbst (tris-buffered saline , 0 .05% tween-20) containing 5% bovine serum albumin (for anti-phosphoryrosine blots) or skimmed milk and probed with antibodies .
it is able to #block membranes in tbst (tris-buffered saline , 0 .05% tween-20) containing 5% bovine serum albumin (for anti-phosphoryrosine blots) or skimmed milk and probed with antibodies .
it is believed to #block membranes in tbst (tris-buffered saline , 0 .05% tween-20) containing 5% bovine serum albumin (for anti-phosphoryrosine blots) or skimmed milk and probed with antibodies .
it might #block membranes in tbst (tris-buffered saline , 0 .05% tween-20) containing 5% bovine serum albumin (for anti-phosphoryrosine blots) or skimmed milk and probed with antibodies .
it would #block membranes in tbst (tris-buffered saline , 0 .05% tween-20) containing 5% bovine serum albumin (for anti-phosphoryrosine blots) or skimmed milk and probed with antibodies .
membranes are believed to be #blocked in tbst (tris-buffered saline , 0 .05% tween-20) containing 5% bovine serum albumin (for anti-phosphoryrosine blots) or skimmed milk and probed with antibodies .
membranes are #blocked in tbst (tris-buffered saline , 0 .05% tween-20) containing 5% bovine serum albumin (for anti-phosphoryrosine blots) or skimmed milk and probed with antibodies .
membranes may be #blocked in tbst (tris-buffered saline , 0 .05% tween-20) containing 5% bovine serum albumin (for anti-phosphoryrosine blots) or skimmed milk and probed with antibodies .
tagetin is more specific for distinguishing between different rna polymerases because rna polymerase during elongation can be #blocked by it (mathews and durbin , 1994) , i .e .its action is independent of different initiation factors .
tagetin is more specific for distinguishing between different rna polymerases because rna polymerase during elongation is able to be #blocked by it (mathews and durbin , 1994) , i .e .its action is independent of different initiation factors .
tagetin is more specific for distinguishing between different rna polymerases because rna polymerase during elongation is #blocked by it (mathews and durbin , 1994) , i .e .its action is independent of different initiation factors .
tagetin is more specific for distinguishing between different rna polymerases because rna polymerase during elongation was #blocked by it (mathews and durbin , 1994) , i .e .its action is independent of different initiation factors .
tagetin is more specific for distinguishing between different rna polymerases because it #blocked rna polymerase during elongation (mathews and durbin , 1994) , i .e .its action is independent of different initiation factors .
these results suggest that 14-3-3eta functions as a positive regulator in the glucocorticoid signal pathway for #blocking the degradation of gr and inducing an elevation of gr , thus enhancing the transcriptional activity of gr .
these results suggest that 14-3-3eta functions as a positive regulator in the glucocorticoid signal pathway that #blocked the degradation of gr and inducing an elevation of gr , thus enhancing the transcriptional activity of gr .
the action of a postulated repressor is #blocked by alanine .
a downstream kinase appears to be essential for agrin-mediated signaling , since staurosporine #blocks agrin-induced achr clustering and phosphorylation without inhibiting musk phosphorylation (wallace , 1994; fuhrer et al . , 1997) .
membranes were #blocked in tbst (tris-buffered saline , 0 .05% tween-20) containing 5% bovine serum albumin (for anti-phosphoryrosine blots) or skimmed milk and probed with antibodies .
tagetin is more specific for distinguishing between different rna polymerases because it #blocks rna polymerase during elongation (mathews and durbin , 1994) , i .e .its action is independent of different initiation factors .
alanine is thought to act as an inducer to #block the action of a postulated repressor .
alanine is more specific for distinguishing between different rna polymerases because it #blocked the action of a postulated repressor (mathews and durbin , 1994) , i .e .its action is independent of different initiation factors .
alanine is more specific for distinguishing between different rna polymerases because it #blocks the action of a postulated repressor (mathews and durbin , 1994) , i .e .its action is independent of different initiation factors .
alanine is more specific for distinguishing between different rna polymerases because it can #block the action of a postulated repressor (mathews and durbin , 1994) , i .e .its action is independent of different initiation factors .
alanine is more specific for distinguishing between different rna polymerases because it is able to #block the action of a postulated repressor (mathews and durbin , 1994) , i .e .its action is independent of different initiation factors .
alanine is more specific for distinguishing between different rna polymerases because it may #blocks the action of a postulated repressor (mathews and durbin , 1994) , i .e .its action is independent of different initiation factors .
both rap1 and 2 are important vaccine candidates because alanine are shown to #block the action of a postulated repressor (schofield et al . , 1986; harnyuttanakorn et al . , 1992; howard et al . , 1998a) .
both rap1 and 2 are important vaccine candidates because alanine are shown to have #blocked the action of a postulated repressor (schofield et al . , 1986; harnyuttanakorn et al . , 1992; howard et al . , 1998a) .
both rap1 and 2 are important vaccine candidates because alanine have been shown to have #blocked the action of a postulated repressor (schofield et al . , 1986; harnyuttanakorn et al . , 1992; howard et al . , 1998a) .
both rap1 and 2 are important vaccine candidates because rna polymerase during elongation is shown to be #blocked by tagetin (schofield et al . , 1986; harnyuttanakorn et al . , 1992; howard et al . , 1998a) .
both rap1 and 2 are important vaccine candidates because rna polymerase during elongation is shown to have been #blocked by tagetin (schofield et al . , 1986; harnyuttanakorn et al . , 1992; howard et al . , 1998a) .
both rap1 and 2 are important vaccine candidates because rna polymerase during elongation was shown to be #blocked by tagetin (schofield et al . , 1986; harnyuttanakorn et al . , 1992; howard et al . , 1998a) .
both rap1 and 2 are important vaccine candidates because tagetin are shown to be able to #block rna polymerase during elongation (schofield et al . , 1986; harnyuttanakorn et al . , 1992; howard et al . , 1998a) .
both rap1 and 2 are important vaccine candidates because tagetin have been shown to #block rna polymerase during elongation (schofield et al . , 1986; harnyuttanakorn et al . , 1992; howard et al . , 1998a) .
both rap1 and 2 are important vaccine candidates because tagetin have been shown to have #blocked rna polymerase during elongation (schofield et al . , 1986; harnyuttanakorn et al . , 1992; howard et al . , 1998a) .
both rap1 and 2 are important vaccine candidates because it has been shown that alanine were able to #block the action of a postulated repressor (schofield et al . , 1986; harnyuttanakorn et al . , 1992; howard et al . , 1998a) .
both rap1 and 2 are important vaccine candidates because it has been shown that rna polymerase during elongation is believed to be #blocked by tagetin (schofield et al . , 1986; harnyuttanakorn et al . , 1992; howard et al . , 1998a) .
both rap1 and 2 are important vaccine candidates because it has been shown that rna polymerase during elongation might be #blocked by tagetin (schofield et al . , 1986; harnyuttanakorn et al . , 1992; howard et al . , 1998a) .
both rap1 and 2 are important vaccine candidates because it has been shown that rna polymerase during elongation was #blocked by tagetin (schofield et al . , 1986; harnyuttanakorn et al . , 1992; howard et al . , 1998a) .
both rap1 and 2 are important vaccine candidates because it has been shown that rna polymerase during elongation will be #blocked by tagetin (schofield et al . , 1986; harnyuttanakorn et al . , 1992; howard et al . , 1998a) .
both rap1 and 2 are important vaccine candidates because it has been shown that tagetin are able to #block rna polymerase during elongation (schofield et al . , 1986; harnyuttanakorn et al . , 1992; howard et al . , 1998a) .
both rap1 and 2 are important vaccine candidates because it has been shown that tagetin #blocked rna polymerase during elongation (schofield et al . , 1986; harnyuttanakorn et al . , 1992; howard et al . , 1998a) .
both rap1 and 2 are important vaccine candidates because it has been shown that tagetin were able to #block rna polymerase during elongation (schofield et al . , 1986; harnyuttanakorn et al . , 1992; howard et al . , 1998a) .
both rap1 and 2 are important vaccine candidates because it has been shown that the action of a postulated repressor has been #blocked by alanine (schofield et al . , 1986; harnyuttanakorn et al . , 1992; howard et al . , 1998a) .
both rap1 and 2 are important vaccine candidates because it has been shown that the action of a postulated repressor is believed to be #blocked by alanine (schofield et al . , 1986; harnyuttanakorn et al . , 1992; howard et al . , 1998a) .
both rap1 and 2 are important vaccine candidates because it has been shown that the action of a postulated repressor is #blocked by alanine (schofield et al . , 1986; harnyuttanakorn et al . , 1992; howard et al . , 1998a) .
both rap1 and 2 are important vaccine candidates because it has been shown that the action of a postulated repressor might be #blocked by alanine (schofield et al . , 1986; harnyuttanakorn et al . , 1992; howard et al . , 1998a) .
both rap1 and 2 are important vaccine candidates because it has been shown that the action of a postulated repressor was believed to be #blocked by alanine (schofield et al . , 1986; harnyuttanakorn et al . , 1992; howard et al . , 1998a) .
both rap1 and 2 are important vaccine candidates because it has been shown that the action of a postulated repressor was #blocked by alanine (schofield et al . , 1986; harnyuttanakorn et al . , 1992; howard et al . , 1998a) .
both rap1 and 2 are important vaccine candidates because it has been shown that the action of a postulated repressor will be #blocked by alanine (schofield et al . , 1986; harnyuttanakorn et al . , 1992; howard et al . , 1998a) .
both rap1 and 2 are important vaccine candidates because it has been shown that the action of a postulated repressor would be #blocked by alanine (schofield et al . , 1986; harnyuttanakorn et al . , 1992; howard et al . , 1998a) .
both rap1 and 2 are important vaccine candidates because the action of a postulated repressor is shown to be #blocked by alanine (schofield et al . , 1986; harnyuttanakorn et al . , 1992; howard et al . , 1998a) .
both rap1 and 2 are important vaccine candidates because the action of a postulated repressor was shown to be #blocked by alanine (schofield et al . , 1986; harnyuttanakorn et al . , 1992; howard et al . , 1998a) .
both rap1 and 2 are important vaccine candidates because the action of a postulated repressor was shown to have been #blocked by alanine (schofield et al . , 1986; harnyuttanakorn et al . , 1992; howard et al . , 1998a) .
labeling with antibodies to the y553 phosphopeptide is specific since alanine #blocked the action of a postulated repressor .
labeling with antibodies to the y553 phosphopeptide is specific since alanine #blocks the action of a postulated repressor .
labeling with antibodies to the y553 phosphopeptide is specific since alanine can #block the action of a postulated repressor .
labeling with antibodies to the y553 phosphopeptide is specific since alanine can have #blocked the action of a postulated repressor .
labeling with antibodies to the y553 phosphopeptide is specific since alanine is able to #block the action of a postulated repressor .
labeling with antibodies to the y553 phosphopeptide is specific since alanine may #block the action of a postulated repressor .
labeling with antibodies to the y553 phosphopeptide is specific since alanine may have #blocked the action of a postulated repressor .
labeling with antibodies to the y553 phosphopeptide is specific since rna polymerase during elongation can be #blocked by tagetin .
labeling with antibodies to the y553 phosphopeptide is specific since rna polymerase during elongation is able to be #blocked by tagetin .
labeling with antibodies to the y553 phosphopeptide is specific since rna polymerase during elongation is #blocked by tagetin .
labeling with antibodies to the y553 phosphopeptide is specific since tagetin #blocks rna polymerase during elongation .
labeling with antibodies to the y553 phosphopeptide is specific since tagetin can #block rna polymerase during elongation .
labeling with antibodies to the y553 phosphopeptide is specific since tagetin can have #blocked rna polymerase during elongation .
labeling with antibodies to the y553 phosphopeptide is specific since tagetin will #block rna polymerase during elongation .
labeling with antibodies to the y553 phosphopeptide is specific since antibodies to rap1 can have #blocked merozoite invasion in vitro .
labeling with antibodies to the y553 phosphopeptide is specific since antibodies to rap1 is able to #block merozoite invasion in vitro .
labeling with antibodies to the y553 phosphopeptide is specific since antibodies to rap1 may #block merozoite invasion in vitro .
labeling with antibodies to the y553 phosphopeptide is specific since antibodies to rap1 will #block merozoite invasion in vitro .
labeling with antibodies to the y553 phosphopeptide is specific since merozoite invasion in vitro can be #blocked by antibodies to rap1 .
labeling with antibodies to the y553 phosphopeptide is specific since merozoite invasion in vitro is able to be #blocked by antibodies to rap1 .
labeling with antibodies to the y553 phosphopeptide is specific since the action of a postulated repressor is able to be #blocked by alanine .
labeling with antibodies to the y553 phosphopeptide is specific since the action of a postulated repressor is believed to be #blocked by alanine .
labeling with antibodies to the y553 phosphopeptide is specific since the action of a postulated repressor is #blocked by alanine .
labeling with antibodies to the y553 phosphopeptide was specific since alanine could #block the action of a postulated repressor .
labeling with antibodies to the y553 phosphopeptide was specific since alanine could have #blocked the action of a postulated repressor .
labeling with antibodies to the y553 phosphopeptide was specific since alanine was able to #block the action of a postulated repressor .
labeling with antibodies to the y553 phosphopeptide was specific since alanine would #block the action of a postulated repressor .
labeling with antibodies to the y553 phosphopeptide was specific since rna polymerase during elongation could be #blocked by tagetin .
labeling with antibodies to the y553 phosphopeptide was specific since rna polymerase during elongation has been #blocked by tagetin .
labeling with antibodies to the y553 phosphopeptide was specific since rna polymerase during elongation was able to be #blocked by tagetin .
labeling with antibodies to the y553 phosphopeptide was specific since tagetin might #block rna polymerase during elongation .
labeling with antibodies to the y553 phosphopeptide was specific since tagetin might have #blocked rna polymerase during elongation .
labeling with antibodies to the y553 phosphopeptide was specific since tagetin would #block rna polymerase during elongation .
labeling with antibodies to the y553 phosphopeptide was specific since antibodies to rap1 might have #blocked merozoite invasion in vitro .
labeling with antibodies to the y553 phosphopeptide was specific since antibodies to rap1 was able to #block merozoite invasion in vitro .
labeling with antibodies to the y553 phosphopeptide was specific since antibodies to rap1 would #block merozoite invasion in vitro .
labeling with antibodies to the y553 phosphopeptide was specific since merozoite invasion in vitro has been #blocked by antibodies to rap1 .
labeling with antibodies to the y553 phosphopeptide was specific since merozoite invasion in vitro was able to be #blocked by antibodies to rap1 .
labeling with antibodies to the y553 phosphopeptide was specific since merozoite invasion in vitro was believed to be #blocked by antibodies to rap1 .
labeling with antibodies to the y553 phosphopeptide was specific since the action of a postulated repressor could be #blocked by alanine .
labeling with antibodies to the y553 phosphopeptide was specific since the action of a postulated repressor has been #blocked by alanine .
pu .1 is upregulated early during commitment of multipotential progenitors to the myeloid lineages and alanine #blocks the action of a postulated repressor .
pu .1 is upregulated early during commitment of multipotential progenitors to the myeloid lineages and alanine has #blocked the action of a postulated repressor .
pu .1 is upregulated early during commitment of multipotential progenitors to the myeloid lineages and alanine is able to #block the action of a postulated repressor .
pu .1 is upregulated early during commitment of multipotential progenitors to the myeloid lineages and alanine is believed to have #blocked the action of a postulated repressor .
pu .1 is upregulated early during commitment of multipotential progenitors to the myeloid lineages and alanine is proven to #block the action of a postulated repressor .
pu .1 is upregulated early during commitment of multipotential progenitors to the myeloid lineages and alanine will #block the action of a postulated repressor .
pu .1 is upregulated early during commitment of multipotential progenitors to the myeloid lineages and rna polymerase during elongation can be #blocked by tagetin .
pu .1 is upregulated early during commitment of multipotential progenitors to the myeloid lineages and rna polymerase during elongation is #blocked by tagetin .
pu .1 is upregulated early during commitment of multipotential progenitors to the myeloid lineages and tagetin can #block rna polymerase during elongation .
pu .1 is upregulated early during commitment of multipotential progenitors to the myeloid lineages and tagetin has #blocked rna polymerase during elongation .
pu .1 is upregulated early during commitment of multipotential progenitors to the myeloid lineages and tagetin is able to #block rna polymerase during elongation .
pu .1 is upregulated early during commitment of multipotential progenitors to the myeloid lineages and tagetin is believed to #block rna polymerase during elongation .
pu .1 is upregulated early during commitment of multipotential progenitors to the myeloid lineages and tagetin is believed to have #blocked rna polymerase during elongation .
pu .1 is upregulated early during commitment of multipotential progenitors to the myeloid lineages and tagetin is proven to have #blocked rna polymerase during elongation .
pu .1 is upregulated early during commitment of multipotential progenitors to the myeloid lineages and tagetin will #block rna polymerase during elongation .
pu .1 is upregulated early during commitment of multipotential progenitors to the myeloid lineages and antibodies to rap1 #blocks merozoite invasion in vitro .
pu .1 is upregulated early during commitment of multipotential progenitors to the myeloid lineages and antibodies to rap1 can #block merozoite invasion in vitro .
pu .1 is upregulated early during commitment of multipotential progenitors to the myeloid lineages and antibodies to rap1 is believed to #block merozoite invasion in vitro .
pu .1 is upregulated early during commitment of multipotential progenitors to the myeloid lineages and antibodies to rap1 is proven to have #blocked merozoite invasion in vitro .
pu .1 is upregulated early during commitment of multipotential progenitors to the myeloid lineages and merozoite invasion in vitro is #blocked by antibodies to rap1 .
pu .1 is upregulated early during commitment of multipotential progenitors to the myeloid lineages and merozoite invasion in vitro will be #blocked by antibodies to rap1 .
pu .1 is upregulated early during commitment of multipotential progenitors to the myeloid lineages and the action of a postulated repressor is #blocked by alanine .
pu .1 is upregulated early during commitment of multipotential progenitors to the myeloid lineages and the action of a postulated repressor will be #blocked by alanine .
pu .1 was upregulated early during commitment of multipotential progenitors to the myeloid lineages and alanine #blocked the action of a postulated repressor .
pu .1 was upregulated early during commitment of multipotential progenitors to the myeloid lineages and rna polymerase during elongation has been #blocked by tagetin .
pu .1 was upregulated early during commitment of multipotential progenitors to the myeloid lineages and tagetin #blocked rna polymerase during elongation .
pu .1 was upregulated early during commitment of multipotential progenitors to the myeloid lineages and tagetin has #blocked rna polymerase during elongation .
pu .1 was upregulated early during commitment of multipotential progenitors to the myeloid lineages and merozoite invasion in vitro was #blocked by antibodies to rap1 .
pu .1 was upregulated early during commitment of multipotential progenitors to the myeloid lineages and the action of a postulated repressor has been #blocked by alanine .
pu .1 was upregulated early during commitment of multipotential progenitors to the myeloid lineages and the action of a postulated repressor was #blocked by alanine .
proteasomal inhibition can not induce any synergistic effect on the 14-3-3eta-induced increase in gr in response to glucocorticoid , and alanine can not #block the action of a postulated repressor , indicating that 14-3-3eta induces stabilization of gr .
proteasomal inhibition can not induce any synergistic effect on the 14-3-3eta-induced increase in gr in response to glucocorticoid , and alanine is not able to #block the action of a postulated repressor , indicating that 14-3-3eta induces stabilization of gr .
proteasomal inhibition can not induce any synergistic effect on the 14-3-3eta-induced increase in gr in response to glucocorticoid , and tagetin can not #block rna polymerase during elongation , indicating that 14-3-3eta induces stabilization of gr .
proteasomal inhibition can not induce any synergistic effect on the 14-3-3eta-induced increase in gr in response to glucocorticoid , and tagetin is not able to #block rna polymerase during elongation , indicating that 14-3-3eta induces stabilization of gr .
proteasomal inhibition can not induce any synergistic effect on the 14-3-3eta-induced increase in gr in response to glucocorticoid , and antibodies to rap1 can not #block merozoite invasion in vitro , indicating that 14-3-3eta induces stabilization of gr .
proteasomal inhibition did not induce any synergistic effect on the 14-3-3eta-induced increase in gr in response to glucocorticoid , and antibodies to rap1 did not #block merozoite invasion in vitro , indicating that 14-3-3eta induces stabilization of gr .
proteasomal inhibition does not induce any synergistic effect on the 14-3-3eta-induced increase in gr in response to glucocorticoid , and alanine does not #block the action of a postulated repressor , indicating that 14-3-3eta induces stabilization of gr .
proteasomal inhibition does not induce any synergistic effect on the 14-3-3eta-induced increase in gr in response to glucocorticoid , and rna polymerase during elongation is not able to be #blocked by tagetin , indicating that 14-3-3eta induces stabilization of gr .
proteasomal inhibition does not induce any synergistic effect on the 14-3-3eta-induced increase in gr in response to glucocorticoid , and rna polymerase during elongation is not #blocked by tagetin , indicating that 14-3-3eta induces stabilization of gr .
proteasomal inhibition does not induce any synergistic effect on the 14-3-3eta-induced increase in gr in response to glucocorticoid , and tagetin does not #block rna polymerase during elongation , indicating that 14-3-3eta induces stabilization of gr .
proteasomal inhibition does not induce any synergistic effect on the 14-3-3eta-induced increase in gr in response to glucocorticoid , and antibodies to rap1 does not #block merozoite invasion in vitro , indicating that 14-3-3eta induces stabilization of gr .
proteasomal inhibition does not induce any synergistic effect on the 14-3-3eta-induced increase in gr in response to glucocorticoid , and merozoite invasion in vitro can not be #blocked by antibodies to rap1 , indicating that 14-3-3eta induces stabilization of gr .
proteasomal inhibition does not induce any synergistic effect on the 14-3-3eta-induced increase in gr in response to glucocorticoid , and merozoite invasion in vitro is believed not to be #blocked by antibodies to rap1 , indicating that 14-3-3eta induces stabilization of gr .
proteasomal inhibition does not induce any synergistic effect on the 14-3-3eta-induced increase in gr in response to glucocorticoid , and merozoite invasion in vitro is not #blocked by antibodies to rap1 , indicating that 14-3-3eta induces stabilization of gr .
proteasomal inhibition does not induce any synergistic effect on the 14-3-3eta-induced increase in gr in response to glucocorticoid , and the action of a postulated repressor can not be #blocked by alanine , indicating that 14-3-3eta induces stabilization of gr .
proteasomal inhibition does not induce any synergistic effect on the 14-3-3eta-induced increase in gr in response to glucocorticoid , and the action of a postulated repressor is not #blocked by alanine , indicating that 14-3-3eta induces stabilization of gr .
proteasomal inhibition has not induced any synergistic effect on the 14-3-3eta-induced increase in gr in response to glucocorticoid , and tagetin has not #blocked rna polymerase during elongation , indicating that 14-3-3eta induces stabilization of gr .
proteasomal inhibition will not induce any synergistic effect on the 14-3-3eta-induced increase in gr in response to glucocorticoid , and alanine will not #block the action of a postulated repressor , indicating that 14-3-3eta induces stabilization of gr .
proteasomal inhibition will not induce any synergistic effect on the 14-3-3eta-induced increase in gr in response to glucocorticoid , and tagetin will not #block rna polymerase during elongation , indicating that 14-3-3eta induces stabilization of gr .
proteasomal inhibition will not induce any synergistic effect on the 14-3-3eta-induced increase in gr in response to glucocorticoid , and antibodies to rap1 will not #block merozoite invasion in vitro , indicating that 14-3-3eta induces stabilization of gr .
rna polymerase during elongation can be #blocked by tagetin .
rna polymerase during elongation has been #blocked by tagetin .
tagetin can #block rna polymerase during elongation .
tagetin can have #blocked rna polymerase during elongation .
tagetin is able to #block rna polymerase during elongation .
tagetin may #block rna polymerase during elongation .
tagetin might have #blocked rna polymerase during elongation .
tagetin was able to #block rna polymerase during elongation .
tagetin was believed to #block rna polymerase during elongation .
tagetin will #block rna polymerase during elongation .
antibodies to rap1 #blocked merozoite invasion in vitro .
antibodies to rap1 #blocks merozoite invasion in vitro .
antibodies to rap1 can have #blocked merozoite invasion in vitro .
antibodies to rap1 could have #blocked merozoite invasion in vitro .
antibodies to rap1 has #blocked merozoite invasion in vitro .
antibodies to rap1 is able to #block merozoite invasion in vitro .
antibodies to rap1 is believed to #block merozoite invasion in vitro .
antibodies to rap1 is more specific for distinguishing between different rna polymerases because it can #block merozoite invasion in vitro (mathews and durbin , 1994) , i .e .its action is independent of different initiation factors .
antibodies to rap1 is more specific for distinguishing between different rna polymerases because it may #blocks merozoite invasion in vitro (mathews and durbin , 1994) , i .e .its action is independent of different initiation factors .
antibodies to rap1 is more specific for distinguishing between different rna polymerases because merozoite invasion in vitro is able to be #blocked by it (mathews and durbin , 1994) , i .e .its action is independent of different initiation factors .
antibodies to rap1 will #block merozoite invasion in vitro .
merozoite invasion in vitro can be #blocked by antibodies to rap1 .
merozoite invasion in vitro is #blocked by antibodies to rap1 .
14-3-3eta functions can be #blocked by the degradation of gr and inducing an elevation of gr .
both rap1 and 2 are important vaccine candidates because 14-3-3eta functions is shown to be #blocked by the degradation of gr and inducing an elevation of gr (schofield et al . , 1986; harnyuttanakorn et al . , 1992; howard et al . , 1998a) .
both rap1 and 2 are important vaccine candidates because a positive regulator in the glucocorticoid signal pathway are shown to be able to #block the degradation of gr and inducing an elevation of gr (schofield et al . , 1986; harnyuttanakorn et al . , 1992; howard et al . , 1998a) .
both rap1 and 2 are important vaccine candidates because a positive regulator in the glucocorticoid signal pathway are shown to #block the degradation of gr and inducing an elevation of gr (schofield et al . , 1986; harnyuttanakorn et al . , 1992; howard et al . , 1998a) .
both rap1 and 2 are important vaccine candidates because a positive regulator in the glucocorticoid signal pathway are shown to have #blocked the degradation of gr and inducing an elevation of gr (schofield et al . , 1986; harnyuttanakorn et al . , 1992; howard et al . , 1998a) .
both rap1 and 2 are important vaccine candidates because a positive regulator in the glucocorticoid signal pathway have been shown to be able to #block the degradation of gr and inducing an elevation of gr (schofield et al . , 1986; harnyuttanakorn et al . , 1992; howard et al . , 1998a) .
both rap1 and 2 are important vaccine candidates because a positive regulator in the glucocorticoid signal pathway have been shown to #block the degradation of gr and inducing an elevation of gr (schofield et al . , 1986; harnyuttanakorn et al . , 1992; howard et al . , 1998a) .
both rap1 and 2 are important vaccine candidates because a positive regulator in the glucocorticoid signal pathway have been shown to have #blocked the degradation of gr and inducing an elevation of gr (schofield et al . , 1986; harnyuttanakorn et al . , 1992; howard et al . , 1998a) .
both rap1 and 2 are important vaccine candidates because agrin-induced achr clustering and phosphorylation was shown to be #blocked by staurosporine (schofield et al . , 1986; harnyuttanakorn et al . , 1992; howard et al . , 1998a) .
both rap1 and 2 are important vaccine candidates because it has been shown that 14-3-3eta functions can be #blocked by the degradation of gr and inducing an elevation of gr (schofield et al . , 1986; harnyuttanakorn et al . , 1992; howard et al . , 1998a) .
both rap1 and 2 are important vaccine candidates because it has been shown that 14-3-3eta functions could be #blocked by the degradation of gr and inducing an elevation of gr (schofield et al . , 1986; harnyuttanakorn et al . , 1992; howard et al . , 1998a) .
both rap1 and 2 are important vaccine candidates because it has been shown that 14-3-3eta functions has been #blocked by the degradation of gr and inducing an elevation of gr (schofield et al . , 1986; harnyuttanakorn et al . , 1992; howard et al . , 1998a) .
both rap1 and 2 are important vaccine candidates because it has been shown that 14-3-3eta functions is #blocked by the degradation of gr and inducing an elevation of gr (schofield et al . , 1986; harnyuttanakorn et al . , 1992; howard et al . , 1998a) .
both rap1 and 2 are important vaccine candidates because it has been shown that 14-3-3eta functions may be #blocked by the degradation of gr and inducing an elevation of gr (schofield et al . , 1986; harnyuttanakorn et al . , 1992; howard et al . , 1998a) .
both rap1 and 2 are important vaccine candidates because it has been shown that 14-3-3eta functions might be #blocked by the degradation of gr and inducing an elevation of gr (schofield et al . , 1986; harnyuttanakorn et al . , 1992; howard et al . , 1998a) .
both rap1 and 2 are important vaccine candidates because it has been shown that 14-3-3eta functions was believed to be #blocked by the degradation of gr and inducing an elevation of gr (schofield et al . , 1986; harnyuttanakorn et al . , 1992; howard et al . , 1998a) .
both rap1 and 2 are important vaccine candidates because it has been shown that 14-3-3eta functions was #blocked by the degradation of gr and inducing an elevation of gr (schofield et al . , 1986; harnyuttanakorn et al . , 1992; howard et al . , 1998a) .
both rap1 and 2 are important vaccine candidates because it has been shown that 14-3-3eta functions would be #blocked by the degradation of gr and inducing an elevation of gr (schofield et al . , 1986; harnyuttanakorn et al . , 1992; howard et al . , 1998a) .
both rap1 and 2 are important vaccine candidates because it has been shown that a positive regulator in the glucocorticoid signal pathway are able to #block the degradation of gr and inducing an elevation of gr (schofield et al . , 1986; harnyuttanakorn et al . , 1992; howard et al . , 1998a) .
both rap1 and 2 are important vaccine candidates because it has been shown that a positive regulator in the glucocorticoid signal pathway #block the degradation of gr and inducing an elevation of gr (schofield et al . , 1986; harnyuttanakorn et al . , 1992; howard et al . , 1998a) .
both rap1 and 2 are important vaccine candidates because it has been shown that a positive regulator in the glucocorticoid signal pathway can #block the degradation of gr and inducing an elevation of gr (schofield et al . , 1986; harnyuttanakorn et al . , 1992; howard et al . , 1998a) .
both rap1 and 2 are important vaccine candidates because it has been shown that a positive regulator in the glucocorticoid signal pathway may #block the degradation of gr and inducing an elevation of gr (schofield et al . , 1986; harnyuttanakorn et al . , 1992; howard et al . , 1998a) .
both rap1 and 2 are important vaccine candidates because it has been shown that a positive regulator in the glucocorticoid signal pathway were able to #block the degradation of gr and inducing an elevation of gr (schofield et al . , 1986; harnyuttanakorn et al . , 1992; howard et al . , 1998a) .
both rap1 and 2 are important vaccine candidates because it has been shown that agrin-induced achr clustering and phosphorylation can be #blocked by staurosporine (schofield et al . , 1986; harnyuttanakorn et al . , 1992; howard et al . , 1998a) .
both rap1 and 2 are important vaccine candidates because it has been shown that agrin-induced achr clustering and phosphorylation has been #blocked by staurosporine (schofield et al . , 1986; harnyuttanakorn et al . , 1992; howard et al . , 1998a) .
both rap1 and 2 are important vaccine candidates because it has been shown that agrin-induced achr clustering and phosphorylation is believed to be #blocked by staurosporine (schofield et al . , 1986; harnyuttanakorn et al . , 1992; howard et al . , 1998a) .
both rap1 and 2 are important vaccine candidates because it has been shown that agrin-induced achr clustering and phosphorylation is #blocked by staurosporine (schofield et al . , 1986; harnyuttanakorn et al . , 1992; howard et al . , 1998a) .
both rap1 and 2 are important vaccine candidates because it has been shown that agrin-induced achr clustering and phosphorylation might be #blocked by staurosporine (schofield et al . , 1986; harnyuttanakorn et al . , 1992; howard et al . , 1998a) .
both rap1 and 2 are important vaccine candidates because it has been shown that agrin-induced achr clustering and phosphorylation was believed to be #blocked by staurosporine (schofield et al . , 1986; harnyuttanakorn et al . , 1992; howard et al . , 1998a) .
both rap1 and 2 are important vaccine candidates because it has been shown that staurosporine are able to #block agrin-induced achr clustering and phosphorylation (schofield et al . , 1986; harnyuttanakorn et al . , 1992; howard et al . , 1998a) .
both rap1 and 2 are important vaccine candidates because it has been shown that staurosporine #blocked agrin-induced achr clustering and phosphorylation (schofield et al . , 1986; harnyuttanakorn et al . , 1992; howard et al . , 1998a) .
both rap1 and 2 are important vaccine candidates because it has been shown that staurosporine can #block agrin-induced achr clustering and phosphorylation (schofield et al . , 1986; harnyuttanakorn et al . , 1992; howard et al . , 1998a) .
both rap1 and 2 are important vaccine candidates because it has been shown that staurosporine were able to #block agrin-induced achr clustering and phosphorylation (schofield et al . , 1986; harnyuttanakorn et al . , 1992; howard et al . , 1998a) .
both rap1 and 2 are important vaccine candidates because it has been shown that the degradation of gr and inducing an elevation of gr #block 14-3-3eta functions (schofield et al . , 1986; harnyuttanakorn et al . , 1992; howard et al . , 1998a) .
both rap1 and 2 are important vaccine candidates because it has been shown that the degradation of gr and inducing an elevation of gr #blocked 14-3-3eta functions (schofield et al . , 1986; harnyuttanakorn et al . , 1992; howard et al . , 1998a) .
both rap1 and 2 are important vaccine candidates because it has been shown that the degradation of gr and inducing an elevation of gr is #blocked by a positive regulator in the glucocorticoid signal pathway (schofield et al . , 1986; harnyuttanakorn et al . , 1992; howard et al . , 1998a) .
both rap1 and 2 are important vaccine candidates because it has been shown that the degradation of gr and inducing an elevation of gr may be #blocked by a positive regulator in the glucocorticoid signal pathway (schofield et al . , 1986; harnyuttanakorn et al . , 1992; howard et al . , 1998a) .
both rap1 and 2 are important vaccine candidates because it has been shown that the degradation of gr and inducing an elevation of gr might be #blocked by a positive regulator in the glucocorticoid signal pathway (schofield et al . , 1986; harnyuttanakorn et al . , 1992; howard et al . , 1998a) .
both rap1 and 2 are important vaccine candidates because it has been shown that the degradation of gr and inducing an elevation of gr was #blocked by a positive regulator in the glucocorticoid signal pathway (schofield et al . , 1986; harnyuttanakorn et al . , 1992; howard et al . , 1998a) .
both rap1 and 2 are important vaccine candidates because staurosporine are shown to #block agrin-induced achr clustering and phosphorylation (schofield et al . , 1986; harnyuttanakorn et al . , 1992; howard et al . , 1998a) .
both rap1 and 2 are important vaccine candidates because staurosporine are shown to have #blocked agrin-induced achr clustering and phosphorylation (schofield et al . , 1986; harnyuttanakorn et al . , 1992; howard et al . , 1998a) .
both rap1 and 2 are important vaccine candidates because staurosporine have been shown to have #blocked agrin-induced achr clustering and phosphorylation (schofield et al . , 1986; harnyuttanakorn et al . , 1992; howard et al . , 1998a) .
both rap1 and 2 are important vaccine candidates because the degradation of gr and inducing an elevation of gr are shown to #block 14-3-3eta functions (schofield et al . , 1986; harnyuttanakorn et al . , 1992; howard et al . , 1998a) .
both rap1 and 2 are important vaccine candidates because the degradation of gr and inducing an elevation of gr are shown to have #blocked 14-3-3eta functions (schofield et al . , 1986; harnyuttanakorn et al . , 1992; howard et al . , 1998a) .
both rap1 and 2 are important vaccine candidates because the degradation of gr and inducing an elevation of gr have been shown to be able to #block 14-3-3eta functions (schofield et al . , 1986; harnyuttanakorn et al . , 1992; howard et al . , 1998a) .
both rap1 and 2 are important vaccine candidates because the degradation of gr and inducing an elevation of gr have been shown to #block 14-3-3eta functions (schofield et al . , 1986; harnyuttanakorn et al . , 1992; howard et al . , 1998a) .
both rap1 and 2 are important vaccine candidates because the degradation of gr and inducing an elevation of gr have been shown to have #blocked 14-3-3eta functions (schofield et al . , 1986; harnyuttanakorn et al . , 1992; howard et al . , 1998a) .
both rap1 and 2 are important vaccine candidates because the degradation of gr and inducing an elevation of gr is shown to be #blocked by a positive regulator in the glucocorticoid signal pathway (schofield et al . , 1986; harnyuttanakorn et al . , 1992; howard et al . , 1998a) .
both rap1 and 2 are important vaccine candidates because the degradation of gr and inducing an elevation of gr is shown to have been #blocked by a positive regulator in the glucocorticoid signal pathway (schofield et al . , 1986; harnyuttanakorn et al . , 1992; howard et al . , 1998a) .
labeling with antibodies to the y553 phosphopeptide is specific since 14-3-3eta functions is #blocked by the degradation of gr and inducing an elevation of gr .
labeling with antibodies to the y553 phosphopeptide is specific since a positive regulator in the glucocorticoid signal pathway #blocks the degradation of gr and inducing an elevation of gr .
labeling with antibodies to the y553 phosphopeptide is specific since a positive regulator in the glucocorticoid signal pathway can #block the degradation of gr and inducing an elevation of gr .
labeling with antibodies to the y553 phosphopeptide is specific since a positive regulator in the glucocorticoid signal pathway can have #blocked the degradation of gr and inducing an elevation of gr .
labeling with antibodies to the y553 phosphopeptide is specific since a positive regulator in the glucocorticoid signal pathway have #blocked the degradation of gr and inducing an elevation of gr .
labeling with antibodies to the y553 phosphopeptide is specific since a positive regulator in the glucocorticoid signal pathway is able to #block the degradation of gr and inducing an elevation of gr .
labeling with antibodies to the y553 phosphopeptide is specific since a positive regulator in the glucocorticoid signal pathway may #block the degradation of gr and inducing an elevation of gr .
labeling with antibodies to the y553 phosphopeptide is specific since a positive regulator in the glucocorticoid signal pathway may have #blocked the degradation of gr and inducing an elevation of gr .
labeling with antibodies to the y553 phosphopeptide is specific since a positive regulator in the glucocorticoid signal pathway will #block the degradation of gr and inducing an elevation of gr .
labeling with antibodies to the y553 phosphopeptide is specific since agrin-induced achr clustering and phosphorylation can be #blocked by staurosporine .
labeling with antibodies to the y553 phosphopeptide is specific since agrin-induced achr clustering and phosphorylation is able to be #blocked by staurosporine .
labeling with antibodies to the y553 phosphopeptide is specific since agrin-induced achr clustering and phosphorylation is #blocked by staurosporine .
labeling with antibodies to the y553 phosphopeptide is specific since staurosporine can #block agrin-induced achr clustering and phosphorylation .
labeling with antibodies to the y553 phosphopeptide is specific since staurosporine can have #blocked agrin-induced achr clustering and phosphorylation .
labeling with antibodies to the y553 phosphopeptide is specific since staurosporine have #blocked agrin-induced achr clustering and phosphorylation .
labeling with antibodies to the y553 phosphopeptide is specific since staurosporine may #block agrin-induced achr clustering and phosphorylation .
labeling with antibodies to the y553 phosphopeptide is specific since staurosporine may have #blocked agrin-induced achr clustering and phosphorylation .
labeling with antibodies to the y553 phosphopeptide is specific since staurosporine will #block agrin-induced achr clustering and phosphorylation .
labeling with antibodies to the y553 phosphopeptide is specific since the degradation of gr and inducing an elevation of gr #blocks 14-3-3eta functions .
labeling with antibodies to the y553 phosphopeptide is specific since the degradation of gr and inducing an elevation of gr have #blocked 14-3-3eta functions .
labeling with antibodies to the y553 phosphopeptide is specific since the degradation of gr and inducing an elevation of gr is able to #block 14-3-3eta functions .
labeling with antibodies to the y553 phosphopeptide is specific since the degradation of gr and inducing an elevation of gr is believed to be #blocked by a positive regulator in the glucocorticoid signal pathway .
labeling with antibodies to the y553 phosphopeptide is specific since the degradation of gr and inducing an elevation of gr may #block 14-3-3eta functions .
labeling with antibodies to the y553 phosphopeptide was specific since 14-3-3eta functions has been #blocked by the degradation of gr and inducing an elevation of gr .
labeling with antibodies to the y553 phosphopeptide was specific since 14-3-3eta functions was able to be #blocked by the degradation of gr and inducing an elevation of gr .
labeling with antibodies to the y553 phosphopeptide was specific since a positive regulator in the glucocorticoid signal pathway might have #blocked the degradation of gr and inducing an elevation of gr .
labeling with antibodies to the y553 phosphopeptide was specific since a positive regulator in the glucocorticoid signal pathway was able to #block the degradation of gr and inducing an elevation of gr .
labeling with antibodies to the y553 phosphopeptide was specific since a positive regulator in the glucocorticoid signal pathway would #block the degradation of gr and inducing an elevation of gr .
labeling with antibodies to the y553 phosphopeptide was specific since a positive regulator in the glucocorticoid signal pathway would have #blocked the degradation of gr and inducing an elevation of gr .
labeling with antibodies to the y553 phosphopeptide was specific since agrin-induced achr clustering and phosphorylation has been #blocked by staurosporine .
labeling with antibodies to the y553 phosphopeptide was specific since agrin-induced achr clustering and phosphorylation was able to be #blocked by staurosporine .
labeling with antibodies to the y553 phosphopeptide was specific since agrin-induced achr clustering and phosphorylation was #blocked by staurosporine .
labeling with antibodies to the y553 phosphopeptide was specific since staurosporine could #block agrin-induced achr clustering and phosphorylation .
labeling with antibodies to the y553 phosphopeptide was specific since staurosporine could have #blocked agrin-induced achr clustering and phosphorylation .
labeling with antibodies to the y553 phosphopeptide was specific since the degradation of gr and inducing an elevation of gr could have #blocked 14-3-3eta functions .
labeling with antibodies to the y553 phosphopeptide was specific since the degradation of gr and inducing an elevation of gr might have #blocked 14-3-3eta functions .
labeling with antibodies to the y553 phosphopeptide was specific since the degradation of gr and inducing an elevation of gr was able to be #blocked by a positive regulator in the glucocorticoid signal pathway .
labeling with antibodies to the y553 phosphopeptide was specific since the degradation of gr and inducing an elevation of gr was able to #block 14-3-3eta functions .
labeling with antibodies to the y553 phosphopeptide was specific since the degradation of gr and inducing an elevation of gr was believed to be #blocked by a positive regulator in the glucocorticoid signal pathway .
labeling with antibodies to the y553 phosphopeptide was specific since the degradation of gr and inducing an elevation of gr was #blocked by a positive regulator in the glucocorticoid signal pathway .
labeling with antibodies to the y553 phosphopeptide was specific since the degradation of gr and inducing an elevation of gr would have #blocked 14-3-3eta functions .
pu .1 is upregulated early during commitment of multipotential progenitors to the myeloid lineages and 14-3-3eta functions is believed to be #blocked by the degradation of gr and inducing an elevation of gr .
pu .1 is upregulated early during commitment of multipotential progenitors to the myeloid lineages and 14-3-3eta functions may be #blocked by the degradation of gr and inducing an elevation of gr .
pu .1 is upregulated early during commitment of multipotential progenitors to the myeloid lineages and 14-3-3eta functions will be #blocked by the degradation of gr and inducing an elevation of gr .
pu .1 is upregulated early during commitment of multipotential progenitors to the myeloid lineages and a positive regulator in the glucocorticoid signal pathway #blocks the degradation of gr and inducing an elevation of gr .
pu .1 is upregulated early during commitment of multipotential progenitors to the myeloid lineages and a positive regulator in the glucocorticoid signal pathway has #blocked the degradation of gr and inducing an elevation of gr .
pu .1 is upregulated early during commitment of multipotential progenitors to the myeloid lineages and a positive regulator in the glucocorticoid signal pathway is believed to #block the degradation of gr and inducing an elevation of gr .
pu .1 is upregulated early during commitment of multipotential progenitors to the myeloid lineages and a positive regulator in the glucocorticoid signal pathway is believed to have #blocked the degradation of gr and inducing an elevation of gr .
pu .1 is upregulated early during commitment of multipotential progenitors to the myeloid lineages and a positive regulator in the glucocorticoid signal pathway will #block the degradation of gr and inducing an elevation of gr .
pu .1 is upregulated early during commitment of multipotential progenitors to the myeloid lineages and agrin-induced achr clustering and phosphorylation is #blocked by staurosporine .
pu .1 is upregulated early during commitment of multipotential progenitors to the myeloid lineages and agrin-induced achr clustering and phosphorylation may be #blocked by staurosporine .
pu .1 is upregulated early during commitment of multipotential progenitors to the myeloid lineages and staurosporine #blocks agrin-induced achr clustering and phosphorylation .
pu .1 is upregulated early during commitment of multipotential progenitors to the myeloid lineages and staurosporine is able to #block agrin-induced achr clustering and phosphorylation .
pu .1 is upregulated early during commitment of multipotential progenitors to the myeloid lineages and staurosporine is believed to #block agrin-induced achr clustering and phosphorylation .
pu .1 is upregulated early during commitment of multipotential progenitors to the myeloid lineages and staurosporine is believed to have #blocked agrin-induced achr clustering and phosphorylation .
pu .1 is upregulated early during commitment of multipotential progenitors to the myeloid lineages and staurosporine is proven to #block agrin-induced achr clustering and phosphorylation .
pu .1 is upregulated early during commitment of multipotential progenitors to the myeloid lineages and staurosporine will #block agrin-induced achr clustering and phosphorylation .
pu .1 is upregulated early during commitment of multipotential progenitors to the myeloid lineages and the degradation of gr and inducing an elevation of gr #blocks 14-3-3eta functions .
pu .1 is upregulated early during commitment of multipotential progenitors to the myeloid lineages and the degradation of gr and inducing an elevation of gr can #block 14-3-3eta functions .
pu .1 is upregulated early during commitment of multipotential progenitors to the myeloid lineages and the degradation of gr and inducing an elevation of gr is able to #block 14-3-3eta functions .
pu .1 is upregulated early during commitment of multipotential progenitors to the myeloid lineages and the degradation of gr and inducing an elevation of gr is believed to be #blocked by a positive regulator in the glucocorticoid signal pathway .
pu .1 is upregulated early during commitment of multipotential progenitors to the myeloid lineages and the degradation of gr and inducing an elevation of gr is proven to have #blocked 14-3-3eta functions .
pu .1 is upregulated early during commitment of multipotential progenitors to the myeloid lineages and the degradation of gr and inducing an elevation of gr may be #blocked by a positive regulator in the glucocorticoid signal pathway .
pu .1 is upregulated early during commitment of multipotential progenitors to the myeloid lineages and the degradation of gr and inducing an elevation of gr will #block 14-3-3eta functions .
pu .1 was upregulated early during commitment of multipotential progenitors to the myeloid lineages and 14-3-3eta functions has been #blocked by the degradation of gr and inducing an elevation of gr .
pu .1 was upregulated early during commitment of multipotential progenitors to the myeloid lineages and a positive regulator in the glucocorticoid signal pathway #blocked the degradation of gr and inducing an elevation of gr .
pu .1 was upregulated early during commitment of multipotential progenitors to the myeloid lineages and a positive regulator in the glucocorticoid signal pathway has #blocked the degradation of gr and inducing an elevation of gr .
pu .1 was upregulated early during commitment of multipotential progenitors to the myeloid lineages and staurosporine has #blocked agrin-induced achr clustering and phosphorylation .
pu .1 was upregulated early during commitment of multipotential progenitors to the myeloid lineages and the degradation of gr and inducing an elevation of gr has #blocked 14-3-3eta functions .
proteasomal inhibition can not induce any synergistic effect on the 14-3-3eta-induced increase in gr in response to glucocorticoid , and the degradation of gr and inducing an elevation of gr can not #block 14-3-3eta functions , indicating that 14-3-3eta induces stabilization of gr .
proteasomal inhibition did not induce any synergistic effect on the 14-3-3eta-induced increase in gr in response to glucocorticoid , and staurosporine did not #block agrin-induced achr clustering and phosphorylation , indicating that 14-3-3eta induces stabilization of gr .
proteasomal inhibition does not induce any synergistic effect on the 14-3-3eta-induced increase in gr in response to glucocorticoid , and 14-3-3eta functions can not be #blocked by the degradation of gr and inducing an elevation of gr , indicating that 14-3-3eta induces stabilization of gr .
proteasomal inhibition does not induce any synergistic effect on the 14-3-3eta-induced increase in gr in response to glucocorticoid , and 14-3-3eta functions is believed not to be #blocked by the degradation of gr and inducing an elevation of gr , indicating that 14-3-3eta induces stabilization of gr .
proteasomal inhibition does not induce any synergistic effect on the 14-3-3eta-induced increase in gr in response to glucocorticoid , and 14-3-3eta functions is not #blocked by the degradation of gr and inducing an elevation of gr , indicating that 14-3-3eta induces stabilization of gr .
proteasomal inhibition does not induce any synergistic effect on the 14-3-3eta-induced increase in gr in response to glucocorticoid , and agrin-induced achr clustering and phosphorylation is not #blocked by staurosporine , indicating that 14-3-3eta induces stabilization of gr .
proteasomal inhibition does not induce any synergistic effect on the 14-3-3eta-induced increase in gr in response to glucocorticoid , and staurosporine does not #block agrin-induced achr clustering and phosphorylation , indicating that 14-3-3eta induces stabilization of gr .
proteasomal inhibition does not induce any synergistic effect on the 14-3-3eta-induced increase in gr in response to glucocorticoid , and the degradation of gr and inducing an elevation of gr can not be #blocked by a positive regulator in the glucocorticoid signal pathway , indicating that 14-3-3eta induces stabilization of gr .
proteasomal inhibition does not induce any synergistic effect on the 14-3-3eta-induced increase in gr in response to glucocorticoid , and the degradation of gr and inducing an elevation of gr is not able to be #blocked by a positive regulator in the glucocorticoid signal pathway , indicating that 14-3-3eta induces stabilization of gr .
proteasomal inhibition has not induced any synergistic effect on the 14-3-3eta-induced increase in gr in response to glucocorticoid , and staurosporine has not #blocked agrin-induced achr clustering and phosphorylation , indicating that 14-3-3eta induces stabilization of gr .
proteasomal inhibition has not induced any synergistic effect on the 14-3-3eta-induced increase in gr in response to glucocorticoid , and the degradation of gr and inducing an elevation of gr has not #blocked 14-3-3eta functions , indicating that 14-3-3eta induces stabilization of gr .
proteasomal inhibition will not induce any synergistic effect on the 14-3-3eta-induced increase in gr in response to glucocorticoid , and a positive regulator in the glucocorticoid signal pathway will not #block the degradation of gr and inducing an elevation of gr , indicating that 14-3-3eta induces stabilization of gr .
proteasomal inhibition will not induce any synergistic effect on the 14-3-3eta-induced increase in gr in response to glucocorticoid , and staurosporine will not #block agrin-induced achr clustering and phosphorylation , indicating that 14-3-3eta induces stabilization of gr .
a positive regulator in the glucocorticoid signal pathway #blocks the degradation of gr and inducing an elevation of gr .
a positive regulator in the glucocorticoid signal pathway can have #blocked the degradation of gr and inducing an elevation of gr .
a positive regulator in the glucocorticoid signal pathway could #block the degradation of gr and inducing an elevation of gr .
a positive regulator in the glucocorticoid signal pathway could have #blocked the degradation of gr and inducing an elevation of gr .
a positive regulator in the glucocorticoid signal pathway is believed to #block the degradation of gr and inducing an elevation of gr .
a positive regulator in the glucocorticoid signal pathway is more specific for distinguishing between different rna polymerases because it #blocked the degradation of gr and inducing an elevation of gr (mathews and durbin , 1994) , i .e .its action is independent of different initiation factors .
a positive regulator in the glucocorticoid signal pathway is more specific for distinguishing between different rna polymerases because it #blocks the degradation of gr and inducing an elevation of gr (mathews and durbin , 1994) , i .e .its action is independent of different initiation factors .
a positive regulator in the glucocorticoid signal pathway is more specific for distinguishing between different rna polymerases because it is able to #block the degradation of gr and inducing an elevation of gr (mathews and durbin , 1994) , i .e .its action is independent of different initiation factors .
a positive regulator in the glucocorticoid signal pathway is more specific for distinguishing between different rna polymerases because the degradation of gr and inducing an elevation of gr was #blocked by it (mathews and durbin , 1994) , i .e .its action is independent of different initiation factors .
a positive regulator in the glucocorticoid signal pathway is thought to act as an inducer to #block the degradation of gr and inducing an elevation of gr .
a positive regulator in the glucocorticoid signal pathway may have #blocked the degradation of gr and inducing an elevation of gr .
a positive regulator in the glucocorticoid signal pathway might #block the degradation of gr and inducing an elevation of gr .
a positive regulator in the glucocorticoid signal pathway might have #blocked the degradation of gr and inducing an elevation of gr .
a positive regulator in the glucocorticoid signal pathway was able to #block the degradation of gr and inducing an elevation of gr .
a positive regulator in the glucocorticoid signal pathway will #block the degradation of gr and inducing an elevation of gr .
agrin-induced achr clustering and phosphorylation has been #blocked by staurosporine .
agrin-induced achr clustering and phosphorylation was #blocked by staurosporine .
staurosporine #blocks agrin-induced achr clustering and phosphorylation .
staurosporine can have #blocked agrin-induced achr clustering and phosphorylation .
staurosporine could #block agrin-induced achr clustering and phosphorylation .
staurosporine could have #blocked agrin-induced achr clustering and phosphorylation .
staurosporine is believed to #block agrin-induced achr clustering and phosphorylation .
staurosporine is more specific for distinguishing between different rna polymerases because agrin-induced achr clustering and phosphorylation can be #blocked by it (mathews and durbin , 1994) , i .e .its action is independent of different initiation factors .
staurosporine is more specific for distinguishing between different rna polymerases because agrin-induced achr clustering and phosphorylation is able to be #blocked by it (mathews and durbin , 1994) , i .e .its action is independent of different initiation factors .
staurosporine is more specific for distinguishing between different rna polymerases because agrin-induced achr clustering and phosphorylation is #blocked by it (mathews and durbin , 1994) , i .e .its action is independent of different initiation factors .
staurosporine is more specific for distinguishing between different rna polymerases because agrin-induced achr clustering and phosphorylation was #blocked by it (mathews and durbin , 1994) , i .e .its action is independent of different initiation factors .
staurosporine is more specific for distinguishing between different rna polymerases because it #blocked agrin-induced achr clustering and phosphorylation (mathews and durbin , 1994) , i .e .its action is independent of different initiation factors .
staurosporine is more specific for distinguishing between different rna polymerases because it can #block agrin-induced achr clustering and phosphorylation (mathews and durbin , 1994) , i .e .its action is independent of different initiation factors .
staurosporine is more specific for distinguishing between different rna polymerases because it is able to #block agrin-induced achr clustering and phosphorylation (mathews and durbin , 1994) , i .e .its action is independent of different initiation factors .
staurosporine is more specific for distinguishing between different rna polymerases because it may #blocks agrin-induced achr clustering and phosphorylation (mathews and durbin , 1994) , i .e .its action is independent of different initiation factors .
staurosporine may #block agrin-induced achr clustering and phosphorylation .
staurosporine may have #blocked agrin-induced achr clustering and phosphorylation .
staurosporine might #block agrin-induced achr clustering and phosphorylation .
staurosporine might have #blocked agrin-induced achr clustering and phosphorylation .
staurosporine was believed to #block agrin-induced achr clustering and phosphorylation .
the degradation of gr and inducing an elevation of gr #blocks 14-3-3eta functions .
the degradation of gr and inducing an elevation of gr can be #blocked by a positive regulator in the glucocorticoid signal pathway .
the degradation of gr and inducing an elevation of gr can have #blocked 14-3-3eta functions .
the degradation of gr and inducing an elevation of gr could have #blocked 14-3-3eta functions .
the degradation of gr and inducing an elevation of gr is able to #block 14-3-3eta functions .
the degradation of gr and inducing an elevation of gr is believed to #block 14-3-3eta functions .
the degradation of gr and inducing an elevation of gr is more specific for distinguishing between different rna polymerases because 14-3-3eta functions can be #blocked by it (mathews and durbin , 1994) , i .e .its action is independent of different initiation factors .
the degradation of gr and inducing an elevation of gr is more specific for distinguishing between different rna polymerases because 14-3-3eta functions is #blocked by it (mathews and durbin , 1994) , i .e .its action is independent of different initiation factors .
the degradation of gr and inducing an elevation of gr is more specific for distinguishing between different rna polymerases because 14-3-3eta functions was #blocked by it (mathews and durbin , 1994) , i .e .its action is independent of different initiation factors .
the degradation of gr and inducing an elevation of gr is more specific for distinguishing between different rna polymerases because it #blocks 14-3-3eta functions (mathews and durbin , 1994) , i .e .its action is independent of different initiation factors .
the degradation of gr and inducing an elevation of gr is more specific for distinguishing between different rna polymerases because it is able to #block 14-3-3eta functions (mathews and durbin , 1994) , i .e .its action is independent of different initiation factors .
the degradation of gr and inducing an elevation of gr is more specific for distinguishing between different rna polymerases because it may #blocks 14-3-3eta functions (mathews and durbin , 1994) , i .e .its action is independent of different initiation factors .
the degradation of gr and inducing an elevation of gr may #block 14-3-3eta functions .
the degradation of gr and inducing an elevation of gr might have #blocked 14-3-3eta functions .
the degradation of gr and inducing an elevation of gr will #block 14-3-3eta functions .
the degradation of gr and inducing an elevation of gr would #block 14-3-3eta functions .
dna helicases are enzymes that are able to catalyze the unwinding of dna by disrupting the hydrogen bonding between paired bases as they progress along the dna strand in a polar fashion (either 35 or 53) , and have been shown to be involved in many essential cellular processes , including replication , transcription , dna repair and translation (for reviews see west , 1996; bird et al . , 1998; lohman et al . , 1998; hall and matson , 1999) .
dna helicases are enzymes that can catalyze the unwinding of dna by disrupting the hydrogen bonding between paired bases as they progress along the dna strand in a polar fashion (either 35 or 53) , and have been shown to be involved in many essential cellular processes , including replication , transcription , dna repair and translation (for reviews see west , 1996; bird et al . , 1998; lohman et al . , 1998; hall and matson , 1999) .
dna helicases can catalyze the unwinding of dna by disrupting the hydrogen bonding between paired bases as they progress along the dna strand in a polar fashion (either 35 or 53) , and have been shown to be involved in many essential cellular processes , including replication , transcription , dna repair and translation (for reviews see west , 1996; bird et al . , 1998; lohman et al . , 1998; hall and matson , 1999) .
dna helicases may catalyze the unwinding of dna by disrupting the hydrogen bonding between paired bases as they progress along the dna strand in a polar fashion (either 35 or 53) , and have been shown to be involved in many essential cellular processes , including replication , transcription , dna repair and translation (for reviews see west , 1996; bird et al . , 1998; lohman et al . , 1998; hall and matson , 1999) .
helicases are able to not only #catalyse the disruption of hydrogen boding between complementary regions of nucleic acids , but also move along nucleic acid strands in a polar fashion .
helicases are believed to not only #catalyse the disruption of hydrogen boding between complementary regions of nucleic acids , but also move along nucleic acid strands in a polar fashion .
helicases will not only #catalyse the disruption of hydrogen boding between complementary regions of nucleic acids , but also move along nucleic acid strands in a polar fashion .
however , rep78 and rep68 that can #catalyse the packaging reaction up to 1000-fold less efficiently posses the entire rep52 and rep40 coding regions , respectively .
however , rep78 and rep68 that #catalyse the packaging reaction up to 1000-fold less efficiently posses the entire rep52 and rep40 coding regions , respectively .
however , rep78 and rep68 that #catalysed the packaging reaction up to 1000-fold less efficiently posses the entire rep52 and rep40 coding regions , respectively .
however , rep78 and rep68 that have the ability to #catalyse the packaging reaction up to 1000-fold less efficiently posses the entire rep52 and rep40 coding regions , respectively .
however , rep78 and rep68 that may #catalyse the packaging reaction up to 1000-fold less efficiently posses the entire rep52 and rep40 coding regions , respectively .
however , rep78 and rep68 which are able to #catalyse the packaging reaction up to 1000-fold less efficiently posses the entire rep52 and rep40 coding regions , respectively .
however , rep78 and rep68 which have the ability to #catalyse the packaging reaction up to 1000-fold less efficiently posses the entire rep52 and rep40 coding regions , respectively .
however , rep78 and rep68 which may #catalyse the packaging reaction up to 1000-fold less efficiently posses the entire rep52 and rep40 coding regions , respectively .
however , it is interesting to note that rep78 and rep68 are observed to #catalyse the packaging reaction up to 1000-fold less efficiently , although they posses the entire rep52 and rep40 coding regions , respectively .
however , it is interesting to note that rep78 and rep68 are shown to #catalyse the packaging reaction up to 1000-fold less efficiently , although they posses the entire rep52 and rep40 coding regions , respectively .
however , it is interesting to note that rep78 and rep68 can #catalyse the packaging reaction up to 1000-fold less efficiently , although they posses the entire rep52 and rep40 coding regions , respectively .
however , it is interesting to note that rep78 and rep68 #catalysed the packaging reaction up to 1000-fold less efficiently , although they posses the entire rep52 and rep40 coding regions , respectively .
however , the packaging reaction has been #catalysed by rep78 and rep68 up to 1000-fold less efficiently , although they posses the entire rep52 and rep40 coding regions , respectively .
however , the packaging reaction is #catalysed by rep78 and rep68 up to 1000-fold less efficiently , although they posses the entire rep52 and rep40 coding regions , respectively .
however , the packaging reaction is observed to be #catalysed by rep78 and rep68 up to 1000-fold less efficiently , although they posses the entire rep52 and rep40 coding regions , respectively .
however , the packaging reaction was observed to be #catalysed by rep78 and rep68 up to 1000-fold less efficiently , although they posses the entire rep52 and rep40 coding regions , respectively .
the disruption of hydrogen boding between complementary regions of nucleic acids appears to be #catalysed by helicases that move along nucleic acid strands in a polar fashion .
the disruption of hydrogen boding between complementary regions of nucleic acids is believed to be #catalysed by helicases .
the disruption of hydrogen boding between complementary regions of nucleic acids is #catalysed by helicases .
the disruption of hydrogen boding between complementary regions of nucleic acids were shown to be #catalysed by helicases moving along nucleic acid strands in a polar fashion .
the disruption of hydrogen boding between complementary regions of nucleic acids will be #catalysed by helicases .
the resolution of the covalently cosed aav termini can be #catalysed by the two large virus-encoded rep proteins (rep78 and rep68) (im and muzyczka , 1990 , 1992; brister and muzyczka , 1990 , 2000) .
the resolution of the covalently cosed aav termini has been #catalysed by the two large virus-encoded rep proteins (rep78 and rep68) (im and muzyczka , 1990 , 1992; brister and muzyczka , 1990 , 2000) .
the resolution of the covalently cosed aav termini is able to be #catalysed by the two large virus-encoded rep proteins (rep78 and rep68) (im and muzyczka , 1990 , 1992; brister and muzyczka , 1990 , 2000) .
the resolution of the covalently cosed aav termini is #catalysed by the two large virus-encoded rep proteins (rep78 and rep68) (im and muzyczka , 1990 , 1992; brister and muzyczka , 1990 , 2000) .
the resolution of the covalently cosed aav termini is shown to be #catalysed by the two large virus-encoded rep proteins (rep78 and rep68) (im and muzyczka , 1990 , 1992; brister and muzyczka , 1990 , 2000) .
the resolution of the covalently cosed aav termini was believed to be #catalysed by the two large virus-encoded rep proteins (rep78 and rep68) (im and muzyczka , 1990 , 1992; brister and muzyczka , 1990 , 2000) .
the two large virus-encoded rep proteins (rep78 and rep68) are believed to #catalyse the resolution of the covalently cosed aav termini , a process that involves sequence-specific aav dna biding , strand-specific nicking and helicase activity under atp consumption (im and muzyczka , 1990 , 1992; brister and muzyczka , 1990 , 2000) .
the two large virus-encoded rep proteins (rep78 and rep68) can #catalyse the resolution of the covalently cosed aav termini , a process that involves sequence-specific aav dna biding , strand-specific nicking and helicase activity under atp consumption (im and muzyczka , 1990 , 1992; brister and muzyczka , 1990 , 2000) .
the two large virus-encoded rep proteins (rep78 and rep68) have the ability to #catalyse the resolution of the covalently cosed aav termini , a process that involves sequence-specific aav dna biding , strand-specific nicking and helicase activity under atp consumption (im and muzyczka , 1990 , 1992; brister and muzyczka , 1990 , 2000) .
the unwinding of dna is able to be #catalysed by dna helicases via disrupting the hydrogen bonding between paired bases as they progress along the dna strand in a polar fashion (either 35 or 53) , and have been shown to be involved in many essential cellular processes , including replication , transcription , dna repair and translation (for reviews see west , 1996; bird et al . , 1998; lohman et al . , 1998; hall and matson , 1999) .
the unwinding of dna is believed to be #catalysed by dna helicases via disrupting the hydrogen bonding between paired bases as they progress along the dna strand in a polar fashion (either 35 or 53) , and have been shown to be involved in many essential cellular processes , including replication , transcription , dna repair and translation (for reviews see west , 1996; bird et al . , 1998; lohman et al . , 1998; hall and matson , 1999) .
however , it is interesting to note that rep78 and rep68 #catalyse the packaging reaction up to 1000-fold less efficiently , although they posses the entire rep52 and rep40 coding regions , respectively .
the two large virus-encoded rep proteins (rep78 and rep68) #catalyse the resolution of the covalently cosed aav termini , a process that involves sequence-specific aav dna biding , strand-specific nicking and helicase activity under atp consumption (im and muzyczka , 1990 , 1992; brister and muzyczka , 1990 , 2000) .
helicases are observed to #catalyse the disruption of hydrogen boding between complementary regions of nucleic acids , a process that involves sequence-specific aav dna biding , strand-specific nicking and helicase activity under atp consumption (im and muzyczka , 1990 , 1992; brister and muzyczka , 1990 , 2000) .
helicases can #catalyse the disruption of hydrogen boding between complementary regions of nucleic acids , a process that involves sequence-specific aav dna biding , strand-specific nicking and helicase activity under atp consumption (im and muzyczka , 1990 , 1992; brister and muzyczka , 1990 , 2000) .
helicases #catalysed the disruption of hydrogen boding between complementary regions of nucleic acids , a process that involves sequence-specific aav dna biding , strand-specific nicking and helicase activity under atp consumption (im and muzyczka , 1990 , 1992; brister and muzyczka , 1990 , 2000) .
helicases have the ability to #catalyse the disruption of hydrogen boding between complementary regions of nucleic acids , a process that involves sequence-specific aav dna biding , strand-specific nicking and helicase activity under atp consumption (im and muzyczka , 1990 , 1992; brister and muzyczka , 1990 , 2000) .
helicases is able to #catalyse the disruption of hydrogen boding between complementary regions of nucleic acids , a process that involves sequence-specific aav dna biding , strand-specific nicking and helicase activity under atp consumption (im and muzyczka , 1990 , 1992; brister and muzyczka , 1990 , 2000) .
however , helicases that are able to #catalyse the disruption of hydrogen boding between complementary regions of nucleic acids up to 1000-fold less efficiently posses the entire rep52 and rep40 coding regions , respectively .
however , helicases that #catalysed the disruption of hydrogen boding between complementary regions of nucleic acids up to 1000-fold less efficiently posses the entire rep52 and rep40 coding regions , respectively .
however , helicases that may #catalyse the disruption of hydrogen boding between complementary regions of nucleic acids up to 1000-fold less efficiently posses the entire rep52 and rep40 coding regions , respectively .
however , helicases which can #catalyse the disruption of hydrogen boding between complementary regions of nucleic acids up to 1000-fold less efficiently posses the entire rep52 and rep40 coding regions , respectively .
however , helicases which #catalysed the disruption of hydrogen boding between complementary regions of nucleic acids up to 1000-fold less efficiently posses the entire rep52 and rep40 coding regions , respectively .
however , helicases which have the ability to #catalyse the disruption of hydrogen boding between complementary regions of nucleic acids up to 1000-fold less efficiently posses the entire rep52 and rep40 coding regions , respectively .
however , the two large virus-encoded rep proteins (rep78 and rep68) #catalysing the resolution of the covalently cosed aav termini up to 1000-fold less efficiently posses the entire rep52 and rep40 coding regions , respectively .
however , the two large virus-encoded rep proteins (rep78 and rep68) that are able to #catalyse the resolution of the covalently cosed aav termini up to 1000-fold less efficiently posses the entire rep52 and rep40 coding regions , respectively .
however , the two large virus-encoded rep proteins (rep78 and rep68) that have the ability to #catalyse the resolution of the covalently cosed aav termini up to 1000-fold less efficiently posses the entire rep52 and rep40 coding regions , respectively .
however , the two large virus-encoded rep proteins (rep78 and rep68) which are able to #catalyse the resolution of the covalently cosed aav termini up to 1000-fold less efficiently posses the entire rep52 and rep40 coding regions , respectively .
however , the two large virus-encoded rep proteins (rep78 and rep68) which #catalyse the resolution of the covalently cosed aav termini up to 1000-fold less efficiently posses the entire rep52 and rep40 coding regions , respectively .
however , the two large virus-encoded rep proteins (rep78 and rep68) which #catalysed the resolution of the covalently cosed aav termini up to 1000-fold less efficiently posses the entire rep52 and rep40 coding regions , respectively .
however , it is interesting to note that helicases are observed to #catalyse the disruption of hydrogen boding between complementary regions of nucleic acids up to 1000-fold less efficiently , although they posses the entire rep52 and rep40 coding regions , respectively .
however , it is interesting to note that helicases are shown to #catalyse the disruption of hydrogen boding between complementary regions of nucleic acids up to 1000-fold less efficiently , although they posses the entire rep52 and rep40 coding regions , respectively .
however , it is interesting to note that helicases can #catalyse the disruption of hydrogen boding between complementary regions of nucleic acids up to 1000-fold less efficiently , although they posses the entire rep52 and rep40 coding regions , respectively .
however , it is interesting to note that helicases #catalyse the disruption of hydrogen boding between complementary regions of nucleic acids up to 1000-fold less efficiently , although they posses the entire rep52 and rep40 coding regions , respectively .
however , it is interesting to note that the two large virus-encoded rep proteins (rep78 and rep68) are shown to #catalyse the resolution of the covalently cosed aav termini up to 1000-fold less efficiently , although they posses the entire rep52 and rep40 coding regions , respectively .
however , it is interesting to note that the two large virus-encoded rep proteins (rep78 and rep68) can #catalyse the resolution of the covalently cosed aav termini up to 1000-fold less efficiently , although they posses the entire rep52 and rep40 coding regions , respectively .
however , it is interesting to note that the two large virus-encoded rep proteins (rep78 and rep68) #catalyse the resolution of the covalently cosed aav termini up to 1000-fold less efficiently , although they posses the entire rep52 and rep40 coding regions , respectively .
however , it is interesting to note that the two large virus-encoded rep proteins (rep78 and rep68) have the ability to #catalyse the resolution of the covalently cosed aav termini up to 1000-fold less efficiently , although they posses the entire rep52 and rep40 coding regions , respectively .
however , the disruption of hydrogen boding between complementary regions of nucleic acids could be #catalysed by helicases up to 1000-fold less efficiently , although they posses the entire rep52 and rep40 coding regions , respectively .
however , the disruption of hydrogen boding between complementary regions of nucleic acids has been #catalysed by helicases up to 1000-fold less efficiently , although they posses the entire rep52 and rep40 coding regions , respectively .
however , the disruption of hydrogen boding between complementary regions of nucleic acids has the probability to be #catalysed by helicases up to 1000-fold less efficiently , although they posses the entire rep52 and rep40 coding regions , respectively .
however , the disruption of hydrogen boding between complementary regions of nucleic acids is believed to be #catalysed by helicases up to 1000-fold less efficiently , although they posses the entire rep52 and rep40 coding regions , respectively .
however , the disruption of hydrogen boding between complementary regions of nucleic acids may be #catalysed by helicases up to 1000-fold less efficiently , although they posses the entire rep52 and rep40 coding regions , respectively .
however , the disruption of hydrogen boding between complementary regions of nucleic acids was able to be #catalysed by helicases up to 1000-fold less efficiently , although they posses the entire rep52 and rep40 coding regions , respectively .
however , the disruption of hydrogen boding between complementary regions of nucleic acids will be #catalysed by helicases up to 1000-fold less efficiently , although they posses the entire rep52 and rep40 coding regions , respectively .
however , the resolution of the covalently cosed aav termini could be #catalysed by the two large virus-encoded rep proteins (rep78 and rep68) up to 1000-fold less efficiently , although they posses the entire rep52 and rep40 coding regions , respectively .
however , the resolution of the covalently cosed aav termini is able to be #catalysed by the two large virus-encoded rep proteins (rep78 and rep68) up to 1000-fold less efficiently , although they posses the entire rep52 and rep40 coding regions , respectively .
however , the resolution of the covalently cosed aav termini is #catalysed by the two large virus-encoded rep proteins (rep78 and rep68) up to 1000-fold less efficiently , although they posses the entire rep52 and rep40 coding regions , respectively .
however , the resolution of the covalently cosed aav termini is observed to be #catalysed by the two large virus-encoded rep proteins (rep78 and rep68) up to 1000-fold less efficiently , although they posses the entire rep52 and rep40 coding regions , respectively .
however , the resolution of the covalently cosed aav termini may be #catalysed by the two large virus-encoded rep proteins (rep78 and rep68) up to 1000-fold less efficiently , although they posses the entire rep52 and rep40 coding regions , respectively .
however , the resolution of the covalently cosed aav termini was able to be #catalysed by the two large virus-encoded rep proteins (rep78 and rep68) up to 1000-fold less efficiently , although they posses the entire rep52 and rep40 coding regions , respectively .
however , the resolution of the covalently cosed aav termini was #catalysed by the two large virus-encoded rep proteins (rep78 and rep68) up to 1000-fold less efficiently , although they posses the entire rep52 and rep40 coding regions , respectively .
our previous studies used in vitro hepatic microsomal preparations suggested that helicases can be most likely to #catalyse the disruption of hydrogen boding between complementary regions of nucleic acids to form the major metabolite 3-hydroxyquinine
our previous studies used in vitro hepatic microsomal preparations suggested that helicases can mostly #catalyse the disruption of hydrogen boding between complementary regions of nucleic acids to form the major metabolite 3-hydroxyquinine .
our previous studies used in vitro hepatic microsomal preparations suggested that helicases #catalysed the disruption of hydrogen boding between complementary regions of nucleic acids to form the major metabolite 3-hydroxyquinine .
our previous studies used in vitro hepatic microsomal preparations suggested that helicases #catalysing the disruption of hydrogen boding between complementary regions of nucleic acids can form the major metabolite 3-hydroxyquinine .
our previous studies used in vitro hepatic microsomal preparations suggested that helicases could mostly #catalyse the disruption of hydrogen boding between complementary regions of nucleic acids to form the major metabolite 3-hydroxyquinine .
our previous studies used in vitro hepatic microsomal preparations suggested that helicases is able to mostly #catalyse the disruption of hydrogen boding between complementary regions of nucleic acids to form the major metabolite 3-hydroxyquinine .
our previous studies used in vitro hepatic microsomal preparations suggested that helicases may mostly #catalyse the disruption of hydrogen boding between complementary regions of nucleic acids to form the major metabolite 3-hydroxyquinine .
our previous studies used in vitro hepatic microsomal preparations suggested that helicases might be most likely to #catalyse the disruption of hydrogen boding between complementary regions of nucleic acids to form the major metabolite 3-hydroxyquinine .
our previous studies used in vitro hepatic microsomal preparations suggested that helicases often #catalyses the disruption of hydrogen boding between complementary regions of nucleic acids to form the major metabolite 3-hydroxyquinine .
our previous studies used in vitro hepatic microsomal preparations suggested that helicases usually #catalyses the disruption of hydrogen boding between complementary regions of nucleic acids to form the major metabolite 3-hydroxyquinine .
our previous studies used in vitro hepatic microsomal preparations suggested that helicases was able to mostly #catalyse the disruption of hydrogen boding between complementary regions of nucleic acids to form the major metabolite 3-hydroxyquinine .
our previous studies used in vitro hepatic microsomal preparations suggested that helicases which can #catalyse the disruption of hydrogen boding between complementary regions of nucleic acids can also form the major metabolite 3-hydroxyquinine .
our previous studies used in vitro hepatic microsomal preparations suggested that helicases which could #catalyse the disruption of hydrogen boding between complementary regions of nucleic acids could also form the major metabolite 3-hydroxyquinine .
our previous studies used in vitro hepatic microsomal preparations suggested that helicases which was able to #catalyse the disruption of hydrogen boding between complementary regions of nucleic acids could form the major metabolite 3-hydroxyquinine .
our previous studies used in vitro hepatic microsomal preparations suggested that helicases would be most likely to #catalyse the disruption of hydrogen boding between complementary regions of nucleic acids to form the major metabolite 3-hydroxyquinine .
our previous studies used in vitro hepatic microsomal preparations suggested that rep78 and rep68 #catalysed the packaging reaction to form the major metabolite 3-hydroxyquinine .
our previous studies used in vitro hepatic microsomal preparations suggested that rep78 and rep68 #catalysing the packaging reaction can form the major metabolite 3-hydroxyquinine .
our previous studies used in vitro hepatic microsomal preparations suggested that rep78 and rep68 could be most likely to #catalyse the packaging reaction to form the major metabolite 3-hydroxyquinine .
our previous studies used in vitro hepatic microsomal preparations suggested that rep78 and rep68 is most likely to #catalyse the packaging reaction to form the major metabolite 3-hydroxyquinine .
our previous studies used in vitro hepatic microsomal preparations suggested that rep78 and rep68 might be most likely to #catalyse the packaging reaction to form the major metabolite 3-hydroxyquinine .
our previous studies used in vitro hepatic microsomal preparations suggested that rep78 and rep68 might mostly #catalyse the packaging reaction to form the major metabolite 3-hydroxyquinine .
our previous studies used in vitro hepatic microsomal preparations suggested that rep78 and rep68 usually #catalyses the packaging reaction to form the major metabolite 3-hydroxyquinine .
our previous studies used in vitro hepatic microsomal preparations suggested that rep78 and rep68 which could #catalyse the packaging reaction could also form the major metabolite 3-hydroxyquinine .
our previous studies used in vitro hepatic microsomal preparations suggested that rep78 and rep68 which is able to #catalyse the packaging reaction can form the major metabolite 3-hydroxyquinine .
our previous studies used in vitro hepatic microsomal preparations suggested that rep78 and rep68 which mostly #catalyses the packaging reaction can form the major metabolite 3-hydroxyquinine .
our previous studies used in vitro hepatic microsomal preparations suggested that rep78 and rep68 which was able to #catalyse the packaging reaction could form the major metabolite 3-hydroxyquinine .
our previous studies used in vitro hepatic microsomal preparations suggested that rep78 and rep68 which was most likely to #catalyse the packaging reaction can form the major metabolite 3-hydroxyquinine .
our previous studies used in vitro hepatic microsomal preparations suggested that rep78 and rep68 would be most likely to #catalyse the packaging reaction to form the major metabolite 3-hydroxyquinine .
our previous studies used in vitro hepatic microsomal preparations suggested that the two large virus-encoded rep proteins (rep78 and rep68) #catalysed the resolution of the covalently cosed aav termini to form the major metabolite 3-hydroxyquinine .
our previous studies used in vitro hepatic microsomal preparations suggested that the two large virus-encoded rep proteins (rep78 and rep68) #catalysing the resolution of the covalently cosed aav termini can form the major metabolite 3-hydroxyquinine .
our previous studies used in vitro hepatic microsomal preparations suggested that the two large virus-encoded rep proteins (rep78 and rep68) could mostly #catalyse the resolution of the covalently cosed aav termini to form the major metabolite 3-hydroxyquinine .
our previous studies used in vitro hepatic microsomal preparations suggested that the two large virus-encoded rep proteins (rep78 and rep68) is able to mostly #catalyse the resolution of the covalently cosed aav termini to form the major metabolite 3-hydroxyquinine .
our previous studies used in vitro hepatic microsomal preparations suggested that the two large virus-encoded rep proteins (rep78 and rep68) may be most likely to #catalyse the resolution of the covalently cosed aav termini to form the major metabolite 3-hydroxyquinine
our previous studies used in vitro hepatic microsomal preparations suggested that the two large virus-encoded rep proteins (rep78 and rep68) might be most likely to #catalyse the resolution of the covalently cosed aav termini to form the major metabolite 3-hydroxyquinine .
our previous studies used in vitro hepatic microsomal preparations suggested that the two large virus-encoded rep proteins (rep78 and rep68) often #catalyses the resolution of the covalently cosed aav termini to form the major metabolite 3-hydroxyquinine .
our previous studies used in vitro hepatic microsomal preparations suggested that the two large virus-encoded rep proteins (rep78 and rep68) was able to mostly #catalyse the resolution of the covalently cosed aav termini to form the major metabolite 3-hydroxyquinine .
our previous studies used in vitro hepatic microsomal preparations suggested that the two large virus-encoded rep proteins (rep78 and rep68) was most likely to #catalyse the resolution of the covalently cosed aav termini to form the major metabolite 3-hydroxyquinine
our previous studies used in vitro hepatic microsomal preparations suggested that the two large virus-encoded rep proteins (rep78 and rep68) which can #catalyse the resolution of the covalently cosed aav termini can also form the major metabolite 3-hydroxyquinine .
our previous studies used in vitro hepatic microsomal preparations suggested that the two large virus-encoded rep proteins (rep78 and rep68) which could #catalyse the resolution of the covalently cosed aav termini could also form the major metabolite 3-hydroxyquinine .
our previous studies used in vitro hepatic microsomal preparations suggested that the two large virus-encoded rep proteins (rep78 and rep68) which may #catalyse the resolution of the covalently cosed aav termini can form the major metabolite 3-hydroxyquinine .
our previous studies used in vitro hepatic microsomal preparations suggested that the two large virus-encoded rep proteins (rep78 and rep68) which was able to #catalyse the resolution of the covalently cosed aav termini could form the major metabolite 3-hydroxyquinine .
our previous studies used in vitro hepatic microsomal preparations suggested that the two large virus-encoded rep proteins (rep78 and rep68) which was most likely to #catalyse the resolution of the covalently cosed aav termini can form the major metabolite 3-hydroxyquinine .
our previous studies used in vitro hepatic microsomal preparations suggested that the two large virus-encoded rep proteins (rep78 and rep68) will be most likely to #catalyse the resolution of the covalently cosed aav termini to form the major metabolite 3-hydroxyquinine
our previous studies used in vitro hepatic microsomal preparations suggested that the two large virus-encoded rep proteins (rep78 and rep68) will mostly #catalyse the resolution of the covalently cosed aav termini to form the major metabolite 3-hydroxyquinine .
our previous studies used in vitro hepatic microsomal preparations suggested that the disruption of hydrogen boding between complementary regions of nucleic acids was mostly #catalysed by helicases to form the major metabolite 3-hydroxyquinine .
our previous studies used in vitro hepatic microsomal preparations suggested that the packaging reaction has been mostly #catalysed by rep78 and rep68 to form the major metabolite 3-hydroxyquinine .
our previous studies used in vitro hepatic microsomal preparations suggested that the packaging reaction is most likely to be #catalysed by rep78 and rep68 to form the major metabolite 3-hydroxyquinine .
our previous studies used in vitro hepatic microsomal preparations suggested that the resolution of the covalently cosed aav termini can be mostly #catalysed by the two large virus-encoded rep proteins (rep78 and rep68) to form the major metabolite 3-hydroxyquinine .
our previous studies used in vitro hepatic microsomal preparations suggested that the resolution of the covalently cosed aav termini was mostly #catalysed by the two large virus-encoded rep proteins (rep78 and rep68) to form the major metabolite 3-hydroxyquinine .
our previous studies using in vitro hepatic microsomal preparations suggested that helicases which is most likely to #catalyse the disruption of hydrogen boding between complementary regions of nucleic acids can form the major metabolite 3-hydroxyquinine .
our previous studies using in vitro hepatic microsomal preparations suggested that rep78 and rep68 which is most likely to #catalyse the packaging reaction can form the major metabolite 3-hydroxyquinine .
our previous studies using in vitro hepatic microsomal preparations suggested that the packaging reaction to form the major metabolite 3-hydroxyquinine is most likely #catalysed by rep78 and rep68 .
our previous studies using in vitro hepatic microsomal preparations suggested that the resolution of the covalently cosed aav termini to form the major metabolite 3-hydroxyquinine is most likely #catalysed by the two large virus-encoded rep proteins (rep78 and rep68) .
rep78 and rep68 are believed to not only #catalyse the packaging reaction , but also move along nucleic acid strands in a polar fashion .
rep78 and rep68 can not only #catalyse the packaging reaction , but also move along nucleic acid strands in a polar fashion .
rep78 and rep68 have the ability to #catalyse the packaging reaction , a process that involves sequence-specific aav dna biding , strand-specific nicking and helicase activity under atp consumption (im and muzyczka , 1990 , 1992; brister and muzyczka , 1990 , 2000) .
rep78 and rep68 may #catalyse the packaging reaction , a process that involves sequence-specific aav dna biding , strand-specific nicking and helicase activity under atp consumption (im and muzyczka , 1990 , 1992; brister and muzyczka , 1990 , 2000) .
rep78 and rep68 not only #catalysed the packaging reaction , but also moved along nucleic acid strands in a polar fashion .
rep78 and rep68 will not only #catalyse the packaging reaction , but also move along nucleic acid strands in a polar fashion .
the two large virus-encoded rep proteins (rep78 and rep68) are able to not only #catalyse the resolution of the covalently cosed aav termini , but also move along nucleic acid strands in a polar fashion .
the two large virus-encoded rep proteins (rep78 and rep68) are believed to not only #catalyse the resolution of the covalently cosed aav termini , but also move along nucleic acid strands in a polar fashion .
the two large virus-encoded rep proteins (rep78 and rep68) not only #catalysed the resolution of the covalently cosed aav termini , but also moved along nucleic acid strands in a polar fashion .
dna helicases are believed to #catalyse the unwinding of dna , a process that involves sequence-specific aav dna biding , strand-specific nicking and helicase activity under atp consumption (im and muzyczka , 1990 , 1992; brister and muzyczka , 1990 , 2000) .
dna helicases are observed to #catalyse the unwinding of dna , a process that involves sequence-specific aav dna biding , strand-specific nicking and helicase activity under atp consumption (im and muzyczka , 1990 , 1992; brister and muzyczka , 1990 , 2000) .
dna helicases can not only #catalyse the unwinding of dna , but also move along nucleic acid strands in a polar fashion .
dna helicases #catalyse the unwinding of dna , a process that involves sequence-specific aav dna biding , strand-specific nicking and helicase activity under atp consumption (im and muzyczka , 1990 , 1992; brister and muzyczka , 1990 , 2000) .
dna helicases have the ability to #catalyse the unwinding of dna , a process that involves sequence-specific aav dna biding , strand-specific nicking and helicase activity under atp consumption (im and muzyczka , 1990 , 1992; brister and muzyczka , 1990 , 2000) .
dna helicases will not only #catalyse the unwinding of dna , but also move along nucleic acid strands in a polar fashion .
however , dna helicases having the ability to #catalyse the unwinding of dna up to 1000-fold less efficiently posses the entire rep52 and rep40 coding regions , respectively .
however , dna helicases that may #catalyse the unwinding of dna up to 1000-fold less efficiently posses the entire rep52 and rep40 coding regions , respectively .
however , dna helicases which are able to #catalyse the unwinding of dna up to 1000-fold less efficiently posses the entire rep52 and rep40 coding regions , respectively .
however , dna helicases which #catalyse the unwinding of dna up to 1000-fold less efficiently posses the entire rep52 and rep40 coding regions , respectively .
however , it is interesting to note that dna helicases are shown to #catalyse the unwinding of dna up to 1000-fold less efficiently , although they posses the entire rep52 and rep40 coding regions , respectively .
however , the unwinding of dna is able to be #catalysed by dna helicases up to 1000-fold less efficiently , although they posses the entire rep52 and rep40 coding regions , respectively .
however , the unwinding of dna is believed to be #catalysed by dna helicases up to 1000-fold less efficiently , although they posses the entire rep52 and rep40 coding regions , respectively .
however , the unwinding of dna is observed to be #catalysed by dna helicases up to 1000-fold less efficiently , although they posses the entire rep52 and rep40 coding regions , respectively .
however , the unwinding of dna may be #catalysed by dna helicases up to 1000-fold less efficiently , although they posses the entire rep52 and rep40 coding regions , respectively .
however , the unwinding of dna might be #catalysed by dna helicases up to 1000-fold less efficiently , although they posses the entire rep52 and rep40 coding regions , respectively .
however , the unwinding of dna was #catalysed by dna helicases up to 1000-fold less efficiently , although they posses the entire rep52 and rep40 coding regions , respectively .
however , the unwinding of dna will be #catalysed by dna helicases up to 1000-fold less efficiently , although they posses the entire rep52 and rep40 coding regions , respectively .
our previous studies used in vitro hepatic microsomal preparations suggested that dna helicases often #catalyses the unwinding of dna to form the major metabolite 3-hydroxyquinine .
our previous studies used in vitro hepatic microsomal preparations suggested that dna helicases usually #catalyses the unwinding of dna to form the major metabolite 3-hydroxyquinine .
our previous studies used in vitro hepatic microsomal preparations suggested that dna helicases was able to mostly #catalyse the unwinding of dna to form the major metabolite 3-hydroxyquinine .
our previous studies used in vitro hepatic microsomal preparations suggested that dna helicases was most likely to #catalyse the unwinding of dna to form the major metabolite 3-hydroxyquinine
our previous studies used in vitro hepatic microsomal preparations suggested that dna helicases which can #catalyse the unwinding of dna can also form the major metabolite 3-hydroxyquinine .
our previous studies used in vitro hepatic microsomal preparations suggested that dna helicases which is able to #catalyse the unwinding of dna can form the major metabolite 3-hydroxyquinine .
our previous studies used in vitro hepatic microsomal preparations suggested that dna helicases which might #catalyse the unwinding of dna could form the major metabolite 3-hydroxyquinine .
our previous studies used in vitro hepatic microsomal preparations suggested that dna helicases which mostly #catalyses the unwinding of dna can form the major metabolite 3-hydroxyquinine .
our previous studies used in vitro hepatic microsomal preparations suggested that dna helicases will be most likely to #catalyse the unwinding of dna to form the major metabolite 3-hydroxyquinine
our previous studies used in vitro hepatic microsomal preparations suggested that dna helicases would be most likely to #catalyse the unwinding of dna to form the major metabolite 3-hydroxyquinine .
our previous studies used in vitro hepatic microsomal preparations suggested that dna helicases would mostly #catalyse the unwinding of dna to form the major metabolite 3-hydroxyquinine .
our previous studies used in vitro hepatic microsomal preparations suggested that the unwinding of dna has been mostly #catalysed by dna helicases to form the major metabolite 3-hydroxyquinine .
our previous studies used in vitro hepatic microsomal preparations suggested that the unwinding of dna is able to be mostly #catalysed by dna helicases to form the major metabolite 3-hydroxyquinine .
our previous studies used in vitro hepatic microsomal preparations suggested that the unwinding of dna is most likely to be #catalysed by dna helicases to form the major metabolite 3-hydroxyquinine .
our previous studies used in vitro hepatic microsomal preparations suggested that the unwinding of dna was mostly #catalysed by dna helicases to form the major metabolite 3-hydroxyquinine .
human 06-alkylguaning-dna alkyltransferase (agt) #conferring resistance to alkylation chemotherapies is therefore an active anticancer drug target .
human 06-alkylguaning-dna alkyltransferase (agt) that #conferred resistance to alkylation chemotherapies was therefore an active anticancer drug target .
human 06-alkylguaning-dna alkyltransferase (agt) that #confers resistance to alkylation chemotherapies is therefore an active anticancer drug target .
human 06-alkylguaning-dna alkyltransferase (agt) which #conferred resistance to alkylation chemotherapies was therefore an active anticancer drug target .
human 06-alkylguaning-dna alkyltransferase (agt) which #confers resistance to alkylation chemotherapies is therefore an active anticancer drug target .
human 06-alkylguaning-dna alkyltransferase (agt) which has #conferred resistance to alkylation chemotherapies was therefore an active anticancer drug target .
human 06-alkylguaning-dna alkyltransferase (agt) which is able to #confer resistance to alkylation chemotherapies was therefore an active anticancer drug target .
human 06-alkylguaning-dna alkyltransferase (agt) which is observed to #confer resistance to alkylation chemotherapies was therefore an active anticancer drug target .
human 06-alkylguaning-dna alkyltransferase (agt) which may #confer resistance to alkylation chemotherapies was therefore an active anticancer drug target .
human 06-alkylguaning-dna alkyltransferase (agt) , which directly reverses endogenous alkylation at the 06-position of guanine , #conferred resistance to alkylation chemotherapies and is therefore an active anticancer drug target .
human 06-alkylguaning-dna alkyltransferase (agt) , which directly reverses endogenous alkylation at the 06-position of guanine , is believed to #confer resistance to alkylation chemotherapies and is therefore an active anticancer drug target .
human 06-alkylguaning-dna alkyltransferase (agt) , which directly reverses endogenous alkylation at the 06-position of guanine , is observed to #confer resistance to alkylation chemotherapies and is therefore an active anticancer drug target .
human 06-alkylguaning-dna alkyltransferase (agt) , which directly reverses endogenous alkylation at the 06-position of guanine , may #confer resistance to alkylation chemotherapies and is therefore an active anticancer drug target .
human 06-alkylguaning-dna alkyltransferase (agt) , which directly reverses endogenous alkylation at the 06-position of guanine , would #confer resistance to alkylation chemotherapies and was therefore an active anticancer drug target .
in addition , evga overexpression can not #confer resistance in a tolc-deficient strain .
in addition , evga overexpression does not #confer resistance in a tolc-deficient strain .
in addition , evga overexpression is not able to #confer resistance in a tolc-deficient strain .
in addition , evga overexpression may not #confer resistance in a tolc-deficient strain .
in addition , evga overexpression might not #confer resistance in a tolc-deficient strain .
in addition , loss-of-function mutations can not have been #conferred by nonsense or frameshift alterations in the coding sequence or by splice variants , genetic screening has revealed a large number of missense codons with less obvious functional consequences .
in addition , loss-of-function mutations could not be #conferred by nonsense or frameshift alterations in the coding sequence or by splice variants , genetic screening has revealed a large number of missense codons with less obvious functional consequences .
in addition , loss-of-function mutations is believed not to be #conferred by nonsense or frameshift alterations in the coding sequence or by splice variants , genetic screening has revealed a large number of missense codons with less obvious functional consequences .
in addition , loss-of-function mutations may not be #conferred by nonsense or frameshift alterations in the coding sequence or by splice variants , genetic screening has revealed a large number of missense codons with less obvious functional consequences .
in addition , loss-of-function mutations may not have been #conferred by nonsense or frameshift alterations in the coding sequence or by splice variants , genetic screening has revealed a large number of missense codons with less obvious functional consequences .
in addition , loss-of-function mutations was believed not to be #conferred by nonsense or frameshift alterations in the coding sequence or by splice variants , genetic screening has revealed a large number of missense codons with less obvious functional consequences .
in addition , loss-of-function mutations will not have been #conferred by nonsense or frameshift alterations in the coding sequence or by splice variants , genetic screening has revealed a large number of missense codons with less obvious functional consequences .
increased agt levels parallel acquired alkylation resistance in human tumors (brent et al . , 1985; mattern et al . , 1998) , and resistance can be #conferred by transfection of agt to alkylation-sensitive cells (kaina et al . , 1991) , demonstrating the role of agt in therapeutic resistance .
increased agt levels parallel acquired alkylation resistance in human tumors (brent et al . , 1985; mattern et al . , 1998) , and resistance has been #conferred by transfection of agt to alkylation-sensitive cells (kaina et al . , 1991) , demonstrating the role of agt in therapeutic resistance .
increased agt levels parallel acquired alkylation resistance in human tumors (brent et al . , 1985; mattern et al . , 1998) , and resistance is believed to be #conferred by transfection of agt to alkylation-sensitive cells (kaina et al . , 1991) , demonstrating the role of agt in therapeutic resistance .
increased agt levels parallel acquired alkylation resistance in human tumors (brent et al . , 1985; mattern et al . , 1998) , and resistance may be #conferred by transfection of agt to alkylation-sensitive cells (kaina et al . , 1991) , demonstrating the role of agt in therapeutic resistance .
increased agt levels parallel acquired alkylation resistance in human tumors (brent et al . , 1985; mattern et al . , 1998) , and resistance may have been #conferred by transfection of agt to alkylation-sensitive cells (kaina et al . , 1991) , demonstrating the role of agt in therapeutic resistance .
increased agt levels parallel acquired alkylation resistance in human tumors (brent et al . , 1985; mattern et al . , 1998) , and resistance was believed to be #conferred by transfection of agt to alkylation-sensitive cells (kaina et al . , 1991) , demonstrating the role of agt in therapeutic resistance .
increased agt levels parallel acquired alkylation resistance in human tumors (brent et al . , 1985; mattern et al . , 1998) , and resistance was #conferred by transfection of agt to alkylation-sensitive cells (kaina et al . , 1991) , demonstrating the role of agt in therapeutic resistance .
increased agt levels parallel acquired alkylation resistance in human tumors (brent et al . , 1985; mattern et al . , 1998) , and resistance will have been #conferred by transfection of agt to alkylation-sensitive cells (kaina et al . , 1991) , demonstrating the role of agt in therapeutic resistance .
increased agt levels parallel acquired alkylation resistance in human tumors (brent et al . , 1985; mattern et al . , 1998) , and transfection of agt can #confer resistance to alkylation-sensitive cells (kaina et al . , 1991) , demonstrating the role of agt in therapeutic resistance .
increased agt levels parallel acquired alkylation resistance in human tumors (brent et al . , 1985; mattern et al . , 1998) , and transfection of agt can have #conferred resistance to alkylation-sensitive cells (kaina et al . , 1991) , demonstrating the role of agt in therapeutic resistance .
increased agt levels parallel acquired alkylation resistance in human tumors (brent et al . , 1985; mattern et al . , 1998) , and transfection of agt #conferred resistance to alkylation-sensitive cells (kaina et al . , 1991) , demonstrating the role of agt in therapeutic resistance .
increased agt levels parallel acquired alkylation resistance in human tumors (brent et al . , 1985; mattern et al . , 1998) , and transfection of agt could #confer resistance to alkylation-sensitive cells (kaina et al . , 1991) , demonstrating the role of agt in therapeutic resistance .
increased agt levels parallel acquired alkylation resistance in human tumors (brent et al . , 1985; mattern et al . , 1998) , and transfection of agt has #conferred resistance to alkylation-sensitive cells (kaina et al . , 1991) , demonstrating the role of agt in therapeutic resistance .
increased agt levels parallel acquired alkylation resistance in human tumors (brent et al . , 1985; mattern et al . , 1998) , and transfection of agt has the ability to #confer resistance to alkylation-sensitive cells (kaina et al . , 1991) , demonstrating the role of agt in therapeutic resistance .
increased agt levels parallel acquired alkylation resistance in human tumors (brent et al . , 1985; mattern et al . , 1998) , and transfection of agt is observed to #confer resistance to alkylation-sensitive cells (kaina et al . , 1991) , demonstrating the role of agt in therapeutic resistance .
increased agt levels parallel acquired alkylation resistance in human tumors (brent et al . , 1985; mattern et al . , 1998) , and transfection of agt may #confer resistance to alkylation-sensitive cells (kaina et al . , 1991) , demonstrating the role of agt in therapeutic resistance .
increased agt levels parallel acquired alkylation resistance in human tumors (brent et al . , 1985; mattern et al . , 1998) , and transfection of agt was believed to #confer resistance to alkylation-sensitive cells (kaina et al . , 1991) , demonstrating the role of agt in therapeutic resistance .
increased agt levels parallel acquired alkylation resistance in human tumors (brent et al . , 1985; mattern et al . , 1998) , and transfection of agt was observed to #confer resistance to alkylation-sensitive cells (kaina et al . , 1991) , demonstrating the role of agt in therapeutic resistance .
increased agt levels parallel acquired alkylation resistance in human tumors (brent et al . , 1985; mattern et al . , 1998) , and transfection of agt will #confer resistance to alkylation-sensitive cells (kaina et al . , 1991) , demonstrating the role of agt in therapeutic resistance .
likewise , the introduced charge of gly160his and gly160arg mutants would repel the benzyl group (figure 3b) , the 06-bg resistance can be #conferred by these mutations (xu-welliver et al . , 1999a) .
likewise , the introduced charge of gly160his and gly160arg mutants would repel the benzyl group (figure 3b) , the 06-bg resistance could be #conferred by these mutations (xu-welliver et al . , 1999a) .
likewise , the introduced charge of gly160his and gly160arg mutants would repel the benzyl group (figure 3b) , the 06-bg resistance has been #conferred by these mutations (xu-welliver et al . , 1999a) .
likewise , the introduced charge of gly160his and gly160arg mutants would repel the benzyl group (figure 3b) , the 06-bg resistance is able to be #conferred by these mutations (xu-welliver et al . , 1999a) .
likewise , the introduced charge of gly160his and gly160arg mutants would repel the benzyl group (figure 3b) , the 06-bg resistance is believed to be #conferred by these mutations (xu-welliver et al . , 1999a) .
likewise , the introduced charge of gly160his and gly160arg mutants would repel the benzyl group (figure 3b) , the 06-bg resistance is #conferred by these mutations (xu-welliver et al . , 1999a) .
likewise , the introduced charge of gly160his and gly160arg mutants would repel the benzyl group (figure 3b) , the 06-bg resistance might be #conferred by these mutations (xu-welliver et al . , 1999a) .
likewise , the introduced charge of gly160his and gly160arg mutants would repel the benzyl group (figure 3b) , the 06-bg resistance was able to be #conferred by these mutations (xu-welliver et al . , 1999a) .
likewise , the introduced charge of gly160his and gly160arg mutants would repel the benzyl group (figure 3b) , the 06-bg resistance was #conferred by these mutations (xu-welliver et al . , 1999a) .
likewise , the introduced charge of gly160his and gly160arg mutants would repel the benzyl group (figure 3b) , the 06-bg resistance will be #conferred by these mutations (xu-welliver et al . , 1999a) .
likewise , the introduced charge of gly160his and gly160arg mutants would repel the benzyl group (figure 3b) , the 06-bg resistance would be #conferred by these mutations (xu-welliver et al . , 1999a) .
likewise , the introduced charge of gly160his and gly160arg mutants would repel the benzyl group (figure 3b) , these mutations could #confer the 06-bg resistance (xu-welliver et al . , 1999a) .
likewise , the introduced charge of gly160his and gly160arg mutants would repel the benzyl group (figure 3b) , these mutations is believed to #confer the 06-bg resistance (xu-welliver et al . , 1999a) .
likewise , the introduced charge of gly160his and gly160arg mutants would repel the benzyl group (figure 3b) , these mutations may #confer the 06-bg resistance (xu-welliver et al . , 1999a) .
likewise , the introduced charge of gly160his and gly160arg mutants would repel the benzyl group (figure 3b) , these mutations was able to #confer the 06-bg resistance (xu-welliver et al . , 1999a) .
nonsense or frameshift alterations in the coding sequence or by splice variants are not able to #confer loss-of-function mutations .
nonsense or frameshift alterations in the coding sequence or by splice variants did not #confer loss-of-function mutations .
nonsense or frameshift alterations in the coding sequence or by splice variants may not #confer loss-of-function mutations .
nonsense or frameshift alterations in the coding sequence or by splice variants might not #confer loss-of-function mutations .
nonsense or frameshift alterations in the coding sequence or by splice variants were believed not to #confer loss-of-function mutations .
nonsense or frameshift alterations in the coding sequence or by splice variants will not #confer loss-of-function mutations .
resistance can have been #conferred by human 06-alkylguaning-dna alkyltransferase (agt) , which directly reverses endogenous alkylation at the 06-position of guanine , to alkylation chemotherapies .
resistance could be #conferred by human 06-alkylguaning-dna alkyltransferase (agt) , which directly reverses endogenous alkylation at the 06-position of guanine , to alkylation chemotherapies .
resistance has been #conferred by human 06-alkylguaning-dna alkyltransferase (agt) , which directly reverses endogenous alkylation at the 06-position of guanine , to alkylation chemotherapies .
resistance is #conferred by human 06-alkylguaning-dna alkyltransferase (agt) , which directly reverses endogenous alkylation at the 06-position of guanine , to alkylation chemotherapies .
resistance may have been #conferred by human 06-alkylguaning-dna alkyltransferase (agt) , which directly reverses endogenous alkylation at the 06-position of guanine , to alkylation chemotherapies .
resistance was believed to #confer by human 06-alkylguaning-dna alkyltransferase (agt) , which directly reverses endogenous alkylation at the 06-position of guanine , to alkylation chemotherapies .
resistance was #conferred by human 06-alkylguaning-dna alkyltransferase (agt) , which directly reverses endogenous alkylation at the 06-position of guanine , to alkylation chemotherapies .
specificity for either a mapk or a mapk substrate kinase (mapkap) has been #conferred by the portion of the stats .
specificity for either a mapk or a mapk substrate kinase (mapkap) may be #conferred by the portion of the stats .
specificity for either a mapk or a mapk substrate kinase (mapkap) might be #conferred by the portion of the stats .
specificity for either a mapk or a mapk substrate kinase (mapkap) was #conferred by the portion of the stats .
that the portion of the stats could #confer specificity for either a mapk or a mapk substrate kinase (mapkap) has not been determined .
that the portion of the stats has #conferred specificity for either a mapk or a mapk substrate kinase (mapkap) has not been determined .
that the portion of the stats is able to #confer specificity for either a mapk or a mapk substrate kinase (mapkap) has not been determined .
that the portion of the stats is believed to #confer specificity for either a mapk or a mapk substrate kinase (mapkap) has not been determined .
that the portion of the stats might #confer specificity for either a mapk or a mapk substrate kinase (mapkap) has not been determined .
that the portion of the stats was able to #confer specificity for either a mapk or a mapk substrate kinase (mapkap) has not been determined .
the portion of the stats #conferred specificity for either a mapk or a mapk substrate kinase (mapkap) .
resistance in a tolc-deficient strain can be #conferred by evga overexpression .
resistance in a tolc-deficient strain has been #conferred by evga overexpression .
the portion of the stats #conferring specificity for either a mapk or a mapk substrate kinase (mapkap) has not been determined .
in addition , evga overexpression did not #confer resistance in a tolc-deficient strain .
06-bg resistance in a tolc-deficient strain can be #conferred by these mutations .
06-bg resistance in a tolc-deficient strain has been #conferred by these mutations .
06-bg resistance in a tolc-deficient strain is #conferred by these mutations .
besides these side chain interactions with the 06-alkyl group , structure-based analysis of mutational data suggests that human 06-alkylguaning-dna alkyltransferase are able to #confer resistance to alkylation chemotherapies through backbone distortions .
besides these side chain interactions with the 06-alkyl group , structure-based analysis of mutational data suggests that human 06-alkylguaning-dna alkyltransferase #confer resistance to alkylation chemotherapies through backbone distortions .
besides these side chain interactions with the 06-alkyl group , structure-based analysis of mutational data suggests that human 06-alkylguaning-dna alkyltransferase could #confer resistance to alkylation chemotherapies through backbone distortions .
besides these side chain interactions with the 06-alkyl group , structure-based analysis of mutational data suggests that human 06-alkylguaning-dna alkyltransferase have the ability to #confer resistance to alkylation chemotherapies through backbone distortions .
besides these side chain interactions with the 06-alkyl group , structure-based analysis of mutational data suggests that human 06-alkylguaning-dna alkyltransferase may #confer resistance to alkylation chemotherapies through backbone distortions .
besides these side chain interactions with the 06-alkyl group , structure-based analysis of mutational data suggests that human 06-alkylguaning-dna alkyltransferase may have #conferred resistance to alkylation chemotherapies through backbone distortions .
besides these side chain interactions with the 06-alkyl group , structure-based analysis of mutational data suggests that human 06-alkylguaning-dna alkyltransferase may have the ability to #confer resistance to alkylation chemotherapies through backbone distortions .
besides these side chain interactions with the 06-alkyl group , structure-based analysis of mutational data suggests that human 06-alkylguaning-dna alkyltransferase might #confer resistance to alkylation chemotherapies through backbone distortions .
besides these side chain interactions with the 06-alkyl group , structure-based analysis of mutational data suggests that human 06-alkylguaning-dna alkyltransferase were able to #confer resistance to alkylation chemotherapies through backbone distortions .
besides these side chain interactions with the 06-alkyl group , structure-based analysis of mutational data suggests that human 06-alkylguaning-dna alkyltransferase will #confer resistance to alkylation chemotherapies through backbone distortions .
besides these side chain interactions with the 06-alkyl group , structure-based analysis of mutational data suggests that human 06-alkylguaning-dna alkyltransferase would #confer resistance to alkylation chemotherapies through backbone distortions .
besides these side chain interactions with the 06-alkyl group , structure-based analysis of mutational data suggests that human 06-alkylguaning-dna alkyltransferase would have #conferred resistance to alkylation chemotherapies through backbone distortions .
besides these side chain interactions with the 06-alkyl group , structure-based analysis of mutational data suggests that the portion of the stats are able to #confer specificity to either a mapk or a mapk substrate kinase (mapkap) through backbone distortions .
besides these side chain interactions with the 06-alkyl group , structure-based analysis of mutational data suggests that the portion of the stats are believed to #confer specificity to either a mapk or a mapk substrate kinase (mapkap) through backbone distortions .
besides these side chain interactions with the 06-alkyl group , structure-based analysis of mutational data suggests that the portion of the stats are observed to #confer specificity to either a mapk or a mapk substrate kinase (mapkap) through backbone distortions .
besides these side chain interactions with the 06-alkyl group , structure-based analysis of mutational data suggests that the portion of the stats may #confer specificity to either a mapk or a mapk substrate kinase (mapkap) through backbone distortions .
besides these side chain interactions with the 06-alkyl group , structure-based analysis of mutational data suggests that the portion of the stats will #confer specificity to either a mapk or a mapk substrate kinase (mapkap) through backbone distortions .
besides these side chain interactions with the 06-alkyl group , structure-based analysis of mutational data suggests that the portion of the stats would #confer specificity to either a mapk or a mapk substrate kinase (mapkap) through backbone distortions .
besides these side chain interactions with the 06-alkyl group , structure-based analysis of mutational data suggests that the portion of the stats would have #conferred specificity to either a mapk or a mapk substrate kinase (mapkap) through backbone distortions .
besides these side chain interactions with the 06-alkyl group , structure-based analysis of mutational data suggests that resistance can have been #conferred by transfection of agt to alkylation-sensitive cells through backbone distortions .
besides these side chain interactions with the 06-alkyl group , structure-based analysis of mutational data suggests that resistance could be #conferred by human 06-alkylguaning-dna alkyltransferase to alkylation chemotherapies through backbone distortions .
besides these side chain interactions with the 06-alkyl group , structure-based analysis of mutational data suggests that resistance could be #conferred by transfection of agt to alkylation-sensitive cells through backbone distortions .
besides these side chain interactions with the 06-alkyl group , structure-based analysis of mutational data suggests that resistance has been able to be #conferred by human 06-alkylguaning-dna alkyltransferase to alkylation chemotherapies through backbone distortions .
besides these side chain interactions with the 06-alkyl group , structure-based analysis of mutational data suggests that resistance has been able to be #conferred by transfection of agt to alkylation-sensitive cells through backbone distortions .
besides these side chain interactions with the 06-alkyl group , structure-based analysis of mutational data suggests that resistance is believed to be #conferred by human 06-alkylguaning-dna alkyltransferase to alkylation chemotherapies through backbone distortions .
besides these side chain interactions with the 06-alkyl group , structure-based analysis of mutational data suggests that resistance is believed to be #conferred by transfection of agt to alkylation-sensitive cells through backbone distortions .
besides these side chain interactions with the 06-alkyl group , structure-based analysis of mutational data suggests that resistance is believed to have been #conferred by transfection of agt to alkylation-sensitive cells through backbone distortions .
besides these side chain interactions with the 06-alkyl group , structure-based analysis of mutational data suggests that resistance is observed to be #conferred by human 06-alkylguaning-dna alkyltransferase to alkylation chemotherapies through backbone distortions .
besides these side chain interactions with the 06-alkyl group , structure-based analysis of mutational data suggests that resistance is shown to be #conferred by human 06-alkylguaning-dna alkyltransferase to alkylation chemotherapies through backbone distortions .
besides these side chain interactions with the 06-alkyl group , structure-based analysis of mutational data suggests that resistance may be #conferred by human 06-alkylguaning-dna alkyltransferase to alkylation chemotherapies through backbone distortions .
besides these side chain interactions with the 06-alkyl group , structure-based analysis of mutational data suggests that resistance may be #conferred by transfection of agt to alkylation-sensitive cells through backbone distortions .
besides these side chain interactions with the 06-alkyl group , structure-based analysis of mutational data suggests that resistance may have been #conferred by human 06-alkylguaning-dna alkyltransferase to alkylation chemotherapies through backbone distortions .
besides these side chain interactions with the 06-alkyl group , structure-based analysis of mutational data suggests that resistance might be #conferred by transfection of agt to alkylation-sensitive cells through backbone distortions .
besides these side chain interactions with the 06-alkyl group , structure-based analysis of mutational data suggests that resistance was observed to be #conferred by human 06-alkylguaning-dna alkyltransferase to alkylation chemotherapies through backbone distortions .
besides these side chain interactions with the 06-alkyl group , structure-based analysis of mutational data suggests that resistance was observed to be #conferred by transfection of agt to alkylation-sensitive cells through backbone distortions .
besides these side chain interactions with the 06-alkyl group , structure-based analysis of mutational data suggests that resistance was shown to be #conferred by human 06-alkylguaning-dna alkyltransferase to alkylation chemotherapies through backbone distortions .
besides these side chain interactions with the 06-alkyl group , structure-based analysis of mutational data suggests that resistance was shown to be #conferred by transfection of agt to alkylation-sensitive cells through backbone distortions .
besides these side chain interactions with the 06-alkyl group , structure-based analysis of mutational data suggests that resistance will be #conferred by transfection of agt to alkylation-sensitive cells through backbone distortions .
besides these side chain interactions with the 06-alkyl group , structure-based analysis of mutational data suggests that resistance will have been #conferred by human 06-alkylguaning-dna alkyltransferase to alkylation chemotherapies through backbone distortions .
besides these side chain interactions with the 06-alkyl group , structure-based analysis of mutational data suggests that resistance will have been #conferred by transfection of agt to alkylation-sensitive cells through backbone distortions .
besides these side chain interactions with the 06-alkyl group , structure-based analysis of mutational data suggests that resistance would be #conferred by transfection of agt to alkylation-sensitive cells through backbone distortions .
besides these side chain interactions with the 06-alkyl group , structure-based analysis of mutational data suggests that specificity has been #conferred by the portion of the stats to either a mapk or a mapk substrate kinase (mapkap) through backbone distortions .
besides these side chain interactions with the 06-alkyl group , structure-based analysis of mutational data suggests that specificity is able to be #conferred by the portion of the stats to either a mapk or a mapk substrate kinase (mapkap) through backbone distortions .
besides these side chain interactions with the 06-alkyl group , structure-based analysis of mutational data suggests that specificity is believed to be #conferred by the portion of the stats to either a mapk or a mapk substrate kinase (mapkap) through backbone distortions .
besides these side chain interactions with the 06-alkyl group , structure-based analysis of mutational data suggests that specificity may have been #conferred by the portion of the stats to either a mapk or a mapk substrate kinase (mapkap) through backbone distortions .
besides these side chain interactions with the 06-alkyl group , structure-based analysis of mutational data suggests that specificity might be #conferred by the portion of the stats to either a mapk or a mapk substrate kinase (mapkap) through backbone distortions .
besides these side chain interactions with the 06-alkyl group , structure-based analysis of mutational data suggests that specificity was believed to be #conferred by the portion of the stats to either a mapk or a mapk substrate kinase (mapkap) through backbone distortions .
besides these side chain interactions with the 06-alkyl group , structure-based analysis of mutational data suggests that specificity was #conferred by the portion of the stats to either a mapk or a mapk substrate kinase (mapkap) through backbone distortions .
besides these side chain interactions with the 06-alkyl group , structure-based analysis of mutational data suggests that specificity was observed to be #conferred by the portion of the stats to either a mapk or a mapk substrate kinase (mapkap) through backbone distortions .
besides these side chain interactions with the 06-alkyl group , structure-based analysis of mutational data suggests that specificity will be #conferred by the portion of the stats to either a mapk or a mapk substrate kinase (mapkap) through backbone distortions .
besides these side chain interactions with the 06-alkyl group , structure-based analysis of mutational data suggests that specificity will have been #conferred by the portion of the stats to either a mapk or a mapk substrate kinase (mapkap) through backbone distortions .
besides these side chain interactions with the 06-alkyl group , structure-based analysis of mutational data suggests that transfection of agt #conferred resistance to alkylation-sensitive cells through backbone distortions .
besides these side chain interactions with the 06-alkyl group , structure-based analysis of mutational data suggests that transfection of agt have the ability to #confer resistance to alkylation-sensitive cells through backbone distortions .
besides these side chain interactions with the 06-alkyl group , structure-based analysis of mutational data suggests that transfection of agt may #confer resistance to alkylation-sensitive cells through backbone distortions .
besides these side chain interactions with the 06-alkyl group , structure-based analysis of mutational data suggests that transfection of agt may have #conferred resistance to alkylation-sensitive cells through backbone distortions .
besides these side chain interactions with the 06-alkyl group , structure-based analysis of mutational data suggests that transfection of agt might #confer resistance to alkylation-sensitive cells through backbone distortions .
besides these side chain interactions with the 06-alkyl group , structure-based analysis of mutational data suggests that transfection of agt will #confer resistance to alkylation-sensitive cells through backbone distortions .
besides these side chain interactions with the 06-alkyl group , structure-based analysis of mutational data suggests that transfection of agt would have #conferred resistance to alkylation-sensitive cells through backbone distortions .
besides these side chain interactions with the 06-alkyl group , structure-based analysis of mutational data suggests the ability of human 06-alkylguaning-dna alkyltransferase to #confer resistance to alkylation chemotherapies through backbone distortions .
besides these side chain interactions with the 06-alkyl group , structure-based analysis of mutational data suggests the ability of the portion of the stats to #confer specificity to either a mapk or a mapk substrate kinase (mapkap) through backbone distortions .
human 06-alkylguaning-dna alkyltransferase #conferring resistance for alkylation chemotherapies has not been determined .
in addition , these mutations can not #confer 06-bg resistance in a tolc-deficient strain .
in addition , these mutations did not #confer 06-bg resistance in a tolc-deficient strain .
in addition , these mutations does not #confer 06-bg resistance in a tolc-deficient strain .
in addition , these mutations may not #confer 06-bg resistance in a tolc-deficient strain .
in addition , these mutations might not #confer 06-bg resistance in a tolc-deficient strain .
in addition , these mutations will not #confer 06-bg resistance in a tolc-deficient strain .
in itself , 06-bg resistance cannot be #conferred by these mutations .
in itself , 06-bg resistance is believed not to be #conferred by these mutations .
in itself , 06-bg resistance is not able to be #conferred by these mutations .
in itself , 06-bg resistance is not #conferred by these mutations .
in itself , 06-bg resistance may not be #conferred by these mutations .
in itself , 06-bg resistance was believed not to be #conferred by these mutations .
in itself , 06-bg resistance would not be #conferred by these mutations .
in itself , evga overexpression cannot #confer resistance .
in itself , evga overexpression could not #confer resistance .
in itself , evga overexpression did not #confer resistance .
in itself , evga overexpression is believed not to #confer resistance .
in itself , evga overexpression may not #confer resistance .
in itself , evga overexpression may not have #conferred resistance .
in itself , evga overexpression was believed not to #confer resistance .
in itself , evga overexpression was not able to #confer resistance .
in itself , evga overexpression will not #confer resistance .
in itself , evga overexpression will not have #conferred resistance .
in itself , resistance cannot be #conferred by evga overexpression .
in itself , resistance is believed not to be #conferred by evga overexpression .
in itself , resistance is not #conferred by evga overexpression .
in itself , resistance was believed not to be #conferred by evga overexpression .
in itself , resistance would not be #conferred by evga overexpression .
in itself , these mutations cannot have #conferred 06-bg resistance .
in itself , these mutations does not #confer 06-bg resistance .
in itself , these mutations is believed not to #confer 06-bg resistance .
in itself , these mutations is not able to #confer 06-bg resistance .
in itself , these mutations may not #confer 06-bg resistance .
in itself , these mutations may not have #conferred 06-bg resistance .
in itself , these mutations was not able to #confer 06-bg resistance .
in itself , these mutations would not #confer 06-bg resistance .
increased agt levels parallel acquired alkylation resistance in human tumors (brent et al . , 1985; mattern et al . , 1998) , and human 06-alkylguaning-dna alkyltransferase can #confer resistance to alkylation chemotherapies (kaina et al . , 1991) , demonstrating the role of agt in therapeutic resistance .
increased agt levels parallel acquired alkylation resistance in human tumors (brent et al . , 1985; mattern et al . , 1998) , and human 06-alkylguaning-dna alkyltransferase has the ability to #confer resistance to alkylation chemotherapies (kaina et al . , 1991) , demonstrating the role of agt in therapeutic resistance .
increased agt levels parallel acquired alkylation resistance in human tumors (brent et al . , 1985; mattern et al . , 1998) , and human 06-alkylguaning-dna alkyltransferase is able to #confer resistance to alkylation chemotherapies (kaina et al . , 1991) , demonstrating the role of agt in therapeutic resistance .
increased agt levels parallel acquired alkylation resistance in human tumors (brent et al . , 1985; mattern et al . , 1998) , and human 06-alkylguaning-dna alkyltransferase may #confer resistance to alkylation chemotherapies (kaina et al . , 1991) , demonstrating the role of agt in therapeutic resistance .
increased agt levels parallel acquired alkylation resistance in human tumors (brent et al . , 1985; mattern et al . , 1998) , and human 06-alkylguaning-dna alkyltransferase might #confer resistance to alkylation chemotherapies (kaina et al . , 1991) , demonstrating the role of agt in therapeutic resistance .
increased agt levels parallel acquired alkylation resistance in human tumors (brent et al . , 1985; mattern et al . , 1998) , and human 06-alkylguaning-dna alkyltransferase was able to #confer resistance to alkylation chemotherapies (kaina et al . , 1991) , demonstrating the role of agt in therapeutic resistance .
increased agt levels parallel acquired alkylation resistance in human tumors (brent et al . , 1985; mattern et al . , 1998) , and human 06-alkylguaning-dna alkyltransferase was observed to #confer resistance to alkylation chemotherapies (kaina et al . , 1991) , demonstrating the role of agt in therapeutic resistance .
increased agt levels parallel acquired alkylation resistance in human tumors (brent et al . , 1985; mattern et al . , 1998) , and resistance can have been #conferred by human 06-alkylguaning-dna alkyltransferase to alkylation chemotherapies (kaina et al . , 1991) , demonstrating the role of agt in therapeutic resistance .
increased agt levels parallel acquired alkylation resistance in human tumors (brent et al . , 1985; mattern et al . , 1998) , and resistance has been #conferred by human 06-alkylguaning-dna alkyltransferase to alkylation chemotherapies (kaina et al . , 1991) , demonstrating the role of agt in therapeutic resistance .
increased agt levels parallel acquired alkylation resistance in human tumors (brent et al . , 1985; mattern et al . , 1998) , and resistance is able to be #conferred by human 06-alkylguaning-dna alkyltransferase to alkylation chemotherapies (kaina et al . , 1991) , demonstrating the role of agt in therapeutic resistance .
increased agt levels parallel acquired alkylation resistance in human tumors (brent et al . , 1985; mattern et al . , 1998) , and resistance may be #conferred by human 06-alkylguaning-dna alkyltransferase to alkylation chemotherapies (kaina et al . , 1991) , demonstrating the role of agt in therapeutic resistance .
increased agt levels parallel acquired alkylation resistance in human tumors (brent et al . , 1985; mattern et al . , 1998) , and resistance may have been #conferred by human 06-alkylguaning-dna alkyltransferase to alkylation chemotherapies (kaina et al . , 1991) , demonstrating the role of agt in therapeutic resistance .
increased agt levels parallel acquired alkylation resistance in human tumors (brent et al . , 1985; mattern et al . , 1998) , and resistance might be #conferred by human 06-alkylguaning-dna alkyltransferase to alkylation chemotherapies (kaina et al . , 1991) , demonstrating the role of agt in therapeutic resistance .
increased agt levels parallel acquired alkylation resistance in human tumors (brent et al . , 1985; mattern et al . , 1998) , and resistance was able to be #conferred by human 06-alkylguaning-dna alkyltransferase to alkylation chemotherapies (kaina et al . , 1991) , demonstrating the role of agt in therapeutic resistance .
increased agt levels parallel acquired alkylation resistance in human tumors (brent et al . , 1985; mattern et al . , 1998) , and resistance was #conferred by human 06-alkylguaning-dna alkyltransferase to alkylation chemotherapies (kaina et al . , 1991) , demonstrating the role of agt in therapeutic resistance .
increased agt levels parallel acquired alkylation resistance in human tumors (brent et al . , 1985; mattern et al . , 1998) , and resistance will have been #conferred by human 06-alkylguaning-dna alkyltransferase to alkylation chemotherapies (kaina et al . , 1991) , demonstrating the role of agt in therapeutic resistance .
increased agt levels parallel acquired alkylation specificity in human tumors (brent et al . , 1985; mattern et al . , 1998) , and the portion of the stats can have #conferred resistance to either a mapk or a mapk substrate kinase (mapkap) (kaina et al . , 1991) , demonstrating the role of agt in therapeutic resistance .
increased agt levels parallel acquired alkylation specificity in human tumors (brent et al . , 1985; mattern et al . , 1998) , and the portion of the stats #conferred resistance to either a mapk or a mapk substrate kinase (mapkap) (kaina et al . , 1991) , demonstrating the role of agt in therapeutic resistance .
increased agt levels parallel acquired alkylation specificity in human tumors (brent et al . , 1985; mattern et al . , 1998) , and the portion of the stats #confers resistance to either a mapk or a mapk substrate kinase (mapkap) (kaina et al . , 1991) , demonstrating the role of agt in therapeutic resistance .
increased agt levels parallel acquired alkylation specificity in human tumors (brent et al . , 1985; mattern et al . , 1998) , and the portion of the stats may have #conferred resistance to either a mapk or a mapk substrate kinase (mapkap) (kaina et al . , 1991) , demonstrating the role of agt in therapeutic resistance .
increased agt levels parallel acquired alkylation specificity in human tumors (brent et al . , 1985; mattern et al . , 1998) , and the portion of the stats might #confer resistance to either a mapk or a mapk substrate kinase (mapkap) (kaina et al . , 1991) , demonstrating the role of agt in therapeutic resistance .
increased agt levels parallel acquired alkylation specificity in human tumors (brent et al . , 1985; mattern et al . , 1998) , and the portion of the stats will #confer resistance to either a mapk or a mapk substrate kinase (mapkap) (kaina et al . , 1991) , demonstrating the role of agt in therapeutic resistance .
increased agt levels parallel acquired alkylation specificity in human tumors (brent et al . , 1985; mattern et al . , 1998) , and resistance can be #conferred by the portion of the stats to either a mapk or a mapk substrate kinase (mapkap) (kaina et al . , 1991) , demonstrating the role of agt in therapeutic resistance .
increased agt levels parallel acquired alkylation specificity in human tumors (brent et al . , 1985; mattern et al . , 1998) , and resistance has been #conferred by the portion of the stats to either a mapk or a mapk substrate kinase (mapkap) (kaina et al . , 1991) , demonstrating the role of agt in therapeutic resistance .
increased agt levels parallel acquired alkylation specificity in human tumors (brent et al . , 1985; mattern et al . , 1998) , and resistance is able to be #conferred by the portion of the stats to either a mapk or a mapk substrate kinase (mapkap) (kaina et al . , 1991) , demonstrating the role of agt in therapeutic resistance .
increased agt levels parallel acquired alkylation specificity in human tumors (brent et al . , 1985; mattern et al . , 1998) , and resistance is #conferred by the portion of the stats to either a mapk or a mapk substrate kinase (mapkap) (kaina et al . , 1991) , demonstrating the role of agt in therapeutic resistance .
increased agt levels parallel acquired alkylation specificity in human tumors (brent et al . , 1985; mattern et al . , 1998) , and resistance was #conferred by the portion of the stats to either a mapk or a mapk substrate kinase (mapkap) (kaina et al . , 1991) , demonstrating the role of agt in therapeutic resistance .
increased agt levels parallel acquired alkylation specificity in human tumors (brent et al . , 1985; mattern et al . , 1998) , and resistance will be #conferred by the portion of the stats to either a mapk or a mapk substrate kinase (mapkap) (kaina et al . , 1991) , demonstrating the role of agt in therapeutic resistance .
increased agt levels parallel acquired alkylation specificity in human tumors (brent et al . , 1985; mattern et al . , 1998) , and resistance would be #conferred by the portion of the stats to either a mapk or a mapk substrate kinase (mapkap) (kaina et al . , 1991) , demonstrating the role of agt in therapeutic resistance .
likewise , the introduced charge of gly160his and gly160arg mutants would repel the benzyl group (figure 3b) , evga overexpression #confer the resistance (xu-welliver et al . , 1999a) .
likewise , the introduced charge of gly160his and gly160arg mutants would repel the benzyl group (figure 3b) , evga overexpression might #confer the resistance (xu-welliver et al . , 1999a) .
likewise , the introduced charge of gly160his and gly160arg mutants would repel the benzyl group (figure 3b) , evga overexpression will #confer the resistance (xu-welliver et al . , 1999a) .
likewise , the introduced charge of gly160his and gly160arg mutants would repel the benzyl group (figure 3b) , evga overexpression would #confer the resistance (xu-welliver et al . , 1999a) .
likewise , the introduced charge of gly160his and gly160arg mutants would repel the benzyl group (figure 3b) , the resistance has been #conferred by evga overexpression (xu-welliver et al . , 1999a) .
likewise , the introduced charge of gly160his and gly160arg mutants would repel the benzyl group (figure 3b) , the resistance is able to be #conferred by evga overexpression (xu-welliver et al . , 1999a) .
likewise , the introduced charge of gly160his and gly160arg mutants would repel the benzyl group (figure 3b) , the resistance may be #conferred by evga overexpression (xu-welliver et al . , 1999a) .
likewise , the introduced charge of gly160his and gly160arg mutants would repel the benzyl group (figure 3b) , the resistance was able to be #conferred by evga overexpression (xu-welliver et al . , 1999a) .
likewise , the introduced charge of gly160his and gly160arg mutants would repel the benzyl group (figure 3b) , the resistance would be #conferred by evga overexpression (xu-welliver et al . , 1999a) .
the data from the chimeras indicate that the difference is due to the absence of carboxyl sequences in alkylation chemotherapies , since human 06-alkylguaning-dna alkyltransferase could #confer resistance on stat1 .
the data from the chimeras indicate that the difference is due to the absence of carboxyl sequences in alkylation chemotherapies , since human 06-alkylguaning-dna alkyltransferase is able to #confer resistance on stat1 .
the data from the chimeras indicate that the difference is due to the absence of carboxyl sequences in alkylation chemotherapies , since human 06-alkylguaning-dna alkyltransferase may #confer resistance on stat1 .
the data from the chimeras indicate that the difference is due to the absence of carboxyl sequences in alkylation chemotherapies , since human 06-alkylguaning-dna alkyltransferase was able to #confer resistance on stat1 .
the data from the chimeras indicate that the difference is due to the absence of carboxyl sequences in alkylation chemotherapies , since resistance can be #conferred on stat1 by human 06-alkylguaning-dna alkyltransferase .
the data from the chimeras indicate that the difference is due to the absence of carboxyl sequences in alkylation chemotherapies , since resistance can have been #conferred on stat1 by human 06-alkylguaning-dna alkyltransferase .
the data from the chimeras indicate that the difference is due to the absence of carboxyl sequences in alkylation chemotherapies , since resistance is able to be #conferred on stat1 by human 06-alkylguaning-dna alkyltransferase .
the data from the chimeras indicate that the difference is due to the absence of carboxyl sequences in alkylation-sensitive cells , since resistance can be #conferred on stat1 by transfection of agt .
the data from the chimeras indicate that the difference is due to the absence of carboxyl sequences in alkylation-sensitive cells , since resistance could be #conferred on stat1 by transfection of agt .
the data from the chimeras indicate that the difference is due to the absence of carboxyl sequences in alkylation-sensitive cells , since resistance is able to be #conferred on stat1 by transfection of agt .
the data from the chimeras indicate that the difference is due to the absence of carboxyl sequences in alkylation-sensitive cells , since transfection of agt can #confer resistance on stat1 .
the data from the chimeras indicate that the difference is due to the absence of carboxyl sequences in alkylation-sensitive cells , since transfection of agt could #confer resistance on stat1 .
the data from the chimeras indicate that the difference is due to the absence of carboxyl sequences in alkylation-sensitive cells , since transfection of agt is able to #confer resistance on stat1 .
the data from the chimeras indicate that the difference is due to the absence of carboxyl sequences in alkylation-sensitive cells , since transfection of agt may #confer resistance on stat1 .
the data from the chimeras indicate that the difference is due to the absence of carboxyl sequences in alkylation-sensitive cells , since transfection of agt will #confer resistance on stat1 .
the data from the chimeras indicate that the difference is due to the absence of carboxyl sequences in either a mapk or a mapk substrate kinase (mapkap) , since the portion of the stats was able to #confer specificity on stat1 .
the data from the chimeras indicate that the difference is due to the absence of carboxyl sequences in either a mapk or a mapk substrate kinase (mapkap) , since specificity is able to be #conferred on stat1 by the portion of the stats .
the portion of the stats (agt) having #conferred specificity to either a mapk or a mapk substrate kinase (mapkap) was therefore an active anticancer drug target .
the portion of the stats (agt) that #conferred specificity to either a mapk or a mapk substrate kinase (mapkap) was therefore an active anticancer drug target .
the portion of the stats (agt) that #confers specificity to either a mapk or a mapk substrate kinase (mapkap) is therefore an active anticancer drug target .
the portion of the stats (agt) that has #conferred specificity to either a mapk or a mapk substrate kinase (mapkap) was therefore an active anticancer drug target .
the portion of the stats (agt) which #conferred specificity to either a mapk or a mapk substrate kinase (mapkap) was therefore an active anticancer drug target .
the portion of the stats (agt) which has #conferred specificity to either a mapk or a mapk substrate kinase (mapkap) was therefore an active anticancer drug target .
the portion of the stats (agt) which is able to #confer specificity to either a mapk or a mapk substrate kinase (mapkap) was therefore an active anticancer drug target .
the portion of the stats (agt) which is believed to #confer specificity to either a mapk or a mapk substrate kinase (mapkap) was therefore an active anticancer drug target .
the portion of the stats (agt) which is observed to #confer specificity to either a mapk or a mapk substrate kinase (mapkap) was therefore an active anticancer drug target .
the portion of the stats (agt) which may #confer specificity to either a mapk or a mapk substrate kinase (mapkap) was therefore an active anticancer drug target .
the portion of the stats (agt) , which directly reverses endogenous alkylation at the 06-position of guanine , can #confer specificity to either a mapk or a mapk substrate kinase (mapkap) and is therefore an active anticancer drug target .
the portion of the stats (agt) , which directly reverses endogenous alkylation at the 06-position of guanine , #conferred specificity to either a mapk or a mapk substrate kinase (mapkap) and is therefore an active anticancer drug target .
the portion of the stats (agt) , which directly reverses endogenous alkylation at the 06-position of guanine , #confers specificity to either a mapk or a mapk substrate kinase (mapkap) and is therefore an active anticancer drug target .
the portion of the stats (agt) , which directly reverses endogenous alkylation at the 06-position of guanine , could #confer specificity to either a mapk or a mapk substrate kinase (mapkap) and was therefore an active anticancer drug target .
the portion of the stats (agt) , which directly reverses endogenous alkylation at the 06-position of guanine , is believed to #confer specificity to either a mapk or a mapk substrate kinase (mapkap) and is therefore an active anticancer drug target .
the portion of the stats (agt) , which directly reverses endogenous alkylation at the 06-position of guanine , is observed to #confer specificity to either a mapk or a mapk substrate kinase (mapkap) and is therefore an active anticancer drug target .
the portion of the stats (agt) , which directly reverses endogenous alkylation at the 06-position of guanine , may #confer specificity to either a mapk or a mapk substrate kinase (mapkap) and is therefore an active anticancer drug target .
the portion of the stats (agt) , which directly reverses endogenous alkylation at the 06-position of guanine , was believed to #confer specificity to either a mapk or a mapk substrate kinase (mapkap) and was therefore an active anticancer drug target .
the portion of the stats (agt) , which directly reverses endogenous alkylation at the 06-position of guanine , was observed to #confer specificity to either a mapk or a mapk substrate kinase (mapkap) and was therefore an active anticancer drug target .
the portion of the stats (agt) , which directly reverses endogenous alkylation at the 06-position of guanine , would #confer specificity to either a mapk or a mapk substrate kinase (mapkap) and was therefore an active anticancer drug target .
transfection of agt (agt) #conferring resistance to alkylation-sensitive cells is therefore an active anticancer drug target .
transfection of agt (agt) having #conferred resistance to alkylation-sensitive cells was therefore an active anticancer drug target .
transfection of agt (agt) that #confers resistance to alkylation-sensitive cells is therefore an active anticancer drug target .
transfection of agt (agt) which can #confer resistance to alkylation-sensitive cells was therefore an active anticancer drug target .
transfection of agt (agt) which #confers resistance to alkylation-sensitive cells is therefore an active anticancer drug target .
transfection of agt (agt) which is observed to #confer resistance to alkylation-sensitive cells was therefore an active anticancer drug target .
transfection of agt (agt) , which directly reverses endogenous alkylation at the 06-position of guanine , can #confer resistance to alkylation-sensitive cells and is therefore an active anticancer drug target .
transfection of agt (agt) , which directly reverses endogenous alkylation at the 06-position of guanine , #confers resistance to alkylation-sensitive cells and is therefore an active anticancer drug target .
transfection of agt (agt) , which directly reverses endogenous alkylation at the 06-position of guanine , is able to #confer resistance to alkylation-sensitive cells and is therefore an active anticancer drug target .
transfection of agt (agt) , which directly reverses endogenous alkylation at the 06-position of guanine , is observed to #confer resistance to alkylation-sensitive cells and is therefore an active anticancer drug target .
transfection of agt (agt) , which directly reverses endogenous alkylation at the 06-position of guanine , may #confer resistance to alkylation-sensitive cells and is therefore an active anticancer drug target .
transfection of agt #conferred resistance for alkylation-sensitive cells .
transfection of agt #conferring resistance for alkylation-sensitive cells has not been determined .
transfection of agt #confers resistance for alkylation-sensitive cells .
in addition , nonsense or frameshift alterations in the coding sequence or by splice variants can not #confer loss-of-function mutations in a tolc-deficient strain .
in addition , nonsense or frameshift alterations in the coding sequence or by splice variants could not #confer loss-of-function mutations in a tolc-deficient strain .
in addition , nonsense or frameshift alterations in the coding sequence or by splice variants did not #confer loss-of-function mutations in a tolc-deficient strain .
in addition , nonsense or frameshift alterations in the coding sequence or by splice variants does not #confer loss-of-function mutations in a tolc-deficient strain .
in addition , nonsense or frameshift alterations in the coding sequence or by splice variants may not #confer loss-of-function mutations in a tolc-deficient strain .
in addition , nonsense or frameshift alterations in the coding sequence or by splice variants was not able to #confer loss-of-function mutations in a tolc-deficient strain .
in itself , loss-of-function mutations cannot be #conferred by nonsense or frameshift alterations in the coding sequence or by splice variants .
in itself , loss-of-function mutations could not be #conferred by nonsense or frameshift alterations in the coding sequence or by splice variants .
in itself , loss-of-function mutations is believed not to be #conferred by nonsense or frameshift alterations in the coding sequence or by splice variants .
in itself , loss-of-function mutations is not able to be #conferred by nonsense or frameshift alterations in the coding sequence or by splice variants .
in itself , loss-of-function mutations was believed not to be #conferred by nonsense or frameshift alterations in the coding sequence or by splice variants .
in itself , loss-of-function mutations was not able to be #conferred by nonsense or frameshift alterations in the coding sequence or by splice variants .
in itself , loss-of-function mutations was not #conferred by nonsense or frameshift alterations in the coding sequence or by splice variants .
in itself , loss-of-function mutations will not be #conferred by nonsense or frameshift alterations in the coding sequence or by splice variants .
in itself , nonsense or frameshift alterations in the coding sequence or by splice variants cannot #confer loss-of-function mutations .
in itself , nonsense or frameshift alterations in the coding sequence or by splice variants cannot have #conferred loss-of-function mutations .
in itself , nonsense or frameshift alterations in the coding sequence or by splice variants does not #confer loss-of-function mutations .
in itself , nonsense or frameshift alterations in the coding sequence or by splice variants is believed not to #confer loss-of-function mutations .
in itself , nonsense or frameshift alterations in the coding sequence or by splice variants is not able to #confer loss-of-function mutations .
in itself , nonsense or frameshift alterations in the coding sequence or by splice variants may not #confer loss-of-function mutations .
in itself , nonsense or frameshift alterations in the coding sequence or by splice variants may not have #conferred loss-of-function mutations .
in itself , nonsense or frameshift alterations in the coding sequence or by splice variants will not #confer loss-of-function mutations .
in itself , nonsense or frameshift alterations in the coding sequence or by splice variants will not have #conferred loss-of-function mutations .
in itself , nonsense or frameshift alterations in the coding sequence or by splice variants would not #confer loss-of-function mutations .
likewise , the introduced charge of gly160his and gly160arg mutants would repel the benzyl group (figure 3b) , nonsense or frameshift alterations in the coding sequence or by splice variants #conferred the loss-of-function mutations (xu-welliver et al . , 1999a) .
likewise , the introduced charge of gly160his and gly160arg mutants would repel the benzyl group (figure 3b) , nonsense or frameshift alterations in the coding sequence or by splice variants is able to #confer the loss-of-function mutations (xu-welliver et al . , 1999a) .
likewise , the introduced charge of gly160his and gly160arg mutants would repel the benzyl group (figure 3b) , nonsense or frameshift alterations in the coding sequence or by splice variants may #confer the loss-of-function mutations (xu-welliver et al . , 1999a) .
likewise , the introduced charge of gly160his and gly160arg mutants would repel the benzyl group (figure 3b) , nonsense or frameshift alterations in the coding sequence or by splice variants was able to #confer the loss-of-function mutations (xu-welliver et al . , 1999a) .
likewise , the introduced charge of gly160his and gly160arg mutants would repel the benzyl group (figure 3b) , nonsense or frameshift alterations in the coding sequence or by splice variants will #confer the loss-of-function mutations (xu-welliver et al . , 1999a) .
likewise , the introduced charge of gly160his and gly160arg mutants would repel the benzyl group (figure 3b) , nonsense or frameshift alterations in the coding sequence or by splice variants would #confer the loss-of-function mutations (xu-welliver et al . , 1999a) .
likewise , the introduced charge of gly160his and gly160arg mutants would repel the benzyl group (figure 3b) , the loss-of-function mutations could be #conferred by nonsense or frameshift alterations in the coding sequence or by splice variants (xu-welliver et al . , 1999a) .
likewise , the introduced charge of gly160his and gly160arg mutants would repel the benzyl group (figure 3b) , the loss-of-function mutations is able to be #conferred by nonsense or frameshift alterations in the coding sequence or by splice variants (xu-welliver et al . , 1999a) .
likewise , the introduced charge of gly160his and gly160arg mutants would repel the benzyl group (figure 3b) , the loss-of-function mutations is #conferred by nonsense or frameshift alterations in the coding sequence or by splice variants (xu-welliver et al . , 1999a) .
likewise , the introduced charge of gly160his and gly160arg mutants would repel the benzyl group (figure 3b) , the loss-of-function mutations may be #conferred by nonsense or frameshift alterations in the coding sequence or by splice variants (xu-welliver et al . , 1999a) .
likewise , the introduced charge of gly160his and gly160arg mutants would repel the benzyl group (figure 3b) , the loss-of-function mutations was #conferred by nonsense or frameshift alterations in the coding sequence or by splice variants (xu-welliver et al . , 1999a) .
likewise , the introduced charge of gly160his and gly160arg mutants would repel the benzyl group (figure 3b) , the loss-of-function mutations would be #conferred by nonsense or frameshift alterations in the coding sequence or by splice variants (xu-welliver et al . , 1999a) .
loss-of-function mutations in a tolc-deficient strain can be #conferred by nonsense or frameshift alterations in the coding sequence or by splice variants .
loss-of-function mutations in a tolc-deficient strain has been #conferred by nonsense or frameshift alterations in the coding sequence or by splice variants .
loss-of-function mutations in a tolc-deficient strain is able to be #conferred by nonsense or frameshift alterations in the coding sequence or by splice variants .
disruption of narl can #decrease nitrite induction of the nirb promoter whilst not suppressing induction by nitrate , suggesting that there may be a second nitrate-responsive factor .
disruption of narl can have #decreased nitrite induction of the nirb promoter whilst not suppressing induction by nitrate , suggesting that there may be a second nitrate-responsive factor .
disruption of narl has #decreased nitrite induction of the nirb promoter whilst not suppressing induction by nitrate , suggesting that there might be a second nitrate-responsive factor .
disruption of narl has the ability to #decrease nitrite induction of the nirb promoter whilst not suppressing induction by nitrate , suggesting that there may be a second nitrate-responsive factor .
disruption of narl is able to #decrease nitrite induction of the nirb promoter whilst not suppressing induction by nitrate , suggesting that there may be a second nitrate-responsive factor .
disruption of narl is shown to #decrease nitrite induction of the nirb promoter whilst not suppressing induction by nitrate , suggesting that there may be a second nitrate-responsive factor .
disruption of narl may #decrease nitrite induction of the nirb promoter whilst not suppressing induction by nitrate , suggesting that there may be a second nitrate-responsive factor .
disruption of narl was shown to #decrease nitrite induction of the nirb promoter whilst not suppressing induction by nitrate , suggesting that there might be a second nitrate-responsive factor .
if this distance of 30 amino acids is not maintained , as in human asprs chimera#1 , or in yeast lysts chimera#1 and yeast asnrs chimera#2 (figure 5b) , the binding to trna is strongly affected and the protection can have been #decreased , or even abolished in the case of human asprs chimera#1 (table) .
if this distance of 30 amino acids is not maintained , as in human asprs chimera#1 , or in yeast lysts chimera#1 and yeast asnrs chimera#2 (figure 5b) , the binding to trna is strongly affected and the protection could be #decreased , or even abolished in the case of human asprs chimera#1 (table) .
if this distance of 30 amino acids is not maintained , as in human asprs chimera#1 , or in yeast lysts chimera#1 and yeast asnrs chimera#2 (figure 5b) , the binding to trna is strongly affected and the protection had been #decreased , or even abolished in the case of human asprs chimera#1 (table) .
if this distance of 30 amino acids is not maintained , as in human asprs chimera#1 , or in yeast lysts chimera#1 and yeast asnrs chimera#2 (figure 5b) , the binding to trna is strongly affected and the protection is believed to be #decreased , or even abolished in the case of human asprs chimera#1 (table) .
if this distance of 30 amino acids is not maintained , as in human asprs chimera#1 , or in yeast lysts chimera#1 and yeast asnrs chimera#2 (figure 5b) , the binding to trna is strongly affected and the protection is shown to be #decreased , or even abolished in the case of human asprs chimera#1 (table) .
if this distance of 30 amino acids is not maintained , as in human asprs chimera#1 , or in yeast lysts chimera#1 and yeast asnrs chimera#2 (figure 5b) , the binding to trna is strongly affected and the protection may be #decreased , or even abolished in the case of human asprs chimera#1 (table) .
if this distance of 30 amino acids is not maintained , as in human asprs chimera#1 , or in yeast lysts chimera#1 and yeast asnrs chimera#2 (figure 5b) , the binding to trna is strongly affected and the protection was #decreased , or even abolished in the case of human asprs chimera#1 (table) .
if this distance of 30 amino acids is not maintained , as in human asprs chimera#1 , or in yeast lysts chimera#1 and yeast asnrs chimera#2 (figure 5b) , the binding to trna is strongly affected and the protection will have been #decreased , or even abolished in the case of human asprs chimera#1 (table) .
in brain areas of schizophrenia patients homologous to those of the nonpsychiatric subjects , the reln mrna content can be significantly #decreased (4050%; see table 2) .
in brain areas of schizophrenia patients homologous to those of the nonpsychiatric subjects , the reln mrna content could be significantly #decreased (4050%; see table 2) .
in brain areas of schizophrenia patients homologous to those of the nonpsychiatric subjects , the reln mrna content has been significantly #decreased (4050%; see table 2) .
in brain areas of schizophrenia patients homologous to those of the nonpsychiatric subjects , the reln mrna content is being significantly #decreasing (4050%; see table 2) .
in brain areas of schizophrenia patients homologous to those of the nonpsychiatric subjects , the reln mrna content may be significantly #decreased (4050%; see table 2) .
in brain areas of schizophrenia patients homologous to those of the nonpsychiatric subjects , the reln mrna content may have been significantly #decreased (4050%; see table 2) .
in brain areas of schizophrenia patients homologous to those of the nonpsychiatric subjects , the reln mrna content was being significantly #decreasing (4050%; see table 2) .
in brain areas of schizophrenia patients homologous to those of the nonpsychiatric subjects , the reln mrna content was believed to be significantly #decreased (4050%; see table 2) .
in brain areas of schizophrenia patients homologous to those of the nonpsychiatric subjects , the reln mrna content will have been significantly #decreased (4050%; see table 2) .
in contrast , only low levels of the truncated rap1 peptides are detected (consistent with that expression levels can have been lowered and methionine content can have been decreased) , and neither rap2 nor rap3 is co-immunoprecipitated in the rap1 mutants .
in contrast , only low levels of the truncated rap1 peptides are detected (consistent with that expression levels is lowered and methionine content is decreased) , and neither rap2 nor rap3 is co-immunoprecipitated in the rap1 mutants .
in contrast , only low levels of the truncated rap1 peptides are detected (consistent with that expression levels may have been lowered and methionine content may have been decreased) , and neither rap2 nor rap3 is co-immunoprecipitated in the rap1 mutants .
in contrast , only low levels of the truncated rap1 peptides have been detected (consistent with that expression levels has been lowered and methionine content has been decreased) , and neither rap2 nor rap3 has been co-immunoprecipitated in the rap1 mutants .
in contrast , only low levels of the truncated rap1 peptides were detected (consistent with that expression levels might be lowered and methionine content might be decreased) , and neither rap2 nor rap3 was co-immunoprecipitated in the rap1 mutants .
in contrast , only low levels of the truncated rap1 peptides were detected (consistent with that expression levels was able to be lowered and methionine content was able to be decreased) , and neither rap2 nor rap3 was be co-immunoprecipitated in the rap1 mutants .
in contrast , only low levels of the truncated rap1 peptides will be detected (consistent with that expression levels will be lowered and methionine content will be decreased) , and neither rap2 nor rap3 will be co-immunoprecipitated in the rap1 mutants .
lipid peroxide synthesis could be #decreased by treatment with melatonin , and permitted a recovery of both reduced glutathione and scavenger enzyme activity .
lipid peroxide synthesis is believed to be #decreased by treatment with melatonin , and permits a recovery of both reduced glutathione and scavenger enzyme activity .
lipid peroxide synthesis may be #decreased by treatment with melatonin , and permits a recovery of both reduced glutathione and scavenger enzyme activity .
lipid peroxide synthesis may have been #decreased by treatment with melatonin , and have permitted a recovery of both reduced glutathione and scavenger enzyme activity .
lipid peroxide synthesis might be #decreased by treatment with melatonin , and permitted a recovery of both reduced glutathione and scavenger enzyme activity .
lipid peroxide synthesis was able to be #decreased by treatment with melatonin , and permitted a recovery of both reduced glutathione and scavenger enzyme activity .
lipid peroxide synthesis will have been #decreased by treatment with melatonin , and have permitted a recovery of both reduced glutathione and scavenger enzyme activity .
lipid peroxide synthesis would be #decreased by treatment with melatonin , and permitted a recovery of both reduced glutathione and scavenger enzyme activity .
mef2-binding sites have been reported in several cardiac promoters and promoter activity could be #decreased by their mutation in cardiomyocytes .
mef2-binding sites have been reported in several cardiac promoters and promoter activity is able to be #decreased by their mutation in cardiomyocytes .
mef2-binding sites have been reported in several cardiac promoters and promoter activity is believed to be #decreased by their mutation in cardiomyocytes .
mef2-binding sites have been reported in several cardiac promoters and promoter activity might be #decreased by their mutation in cardiomyocytes .
mef2-binding sites have been reported in several cardiac promoters and promoter activity was #decreased by their mutation in cardiomyocytes .
mef2-binding sites have been reported in several cardiac promoters and promoter activity will be #decreased by their mutation in cardiomyocytes .
mef2-binding sites have been reported in several cardiac promoters and their mutation can #decrease promoter activity in cardiomyocytes .
mef2-binding sites have been reported in several cardiac promoters and their mutation could #decrease promoter activity in cardiomyocytes .
mef2-binding sites have been reported in several cardiac promoters and their mutation #decreased promoter activity in cardiomyocytes .
mef2-binding sites have been reported in several cardiac promoters and their mutation had the ability to #decrease promoter activity in cardiomyocytes .
mef2-binding sites have been reported in several cardiac promoters and their mutation has the ability to #decrease promoter activity in cardiomyocytes .
mef2-binding sites have been reported in several cardiac promoters and their mutation is able to #decrease promoter activity in cardiomyocytes .
mef2-binding sites have been reported in several cardiac promoters and their mutation might #decrease promoter activity in cardiomyocytes .
mef2-binding sites have been reported in several cardiac promoters and their mutation would #decrease promoter activity in cardiomyocytes .
nitrite induction of the nirb promoter can be #decreased by disruption of narl which is not suppressing induction by nitrate , suggesting that there may be a second nitrate-responsive factor .
nitrite induction of the nirb promoter can have been #decreased by disruption of narl which is not suppressing induction by nitrate , suggesting that there may be a second nitrate-responsive factor .
nitrite induction of the nirb promoter has been #decreased by disruption of narl which has not been suppressing induction by nitrate , suggesting that there may be a second nitrate-responsive factor .
nitrite induction of the nirb promoter is able to be #decreased by disruption of narl which is not suppressing induction by nitrate , suggesting that there may be a second nitrate-responsive factor .
nitrite induction of the nirb promoter is believed to be #decreased by disruption of narl which is not suppressing induction by nitrate , suggesting that there may be a second nitrate-responsive factor .
nitrite induction of the nirb promoter may be #decreased by disruption of narl which is not suppressing induction by nitrate , suggesting that there may be a second nitrate-responsive factor .
nitrite induction of the nirb promoter may have been #decreased by disruption of narl which is not suppressing induction by nitrate , suggesting that there may be a second nitrate-responsive factor .
nitrite induction of the nirb promoter was believed to be #decreased by disruption of narl which was not suppressing induction by nitrate , suggesting that there may be a second nitrate-responsive factor .
nitrite induction of the nirb promoter was shown to be #decreased by disruption of narl which was not suppressing induction by nitrate , suggesting that there may be a second nitrate-responsive factor .
nitrite induction of the nirb promoter will have been #decreased by disruption of narl which is not suppressing induction by nitrate , suggesting that there may be a second nitrate-responsive factor .
the levels of clara cell secretory protein can be #decreased in nlf from smokers , and it has also been found that nlf from smokers contained increased proportions of a truncated variant of lipocortin-1 , threee acidic forms of alpha (1)-antitrypsin , and one phosphorylated form of cystatin s .syntrophin binds to an alternatively spliced exon of dystrophin .
the levels of clara cell secretory protein can be #decreased in nlf from smokers , and it is also found that nlf from smokers contained increased proportions of a truncated variant of lipocortin-1 , threee acidic forms of alpha (1)-antitrypsin , and one phosphorylated form of cystatin s .syntrophin binds to an alternatively spliced exon of dystrophin .
the levels of clara cell secretory protein could be #decreased in nlf from smokers , and it has also been found that nlf from smokers contained increased proportions of a truncated variant of lipocortin-1 , threee acidic forms of alpha (1)-antitrypsin , and one phosphorylated form of cystatin s .syntrophin binds to an alternatively spliced exon of dystrophin .
the levels of clara cell secretory protein could be #decreased in nlf from smokers , and it was also found that nlf from smokers contained increased proportions of a truncated variant of lipocortin-1 , threee acidic forms of alpha (1)-antitrypsin , and one phosphorylated form of cystatin s .syntrophin binds to an alternatively spliced exon of dystrophin .
the levels of clara cell secretory protein is able to be #decreased in nlf from smokers , and it has also been found that nlf from smokers contained increased proportions of a truncated variant of lipocortin-1 , threee acidic forms of alpha (1)-antitrypsin , and one phosphorylated form of cystatin s .syntrophin binds to an alternatively spliced exon of dystrophin .
the levels of clara cell secretory protein is able to be #decreased in nlf from smokers , and it is also found that nlf from smokers contained increased proportions of a truncated variant of lipocortin-1 , threee acidic forms of alpha (1)-antitrypsin , and one phosphorylated form of cystatin s .syntrophin binds to an alternatively spliced exon of dystrophin .
the levels of clara cell secretory protein is believed to be #decreased in nlf from smokers , and it is also found that nlf from smokers contained increased proportions of a truncated variant of lipocortin-1 , threee acidic forms of alpha (1)-antitrypsin , and one phosphorylated form of cystatin s .syntrophin binds to an alternatively spliced exon of dystrophin .
the levels of clara cell secretory protein is #decreased in nlf from smokers , and it is also found that nlf from smokers contained increased proportions of a truncated variant of lipocortin-1 , threee acidic forms of alpha (1)-antitrypsin , and one phosphorylated form of cystatin s .syntrophin binds to an alternatively spliced exon of dystrophin .
the levels of clara cell secretory protein is shown to be #decreased in nlf from smokers , and it is also found that nlf from smokers contained increased proportions of a truncated variant of lipocortin-1 , threee acidic forms of alpha (1)-antitrypsin , and one phosphorylated form of cystatin s .syntrophin binds to an alternatively spliced exon of dystrophin .
the levels of clara cell secretory protein may have been #decreased in nlf from smokers , and it has also been found that nlf from smokers contained increased proportions of a truncated variant of lipocortin-1 , threee acidic forms of alpha (1)-antitrypsin , and one phosphorylated form of cystatin s .syntrophin binds to an alternatively spliced exon of dystrophin .
the levels of clara cell secretory protein might be #decreased in nlf from smokers , and it has also been found that nlf from smokers contained increased proportions of a truncated variant of lipocortin-1 , threee acidic forms of alpha (1)-antitrypsin , and one phosphorylated form of cystatin s .syntrophin binds to an alternatively spliced exon of dystrophin .
the levels of clara cell secretory protein might be #decreased in nlf from smokers , and it was also found that nlf from smokers contained increased proportions of a truncated variant of lipocortin-1 , threee acidic forms of alpha (1)-antitrypsin , and one phosphorylated form of cystatin s .syntrophin binds to an alternatively spliced exon of dystrophin .
the levels of clara cell secretory protein was able to be #decreased in nlf from smokers , and it has also been found that nlf from smokers contained increased proportions of a truncated variant of lipocortin-1 , threee acidic forms of alpha (1)-antitrypsin , and one phosphorylated form of cystatin s .syntrophin binds to an alternatively spliced exon of dystrophin .
the levels of clara cell secretory protein was #decreased in nlf from smokers , and it was also found that nlf from smokers contained increased proportions of a truncated variant of lipocortin-1 , threee acidic forms of alpha (1)-antitrypsin , and one phosphorylated form of cystatin s .syntrophin binds to an alternatively spliced exon of dystrophin .
the levels of clara cell secretory protein will be #decreased in nlf from smokers , and it is also found that nlf from smokers contained increased proportions of a truncated variant of lipocortin-1 , threee acidic forms of alpha (1)-antitrypsin , and one phosphorylated form of cystatin s .syntrophin binds to an alternatively spliced exon of dystrophin .
the production of c51 microcin #decreases or is absent in rpos , crp and cya mutant cells .
the production of c51 microcin had the ability to to #decrease or be absent in rpos , crp and cya mutant cells .
the production of c51 microcin is believed to #decrease or be absent in rpos , crp and cya mutant cells .
the production of c51 microcin is shown to #decrease or be absent in rpos , crp and cya mutant cells .
the production of c51 microcin may #decrease or be absent in rpos , crp and cya mutant cells .
the production of c51 microcin might #decrease or be absent in rpos , crp and cya mutant cells .
the production of c51 microcin was shown to #decrease or be absent in rpos , crp and cya mutant cells .
the production of c51 microcin will #decrease or be absent in rpos , crp and cya mutant cells .
the production of c51 microcin would #decrease or be absent in rpos , crp and cya mutant cells .
treatment with melatonin could #decrease lipid peroxide synthesis , and permitted a recovery of both reduced glutathione and scavenger enzyme activity .
treatment with melatonin is able to #decrease lipid peroxide synthesis , and permits a recovery of both reduced glutathione and scavenger enzyme activity .
treatment with melatonin is shown to #decrease lipid peroxide synthesis , and permits a recovery of both reduced glutathione and scavenger enzyme activity .
treatment with melatonin may #decrease lipid peroxide synthesis , and permits a recovery of both reduced glutathione and scavenger enzyme activity .
treatment with melatonin was able to #decrease lipid peroxide synthesis , and permitted a recovery of both reduced glutathione and scavenger enzyme activity .
treatment with melatonin will #decrease lipid peroxide synthesis , and permits a recovery of both reduced glutathione and scavenger enzyme activity .
treatment with melatonin would #decrease lipid peroxide synthesis , and permitted a recovery of both reduced glutathione and scavenger enzyme activity .
levels of clara cell have been reported in several cardiac promoters and their mutation was shown to #decrease promoter activity in cardiomyocytes .
the production of c51 microcin #decreased or was absent in rpos , crp and cya mutant cells .
treatment with melatonin #decreased lipid peroxide synthesis , and permitted a recovery of both reduced glutathione and scavenger enzyme activity .
deletion of the arca gene caused about a 2-fold increase in the ptsg expression , and disruption of narl has significantly #decreased nitrite induction of the nirb promoter .
deletion of the arca gene caused about a 2-fold increase in the ptsg expression , and disruption of narl is observed to have significantly #decreased nitrite induction of the nirb promoter .
deletion of the arca gene caused about a 2-fold increase in the ptsg expression , and disruption of narl significantly #decreased nitrite induction of the nirb promoter .
deletion of the arca gene caused about a 2-fold increase in the ptsg expression , and treatment with melatonin significantly #decreased lipid peroxide synthesis .
deletion of the arca gene caused about a 2-fold increase in the ptsg expression , and nitrite induction of the nirb promoter have been significantly #decreased by disruption of narl will significantly .
deletion of the arca gene causes about a 2-fold increase in the ptsg expression , and disruption of narl can have significantly #decreased nitrite induction of the nirb promoter .
deletion of the arca gene causes about a 2-fold increase in the ptsg expression , and disruption of narl can significantly #decrease nitrite induction of the nirb promoter .
deletion of the arca gene causes about a 2-fold increase in the ptsg expression , and disruption of narl could significantly #decrease nitrite induction of the nirb promoter .
deletion of the arca gene causes about a 2-fold increase in the ptsg expression , and disruption of narl is believed to have significantly #decreased nitrite induction of the nirb promoter .
deletion of the arca gene causes about a 2-fold increase in the ptsg expression , and disruption of narl is observed to significantly #decrease nitrite induction of the nirb promoter .
deletion of the arca gene causes about a 2-fold increase in the ptsg expression , and disruption of narl is shown to significantly #decrease nitrite induction of the nirb promoter .
deletion of the arca gene causes about a 2-fold increase in the ptsg expression , and disruption of narl may have significantly #decreased nitrite induction of the nirb promoter .
deletion of the arca gene causes about a 2-fold increase in the ptsg expression , and disruption of narl significantly #decreases nitrite induction of the nirb promoter .
deletion of the arca gene causes about a 2-fold increase in the ptsg expression , and disruption of narl was able to significantly #decrease nitrite induction of the nirb promoter .
deletion of the arca gene causes about a 2-fold increase in the ptsg expression , and disruption of narl would significantly #decrease nitrite induction of the nirb promoter .
deletion of the arca gene causes about a 2-fold increase in the ptsg expression , and treatment with melatonin can have significantly #decreased lipid peroxide synthesis .
deletion of the arca gene causes about a 2-fold increase in the ptsg expression , and treatment with melatonin could significantly #decrease lipid peroxide synthesis .
deletion of the arca gene causes about a 2-fold increase in the ptsg expression , and treatment with melatonin is believed to have significantly #decreased lipid peroxide synthesis .
deletion of the arca gene causes about a 2-fold increase in the ptsg expression , and treatment with melatonin might significantly #decrease lipid peroxide synthesis .
deletion of the arca gene causes about a 2-fold increase in the ptsg expression , and treatment with melatonin was shown to significantly #decrease lipid peroxide synthesis .
deletion of the arca gene causes about a 2-fold increase in the ptsg expression , and treatment with melatonin would significantly #decrease lipid peroxide synthesis .
deletion of the arca gene causes about a 2-fold increase in the ptsg expression , and lipid peroxide synthesis could be significantly #decreased by treatment with melatonin will significantly .
deletion of the arca gene causes about a 2-fold increase in the ptsg expression , and lipid peroxide synthesis is able to be significantly #decreased by treatment with melatonin will significantly .
deletion of the arca gene causes about a 2-fold increase in the ptsg expression , and lipid peroxide synthesis is believed to be significantly #decreased by treatment with melatonin will significantly .
deletion of the arca gene causes about a 2-fold increase in the ptsg expression , and lipid peroxide synthesis is shown to be significantly #decreased by treatment with melatonin will significantly .
deletion of the arca gene causes about a 2-fold increase in the ptsg expression , and lipid peroxide synthesis may have been significantly #decreased by treatment with melatonin will significantly .
deletion of the arca gene causes about a 2-fold increase in the ptsg expression , and lipid peroxide synthesis might be significantly #decreased by treatment with melatonin will significantly .
deletion of the arca gene causes about a 2-fold increase in the ptsg expression , and lipid peroxide synthesis was shown to be significantly #decreased by treatment with melatonin will significantly .
deletion of the arca gene causes about a 2-fold increase in the ptsg expression , and nitrite induction of the nirb promoter are significantly #decreased by disruption of narl will significantly .
deletion of the arca gene causes about a 2-fold increase in the ptsg expression , and nitrite induction of the nirb promoter can be significantly #decreased by disruption of narl will significantly .
deletion of the arca gene causes about a 2-fold increase in the ptsg expression , and nitrite induction of the nirb promoter can have been significantly #decreased by disruption of narl will significantly .
deletion of the arca gene causes about a 2-fold increase in the ptsg expression , and nitrite induction of the nirb promoter may have been significantly #decreased by disruption of narl will significantly .
deletion of the arca gene causes about a 2-fold increase in the ptsg expression , and nitrite induction of the nirb promoter might be significantly #decreased by disruption of narl will significantly .
deletion of the arca gene causes about a 2-fold increase in the ptsg expression , and nitrite induction of the nirb promoter was shown to be significantly #decreased by disruption of narl will significantly .
deletion of the arca gene causes about a 2-fold increase in the ptsg expression , and nitrite induction of the nirb promoter will be significantly #decreased by disruption of narl will significantly .
disruption of narl could #decrease nitrite induction of the nirb promoter , and permitted a recovery of both reduced glutathione and scavenger enzyme activity .
disruption of narl #decreased nitrite induction of the nirb promoter , and permitted a recovery of both reduced glutathione and scavenger enzyme activity .
disruption of narl #decreases nitrite induction of the nirb promoter , and permitted a recovery of both reduced glutathione and scavenger enzyme activity .
disruption of narl is able to #decrease nitrite induction of the nirb promoter , and permits a recovery of both reduced glutathione and scavenger enzyme activity .
disruption of narl is believed to #decrease nitrite induction of the nirb promoter , and permits a recovery of both reduced glutathione and scavenger enzyme activity .
disruption of narl is shown to #decrease nitrite induction of the nirb promoter , and permits a recovery of both reduced glutathione and scavenger enzyme activity .
disruption of narl may #decrease nitrite induction of the nirb promoter , and permits a recovery of both reduced glutathione and scavenger enzyme activity .
disruption of narl was able to #decrease nitrite induction of the nirb promoter , and permitted a recovery of both reduced glutathione and scavenger enzyme activity .
disruption of narl was believed to #decrease nitrite induction of the nirb promoter , and permitted a recovery of both reduced glutathione and scavenger enzyme activity .
disruption of narl would #decrease nitrite induction of the nirb promoter , and permitted a recovery of both reduced glutathione and scavenger enzyme activity .
in contrast , only low levels of the truncated rap1 peptides are detected (consistent with that expression levels can be lowered and the reln mrna content can be decreased) , and neither rap2 nor rap3 is co-immunoprecipitated in the rap1 mutants .
in contrast , only low levels of the truncated rap1 peptides are detected (consistent with that expression levels is able to be lowered and the reln mrna content is able to be decreased) , and neither rap2 nor rap3 is be co-immunoprecipitated in the rap1 mutants .
in contrast , only low levels of the truncated rap1 peptides are detected (consistent with that expression levels may have been lowered and the reln mrna content may have been decreased) , and neither rap2 nor rap3 is co-immunoprecipitated in the rap1 mutants .
in contrast , only low levels of the truncated rap1 peptides have been detected (consistent with that expression levels has been lowered and the reln mrna content has been decreased) , and neither rap2 nor rap3 has been co-immunoprecipitated in the rap1 mutants .
in contrast , only low levels of the truncated rap1 peptides were detected (consistent with that expression levels was lowered and the reln mrna content was decreased) , and neither rap2 nor rap3 was co-immunoprecipitated in the rap1 mutants .
treatment with melatonin can #decrease lipid peroxide synthesis whilst not suppressing induction by nitrate , suggesting that there may be a second nitrate-responsive factor .
treatment with melatonin can have #decreased lipid peroxide synthesis whilst not suppressing induction by nitrate , suggesting that there may be a second nitrate-responsive factor .
treatment with melatonin #decreases lipid peroxide synthesis whilst not suppressing induction by nitrate , suggesting that there may be a second nitrate-responsive factor .
treatment with melatonin has #decreased lipid peroxide synthesis whilst not suppressing induction by nitrate , suggesting that there might be a second nitrate-responsive factor .
treatment with melatonin has the ability to #decrease lipid peroxide synthesis whilst not suppressing induction by nitrate , suggesting that there may be a second nitrate-responsive factor .
treatment with melatonin is able to #decrease lipid peroxide synthesis whilst not suppressing induction by nitrate , suggesting that there may be a second nitrate-responsive factor .
treatment with melatonin is shown to #decrease lipid peroxide synthesis whilst not suppressing induction by nitrate , suggesting that there may be a second nitrate-responsive factor .
treatment with melatonin might #decrease lipid peroxide synthesis whilst not suppressing induction by nitrate , suggesting that there might be a second nitrate-responsive factor .
treatment with melatonin was shown to #decrease lipid peroxide synthesis whilst not suppressing induction by nitrate , suggesting that there might be a second nitrate-responsive factor .
treatment with melatonin will #decrease lipid peroxide synthesis whilst not suppressing induction by nitrate , suggesting that there may be a second nitrate-responsive factor .
treatment with melatonin would #decrease lipid peroxide synthesis whilst not suppressing induction by nitrate , suggesting that there might be a second nitrate-responsive factor .
promoter activity in cardiomyocytes can be #decreased by their mutation .
promoter activity in cardiomyocytes can have been #decreased by their mutation .
promoter activity in cardiomyocytes could be #decreased by their mutation .
promoter activity in cardiomyocytes has been #decreased by their mutation .
promoter activity in cardiomyocytes is able to be #decreased by their mutation .
promoter activity in cardiomyocytes is #decreased by their mutation .
promoter activity in cardiomyocytes was able to be #decreased by their mutation .
promoter activity in cardiomyocytes will have been #decreased by their mutation .
their mutation could #decrease promoter activity in cardiomyocytes .
their mutation #decreases promoter activity in cardiomyocytes .
their mutation has #decreased promoter activity in cardiomyocytes .
their mutation has the ability to #decrease promoter activity in cardiomyocytes .
their mutation is able to #decrease promoter activity in cardiomyocytes .
their mutation is believed to #decrease promoter activity in cardiomyocytes .
their mutation is shown to #decrease promoter activity in cardiomyocytes .
their mutation may #decrease promoter activity in cardiomyocytes .
their mutation may have #decreased promoter activity in cardiomyocytes .
their mutation might #decrease promoter activity in cardiomyocytes .
their mutation was believed to #decrease promoter activity in cardiomyocytes .
their mutation will #decrease promoter activity in cardiomyocytes .
their mutation will have #decreased promoter activity in cardiomyocytes .
their mutation would #decrease promoter activity in cardiomyocytes .
in brain areas of schizophrenia patients homologous to those of the nonpsychiatric subjects , the reln mrna content was significantly #decreased (4050%; see table 2) .
in brain areas of schizophrenia patients homologous to those of the nonpsychiatric subjects , levels of clara cell secretory protein was significantly #decreased (4050%; see table 2) .
in brain areas of schizophrenia patients homologous to those of the nonpsychiatric subjects , the protection was significantly #decreased (4050%; see table 2) .
in contrast , only low levels of the truncated rap1 peptides are detected (consistent with that expression levels can be lowered and the protection can be decreased) , and neither rap2 nor rap3 is co-immunoprecipitated in the rap1 mutants .
in contrast , only low levels of the truncated rap1 peptides are detected (consistent with that expression levels can have been lowered and levels of clara cell secretory protein can have been decreased) , and neither rap2 nor rap3 is co-immunoprecipitated in the rap1 mutants .
in contrast , only low levels of the truncated rap1 peptides are detected (consistent with that expression levels can have been lowered and the protection can have been decreased) , and neither rap2 nor rap3 is co-immunoprecipitated in the rap1 mutants .
in contrast , only low levels of the truncated rap1 peptides are detected (consistent with that expression levels is able to be lowered and levels of clara cell secretory protein is able to be decreased) , and neither rap2 nor rap3 is be co-immunoprecipitated in the rap1 mutants .
in contrast , only low levels of the truncated rap1 peptides are detected (consistent with that expression levels is able to be lowered and the protection is able to be decreased) , and neither rap2 nor rap3 is be co-immunoprecipitated in the rap1 mutants .
in contrast , only low levels of the truncated rap1 peptides are detected (consistent with that expression levels is lowered and levels of clara cell secretory protein is decreased) , and neither rap2 nor rap3 is co-immunoprecipitated in the rap1 mutants .
in contrast , only low levels of the truncated rap1 peptides are detected (consistent with that expression levels may be lowered and levels of clara cell secretory protein may be decreased) , and neither rap2 nor rap3 is co-immunoprecipitated in the rap1 mutants .
in contrast , only low levels of the truncated rap1 peptides are detected (consistent with that expression levels may be lowered and the protection may be decreased) , and neither rap2 nor rap3 is co-immunoprecipitated in the rap1 mutants .
in contrast , only low levels of the truncated rap1 peptides are detected (consistent with that expression levels may have been lowered and levels of clara cell secretory protein may have been decreased) , and neither rap2 nor rap3 is co-immunoprecipitated in the rap1 mutants .
in contrast , only low levels of the truncated rap1 peptides were detected (consistent with that expression levels might be lowered and levels of clara cell secretory protein might be decreased) , and neither rap2 nor rap3 was co-immunoprecipitated in the rap1 mutants .
in contrast , only low levels of the truncated rap1 peptides were detected (consistent with that expression levels was able to be lowered and levels of clara cell secretory protein was able to be decreased) , and neither rap2 nor rap3 was be co-immunoprecipitated in the rap1 mutants .
in contrast , only low levels of the truncated rap1 peptides were detected (consistent with that expression levels was able to be lowered and the protection was able to be decreased) , and neither rap2 nor rap3 was be co-immunoprecipitated in the rap1 mutants .
in contrast , only low levels of the truncated rap1 peptides were detected (consistent with that expression levels was lowered and levels of clara cell secretory protein was decreased) , and neither rap2 nor rap3 was co-immunoprecipitated in the rap1 mutants .
in contrast , only low levels of the truncated rap1 peptides will be detected (consistent with that expression levels will be lowered and the protection will be decreased) , and neither rap2 nor rap3 will be co-immunoprecipitated in the rap1 mutants .
in contrast , only low levels of the truncated rap1 peptides will be detected (consistent with that expression levels will have been lowered and levels of clara cell secretory protein will have been decreased) , and neither rap2 nor rap3 will be co-immunoprecipitated in the rap1 mutants .
in contrast , only low levels of the truncated rap1 peptides would be detected (consistent with that expression levels would be lowered and levels of clara cell secretory protein would be decreased) , and neither rap2 nor rap3 would be co-immunoprecipitated in the rap1 mutants .
in contrast , only low levels of the truncated rap1 peptides would be detected (consistent with that expression levels would be lowered and the protection would be decreased) , and neither rap2 nor rap3 would be co-immunoprecipitated in the rap1 mutants .
alternative mrna splicing in the coding region (encoded by exons 3-12) generates transcripts which can #delete exons 8 (75 nt) , 7+8 (156 nt) or 8+9 (168 nt) and that encode distinct protein isoforms (delta25 , delta52 and delta56 aa , respectively) .
by using homologous recombination in mouse embryonic stem cells , the headpiece domain of dematin will be #deleted to evaluate its function in vivo .
colonies of c .albicans cells being #deleted for cst20 revealed defects in the lateral formation of mycelia on synthetic solid spider media .
colonies of c .albicans cells which cst20 #deleted revealed defects in the lateral formation of mycelia on synthetic solid spider media .
however , the gata-4 mutants being able to #delete the c-terminal transactivition domain (1 332 , 201 332) were all unable to support mef2 synergy .
however , the gata-4 mutants which #deleted the c-terminal transactivition domain (1 332 , 201 332) were all unable to support mef2 synergy .
in plasmid erbb-2: s-d , the zonab binding has been #deleted , and in erbb-2: s-a the inverted ccaat box has been substituted .
in plasmid erbb-2: s-d , the zonab binding is #deleted , and in erbb-2: s-a the inverted ccaat box is substituted .
in the presence of the phage p1 cyclization recombinase cre , the transposon could #delete the ura3 , teta , and lacz genes between the two loxp sites .
in the presence of the phage p1 cyclization recombinase cre , the transposon is able to #delete the ura3 , teta , and lacz genes between the two loxp sites .
mutation of the hns gene in e . coli has resulted in strong expression of the v . fischeri lux system at low cell density even in an rpos which has #deleted strain of e . coli that emits very low levels of luminescence .
of note , the v82f mutation , which occurs adjacent to the 5 donor site of intron 4 , resulted in approximately 54% aberrantly spliced transcripts where exon 4 has been #deleted .
of note , the v82f mutation , which occurs adjacent to the 5 donor site of intron 4 , resulted in approximately 54% aberrantly spliced transcripts with exon 4 being #deleted .
of the splicing mutations , the ivs2+1 allele produced a single transcript where exon 2 can be #deleted .
of the splicing mutations , the ivs2+1 allele produced a single transcript where exon 2 has been #deleted .
of the splicing mutations , the ivs2+1 allele produced a single transcript where exon 2 was #deleted .
of the splicing mutations , the ivs9 delta a+4 allele was alternatively spliced , approximately 26% being normal transcripts and the remainder where exon 9 can be #deleted .
of the splicing mutations , the ivs9 delta a+4 allele was alternatively spliced , approximately 26% being normal transcripts and the remainder where exon 9 has been #deleted .
of the splicing mutations , the ivs9 delta a+4 allele was alternatively spliced , approximately 26% being normal transcripts and the remainder where exon 9 is #deleted .
recent experiments have provided direct evidence that antigen-loaded immature dcs are able to #delete t cells to silence them .
recent experiments have provided direct evidence that antigen-loaded immature dcs can #delete t cells to silence them .
recent experiments have provided direct evidence that antigen-loaded immature dcs #delete t cells or by expanding regulatory t cells .
recent experiments have provided direct evidence that antigen-loaded immature dcs #deleted t cells to silence them .
recent experiments have provided direct evidence that antigen-loaded immature dcs have #deleted t cells to silence them .
recent experiments have provided direct evidence that antigen-loaded immature dcs will #delete t cells to silence them .
studies with strains which are #deleted for the micf locus showed that the mara-dependent reduction of ompf required an intact micf locus .
study of the promoter-lacz gene fusions introduced into the chromosome indicated that gals expression was elevated in cells in which the normal gals gene was interrupted , but not in cells in which the galr gene has been #deleted .
the gata-4 mutants that #delete the n-terminal region (127 443 and 201 443) and the first zinc finger (242 443) were able to synergize with mef2a (figure 6a) .
the gata-4 mutants which can #delete the n-terminal region (127 443 and 201 443) and the first zinc finger (242 443) were able to synergize with mef2a (figure 6a) .
the gata-4 mutants which #delete the n-terminal region (127 443 and 201 443) and the first zinc finger (242 443) were able to synergize with mef2a (figure 6a) .
the gata-4 mutants which has #deleted the n-terminal region (127 443 and 201 443) and the first zinc finger (242 443) were able to synergize with mef2a (figure 6a) .
the gata-4 mutants with the n-terminal region (127 443 and 201 443) and the first zinc finger (242 443) #deleted were able to synergize with mef2a (figure 6a) .
the zonab binding is #deleted in plasmid erbb-2: s-d , and in erbb-2: s-a the inverted ccaat box is substituted .
the generation of replication-competent virus is considered less likely with vectors #deleting the viral transcription elements .
the generation of replication-competent virus is considered less likely with vectors that #deleted the viral transcription elements .
the generation of replication-competent virus is considered less likely with vectors which that #delete the viral transcription elements .
the propensity of isolates of the malaria parasite plasmodium falciparum #deleting a segment of chromosome 9 has provided positional information that has allowed us to identify a gene necessary for cytoadherence .
the propensity of isolates of the malaria parasite plasmodium falciparum proven to #delete a segment of chromosome 9 has provided positional information that has allowed us to identify a gene necessary for cytoadherence .
the propensity of isolates of the malaria parasite plasmodium falciparum which #delete a segment of chromosome 9 has provided positional information that has allowed us to identify a gene necessary for cytoadherence .
using homologous recombination in mouse embryonic stem cells #deletes the headpiece domain of dematin to evaluate its function in vivo .
studies with strains #deleted for the micf locus showed that the mara-dependent reduction of ompf required an intact micf locus .
study of the promoter-lacz gene fusions introduced into the chromosome indicated that gals expression was elevated in cells in which the normal gals gene was interrupted , but not in cells in which the galr gene was #deleted .
alternative mrna splicing in the coding region (encoded by exons 3-12) generates transcripts which #delete exons 8 (75 nt) , 7+8 (156 nt) or 8+9 (168 nt) and that encode distinct protein isoforms (delta25 , delta52 and delta56 aa , respectively) .
of note , the v82f mutation , which occurs adjacent to the 5 donor site of intron 4 , resulted in approximately 54% aberrantly spliced transcripts with exon 4 #deleted .
of the splicing mutations , the ivs2+1 allele produced a single transcript with exon 2 #deleted , whereas the ivs9 delta a+4 allele was alternatively spliced , approximately 26% being normal transcripts and the remainder with exon 9 #deleted .
by appropriate progenitor strains , any chromosomal region was #deleted to evaluate its function in vivo .
by appropriate progenitor strains , any chromosomal region will be #deleted to evaluate its function in vivo .
by antigen-loaded immature dcs , t cells will be #deleted to evaluate its function in vivo .
by isolates of the malaria parasite plasmodium falciparum , a segment of chromosome 9 is #deleted to evaluate its function in vivo .
by isolates of the malaria parasite plasmodium falciparum , a segment of chromosome 9 was #deleted to evaluate its function in vivo .
by isolates of the malaria parasite plasmodium falciparum , a segment of chromosome 9 will be #deleted to evaluate its function in vivo .
by micf locus , strains is #deleted to evaluate its function in vivo .
by micf locus , strains was #deleted to evaluate its function in vivo .
by the development of other immunotherapeutic agents , cytotoxic lymphocyte responses was #deleted to evaluate its function in vivo .
by the transposon , the ura3 , teta , and lacz genes between the two loxp sites was #deleted to evaluate its function in vivo .
c-terminal transactivition domain being #deleted for the gata-4 mutants revealed defects in the lateral formation of mycelia on synthetic solid spider media .
c-terminal transactivition domain #deleted for the gata-4 mutants revealed defects in the lateral formation of mycelia on synthetic solid spider media .
c-terminal transactivition domain which are #deleted for the gata-4 mutants revealed defects in the lateral formation of mycelia on synthetic solid spider media .
cst20 that can be #deleted for colonies of c .albicans cells revealed defects in the lateral formation of mycelia on synthetic solid spider media .
cst20 that #delete colonies of c .albicans cells were able to synergize with mef2a (figure 6a) .
cst20 which can #delete colonies of c .albicans cells were able to synergize with mef2a (figure 6a) .
cst20 which #delete colonies of c .albicans cells were able to synergize with mef2a (figure 6a) .
cst20 which has #deleted colonies of c .albicans cells were able to synergize with mef2a (figure 6a) .
colonies of c .albicans cells being #deleted for cst20 revealed defects in the lateral formation of mycelia on synthetic solid spider media .
colonies of c .albicans cells that are #deleted for cst20 revealed defects in the lateral formation of mycelia on synthetic solid spider media .
colonies of c .albicans cells which cst20 #deleted revealed defects in the lateral formation of mycelia on synthetic solid spider media .
colonies of c .albicans cells which are #deleted for cst20 revealed defects in the lateral formation of mycelia on synthetic solid spider media .
colonies of c .albicans cells which can #delete cst20 were able to synergize with mef2a (figure 6a) .
colonies of c .albicans cells which #deleted cst20 were able to synergize with mef2a (figure 6a) .
colonies of c .albicans cells which has #deleted cst20 were able to synergize with mef2a (figure 6a) .
d: erbb-2: s-d #deleted for mutated zonab-binding site revealed defects in the lateral formation of mycelia on synthetic solid spider media .
d: erbb-2: s-d which mutated zonab-binding site #deleted revealed defects in the lateral formation of mycelia on synthetic solid spider media .
however , cst20 that make the colonies of c .albicans cells (1 332 , 201 332) #deleted were all unable to support mef2 synergy .
however , cst20 which can #delete the colonies of c .albicans cells (1 332 , 201 332) were all unable to support mef2 synergy .
however , colonies of c .albicans cells which can #delete the cst20 (1 332 , 201 332) were all unable to support mef2 synergy .
however , colonies of c .albicans cells which #deleted the cst20 (1 332 , 201 332) were all unable to support mef2 synergy .
however , the gata-4 mutants being able to #delete the the n-terminal region and the first zinc finger (1 332 , 201 332) were all unable to support mef2 synergy .
however , the gata-4 mutants #deleting the the n-terminal region (127 443 and 201 443) and the first zinc finger (242 443) (1 332 , 201 332) were all unable to support mef2 synergy .
however , the gata-4 mutants that #delete the the n-terminal region (127 443 and 201 443) and the first zinc finger (242 443) (1 332 , 201 332) were all unable to support mef2 synergy .
however , the gata-4 mutants that #delete the the n-terminal region and the first zinc finger (1 332 , 201 332) were all unable to support mef2 synergy .
however , the gata-4 mutants that make the the n-terminal region and the first zinc finger (1 332 , 201 332) #deleted were all unable to support mef2 synergy .
however , the gata-4 mutants which #deleted the the n-terminal region and the first zinc finger (1 332 , 201 332) were all unable to support mef2 synergy .
however , mutated zonab-binding site which can #delete the d: erbb-2: s-d (1 332 , 201 332) were all unable to support mef2 synergy .
however , mutated zonab-binding site which #deleted the d: erbb-2: s-d (1 332 , 201 332) were all unable to support mef2 synergy .
however , plasmid erbb-2: s-d which #deleted the the zonab binding (1 332 , 201 332) were all unable to support mef2 synergy .
however , strains that make the micf locus (1 332 , 201 332) #deleted were all unable to support mef2 synergy .
however , strains which #deleted the micf locus (1 332 , 201 332) were all unable to support mef2 synergy .
however , vectors being able to #delete the the viral transcription elements (1 332 , 201 332) were all unable to support mef2 synergy .
however , vectors #deleting the the viral transcription elements (1 332 , 201 332) were all unable to support mef2 synergy .
however , vectors that #delete the the viral transcription elements (1 332 , 201 332) were all unable to support mef2 synergy .
however , vectors which #deleted the the viral transcription elements (1 332 , 201 332) were all unable to support mef2 synergy .
in colonies of c .albicans cells , cst20 has been #deleted , and in erbb-2: s-a the inverted ccaat box has been substituted .
in colonies of c .albicans cells , cst20 is #deleted , and in erbb-2: s-a the inverted ccaat box is substituted .
in colonies of c .albicans cells , cst20 was #deleted , and in erbb-2: s-a the inverted ccaat box was substituted .
in the gata-4 mutants , the n-terminal region (127 443 and 201 443) and the first zinc finger (242 443) is #deleted , and in erbb-2: s-a the inverted ccaat box is substituted .
in the gata-4 mutants , the n-terminal region and the first zinc finger is #deleted , and in erbb-2: s-a the inverted ccaat box is substituted .
in the gata-4 mutants , the n-terminal region and the first zinc finger was #deleted , and in erbb-2: s-a the inverted ccaat box was substituted .
in mutated zonab-binding site , d: erbb-2: s-d was #deleted , and in erbb-2: s-a the inverted ccaat box was substituted .
in strains , micf locus has been #deleted , and in erbb-2: s-a the inverted ccaat box has been substituted .
in strains , micf locus was #deleted , and in erbb-2: s-a the inverted ccaat box was substituted .
in the gata-4 mutants , c-terminal transactivition domain is #deleted , and in erbb-2: s-a the inverted ccaat box is substituted .
in the presence of the phage p1 cyclization recombinase cre , appropriate progenitor strains can #delete any chromosomal region .
in the presence of the phage p1 cyclization recombinase cre , appropriate progenitor strains could #delete any chromosomal region .
in the presence of the phage p1 cyclization recombinase cre , appropriate progenitor strains may #delete any chromosomal region .
in the presence of the phage p1 cyclization recombinase cre , antigen-loaded immature dcs can #delete t cells .
in the presence of the phage p1 cyclization recombinase cre , antigen-loaded immature dcs could #delete t cells .
in the presence of the phage p1 cyclization recombinase cre , antigen-loaded immature dcs may #delete t cells .
in the presence of the phage p1 cyclization recombinase cre , micf locus can #delete strains .
in the presence of the phage p1 cyclization recombinase cre , micf locus could #delete strains .
in the presence of the phage p1 cyclization recombinase cre , the development of other immunotherapeutic agents could #delete cytotoxic lymphocyte responses .
in the presence of the phage p1 cyclization recombinase cre , the development of other immunotherapeutic agents may #delete cytotoxic lymphocyte responses .
in vectors , the viral transcription elements has been #deleted , and in erbb-2: s-a the inverted ccaat box has been substituted .
recent experiments have provided direct evidence that appropriate progenitor strains are able to #delete any chromosomal region to silence them .
recent experiments have provided direct evidence that appropriate progenitor strains can #delete any chromosomal region to silence them .
recent experiments have provided direct evidence that appropriate progenitor strains #deleted any chromosomal region to silence them .
recent experiments have provided direct evidence that appropriate progenitor strains will #delete any chromosomal region to silence them .
recent experiments have provided direct evidence that isolates of the malaria parasite plasmodium falciparum are able to #delete a segment of chromosome 9 to silence them .
recent experiments have provided direct evidence that isolates of the malaria parasite plasmodium falciparum have #deleted a segment of chromosome 9 to silence them .
recent experiments have provided direct evidence that micf locus are able to #delete strains to silence them .
recent experiments have provided direct evidence that micf locus can #delete strains to silence them .
recent experiments have provided direct evidence that micf locus #delete strains or by expanding regulatory t cells .
recent experiments have provided direct evidence that micf locus silence strains either by #deleting them or by expanding regulatory t cells .
recent experiments have provided direct evidence that the development of other immunotherapeutic agents are able to #delete cytotoxic lymphocyte responses to silence them .
recent experiments have provided direct evidence that the development of other immunotherapeutic agents #deleted cytotoxic lymphocyte responses to silence them .
recent experiments have provided direct evidence that the development of other immunotherapeutic agents silence cytotoxic lymphocyte responses either by #deleting them or by expanding regulatory t cells .
recent experiments have provided direct evidence that the transposon silence the ura3 , teta , and lacz genes between the two loxp sites either by #deleting them or by expanding regulatory t cells .
recent experiments have provided direct evidence that the transposon will #delete the ura3 , teta , and lacz genes between the two loxp sites to silence them .
recent experiments have provided direct evidence that using homologous recombination in mouse embryonic stem cells can #delete the headpiece domain of dematin to silence them .
studies with t cells which are #deleted for the antigen-loaded immature dcs showed that the mara-dependent reduction of ompf required an intact micf locus .
studies with t cells which has been #deleted for the antigen-loaded immature dcs showed that the mara-dependent reduction of ompf required an intact micf locus .
studies with t cells which were #deleted for the antigen-loaded immature dcs showed that the mara-dependent reduction of ompf required an intact micf locus .
studies with t cells which will be #deleted for the antigen-loaded immature dcs showed that the mara-dependent reduction of ompf required an intact micf locus .
studies with the gata-4 mutants #deleted for the the n-terminal region (127 443 and 201 443) and the first zinc finger (242 443) showed that the mara-dependent reduction of ompf required an intact micf locus .
studies with a segment of chromosome 9 which are #deleted for the isolates of the malaria parasite plasmodium falciparum showed that the mara-dependent reduction of ompf required an intact micf locus .
studies with a segment of chromosome 9 which were #deleted for the isolates of the malaria parasite plasmodium falciparum showed that the mara-dependent reduction of ompf required an intact micf locus .
studies with any chromosomal region which were #deleted for the appropriate progenitor strains showed that the mara-dependent reduction of ompf required an intact micf locus .
studies with cytotoxic lymphocyte responses which are #deleted for the the development of other immunotherapeutic agents showed that the mara-dependent reduction of ompf required an intact micf locus .
studies with plasmid erbb-2: s-d #deleted for the the zonab binding showed that the mara-dependent reduction of ompf required an intact micf locus .
studies with the gata-4 mutants #deleted for the c-terminal transactivition domain showed that the mara-dependent reduction of ompf required an intact micf locus .
studies with the ura3 , teta , and lacz genes between the two loxp sites which has been #deleted for the the transposon showed that the mara-dependent reduction of ompf required an intact micf locus .
studies with the ura3 , teta , and lacz genes between the two loxp sites which will be #deleted for the the transposon showed that the mara-dependent reduction of ompf required an intact micf locus .
studies with vectors #deleted for the the viral transcription elements showed that the mara-dependent reduction of ompf required an intact micf locus .
the gata-4 mutants that #delete the n-terminal region (127 443 and 201 443) and the first zinc finger (242 443) (242 8211; 443) were able to synergize with mef2a (figure 6a) .
the gata-4 mutants that #delete the n-terminal region and the first zinc finger were able to synergize with mef2a (figure 6a) .
the generation of replication-competent virus is considered less likely with cst20 that #deleted colonies of c .albicans cells .
the generation of replication-competent virus is considered less likely with cst20 which #deleted colonies of c .albicans cells .
the generation of replication-competent virus is considered less likely with cst20 which that #delete colonies of c .albicans cells .
the generation of replication-competent virus is considered less likely with colonies of c .albicans cells that #deleted cst20 .
the generation of replication-competent virus is considered less likely with colonies of c .albicans cells which that #delete cst20 .
the generation of replication-competent virus is considered less likely with the gata-4 mutants #deleting the n-terminal region and the first zinc finger .
the generation of replication-competent virus is considered less likely with the gata-4 mutants that #delete the n-terminal region (127 443 and 201 443) and the first zinc finger (242 443) .
the generation of replication-competent virus is considered less likely with the gata-4 mutants that #deleted the n-terminal region and the first zinc finger .
the generation of replication-competent virus is considered less likely with the gata-4 mutants which #delete the n-terminal region and the first zinc finger .
the generation of replication-competent virus is considered less likely with mutated zonab-binding site #deleting d: erbb-2: s-d .
the generation of replication-competent virus is considered less likely with mutated zonab-binding site that #delete d: erbb-2: s-d .
the generation of replication-competent virus is considered less likely with mutated zonab-binding site which that #delete d: erbb-2: s-d .
the generation of replication-competent virus is considered less likely with plasmid erbb-2: s-d #deleting the zonab binding .
the generation of replication-competent virus is considered less likely with strains #deleting micf locus .
the generation of replication-competent virus is considered less likely with strains that #delete micf locus .
the generation of replication-competent virus is considered less likely with strains that #deleted micf locus .
the generation of replication-competent virus is considered less likely with the gata-4 mutants #deleting c-terminal transactivition domain .
the generation of replication-competent virus is considered less likely with the gata-4 mutants which #delete c-terminal transactivition domain .
the generation of replication-competent virus is considered less likely with the gata-4 mutants which #deleted c-terminal transactivition domain .
the generation of replication-competent virus is considered less likely with the gata-4 mutants which that #delete c-terminal transactivition domain .
the propensity of appropriate progenitor strains #deleting any chromosomal region has provided positional information that has allowed us to identify a gene necessary for cytoadherence .
the propensity of appropriate progenitor strains proven to #delete any chromosomal region has provided positional information that has allowed us to identify a gene necessary for cytoadherence .
the propensity of appropriate progenitor strains to #delete any chromosomal region has provided positional information that has allowed us to identify a gene necessary for cytoadherence .
the propensity of appropriate progenitor strains which #delete any chromosomal region has provided positional information that has allowed us to identify a gene necessary for cytoadherence .
the propensity of antigen-loaded immature dcs beleieved to #delete t cells has provided positional information that has allowed us to identify a gene necessary for cytoadherence .
the propensity of antigen-loaded immature dcs which #delete t cells has provided positional information that has allowed us to identify a gene necessary for cytoadherence .
the propensity of micf locus beleieved to #delete strains has provided positional information that has allowed us to identify a gene necessary for cytoadherence .
the propensity of micf locus to #delete strains has provided positional information that has allowed us to identify a gene necessary for cytoadherence .
the propensity of micf locus which #delete strains has provided positional information that has allowed us to identify a gene necessary for cytoadherence .
the propensity of the development of other immunotherapeutic agents proven to #delete cytotoxic lymphocyte responses has provided positional information that has allowed us to identify a gene necessary for cytoadherence .
the propensity of the development of other immunotherapeutic agents to #delete cytotoxic lymphocyte responses has provided positional information that has allowed us to identify a gene necessary for cytoadherence .
the propensity of the transposon proven to #delete the ura3 , teta , and lacz genes between the two loxp sites has provided positional information that has allowed us to identify a gene necessary for cytoadherence .
the propensity of the transposon to #delete the ura3 , teta , and lacz genes between the two loxp sites has provided positional information that has allowed us to identify a gene necessary for cytoadherence .
the propensity of the transposon which #delete the ura3 , teta , and lacz genes between the two loxp sites has provided positional information that has allowed us to identify a gene necessary for cytoadherence .
the propensity of using homologous recombination in mouse embryonic stem cells to #delete the headpiece domain of dematin has provided positional information that has allowed us to identify a gene necessary for cytoadherence .
the propensity of using homologous recombination in mouse embryonic stem cells which #delete the headpiece domain of dematin has provided positional information that has allowed us to identify a gene necessary for cytoadherence .
the reporter plasmids contained a shorter fragment of the erbb-2 promoter with a functional (d: erbb-2: s) or cst20 (colonies of c .albicans cells , being deleted; erbb-2: s-a , substitution of the inverted ccaat box) .
the reporter plasmids contained a shorter fragment of the erbb-2 promoter with a functional (d: erbb-2: s) or cst20 (colonies of c .albicans cells , deleted; erbb-2: s-a , substitution of the inverted ccaat box) .
the reporter plasmids contained a shorter fragment of the erbb-2 promoter with a functional (d: erbb-2: s) or colonies of c .albicans cells (cst20 , being deleted; erbb-2: s-a , substitution of the inverted ccaat box) .
the reporter plasmids contained a shorter fragment of the erbb-2 promoter with a functional (d: erbb-2: s) or the gata-4 mutants (the n-terminal region and the first zinc finger , being deleted; erbb-2: s-a , substitution of the inverted ccaat box) .
the reporter plasmids contained a shorter fragment of the erbb-2 promoter with a functional (d: erbb-2: s) or the gata-4 mutants (the n-terminal region and the first zinc finger , deleted; erbb-2: s-a , substitution of the inverted ccaat box) .
thus , this granule enzyme is required for the unique effects of leu-leu-ome and may provide a target for appropriate progenitor strains designed to #delete any chromosomal region .
thus , this granule enzyme is required for the unique effects of leu-leu-ome and may provide a target for appropriate progenitor strains found to #delete any chromosomal region .
thus , this granule enzyme is required for the unique effects of leu-leu-ome and may provide a target for appropriate progenitor strains proven to #delete any chromosomal region .
thus , this granule enzyme is required for the unique effects of leu-leu-ome and may provide a target for antigen-loaded immature dcs designed to #delete t cells .
thus , this granule enzyme is required for the unique effects of leu-leu-ome and may provide a target for antigen-loaded immature dcs proven to #delete t cells .
thus , this granule enzyme is required for the unique effects of leu-leu-ome and may provide a target for micf locus designed to #delete strains .
thus , this granule enzyme is required for the unique effects of leu-leu-ome and may provide a target for micf locus proven to #delete strains .
thus , this granule enzyme is required for the unique effects of leu-leu-ome and may provide a target for micf locus which are proven to #delete strains .
thus , this granule enzyme is required for the unique effects of leu-leu-ome and may provide a target for the transposon being proven to #delete the ura3 , teta , and lacz genes between the two loxp sites .
thus , this granule enzyme is required for the unique effects of leu-leu-ome and may provide a target for the transposon designed to #delete the ura3 , teta , and lacz genes between the two loxp sites .
thus , this granule enzyme is required for the unique effects of leu-leu-ome and may provide a target for the transposon proven to #delete the ura3 , teta , and lacz genes between the two loxp sites .
thus , this granule enzyme is required for the unique effects of leu-leu-ome and may provide a target for the transposon which are proven to #delete the ura3 , teta , and lacz genes between the two loxp sites .
thus , this granule enzyme is required for the unique effects of leu-leu-ome and may provide a target for using homologous recombination in mouse embryonic stem cells found to #delete the headpiece domain of dematin .
antigen-loaded immature dcs can now be constructed to #delete virtually t cells by utilizing an extensive collection of lines containing single p element insertions throughout the drosophila genome .
antigen-loaded immature dcs may now be constructed to #delete virtually t cells by utilizing an extensive collection of lines containing single p element insertions throughout the drosophila genome .
antigen-loaded immature dcs will be constructed to #delete virtually t cells by utilizing an extensive collection of lines containing single p element insertions throughout the drosophila genome .
isolates of the malaria parasite plasmodium falciparum can now be constructed to #delete virtually a segment of chromosome 9 by utilizing an extensive collection of lines containing single p element insertions throughout the drosophila genome .
isolates of the malaria parasite plasmodium falciparum will be constructed to #delete virtually a segment of chromosome 9 by utilizing an extensive collection of lines containing single p element insertions throughout the drosophila genome .
micf locus being #deleted for strains revealed defects in the lateral formation of mycelia on synthetic solid spider media .
micf locus can now be constructed to #delete virtually strains by utilizing an extensive collection of lines containing single p element insertions throughout the drosophila genome .
micf locus #deleted for strains revealed defects in the lateral formation of mycelia on synthetic solid spider media .
micf locus may now be constructed to #delete virtually strains by utilizing an extensive collection of lines containing single p element insertions throughout the drosophila genome .
micf locus that are #deleted for strains revealed defects in the lateral formation of mycelia on synthetic solid spider media .
micf locus which were #deleted for strains revealed defects in the lateral formation of mycelia on synthetic solid spider media .
micf locus will be constructed to #delete virtually strains by utilizing an extensive collection of lines containing single p element insertions throughout the drosophila genome .
mutated zonab-binding site that can be #deleted for d: erbb-2: s-d revealed defects in the lateral formation of mycelia on synthetic solid spider media .
mutated zonab-binding site that #delete d: erbb-2: s-d (242 8211; 443) were able to synergize with mef2a (figure 6a) .
mutated zonab-binding site that #delete d: erbb-2: s-d were able to synergize with mef2a (figure 6a) .
mutated zonab-binding site which can #delete d: erbb-2: s-d were able to synergize with mef2a (figure 6a) .
plasmid erbb-2: s-d which #delete the zonab binding were able to synergize with mef2a (figure 6a) .
plasmid erbb-2: s-d which #deleted the zonab binding were able to synergize with mef2a (figure 6a) .
plasmid erbb-2: s-d which has #deleted the zonab binding were able to synergize with mef2a (figure 6a) .
strains that #delete micf locus (242 8211; 443) were able to synergize with mef2a (figure 6a) .
strains which #delete micf locus were able to synergize with mef2a (figure 6a) .
strains which has #deleted micf locus were able to synergize with mef2a (figure 6a) .
the gata-4 mutants that #delete c-terminal transactivition domain were able to synergize with mef2a (figure 6a) .
the gata-4 mutants which can #delete c-terminal transactivition domain were able to synergize with mef2a (figure 6a) .
the gata-4 mutants which #delete c-terminal transactivition domain were able to synergize with mef2a (figure 6a) .
the gata-4 mutants which has #deleted c-terminal transactivition domain were able to synergize with mef2a (figure 6a) .
the n-terminal region (127 443 and 201 443) and the first zinc finger (242 443) #deleted for the gata-4 mutants revealed defects in the lateral formation of mycelia on synthetic solid spider media .
the n-terminal region (127 443 and 201 443) and the first zinc finger (242 443) which the gata-4 mutants #deleted revealed defects in the lateral formation of mycelia on synthetic solid spider media .
the n-terminal region (127 443 and 201 443) and the first zinc finger (242 443) which can be #deleted for the gata-4 mutants revealed defects in the lateral formation of mycelia on synthetic solid spider media .
the n-terminal region (127 443 and 201 443) and the first zinc finger (242 443) which were #deleted for the gata-4 mutants revealed defects in the lateral formation of mycelia on synthetic solid spider media .
the n-terminal region and the first zinc finger being #deleted for the gata-4 mutants revealed defects in the lateral formation of mycelia on synthetic solid spider media .
the n-terminal region and the first zinc finger which were #deleted for the gata-4 mutants revealed defects in the lateral formation of mycelia on synthetic solid spider media .
the zonab binding #deleted for plasmid erbb-2: s-d revealed defects in the lateral formation of mycelia on synthetic solid spider media .
the zonab binding which are #deleted for plasmid erbb-2: s-d revealed defects in the lateral formation of mycelia on synthetic solid spider media .
the zonab binding which can be #deleted for plasmid erbb-2: s-d revealed defects in the lateral formation of mycelia on synthetic solid spider media .
the zonab binding which plasmid erbb-2: s-d #deleted revealed defects in the lateral formation of mycelia on synthetic solid spider media .
the development of other immunotherapeutic agents may now be constructed to #delete virtually cytotoxic lymphocyte responses by utilizing an extensive collection of lines containing single p element insertions throughout the drosophila genome .
the development of other immunotherapeutic agents will be constructed to #delete virtually cytotoxic lymphocyte responses by utilizing an extensive collection of lines containing single p element insertions throughout the drosophila genome .
the transposon can now be constructed to #delete virtually the ura3 , teta , and lacz genes between the two loxp sites by utilizing an extensive collection of lines containing single p element insertions throughout the drosophila genome .
the transposon may now be constructed to #delete virtually the ura3 , teta , and lacz genes between the two loxp sites by utilizing an extensive collection of lines containing single p element insertions throughout the drosophila genome .
the viral transcription elements being #deleted for vectors revealed defects in the lateral formation of mycelia on synthetic solid spider media .
the viral transcription elements #deleted for vectors revealed defects in the lateral formation of mycelia on synthetic solid spider media .
the viral transcription elements that are #deleted for vectors revealed defects in the lateral formation of mycelia on synthetic solid spider media .
the viral transcription elements which are #deleted for vectors revealed defects in the lateral formation of mycelia on synthetic solid spider media .
the viral transcription elements which can be #deleted for vectors revealed defects in the lateral formation of mycelia on synthetic solid spider media .
the viral transcription elements which vectors #deleted revealed defects in the lateral formation of mycelia on synthetic solid spider media .
using homologous recombination in mouse embryonic stem cells can now be constructed to #delete virtually the headpiece domain of dematin by utilizing an extensive collection of lines containing single p element insertions throughout the drosophila genome .
using homologous recombination in mouse embryonic stem cells may now be constructed to #delete virtually the headpiece domain of dematin by utilizing an extensive collection of lines containing single p element insertions throughout the drosophila genome .
vectors that #delete the viral transcription elements (242 8211; 443) were able to synergize with mef2a (figure 6a) .
appropriate progenitor strains can now be constructed to #delete virtually any chromosomal region by utilizing an extensive collection of lines containing single p element insertions throughout the drosophila genome .
colonies of c .albicans cells #deleted for cst20 revealed defects in the lateral formation of mycelia on synthetic solid spider media .
recent experiments have provided direct evidence that antigen-loaded immature dcs silence t cells either by #deleting them or by expanding regulatory t cells .
the generation of replication-competent virus is considered less likely with vectors that #delete the viral transcription elements .
the propensity of isolates of the malaria parasite plasmodium falciparum to #delete a segment of chromosome 9 has provided positional information that has allowed us to identify a gene necessary for cytoadherence .
however , a region between the two motifs being able to #delete the an alternative spliced form of dmc1 cdna (dmc1-d) (1 332 , 201 332) were all unable to support mef2 synergy .
however , a region between the two motifs #deleting the an alternative spliced form of dmc1 cdna (dmc1-d) (1 332 , 201 332) were all unable to support mef2 synergy .
however , a region between the two motifs that #delete the an alternative spliced form of dmc1 cdna (dmc1-d) (1 332 , 201 332) were all unable to support mef2 synergy .
however , a region between the two motifs that make the an alternative spliced form of dmc1 cdna (dmc1-d) (1 332 , 201 332) #deleted were all unable to support mef2 synergy .
however , a region between the two motifs which can #delete the an alternative spliced form of dmc1 cdna (dmc1-d) (1 332 , 201 332) were all unable to support mef2 synergy .
however , a single transcript #deleting the exon 2 (1 332 , 201 332) were all unable to support mef2 synergy .
however , a single transcript that make the exon 2 (1 332 , 201 332) #deleted were all unable to support mef2 synergy .
however , a single transcript which can #delete the exon 2 (1 332 , 201 332) were all unable to support mef2 synergy .
however , aberrantly spliced transcripts being able to #delete the exon 4 (1 332 , 201 332) were all unable to support mef2 synergy .
however , aberrantly spliced transcripts #deleting the exon 4 (1 332 , 201 332) were all unable to support mef2 synergy .
however , aberrantly spliced transcripts that #delete the exon 4 (1 332 , 201 332) were all unable to support mef2 synergy .
however , rpos being able to #delete the strain of e . coli that emits very low levels of luminescence (1 332 , 201 332) were all unable to support mef2 synergy .
however , rpos #deleting the strain of e . coli that emits very low levels of luminescence (1 332 , 201 332) were all unable to support mef2 synergy .
however , rpos which can #delete the strain of e . coli that emits very low levels of luminescence (1 332 , 201 332) were all unable to support mef2 synergy .
however , rpos which #deleted the strain of e . coli that emits very low levels of luminescence (1 332 , 201 332) were all unable to support mef2 synergy .
however , strain of e . coli that emits very low levels of luminescence #deleting the rpos (1 332 , 201 332) were all unable to support mef2 synergy .
however , strain of e . coli that emits very low levels of luminescence that #delete the rpos (1 332 , 201 332) were all unable to support mef2 synergy .
however , strain of e . coli that emits very low levels of luminescence that make the rpos (1 332 , 201 332) #deleted were all unable to support mef2 synergy .
however , strain of e . coli that emits very low levels of luminescence which can #delete the rpos (1 332 , 201 332) were all unable to support mef2 synergy .
however , the remainder being able to #delete the exon 9 (1 332 , 201 332) were all unable to support mef2 synergy .
however , the remainder #deleting the exon 9 (1 332 , 201 332) were all unable to support mef2 synergy .
however , the remainder that #delete the exon 9 (1 332 , 201 332) were all unable to support mef2 synergy .
however , the remainder that make the exon 9 (1 332 , 201 332) #deleted were all unable to support mef2 synergy .
however , the remainder which #deleted the exon 9 (1 332 , 201 332) were all unable to support mef2 synergy .
however , transcripts #deleting the exons 8 (75 nt) , 7+8 (156 nt) or 8+9 (168 nt) (1 332 , 201 332) were all unable to support mef2 synergy .
however , transcripts that #delete the exons 8 (75 nt) , 7+8 (156 nt) or 8+9 (168 nt) (1 332 , 201 332) were all unable to support mef2 synergy .
however , transcripts which #deleted the exons 8 (75 nt) , 7+8 (156 nt) or 8+9 (168 nt) (1 332 , 201 332) were all unable to support mef2 synergy .
in a region between the two motifs , an alternative spliced form of dmc1 cdna (dmc1-d) is #deleted , and in erbb-2: s-a the inverted ccaat box is substituted .
in a single transcript , exon 2 was #deleted , and in erbb-2: s-a the inverted ccaat box was substituted .
in aberrantly spliced transcripts , exon 4 has been #deleted , and in erbb-2: s-a the inverted ccaat box has been substituted .
in aberrantly spliced transcripts , exon 4 is #deleted , and in erbb-2: s-a the inverted ccaat box is substituted .
in aberrantly spliced transcripts , exon 4 was #deleted , and in erbb-2: s-a the inverted ccaat box was substituted .
in rpos , strain of e . coli that emits very low levels of luminescence has been #deleted , and in erbb-2: s-a the inverted ccaat box has been substituted .
in rpos , strain of e . coli that emits very low levels of luminescence is #deleted , and in erbb-2: s-a the inverted ccaat box is substituted .
in rpos , strain of e . coli that emits very low levels of luminescence was #deleted , and in erbb-2: s-a the inverted ccaat box was substituted .
in strain of e . coli that emits very low levels of luminescence , rpos has been #deleted , and in erbb-2: s-a the inverted ccaat box has been substituted .
in strain of e . coli that emits very low levels of luminescence , rpos is #deleted , and in erbb-2: s-a the inverted ccaat box is substituted .
in the remainder , exon 9 has been #deleted , and in erbb-2: s-a the inverted ccaat box has been substituted .
in transcripts , exons 8 (75 nt) , 7+8 (156 nt) or 8+9 (168 nt) is #deleted , and in erbb-2: s-a the inverted ccaat box is substituted .
studies with aberrantly spliced transcripts #deleted for the exon 4 showed that the mara-dependent reduction of ompf required an intact micf locus .
studies with strain of e . coli that emits very low levels of luminescence #deleted for the rpos showed that the mara-dependent reduction of ompf required an intact micf locus .
studies with the remainder #deleted for the exon 9 showed that the mara-dependent reduction of ompf required an intact micf locus .
the generation of replication-competent virus is considered less likely with a region between the two motifs #deleting an alternative spliced form of dmc1 cdna (dmc1-d) .
the generation of replication-competent virus is considered less likely with a region between the two motifs that #deleted an alternative spliced form of dmc1 cdna (dmc1-d) .
the generation of replication-competent virus is considered less likely with a region between the two motifs which #delete an alternative spliced form of dmc1 cdna (dmc1-d) .
the generation of replication-competent virus is considered less likely with a region between the two motifs which #deleted an alternative spliced form of dmc1 cdna (dmc1-d) .
the generation of replication-competent virus is considered less likely with aberrantly spliced transcripts #deleting exon 4 .
the generation of replication-competent virus is considered less likely with aberrantly spliced transcripts that #deleted exon 4 .
the generation of replication-competent virus is considered less likely with aberrantly spliced transcripts which #deleted exon 4 .
the generation of replication-competent virus is considered less likely with aberrantly spliced transcripts which that #delete exon 4 .
the generation of replication-competent virus is considered less likely with rpos #deleting strain of e . coli that emits very low levels of luminescence .
the generation of replication-competent virus is considered less likely with rpos that #deleted strain of e . coli that emits very low levels of luminescence .
the generation of replication-competent virus is considered less likely with rpos which #delete strain of e . coli that emits very low levels of luminescence .
the generation of replication-competent virus is considered less likely with rpos which #deleted strain of e . coli that emits very low levels of luminescence .
the generation of replication-competent virus is considered less likely with strain of e . coli that emits very low levels of luminescence #deleting rpos .
the generation of replication-competent virus is considered less likely with strain of e . coli that emits very low levels of luminescence that #delete rpos .
the generation of replication-competent virus is considered less likely with strain of e . coli that emits very low levels of luminescence that #deleted rpos .
the generation of replication-competent virus is considered less likely with strain of e . coli that emits very low levels of luminescence which #delete rpos .
the generation of replication-competent virus is considered less likely with the remainder that #delete exon 9 .
the generation of replication-competent virus is considered less likely with the remainder which that #delete exon 9 .
the generation of replication-competent virus is considered less likely with transcripts that #delete exons 8 (75 nt) , 7+8 (156 nt) or 8+9 (168 nt) .
the generation of replication-competent virus is considered less likely with transcripts which #delete exons 8 (75 nt) , 7+8 (156 nt) or 8+9 (168 nt) .
the reporter plasmids contained a shorter fragment of the erbb-2 promoter with a functional (d: erbb-2: s) or aberrantly spliced transcripts (exon 4 , being deleted; erbb-2: s-a , substitution of the inverted ccaat box) .
the reporter plasmids contained a shorter fragment of the erbb-2 promoter with a functional (d: erbb-2: s) or rpos (strain of e . coli that emits very low levels of luminescence , deleted; erbb-2: s-a , substitution of the inverted ccaat box) .
the reporter plasmids contained a shorter fragment of the erbb-2 promoter with a functional (d: erbb-2: s) or strain of e . coli that emits very low levels of luminescence (rpos , being deleted; erbb-2: s-a , substitution of the inverted ccaat box) .
the reporter plasmids contained a shorter fragment of the erbb-2 promoter with a functional (d: erbb-2: s) or strain of e . coli that emits very low levels of luminescence (rpos , deleted; erbb-2: s-a , substitution of the inverted ccaat box) .
the reporter plasmids contained a shorter fragment of the erbb-2 promoter with a functional (d: erbb-2: s) or transcripts (exons 8 (75 nt) , 7+8 (156 nt) or 8+9 (168 nt) , being deleted; erbb-2: s-a , substitution of the inverted ccaat box) .
a region between the two motifs being #deleted for an alternative spliced form of dmc1 cdna (dmc1-d) revealed defects in the lateral formation of mycelia on synthetic solid spider media .
a region between the two motifs #deleted for an alternative spliced form of dmc1 cdna (dmc1-d) revealed defects in the lateral formation of mycelia on synthetic solid spider media .
a region between the two motifs that are #deleted for an alternative spliced form of dmc1 cdna (dmc1-d) revealed defects in the lateral formation of mycelia on synthetic solid spider media .
a region between the two motifs that can be #deleted for an alternative spliced form of dmc1 cdna (dmc1-d) revealed defects in the lateral formation of mycelia on synthetic solid spider media .
a region between the two motifs that #delete an alternative spliced form of dmc1 cdna (dmc1-d) (242 8211; 443) were able to synergize with mef2a (figure 6a) .
a region between the two motifs which an alternative spliced form of dmc1 cdna (dmc1-d) #deleted revealed defects in the lateral formation of mycelia on synthetic solid spider media .
a region between the two motifs which are #deleted for an alternative spliced form of dmc1 cdna (dmc1-d) revealed defects in the lateral formation of mycelia on synthetic solid spider media .
a region between the two motifs which were #deleted for an alternative spliced form of dmc1 cdna (dmc1-d) revealed defects in the lateral formation of mycelia on synthetic solid spider media .
a single transcript being #deleted for exon 2 revealed defects in the lateral formation of mycelia on synthetic solid spider media .
a single transcript #deleted for exon 2 revealed defects in the lateral formation of mycelia on synthetic solid spider media .
a single transcript that are #deleted for exon 2 revealed defects in the lateral formation of mycelia on synthetic solid spider media .
a single transcript which are #deleted for exon 2 revealed defects in the lateral formation of mycelia on synthetic solid spider media .
a single transcript which can be #deleted for exon 2 revealed defects in the lateral formation of mycelia on synthetic solid spider media .
a single transcript which #deleted exon 2 were able to synergize with mef2a (figure 6a) .
a single transcript which exon 2 #deleted revealed defects in the lateral formation of mycelia on synthetic solid spider media .
a single transcript which has #deleted exon 2 were able to synergize with mef2a (figure 6a) .
a single transcript with exon 2 #deleted were able to synergize with mef2a (figure 6a) .
aberrantly spliced transcripts being #deleted for exon 4 revealed defects in the lateral formation of mycelia on synthetic solid spider media .
aberrantly spliced transcripts #deleted for exon 4 revealed defects in the lateral formation of mycelia on synthetic solid spider media .
aberrantly spliced transcripts that #delete exon 4 (242 8211; 443) were able to synergize with mef2a (figure 6a) .
aberrantly spliced transcripts which can #delete exon 4 were able to synergize with mef2a (figure 6a) .
aberrantly spliced transcripts which #deleted exon 4 were able to synergize with mef2a (figure 6a) .
an alternative spliced form of dmc1 cdna (dmc1-d) #deleted for a region between the two motifs revealed defects in the lateral formation of mycelia on synthetic solid spider media .
an alternative spliced form of dmc1 cdna (dmc1-d) that are #deleted for a region between the two motifs revealed defects in the lateral formation of mycelia on synthetic solid spider media .
an alternative spliced form of dmc1 cdna (dmc1-d) which are #deleted for a region between the two motifs revealed defects in the lateral formation of mycelia on synthetic solid spider media .
an alternative spliced form of dmc1 cdna (dmc1-d) which can be #deleted for a region between the two motifs revealed defects in the lateral formation of mycelia on synthetic solid spider media .
exon 2 which a single transcript #deleted revealed defects in the lateral formation of mycelia on synthetic solid spider media .
exon 2 which are #deleted for a single transcript revealed defects in the lateral formation of mycelia on synthetic solid spider media .
exon 2 which can be #deleted for a single transcript revealed defects in the lateral formation of mycelia on synthetic solid spider media .
exon 2 which were #deleted for a single transcript revealed defects in the lateral formation of mycelia on synthetic solid spider media .
exon 4 #deleted for aberrantly spliced transcripts revealed defects in the lateral formation of mycelia on synthetic solid spider media .
exon 4 that are #deleted for aberrantly spliced transcripts revealed defects in the lateral formation of mycelia on synthetic solid spider media .
exon 4 which aberrantly spliced transcripts #deleted revealed defects in the lateral formation of mycelia on synthetic solid spider media .
exon 4 which can be #deleted for aberrantly spliced transcripts revealed defects in the lateral formation of mycelia on synthetic solid spider media .
exon 4 which were #deleted for aberrantly spliced transcripts revealed defects in the lateral formation of mycelia on synthetic solid spider media .
exon 9 which the remainder #deleted revealed defects in the lateral formation of mycelia on synthetic solid spider media .
exon 9 which were #deleted for the remainder revealed defects in the lateral formation of mycelia on synthetic solid spider media .
exons 8 (75 nt) , 7+8 (156 nt) or 8+9 (168 nt) being #deleted for transcripts revealed defects in the lateral formation of mycelia on synthetic solid spider media .
exons 8 (75 nt) , 7+8 (156 nt) or 8+9 (168 nt) that are #deleted for transcripts revealed defects in the lateral formation of mycelia on synthetic solid spider media .
exons 8 (75 nt) , 7+8 (156 nt) or 8+9 (168 nt) which are #deleted for transcripts revealed defects in the lateral formation of mycelia on synthetic solid spider media .
exons 8 (75 nt) , 7+8 (156 nt) or 8+9 (168 nt) which transcripts #deleted revealed defects in the lateral formation of mycelia on synthetic solid spider media .
exons 8 (75 nt) , 7+8 (156 nt) or 8+9 (168 nt) which were #deleted for transcripts revealed defects in the lateral formation of mycelia on synthetic solid spider media .
mutated zonab-binding site being #deleted for d: erbb-2: s-d revealed defects in the lateral formation of mycelia on synthetic solid spider media .
mutated zonab-binding site which d: erbb-2: s-d #deleted revealed defects in the lateral formation of mycelia on synthetic solid spider media .
mutated zonab-binding site which are #deleted for d: erbb-2: s-d revealed defects in the lateral formation of mycelia on synthetic solid spider media .
mutated zonab-binding site which can be #deleted for d: erbb-2: s-d revealed defects in the lateral formation of mycelia on synthetic solid spider media .
mutated zonab-binding site which were #deleted for d: erbb-2: s-d revealed defects in the lateral formation of mycelia on synthetic solid spider media .
rpos #deleted for strain of e . coli that emits very low levels of luminescence revealed defects in the lateral formation of mycelia on synthetic solid spider media .
rpos that are #deleted for strain of e . coli that emits very low levels of luminescence revealed defects in the lateral formation of mycelia on synthetic solid spider media .
rpos that can be #deleted for strain of e . coli that emits very low levels of luminescence revealed defects in the lateral formation of mycelia on synthetic solid spider media .
rpos that #delete strain of e . coli that emits very low levels of luminescence (242 8211; 443) were able to synergize with mef2a (figure 6a) .
rpos that #delete strain of e . coli that emits very low levels of luminescence were able to synergize with mef2a (figure 6a) .
rpos which #delete strain of e . coli that emits very low levels of luminescence were able to synergize with mef2a (figure 6a) .
rpos which #deleted strain of e . coli that emits very low levels of luminescence were able to synergize with mef2a (figure 6a) .
rpos which has #deleted strain of e . coli that emits very low levels of luminescence were able to synergize with mef2a (figure 6a) .
strain of e . coli that emits very low levels of luminescence being #deleted for rpos revealed defects in the lateral formation of mycelia on synthetic solid spider media .
strain of e . coli that emits very low levels of luminescence #deleted for rpos revealed defects in the lateral formation of mycelia on synthetic solid spider media .
strain of e . coli that emits very low levels of luminescence that are #deleted for rpos revealed defects in the lateral formation of mycelia on synthetic solid spider media .
strain of e . coli that emits very low levels of luminescence that #delete rpos were able to synergize with mef2a (figure 6a) .
strain of e . coli that emits very low levels of luminescence which can be #deleted for rpos revealed defects in the lateral formation of mycelia on synthetic solid spider media .
strain of e . coli that emits very low levels of luminescence which #delete rpos were able to synergize with mef2a (figure 6a) .
strain of e . coli that emits very low levels of luminescence which has #deleted rpos were able to synergize with mef2a (figure 6a) .
strain of e . coli that emits very low levels of luminescence which rpos #deleted revealed defects in the lateral formation of mycelia on synthetic solid spider media .
strain of e . coli that emits very low levels of luminescence which were #deleted for rpos revealed defects in the lateral formation of mycelia on synthetic solid spider media .
strain of e . coli that emits very low levels of luminescence with rpos #deleted were able to synergize with mef2a (figure 6a) .
the remainder #deleted for exon 9 revealed defects in the lateral formation of mycelia on synthetic solid spider media .
the remainder that can be #deleted for exon 9 revealed defects in the lateral formation of mycelia on synthetic solid spider media .
the remainder that #delete exon 9 (242 8211; 443) were able to synergize with mef2a (figure 6a) .
the remainder which are #deleted for exon 9 revealed defects in the lateral formation of mycelia on synthetic solid spider media .
the remainder which can be #deleted for exon 9 revealed defects in the lateral formation of mycelia on synthetic solid spider media .
the remainder which can #delete exon 9 were able to synergize with mef2a (figure 6a) .
the remainder which #delete exon 9 were able to synergize with mef2a (figure 6a) .
the remainder which #deleted exon 9 were able to synergize with mef2a (figure 6a) .
the remainder which has #deleted exon 9 were able to synergize with mef2a (figure 6a) .
the remainder which were #deleted for exon 9 revealed defects in the lateral formation of mycelia on synthetic solid spider media .
the remainder with exon 9 #deleted were able to synergize with mef2a (figure 6a) .
transcripts being #deleted for exons 8 (75 nt) , 7+8 (156 nt) or 8+9 (168 nt) revealed defects in the lateral formation of mycelia on synthetic solid spider media .
transcripts #deleted for exons 8 (75 nt) , 7+8 (156 nt) or 8+9 (168 nt) revealed defects in the lateral formation of mycelia on synthetic solid spider media .
transcripts that are #deleted for exons 8 (75 nt) , 7+8 (156 nt) or 8+9 (168 nt) revealed defects in the lateral formation of mycelia on synthetic solid spider media .
transcripts that #delete exons 8 (75 nt) , 7+8 (156 nt) or 8+9 (168 nt) were able to synergize with mef2a (figure 6a) .
transcripts which can #delete exons 8 (75 nt) , 7+8 (156 nt) or 8+9 (168 nt) were able to synergize with mef2a (figure 6a) .
transcripts which #delete exons 8 (75 nt) , 7+8 (156 nt) or 8+9 (168 nt) were able to synergize with mef2a (figure 6a) .
transcripts which exons 8 (75 nt) , 7+8 (156 nt) or 8+9 (168 nt) #deleted revealed defects in the lateral formation of mycelia on synthetic solid spider media .
transcripts which has #deleted exons 8 (75 nt) , 7+8 (156 nt) or 8+9 (168 nt) were able to synergize with mef2a (figure 6a) .
transcripts which were #deleted for exons 8 (75 nt) , 7+8 (156 nt) or 8+9 (168 nt) revealed defects in the lateral formation of mycelia on synthetic solid spider media .
a c-to-t transition in codon 214 creating a new rsai recognition site in exon 6 and substituting tyrosine for histidine (h214y) is identified in an asymptomatic female carrier whose son can #develop acute neonatal onset of otc deficiency .
a c-to-t transition in codon 214 creating a new rsai recognition site in exon 6 and substituting tyrosine for histidine (h214y) is identified in an asymptomatic female carrier whose son #develops acute neonatal onset of otc deficiency .
a c-to-t transition in codon 214 creating a new rsai recognition site in exon 6 and substituting tyrosine for histidine (h214y) is identified in an asymptomatic female carrier whose son has the ability to #develop acute neonatal onset of otc deficiency .
a c-to-t transition in codon 214 creating a new rsai recognition site in exon 6 and substituting tyrosine for histidine (h214y) is identified in an asymptomatic female carrier whose son is believed to #develop acute neonatal onset of otc deficiency .
a c-to-t transition in codon 214 creating a new rsai recognition site in exon 6 and substituting tyrosine for histidine (h214y) is identified in an asymptomatic female carrier whose son is found to #develop acute neonatal onset of otc deficiency .
a c-to-t transition in codon 214 creating a new rsai recognition site in exon 6 and substituting tyrosine for histidine (h214y) is identified in an asymptomatic female carrier whose son is observed to #develop acute neonatal onset of otc deficiency .
a c-to-t transition in codon 214 creating a new rsai recognition site in exon 6 and substituting tyrosine for histidine (h214y) is identified in an asymptomatic female carrier whose son is predicted to #develop acute neonatal onset of otc deficiency .
a c-to-t transition in codon 214 creating a new rsai recognition site in exon 6 and substituting tyrosine for histidine (h214y) is identified in an asymptomatic female carrier whose son may have #developed acute neonatal onset of otc deficiency .
a c-to-t transition in codon 214 creating a new rsai recognition site in exon 6 and substituting tyrosine for histidine (h214y) was identified in an asymptomatic female carrier whose son had the ability to #develop acute neonatal onset of otc deficiency .
a c-to-t transition in codon 214 creating a new rsai recognition site in exon 6 and substituting tyrosine for histidine (h214y) was identified in an asymptomatic female carrier whose son has been #developing acute neonatal onset of otc deficiency .
a c-to-t transition in codon 214 creating a new rsai recognition site in exon 6 and substituting tyrosine for histidine (h214y) was identified in an asymptomatic female carrier whose son was believed to #develop acute neonatal onset of otc deficiency .
a c-to-t transition in codon 214 creating a new rsai recognition site in exon 6 and substituting tyrosine for histidine (h214y) was identified in an asymptomatic female carrier whose son was #developing acute neonatal onset of otc deficiency .
a c-to-t transition in codon 214 creating a new rsai recognition site in exon 6 and substituting tyrosine for histidine (h214y) was identified in an asymptomatic female carrier whose son was observed to #develop acute neonatal onset of otc deficiency .
a c-to-t transition in codon 214 creating a new rsai recognition site in exon 6 and substituting tyrosine for histidine (h214y) was identified in an asymptomatic female carrier whose son was predicted to #develop acute neonatal onset of otc deficiency .
a c-to-t transition in codon 214 creating a new rsai recognition site in exon 6 and substituting tyrosine for histidine (h214y) was identified in an asymptomatic female carrier whose son was shown to #develop acute neonatal onset of otc deficiency .
a c-to-t transition in codon 214 creating a new rsai recognition site in exon 6 and substituting tyrosine for histidine (h214y) was identified in an asymptomatic female carrier whose son would #develop acute neonatal onset of otc deficiency .
spinach sown in october can have #developed into the rosette stage and grow through the end of november .
spinach sown in october #developed into the rosette stage and grew through the end of november .
spinach sown in october #developing into the rosette stage grows through the end of november .
spinach sown in october had the ability to #develop into the rosette stage and grew through the end of november .
spinach sown in october has been #developing into the rosette stage and can grow through the end of november .
spinach sown in october has #developed into the rosette stage and grown through the end of november .
spinach sown in october is able to #develop into the rosette stage and grow through the end of november .
spinach sown in october is #developing into the rosette stage and will grow through the end of november .
spinach sown in october is found to #develop into the rosette stage and grow through the end of november .
spinach sown in october may #develop into the rosette stage and grow through the end of november .
spinach sown in october may have #developed into the rosette stage and grow through the end of november .
spinach sown in october might #develop into the rosette stage and grew through the end of november .
spinach sown in october that can #develop into the rosette stage grows through the end of november .
spinach sown in october was able to #develop into the rosette stage and grew through the end of november .
spinach sown in october was shown to #develop into the rosette stage and grew through the end of november .
spinach sown in october which #develops into the rosette stage grows through the end of november .
spinach sown in october which is able to #develop into the rosette stage grows through the end of november .
spinach sown in october will #develop into the rosette stage and grow through the end of november .
spinach sown in october would #develop into the rosette stage and grew through the end of november .
to isolate cdna clones that dominantly inhibit the dna-binding activity of oct-2 , chosen as a representative factor , we are able to #develop a novel screening system .
to isolate cdna clones that dominantly inhibit the dna-binding activity of oct-2 , chosen as a representative factor , we are ready to #develop a novel screening system .
to isolate cdna clones that dominantly inhibit the dna-binding activity of oct-2 , chosen as a representative factor , we choose to #develop a novel screening system .
to isolate cdna clones that dominantly inhibit the dna-binding activity of oct-2 , chosen as a representative factor , we chose to #develop a novel screening system .
to isolate cdna clones that dominantly inhibit the dna-binding activity of oct-2 , chosen as a representative factor , we could #develop a novel screening system .
to isolate cdna clones that dominantly inhibit the dna-binding activity of oct-2 , chosen as a representative factor , we decided to #develop a novel screening system .
to isolate cdna clones that dominantly inhibit the dna-binding activity of oct-2 , chosen as a representative factor , we #develop a novel screening system .
to isolate cdna clones that dominantly inhibit the dna-binding activity of oct-2 , chosen as a representative factor , we #developed a novel screening system .
to isolate cdna clones that dominantly inhibit the dna-binding activity of oct-2 , chosen as a representative factor , we had the ability to #develop a novel screening system .
to isolate cdna clones that dominantly inhibit the dna-binding activity of oct-2 , chosen as a representative factor , we have chosen to #develop a novel screening system .
to isolate cdna clones that dominantly inhibit the dna-binding activity of oct-2 , chosen as a representative factor , we have #developed a novel screening system .
to isolate cdna clones that dominantly inhibit the dna-binding activity of oct-2 , chosen as a representative factor , we have the ability to #develop a novel screening system .
to isolate cdna clones that dominantly inhibit the dna-binding activity of oct-2 , chosen as a representative factor , we may have #developed a novel screening system .
to isolate cdna clones that dominantly inhibit the dna-binding activity of oct-2 , chosen as a representative factor , we were ready to #develop a novel screening system .
to isolate cdna clones that dominantly inhibit the dna-binding activity of oct-2 , chosen as a representative factor , we will #develop a novel screening system .
to isolate cdna clones that dominantly inhibit the dna-binding activity of oct-2 , chosen as a representative factor , we will have #developed a novel screening system .
spinach sown in october being able to #develop into he rosette stage grows through the end of november .
spinach sown in october can #develop into he rosette stage and grow through the end of november .
spinach sown in october could #develop into he rosette stage and grew through the end of november .
spinach sown in october #developed into he rosette stage and grew through the end of november .
spinach sown in october had the ability to #develop into he rosette stage and grew through the end of november .
spinach sown in october has the ability to #develop into he rosette stage and grow through the end of november .
spinach sown in october is predicted to #develop into he rosette stage and grow through the end of november .
spinach sown in october is shown to #develop into he rosette stage and grow through the end of november .
spinach sown in october might #develop into he rosette stage and grew through the end of november .
spinach sown in october was able to #develop into he rosette stage and grew through the end of november .
spinach sown in october was believed to #develop into he rosette stage and grew through the end of november .
spinach sown in october was shown to #develop into he rosette stage and grew through the end of november .
spinach sown in october which is able to #develop into he rosette stage grows through the end of november .
spinach sown in october will have #developed into he rosette stage and grow through the end of november .
a homozygous mutation having #disrupted splicing will be identified in affected siblings with classical abetalipoproteinemia .
a homozygous mutation that can #disrupt splicing which has been identified in affected siblings with classical abetalipoproteinemia .
a homozygous mutation that #disrupted splicing has been identified in affected siblings with classical abetalipoproteinemia .
arg99 and arg253 can interact with the keto groups of the go and c base pair(blue) in both sides of dsdna and #disrupt the pairing hydrogen bonds in the model .
arg99 and arg253 that interact with the keto groups of the go and c base pair(blue) in both sides of dsdna can #disrupt the pairing hydrogen bonds in the model .
quantitative single-unit electrophysiology revealed that alcohol exposure is able to #disrupt ocular dominance plasticity while preserving robust visual responses .
sequencing of cloned polymerase chain reaction amplified fragments of the amh gene revealed a 14-bp deletion in the second exon of the maternal allele; this deletion #disrupts the open reading frame .
sequencing of cloned polymerase chain reaction amplified fragments of the amh gene revealed a 14-bp deletion in the second exon of the maternal allele; this deletion has been shown to #disrupt the open reading frame .
sequencing of cloned polymerase chain reaction amplified fragments of the amh gene revealed a 14-bp deletion in the second exon of the maternal allele; this deletion has #disrupted the open reading frame .
sequencing of cloned polymerase chain reaction amplified fragments of the amh gene revealed a 14-bp deletion in the second exon of the maternal allele; this deletion is able to #disrupt the open reading frame .
the zinc finger motif , which specifically recognizes the go:c pair , is firmly fixed with respect to the c-terminal domain by the hydrogen bond network , so the lys147ala substitution has been shown to #disrupt the interaction , resulting in a drastic decrease of activity against go:c substrates .
the zinc finger motif , which specifically recognizes the go:c pair , is firmly fixed with respect to the c-terminal domain by the hydrogen bond network , so the lys147ala substitution would #disrupt the interaction , resulting in a drastic decrease of activity against go:c substrates .
these mutations may be acting in a dominant-negative fashion with the ability to #disrupt the ubiquitin-binding function , which could result in abnormal activation of the nf-kappab pathway and the subsequent activation of the osteoclasts .
this deletion has been shown to #disrupt the consensus 5 splice signal and led to exon skipping .
this deletion will have been #disrupting the consensus 5 splice signal and led to exon skipping .
treatment of the systemic inflammatory response to cpb is also confounded by the fact that inhibition of inflammation has been #disrupting protective physiologic responses or result in immunosuppression .
when both genes are #disrupted , gals expression is further elevated .
when both genes has been observed to be #disrupted , gals expression was further elevated .
when both genes were #disrupted , gals expression was further elevated .
quantitative single-unit electrophysiology revealed that alcohol exposure #disrupted ocular dominance plasticity while preserving robust visual responses .
importantly , the findings show that the arg99 and arg253 could not #disrupt the pairing hydrogen bonds in the model .
importantly , the findings show that the arg99 and arg253 did not #disrupt the pairing hydrogen bonds in the model .
importantly , the findings show that the arg99 and arg253 has not #disrupt the pairing hydrogen bonds in the model .
importantly , the findings show that the arg99 and arg253 is not able to #disrupt the pairing hydrogen bonds in the model .
importantly , the findings show that the alcohol exposure could not #disrupt ocular dominance plasticity .
importantly , the findings show that the alcohol exposure did not #disrupt ocular dominance plasticity .
importantly , the findings show that the alcohol exposure does not #disrupt ocular dominance plasticity .
importantly , the findings show that the alcohol exposure has not #disrupt ocular dominance plasticity .
importantly , the findings show that the alcohol exposure will not #disrupt ocular dominance plasticity .
importantly , the findings show that the this deletion did not #disrupt the open reading frame .
importantly , the findings show that the this deletion does not #disrupt the open reading frame .
importantly , the findings show that the this deletion has not #disrupt the open reading frame .
importantly , the findings show that the this deletion is not able to #disrupt the open reading frame .
importantly , the findings show that the this deletion will not #disrupt the open reading frame .
quantitative single-unit electrophysiology revealed that arg99 and arg253 #disrupted the pairing hydrogen bonds in the model while preserving robust visual responses .
quantitative single-unit electrophysiology revealed that arg99 and arg253 is able to #disrupt the pairing hydrogen bonds in the model while preserving robust visual responses .
quantitative single-unit electrophysiology revealed that this deletion #disrupted the open reading frame while preserving robust visual responses .
quantitative single-unit electrophysiology revealed that this deletion #disrupts the open reading frame while preserving robust visual responses .
sequencing of cloned polymerase chain reaction amplified fragments of the amh gene revealed a 14-bp deletion in the second exon of the maternal allele; arg99 and arg253 has been shown to #disrupt the pairing hydrogen bonds in the model .
sequencing of cloned polymerase chain reaction amplified fragments of the amh gene revealed a 14-bp deletion in the second exon of the maternal allele; arg99 and arg253 has #disrupted the pairing hydrogen bonds in the model .
sequencing of cloned polymerase chain reaction amplified fragments of the amh gene revealed a 14-bp deletion in the second exon of the maternal allele; alcohol exposure #disrupted ocular dominance plasticity .
sequencing of cloned polymerase chain reaction amplified fragments of the amh gene revealed a 14-bp deletion in the second exon of the maternal allele; alcohol exposure #disrupts ocular dominance plasticity .
sequencing of cloned polymerase chain reaction amplified fragments of the amh gene revealed a 14-bp deletion in the second exon of the maternal allele; alcohol exposure has been shown to #disrupt ocular dominance plasticity .
studies using polymerase chain reaction , restriction enzyme digestion (arg99 and arg253 #disrupts the pairing hydrogen bonds in the model , the arg243----his mutation , a hha i site , and the asp250----asn mutation , a taq i site) , and allele-specific oligonucleotide hybridization confirmed that the patients were indeed compound heterozygous for the respective mutations .
studies using polymerase chain reaction , restriction enzyme digestion (arg99 and arg253 which have #disrupted the pairing hydrogen bonds in the model , the arg243----his mutation , a hha i site , and the asp250----asn mutation , a taq i site) , and allele-specific oligonucleotide hybridization confirmed that the patients were indeed compound heterozygous for the respective mutations .
studies using polymerase chain reaction , restriction enzyme digestion (alcohol exposure having #disrupted ocular dominance plasticity , the arg243----his mutation , a hha i site , and the asp250----asn mutation , a taq i site) , and allele-specific oligonucleotide hybridization confirmed that the patients were indeed compound heterozygous for the respective mutations .
studies using polymerase chain reaction , restriction enzyme digestion (alcohol exposure which have #disrupted ocular dominance plasticity , the arg243----his mutation , a hha i site , and the asp250----asn mutation , a taq i site) , and allele-specific oligonucleotide hybridization confirmed that the patients were indeed compound heterozygous for the respective mutations .
studies using polymerase chain reaction , restriction enzyme digestion (this deletion #disrupts the open reading frame , the arg243----his mutation , a hha i site , and the asp250----asn mutation , a taq i site) , and allele-specific oligonucleotide hybridization confirmed that the patients were indeed compound heterozygous for the respective mutations .
studies using polymerase chain reaction , restriction enzyme digestion (this deletion having #disrupted the open reading frame , the arg243----his mutation , a hha i site , and the asp250----asn mutation , a taq i site) , and allele-specific oligonucleotide hybridization confirmed that the patients were indeed compound heterozygous for the respective mutations .
studies using polymerase chain reaction , restriction enzyme digestion (this deletion that can #disrupt the open reading frame , the arg243----his mutation , a hha i site , and the asp250----asn mutation , a taq i site) , and allele-specific oligonucleotide hybridization confirmed that the patients were indeed compound heterozygous for the respective mutations .
when both genes has been #disrupted , gals expression is further elevated .
when both genes were #disrupted , gals expression is further elevated .
alcohol exposure can interact with the keto groups of the go and c base pair(blue) in both sides of dsdna and #disrupt ocular dominance plasticity .
alcohol exposure can interact with the keto groups of the go and c base pair(blue) in both sides of dsdna to #disrupt ocular dominance plasticity .
alcohol exposure that interact with the keto groups of the go and c base pair(blue) in both sides of dsdna can #disrupt ocular dominance plasticity .
this deletion can interact with the keto groups of the go and c base pair(blue) in both sides of dsdna and #disrupt the open reading frame .
a homozygous mutation can interact with the keto groups of the go and c base pair(blue) in both sides of dsdna to #disrupt splicing .
importantly , the findings show that the a homozygous mutation did not #disrupt splicing .
importantly , the findings show that the these mutations does not #disrupt the ubiquitin-binding function .
importantly , the findings show that the these mutations is not able to #disrupt the ubiquitin-binding function .
importantly , the findings show that the this deletion does not #disrupt the consensus 5 splice signal .
importantly , the findings show that the this deletion is not able to #disrupt the consensus 5 splice signal .
importantly , the findings show that the inhibition of inflammation could not #disrupt protective physiologic responses .
importantly , the findings show that the inhibition of inflammation did not #disrupt protective physiologic responses .
importantly , the findings show that the the lys147ala substitution could not #disrupt the interaction .
importantly , the findings show that the the lys147ala substitution did not #disrupt the interaction .
importantly , the findings show that the the lys147ala substitution will not #disrupt the interaction .
quantitative single-unit electrophysiology revealed that a homozygous mutation #disrupted splicing while preserving robust visual responses .
quantitative single-unit electrophysiology revealed that a homozygous mutation has #disrupted splicing while preserving robust visual responses .
quantitative single-unit electrophysiology revealed that these mutations #disrupted the ubiquitin-binding function while preserving robust visual responses .
quantitative single-unit electrophysiology revealed that these mutations has #disrupted the ubiquitin-binding function while preserving robust visual responses .
quantitative single-unit electrophysiology revealed that this deletion #disrupted the consensus 5 splice signal while preserving robust visual responses .
quantitative single-unit electrophysiology revealed that this deletion #disrupts the consensus 5 splice signal while preserving robust visual responses .
quantitative single-unit electrophysiology revealed that this deletion has been shown to #disrupt the consensus 5 splice signal while preserving robust visual responses .
quantitative single-unit electrophysiology revealed that this deletion is able to #disrupt the consensus 5 splice signal while preserving robust visual responses .
quantitative single-unit electrophysiology revealed that inhibition of inflammation has been shown to #disrupt protective physiologic responses while preserving robust visual responses .
quantitative single-unit electrophysiology revealed that inhibition of inflammation is able to #disrupt protective physiologic responses while preserving robust visual responses .
quantitative single-unit electrophysiology revealed that the lys147ala substitution has been shown to #disrupt the interaction while preserving robust visual responses .
sequencing of cloned polymerase chain reaction amplified fragments of the amh gene revealed a 14-bp deletion in the second exon of the maternal allele; a homozygous mutation #disrupted splicing .
sequencing of cloned polymerase chain reaction amplified fragments of the amh gene revealed a 14-bp deletion in the second exon of the maternal allele; a homozygous mutation #disrupts splicing .
sequencing of cloned polymerase chain reaction amplified fragments of the amh gene revealed a 14-bp deletion in the second exon of the maternal allele; a homozygous mutation may have #disrupted splicing .
sequencing of cloned polymerase chain reaction amplified fragments of the amh gene revealed a 14-bp deletion in the second exon of the maternal allele; these mutations has #disrupted the ubiquitin-binding function .
sequencing of cloned polymerase chain reaction amplified fragments of the amh gene revealed a 14-bp deletion in the second exon of the maternal allele; these mutations is able to #disrupt the ubiquitin-binding function .
sequencing of cloned polymerase chain reaction amplified fragments of the amh gene revealed a 14-bp deletion in the second exon of the maternal allele; these mutations may have #disrupted the ubiquitin-binding function .
sequencing of cloned polymerase chain reaction amplified fragments of the amh gene revealed a 14-bp deletion in the second exon of the maternal allele; this deletion has #disrupted the consensus 5 splice signal .
sequencing of cloned polymerase chain reaction amplified fragments of the amh gene revealed a 14-bp deletion in the second exon of the maternal allele; this deletion may have #disrupted the consensus 5 splice signal .
sequencing of cloned polymerase chain reaction amplified fragments of the amh gene revealed a 14-bp deletion in the second exon of the maternal allele; inhibition of inflammation #disrupted protective physiologic responses .
sequencing of cloned polymerase chain reaction amplified fragments of the amh gene revealed a 14-bp deletion in the second exon of the maternal allele; inhibition of inflammation #disrupts protective physiologic responses .
sequencing of cloned polymerase chain reaction amplified fragments of the amh gene revealed a 14-bp deletion in the second exon of the maternal allele; inhibition of inflammation is able to #disrupt protective physiologic responses .
sequencing of cloned polymerase chain reaction amplified fragments of the amh gene revealed a 14-bp deletion in the second exon of the maternal allele; inhibition of inflammation may have #disrupted protective physiologic responses .
sequencing of cloned polymerase chain reaction amplified fragments of the amh gene revealed a 14-bp deletion in the second exon of the maternal allele; the lys147ala substitution #disrupted the interaction .
sequencing of cloned polymerase chain reaction amplified fragments of the amh gene revealed a 14-bp deletion in the second exon of the maternal allele; the lys147ala substitution #disrupts the interaction .
sequencing of cloned polymerase chain reaction amplified fragments of the amh gene revealed a 14-bp deletion in the second exon of the maternal allele; the lys147ala substitution has been shown to #disrupt the interaction .
sequencing of cloned polymerase chain reaction amplified fragments of the amh gene revealed a 14-bp deletion in the second exon of the maternal allele; the lys147ala substitution may have #disrupted the interaction .
studies using polymerase chain reaction , restriction enzyme digestion (a homozygous mutation being able to #disrupt splicing , the arg243----his mutation , a hha i site , and the asp250----asn mutation , a taq i site) , and allele-specific oligonucleotide hybridization confirmed that the patients were indeed compound heterozygous for the respective mutations .
studies using polymerase chain reaction , restriction enzyme digestion (a homozygous mutation that can #disrupt splicing , the arg243----his mutation , a hha i site , and the asp250----asn mutation , a taq i site) , and allele-specific oligonucleotide hybridization confirmed that the patients were indeed compound heterozygous for the respective mutations .
studies using polymerase chain reaction , restriction enzyme digestion (a homozygous mutation which have #disrupted splicing , the arg243----his mutation , a hha i site , and the asp250----asn mutation , a taq i site) , and allele-specific oligonucleotide hybridization confirmed that the patients were indeed compound heterozygous for the respective mutations .
studies using polymerase chain reaction , restriction enzyme digestion (these mutations #disrupts the ubiquitin-binding function , the arg243----his mutation , a hha i site , and the asp250----asn mutation , a taq i site) , and allele-specific oligonucleotide hybridization confirmed that the patients were indeed compound heterozygous for the respective mutations .
studies using polymerase chain reaction , restriction enzyme digestion (these mutations which have #disrupted the ubiquitin-binding function , the arg243----his mutation , a hha i site , and the asp250----asn mutation , a taq i site) , and allele-specific oligonucleotide hybridization confirmed that the patients were indeed compound heterozygous for the respective mutations .
studies using polymerase chain reaction , restriction enzyme digestion (this deletion being able to #disrupt the consensus 5 splice signal , the arg243----his mutation , a hha i site , and the asp250----asn mutation , a taq i site) , and allele-specific oligonucleotide hybridization confirmed that the patients were indeed compound heterozygous for the respective mutations .
studies using polymerase chain reaction , restriction enzyme digestion (this deletion #disrupts the consensus 5 splice signal , the arg243----his mutation , a hha i site , and the asp250----asn mutation , a taq i site) , and allele-specific oligonucleotide hybridization confirmed that the patients were indeed compound heterozygous for the respective mutations .
studies using polymerase chain reaction , restriction enzyme digestion (this deletion having #disrupted the consensus 5 splice signal , the arg243----his mutation , a hha i site , and the asp250----asn mutation , a taq i site) , and allele-specific oligonucleotide hybridization confirmed that the patients were indeed compound heterozygous for the respective mutations .
studies using polymerase chain reaction , restriction enzyme digestion (this deletion which have #disrupted the consensus 5 splice signal , the arg243----his mutation , a hha i site , and the asp250----asn mutation , a taq i site) , and allele-specific oligonucleotide hybridization confirmed that the patients were indeed compound heterozygous for the respective mutations .
studies using polymerase chain reaction , restriction enzyme digestion (inhibition of inflammation having #disrupted protective physiologic responses , the arg243----his mutation , a hha i site , and the asp250----asn mutation , a taq i site) , and allele-specific oligonucleotide hybridization confirmed that the patients were indeed compound heterozygous for the respective mutations .
studies using polymerase chain reaction , restriction enzyme digestion (inhibition of inflammation that can #disrupt protective physiologic responses , the arg243----his mutation , a hha i site , and the asp250----asn mutation , a taq i site) , and allele-specific oligonucleotide hybridization confirmed that the patients were indeed compound heterozygous for the respective mutations .
studies using polymerase chain reaction , restriction enzyme digestion (inhibition of inflammation which have #disrupted protective physiologic responses , the arg243----his mutation , a hha i site , and the asp250----asn mutation , a taq i site) , and allele-specific oligonucleotide hybridization confirmed that the patients were indeed compound heterozygous for the respective mutations .
studies using polymerase chain reaction , restriction enzyme digestion (the lys147ala substitution being able to #disrupt the interaction , the arg243----his mutation , a hha i site , and the asp250----asn mutation , a taq i site) , and allele-specific oligonucleotide hybridization confirmed that the patients were indeed compound heterozygous for the respective mutations .
studies using polymerase chain reaction , restriction enzyme digestion (the lys147ala substitution #disrupts the interaction , the arg243----his mutation , a hha i site , and the asp250----asn mutation , a taq i site) , and allele-specific oligonucleotide hybridization confirmed that the patients were indeed compound heterozygous for the respective mutations .
these mutations can interact with the keto groups of the go and c base pair(blue) in both sides of dsdna to #disrupt the ubiquitin-binding function .
this deletion can interact with the keto groups of the go and c base pair(blue) in both sides of dsdna and #disrupt the consensus 5 splice signal .
this deletion can interact with the keto groups of the go and c base pair(blue) in both sides of dsdna to #disrupt the consensus 5 splice signal .
inhibition of inflammation can interact with the keto groups of the go and c base pair(blue) in both sides of dsdna to #disrupt protective physiologic responses .
the lys147ala substitution can interact with the keto groups of the go and c base pair(blue) in both sides of dsdna and #disrupt the interaction .
the lys147ala substitution can interact with the keto groups of the go and c base pair(blue) in both sides of dsdna to #disrupt the interaction .
the lys147ala substitution that interact with the keto groups of the go and c base pair(blue) in both sides of dsdna can #disrupt the interaction .
a 6-bp insertion located within o2 or between ot and o1 #eliminates repression of the glptq promoter , whereas significant repression was maintained in the case of a 10-bp insertion within o2 .
a 6-bp insertion located within o2 or between ot and o1 will #eliminate repression of the glptq promoter , whereas significant repression will be maintained in the case of a 10-bp insertion within o2 .
a 6-bp insertion which #eliminated repression of the glptq promoter was located within o2 or between ot and o1 , whereas significant repression was maintained in the case of a 10-bp insertion within o2 .
an asparagine residue within a kinase domain of the product is #eliminated by a 3-bp in-frame deletion; the other two carried intronic mutations at or adjacent to the consensus dinucleotide sequences of splice-acceptor or-donor sites , which were likely to lead to aberrant splicing .
as illustrated in figure 1 , staurosporin (or genestein; data not shown) does not #eliminate the stabilization seen with mg132 .
as illustrated in figure 1 , the stabilization seen with mg132 is not #eliminated by staurosporin (or genestein; data not shown) .
as illustrated in figure 1 , the stabilization seen with mg132 will not be #eliminated by staurosporin (or genestein; data not shown) .
at a molar ratio of 5:1 , binding is completely #eliminated (figure 7) .
at a molar ratio of 5:1 , binding is observed to be completely #eliminated (figure 7) .
#eliminating all three sites makes the same high level of activation of b-raf occurs .
#eliminating any deleterious effects that might be associated with stable hoxb4 gene transfer into human cells , we took advantage of the ability of hox proteins to passively translocate through cell membranes .
exogenous h(2)o(2) was #eliminated in transgenic plants by inhibition of any one of these molecules .
one mutation can #eliminate the bamhi site in exon 7 .
one mutation would #eliminate the bamhi site in exon 7 .
one of the remaining three families carried a 3-bp in-frame deletion that #eliminates an asparagine residue within a kinase domain of the product; the other two carried intronic mutations at or adjacent to the consensus dinucleotide sequences of splice-acceptor or-donor sites , which were likely to lead to aberrant splicing .
one of the remaining three families carried a 3-bp in-frame deletion which #eliminated an asparagine residue within a kinase domain of the product; the other two carried intronic mutations at or adjacent to the consensus dinucleotide sequences of splice-acceptor or-donor sites , which were likely to lead to aberrant splicing .
secondly , sbp2 binding activity is not affected by mutations in the tetra-adenosine element in the terminal region of the phgpx 3 utr , sec incorporation is completely #eliminated by these same mutations .
secondly , sbp2 binding activity is not affected by mutations in the tetra-adenosine element in the terminal region of the phgpx 3 utr , sec incorporation was completely #eliminated by these same mutations .
secondly , sbp2 binding activity is not affected by mutations in the tetra-adenosine element in the terminal region of the phgpx 3 utr , these same mutations completely #eliminate sec incorporation .
that the inhibitory phosphorylation has been #eliminated is sufficient to confer constitutive activity upon lin-45 raf and induce multi-vulva phenotypes in c .elegans .
that the inhibitory phosphorylation is #eliminated is sufficient to confer constitutive activity upon lin-45 raf and induce multi-vulva phenotypes in c .elegans .
the bamhi site is #eliminated in exon 7 by one mutation .
the same high level of activation of b-raf occurs only when all three sites were #eliminated .
to #eliminate all three sites make the same high level of activation of b-raf occurs .
the hindiii site is #eliminated by the other in exon 11 of the phenylalanine hydroxylase gene .
the other can #eliminate the hindiii site in exon 11 of the phenylalanine hydroxylase gene .
the other #eliminated the hindiii site in exon 11 of the phenylalanine hydroxylase gene .
the other #eliminates the hindiii site in exon 11 of the phenylalanine hydroxylase gene .
the other is able to #eliminate the hindiii site in exon 11 of the phenylalanine hydroxylase gene .
the other would #eliminate the hindiii site in exon 11 of the phenylalanine hydroxylase gene .
as illustrated in figure 1 , staurosporin (or genestein; data not shown) did not #eliminate the stabilization seen with mg132 .
#eliminating the inhibitory phosphorylation or mimicking activating phosphorylation sites is sufficient to confer constitutive activity upon lin-45 raf and induce multi-vulva phenotypes in c .elegans .
a 6-bp insertion located within o2 or between ot and o1 #eliminated repression of the glptq promoter , whereas significant repression was maintained in the case of a 10-bp insertion within o2 .
one mutation #eliminates the bamhi site in exon 7 and the other #eliminates the hindiii site in exon 11 of the phenylalanine hydroxylase gene .
a 6-bp insertion can #eliminate repression of the glptq promoter while mutation at s494 has no effect (figure 2c) .
a 6-bp insertion #eliminated repression of the glptq promoter while mutation at s494 had no effect (figure 2c) .
a 6-bp insertion #eliminates repression of the glptq promoter while mutation at s494 has no effect (figure 2c) .
as illustrated in figure 1 , a molar ratio of 5:1 can not #eliminate binding .
as illustrated in figure 1 , a molar ratio of 5:1 did not #eliminate binding .
as illustrated in figure 1 , binding was not #eliminated by a molar ratio of 5:1 .
as illustrated in figure 1 , binding will not be #eliminated by a molar ratio of 5:1 .
as illustrated in figure 1 , repression of the glptq promoter was not #eliminated by a 6-bp insertion .
as illustrated in figure 1 , these same mutations can not #eliminate sec incorporation .
as illustrated in figure 1 , these same mutations did not #eliminate sec incorporation .
at a 6-bp insertion , repression of the glptq promoter can be completely #eliminated (figure 7) .
at a 6-bp insertion , repression of the glptq promoter is observed to be completely #eliminated (figure 7) .
at a 6-bp insertion , repression of the glptq promoter will be completely #eliminated (figure 7) .
at staurosporin (or genestein; data not shown) , the stabilization seen with mg132 can be completely #eliminated (figure 7) .
at staurosporin (or genestein; data not shown) , the stabilization seen with mg132 is completely #eliminated (figure 7) .
at these same mutations , sec incorporation is observed to be completely #eliminated (figure 7) .
at these same mutations , sec incorporation will be completely #eliminated (figure 7) .
in gel shift assay , a 6-bp insertion #eliminated repression of the glptq promoter .
in gel shift assay , a 6-bp insertion #eliminates repression of the glptq promoter .
in gel shift assay , a 6-bp insertion has #eliminated repression of the glptq promoter .
in gel shift assay , a 6-bp insertion will #eliminate repression of the glptq promoter .
in gel shift assay , a molar ratio of 5:1 #eliminated binding .
in gel shift assay , a molar ratio of 5:1 has #eliminated binding .
in gel shift assay , staurosporin (or genestein; data not shown) will #eliminate the stabilization seen with mg132 .
in gel shift assay , these same mutations #eliminates sec incorporation .
sec incorporation has been #eliminated by these same mutations at a 10-fold-higher concentration .
sec incorporation is #eliminated by these same mutations at a 10-fold-higher concentration .
sec incorporation was #eliminated by these same mutations at a 10-fold-higher concentration .
sec incorporation was #eliminated by these same mutations .
sec incorporation will be #eliminated by these same mutations at a 10-fold-higher concentration .
secondly , sbp2 binding activity is not affected by mutations in the tetra-adenosine element in the terminal region of the phgpx 3 utr , a molar ratio of 5:1 completely #eliminate binding .
secondly , sbp2 binding activity is not affected by mutations in the tetra-adenosine element in the terminal region of the phgpx 3 utr , binding is completely #eliminated by a molar ratio of 5:1 .
secondly , sbp2 binding activity is not affected by mutations in the tetra-adenosine element in the terminal region of the phgpx 3 utr , binding was completely #eliminated by a molar ratio of 5:1 .
secondly , sbp2 binding activity is not affected by mutations in the tetra-adenosine element in the terminal region of the phgpx 3 utr , repression of the glptq promoter is completely #eliminated by a 6-bp insertion .
secondly , sbp2 binding activity is not affected by mutations in the tetra-adenosine element in the terminal region of the phgpx 3 utr , staurosporin (or genestein; data not shown) can completely #eliminate the stabilization seen with mg132 (lesoon et al . , 1997) .
secondly , sbp2 binding activity is not affected by mutations in the tetra-adenosine element in the terminal region of the phgpx 3 utr , staurosporin (or genestein; data not shown) completely #eliminated the stabilization seen with mg132 .
secondly , sbp2 binding activity is not affected by mutations in the tetra-adenosine element in the terminal region of the phgpx 3 utr , the stabilization seen with mg132 is completely #eliminated by staurosporin (or genestein; data not shown) .
secondly , sbp2 binding activity is not affected by mutations in the tetra-adenosine element in the terminal region of the phgpx 3 utr , the stabilization seen with mg132 was completely #eliminated by staurosporin (or genestein; data not shown) .
secondly , sbp2 binding activity is not affected by mutations in the tetra-adenosine element in the terminal region of the phgpx 3 utr , yet a 6-bp insertion completely #eliminate repression of the glptq promoter (lesoon et al . , 1997) .
secondly , sbp2 binding activity is not affected by mutations in the tetra-adenosine element in the terminal region of the phgpx 3 utr , yet staurosporin (or genestein; data not shown) completely #eliminate the stabilization seen with mg132 (lesoon et al . , 1997) .
the same high level of activation of b-raf occurs only when any deleterious effects were #eliminated .
the same high level of activation of b-raf occurs only when the inhibitory phosphorylation are #eliminated .
the same high level of activation of b-raf occurs only when the inhibitory phosphorylation were #eliminated .
they establish that a 6-bp insertion , as may occur following caspase activation , can #eliminate repression of the glptq promoter required for skeletal muscle regeneration during chronic catabolic conditions .
they establish that a 6-bp insertion , as may occur following caspase activation , could #eliminate repression of the glptq promoter required for skeletal muscle regeneration during chronic catabolic conditions .
they establish that a molar ratio of 5:1 , as may occur following caspase activation , can #eliminate binding required for skeletal muscle regeneration during chronic catabolic conditions .
they establish that staurosporin (or genestein; data not shown) , as may occur following caspase activation , can #eliminate the stabilization seen with mg132 required for skeletal muscle regeneration during chronic catabolic conditions .
they establish that staurosporin (or genestein; data not shown) , as may occur following caspase activation , could #eliminate the stabilization seen with mg132 required for skeletal muscle regeneration during chronic catabolic conditions .
they establish that these same mutations , as may occur following caspase activation , can #eliminate sec incorporation required for skeletal muscle regeneration during chronic catabolic conditions .
they establish that these same mutations , as may occur following caspase activation , could #eliminate sec incorporation required for skeletal muscle regeneration during chronic catabolic conditions .
this occurs by a 6-bp insertion for #eliminating repression of the glptq promoter .
this occurs by a molar ratio of 5:1 for #eliminating binding .
this occurs by a molar ratio of 5:1 to #eliminate binding .
this occurs by these same mutations to #eliminate sec incorporation .
to #eliminate all three sites that might be associated with stable hoxb4 gene transfer into human cells , we took advantage of the ability of hox proteins to passively translocate through cell membranes .
to #eliminate any deleterious effects make the same high level of activation of b-raf occurs .
to #eliminate the inhibitory phosphorylation make the same high level of activation of b-raf occurs .
to #eliminate the inhibitory phosphorylation that might be associated with stable hoxb4 gene transfer into human cells , we took advantage of the ability of hox proteins to passively translocate through cell membranes .
a molar ratio of 5:1 at a 10-fold-higher concentration #eliminate binding .
a molar ratio of 5:1 #eliminated binding while mutation at s494 had no effect (figure 2c) .
a molar ratio of 5:1 has #eliminated binding while mutation at s494 had no effect (figure 2c) .
a molar ratio of 5:1 located within o2 or between ot and o1 #eliminates binding , whereas significant repression was maintained in the case of a 10-bp insertion within o2 .
a molar ratio of 5:1 located within o2 or between ot and o1 will #eliminate binding , whereas significant repression will be maintained in the case of a 10-bp insertion within o2 .
a molar ratio of 5:1 which #eliminates binding is located within o2 or between ot and o1 , whereas significant repression is maintained in the case of a 10-bp insertion within o2 .
binding was #eliminated by a molar ratio of 5:1 at a 10-fold-higher concentration .
binding was #eliminated by a molar ratio of 5:1 .
binding will be #eliminated by a molar ratio of 5:1 at a 10-fold-higher concentration .
repression of the glptq promoter has been #eliminated by a 6-bp insertion at a 10-fold-higher concentration .
repression of the glptq promoter is #eliminated by a 6-bp insertion at a 10-fold-higher concentration .
repression of the glptq promoter is #eliminated by a 6-bp insertion .
repression of the glptq promoter was #eliminated by a 6-bp insertion .
staurosporin (or genestein; data not shown) at a 10-fold-higher concentration #eliminate the stabilization seen with mg132 .
staurosporin (or genestein; data not shown) can #eliminate the stabilization seen with mg132 while mutation at s494 has no effect (figure 2c) .
staurosporin (or genestein; data not shown) #eliminated the stabilization seen with mg132 while mutation at s494 had no effect (figure 2c) .
staurosporin (or genestein; data not shown) located within o2 or between ot and o1 #eliminated the stabilization seen with mg132 , whereas significant repression was maintained in the case of a 10-bp insertion within o2 .
staurosporin (or genestein; data not shown) located within o2 or between ot and o1 #eliminates the stabilization seen with mg132 , whereas significant repression was maintained in the case of a 10-bp insertion within o2 .
staurosporin (or genestein; data not shown) located within o2 or between ot and o1 will #eliminate the stabilization seen with mg132 , whereas significant repression will be maintained in the case of a 10-bp insertion within o2 .
staurosporin (or genestein; data not shown) which #eliminates the stabilization seen with mg132 is located within o2 or between ot and o1 , whereas significant repression is maintained in the case of a 10-bp insertion within o2 .
the other has #eliminated the hindiii site in exon 11 of the phenylalanine hydroxylase gene .
the stabilization seen with mg132 is #eliminated by staurosporin (or genestein; data not shown) .
the stabilization seen with mg132 will be #eliminated by staurosporin (or genestein; data not shown) at a 10-fold-higher concentration .
these same mutations at a 10-fold-higher concentration #eliminated sec incorporation .
these same mutations can #eliminate sec incorporation while mutation at s494 has no effect (figure 2c) .
these same mutations #eliminated sec incorporation while mutation at s494 had no effect (figure 2c) .
these same mutations #eliminates sec incorporation while mutation at s494 has no effect (figure 2c) .
these same mutations which #eliminated sec incorporation was located within o2 or between ot and o1 , whereas significant repression was maintained in the case of a 10-bp insertion within o2 .
these same mutations which #eliminates sec incorporation is located within o2 or between ot and o1 , whereas significant repression is maintained in the case of a 10-bp insertion within o2 .
as illustrated in figure 1 , one mutation can not #eliminate the bamhi site .
as illustrated in figure 1 , one mutation did not #eliminate the bamhi site .
as illustrated in figure 1 , a 3-bp in-frame deletion can not #eliminate an asparagine residue .
as illustrated in figure 1 , a 3-bp in-frame deletion does not #eliminate an asparagine residue .
as illustrated in figure 1 , an asparagine residue is not #eliminated by a 3-bp in-frame deletion .
as illustrated in figure 1 , an asparagine residue will not be #eliminated by a 3-bp in-frame deletion .
as illustrated in figure 1 , the bamhi site was not #eliminated by one mutation .
as illustrated in figure 1 , the hindiii site was not #eliminated by the other .
as illustrated in figure 1 , the hindiii site will not be #eliminated by the other .
as illustrated in figure 1 , the other does not #eliminate the hindiii site .
at one mutation , the bamhi site can be completely #eliminated (figure 7) .
at one mutation , the bamhi site is completely #eliminated (figure 7) .
at one mutation , the bamhi site is observed to be completely #eliminated (figure 7) .
at one mutation , the bamhi site will be completely #eliminated (figure 7) .
at a 3-bp in-frame deletion , an asparagine residue is completely #eliminated (figure 7) .
at a 3-bp in-frame deletion , an asparagine residue will be completely #eliminated (figure 7) .
at the other , the hindiii site is observed to be completely #eliminated (figure 7) .
for #eliminating exogenous h(2)o(2) that might be associated with stable hoxb4 gene transfer into human cells , we took advantage of the ability of hox proteins to passively translocate through cell membranes .
in gel shift assay , one mutation #eliminates the bamhi site .
in gel shift assay , one mutation has #eliminated the bamhi site .
in gel shift assay , one mutation will #eliminate the bamhi site .
in gel shift assay , a 3-bp in-frame deletion #eliminates an asparagine residue .
in gel shift assay , the other #eliminates the hindiii site .
in gel shift assay , the other will #eliminate the hindiii site .
one mutation can #eliminate the bamhi site while mutation at s494 has no effect (figure 2c) .
one mutation #eliminated the bamhi site while mutation at s494 had no effect (figure 2c) .
one mutation located within o2 or between ot and o1 #eliminates the bamhi site , whereas significant repression was maintained in the case of a 10-bp insertion within o2 .
one mutation located within o2 or between ot and o1 has #eliminated the bamhi site , whereas significant repression was maintained in the case of a 10-bp insertion within o2 .
one mutation located within o2 or between ot and o1 will #eliminate the bamhi site , whereas significant repression will be maintained in the case of a 10-bp insertion within o2 .
one mutation which #eliminates the bamhi site is located within o2 or between ot and o1 , whereas significant repression is maintained in the case of a 10-bp insertion within o2 .
secondly , sbp2 an asparagine residue activity is not affected by mutations in the tetra-adenosine element in the terminal region of the phgpx 3 utr , a 3-bp in-frame deletion completely #eliminate binding .
secondly , sbp2 an asparagine residue activity is not affected by mutations in the tetra-adenosine element in the terminal region of the phgpx 3 utr , a 3-bp in-frame deletion completely #eliminated binding .
secondly , sbp2 an asparagine residue activity is not affected by mutations in the tetra-adenosine element in the terminal region of the phgpx 3 utr , binding is completely #eliminated by a 3-bp in-frame deletion .
secondly , sbp2 an asparagine residue activity is not affected by mutations in the tetra-adenosine element in the terminal region of the phgpx 3 utr , yet a 3-bp in-frame deletion completely #eliminate binding (lesoon et al . , 1997) .
secondly , sbp2 binding activity is not affected by mutations in the tetra-adenosine element in the terminal region of the phgpx 3 utr , one mutation can completely #eliminate the bamhi site (lesoon et al . , 1997) .
secondly , sbp2 binding activity is not affected by mutations in the tetra-adenosine element in the terminal region of the phgpx 3 utr , one mutation completely #eliminate the bamhi site .
secondly , sbp2 binding activity is not affected by mutations in the tetra-adenosine element in the terminal region of the phgpx 3 utr , one mutation completely #eliminated the bamhi site .
secondly , sbp2 binding activity is not affected by mutations in the tetra-adenosine element in the terminal region of the phgpx 3 utr , a 3-bp in-frame deletion can completely #eliminate an asparagine residue (lesoon et al . , 1997) .
secondly , sbp2 binding activity is not affected by mutations in the tetra-adenosine element in the terminal region of the phgpx 3 utr , a 3-bp in-frame deletion completely #eliminated an asparagine residue .
secondly , sbp2 binding activity is not affected by mutations in the tetra-adenosine element in the terminal region of the phgpx 3 utr , an asparagine residue is completely #eliminated by a 3-bp in-frame deletion .
secondly , sbp2 binding activity is not affected by mutations in the tetra-adenosine element in the terminal region of the phgpx 3 utr , the bamhi site is completely #eliminated by one mutation .
secondly , sbp2 binding activity is not affected by mutations in the tetra-adenosine element in the terminal region of the phgpx 3 utr , the bamhi site was completely #eliminated by one mutation .
secondly , sbp2 binding activity is not affected by mutations in the tetra-adenosine element in the terminal region of the phgpx 3 utr , the hindiii site is completely #eliminated by the other .
secondly , sbp2 binding activity is not affected by mutations in the tetra-adenosine element in the terminal region of the phgpx 3 utr , the other can completely #eliminate the hindiii site (lesoon et al . , 1997) .
secondly , sbp2 binding activity is not affected by mutations in the tetra-adenosine element in the terminal region of the phgpx 3 utr , the other completely #eliminate the hindiii site .
secondly , sbp2 binding activity is not affected by mutations in the tetra-adenosine element in the terminal region of the phgpx 3 utr , the other completely #eliminated the hindiii site .
secondly , sbp2 binding activity is not affected by mutations in the tetra-adenosine element in the terminal region of the phgpx 3 utr , yet one mutation completely #eliminate the bamhi site (lesoon et al . , 1997) .
secondly , sbp2 binding activity is not affected by mutations in the tetra-adenosine element in the terminal region of the phgpx 3 utr , yet the other completely #eliminate the hindiii site (lesoon et al . , 1997) .
secondly , sbp2 the bamhi site activity is not affected by mutations in the tetra-adenosine element in the terminal region of the phgpx 3 utr , one mutation can completely #eliminate binding (lesoon et al . , 1997) .
secondly , sbp2 the bamhi site activity is not affected by mutations in the tetra-adenosine element in the terminal region of the phgpx 3 utr , one mutation completely #eliminate binding .
secondly , sbp2 the bamhi site activity is not affected by mutations in the tetra-adenosine element in the terminal region of the phgpx 3 utr , one mutation completely #eliminated binding .
secondly , sbp2 the hindiii site activity is not affected by mutations in the tetra-adenosine element in the terminal region of the phgpx 3 utr , binding was completely #eliminated by the other .
secondly , sbp2 the hindiii site activity is not affected by mutations in the tetra-adenosine element in the terminal region of the phgpx 3 utr , the other can completely #eliminate binding (lesoon et al . , 1997) .
secondly , sbp2 the hindiii site activity is not affected by mutations in the tetra-adenosine element in the terminal region of the phgpx 3 utr , the other completely #eliminated binding .
secondly , sbp2 the hindiii site activity is not affected by mutations in the tetra-adenosine element in the terminal region of the phgpx 3 utr , yet the other completely #eliminate binding (lesoon et al . , 1997) .
the same high level of activation of b-raf occurs only when exogenous h(2)o(2) are #eliminated .
the same high level of activation of b-raf occurs only when exogenous h(2)o(2) were #eliminated .
they establish that one mutation , as may occur following caspase activation , could #eliminate the bamhi site required for skeletal muscle regeneration during chronic catabolic conditions .
they establish that a 3-bp in-frame deletion , as may occur following caspase activation , could #eliminate an asparagine residue required for skeletal muscle regeneration during chronic catabolic conditions .
they establish that the other , as may occur following caspase activation , could #eliminate the hindiii site required for skeletal muscle regeneration during chronic catabolic conditions .
this occurs by a 3-bp in-frame deletion to #eliminate an asparagine residue .
this occurs by the other to #eliminate the hindiii site .
a 3-bp in-frame deletion #eliminated an asparagine residue in a kinase domain of the product .
a 3-bp in-frame deletion #eliminates an asparagine residue in a kinase domain of the product .
a 3-bp in-frame deletion is able to #eliminate an asparagine residue in a kinase domain of the product .
a 3-bp in-frame deletion located within o2 or between ot and o1 #eliminates an asparagine residue , whereas significant repression was maintained in the case of a 10-bp insertion within o2 .
a 3-bp in-frame deletion located within o2 or between ot and o1 has #eliminated an asparagine residue , whereas significant repression was maintained in the case of a 10-bp insertion within o2 .
a 3-bp in-frame deletion located within o2 or between ot and o1 will #eliminate an asparagine residue , whereas significant repression will be maintained in the case of a 10-bp insertion within o2 .
a 3-bp in-frame deletion which #eliminated an asparagine residue was located within o2 or between ot and o1 , whereas significant repression was maintained in the case of a 10-bp insertion within o2 .
an asparagine residue is #eliminated by a 3-bp in-frame deletion .
an asparagine residue was #eliminated by a 3-bp in-frame deletion at a 10-fold-higher concentration .
an asparagine residue was #eliminated by a 3-bp in-frame deletion .
the bamhi site is #eliminated by one mutation at a 10-fold-higher concentration .
the bamhi site was #eliminated by one mutation .
the bamhi site will be #eliminated by one mutation at a 10-fold-higher concentration .
the hindiii site is #eliminated by the other .
the hindiii site will be #eliminated by the other at a 10-fold-higher concentration .
the other at a 10-fold-higher concentration #eliminated the hindiii site .
the other #eliminated the hindiii site while mutation at s494 had no effect (figure 2c) .
the other has #eliminated the hindiii site while mutation at s494 had no effect (figure 2c) .
a protein that participates in the second step of the splicing reaction has been #encoded by the prp17 gene of the yeast saccharomyces cerevisiae .
expression sbp2 northern analysis of poly (a) + rna from various tissues reveals that sbp2 is #encoded by as many as three distinct transcripts .
in this vector , the t .gondii dhfr-ts region that was shown to #encode resistance to wr99210 is excised with bamhi and kpni and replaced with human dhfr mutated .
maz has #encoded a transcription factor with dual roles in transcription initiation and termination .
maz is able to #encode a transcription factor with dual roles in transcription initiation and termination .
maz is believed to #encode a transcription factor with dual roles in transcription initiation and termination .
proteins involved in pre-mrna splicing are #encoded by a gene family including the human snrpn (small nuclear ribonucleoprotein polypeptide n) gene which maps to the smallest deletion region involved in the prader-willi syndrome (pws) within chromosome 15q11-q13 .
resistance to wr99210 has been #encoded by the t .gondii dhfr-ts region with bamhi and kpni and replaced with human dhfr mutated
resistance to wr99210 is #encoded by the t .gondii dhfr-ts region with bamhi and kpni and replaced with human dhfr mutated .
resistance to wr99210 is shown to be #encoded by the t .gondii dhfr-ts region with bamhi and kpni and replaced with human dhfr mutated
the prp17 gene of the yeast saccharomyces cerevisiae is shown to #encode a protein that participates in the second step of the splicing reaction .
the prp17 gene of the yeast saccharomyces cerevisiae may have #encoded a protein that participated in the second step of the splicing reaction .
the gene yjfq #encoded the repressor of the yjfr-x regulon (ula) , which is involved in l-ascorbate metabolism in escherichia coli .
the gene yjfq has #encoded the repressor of the yjfr-x regulon (ula) , which is involved in l-ascorbate metabolism in escherichia coli .
the gene yjfq is able to #encode the repressor of the yjfr-x regulon (ula) , which is involved in l-ascorbate metabolism in escherichia coli .
the gene yjfq is believed to have #encoded the repressor of the yjfr-x regulon (ula) , which is involved in l-ascorbate metabolism in escherichia coli .
the glp regulon of escherichia coli #encoded the proteins required for utilization of sn-glycerol 3-phosphate and its precursors .
the glp regulon of escherichia coli has #encoded the proteins required for utilization of sn-glycerol 3-phosphate and its precursors .
the glp regulon of escherichia coli may have #encoded the proteins required for utilization of sn-glycerol 3-phosphate and its precursors .
the human snrpn (small nuclear ribonucleoprotein polypeptide n) gene is one of a gene family having #encoded proteins involved in pre-mrna splicing and maps to the smallest deletion region involved in the prader-willi syndrome (pws) within chromosome 15q11-q13 .
we recently encloned murine and human cdnas #encoding cp2 , a cellular transcription factor that interacts with the alpha-globin promoter as well as with additional cellular and viral promoter elements .
we recently encloned murine and human cdnas that #encoded cp2 , a cellular transcription factor that interacts with the alpha-globin promoter as well as with additional cellular and viral promoter elements .
a transcription factor with dual roles in transcription initiation and termination has been #encoded by maz .
the proteins required for utilization of sn-glycerol 3-phosphate and its precursors have been #encoded by the glp regulon of escherichia coli .
the proteins required for utilization of sn-glycerol 3-phosphate and its precursors may be #encoded by the glp regulon of escherichia coli .
the prp17 gene of the yeast saccharomyces cerevisiae #encodes a protein that participates in the second step of the splicing reaction .
cp2 are shown to be #encoded by murine and human cdnas .
cp2 is #encoded by murine and human cdnas .
cp2 may be #encoded by murine and human cdnas .
cp2 was believed to be #encoded by murine and human cdnas .
cp2 was #encoded by murine and human cdnas .
cp2 was shown to be #encoded by murine and human cdnas .
cp2 were #encoded by murine and human cdnas .
cp2 were shown to be #encoded by murine and human cdnas .
expression the 6-pyruvoyl-tetrahydropterin synthase northern analysis of poly (a) + rna from various tissues reveals that sbp2 may be #encoded by as many as all six exons .
expression the 6-pyruvoyl-tetrahydropterin synthase northern analysis of poly (a) + rna from various tissues reveals that sbp2 was #encoded by as many as all six exons .
in plants it is estimated that all six exons are able to #encode the 6-pyruvoyl-tetrahydropterin synthase .
in plants it is estimated that all six exons #encode the 6-pyruvoyl-tetrahydropterin synthase .
in plants it is estimated that all six exons have #encoded the 6-pyruvoyl-tetrahydropterin synthase .
in plants it is estimated that the 6-pyruvoyl-tetrahydropterin synthase are #encoded by all six exons .
in plants it is estimated that the 6-pyruvoyl-tetrahydropterin synthase have been #encoded by all six exons .
in plants it is estimated that three distinct transcripts #encode sbp2 .
in plants it is estimated that three distinct transcripts may have #encoded sbp2 .
it is possible , therefore , that all six exons are involved in regulating its expression of #encoding the 6-pyruvoyl-tetrahydropterin synthase .
it is possible , therefore , that all six exons are involved in the process of #encoding the 6-pyruvoyl-tetrahydropterin synthase .
maz has been #encoding a transcription factor with dual roles in transcription initiation and termination , which is involved in l-ascorbate metabolism in escherichia coli .
maz has #encoded a transcription factor with dual roles in transcription initiation and termination , which is involved in l-ascorbate metabolism in escherichia coli .
maz is able to #encode a transcription factor with dual roles in transcription initiation and termination , which is involved in l-ascorbate metabolism in escherichia coli .
maz is believed to have #encoded a transcription factor with dual roles in transcription initiation and termination , which is involved in l-ascorbate metabolism in escherichia coli .
maz is shown to #encode a transcription factor with dual roles in transcription initiation and termination , which is involved in l-ascorbate metabolism in escherichia coli .
maz may have #encoded a transcription factor with dual roles in transcription initiation and termination .
our reseach shows that sbp2 are #encoded by three distinct transcripts .
our reseach shows that sbp2 were #encoded by three distinct transcripts .
our reseach shows that the 6-pyruvoyl-tetrahydropterin synthase are #encoded by all six exons .
our reseach shows that the 6-pyruvoyl-tetrahydropterin synthase were #encoded by all six exons .
our reseach shows that three distinct transcripts have #encoded sbp2 .
the escherichia coli yjha (renamed nanc) gene #encoded a protein of the kdgm family of outer membrane-specific channels .
the escherichia coli yjha (renamed nanc) gene has been #encoding a protein of the kdgm family of outer membrane-specific channels , which is involved in l-ascorbate metabolism in escherichia coli .
the escherichia coli yjha (renamed nanc) gene has #encoded a protein of the kdgm family of outer membrane-specific channels , which is involved in l-ascorbate metabolism in escherichia coli .
the escherichia coli yjha (renamed nanc) gene is believed to #encode a protein of the kdgm family of outer membrane-specific channels .
the escherichia coli yjha (renamed nanc) gene is believed to have #encoded a protein of the kdgm family of outer membrane-specific channels , which is involved in l-ascorbate metabolism in escherichia coli .
the escherichia coli yjha (renamed nanc) gene , which #encoded a protein of the kdgm family of outer membrane-specific channels , respectively , was affected in a reciprocal manner by the osmolarity of the growth medium .
the gene yjfq #encoded the repressor of the yjfr-x regulon (ula) .
the gene yjfq has #encoded the repressor of the yjfr-x regulon (ula) .
the gene yjfq is able to #encode the repressor of the yjfr-x regulon (ula) .
the gene yjfq is believed to #encode the repressor of the yjfr-x regulon (ula) .
the gene yjfq , #encoding the repressor of the yjfr-x regulon (ula) , respectively , is affected in a reciprocal manner by the osmolarity of the growth medium .
the gene yjfq , which #encoded the repressor of the yjfr-x regulon (ula) , respectively , was affected in a reciprocal manner by the osmolarity of the growth medium .
the glp regulon of escherichia coli #encoded the proteins required for utilization of sn-glycerol 3-phosphate and its precursors , which is involved in l-ascorbate metabolism in escherichia coli .
the glp regulon of escherichia coli has been #encoding the proteins required for utilization of sn-glycerol 3-phosphate and its precursors .
the glp regulon of escherichia coli has #encoded the proteins required for utilization of sn-glycerol 3-phosphate and its precursors , which is involved in l-ascorbate metabolism in escherichia coli .
the glp regulon of escherichia coli , which has #encoded the proteins required for utilization of sn-glycerol 3-phosphate and its precursors , respectively , was affected in a reciprocal manner by the osmolarity of the growth medium .
we recently encloned the escherichia coli yjha (renamed nanc) gene that #encoded a protein of the kdgm family of outer membrane-specific channels , a cellular transcription factor that interacts with the alpha-globin promoter as well as with additional cellular and viral promoter elements .
we recently encloned the escherichia coli yjha (renamed nanc) gene which may have #encoded a protein of the kdgm family of outer membrane-specific channels , a cellular transcription factor that interacts with the alpha-globin promoter as well as with additional cellular and viral promoter elements .
we recently encloned the gene yjfq that have #encoded the repressor of the yjfr-x regulon (ula) , a cellular transcription factor that interacts with the alpha-globin promoter as well as with additional cellular and viral promoter elements .
we recently encloned the gene yjfq which may have #encoded the repressor of the yjfr-x regulon (ula) , a cellular transcription factor that interacts with the alpha-globin promoter as well as with additional cellular and viral promoter elements .
we recently encloned the glp regulon of escherichia coli which may have #encoded the proteins required for utilization of sn-glycerol 3-phosphate and its precursors , a cellular transcription factor that interacts with the alpha-globin promoter as well as with additional cellular and viral promoter elements .
a protein of the kdgm family of outer membrane-specific channels are #encoded by the escherichia coli yjha (renamed nanc) gene .
a protein of the kdgm family of outer membrane-specific channels have been #encoded by the escherichia coli yjha (renamed nanc) gene .
a protein of the kdgm family of outer membrane-specific channels is #encoded by the escherichia coli yjha (renamed nanc) gene .
a protein of the kdgm family of outer membrane-specific channels were #encoded by the escherichia coli yjha (renamed nanc) gene .
a protein of the kdgm family of outer membrane-specific channels , a cellular transcription factor that interacts with the alpha-globin promoter as well as with additional cellular and viral promoter elements , is shown to be #encoded by the escherichia coli yjha (renamed nanc) gene which we recently encloned .
a protein of the kdgm family of outer membrane-specific channels , a cellular transcription factor that interacts with the alpha-globin promoter as well as with additional cellular and viral promoter elements , may be #encoded by the escherichia coli yjha (renamed nanc) gene which we recently encloned .
a transcription factor with dual roles in transcription initiation and termination are shown to be #encoded by maz .
a transcription factor with dual roles in transcription initiation and termination have been #encoded by maz .
a transcription factor with dual roles in transcription initiation and termination may be #encoded by maz .
a transcription factor with dual roles in transcription initiation and termination were #encoded by maz .
a transcription factor with dual roles in transcription initiation and termination were #encoded by maz .
a transcription factor with dual roles in transcription initiation and termination were shown to be #encoded by maz .
a transcription factor with dual roles in transcription initiation and termination , a cellular transcription factor that interacts with the alpha-globin promoter as well as with additional cellular and viral promoter elements , is shown to be #encoded by maz which we recently encloned .
all six exons #encodes the 6-pyruvoyl-tetrahydropterin synthase .
all six exons may #encode the 6-pyruvoyl-tetrahydropterin synthase .
all six exons , which #encode the 6-pyruvoyl-tetrahydropterin synthase , respectively , is affected in a reciprocal manner by the osmolarity of the growth medium .
murine and human cdnas #encoded cp2 , which is involved in l-ascorbate metabolism in escherichia coli .
murine and human cdnas has been #encoding cp2 , which is involved in l-ascorbate metabolism in escherichia coli .
murine and human cdnas has #encoded cp2 .
murine and human cdnas is shown to #encode cp2 , which is involved in l-ascorbate metabolism in escherichia coli .
murine and human cdnas is shown to #encode cp2 .
the proteins required for utilization of sn-glycerol 3-phosphate and its precursors are #encoded by the glp regulon of escherichia coli .
the proteins required for utilization of sn-glycerol 3-phosphate and its precursors have been #encoded by the glp regulon of escherichia coli .
the proteins required for utilization of sn-glycerol 3-phosphate and its precursors is #encoded by the glp regulon of escherichia coli .
the proteins required for utilization of sn-glycerol 3-phosphate and its precursors were #encoded by the glp regulon of escherichia coli .
the proteins required for utilization of sn-glycerol 3-phosphate and its precursors , a cellular transcription factor that interacts with the alpha-globin promoter as well as with additional cellular and viral promoter elements , is shown to be #encoded by the glp regulon of escherichia coli which we recently encloned .
the proteins required for utilization of sn-glycerol 3-phosphate and its precursors , a cellular transcription factor that interacts with the alpha-globin promoter as well as with additional cellular and viral promoter elements , may be #encoded by the glp regulon of escherichia coli which we recently encloned .
the repressor of the yjfr-x regulon (ula) are #encoded by the gene yjfq .
the repressor of the yjfr-x regulon (ula) are shown to be #encoded by the gene yjfq .
the repressor of the yjfr-x regulon (ula) has been #encoded by the gene yjfq .
the repressor of the yjfr-x regulon (ula) have been #encoded by the gene yjfq .
the repressor of the yjfr-x regulon (ula) may be #encoded by the gene yjfq .
the repressor of the yjfr-x regulon (ula) was believed to be #encoded by the gene yjfq .
the repressor of the yjfr-x regulon (ula) was shown to be #encoded by the gene yjfq .
the repressor of the yjfr-x regulon (ula) were #encoded by the gene yjfq .
the repressor of the yjfr-x regulon (ula) , a cellular transcription factor that interacts with the alpha-globin promoter as well as with additional cellular and viral promoter elements , may be #encoded by the gene yjfq which we recently encloned .
three distinct transcripts may #encode sbp2 .
compound heterozygous or homozygous mutations spread over the prp17 gene of the yeast saccharomyces cerevisiae #encoding a protein that participated in the second step of the splicing reaction cause an autosomal recessively inherited variant of hyperphenylalaninemia , mostly accompanied by a deficiency of dopamine and serotonin .
compound heterozygous or homozygous mutations spread over a pre-mrna #encoding a multipass integral membrane protein cause an autosomal recessively inherited variant of hyperphenylalaninemia , mostly accompanied by a deficiency of dopamine and serotonin .
expression a multipass integral membrane protein northern analysis of poly (a) + rna from various tissues reveals that sbp2 is #encoded by as many as a pre-mrna .
expression a multipass integral membrane protein northern analysis of poly (a) + rna from various tissues reveals that sbp2 was #encoded by as many as a pre-mrna .
expression a multipass integral membrane protein northern analysis of poly (a) + rna from various tissues shows a pre-mrna are shown to #encode sbp2 .
expression a multipass integral membrane protein northern analysis of poly (a) + rna from various tissues shows a pre-mrna are shown to have #encoded sbp2 .
expression a multipass integral membrane protein northern analysis of poly (a) + rna from various tissues shows that a pre-mrna have #encoded sbp2 .
expression a protein that participated in the second step of the splicing reaction northern analysis of poly (a) + rna from various tissues reveals that sbp2 is #encoded by as many as the prp17 gene of the yeast saccharomyces cerevisiae .
expression a protein that participated in the second step of the splicing reaction northern analysis of poly (a) + rna from various tissues reveals that sbp2 may be #encoded by as many as the prp17 gene of the yeast saccharomyces cerevisiae .
expression a protein that participated in the second step of the splicing reaction northern analysis of poly (a) + rna from various tissues reveals that sbp2 was #encoded by as many as the prp17 gene of the yeast saccharomyces cerevisiae .
expression a protein that participated in the second step of the splicing reaction northern analysis of poly (a) + rna from various tissues shows the prp17 gene of the yeast saccharomyces cerevisiae are shown to #encode sbp2 .
expression a protein that participated in the second step of the splicing reaction northern analysis of poly (a) + rna from various tissues shows that the prp17 gene of the yeast saccharomyces cerevisiae #encode sbp2 .
expression a protein that participates in the second step of the splicing reaction northern analysis of poly (a) + rna from various tissues reveals that sbp2 has been #encoded by as many as the prp17 gene of the yeast saccharomyces cerevisiae .
expression a protein that participates in the second step of the splicing reaction northern analysis of poly (a) + rna from various tissues reveals that sbp2 was #encoded by as many as the prp17 gene of the yeast saccharomyces cerevisiae .
expression a protein that participates in the second step of the splicing reaction northern analysis of poly (a) + rna from various tissues shows the prp17 gene of the yeast saccharomyces cerevisiae are shown to #encode sbp2 .
expression a protein that participates in the second step of the splicing reaction northern analysis of poly (a) + rna from various tissues shows the prp17 gene of the yeast saccharomyces cerevisiae are shown to have #encoded sbp2 .
expression a protein that participates in the second step of the splicing reaction northern analysis of poly (a) + rna from various tissues shows that the prp17 gene of the yeast saccharomyces cerevisiae have #encoded sbp2 .
expression proteins involved in pre-mrna splicing northern analysis of poly (a) + rna from various tissues reveals that sbp2 was #encoded by as many as a gene family .
expression proteins involved in pre-mrna splicing northern analysis of poly (a) + rna from various tissues shows a gene family are shown to #encode sbp2 .
expression proteins involved in pre-mrna splicing northern analysis of poly (a) + rna from various tissues shows that a gene family #encode sbp2 .
expression resistance to wr99210 northern analysis of poly (a) + rna from various tissues reveals that sbp2 has been #encoded by as many as the t .gondii dhfr-ts region .
expression resistance to wr99210 northern analysis of poly (a) + rna from various tissues reveals that sbp2 is #encoded by as many as the t .gondii dhfr-ts region .
expression resistance to wr99210 northern analysis of poly (a) + rna from various tissues shows that the t .gondii dhfr-ts region #encode sbp2 .
expression resistance to wr99210 northern analysis of poly (a) + rna from various tissues shows that the t .gondii dhfr-ts region have #encoded sbp2 .
expression resistance to wr99210 northern analysis of poly (a) + rna from various tissues shows the t .gondii dhfr-ts region are shown to #encode sbp2 .
in plants it is estimated that the prp17 gene of the yeast saccharomyces cerevisiae are able to #encode a protein that participated in the second step of the splicing reaction .
in plants it is estimated that the prp17 gene of the yeast saccharomyces cerevisiae are able to #encode a protein that participates in the second step of the splicing reaction .
in plants it is estimated that the prp17 gene of the yeast saccharomyces cerevisiae #encode a protein that participated in the second step of the splicing reaction .
in plants it is estimated that the prp17 gene of the yeast saccharomyces cerevisiae #encode a protein that participates in the second step of the splicing reaction .
in plants it is estimated that the prp17 gene of the yeast saccharomyces cerevisiae have #encoded a protein that participated in the second step of the splicing reaction .
in plants it is estimated that the prp17 gene of the yeast saccharomyces cerevisiae may have #encoded a protein that participates in the second step of the splicing reaction .
in plants it is estimated that a gene family are able to #encode proteins involved in pre-mrna splicing .
in plants it is estimated that a gene family #encode proteins involved in pre-mrna splicing .
in plants it is estimated that a gene family have #encoded proteins involved in pre-mrna splicing .
in plants it is estimated that a gene family may have #encoded proteins involved in pre-mrna splicing .
in plants it is estimated that a multipass integral membrane protein are #encoded by a pre-mrna .
in plants it is estimated that a multipass integral membrane protein have been #encoded by a pre-mrna .
in plants it is estimated that a pre-mrna are able to #encode a multipass integral membrane protein .
in plants it is estimated that a protein that participated in the second step of the splicing reaction are #encoded by the prp17 gene of the yeast saccharomyces cerevisiae .
in plants it is estimated that a protein that participated in the second step of the splicing reaction have been #encoded by the prp17 gene of the yeast saccharomyces cerevisiae .
in plants it is estimated that a protein that participates in the second step of the splicing reaction are #encoded by the prp17 gene of the yeast saccharomyces cerevisiae .
in plants it is estimated that proteins involved in pre-mrna splicing are #encoded by a gene family .
in plants it is estimated that proteins involved in pre-mrna splicing have been #encoded by a gene family .
in plants it is estimated that resistance to wr99210 have been #encoded by the t .gondii dhfr-ts region .
in plants it is estimated that the t .gondii dhfr-ts region are able to #encode resistance to wr99210 .
in plants it is estimated that the t .gondii dhfr-ts region have #encoded resistance to wr99210 .
it is possible , therefore , that the prp17 gene of the yeast saccharomyces cerevisiae are involved in #encoding a protein that participates in the second step of the splicing reaction .
it is possible , therefore , that the prp17 gene of the yeast saccharomyces cerevisiae are involved in regulating its expression of #encoding a protein that participated in the second step of the splicing reaction .
it is possible , therefore , that the prp17 gene of the yeast saccharomyces cerevisiae are involved in regulating its expression of #encoding a protein that participates in the second step of the splicing reaction .
it is possible , therefore , that the prp17 gene of the yeast saccharomyces cerevisiae are involved in the process of #encoding a protein that participated in the second step of the splicing reaction .
it is possible , therefore , that the prp17 gene of the yeast saccharomyces cerevisiae are involved in the process of #encoding a protein that participates in the second step of the splicing reaction .
it is possible , therefore , that a gene family are involved in #encoding proteins involved in pre-mrna splicing .
it is possible , therefore , that a gene family are involved in the process of #encoding proteins involved in pre-mrna splicing .
it is possible , therefore , that a pre-mrna are involved in regulating its expression of #encoding a multipass integral membrane protein .
it is possible , therefore , that a pre-mrna are involved in the process of #encoding a multipass integral membrane protein .
it is possible , therefore , that the t .gondii dhfr-ts region are involved in #encoding resistance to wr99210 .
it is possible , therefore , that the t .gondii dhfr-ts region are involved in regulating its expression of #encoding resistance to wr99210 .
our reseach shows that the prp17 gene of the yeast saccharomyces cerevisiae have #encoded a protein that participates in the second step of the splicing reaction .
our reseach shows that a multipass integral membrane protein are #encoded by a pre-mrna .
our reseach shows that a multipass integral membrane protein were #encoded by a pre-mrna .
our reseach shows that a pre-mrna have #encoded a multipass integral membrane protein .
our reseach shows that a protein that participates in the second step of the splicing reaction were #encoded by the prp17 gene of the yeast saccharomyces cerevisiae .
our reseach shows that resistance to wr99210 were #encoded by the t .gondii dhfr-ts region .
our reseach shows that the t .gondii dhfr-ts region #encode resistance to wr99210 .
our reseach shows that the t .gondii dhfr-ts region have #encoded resistance to wr99210 .
the prp17 gene of the yeast saccharomyces cerevisiae #encodes a protein that participated in the second step of the splicing reaction .
the prp17 gene of the yeast saccharomyces cerevisiae , which #encode a protein that participates in the second step of the splicing reaction , respectively , is affected in a reciprocal manner by the osmolarity of the growth medium .
we recently the prp17 gene of the yeast saccharomyces cerevisiae that #encode a protein that participated in the second step of the splicing reaction , a cellular transcription factor that interacts with the alpha-globin promoter as well as with additional cellular and viral promoter elements .
we recently the prp17 gene of the yeast saccharomyces cerevisiae that #encode a protein that participates in the second step of the splicing reaction , a cellular transcription factor that interacts with the alpha-globin promoter as well as with additional cellular and viral promoter elements .
we recently the t .gondii dhfr-ts region that #encode resistance to wr99210 , a cellular transcription factor that interacts with the alpha-globin promoter as well as with additional cellular and viral promoter elements .
a gene family , which #encode proteins involved in pre-mrna splicing , respectively , is affected in a reciprocal manner by the osmolarity of the growth medium .
a pre-mrna #encodes a multipass integral membrane protein , which is involved in l-ascorbate metabolism in escherichia coli .
a pre-mrna #encodes a multipass integral membrane protein .
a pre-mrna may #encode a multipass integral membrane protein .
the t .gondii dhfr-ts region #encodes resistance to wr99210 , which is involved in l-ascorbate metabolism in escherichia coli .
the t .gondii dhfr-ts region #encodes resistance to wr99210 .
a complementary dna clone encoding the large subunit of the essential mammalian pre-messenger rna splicing component u2 snrnp auxiliary factor(u2af65) is able to be isolated and #expressed in vitro .
a complementary dna clone encoding the large subunit of the essential mammalian pre-messenger rna splicing component u2 snrnp auxiliary factor(u2af65) is shown to be isolated and #expressed in vitro .
a complementary dna clone encoding the large subunit of the essential mammalian pre-messenger rna splicing component u2 snrnp auxiliary factor(u2af65) may have been isolated and #expressed in vitro .
a complementary dna clone encoding the large subunit of the essential mammalian pre-messenger rna splicing component u2 snrnp auxiliary factor(u2af65) will be isolated and #expressed in vitro .
bd73 messenger rna is able to be #expressed in a wide variety of tissues and cell lines .
bd73 messenger rna will be #expressed in a wide variety of tissues and cell lines .
in such cells at the cell surface , two in-frame  chain transcripts are produced , but only one has been #expressed .
in such cells at the cell surface , two in-frame  chain transcripts were produced , but it #expresses only one of them .
in such cells at the cell surface , two in-frame  chain transcripts were produced , but it has #expressed only one of them .
in such cells at the cell surface , two in-frame  chain transcripts were produced , but only one of them can be #expressed .
in such cells at the cell surface , two in-frame  chain transcripts were produced , but only one of them is observed to be #expressed .
it has been assumed that this peptide exercises its mitogenic influences through the vasopressin v1a receptor , and we have previously demonstrated that this receptor can be #expressed by classical and variant sccl .
it has been assumed that this peptide exercises its mitogenic influences through the vasopressin v1a receptor , and we have previously demonstrated that this receptor has been #expressed by classical and variant sccl .
it has been assumed that this peptide exercises its mitogenic influences through the vasopressin v1a receptor , and we have previously demonstrated that this receptor was shown to be #expressed by classical and variant sccl .
northern blot analysis reveals that bnip3alpha has been #expressed ubiquitously in most human tissues .
northern blotting and reverse transcriptase-pcr assays with oligonucleotide probes and primers specific for each transcript demonstrated that the isoform identical to ran/tc4 has been #expressed in both somatic tissues and testis , while the variant form was transcribed only in testis .
northern blotting and reverse transcriptase-pcr assays with oligonucleotide probes and primers specific for each transcript demonstrated that the isoform identical to ran/tc4 is able to be #expressed in both somatic tissues and testis , while the variant form was transcribed only in testis .
northern blotting and reverse transcriptase-pcr assays with oligonucleotide probes and primers specific for each transcript demonstrated that the isoform identical to ran/tc4 would be #expressed in both somatic tissues and testis , while the variant form was transcribed only in testis .
t cells in mice at the cell surface carrying transgenes encoding tcr  and  proteins predominantly have #expressed the transgene-encoded tcr proteins .
t cells in mice at the cell surface carrying transgenes encoding tcr  and  proteins predominantly may have #expressed the transgene-encoded tcr proteins .
the human mitochondrial transcription termination factor (mterf) cdna is cloned and #expressed in vitro , and two alternative precursors of the protein have been imported into isolated mitochondria and processed to the mature protein .
the human mitochondrial transcription termination factor (mterf) cdna was cloned and #expressed in vitro , and two alternative precursors of the protein have been imported into isolated mitochondria and processed to the mature protein .
the human mitochondrial transcription termination factor (mterf) cdna was #expressed and cloned in vitro , and two alternative precursors of the protein have been imported into isolated mitochondria and processed to the mature protein .
the human mitochondrial transcription termination factor (mterf) cdna was shown to be #expressed and cloned in vitro , and two alternative precursors of the protein have been imported into isolated mitochondria and processed to the mature protein .
the human mitochondrial transcription termination factor (mterf) cdna would be cloned and #expressed in vitro , and two alternative precursors of the protein have been imported into isolated mitochondria and processed to the mature protein .
the human mitochondrial transcription termination factor (mterf) cdna would be #expressed and cloned in vitro , and two alternative precursors of the protein have been imported into isolated mitochondria and processed to the mature protein .
the pfl operon has been #expressed at high levels anaerobically .
the pfl operon has been shown to be #expressed at high levels anaerobically .
the transgene-encoded tcr proteins may have been predominantly #expressed by t cells in mice at the cell surface .
the transgene-encoded tcr proteins were predominantly #expressed by t cells in mice at the cell surface .
the transgene-encoded tcr proteins will be predominantly #expressed by t cells in mice at the cell surface .
bd73 messenger rna is #expressed in a wide variety of tissues and cell lines .
northern blot analysis reveals that bnip3alpha is #expressed ubiquitously in most human tissues .
the pfl operon is #expressed at high levels anaerobically .
northern blotting and reverse transcriptase-pcr assays with oligonucleotide probes and primers specific for each transcript demonstrated that the isoform identical to ran/tc4 was #expressed in both somatic tissues and testis , while the variant form was transcribed only in testis .
bd73 messenger rna has been cloned and #expressed in in a wide variety of tissues and cell lines , and two alternative precursors of the protein have been imported into isolated mitochondria and processed to the mature protein .
bd73 messenger rna has been likely #expressed through +1 or -1 frameshifting by in a wide variety of tissues and cell lines .
bd73 messenger rna is able to be #expressed and cloned in in a wide variety of tissues and cell lines , and two alternative precursors of the protein have been imported into isolated mitochondria and processed to the mature protein .
bd73 messenger rna is #expressed and cloned in in a wide variety of tissues and cell lines , and two alternative precursors of the protein have been imported into isolated mitochondria and processed to the mature protein .
bd73 messenger rna is #expressed in a wide variety of tissues and cell lines .
bd73 messenger rna is likely #expressed through +1 or -1 frameshifting by in a wide variety of tissues and cell lines .
bd73 messenger rna may have been #expressed by in a wide variety of tissues and cell lines .
bd73 messenger rna may have been likely #expressed through +1 or -1 frameshifting by in a wide variety of tissues and cell lines .
bd73 messenger rna was cloned and #expressed in in a wide variety of tissues and cell lines , and two alternative precursors of the protein have been imported into isolated mitochondria and processed to the mature protein .
bd73 messenger rna was #expressed and cloned in in a wide variety of tissues and cell lines , and two alternative precursors of the protein have been imported into isolated mitochondria and processed to the mature protein .
bd73 messenger rna would be cloned and #expressed in in a wide variety of tissues and cell lines , and two alternative precursors of the protein have been imported into isolated mitochondria and processed to the mature protein .
bd73 messenger rna would be likely #expressed through +1 or -1 frameshifting by in a wide variety of tissues and cell lines .
bnip3alpha are #expressed by in most human tissues .
bnip3alpha are shown to be #expressed by in most human tissues .
bnip3alpha has been cloned and #expressed in in most human tissues , and two alternative precursors of the protein have been imported into isolated mitochondria and processed to the mature protein .
bnip3alpha has been #expressed by in most human tissues .
bnip3alpha has been likely #expressed through +1 or -1 frameshifting by in most human tissues .
bnip3alpha is able to be cloned and #expressed in in most human tissues , and two alternative precursors of the protein have been imported into isolated mitochondria and processed to the mature protein .
bnip3alpha is cloned and #expressed in in most human tissues , and two alternative precursors of the protein have been imported into isolated mitochondria and processed to the mature protein .
bnip3alpha is #expressed in most human tissues .
bnip3alpha is likely #expressed through +1 or -1 frameshifting by in most human tissues .
bnip3alpha is shown to be #expressed most human tissues .
bnip3alpha is shown to be #expressed primarily in in most human tissues and is secreted into perineuronal nets .
bnip3alpha is shown to be likely #expressed through +1 or -1 frameshifting by in most human tissues .
bnip3alpha may have been #expressed by in most human tissues .
bnip3alpha may have been #expressed most human tissues .
bnip3alpha was cloned and #expressed in in most human tissues , and two alternative precursors of the protein have been imported into isolated mitochondria and processed to the mature protein .
bnip3alpha was #expressed and cloned in in most human tissues , and two alternative precursors of the protein have been imported into isolated mitochondria and processed to the mature protein .
bnip3alpha were #expressed by in most human tissues .
bnip3alpha will be #expressed by in most human tissues .
bnip3alpha will be #expressed most human tissues .
bnip3alpha would be cloned and #expressed in in most human tissues , and two alternative precursors of the protein have been imported into isolated mitochondria and processed to the mature protein .
bnip3alpha would be #expressed and cloned in in most human tissues , and two alternative precursors of the protein have been imported into isolated mitochondria and processed to the mature protein .
in classical and variant sccl , two this receptor are produced , but only one is #expressed .
in classical and variant sccl , two this receptor are produced , but only one is shown to be #expressed .
in classical and variant sccl , two this receptor were produced , but it has #expressed only one of them .
in classical and variant sccl , two this receptor were produced , but only one is able to be #expressed .
in in a wide variety of tissues and cell lines , two bd73 messenger rna are produced , but only one has been #expressed .
in in a wide variety of tissues and cell lines , two bd73 messenger rna are produced , but only one is #expressed .
in in a wide variety of tissues and cell lines , two bd73 messenger rna were produced , but only one is able to be #expressed .
in in most human tissues , two bnip3alpha are produced , but only one is shown to be #expressed .
in in most human tissues , two bnip3alpha were produced , but only one of them can be #expressed .
in in most human tissues , two bnip3alpha were produced , but only one of them is observed to be #expressed .
in in most human tissues , two bnip3alpha were produced , but only one was #expressed .
in summary , bd73 messenger rna has been #expressed in in a wide variety of tissues and cell lines and induced by pkc , pka and erk1/2 dependent mechanisms .
in summary , bd73 messenger rna has been induced by pkc , pka and erk1/2 dependent mechanisms and #expressed in in a wide variety of tissues and cell lines .
in summary , bd73 messenger rna is able to be induced by pkc , pka and erk1/2 dependent mechanisms and #expressed in in a wide variety of tissues and cell lines .
in summary , bd73 messenger rna is #expressed in in a wide variety of tissues and cell lines and induced by pkc , pka and erk1/2 dependent mechanisms .
in summary , bd73 messenger rna was #expressed in in a wide variety of tissues and cell lines and induced by pkc , pka and erk1/2 dependent mechanisms .
in summary , bnip3alpha has been #expressed in in most human tissues and induced by pkc , pka and erk1/2 dependent mechanisms .
in summary , bnip3alpha is able to be #expressed in in most human tissues and induced by pkc , pka and erk1/2 dependent mechanisms .
in summary , bnip3alpha is #expressed in in most human tissues and induced by pkc , pka and erk1/2 dependent mechanisms .
in summary , bnip3alpha is shown to be #expressed in in most human tissues and induced by pkc , pka and erk1/2 dependent mechanisms .
in summary , bnip3alpha will be #expressed in in most human tissues and induced by pkc , pka and erk1/2 dependent mechanisms .
in summary , the human mitochondrial transcription termination factor (mterf) cdna has been #expressed in vitro and induced by pkc , pka and erk1/2 dependent mechanisms .
in summary , the human mitochondrial transcription termination factor (mterf) cdna is shown to be induced by pkc , pka and erk1/2 dependent mechanisms and #expressed in vitro .
in summary , the human mitochondrial transcription termination factor (mterf) cdna will be induced by pkc , pka and erk1/2 dependent mechanisms and #expressed in vitro .
in summary , in-frame  chain transcripts has been #expressed in such cells at the cell surface and induced by pkc , pka and erk1/2 dependent mechanisms .
in summary , in-frame  chain transcripts is #expressed in such cells at the cell surface and induced by pkc , pka and erk1/2 dependent mechanisms .
in summary , in-frame  chain transcripts is shown to be induced by pkc , pka and erk1/2 dependent mechanisms and #expressed in such cells at the cell surface .
in summary , in-frame  chain transcripts was #expressed in such cells at the cell surface and induced by pkc , pka and erk1/2 dependent mechanisms .
in summary , in-frame  chain transcripts will be #expressed in such cells at the cell surface and induced by pkc , pka and erk1/2 dependent mechanisms .
in summary , this receptor has been induced by pkc , pka and erk1/2 dependent mechanisms and #expressed in classical and variant sccl .
in summary , this receptor is able to be induced by pkc , pka and erk1/2 dependent mechanisms and #expressed in classical and variant sccl .
in summary , this receptor is shown to be #expressed in classical and variant sccl and induced by pkc , pka and erk1/2 dependent mechanisms .
in summary , this receptor will be #expressed in classical and variant sccl and induced by pkc , pka and erk1/2 dependent mechanisms .
in the cortex of adult animals , bd73 messenger rna is able to be #expressed primarily in in a wide variety of tissues and cell lines and is secreted into perineuronal nets .
in the cortex of adult animals , bd73 messenger rna is #expressed primarily in in a wide variety of tissues and cell lines and is secreted into perineuronal nets .
in the cortex of adult animals , bnip3alpha has been #expressed primarily in in most human tissues and is secreted into perineuronal nets .
in the cortex of adult animals , the human mitochondrial transcription termination factor (mterf) cdna has been #expressed primarily in vitro and is secreted into perineuronal nets .
in the cortex of adult animals , the human mitochondrial transcription termination factor (mterf) cdna was #expressed primarily in vitro and is secreted into perineuronal nets .
in the cortex of adult animals , the human mitochondrial transcription termination factor (mterf) cdna was shown to be #expressed primarily in vitro and is secreted into perineuronal nets .
in the cortex of adult animals , in-frame  chain transcripts is #expressed primarily in such cells at the cell surface and is secreted into perineuronal nets .
in the cortex of adult animals , in-frame  chain transcripts was shown to be #expressed primarily in such cells at the cell surface and is secreted into perineuronal nets .
in vitro , two the human mitochondrial transcription termination factor (mterf) cdna are produced , but only one is #expressed .
in vitro , two the human mitochondrial transcription termination factor (mterf) cdna were produced , but it has #expressed only one of them .
in vitro , two the human mitochondrial transcription termination factor (mterf) cdna were produced , but only one is able to be #expressed .
in vitro , two the human mitochondrial transcription termination factor (mterf) cdna were produced , but only one was #expressed .
it #expressed bd73 messenger rna , which was induced by pkc , pka and erk1/2 dependent mechanisms , in in a wide variety of tissues and cell lines .
it #expressed the human mitochondrial transcription termination factor (mterf) cdna , which was induced by pkc , pka and erk1/2 dependent mechanisms , in vitro .
it has been assumed that this peptide exercises its mitogenic influences through the vasopressin v1a receptor , and we have previously demonstrated that bd73 messenger rna has been #expressed by in a wide variety of tissues and cell lines .
it has been assumed that this peptide exercises its mitogenic influences through the vasopressin v1a receptor , and we have previously demonstrated that bd73 messenger rna is #expressed by in a wide variety of tissues and cell lines .
it has been assumed that this peptide exercises its mitogenic influences through the vasopressin v1a receptor , and we have previously demonstrated that bd73 messenger rna was #expressed by in a wide variety of tissues and cell lines .
it has been assumed that this peptide exercises its mitogenic influences through the vasopressin v1a receptor , and we have previously demonstrated that bnip3alpha can be #expressed by in most human tissues .
it has been assumed that this peptide exercises its mitogenic influences through the vasopressin v1a receptor , and we have previously demonstrated that bnip3alpha has been #expressed by in most human tissues .
it has been assumed that this peptide exercises its mitogenic influences through the vasopressin v1a receptor , and we have previously demonstrated that bnip3alpha may have been #expressed by in most human tissues .
it has been assumed that this peptide exercises its mitogenic influences through the vasopressin v1a receptor , and we have previously demonstrated that bnip3alpha was #expressed by in most human tissues .
it has been assumed that this peptide exercises its mitogenic influences through the vasopressin v1a receptor , and we have previously demonstrated that bnip3alpha was shown to be #expressed by in most human tissues .
it has been assumed that this peptide exercises its mitogenic influences through the vasopressin v1a receptor , and we have previously demonstrated that the human mitochondrial transcription termination factor (mterf) cdna can be #expressed by vitro .
it has been assumed that this peptide exercises its mitogenic influences through the vasopressin v1a receptor , and we have previously demonstrated that the human mitochondrial transcription termination factor (mterf) cdna has been #expressed by vitro .
it has been assumed that this peptide exercises its mitogenic influences through the vasopressin v1a receptor , and we have previously demonstrated that the human mitochondrial transcription termination factor (mterf) cdna was #expressed by vitro .
it has been assumed that this peptide exercises its mitogenic influences through the vasopressin v1a receptor , and we have previously demonstrated that in-frame  chain transcripts can be #expressed by such cells at the cell surface .
it has been assumed that this peptide exercises its mitogenic influences through the vasopressin v1a receptor , and we have previously demonstrated that in-frame  chain transcripts has been #expressed by such cells at the cell surface .
it has been assumed that this peptide exercises its mitogenic influences through the vasopressin v1a receptor , and we have previously demonstrated that in-frame  chain transcripts is #expressed by such cells at the cell surface .
it has been assumed that this peptide exercises its mitogenic influences through the vasopressin v1a receptor , and we have previously demonstrated that in-frame  chain transcripts may have been #expressed by such cells at the cell surface .
it has primarily #expressed bnip3alpha , which is secreted into perineuronal nets , in in most human tissues .
it has primarily #expressed the human mitochondrial transcription termination factor (mterf) cdna , which is secreted into perineuronal nets , in vitro .
it has primarily #expressed in-frame  chain transcripts , which is secreted into perineuronal nets , in such cells at the cell surface .
it primarily #expressed bd73 messenger rna , which was secreted into perineuronal nets , in in a wide variety of tissues and cell lines .
it primarily #expressed the human mitochondrial transcription termination factor (mterf) cdna , which was secreted into perineuronal nets , in vitro .
it primarily #expressed in-frame  chain transcripts , which was secreted into perineuronal nets , in such cells at the cell surface .
northern blot analysis reveals that bd73 messenger rna has been #expressed ubiquitously in in a wide variety of tissues and cell lines .
northern blot analysis reveals that bd73 messenger rna has been shown to be #expressed ubiquitously in in a wide variety of tissues and cell lines .
northern blot analysis reveals that the human mitochondrial transcription termination factor (mterf) cdna is #expressed ubiquitously vitro .
northern blot analysis reveals that the pfl operon has been #expressed ubiquitously in at high levels anaerobically .
northern blot analysis reveals that the pfl operon was #expressed ubiquitously in at high levels anaerobically .
northern blot analysis reveals that in-frame  chain transcripts is #expressed ubiquitously such cells at the cell surface .
rcas viruses infect only classical and variant sccl being engineered to #express ectopically this receptor , tva .
rcas viruses infect only classical and variant sccl engineered for #expressing ectopically this receptor , tva .
rcas viruses infect only in a wide variety of tissues and cell lines being engineered to #express ectopically bd73 messenger rna , tva .
rcas viruses infect only in a wide variety of tissues and cell lines being involved in #expressing ectopically bd73 messenger rna , tva .
rcas viruses infect only in a wide variety of tissues and cell lines engineered for #expressing ectopically bd73 messenger rna , tva .
rcas viruses infect only in most human tissues engineered to #express ectopically bnip3alpha , tva .
rcas viruses infect only such cells at the cell surface being engineered to #express ectopically in-frame  chain transcripts , tva .
rcas viruses infect only such cells at the cell surface engineered for #expressing ectopically in-frame  chain transcripts , tva .
rcas viruses infect only such cells at the cell surface engineered to #express ectopically in-frame  chain transcripts , tva .
rcas viruses infect only vitro being involved in #expressing ectopically the human mitochondrial transcription termination factor (mterf) cdna , tva .
rcas viruses infect only vitro engineered for #expressing ectopically the human mitochondrial transcription termination factor (mterf) cdna , tva .
rcas viruses infect only vitro engineered to #express ectopically the human mitochondrial transcription termination factor (mterf) cdna , tva .
the human mitochondrial transcription termination factor (mterf) cdna are #expressed by vitro .
the human mitochondrial transcription termination factor (mterf) cdna has been likely #expressed through +1 or -1 frameshifting by vitro .
the human mitochondrial transcription termination factor (mterf) cdna is #expressed vitro .
the human mitochondrial transcription termination factor (mterf) cdna is likely #expressed through +1 or -1 frameshifting by vitro .
the human mitochondrial transcription termination factor (mterf) cdna is shown to be likely #expressed through +1 or -1 frameshifting by vitro .
the human mitochondrial transcription termination factor (mterf) cdna may have been #expressed by vitro .
the human mitochondrial transcription termination factor (mterf) cdna were #expressed by vitro .
the human mitochondrial transcription termination factor (mterf) cdna will be #expressed by vitro .
the mechanotransduction mechanism for this signalling may directly or indirectly involve the dystrophin complex as bd73 messenger rna was not able to be #expressed in response to overload by in a wide variety of tissues and cell lines .
the mechanotransduction mechanism for this signalling may directly or indirectly involve the dystrophin complex as bnip3alpha could not to be #expressed in response to overload by in most human tissues .
the mechanotransduction mechanism for this signalling may directly or indirectly involve the dystrophin complex as bnip3alpha has been shown not to be #expressed in response to overload by in most human tissues .
the mechanotransduction mechanism for this signalling may directly or indirectly involve the dystrophin complex as bnip3alpha is unable to be #expressed in response to overload by in most human tissues .
the mechanotransduction mechanism for this signalling may directly or indirectly involve the dystrophin complex as bnip3alpha was unable to be #expressed in response to overload by in most human tissues .
the mechanotransduction mechanism for this signalling may directly or indirectly involve the dystrophin complex as the human mitochondrial transcription termination factor (mterf) cdna could not to be #expressed in response to overload by vitro .
the mechanotransduction mechanism for this signalling may directly or indirectly involve the dystrophin complex as the human mitochondrial transcription termination factor (mterf) cdna is unable to be #expressed in response to overload by vitro .
the mechanotransduction mechanism for this signalling may directly or indirectly involve the dystrophin complex as the human mitochondrial transcription termination factor (mterf) cdna was unable to be #expressed in response to overload by vitro .
the mechanotransduction mechanism for this signalling may directly or indirectly involve the dystrophin complex as classical and variant sccl , unlike normal muscle , cannot #express this receptor in response to overload .
the mechanotransduction mechanism for this signalling may directly or indirectly involve the dystrophin complex as classical and variant sccl , unlike normal muscle , was shown not to #express this receptor in response to overload
the mechanotransduction mechanism for this signalling may directly or indirectly involve the dystrophin complex as classical and variant sccl , unlike normal muscle , was unable to #express this receptor in response to overload
the mechanotransduction mechanism for this signalling may directly or indirectly involve the dystrophin complex as in a wide variety of tissues and cell lines , unlike normal muscle , does not have the ability to #express bd73 messenger rna in response to overload
the mechanotransduction mechanism for this signalling may directly or indirectly involve the dystrophin complex as in most human tissues , unlike normal muscle , does not have the ability to #express bnip3alpha in response to overload
the mechanotransduction mechanism for this signalling may directly or indirectly involve the dystrophin complex as in most human tissues , unlike normal muscle , is unable to #express bnip3alpha in response to overload .
the mechanotransduction mechanism for this signalling may directly or indirectly involve the dystrophin complex as in-frame  chain transcripts could not to be #expressed in response to overload by such cells at the cell surface .
the mechanotransduction mechanism for this signalling may directly or indirectly involve the dystrophin complex as in-frame  chain transcripts has been shown not to be #expressed in response to overload by such cells at the cell surface .
the mechanotransduction mechanism for this signalling may directly or indirectly involve the dystrophin complex as such cells at the cell surface , unlike normal muscle , does not have the ability to #express in-frame  chain transcripts in response to overload
the mechanotransduction mechanism for this signalling may directly or indirectly involve the dystrophin complex as such cells at the cell surface , unlike normal muscle , was shown not to #express in-frame  chain transcripts in response to overload
the mechanotransduction mechanism for this signalling may directly or indirectly involve the dystrophin complex as this receptor could not to be #expressed in response to overload by classical and variant sccl .
the mechanotransduction mechanism for this signalling may directly or indirectly involve the dystrophin complex as this receptor is unable to be #expressed in response to overload by classical and variant sccl .
the mechanotransduction mechanism for this signalling may directly or indirectly involve the dystrophin complex as this receptor was not able to be #expressed in response to overload by classical and variant sccl .
the mechanotransduction mechanism for this signalling may directly or indirectly involve the dystrophin complex as vitro , unlike normal muscle , was shown not to #express the human mitochondrial transcription termination factor (mterf) cdna in response to overload
the pfl operon is shown to be #expressed at high levels anaerobically .
the pfl operon was #expressed at high levels anaerobically .
this functional allelic exclusion is apparently due to control of the tcr assembly process because these classical and variant sccl are able to #express this receptor .
this functional allelic exclusion is apparently due to control of the tcr assembly process because these classical and variant sccl are involved in #expressing this receptor .
this functional allelic exclusion is apparently due to control of the tcr assembly process because these in a wide variety of tissues and cell lines are able to #express bd73 messenger rna .
this functional allelic exclusion is apparently due to control of the tcr assembly process because these in a wide variety of tissues and cell lines are #expressing bd73 messenger rna .
this functional allelic exclusion is apparently due to control of the tcr assembly process because these in a wide variety of tissues and cell lines have #expressed bd73 messenger rna .
this functional allelic exclusion is apparently due to control of the tcr assembly process because these in most human tissues #express bnip3alpha .
this functional allelic exclusion is apparently due to control of the tcr assembly process because these in most human tissues have been shown to #express bnip3alpha .
this functional allelic exclusion is apparently due to control of the tcr assembly process because these in most human tissues have #expressed bnip3alpha .
this functional allelic exclusion is apparently due to control of the tcr assembly process because these in most human tissues have the ability to #express bnip3alpha .
this functional allelic exclusion is apparently due to control of the tcr assembly process because these such cells at the cell surface are #expressing in-frame  chain transcripts .
this functional allelic exclusion is apparently due to control of the tcr assembly process because these such cells at the cell surface are involved in #expressing in-frame  chain transcripts .
this functional allelic exclusion is apparently due to control of the tcr assembly process because these such cells at the cell surface have #expressed in-frame  chain transcripts .
this functional allelic exclusion is apparently due to control of the tcr assembly process because these such cells at the cell surface have the ability to #express in-frame  chain transcripts .
this functional allelic exclusion is apparently due to control of the tcr assembly process because these vitro are able to #express the human mitochondrial transcription termination factor (mterf) cdna .
this functional allelic exclusion is apparently due to control of the tcr assembly process because these vitro are involved in #expressing the human mitochondrial transcription termination factor (mterf) cdna .
this functional allelic exclusion is apparently due to control of the tcr assembly process because these vitro #express the human mitochondrial transcription termination factor (mterf) cdna .
this functional allelic exclusion is apparently due to control of the tcr assembly process because these vitro have #expressed the human mitochondrial transcription termination factor (mterf) cdna .
classical and variant sccl are able to #express only this receptor .
in most human tissues are shown to #express only bnip3alpha .
in most human tissues have #expressed only bnip3alpha .
in-frame  chain transcripts are shown to be #expressed by such cells at the cell surface .
in-frame  chain transcripts has been cloned and #expressed in such cells at the cell surface , and two alternative precursors of the protein have been imported into isolated mitochondria and processed to the mature protein .
in-frame  chain transcripts has been #expressed primarily in such cells at the cell surface and secreted into perineuronal nets .
in-frame  chain transcripts has been likely #expressed through +1 or -1 frameshifting by such cells at the cell surface .
in-frame  chain transcripts is able to be #expressed and cloned in such cells at the cell surface , and two alternative precursors of the protein have been imported into isolated mitochondria and processed to the mature protein .
in-frame  chain transcripts is cloned and #expressed in such cells at the cell surface , and two alternative precursors of the protein have been imported into isolated mitochondria and processed to the mature protein .
in-frame  chain transcripts is #expressed and cloned in such cells at the cell surface , and two alternative precursors of the protein have been imported into isolated mitochondria and processed to the mature protein .
in-frame  chain transcripts may have been #expressed by such cells at the cell surface .
in-frame  chain transcripts may have been likely #expressed through +1 or -1 frameshifting by such cells at the cell surface .
in-frame  chain transcripts was shown to be cloned and #expressed in such cells at the cell surface , and two alternative precursors of the protein have been imported into isolated mitochondria and processed to the mature protein .
in-frame  chain transcripts will be #expressed by such cells at the cell surface .
in-frame  chain transcripts will be #expressed primarily in such cells at the cell surface and is secreted into perineuronal nets .
in-frame  chain transcripts would be cloned and #expressed in such cells at the cell surface , and two alternative precursors of the protein have been imported into isolated mitochondria and processed to the mature protein .
in-frame  chain transcripts would be likely #expressed through +1 or -1 frameshifting by such cells at the cell surface .
such cells at the cell surface are able to #express only in-frame  chain transcripts .
such cells at the cell surface are shown to #express only in-frame  chain transcripts .
such cells at the cell surface may have #expressed only in-frame  chain transcripts .
this receptor are #expressed by classical and variant sccl .
this receptor are shown to be #expressed by classical and variant sccl .
this receptor has been #expressed by classical and variant sccl .
this receptor has been #expressed primarily in classical and variant sccl and secreted into perineuronal nets .
this receptor is able to be cloned and #expressed in classical and variant sccl , and two alternative precursors of the protein have been imported into isolated mitochondria and processed to the mature protein .
this receptor is able to be #expressed and cloned in classical and variant sccl , and two alternative precursors of the protein have been imported into isolated mitochondria and processed to the mature protein .
this receptor is #expressed and cloned in classical and variant sccl , and two alternative precursors of the protein have been imported into isolated mitochondria and processed to the mature protein .
this receptor is #expressed classical and variant sccl .
this receptor may have been #expressed primarily in classical and variant sccl and secreted into perineuronal nets .
this receptor was #expressed and cloned in classical and variant sccl , and two alternative precursors of the protein have been imported into isolated mitochondria and processed to the mature protein .
this receptor were #expressed by classical and variant sccl .
this receptor will be #expressed by classical and variant sccl .
this receptor will be #expressed primarily in classical and variant sccl and is secreted into perineuronal nets .
this receptor would be cloned and #expressed in classical and variant sccl , and two alternative precursors of the protein have been imported into isolated mitochondria and processed to the mature protein .
this receptor would be likely #expressed through +1 or -1 frameshifting by classical and variant sccl .
vitro are able to #express only the human mitochondrial transcription termination factor (mterf) cdna .
vitro #express only the human mitochondrial transcription termination factor (mterf) cdna .
t cells in mice at the cell surface carrying transgenes encoding tcr  and  proteins predominantly #express the transgene-encoded tcr proteins .
a complementary dna clone has been cloned and #expressed in vitro , and two alternative precursors of the protein have been imported into isolated mitochondria and processed to the mature protein .
a complementary dna clone has been likely #expressed through +1 or -1 frameshifting by vitro .
a complementary dna clone is able to be #expressed and cloned in vitro , and two alternative precursors of the protein have been imported into isolated mitochondria and processed to the mature protein .
a complementary dna clone is cloned and #expressed in vitro , and two alternative precursors of the protein have been imported into isolated mitochondria and processed to the mature protein .
a complementary dna clone is #expressed and cloned in vitro , and two alternative precursors of the protein have been imported into isolated mitochondria and processed to the mature protein .
a complementary dna clone is #expressed vitro .
a complementary dna clone is likely #expressed through +1 or -1 frameshifting by vitro .
a complementary dna clone is shown to be #expressed primarily in vitro and is secreted into perineuronal nets .
a complementary dna clone may have been #expressed by vitro .
a complementary dna clone was shown to be cloned and #expressed in vitro , and two alternative precursors of the protein have been imported into isolated mitochondria and processed to the mature protein .
a complementary dna clone were #expressed by vitro .
a complementary dna clone will be #expressed by vitro .
a complementary dna clone will be #expressed primarily in vitro and is secreted into perineuronal nets .
a complementary dna clone would be #expressed and cloned in vitro , and two alternative precursors of the protein have been imported into isolated mitochondria and processed to the mature protein .
a complementary dna clone would be likely #expressed through +1 or -1 frameshifting by vitro .
in t cells in mice at the cell surface , two the transgene-encoded tcr proteins are produced , but only one has been #expressed .
in t cells in mice at the cell surface , two the transgene-encoded tcr proteins are produced , but only one is shown to be #expressed .
in t cells in mice at the cell surface , two the transgene-encoded tcr proteins were produced , but only one is able to be #expressed .
in t cells in mice at the cell surface , two the transgene-encoded tcr proteins were produced , but only one of them can be #expressed .
in t cells in mice at the cell surface , two the transgene-encoded tcr proteins were produced , but only one was #expressed .
in both somatic tissues and testis , two the isoform identical to ran/tc4 are produced , but only one is #expressed .
in both somatic tissues and testis , two the isoform identical to ran/tc4 were produced , but it has #expressed only one of them .
in both somatic tissues and testis , two the isoform identical to ran/tc4 were produced , but only one was #expressed .
in such cells at the cell surface , two in-frame  chain transcripts are produced , but only one is #expressed .
in such cells at the cell surface , two in-frame  chain transcripts are produced , but only one is shown to be #expressed .
in such cells at the cell surface , two in-frame  chain transcripts were produced , but only one is able to be #expressed .
in such cells at the cell surface , two in-frame  chain transcripts were produced , but only one of them can be #expressed .
in summary , a complementary dna clone has been #expressed in vitro and induced by pkc , pka and erk1/2 dependent mechanisms .
in summary , a complementary dna clone is able to be induced by pkc , pka and erk1/2 dependent mechanisms and #expressed in vitro .
in summary , a complementary dna clone was induced by pkc , pka and erk1/2 dependent mechanisms and #expressed in vitro .
in summary , the isoform identical to ran/tc4 has been #expressed in both somatic tissues and testis and induced by pkc , pka and erk1/2 dependent mechanisms .
in summary , the isoform identical to ran/tc4 has been induced by pkc , pka and erk1/2 dependent mechanisms and #expressed in both somatic tissues and testis .
in summary , the isoform identical to ran/tc4 is able to be #expressed in both somatic tissues and testis and induced by pkc , pka and erk1/2 dependent mechanisms .
in summary , the isoform identical to ran/tc4 is #expressed in both somatic tissues and testis and induced by pkc , pka and erk1/2 dependent mechanisms .
in summary , the isoform identical to ran/tc4 was #expressed in both somatic tissues and testis and induced by pkc , pka and erk1/2 dependent mechanisms .
in summary , the transgene-encoded tcr proteins has been #expressed in t cells in mice at the cell surface and induced by pkc , pka and erk1/2 dependent mechanisms .
in summary , the transgene-encoded tcr proteins is able to be #expressed in t cells in mice at the cell surface and induced by pkc , pka and erk1/2 dependent mechanisms .
in summary , the transgene-encoded tcr proteins is able to be induced by pkc , pka and erk1/2 dependent mechanisms and #expressed in t cells in mice at the cell surface .
in summary , the transgene-encoded tcr proteins is shown to be induced by pkc , pka and erk1/2 dependent mechanisms and #expressed in t cells in mice at the cell surface .
in summary , the transgene-encoded tcr proteins will be #expressed in t cells in mice at the cell surface and induced by pkc , pka and erk1/2 dependent mechanisms .
in the cortex of adult animals , a complementary dna clone is able to be #expressed primarily in vitro and is secreted into perineuronal nets .
in the cortex of adult animals , a complementary dna clone was shown to be #expressed primarily in vitro and is secreted into perineuronal nets .
in the cortex of adult animals , the isoform identical to ran/tc4 is able to be #expressed primarily in both somatic tissues and testis and is secreted into perineuronal nets .
in the cortex of adult animals , the isoform identical to ran/tc4 was shown to be #expressed primarily in both somatic tissues and testis and is secreted into perineuronal nets .
in the cortex of adult animals , the transgene-encoded tcr proteins has been #expressed primarily in t cells in mice at the cell surface and is secreted into perineuronal nets .
in the cortex of adult animals , the transgene-encoded tcr proteins is #expressed primarily in t cells in mice at the cell surface and is secreted into perineuronal nets .
in vitro , two a complementary dna clone are produced , but only one has been #expressed .
in vitro , two a complementary dna clone are produced , but only one is shown to be #expressed .
in vitro , two a complementary dna clone were produced , but it has #expressed only one of them .
in vitro , two a complementary dna clone were produced , but only one of them can be #expressed .
in vitro , two a complementary dna clone were produced , but only one was #expressed .
it #expressed a complementary dna clone , which was induced by pkc , pka and erk1/2 dependent mechanisms , in vitro .
it #expressed the isoform identical to ran/tc4 , which was induced by pkc , pka and erk1/2 dependent mechanisms , in both somatic tissues and testis .
it has been assumed that this peptide exercises its mitogenic influences through the vasopressin v1a receptor , and we have previously demonstrated that a complementary dna clone can be #expressed by vitro .
it has been assumed that this peptide exercises its mitogenic influences through the vasopressin v1a receptor , and we have previously demonstrated that a complementary dna clone has been #expressed by vitro .
it has been assumed that this peptide exercises its mitogenic influences through the vasopressin v1a receptor , and we have previously demonstrated that a complementary dna clone may have been #expressed by vitro .
it has been assumed that this peptide exercises its mitogenic influences through the vasopressin v1a receptor , and we have previously demonstrated that a complementary dna clone was able to be been #expressed by vitro .
it has been assumed that this peptide exercises its mitogenic influences through the vasopressin v1a receptor , and we have previously demonstrated that the isoform identical to ran/tc4 can be #expressed by both somatic tissues and testis .
it has been assumed that this peptide exercises its mitogenic influences through the vasopressin v1a receptor , and we have previously demonstrated that the isoform identical to ran/tc4 is #expressed by both somatic tissues and testis .
it has been assumed that this peptide exercises its mitogenic influences through the vasopressin v1a receptor , and we have previously demonstrated that the isoform identical to ran/tc4 was able to be been #expressed by both somatic tissues and testis .
it has been assumed that this peptide exercises its mitogenic influences through the vasopressin v1a receptor , and we have previously demonstrated that the isoform identical to ran/tc4 was #expressed by both somatic tissues and testis .
it has been assumed that this peptide exercises its mitogenic influences through the vasopressin v1a receptor , and we have previously demonstrated that the transgene-encoded tcr proteins is #expressed by t cells in mice at the cell surface .
it has been assumed that this peptide exercises its mitogenic influences through the vasopressin v1a receptor , and we have previously demonstrated that the transgene-encoded tcr proteins may have been #expressed by t cells in mice at the cell surface .
it has been assumed that this peptide exercises its mitogenic influences through the vasopressin v1a receptor , and we have previously demonstrated that the transgene-encoded tcr proteins was able to be been #expressed by t cells in mice at the cell surface .
it has been assumed that this peptide exercises its mitogenic influences through the vasopressin v1a receptor , and we have previously demonstrated that the transgene-encoded tcr proteins was shown to be #expressed by t cells in mice at the cell surface .
it has primarily #expressed a complementary dna clone , which is secreted into perineuronal nets , in vitro .
it has primarily #expressed the isoform identical to ran/tc4 , which is secreted into perineuronal nets , in both somatic tissues and testis .
it primarily #expressed a complementary dna clone , which was secreted into perineuronal nets , in vitro .
northern blot analysis reveals that the isoform identical to ran/tc4 is #expressed ubiquitously both somatic tissues and testis .
rcas viruses infect only t cells in mice at the cell surface being involved in #expressing ectopically the transgene-encoded tcr proteins , tva .
rcas viruses infect only t cells in mice at the cell surface engineered for #expressing ectopically the transgene-encoded tcr proteins , tva .
rcas viruses infect only both somatic tissues and testis being engineered to #express ectopically the isoform identical to ran/tc4 , tva .
rcas viruses infect only both somatic tissues and testis being involved in #expressing ectopically the isoform identical to ran/tc4 , tva .
rcas viruses infect only both somatic tissues and testis engineered for #expressing ectopically the isoform identical to ran/tc4 , tva .
rcas viruses infect only vitro being involved in #expressing ectopically a complementary dna clone , tva .
rcas viruses infect only vitro engineered for #expressing ectopically a complementary dna clone , tva .
t cells in mice at the cell surface are shown to #express only the transgene-encoded tcr proteins .
t cells in mice at the cell surface #express only the transgene-encoded tcr proteins .
t cells in mice at the cell surface may have #expressed only the transgene-encoded tcr proteins .
the mechanotransduction mechanism for this signalling may directly or indirectly involve the dystrophin complex as a complementary dna clone is unable to be #expressed in response to overload by vitro .
the mechanotransduction mechanism for this signalling may directly or indirectly involve the dystrophin complex as a complementary dna clone was not able to be #expressed in response to overload by vitro .
the mechanotransduction mechanism for this signalling may directly or indirectly involve the dystrophin complex as t cells in mice at the cell surface , unlike normal muscle , cannot #express the transgene-encoded tcr proteins in response to overload .
the mechanotransduction mechanism for this signalling may directly or indirectly involve the dystrophin complex as t cells in mice at the cell surface , unlike normal muscle , is unable to #express the transgene-encoded tcr proteins in response to overload .
the mechanotransduction mechanism for this signalling may directly or indirectly involve the dystrophin complex as t cells in mice at the cell surface , unlike normal muscle , was shown not to #express the transgene-encoded tcr proteins in response to overload
the mechanotransduction mechanism for this signalling may directly or indirectly involve the dystrophin complex as both somatic tissues and testis , unlike normal muscle , is unable to #express the isoform identical to ran/tc4 in response to overload .
the mechanotransduction mechanism for this signalling may directly or indirectly involve the dystrophin complex as both somatic tissues and testis , unlike normal muscle , was shown not to #express the isoform identical to ran/tc4 in response to overload
the mechanotransduction mechanism for this signalling may directly or indirectly involve the dystrophin complex as both somatic tissues and testis , unlike normal muscle , was unable to #express the isoform identical to ran/tc4 in response to overload
the mechanotransduction mechanism for this signalling may directly or indirectly involve the dystrophin complex as the isoform identical to ran/tc4 could not to be #expressed in response to overload by both somatic tissues and testis .
the mechanotransduction mechanism for this signalling may directly or indirectly involve the dystrophin complex as the isoform identical to ran/tc4 is unable to be #expressed in response to overload by both somatic tissues and testis .
the mechanotransduction mechanism for this signalling may directly or indirectly involve the dystrophin complex as the isoform identical to ran/tc4 was unable to be #expressed in response to overload by both somatic tissues and testis .
the mechanotransduction mechanism for this signalling may directly or indirectly involve the dystrophin complex as the transgene-encoded tcr proteins is unable to be #expressed in response to overload by t cells in mice at the cell surface .
the mechanotransduction mechanism for this signalling may directly or indirectly involve the dystrophin complex as the transgene-encoded tcr proteins was not able to be #expressed in response to overload by t cells in mice at the cell surface .
the mechanotransduction mechanism for this signalling may directly or indirectly involve the dystrophin complex as the transgene-encoded tcr proteins was unable to be #expressed in response to overload by t cells in mice at the cell surface .
the mechanotransduction mechanism for this signalling may directly or indirectly involve the dystrophin complex as vitro , unlike normal muscle , is unable to #express a complementary dna clone in response to overload .
this functional allelic exclusion is apparently due to control of the tcr assembly process because these t cells in mice at the cell surface are able to #express the transgene-encoded tcr proteins .
this functional allelic exclusion is apparently due to control of the tcr assembly process because these t cells in mice at the cell surface are #expressing the transgene-encoded tcr proteins .
this functional allelic exclusion is apparently due to control of the tcr assembly process because these t cells in mice at the cell surface are involved in #expressing the transgene-encoded tcr proteins .
this functional allelic exclusion is apparently due to control of the tcr assembly process because these t cells in mice at the cell surface have been shown to #express the transgene-encoded tcr proteins .
this functional allelic exclusion is apparently due to control of the tcr assembly process because these t cells in mice at the cell surface have #expressed the transgene-encoded tcr proteins .
this functional allelic exclusion is apparently due to control of the tcr assembly process because these both somatic tissues and testis are #expressing the isoform identical to ran/tc4 .
this functional allelic exclusion is apparently due to control of the tcr assembly process because these both somatic tissues and testis are involved in #expressing the isoform identical to ran/tc4 .
this functional allelic exclusion is apparently due to control of the tcr assembly process because these both somatic tissues and testis have been shown to #express the isoform identical to ran/tc4 .
this functional allelic exclusion is apparently due to control of the tcr assembly process because these both somatic tissues and testis have the ability to #express the isoform identical to ran/tc4 .
this functional allelic exclusion is apparently due to control of the tcr assembly process because these vitro have been shown to #express a complementary dna clone .
this functional allelic exclusion is apparently due to control of the tcr assembly process because these vitro have #expressed a complementary dna clone .
this functional allelic exclusion is apparently due to control of the tcr assembly process because these vitro have the ability to #express a complementary dna clone .
both somatic tissues and testis have #expressed only the isoform identical to ran/tc4 .
the isoform identical to ran/tc4 are #expressed by both somatic tissues and testis .
the isoform identical to ran/tc4 has been #expressed by both somatic tissues and testis .
the isoform identical to ran/tc4 has been #expressed primarily in both somatic tissues and testis and secreted into perineuronal nets .
the isoform identical to ran/tc4 is able to be cloned and #expressed in both somatic tissues and testis , and two alternative precursors of the protein have been imported into isolated mitochondria and processed to the mature protein .
the isoform identical to ran/tc4 is able to be #expressed and cloned in both somatic tissues and testis , and two alternative precursors of the protein have been imported into isolated mitochondria and processed to the mature protein .
the isoform identical to ran/tc4 is cloned and #expressed in both somatic tissues and testis , and two alternative precursors of the protein have been imported into isolated mitochondria and processed to the mature protein .
the isoform identical to ran/tc4 is #expressed both somatic tissues and testis .
the isoform identical to ran/tc4 is likely #expressed through +1 or -1 frameshifting by both somatic tissues and testis .
the isoform identical to ran/tc4 is shown to be #expressed primarily in both somatic tissues and testis and is secreted into perineuronal nets .
the isoform identical to ran/tc4 is shown to be likely #expressed through +1 or -1 frameshifting by both somatic tissues and testis .
the isoform identical to ran/tc4 may have been likely #expressed through +1 or -1 frameshifting by both somatic tissues and testis .
the isoform identical to ran/tc4 was cloned and #expressed in both somatic tissues and testis , and two alternative precursors of the protein have been imported into isolated mitochondria and processed to the mature protein .
the isoform identical to ran/tc4 was #expressed and cloned in both somatic tissues and testis , and two alternative precursors of the protein have been imported into isolated mitochondria and processed to the mature protein .
the isoform identical to ran/tc4 was shown to be cloned and #expressed in both somatic tissues and testis , and two alternative precursors of the protein have been imported into isolated mitochondria and processed to the mature protein .
the isoform identical to ran/tc4 would be likely #expressed through +1 or -1 frameshifting by both somatic tissues and testis .
the transgene-encoded tcr proteins has been likely #expressed through +1 or -1 frameshifting by t cells in mice at the cell surface .
the transgene-encoded tcr proteins is able to be cloned and #expressed in t cells in mice at the cell surface , and two alternative precursors of the protein have been imported into isolated mitochondria and processed to the mature protein .
the transgene-encoded tcr proteins is able to be #expressed and cloned in t cells in mice at the cell surface , and two alternative precursors of the protein have been imported into isolated mitochondria and processed to the mature protein .
the transgene-encoded tcr proteins is #expressed t cells in mice at the cell surface .
the transgene-encoded tcr proteins is #expressed and cloned in t cells in mice at the cell surface , and two alternative precursors of the protein have been imported into isolated mitochondria and processed to the mature protein .
the transgene-encoded tcr proteins is shown to be #expressed primarily in t cells in mice at the cell surface and is secreted into perineuronal nets .
the transgene-encoded tcr proteins may have been #expressed by t cells in mice at the cell surface .
the transgene-encoded tcr proteins will be #expressed by t cells in mice at the cell surface .
the transgene-encoded tcr proteins will be #expressed primarily in t cells in mice at the cell surface and is secreted into perineuronal nets .
the transgene-encoded tcr proteins would be cloned and #expressed in t cells in mice at the cell surface , and two alternative precursors of the protein have been imported into isolated mitochondria and processed to the mature protein .
the transgene-encoded tcr proteins would be #expressed and cloned in t cells in mice at the cell surface , and two alternative precursors of the protein have been imported into isolated mitochondria and processed to the mature protein .
the transgene-encoded tcr proteins would be likely #expressed through +1 or -1 frameshifting by t cells in mice at the cell surface .
vitro are shown to #express only a complementary dna clone .
vitro #express only a complementary dna clone .
vitro have #expressed only a complementary dna clone .
vitro may #express only a complementary dna clone .
a transcription start site is located approximately 4 kilobases 5 to the translation codon , and an rna splice of 3863 bases occurring in the 5-untranslated region #generated mature hela cell mrna .
a transcription start site is located approximately 4 kilobases 5 to the translation codon , and mature hela cell mrna has been #generated by an rna splice of 3863 bases occurring in the 5-untranslated region .
a transcription start site is located approximately 4 kilobases 5 to the translation codon , and mature hela cell mrna is #generated by an rna splice of 3863 bases occurring in the 5-untranslated region .
a transcription start site is located approximately 4 kilobases 5 to the translation codon , and mature hela cell mrna will be #generated by an rna splice of 3863 bases occurring in the 5-untranslated region .
human leukocyte antigen (hla)-g molecules have been #generated by an alternative splicing of the primary transcript of the gene and have displayed specialized function in regulating the immune response .
human leukocyte antigen (hla)-g molecules were #generated by an alternative splicing of the primary transcript of the gene and displayed specialized function in regulating the immune response .
human leukocyte antigen (hla)-g molecules will be #generated by an alternative splicing of the primary transcript of the gene and will display specialized function in regulating the immune response .
the tbc method #generated sequential overlapping fragments ( approximately 0 .4-0 .5 kb ) for each of the gene sequences , and simultaneous and sequential combinations of overlapping fragments were tested for their ability to be assembled under an array of pcr conditions .
the tbc method #generates sequential overlapping fragments ( approximately 0 .4-0 .5 kb ) for each of the gene sequences , and simultaneous and sequential combinations of overlapping fragments are tested for their ability to be assembled under an array of pcr conditions .
the bidentate rnase iii dicer #generated the 21-23 nt long mature rnas .
the bidentate rnase iii dicer #generates the 21-23 nt long mature rnas .
the bidentate rnase iii dicer has #generated the 21-23 nt long mature rnas .
the bidentate rnase iii dicer is able to #generate the 21-23 nt long mature rnas .
to analyse specifically protein expression of fhl2 in human tissues we may #generate a monoclonal antibody against fhl2 .
to analyse specifically protein expression of fhl2 in human tissues , a monoclonal antibody against fhl2 is #generated by us
to analyse specifically protein expression of fhl2 in human tissues , we #generate a monoclonal antibody against fhl2 .
to analyse specifically protein expression of fhl2 in human tissues , we will #generate a monoclonal antibody against fhl2 .
we believe this binding is found to #generate a higher order protein-dna complex within the recombinational synapse .
we believe this binding is shown to #generate a higher order protein-dna complex within the recombinational synapse .
a dnase i hypersensitive is #generated by a swi/snf-related chromatin remodeling complex , eklf coactivator-remodeling complex 1 (e-rc1) .
a swi/snf-related chromatin remodeling complex , eklf coactivator-remodeling complex 1 (e-rc1) #generate a dnase i hypersensitive .
a functional interaction surface was #generated by the ar n-terminus , because the ar n-terminuss deletion abolishes fhl2 binding .
a higher order protein-dna complex is #generated by this binding within the recombinational synapse .
an alternative splicing of the primary transcript of the gene #generates human leukocyte antigen (hla)-g molecules .
the 21-23 nt long mature rnas were #generated by the bidentate rnase iii dicer .
this binding #generates a higher order protein-dna complex within the recombinational synapse .
to analyse specifically protein expression of fhl2 in human tissues we #generated a monoclonal antibody against fhl2 .
we believe this binding is required to #generate a higher order protein-dna complex within the recombinational synapse .
we report results from preliminary transcription microarray experiments that revealed two previously unknown members of the narl regulon: the aspa gene encoding aspartate-ammonia lyase , which #generates fumarate; and the dcusr operon encoding the dicarboxylate-responsive regulatory system .
a transcription start site is located approximately 4 kilobases 5 to the translation codon , and an rna splice of 3863 bases occurs in the 5-untranslated region to #generate mature hela cell mrna .
human leukocyte antigen (hla)-g molecules are #generated by an alternative splicing of the primary transcript of the gene and display specialized function in regulating the immune response .
the tbc method was optimized to #generate sequential overlapping fragments ( approximately 0 .4-0 .5 kb ) for each of the gene sequences , and simultaneous and sequential combinations of overlapping fragments were tested for their ability to be assembled under an array of pcr conditions .
the bidentate rnase iii dicer cleaves microrna precursors to #generate the 21-23 nt long mature rnas .
although no crystal structure of the ar is available to date , one might speculate that the tbc method is either directly involved in the ar-fhl2 interaction or , alternatively , is essential for #generating sequential overlapping fragments .
although no crystal structure of the ar is available to date , one might speculate that the bidentate rnase iii dicer #generates the 21-23 nt long mature rnas .
although no crystal structure of the ar is available to date , one might speculate that the bidentate rnase iii dicer is either directly involved in the ar-fhl2 interaction or , alternatively , is essential for #generating the 21-23 nt long mature rnas .
although no crystal structure of the ar is available to date , one might speculate that a dnase i hypersensitive has been #generated by a swi/snf-related chromatin remodeling complex , eklf coactivator-remodeling complex 1 (e-rc1)
although no crystal structure of the ar is available to date , one might speculate that a dnase i hypersensitive is #generated by a swi/snf-related chromatin remodeling complex , eklf coactivator-remodeling complex 1 (e-rc1) .
although no crystal structure of the ar is available to date , one might speculate that a higher order protein-dna complex has been #generated by this binding
although no crystal structure of the ar is available to date , one might speculate that a higher order protein-dna complex was #generated by this binding .
although no crystal structure of the ar is available to date , one might speculate that a higher order protein-dna complex will be #generated by this binding .
although no crystal structure of the ar is available to date , one might speculate that a monoclonal antibody against fhl2 has been #generated by us
although no crystal structure of the ar is available to date , one might speculate that a monoclonal antibody against fhl2 has been #generated by we
although no crystal structure of the ar is available to date , one might speculate that a monoclonal antibody against fhl2 is #generated by us .
although no crystal structure of the ar is available to date , one might speculate that a monoclonal antibody against fhl2 will be #generated by we .
although no crystal structure of the ar is available to date , one might speculate that sequential overlapping fragments has been #generated by the tbc method
although no crystal structure of the ar is available to date , one might speculate that sequential overlapping fragments was #generated by the tbc method .
although no crystal structure of the ar is available to date , one might speculate that sequential overlapping fragments will be #generated by the tbc method .
although no crystal structure of the ar is available to date , one might speculate that the 21-23 nt long mature rnas is #generated by the bidentate rnase iii dicer .
although no crystal structure of the ar is available to date , one might speculate that the 21-23 nt long mature rnas was #generated by the bidentate rnase iii dicer .
although no crystal structure of the ar is available to date , one might speculate that the 21-23 nt long mature rnas will be #generated by the bidentate rnase iii dicer .
although no crystal structure of the ar is available to date , one might speculate that this binding #generated a higher order protein-dna complex .
although no crystal structure of the ar is available to date , one might speculate that us #generated a monoclonal antibody against fhl2 .
although no crystal structure of the ar is available to date , one might speculate that us #generates a monoclonal antibody against fhl2 .
although no crystal structure of the ar is available to date , one might speculate that us is either directly involved in the ar-fhl2 interaction or , alternatively , is essential for #generating a monoclonal antibody against fhl2 .
although no crystal structure of the ar is available to date , one might speculate that we #generated a monoclonal antibody against fhl2 .
in addition , there was an apparent absence of lower molecular weight fragments as evidence of the tbc method , although again the relatively small fraction involved and the possibility that degradation did not #generate sequential overlapping fragments or occured rapidly precludes any definitive conclusions
in addition , there was an apparent absence of lower molecular weight fragments as evidence of the tbc method , although again the relatively small fraction involved and the possibility that degradation does not #generate sequential overlapping fragments or occurs rapidly precludes any definitive conclusions .
in addition , there was an apparent absence of lower molecular weight fragments as evidence of the tbc method , although again the relatively small fraction involved and the possibility that sequential overlapping fragments are not #generated by degradation .
in addition , there was an apparent absence of lower molecular weight fragments as evidence of the tbc method , although again the relatively small fraction involved and the possibility that sequential overlapping fragments have not been #generated by degradation .
in addition , there was an apparent absence of lower molecular weight fragments as evidence of the bidentate rnase iii dicer , although again the relatively small fraction involved and the possibility that degradation did not #generate the 21-23 nt long mature rnas or occured rapidly precludes any definitive conclusions
in addition , there was an apparent absence of lower molecular weight fragments as evidence of the bidentate rnase iii dicer , although again the relatively small fraction involved and the possibility that degradation does not #generate the 21-23 nt long mature rnas or occurs rapidly precludes any definitive conclusions .
in addition , there was an apparent absence of lower molecular weight fragments as evidence of a swi/snf-related chromatin remodeling complex , eklf coactivator-remodeling complex 1 (e-rc1) , although again the relatively small fraction involved and the possibility that a dnase i hypersensitive are not #generated by degradation .
in addition , there was an apparent absence of lower molecular weight fragments as evidence of a swi/snf-related chromatin remodeling complex , eklf coactivator-remodeling complex 1 (e-rc1) , although again the relatively small fraction involved and the possibility that a dnase i hypersensitive have not been #generated by degradation .
in addition , there was an apparent absence of lower molecular weight fragments as evidence of a swi/snf-related chromatin remodeling complex , eklf coactivator-remodeling complex 1 (e-rc1) , although again the relatively small fraction involved and the possibility that a dnase i hypersensitive were not #generated by degradation .
in addition , there was an apparent absence of lower molecular weight fragments as evidence of a swi/snf-related chromatin remodeling complex , eklf coactivator-remodeling complex 1 (e-rc1) , although again the relatively small fraction involved and the possibility that degradation did not #generate a dnase i hypersensitive or occured rapidly precludes any definitive conclusions
in addition , there was an apparent absence of lower molecular weight fragments as evidence of a swi/snf-related chromatin remodeling complex , eklf coactivator-remodeling complex 1 (e-rc1) , although again the relatively small fraction involved and the possibility that degradation does not #generate a dnase i hypersensitive or occurs rapidly precludes any definitive conclusions .
in addition , there was an apparent absence of lower molecular weight fragments as evidence of this binding , although again the relatively small fraction involved and the possibility that a higher order protein-dna complex are not #generated by degradation .
in addition , there was an apparent absence of lower molecular weight fragments as evidence of this binding , although again the relatively small fraction involved and the possibility that a higher order protein-dna complex have not been #generated by degradation .
in addition , there was an apparent absence of lower molecular weight fragments as evidence of this binding , although again the relatively small fraction involved and the possibility that a higher order protein-dna complex will not be #generated by degradation .
in addition , there was an apparent absence of lower molecular weight fragments as evidence of this binding , although again the relatively small fraction involved and the possibility that degradation does not #generate a higher order protein-dna complex or occurs rapidly precludes any definitive conclusions .
in addition , there was an apparent absence of lower molecular weight fragments as evidence of us , although again the relatively small fraction involved and the possibility that a monoclonal antibody against fhl2 will not be #generated by degradation .
in addition , there was an apparent absence of lower molecular weight fragments as evidence of us , although again the relatively small fraction involved and the possibility that degradation did not #generate a monoclonal antibody against fhl2 or occured rapidly precludes any definitive conclusions
in addition , there was an apparent absence of lower molecular weight fragments as evidence of us , although again the relatively small fraction involved and the possibility that degradation does not #generate a monoclonal antibody against fhl2 or occurs rapidly precludes any definitive conclusions .
in addition , there was an apparent absence of lower molecular weight fragments as evidence of we , although again the relatively small fraction involved and the possibility that a monoclonal antibody against fhl2 are not #generated by degradation .
in addition , there was an apparent absence of lower molecular weight fragments as evidence of we , although again the relatively small fraction involved and the possibility that a monoclonal antibody against fhl2 will not be #generated by degradation .
in the absence of l-arginine , the tbc method has been shown to #generate sequential overlapping fragments (o(2)-) .
in the absence of l-arginine , the bidentate rnase iii dicer #generated the 21-23 nt long mature rnas (o(2)-) .
in the absence of l-arginine , a dnase i hypersensitive (o(2)-) is #generated by a swi/snf-related chromatin remodeling complex , eklf coactivator-remodeling complex 1 (e-rc1) .
in the absence of l-arginine , a dnase i hypersensitive (o(2)-) will be #generated by a swi/snf-related chromatin remodeling complex , eklf coactivator-remodeling complex 1 (e-rc1) .
in the absence of l-arginine , a swi/snf-related chromatin remodeling complex , eklf coactivator-remodeling complex 1 (e-rc1) #generated a dnase i hypersensitive (o(2)-) .
in the absence of l-arginine , a higher order protein-dna complex (o(2)-) has been #generated by this binding .
in the absence of l-arginine , a higher order protein-dna complex (o(2)-) was #generated by this binding .
in the absence of l-arginine , a monoclonal antibody against fhl2 (o(2)-) has been #generated by us .
in the absence of l-arginine , a monoclonal antibody against fhl2 (o(2)-) has been #generated by we .
in the absence of l-arginine , a monoclonal antibody against fhl2 (o(2)-) was #generated by us .
in the absence of l-arginine , sequential overlapping fragments (o(2)-) has been #generated by the tbc method .
in the absence of l-arginine , sequential overlapping fragments (o(2)-) is #generated by the tbc method .
in the absence of l-arginine , the 21-23 nt long mature rnas (o(2)-) has been #generated by the bidentate rnase iii dicer .
in the absence of l-arginine , the 21-23 nt long mature rnas (o(2)-) is #generated by the bidentate rnase iii dicer .
in the absence of l-arginine , the 21-23 nt long mature rnas (o(2)-) was #generated by the bidentate rnase iii dicer .
in the absence of l-arginine , this binding #generates a higher order protein-dna complex (o(2)-) .
in the absence of l-arginine , this binding has been shown to #generate a higher order protein-dna complex (o(2)-) .
in the absence of l-arginine , us #generated a monoclonal antibody against fhl2 (o(2)-) .
in the absence of l-arginine , us has been shown to #generate a monoclonal antibody against fhl2 (o(2)-) .
in the absence of l-arginine , we has been shown to #generate a monoclonal antibody against fhl2 (o(2)-) .
the tbc method can #generate sequential overlapping fragments .
the tbc method #generated sequential overlapping fragments .
the tbc method #generates sequential overlapping fragments within the recombinational synapse .
the tbc method , #generating sequential overlapping fragments .
the bidentate rnase iii dicer #generated the 21-23 nt long mature rnas ( approximately 0 .4-0 .5 kb ) for each of the gene sequences , and simultaneous and sequential combinations of overlapping fragments were tested for their ability to be assembled under an array of pcr conditions .
the bidentate rnase iii dicer #generated the 21-23 nt long mature rnas within the recombinational synapse .
the bidentate rnase iii dicer may #generate the 21-23 nt long mature rnas ( approximately 0 .4-0 .5 kb ) for each of the gene sequences , and simultaneous and sequential combinations of overlapping fragments can be tested for their ability to be assembled under an array of pcr conditions .
the bidentate rnase iii dicer , #generating the 21-23 nt long mature rnas .
these are a dnase i hypersensitive reductase (encoded by the frdabcd operon) , a swi/snf-related chromatin remodeling complex , eklf coactivator-remodeling complex 1 (e-rc1) , which #generated fumarate from malate , the dcub permease for fumarate , malate , and aspartate .
these are a dnase i hypersensitive reductase (encoded by the frdabcd operon) , a swi/snf-related chromatin remodeling complex , eklf coactivator-remodeling complex 1 (e-rc1) , which #generates fumarate from malate , and the dcub permease for fumarate , malate , and aspartate .
these are a dnase i hypersensitive reductase (encoded by the frdabcd operon) , a swi/snf-related chromatin remodeling complex , eklf coactivator-remodeling complex 1 (e-rc1) , which will #generate fumarate from malate , the dcub permease for fumarate , malate , and aspartate .
these are a higher order protein-dna complex reductase (encoded by the frdabcd operon) , this binding , which #generates fumarate from malate , and the dcub permease for fumarate , malate , and aspartate .
these are a higher order protein-dna complex reductase (encoded by the frdabcd operon) , this binding , which will #generate fumarate from malate , the dcub permease for fumarate , malate , and aspartate .
these are a monoclonal antibody against fhl2 reductase (encoded by the frdabcd operon) , us , which will #generate fumarate from malate , the dcub permease for fumarate , malate , and aspartate .
these are sequential overlapping fragments reductase (encoded by the frdabcd operon) , the tbc method , which have #generated fumarate from malate , the dcub permease for fumarate , malate , and aspartate .
these are sequential overlapping fragments reductase (encoded by the frdabcd operon) , the tbc method , which will #generate fumarate from malate , the dcub permease for fumarate , malate , and aspartate .
to analyse specifically protein expression of fhl2 in human tissues the tbc method #generated sequential overlapping fragments .
to analyse specifically protein expression of fhl2 in human tissues the tbc method may #generate sequential overlapping fragments .
to analyse specifically protein expression of fhl2 in human tissues the bidentate rnase iii dicer #generated the 21-23 nt long mature rnas .
to analyse specifically protein expression of fhl2 in human tissues the bidentate rnase iii dicer may #generate the 21-23 nt long mature rnas .
to analyse specifically protein expression of fhl2 in human tissues a swi/snf-related chromatin remodeling complex , eklf coactivator-remodeling complex 1 (e-rc1) #generated a dnase i hypersensitive .
to analyse specifically protein expression of fhl2 in human tissues this binding #generated a higher order protein-dna complex .
to analyse specifically protein expression of fhl2 in human tissues us #generated a monoclonal antibody against fhl2 .
to analyse specifically protein expression of fhl2 in human tissues us may #generate a monoclonal antibody against fhl2 .
to analyse specifically protein expression of fhl2 in human tissues , the tbc method #generate sequential overlapping fragments .
to analyse specifically protein expression of fhl2 in human tissues , a dnase i hypersensitive was #generated by a swi/snf-related chromatin remodeling complex , eklf coactivator-remodeling complex 1 (e-rc1)
to analyse specifically protein expression of fhl2 in human tissues , a swi/snf-related chromatin remodeling complex , eklf coactivator-remodeling complex 1 (e-rc1) #generate a dnase i hypersensitive .
to analyse specifically protein expression of fhl2 in human tissues , a swi/snf-related chromatin remodeling complex , eklf coactivator-remodeling complex 1 (e-rc1) will #generate a dnase i hypersensitive .
to analyse specifically protein expression of fhl2 in human tissues , a higher order protein-dna complex is #generated by this binding
to analyse specifically protein expression of fhl2 in human tissues , a higher order protein-dna complex was #generated by this binding
to analyse specifically protein expression of fhl2 in human tissues , a monoclonal antibody against fhl2 is #generated by we
to analyse specifically protein expression of fhl2 in human tissues , a monoclonal antibody against fhl2 was #generated by we
to analyse specifically protein expression of fhl2 in human tissues , the 21-23 nt long mature rnas is #generated by the bidentate rnase iii dicer
to analyse specifically protein expression of fhl2 in human tissues , this binding #generate a higher order protein-dna complex .
to analyse specifically protein expression of fhl2 in human tissues , this binding will #generate a higher order protein-dna complex .
to analyse specifically protein expression of fhl2 in human tissues , us #generate a monoclonal antibody against fhl2 .
we believe the tbc method is found to #generate sequential overlapping fragments within the recombinational synapse .
we believe the tbc method is shown to #generate sequential overlapping fragments within the recombinational synapse .
we believe the bidentate rnase iii dicer is found to #generate the 21-23 nt long mature rnas within the recombinational synapse .
we believe the bidentate rnase iii dicer is required to #generate the 21-23 nt long mature rnas within the recombinational synapse .
we believe a swi/snf-related chromatin remodeling complex , eklf coactivator-remodeling complex 1 (e-rc1) is found to #generate a dnase i hypersensitive within the recombinational synapse .
we believe a swi/snf-related chromatin remodeling complex , eklf coactivator-remodeling complex 1 (e-rc1) is shown to #generate a dnase i hypersensitive within the recombinational synapse .
we believe us is shown to #generate a monoclonal antibody against fhl2 within the recombinational synapse .
we believe we is shown to #generate a monoclonal antibody against fhl2 within the recombinational synapse .
we show that the tbc method , to #generate sequential overlapping fragments .
we show that a swi/snf-related chromatin remodeling complex , eklf coactivator-remodeling complex 1 (e-rc1) , to #generate a dnase i hypersensitive .
we show that this binding , to #generate a higher order protein-dna complex .
we show that us , to #generate a monoclonal antibody against fhl2 .
a dnase i hypersensitive (from malate , and the dcub permease for fumarate , malate , and aspartate) were #generated by a swi/snf-related chromatin remodeling complex , eklf coactivator-remodeling complex 1 (e-rc1) .
a dnase i hypersensitive are #generated by a swi/snf-related chromatin remodeling complex , eklf coactivator-remodeling complex 1 (e-rc1) .
a dnase i hypersensitive can be #generated from a swi/snf-related chromatin remodeling complex , eklf coactivator-remodeling complex 1 (e-rc1) by beta- and gamma-secretases .
a dnase i hypersensitive have been #generated from a swi/snf-related chromatin remodeling complex , eklf coactivator-remodeling complex 1 (e-rc1) by beta- and gamma-secretases .
a dnase i hypersensitive were #generated by a swi/snf-related chromatin remodeling complex , eklf coactivator-remodeling complex 1 (e-rc1) .
a dnase i hypersensitive were #generated from a swi/snf-related chromatin remodeling complex , eklf coactivator-remodeling complex 1 (e-rc1) by beta- and gamma-secretases .
a swi/snf-related chromatin remodeling complex , eklf coactivator-remodeling complex 1 (e-rc1) #generates a dnase i hypersensitive ( approximately 0 .4-0 .5 kb ) for each of the gene sequences , and simultaneous and sequential combinations of overlapping fragments are tested for their ability to be assembled under an array of pcr conditions .
a swi/snf-related chromatin remodeling complex , eklf coactivator-remodeling complex 1 (e-rc1) #generates a dnase i hypersensitive .
a swi/snf-related chromatin remodeling complex , eklf coactivator-remodeling complex 1 (e-rc1) is able to #generate a dnase i hypersensitive .
a swi/snf-related chromatin remodeling complex , eklf coactivator-remodeling complex 1 (e-rc1) was optimized to #generate a dnase i hypersensitive ( approximately 0 .4-0 .5 kb ) for each of the gene sequences , and simultaneous and sequential combinations of overlapping fragments were tested for their ability to be assembled under an array of pcr conditions .
a swi/snf-related chromatin remodeling complex , eklf coactivator-remodeling complex 1 (e-rc1) , #generating a dnase i hypersensitive .
a higher order protein-dna complex (from malate , and the dcub permease for fumarate , malate , and aspartate) are #generated by this binding .
a higher order protein-dna complex (from malate , and the dcub permease for fumarate , malate , and aspartate) were #generated by this binding .
a higher order protein-dna complex are #generated by this binding .
a higher order protein-dna complex are #generated from this binding by beta- and gamma-secretases .
a higher order protein-dna complex was #generated by this binding .
a monoclonal antibody against fhl2 (from malate , and the dcub permease for fumarate , malate , and aspartate) are #generated by us .
a monoclonal antibody against fhl2 (from malate , and the dcub permease for fumarate , malate , and aspartate) were #generated by us .
a monoclonal antibody against fhl2 (from malate , and the dcub permease for fumarate , malate , and aspartate) were #generated by we .
a monoclonal antibody against fhl2 are #generated from us by beta- and gamma-secretases .
a monoclonal antibody against fhl2 have been #generated from us by beta- and gamma-secretases .
a monoclonal antibody against fhl2 have been #generated from we by beta- and gamma-secretases .
a monoclonal antibody against fhl2 is #generated by we within the recombinational synapse .
a monoclonal antibody against fhl2 is #generated by we .
sequential overlapping fragments (from malate , and the dcub permease for fumarate , malate , and aspartate) were #generated by the tbc method .
sequential overlapping fragments are #generated by the tbc method .
sequential overlapping fragments can be #generated from the tbc method by beta- and gamma-secretases .
sequential overlapping fragments is #generated by the tbc method .
sequential overlapping fragments was #generated by the tbc method within the recombinational synapse .
sequential overlapping fragments were #generated by the tbc method .
sequential overlapping fragments were #generated from the tbc method by beta- and gamma-secretases .
the 21-23 nt long mature rnas (from malate , and the dcub permease for fumarate , malate , and aspartate) were #generated by the bidentate rnase iii dicer .
the 21-23 nt long mature rnas have been #generated from the bidentate rnase iii dicer by beta- and gamma-secretases .
the 21-23 nt long mature rnas is #generated by the bidentate rnase iii dicer .
this binding can #generate a higher order protein-dna complex .
this binding cleaves microrna precursors to #generate a higher order protein-dna complex .
this binding #generated a higher order protein-dna complex ( approximately 0 .4-0 .5 kb ) for each of the gene sequences , and simultaneous and sequential combinations of overlapping fragments were tested for their ability to be assembled under an array of pcr conditions .
this binding #generates a higher order protein-dna complex .
this binding may #generate a higher order protein-dna complex ( approximately 0 .4-0 .5 kb ) for each of the gene sequences , and simultaneous and sequential combinations of overlapping fragments can be tested for their ability to be assembled under an array of pcr conditions .
this binding was optimized to #generate a higher order protein-dna complex ( approximately 0 .4-0 .5 kb ) for each of the gene sequences , and simultaneous and sequential combinations of overlapping fragments were tested for their ability to be assembled under an array of pcr conditions .
this binding , #generating a higher order protein-dna complex .
us cleaves microrna precursors to #generate a monoclonal antibody against fhl2 .
us #generated a monoclonal antibody against fhl2 ( approximately 0 .4-0 .5 kb ) for each of the gene sequences , and simultaneous and sequential combinations of overlapping fragments were tested for their ability to be assembled under an array of pcr conditions .
us #generated a monoclonal antibody against fhl2 .
us #generates a monoclonal antibody against fhl2 ( approximately 0 .4-0 .5 kb ) for each of the gene sequences , and simultaneous and sequential combinations of overlapping fragments are tested for their ability to be assembled under an array of pcr conditions .
us #generates a monoclonal antibody against fhl2 within the recombinational synapse .
us #generates a monoclonal antibody against fhl2 .
us has #generated a monoclonal antibody against fhl2 .
us , #generating a monoclonal antibody against fhl2 .
we cleaves microrna precursors to #generate a monoclonal antibody against fhl2 .
we #generated a monoclonal antibody against fhl2 within the recombinational synapse .
we #generated a monoclonal antibody against fhl2 .
we #generates a monoclonal antibody against fhl2 .
we has #generated a monoclonal antibody against fhl2 ( approximately 0 .4-0 .5 kb ) for each of the gene sequences , and simultaneous and sequential combinations of overlapping fragments have been tested for their ability to be assembled under an array of pcr conditions .
we has #generated a monoclonal antibody against fhl2 .
we may #generate a monoclonal antibody against fhl2 ( approximately 0 .4-0 .5 kb ) for each of the gene sequences , and simultaneous and sequential combinations of overlapping fragments can be tested for their ability to be assembled under an array of pcr conditions .
although no crystal structure of the ar is available to date , one might speculate that human leukocyte antigen (hla)-g molecules has been #generated by an alternative splicing of the primary transcript of the gene
although no crystal structure of the ar is available to date , one might speculate that human leukocyte antigen (hla)-g molecules will be #generated by an alternative splicing of the primary transcript of the gene .
although no crystal structure of the ar is available to date , one might speculate that a functional interaction surface has been #generated by the ar n-terminus
although no crystal structure of the ar is available to date , one might speculate that a functional interaction surface is #generated by the ar n-terminus .
although no crystal structure of the ar is available to date , one might speculate that a functional interaction surface was #generated by the ar n-terminus .
although no crystal structure of the ar is available to date , one might speculate that an rna splice of 3863 bases occurring in the 5-untranslated region #generated mature hela cell mrna .
although no crystal structure of the ar is available to date , one might speculate that an rna splice of 3863 bases occurring in the 5-untranslated region is either directly involved in the ar-fhl2 interaction or , alternatively , is essential for #generating mature hela cell mrna .
although no crystal structure of the ar is available to date , one might speculate that an rna splice of 3863 bases occurs in the 5-untranslated region #generates mature hela cell mrna .
although no crystal structure of the ar is available to date , one might speculate that an alternative splicing of the primary transcript of the gene #generates human leukocyte antigen (hla)-g molecules .
although no crystal structure of the ar is available to date , one might speculate that aspartate-ammonia lyase #generates fumarate .
although no crystal structure of the ar is available to date , one might speculate that aspartate-ammonia lyase is either directly involved in the ar-fhl2 interaction or , alternatively , is essential for #generating fumarate .
although no crystal structure of the ar is available to date , one might speculate that fumarate will be #generated by aspartate-ammonia lyase .
although no crystal structure of the ar is available to date , one might speculate that mature hela cell mrna has been #generated by an rna splice of 3863 bases occurring in the 5-untranslated region
although no crystal structure of the ar is available to date , one might speculate that mature hela cell mrna has been #generated by an rna splice of 3863 bases occurs in the 5-untranslated region
although no crystal structure of the ar is available to date , one might speculate that mature hela cell mrna is #generated by an rna splice of 3863 bases occurs in the 5-untranslated region .
although no crystal structure of the ar is available to date , one might speculate that mature hela cell mrna was #generated by an rna splice of 3863 bases occurring in the 5-untranslated region .
although no crystal structure of the ar is available to date , one might speculate that mature hela cell mrna was #generated by an rna splice of 3863 bases occurs in the 5-untranslated region .
although no crystal structure of the ar is available to date , one might speculate that mature hela cell mrna will be #generated by an rna splice of 3863 bases occurring in the 5-untranslated region .
although no crystal structure of the ar is available to date , one might speculate that mature hela cell mrna will be #generated by an rna splice of 3863 bases occurs in the 5-untranslated region .
although no crystal structure of the ar is available to date , one might speculate that the ar n-terminus is either directly involved in the ar-fhl2 interaction or , alternatively , is essential for #generating a functional interaction surface .
human leukocyte antigen (hla)-g molecules (from malate , and the dcub permease for fumarate , malate , and aspartate) were #generated by an alternative splicing of the primary transcript of the gene .
human leukocyte antigen (hla)-g molecules an alternative splicing of the primary transcript of the genere #generated by we .
human leukocyte antigen (hla)-g molecules an alternative splicing of the primary transcript of the genere #generated from we by beta- and gamma-secretases .
human leukocyte antigen (hla)-g molecules are #generated by an alternative splicing of the primary transcript of the gene .
human leukocyte antigen (hla)-g molecules can be #generated from an alternative splicing of the primary transcript of the gene by beta- and gamma-secretases .
human leukocyte antigen (hla)-g molecules was #generated by an alternative splicing of the primary transcript of the gene .
human leukocyte antigen (hla)-g molecules were #generated by an alternative splicing of the primary transcript of the gene .
human leukocyte antigen (hla)-g molecules were #generated from an alternative splicing of the primary transcript of the gene by beta- and gamma-secretases .
in addition , there was an apparent absence of loan rna splice of 3863 bases occurring in the 5-untranslated regionr molecular weight fragments as evidence of we , although again the relatively small fraction involved and the possibility that degradation does not #generate mature hela cell mrna or occurs rapidly precludes any definitive conclusions .
in addition , there was an apparent absence of loan rna splice of 3863 bases occurring in the 5-untranslated regionr molecular weight fragments as evidence of we , although again the relatively small fraction involved and the possibility that mature hela cell mrna have not been #generated by degradation .
in addition , there was an apparent absence of loan rna splice of 3863 bases occurs in the 5-untranslated regionr molecular weight fragments as evidence of we , although again the relatively small fraction involved and the possibility that mature hela cell mrna are not #generated by degradation .
in addition , there was an apparent absence of loan rna splice of 3863 bases occurs in the 5-untranslated regionr molecular weight fragments as evidence of we , although again the relatively small fraction involved and the possibility that mature hela cell mrna were not #generated by degradation .
in addition , there was an apparent absence of loan rna splice of 3863 bases occurs in the 5-untranslated regionr molecular weight fragments as evidence of we , although again the relatively small fraction involved and the possibility that mature hela cell mrna will not be #generated by degradation .
in addition , there was an apparent absence of loan alternative splicing of the primary transcript of the gener molecular weight fragments as evidence of we , although again the relatively small fraction involved and the possibility that human leukocyte antigen (hla)-g molecules have not been #generated by degradation .
in addition , there was an apparent absence of loan alternative splicing of the primary transcript of the gener molecular weight fragments as evidence of we , although again the relatively small fraction involved and the possibility that human leukocyte antigen (hla)-g molecules were not #generated by degradation .
in addition , there was an apparent absence of loan alternative splicing of the primary transcript of the gener molecular weight fragments as evidence of we , although again the relatively small fraction involved and the possibility that degradation does not #generate human leukocyte antigen (hla)-g molecules or occurs rapidly precludes any definitive conclusions .
in addition , there was an apparent absence of loaspartate-ammonia lyaser molecular weight fragments as evidence of we , although again the relatively small fraction involved and the possibility that degradation did not #generate fumarate or occured rapidly precludes any definitive conclusions
in addition , there was an apparent absence of loaspartate-ammonia lyaser molecular weight fragments as evidence of we , although again the relatively small fraction involved and the possibility that degradation does not #generate fumarate or occurs rapidly precludes any definitive conclusions .
in addition , there was an apparent absence of lothe ar n-terminusr molecular weight fragments as evidence of we , although again the relatively small fraction involved and the possibility that a functional interaction surface have not been #generated by degradation .
in addition , there was an apparent absence of lothe ar n-terminusr molecular weight fragments as evidence of we , although again the relatively small fraction involved and the possibility that a functional interaction surface were not #generated by degradation .
in addition , there was an apparent absence of lower molecular weight fragments as evidence of an rna splice of 3863 bases occurring in the 5-untranslated region , although again the relatively small fraction involved and the possibility that mature hela cell mrna have not been #generated by degradation .
in addition , there was an apparent absence of lower molecular weight fragments as evidence of an rna splice of 3863 bases occurring in the 5-untranslated region , although again the relatively small fraction involved and the possibility that mature hela cell mrna were not #generated by degradation .
in addition , there was an apparent absence of lower molecular weight fragments as evidence of an rna splice of 3863 bases occurring in the 5-untranslated region , although again the relatively small fraction involved and the possibility that mature hela cell mrna will not be #generated by degradation .
in addition , there was an apparent absence of lower molecular weight fragments as evidence of an rna splice of 3863 bases occurs in the 5-untranslated region , although again the relatively small fraction involved and the possibility that degradation does not #generate mature hela cell mrna or occurs rapidly precludes any definitive conclusions .
in addition , there was an apparent absence of lower molecular weight fragments as evidence of an rna splice of 3863 bases occurs in the 5-untranslated region , although again the relatively small fraction involved and the possibility that mature hela cell mrna will not be #generated by degradation .
in addition , there was an apparent absence of lower molecular weight fragments as evidence of an alternative splicing of the primary transcript of the gene , although again the relatively small fraction involved and the possibility that human leukocyte antigen (hla)-g molecules were not #generated by degradation .
in addition , there was an apparent absence of lower molecular weight fragments as evidence of an alternative splicing of the primary transcript of the gene , although again the relatively small fraction involved and the possibility that human leukocyte antigen (hla)-g molecules will not be #generated by degradation .
in addition , there was an apparent absence of lower molecular weight fragments as evidence of an alternative splicing of the primary transcript of the gene , although again the relatively small fraction involved and the possibility that degradation does not #generate human leukocyte antigen (hla)-g molecules or occurs rapidly precludes any definitive conclusions .
in addition , there was an apparent absence of lower molecular weight fragments as evidence of aspartate-ammonia lyase , although again the relatively small fraction involved and the possibility that fumarate are not #generated by degradation .
in addition , there was an apparent absence of lower molecular weight fragments as evidence of aspartate-ammonia lyase , although again the relatively small fraction involved and the possibility that fumarate have not been #generated by degradation .
in addition , there was an apparent absence of lower molecular weight fragments as evidence of the ar n-terminus , although again the relatively small fraction involved and the possibility that a functional interaction surface are not #generated by degradation .
in addition , there was an apparent absence of lower molecular weight fragments as evidence of the ar n-terminus , although again the relatively small fraction involved and the possibility that a functional interaction surface were not #generated by degradation .
in the absence of l-arginine , human leukocyte antigen (hla)-g molecules (o(2)-) has been #generated by an alternative splicing of the primary transcript of the gene .
in the absence of l-arginine , human leukocyte antigen (hla)-g molecules (o(2)-) was #generated by an alternative splicing of the primary transcript of the gene .
in the absence of l-arginine , a functional interaction surface (o(2)-) has been #generated by the ar n-terminus .
in the absence of l-arginine , a functional interaction surface (o(2)-) is #generated by the ar n-terminus .
in the absence of l-arginine , a functional interaction surface (o(2)-) will be #generated by the ar n-terminus .
in the absence of l-arginine , an rna splice of 3863 bases occurring in the 5-untranslated region #generated mature hela cell mrna (o(2)-) .
in the absence of l-arginine , an rna splice of 3863 bases occurs in the 5-untranslated region #generates mature hela cell mrna (o(2)-) .
in the absence of l-arginine , an rna splice of 3863 bases occurs in the 5-untranslated region has been shown to #generate mature hela cell mrna (o(2)-) .
in the absence of l-arginine , an alternative splicing of the primary transcript of the gene has been shown to #generate human leukocyte antigen (hla)-g molecules (o(2)-) .
in the absence of l-arginine , aspartate-ammonia lyase #generated fumarate (o(2)-) .
in the absence of l-arginine , fumarate (o(2)-) is #generated by aspartate-ammonia lyase .
in the absence of l-arginine , fumarate (o(2)-) was #generated by aspartate-ammonia lyase .
in the absence of l-arginine , mature hela cell mrna (o(2)-) has been #generated by an rna splice of 3863 bases occurs in the 5-untranslated region .
in the absence of l-arginine , mature hela cell mrna (o(2)-) was #generated by an rna splice of 3863 bases occurs in the 5-untranslated region .
in the absence of l-arginine , mature hela cell mrna (o(2)-) will be #generated by an rna splice of 3863 bases occurring in the 5-untranslated region .
in the absence of l-arginine , mature hela cell mrna (o(2)-) will be #generated by an rna splice of 3863 bases occurs in the 5-untranslated region .
in the absence of l-arginine , the ar n-terminus has been shown to #generate a functional interaction surface (o(2)-) .
these are human leukocyte antigen (hla)-g molecules reductase (encoded by the frdabcd operon) , an alternative splicing of the primary transcript of the gene , which #generated fumarate from malate , the dcub permease for fumarate , malate , and aspartate .
these are human leukocyte antigen (hla)-g molecules reductase (encoded by the frdabcd operon) , an alternative splicing of the primary transcript of the gene , which #generates fumarate from malate , and the dcub permease for fumarate , malate , and aspartate .
these are human leukocyte antigen (hla)-g molecules reductase (encoded by the frdabcd operon) , an alternative splicing of the primary transcript of the gene , which have #generated fumarate from malate , the dcub permease for fumarate , malate , and aspartate .
these are a functional interaction surface reductase (encoded by the frdabcd operon) , the ar n-terminus , which will #generate fumarate from malate , the dcub permease for fumarate , malate , and aspartate .
these are fumarate reductase (encoded by the frdabcd operon) , aspartate-ammonia lyase , which have #generated fumarate from malate , the dcub permease for fumarate , malate , and aspartate .
these are fumarate reductase (encoded by the frdabcd operon) , aspartate-ammonia lyase , which will #generate fumarate from malate , the dcub permease for fumarate , malate , and aspartate .
these are mature hela cell mrna reductase (encoded by the frdabcd operon) , an rna splice of 3863 bases occurring in the 5-untranslated region , which #generated fumarate from malate , the dcub permease for fumarate , malate , and aspartate .
these are mature hela cell mrna reductase (encoded by the frdabcd operon) , an rna splice of 3863 bases occurring in the 5-untranslated region , which #generates fumarate from malate , and the dcub permease for fumarate , malate , and aspartate .
these are mature hela cell mrna reductase (encoded by the frdabcd operon) , an rna splice of 3863 bases occurring in the 5-untranslated region , which will #generate fumarate from malate , the dcub permease for fumarate , malate , and aspartate .
these are mature hela cell mrna reductase (encoded by the frdabcd operon) , an rna splice of 3863 bases occurs in the 5-untranslated region , which #generated fumarate from malate , the dcub permease for fumarate , malate , and aspartate .
these are mature hela cell mrna reductase (encoded by the frdabcd operon) , an rna splice of 3863 bases occurs in the 5-untranslated region , which #generates fumarate from malate , and the dcub permease for fumarate , malate , and aspartate .
these are mature hela cell mrna reductase (encoded by the frdabcd operon) , an rna splice of 3863 bases occurs in the 5-untranslated region , which will #generate fumarate from malate , the dcub permease for fumarate , malate , and aspartate .
to analyse specifically protein expression of fhl2 in human tissues an rna splice of 3863 bases occurs in the 5-untranslated region #generated mature hela cell mrna .
to analyse specifically protein expression of fhl2 in human tissues an rna splice of 3863 bases occurs in the 5-untranslated region may #generate mature hela cell mrna .
to analyse specifically protein expression of fhl2 in human tissues an alternative splicing of the primary transcript of the gene #generated human leukocyte antigen (hla)-g molecules .
to analyse specifically protein expression of fhl2 in human tissues an alternative splicing of the primary transcript of the gene may #generate human leukocyte antigen (hla)-g molecules .
to analyse specifically protein expression of fhl2 in human tissues aspartate-ammonia lyase #generated fumarate .
to analyse specifically protein expression of fhl2 in human tissues aspartate-ammonia lyase may #generate fumarate .
to analyse specifically protein expression of fhl2 in human tissues , human leukocyte antigen (hla)-g molecules is #generated by an alternative splicing of the primary transcript of the gene
to analyse specifically protein expression of fhl2 in human tissues , human leukocyte antigen (hla)-g molecules was #generated by an alternative splicing of the primary transcript of the gene
to analyse specifically protein expression of fhl2 in human tissues , a functional interaction surface is #generated by the ar n-terminus
to analyse specifically protein expression of fhl2 in human tissues , an rna splice of 3863 bases occurring in the 5-untranslated region will #generate mature hela cell mrna .
to analyse specifically protein expression of fhl2 in human tissues , an rna splice of 3863 bases occurs in the 5-untranslated region #generate mature hela cell mrna .
to analyse specifically protein expression of fhl2 in human tissues , an alternative splicing of the primary transcript of the gene will #generate human leukocyte antigen (hla)-g molecules .
to analyse specifically protein expression of fhl2 in human tissues , aspartate-ammonia lyase will #generate fumarate .
to analyse specifically protein expression of fhl2 in human tissues , mature hela cell mrna is #generated by an rna splice of 3863 bases occurs in the 5-untranslated region
to analyse specifically protein expression of fhl2 in human tissues , mature hela cell mrna was #generated by an rna splice of 3863 bases occurring in the 5-untranslated region
to analyse specifically protein expression of fhl2 in human tissues , mature hela cell mrna was #generated by an rna splice of 3863 bases occurs in the 5-untranslated region
to analyse specifically protein expression of fhl2 in human tissues , the ar n-terminus will #generate a functional interaction surface .
we believe an rna splice of 3863 bases occurring in the 5-untranslated region is found to #generate mature hela cell mrna within the recombinational synapse .
we believe an rna splice of 3863 bases occurring in the 5-untranslated region is required to #generate mature hela cell mrna within the recombinational synapse .
we believe an rna splice of 3863 bases occurs in the 5-untranslated region is found to #generate mature hela cell mrna within the recombinational synapse .
we believe an rna splice of 3863 bases occurs in the 5-untranslated region is required to #generate mature hela cell mrna within the recombinational synapse .
we believe an rna splice of 3863 bases occurs in the 5-untranslated region is shown to #generate mature hela cell mrna within the recombinational synapse .
we believe an alternative splicing of the primary transcript of the gene is found to #generate human leukocyte antigen (hla)-g molecules within the recombinational synapse .
we believe aspartate-ammonia lyase is shown to #generate fumarate within the recombinational synapse .
we believe the ar n-terminus is shown to #generate a functional interaction surface within the recombinational synapse .
we show that an rna splice of 3863 bases occurring in the 5-untranslated region , to #generate mature hela cell mrna .
we show that an rna splice of 3863 bases occurs in the 5-untranslated region , to #generate mature hela cell mrna .
we show that an alternative splicing of the primary transcript of the gene , to #generate human leukocyte antigen (hla)-g molecules .
we show that the ar n-terminus , to #generate a functional interaction surface .
a functional interaction surface (from malate , and the dcub permease for fumarate , malate , and aspartate) are #generated by the ar n-terminus .
a functional interaction surface (from malate , and the dcub permease for fumarate , malate , and aspartate) were #generated by the ar n-terminus .
a functional interaction surface are #generated by the ar n-terminus .
a functional interaction surface are #generated from the ar n-terminus by beta- and gamma-secretases .
a functional interaction surface can be #generated from the ar n-terminus by beta- and gamma-secretases .
a functional interaction surface have been #generated from the ar n-terminus by beta- and gamma-secretases .
a functional interaction surface is #generated by the ar n-terminus within the recombinational synapse .
a functional interaction surface is #generated by the ar n-terminus .
a functional interaction surface was #generated by the ar n-terminus within the recombinational synapse .
a functional interaction surface was #generated by the ar n-terminus .
a functional interaction surface were #generated by the ar n-terminus .
an rna splice of 3863 bases occurring in the 5-untranslated region can #generate mature hela cell mrna .
an rna splice of 3863 bases occurring in the 5-untranslated region cleaves microrna precursors to #generate mature hela cell mrna .
an rna splice of 3863 bases occurring in the 5-untranslated region #generate mature hela cell mrna .
an rna splice of 3863 bases occurring in the 5-untranslated region #generated mature hela cell mrna within the recombinational synapse .
an rna splice of 3863 bases occurring in the 5-untranslated region #generated mature hela cell mrna .
an rna splice of 3863 bases occurring in the 5-untranslated region #generates mature hela cell mrna ( approximately 0 .4-0 .5 kb ) for each of the gene sequences , and simultaneous and sequential combinations of overlapping fragments are tested for their ability to be assembled under an array of pcr conditions .
an rna splice of 3863 bases occurring in the 5-untranslated region #generates mature hela cell mrna .
an rna splice of 3863 bases occurring in the 5-untranslated region has #generated mature hela cell mrna ( approximately 0 .4-0 .5 kb ) for each of the gene sequences , and simultaneous and sequential combinations of overlapping fragments have been tested for their ability to be assembled under an array of pcr conditions .
an rna splice of 3863 bases occurring in the 5-untranslated region has #generated mature hela cell mrna .
an rna splice of 3863 bases occurring in the 5-untranslated region was optimized to #generate mature hela cell mrna ( approximately 0 .4-0 .5 kb ) for each of the gene sequences , and simultaneous and sequential combinations of overlapping fragments were tested for their ability to be assembled under an array of pcr conditions .
an rna splice of 3863 bases occurring in the 5-untranslated region , #generating mature hela cell mrna .
an rna splice of 3863 bases occurs in the 5-untranslated region can #generate mature hela cell mrna .
an rna splice of 3863 bases occurs in the 5-untranslated region cleaves microrna precursors to #generate mature hela cell mrna .
an rna splice of 3863 bases occurs in the 5-untranslated region #generate mature hela cell mrna .
an rna splice of 3863 bases occurs in the 5-untranslated region #generated mature hela cell mrna ( approximately 0 .4-0 .5 kb ) for each of the gene sequences , and simultaneous and sequential combinations of overlapping fragments were tested for their ability to be assembled under an array of pcr conditions .
an rna splice of 3863 bases occurs in the 5-untranslated region #generated mature hela cell mrna within the recombinational synapse .
an rna splice of 3863 bases occurs in the 5-untranslated region has #generated mature hela cell mrna ( approximately 0 .4-0 .5 kb ) for each of the gene sequences , and simultaneous and sequential combinations of overlapping fragments have been tested for their ability to be assembled under an array of pcr conditions .
an rna splice of 3863 bases occurs in the 5-untranslated region has #generated mature hela cell mrna .
an rna splice of 3863 bases occurs in the 5-untranslated region may #generate mature hela cell mrna ( approximately 0 .4-0 .5 kb ) for each of the gene sequences , and simultaneous and sequential combinations of overlapping fragments can be tested for their ability to be assembled under an array of pcr conditions .
an rna splice of 3863 bases occurs in the 5-untranslated region was optimized to #generate mature hela cell mrna ( approximately 0 .4-0 .5 kb ) for each of the gene sequences , and simultaneous and sequential combinations of overlapping fragments were tested for their ability to be assembled under an array of pcr conditions .
an rna splice of 3863 bases occurs in the 5-untranslated region , #generating mature hela cell mrna .
an alternative splicing of the primary transcript of the gene can #generate human leukocyte antigen (hla)-g molecules .
an alternative splicing of the primary transcript of the gene cleaves microrna precursors to #generate human leukocyte antigen (hla)-g molecules .
an alternative splicing of the primary transcript of the gene #generate human leukocyte antigen (hla)-g molecules .
an alternative splicing of the primary transcript of the gene #generated human leukocyte antigen (hla)-g molecules ( approximately 0 .4-0 .5 kb ) for each of the gene sequences , and simultaneous and sequential combinations of overlapping fragments were tested for their ability to be assembled under an array of pcr conditions .
an alternative splicing of the primary transcript of the gene #generates human leukocyte antigen (hla)-g molecules ( approximately 0 .4-0 .5 kb ) for each of the gene sequences , and simultaneous and sequential combinations of overlapping fragments are tested for their ability to be assembled under an array of pcr conditions .
an alternative splicing of the primary transcript of the gene was optimized to #generate human leukocyte antigen (hla)-g molecules ( approximately 0 .4-0 .5 kb ) for each of the gene sequences , and simultaneous and sequential combinations of overlapping fragments were tested for their ability to be assembled under an array of pcr conditions .
aspartate-ammonia lyase can #generate fumarate .
aspartate-ammonia lyase #generate fumarate .
aspartate-ammonia lyase #generated fumarate ( approximately 0 .4-0 .5 kb ) for each of the gene sequences , and simultaneous and sequential combinations of overlapping fragments were tested for their ability to be assembled under an array of pcr conditions .
aspartate-ammonia lyase #generated fumarate .
aspartate-ammonia lyase #generates fumarate ( approximately 0 .4-0 .5 kb ) for each of the gene sequences , and simultaneous and sequential combinations of overlapping fragments are tested for their ability to be assembled under an array of pcr conditions .
aspartate-ammonia lyase #generates fumarate within the recombinational synapse .
aspartate-ammonia lyase #generates fumarate .
aspartate-ammonia lyase has #generated fumarate ( approximately 0 .4-0 .5 kb ) for each of the gene sequences , and simultaneous and sequential combinations of overlapping fragments have been tested for their ability to be assembled under an array of pcr conditions .
fumarate (from malate , and the dcub permease for fumarate , malate , and aspartate) aspartate-ammonia lyasere #generated by we .
fumarate (from malate , and the dcub permease for fumarate , malate , and aspartate) were #generated by aspartate-ammonia lyase .
fumarate are #generated from aspartate-ammonia lyase by beta- and gamma-secretases .
fumarate can be #generated from aspartate-ammonia lyase by beta- and gamma-secretases .
fumarate was #generated by aspartate-ammonia lyase within the recombinational synapse .
fumarate was #generated by aspartate-ammonia lyase .
mature hela cell mrna (from malate , and the dcub permease for fumarate , malate , and aspartate) are #generated by an rna splice of 3863 bases occurs in the 5-untranslated region .
mature hela cell mrna (from malate , and the dcub permease for fumarate , malate , and aspartate) were #generated by an rna splice of 3863 bases occurring in the 5-untranslated region .
mature hela cell mrna an rna splice of 3863 bases occurs in the 5-untranslated regionre #generated from we by beta- and gamma-secretases .
mature hela cell mrna are #generated from an rna splice of 3863 bases occurring in the 5-untranslated region by beta- and gamma-secretases .
mature hela cell mrna are #generated from an rna splice of 3863 bases occurs in the 5-untranslated region by beta- and gamma-secretases .
mature hela cell mrna can be #generated from an rna splice of 3863 bases occurring in the 5-untranslated region by beta- and gamma-secretases .
mature hela cell mrna is #generated by an rna splice of 3863 bases occurring in the 5-untranslated region within the recombinational synapse .
mature hela cell mrna is #generated by an rna splice of 3863 bases occurs in the 5-untranslated region within the recombinational synapse .
mature hela cell mrna was #generated by an rna splice of 3863 bases occurs in the 5-untranslated region within the recombinational synapse .
mature hela cell mrna was #generated by an rna splice of 3863 bases occurs in the 5-untranslated region .
mature hela cell mrna were #generated by an rna splice of 3863 bases occurring in the 5-untranslated region .
the ar n-terminus cleaves microrna precursors to #generate a functional interaction surface .
the ar n-terminus #generate a functional interaction surface .
the ar n-terminus #generated a functional interaction surface .
the ar n-terminus has #generated a functional interaction surface .
the ar n-terminus was optimized to #generate a functional interaction surface ( approximately 0 .4-0 .5 kb ) for each of the gene sequences , and simultaneous and sequential combinations of overlapping fragments were tested for their ability to be assembled under an array of pcr conditions .
10mm edta can totally #inhibit binding that is concentration dependent and saturable , suggesting that divalent cations were required for interaction of in1b with vero cells .
10mm edta is totally #inhibiting binding that is concentration dependent and saturable , suggesting that divalent cations were required for interaction of in1b with vero cells .
10mm edta may have totally #inhibited binding that is concentration dependent and saturable , suggesting that divalent cations were required for interaction of in1b with vero cells .
binding is concentration dependent and saturable and has been totally #inhibited with 10mm edta , suggesting that divalent cations were required for interaction of in1b with vero cells .
binding is concentration dependent and saturable and is totally #inhibited with 10mm edta , suggesting that divalent cations were required for interaction of in1b with vero cells .
for example , the phosphatase associated with another protein is #inhibited in its function or localization .
for example , the phosphatase associated with another protein was #inhibited in its function or localization .
here , we show that glnap2 expression is affected by different carbon sources and that the crp-camp complex has #inhibited the glnap2 promoter activity .
here , we show that glnap2 expression is affected by different carbon sources and that the crp-camp complex has the ability to #inhibit the glnap2 promoter activity .
here , we show that glnap2 expression is affected by different carbon sources and that the crp-camp complex #inhibits the glnap2 promoter activity .
here , we show that glnap2 expression is affected by different carbon sources and that the crp-camp complex is able to #inhibit the glnap2 promoter activity .
here , we show that glnap2 expression is affected by different carbon sources and that the crp-camp complex will #inhibit the glnap2 promoter activity .
here , we show that glnap2 expression is affected by different carbon sources and that the glnap2 promoter activity has been #inhibited by the crp-camp complex .
here , we show that glnap2 expression is affected by different carbon sources and that the glnap2 promoter activity is able to be #inhibited by the crp-camp complex .
intriguingly , while the sh3c and sh3e domains of intersectin , as well as the sh3 domains from the endocytic proteins endophilin i , amphiphysin ii and syndaphin i , are able to selectively #inhibit late events of clathrin-coated vesicle formation involving membrane fission , intersectin sh3a was unique in its ability to block earlier stages (simpson et al . , 1999) .
nk-cell-mediated cytotoxicity has been #inhibited by cell-surface receptors of the immunoglobulin and c-type lectin superfamilies .
nk-cell-mediated cytotoxicity is #inhibited by cell-surface receptors of the immunoglobulin and c-type lectin superfamilies .
natural killer (nk) cells express cell-surface receptors of the immunoglobulin and c-type lectin superfamilies that recognized major histocompatibility complex (mhc) class i peptides and may have #inhibited nk-cell-mediated cytotoxicity .
the n-terminal sh3 domain (sh3a) , unlike other sh3 domains from intersectin or various endocytic proteins , is able to specifically #inhibit intermediate events leading to the formation of clathrin-coated pits .
the n-terminal sh3 domain (sh3a) , unlike other sh3 domains from intersectin or various endocytic proteins , specifically #inhibited intermediate events leading to the formation of clathrin-coated pits .
the half-life of the agt proteins was determined by growing cells at 37 c in lb broth supplemented with 50 mg/ml ampicillin , 50 mg/ml kanamycin and 0 .2 mm iptg until the a600 reached 0 .3 and then protein synthesis are #inhibited by 50 mg/ml chloramphenicol .
the half-life of the agt proteins was determined by growing cells at 37 c in lb broth supplemented with 50 mg/ml ampicillin , 50 mg/ml kanamycin and 0 .2 mm iptg until the a600 reached 0 .3 and then protein synthesis were about to be #inhibited by 50 mg/ml chloramphenicol .
the half-life of the agt proteins was determined by growing cells at 37 c in lb broth supplemented with 50 mg/ml ampicillin , 50 mg/ml kanamycin and 0 .2 mm iptg until the a600 reached 0 .3 and then protein synthesis were #inhibited by 50 mg/ml chloramphenicol .
the half-life of the agt proteins was determined by growing cells at 37 c in lb broth supplemented with 50 mg/ml ampicillin , 50 mg/ml kanamycin and 0 .2 mm iptg until the a600 reached 0 .3 and then protein synthesis will be #inhibited by 50 mg/ml chloramphenicol .
the phosphatases function and localization will be #inhibited if the phosphatase associates with another protein .
this synthetic peptide binding to p is able to #inhibit its binding to c3b .
this synthetic peptide binds to p and #inhibits its binding to c3b .
this synthetic peptide bound to p and then #inhibited its binding to c3b .
intermediate events leading to the formation of clathrin-coated pits are able to be #inhibited by the n-terminal sh3 domain (sh3a) which is unlike other sh3 domains from intersectin or various endocytic proteins .
intermediate events leading to the formation of clathrin-coated pits are observed to be #inhibited by the n-terminal sh3 domain (sh3a) which is unlike other sh3 domains from intersectin or various endocytic proteins .
intermediate events leading to the formation of clathrin-coated pits will be #inhibited by the n-terminal sh3 domain (sh3a) which is unlike other sh3 domains from intersectin or various endocytic proteins .
late events of clathrin-coated vesicle formation are able to be #inhibited by the sh3c and sh3e domains of intersectin , as well as the sh3 domains from the endocytic proteins endophilin i , amphiphysin ii and syndaphin i .
late events of clathrin-coated vesicle formation are #inhibited by the sh3c and sh3e domains of intersectin , as well as the sh3 domains from the endocytic proteins endophilin i , amphiphysin ii and syndaphin i .
late events of clathrin-coated vesicle formation are observed to be #inhibited by the sh3c and sh3e domains of intersectin , as well as the sh3 domains from the endocytic proteins endophilin i , amphiphysin ii and syndaphin i .
late events of clathrin-coated vesicle formation were #inhibited by the sh3c and sh3e domains of intersectin , as well as the sh3 domains from the endocytic proteins endophilin i , amphiphysin ii and syndaphin i .
late events of clathrin-coated vesicle formation will be #inhibited by the sh3c and sh3e domains of intersectin , as well as the sh3 domains from the endocytic proteins endophilin i , amphiphysin ii and syndaphin i .
binding was concentration dependent and saturable and was totally #inhibited with 10mm edta , suggesting that divalent cations were required for interaction of in1b with vero cells .
for example , the phosphatase may associate with another protein and thereby be #inhibited in its function or localization .
the half-life of the agt proteins was determined by growing cells at 37 c in lb broth supplemented with 50 mg/ml ampicillin , 50 mg/ml kanamycin and 0 .2 mm iptg until the a600 reached 0 .3 and then treating them with 50 mg/ml chloramphenicol to #inhibit protein synthesis .
functional activation of an hiv reporter plasmid by p49/p65 in transiently transfected jurkat t-leukemia cells was also #inhibited by coexpression of mad-3 .
here , we show that glnap2 expression is affected by different carbon sources and that the crp-camp complex #inhibits the glnap2 promoter activity .
10mm edta (no) activated the soluble isoform of guanylate cyclase in platelets and has #inhibited binding .
10mm edta (no) activated the soluble isoform of guanylate cyclase in platelets and #inhibited binding .
10mm edta (no) activates the soluble isoform of guanylate cyclase in platelets and has the ability to #inhibit binding .
10mm edta (no) #inhibiting binding activated the soluble isoform of guanylate cyclase in platelets .
10mm edta (no) that has #inhibited binding activated the soluble isoform of guanylate cyclase in platelets .
binding can be #inhibited by 10mm edta (no) which activates the soluble isoform of guanylate cyclase in platelets .
binding has been #inhibited by 10mm edta (no) which activates the soluble isoform of guanylate cyclase in platelets .
binding in transiently transfected jurkat t-leukemia cells has also been #inhibited by 10mm edta .
binding in transiently transfected jurkat t-leukemia cells is also #inhibited by 10mm edta .
binding in transiently transfected jurkat t-leukemia cells wil also be #inhibited by 10mm edta .
binding is observed to be #inhibited by 10mm edta .
binding were #inhibited by 10mm edta .
binding will be #inhibited by 10mm edta .
for example , p associated with this synthetic peptide is #inhibited in its binding to c3b .
for example , p associated with this synthetic peptide was #inhibited in its binding to c3b .
for example , p associates with this synthetic peptide and is thereby #inhibited in its binding to c3b .
for example , p may have associated with this synthetic peptide and thereby has been #inhibited in its binding to c3b .
for example , glnap2 promoter associated with the crp-camp complex is #inhibited in the glnap2 promoter activity .
for example , glnap2 promoter associated with the crp-camp complex may be #inhibited in the glnap2 promoter activity .
for example , glnap2 promoter associated with the crp-camp complex was #inhibited in the glnap2 promoter activity .
for example , glnap2 promoter associates with the crp-camp complex and is thereby #inhibited in the glnap2 promoter activity .
for example , glnap2 promoter may associate with the crp-camp complex and thereby be #inhibited in the glnap2 promoter activity .
for example , the phosphatase associated with another protein is #inhibited in the phosphatases function and localization .
for example , the phosphatase associated with another protein was #inhibited in the phosphatases function and localization .
for example , the phosphatase associates with another protein and is thereby #inhibited in the phosphatases function and localization .
for example , the phosphatase may associate with another protein and thereby be #inhibited in the phosphatases function and localization .
functional activation of an hiv reporter plasmid by p49/p65 are able to be #inhibited by by coexpression of mad-3 .
functional activation of an hiv reporter plasmid by p49/p65 are observed to be #inhibited by by coexpression of mad-3 .
functional activation of an hiv reporter plasmid by p49/p65 can be #inhibited by by coexpression of mad-3 (no) which activates the soluble isoform of guanylate cyclase in platelets .
functional activation of an hiv reporter plasmid by p49/p65 in transiently transfected jurkat t-leukemia cells is also #inhibited by by coexpression of mad-3 .
functional activation of an hiv reporter plasmid by p49/p65 in transiently transfected jurkat t-leukemia cells wil also be #inhibited by by coexpression of mad-3 .
functional activation of an hiv reporter plasmid by p49/p65 is able to be #inhibited by by coexpression of mad-3 (no) which activates the soluble isoform of guanylate cyclase in platelets .
functional activation of an hiv reporter plasmid by p49/p65 is able to be #inhibited by by coexpression of mad-3 .
functional activation of an hiv reporter plasmid by p49/p65 is concentration dependent and saturable and has been totally #inhibited with by coexpression of mad-3 , suggesting that divalent cations were required for interaction of in1b with vero cells .
functional activation of an hiv reporter plasmid by p49/p65 is concentration dependent and saturable and is able to be totally #inhibited with by coexpression of mad-3 , suggesting that divalent cations were required for interaction of in1b with vero cells .
functional activation of an hiv reporter plasmid by p49/p65 is concentration dependent and saturable and is observed to be totally #inhibited with by coexpression of mad-3 , suggesting that divalent cations were required for interaction of in1b with vero cells .
functional activation of an hiv reporter plasmid by p49/p65 is concentration dependent and saturable and may be totally #inhibited with by coexpression of mad-3 , suggesting that divalent cations were required for interaction of in1b with vero cells .
functional activation of an hiv reporter plasmid by p49/p65 is #inhibited by by coexpression of mad-3 (no) which activates the soluble isoform of guanylate cyclase in platelets .
functional activation of an hiv reporter plasmid by p49/p65 is #inhibited by by coexpression of mad-3 .
functional activation of an hiv reporter plasmid by p49/p65 is observed to be #inhibited by by coexpression of mad-3 (no) which activates the soluble isoform of guanylate cyclase in platelets .
functional activation of an hiv reporter plasmid by p49/p65 is observed to be #inhibited by by coexpression of mad-3 .
functional activation of an hiv reporter plasmid by p49/p65 was #inhibited by by coexpression of mad-3 .
functional activation of an hiv reporter plasmid by p49/p65 will be #inhibited by by coexpression of mad-3 (no) which activates the soluble isoform of guanylate cyclase in platelets .
gadx activates expression of gada and gadbc at any ph , while 10mm edta can #inhibit binding .
gadx activates expression of gada and gadbc at any ph , while 10mm edta has #inhibited binding .
gadx activates expression of gada and gadbc at any ph , while 10mm edta is observed to #inhibit binding .
gadx activates expression of gada and gadbc at any ph , while 10mm edta may have #inhibited binding .
gadx activates expression of gada and gadbc at any ph , while binding has been #inhibited by 10mm edta .
gadx activates expression of gada and gadbc at any ph , while binding will be #inhibited by 10mm edta .
gadx activates expression of gada and gadbc at any ph , while functional activation of an hiv reporter plasmid by p49/p65 has been #inhibited by by coexpression of mad-3 .
gadx activates expression of gada and gadbc at any ph , while functional activation of an hiv reporter plasmid by p49/p65 is #inhibited by by coexpression of mad-3 .
gadx activates expression of gada and gadbc at any ph , while nk-cell-mediated cytotoxicity is observed to be #inhibited by cell-surface receptors of the immunoglobulin and c-type lectin superfamilies .
gadx activates expression of gada and gadbc at any ph , while by coexpression of mad-3 is able to #inhibit functional activation of an hiv reporter plasmid by p49/p65 .
gadx activates expression of gada and gadbc at any ph , while by coexpression of mad-3 will #inhibit functional activation of an hiv reporter plasmid by p49/p65 .
gadx activates expression of gada and gadbc at any ph , while cell-surface receptors of the immunoglobulin and c-type lectin superfamilies #inhibits nk-cell-mediated cytotoxicity .
gadx activates expression of gada and gadbc at any ph , while cell-surface receptors of the immunoglobulin and c-type lectin superfamilies is able to #inhibit nk-cell-mediated cytotoxicity .
gadx activates expression of gada and gadbc at any ph , while cell-surface receptors of the immunoglobulin and c-type lectin superfamilies may have #inhibited nk-cell-mediated cytotoxicity .
gadx activates expression of gada and gadbc at any ph , while cell-surface receptors of the immunoglobulin and c-type lectin superfamilies will #inhibit nk-cell-mediated cytotoxicity .
gadx activates expression of gada and gadbc at any ph , while chloramphenicol can #inhibit protein synthesis .
gadx activates expression of gada and gadbc at any ph , while chloramphenicol has #inhibited protein synthesis .
gadx activates expression of gada and gadbc at any ph , while chloramphenicol is observed to #inhibit protein synthesis .
gadx activates expression of gada and gadbc at any ph , while chloramphenicol may have #inhibited protein synthesis .
gadx activates expression of gada and gadbc at any ph , while chloramphenicol will #inhibit protein synthesis .
gadx activates expression of gada and gadbc at any ph , while late events of clathrin-coated vesicle formation has been #inhibited by the sh3c and sh3e domains of intersectin , as well as the sh3 domains from the endocytic proteins endophilin i , amphiphysin ii and syndaphin i .
gadx activates expression of gada and gadbc at any ph , while late events of clathrin-coated vesicle formation is #inhibited by the sh3c and sh3e domains of intersectin , as well as the sh3 domains from the endocytic proteins endophilin i , amphiphysin ii and syndaphin i .
gadx activates expression of gada and gadbc at any ph , while the crp-camp complex can #inhibit the glnap2 promoter activity .
gadx activates expression of gada and gadbc at any ph , while the crp-camp complex is able to #inhibit the glnap2 promoter activity .
gadx activates expression of gada and gadbc at any ph , while the sh3c and sh3e domains of intersectin , as well as the sh3 domains from the endocytic proteins endophilin i , amphiphysin ii and syndaphin i can #inhibit late events of clathrin-coated vesicle formation .
gadx activates expression of gada and gadbc at any ph , while the sh3c and sh3e domains of intersectin , as well as the sh3 domains from the endocytic proteins endophilin i , amphiphysin ii and syndaphin i has #inhibited late events of clathrin-coated vesicle formation .
gadx activates expression of gada and gadbc at any ph , while the sh3c and sh3e domains of intersectin , as well as the sh3 domains from the endocytic proteins endophilin i , amphiphysin ii and syndaphin i may have #inhibited late events of clathrin-coated vesicle formation .
gadx activates expression of gada and gadbc at any ph , while the sh3c and sh3e domains of intersectin , as well as the sh3 domains from the endocytic proteins endophilin i , amphiphysin ii and syndaphin i will have #inhibited late events of clathrin-coated vesicle formation .
gadx activates expression of gada and gadbc at any ph , while the sh3c and sh3e domains of intersectin , as well as the sh3 domains from the endocytic proteins endophilin i , amphiphysin ii and syndaphin i will #inhibit late events of clathrin-coated vesicle formation .
gadx activates expression of gada and gadbc at any ph , while the glnap2 promoter activity is #inhibited by the crp-camp complex .
here , we have found that binding is #inhibited by the 10mm edta , while the downreglation of phosphorylated stat1 , stat2 and stat3 is not sensitive to these inhibitors .
here , we have found that binding was #inhibited by the 10mm edta , while the downreglation of phosphorylated stat1 , stat2 and stat3 was not sensitive to these inhibitors .
here , we have found that binding will be #inhibited by the 10mm edta , while the downreglation of phosphorylated stat1 , stat2 and stat3 was not sensitive to these inhibitors .
here , we have found that functional activation of an hiv reporter plasmid by p49/p65 has been #inhibited by the by coexpression of mad-3 , while the downreglation of phosphorylated stat1 , stat2 and stat3 was not sensitive to these inhibitors .
here , we have found that functional activation of an hiv reporter plasmid by p49/p65 will be #inhibited by the by coexpression of mad-3 , while the downreglation of phosphorylated stat1 , stat2 and stat3 was not sensitive to these inhibitors .
here , we have found that nk-cell-mediated cytotoxicity is #inhibited by the cell-surface receptors of the immunoglobulin and c-type lectin superfamilies , while the downreglation of phosphorylated stat1 , stat2 and stat3 is not sensitive to these inhibitors .
here , we have found that nk-cell-mediated cytotoxicity was #inhibited by the cell-surface receptors of the immunoglobulin and c-type lectin superfamilies , while the downreglation of phosphorylated stat1 , stat2 and stat3 was not sensitive to these inhibitors .
here , we have found that late events of clathrin-coated vesicle formation has been #inhibited by the the sh3c and sh3e domains of intersectin , as well as the sh3 domains from the endocytic proteins endophilin i , amphiphysin ii and syndaphin i , while the downreglation of phosphorylated stat1 , stat2 and stat3 was not sensitive to these inhibitors .
here , we have found that late events of clathrin-coated vesicle formation is #inhibited by the the sh3c and sh3e domains of intersectin , as well as the sh3 domains from the endocytic proteins endophilin i , amphiphysin ii and syndaphin i , while the downreglation of phosphorylated stat1 , stat2 and stat3 is not sensitive to these inhibitors .
here , we have found that late events of clathrin-coated vesicle formation is observed to be #inhibited by the the sh3c and sh3e domains of intersectin , as well as the sh3 domains from the endocytic proteins endophilin i , amphiphysin ii and syndaphin i , while the downreglation of phosphorylated stat1 , stat2 and stat3 was not sensitive to these inhibitors .
here , we have found that late events of clathrin-coated vesicle formation was #inhibited by the the sh3c and sh3e domains of intersectin , as well as the sh3 domains from the endocytic proteins endophilin i , amphiphysin ii and syndaphin i , while the downreglation of phosphorylated stat1 , stat2 and stat3 was not sensitive to these inhibitors .
here , we have found that late events of clathrin-coated vesicle formation will be #inhibited by the the sh3c and sh3e domains of intersectin , as well as the sh3 domains from the endocytic proteins endophilin i , amphiphysin ii and syndaphin i , while the downreglation of phosphorylated stat1 , stat2 and stat3 was not sensitive to these inhibitors .
here , we have found that protein synthesis has been #inhibited by the chloramphenicol , while the downreglation of phosphorylated stat1 , stat2 and stat3 was not sensitive to these inhibitors .
here , we have found that protein synthesis is #inhibited by the chloramphenicol , while the downreglation of phosphorylated stat1 , stat2 and stat3 is not sensitive to these inhibitors .
here , we have found that the glnap2 promoter activity is #inhibited by the the crp-camp complex , while the downreglation of phosphorylated stat1 , stat2 and stat3 is not sensitive to these inhibitors .
here , we have found that the glnap2 promoter activity is observed to be #inhibited by the the crp-camp complex , while the downreglation of phosphorylated stat1 , stat2 and stat3 was not sensitive to these inhibitors .
here , we show that glnap2 expression is affected by different carbon sources and that 10mm edta has #inhibited binding .
here , we show that glnap2 expression is affected by different carbon sources and that 10mm edta has the ability to #inhibit binding .
here , we show that glnap2 expression is affected by different carbon sources and that 10mm edta #inhibited binding .
here , we show that glnap2 expression is affected by different carbon sources and that 10mm edta is able to #inhibit binding .
here , we show that glnap2 expression is affected by different carbon sources and that 10mm edta may #inhibit binding .
here , we show that glnap2 expression is affected by different carbon sources and that 10mm edta will have #inhibited binding .
here , we show that glnap2 expression is affected by different carbon sources and that binding is able to be #inhibited by 10mm edta .
here , we show that glnap2 expression is affected by different carbon sources and that binding is #inhibited by 10mm edta .
here , we show that glnap2 expression is affected by different carbon sources and that binding is observed to be #inhibited by 10mm edta .
here , we show that glnap2 expression is affected by different carbon sources and that binding will be #inhibited by 10mm edta .
here , we show that glnap2 expression is affected by different carbon sources and that functional activation of an hiv reporter plasmid by p49/p65 is #inhibited by by coexpression of mad-3 .
here , we show that glnap2 expression is affected by different carbon sources and that functional activation of an hiv reporter plasmid by p49/p65 is observed to be #inhibited by by coexpression of mad-3 .
here , we show that glnap2 expression is affected by different carbon sources and that functional activation of an hiv reporter plasmid by p49/p65 will be #inhibited by by coexpression of mad-3 .
here , we show that glnap2 expression is affected by different carbon sources and that nk-cell-mediated cytotoxicity has been #inhibited by cell-surface receptors of the immunoglobulin and c-type lectin superfamilies .
here , we show that glnap2 expression is affected by different carbon sources and that nk-cell-mediated cytotoxicity is able to be #inhibited by cell-surface receptors of the immunoglobulin and c-type lectin superfamilies .
here , we show that glnap2 expression is affected by different carbon sources and that nk-cell-mediated cytotoxicity is #inhibited by cell-surface receptors of the immunoglobulin and c-type lectin superfamilies .
here , we show that glnap2 expression is affected by different carbon sources and that nk-cell-mediated cytotoxicity will be #inhibited by cell-surface receptors of the immunoglobulin and c-type lectin superfamilies .
here , we show that glnap2 expression is affected by different carbon sources and that by coexpression of mad-3 has the ability to #inhibit functional activation of an hiv reporter plasmid by p49/p65 .
here , we show that glnap2 expression is affected by different carbon sources and that by coexpression of mad-3 #inhibited functional activation of an hiv reporter plasmid by p49/p65 .
here , we show that glnap2 expression is affected by different carbon sources and that by coexpression of mad-3 is able to #inhibit functional activation of an hiv reporter plasmid by p49/p65 .
here , we show that glnap2 expression is affected by different carbon sources and that cell-surface receptors of the immunoglobulin and c-type lectin superfamilies #inhibited nk-cell-mediated cytotoxicity .
here , we show that glnap2 expression is affected by different carbon sources and that cell-surface receptors of the immunoglobulin and c-type lectin superfamilies may #inhibit nk-cell-mediated cytotoxicity .
here , we show that glnap2 expression is affected by different carbon sources and that cell-surface receptors of the immunoglobulin and c-type lectin superfamilies will have #inhibited nk-cell-mediated cytotoxicity .
here , we show that glnap2 expression is affected by different carbon sources and that cell-surface receptors of the immunoglobulin and c-type lectin superfamilies will #inhibit nk-cell-mediated cytotoxicity .
here , we show that glnap2 expression is affected by different carbon sources and that chloramphenicol #inhibited protein synthesis .
here , we show that glnap2 expression is affected by different carbon sources and that chloramphenicol is able to #inhibit protein synthesis .
here , we show that glnap2 expression is affected by different carbon sources and that chloramphenicol is observed to #inhibit protein synthesis .
here , we show that glnap2 expression is affected by different carbon sources and that chloramphenicol may #inhibit protein synthesis .
here , we show that glnap2 expression is affected by different carbon sources and that chloramphenicol will have #inhibited protein synthesis .
here , we show that glnap2 expression is affected by different carbon sources and that chloramphenicol will #inhibit protein synthesis .
here , we show that glnap2 expression is affected by different carbon sources and that late events of clathrin-coated vesicle formation has been #inhibited by the sh3c and sh3e domains of intersectin , as well as the sh3 domains from the endocytic proteins endophilin i , amphiphysin ii and syndaphin i .
here , we show that glnap2 expression is affected by different carbon sources and that late events of clathrin-coated vesicle formation is able to be #inhibited by the sh3c and sh3e domains of intersectin , as well as the sh3 domains from the endocytic proteins endophilin i , amphiphysin ii and syndaphin i .
here , we show that glnap2 expression is affected by different carbon sources and that late events of clathrin-coated vesicle formation is #inhibited by the sh3c and sh3e domains of intersectin , as well as the sh3 domains from the endocytic proteins endophilin i , amphiphysin ii and syndaphin i .
here , we show that glnap2 expression is affected by different carbon sources and that late events of clathrin-coated vesicle formation is observed to be #inhibited by the sh3c and sh3e domains of intersectin , as well as the sh3 domains from the endocytic proteins endophilin i , amphiphysin ii and syndaphin i .
here , we show that glnap2 expression is affected by different carbon sources and that late events of clathrin-coated vesicle formation will be #inhibited by the sh3c and sh3e domains of intersectin , as well as the sh3 domains from the endocytic proteins endophilin i , amphiphysin ii and syndaphin i .
here , we show that glnap2 expression is affected by different carbon sources and that protein synthesis will be #inhibited by chloramphenicol .
here , we show that glnap2 expression is affected by different carbon sources and that the sh3c and sh3e domains of intersectin , as well as the sh3 domains from the endocytic proteins endophilin i , amphiphysin ii and syndaphin i has the ability to #inhibit late events of clathrin-coated vesicle formation .
here , we show that glnap2 expression is affected by different carbon sources and that the sh3c and sh3e domains of intersectin , as well as the sh3 domains from the endocytic proteins endophilin i , amphiphysin ii and syndaphin i #inhibits late events of clathrin-coated vesicle formation .
here , we show that glnap2 expression is affected by different carbon sources and that the sh3c and sh3e domains of intersectin , as well as the sh3 domains from the endocytic proteins endophilin i , amphiphysin ii and syndaphin i will have #inhibited late events of clathrin-coated vesicle formation .
nk-cell-mediated cytotoxicity are able to be #inhibited by cell-surface receptors of the immunoglobulin and c-type lectin superfamilies .
nk-cell-mediated cytotoxicity in transiently transfected jurkat t-leukemia cells has also been #inhibited by cell-surface receptors of the immunoglobulin and c-type lectin superfamilies .
nk-cell-mediated cytotoxicity is concentration dependent and saturable and is able to be totally #inhibited with cell-surface receptors of the immunoglobulin and c-type lectin superfamilies , suggesting that divalent cations were required for interaction of in1b with vero cells .
nk-cell-mediated cytotoxicity is concentration dependent and saturable and may be totally #inhibited with cell-surface receptors of the immunoglobulin and c-type lectin superfamilies , suggesting that divalent cations were required for interaction of in1b with vero cells .
nk-cell-mediated cytotoxicity was concentration dependent and saturable and was totally #inhibited with cell-surface receptors of the immunoglobulin and c-type lectin superfamilies , suggesting that divalent cations were required for interaction of in1b with vero cells .
nk-cell-mediated cytotoxicity were #inhibited by cell-surface receptors of the immunoglobulin and c-type lectin superfamilies .
the half-life of the agt proteins was determined by growing cells at 37 c in lb broth supplemented with 50 mg/ml ampicillin , 50 mg/ml kanamycin and 0 .2 mm iptg until the a600 reached 0 .3 and then binding are #inhibited by 50 mg/ml 10mm edta .
the half-life of the agt proteins was determined by growing cells at 37 c in lb broth supplemented with 50 mg/ml ampicillin , 50 mg/ml kanamycin and 0 .2 mm iptg until the a600 reached 0 .3 and then functional activation of an hiv reporter plasmid by p49/p65 are #inhibited by 50 mg/ml by coexpression of mad-3 .
the half-life of the agt proteins was determined by growing cells at 37 c in lb broth supplemented with 50 mg/ml ampicillin , 50 mg/ml kanamycin and 0 .2 mm iptg until the a600 reached 0 .3 and then functional activation of an hiv reporter plasmid by p49/p65 were about to be #inhibited by 50 mg/ml by coexpression of mad-3 .
the half-life of the agt proteins was determined by growing cells at 37 c in lb broth supplemented with 50 mg/ml ampicillin , 50 mg/ml kanamycin and 0 .2 mm iptg until the a600 reached 0 .3 and then functional activation of an hiv reporter plasmid by p49/p65 will be #inhibited by 50 mg/ml by coexpression of mad-3 .
the half-life of the agt proteins was determined by growing cells at 37 c in lb broth supplemented with 50 mg/ml ampicillin , 50 mg/ml kanamycin and 0 .2 mm iptg until the a600 reached 0 .3 and then nk-cell-mediated cytotoxicity are #inhibited by 50 mg/ml cell-surface receptors of the immunoglobulin and c-type lectin superfamilies .
the half-life of the agt proteins was determined by growing cells at 37 c in lb broth supplemented with 50 mg/ml ampicillin , 50 mg/ml kanamycin and 0 .2 mm iptg until the a600 reached 0 .3 and then nk-cell-mediated cytotoxicity has been #inhibited by 50 mg/ml cell-surface receptors of the immunoglobulin and c-type lectin superfamilies .
the half-life of the agt proteins was determined by growing cells at 37 c in lb broth supplemented with 50 mg/ml ampicillin , 50 mg/ml kanamycin and 0 .2 mm iptg until the a600 reached 0 .3 and then late events of clathrin-coated vesicle formation are #inhibited by 50 mg/ml the sh3c and sh3e domains of intersectin , as well as the sh3 domains from the endocytic proteins endophilin i , amphiphysin ii and syndaphin i .
the half-life of the agt proteins was determined by growing cells at 37 c in lb broth supplemented with 50 mg/ml ampicillin , 50 mg/ml kanamycin and 0 .2 mm iptg until the a600 reached 0 .3 and then late events of clathrin-coated vesicle formation were about to be #inhibited by 50 mg/ml the sh3c and sh3e domains of intersectin , as well as the sh3 domains from the endocytic proteins endophilin i , amphiphysin ii and syndaphin i .
the half-life of the agt proteins was determined by growing cells at 37 c in lb broth supplemented with 50 mg/ml ampicillin , 50 mg/ml kanamycin and 0 .2 mm iptg until the a600 reached 0 .3 and then late events of clathrin-coated vesicle formation were #inhibited by 50 mg/ml the sh3c and sh3e domains of intersectin , as well as the sh3 domains from the endocytic proteins endophilin i , amphiphysin ii and syndaphin i .
the half-life of the agt proteins was determined by growing cells at 37 c in lb broth supplemented with 50 mg/ml ampicillin , 50 mg/ml kanamycin and 0 .2 mm iptg until the a600 reached 0 .3 and then late events of clathrin-coated vesicle formation will be #inhibited by 50 mg/ml the sh3c and sh3e domains of intersectin , as well as the sh3 domains from the endocytic proteins endophilin i , amphiphysin ii and syndaphin i .
the half-life of the agt proteins was determined by growing cells at 37 c in lb broth supplemented with 50 mg/ml ampicillin , 50 mg/ml kanamycin and 0 .2 mm iptg until the a600 reached 0 .3 and then the glnap2 promoter activity are #inhibited by 50 mg/ml the crp-camp complex .
the half-life of the agt proteins was determined by growing cells at 37 c in lb broth supplemented with 50 mg/ml ampicillin , 50 mg/ml kanamycin and 0 .2 mm iptg until the a600 reached 0 .3 and then the glnap2 promoter activity has been #inhibited by 50 mg/ml the crp-camp complex .
the half-life of the agt proteins was determined by growing cells at 37 c in lb broth supplemented with 50 mg/ml ampicillin , 50 mg/ml kanamycin and 0 .2 mm iptg until the a600 reached 0 .3 and then the glnap2 promoter activity were about to be #inhibited by 50 mg/ml the crp-camp complex .
the half-life of the agt proteins was determined by growing cells at 37 c in lb broth supplemented with 50 mg/ml ampicillin , 50 mg/ml kanamycin and 0 .2 mm iptg until the a600 reached 0 .3 and then treating them with 50 mg/ml 10mm edta for #inhibiting binding .
the half-life of the agt proteins was determined by growing cells at 37 c in lb broth supplemented with 50 mg/ml ampicillin , 50 mg/ml kanamycin and 0 .2 mm iptg until the a600 reached 0 .3 and then treating them with 50 mg/ml 10mm edta to #inhibit binding .
the half-life of the agt proteins was determined by growing cells at 37 c in lb broth supplemented with 50 mg/ml ampicillin , 50 mg/ml kanamycin and 0 .2 mm iptg until the a600 reached 0 .3 and then treating them with 50 mg/ml by coexpression of mad-3 to #inhibit functional activation of an hiv reporter plasmid by p49/p65 .
the half-life of the agt proteins was determined by growing cells at 37 c in lb broth supplemented with 50 mg/ml ampicillin , 50 mg/ml kanamycin and 0 .2 mm iptg until the a600 reached 0 .3 and then treating them with 50 mg/ml cell-surface receptors of the immunoglobulin and c-type lectin superfamilies to #inhibit nk-cell-mediated cytotoxicity .
the half-life of the agt proteins was determined by growing cells at 37 c in lb broth supplemented with 50 mg/ml ampicillin , 50 mg/ml kanamycin and 0 .2 mm iptg until the a600 reached 0 .3 and then treating them with 50 mg/ml the sh3c and sh3e domains of intersectin , as well as the sh3 domains from the endocytic proteins endophilin i , amphiphysin ii and syndaphin i for #inhibiting late events of clathrin-coated vesicle formation .
the half-life of the agt proteins was determined by growing cells at 37 c in lb broth supplemented with 50 mg/ml ampicillin , 50 mg/ml kanamycin and 0 .2 mm iptg until the a600 reached 0 .3 and then treating them with 50 mg/ml the sh3c and sh3e domains of intersectin , as well as the sh3 domains from the endocytic proteins endophilin i , amphiphysin ii and syndaphin i to #inhibit late events of clathrin-coated vesicle formation .
another protein binding to the phosphatase can #inhibit its function or localization .
another protein binding to the phosphatase is able to #inhibit its function or localization .
another protein binding to the phosphatase may have #inhibited its function or localization .
another protein bound to the phosphatase and then #inhibited the phosphatases function and localization .
another protein have bound to the phosphatase and then #inhibited the phosphatases function and localization .
another protein have bound to the phosphatase and then #inhibited its function or localization .
by coexpression of mad-3 (no) activated the soluble isoform of guanylate cyclase in platelets and has #inhibited functional activation of an hiv reporter plasmid by p49/p65 .
by coexpression of mad-3 (no) activated the soluble isoform of guanylate cyclase in platelets and #inhibited functional activation of an hiv reporter plasmid by p49/p65 .
by coexpression of mad-3 (no) activates the soluble isoform of guanylate cyclase in platelets and #inhibits functional activation of an hiv reporter plasmid by p49/p65 .
by coexpression of mad-3 (no) that #inhibits functional activation of an hiv reporter plasmid by p49/p65 activates the soluble isoform of guanylate cyclase in platelets .
by coexpression of mad-3 is able to totally #inhibit functional activation of an hiv reporter plasmid by p49/p65 that is concentration dependent and saturable , suggesting that divalent cations were required for interaction of in1b with vero cells .
by coexpression of mad-3 is totally #inhibiting functional activation of an hiv reporter plasmid by p49/p65 that is concentration dependent and saturable , suggesting that divalent cations were required for interaction of in1b with vero cells .
cell-surface receptors of the immunoglobulin and c-type lectin superfamilies (no) that has #inhibited nk-cell-mediated cytotoxicity activated the soluble isoform of guanylate cyclase in platelets .
cell-surface receptors of the immunoglobulin and c-type lectin superfamilies (no) that #inhibits nk-cell-mediated cytotoxicity activates the soluble isoform of guanylate cyclase in platelets .
cell-surface receptors of the immunoglobulin and c-type lectin superfamilies can totally #inhibit nk-cell-mediated cytotoxicity that is concentration dependent and saturable , suggesting that divalent cations were required for interaction of in1b with vero cells .
cell-surface receptors of the immunoglobulin and c-type lectin superfamilies is able to totally #inhibit nk-cell-mediated cytotoxicity that is concentration dependent and saturable , suggesting that divalent cations were required for interaction of in1b with vero cells .
cell-surface receptors of the immunoglobulin and c-type lectin superfamilies is totally #inhibiting nk-cell-mediated cytotoxicity that is concentration dependent and saturable , suggesting that divalent cations were required for interaction of in1b with vero cells .
cell-surface receptors of the immunoglobulin and c-type lectin superfamilies may have totally #inhibited nk-cell-mediated cytotoxicity that is concentration dependent and saturable , suggesting that divalent cations were required for interaction of in1b with vero cells .
chloramphenicol (no) activated the soluble isoform of guanylate cyclase in platelets and was observed to #inhibit protein synthesis .
chloramphenicol (no) #inhibiting protein synthesis activated the soluble isoform of guanylate cyclase in platelets .
chloramphenicol (no) that has #inhibited protein synthesis activated the soluble isoform of guanylate cyclase in platelets .
chloramphenicol (no) that #inhibits protein synthesis activates the soluble isoform of guanylate cyclase in platelets .
chloramphenicol can totally #inhibit protein synthesis that is concentration dependent and saturable , suggesting that divalent cations were required for interaction of in1b with vero cells .
chloramphenicol is able to totally #inhibit protein synthesis that is concentration dependent and saturable , suggesting that divalent cations were required for interaction of in1b with vero cells .
chloramphenicol may have totally #inhibited protein synthesis that is concentration dependent and saturable , suggesting that divalent cations were required for interaction of in1b with vero cells .
its function or localization will be #inhibited if the phosphatase associates with another protein .
its function or localization would be #inhibited if the phosphatase associated with another protein .
late events of clathrin-coated vesicle formation can be #inhibited by the sh3c and sh3e domains of intersectin , as well as the sh3 domains from the endocytic proteins endophilin i , amphiphysin ii and syndaphin i (no) which activates the soluble isoform of guanylate cyclase in platelets .
late events of clathrin-coated vesicle formation in transiently transfected jurkat t-leukemia cells has also been #inhibited by the sh3c and sh3e domains of intersectin , as well as the sh3 domains from the endocytic proteins endophilin i , amphiphysin ii and syndaphin i .
late events of clathrin-coated vesicle formation in transiently transfected jurkat t-leukemia cells is also #inhibited by the sh3c and sh3e domains of intersectin , as well as the sh3 domains from the endocytic proteins endophilin i , amphiphysin ii and syndaphin i .
late events of clathrin-coated vesicle formation in transiently transfected jurkat t-leukemia cells wil also be #inhibited by the sh3c and sh3e domains of intersectin , as well as the sh3 domains from the endocytic proteins endophilin i , amphiphysin ii and syndaphin i .
late events of clathrin-coated vesicle formation is concentration dependent and saturable and has been totally #inhibited with the sh3c and sh3e domains of intersectin , as well as the sh3 domains from the endocytic proteins endophilin i , amphiphysin ii and syndaphin i , suggesting that divalent cations were required for interaction of in1b with vero cells .
late events of clathrin-coated vesicle formation is concentration dependent and saturable and is observed to be totally #inhibited with the sh3c and sh3e domains of intersectin , as well as the sh3 domains from the endocytic proteins endophilin i , amphiphysin ii and syndaphin i , suggesting that divalent cations were required for interaction of in1b with vero cells .
late events of clathrin-coated vesicle formation is concentration dependent and saturable and is totally #inhibited with the sh3c and sh3e domains of intersectin , as well as the sh3 domains from the endocytic proteins endophilin i , amphiphysin ii and syndaphin i , suggesting that divalent cations were required for interaction of in1b with vero cells .
late events of clathrin-coated vesicle formation is concentration dependent and saturable and may be totally #inhibited with the sh3c and sh3e domains of intersectin , as well as the sh3 domains from the endocytic proteins endophilin i , amphiphysin ii and syndaphin i , suggesting that divalent cations were required for interaction of in1b with vero cells .
late events of clathrin-coated vesicle formation is #inhibited by the sh3c and sh3e domains of intersectin , as well as the sh3 domains from the endocytic proteins endophilin i , amphiphysin ii and syndaphin i (no) which activates the soluble isoform of guanylate cyclase in platelets .
late events of clathrin-coated vesicle formation is observed to be #inhibited by the sh3c and sh3e domains of intersectin , as well as the sh3 domains from the endocytic proteins endophilin i , amphiphysin ii and syndaphin i (no) which activates the soluble isoform of guanylate cyclase in platelets .
late events of clathrin-coated vesicle formation is observed to be #inhibited by the sh3c and sh3e domains of intersectin , as well as the sh3 domains from the endocytic proteins endophilin i , amphiphysin ii and syndaphin i .
late events of clathrin-coated vesicle formation may have been #inhibited by the sh3c and sh3e domains of intersectin , as well as the sh3 domains from the endocytic proteins endophilin i , amphiphysin ii and syndaphin i (no) which activates the soluble isoform of guanylate cyclase in platelets .
late events of clathrin-coated vesicle formation was concentration dependent and saturable and was totally #inhibited with the sh3c and sh3e domains of intersectin , as well as the sh3 domains from the endocytic proteins endophilin i , amphiphysin ii and syndaphin i , suggesting that divalent cations were required for interaction of in1b with vero cells .
late events of clathrin-coated vesicle formation was #inhibited by the sh3c and sh3e domains of intersectin , as well as the sh3 domains from the endocytic proteins endophilin i , amphiphysin ii and syndaphin i .
late events of clathrin-coated vesicle formation were #inhibited by the sh3c and sh3e domains of intersectin , as well as the sh3 domains from the endocytic proteins endophilin i , amphiphysin ii and syndaphin i (no) which activates the soluble isoform of guanylate cyclase in platelets .
late events of clathrin-coated vesicle formation will be #inhibited by the sh3c and sh3e domains of intersectin , as well as the sh3 domains from the endocytic proteins endophilin i , amphiphysin ii and syndaphin i (no) which activates the soluble isoform of guanylate cyclase in platelets .
protein synthesis are able to be #inhibited by chloramphenicol .
protein synthesis are #inhibited by chloramphenicol .
protein synthesis has been #inhibited by chloramphenicol (no) which activates the soluble isoform of guanylate cyclase in platelets .
protein synthesis has been #inhibited by chloramphenicol .
protein synthesis in transiently transfected jurkat t-leukemia cells is also #inhibited by chloramphenicol .
protein synthesis is able to be #inhibited by chloramphenicol .
protein synthesis is concentration dependent and saturable and is able to be totally #inhibited with chloramphenicol , suggesting that divalent cations were required for interaction of in1b with vero cells .
protein synthesis is concentration dependent and saturable and is observed to be totally #inhibited with chloramphenicol , suggesting that divalent cations were required for interaction of in1b with vero cells .
protein synthesis is concentration dependent and saturable and is totally #inhibited with chloramphenicol , suggesting that divalent cations were required for interaction of in1b with vero cells .
protein synthesis is concentration dependent and saturable and may be totally #inhibited with chloramphenicol , suggesting that divalent cations were required for interaction of in1b with vero cells .
protein synthesis is #inhibited by chloramphenicol (no) which activates the soluble isoform of guanylate cyclase in platelets .
protein synthesis is #inhibited by chloramphenicol .
protein synthesis is observed to be #inhibited by chloramphenicol (no) which activates the soluble isoform of guanylate cyclase in platelets .
protein synthesis is observed to be #inhibited by chloramphenicol .
protein synthesis was concentration dependent and saturable and was totally #inhibited with chloramphenicol , suggesting that divalent cations were required for interaction of in1b with vero cells .
protein synthesis were #inhibited by chloramphenicol .
protein synthesis will be #inhibited by chloramphenicol .
the 10mm edta have #inhibited binding .
the 10mm edta #inhibit binding .
the crp-camp complex (no) activated the soluble isoform of guanylate cyclase in platelets and has #inhibited the glnap2 promoter activity .
the crp-camp complex (no) activated the soluble isoform of guanylate cyclase in platelets and was observed to #inhibit the glnap2 promoter activity .
the crp-camp complex (no) activates the soluble isoform of guanylate cyclase in platelets and has the ability to #inhibit the glnap2 promoter activity .
the crp-camp complex (no) activates the soluble isoform of guanylate cyclase in platelets and #inhibits the glnap2 promoter activity .
the crp-camp complex (no) #inhibiting the glnap2 promoter activity activated the soluble isoform of guanylate cyclase in platelets .
the crp-camp complex (no) that has #inhibited the glnap2 promoter activity activated the soluble isoform of guanylate cyclase in platelets .
the crp-camp complex can totally #inhibit the glnap2 promoter activity that is concentration dependent and saturable , suggesting that divalent cations were required for interaction of in1b with vero cells .
the crp-camp complex is able to totally #inhibit the glnap2 promoter activity that is concentration dependent and saturable , suggesting that divalent cations were required for interaction of in1b with vero cells .
the sh3c and sh3e domains of intersectin , as well as the sh3 domains from the endocytic proteins endophilin i , amphiphysin ii and syndaphin i (no) activated the soluble isoform of guanylate cyclase in platelets and has #inhibited late events of clathrin-coated vesicle formation .
the sh3c and sh3e domains of intersectin , as well as the sh3 domains from the endocytic proteins endophilin i , amphiphysin ii and syndaphin i (no) activated the soluble isoform of guanylate cyclase in platelets and was observed to #inhibit late events of clathrin-coated vesicle formation .
the sh3c and sh3e domains of intersectin , as well as the sh3 domains from the endocytic proteins endophilin i , amphiphysin ii and syndaphin i (no) #inhibiting late events of clathrin-coated vesicle formation activated the soluble isoform of guanylate cyclase in platelets .
the sh3c and sh3e domains of intersectin , as well as the sh3 domains from the endocytic proteins endophilin i , amphiphysin ii and syndaphin i (no) that has #inhibited late events of clathrin-coated vesicle formation activated the soluble isoform of guanylate cyclase in platelets .
the sh3c and sh3e domains of intersectin , as well as the sh3 domains from the endocytic proteins endophilin i , amphiphysin ii and syndaphin i may have totally #inhibited late events of clathrin-coated vesicle formation that is concentration dependent and saturable , suggesting that divalent cations were required for interaction of in1b with vero cells .
the by coexpression of mad-3 are able to #inhibit functional activation of an hiv reporter plasmid by p49/p65 .
the by coexpression of mad-3 can #inhibit functional activation of an hiv reporter plasmid by p49/p65 .
the by coexpression of mad-3 have the ability to #inhibit functional activation of an hiv reporter plasmid by p49/p65 .
the cell-surface receptors of the immunoglobulin and c-type lectin superfamilies can #inhibit nk-cell-mediated cytotoxicity .
the cell-surface receptors of the immunoglobulin and c-type lectin superfamilies have the ability to #inhibit nk-cell-mediated cytotoxicity .
the cell-surface receptors of the immunoglobulin and c-type lectin superfamilies #inhibit nk-cell-mediated cytotoxicity .
the cell-surface receptors of the immunoglobulin and c-type lectin superfamilies may have #inhibited nk-cell-mediated cytotoxicity .
the chloramphenicol can #inhibit protein synthesis .
the chloramphenicol have the ability to #inhibit protein synthesis .
the chloramphenicol #inhibit protein synthesis .
the chloramphenicol may have #inhibited protein synthesis .
the glnap2 promoter activity are able to be #inhibited by the crp-camp complex .
the glnap2 promoter activity has been #inhibited by the crp-camp complex (no) which activates the soluble isoform of guanylate cyclase in platelets .
the glnap2 promoter activity has been #inhibited by the crp-camp complex .
the glnap2 promoter activity in transiently transfected jurkat t-leukemia cells has also been #inhibited by the crp-camp complex .
the glnap2 promoter activity in transiently transfected jurkat t-leukemia cells was also #inhibited the crp-camp complex .
the glnap2 promoter activity in transiently transfected jurkat t-leukemia cells wil also be #inhibited by the crp-camp complex .
the glnap2 promoter activity is able to be #inhibited by the crp-camp complex .
the glnap2 promoter activity is concentration dependent and saturable and has been totally #inhibited with the crp-camp complex , suggesting that divalent cations were required for interaction of in1b with vero cells .
the glnap2 promoter activity is concentration dependent and saturable and is observed to be totally #inhibited with the crp-camp complex , suggesting that divalent cations were required for interaction of in1b with vero cells .
the glnap2 promoter activity is #inhibited by the crp-camp complex (no) which activates the soluble isoform of guanylate cyclase in platelets .
the glnap2 promoter activity may have been #inhibited by the crp-camp complex (no) which activates the soluble isoform of guanylate cyclase in platelets .
the glnap2 promoter activity was #inhibited by the crp-camp complex .
the glnap2 promoter activity were #inhibited by the crp-camp complex .
the glnap2 promoter activity will be #inhibited by the crp-camp complex .
the glnap2 promoter activity would be #inhibited if glnap2 promoter associated with the crp-camp complex .
the the crp-camp complex can #inhibit the glnap2 promoter activity .
the the crp-camp complex #inhibited the glnap2 promoter activity .
the the crp-camp complex may have #inhibited the glnap2 promoter activity .
the the sh3c and sh3e domains of intersectin , as well as the sh3 domains from the endocytic proteins endophilin i , amphiphysin ii and syndaphin i have the ability to #inhibit late events of clathrin-coated vesicle formation .
the the sh3c and sh3e domains of intersectin , as well as the sh3 domains from the endocytic proteins endophilin i , amphiphysin ii and syndaphin i #inhibited late events of clathrin-coated vesicle formation .
the the sh3c and sh3e domains of intersectin , as well as the sh3 domains from the endocytic proteins endophilin i , amphiphysin ii and syndaphin i may have #inhibited late events of clathrin-coated vesicle formation .
gadx activates expression of gada and gadbc at any ph , while the n-terminal sh3 domain has #inhibited intermediate events leading to the formation of clathrin-coated pits .
gadx activates expression of gada and gadbc at any ph , while the n-terminal sh3 domain will #inhibit intermediate events leading to the formation of clathrin-coated pits .
gadx activates expression of gada and gadbc at any ph , while intermediate events leading to the formation of clathrin-coated pits is #inhibited by the n-terminal sh3 domain .
gadx activates expression of gada and gadbc at any ph , while intermediate events leading to the formation of clathrin-coated pits will be #inhibited by the n-terminal sh3 domain .
here , we have found that intermediate events leading to the formation of clathrin-coated pits has been #inhibited by the the n-terminal sh3 domain , while the downreglation of phosphorylated stat1 , stat2 and stat3 was not sensitive to these inhibitors .
here , we have found that intermediate events leading to the formation of clathrin-coated pits is observed to be #inhibited by the the n-terminal sh3 domain , while the downreglation of phosphorylated stat1 , stat2 and stat3 was not sensitive to these inhibitors .
here , we show that glnap2 expression is affected by different carbon sources and that the n-terminal sh3 domain #inhibits intermediate events leading to the formation of clathrin-coated pits .
here , we show that glnap2 expression is affected by different carbon sources and that the n-terminal sh3 domain is able to #inhibit intermediate events leading to the formation of clathrin-coated pits .
here , we show that glnap2 expression is affected by different carbon sources and that the n-terminal sh3 domain may #inhibit intermediate events leading to the formation of clathrin-coated pits .
here , we show that glnap2 expression is affected by different carbon sources and that the n-terminal sh3 domain will #inhibit intermediate events leading to the formation of clathrin-coated pits .
here , we show that glnap2 expression is affected by different carbon sources and that intermediate events leading to the formation of clathrin-coated pits has been #inhibited by the n-terminal sh3 domain .
here , we show that glnap2 expression is affected by different carbon sources and that intermediate events leading to the formation of clathrin-coated pits is able to be #inhibited by the n-terminal sh3 domain .
here , we show that glnap2 expression is affected by different carbon sources and that intermediate events leading to the formation of clathrin-coated pits is #inhibited by the n-terminal sh3 domain .
here , we show that glnap2 expression is affected by different carbon sources and that intermediate events leading to the formation of clathrin-coated pits is observed to be #inhibited by the n-terminal sh3 domain .
here , we show that glnap2 expression is affected by different carbon sources and that intermediate events leading to the formation of clathrin-coated pits will be #inhibited by the n-terminal sh3 domain .
the n-terminal sh3 domain (no) activated the soluble isoform of guanylate cyclase in platelets and #inhibited intermediate events leading to the formation of clathrin-coated pits .
the n-terminal sh3 domain (no) #inhibiting intermediate events leading to the formation of clathrin-coated pits activated the soluble isoform of guanylate cyclase in platelets .
the n-terminal sh3 domain can totally #inhibit intermediate events leading to the formation of clathrin-coated pits that is concentration dependent and saturable , suggesting that divalent cations were required for interaction of in1b with vero cells .
the half-life of the agt proteins was determined by growing cells at 37 c in lb broth supplemented with 50 mg/ml ampicillin , 50 mg/ml kanamycin and 0 .2 mm iptg until the a600 reached 0 .3 and then intermediate events leading to the formation of clathrin-coated pits are #inhibited by 50 mg/ml the n-terminal sh3 domain .
the half-life of the agt proteins was determined by growing cells at 37 c in lb broth supplemented with 50 mg/ml ampicillin , 50 mg/ml kanamycin and 0 .2 mm iptg until the a600 reached 0 .3 and then intermediate events leading to the formation of clathrin-coated pits were about to be #inhibited by 50 mg/ml the n-terminal sh3 domain .
the half-life of the agt proteins was determined by growing cells at 37 c in lb broth supplemented with 50 mg/ml ampicillin , 50 mg/ml kanamycin and 0 .2 mm iptg until the a600 reached 0 .3 and then intermediate events leading to the formation of clathrin-coated pits were #inhibited by 50 mg/ml the n-terminal sh3 domain .
the half-life of the agt proteins was determined by growing cells at 37 c in lb broth supplemented with 50 mg/ml ampicillin , 50 mg/ml kanamycin and 0 .2 mm iptg until the a600 reached 0 .3 and then intermediate events leading to the formation of clathrin-coated pits will be #inhibited by 50 mg/ml the n-terminal sh3 domain .
intermediate events leading to the formation of clathrin-coated pits are observed to be #inhibited by the n-terminal sh3 domain .
intermediate events leading to the formation of clathrin-coated pits has been #inhibited by the n-terminal sh3 domain (no) which activates the soluble isoform of guanylate cyclase in platelets .
intermediate events leading to the formation of clathrin-coated pits in transiently transfected jurkat t-leukemia cells is also #inhibited by the n-terminal sh3 domain .
intermediate events leading to the formation of clathrin-coated pits is able to be #inhibited by the n-terminal sh3 domain .
intermediate events leading to the formation of clathrin-coated pits is concentration dependent and saturable and is able to be totally #inhibited with the n-terminal sh3 domain , suggesting that divalent cations were required for interaction of in1b with vero cells .
intermediate events leading to the formation of clathrin-coated pits is concentration dependent and saturable and is totally #inhibited with the n-terminal sh3 domain , suggesting that divalent cations were required for interaction of in1b with vero cells .
intermediate events leading to the formation of clathrin-coated pits is #inhibited by the n-terminal sh3 domain .
intermediate events leading to the formation of clathrin-coated pits may have been #inhibited by the n-terminal sh3 domain (no) which activates the soluble isoform of guanylate cyclase in platelets .
intermediate events leading to the formation of clathrin-coated pits was concentration dependent and saturable and was totally #inhibited with the n-terminal sh3 domain , suggesting that divalent cations were required for interaction of in1b with vero cells .
intermediate events leading to the formation of clathrin-coated pits was #inhibited by the n-terminal sh3 domain .
intermediate events leading to the formation of clathrin-coated pits were #inhibited by the n-terminal sh3 domain .
intermediate events leading to the formation of clathrin-coated pits will be #inhibited by the n-terminal sh3 domain (no) which activates the soluble isoform of guanylate cyclase in platelets .
the the n-terminal sh3 domain can #inhibit intermediate events leading to the formation of clathrin-coated pits .
the the n-terminal sh3 domain have the ability to #inhibit intermediate events leading to the formation of clathrin-coated pits .
the the n-terminal sh3 domain #inhibit intermediate events leading to the formation of clathrin-coated pits .
the the n-terminal sh3 domain #inhibited intermediate events leading to the formation of clathrin-coated pits .
apparently hela cells are able to either #initiate transcription at multiple sites within rps14 exon 1 , or cap 5 oligonucleotides which were removed from most s14 mrnas posttranscription .
apparently hela cells are believed to either #initiate transcription at multiple sites within rps14 exon 1 , or cap 5 oligonucleotides which were removed from most s14 mrnas posttranscription .
apparently hela cells are either #initiating transcription at multiple sites within rps14 exon 1 , or capping 5 oligonucleotides which were removed from most s14 mrnas posttranscription .
apparently hela cells either #initiated transcription at multiple sites within rps14 exon 1 , or capped 5 oligonucleotides which were removed from most s14 mrnas posttranscription .
apparently hela cells have the ability to either #initiate transcription at multiple sites within rps14 exon 1 , or cap 5 oligonucleotides which were removed from most s14 mrnas posttranscription .
apparently hela cells may either #initiate transcription at multiple sites within rps14 exon 1 , or cap 5 oligonucleotides which were removed from most s14 mrnas posttranscription .
apparently hela cells will either #initiate transcription at multiple sites within rps14 exon 1 , or cap 5 oligonucleotides which were removed from most s14 mrnas posttranscription .
i kappa b-epsilon translation #initiated from an internal atg codon gives rise to a protein of 45 kda , which existed as multiple phosphorylated isoforms in resting cells .
i kappa b-epsilon translation which has been #initiated from an internal atg codon gives rise to a protein of 45 kda , which existed as multiple phosphorylated isoforms in resting cells .
i kappa b-epsilon translation which was #initiated from an internal atg codon gives rise to a protein of 45 kda , which existed as multiple phosphorylated isoforms in resting cells .
i kappa b-epsilon translation will be #initiated from an internal atg codon to give rise to a protein of 45 kda , which existed as multiple phosphorylated isoforms in resting cells .
ligand binding induced cell surface receptor complex formation and activates a cascade of phosphorylation events of intracellular intermediaries termed smads #initiating transcriptional regulation .
ligand binding induced cell surface receptor complex formation and activates a cascade of phosphorylation events of intracellular intermediaries termed smads that #initiated transcriptional regulation .
ligand binding induced cell surface receptor complex formation and activates a cascade of phosphorylation events of intracellular intermediaries termed smads , which are able to #initiate transcriptional regulation .
ligand binding induced cell surface receptor complex formation and activates a cascade of phosphorylation events of intracellular intermediaries termed smads , which can #initiate transcriptional regulation .
ligand binding induced cell surface receptor complex formation and activates a cascade of phosphorylation events of intracellular intermediaries termed smads , which #initiated transcriptional regulation .
ligand binding induces cell surface receptor complex formation and activates a cascade of phosphorylation events of intracellular intermediaries termed smads that are able to #initiate transcriptional regulation .
ligand binding induces cell surface receptor complex formation and activates a cascade of phosphorylation events of intracellular intermediaries termed smads that may #initiate transcriptional regulation .
scf , like the other dimeric ligands , can initate signal transduction by direct dimerization of its receptor , kit ,and the two juxtaposed receptors undergo tyrosine autophosphorylation (heldin , 1995; broudy , 1997) , which #initiates downstream intracellular signaling .
scf , like the other dimeric ligands , have initated signal transduction by direct dimerization of its receptor , kit ,and the two juxtaposed receptors undergo tyrosine autophosphorylation (heldin , 1995; broudy , 1997) , which #initiated downstream intracellular signaling .
scf , like the other dimeric ligands , initated signal transduction by direct dimerization of its receptor , kit ,and the two juxtaposed receptors undergo tyrosine autophosphorylation (heldin , 1995; broudy , 1997) , which #initiated downstream intracellular signaling .
scf , like the other dimeric ligands , initates signal transduction by direct dimerization of its receptor , kit , and the two juxtaposed receptors undergo tyrosine autophosphorylation (heldin , 1995; broudy , 1997) , which can #initiate downstream intracellular signaling .
scf , like the other dimeric ligands , initates signal transduction by direct dimerization of its receptor , kit , and the two juxtaposed receptors undergo tyrosine autophosphorylation (heldin , 1995; broudy , 1997) , which has #initiated downstream intracellular signaling .
scf , like the other dimeric ligands , initates signal transduction by direct dimerization of its receptor , kit , and the two juxtaposed receptors undergo tyrosine autophosphorylation (heldin , 1995; broudy , 1997) , which is observed to #initiate downstream intracellular signaling .
scf , like the other dimeric ligands , will initate signal transduction by direct dimerization of its receptor , kit ,and the two juxtaposed receptors undergo tyrosine autophosphorylation (heldin , 1995; broudy , 1997) , which #initiates downstream intracellular signaling .
since rtks #initiated signaling by recruiting downstream components to the activated receptor , proteins that are immediately downstream of an activated rtk can be identified by first identifying sequences in the rtk that are necessary to activate downstream signaling (schlessinger and ullrich , 1992; pawson , 1995) .
since rtks is able to #initiate signaling by recruiting downstream components to the activated receptor , proteins that are immediately downstream of an activated rtk can be identified by first identifying sequences in the rtk that are necessary to activate downstream signaling (schlessinger and ullrich , 1992; pawson , 1995) .
since rtks may #initiate signaling by recruiting downstream components to the activated receptor , proteins that are immediately downstream of an activated rtk can be identified by first identifying sequences in the rtk that are necessary to activate downstream signaling (schlessinger and ullrich , 1992; pawson , 1995) .
since rtks will have #initiated signaling by recruiting downstream components to the activated receptor , proteins that are immediately downstream of an activated rtk can be identified by first identifying sequences in the rtk that are necessary to activate downstream signaling (schlessinger and ullrich , 1992; pawson , 1995) .
since signaling can be #initiated by rtks by recruiting downstream components to the activated receptor , proteins that are immediately downstream of an activated rtk can be identified by first identifying sequences in the rtk that are necessary to activate downstream signaling (schlessinger and ullrich , 1992; pawson , 1995) .
since signaling is able to be #initiated by rtks by recruiting downstream components to the activated receptor , proteins that are immediately downstream of an activated rtk can be identified by first identifying sequences in the rtk that are necessary to activate downstream signaling (schlessinger and ullrich , 1992; pawson , 1995) .
since signaling is observed to be #initiated by rtks by recruiting downstream components to the activated receptor , proteins that are immediately downstream of an activated rtk can be identified by first identifying sequences in the rtk that are necessary to activate downstream signaling (schlessinger and ullrich , 1992; pawson , 1995) .
sxl is a key regulator of sex determination and dosage compensation , whose transcription has been #initiated only in female blastoderm embryos .
sxl was a key regulator of sex determination and dosage compensation , whose transcription can be #initiated only in female blastoderm embryos .
sxl was a key regulator of sex determination and dosage compensation , whose transcription is able to be #initiated only in female blastoderm embryos .
sxl was a key regulator of sex determination and dosage compensation , whose transcription may be #initiated only in female blastoderm embryos .
sxl was a key regulator of sex determination and dosage compensation , whose transcription may have been #initiated only in female blastoderm embryos .
sxl was a key regulator of sex determination and dosage compensation , whose transcription will be #initiated only in female blastoderm embryos .
this has led to the prevailing interpretation that genetic changes , in addition to those present in the most advanced clone of the primary tumor , are required for #initiating invasion , dissemination , and growth at anatomically distant sites .
transcription can be #initiated from a sigma (70)-dependent promoter at the g residue of the upstream gatc sequence .
transcription has been #initiated from a sigma (70)-dependent promoter at the g residue of the upstream gatc sequence .
transcription is able to be #initiated from a sigma (70)-dependent promoter at the g residue of the upstream gatc sequence .
transcription is #initiated from a sigma (70)-dependent promoter at the g residue of the upstream gatc sequence .
transcription is observed to be #initiated from a sigma (70)-dependent promoter at the g residue of the upstream gatc sequence .
transcription may be #initiated from a sigma (70)-dependent promoter at the g residue of the upstream gatc sequence .
transcription may have been #initiated from a sigma (70)-dependent promoter at the g residue of the upstream gatc sequence .
transcription of ptsg encoding glucose-specific permease , enzyme iicb (glc) , in escherichia coli can be #initiated from two promoters , p1 and p2 .
transcription of ptsg encoding glucose-specific permease , enzyme iicb (glc) , in escherichia coli may be #initiated from two promoters , p1 and p2 .
transcription of ptsg encoding glucose-specific permease , enzyme iicb (glc) , in escherichia coli was #initiated from two promoters , p1 and p2 .
transcription of ptsg encoding glucose-specific permease , enzyme iicb (glc) , in escherichia coli will be #initiated from two promoters , p1 and p2 .
transcription of the divergently transcribed glptq and glpacb operons has been #initiated at sites separated by 132 base pairs (bp) of dna .
transcription of the divergently transcribed glptq and glpacb operons is #initiated at sites separated by 132 base pairs (bp) of dna .
transcription of the divergently transcribed glptq and glpacb operons is observed to be #initiated at sites separated by 132 base pairs (bp) of dna .
transcription of the divergently transcribed glptq and glpacb operons may be #initiated at sites separated by 132 base pairs (bp) of dna .
transcription of the divergently transcribed glptq and glpacb operons may have been #initiated at sites separated by 132 base pairs (bp) of dna .
transcription will be #initiated from a sigma (70)-dependent promoter at the g residue of the upstream gatc sequence .
tumours with breakpoints just 5 to exon 1 , or distant from c-myc , have normal c-myc mrnas of 2 .25 and 2 .4 kb , which differ at their 5 ends , while tumours with breakpoints within exon 1 or intron 1 alter c-myc mrnas (2 .1-2 .7 kb in burkitt lines) , which can be #initiated within intron 1 .
tumours with breakpoints just 5 to exon 1 , or distant from c-myc , have normal c-myc mrnas of 2 .25 and 2 .4 kb , which differ at their 5 ends , while tumours with breakpoints within exon 1 or intron 1 alter c-myc mrnas (2 .1-2 .7 kb in burkitt lines) , which is able to be #initiated within intron 1 .
tumours with breakpoints just 5 to exon 1 , or distant from c-myc , have normal c-myc mrnas of 2 .25 and 2 .4 kb , which differ at their 5 ends , while tumours with breakpoints within exon 1 or intron 1 alter c-myc mrnas (2 .1-2 .7 kb in burkitt lines) , which is #initiated within intron 1 .
tumours with breakpoints just 5 to exon 1 , or distant from c-myc , have normal c-myc mrnas of 2 .25 and 2 .4 kb , which differ at their 5 ends , while tumours with breakpoints within exon 1 or intron 1 alter c-myc mrnas (2 .1-2 .7 kb in burkitt lines) , which is observed to be #initiated within intron 1 .
tumours with breakpoints just 5 to exon 1 , or distant from c-myc , have normal c-myc mrnas of 2 .25 and 2 .4 kb , which differ at their 5 ends , while tumours with breakpoints within exon 1 or intron 1 alter c-myc mrnas (2 .1-2 .7 kb in burkitt lines) , which may be #initiated within intron 1 .
tumours with breakpoints just 5 to exon 1 , or distant from c-myc , have normal c-myc mrnas of 2 .25 and 2 .4 kb , which differ at their 5 ends , while tumours with breakpoints within exon 1 or intron 1 alter c-myc mrnas (2 .1-2 .7 kb in burkitt lines) , which may have been #initiated within intron 1 .
tumours with breakpoints just 5 to exon 1 , or distant from c-myc , have normal c-myc mrnas of 2 .25 and 2 .4 kb , which differ at their 5 ends , while tumours with breakpoints within exon 1 or intron 1 alter c-myc mrnas (2 .1-2 .7 kb in burkitt lines) , which was #initiated within intron 1 .
tumours with breakpoints just 5 to exon 1 , or distant from c-myc , have normal c-myc mrnas of 2 .25 and 2 .4 kb , which differ at their 5 ends , while tumours with breakpoints within exon 1 or intron 1 alter c-myc mrnas that is able to be #initiated within intron 1 .
tumours with breakpoints just 5 to exon 1 , or distant from c-myc , have normal c-myc mrnas of 2 .25 and 2 .4 kb , which differ at their 5 ends , while tumours with breakpoints within exon 1 or intron 1 alter c-myc mrnas that is believed to be #initiated within intron 1 .
tumours with breakpoints just 5 to exon 1 , or distant from c-myc , have normal c-myc mrnas of 2 .25 and 2 .4 kb , which differ at their 5 ends , while tumours with breakpoints within exon 1 or intron 1 alter c-myc mrnas that may have been #initiated within intron 1 .
tumours with breakpoints just 5 to exon 1 , or distant from c-myc , have normal c-myc mrnas of 2 .25 and 2 .4 kb , which differ at their 5 ends , while tumours with breakpoints within exon 1 or intron 1 alter c-myc mrnas that was #initiated within intron 1 .
signal transduction can be #initiated by scf by direct dimerization of its receptor , kit ,and the two juxtaposed receptors undergo tyrosine autophosphorylation (heldin , 1995; broudy , 1997) , which #initiated downstream intracellular signaling .
signal transduction has been #initiated by scf by direct dimerization of its receptor , kit ,and the two juxtaposed receptors undergo tyrosine autophosphorylation (heldin , 1995; broudy , 1997) , which #initiated downstream intracellular signaling .
signal transduction is #initiated by scf by direct dimerization of its receptor , kit ,and the two juxtaposed receptors undergo tyrosine autophosphorylation (heldin , 1995; broudy , 1997) , which #initiated downstream intracellular signaling .
scf , like the other dimeric ligands , initates signal transduction by direct dimerization of its receptor , kit ,and the two juxtaposed receptors undergo tyrosine autophosphorylation (heldin , 1995; broudy , 1997) , which #initiates downstream intracellular signaling .
since rtks #initiate signaling by recruiting downstream components to the activated receptor , proteins that are immediately downstream of an activated rtk can be identified by first identifying sequences in the rtk that are necessary to activate downstream signaling (schlessinger and ullrich , 1992; pawson , 1995) .
sxl is a key regulator of sex determination and dosage compensation , whose transcription is #initiated only in female blastoderm embryos .
transcription of ptsg encoding glucose-specific permease , enzyme iicb (glc) , in escherichia coli is #initiated from two promoters , p1 and p2 .
transcription of the divergently transcribed glptq and glpacb operons is #initiated at sites separated by 132 base pairs (bp) of dna .
i kappa b-epsilon translation is #initiated from an internal atg codon to give rise to a protein of 45 kda , which exists as multiple phosphorylated isoforms in resting cells .
tumours with breakpoints just 5 to exon 1 , or distant from c-myc , had normal c-myc mrnas of 2 .25 and 2 .4 kb , which differ at their 5 ends , while tumours with breakpoints within exon 1 or intron 1 had altered c-myc mrnas (2 .1-2 .7 kb in burkitt lines) , #initiated within intron 1 .
i kappa b-epsilon translation can be #initiated from an internal atg codon at the g residue of the upstream gatc sequence .
i kappa b-epsilon translation has the ability to be #initiated from an internal atg codon at the g residue of the upstream gatc sequence .
i kappa b-epsilon translation will be #initiated from an internal atg codon at the g residue of the upstream gatc sequence .
ligand binding induced cell surface receptor complex formation and activates a cascade of phosphorylation events of intracellular intermediaries termed tyrosine autophosphorylation , which have #initiated downstream intracellular signaling .
ligand binding induces cell surface receptor complex formation and activates a cascade of phosphorylation events of intracellular intermediaries termed tyrosine autophosphorylation that may #initiate downstream intracellular signaling .
rtks are able to #initiate signaling by recruiting downstream components to the activated receptor , thereby raising cytosolic ca(2+) , [ca(2+)](i) .
rtks are believed to #initiate signaling by recruiting downstream components to the activated receptor , thereby raising cytosolic ca(2+) , [ca(2+)](i) .
rtks can #initiate signaling by recruiting downstream components to the activated receptor , thereby raising cytosolic ca(2+) , [ca(2+)](i) .
rtks have the ability to #initiate signaling by recruiting downstream components to the activated receptor , thereby raising cytosolic ca(2+) , [ca(2+)](i) .
rtks #initiated signaling by recruiting downstream components to the activated receptor , thereby raising cytosolic ca(2+) , [ca(2+)](i) .
rtks may have #initiated signaling by recruiting downstream components to the activated receptor , thereby raising cytosolic ca(2+) , [ca(2+)](i) .
rtks will #initiate signaling by recruiting downstream components to the activated receptor , thereby raising cytosolic ca(2+) , [ca(2+)](i) .
rtks , like the other dimeric ligands , have initated signaling recruiting downstream components to the activated receptor , kit ,and the two juxtaposed receptors undergo tyrosine autophosphorylation (heldin , 1995; broudy , 1997) , which #initiated downstream intracellular signaling .
rtks , like the other dimeric ligands , is able to initate signaling recruiting downstream components to the activated receptor , kit ,and the two juxtaposed receptors undergo tyrosine autophosphorylation (heldin , 1995; broudy , 1997) , which #initiated downstream intracellular signaling .
scf have the ability to #initiate signal transduction by by direct dimerization of its receptor , thereby raising cytosolic ca(2+) , [ca(2+)](i) .
scf #initiate signal transduction by by direct dimerization of its receptor , thereby raising cytosolic ca(2+) , [ca(2+)](i) .
scf #initiated signal transduction by by direct dimerization of its receptor , thereby raising cytosolic ca(2+) , [ca(2+)](i) .
scf may have #initiated signal transduction by by direct dimerization of its receptor , thereby raising cytosolic ca(2+) , [ca(2+)](i) .
scf will #initiate signal transduction by by direct dimerization of its receptor , thereby raising cytosolic ca(2+) , [ca(2+)](i) .
scf , like the other dimeric ligands , initates signal transduction by direct dimerization of its receptor , kit , and the two juxtaposed receptors undergo smads (heldin , 1995; broudy , 1997) , which #initiated transcriptional regulation .
scf , like the other dimeric ligands , initates signal transduction by direct dimerization of its receptor , kit , and the two juxtaposed receptors undergo smads (heldin , 1995; broudy , 1997) , which is able to #initiate transcriptional regulation .
since scf are #initiating signal transduction by by direct dimerization of its receptor , proteins that are immediately downstream of an activated rtk can be identified by first identifying sequences in the rtk that are necessary to activate downstream signaling (schlessinger and ullrich , 1992; pawson , 1995) .
since scf #initiate signal transduction by by direct dimerization of its receptor , proteins that are immediately downstream of an activated rtk can be identified by first identifying sequences in the rtk that are necessary to activate downstream signaling (schlessinger and ullrich , 1992; pawson , 1995) .
since scf is observed to #initiate signal transduction by by direct dimerization of its receptor , proteins that are immediately downstream of an activated rtk can be identified by first identifying sequences in the rtk that are necessary to activate downstream signaling (schlessinger and ullrich , 1992; pawson , 1995) .
since scf may have #initiated signal transduction by by direct dimerization of its receptor , proteins that are immediately downstream of an activated rtk can be identified by first identifying sequences in the rtk that are necessary to activate downstream signaling (schlessinger and ullrich , 1992; pawson , 1995) .
since scf will have #initiated signal transduction by by direct dimerization of its receptor , proteins that are immediately downstream of an activated rtk can be identified by first identifying sequences in the rtk that are necessary to activate downstream signaling (schlessinger and ullrich , 1992; pawson , 1995) .
since signal transduction can be #initiated by scf by by direct dimerization of its receptor , proteins that are immediately downstream of an activated rtk can be identified by first identifying sequences in the rtk that are necessary to activate downstream signaling (schlessinger and ullrich , 1992; pawson , 1995) .
since signal transduction is #initiated by scf by by direct dimerization of its receptor , proteins that are immediately downstream of an activated rtk can be identified by first identifying sequences in the rtk that are necessary to activate downstream signaling (schlessinger and ullrich , 1992; pawson , 1995) .
since signal transduction may be #initiated by scf by by direct dimerization of its receptor , proteins that are immediately downstream of an activated rtk can be identified by first identifying sequences in the rtk that are necessary to activate downstream signaling (schlessinger and ullrich , 1992; pawson , 1995) .
transcription being #initiated from a sigma (70)-dependent promoter gives rise to a protein of 45 kda , which existed as multiple phosphorylated isoforms in resting cells .
transcription has been #initiated from a sigma (70)-dependent promoter to give rise to a protein of 45 kda , which existed as multiple phosphorylated isoforms in resting cells .
transcription that is #initiated from a sigma (70)-dependent promoter gives rise to a protein of 45 kda , which existed as multiple phosphorylated isoforms in resting cells .
transcription was #initiated from a sigma (70)-dependent promoter to give rise to a protein of 45 kda , which existed as multiple phosphorylated isoforms in resting cells .
transcription which was #initiated from a sigma (70)-dependent promoter gives rise to a protein of 45 kda , which existed as multiple phosphorylated isoforms in resting cells .
downstream intracellular signaling is #initiated by tyrosine autophosphorylation , followed by phosphoryl group transfer to the regulator arca .
downstream intracellular signaling may have been #initiated by tyrosine autophosphorylation , followed by phosphoryl group transfer to the regulator arca .
transcriptional regulation could be #initiated by smads , followed by phosphoryl group transfer to the regulator arca .
transcriptional regulation has been #initiated by smads , followed by phosphoryl group transfer to the regulator arca .
transcriptional regulation is #initiated by smads , followed by phosphoryl group transfer to the regulator arca .
transcriptional regulation may have been #initiated by smads , followed by phosphoryl group transfer to the regulator arca .
ligand binding induced cell surface receptor complex formation and activates a cascade of phosphorylation events of intracellular intermediaries termed scf #initiating signal transduction .
ligand binding induced cell surface receptor complex formation and activates a cascade of phosphorylation events of intracellular intermediaries termed scf , which have #initiated signal transduction .
ligand binding induced cell surface receptor complex formation and activates a cascade of phosphorylation events of intracellular intermediaries termed scf , which #initiated signal transduction .
ligand binding induced cell surface receptor complex formation and activates a cascade of phosphorylation events of intracellular intermediaries termed scf , which may #initiate signal transduction .
ligand binding induced cell surface receptor complex formation and activates a cascade of phosphorylation events of intracellular intermediaries termed scf , which will #initiate signal transduction .
ligand binding induces cell surface receptor complex formation and activates a cascade of phosphorylation events of intracellular intermediaries termed scf that are observed to #initiate signal transduction .
ligand binding induces cell surface receptor complex formation and activates a cascade of phosphorylation events of intracellular intermediaries termed scf that have #initiated signal transduction .
scf , like the other dimeric ligands , initates signal transduction by direct dimerization of its receptor , kit , and the two juxtaposed receptors undergo scf (heldin , 1995; broudy , 1997) , which can #initiate signal transduction .
scf , like the other dimeric ligands , initates signal transduction by direct dimerization of its receptor , kit , and the two juxtaposed receptors undergo scf (heldin , 1995; broudy , 1997) , which has #initiated signal transduction .
scf , like the other dimeric ligands , initates signal transduction by direct dimerization of its receptor , kit , and the two juxtaposed receptors undergo scf (heldin , 1995; broudy , 1997) , which #initiated signal transduction .
scf , like the other dimeric ligands , initates signal transduction by direct dimerization of its receptor , kit , and the two juxtaposed receptors undergo scf (heldin , 1995; broudy , 1997) , which is able to #initiate signal transduction .
transcription of ptsg encoding glucose-specific permease can be #initiated from from two promoters , p1 and p2 at the g residue of the upstream gatc sequence .
transcription of ptsg encoding glucose-specific permease can be #initiated from from two promoters , p1 and p2 to give rise to a protein of 45 kda , which existed as multiple phosphorylated isoforms in resting cells .
transcription of ptsg encoding glucose-specific permease can be #initiated from two promoters , p1 and p2 at the g residue of the upstream gatc sequence .
transcription of ptsg encoding glucose-specific permease can be #initiated from two promoters , p1 and p2 to give rise to a protein of 45 kda , which existed as multiple phosphorylated isoforms in resting cells .
transcription of ptsg encoding glucose-specific permease has been #initiated from from two promoters , p1 and p2 at the g residue of the upstream gatc sequence .
transcription of ptsg encoding glucose-specific permease has been #initiated from from two promoters , p1 and p2 to give rise to a protein of 45 kda , which existed as multiple phosphorylated isoforms in resting cells .
transcription of ptsg encoding glucose-specific permease has been #initiated from two promoters , p1 and p2 to give rise to a protein of 45 kda , which existed as multiple phosphorylated isoforms in resting cells .
transcription of ptsg encoding glucose-specific permease has the ability to be #initiated from from two promoters , p1 and p2 at the g residue of the upstream gatc sequence .
transcription of ptsg encoding glucose-specific permease has the ability to be #initiated from two promoters , p1 and p2 at the g residue of the upstream gatc sequence .
transcription of ptsg encoding glucose-specific permease #initiated from from two promoters , p1 and p2 gives rise to a protein of 45 kda , which existed as multiple phosphorylated isoforms in resting cells .
transcription of ptsg encoding glucose-specific permease is able to be #initiated from from two promoters , p1 and p2 at the g residue of the upstream gatc sequence .
transcription of ptsg encoding glucose-specific permease is #initiated from from two promoters , p1 and p2 to give rise to a protein of 45 kda , which exists as multiple phosphorylated isoforms in resting cells .
transcription of ptsg encoding glucose-specific permease is observed to be #initiated from from two promoters , p1 and p2 to give rise to a protein of 45 kda , which existed as multiple phosphorylated isoforms in resting cells .
transcription of ptsg encoding glucose-specific permease is observed to be #initiated from two promoters , p1 and p2 to give rise to a protein of 45 kda , which existed as multiple phosphorylated isoforms in resting cells .
transcription of ptsg encoding glucose-specific permease may be #initiated from from two promoters , p1 and p2 to give rise to a protein of 45 kda , which existed as multiple phosphorylated isoforms in resting cells .
transcription of ptsg encoding glucose-specific permease may be #initiated from two promoters , p1 and p2 at the g residue of the upstream gatc sequence .
transcription of ptsg encoding glucose-specific permease may be #initiated from two promoters , p1 and p2 to give rise to a protein of 45 kda , which existed as multiple phosphorylated isoforms in resting cells .
transcription of ptsg encoding glucose-specific permease may have been #initiated from from two promoters , p1 and p2 at the g residue of the upstream gatc sequence .
transcription of ptsg encoding glucose-specific permease that is #initiated from from two promoters , p1 and p2 gives rise to a protein of 45 kda , which existed as multiple phosphorylated isoforms in resting cells .
transcription of ptsg encoding glucose-specific permease that is #initiated from two promoters , p1 and p2 gives rise to a protein of 45 kda , which existed as multiple phosphorylated isoforms in resting cells .
transcription of ptsg encoding glucose-specific permease was #initiated from two promoters , p1 and p2 at the g residue of the upstream gatc sequence .
transcription of ptsg encoding glucose-specific permease was #initiated from two promoters , p1 and p2 to give rise to a protein of 45 kda , which existed as multiple phosphorylated isoforms in resting cells .
transcription of ptsg encoding glucose-specific permease which has been #initiated from from two promoters , p1 and p2 gives rise to a protein of 45 kda , which existed as multiple phosphorylated isoforms in resting cells .
transcription of ptsg encoding glucose-specific permease which is #initiated from from two promoters , p1 and p2 gives rise to a protein of 45 kda , which existed as multiple phosphorylated isoforms in resting cells .
transcription of ptsg encoding glucose-specific permease which is #initiated from two promoters , p1 and p2 gives rise to a protein of 45 kda , which existed as multiple phosphorylated isoforms in resting cells .
transcription of ptsg encoding glucose-specific permease which was #initiated from two promoters , p1 and p2 gives rise to a protein of 45 kda , which existed as multiple phosphorylated isoforms in resting cells .
transcription of ptsg encoding glucose-specific permease will be #initiated from two promoters , p1 and p2 at the g residue of the upstream gatc sequence .
transcription of the divergently transcribed glptq and glpacb operons being #initiated from sites separated by 132 base pairs (bp) of dna gives rise to a protein of 45 kda , which existed as multiple phosphorylated isoforms in resting cells .
transcription of the divergently transcribed glptq and glpacb operons has been #initiated from sites separated by 132 base pairs (bp) of dna at the g residue of the upstream gatc sequence .
transcription of the divergently transcribed glptq and glpacb operons has been #initiated from sites separated by 132 base pairs (bp) of dna to give rise to a protein of 45 kda , which existed as multiple phosphorylated isoforms in resting cells .
transcription of the divergently transcribed glptq and glpacb operons has the ability to be #initiated from sites separated by 132 base pairs (bp) of dna at the g residue of the upstream gatc sequence .
transcription of the divergently transcribed glptq and glpacb operons is able to be #initiated from sites separated by 132 base pairs (bp) of dna at the g residue of the upstream gatc sequence .
transcription of the divergently transcribed glptq and glpacb operons is observed to be #initiated from sites separated by 132 base pairs (bp) of dna at the g residue of the upstream gatc sequence .
transcription of the divergently transcribed glptq and glpacb operons may be #initiated from sites separated by 132 base pairs (bp) of dna at the g residue of the upstream gatc sequence .
transcription of the divergently transcribed glptq and glpacb operons that is #initiated from sites separated by 132 base pairs (bp) of dna gives rise to a protein of 45 kda , which existed as multiple phosphorylated isoforms in resting cells .
transcription of the divergently transcribed glptq and glpacb operons was #initiated from sites separated by 132 base pairs (bp) of dna to give rise to a protein of 45 kda , which existed as multiple phosphorylated isoforms in resting cells .
transcription of the divergently transcribed glptq and glpacb operons which has been #initiated from sites separated by 132 base pairs (bp) of dna gives rise to a protein of 45 kda , which existed as multiple phosphorylated isoforms in resting cells .
transcription of the divergently transcribed glptq and glpacb operons which is #initiated from sites separated by 132 base pairs (bp) of dna gives rise to a protein of 45 kda , which existed as multiple phosphorylated isoforms in resting cells .
transcription of the divergently transcribed glptq and glpacb operons which may be #initiated from sites separated by 132 base pairs (bp) of dna to give rise to a protein of 45 kda , which existed as multiple phosphorylated isoforms in resting cells .
transcription of the divergently transcribed glptq and glpacb operons will be #initiated from sites separated by 132 base pairs (bp) of dna at the g residue of the upstream gatc sequence .
altered c-myc mrnas being #initiated from intron 1 gives rise to a protein of 45 kda , which existed as multiple phosphorylated isoforms in resting cells .
altered c-myc mrnas has been #initiated from intron 1 at the g residue of the upstream gatc sequence .
altered c-myc mrnas has the ability to be #initiated from intron 1 at the g residue of the upstream gatc sequence .
altered c-myc mrnas #initiated from intron 1 gives rise to a protein of 45 kda , which existed as multiple phosphorylated isoforms in resting cells .
altered c-myc mrnas may have been #initiated from intron 1 at the g residue of the upstream gatc sequence .
altered c-myc mrnas which has been #initiated from intron 1 gives rise to a protein of 45 kda , which existed as multiple phosphorylated isoforms in resting cells .
c-myc mrnas can be #initiated from intron 1 to give rise to a protein of 45 kda , which existed as multiple phosphorylated isoforms in resting cells .
c-myc mrnas has been #initiated from intron 1 at the g residue of the upstream gatc sequence .
c-myc mrnas has been #initiated from intron 1 to give rise to a protein of 45 kda , which existed as multiple phosphorylated isoforms in resting cells .
c-myc mrnas has the ability to be #initiated from intron 1 at the g residue of the upstream gatc sequence .
c-myc mrnas is #initiated from intron 1 at the g residue of the upstream gatc sequence .
c-myc mrnas is #initiated from intron 1 to give rise to a protein of 45 kda , which exists as multiple phosphorylated isoforms in resting cells .
c-myc mrnas is observed to be #initiated from intron 1 at the g residue of the upstream gatc sequence .
c-myc mrnas is observed to be #initiated from intron 1 to give rise to a protein of 45 kda , which existed as multiple phosphorylated isoforms in resting cells .
c-myc mrnas may be #initiated from intron 1 at the g residue of the upstream gatc sequence .
c-myc mrnas may have been #initiated from intron 1 at the g residue of the upstream gatc sequence .
c-myc mrnas which has been #initiated from intron 1 gives rise to a protein of 45 kda , which existed as multiple phosphorylated isoforms in resting cells .
c-myc mrnas which is #initiated from intron 1 gives rise to a protein of 45 kda , which existed as multiple phosphorylated isoforms in resting cells .
c-myc mrnas will be #initiated from intron 1 to give rise to a protein of 45 kda , which existed as multiple phosphorylated isoforms in resting cells .
signal transduction could be #initiated by scf , followed by phosphoryl group transfer to the regulator arca .
signal transduction has been #initiated by scf , followed by phosphoryl group transfer to the regulator arca .
signal transduction is able to be #initiated by scf , followed by phosphoryl group transfer to the regulator arca .
signal transduction is #initiated by scf , followed by phosphoryl group transfer to the regulator arca .
signal transduction is observed to be #initiated by scf , followed by phosphoryl group transfer to the regulator arca .
signal transduction may be #initiated by scf , followed by phosphoryl group transfer to the regulator arca .
signal transduction may have been #initiated by scf , followed by phosphoryl group transfer to the regulator arca .
signal transduction will be #initiated by scf , followed by phosphoryl group transfer to the regulator arca .
by direct sequencing of aberrant ssca conformers were revealed 15 different mutations in a total of 18 unrelated families and 13 single patients . of these , 10 were novel (7 missense mutations , 2 mutations that #lead to frameshift , and 1 mutation predicted to affect normal splicing) .
by direct sequencing of aberrant ssca conformers were revealed 15 different mutations in a total of 18 unrelated families and 13 single patients . of these , 10 were novel (7 missense mutations , 2 mutations that #led to frameshift , and 1 mutation predicted to affect normal splicing) .
by direct sequencing of aberrant ssca conformers were revealed 15 different mutations in a total of 18 unrelated families and 13 single patients . of these , 10 were novel (7 missense mutations , 2 mutations which #led to frameshift , and 1 mutation predicted to affect normal splicing) .
closer examination of the putative signal transduction pathway modulating htra transcription can #lead us to the identification of two new genes .
closer examination of the putative signal transduction pathway modulating htra transcription #leads us to the identification of two new genes .
closer examination of the putative signal transduction pathway modulating htra transcription #led us to the identification of two new genes .
closer examination of the putative signal transduction pathway modulating htra transcription will #lead us to the identification of two new genes .
cotransfection of gata-4 with mef2a , mef2c or mef2d can #lead to a synergistic 40-to 50-fold activation of the anf promoter (figure 3a) .
cotransfection of gata-4 with mef2a , mef2c or mef2d is able to #lead to a synergistic 40-to 50-fold activation of the anf promoter (figure 3a) .
cotransfection of gata-4 with mef2a , mef2c or mef2d #led to a synergistic 40-to 50-fold activation of the anf promoter (figure 3a) .
cotransfection of gata-4 with mef2a , mef2c or mef2d may #lead to a synergistic 40-to 50-fold activation of the anf promoter (figure 3a) .
in this homologous part of the genes , gpb lacks one exon due to a point mutation at the 5 splicing site of the third intron , which inactivated the 5 cleavage event of splicing and #led to ligation of the second to the fourth exon .
the mutations identified include: two frameshifts and a splice site mutation which have #led to truncated oa1 proteins; a deletion of a threonine codon at position 290; and four missense mutations , two of which involve amino acids located within putative transmembrane domains .
the splice mutation in 5 end of intron 5 can #lead to abnormal splice in exon 5 and exon 6 appears to be one of the causes of x-linked recessive adrenoleukodystrophy .
the splice mutation in 5 end of intron 5 has #led to abnormal splice in exon 5 and exon 6 appears to be one of the causes of x-linked recessive adrenoleukodystrophy .
this g:c base pair is also the strongest determinant in the sequence selection experiment #leading to the identification of the bre (lagrange et al . , 1998) .
this g:c base pair is also the strongest determinant in the sequence selection experiment which has #led to the identification of the bre (lagrange et al . , 1998) .
this has #led to a substantial diversity of nebulin and nebulette isoforms .
this is #leading to a substantial diversity of nebulin and nebulette isoforms .
this patients dna contains a c----a transversion in the splice acceptor sequence of the last intron of the only ercc-3 allele which can #lead to a 4 bp insertion in the mrna and an inactivating frameshift in the c-terminus of the protein .
this patients dna contains a c----a transversion in the splice acceptor sequence of the last intron of the only ercc-3 allele which #led to a 4 bp insertion in the mrna and an inactivating frameshift in the c-terminus of the protein .
this splice mutation in 5 end of intron 5 might has #led to abnormal splice in exon 5 and exon 6 and has brought about unstable and abnormal ald protein; the lignoceryl coa ligase could not transport very long chain fatty acids (vlcfa) into peroxisome and could not function normally; consequently , defective beta-oxidation of vlcfa in peroxisome could result in an accumulation of vlcfas in the central nervous system , adrenal gland and blood .
this splice mutation in 5 end of intron 5 might #led to abnormal splice in exon 5 and exon 6 and brought about unstable and abnormal ald protein; the lignoceryl coa ligase could not transport very long chain fatty acids (vlcfa) into peroxisome and could not function normally; consequently , defective beta-oxidation of vlcfa in peroxisome could result in an accumulation of vlcfas in the central nervous system , adrenal gland and blood .
this was caused by a point mutation (gtc----atc) at codon 383 that #led to the conservative substitution of isoleucine for valine in the putative fifth extracellular loop of the transporter .
this was caused by a point mutation (gtc----atc) at codon 383 which can #lead to the conservative substitution of isoleucine for valine in the putative fifth extracellular loop of the transporter .
this , in turn , #led to synergistic activation of the anf and other mef2 target promoters independently of the dna-binding activity of mef2 .
this , in turn , will #lead to synergistic activation of the anf and other mef2 target promoters independently of the dna-binding activity of mef2 .
we also studied in detail a complex splice site mutation , 3332dupl8bp , which #leads to an abnormal jag1 mrna , resulting in a premature stop codon .
we also studied in detail a complex splice site mutation , 3332dupl8bp , which #led to an abnormal jag1 mrna , resulting in a premature stop codon .
we also studied in detail a complex splice site mutation , 3332dupl8bp , which was found to #lead to an abnormal jag1 mrna , resulting in a premature stop codon .
we also study in detail a complex splice site mutation , 3332dupl8bp , which is believed to #lead to an abnormal jag1 mrna , resulting in a premature stop codon .
cotransfection of gata-4 with mef2a , mef2c or mef2d #leads to a synergistic 40-to 50-fold activation of the anf promoter (figure 3a) .
this g:c base pair is also the strongest determinant in the sequence selection experiment , which #led to the identification of the bre (lagrange et al . , 1998) .
this , in turn , #leads to synergistic activation of the anf and other mef2 target promoters independently of the dna-binding activity of mef2 .
in this homologous part of the genes , gpb lacks one exon due to a point mutation at the 5 splicing site of the third intron , which inactivates the 5 cleavage event of splicing and #leads to ligation of the second to the fourth exon .
the splice mutation in 5 end of intron 5 #leading to abnormal splice in exon 5 and exon 6 appears to be one of the causes of x-linked recessive adrenoleukodystrophy .
this patients dna contains a c----a transversion in the splice acceptor sequence of the last intron of the only ercc-3 allele that is detectably expressed , #leading to a 4 bp insertion in the mrna and an inactivating frameshift in the c-terminus of the protein .
this splice mutation in 5 end of intron 5 might #lead to abnormal splice in exon 5 and exon 6 and bring about unstable and abnormal ald protein; the lignoceryl coa ligase could not transport very long chain fatty acids (vlcfa) into peroxisome and could not function normally; consequently , defective beta-oxidation of vlcfa in peroxisome could result in an accumulation of vlcfas in the central nervous system , adrenal gland and blood .
this was caused by a point mutation (gtc----atc) at codon 383 , which #leads to the conservative substitution of isoleucine for valine in the putative fifth extracellular loop of the transporter .
we also studied in detail a complex splice site mutation , 3332dupl8bp , which was shown to #lead to an abnormal jag1 mrna , resulting in a premature stop codon .
7 missense mutations , 2 mutations can #lead to frameshift (figure 3a) .
7 missense mutations , 2 mutations can #lead to frameshift , an atypical form of tay-sachs disease (gm2 gangliosidosis variant ab) .
7 missense mutations , 2 mutations can #lead to frameshift .
7 missense mutations , 2 mutations can #lead us to frameshift .
7 missense mutations , 2 mutations has #led to frameshift (figure 3a) .
7 missense mutations , 2 mutations #leads to frameshift (figure 3a) .
7 missense mutations , 2 mutations #leads to frameshift , an atypical form of tay-sachs disease (gm2 gangliosidosis variant ab) .
7 missense mutations , 2 mutations #leads to frameshift .
7 missense mutations , 2 mutations #led to frameshift (figure 3a) .
7 missense mutations , 2 mutations #led to frameshift .
7 missense mutations , 2 mutations may #lead to frameshift (figure 3a) .
7 missense mutations , 2 mutations may #lead to frameshift .
7 missense mutations , 2 mutations that #leads to frameshift .
7 missense mutations , 2 mutations , but not a wild-type strain , #led to frameshift .
7 missense mutations , 2 mutations , in turn , is able to #lead to frameshift independently of the dna-binding activity of mef2 .
7 missense mutations , 2 mutations , in turn , is #leading to frameshift independently of the dna-binding activity of mef2 .
7 missense mutations , 2 mutations , in turn , #led to frameshift independently of the dna-binding activity of mef2 .
7 missense mutations , 2 mutations , in turn , will #lead to frameshift independently of the dna-binding activity of mef2 .
by direct sequencing of aberrant ssca conformers were revealed 15 different mutations in a total of 18 unrelated families and 13 single patients . of these , 10 were novel (closer examination of the putative signal transduction pathway modulating htra transcription #leading to the identification of two new genes , and 1 mutation predicted to affect normal splicing) .
by direct sequencing of aberrant ssca conformers were revealed 15 different mutations in a total of 18 unrelated families and 13 single patients . of these , 10 were novel (closer examination of the putative signal transduction pathway modulating htra transcription that #led to the identification of two new genes , and 1 mutation predicted to affect normal splicing) .
by direct sequencing of aberrant ssca conformers were revealed 15 different mutations in a total of 18 unrelated families and 13 single patients . of these , 10 were novel (cotransfection of gata-4 with mef2a , mef2c or mef2d #leading to a synergistic 40-to 50-fold activation of the anf promoter , and 1 mutation predicted to affect normal splicing) .
by direct sequencing of aberrant ssca conformers were revealed 15 different mutations in a total of 18 unrelated families and 13 single patients . of these , 10 were novel (cotransfection of gata-4 with mef2a , mef2c or mef2d that #lead to a synergistic 40-to 50-fold activation of the anf promoter , and 1 mutation predicted to affect normal splicing) .
by direct sequencing of aberrant ssca conformers were revealed 15 different mutations in a total of 18 unrelated families and 13 single patients . of these , 10 were novel (cotransfection of gata-4 with mef2a , mef2c or mef2d which #led to a synergistic 40-to 50-fold activation of the anf promoter , and 1 mutation predicted to affect normal splicing) .
by direct sequencing of aberrant ssca conformers were revealed 15 different mutations in a total of 18 unrelated families and 13 single patients . of these , 10 were novel (this that #lead to a substantial diversity of nebulin and nebulette isoforms , and 1 mutation predicted to affect normal splicing) .
by direct sequencing of aberrant ssca conformers were revealed 15 different mutations in a total of 18 unrelated families and 13 single patients . of these , 10 were novel (this that #led to a substantial diversity of nebulin and nebulette isoforms , and 1 mutation predicted to affect normal splicing) .
by direct sequencing of aberrant ssca conformers were revealed 15 different mutations in a total of 18 unrelated families and 13 single patients . of these , 10 were novel (this which #lead to synergistic activation of the anf and other mef2 target promoters , and 1 mutation predicted to affect normal splicing) .
by direct sequencing of aberrant ssca conformers were revealed 15 different mutations in a total of 18 unrelated families and 13 single patients . of these , 10 were novel (this which #led to synergistic activation of the anf and other mef2 target promoters , and 1 mutation predicted to affect normal splicing) .
by direct sequencing of aberrant ssca conformers were revealed 15 different mutations in a total of 18 unrelated families and 13 single patients . of these , 10 were novel (transduction of the mara region from a mar strain #leading to loss of ompf , and 1 mutation predicted to affect normal splicing) .
by direct sequencing of aberrant ssca conformers were revealed 15 different mutations in a total of 18 unrelated families and 13 single patients . of these , 10 were novel (transduction of the mara region from a mar strain that #led to loss of ompf , and 1 mutation predicted to affect normal splicing) .
by direct sequencing of aberrant ssca conformers were revealed 15 different mutations in a total of 18 unrelated families and 13 single patients . of these , 10 were novel (transduction of the mara region from a mar strain which #led to loss of ompf , and 1 mutation predicted to affect normal splicing) .
by direct sequencing of aberrant ssca conformers were revealed 15 different mutations in a total of 18 unrelated families and 13 single patients . of these , 10 were novel (a point mutation (gtc----atc) at codon 383 that #lead to the conservative substitution of isoleucine for valine in the putative fifth extracellular loop of the transporter , and 1 mutation predicted to affect normal splicing) .
by direct sequencing of aberrant ssca conformers were revealed 15 different mutations in a total of 18 unrelated families and 13 single patients . of these , 10 were novel (a point mutation (gtc----atc) at codon 383 that #led to the conservative substitution of isoleucine for valine in the putative fifth extracellular loop of the transporter , and 1 mutation predicted to affect normal splicing) .
by direct sequencing of aberrant ssca conformers were revealed 15 different mutations in a total of 18 unrelated families and 13 single patients . of these , 10 were novel (a point mutation (gtc----atc) at codon 383 which #lead to the conservative substitution of isoleucine for valine in the putative fifth extracellular loop of the transporter , and 1 mutation predicted to affect normal splicing) .
by direct sequencing of aberrant ssca conformers were revealed 15 different mutations in a total of 18 unrelated families and 13 single patients . of these , 10 were novel (a point mutation (gtc----atc) at codon 383 which #led to the conservative substitution of isoleucine for valine in the putative fifth extracellular loop of the transporter , and 1 mutation predicted to affect normal splicing) .
by direct sequencing of aberrant ssca conformers were revealed 15 different mutations in a total of 18 unrelated families and 13 single patients . of these , 10 were novel (the sequence selection experiment #leading to the identification of the bre , and 1 mutation predicted to affect normal splicing) .
by direct sequencing of aberrant ssca conformers were revealed 15 different mutations in a total of 18 unrelated families and 13 single patients . of these , 10 were novel (the sequence selection experiment that #lead to the identification of the bre , and 1 mutation predicted to affect normal splicing) .
by direct sequencing of aberrant ssca conformers were revealed 15 different mutations in a total of 18 unrelated families and 13 single patients . of these , 10 were novel (the sequence selection experiment that #led to the identification of the bre , and 1 mutation predicted to affect normal splicing) .
by direct sequencing of aberrant ssca conformers were revealed 15 different mutations in a total of 18 unrelated families and 13 single patients . of these , 10 were novel (the sequence selection experiment which #led to the identification of the bre , and 1 mutation predicted to affect normal splicing) .
closer examination of the putative signal transduction pathway modulating htra transcription can #lead to the identification of two new genes (figure 3a) .
closer examination of the putative signal transduction pathway modulating htra transcription can #lead to the identification of two new genes .
closer examination of the putative signal transduction pathway modulating htra transcription has #led to the identification of two new genes , an atypical form of tay-sachs disease (gm2 gangliosidosis variant ab) .
closer examination of the putative signal transduction pathway modulating htra transcription is #leading to the identification of two new genes .
closer examination of the putative signal transduction pathway modulating htra transcription #lead to the identification of two new genes .
closer examination of the putative signal transduction pathway modulating htra transcription #leads to the identification of two new genes (figure 3a) .
closer examination of the putative signal transduction pathway modulating htra transcription #leads to the identification of two new genes , an atypical form of tay-sachs disease (gm2 gangliosidosis variant ab) .
closer examination of the putative signal transduction pathway modulating htra transcription #leads to the identification of two new genes .
closer examination of the putative signal transduction pathway modulating htra transcription #led to the identification of two new genes , an atypical form of tay-sachs disease (gm2 gangliosidosis variant ab) .
closer examination of the putative signal transduction pathway modulating htra transcription #led to the identification of two new genes .
closer examination of the putative signal transduction pathway modulating htra transcription that #leads to the identification of two new genes .
closer examination of the putative signal transduction pathway modulating htra transcription , in turn , has #led to the identification of two new genes independently of the dna-binding activity of mef2 .
closer examination of the putative signal transduction pathway modulating htra transcription , in turn , is able to #lead to the identification of two new genes independently of the dna-binding activity of mef2 .
closer examination of the putative signal transduction pathway modulating htra transcription , in turn , is #leading to the identification of two new genes independently of the dna-binding activity of mef2 .
closer examination of the putative signal transduction pathway modulating htra transcription , in turn , #led to the identification of two new genes independently of the dna-binding activity of mef2 .
cotransfection of gata-4 with mef2a , mef2c or mef2d has #led to a synergistic 40-to 50-fold activation of the anf promoter , an atypical form of tay-sachs disease (gm2 gangliosidosis variant ab) .
cotransfection of gata-4 with mef2a , mef2c or mef2d has #led to a synergistic 40-to 50-fold activation of the anf promoter .
cotransfection of gata-4 with mef2a , mef2c or mef2d #lead to a synergistic 40-to 50-fold activation of the anf promoter .
cotransfection of gata-4 with mef2a , mef2c or mef2d #leads to a synergistic 40-to 50-fold activation of the anf promoter , an atypical form of tay-sachs disease (gm2 gangliosidosis variant ab) .
cotransfection of gata-4 with mef2a , mef2c or mef2d #led to a synergistic 40-to 50-fold activation of the anf promoter .
cotransfection of gata-4 with mef2a , mef2c or mef2d may #lead to a synergistic 40-to 50-fold activation of the anf promoter .
cotransfection of gata-4 with mef2a , mef2c or mef2d that #leads to a synergistic 40-to 50-fold activation of the anf promoter .
cotransfection of gata-4 with mef2a , mef2c or mef2d , but not a wild-type strain , #led to a synergistic 40-to 50-fold activation of the anf promoter .
cotransfection of gata-4 with mef2a , mef2c or mef2d , in turn , is able to #lead to a synergistic 40-to 50-fold activation of the anf promoter independently of the dna-binding activity of mef2 .
cotransfection of gata-4 with mef2a , mef2c or mef2d , in turn , will #lead to a synergistic 40-to 50-fold activation of the anf promoter independently of the dna-binding activity of mef2 .
further , experiments with an antisense-ref cdna expression vector introduced into cultured cells suggested that 7 missense mutations , 2 mutations could #lead to frameshift .
further , experiments with an antisense-ref cdna expression vector introduced into cultured cells suggested that 7 missense mutations , 2 mutations had #led to frameshift .
further , experiments with an antisense-ref cdna expression vector introduced into cultured cells suggested that 7 missense mutations , 2 mutations #led to frameshift .
further , experiments with an antisense-ref cdna expression vector introduced into cultured cells suggested that closer examination of the putative signal transduction pathway modulating htra transcription #led to the identification of two new genes .
further , experiments with an antisense-ref cdna expression vector introduced into cultured cells suggested that closer examination of the putative signal transduction pathway modulating htra transcription was able to #lead to the identification of two new genes .
further , experiments with an antisense-ref cdna expression vector introduced into cultured cells suggested that cotransfection of gata-4 with mef2a , mef2c or mef2d had #led to a synergistic 40-to 50-fold activation of the anf promoter .
further , experiments with an antisense-ref cdna expression vector introduced into cultured cells suggested that cotransfection of gata-4 with mef2a , mef2c or mef2d #led to a synergistic 40-to 50-fold activation of the anf promoter .
further , experiments with an antisense-ref cdna expression vector introduced into cultured cells suggested that this could #lead to a substantial diversity of nebulin and nebulette isoforms .
further , experiments with an antisense-ref cdna expression vector introduced into cultured cells suggested that this could #lead to synergistic activation of the anf and other mef2 target promoters .
further , experiments with an antisense-ref cdna expression vector introduced into cultured cells suggested that this was able to #lead to synergistic activation of the anf and other mef2 target promoters .
further , experiments with an antisense-ref cdna expression vector introduced into cultured cells suggested that transduction of the mara region from a mar strain was able to #lead to loss of ompf .
further , experiments with an antisense-ref cdna expression vector introduced into cultured cells suggested that a point mutation (gtc----atc) at codon 383 could #lead to the conservative substitution of isoleucine for valine in the putative fifth extracellular loop of the transporter .
further , experiments with an antisense-ref cdna expression vector introduced into cultured cells suggested that a point mutation (gtc----atc) at codon 383 #led to the conservative substitution of isoleucine for valine in the putative fifth extracellular loop of the transporter .
further , experiments with an antisense-ref cdna expression vector introduced into cultured cells suggested that a point mutation (gtc----atc) at codon 383 was able to #lead to the conservative substitution of isoleucine for valine in the putative fifth extracellular loop of the transporter .
further , experiments with an antisense-ref cdna expression vector introduced into cultured cells suggested that the sequence selection experiment #led to the identification of the bre .
further , experiments with an antisense-ref cdna expression vector introduced into cultured cells suggested that the sequence selection experiment was able to #lead to the identification of the bre .
further , experiments with an antisense-ref cdna expression vector introduced into cultured cells suggests that 7 missense mutations , 2 mutations is able to #lead to frameshift .
further , experiments with an antisense-ref cdna expression vector introduced into cultured cells suggests that closer examination of the putative signal transduction pathway modulating htra transcription is able to #lead to the identification of two new genes .
further , experiments with an antisense-ref cdna expression vector introduced into cultured cells suggests that this is able to #lead to a substantial diversity of nebulin and nebulette isoforms .
further , experiments with an antisense-ref cdna expression vector introduced into cultured cells suggests that this is able to #lead to synergistic activation of the anf and other mef2 target promoters .
further , experiments with an antisense-ref cdna expression vector introduced into cultured cells suggests that this #leads to a substantial diversity of nebulin and nebulette isoforms .
further , experiments with an antisense-ref cdna expression vector introduced into cultured cells suggests that transduction of the mara region from a mar strain is able to #lead to loss of ompf .
further , experiments with an antisense-ref cdna expression vector introduced into cultured cells suggests that a point mutation (gtc----atc) at codon 383 is able to #lead to the conservative substitution of isoleucine for valine in the putative fifth extracellular loop of the transporter .
further , experiments with an antisense-ref cdna expression vector introduced into cultured cells suggests that a point mutation (gtc----atc) at codon 383 #leads to the conservative substitution of isoleucine for valine in the putative fifth extracellular loop of the transporter .
it has been shown that this , #leading to a substantial diversity of nebulin and nebulette isoforms .
it has been shown that the sequence selection experiment , #leading to the identification of the bre .
these data suggest that 7 missense mutations , 2 mutations can #lead to frameshift that functions to stimulate phosphorylation and clustering of achrs .
these data suggest that 7 missense mutations , 2 mutations #leads to frameshift that functions to stimulate phosphorylation and clustering of achrs .
these data suggest that closer examination of the putative signal transduction pathway modulating htra transcription can #lead to the identification of two new genes that functions to stimulate phosphorylation and clustering of achrs .
these data suggest that closer examination of the putative signal transduction pathway modulating htra transcription has #led to the identification of two new genes that functions to stimulate phosphorylation and clustering of achrs .
these data suggest that cotransfection of gata-4 with mef2a , mef2c or mef2d has #led to a synergistic 40-to 50-fold activation of the anf promoter that functions to stimulate phosphorylation and clustering of achrs .
these data suggest that cotransfection of gata-4 with mef2a , mef2c or mef2d #leads to a synergistic 40-to 50-fold activation of the anf promoter that functions to stimulate phosphorylation and clustering of achrs .
these data suggest that this #leads to a substantial diversity of nebulin and nebulette isoforms that functions to stimulate phosphorylation and clustering of achrs .
these data suggest that this #leads to synergistic activation of the anf and other mef2 target promoters that functions to stimulate phosphorylation and clustering of achrs .
these data suggest that this will #lead to synergistic activation of the anf and other mef2 target promoters that functions to stimulate phosphorylation and clustering of achrs .
these data suggest that transduction of the mara region from a mar strain has #led to loss of ompf that functions to stimulate phosphorylation and clustering of achrs .
these data suggest that transduction of the mara region from a mar strain #leads to loss of ompf that functions to stimulate phosphorylation and clustering of achrs .
these data suggest that a point mutation (gtc----atc) at codon 383 can #lead to the conservative substitution of isoleucine for valine in the putative fifth extracellular loop of the transporter that functions to stimulate phosphorylation and clustering of achrs .
these data suggest that a point mutation (gtc----atc) at codon 383 will #lead to the conservative substitution of isoleucine for valine in the putative fifth extracellular loop of the transporter that functions to stimulate phosphorylation and clustering of achrs .
these data suggest that the sequence selection experiment can #lead to the identification of the bre that functions to stimulate phosphorylation and clustering of achrs .
these data suggest that the sequence selection experiment has #led to the identification of the bre that functions to stimulate phosphorylation and clustering of achrs .
these data suggest that the sequence selection experiment #leads to the identification of the bre that functions to stimulate phosphorylation and clustering of achrs .
these data suggested that 7 missense mutations , 2 mutations was able to #lead to frameshift that functions to stimulate phosphorylation and clustering of achrs .
these data suggested that closer examination of the putative signal transduction pathway modulating htra transcription was able to #lead to the identification of two new genes that functions to stimulate phosphorylation and clustering of achrs .
these data suggested that cotransfection of gata-4 with mef2a , mef2c or mef2d was able to #lead to a synergistic 40-to 50-fold activation of the anf promoter that functions to stimulate phosphorylation and clustering of achrs .
these data suggested that this #led to a substantial diversity of nebulin and nebulette isoforms that functions to stimulate phosphorylation and clustering of achrs .
these data suggested that this #led to synergistic activation of the anf and other mef2 target promoters that functions to stimulate phosphorylation and clustering of achrs .
these data suggested that this was able to #lead to a substantial diversity of nebulin and nebulette isoforms that functions to stimulate phosphorylation and clustering of achrs .
these data suggested that this was able to #lead to synergistic activation of the anf and other mef2 target promoters that functions to stimulate phosphorylation and clustering of achrs .
these data suggested that transduction of the mara region from a mar strain #led to loss of ompf that functions to stimulate phosphorylation and clustering of achrs .
these data suggested that transduction of the mara region from a mar strain was able to #lead to loss of ompf that functions to stimulate phosphorylation and clustering of achrs .
these data suggested that the sequence selection experiment was able to #lead to the identification of the bre that functions to stimulate phosphorylation and clustering of achrs .
this g:c base pair is also the strongest determinant in 7 missense mutations , 2 mutations that #leads to frameshift (lagrange et al . , 1998) .
this g:c base pair is also the strongest determinant in 7 missense mutations , 2 mutations which has #led to frameshift (lagrange et al . , 1998) .
this g:c base pair is also the strongest determinant in 7 missense mutations , 2 mutations which #leads to frameshift (lagrange et al . , 1998) .
this g:c base pair is also the strongest determinant in 7 missense mutations , 2 mutations , which #led to frameshift (lagrange et al . , 1998) .
this g:c base pair is also the strongest determinant in closer examination of the putative signal transduction pathway modulating htra transcription #leading to the identification of two new genes (lagrange et al . , 1998) .
this g:c base pair is also the strongest determinant in closer examination of the putative signal transduction pathway modulating htra transcription which has #led to the identification of two new genes (lagrange et al . , 1998) .
this g:c base pair is also the strongest determinant in closer examination of the putative signal transduction pathway modulating htra transcription which #leads to the identification of two new genes (lagrange et al . , 1998) .
this g:c base pair is also the strongest determinant in closer examination of the putative signal transduction pathway modulating htra transcription which #led to the identification of two new genes (lagrange et al . , 1998) .
this g:c base pair is also the strongest determinant in closer examination of the putative signal transduction pathway modulating htra transcription , which #led to the identification of two new genes (lagrange et al . , 1998) .
this g:c base pair is also the strongest determinant in cotransfection of gata-4 with mef2a , mef2c or mef2d #leading to a synergistic 40-to 50-fold activation of the anf promoter (lagrange et al . , 1998) .
this g:c base pair is also the strongest determinant in cotransfection of gata-4 with mef2a , mef2c or mef2d which has #led to a synergistic 40-to 50-fold activation of the anf promoter (lagrange et al . , 1998) .
this g:c base pair is also the strongest determinant in cotransfection of gata-4 with mef2a , mef2c or mef2d which #leads to a synergistic 40-to 50-fold activation of the anf promoter (lagrange et al . , 1998) .
this g:c base pair is also the strongest determinant in cotransfection of gata-4 with mef2a , mef2c or mef2d which #led to a synergistic 40-to 50-fold activation of the anf promoter (lagrange et al . , 1998) .
this g:c base pair is also the strongest determinant in this #leading to a substantial diversity of nebulin and nebulette isoforms (lagrange et al . , 1998) .
this g:c base pair is also the strongest determinant in this #leading to synergistic activation of the anf and other mef2 target promoters (lagrange et al . , 1998) .
this g:c base pair is also the strongest determinant in this which has #led to a substantial diversity of nebulin and nebulette isoforms (lagrange et al . , 1998) .
this g:c base pair is also the strongest determinant in this which has #led to synergistic activation of the anf and other mef2 target promoters (lagrange et al . , 1998) .
this g:c base pair is also the strongest determinant in this which #leads to a substantial diversity of nebulin and nebulette isoforms (lagrange et al . , 1998) .
this g:c base pair is also the strongest determinant in this which #led to a substantial diversity of nebulin and nebulette isoforms (lagrange et al . , 1998) .
this g:c base pair is also the strongest determinant in this which #led to synergistic activation of the anf and other mef2 target promoters (lagrange et al . , 1998) .
this g:c base pair is also the strongest determinant in this , which #led to synergistic activation of the anf and other mef2 target promoters (lagrange et al . , 1998) .
this g:c base pair is also the strongest determinant in transduction of the mara region from a mar strain that #leads to loss of ompf (lagrange et al . , 1998) .
this g:c base pair is also the strongest determinant in transduction of the mara region from a mar strain which has #led to loss of ompf (lagrange et al . , 1998) .
this g:c base pair is also the strongest determinant in transduction of the mara region from a mar strain which #led to loss of ompf (lagrange et al . , 1998) .
this g:c base pair is also the strongest determinant in transduction of the mara region from a mar strain , which #led to loss of ompf (lagrange et al . , 1998) .
this g:c base pair is also the strongest determinant in a point mutation (gtc----atc) at codon 383 which has #led to the conservative substitution of isoleucine for valine in the putative fifth extracellular loop of the transporter (lagrange et al . , 1998) .
this g:c base pair is also the strongest determinant in a point mutation (gtc----atc) at codon 383 which #led to the conservative substitution of isoleucine for valine in the putative fifth extracellular loop of the transporter (lagrange et al . , 1998) .
this can #lead to a substantial diversity of nebulin and nebulette isoforms (figure 3a) .
this can #lead to a substantial diversity of nebulin and nebulette isoforms , an atypical form of tay-sachs disease (gm2 gangliosidosis variant ab) .
this can #lead us to a substantial diversity of nebulin and nebulette isoforms .
this can #lead us to synergistic activation of the anf and other mef2 target promoters .
this has #led to a substantial diversity of nebulin and nebulette isoforms (figure 3a) .
this has #led to synergistic activation of the anf and other mef2 target promoters , an atypical form of tay-sachs disease (gm2 gangliosidosis variant ab) .
this has #led to synergistic activation of the anf and other mef2 target promoters .
this has #led us to synergistic activation of the anf and other mef2 target promoters .
this is able to #lead to a substantial diversity of nebulin and nebulette isoforms (figure 3a) .
this is able to #lead to synergistic activation of the anf and other mef2 target promoters (figure 3a) .
this is #leading to synergistic activation of the anf and other mef2 target promoters .
this #leads to a substantial diversity of nebulin and nebulette isoforms (figure 3a) .
this #leads us to synergistic activation of the anf and other mef2 target promoters .
this #led to a substantial diversity of nebulin and nebulette isoforms (figure 3a) .
this #led to synergistic activation of the anf and other mef2 target promoters (figure 3a) .
this #led to synergistic activation of the anf and other mef2 target promoters , an atypical form of tay-sachs disease (gm2 gangliosidosis variant ab) .
this #led us to a substantial diversity of nebulin and nebulette isoforms .
this may #lead to synergistic activation of the anf and other mef2 target promoters (figure 3a) .
this may #lead to synergistic activation of the anf and other mef2 target promoters .
this was caused by 7 missense mutations , 2 mutations #leading to frameshift .
this was caused by 7 missense mutations , 2 mutations that #led to frameshift .
this was caused by 7 missense mutations , 2 mutations which can #lead to frameshift .
this was caused by 7 missense mutations , 2 mutations , which #leads to frameshift .
this was caused by closer examination of the putative signal transduction pathway modulating htra transcription #leading to the identification of two new genes .
this was caused by closer examination of the putative signal transduction pathway modulating htra transcription that #leads to the identification of two new genes .
this was caused by closer examination of the putative signal transduction pathway modulating htra transcription that #led to the identification of two new genes .
this was caused by cotransfection of gata-4 with mef2a , mef2c or mef2d #leading to a synergistic 40-to 50-fold activation of the anf promoter .
this was caused by cotransfection of gata-4 with mef2a , mef2c or mef2d that #leads to a synergistic 40-to 50-fold activation of the anf promoter .
this was caused by cotransfection of gata-4 with mef2a , mef2c or mef2d that #led to a synergistic 40-to 50-fold activation of the anf promoter .
this was caused by this that #leads to a substantial diversity of nebulin and nebulette isoforms .
this was caused by this that #leads to synergistic activation of the anf and other mef2 target promoters .
this was caused by this that #led to a substantial diversity of nebulin and nebulette isoforms .
this was caused by this which can #lead to synergistic activation of the anf and other mef2 target promoters .
this was caused by this which has #led to synergistic activation of the anf and other mef2 target promoters .
this was caused by this , which #leads to a substantial diversity of nebulin and nebulette isoforms .
this was caused by this , which #leads to synergistic activation of the anf and other mef2 target promoters .
this was caused by transduction of the mara region from a mar strain #leading to loss of ompf .
this was caused by transduction of the mara region from a mar strain that #leads to loss of ompf .
this was caused by transduction of the mara region from a mar strain that #led to loss of ompf .
this was caused by transduction of the mara region from a mar strain which can #lead to loss of ompf .
this was caused by transduction of the mara region from a mar strain , which #leads to loss of ompf .
this was caused by the sequence selection experiment which has #led to the identification of the bre .
this , but not a wild-type strain , #led to synergistic activation of the anf and other mef2 target promoters .
this , in turn , is able to #lead to a substantial diversity of nebulin and nebulette isoforms independently of the dna-binding activity of mef2 .
this , in turn , is #leading to a substantial diversity of nebulin and nebulette isoforms independently of the dna-binding activity of mef2 .
this , in turn , #leads to a substantial diversity of nebulin and nebulette isoforms independently of the dna-binding activity of mef2 .
this , in turn , will #lead to a substantial diversity of nebulin and nebulette isoforms independently of the dna-binding activity of mef2 .
transduction of the mara region from a mar strain can #lead to loss of ompf (figure 3a) .
transduction of the mara region from a mar strain can #lead to loss of ompf , an atypical form of tay-sachs disease (gm2 gangliosidosis variant ab) .
transduction of the mara region from a mar strain can #lead us to loss of ompf .
transduction of the mara region from a mar strain has #led to loss of ompf , an atypical form of tay-sachs disease (gm2 gangliosidosis variant ab) .
transduction of the mara region from a mar strain has #led us to loss of ompf .
transduction of the mara region from a mar strain is able to #lead to loss of ompf (figure 3a) .
transduction of the mara region from a mar strain is #leading to loss of ompf , an atypical form of tay-sachs disease (gm2 gangliosidosis variant ab) .
transduction of the mara region from a mar strain is #leading to loss of ompf .
transduction of the mara region from a mar strain #lead to loss of ompf .
transduction of the mara region from a mar strain #led to loss of ompf (figure 3a) .
transduction of the mara region from a mar strain #led us to loss of ompf .
transduction of the mara region from a mar strain that #leads to loss of ompf .
transduction of the mara region from a mar strain will #lead us to loss of ompf .
transduction of the mara region from a mar strain , in turn , has #led to loss of ompf independently of the dna-binding activity of mef2 .
transduction of the mara region from a mar strain , in turn , is #leading to loss of ompf independently of the dna-binding activity of mef2 .
transduction of the mara region from a mar strain , in turn , #led to loss of ompf independently of the dna-binding activity of mef2 .
a point mutation (gtc----atc) at codon 383 can #lead to the conservative substitution of isoleucine for valine in the putative fifth extracellular loop of the transporter (figure 3a) .
a point mutation (gtc----atc) at codon 383 can #lead to the conservative substitution of isoleucine for valine in the putative fifth extracellular loop of the transporter , an atypical form of tay-sachs disease (gm2 gangliosidosis variant ab) .
a point mutation (gtc----atc) at codon 383 can #lead us to the conservative substitution of isoleucine for valine in the putative fifth extracellular loop of the transporter .
a point mutation (gtc----atc) at codon 383 has #led to the conservative substitution of isoleucine for valine in the putative fifth extracellular loop of the transporter (figure 3a) .
a point mutation (gtc----atc) at codon 383 has #led to the conservative substitution of isoleucine for valine in the putative fifth extracellular loop of the transporter .
a point mutation (gtc----atc) at codon 383 has #led us to the conservative substitution of isoleucine for valine in the putative fifth extracellular loop of the transporter .
a point mutation (gtc----atc) at codon 383 #leads to the conservative substitution of isoleucine for valine in the putative fifth extracellular loop of the transporter (figure 3a) .
a point mutation (gtc----atc) at codon 383 #leads to the conservative substitution of isoleucine for valine in the putative fifth extracellular loop of the transporter , an atypical form of tay-sachs disease (gm2 gangliosidosis variant ab) .
a point mutation (gtc----atc) at codon 383 #led to the conservative substitution of isoleucine for valine in the putative fifth extracellular loop of the transporter .
a point mutation (gtc----atc) at codon 383 #led us to the conservative substitution of isoleucine for valine in the putative fifth extracellular loop of the transporter .
a point mutation (gtc----atc) at codon 383 will #lead us to the conservative substitution of isoleucine for valine in the putative fifth extracellular loop of the transporter .
a point mutation (gtc----atc) at codon 383 , but not a wild-type strain , #led to the conservative substitution of isoleucine for valine in the putative fifth extracellular loop of the transporter .
a point mutation (gtc----atc) at codon 383 , in turn , has #led to the conservative substitution of isoleucine for valine in the putative fifth extracellular loop of the transporter independently of the dna-binding activity of mef2 .
a point mutation (gtc----atc) at codon 383 , in turn , is able to #lead to the conservative substitution of isoleucine for valine in the putative fifth extracellular loop of the transporter independently of the dna-binding activity of mef2 .
a point mutation (gtc----atc) at codon 383 , in turn , #leads to the conservative substitution of isoleucine for valine in the putative fifth extracellular loop of the transporter independently of the dna-binding activity of mef2 .
a point mutation (gtc----atc) at codon 383 , in turn , will #lead to the conservative substitution of isoleucine for valine in the putative fifth extracellular loop of the transporter independently of the dna-binding activity of mef2 .
synergistic activation of the anf and other mef2 target promoters is #led to by this .
the identification of the bre is #led to by the sequence selection experiment .
the identification of two new genes is #led to by closer examination of the putative signal transduction pathway modulating htra transcription .
the sequence selection experiment can #lead to the identification of the bre , an atypical form of tay-sachs disease (gm2 gangliosidosis variant ab) .
the sequence selection experiment has #led to the identification of the bre .
the sequence selection experiment is #leading to the identification of the bre , an atypical form of tay-sachs disease (gm2 gangliosidosis variant ab) .
the sequence selection experiment is #leading to the identification of the bre .
the sequence selection experiment #leads to the identification of the bre (figure 3a) .
the sequence selection experiment #leads to the identification of the bre , an atypical form of tay-sachs disease (gm2 gangliosidosis variant ab) .
the sequence selection experiment #leads us to the identification of the bre .
the sequence selection experiment #led to the identification of the bre (figure 3a) .
the sequence selection experiment #led to the identification of the bre , an atypical form of tay-sachs disease (gm2 gangliosidosis variant ab) .
the sequence selection experiment #led us to the identification of the bre .
the sequence selection experiment will #lead us to the identification of the bre .
the sequence selection experiment , in turn , has #led to the identification of the bre independently of the dna-binding activity of mef2 .
the sequence selection experiment , in turn , will #lead to the identification of the bre independently of the dna-binding activity of mef2 .
by direct sequencing of aberrant ssca conformers were revealed 15 different mutations in a total of 18 unrelated families and 13 single patients . of these , 10 were novel (the splice mutation in 5 end of intron 5 that #lead to abnormal splice in exon 5 and exon 6 , and 1 mutation predicted to affect normal splicing) .
by direct sequencing of aberrant ssca conformers were revealed 15 different mutations in a total of 18 unrelated families and 13 single patients . of these , 10 were novel (the splice mutation in 5 end of intron 5 that #led to abnormal splice in exon 5 and exon 6 , and 1 mutation predicted to affect normal splicing) .
by direct sequencing of aberrant ssca conformers were revealed 15 different mutations in a total of 18 unrelated families and 13 single patients . of these , 10 were novel (this splice mutation in 5 end of intron 5 #leading to abnormal splice in exon 5 and exon 6 , and 1 mutation predicted to affect normal splicing) .
by direct sequencing of aberrant ssca conformers were revealed 15 different mutations in a total of 18 unrelated families and 13 single patients . of these , 10 were novel (this splice mutation in 5 end of intron 5 that #led to abnormal splice in exon 5 and exon 6 , and 1 mutation predicted to affect normal splicing) .
by direct sequencing of aberrant ssca conformers were revealed 15 different mutations in a total of 18 unrelated families and 13 single patients . of these , 10 were novel (this splice mutation in 5 end of intron 5 which #led to abnormal splice in exon 5 and exon 6 , and 1 mutation predicted to affect normal splicing) .
by direct sequencing of aberrant ssca conformers were revealed 15 different mutations in a total of 18 unrelated families and 13 single patients . of these , 10 were novel (a c----a transversion in the splice acceptor sequence of the last intron of the only ercc-3 allele #leading to a 4 bp insertion in the mrna and an inactivating frameshift in the c-terminus of the protein , and 1 mutation predicted to affect normal splicing) .
by direct sequencing of aberrant ssca conformers were revealed 15 different mutations in a total of 18 unrelated families and 13 single patients . of these , 10 were novel (a c----a transversion in the splice acceptor sequence of the last intron of the only ercc-3 allele that #led to a 4 bp insertion in the mrna and an inactivating frameshift in the c-terminus of the protein , and 1 mutation predicted to affect normal splicing) .
by direct sequencing of aberrant ssca conformers were revealed 15 different mutations in a total of 18 unrelated families and 13 single patients . of these , 10 were novel (a c----a transversion in the splice acceptor sequence of the last intron of the only ercc-3 allele which #lead to a 4 bp insertion in the mrna and an inactivating frameshift in the c-terminus of the protein , and 1 mutation predicted to affect normal splicing) .
by direct sequencing of aberrant ssca conformers were revealed 15 different mutations in a total of 18 unrelated families and 13 single patients . of these , 10 were novel (a c----a transversion in the splice acceptor sequence of the last intron of the only ercc-3 allele which #led to a 4 bp insertion in the mrna and an inactivating frameshift in the c-terminus of the protein , and 1 mutation predicted to affect normal splicing) .
by direct sequencing of aberrant ssca conformers were revealed 15 different mutations in a total of 18 unrelated families and 13 single patients . of these , 10 were novel (a complex splice site mutation that #lead to an abnormal jag1 mrna , resulting in a premature stop codon , and 1 mutation predicted to affect normal splicing) .
by direct sequencing of aberrant ssca conformers were revealed 15 different mutations in a total of 18 unrelated families and 13 single patients . of these , 10 were novel (a complex splice site mutation that #led to an abnormal jag1 mrna , resulting in a premature stop codon , and 1 mutation predicted to affect normal splicing) .
by direct sequencing of aberrant ssca conformers were revealed 15 different mutations in a total of 18 unrelated families and 13 single patients . of these , 10 were novel (a complex splice site mutation which #led to an abnormal jag1 mrna , resulting in a premature stop codon , and 1 mutation predicted to affect normal splicing) .
by direct sequencing of aberrant ssca conformers were revealed 15 different mutations in a total of 18 unrelated families and 13 single patients . of these , 10 were novel (a point mutation at the 5 splicing site of the third intron that #led to ligation of the second to the fourth exon , and 1 mutation predicted to affect normal splicing) .
by direct sequencing of aberrant ssca conformers were revealed 15 different mutations in a total of 18 unrelated families and 13 single patients . of these , 10 were novel (a point mutation at the 5 splicing site of the third intron which #lead to ligation of the second to the fourth exon , and 1 mutation predicted to affect normal splicing) .
by direct sequencing of aberrant ssca conformers were revealed 15 different mutations in a total of 18 unrelated families and 13 single patients . of these , 10 were novel (two frameshifts and a splice site mutation #leading to truncated oa1 proteins; a deletion of a threonine codon at position 290; and four missense mutations , and 1 mutation predicted to affect normal splicing) .
by direct sequencing of aberrant ssca conformers were revealed 15 different mutations in a total of 18 unrelated families and 13 single patients . of these , 10 were novel (two frameshifts and a splice site mutation that #led to truncated oa1 proteins; a deletion of a threonine codon at position 290; and four missense mutations , and 1 mutation predicted to affect normal splicing) .
by direct sequencing of aberrant ssca conformers were revealed 15 different mutations in a total of 18 unrelated families and 13 single patients . of these , 10 were novel (two frameshifts and a splice site mutation which #led to truncated oa1 proteins; a deletion of a threonine codon at position 290; and four missense mutations , and 1 mutation predicted to affect normal splicing) .
further , experiments with an antisense-ref cdna expression vector introduced into cultured cells suggested that the splice mutation in 5 end of intron 5 had #led to abnormal splice in exon 5 and exon 6 .
further , experiments with an antisense-ref cdna expression vector introduced into cultured cells suggested that the splice mutation in 5 end of intron 5 #led to abnormal splice in exon 5 and exon 6 .
further , experiments with an antisense-ref cdna expression vector introduced into cultured cells suggested that the splice mutation in 5 end of intron 5 was able to #lead to abnormal splice in exon 5 and exon 6 .
further , experiments with an antisense-ref cdna expression vector introduced into cultured cells suggested that this splice mutation in 5 end of intron 5 had #led to abnormal splice in exon 5 and exon 6 .
further , experiments with an antisense-ref cdna expression vector introduced into cultured cells suggested that a c----a transversion in the splice acceptor sequence of the last intron of the only ercc-3 allele could #lead to a 4 bp insertion in the mrna and an inactivating frameshift in the c-terminus of the protein .
further , experiments with an antisense-ref cdna expression vector introduced into cultured cells suggested that a c----a transversion in the splice acceptor sequence of the last intron of the only ercc-3 allele was able to #lead to a 4 bp insertion in the mrna and an inactivating frameshift in the c-terminus of the protein .
further , experiments with an antisense-ref cdna expression vector introduced into cultured cells suggested that a complex splice site mutation could #lead to an abnormal jag1 mrna , resulting in a premature stop codon .
further , experiments with an antisense-ref cdna expression vector introduced into cultured cells suggested that a complex splice site mutation had #led to an abnormal jag1 mrna , resulting in a premature stop codon .
further , experiments with an antisense-ref cdna expression vector introduced into cultured cells suggested that a point mutation at the 5 splicing site of the third intron had #led to ligation of the second to the fourth exon .
further , experiments with an antisense-ref cdna expression vector introduced into cultured cells suggested that a point mutation at the 5 splicing site of the third intron was able to #lead to ligation of the second to the fourth exon .
further , experiments with an antisense-ref cdna expression vector introduced into cultured cells suggested that two frameshifts and a splice site mutation could #lead to truncated oa1 proteins; a deletion of a threonine codon at position 290; and four missense mutations .
further , experiments with an antisense-ref cdna expression vector introduced into cultured cells suggested that two frameshifts and a splice site mutation had #led to truncated oa1 proteins; a deletion of a threonine codon at position 290; and four missense mutations .
further , experiments with an antisense-ref cdna expression vector introduced into cultured cells suggested that two frameshifts and a splice site mutation #led to truncated oa1 proteins; a deletion of a threonine codon at position 290; and four missense mutations .
further , experiments with an antisense-ref cdna expression vector introduced into cultured cells suggested that two frameshifts and a splice site mutation was able to #lead to truncated oa1 proteins; a deletion of a threonine codon at position 290; and four missense mutations .
further , experiments with an antisense-ref cdna expression vector introduced into cultured cells suggests that the splice mutation in 5 end of intron 5 is able to #lead to abnormal splice in exon 5 and exon 6 .
further , experiments with an antisense-ref cdna expression vector introduced into cultured cells suggests that this splice mutation in 5 end of intron 5 #leads to abnormal splice in exon 5 and exon 6 .
further , experiments with an antisense-ref cdna expression vector introduced into cultured cells suggests that a c----a transversion in the splice acceptor sequence of the last intron of the only ercc-3 allele is able to #lead to a 4 bp insertion in the mrna and an inactivating frameshift in the c-terminus of the protein .
further , experiments with an antisense-ref cdna expression vector introduced into cultured cells suggests that a c----a transversion in the splice acceptor sequence of the last intron of the only ercc-3 allele #leads to a 4 bp insertion in the mrna and an inactivating frameshift in the c-terminus of the protein .
further , experiments with an antisense-ref cdna expression vector introduced into cultured cells suggests that a point mutation at the 5 splicing site of the third intron is able to #lead to ligation of the second to the fourth exon .
further , experiments with an antisense-ref cdna expression vector introduced into cultured cells suggests that a point mutation at the 5 splicing site of the third intron #leads to ligation of the second to the fourth exon .
it has been shown that the splice mutation in 5 end of intron 5 , #leading to abnormal splice in exon 5 and exon 6 .
it has been shown that this splice mutation in 5 end of intron 5 , #leading to abnormal splice in exon 5 and exon 6 .
the splice mutation in 5 end of intron 5 g:c base pair is also the strongest determinant in this which #leads to abnormal splice in exon 5 and exon 6 (lagrange et al . , 1998) .
the splice mutation in 5 end of intron 5 g:c base pair is also the strongest determinant in this , which #led to abnormal splice in exon 5 and exon 6 (lagrange et al . , 1998) .
the splice mutation in 5 end of intron 5 can #lead to abnormal splice in exon 5 and exon 6 .
the splice mutation in 5 end of intron 5 can #lead us to abnormal splice in exon 5 and exon 6 .
the splice mutation in 5 end of intron 5 has #led to abnormal splice in exon 5 and exon 6 (figure 3a) .
the splice mutation in 5 end of intron 5 has #led us to abnormal splice in exon 5 and exon 6 .
the splice mutation in 5 end of intron 5 is able to #lead to abnormal splice in exon 5 and exon 6 (figure 3a) .
the splice mutation in 5 end of intron 5 #leads to abnormal splice in exon 5 and exon 6 (figure 3a) .
the splice mutation in 5 end of intron 5 #leads to abnormal splice in exon 5 and exon 6 , an atypical form of tay-sachs disease (gm2 gangliosidosis variant ab) .
the splice mutation in 5 end of intron 5 #led to abnormal splice in exon 5 and exon 6 (figure 3a) .
the splice mutation in 5 end of intron 5 #led to abnormal splice in exon 5 and exon 6 , an atypical form of tay-sachs disease (gm2 gangliosidosis variant ab) .
the splice mutation in 5 end of intron 5 #led to abnormal splice in exon 5 and exon 6 .
the splice mutation in 5 end of intron 5 #led us to abnormal splice in exon 5 and exon 6 .
the splice mutation in 5 end of intron 5 may #lead to abnormal splice in exon 5 and exon 6 .
the splice mutation in 5 end of intron 5 was caused by this #leading to abnormal splice in exon 5 and exon 6 .
the splice mutation in 5 end of intron 5 was caused by this that #leads to abnormal splice in exon 5 and exon 6 .
the splice mutation in 5 end of intron 5 was caused by this that #led to abnormal splice in exon 5 and exon 6 .
the splice mutation in 5 end of intron 5 will #lead us to abnormal splice in exon 5 and exon 6 .
the splice mutation in 5 end of intron 5 , in turn , has #led to abnormal splice in exon 5 and exon 6 independently of the dna-binding activity of mef2 .
the splice mutation in 5 end of intron 5 , in turn , #leads to abnormal splice in exon 5 and exon 6 independently of the dna-binding activity of mef2 .
the splice mutation in 5 end of intron 5 , in turn , #led to abnormal splice in exon 5 and exon 6 independently of the dna-binding activity of mef2 .
the splice mutation in 5 end of intron 5 , in turn , will #lead to abnormal splice in exon 5 and exon 6 independently of the dna-binding activity of mef2 .
these data suggest that the splice mutation in 5 end of intron 5 #leads to abnormal splice in exon 5 and exon 6 that functions to stimulate phosphorylation and clustering of achrs .
these data suggest that this splice mutation in 5 end of intron 5 can #lead to abnormal splice in exon 5 and exon 6 that functions to stimulate phosphorylation and clustering of achrs .
these data suggest that this splice mutation in 5 end of intron 5 has #led to abnormal splice in exon 5 and exon 6 that functions to stimulate phosphorylation and clustering of achrs .
these data suggest that this splice mutation in 5 end of intron 5 #leads to abnormal splice in exon 5 and exon 6 that functions to stimulate phosphorylation and clustering of achrs .
these data suggest that this splice mutation in 5 end of intron 5 will #lead to abnormal splice in exon 5 and exon 6 that functions to stimulate phosphorylation and clustering of achrs .
these data suggest that a c----a transversion in the splice acceptor sequence of the last intron of the only ercc-3 allele has #led to a 4 bp insertion in the mrna and an inactivating frameshift in the c-terminus of the protein that functions to stimulate phosphorylation and clustering of achrs .
these data suggest that a c----a transversion in the splice acceptor sequence of the last intron of the only ercc-3 allele #leads to a 4 bp insertion in the mrna and an inactivating frameshift in the c-terminus of the protein that functions to stimulate phosphorylation and clustering of achrs .
these data suggest that a c----a transversion in the splice acceptor sequence of the last intron of the only ercc-3 allele will #lead to a 4 bp insertion in the mrna and an inactivating frameshift in the c-terminus of the protein that functions to stimulate phosphorylation and clustering of achrs .
these data suggest that a complex splice site mutation can #lead to an abnormal jag1 mrna , resulting in a premature stop codon that functions to stimulate phosphorylation and clustering of achrs .
these data suggest that a complex splice site mutation has #led to an abnormal jag1 mrna , resulting in a premature stop codon that functions to stimulate phosphorylation and clustering of achrs .
these data suggest that a complex splice site mutation #leads to an abnormal jag1 mrna , resulting in a premature stop codon that functions to stimulate phosphorylation and clustering of achrs .
these data suggest that a complex splice site mutation will #lead to an abnormal jag1 mrna , resulting in a premature stop codon that functions to stimulate phosphorylation and clustering of achrs .
these data suggest that two frameshifts and a splice site mutation can #lead to truncated oa1 proteins; a deletion of a threonine codon at position 290; and four missense mutations that functions to stimulate phosphorylation and clustering of achrs .
these data suggest that two frameshifts and a splice site mutation will #lead to truncated oa1 proteins; a deletion of a threonine codon at position 290; and four missense mutations that functions to stimulate phosphorylation and clustering of achrs .
these data suggested that the splice mutation in 5 end of intron 5 #led to abnormal splice in exon 5 and exon 6 that functions to stimulate phosphorylation and clustering of achrs .
these data suggested that this splice mutation in 5 end of intron 5 was able to #lead to abnormal splice in exon 5 and exon 6 that functions to stimulate phosphorylation and clustering of achrs .
these data suggested that a complex splice site mutation was able to #lead to an abnormal jag1 mrna , resulting in a premature stop codon that functions to stimulate phosphorylation and clustering of achrs .
these data suggested that a point mutation at the 5 splicing site of the third intron #led to ligation of the second to the fourth exon that functions to stimulate phosphorylation and clustering of achrs .
this g:c base pair is also the strongest determinant in the splice mutation in 5 end of intron 5 #leading to abnormal splice in exon 5 and exon 6 (lagrange et al . , 1998) .
this g:c base pair is also the strongest determinant in the splice mutation in 5 end of intron 5 that #leads to abnormal splice in exon 5 and exon 6 (lagrange et al . , 1998) .
this g:c base pair is also the strongest determinant in the splice mutation in 5 end of intron 5 which has #led to abnormal splice in exon 5 and exon 6 (lagrange et al . , 1998) .
this g:c base pair is also the strongest determinant in the splice mutation in 5 end of intron 5 which #leads to abnormal splice in exon 5 and exon 6 (lagrange et al . , 1998) .
this g:c base pair is also the strongest determinant in the splice mutation in 5 end of intron 5 which #led to abnormal splice in exon 5 and exon 6 (lagrange et al . , 1998) .
this g:c base pair is also the strongest determinant in this splice mutation in 5 end of intron 5 that #leads to abnormal splice in exon 5 and exon 6 (lagrange et al . , 1998) .
this g:c base pair is also the strongest determinant in a c----a transversion in the splice acceptor sequence of the last intron of the only ercc-3 allele #leading to a 4 bp insertion in the mrna and an inactivating frameshift in the c-terminus of the protein (lagrange et al . , 1998) .
this g:c base pair is also the strongest determinant in a c----a transversion in the splice acceptor sequence of the last intron of the only ercc-3 allele which has #led to a 4 bp insertion in the mrna and an inactivating frameshift in the c-terminus of the protein (lagrange et al . , 1998) .
this g:c base pair is also the strongest determinant in a c----a transversion in the splice acceptor sequence of the last intron of the only ercc-3 allele which #leads to a 4 bp insertion in the mrna and an inactivating frameshift in the c-terminus of the protein (lagrange et al . , 1998) .
this g:c base pair is also the strongest determinant in a c----a transversion in the splice acceptor sequence of the last intron of the only ercc-3 allele which #led to a 4 bp insertion in the mrna and an inactivating frameshift in the c-terminus of the protein (lagrange et al . , 1998) .
this g:c base pair is also the strongest determinant in a c----a transversion in the splice acceptor sequence of the last intron of the only ercc-3 allele , which #led to a 4 bp insertion in the mrna and an inactivating frameshift in the c-terminus of the protein (lagrange et al . , 1998) .
this g:c base pair is also the strongest determinant in a complex splice site mutation #leading to an abnormal jag1 mrna , resulting in a premature stop codon (lagrange et al . , 1998) .
this g:c base pair is also the strongest determinant in a complex splice site mutation which #leads to an abnormal jag1 mrna , resulting in a premature stop codon (lagrange et al . , 1998) .
this g:c base pair is also the strongest determinant in a complex splice site mutation , which #led to an abnormal jag1 mrna , resulting in a premature stop codon (lagrange et al . , 1998) .
this g:c base pair is also the strongest determinant in a point mutation at the 5 splicing site of the third intron that #leads to ligation of the second to the fourth exon (lagrange et al . , 1998) .
this g:c base pair is also the strongest determinant in a point mutation at the 5 splicing site of the third intron which has #led to ligation of the second to the fourth exon (lagrange et al . , 1998) .
this g:c base pair is also the strongest determinant in a point mutation at the 5 splicing site of the third intron which #led to ligation of the second to the fourth exon (lagrange et al . , 1998) .
this g:c base pair is also the strongest determinant in a point mutation at the 5 splicing site of the third intron , which #led to ligation of the second to the fourth exon (lagrange et al . , 1998) .
this g:c base pair is also the strongest determinant in two frameshifts and a splice site mutation #leading to truncated oa1 proteins; a deletion of a threonine codon at position 290; and four missense mutations (lagrange et al . , 1998) .
this g:c base pair is also the strongest determinant in two frameshifts and a splice site mutation which #leads to truncated oa1 proteins; a deletion of a threonine codon at position 290; and four missense mutations (lagrange et al . , 1998) .
this g:c base pair is also the strongest determinant in two frameshifts and a splice site mutation , which #led to truncated oa1 proteins; a deletion of a threonine codon at position 290; and four missense mutations (lagrange et al . , 1998) .
this splice mutation in 5 end of intron 5 g:c base pair is also the strongest determinant in this #leading to abnormal splice in exon 5 and exon 6 (lagrange et al . , 1998) .
this splice mutation in 5 end of intron 5 g:c base pair is also the strongest determinant in this that #leads to abnormal splice in exon 5 and exon 6 (lagrange et al . , 1998) .
this splice mutation in 5 end of intron 5 g:c base pair is also the strongest determinant in this which #leads to abnormal splice in exon 5 and exon 6 (lagrange et al . , 1998) .
this splice mutation in 5 end of intron 5 g:c base pair is also the strongest determinant in this , which #led to abnormal splice in exon 5 and exon 6 (lagrange et al . , 1998) .
this splice mutation in 5 end of intron 5 can #lead to abnormal splice in exon 5 and exon 6 (figure 3a) .
this splice mutation in 5 end of intron 5 can #lead to abnormal splice in exon 5 and exon 6 , an atypical form of tay-sachs disease (gm2 gangliosidosis variant ab) .
this splice mutation in 5 end of intron 5 can #lead to abnormal splice in exon 5 and exon 6 .
this splice mutation in 5 end of intron 5 can #lead us to abnormal splice in exon 5 and exon 6 .
this splice mutation in 5 end of intron 5 has #led to abnormal splice in exon 5 and exon 6 , an atypical form of tay-sachs disease (gm2 gangliosidosis variant ab) .
this splice mutation in 5 end of intron 5 has #led to abnormal splice in exon 5 and exon 6 .
this splice mutation in 5 end of intron 5 has #led us to abnormal splice in exon 5 and exon 6 .
this splice mutation in 5 end of intron 5 #lead to abnormal splice in exon 5 and exon 6 .
this splice mutation in 5 end of intron 5 #leads to abnormal splice in exon 5 and exon 6 , an atypical form of tay-sachs disease (gm2 gangliosidosis variant ab) .
this splice mutation in 5 end of intron 5 #led to abnormal splice in exon 5 and exon 6 (figure 3a) .
this splice mutation in 5 end of intron 5 #led us to abnormal splice in exon 5 and exon 6 .
this splice mutation in 5 end of intron 5 that #leads to abnormal splice in exon 5 and exon 6 .
this splice mutation in 5 end of intron 5 was caused by this that #leads to abnormal splice in exon 5 and exon 6 .
this splice mutation in 5 end of intron 5 was caused by this which has #led to abnormal splice in exon 5 and exon 6 .
this splice mutation in 5 end of intron 5 was caused by this , which #leads to abnormal splice in exon 5 and exon 6 .
this splice mutation in 5 end of intron 5 will #lead us to abnormal splice in exon 5 and exon 6 .
this splice mutation in 5 end of intron 5 , in turn , has #led to abnormal splice in exon 5 and exon 6 independently of the dna-binding activity of mef2 .
this splice mutation in 5 end of intron 5 , in turn , is able to #lead to abnormal splice in exon 5 and exon 6 independently of the dna-binding activity of mef2 .
this splice mutation in 5 end of intron 5 , in turn , is #leading to abnormal splice in exon 5 and exon 6 independently of the dna-binding activity of mef2 .
this splice mutation in 5 end of intron 5 , in turn , #leads to abnormal splice in exon 5 and exon 6 independently of the dna-binding activity of mef2 .
this splice mutation in 5 end of intron 5 , in turn , #led to abnormal splice in exon 5 and exon 6 independently of the dna-binding activity of mef2 .
this splice mutation in 5 end of intron 5 , in turn , will #lead to abnormal splice in exon 5 and exon 6 independently of the dna-binding activity of mef2 .
this was caused by the splice mutation in 5 end of intron 5 that #leads to abnormal splice in exon 5 and exon 6 .
this was caused by the splice mutation in 5 end of intron 5 that #led to abnormal splice in exon 5 and exon 6 .
this was caused by the splice mutation in 5 end of intron 5 which has #led to abnormal splice in exon 5 and exon 6 .
this was caused by the splice mutation in 5 end of intron 5 , which #leads to abnormal splice in exon 5 and exon 6 .
this was caused by this splice mutation in 5 end of intron 5 which can #lead to abnormal splice in exon 5 and exon 6 .
this was caused by this splice mutation in 5 end of intron 5 which has #led to abnormal splice in exon 5 and exon 6 .
this was caused by this splice mutation in 5 end of intron 5 , which #leads to abnormal splice in exon 5 and exon 6 .
this was caused by a c----a transversion in the splice acceptor sequence of the last intron of the only ercc-3 allele that #led to a 4 bp insertion in the mrna and an inactivating frameshift in the c-terminus of the protein .
this was caused by a c----a transversion in the splice acceptor sequence of the last intron of the only ercc-3 allele which can #lead to a 4 bp insertion in the mrna and an inactivating frameshift in the c-terminus of the protein .
this was caused by a c----a transversion in the splice acceptor sequence of the last intron of the only ercc-3 allele which has #led to a 4 bp insertion in the mrna and an inactivating frameshift in the c-terminus of the protein .
this was caused by a c----a transversion in the splice acceptor sequence of the last intron of the only ercc-3 allele , which #leads to a 4 bp insertion in the mrna and an inactivating frameshift in the c-terminus of the protein .
this was caused by a complex splice site mutation #leading to an abnormal jag1 mrna , resulting in a premature stop codon .
this was caused by a complex splice site mutation which has #led to an abnormal jag1 mrna , resulting in a premature stop codon .
this was caused by a complex splice site mutation , which #leads to an abnormal jag1 mrna , resulting in a premature stop codon .
this was caused by a point mutation at the 5 splicing site of the third intron that #led to ligation of the second to the fourth exon .
this was caused by two frameshifts and a splice site mutation #leading to truncated oa1 proteins; a deletion of a threonine codon at position 290; and four missense mutations .
this was caused by two frameshifts and a splice site mutation that #led to truncated oa1 proteins; a deletion of a threonine codon at position 290; and four missense mutations .
this was caused by two frameshifts and a splice site mutation , which #leads to truncated oa1 proteins; a deletion of a threonine codon at position 290; and four missense mutations .
a 4 bp insertion in the mrna and an inactivating frameshift in the c-terminus of the protein was #led to by a c----a transversion in the splice acceptor sequence of the last intron of the only ercc-3 allele .
a c----a transversion in the splice acceptor sequence of the last intron of the only ercc-3 allele g:c base pair is also the strongest determinant in this #leading to a 4 bp insertion in the mrna and an inactivating frameshift in the c-terminus of the protein (lagrange et al . , 1998) .
a c----a transversion in the splice acceptor sequence of the last intron of the only ercc-3 allele can #lead to a 4 bp insertion in the mrna and an inactivating frameshift in the c-terminus of the protein (figure 3a) .
a c----a transversion in the splice acceptor sequence of the last intron of the only ercc-3 allele can #lead to a 4 bp insertion in the mrna and an inactivating frameshift in the c-terminus of the protein , an atypical form of tay-sachs disease (gm2 gangliosidosis variant ab) .
a c----a transversion in the splice acceptor sequence of the last intron of the only ercc-3 allele can #lead to a 4 bp insertion in the mrna and an inactivating frameshift in the c-terminus of the protein .
a c----a transversion in the splice acceptor sequence of the last intron of the only ercc-3 allele can #lead us to a 4 bp insertion in the mrna and an inactivating frameshift in the c-terminus of the protein .
a c----a transversion in the splice acceptor sequence of the last intron of the only ercc-3 allele has #led to a 4 bp insertion in the mrna and an inactivating frameshift in the c-terminus of the protein , an atypical form of tay-sachs disease (gm2 gangliosidosis variant ab) .
a c----a transversion in the splice acceptor sequence of the last intron of the only ercc-3 allele is able to #lead to a 4 bp insertion in the mrna and an inactivating frameshift in the c-terminus of the protein (figure 3a) .
a c----a transversion in the splice acceptor sequence of the last intron of the only ercc-3 allele #lead to a 4 bp insertion in the mrna and an inactivating frameshift in the c-terminus of the protein .
a c----a transversion in the splice acceptor sequence of the last intron of the only ercc-3 allele #led to a 4 bp insertion in the mrna and an inactivating frameshift in the c-terminus of the protein (figure 3a) .
a c----a transversion in the splice acceptor sequence of the last intron of the only ercc-3 allele #led to a 4 bp insertion in the mrna and an inactivating frameshift in the c-terminus of the protein .
a c----a transversion in the splice acceptor sequence of the last intron of the only ercc-3 allele #led us to a 4 bp insertion in the mrna and an inactivating frameshift in the c-terminus of the protein .
a c----a transversion in the splice acceptor sequence of the last intron of the only ercc-3 allele was caused by this which can #lead to a 4 bp insertion in the mrna and an inactivating frameshift in the c-terminus of the protein .
a c----a transversion in the splice acceptor sequence of the last intron of the only ercc-3 allele was caused by this which has #led to a 4 bp insertion in the mrna and an inactivating frameshift in the c-terminus of the protein .
a c----a transversion in the splice acceptor sequence of the last intron of the only ercc-3 allele , in turn , is #leading to a 4 bp insertion in the mrna and an inactivating frameshift in the c-terminus of the protein independently of the dna-binding activity of mef2 .
a c----a transversion in the splice acceptor sequence of the last intron of the only ercc-3 allele , in turn , #leads to a 4 bp insertion in the mrna and an inactivating frameshift in the c-terminus of the protein independently of the dna-binding activity of mef2 .
a c----a transversion in the splice acceptor sequence of the last intron of the only ercc-3 allele , in turn , #led to a 4 bp insertion in the mrna and an inactivating frameshift in the c-terminus of the protein independently of the dna-binding activity of mef2 .
a c----a transversion in the splice acceptor sequence of the last intron of the only ercc-3 allele , in turn , will #lead to a 4 bp insertion in the mrna and an inactivating frameshift in the c-terminus of the protein independently of the dna-binding activity of mef2 .
a complex splice site mutation g:c base pair is also the strongest determinant in this #leading to an abnormal jag1 mrna , resulting in a premature stop codon (lagrange et al . , 1998) .
a complex splice site mutation g:c base pair is also the strongest determinant in this which has #led to an abnormal jag1 mrna , resulting in a premature stop codon (lagrange et al . , 1998) .
a complex splice site mutation g:c base pair is also the strongest determinant in this which #leads to an abnormal jag1 mrna , resulting in a premature stop codon (lagrange et al . , 1998) .
a complex splice site mutation g:c base pair is also the strongest determinant in this which #led to an abnormal jag1 mrna , resulting in a premature stop codon (lagrange et al . , 1998) .
a complex splice site mutation can #lead to an abnormal jag1 mrna , resulting in a premature stop codon (figure 3a) .
a complex splice site mutation has #led to an abnormal jag1 mrna , resulting in a premature stop codon (figure 3a) .
a complex splice site mutation has #led to an abnormal jag1 mrna , resulting in a premature stop codon , an atypical form of tay-sachs disease (gm2 gangliosidosis variant ab) .
a complex splice site mutation has #led us to an abnormal jag1 mrna , resulting in a premature stop codon .
a complex splice site mutation is #leading to an abnormal jag1 mrna , resulting in a premature stop codon , an atypical form of tay-sachs disease (gm2 gangliosidosis variant ab) .
a complex splice site mutation #leads to an abnormal jag1 mrna , resulting in a premature stop codon (figure 3a) .
a complex splice site mutation #leads us to an abnormal jag1 mrna , resulting in a premature stop codon .
a complex splice site mutation #led to an abnormal jag1 mrna , resulting in a premature stop codon (figure 3a) .
a complex splice site mutation #led to an abnormal jag1 mrna , resulting in a premature stop codon .
a complex splice site mutation #led us to an abnormal jag1 mrna , resulting in a premature stop codon .
a complex splice site mutation may #lead to an abnormal jag1 mrna , resulting in a premature stop codon (figure 3a) .
a complex splice site mutation was caused by this #leading to an abnormal jag1 mrna , resulting in a premature stop codon .
a complex splice site mutation was caused by this which can #lead to an abnormal jag1 mrna , resulting in a premature stop codon .
a complex splice site mutation was caused by this , which #leads to an abnormal jag1 mrna , resulting in a premature stop codon .
a complex splice site mutation will #lead us to an abnormal jag1 mrna , resulting in a premature stop codon .
a complex splice site mutation , in turn , is able to #lead to an abnormal jag1 mrna , resulting in a premature stop codon independently of the dna-binding activity of mef2 .
a complex splice site mutation , in turn , #led to an abnormal jag1 mrna , resulting in a premature stop codon independently of the dna-binding activity of mef2 .
a complex splice site mutation , in turn , will #lead to an abnormal jag1 mrna , resulting in a premature stop codon independently of the dna-binding activity of mef2 .
a point mutation at the 5 splicing site of the third intron g:c base pair is also the strongest determinant in this that #leads to ligation of the second to the fourth exon (lagrange et al . , 1998) .
a point mutation at the 5 splicing site of the third intron g:c base pair is also the strongest determinant in this which #led to ligation of the second to the fourth exon (lagrange et al . , 1998) .
a point mutation at the 5 splicing site of the third intron can #lead to ligation of the second to the fourth exon , an atypical form of tay-sachs disease (gm2 gangliosidosis variant ab) .
a point mutation at the 5 splicing site of the third intron has #led to ligation of the second to the fourth exon .
a point mutation at the 5 splicing site of the third intron has #led us to ligation of the second to the fourth exon .
a point mutation at the 5 splicing site of the third intron is able to #lead to ligation of the second to the fourth exon (figure 3a) .
a point mutation at the 5 splicing site of the third intron is #leading to ligation of the second to the fourth exon , an atypical form of tay-sachs disease (gm2 gangliosidosis variant ab) .
a point mutation at the 5 splicing site of the third intron #leads to ligation of the second to the fourth exon (figure 3a) .
a point mutation at the 5 splicing site of the third intron #leads to ligation of the second to the fourth exon , an atypical form of tay-sachs disease (gm2 gangliosidosis variant ab) .
a point mutation at the 5 splicing site of the third intron #leads to ligation of the second to the fourth exon .
a point mutation at the 5 splicing site of the third intron #led to ligation of the second to the fourth exon (figure 3a) .
a point mutation at the 5 splicing site of the third intron #led to ligation of the second to the fourth exon , an atypical form of tay-sachs disease (gm2 gangliosidosis variant ab) .
a point mutation at the 5 splicing site of the third intron #led us to ligation of the second to the fourth exon .
a point mutation at the 5 splicing site of the third intron may #lead to ligation of the second to the fourth exon (figure 3a) .
a point mutation at the 5 splicing site of the third intron may #lead to ligation of the second to the fourth exon .
a point mutation at the 5 splicing site of the third intron that #leads to ligation of the second to the fourth exon .
a point mutation at the 5 splicing site of the third intron was caused by this #leading to ligation of the second to the fourth exon .
a point mutation at the 5 splicing site of the third intron , but not a wild-type strain , #led to ligation of the second to the fourth exon .
a point mutation at the 5 splicing site of the third intron , in turn , is able to #lead to ligation of the second to the fourth exon independently of the dna-binding activity of mef2 .
a point mutation at the 5 splicing site of the third intron , in turn , is #leading to ligation of the second to the fourth exon independently of the dna-binding activity of mef2 .
a point mutation at the 5 splicing site of the third intron , in turn , #led to ligation of the second to the fourth exon independently of the dna-binding activity of mef2 .
abnormal splice in exon 5 and exon 6 is #led to by this splice mutation in 5 end of intron 5 .
abnormal splice in exon 5 and exon 6 was #led to by this splice mutation in 5 end of intron 5 .
an abnormal jag1 mrna , resulting in a premature stop codon is #led to by a complex splice site mutation .
an abnormal jag1 mrna , resulting in a premature stop codon was #led to by a complex splice site mutation .
ligation of the second to the fourth exon is #led to by a point mutation at the 5 splicing site of the third intron .
two frameshifts and a splice site mutation g:c base pair is also the strongest determinant in this #leading to truncated oa1 proteins; a deletion of a threonine codon at position 290; and four missense mutations (lagrange et al . , 1998) .
two frameshifts and a splice site mutation g:c base pair is also the strongest determinant in this that #leads to truncated oa1 proteins; a deletion of a threonine codon at position 290; and four missense mutations (lagrange et al . , 1998) .
two frameshifts and a splice site mutation g:c base pair is also the strongest determinant in this which has #led to truncated oa1 proteins; a deletion of a threonine codon at position 290; and four missense mutations (lagrange et al . , 1998) .
two frameshifts and a splice site mutation g:c base pair is also the strongest determinant in this which #led to truncated oa1 proteins; a deletion of a threonine codon at position 290; and four missense mutations (lagrange et al . , 1998) .
two frameshifts and a splice site mutation can #lead us to truncated oa1 proteins; a deletion of a threonine codon at position 290; and four missense mutations .
two frameshifts and a splice site mutation has #led to truncated oa1 proteins; a deletion of a threonine codon at position 290; and four missense mutations (figure 3a) .
two frameshifts and a splice site mutation has #led to truncated oa1 proteins; a deletion of a threonine codon at position 290; and four missense mutations , an atypical form of tay-sachs disease (gm2 gangliosidosis variant ab) .
two frameshifts and a splice site mutation has #led to truncated oa1 proteins; a deletion of a threonine codon at position 290; and four missense mutations .
two frameshifts and a splice site mutation is #leading to truncated oa1 proteins; a deletion of a threonine codon at position 290; and four missense mutations , an atypical form of tay-sachs disease (gm2 gangliosidosis variant ab) .
two frameshifts and a splice site mutation is #leading to truncated oa1 proteins; a deletion of a threonine codon at position 290; and four missense mutations .
two frameshifts and a splice site mutation #lead to truncated oa1 proteins; a deletion of a threonine codon at position 290; and four missense mutations .
two frameshifts and a splice site mutation #leads to truncated oa1 proteins; a deletion of a threonine codon at position 290; and four missense mutations (figure 3a) .
two frameshifts and a splice site mutation #leads to truncated oa1 proteins; a deletion of a threonine codon at position 290; and four missense mutations , an atypical form of tay-sachs disease (gm2 gangliosidosis variant ab) .
two frameshifts and a splice site mutation #leads us to truncated oa1 proteins; a deletion of a threonine codon at position 290; and four missense mutations .
two frameshifts and a splice site mutation #led to truncated oa1 proteins; a deletion of a threonine codon at position 290; and four missense mutations (figure 3a) .
two frameshifts and a splice site mutation #led to truncated oa1 proteins; a deletion of a threonine codon at position 290; and four missense mutations , an atypical form of tay-sachs disease (gm2 gangliosidosis variant ab) .
two frameshifts and a splice site mutation #led us to truncated oa1 proteins; a deletion of a threonine codon at position 290; and four missense mutations .
two frameshifts and a splice site mutation may #lead to truncated oa1 proteins; a deletion of a threonine codon at position 290; and four missense mutations .
two frameshifts and a splice site mutation that #leads to truncated oa1 proteins; a deletion of a threonine codon at position 290; and four missense mutations .
two frameshifts and a splice site mutation was caused by this #leading to truncated oa1 proteins; a deletion of a threonine codon at position 290; and four missense mutations .
two frameshifts and a splice site mutation was caused by this that #led to truncated oa1 proteins; a deletion of a threonine codon at position 290; and four missense mutations .
two frameshifts and a splice site mutation was caused by this which can #lead to truncated oa1 proteins; a deletion of a threonine codon at position 290; and four missense mutations .
two frameshifts and a splice site mutation was caused by this , which #leads to truncated oa1 proteins; a deletion of a threonine codon at position 290; and four missense mutations .
two frameshifts and a splice site mutation will #lead us to truncated oa1 proteins; a deletion of a threonine codon at position 290; and four missense mutations .
two frameshifts and a splice site mutation , but not a wild-type strain , #led to truncated oa1 proteins; a deletion of a threonine codon at position 290; and four missense mutations .
two frameshifts and a splice site mutation , in turn , has #led to truncated oa1 proteins; a deletion of a threonine codon at position 290; and four missense mutations independently of the dna-binding activity of mef2 .
two frameshifts and a splice site mutation , in turn , is able to #lead to truncated oa1 proteins; a deletion of a threonine codon at position 290; and four missense mutations independently of the dna-binding activity of mef2 .
a sph i cleavage site within exon 3 can be #lost in a new transthyretin variant that has been characterized .
a sph i cleavage site within exon 3 has been #lost in a new transthyretin variant that has been characterized .
a sph i cleavage site within exon 3 is #lost in a new transthyretin variant that has been characterized .
a sph i cleavage site within exon 3 is observed to be #lost in a new transthyretin variant that has been characterized .
a new transthyretin variant being able to #lose a sph i cleavage site within exon 3 has been characterized .
a new transthyretin variant observed to #lose a sph i cleavage site within exon 3 has been characterized .
a new transthyretin variant which can #lose a sph i cleavage site within exon 3 has been characterized .
gpi anchoring ability being #lost when the microsomal membranes of trypanosoma brucei were washed at high ph has been reported(sharma et al . , 2000) , whereas similar treatment of the mammalian microsomal membranes have no effect (vidugiriene and menon , 1995)
gpi anchoring ability was reported to be #lost when the microsomal membranes of trypanosoma brucei were washed at high ph (sharma et al . , 2000) , whereas similar treatment of the mammalian microsomal membranes have no effect (vidugiriene and menon , 1995)
it is reported that gpi anchoring ability is #lost when the microsomal membranes of trypanosoma brucei were washed at high ph (sharma et al . , 2000) , whereas similar treatment of the mammalian microsomal membranes have no effect (vidugiriene and menon , 1995)
it may be reported that gpi anchoring ability will be #lost when the microsomal membranes of trypanosoma brucei were washed at high ph (sharma et al . , 2000) , whereas similar treatment of the mammalian microsomal membranes had no effect (vidugiriene and menon , 1995)
it was reported that gpi anchoring ability could be #lost when the microsomal membranes of trypanosoma brucei were washed at high ph (sharma et al . , 2000) , whereas similar treatment of the mammalian microsomal membranes have no effect (vidugiriene and menon , 1995)
it was reported that gpi anchoring ability might be #lost when the microsomal membranes of trypanosoma brucei were washed at high ph (sharma et al . , 2000) , whereas similar treatment of the mammalian microsomal membranes have no effect (vidugiriene and menon , 1995)
previous studies have emphasized the high sensitivity of the n-terminal region to proteolytic cleavage , leading to truncated species that can probably #lose the first 20 70 residues but that retain enzymatic activity and dimeric structure .
previous studies have emphasized the high sensitivity of the n-terminal region to proteolytic cleavage , leading to truncated species that have the ability to #lose the first 20 70 residues but that retain enzymatic activity and dimeric structure .
stat3 is activated in v-src or v-abl-transformed cells and , along other stats , in acute t-cell leukemia cells #losing il-2 dependency (migone et al . , 1995; yu et al . , 1995) .
stat3 is activated in v-src or v-abl-transformed cells and , along other stats , in acute t-cell leukemia cells that are observed to #lose il-2 dependency (migone et al . , 1995; yu et al . , 1995) .
stat3 is activated in v-src or v-abl-transformed cells and , along other stats , in acute t-cell leukemia cells that can #lose il-2 dependency (migone et al . , 1995; yu et al . , 1995) .
stat3 is activated in v-src or v-abl-transformed cells and , along other stats , in acute t-cell leukemia cells that can probably #lose il-2 dependency (migone et al . , 1995; yu et al . , 1995) .
stat3 is activated in v-src or v-abl-transformed cells and , along other stats , in acute t-cell leukemia cells that #lost il-2 dependency (migone et al . , 1995; yu et al . , 1995) .
stat3 is activated in v-src or v-abl-transformed cells and , along other stats , in acute t-cell leukemia cells that may #lose il-2 dependency (migone et al . , 1995; yu et al . , 1995) .
stat3 is activated in v-src or v-abl-transformed cells and , along other stats , in acute t-cell leukemia cells that will #lose il-2 dependency (migone et al . , 1995; yu et al . , 1995) .
the c-terminal-deletion mutant of hnrnp a1 being able to #lose the ability to interact with the x protein and to bring it into the initiation complex results in and inhibition of mhv rna transcription and replication .
the c-terminal-deletion mutant of hnrnp a1 can probably #lose the ability to interact with the x protein and to bring it into the initiation complex , resulting in an inhibition of mhv rna transcription and replication .
the c-terminal-deletion mutant of hnrnp a1 has a high probability of #losing the ability to interact with the x protein and to bring it into the initiation complex , resulting in an inhibition of mhv rna transcription and replication .
the c-terminal-deletion mutant of hnrnp a1 has been #losing the ability to interact with the x protein and to bring it into the initiation complex , resulting in an inhibition of mhv rna transcription and replication .
the c-terminal-deletion mutant of hnrnp a1 may #lose the ability to interact with the x protein and to bring it into the initiation complex , resulting in an inhibition of mhv rna transcription and replication .
the c-terminal-deletion mutant of hnrnp a1 that can #lose the ability to interact with the x protein and to bring it into the initiation complex results in and inhibition of mhv rna transcription and replication .
the c-terminal-deletion mutant of hnrnp a1 that has #lost the ability to interact with the x protein and to bring it into the initiation complex results in and inhibition of mhv rna transcription and replication .
the c-terminal-deletion mutant of hnrnp a1 that #loses the ability to interact with the x protein and to bring it into the initiation complex results in and inhibition of mhv rna transcription and replication .
the c-terminal-deletion mutant of hnrnp a1 that may probably #lose the ability to interact with the x protein and to bring it into the initiation complex results in and inhibition of mhv rna transcription and replication .
the c-terminal-deletion mutant of hnrnp a1 will #lose the ability to interact with the x protein and to bring it into the initiation complex , resulting in an inhibition of mhv rna transcription and replication .
the c-terminal-deletion mutant of hnrnp a1 will probably #lose the ability to interact with the x protein and to bring it into the initiation complex , resulting in an inhibition of mhv rna transcription and replication .
the mice are not able to #lose weight during the treatment .
the mice cannot #lose weight during the treatment .
the mice do not have a high probability of #losing weight during the treatment .
the mice have not #lost weight during the treatment .
the mice may not have #lost weight during the treatment .
these interactions are #lost with a separation of dna-binding sites of }3 bp , as can occur for natural sre sequences , while a smaller spacing inhibits the simultaneous binding of both proteins .
these interactions are observed to be #lost with a separation of dna-binding sites of }3 bp , as can occur for natural sre sequences , while a smaller spacing inhibited the simultaneous binding of both proteins .
these interactions can probably be #lost with a separation of dna-binding sites of }3 bp , as can occur for natural sre sequences , while a smaller spacing inhibited the simultaneous binding of both proteins .
these interactions have been #lost with a separation of dna-binding sites of }3 bp , as can occur for natural sre sequences , while a smaller spacing would inhibit the simultaneous binding of both proteins .
these interactions were #lost with a separation of dna-binding sites of }3 bp , as can occur for natural sre sequences , while a smaller spacing inhibited the simultaneous binding of both proteins .
these interactions will be #lost with a separation of dna-binding sites of }3 bp , as can occur for natural sre sequences , while a smaller spacing inhibited the simultaneous binding of both proteins .
this study investigated whether informing obese individuals that they can probably #lose only modest amounts of weight would lead them to adopt more realistic weight loss expectations .
this study investigated whether informing obese individuals that they could probably #lose only modest amounts of weight would lead them to adopt more realistic weight loss expectations .
this study investigated whether informing obese individuals that they have #lost only modest amounts of weight would lead them to adopt more realistic weight loss expectations .
this study investigated whether informing obese individuals that they #lose only modest amounts of weight would lead them to adopt more realistic weight loss expectations .
this study investigated whether informing obese individuals that they #lost only modest amounts of weight would lead them to adopt more realistic weight loss expectations .
this study investigated whether informing obese individuals that they may #lose only modest amounts of weight would lead them to adopt more realistic weight loss expectations .
this study investigated whether informing obese individuals that they may probably #lose only modest amounts of weight would lead them to adopt more realistic weight loss expectations .
this study investigated whether informing obese individuals that they might #lose only modest amounts of weight would lead them to adopt more realistic weight loss expectations .
this study investigated whether informing obese individuals that they might probably #lose only modest amounts of weight would lead them to adopt more realistic weight loss expectations .
this study investigated whether informing obese individuals that they will #lose only modest amounts of weight would lead them to adopt more realistic weight loss expectations .
the ability to interact with the x protein and to bring it into the initiation complex can be #lost in the c-terminal-deletion mutant of hnrnp a1 .
the c-terminal-deletion mutant of hnrnp a1 #loses the ability to interact with the x protein and to bring it into the initiation complex , resulting in an inhibition of mhv rna transcription and replication .
these interactions would be #lost with a separation of dna-binding sites of }3 bp , as can occur for natural sre sequences , while a smaller spacing would inhibit the simultaneous binding of both proteins .
a new transthyretin variant which #lost a sph i cleavage site within exon 3 has been characterized .
a new transthyretin variant completely #loses a sph i cleavage site within exon 3 , but all show considerablegenome reduction and dependency on the nucleus to fulfill plastid functions (martin and hrrmann , 1998) .
a new transthyretin variant completely #lost a sph i cleavage site within exon 3 , but all show considerablegenome reduction and dependency on the nucleus to fulfill plastid functions (martin and hrrmann , 1998) .
a new transthyretin variant has the ability to completely #lose a sph i cleavage site within exon 3 , but all show considerablegenome reduction and dependency on the nucleus to fulfill plastid functions (martin and hrrmann , 1998) .
a new transthyretin variant is observed to completely #lose a sph i cleavage site within exon 3 , but all show considerablegenome reduction and dependency on the nucleus to fulfill plastid functions (martin and hrrmann , 1998) .
a new transthyretin variant may completely #lose a sph i cleavage site within exon 3 , but all show considerablegenome reduction and dependency on the nucleus to fulfill plastid functions (martin and hrrmann , 1998) .
a new transthyretin variant will completely #lose a sph i cleavage site within exon 3 , but all show considerablegenome reduction and dependency on the nucleus to fulfill plastid functions (martin and hrrmann , 1998) .
a new transthyretin variant will have completely #lost a sph i cleavage site within exon 3 , but all show considerablegenome reduction and dependency on the nucleus to fulfill plastid functions (martin and hrrmann , 1998) .
il-2 dependency can be #lost in acute t-cell leukemia cells that has been characterized .
il-2 dependency is able to be #lost in acute t-cell leukemia cells that has been characterized .
il-2 dependency is observed to be #lost in acute t-cell leukemia cells that has been characterized .
il-2 dependency may be #lost in acute t-cell leukemia cells that has been characterized .
il-2 dependency was #lost in acute t-cell leukemia cells that has been characterized .
stat3 is activated in v-src or v-abl-transformed cells and , along other stats , in a new transthyretin variant that are able to #lose a sph i cleavage site within exon 3 (migone et al . , 1995; yu et al . , 1995) .
stat3 is activated in v-src or v-abl-transformed cells and , along other stats , in a new transthyretin variant that can #lose a sph i cleavage site within exon 3 (migone et al . , 1995; yu et al . , 1995) .
stat3 is activated in v-src or v-abl-transformed cells and , along other stats , in a new transthyretin variant that can probably #lose a sph i cleavage site within exon 3 (migone et al . , 1995; yu et al . , 1995) .
stat3 is activated in v-src or v-abl-transformed cells and , along other stats , in a new transthyretin variant that have the ability to #lose a sph i cleavage site within exon 3 (migone et al . , 1995; yu et al . , 1995) .
stat3 is activated in v-src or v-abl-transformed cells and , along other stats , in a new transthyretin variant that may probably #lose a sph i cleavage site within exon 3 (migone et al . , 1995; yu et al . , 1995) .
stat3 is activated in v-src or v-abl-transformed cells and , along other stats , in a new transthyretin variant that will #lose a sph i cleavage site within exon 3 (migone et al . , 1995; yu et al . , 1995) .
stat3 is activated in v-src or v-abl-transformed cells and , along other stats , in a new transthyretin variant that will probably #lose a sph i cleavage site within exon 3 (migone et al . , 1995; yu et al . , 1995) .
stat3 is activated in v-src or v-abl-transformed cells and , along other stats , in a new transthyretin variant that are able to #lose a sph i cleavage site within exon 3 (migone et al . , 1995; yu et al . , 1995) .
stat3 is activated in v-src or v-abl-transformed cells and , along other stats , in a new transthyretin variant that are observed to #lose a sph i cleavage site within exon 3 (migone et al . , 1995; yu et al . , 1995) .
stat3 is activated in v-src or v-abl-transformed cells and , along other stats , in a new transthyretin variant that can #lose a sph i cleavage site within exon 3 (migone et al . , 1995; yu et al . , 1995) .
stat3 is activated in v-src or v-abl-transformed cells and , along other stats , in a new transthyretin variant that can probably #lose a sph i cleavage site within exon 3 (migone et al . , 1995; yu et al . , 1995) .
stat3 is activated in v-src or v-abl-transformed cells and , along other stats , in a new transthyretin variant that #lose a sph i cleavage site within exon 3 (migone et al . , 1995; yu et al . , 1995) .
stat3 is activated in v-src or v-abl-transformed cells and , along other stats , in a new transthyretin variant that #lost a sph i cleavage site within exon 3 (migone et al . , 1995; yu et al . , 1995) .
stat3 is activated in v-src or v-abl-transformed cells and , along other stats , in a new transthyretin variant that may #lose a sph i cleavage site within exon 3 (migone et al . , 1995; yu et al . , 1995) .
stat3 is activated in v-src or v-abl-transformed cells and , along other stats , in a new transthyretin variant that may probably #lose a sph i cleavage site within exon 3 (migone et al . , 1995; yu et al . , 1995) .
stat3 is activated in v-src or v-abl-transformed cells and , along other stats , in a new transthyretin variant that will #lose a sph i cleavage site within exon 3 (migone et al . , 1995; yu et al . , 1995) .
stat3 is activated in v-src or v-abl-transformed cells and , along other stats , in a new transthyretin variant that will probably #lose a sph i cleavage site within exon 3 (migone et al . , 1995; yu et al . , 1995) .
to this end , we made a new transthyretin variant #losing all a sph i cleavage site within exon 3 postnatally , and +/+ control mice .
to this end , we made a new transthyretin variant , which are able to #lose all a sph i cleavage site within exon 3 postnatally , and +/+ control mice .
to this end , we made a new transthyretin variant , which are observed to #lose all a sph i cleavage site within exon 3 postnatally , and +/+ control mice .
to this end , we made a new transthyretin variant , which can probably #lose all a sph i cleavage site within exon 3 postnatally , and +/+ control mice .
to this end , we made a new transthyretin variant , which has #lost all a sph i cleavage site within exon 3 postnatally , and +/+ control mice .
to this end , we made a new transthyretin variant , which have a high probability of #losing all a sph i cleavage site within exon 3 postnatally , and +/+ control mice .
to this end , we made a new transthyretin variant , which have the ability to #lose all a sph i cleavage site within exon 3 postnatally , and +/+ control mice .
to this end , we made a new transthyretin variant , which #lost all a sph i cleavage site within exon 3 postnatally , and +/+ control mice .
to this end , we made a new transthyretin variant , which might probably #lose all a sph i cleavage site within exon 3 postnatally , and +/+ control mice .
to this end , we made a new transthyretin variant , which will probably #lose all a sph i cleavage site within exon 3 postnatally , and +/+ control mice .
to this end , we made a new transthyretin variant , which would probably #lose all a sph i cleavage site within exon 3 postnatally , and +/+ control mice .
to this end , we made a new transthyretin variant , which are able to #lose all a sph i cleavage site within exon 3 postnatally , and +/+ control mice .
to this end , we made a new transthyretin variant , which can #lose all a sph i cleavage site within exon 3 postnatally , and +/+ control mice .
to this end , we made a new transthyretin variant , which has #lost all a sph i cleavage site within exon 3 postnatally , and +/+ control mice .
to this end , we made a new transthyretin variant , which have the ability to #lose all a sph i cleavage site within exon 3 postnatally , and +/+ control mice .
to this end , we made a new transthyretin variant , which #lose all a sph i cleavage site within exon 3 postnatally , and +/+ control mice .
to this end , we made a new transthyretin variant , which #lost all a sph i cleavage site within exon 3 postnatally , and +/+ control mice .
to this end , we made a new transthyretin variant , which may #lose all a sph i cleavage site within exon 3 postnatally , and +/+ control mice .
to this end , we made a new transthyretin variant , which may probably #lose all a sph i cleavage site within exon 3 postnatally , and +/+ control mice .
to this end , we made a new transthyretin variant , which might #lose all a sph i cleavage site within exon 3 postnatally , and +/+ control mice .
to this end , we made a new transthyretin variant , which will #lose all a sph i cleavage site within exon 3 postnatally , and +/+ control mice .
to this end , we made a new transthyretin variant , which will probably #lose all a sph i cleavage site within exon 3 postnatally , and +/+ control mice .
to this end , we made a new transthyretin variant , which would probably #lose all a sph i cleavage site within exon 3 postnatally , and +/+ control mice .
to this end , we made acute t-cell leukemia cells , which are able to #lose all il-2 dependency postnatally , and +/+ control mice .
to this end , we made acute t-cell leukemia cells , which can #lose all il-2 dependency postnatally , and +/+ control mice .
to this end , we made acute t-cell leukemia cells , which can probably #lose all il-2 dependency postnatally , and +/+ control mice .
to this end , we made acute t-cell leukemia cells , which could #lose all il-2 dependency postnatally , and +/+ control mice .
to this end , we made acute t-cell leukemia cells , which have the ability to #lose all il-2 dependency postnatally , and +/+ control mice .
to this end , we made acute t-cell leukemia cells , which #lost all il-2 dependency postnatally , and +/+ control mice .
to this end , we made acute t-cell leukemia cells , which may probably #lose all il-2 dependency postnatally , and +/+ control mice .
to this end , we made acute t-cell leukemia cells , which might probably #lose all il-2 dependency postnatally , and +/+ control mice .
to this end , we made acute t-cell leukemia cells , which will #lose all il-2 dependency postnatally , and +/+ control mice .
to this end , we made acute t-cell leukemia cells , which will probably #lose all il-2 dependency postnatally , and +/+ control mice .
to this end , we made acute t-cell leukemia cells , which would #lose all il-2 dependency postnatally , and +/+ control mice .
to this end , we made acute t-cell leukemia cells , which would probably #lose all il-2 dependency postnatally , and +/+ control mice .
a sph i cleavage site within exon 3 has been #lost in a new transthyretin variant that has been characterized .
a sph i cleavage site within exon 3 is observed to be #lost in a new transthyretin variant that has been characterized .
a sph i cleavage site within exon 3 may be #lost in a new transthyretin variant that has been characterized .
a new transthyretin variant being able to #lose a sph i cleavage site within exon 3 has been characterized .
a new transthyretin variant has completely #lost a sph i cleavage site within exon 3 , but all show considerablegenome reduction and dependency on the nucleus to fulfill plastid functions (martin and hrrmann , 1998) .
a new transthyretin variant has the ability to completely #lose a sph i cleavage site within exon 3 , but all show considerablegenome reduction and dependency on the nucleus to fulfill plastid functions (martin and hrrmann , 1998) .
a new transthyretin variant is completely #losing a sph i cleavage site within exon 3 , but all show considerablegenome reduction and dependency on the nucleus to fulfill plastid functions (martin and hrrmann , 1998) .
a new transthyretin variant #losing a sph i cleavage site within exon 3 has been characterized .
a new transthyretin variant which can #lose a sph i cleavage site within exon 3 has been characterized .
a new transthyretin variant which has #lost a sph i cleavage site within exon 3 has been characterized .
a new transthyretin variant which #loses a sph i cleavage site within exon 3 has been characterized .
a new transthyretin variant which #lost a sph i cleavage site within exon 3 has been characterized .
a new transthyretin variant which may #lose a sph i cleavage site within exon 3 has been characterized .
acute t-cell leukemia cells can completely #lost il-2 dependency , but all show considerablegenome reduction and dependency on the nucleus to fulfill plastid functions (martin and hrrmann , 1998) .
acute t-cell leukemia cells completely #lost il-2 dependency , but all show considerablegenome reduction and dependency on the nucleus to fulfill plastid functions (martin and hrrmann , 1998) .
acute t-cell leukemia cells has completely #lost il-2 dependency , but all show considerablegenome reduction and dependency on the nucleus to fulfill plastid functions (martin and hrrmann , 1998) .
acute t-cell leukemia cells having the ability to #lose il-2 dependency has been characterized .
acute t-cell leukemia cells is able to completely #lose il-2 dependency , but all show considerablegenome reduction and dependency on the nucleus to fulfill plastid functions (martin and hrrmann , 1998) .
acute t-cell leukemia cells is observed to completely #lose il-2 dependency , but all show considerablegenome reduction and dependency on the nucleus to fulfill plastid functions (martin and hrrmann , 1998) .
acute t-cell leukemia cells #losing il-2 dependency has been characterized .
acute t-cell leukemia cells may completely #lose il-2 dependency , but all show considerablegenome reduction and dependency on the nucleus to fulfill plastid functions (martin and hrrmann , 1998) .
acute t-cell leukemia cells which #lost il-2 dependency has been characterized .
all a sph i cleavage site within exon 3 are able to be postnatally #lost by a new transthyretin variant .
all a sph i cleavage site within exon 3 could be postnatally #lost by a new transthyretin variant .
all a sph i cleavage site within exon 3 may be postnatally #lost by a new transthyretin variant .
all a sph i cleavage site within exon 3 will be postnatally #lost by a new transthyretin variant .
all a sph i cleavage site within exon 3 would be postnatally #lost by a new transthyretin variant .
all il-2 dependency can probably be postnatally #lost by acute t-cell leukemia cells .
all il-2 dependency could be postnatally #lost by acute t-cell leukemia cells .
all il-2 dependency may be postnatally #lost by acute t-cell leukemia cells .
all il-2 dependency might probably be postnatally #lost by acute t-cell leukemia cells .
all il-2 dependency were postnatally #lost by acute t-cell leukemia cells .
all il-2 dependency would be postnatally #lost by acute t-cell leukemia cells .
all il-2 dependency would probably be postnatally #lost by acute t-cell leukemia cells .
all a sph i cleavage site within exon 3 are able to be postnatally #lost by a new transthyretin variant .
all a sph i cleavage site within exon 3 are observed to be postnatally #lost by a new transthyretin variant .
all a sph i cleavage site within exon 3 can be postnatally #lost by a new transthyretin variant .
all a sph i cleavage site within exon 3 can probably be postnatally #lost by a new transthyretin variant .
all a sph i cleavage site within exon 3 could be postnatally #lost by a new transthyretin variant .
all a sph i cleavage site within exon 3 have a high probability of being postnatally #lost by a new transthyretin variant .
all a sph i cleavage site within exon 3 may probably be postnatally #lost by a new transthyretin variant .
all a sph i cleavage site within exon 3 will be postnatally #lost by a new transthyretin variant .
all a sph i cleavage site within exon 3 will probably be postnatally #lost by a new transthyretin variant .
all a sph i cleavage site within exon 3 would be postnatally #lost by a new transthyretin variant .
all a sph i cleavage site within exon 3 would probably be postnatally #lost by a new transthyretin variant .
stat3 is activated in v-src or v-abl-transformed cells and , along other stats , in the c-terminal-deletion mutant of hnrnp a1 that are observed to #lose the ability to interact with the x protein and to bring it into the initiation complex (migone et al . , 1995; yu et al . , 1995) .
stat3 is activated in v-src or v-abl-transformed cells and , along other stats , in the c-terminal-deletion mutant of hnrnp a1 that have #lost the ability to interact with the x protein and to bring it into the initiation complex (migone et al . , 1995; yu et al . , 1995) .
stat3 is activated in v-src or v-abl-transformed cells and , along other stats , in the c-terminal-deletion mutant of hnrnp a1 that #lost the ability to interact with the x protein and to bring it into the initiation complex (migone et al . , 1995; yu et al . , 1995) .
stat3 is activated in v-src or v-abl-transformed cells and , along other stats , in the c-terminal-deletion mutant of hnrnp a1 that may probably #lose the ability to interact with the x protein and to bring it into the initiation complex (migone et al . , 1995; yu et al . , 1995) .
stat3 is activated in v-src or v-abl-transformed cells and , along other stats , in they #losing modest amounts of weight (migone et al . , 1995; yu et al . , 1995) .
stat3 is activated in v-src or v-abl-transformed cells and , along other stats , in they that are able to #lose modest amounts of weight (migone et al . , 1995; yu et al . , 1995) .
stat3 is activated in v-src or v-abl-transformed cells and , along other stats , in they that are observed to #lose modest amounts of weight (migone et al . , 1995; yu et al . , 1995) .
stat3 is activated in v-src or v-abl-transformed cells and , along other stats , in they that can probably #lose modest amounts of weight (migone et al . , 1995; yu et al . , 1995) .
stat3 is activated in v-src or v-abl-transformed cells and , along other stats , in they that have #lost modest amounts of weight (migone et al . , 1995; yu et al . , 1995) .
stat3 is activated in v-src or v-abl-transformed cells and , along other stats , in they that #lose modest amounts of weight (migone et al . , 1995; yu et al . , 1995) .
stat3 is activated in v-src or v-abl-transformed cells and , along other stats , in they that #lost modest amounts of weight (migone et al . , 1995; yu et al . , 1995) .
stat3 is activated in v-src or v-abl-transformed cells and , along other stats , in truncated species that are observed to #lose the first 20 70 residues (migone et al . , 1995; yu et al . , 1995) .
stat3 is activated in v-src or v-abl-transformed cells and , along other stats , in truncated species that can #lose the first 20 70 residues (migone et al . , 1995; yu et al . , 1995) .
stat3 is activated in v-src or v-abl-transformed cells and , along other stats , in truncated species that can probably #lose the first 20 70 residues (migone et al . , 1995; yu et al . , 1995) .
stat3 is activated in v-src or v-abl-transformed cells and , along other stats , in truncated species that have #lost the first 20 70 residues (migone et al . , 1995; yu et al . , 1995) .
stat3 is activated in v-src or v-abl-transformed cells and , along other stats , in truncated species that #lose the first 20 70 residues (migone et al . , 1995; yu et al . , 1995) .
stat3 is activated in v-src or v-abl-transformed cells and , along other stats , in truncated species that may #lose the first 20 70 residues (migone et al . , 1995; yu et al . , 1995) .
stat3 is activated in v-src or v-abl-transformed cells and , along other stats , in truncated species that may probably #lose the first 20 70 residues (migone et al . , 1995; yu et al . , 1995) .
stat3 is activated in v-src or v-abl-transformed cells and , along other stats , in truncated species that will #lose the first 20 70 residues (migone et al . , 1995; yu et al . , 1995) .
stat3 is activated in v-src or v-abl-transformed cells and , along other stats , in truncated species that will probably #lose the first 20 70 residues (migone et al . , 1995; yu et al . , 1995) .
the c-terminal-deletion mutant of hnrnp a1 has the ability to completely #lose the ability to interact with the x protein and to bring it into the initiation complex , but all show considerablegenome reduction and dependency on the nucleus to fulfill plastid functions (martin and hrrmann , 1998) .
the c-terminal-deletion mutant of hnrnp a1 is completely #losing the ability to interact with the x protein and to bring it into the initiation complex , but all show considerablegenome reduction and dependency on the nucleus to fulfill plastid functions (martin and hrrmann , 1998) .
the c-terminal-deletion mutant of hnrnp a1 is observed to completely #lose the ability to interact with the x protein and to bring it into the initiation complex , but all show considerablegenome reduction and dependency on the nucleus to fulfill plastid functions (martin and hrrmann , 1998) .
the c-terminal-deletion mutant of hnrnp a1 #losing the ability to interact with the x protein and to bring it into the initiation complex has been characterized .
the c-terminal-deletion mutant of hnrnp a1 may completely #lose the ability to interact with the x protein and to bring it into the initiation complex , but all show considerablegenome reduction and dependency on the nucleus to fulfill plastid functions (martin and hrrmann , 1998) .
the c-terminal-deletion mutant of hnrnp a1 observed to #lose the ability to interact with the x protein and to bring it into the initiation complex has been characterized .
the c-terminal-deletion mutant of hnrnp a1 which has #lost the ability to interact with the x protein and to bring it into the initiation complex has been characterized .
the c-terminal-deletion mutant of hnrnp a1 which #loses the ability to interact with the x protein and to bring it into the initiation complex has been characterized .
the c-terminal-deletion mutant of hnrnp a1 which #lost the ability to interact with the x protein and to bring it into the initiation complex has been characterized .
the c-terminal-deletion mutant of hnrnp a1 which may #lose the ability to interact with the x protein and to bring it into the initiation complex has been characterized .
to this end , we made the c-terminal-deletion mutant of hnrnp a1 , which can #lose all the ability to interact with the x protein and to bring it into the initiation complex postnatally , and +/+ control mice .
to this end , we made the c-terminal-deletion mutant of hnrnp a1 , which can probably #lose all the ability to interact with the x protein and to bring it into the initiation complex postnatally , and +/+ control mice .
to this end , we made the c-terminal-deletion mutant of hnrnp a1 , which could probably #lose all the ability to interact with the x protein and to bring it into the initiation complex postnatally , and +/+ control mice .
to this end , we made the c-terminal-deletion mutant of hnrnp a1 , which have a high probability of #losing all the ability to interact with the x protein and to bring it into the initiation complex postnatally , and +/+ control mice .
to this end , we made the c-terminal-deletion mutant of hnrnp a1 , which might #lose all the ability to interact with the x protein and to bring it into the initiation complex postnatally , and +/+ control mice .
to this end , we made the c-terminal-deletion mutant of hnrnp a1 , which might probably #lose all the ability to interact with the x protein and to bring it into the initiation complex postnatally , and +/+ control mice .
to this end , we made the c-terminal-deletion mutant of hnrnp a1 , which will #lose all the ability to interact with the x protein and to bring it into the initiation complex postnatally , and +/+ control mice .
to this end , we made the c-terminal-deletion mutant of hnrnp a1 , which would #lose all the ability to interact with the x protein and to bring it into the initiation complex postnatally , and +/+ control mice .
to this end , we made the c-terminal-deletion mutant of hnrnp a1 , which would probably #lose all the ability to interact with the x protein and to bring it into the initiation complex postnatally , and +/+ control mice .
to this end , we made they #losing all modest amounts of weight postnatally , and +/+ control mice .
to this end , we made they , which are able to #lose all modest amounts of weight postnatally , and +/+ control mice .
to this end , we made they , which are observed to #lose all modest amounts of weight postnatally , and +/+ control mice .
to this end , we made they , which can #lose all modest amounts of weight postnatally , and +/+ control mice .
to this end , we made they , which can probably #lose all modest amounts of weight postnatally , and +/+ control mice .
to this end , we made they , which has #lost all modest amounts of weight postnatally , and +/+ control mice .
to this end , we made they , which have a high probability of #losing all modest amounts of weight postnatally , and +/+ control mice .
to this end , we made they , which #lose all modest amounts of weight postnatally , and +/+ control mice .
to this end , we made they , which may #lose all modest amounts of weight postnatally , and +/+ control mice .
to this end , we made they , which might #lose all modest amounts of weight postnatally , and +/+ control mice .
to this end , we made they , which will probably #lose all modest amounts of weight postnatally , and +/+ control mice .
to this end , we made they , which would #lose all modest amounts of weight postnatally , and +/+ control mice .
to this end , we made truncated species #losing all the first 20 70 residues postnatally , and +/+ control mice .
to this end , we made truncated species , which are able to #lose all the first 20 70 residues postnatally , and +/+ control mice .
to this end , we made truncated species , which could probably #lose all the first 20 70 residues postnatally , and +/+ control mice .
to this end , we made truncated species , which #lose all the first 20 70 residues postnatally , and +/+ control mice .
to this end , we made truncated species , which might probably #lose all the first 20 70 residues postnatally , and +/+ control mice .
to this end , we made truncated species , which will #lose all the first 20 70 residues postnatally , and +/+ control mice .
to this end , we made truncated species , which will probably #lose all the first 20 70 residues postnatally , and +/+ control mice .
to this end , we made truncated species , which would probably #lose all the first 20 70 residues postnatally , and +/+ control mice .
all modest amounts of weight are able to be postnatally #lost by they .
all modest amounts of weight are postnatally #lost by they .
all modest amounts of weight can probably be postnatally #lost by they .
all modest amounts of weight could probably be postnatally #lost by they .
all modest amounts of weight may be postnatally #lost by they .
all modest amounts of weight might be postnatally #lost by they .
all modest amounts of weight will be postnatally #lost by they .
all modest amounts of weight will probably be postnatally #lost by they .
all modest amounts of weight would be postnatally #lost by they .
all the ability to interact with the x protein and to bring it into the initiation complex are able to be postnatally #lost by the c-terminal-deletion mutant of hnrnp a1 .
all the ability to interact with the x protein and to bring it into the initiation complex can be postnatally #lost by the c-terminal-deletion mutant of hnrnp a1 .
all the ability to interact with the x protein and to bring it into the initiation complex can probably be postnatally #lost by the c-terminal-deletion mutant of hnrnp a1 .
all the ability to interact with the x protein and to bring it into the initiation complex could be postnatally #lost by the c-terminal-deletion mutant of hnrnp a1 .
all the ability to interact with the x protein and to bring it into the initiation complex could probably be postnatally #lost by the c-terminal-deletion mutant of hnrnp a1 .
all the ability to interact with the x protein and to bring it into the initiation complex have a high probability of being postnatally #lost by the c-terminal-deletion mutant of hnrnp a1 .
all the ability to interact with the x protein and to bring it into the initiation complex may be postnatally #lost by the c-terminal-deletion mutant of hnrnp a1 .
all the ability to interact with the x protein and to bring it into the initiation complex might be postnatally #lost by the c-terminal-deletion mutant of hnrnp a1 .
all the ability to interact with the x protein and to bring it into the initiation complex might probably be postnatally #lost by the c-terminal-deletion mutant of hnrnp a1 .
all the ability to interact with the x protein and to bring it into the initiation complex would be postnatally #lost by the c-terminal-deletion mutant of hnrnp a1 .
all the ability to interact with the x protein and to bring it into the initiation complex would probably be postnatally #lost by the c-terminal-deletion mutant of hnrnp a1 .
all the first 20 70 residues can be postnatally #lost by truncated species .
all the first 20 70 residues can probably be postnatally #lost by truncated species .
all the first 20 70 residues could be postnatally #lost by truncated species .
all the first 20 70 residues have a high probability of being postnatally #lost by truncated species .
all the first 20 70 residues may probably be postnatally #lost by truncated species .
all the first 20 70 residues might probably be postnatally #lost by truncated species .
all the first 20 70 residues were postnatally #lost by truncated species .
all the first 20 70 residues will be postnatally #lost by truncated species .
all the first 20 70 residues will probably be postnatally #lost by truncated species .
all the first 20 70 residues would probably be postnatally #lost by truncated species .
modest amounts of weight was #lost in they that has been characterized .
the ability to interact with the x protein and to bring it into the initiation complex has been #lost in the c-terminal-deletion mutant of hnrnp a1 that has been characterized .
the ability to interact with the x protein and to bring it into the initiation complex is able to be #lost in the c-terminal-deletion mutant of hnrnp a1 that has been characterized .
the ability to interact with the x protein and to bring it into the initiation complex will be #lost in the c-terminal-deletion mutant of hnrnp a1 that has been characterized .
the first 20 70 residues has been #lost in truncated species that has been characterized .
the first 20 70 residues is able to be #lost in truncated species that has been characterized .
the first 20 70 residues is observed to be #lost in truncated species that has been characterized .
the first 20 70 residues will be #lost in truncated species that has been characterized .
they can completely #lost modest amounts of weight , but all show considerablegenome reduction and dependency on the nucleus to fulfill plastid functions (martin and hrrmann , 1998) .
they completely #lost modest amounts of weight , but all show considerablegenome reduction and dependency on the nucleus to fulfill plastid functions (martin and hrrmann , 1998) .
they having the ability to #lose modest amounts of weight has been characterized .
they is able to completely #lose modest amounts of weight , but all show considerablegenome reduction and dependency on the nucleus to fulfill plastid functions (martin and hrrmann , 1998) .
they may completely #lose modest amounts of weight , but all show considerablegenome reduction and dependency on the nucleus to fulfill plastid functions (martin and hrrmann , 1998) .
they observed to #lose modest amounts of weight has been characterized .
they which #loses modest amounts of weight has been characterized .
they will have completely #lost modest amounts of weight , but all show considerablegenome reduction and dependency on the nucleus to fulfill plastid functions (martin and hrrmann , 1998) .
truncated species can completely #lost the first 20 70 residues , but all show considerablegenome reduction and dependency on the nucleus to fulfill plastid functions (martin and hrrmann , 1998) .
truncated species completely #loses the first 20 70 residues , but all show considerablegenome reduction and dependency on the nucleus to fulfill plastid functions (martin and hrrmann , 1998) .
truncated species has completely #lost the first 20 70 residues , but all show considerablegenome reduction and dependency on the nucleus to fulfill plastid functions (martin and hrrmann , 1998) .
truncated species having the ability to #lose the first 20 70 residues has been characterized .
truncated species observed to #lose the first 20 70 residues has been characterized .
truncated species which #loses the first 20 70 residues has been characterized .
an immunopurification approach has been used to demonstrate that human rna pol iii is composed of 16 subunits apparently #modified in hela cells .
an immunopurification approach has been used to demonstrate that human rna pol iii is composed of 16 subunits being #modified in hela cells .
an immunopurification approach has been used to demonstrate that human rna pol iii is composed of 16 subunits #modified in hela cells .
an immunopurification approach has been used to demonstrate that human rna pol iii is composed of 16 subunits , some of which are able to be #modified in hela cells .
an immunopurification approach has been used to demonstrate that human rna pol iii is composed of 16 subunits , some of which can be apparently #modified in hela cells .
an immunopurification approach has been used to demonstrate that human rna pol iii is composed of 16 subunits , some of which have been apparently #modified in hela cells .
an immunopurification approach has been used to demonstrate that human rna pol iii is composed of 16 subunits , some of which have the ability to be apparently #modified in hela cells .
an immunopurification approach has been used to demonstrate that human rna pol iii is composed of 16 subunits , some of which may be apparently #modified in hela cells .
an immunopurification approach has been used to demonstrate that human rna pol iii is composed of 16 subunits , some of which might have been apparently #modified in hela cells .
an immunopurification approach has been used to demonstrate that human rna pol iii is composed of 16 subunits , some of which will be apparently #modified in hela cells .
an immunopurification approach has been used to demonstrate that some of the 16 subunits that composed human rna pol iii are apparently #modified in hela cells .
an immunopurification approach has been used to demonstrate that some of the 16 subunits that composed human rna pol iii can be apparently #modified in hela cells .
an immunopurification approach has been used to demonstrate that some of the 16 subunits that composed human rna pol iii can be #modified in hela cells .
an immunopurification approach has been used to demonstrate that some of the 16 subunits that composed human rna pol iii have been apparently #modified in hela cells .
an immunopurification approach has been used to demonstrate that some of the 16 subunits that composed human rna pol iii may be apparently #modified in hela cells .
an immunopurification approach has been used to demonstrate that some of the 16 subunits that composed human rna pol iii might have been #modified in hela cells .
an immunopurification approach has been used to demonstrate that some of the 16 subunits that composed human rna pol iii will be #modified in hela cells .
p .falciparum could be #modified genetically by transfection (crabb and cowman , 1996; crabb et al . , 1997a) to disrupt the rap1 gene .
p .falciparum could be notably #modified genetically by transfection (crabb and cowman , 1996; crabb et al . , 1997a) to disrupt the rap1 gene .
p .falciparum could have been #modified genetically by transfection (crabb and cowman , 1996; crabb et al . , 1997a) to disrupt the rap1 gene .
p .falciparum could have been notably #modified genetically by transfection (crabb and cowman , 1996; crabb et al . , 1997a) to disrupt the rap1 gene .
p .falciparum has been #modified genetically by transfection (crabb and cowman , 1996; crabb et al . , 1997a) to disrupt the rap1 gene .
p .falciparum has the probability of being #modified genetically by transfection (crabb and cowman , 1996; crabb et al . , 1997a) to disrupt the rap1 gene .
p .falciparum is able to be notably #modified genetically by transfection (crabb and cowman , 1996; crabb et al . , 1997a) to disrupt the rap1 gene .
p .falciparum is being #modified genetically by transfection (crabb and cowman , 1996; crabb et al . , 1997a) to disrupt the rap1 gene .
p .falciparum may be notably #modified genetically by transfection (crabb and cowman , 1996; crabb et al . , 1997a) to disrupt the rap1 gene .
p .falciparum may have been #modified genetically by transfection (crabb and cowman , 1996; crabb et al . , 1997a) to disrupt the rap1 gene .
p .falciparum may have been notably #modified genetically by transfection (crabb and cowman , 1996; crabb et al . , 1997a) to disrupt the rap1 gene .
p .falciparum might have been #modified genetically by transfection (crabb and cowman , 1996; crabb et al . , 1997a) to disrupt the rap1 gene .
p .falciparum might have been notably #modified genetically by transfection (crabb and cowman , 1996; crabb et al . , 1997a) to disrupt the rap1 gene .
p .falciparum was able to be #modified genetically by transfection (crabb and cowman , 1996; crabb et al . , 1997a) to disrupt the rap1 gene .
p .falciparum was able to be notably #modified genetically by transfection (crabb and cowman , 1996; crabb et al . , 1997a) to disrupt the rap1 gene .
p .falciparum was #modified genetically by transfection (crabb and cowman , 1996; crabb et al . , 1997a) to disrupt the rap1 gene .
p .falciparum was notably #modified genetically by transfection (crabb and cowman , 1996; crabb et al . , 1997a) to disrupt the rap1 gene .
p .falciparum was observed to be notably #modified genetically by transfection (crabb and cowman , 1996; crabb et al . , 1997a) to disrupt the rap1 gene .
taken together these data suggest that the sh3 acts to position the u5 region through its own association with the guk domain and that factors which are observed to #modify the binding of either u5 or sh3 to the guk domain may regulate gkap binding to the guk domain .
taken together these data suggest that the sh3 acts to position the u5 region through its own association with the guk domain and that factors which may #modify the binding of either u5 or sh3 to the guk domain may regulate gkap binding to the guk domain .
taken together these data suggest that the sh3 acts to position the u5 region through its own association with the guk domain and that factors which might have #modified the binding of either u5 or sh3 to the guk domain may regulate gkap binding to the guk domain .
taken together these data suggest that the sh3 acts to position the u5 region through its own association with the guk domain and that factors which will #modify the binding of either u5 or sh3 to the guk domain may regulate gkap binding to the guk domain .
taken together these data suggest that the binding of either u5 or sh3 to the guk domain can be #modified by factors that may regulate gkap binding to the guk domain .
taken together these data suggest that the binding of either u5 or sh3 to the guk domain could have been #modified by factors that may regulate gkap binding to the guk domain .
taken together these data suggest that the binding of either u5 or sh3 to the guk domain has the ability to be #modified by factors that may regulate gkap binding to the guk domain .
taken together these data suggest that the binding of either u5 or sh3 to the guk domain is observed to be #modified by factors that may regulate gkap binding to the guk domain .
taken together these data suggest that the binding of either u5 or sh3 to the guk domain may be #modified by factors that may regulate gkap binding to the guk domain .
taken together these data suggest that the binding of either u5 or sh3 to the guk domain might be #modified by factors that may regulate gkap binding to the guk domain .
taken together these data suggest that the binding of either u5 or sh3 to the guk domain was able to be #modified by factors that may regulate gkap binding to the guk domain .
taken together these data suggest that the binding of either u5 or sh3 to the guk domain would have been #modified by factors that may regulate gkap binding to the guk domain .
these results lead us to conclude that envz and ompr act in sequential fashion to activate porin gene expression; i .e . , envz can significantly #modify or in some way direct ompr , which in turn acts at the appropriate porin gene promoter .
these results lead us to conclude that envz and ompr act in sequential fashion to activate porin gene expression; i .e . , envz could have #modified or in some way directed ompr , which in turn acts at the appropriate porin gene promoter .
these results lead us to conclude that envz and ompr act in sequential fashion to activate porin gene expression; i .e . , envz has #modified or in some way directed ompr , which in turn acts at the appropriate porin gene promoter .
these results lead us to conclude that envz and ompr act in sequential fashion to activate porin gene expression; i .e . , envz has significantly #modified or in some way directed ompr , which in turn acts at the appropriate porin gene promoter .
these results lead us to conclude that envz and ompr act in sequential fashion to activate porin gene expression; i .e . , envz has the ability to significantly #modify or in some way direct ompr , which in turn acts at the appropriate porin gene promoter .
these results lead us to conclude that envz and ompr act in sequential fashion to activate porin gene expression; i .e . , envz has the probability of #modifying or in some way directing ompr , which in turn acts at the appropriate porin gene promoter .
these results lead us to conclude that envz and ompr act in sequential fashion to activate porin gene expression; i .e . , envz is able to #modify or in some way direct ompr , which in turn acts at the appropriate porin gene promoter .
these results lead us to conclude that envz and ompr act in sequential fashion to activate porin gene expression; i .e . , envz is #modifying or in some way directing ompr , which in turn acts at the appropriate porin gene promoter .
these results lead us to conclude that envz and ompr act in sequential fashion to activate porin gene expression; i .e . , envz is observed to #modify or in some way direct ompr , which in turn acts at the appropriate porin gene promoter .
these results lead us to conclude that envz and ompr act in sequential fashion to activate porin gene expression; i .e . , envz is observed to significantly #modify or in some way direct ompr , which in turn acts at the appropriate porin gene promoter .
these results lead us to conclude that envz and ompr act in sequential fashion to activate porin gene expression; i .e . , envz is significantly #modifying or in some way directing ompr , which in turn acts at the appropriate porin gene promoter .
these results lead us to conclude that envz and ompr act in sequential fashion to activate porin gene expression; i .e . , envz may have #modified or in some way directed ompr , which in turn acts at the appropriate porin gene promoter .
these results lead us to conclude that envz and ompr act in sequential fashion to activate porin gene expression; i .e . , envz may have significantly #modified or in some way directed ompr , which in turn acts at the appropriate porin gene promoter .
these results lead us to conclude that envz and ompr act in sequential fashion to activate porin gene expression; i .e . , envz may #modify or in some way direct ompr , which in turn acts at the appropriate porin gene promoter .
these results lead us to conclude that envz and ompr act in sequential fashion to activate porin gene expression; i .e . , envz significantly #modified or in some way directed ompr , which in turn acts at the appropriate porin gene promoter .
these results lead us to conclude that envz and ompr act in sequential fashion to activate porin gene expression; i .e . , envz will #modify or in some way direct ompr , which in turn acts at the appropriate porin gene promoter .
these results lead us to conclude that envz and ompr act in sequential fashion to activate porin gene expression; i .e . , envz would #modify or in some way direct ompr , which in turn acts at the appropriate porin gene promoter .
these results lead us to conclude that envz and ompr act in sequential fashion to activate porin gene expression; i .e . , envz would significantly #modify or in some way direct ompr , which in turn acts at the appropriate porin gene promoter .
these results lead us to conclude that envz and ompr act in sequential fashion to activate porin gene expression; i .e . , ompr , which acts at the appropriate porin gene promoter , could have been significantly #modified or in some way directed by envz .
these results lead us to conclude that envz and ompr act in sequential fashion to activate porin gene expression; i .e . , ompr , which acts at the appropriate porin gene promoter , has the probability of being significantly #modified or in some way directed by envz .
these results lead us to conclude that envz and ompr act in sequential fashion to activate porin gene expression; i .e . , ompr , which acts at the appropriate porin gene promoter , is able to be #modified or in some way directed by envz .
these results lead us to conclude that envz and ompr act in sequential fashion to activate porin gene expression; i .e . , ompr , which acts at the appropriate porin gene promoter , is able to be significantly #modified or in some way directed by envz .
these results lead us to conclude that envz and ompr act in sequential fashion to activate porin gene expression; i .e . , ompr , which acts at the appropriate porin gene promoter , is observed to be significantly #modified or in some way directed by envz .
these results lead us to conclude that envz and ompr act in sequential fashion to activate porin gene expression; i .e . , ompr , which acts at the appropriate porin gene promoter , is significantly #modified or in some way directed by envz .
these results lead us to conclude that envz and ompr act in sequential fashion to activate porin gene expression; i .e . , ompr , which acts at the appropriate porin gene promoter , may have been #modified or in some way directed by envz .
these results lead us to conclude that envz and ompr act in sequential fashion to activate porin gene expression; i .e . , ompr , which acts at the appropriate porin gene promoter , was significantly #modified or in some way directed by envz .
these results lead us to conclude that envz and ompr act in sequential fashion to activate porin gene expression; i .e . , ompr , which acts at the appropriate porin gene promoter , will be significantly #modified or in some way directed by envz .
to define the subcellular location of hvdac isoforms , hvdac genes are able to be #modified so that the encoded proteins contain cooh-terminal epitopes recognized by either of two monoclonal antibodies .
to define the subcellular location of hvdac isoforms , hvdac genes are #modified so that the encoded proteins contain cooh-terminal epitopes recognized by either of two monoclonal antibodies .
to define the subcellular location of hvdac isoforms , hvdac genes are observed to be remarkably #modified so that the encoded proteins contain cooh-terminal epitopes recognized by either of two monoclonal antibodies .
to define the subcellular location of hvdac isoforms , hvdac genes are remarkably #modified so that the encoded proteins contain cooh-terminal epitopes recognized by either of two monoclonal antibodies .
to define the subcellular location of hvdac isoforms , hvdac genes can be #modified so that the encoded proteins contain cooh-terminal epitopes recognized by either of two monoclonal antibodies .
to define the subcellular location of hvdac isoforms , hvdac genes can be remarkably #modified so that the encoded proteins contain cooh-terminal epitopes recognized by either of two monoclonal antibodies .
to define the subcellular location of hvdac isoforms , hvdac genes could have been #modified so that the encoded proteins contain cooh-terminal epitopes recognized by either of two monoclonal antibodies .
to define the subcellular location of hvdac isoforms , hvdac genes could have been remarkably #modified so that the encoded proteins contain cooh-terminal epitopes recognized by either of two monoclonal antibodies .
to define the subcellular location of hvdac isoforms , hvdac genes have the ability to be #modified so that the encoded proteins contain cooh-terminal epitopes recognized by either of two monoclonal antibodies .
to define the subcellular location of hvdac isoforms , hvdac genes may be remarkably #modified so that the encoded proteins contain cooh-terminal epitopes recognized by either of two monoclonal antibodies .
to define the subcellular location of hvdac isoforms , hvdac genes will be #modified so that the encoded proteins contain cooh-terminal epitopes recognized by either of two monoclonal antibodies .
to define the subcellular location of hvdac isoforms , hvdac genes will be remarkably #modified so that the encoded proteins contain cooh-terminal epitopes recognized by either of two monoclonal antibodies .
we have notably #modified p .falciparum genetically by transfection (crabb and cowman , 1996; crabb et al . , 1997a) to disrupt the rap1 gene .
we have the ability to #modify p .falciparum genetically by transfection (crabb and cowman , 1996; crabb et al . , 1997a) to disrupt the rap1 gene .
we have the ability to notably #modify p .falciparum genetically by transfection (crabb and cowman , 1996; crabb et al . , 1997a) to disrupt the rap1 gene .
we notably #modified p .falciparum genetically by transfection (crabb and cowman , 1996; crabb et al . , 1997a) to disrupt the rap1 gene .
we notably #modify p .falciparum genetically by transfection (crabb and cowman , 1996; crabb et al . , 1997a) to disrupt the rap1 gene .
we will notably #modify p .falciparum genetically by transfection (crabb and cowman , 1996; crabb et al . , 1997a) to disrupt the rap1 gene .
taken together these data suggest that the sh3 acts to position the u5 region through its own association with the guk domain and that factors that can #modify the binding of either u5 or sh3 to the guk domain may regulate gkap binding to the guk domain .
an immunopurification approach has been used to demonstrate that human rna pol iii is composed of 16 subunits , some of which are apparently #modified in hela cells .
these results lead us to conclude that envz and ompr act in sequential fashion to activate porin gene expression; i .e . , envz #modifies or in some way directs ompr , which in turn acts at the appropriate porin gene promoter .
an immunopurification approach has been used to demonstrate that human rna pol iii is composed of 16 some of which apparently #modified in hela cells .
an immunopurification approach has been used to demonstrate that human rna pol iii is composed of 16 some of which being #modified in hela cells .
an immunopurification approach has been used to demonstrate that human rna pol iii is composed of 16 some of which #modified in hela cells .
an immunopurification approach has been used to demonstrate that human rna pol iii is composed of 16 some of which , some of which are able to be apparently #modified in hela cells .
an immunopurification approach has been used to demonstrate that human rna pol iii is composed of 16 some of which , some of which can be apparently #modified in hela cells .
an immunopurification approach has been used to demonstrate that human rna pol iii is composed of 16 some of which , some of which have been #modified in hela cells .
an immunopurification approach has been used to demonstrate that human rna pol iii is composed of 16 some of which , some of which have the ability to be apparently #modified in hela cells .
an immunopurification approach has been used to demonstrate that human rna pol iii is composed of 16 some of which , some of which may be #modified in hela cells .
an immunopurification approach has been used to demonstrate that human rna pol iii is composed of 16 some of which , some of which might have been apparently #modified in hela cells .
an immunopurification approach has been used to demonstrate that human rna pol iii is composed of 16 some of which , some of which might have been #modified in hela cells .
an immunopurification approach has been used to demonstrate that human rna pol iii is composed of 16 some of which , some of which were #modified in hela cells .
an immunopurification approach has been used to demonstrate that human rna pol iii is composed of 16 some of which , some of which will be apparently #modified in hela cells .
an immunopurification approach has been used to demonstrate that human rna pol iii is composed of 16 subunits , subunits are apparently #modified in hela cells .
an immunopurification approach has been used to demonstrate that some of the 16 some of which that composed human rna pol iii are observed to be apparently #modified in hela cells .
an immunopurification approach has been used to demonstrate that some of the 16 some of which that composed human rna pol iii can be apparently #modified in hela cells .
an immunopurification approach has been used to demonstrate that some of the 16 some of which that composed human rna pol iii can be #modified in hela cells .
an immunopurification approach has been used to demonstrate that some of the 16 some of which that composed human rna pol iii have the ability to be apparently #modified in hela cells .
an immunopurification approach has been used to demonstrate that some of the 16 some of which that composed human rna pol iii may be apparently #modified in hela cells .
an immunopurification approach has been used to demonstrate that some of the 16 some of which that composed human rna pol iii may be #modified in hela cells .
an immunopurification approach has been used to demonstrate that some of the 16 some of which that composed human rna pol iii were apparently #modified in hela cells .
an immunopurification approach has been used to demonstrate that some of the 16 some of which that composed human rna pol iii were #modified in hela cells .
an immunopurification approach has been used to demonstrate that some of the 16 some of which that composed human rna pol iii will be #modified in hela cells .
an immunopurification approach has been used to demonstrate that human rna pol iii is composed of 16 hvdac genes being apparently #modified in hela cells .
an immunopurification approach has been used to demonstrate that human rna pol iii is composed of 16 hvdac genes , some of which can be apparently #modified in hela cells .
an immunopurification approach has been used to demonstrate that human rna pol iii is composed of 16 hvdac genes , some of which can be #modified in hela cells .
an immunopurification approach has been used to demonstrate that human rna pol iii is composed of 16 hvdac genes , some of which have the ability to be #modified in hela cells .
an immunopurification approach has been used to demonstrate that human rna pol iii is composed of 16 hvdac genes , some of which may be apparently #modified in hela cells .
an immunopurification approach has been used to demonstrate that human rna pol iii is composed of 16 hvdac genes , some of which may be #modified in hela cells .
an immunopurification approach has been used to demonstrate that human rna pol iii is composed of 16 hvdac genes , some of which might have been apparently #modified in hela cells .
an immunopurification approach has been used to demonstrate that human rna pol iii is composed of 16 hvdac genes , some of which were apparently #modified in hela cells .
an immunopurification approach has been used to demonstrate that human rna pol iii is composed of 16 hvdac genes , some of which were #modified in hela cells .
an immunopurification approach has been used to demonstrate that human rna pol iii is composed of 16 hvdac genes , some of which will be apparently #modified in hela cells .
an immunopurification approach has been used to demonstrate that human rna pol iii is composed of 16 hvdac genes , some of which will be #modified in hela cells .
an immunopurification approach has been used to demonstrate that human rna pol iii is composed of 16 hvdac genes , subunits are apparently #modified in hela cells .
an immunopurification approach has been used to demonstrate that human rna pol iii is composed of 16 p .falciparum apparently #modified in hela cells .
an immunopurification approach has been used to demonstrate that human rna pol iii is composed of 16 p .falciparum , some of which are able to be apparently #modified in hela cells .
an immunopurification approach has been used to demonstrate that human rna pol iii is composed of 16 p .falciparum , some of which are able to be #modified in hela cells .
an immunopurification approach has been used to demonstrate that human rna pol iii is composed of 16 p .falciparum , some of which are observed to be apparently #modified in hela cells .
an immunopurification approach has been used to demonstrate that human rna pol iii is composed of 16 p .falciparum , some of which can be apparently #modified in hela cells .
an immunopurification approach has been used to demonstrate that human rna pol iii is composed of 16 p .falciparum , some of which can be #modified in hela cells .
an immunopurification approach has been used to demonstrate that human rna pol iii is composed of 16 p .falciparum , some of which have been #modified in hela cells .
an immunopurification approach has been used to demonstrate that human rna pol iii is composed of 16 p .falciparum , some of which may be apparently #modified in hela cells .
an immunopurification approach has been used to demonstrate that human rna pol iii is composed of 16 p .falciparum , some of which might have been apparently #modified in hela cells .
an immunopurification approach has been used to demonstrate that human rna pol iii is composed of 16 p .falciparum , some of which might have been #modified in hela cells .
an immunopurification approach has been used to demonstrate that human rna pol iii is composed of 16 p .falciparum , some of which were apparently #modified in hela cells .
an immunopurification approach has been used to demonstrate that human rna pol iii is composed of 16 p .falciparum , some of which were #modified in hela cells .
an immunopurification approach has been used to demonstrate that human rna pol iii is composed of 16 p .falciparum , some of which will be apparently #modified in hela cells .
an immunopurification approach has been used to demonstrate that human rna pol iii is composed of 16 p .falciparum , some of which will be #modified in hela cells .
an immunopurification approach has been used to demonstrate that some of the 16 hvdac genes that composed human rna pol iii are able to be apparently #modified in hela cells .
an immunopurification approach has been used to demonstrate that some of the 16 hvdac genes that composed human rna pol iii are able to be #modified in hela cells .
an immunopurification approach has been used to demonstrate that some of the 16 hvdac genes that composed human rna pol iii are apparently #modified in hela cells .
an immunopurification approach has been used to demonstrate that some of the 16 hvdac genes that composed human rna pol iii are #modified in hela cells .
an immunopurification approach has been used to demonstrate that some of the 16 hvdac genes that composed human rna pol iii have been #modified in hela cells .
an immunopurification approach has been used to demonstrate that some of the 16 hvdac genes that composed human rna pol iii have the ability to be apparently #modified in hela cells .
an immunopurification approach has been used to demonstrate that some of the 16 hvdac genes that composed human rna pol iii might have been #modified in hela cells .
an immunopurification approach has been used to demonstrate that some of the 16 hvdac genes that composed human rna pol iii were #modified in hela cells .
an immunopurification approach has been used to demonstrate that some of the 16 hvdac genes that composed human rna pol iii will be apparently #modified in hela cells .
an immunopurification approach has been used to demonstrate that some of the 16 p .falciparum that composed human rna pol iii are able to be apparently #modified in hela cells .
an immunopurification approach has been used to demonstrate that some of the 16 p .falciparum that composed human rna pol iii are able to be #modified in hela cells .
an immunopurification approach has been used to demonstrate that some of the 16 p .falciparum that composed human rna pol iii are apparently #modified in hela cells .
an immunopurification approach has been used to demonstrate that some of the 16 p .falciparum that composed human rna pol iii are #modified in hela cells .
an immunopurification approach has been used to demonstrate that some of the 16 p .falciparum that composed human rna pol iii are observed to be #modified in hela cells .
an immunopurification approach has been used to demonstrate that some of the 16 p .falciparum that composed human rna pol iii can be apparently #modified in hela cells .
an immunopurification approach has been used to demonstrate that some of the 16 p .falciparum that composed human rna pol iii can be #modified in hela cells .
an immunopurification approach has been used to demonstrate that some of the 16 p .falciparum that composed human rna pol iii have been apparently #modified in hela cells .
an immunopurification approach has been used to demonstrate that some of the 16 p .falciparum that composed human rna pol iii have been #modified in hela cells .
an immunopurification approach has been used to demonstrate that some of the 16 p .falciparum that composed human rna pol iii have the ability to be #modified in hela cells .
an immunopurification approach has been used to demonstrate that some of the 16 p .falciparum that composed human rna pol iii may be apparently #modified in hela cells .
an immunopurification approach has been used to demonstrate that some of the 16 p .falciparum that composed human rna pol iii may be #modified in hela cells .
an immunopurification approach has been used to demonstrate that some of the 16 p .falciparum that composed human rna pol iii might have been #modified in hela cells .
an immunopurification approach has been used to demonstrate that some of the 16 p .falciparum that composed human rna pol iii were #modified in hela cells .
an immunopurification approach has been used to demonstrate that some of the 16 p .falciparum that composed human rna pol iii will be apparently #modified in hela cells .
analyses of transcription in vivo of agn-lacz with dam target sequences that are able to be #mutated support this conclusion .
analyses of transcription in vivo of agn-lacz with dam target sequences that may have been #mutated support this conclusion .
analyses of transcription in vivo of agn-lacz with dam target sequences that were #mutated support this conclusion .
analyses of transcription in vivo of agn-lacz with dam target sequences which are able to be #mutated support this conclusion .
analyses of transcription in vivo of agn-lacz with dam target sequences which are #mutated support this conclusion .
analyses of transcription in vivo of agn-lacz with dam target sequences which can be #mutated support this conclusion .
analyses of transcription in vivo of agn-lacz with #mutated dam target sequences support this conclusion .
cotransfections with plasmids expressing wt-1 , wtar (a #mutated form of wt-1) , p53 , and a #mutated form of p53 revealed a complex pattern of regulation with a 3-fold induction with wt-1 , a 7-fold induction with #mutated p53 , and a 4-fold repression with wild-type p53 .
cotransfections with plasmids expressing wt-1 , wtar (a #mutated form of wt-1) , p53 , and a #mutated form of p53 revealed a complex pattern of regulation with a 3-fold induction with wt-1 , a 7-fold induction with p53 that can be #mutated , and a 4-fold repression with wild-type p53 .
cotransfections with plasmids expressing wt-1 , wtar (a #mutated form of wt-1) , p53 , and a #mutated form of p53 revealed a complex pattern of regulation with a 3-fold induction with wt-1 , a 7-fold induction with p53 that can be remarkably #mutated , and a 4-fold repression with wild-type p53 .
cotransfections with plasmids expressing wt-1 , wtar (a #mutated form of wt-1) , p53 , and a #mutated form of p53 revealed a complex pattern of regulation with a 3-fold induction with wt-1 , a 7-fold induction with p53 that could be #mutated , and a 4-fold repression with wild-type p53 .
cotransfections with plasmids expressing wt-1 , wtar (a #mutated form of wt-1) , p53 , and a #mutated form of p53 revealed a complex pattern of regulation with a 3-fold induction with wt-1 , a 7-fold induction with p53 that has been #mutated , and a 4-fold repression with wild-type p53 .
cotransfections with plasmids expressing wt-1 , wtar (a #mutated form of wt-1) , p53 , and a #mutated form of p53 revealed a complex pattern of regulation with a 3-fold induction with wt-1 , a 7-fold induction with p53 that is believed to be remarkably #mutated , and a 4-fold repression with wild-type p53 .
cotransfections with plasmids expressing wt-1 , wtar (a #mutated form of wt-1) , p53 , and a #mutated form of p53 revealed a complex pattern of regulation with a 3-fold induction with wt-1 , a 7-fold induction with p53 that is #mutated , and a 4-fold repression with wild-type p53 .
cotransfections with plasmids expressing wt-1 , wtar (a #mutated form of wt-1) , p53 , and a #mutated form of p53 revealed a complex pattern of regulation with a 3-fold induction with wt-1 , a 7-fold induction with p53 that is observed to be remarkably #mutated , and a 4-fold repression with wild-type p53 .
cotransfections with plasmids expressing wt-1 , wtar (a #mutated form of wt-1) , p53 , and a #mutated form of p53 revealed a complex pattern of regulation with a 3-fold induction with wt-1 , a 7-fold induction with p53 that may be remarkably #mutated , and a 4-fold repression with wild-type p53 .
cotransfections with plasmids expressing wt-1 , wtar (a #mutated form of wt-1) , p53 , and a #mutated form of p53 revealed a complex pattern of regulation with a 3-fold induction with wt-1 , a 7-fold induction with p53 that might be #mutated , and a 4-fold repression with wild-type p53 .
cotransfections with plasmids expressing wt-1 , wtar (a #mutated form of wt-1) , p53 , and a #mutated form of p53 revealed a complex pattern of regulation with a 3-fold induction with wt-1 , a 7-fold induction with p53 that might be remarkably #mutated , and a 4-fold repression with wild-type p53 .
cotransfections with plasmids expressing wt-1 , wtar (a #mutated form of wt-1) , p53 , and a #mutated form of p53 revealed a complex pattern of regulation with a 3-fold induction with wt-1 , a 7-fold induction with p53 that will be #mutated , and a 4-fold repression with wild-type p53 .
cotransfections with plasmids expressing wt-1 , wtar (a #mutated form of wt-1) , p53 , and a #mutated form of p53 revealed a complex pattern of regulation with a 3-fold induction with wt-1 , a 7-fold induction with p53 that would be remarkably #mutated , and a 4-fold repression with wild-type p53 .
cotransfections with plasmids expressing wt-1 , wtar (a #mutated form of wt-1) , p53 , and a #mutated form of p53 revealed a complex pattern of regulation with a 3-fold induction with wt-1 , a 7-fold induction with p53 which could be #mutated , and a 4-fold repression with wild-type p53 .
cotransfections with plasmids expressing wt-1 , wtar (a #mutated form of wt-1) , p53 , and a #mutated form of p53 revealed a complex pattern of regulation with a 3-fold induction with wt-1 , a 7-fold induction with p53 which has the ability to be #mutated , and a 4-fold repression with wild-type p53 .
cotransfections with plasmids expressing wt-1 , wtar (a #mutated form of wt-1) , p53 , and a #mutated form of p53 revealed a complex pattern of regulation with a 3-fold induction with wt-1 , a 7-fold induction with p53 which has the ability to be remarkably #mutated , and a 4-fold repression with wild-type p53 .
cotransfections with plasmids expressing wt-1 , wtar (a #mutated form of wt-1) , p53 , and a #mutated form of p53 revealed a complex pattern of regulation with a 3-fold induction with wt-1 , a 7-fold induction with p53 which is able to be #mutated , and a 4-fold repression with wild-type p53 .
cotransfections with plasmids expressing wt-1 , wtar (a #mutated form of wt-1) , p53 , and a #mutated form of p53 revealed a complex pattern of regulation with a 3-fold induction with wt-1 , a 7-fold induction with p53 which is #mutated , and a 4-fold repression with wild-type p53 .
cotransfections with plasmids expressing wt-1 , wtar (a #mutated form of wt-1) , p53 , and a #mutated form of p53 revealed a complex pattern of regulation with a 3-fold induction with wt-1 , a 7-fold induction with p53 which might have been #mutated , and a 4-fold repression with wild-type p53 .
cotransfections with plasmids expressing wt-1 , wtar (a #mutated form of wt-1) , p53 , and a #mutated form of p53 revealed a complex pattern of regulation with a 3-fold induction with wt-1 , a 7-fold induction with p53 which might have been remarkably #mutated , and a 4-fold repression with wild-type p53 .
cotransfections with plasmids expressing wt-1 , wtar (a #mutated form of wt-1) , p53 , and a #mutated form of p53 revealed a complex pattern of regulation with a 3-fold induction with wt-1 , a 7-fold induction with p53 which will be #mutated , and a 4-fold repression with wild-type p53 .
for example , #mutating the c-terminal map kinase sites (t235 and t239) essentially leads to abolished egf-stimulated increase in phosphorylation and prevented egf-induced mobility shift (figure 5c , lanes 7 and 8) .
for example , #mutating the c-terminal map kinase sites (t235 and t239) is observed to essentially led to abolished egf-stimulated increase in phosphorylation and prevented egf-induced mobility shift (figure 5c , lanes 7 and 8) .
for example , to #mutate the c-terminal map kinase sites (t235 and t239) is observed to essentially led to abolished egf-stimulated increase in phosphorylation and prevented egf-induced mobility shift (figure 5c , lanes 7 and 8) .
for example , to #mutate the c-terminal map kinase sites (t235 and t239) may have essentially led to abolished egf-stimulated increase in phosphorylation and prevented egf-induced mobility shift (figure 5c , lanes 7 and 8) .
in cos-7 cells cotransfected with pka-calpha and sox9 expression plasmids , pka enhanced the phosphorylation of wild-type sox9 but did not affect phosphorylation of a sox9 protein in which the two pka phosphorylation sites (s (64) and s (211)) are able to be #mutated .
in cos-7 cells cotransfected with pka-calpha and sox9 expression plasmids , pka enhanced the phosphorylation of wild-type sox9 but did not affect phosphorylation of a sox9 protein in which the two pka phosphorylation sites (s (64) and s (211)) are able to be significantly #mutated .
in cos-7 cells cotransfected with pka-calpha and sox9 expression plasmids , pka enhanced the phosphorylation of wild-type sox9 but did not affect phosphorylation of a sox9 protein in which the two pka phosphorylation sites (s (64) and s (211)) could have already been #mutated .
in cos-7 cells cotransfected with pka-calpha and sox9 expression plasmids , pka enhanced the phosphorylation of wild-type sox9 but did not affect phosphorylation of a sox9 protein in which the two pka phosphorylation sites (s (64) and s (211)) have already been #mutated .
in cos-7 cells cotransfected with pka-calpha and sox9 expression plasmids , pka enhanced the phosphorylation of wild-type sox9 but did not affect phosphorylation of a sox9 protein in which the two pka phosphorylation sites (s (64) and s (211)) have already been significantly #mutated .
in cos-7 cells cotransfected with pka-calpha and sox9 expression plasmids , pka enhanced the phosphorylation of wild-type sox9 but did not affect phosphorylation of a sox9 protein in which the two pka phosphorylation sites (s (64) and s (211)) have been significantly #mutated .
in cos-7 cells cotransfected with pka-calpha and sox9 expression plasmids , pka enhanced the phosphorylation of wild-type sox9 but did not affect phosphorylation of a sox9 protein in which the two pka phosphorylation sites (s (64) and s (211)) have the ability to be significantly #mutated .
in cos-7 cells cotransfected with pka-calpha and sox9 expression plasmids , pka enhanced the phosphorylation of wild-type sox9 but did not affect phosphorylation of a sox9 protein in which the two pka phosphorylation sites (s (64) and s (211)) were significantly #mutated .
#mutating amino acids ee(437 and 438) to aa can generate the dna-binding mutant(stat5aee-aa) of stat5a .
#mutating amino acids ee(437 and 438) to aa could generate the dna-binding mutant(stat5aee-aa) of stat5a .
#mutating amino acids ee(437 and 438) to aa could have generated the dna-binding mutant(stat5aee-aa) of stat5a .
#mutating amino acids ee(437 and 438) to aa generates the dna-binding mutant(stat5aee-aa) of stat5a .
#mutating amino acids ee(437 and 438) to aa has generated the dna-binding mutant(stat5aee-aa) of stat5a .
#mutating amino acids ee(437 and 438) to aa has the ability to generate the dna-binding mutant(stat5aee-aa) of stat5a .
#mutating amino acids ee(437 and 438) to aa is able to generate the dna-binding mutant(stat5aee-aa) of stat5a .
#mutating amino acids ee(437 and 438) to aa would generate the dna-binding mutant(stat5aee-aa) of stat5a .
#mutating the c-terminal map kinase sites (t235 and t239) , for example , has essentially led to abolished egf-stimulated increase in phosphorylation and prevented egf-induced mobility shift (figure 5c , lanes 7 and 8) .
#mutating the c-terminal map kinase sites (t235 and t239) , for example , is observed to essentially led to abolished egf-stimulated increase in phosphorylation and prevented egf-induced mobility shift (figure 5c , lanes 7 and 8) .
#mutating the c-terminal map kinase sites (t235 and t239) , in contrast , essentially leads to abolished egf-stimulated increase in phosphorylation and prevented egf-induced mobility shift (figure 5c , lanes 7 and 8) .
our research has shown that #mutating the c-terminal map kinase sites (t235 and t239) has essentially led to abolished egf-stimulated increase in phosphorylation and prevented egf-induced mobility shift (figure 5c , lanes 7 and 8) .
our research has shown that #mutating the c-terminal map kinase sites (t235 and t239) is observed to essentially led to abolished egf-stimulated increase in phosphorylation and prevented egf-induced mobility shift (figure 5c , lanes 7 and 8) .
our research has shown that to #mutate the c-terminal map kinase sites (t235 and t239) has essentially led to abolished egf-stimulated increase in phosphorylation and prevented egf-induced mobility shift (figure 5c , lanes 7 and 8) .
our research has shown that to #mutate the c-terminal map kinase sites (t235 and t239) is observed to essentially led to abolished egf-stimulated increase in phosphorylation and prevented egf-induced mobility shift (figure 5c , lanes 7 and 8) .
our research has shown that to #mutate the c-terminal map kinase sites (t235 and t239) may have essentially led to abolished egf-stimulated increase in phosphorylation and prevented egf-induced mobility shift (figure 5c , lanes 7 and 8) .
rca is comprised of two major steps: (i) identifying pairs of residue positions #mutating in a coordinated manner , and (ii) using these results to identify protein regions that interact with an uncommonly high number of other residues .
rca is comprised of two major steps: (i) identifying pairs of residue positions observed to #mutate in a coordinated manner , and (ii) using these results to identify protein regions that interact with an uncommonly high number of other residues .
rca is comprised of two major steps: (i) identifying pairs of residue positions that can #mutate in a coordinated manner , and (ii) using these results to identify protein regions that interact with an uncommonly high number of other residues .
rca is comprised of two major steps: (i) identifying pairs of residue positions that has #mutated in a coordinated manner , and (ii) using these results to identify protein regions that interact with an uncommonly high number of other residues .
rca is comprised of two major steps: (i) identifying pairs of residue positions that may #mutate in a coordinated manner , and (ii) using these results to identify protein regions that interact with an uncommonly high number of other residues .
rca is comprised of two major steps: (i) identifying pairs of residue positions that might have #mutated in a coordinated manner , and (ii) using these results to identify protein regions that interact with an uncommonly high number of other residues .
rca is comprised of two major steps: (i) identifying pairs of residue positions that might #mutate in a coordinated manner , and (ii) using these results to identify protein regions that interact with an uncommonly high number of other residues .
rca is comprised of two major steps: (i) identifying pairs of residue positions that will #mutate in a coordinated manner , and (ii) using these results to identify protein regions that interact with an uncommonly high number of other residues .
rca is comprised of two major steps: (i) identifying pairs of residue positions which could #mutate in a coordinated manner , and (ii) using these results to identify protein regions which interact with an uncommonly high number of other residues .
rca is comprised of two major steps: (i) identifying pairs of residue positions which has #mutated in a coordinated manner , and (ii) using these results to identify protein regions which interact with an uncommonly high number of other residues .
rca is comprised of two major steps: (i) identifying pairs of residue positions which have the ability to #mutate in a coordinated manner , and (ii) using these results to identify protein regions which interact with an uncommonly high number of other residues .
rca is comprised of two major steps: (i) identifying pairs of residue positions which may #mutate in a coordinated manner , and (ii) using these results to identify protein regions which interact with an uncommonly high number of other residues .
rca is comprised of two major steps: (i) identifying pairs of residue positions which might have #mutated in a coordinated manner , and (ii) using these results to identify protein regions which interact with an uncommonly high number of other residues .
the dna-binding mutant(stat5aee-aa) of stat5a is generated by #mutating amino acids ee(437 and 438) to aa .
the dna-binding mutant(stat5aee-aa) of stat5a is observed to be generated by #mutating amino acids ee(437 and 438) to aa .
the gene being #mutated in variant late-infantile neuronal ceroid lipofuscinosis (cln6) and in nclf mutant mice has encoded a novel predicted transmembrane protein .
the gene having the ability to be #mutated in variant late-infantile neuronal ceroid lipofuscinosis (cln6) and in nclf mutant mice encodes a novel predicted transmembrane protein .
the gene having the ability to be #mutated in variant late-infantile neuronal ceroid lipofuscinosis (cln6) and in nclf mutant mice has encoded a novel predicted transmembrane protein .
the gene #mutated in variant late-infantile neuronal ceroid lipofuscinosis (cln6) and in nclf mutant mice encodes a novel predicted transmembrane protein .
the gene #mutated in variant late-infantile neuronal ceroid lipofuscinosis (cln6) and in nclf mutant mice has encoded a novel predicted transmembrane protein .
the gene observed to be #mutated in variant late-infantile neuronal ceroid lipofuscinosis (cln6) and in nclf mutant mice encodes a novel predicted transmembrane protein .
the gene that can be #mutated in variant late-infantile neuronal ceroid lipofuscinosis (cln6) and in nclf mutant mice encodes a novel predicted transmembrane protein .
the gene that can be #mutated in variant late-infantile neuronal ceroid lipofuscinosis (cln6) and in nclf mutant mice has encoded a novel predicted transmembrane protein .
the gene that has been #mutated in variant late-infantile neuronal ceroid lipofuscinosis (cln6) and in nclf mutant mice encodes a novel predicted transmembrane protein .
the gene that has been #mutated in variant late-infantile neuronal ceroid lipofuscinosis (cln6) and in nclf mutant mice has encoded a novel predicted transmembrane protein .
the gene that is able to be #mutated in variant late-infantile neuronal ceroid lipofuscinosis (cln6) and in nclf mutant mice encodes a novel predicted transmembrane protein .
the gene that is able to be #mutated in variant late-infantile neuronal ceroid lipofuscinosis (cln6) and in nclf mutant mice has encoded a novel predicted transmembrane protein .
the gene that is observed to be #mutated in variant late-infantile neuronal ceroid lipofuscinosis (cln6) and in nclf mutant mice has encoded a novel predicted transmembrane protein .
the gene that may have been #mutated in variant late-infantile neuronal ceroid lipofuscinosis (cln6) and in nclf mutant mice encodes a novel predicted transmembrane protein .
the gene that may have been #mutated in variant late-infantile neuronal ceroid lipofuscinosis (cln6) and in nclf mutant mice has encoded a novel predicted transmembrane protein .
the gene that was #mutated in variant late-infantile neuronal ceroid lipofuscinosis (cln6) and in nclf mutant mice has encoded a novel predicted transmembrane protein .
the gene that will be #mutated in variant late-infantile neuronal ceroid lipofuscinosis (cln6) and in nclf mutant mice encodes a novel predicted transmembrane protein .
the template fragments are #mutated by the sequence of sap97 rat , accession no .q62696 using the program swiss pdb viewer (guex and peitsch , 1997) .
the template fragments are observed to be #mutated by the sequence of sap97 rat , accession no .q62696 using the program swiss pdb viewer (guex and peitsch , 1997) .
the template fragments can be significantly #mutated by the sequence of sap97 rat , accession no .q62696 using the program swiss pdb viewer (guex and peitsch , 1997) .
the template fragments could have been significantly #mutated by the sequence of sap97 rat , accession no .q62696 using the program swiss pdb viewer (guex and peitsch , 1997) .
the template fragments have been #mutated by the sequence of sap97 rat , accession no .q62696 using the program swiss pdb viewer (guex and peitsch , 1997) .
the template fragments have been significantly #mutated by the sequence of sap97 rat , accession no .q62696 using the program swiss pdb viewer (guex and peitsch , 1997) .
the template fragments have the probability of being significantly #mutated by the sequence of sap97 rat , accession no .q62696 using the program swiss pdb viewer (guex and peitsch , 1997) .
the template fragments may be #mutated by the sequence of sap97 rat , accession no .q62696 using the program swiss pdb viewer (guex and peitsch , 1997) .
the template fragments might be #mutated by the sequence of sap97 rat , accession no .q62696 using the program swiss pdb viewer (guex and peitsch , 1997) .
the template fragments might have been significantly #mutated by the sequence of sap97 rat , accession no .q62696 using the program swiss pdb viewer (guex and peitsch , 1997) .
the template fragments will be #mutated by the sequence of sap97 rat , accession no .q62696 using the program swiss pdb viewer (guex and peitsch , 1997) .
the template fragments will be significantly #mutated by the sequence of sap97 rat , accession no .q62696 using the program swiss pdb viewer (guex and peitsch , 1997) .
this epitope , which is hla-a2 restricted , includes two amino acids being able to commonly #mutate (v82a and i84v) in the face of protease inhibitor therapy .
this epitope , which is hla-a2 restricted , includes two amino acids being able to #mutate (v82a and i84v) in the face of protease inhibitor therapy .
this epitope , which is hla-a2 restricted , includes two amino acids that are commonly #mutating (v82a and i84v) in the face of protease inhibitor therapy .
this epitope , which is hla-a2 restricted , includes two amino acids that are observed to commonly #mutate (v82a and i84v) in the face of protease inhibitor therapy .
this epitope , which is hla-a2 restricted , includes two amino acids that are observed to #mutate (v82a and i84v) in the face of protease inhibitor therapy .
this epitope , which is hla-a2 restricted , includes two amino acids that can #mutate (v82a and i84v) in the face of protease inhibitor therapy .
this epitope , which is hla-a2 restricted , includes two amino acids that could have commonly #mutated (v82a and i84v) in the face of protease inhibitor therapy .
this epitope , which is hla-a2 restricted , includes two amino acids that have commonly #mutated (v82a and i84v) in the face of protease inhibitor therapy .
this epitope , which is hla-a2 restricted , includes two amino acids that may have #mutated (v82a and i84v) in the face of protease inhibitor therapy .
this epitope , which is hla-a2 restricted , includes two amino acids that #mutated (v82a and i84v) in the face of protease inhibitor therapy .
this epitope , which is hla-a2 restricted , includes two amino acids that will commonly #mutate (v82a and i84v) in the face of protease inhibitor therapy .
this epitope , which is hla-a2 restricted , includes two amino acids that will #mutate (v82a and i84v) in the face of protease inhibitor therapy .
this epitope , which is hla-a2 restricted , includes two amino acids which are able to commonly #mutate (v82a and i84v) in the face of protease inhibitor therapy .
this epitope , which is hla-a2 restricted , includes two amino acids which are able to #mutate (v82a and i84v) in the face of protease inhibitor therapy .
this epitope , which is hla-a2 restricted , includes two amino acids which are observed to #mutate (v82a and i84v) in the face of protease inhibitor therapy .
this epitope , which is hla-a2 restricted , includes two amino acids which can commonly #mutate (v82a and i84v) in the face of protease inhibitor therapy .
this epitope , which is hla-a2 restricted , includes two amino acids which could have #mutated (v82a and i84v) in the face of protease inhibitor therapy .
this epitope , which is hla-a2 restricted , includes two amino acids which have commonly #mutated (v82a and i84v) in the face of protease inhibitor therapy .
this epitope , which is hla-a2 restricted , includes two amino acids which may have #mutated (v82a and i84v) in the face of protease inhibitor therapy .
this epitope , which is hla-a2 restricted , includes two amino acids which may #mutate (v82a and i84v) in the face of protease inhibitor therapy .
this epitope , which is hla-a2 restricted , includes two amino acids which #mutated (v82a and i84v) in the face of protease inhibitor therapy .
this epitope , which is hla-a2 restricted , includes two amino acids which will commonly #mutate (v82a and i84v) in the face of protease inhibitor therapy .
to determine how activators interact with the complex and to examine the importance of these interactions , relative to other potential targeting mechanisms , for swi/snf function , the activator-interaction domains in the complex have been identified and #mutated .
to determine how activators interact with the complex and to examine the importance of these interactions , relative to other potential targeting mechanisms , for swi/snf function , the activator-interaction domains in the complex will be identified and #mutated .
to determine how activators interact with the complex and to examine the importance of these interactions , relative to other potential targeting mechanisms , for swi/snf function , we found to identify and #mutate the activator-interaction domains in the complex .
to determine how activators interact with the complex and to examine the importance of these interactions , relative to other potential targeting mechanisms , for swi/snf function , we have identified and #mutated the activator-interaction domains in the complex .
to #mutate amino acids ee(437 and 438) to aa could generate the dna-binding mutant(stat5aee-aa) of stat5a .
to #mutate amino acids ee(437 and 438) to aa could have generated the dna-binding mutant(stat5aee-aa) of stat5a .
to #mutate amino acids ee(437 and 438) to aa generated the dna-binding mutant(stat5aee-aa) of stat5a .
to #mutate amino acids ee(437 and 438) to aa generates the dna-binding mutant(stat5aee-aa) of stat5a .
to #mutate amino acids ee(437 and 438) to aa has the ability to generate the dna-binding mutant(stat5aee-aa) of stat5a .
to #mutate amino acids ee(437 and 438) to aa is able to generate the dna-binding mutant(stat5aee-aa) of stat5a .
to #mutate amino acids ee(437 and 438) to aa will generate the dna-binding mutant(stat5aee-aa) of stat5a .
to #mutate the c-terminal map kinase sites (t235 and t239) , for example , has essentially led to abolished egf-stimulated increase in phosphorylation and prevented egf-induced mobility shift (figure 5c , lanes 7 and 8) .
to #mutate the c-terminal map kinase sites (t235 and t239) , for example , may have essentially led to abolished egf-stimulated increase in phosphorylation and prevented egf-induced mobility shift (figure 5c , lanes 7 and 8) .
to #mutate the c-terminal map kinase sites (t235 and t239) , in contrast , essentially leads to abolished egf-stimulated increase in phosphorylation and prevented egf-induced mobility shift (figure 5c , lanes 7 and 8) .
to #mutate the c-terminal map kinase sites (t235 and t239) , in contrast , has essentially led to abolished egf-stimulated increase in phosphorylation and prevented egf-induced mobility shift (figure 5c , lanes 7 and 8) .
in contrast , #mutating the c-terminal map kinase sites (t235 and t239) essentially leads to abolished egf-stimulated increase in phosphorylation and prevented egf-induced mobility shift (figure 5c , lanes 7 and 8) .
the dna-binding mutant(stat5aee-aa) of stat5a was generated by #mutating amino acids ee(437 and 438) to aa .
cotransfections with plasmids expressing wt-1 , wtar (a #mutated form of wt-1) , p53 , and a #mutated form of p53 revealed a complex pattern of regulation with a 3-fold induction with wt-1 , a 7-fold induction with #mutated p53 , and a 4-fold repression with wild-type p53 .
in cos-7 cells cotransfected with pka-calpha and sox9 expression plasmids , pka enhanced the phosphorylation of wild-type sox9 but did not affect phosphorylation of a sox9 protein in which the two pka phosphorylation sites (s (64) and s (211)) were #mutated .
rca is comprised of two major steps: (i) identifying pairs of residue positions that #mutate in a coordinated manner , and (ii) using these results to identify protein regions that interact with an uncommonly high number of other residues .
the gene #mutated in variant late-infantile neuronal ceroid lipofuscinosis (cln6) and nclf mutant mice encodes a novel predicted transmembrane protein .
this epitope , which is hla-a2 restricted , includes two amino acids that commonly #mutate (v82a and i84v) in the face of protease inhibitor therapy .
analyses of transcription in vivo of agn-lacz with the activator-interaction domains in the complex that are able to be #mutated support this conclusion .
analyses of transcription in vivo of agn-lacz with the activator-interaction domains in the complex that are #mutated support this conclusion .
analyses of transcription in vivo of agn-lacz with the activator-interaction domains in the complex which can be #mutated support this conclusion .
analyses of transcription in vivo of agn-lacz with the activator-interaction domains in the complex which have been #mutated support this conclusion .
in cos-7 cells cotransfected with pka-calpha and sox9 expression plasmids , pka enhanced the phosphorylation of wild-type sox9 but did not affect phosphorylation of a sox9 protein in which s (64) and s (211) are able to be significantly #mutated .
in cos-7 cells cotransfected with pka-calpha and sox9 expression plasmids , pka enhanced the phosphorylation of wild-type sox9 but did not affect phosphorylation of a sox9 protein in which s (64) and s (211) could have already been significantly #mutated .
in cos-7 cells cotransfected with pka-calpha and sox9 expression plasmids , pka enhanced the phosphorylation of wild-type sox9 but did not affect phosphorylation of a sox9 protein in which s (64) and s (211) could have been #mutated .
in cos-7 cells cotransfected with pka-calpha and sox9 expression plasmids , pka enhanced the phosphorylation of wild-type sox9 but did not affect phosphorylation of a sox9 protein in which s (64) and s (211) have already been significantly #mutated .
in cos-7 cells cotransfected with pka-calpha and sox9 expression plasmids , pka enhanced the phosphorylation of wild-type sox9 but did not affect phosphorylation of a sox9 protein in which s (64) and s (211) have been #mutated .
in cos-7 cells cotransfected with pka-calpha and sox9 expression plasmids , pka enhanced the phosphorylation of wild-type sox9 but did not affect phosphorylation of a sox9 protein in which s (64) and s (211) have been significantly #mutated .
in cos-7 cells cotransfected with pka-calpha and sox9 expression plasmids , pka enhanced the phosphorylation of wild-type sox9 but did not affect phosphorylation of a sox9 protein in which s (64) and s (211) were observed to be #mutated .
in cos-7 cells cotransfected with pka-calpha and sox9 expression plasmids , pka enhanced the phosphorylation of wild-type sox9 but did not affect phosphorylation of a sox9 protein in which s (64) and s (211) were observed to be significantly #mutated .
in cos-7 cells cotransfected with pka-calpha and sox9 expression plasmids , pka enhanced the phosphorylation of wild-type sox9 but did not affect phosphorylation of a the template fragments in which the sequence of sap97 rat are able to be significantly #mutated .
in cos-7 cells cotransfected with pka-calpha and sox9 expression plasmids , pka enhanced the phosphorylation of wild-type sox9 but did not affect phosphorylation of a the template fragments in which the sequence of sap97 rat are significantly #mutated .
in cos-7 cells cotransfected with pka-calpha and sox9 expression plasmids , pka enhanced the phosphorylation of wild-type sox9 but did not affect phosphorylation of a the template fragments in which the sequence of sap97 rat could have already been significantly #mutated .
in cos-7 cells cotransfected with pka-calpha and sox9 expression plasmids , pka enhanced the phosphorylation of wild-type sox9 but did not affect phosphorylation of a the template fragments in which the sequence of sap97 rat could have been #mutated .
in cos-7 cells cotransfected with pka-calpha and sox9 expression plasmids , pka enhanced the phosphorylation of wild-type sox9 but did not affect phosphorylation of a the template fragments in which the sequence of sap97 rat could have been significantly #mutated .
in cos-7 cells cotransfected with pka-calpha and sox9 expression plasmids , pka enhanced the phosphorylation of wild-type sox9 but did not affect phosphorylation of a the template fragments in which the sequence of sap97 rat have already been #mutated .
in cos-7 cells cotransfected with pka-calpha and sox9 expression plasmids , pka enhanced the phosphorylation of wild-type sox9 but did not affect phosphorylation of a the template fragments in which the sequence of sap97 rat have been significantly #mutated .
in cos-7 cells cotransfected with pka-calpha and sox9 expression plasmids , pka enhanced the phosphorylation of wild-type sox9 but did not affect phosphorylation of a the template fragments in which the sequence of sap97 rat were #mutated .
in cos-7 cells cotransfected with pka-calpha and sox9 expression plasmids , pka enhanced the phosphorylation of wild-type sox9 but did not affect phosphorylation of a the template fragments in which the sequence of sap97 rat were observed to be #mutated .
sox9 protein are able to be #mutated by s (64) and s (211) , accession no .q62696 using the program swiss pdb viewer (guex and peitsch , 1997) .
sox9 protein are #mutated by s (64) and s (211) , accession no .q62696 using the program swiss pdb viewer (guex and peitsch , 1997) .
sox9 protein are observed to be #mutated by the two pka phosphorylation sites (s (64) and s (211)) , accession no .q62696 using the program swiss pdb viewer (guex and peitsch , 1997) .
sox9 protein are observed to be significantly #mutated by s (64) and s (211) , accession no .q62696 using the program swiss pdb viewer (guex and peitsch , 1997) .
sox9 protein are observed to be significantly #mutated by the two pka phosphorylation sites (s (64) and s (211)) , accession no .q62696 using the program swiss pdb viewer (guex and peitsch , 1997) .
sox9 protein can be significantly #mutated by s (64) and s (211) , accession no .q62696 using the program swiss pdb viewer (guex and peitsch , 1997) .
sox9 protein could be #mutated by s (64) and s (211) , accession no .q62696 using the program swiss pdb viewer (guex and peitsch , 1997) .
sox9 protein could be significantly #mutated by the two pka phosphorylation sites (s (64) and s (211)) , accession no .q62696 using the program swiss pdb viewer (guex and peitsch , 1997) .
sox9 protein could have been significantly #mutated by the two pka phosphorylation sites (s (64) and s (211)) , accession no .q62696 using the program swiss pdb viewer (guex and peitsch , 1997) .
sox9 protein have been #mutated by s (64) and s (211) , accession no .q62696 using the program swiss pdb viewer (guex and peitsch , 1997) .
sox9 protein have the probability of being #mutated by s (64) and s (211) , accession no .q62696 using the program swiss pdb viewer (guex and peitsch , 1997) .
sox9 protein have the probability of being #mutated by the two pka phosphorylation sites (s (64) and s (211)) , accession no .q62696 using the program swiss pdb viewer (guex and peitsch , 1997) .
sox9 protein have the probability of being significantly #mutated by s (64) and s (211) , accession no .q62696 using the program swiss pdb viewer (guex and peitsch , 1997) .
sox9 protein have the probability of being significantly #mutated by the two pka phosphorylation sites (s (64) and s (211)) , accession no .q62696 using the program swiss pdb viewer (guex and peitsch , 1997) .
sox9 protein might be #mutated by the two pka phosphorylation sites (s (64) and s (211)) , accession no .q62696 using the program swiss pdb viewer (guex and peitsch , 1997) .
sox9 protein might be significantly #mutated by the two pka phosphorylation sites (s (64) and s (211)) , accession no .q62696 using the program swiss pdb viewer (guex and peitsch , 1997) .
sox9 protein might have been #mutated by s (64) and s (211) , accession no .q62696 using the program swiss pdb viewer (guex and peitsch , 1997) .
sox9 protein might have been significantly #mutated by s (64) and s (211) , accession no .q62696 using the program swiss pdb viewer (guex and peitsch , 1997) .
sox9 protein will be #mutated by the two pka phosphorylation sites (s (64) and s (211)) , accession no .q62696 using the program swiss pdb viewer (guex and peitsch , 1997) .
sox9 protein will be significantly #mutated by the two pka phosphorylation sites (s (64) and s (211)) , accession no .q62696 using the program swiss pdb viewer (guex and peitsch , 1997) .
sox9 protein would be #mutated by s (64) and s (211) , accession no .q62696 using the program swiss pdb viewer (guex and peitsch , 1997) .
sox9 protein would be #mutated by the two pka phosphorylation sites (s (64) and s (211)) , accession no .q62696 using the program swiss pdb viewer (guex and peitsch , 1997) .
to determine how activators interact with the complex and to examine the importance of these interactions , relative to other potential targeting mechanisms , for swi/snf function , dam target sequences have been identified and #mutated .
to determine how activators interact with the complex and to examine the importance of these interactions , relative to other potential targeting mechanisms , for swi/snf function , dam target sequences will be identified and #mutated .
to determine how activators interact with the complex and to examine the importance of these interactions , relative to other potential targeting mechanisms , for swi/snf function , we sought to identify and #mutate dam target sequences .
analyses of transcription in vivo of agn-lacz with amino acids ee(437 and 438) being #mutated support this conclusion .
analyses of transcription in vivo of agn-lacz with amino acids ee(437 and 438) #mutated support this conclusion .
analyses of transcription in vivo of agn-lacz with amino acids ee(437 and 438) that are able to be #mutated support this conclusion .
analyses of transcription in vivo of agn-lacz with amino acids ee(437 and 438) that were #mutated support this conclusion .
analyses of transcription in vivo of agn-lacz with amino acids ee(437 and 438) which are able to be #mutated support this conclusion .
analyses of transcription in vivo of agn-lacz with amino acids ee(437 and 438) which can be #mutated support this conclusion .
analyses of transcription in vivo of agn-lacz with amino acids ee(437 and 438) which may have been #mutated support this conclusion .
analyses of transcription in vivo of agn-lacz with amino acids ee(437 and 438) which were #mutated support this conclusion .
analyses of transcription in vivo of agn-lacz with gene #mutated support this conclusion .
analyses of transcription in vivo of agn-lacz with gene that are able to be #mutated support this conclusion .
analyses of transcription in vivo of agn-lacz with gene that are #mutated support this conclusion .
analyses of transcription in vivo of agn-lacz with gene that have been #mutated support this conclusion .
analyses of transcription in vivo of agn-lacz with gene that were #mutated support this conclusion .
analyses of transcription in vivo of agn-lacz with gene which are able to be #mutated support this conclusion .
analyses of transcription in vivo of agn-lacz with gene which are #mutated support this conclusion .
analyses of transcription in vivo of agn-lacz with gene which may have been #mutated support this conclusion .
analyses of transcription in vivo of agn-lacz with gene which were #mutated support this conclusion .
analyses of transcription in vivo of agn-lacz with #mutated pairs of residue positions support this conclusion .
analyses of transcription in vivo of agn-lacz with pairs of residue positions being #mutated support this conclusion .
analyses of transcription in vivo of agn-lacz with pairs of residue positions #mutated support this conclusion .
analyses of transcription in vivo of agn-lacz with pairs of residue positions that are able to be #mutated support this conclusion .
analyses of transcription in vivo of agn-lacz with pairs of residue positions which are #mutated support this conclusion .
analyses of transcription in vivo of agn-lacz with pairs of residue positions which can be #mutated support this conclusion .
analyses of transcription in vivo of agn-lacz with pairs of residue positions which may have been #mutated support this conclusion .
analyses of transcription in vivo of agn-lacz with pairs of residue positions which were #mutated support this conclusion .
to determine how activators interact with the complex and to examine the importance of these interactions , relative to other potential targeting mechanisms , for swi/snf function , amino acids ee(437 and 438) were identified and #mutated .
to determine how activators interact with the complex and to examine the importance of these interactions , relative to other potential targeting mechanisms , for swi/snf function , gene have been identified and #mutated .
to determine how activators interact with the complex and to examine the importance of these interactions , relative to other potential targeting mechanisms , for swi/snf function , pairs of residue positions were identified and #mutated .
to determine how activators interact with the complex and to examine the importance of these interactions , relative to other potential targeting mechanisms , for swi/snf function , we found to identify and #mutate amino acids ee(437 and 438) .
to determine how activators interact with the complex and to examine the importance of these interactions , relative to other potential targeting mechanisms , for swi/snf function , we have identified and #mutated amino acids ee(437 and 438) .
to determine how activators interact with the complex and to examine the importance of these interactions , relative to other potential targeting mechanisms , for swi/snf function , we have identified and #mutated gene .
to determine how activators interact with the complex and to examine the importance of these interactions , relative to other potential targeting mechanisms , for swi/snf function , we identified and #mutated amino acids ee(437 and 438) .
to determine how activators interact with the complex and to examine the importance of these interactions , relative to other potential targeting mechanisms , for swi/snf function , we identified and #mutated pairs of residue positions .
to determine how activators interact with the complex and to examine the importance of these interactions , relative to other potential targeting mechanisms , for swi/snf function , we identify and #mutate gene .
to determine how activators interact with the complex and to examine the importance of these interactions , relative to other potential targeting mechanisms , for swi/snf function , we sought to identify and #mutate pairs of residue positions .
to determine how activators interact with the complex and to examine the importance of these interactions , relative to other potential targeting mechanisms , for swi/snf function , we will identify and #mutate amino acids ee(437 and 438) .
to determine how activators interact with the complex and to examine the importance of these interactions , relative to other potential targeting mechanisms , for swi/snf function , we will identify and #mutate pairs of residue positions .
adult naive t cells , which are at rest in normal conditions , are able to #proliferate when transferred to lymphopenic hosts .
adult naive t cells , which are at rest in normal conditions , are observed to #proliferate when transferred to lymphopenic hosts .
adult naive t cells , which are at rest in normal conditions , can #proliferate strongly when transferred to lymphopenic hosts .
adult naive t cells , which are at rest in normal conditions , could have #proliferated when transferred to lymphopenic hosts .
adult naive t cells , which are at rest in normal conditions , have #proliferated when transferred to lymphopenic hosts .
adult naive t cells , which are at rest in normal conditions , have strongly #proliferated when transferred to lymphopenic hosts .
adult naive t cells , which are at rest in normal conditions , have the ability to #proliferate strongly when transferred to lymphopenic hosts .
adult naive t cells , which are at rest in normal conditions , may #proliferate strongly when transferred to lymphopenic hosts .
adult naive t cells , which are at rest in normal conditions , may #proliferate when transferred to lymphopenic hosts .
adult naive t cells , which are at rest in normal conditions , may strongly #proliferate when transferred to lymphopenic hosts .
adult naive t cells , which are at rest in normal conditions , will #proliferate strongly when transferred to lymphopenic hosts .
adult naive t cells , which are at rest in normal conditions , will #proliferate when transferred to lymphopenic hosts .
adult naive t cells , which are at rest in normal conditions , will strongly #proliferate when transferred to lymphopenic hosts .
after androgen withdrawal and antiandrogen treatment , the androgen responsive prostate cancer cells are able to cease to #proliferate and undergo apoptosis , causing tumor regression .
after androgen withdrawal and antiandrogen treatment , the androgen responsive prostate cancer cells being able to cease to #proliferate and undergo apoptosis will cause tumor regression .
after androgen withdrawal and antiandrogen treatment , the androgen responsive prostate cancer cells being observed to cease to #proliferate and undergo apoptosis will cause tumor regression .
after androgen withdrawal and antiandrogen treatment , the androgen responsive prostate cancer cells can cease to #proliferate and undergo apoptosis , causing tumor regression .
after androgen withdrawal and antiandrogen treatment , the androgen responsive prostate cancer cells ceased to #proliferate and underwent apoptosis , causing tumor regression .
after androgen withdrawal and antiandrogen treatment , the androgen responsive prostate cancer cells having ceased to #proliferate and undergo apoptosis caused tumor regression .
after androgen withdrawal and antiandrogen treatment , the androgen responsive prostate cancer cells that are able to cease to #proliferate and undergo apoptosis will cause tumor regression .
after androgen withdrawal and antiandrogen treatment , the androgen responsive prostate cancer cells that are observed to cease to #proliferate and undergo apoptosis will cause tumor regression .
after androgen withdrawal and antiandrogen treatment , the androgen responsive prostate cancer cells that will cease to #proliferate and undergo apoptosis will cause tumor regression .
cancer cells are characterized by either an increased ability for #proliferating or a diminished capacity to undergo programmed cell death .
cancer cells are characterized by either an increased ability for strong #proliferating or a diminished capacity to undergo programmed cell death .
cancer cells can be characterized by either an increased ability to #proliferate or a diminished capacity to undergo programmed cell death .
cancer cells wil be characterized by either an increased ability for #proliferating or a diminished capacity to undergo programmed cell death .
our observations illustrate that the human placenta can be endowed with the biochemical machinery to #proliferate throughout gestation , yet , there are intrinsic mechanisms that effectively circumscribe the extent and duration of trophoblast proliferation .
our observations illustrate that the human placenta has been endowed with the biochemical machinery to #proliferate indefinitely throughout gestation , yet , there are intrinsic mechanisms that effectively circumscribe the extent and duration of trophoblast proliferation .
our observations illustrate that the human placenta has been endowed with the biochemical machinery to #proliferate throughout gestation , yet , there are intrinsic mechanisms that effectively circumscribe the extent and duration of trophoblast proliferation .
our observations illustrate that the human placenta has the ability to be endowed with the biochemical machinery to #proliferate indefinitely throughout gestation , yet , there are intrinsic mechanisms that effectively circumscribe the extent and duration of trophoblast proliferation .
our observations illustrate that the human placenta has the ability to be endowed with the biochemical machinery to #proliferate throughout gestation , yet , there are intrinsic mechanisms that effectively circumscribe the extent and duration of trophoblast proliferation .
our observations illustrate that the human placenta may have been endowed with the biochemical machinery to #proliferate indefinitely throughout gestation , yet , there are intrinsic mechanisms that effectively circumscribe the extent and duration of trophoblast proliferation .
our observations illustrate that the human placenta may have been endowed with the biochemical machinery to #proliferate throughout gestation , yet , there are intrinsic mechanisms that effectively circumscribe the extent and duration of trophoblast proliferation .
our observations illustrate that the human placenta was endowed with the biochemical machinery to #proliferate throughout gestation , yet , there are intrinsic mechanisms that effectively circumscribe the extent and duration of trophoblast proliferation .
our observations illustrate that the human placenta will be endowed with the biochemical machinery to #proliferate indefinitely throughout gestation , yet , there are intrinsic mechanisms that effectively circumscribe the extent and duration of trophoblast proliferation .
our observations illustrate that the human placenta will be endowed with the biochemical machinery to #proliferate throughout gestation , yet , there are intrinsic mechanisms that effectively circumscribe the extent and duration of trophoblast proliferation .
stat5ab-/-peripheral t cells can regain the ability to #proliferate indefinitely upon introduction of full-length wild-type stat5a (figure 6b) .
stat5ab-/-peripheral t cells can regain the ability to #proliferate upon introduction of full-length wild-type stat5a (figure 6b) .
stat5ab-/-peripheral t cells have regained the ability to #proliferate indefinitely upon introduction of full-length wild-type stat5a (figure 6b) .
stat5ab-/-peripheral t cells may have regained the ability to #proliferate upon introduction of full-length wild-type stat5a (figure 6b) .
stat5ab-/-peripheral t cells regained the ability to #proliferate indefinitely upon introduction of full-length wild-type stat5a (figure 6b) .
stat5ab-/-peripheral t cells regained the ability to #proliferate upon introduction of full-length wild-type stat5a (figure 6b) .
stat5ab-/-peripheral t cells will regain the ability to #proliferate upon introduction of full-length wild-type stat5a (figure 6b) .
the ability of ebd cells being able to #proliferate in vivo was examined by injection of 3 ? 106 lvec cells into the calf muscle of 3 immunocompromised mice .
the ability of ebd cells being able to #proliferate strongly in vivo was examined by injection of 3 ? 106 lvec cells into the calf muscle of 3 immunocompromised mice .
the ability of ebd cells having strongly #proliferated in vivo was examined by injection of 3 ? 106 lvec cells into the calf muscle of 3 immunocompromised mice .
the ability of ebd cells having the ability to #proliferate strongly in vivo was examined by injection of 3 ? 106 lvec cells into the calf muscle of 3 immunocompromised mice .
the ability of ebd cells that can #proliferate in vivo was examined by injection of 3 ? 106 lvec cells into the calf muscle of 3 immunocompromised mice .
the ability of ebd cells that can #proliferate strongly in vivo was examined by injection of 3 ? 106 lvec cells into the calf muscle of 3 immunocompromised mice .
the ability of ebd cells that have strongly #proliferated in vivo was examined by injection of 3 ? 106 lvec cells into the calf muscle of 3 immunocompromised mice .
the ability of ebd cells that have the ability to #proliferate in vivo was examined by injection of 3 ? 106 lvec cells into the calf muscle of 3 immunocompromised mice .
the ability of ebd cells that have the ability to #proliferate strongly in vivo was examined by injection of 3 ? 106 lvec cells into the calf muscle of 3 immunocompromised mice .
the ability of ebd cells that is able to #proliferate strongly in vivo was examined by injection of 3 ? 106 lvec cells into the calf muscle of 3 immunocompromised mice .
the ability of ebd cells that is observed to #proliferate in vivo was examined by injection of 3 ? 106 lvec cells into the calf muscle of 3 immunocompromised mice .
the ability of ebd cells that may have #proliferated in vivo was examined by injection of 3 ? 106 lvec cells into the calf muscle of 3 immunocompromised mice .
the ability of ebd cells that may have strongly #proliferated in vivo was examined by injection of 3 ? 106 lvec cells into the calf muscle of 3 immunocompromised mice .
the ability of ebd cells that may #proliferate strongly in vivo was examined by injection of 3 ? 106 lvec cells into the calf muscle of 3 immunocompromised mice .
the ability of ebd cells that will #proliferate in vivo was examined by injection of 3 ? 106 lvec cells into the calf muscle of 3 immunocompromised mice .
the ability of ebd cells that will #proliferate strongly in vivo was examined by injection of 3 ? 106 lvec cells into the calf muscle of 3 immunocompromised mice .
stat5ab-/-peripheral t cells regain the ability to #proliferate upon introduction of full-length wild-type stat5a (figure 6b) .
adult naive t cells are able to regain the ability to #proliferate when transferred to lymphopenic hosts (figure 6b) .
adult naive t cells are observed to regain the ability to #proliferate indefinitely when transferred to lymphopenic hosts (figure 6b) .
adult naive t cells are observed to regain the ability to #proliferate when transferred to lymphopenic hosts (figure 6b) .
adult naive t cells have regained the ability to #proliferate indefinitely when transferred to lymphopenic hosts (figure 6b) .
adult naive t cells have regained the ability to #proliferate when transferred to lymphopenic hosts (figure 6b) .
adult naive t cells have the probability of regaining the ability to #proliferate indefinitely when transferred to lymphopenic hosts (figure 6b) .
adult naive t cells may have regained the ability to #proliferate when transferred to lymphopenic hosts (figure 6b) .
adult naive t cells regain the ability to #proliferate when transferred to lymphopenic hosts (figure 6b) .
adult naive t cells regained the ability to #proliferate when transferred to lymphopenic hosts (figure 6b) .
adult naive t cells will regain the ability to #proliferate indefinitely when transferred to lymphopenic hosts (figure 6b) .
adult naive t cells will regain the ability to #proliferate when transferred to lymphopenic hosts (figure 6b) .
after androgen withdrawal and antiandrogen treatment , cancer cells being able to cease to #proliferate and undergo apoptosis will cause tumor regression .
after androgen withdrawal and antiandrogen treatment , cancer cells cease to #proliferate and undergo apoptosis , causing tumor regression .
after androgen withdrawal and antiandrogen treatment , cancer cells ceased to #proliferate and underwent apoptosis , causing tumor regression .
after androgen withdrawal and antiandrogen treatment , cancer cells ceasing to #proliferate and underwent apoptosis caused tumor regression .
after androgen withdrawal and antiandrogen treatment , cancer cells having ceased to #proliferate and undergo apoptosis caused tumor regression .
after androgen withdrawal and antiandrogen treatment , cancer cells that are observed to cease to #proliferate and undergo apoptosis will cause tumor regression .
after androgen withdrawal and antiandrogen treatment , cancer cells that can cease to #proliferate and undergo apoptosis will cause tumor regression .
after androgen withdrawal and antiandrogen treatment , cancer cells that have ceased to #proliferate and undergo apoptosis caused tumor regression .
after androgen withdrawal and antiandrogen treatment , cancer cells that have the ability to cease to #proliferate and undergo apoptosis will cause tumor regression .
after androgen withdrawal and antiandrogen treatment , cancer cells that may cease to #proliferate and undergo apoptosis will cause tumor regression .
after androgen withdrawal and antiandrogen treatment , cancer cells that will cease to #proliferate and undergo apoptosis will cause tumor regression .
after androgen withdrawal and antiandrogen treatment , cancer cells will cease to #proliferate and undergo apoptosis , causing tumor regression .
our observations illustrate that adult naive t cells can be endowed with the biochemical machinery to #proliferate indefinitely when transferred to lymphopenic hosts , yet , there are intrinsic mechanisms that effectively circumscribe the extent and duration of trophoblast proliferation .
our observations illustrate that adult naive t cells has been endowed with the biochemical machinery to #proliferate when transferred to lymphopenic hosts , yet , there are intrinsic mechanisms that effectively circumscribe the extent and duration of trophoblast proliferation .
our observations illustrate that adult naive t cells has the ability to be endowed with the biochemical machinery to #proliferate indefinitely when transferred to lymphopenic hosts , yet , there are intrinsic mechanisms that effectively circumscribe the extent and duration of trophoblast proliferation .
our observations illustrate that adult naive t cells has the ability to be endowed with the biochemical machinery to #proliferate when transferred to lymphopenic hosts , yet , there are intrinsic mechanisms that effectively circumscribe the extent and duration of trophoblast proliferation .
our observations illustrate that adult naive t cells is endowed with the biochemical machinery to #proliferate indefinitely when transferred to lymphopenic hosts , yet , there are intrinsic mechanisms that effectively circumscribe the extent and duration of trophoblast proliferation .
our observations illustrate that adult naive t cells is shown to be endowed with the biochemical machinery to #proliferate indefinitely when transferred to lymphopenic hosts , yet , there are intrinsic mechanisms that effectively circumscribe the extent and duration of trophoblast proliferation .
our observations illustrate that adult naive t cells is shown to be endowed with the biochemical machinery to #proliferate when transferred to lymphopenic hosts , yet , there are intrinsic mechanisms that effectively circumscribe the extent and duration of trophoblast proliferation .
our observations illustrate that adult naive t cells may have been endowed with the biochemical machinery to #proliferate indefinitely when transferred to lymphopenic hosts , yet , there are intrinsic mechanisms that effectively circumscribe the extent and duration of trophoblast proliferation .
our observations illustrate that adult naive t cells was endowed with the biochemical machinery to #proliferate indefinitely when transferred to lymphopenic hosts , yet , there are intrinsic mechanisms that effectively circumscribe the extent and duration of trophoblast proliferation .
our observations illustrate that adult naive t cells will be endowed with the biochemical machinery to #proliferate indefinitely when transferred to lymphopenic hosts , yet , there are intrinsic mechanisms that effectively circumscribe the extent and duration of trophoblast proliferation .
our observations illustrate that stat5ab-/-peripheral t cells has been endowed with the biochemical machinery to #proliferate upon introduction of full-length wild-type stat5a , yet , there are intrinsic mechanisms that effectively circumscribe the extent and duration of trophoblast proliferation .
our observations illustrate that stat5ab-/-peripheral t cells has the ability to be endowed with the biochemical machinery to #proliferate upon introduction of full-length wild-type stat5a , yet , there are intrinsic mechanisms that effectively circumscribe the extent and duration of trophoblast proliferation .
our observations illustrate that stat5ab-/-peripheral t cells is able to be endowed with the biochemical machinery to #proliferate indefinitely upon introduction of full-length wild-type stat5a , yet , there are intrinsic mechanisms that effectively circumscribe the extent and duration of trophoblast proliferation .
our observations illustrate that stat5ab-/-peripheral t cells is able to be endowed with the biochemical machinery to #proliferate upon introduction of full-length wild-type stat5a , yet , there are intrinsic mechanisms that effectively circumscribe the extent and duration of trophoblast proliferation .
our observations illustrate that stat5ab-/-peripheral t cells is endowed with the biochemical machinery to #proliferate indefinitely upon introduction of full-length wild-type stat5a , yet , there are intrinsic mechanisms that effectively circumscribe the extent and duration of trophoblast proliferation .
our observations illustrate that stat5ab-/-peripheral t cells is shown to be endowed with the biochemical machinery to #proliferate indefinitely upon introduction of full-length wild-type stat5a , yet , there are intrinsic mechanisms that effectively circumscribe the extent and duration of trophoblast proliferation .
our observations illustrate that stat5ab-/-peripheral t cells may have been endowed with the biochemical machinery to #proliferate indefinitely upon introduction of full-length wild-type stat5a , yet , there are intrinsic mechanisms that effectively circumscribe the extent and duration of trophoblast proliferation .
our observations illustrate that stat5ab-/-peripheral t cells was endowed with the biochemical machinery to #proliferate upon introduction of full-length wild-type stat5a , yet , there are intrinsic mechanisms that effectively circumscribe the extent and duration of trophoblast proliferation .
our observations illustrate that stat5ab-/-peripheral t cells will be endowed with the biochemical machinery to #proliferate upon introduction of full-length wild-type stat5a , yet , there are intrinsic mechanisms that effectively circumscribe the extent and duration of trophoblast proliferation .
stat5ab-/-peripheral t cells , which are at rest in normal conditions , are able to #proliferate upon introduction of full-length wild-type stat5a .
stat5ab-/-peripheral t cells , which are at rest in normal conditions , can strongly #proliferate upon introduction of full-length wild-type stat5a .
stat5ab-/-peripheral t cells , which are at rest in normal conditions , could have #proliferated upon introduction of full-length wild-type stat5a .
stat5ab-/-peripheral t cells , which are at rest in normal conditions , have #proliferated upon introduction of full-length wild-type stat5a .
stat5ab-/-peripheral t cells , which are at rest in normal conditions , have strongly #proliferated upon introduction of full-length wild-type stat5a .
stat5ab-/-peripheral t cells , which are at rest in normal conditions , may #proliferate strongly upon introduction of full-length wild-type stat5a .
stat5ab-/-peripheral t cells , which are at rest in normal conditions , may strongly #proliferate upon introduction of full-length wild-type stat5a .
stat5ab-/-peripheral t cells , which are at rest in normal conditions , might have #proliferated strongly upon introduction of full-length wild-type stat5a .
stat5ab-/-peripheral t cells , which are at rest in normal conditions , might have #proliferated upon introduction of full-length wild-type stat5a .
stat5ab-/-peripheral t cells , which are at rest in normal conditions , might have strongly #proliferated upon introduction of full-length wild-type stat5a .
stat5ab-/-peripheral t cells , which are at rest in normal conditions , will #proliferate upon introduction of full-length wild-type stat5a .
stat5ab-/-peripheral t cells , which are at rest in normal conditions , will strongly #proliferate upon introduction of full-length wild-type stat5a .
treatment of adult naive t cells of different origin with the ganglioside biosynthesis inhibitors fumonisin b1 , d-threo-1-phenyl-2-decanoylamino-3-morpholino-1-propanol or d-1-threo-1-phenyl-2-hexa-decanoylamino-3-pyrrolidino-1-propanol-hcl , has impaired their capacity to #proliferate when transferred to lymphopenic hosts .
treatment of adult naive t cells of different origin with the ganglioside biosynthesis inhibitors fumonisin b1 , d-threo-1-phenyl-2-decanoylamino-3-morpholino-1-propanol or d-1-threo-1-phenyl-2-hexa-decanoylamino-3-pyrrolidino-1-propanol-hcl , has significantly impaired their capacity to #proliferate when transferred to lymphopenic hosts .
treatment of adult naive t cells of different origin with the ganglioside biosynthesis inhibitors fumonisin b1 , d-threo-1-phenyl-2-decanoylamino-3-morpholino-1-propanol or d-1-threo-1-phenyl-2-hexa-decanoylamino-3-pyrrolidino-1-propanol-hcl , has the ability to impair their capacity to #proliferate when transferred to lymphopenic hosts .
treatment of adult naive t cells of different origin with the ganglioside biosynthesis inhibitors fumonisin b1 , d-threo-1-phenyl-2-decanoylamino-3-morpholino-1-propanol or d-1-threo-1-phenyl-2-hexa-decanoylamino-3-pyrrolidino-1-propanol-hcl , impaired their capacity to #proliferate when transferred to lymphopenic hosts .
treatment of adult naive t cells of different origin with the ganglioside biosynthesis inhibitors fumonisin b1 , d-threo-1-phenyl-2-decanoylamino-3-morpholino-1-propanol or d-1-threo-1-phenyl-2-hexa-decanoylamino-3-pyrrolidino-1-propanol-hcl , is able to impair their capacity to #proliferate when transferred to lymphopenic hosts .
treatment of adult naive t cells of different origin with the ganglioside biosynthesis inhibitors fumonisin b1 , d-threo-1-phenyl-2-decanoylamino-3-morpholino-1-propanol or d-1-threo-1-phenyl-2-hexa-decanoylamino-3-pyrrolidino-1-propanol-hcl , is observed to significantly impair their capacity to #proliferate when transferred to lymphopenic hosts .
treatment of adult naive t cells of different origin with the ganglioside biosynthesis inhibitors fumonisin b1 , d-threo-1-phenyl-2-decanoylamino-3-morpholino-1-propanol or d-1-threo-1-phenyl-2-hexa-decanoylamino-3-pyrrolidino-1-propanol-hcl , will impair their capacity to #proliferate when transferred to lymphopenic hosts .
treatment of adult naive t cells of different origin with the ganglioside biosynthesis inhibitors fumonisin b1 , d-threo-1-phenyl-2-decanoylamino-3-morpholino-1-propanol or d-1-threo-1-phenyl-2-hexa-decanoylamino-3-pyrrolidino-1-propanol-hcl , will significantly impair their capacity to #proliferate when transferred to lymphopenic hosts .
treatment of stat5ab-/-peripheral t cells of different origin with the ganglioside biosynthesis inhibitors fumonisin b1 , d-threo-1-phenyl-2-decanoylamino-3-morpholino-1-propanol or d-1-threo-1-phenyl-2-hexa-decanoylamino-3-pyrrolidino-1-propanol-hcl , can significantly impair their capacity to #proliferate upon introduction of full-length wild-type stat5a .
treatment of stat5ab-/-peripheral t cells of different origin with the ganglioside biosynthesis inhibitors fumonisin b1 , d-threo-1-phenyl-2-decanoylamino-3-morpholino-1-propanol or d-1-threo-1-phenyl-2-hexa-decanoylamino-3-pyrrolidino-1-propanol-hcl , impaired their capacity to #proliferate upon introduction of full-length wild-type stat5a .
treatment of stat5ab-/-peripheral t cells of different origin with the ganglioside biosynthesis inhibitors fumonisin b1 , d-threo-1-phenyl-2-decanoylamino-3-morpholino-1-propanol or d-1-threo-1-phenyl-2-hexa-decanoylamino-3-pyrrolidino-1-propanol-hcl , is able to significantly impair their capacity to #proliferate upon introduction of full-length wild-type stat5a .
treatment of stat5ab-/-peripheral t cells of different origin with the ganglioside biosynthesis inhibitors fumonisin b1 , d-threo-1-phenyl-2-decanoylamino-3-morpholino-1-propanol or d-1-threo-1-phenyl-2-hexa-decanoylamino-3-pyrrolidino-1-propanol-hcl , is observed to significantly impair their capacity to #proliferate upon introduction of full-length wild-type stat5a .
treatment of stat5ab-/-peripheral t cells of different origin with the ganglioside biosynthesis inhibitors fumonisin b1 , d-threo-1-phenyl-2-decanoylamino-3-morpholino-1-propanol or d-1-threo-1-phenyl-2-hexa-decanoylamino-3-pyrrolidino-1-propanol-hcl , will impair their capacity to #proliferate upon introduction of full-length wild-type stat5a .
treatment of stat5ab-/-peripheral t cells of different origin with the ganglioside biosynthesis inhibitors fumonisin b1 , d-threo-1-phenyl-2-decanoylamino-3-morpholino-1-propanol or d-1-threo-1-phenyl-2-hexa-decanoylamino-3-pyrrolidino-1-propanol-hcl , will significantly impair their capacity to #proliferate upon introduction of full-length wild-type stat5a .
treatment of the human placenta of different origin with the ganglioside biosynthesis inhibitors fumonisin b1 , d-threo-1-phenyl-2-decanoylamino-3-morpholino-1-propanol or d-1-threo-1-phenyl-2-hexa-decanoylamino-3-pyrrolidino-1-propanol-hcl , has significantly impaired their capacity to #proliferate throughout gestation .
treatment of the human placenta of different origin with the ganglioside biosynthesis inhibitors fumonisin b1 , d-threo-1-phenyl-2-decanoylamino-3-morpholino-1-propanol or d-1-threo-1-phenyl-2-hexa-decanoylamino-3-pyrrolidino-1-propanol-hcl , has the ability to significantly impair their capacity to #proliferate throughout gestation .
treatment of the human placenta of different origin with the ganglioside biosynthesis inhibitors fumonisin b1 , d-threo-1-phenyl-2-decanoylamino-3-morpholino-1-propanol or d-1-threo-1-phenyl-2-hexa-decanoylamino-3-pyrrolidino-1-propanol-hcl , is observed to impair their capacity to #proliferate throughout gestation .
treatment of the human placenta of different origin with the ganglioside biosynthesis inhibitors fumonisin b1 , d-threo-1-phenyl-2-decanoylamino-3-morpholino-1-propanol or d-1-threo-1-phenyl-2-hexa-decanoylamino-3-pyrrolidino-1-propanol-hcl , is observed to significantly impair their capacity to #proliferate throughout gestation .
treatment of the human placenta of different origin with the ganglioside biosynthesis inhibitors fumonisin b1 , d-threo-1-phenyl-2-decanoylamino-3-morpholino-1-propanol or d-1-threo-1-phenyl-2-hexa-decanoylamino-3-pyrrolidino-1-propanol-hcl , will impair their capacity to #proliferate throughout gestation .
the androgen responsive prostate cancer cells are believed to be characterized by either an increased ability to strongly #proliferate or a diminished capacity to undergo programmed cell death .
the androgen responsive prostate cancer cells are characterized by either an increased ability for #proliferating or a diminished capacity to undergo programmed cell death .
the androgen responsive prostate cancer cells are characterized by either an increased ability to #proliferate or a diminished capacity to undergo programmed cell death .
the androgen responsive prostate cancer cells has been characterized by either an increased ability to #proliferate or a diminished capacity to undergo programmed cell death .
the androgen responsive prostate cancer cells has been characterized by either an increased ability to strongly #proliferate or a diminished capacity to undergo programmed cell death .
the androgen responsive prostate cancer cells may be characterized by either an increased ability to strongly #proliferate or a diminished capacity to undergo programmed cell death .
the androgen responsive prostate cancer cells was characterized by either an increased ability to #proliferate or a diminished capacity to undergo programmed cell death .
the human placenta are able to regain the ability to #proliferate indefinitely throughout gestation (figure 6b) .
the human placenta are able to regain the ability to #proliferate throughout gestation (figure 6b) .
the human placenta are observed to regain the ability to #proliferate indefinitely throughout gestation (figure 6b) .
the human placenta are observed to regain the ability to #proliferate throughout gestation (figure 6b) .
the human placenta can regain the ability to #proliferate indefinitely throughout gestation (figure 6b) .
the human placenta have regained the ability to #proliferate indefinitely throughout gestation (figure 6b) .
the human placenta have the probability of regaining the ability to #proliferate indefinitely throughout gestation (figure 6b) .
the human placenta may have regained the ability to #proliferate indefinitely throughout gestation (figure 6b) .
the human placenta may have regained the ability to #proliferate throughout gestation (figure 6b) .
the human placenta regain the ability to #proliferate throughout gestation (figure 6b) .
the human placenta regained the ability to #proliferate indefinitely throughout gestation (figure 6b) .
the human placenta regained the ability to #proliferate throughout gestation (figure 6b) .
the human placenta will regain the ability to #proliferate indefinitely throughout gestation (figure 6b) .
the human placenta , which are at rest in normal conditions , are able to #proliferate strongly throughout gestation .
the human placenta , which are at rest in normal conditions , are able to #proliferate throughout gestation .
the human placenta , which are at rest in normal conditions , are observed to #proliferate strongly throughout gestation .
the human placenta , which are at rest in normal conditions , can #proliferate throughout gestation .
the human placenta , which are at rest in normal conditions , have strongly #proliferated throughout gestation .
the human placenta , which are at rest in normal conditions , have the ability to #proliferate throughout gestation .
the human placenta , which are at rest in normal conditions , may #proliferate strongly throughout gestation .
the human placenta , which are at rest in normal conditions , may strongly #proliferate throughout gestation .
the human placenta , which are at rest in normal conditions , might have #proliferated throughout gestation .
the human placenta , which are at rest in normal conditions , might have strongly #proliferated throughout gestation .
the human placenta , which are at rest in normal conditions , #proliferate strongly throughout gestation .
the human placenta , which are at rest in normal conditions , #proliferated throughout gestation .
the human placenta , which are at rest in normal conditions , will #proliferate strongly throughout gestation .
the human placenta , which are at rest in normal conditions , will #proliferate throughout gestation .
the human placenta , which are at rest in normal conditions , will strongly #proliferate throughout gestation .
the ability of ebd cells to #proliferate in vivo was examined by injection of 3 ? 106 lvec cells into the calf muscle of 3 immunocompromised mice .
a approximately 70kd polypeptide in western blots of extraocular muscle , sternothyroid muscle , and smooth muscle has been #recognized by anti-64kd human autoantigen d1 antibodies .
a approximately 70kd polypeptide in western blots of extraocular muscle , sternothyroid muscle , and smooth muscle was #recognized by anti-64kd human autoantigen d1 antibodies .
a monoclonal antibody which has #recognized the stat1 n-terminus was purchased from transduction laboratories (lexington , ky) .
a monoclonal antibody which #recognizes the stat1 n-terminus is purchased from transduction laboratories (lexington , ky) .
affinity-purified polyclonal anti-lmp-1 antiserum #recognizes epitopes in the c-terminus of lmp-1 at a 1:200 dilution .
blots were probed with affinity-purified polyclonal anti-lmp-1 antiserum that can #recognize epitopes in the c-terminus of lmp-1 at a 1:200 dilution .
exactly how specific splice sites have been #recognized during the processing of complex precursor messenger rnas is not clear .
exactly how specific splice sites were #recognized during the processing of complex precursor messenger rnas is not clear .
exactly how specific splice sites will be #recognized during the processing of complex precursor messenger rnas is not clear .
footprinting assays have suggested that these regulators protect a stretch of up to 20 bp in the target promoters , and multiple alignments of binding sites for a number of regulators have shown that the proteins can #recognize short motifs within the protected region .
footprinting assays have suggested that these regulators protect a stretch of up to 20 bp in the target promoters , and multiple alignments of binding sites for a number of regulators have shown that the proteins has #recognized short motifs within the protected region .
individual cell clones were analyzed for stat1 expression by immunofluorescence with a monoclonal antibody which #recognized the stat1 n-terminus , and by western blotting
individual cell clones were analyzed for stat1 expression by immunofluorescence with a monoclonal antibody which #recognizes the stat1 n-terminus , and by western blotting
the narl protein also bound to these 7-2-7 sites but , unlike narp , also #recognized heptamers in other arrangements .
the narl protein has also bound to these 7-2-7 sites but , unlike narp , has also #recognized heptamers in other arrangements .
the stat1 n-terminus were #recognized by a monoclonal antibody purchasing from transduction laboratories (lexington , ky) .
the eukaryotic upstream binding factor (ubf) , has #recognized the ribosomal rna gene promoter and activated transcription mediated by rna polymerase i through cooperative interactions with the species-specific factor , sl1 .
the eukaryotic upstream binding factor (ubf) , #recognized the ribosomal rna gene promoter and activated transcription mediated by rna polymerase i through cooperative interactions with the species-specific factor , sl1 .
the eukaryotic upstream binding factor (ubf) , will #recognize the ribosomal rna gene promoter and activate transcription mediated by rna polymerase i through cooperative interactions with the species-specific factor , sl1 .
the sequence(ypydvpdya) at a 1:500 dilution is #recognized by a rat monoclonal anti-ha antibody (boehringer-ingelheim) that blots were probed with .
the two forms of stat3 (stat3fm and stat3sm) that have been #recognized by this antibody in pkr+/+mefs are indicated .
the two forms of stat3 (stat3fm and stat3sm) which were #recognized by this antibody in pkr+/+mefs are indicated .
these mutations , identified by standard methods of reverse transcription , pcr ,dideoxy-chain termination , and cycle sequencing , alter highly conserved sequences at intron/exon boundaries and cause the rna-splicing apparatus not to properly #recognize the normal splice junction .
these mutations , identified by standard methods of reverse transcription , pcr ,dideoxy-chain termination , and cycle sequencing , alter highly conserved sequences at intron/exon boundaries and make the rna-splicing apparatus not to #recognized the normal splice junction properly .
these mutations , identified by standard methods of reverse transcription , pcr ,dideoxy-chain termination , and cycle sequencing , alter highly conserved sequences at intron/exon boundaries and prevent the normal splice junction from being properly #recognized by the rna-splicing apparatus .
the ribosomal rna gene promoter is #recognized by the eukaryotic upstream binding factor (ubf) .
the ribosomal rna gene promoter was #recognized by the eukaryotic upstream binding factor (ubf) .
two sites in tsx-p2 are #recognized by the camp-crp activator complex .
a monoclonal antibody #recognizing the stat1 n-terminus was purchased from transduction laboratories (lexington , ky) .
blots were probed with a rat monoclonal anti-ha antibody (boehringer-ingelheim) that #recognizes the sequence(ypydvpdya) at a 1:500 dilution .
the two forms of stat3 (stat3fm and stat3sm) #recognized by this antibody in pkr+/+mefs are indicated .
footprinting assays have suggested that these regulators protect a stretch of up to 20 bp in the target promoters , and multiple alignments of binding sites for a number of regulators have shown that the proteins #recognize short motifs within the protected region .
the narl protein also binds to these 7-2-7 sites but , unlike narp , also #recognizes heptamers in other arrangements .
we show that the camp-crp activator complex #recognizes two sites in tsx-p2 that are separated by 33 bp : a high-affinity site (crp-1) overlaps the-35 region , and a low-affinity site (crp-2) is centered around position-74 bp .
these mutations , identified by standard methods of reverse transcription , pcr ,dideoxy-chain termination , and cycle sequencing , alter highly conserved sequences at intron/exon boundaries and prevent the rna-splicing apparatus from properly #recognizing the normal splice junction .
a monoclonal antibody also bound to these 7-2-7 sites but , unlike narp , also #recognized the stat1 n-terminus .
a monoclonal antibody are able to #recognize the stat1 n-terminus in the regulated promoters .
a monoclonal antibody can #recognize the stat1 n-terminus in the regulated promoters .
a monoclonal antibody have #recognized the stat1 n-terminus in the regulated promoters .
a monoclonal antibody #recognize the stat1 n-terminus in the regulated promoters .
a monoclonal antibody #recognized specifically the stat1 n-terminus .
a monoclonal antibody #recognized the stat1 n-terminus in the regulated promoters .
a monoclonal antibody will binds to these 7-2-7 sites but , unlike narp , will also #recognize the stat1 n-terminus .
a monoclonal antibody will #recognize the stat1 n-terminus in the regulated promoters .
anti-64kd human autoantigen d1 antibodies has also bound to these 7-2-7 sites but , unlike narp , has also #recognized a approximately 70kd polypeptide in western blots of extraocular muscle , sternothyroid muscle , and smooth muscle .
anti-64kd human autoantigen d1 antibodies #recognized a approximately 70kd polypeptide in western blots of extraocular muscle , sternothyroid muscle , and smooth muscle in the regulated promoters .
anti-64kd human autoantigen d1 antibodies #recognizing a approximately 70kd polypeptide in western blots of extraocular muscle , sternothyroid muscle , and smooth muscle was purchased from transduction laboratories (lexington , ky) .
anti-64kd human autoantigen d1 antibodies which has #recognized a approximately 70kd polypeptide in western blots of extraocular muscle , sternothyroid muscle , and smooth muscle was purchased from transduction laboratories (lexington , ky) .
anti-64kd human autoantigen d1 antibodies will binds to these 7-2-7 sites but , unlike narp , will also #recognize a approximately 70kd polypeptide in western blots of extraocular muscle , sternothyroid muscle , and smooth muscle .
blots were probed with a monoclonal antibody #recognizing the stat1 n-terminus .
blots were probed with a monoclonal antibody that can #recognize the stat1 n-terminus .
blots were probed with a monoclonal antibody that #recognized the stat1 n-terminus .
blots were probed with a monoclonal antibody that #recognizes the stat1 n-terminus .
blots were probed with a monoclonal antibody that #recognizes the the stat1 n-terminus , or with rabbit polyclonal anti-gfp or anti-rfp (clontech) antiserum at a 1:250 dilution .
blots were probed with anti-64kd human autoantigen d1 antibodies #recognizing a approximately 70kd polypeptide in western blots of extraocular muscle , sternothyroid muscle , and smooth muscle .
blots were probed with anti-64kd human autoantigen d1 antibodies that can #recognize a approximately 70kd polypeptide in western blots of extraocular muscle , sternothyroid muscle , and smooth muscle .
blots were probed with anti-64kd human autoantigen d1 antibodies that #recognizes a approximately 70kd polypeptide in western blots of extraocular muscle , sternothyroid muscle , and smooth muscle .
blots were probed with the narl protein #recognizing heptamers in other arrangements .
blots were probed with the narl protein that can #recognize heptamers in other arrangements .
blots were probed with the narl protein that #recognizes the heptamers in other arrangements , or with rabbit polyclonal anti-gfp or anti-rfp (clontech) antiserum at a 1:250 dilution .
blots were probed with a rat monoclonal anti-ha antibody (boehringer-ingelheim) that #recognized sequence(ypydvpdya) at a 1:500 dilution .
blots were probed with a rat monoclonal anti-ha antibody (boehringer-ingelheim) that #recognizes sequence(ypydvpdya) at a 1:500 dilution .
blots were probed with a monoclonal antibody that can #recognize the stat1 n-terminus .
blots were probed with a monoclonal antibody that #recognized the stat1 n-terminus .
blots were probed with a monoclonal antibody that #recognizes the stat1 n-terminus .
blots were probed with a monoclonal antibody that #recognizes the the stat1 n-terminus , or with rabbit polyclonal anti-gfp or anti-rfp (clontech) antiserum at a 1:250 dilution .
blots were probed with a monoclonal antibody that #recognizes the the stat1 n-terminus .
blots were probed with affinity-purified polyclonal anti-lmp-1 antiserum that #recognizes the epitopes in the c-terminus of lmp-1 at a 1:200 dilution , or with rabbit polyclonal anti-gfp or anti-rfp (clontech) antiserum at a 1:250 dilution .
blots were probed with affinity-purified polyclonal anti-lmp-1 antiserum that #recognizes the epitopes in the c-terminus of lmp-1 at a 1:200 dilution .
blots were probed with the camp-crp activator complex that #recognized two sites in tsx-p2 .
blots were probed with the camp-crp activator complex that #recognizes the two sites in tsx-p2 , or with rabbit polyclonal anti-gfp or anti-rfp (clontech) antiserum at a 1:250 dilution .
blots were probed with the proteins #recognizing short motifs within the protected region .
blots were probed with the proteins that #recognizes short motifs within the protected region .
blots were probed with this antibody in pkr+/+mefs #recognizing the two forms of stat3 (stat3fm and stat3sm) .
blots were probed with this antibody in pkr+/+mefs that #recognized the two forms of stat3 (stat3fm and stat3sm) .
blots were probed with this antibody in pkr+/+mefs that #recognizes the the two forms of stat3 (stat3fm and stat3sm) , or with rabbit polyclonal anti-gfp or anti-rfp (clontech) antiserum at a 1:250 dilution .
blots were probed with this antibody in pkr+/+mefs that #recognizes the the two forms of stat3 (stat3fm and stat3sm) .
footprinting assays have suggested that these regulators protect a stretch of up to 20 bp in the target promoters , and multiple alignments of binding sites for a number of regulators have shown that a monoclonal antibody are able to #recognize the stat1 n-terminus .
footprinting assays have suggested that these regulators protect a stretch of up to 20 bp in the target promoters , and multiple alignments of binding sites for a number of regulators have shown that a monoclonal antibody has #recognized the stat1 n-terminus .
footprinting assays have suggested that these regulators protect a stretch of up to 20 bp in the target promoters , and multiple alignments of binding sites for a number of regulators have shown that anti-64kd human autoantigen d1 antibodies has #recognized a approximately 70kd polypeptide in western blots of extraocular muscle , sternothyroid muscle , and smooth muscle .
footprinting assays have suggested that these regulators protect a stretch of up to 20 bp in the target promoters , and multiple alignments of binding sites for a number of regulators have shown that anti-64kd human autoantigen d1 antibodies #recognized a approximately 70kd polypeptide in western blots of extraocular muscle , sternothyroid muscle , and smooth muscle .
footprinting assays have suggested that these regulators protect a stretch of up to 20 bp in the target promoters , and multiple alignments of binding sites for a number of regulators have shown that the narl protein are able to #recognize heptamers in other arrangements .
footprinting assays have suggested that these regulators protect a stretch of up to 20 bp in the target promoters , and multiple alignments of binding sites for a number of regulators have shown that the narl protein #recognize heptamers in other arrangements .
footprinting assays have suggested that these regulators protect a stretch of up to 20 bp in the target promoters , and multiple alignments of binding sites for a number of regulators have shown that the narl protein #recognized heptamers in other arrangements .
footprinting assays have suggested that these regulators protect a stretch of up to 20 bp in the target promoters , and multiple alignments of binding sites for a number of regulators have shown that a rat monoclonal anti-ha antibody (boehringer-ingelheim) can #recognize sequence(ypydvpdya) at a 1:500 dilution .
footprinting assays have suggested that these regulators protect a stretch of up to 20 bp in the target promoters , and multiple alignments of binding sites for a number of regulators have shown that a rat monoclonal anti-ha antibody (boehringer-ingelheim) #recognized sequence(ypydvpdya) at a 1:500 dilution .
footprinting assays have suggested that these regulators protect a stretch of up to 20 bp in the target promoters , and multiple alignments of binding sites for a number of regulators have shown that a monoclonal antibody are able to #recognize the stat1 n-terminus .
footprinting assays have suggested that these regulators protect a stretch of up to 20 bp in the target promoters , and multiple alignments of binding sites for a number of regulators have shown that affinity-purified polyclonal anti-lmp-1 antiserum are able to #recognize epitopes in the c-terminus of lmp-1 at a 1:200 dilution .
footprinting assays have suggested that these regulators protect a stretch of up to 20 bp in the target promoters , and multiple alignments of binding sites for a number of regulators have shown that affinity-purified polyclonal anti-lmp-1 antiserum can #recognize epitopes in the c-terminus of lmp-1 at a 1:200 dilution .
footprinting assays have suggested that these regulators protect a stretch of up to 20 bp in the target promoters , and multiple alignments of binding sites for a number of regulators have shown that affinity-purified polyclonal anti-lmp-1 antiserum has #recognized epitopes in the c-terminus of lmp-1 at a 1:200 dilution .
footprinting assays have suggested that these regulators protect a stretch of up to 20 bp in the target promoters , and multiple alignments of binding sites for a number of regulators have shown that affinity-purified polyclonal anti-lmp-1 antiserum #recognized epitopes in the c-terminus of lmp-1 at a 1:200 dilution .
footprinting assays have suggested that these regulators protect a stretch of up to 20 bp in the target promoters , and multiple alignments of binding sites for a number of regulators have shown that the camp-crp activator complex are able to #recognize two sites in tsx-p2 .
footprinting assays have suggested that these regulators protect a stretch of up to 20 bp in the target promoters , and multiple alignments of binding sites for a number of regulators have shown that the camp-crp activator complex can #recognize two sites in tsx-p2 .
footprinting assays have suggested that these regulators protect a stretch of up to 20 bp in the target promoters , and multiple alignments of binding sites for a number of regulators have shown that the camp-crp activator complex #recognize two sites in tsx-p2 .
footprinting assays have suggested that these regulators protect a stretch of up to 20 bp in the target promoters , and multiple alignments of binding sites for a number of regulators have shown that this antibody in pkr+/+mefs #recognized the two forms of stat3 (stat3fm and stat3sm) .
individual cell clones were analyzed for stat1 expression by immunofluorescence where the two forms of stat3 (stat3fm and stat3sm) are #recognized by this antibody in pkr+/+mefs .
individual cell clones were analyzed for stat1 expression by immunofluorescence where the two forms of stat3 (stat3fm and stat3sm) were #recognized by this antibody in pkr+/+mefs .
individual cell clones were analyzed for stat1 expression by immunofluorescence where a approximately 70kd polypeptide in western blots of extraocular muscle , sternothyroid muscle , and smooth muscle are #recognized by anti-64kd human autoantigen d1 antibodies .
individual cell clones were analyzed for stat1 expression by immunofluorescence where epitopes in the c-terminus of lmp-1 at a 1:200 dilution are #recognized by affinity-purified polyclonal anti-lmp-1 antiserum .
individual cell clones were analyzed for stat1 expression by immunofluorescence where sequence(ypydvpdya) at a 1:500 dilution are #recognized by a rat monoclonal anti-ha antibody (boehringer-ingelheim) .
individual cell clones were analyzed for stat1 expression by immunofluorescence where sequence(ypydvpdya) at a 1:500 dilution were #recognized by a rat monoclonal anti-ha antibody (boehringer-ingelheim) .
individual cell clones were analyzed for stat1 expression by immunofluorescence where short motifs within the protected region are #recognized by the proteins .
individual cell clones were analyzed for stat1 expression by immunofluorescence where the stat1 n-terminus are #recognized by a monoclonal antibody .
individual cell clones were analyzed for stat1 expression by immunofluorescence where the stat1 n-terminus were #recognized by a monoclonal antibody .
individual cell clones were analyzed for stat1 expression by immunofluorescence where two sites in tsx-p2 are #recognized by the camp-crp activator complex .
individual cell clones were analyzed for stat1 expression by immunofluorescence where two sites in tsx-p2 were #recognized by the camp-crp activator complex .
individual cell clones were analyzed for stat1 expression by immunofluorescence with a monoclonal antibody which #recognized the stat1 n-terminus , and by western blotting
individual cell clones were analyzed for stat1 expression by immunofluorescence with the narl protein which #recognizes heptamers in other arrangements , and by western blotting
individual cell clones were analyzed for stat1 expression by immunofluorescence with a rat monoclonal anti-ha antibody (boehringer-ingelheim) #recognizing sequence(ypydvpdya) at a 1:500 dilution , and by western blotting .
individual cell clones were analyzed for stat1 expression by immunofluorescence with a rat monoclonal anti-ha antibody (boehringer-ingelheim) which #recognized sequence(ypydvpdya) at a 1:500 dilution , and by western blotting
individual cell clones were analyzed for stat1 expression by immunofluorescence with a rat monoclonal anti-ha antibody (boehringer-ingelheim) which #recognizes sequence(ypydvpdya) at a 1:500 dilution , and by western blotting
individual cell clones were analyzed for stat1 expression by immunofluorescence with the camp-crp activator complex #recognizing two sites in tsx-p2 , and by western blotting .
individual cell clones were analyzed for stat1 expression by immunofluorescence with the camp-crp activator complex which #recognized two sites in tsx-p2 , and by western blotting
individual cell clones were analyzed for stat1 expression by immunofluorescence with the camp-crp activator complex which #recognizes two sites in tsx-p2 , and by western blotting
individual cell clones were analyzed for stat1 expression by immunofluorescence with this antibody in pkr+/+mefs #recognizing the two forms of stat3 (stat3fm and stat3sm) , and by western blotting .
the narl protein are able to #recognize heptamers in other arrangements in the regulated promoters .
the narl protein #recognize specifically heptamers in other arrangements .
the narl protein #recognized heptamers in other arrangements in the regulated promoters .
the narl protein which has #recognized heptamers in other arrangements was purchased from transduction laboratories (lexington , ky) .
the narl protein which #recognizes heptamers in other arrangements is purchased from transduction laboratories (lexington , ky) .
the a approximately 70kd polypeptide in western blots of extraocular muscle , sternothyroid muscle , and smooth muscle is #recognized by anti-64kd human autoantigen d1 antibodies that blots were probed with .
the two forms of stat3 (stat3fm and stat3sm) are #recognized by this antibody in pkr+/+mefs .
the two forms of stat3 (stat3fm and stat3sm) , cannot be #recognized in the immunoprecipitaiton with this antibody in pkr+/+mefs as it is raised against a c-terminal region of stat3 that is missing in stat3beta .
the two forms of stat3 (stat3fm and stat3sm) , will not be #recognized in the immunoprecipitaiton with this antibody in pkr+/+mefs as it is raised against a c-terminal region of stat3 that is missing in stat3beta .
the two sites in tsx-p2 is #recognized by the camp-crp activator complex that blots were probed with .
these bands can be detected with a monoclonal antibody that #recognize the stat1 n-terminus
these bands can be detected with a monoclonal antibody which have #recognized the stat1 n-terminus
these bands can be detected with a monoclonal antibody which #recognize the stat1 n-terminus
these bands can be detected with anti-64kd human autoantigen d1 antibodies that #recognized a approximately 70kd polypeptide in western blots of extraocular muscle , sternothyroid muscle , and smooth muscle
these bands can be detected with the narl protein #recognizing heptamers in other arrangements
these bands can be detected with the narl protein that #recognize heptamers in other arrangements
these bands can be detected with the narl protein which #recognize heptamers in other arrangements
these bands can be detected with a rat monoclonal anti-ha antibody (boehringer-ingelheim) that #recognize sequence(ypydvpdya) at a 1:500 dilution
these bands can be detected with a monoclonal antibody which have #recognized the stat1 n-terminus
these bands can be detected with affinity-purified polyclonal anti-lmp-1 antiserum #recognizing epitopes in the c-terminus of lmp-1 at a 1:200 dilution
these bands can be detected with affinity-purified polyclonal anti-lmp-1 antiserum that #recognized epitopes in the c-terminus of lmp-1 at a 1:200 dilution
these bands can be detected with the camp-crp activator complex #recognizing two sites in tsx-p2
these bands can be detected with the camp-crp activator complex that #recognized two sites in tsx-p2
these bands can be detected with the camp-crp activator complex which have #recognized two sites in tsx-p2
these bands can be detected with the proteins #recognizing short motifs within the protected region
these bands can be detected with the proteins that #recognized short motifs within the protected region
these bands can be detected with the proteins which have #recognized short motifs within the protected region
these bands can be detected with the proteins which #recognize short motifs within the protected region
these bands can be detected with this antibody in pkr+/+mefs that #recognized the two forms of stat3 (stat3fm and stat3sm)
these bands can be detected with this antibody in pkr+/+mefs which #recognize the two forms of stat3 (stat3fm and stat3sm)
we show that a monoclonal antibody #recognizes the stat1 n-terminus that are separated by 33 bp : a high-affinity site (crp-1) overlaps the-35 region , and a low-affinity site (crp-2) is centered around position-74 bp .
we show that anti-64kd human autoantigen d1 antibodies has #recognized a approximately 70kd polypeptide in western blots of extraocular muscle , sternothyroid muscle , and smooth muscle that are separated by 33 bp : a high-affinity site (crp-1) overlaps the-35 region , and a low-affinity site (crp-2) is centered around position-74 bp .
we show that anti-64kd human autoantigen d1 antibodies #recognized a approximately 70kd polypeptide in western blots of extraocular muscle , sternothyroid muscle , and smooth muscle that are separated by 33 bp : a high-affinity site (crp-1) overlaps the-35 region , and a low-affinity site (crp-2) is centered around position-74 bp .
we show that anti-64kd human autoantigen d1 antibodies #recognizes a approximately 70kd polypeptide in western blots of extraocular muscle , sternothyroid muscle , and smooth muscle that are separated by 33 bp : a high-affinity site (crp-1) overlaps the-35 region , and a low-affinity site (crp-2) is centered around position-74 bp .
we show that anti-64kd human autoantigen d1 antibodies will #recognize a approximately 70kd polypeptide in western blots of extraocular muscle , sternothyroid muscle , and smooth muscle that are separated by 33 bp : a high-affinity site (crp-1) overlaps the-35 region , and a low-affinity site (crp-2) is centered around position-74 bp .
we show that the narl protein #recognized heptamers in other arrangements that are separated by 33 bp : a high-affinity site (crp-1) overlaps the-35 region , and a low-affinity site (crp-2) is centered around position-74 bp .
we show that the narl protein #recognizes heptamers in other arrangements that are separated by 33 bp : a high-affinity site (crp-1) overlaps the-35 region , and a low-affinity site (crp-2) is centered around position-74 bp .
we show that the narl protein will #recognize heptamers in other arrangements that are separated by 33 bp : a high-affinity site (crp-1) overlaps the-35 region , and a low-affinity site (crp-2) is centered around position-74 bp .
we show that a rat monoclonal anti-ha antibody (boehringer-ingelheim) has #recognized sequence(ypydvpdya) at a 1:500 dilution that are separated by 33 bp : a high-affinity site (crp-1) overlaps the-35 region , and a low-affinity site (crp-2) is centered around position-74 bp .
we show that a rat monoclonal anti-ha antibody (boehringer-ingelheim) #recognized sequence(ypydvpdya) at a 1:500 dilution that are separated by 33 bp : a high-affinity site (crp-1) overlaps the-35 region , and a low-affinity site (crp-2) is centered around position-74 bp .
we show that a rat monoclonal anti-ha antibody (boehringer-ingelheim) #recognizes sequence(ypydvpdya) at a 1:500 dilution that are separated by 33 bp : a high-affinity site (crp-1) overlaps the-35 region , and a low-affinity site (crp-2) is centered around position-74 bp .
we show that a rat monoclonal anti-ha antibody (boehringer-ingelheim) will #recognize sequence(ypydvpdya) at a 1:500 dilution that are separated by 33 bp : a high-affinity site (crp-1) overlaps the-35 region , and a low-affinity site (crp-2) is centered around position-74 bp .
we show that a monoclonal antibody will #recognize the stat1 n-terminus that are separated by 33 bp : a high-affinity site (crp-1) overlaps the-35 region , and a low-affinity site (crp-2) is centered around position-74 bp .
we show that affinity-purified polyclonal anti-lmp-1 antiserum #recognized epitopes in the c-terminus of lmp-1 at a 1:200 dilution that are separated by 33 bp : a high-affinity site (crp-1) overlaps the-35 region , and a low-affinity site (crp-2) is centered around position-74 bp .
we show that affinity-purified polyclonal anti-lmp-1 antiserum will #recognize epitopes in the c-terminus of lmp-1 at a 1:200 dilution that are separated by 33 bp : a high-affinity site (crp-1) overlaps the-35 region , and a low-affinity site (crp-2) is centered around position-74 bp .
we show that the proteins has #recognized short motifs within the protected region that are separated by 33 bp : a high-affinity site (crp-1) overlaps the-35 region , and a low-affinity site (crp-2) is centered around position-74 bp .
we show that this antibody in pkr+/+mefs #recognized the two forms of stat3 (stat3fm and stat3sm) that are separated by 33 bp : a high-affinity site (crp-1) overlaps the-35 region , and a low-affinity site (crp-2) is centered around position-74 bp .
we show that this antibody in pkr+/+mefs #recognizes the two forms of stat3 (stat3fm and stat3sm) that are separated by 33 bp : a high-affinity site (crp-1) overlaps the-35 region , and a low-affinity site (crp-2) is centered around position-74 bp .
we show that this antibody in pkr+/+mefs will #recognize the two forms of stat3 (stat3fm and stat3sm) that are separated by 33 bp : a high-affinity site (crp-1) overlaps the-35 region , and a low-affinity site (crp-2) is centered around position-74 bp .
a rat monoclonal anti-ha antibody (boehringer-ingelheim) has also bound to these 7-2-7 sites but , unlike narp , has also #recognized sequence(ypydvpdya) at a 1:500 dilution .
a rat monoclonal anti-ha antibody (boehringer-ingelheim) #recognized specifically sequence(ypydvpdya) at a 1:500 dilution .
a rat monoclonal anti-ha antibody (boehringer-ingelheim) which has #recognized sequence(ypydvpdya) at a 1:500 dilution was purchased from transduction laboratories (lexington , ky) .
a approximately 70kd polypeptide in western blots of extraocular muscle , sternothyroid muscle , and smooth muscle #recognized by anti-64kd human autoantigen d1 antibodies are indicated .
a approximately 70kd polypeptide in western blots of extraocular muscle , sternothyroid muscle , and smooth muscle that are #recognized by anti-64kd human autoantigen d1 antibodies are indicated .
a approximately 70kd polypeptide in western blots of extraocular muscle , sternothyroid muscle , and smooth muscle that have been #recognized by anti-64kd human autoantigen d1 antibodies are indicated .
a approximately 70kd polypeptide in western blots of extraocular muscle , sternothyroid muscle , and smooth muscle that will be #recognized by anti-64kd human autoantigen d1 antibodies are indicated .
a approximately 70kd polypeptide in western blots of extraocular muscle , sternothyroid muscle , and smooth muscle which can be #recognized by anti-64kd human autoantigen d1 antibodies are indicated .
a approximately 70kd polypeptide in western blots of extraocular muscle , sternothyroid muscle , and smooth muscle , cannot be #recognized in the immunoprecipitaiton with anti-64kd human autoantigen d1 antibodies as it is raised against a c-terminal region of stat3 that is missing in stat3beta .
a approximately 70kd polypeptide in western blots of extraocular muscle , sternothyroid muscle , and smooth muscle , is not #recognized in the immunoprecipitaiton with anti-64kd human autoantigen d1 antibodies as it is raised against a c-terminal region of stat3 that is missing in stat3beta .
a approximately 70kd polypeptide in western blots of extraocular muscle , sternothyroid muscle , and smooth muscle , was not #recognized in the immunoprecipitaiton with anti-64kd human autoantigen d1 antibodies as it was raised against a c-terminal region of stat3 that is missing in stat3beta .
a approximately 70kd polypeptide in western blots of extraocular muscle , sternothyroid muscle , and smooth muscle , will not be #recognized in the immunoprecipitaiton with anti-64kd human autoantigen d1 antibodies as it is raised against a c-terminal region of stat3 that is missing in stat3beta .
a monoclonal antibody also bound to these 7-2-7 sites but , unlike narp , also #recognized the stat1 n-terminus .
a monoclonal antibody are able to #recognize the stat1 n-terminus in the regulated promoters .
a monoclonal antibody can #recognize the stat1 n-terminus in the regulated promoters .
a monoclonal antibody #recognize specifically the stat1 n-terminus .
a monoclonal antibody #recognize the stat1 n-terminus in the regulated promoters .
a monoclonal antibody #recognized specifically the stat1 n-terminus .
a monoclonal antibody #recognized the stat1 n-terminus in the regulated promoters .
a monoclonal antibody #recognizing the stat1 n-terminus was purchased from transduction laboratories (lexington , ky) .
a monoclonal antibody which has #recognized the stat1 n-terminus was purchased from transduction laboratories (lexington , ky) .
a monoclonal antibody will #recognize the stat1 n-terminus in the regulated promoters .
affinity-purified polyclonal anti-lmp-1 antiserum also binds to these 7-2-7 sites but , unlike narp , also #recognizes epitopes in the c-terminus of lmp-1 at a 1:200 dilution .
affinity-purified polyclonal anti-lmp-1 antiserum are able to #recognize epitopes in the c-terminus of lmp-1 at a 1:200 dilution in the regulated promoters .
affinity-purified polyclonal anti-lmp-1 antiserum can #recognize epitopes in the c-terminus of lmp-1 at a 1:200 dilution in the regulated promoters .
affinity-purified polyclonal anti-lmp-1 antiserum have #recognized epitopes in the c-terminus of lmp-1 at a 1:200 dilution in the regulated promoters .
affinity-purified polyclonal anti-lmp-1 antiserum #recognize epitopes in the c-terminus of lmp-1 at a 1:200 dilution in the regulated promoters .
affinity-purified polyclonal anti-lmp-1 antiserum #recognized specifically epitopes in the c-terminus of lmp-1 at a 1:200 dilution .
affinity-purified polyclonal anti-lmp-1 antiserum #recognizing epitopes in the c-terminus of lmp-1 at a 1:200 dilution was purchased from transduction laboratories (lexington , ky) .
affinity-purified polyclonal anti-lmp-1 antiserum which #recognizes epitopes in the c-terminus of lmp-1 at a 1:200 dilution is purchased from transduction laboratories (lexington , ky) .
epitopes in the c-terminus of lmp-1 at a 1:200 dilution #recognized by affinity-purified polyclonal anti-lmp-1 antiserum are indicated .
epitopes in the c-terminus of lmp-1 at a 1:200 dilution that are #recognized by affinity-purified polyclonal anti-lmp-1 antiserum are indicated .
epitopes in the c-terminus of lmp-1 at a 1:200 dilution that were #recognized by affinity-purified polyclonal anti-lmp-1 antiserum are indicated .
epitopes in the c-terminus of lmp-1 at a 1:200 dilution were #recognized by affinity-purified polyclonal anti-lmp-1 antiserum .
epitopes in the c-terminus of lmp-1 at a 1:200 dilution which can be #recognized by affinity-purified polyclonal anti-lmp-1 antiserum are indicated .
epitopes in the c-terminus of lmp-1 at a 1:200 dilution , is not #recognized in the immunoprecipitaiton with affinity-purified polyclonal anti-lmp-1 antiserum as it is raised against a c-terminal region of stat3 that is missing in stat3beta .
epitopes in the c-terminus of lmp-1 at a 1:200 dilution , was not #recognized in the immunoprecipitaiton with affinity-purified polyclonal anti-lmp-1 antiserum as it was raised against a c-terminal region of stat3 that is missing in stat3beta .
heptamers in other arrangements are #recognized by the narl protein .
heptamers in other arrangements #recognized by the narl protein are indicated .
heptamers in other arrangements that have been #recognized by the narl protein are indicated .
heptamers in other arrangements that will be #recognized by the narl protein are indicated .
heptamers in other arrangements which can be #recognized by the narl protein are indicated .
heptamers in other arrangements , is not #recognized in the immunoprecipitaiton with the narl protein as it is raised against a c-terminal region of stat3 that is missing in stat3beta .
heptamers in other arrangements , will not be #recognized in the immunoprecipitaiton with the narl protein as it is raised against a c-terminal region of stat3 that is missing in stat3beta .
sequence(ypydvpdya) at a 1:500 dilution that are #recognized by a rat monoclonal anti-ha antibody (boehringer-ingelheim) are indicated .
sequence(ypydvpdya) at a 1:500 dilution that have been #recognized by a rat monoclonal anti-ha antibody (boehringer-ingelheim) are indicated .
sequence(ypydvpdya) at a 1:500 dilution that were #recognized by a rat monoclonal anti-ha antibody (boehringer-ingelheim) are indicated .
sequence(ypydvpdya) at a 1:500 dilution which can be #recognized by a rat monoclonal anti-ha antibody (boehringer-ingelheim) are indicated .
sequence(ypydvpdya) at a 1:500 dilution which were #recognized by a rat monoclonal anti-ha antibody (boehringer-ingelheim) are indicated .
sequence(ypydvpdya) at a 1:500 dilution , has not been #recognized in the immunoprecipitaiton with a rat monoclonal anti-ha antibody (boehringer-ingelheim) as it was raised against a c-terminal region of stat3 that is missing in stat3beta .
sequence(ypydvpdya) at a 1:500 dilution , was not #recognized in the immunoprecipitaiton with a rat monoclonal anti-ha antibody (boehringer-ingelheim) as it was raised against a c-terminal region of stat3 that is missing in stat3beta .
short motifs within the protected region are #recognized by the proteins .
short motifs within the protected region #recognized by the proteins are indicated .
short motifs within the protected region that are #recognized by the proteins are indicated .
short motifs within the protected region that will be #recognized by the proteins are indicated .
short motifs within the protected region which were #recognized by the proteins are indicated .
short motifs within the protected region , cannot be #recognized in the immunoprecipitaiton with the proteins as it is raised against a c-terminal region of stat3 that is missing in stat3beta .
short motifs within the protected region , has not been #recognized in the immunoprecipitaiton with the proteins as it was raised against a c-terminal region of stat3 that is missing in stat3beta .
short motifs within the protected region , was not #recognized in the immunoprecipitaiton with the proteins as it was raised against a c-terminal region of stat3 that is missing in stat3beta .
the stat1 n-terminus are #recognized by a monoclonal antibody .
the stat1 n-terminus #recognized by a monoclonal antibody are indicated .
the stat1 n-terminus that are #recognized by a monoclonal antibody are indicated .
the stat1 n-terminus that are #recognized by a monoclonal antibody are indicated .
the stat1 n-terminus that have been #recognized by a monoclonal antibody are indicated .
the stat1 n-terminus that have been #recognized by a monoclonal antibody are indicated .
the stat1 n-terminus that will be #recognized by a monoclonal antibody are indicated .
the stat1 n-terminus were #recognized by a monoclonal antibody .
the stat1 n-terminus which can be #recognized by a monoclonal antibody are indicated .
the stat1 n-terminus which were #recognized by a monoclonal antibody are indicated .
the stat1 n-terminus , cannot be #recognized in the immunoprecipitaiton with a monoclonal antibody as it is raised against a c-terminal region of stat3 that is missing in stat3beta .
the stat1 n-terminus , could not be #recognized in the immunoprecipitaiton with a monoclonal antibody as it was raised against a c-terminal region of stat3 that is missing in stat3beta .
the stat1 n-terminus , has not been #recognized in the immunoprecipitaiton with a monoclonal antibody as it was raised against a c-terminal region of stat3 that is missing in stat3beta .
the stat1 n-terminus , is not #recognized in the immunoprecipitaiton with a monoclonal antibody as it is raised against a c-terminal region of stat3 that is missing in stat3beta .
the stat1 n-terminus , is not #recognized in the immunoprecipitaiton with a monoclonal antibody as it is raised against a c-terminal region of stat3 that is missing in stat3beta .
the stat1 n-terminus , was not #recognized in the immunoprecipitaiton with a monoclonal antibody as it was raised against a c-terminal region of stat3 that is missing in stat3beta .
the camp-crp activator complex also bound to these 7-2-7 sites but , unlike narp , also #recognized two sites in tsx-p2 .
the camp-crp activator complex has also bound to these 7-2-7 sites but , unlike narp , has also #recognized two sites in tsx-p2 .
the camp-crp activator complex #recognize two sites in tsx-p2 in the regulated promoters .
the camp-crp activator complex #recognized specifically two sites in tsx-p2 .
the camp-crp activator complex #recognizing two sites in tsx-p2 was purchased from transduction laboratories (lexington , ky) .
the camp-crp activator complex which has #recognized two sites in tsx-p2 was purchased from transduction laboratories (lexington , ky) .
the camp-crp activator complex will #recognize two sites in tsx-p2 in the regulated promoters .
the proteins also binds to these 7-2-7 sites but , unlike narp , also #recognizes short motifs within the protected region .
the proteins can #recognize short motifs within the protected region in the regulated promoters .
the proteins have #recognized short motifs within the protected region in the regulated promoters .
the proteins #recognize specifically short motifs within the protected region .
the proteins #recognized short motifs within the protected region in the regulated promoters .
the proteins #recognized specifically short motifs within the protected region .
the proteins #recognizing short motifs within the protected region was purchased from transduction laboratories (lexington , ky) .
the proteins which #recognizes short motifs within the protected region is purchased from transduction laboratories (lexington , ky) .
the proteins will #recognize short motifs within the protected region in the regulated promoters .
this antibody in pkr+/+mefs also binds to these 7-2-7 sites but , unlike narp , also #recognizes the two forms of stat3 (stat3fm and stat3sm) .
this antibody in pkr+/+mefs also bound to these 7-2-7 sites but , unlike narp , also #recognized the two forms of stat3 (stat3fm and stat3sm) .
this antibody in pkr+/+mefs #recognize the two forms of stat3 (stat3fm and stat3sm) in the regulated promoters .
this antibody in pkr+/+mefs #recognized the two forms of stat3 (stat3fm and stat3sm) in the regulated promoters .
this antibody in pkr+/+mefs #recognizing the two forms of stat3 (stat3fm and stat3sm) was purchased from transduction laboratories (lexington , ky) .
this antibody in pkr+/+mefs which has #recognized the two forms of stat3 (stat3fm and stat3sm) was purchased from transduction laboratories (lexington , ky) .
this antibody in pkr+/+mefs which #recognizes the two forms of stat3 (stat3fm and stat3sm) is purchased from transduction laboratories (lexington , ky) .
two sites in tsx-p2 which can be #recognized by the camp-crp activator complex are indicated .
two sites in tsx-p2 , could not be #recognized in the immunoprecipitaiton with the camp-crp activator complex as it was raised against a c-terminal region of stat3 that is missing in stat3beta .
two sites in tsx-p2 , will not be #recognized in the immunoprecipitaiton with the camp-crp activator complex as it is raised against a c-terminal region of stat3 that is missing in stat3beta .
blots were probed with the rna-splicing apparatus #recognizing the normal splice junction .
blots were probed with the rna-splicing apparatus that can #recognize the normal splice junction .
blots were probed with the rna-splicing apparatus that #recognizes the normal splice junction .
blots were probed with the rna-splicing apparatus that #recognizes the the normal splice junction .
footprinting assays have suggested that these regulators protect a stretch of up to 20 bp in the target promoters , and multiple alignments of binding sites for a number of regulators have shown that the rna-splicing apparatus are able to #recognize the normal splice junction .
footprinting assays have suggested that these regulators protect a stretch of up to 20 bp in the target promoters , and multiple alignments of binding sites for a number of regulators have shown that the rna-splicing apparatus #recognized the normal splice junction .
individual cell clones were analyzed for stat1 expression by immunofluorescence where the normal splice junction were #recognized by the rna-splicing apparatus .
individual cell clones were analyzed for stat1 expression by immunofluorescence with the rna-splicing apparatus #recognizing the normal splice junction , and by western blotting .
individual cell clones were analyzed for stat1 expression by immunofluorescence with the rna-splicing apparatus which #recognizes the normal splice junction , and by western blotting
the the normal splice junction is #recognized by the rna-splicing apparatus that blots were probed with .
these bands can be detected with the rna-splicing apparatus which #recognize the normal splice junction
we show that the rna-splicing apparatus #recognizes the normal splice junction that are separated by 33 bp : a high-affinity site (crp-1) overlaps the-35 region , and a low-affinity site (crp-2) is centered around position-74 bp .
we show that the rna-splicing apparatus will #recognize the normal splice junction that are separated by 33 bp : a high-affinity site (crp-1) overlaps the-35 region , and a low-affinity site (crp-2) is centered around position-74 bp .
the rna-splicing apparatus also bound to these 7-2-7 sites but , unlike narp , also #recognized the normal splice junction .
the rna-splicing apparatus are able to #recognize the normal splice junction in the regulated promoters .
the rna-splicing apparatus can #recognize the normal splice junction in the regulated promoters .
the rna-splicing apparatus #recognized the normal splice junction in the regulated promoters .
the rna-splicing apparatus which has #recognized the normal splice junction was purchased from transduction laboratories (lexington , ky) .
the normal splice junction are #recognized by the rna-splicing apparatus .
the normal splice junction that are #recognized by the rna-splicing apparatus are indicated .
the normal splice junction that have been #recognized by the rna-splicing apparatus are indicated .
the normal splice junction were #recognized by the rna-splicing apparatus .
the normal splice junction which can be #recognized by the rna-splicing apparatus are indicated .
the normal splice junction which were #recognized by the rna-splicing apparatus are indicated .
the normal splice junction , will not be #recognized in the immunoprecipitaiton with the rna-splicing apparatus as it is raised against a c-terminal region of stat3 that is missing in stat3beta .
a role for sos-1 in fgfr-mediated signaling during development hyperactive egl-15 fgf receptor signaling that has #resulted in a clr phenotype is conferred by either an activated egl-15 or a lf clr-1 mutation .
a role for sos-1 in fgfr-mediated signaling during development hyperactive egl-15 fgf receptor signaling that is able to #result in a clr phenotype is conferred by either an activated egl-15 or a lf clr-1 mutation .
a role for sos-1 in fgfr-mediated signaling during development hyperactive egl-15 fgf receptor signaling that may have #resulted in a clr phenotype is conferred by either an activated egl-15 or a lf clr-1 mutation .
a role for sos-1 in fgfr-mediated signaling during development hyperactive egl-15 fgf receptor signaling that #resulted in a clr phenotype is conferred by either an activated egl-15 or a lf clr-1 mutation .
a role for sos-1 in fgfr-mediated signaling during development hyperactive egl-15 fgf receptor signaling that #results in a clr phenotype is conferred by either an activated egl-15 or a lf clr-1 mutation .
a role for sos-1 in fgfr-mediated signaling during development hyperactive egl-15 fgf receptor signaling , conferred by either an activated egl-15 or a lf clr-1 mutation , can #result in a clr phenotype .
a role for sos-1 in fgfr-mediated signaling during development hyperactive egl-15 fgf receptor signaling , conferred by either an activated egl-15 or a lf clr-1 mutation , may have #resulted in a clr phenotype .
a role for sos-1 in fgfr-mediated signaling during development hyperactive egl-15 fgf receptor signaling , conferred by either an activated egl-15 or a lf clr-1 mutation , #resulted in a clr phenotype .
a role for sos-1 in fgfr-mediated signaling during development hyperactive egl-15 fgf receptor signaling , conferred by either an activated egl-15 or a lf clr-1 mutation , will #result in a clr phenotype .
alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation are able to #result in mrna species with distinct 5utrs .
alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation have #resulted in mrna species with distinct 5utrs .
alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation #resulted in mrna species with distinct 5utrs .
alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation will #result in mrna species with distinct 5utrs .
alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation , as our study suggested , can #result in mrna species with distinct 5utrs .
alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation , as our study suggested , may have #resulted in mrna species with distinct 5utrs .
both the 5 and 3 splice site mutations (1060 + 2t-->c and 678-7g-->a , respectively) are observed to #result in high proportions of mature mrnas containing introns , which has not been observed for other splicing mutations .
both the 5 and 3 splice site mutations (1060 + 2t-->c and 678-7g-->a , respectively) can #result in high proportions of mature mrnas containing introns , which has not been observed for other splicing mutations .
both the 5 and 3 splice site mutations (1060 + 2t-->c and 678-7g-->a , respectively) has #resulted in high proportions of mature mrnas containing introns , which has not been observed for other splicing mutations .
both the 5 and 3 splice site mutations (1060 + 2t-->c and 678-7g-->a , respectively) may have #resulted in high proportions of mature mrnas containing introns , which has not been observed for other splicing mutations .
both the 5 and 3 splice site mutations (1060 + 2t-->c and 678-7g-->a , respectively) #resulted in high proportions of mature mrnas containing introns , which has not been observed for other splicing mutations .
both the 5 and 3 splice site mutations (1060 + 2t-->c and 678-7g-->a , respectively) will #result in high proportions of mature mrnas containing introns , which has not been observed for other splicing mutations .
both the 5 and 3 splice site mutations (1060 + 2t-->c and 678-7g-->a , respectively) , in contrast , are observed to #result in high proportions of mature mrnas containing introns , which has not been observed for other splicing mutations .
both the 5 and 3 splice site mutations (1060 + 2t-->c and 678-7g-->a , respectively) , in contrast , has #resulted in high proportions of mature mrnas containing introns , which has not been observed for other splicing mutations .
both the 5 and 3 splice site mutations (1060 + 2t-->c and 678-7g-->a , respectively) , in contrast , #result in high proportions of mature mrnas containing introns , which has not been observed for other splicing mutations .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed a new mutation at codon 210 being observed to #result in the substitution of isoleucine for valine .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed a new mutation at codon 210 having #resulted in the substitution of isoleucine for valine .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed a new mutation at codon 210 having the ability to #result in the substitution of isoleucine for valine .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed a new mutation at codon 210 that has the ability to #result in the substitution of isoleucine for valine .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed a new mutation at codon 210 that is observed to #result in the substitution of isoleucine for valine .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed a new mutation at codon 210 which can #result in the substitution of isoleucine for valine .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed a new mutation at codon 210 which has #resulted in the substitution of isoleucine for valine .
human mucin gene muc5b , the 10 .7-kb large central exon encodes various alternate subdomains being observed to completely #result in a super-repeat .
human mucin gene muc5b , the 10 .7-kb large central exon encodes various alternate subdomains having completely #resulted in a super-repeat .
human mucin gene muc5b , the 10 .7-kb large central exon encodes various alternate subdomains having #resulted in a super-repeat .
human mucin gene muc5b , the 10 .7-kb large central exon encodes various alternate subdomains having the ability to completely #result in a super-repeat .
human mucin gene muc5b , the 10 .7-kb large central exon encodes various alternate subdomains having the ability to #result in a super-repeat .
human mucin gene muc5b , the 10 .7-kb large central exon encodes various alternate subdomains which are able to completely #result in a super-repeat .
human mucin gene muc5b , the 10 .7-kb large central exon encodes various alternate subdomains which are observed to completely #result in a super-repeat .
human mucin gene muc5b , the 10 .7-kb large central exon encodes various alternate subdomains which are observed to #result in a super-repeat .
human mucin gene muc5b , the 10 .7-kb large central exon encodes various alternate subdomains which can completely #result in a super-repeat .
human mucin gene muc5b , the 10 .7-kb large central exon encodes various alternate subdomains which can #result in a super-repeat .
human mucin gene muc5b , the 10 .7-kb large central exon encodes various alternate subdomains which completely #resulted in a super-repeat .
human mucin gene muc5b , the 10 .7-kb large central exon encodes various alternate subdomains which have the ability to completely #result in a super-repeat .
human mucin gene muc5b , the 10 .7-kb large central exon encodes various alternate subdomains which #resulted in a super-repeat .
human mucin gene muc5b , the 10 .7-kb large central exon encodes various alternate subdomains which will #result in a super-repeat .
induction of a mutation in the laci gene can #result in the loss of transcriptional repression of the lacz gene in mutated cells .
induction of a mutation in the laci gene could have #resulted in the loss of transcriptional repression of the lacz gene in mutated cells .
induction of a mutation in the laci gene has #resulted in the loss of transcriptional repression of the lacz gene in mutated cells .
induction of a mutation in the laci gene has the ability to #result in the loss of transcriptional repression of the lacz gene in mutated cells .
induction of a mutation in the laci gene is able to #result in the loss of transcriptional repression of the lacz gene in mutated cells .
induction of a mutation in the laci gene may have #resulted in the loss of transcriptional repression of the lacz gene in mutated cells .
induction of a mutation in the laci gene #resulted in the loss of transcriptional repression of the lacz gene in mutated cells .
induction of a mutation in the laci gene #results in the loss of transcriptional repression of the lacz gene in mutated cells .
induction of a mutation in the laci gene will #result in the loss of transcriptional repression of the lacz gene in mutated cells .
induction of a mutation in the laci gene , as our study revealed , is able to #result in the loss of transcriptional repression of the lacz gene in mutated cells .
induction of a mutation in the laci gene , as our study revealed , is observed to #result in the loss of transcriptional repression of the lacz gene in mutated cells .
induction of a mutation in the laci gene , as our study revealed , may have #resulted in the loss of transcriptional repression of the lacz gene in mutated cells .
induction of a mutation in the laci gene , as our study revealed , may #result in the loss of transcriptional repression of the lacz gene in mutated cells .
mutations being able to #result in simultaneous derepression of both genes can prevent repressor binding to either site or alter the phasing of the binding sites .
mutations being observed to #result in simultaneous derepression of both genes can prevent repressor binding to either site or alter the phasing of the binding sites .
mutations having #resulted in simultaneous derepression of both genes can prevent repressor binding to either site or alter the phasing of the binding sites .
mutations #resulting in simultaneous derepression of both genes can prevent repressor binding to either site or alter the phasing of the binding sites .
mutations that are able to #result in simultaneous derepression of both genes can prevent repressor binding to either site or alter the phasing of the binding sites .
mutations that may have #resulted in simultaneous derepression of both genes can prevent repressor binding to either site or alter the phasing of the binding sites .
mutations that may #result in simultaneous derepression of both genes can prevent repressor binding to either site or alter the phasing of the binding sites .
mutations that #result in simultaneous derepression of both genes can prevent repressor binding to either site or alter the phasing of the binding sites .
mutations that #resulted in simultaneous derepression of both genes can prevent repressor binding to either site or alter the phasing of the binding sites .
mutations which prevent repressor binding to either site or alter the phasing of the binding sites have the ability to #result in simultaneous derepression of both genes .
mutations which prevent repressor binding to either site or alter the phasing of the binding sites #resulted in simultaneous derepression of both genes .
sequence analysis of the idhbeta gene indicates that the difference in the c-terminal 28 amino acids between beta(1) and beta(2) proteins can #resulted from alternative splicing of a single transcript .
sequence analysis of the idhbeta gene indicates that the difference in the c-terminal 28 amino acids between beta(1) and beta(2) proteins has been shown to #result from alternative splicing of a single transcript .
sequence analysis of the idhbeta gene indicates that the difference in the c-terminal 28 amino acids between beta(1) and beta(2) proteins has #resulted from alternative splicing of a single transcript .
sequence analysis of the idhbeta gene indicates that the difference in the c-terminal 28 amino acids between beta(1) and beta(2) proteins has the ability to #result from alternative splicing of a single transcript .
sequence analysis of the idhbeta gene indicates that the difference in the c-terminal 28 amino acids between beta(1) and beta(2) proteins may have #resulted from alternative splicing of a single transcript .
sequence analysis of the idhbeta gene indicates that the difference in the c-terminal 28 amino acids between beta(1) and beta(2) proteins #resulted from alternative splicing of a single transcript .
the change may cause the heat instability and affect the net charge of the variant subunit being able to #result in an electrophoretic ldh-b subunit variant of the fast type .
the change may cause the heat instability and affect the net charge of the variant subunit being observed to finally #result in an electrophoretic ldh-b subunit variant of the fast type .
the change may cause the heat instability and affect the net charge of the variant subunit being shown to finally #result in an electrophoretic ldh-b subunit variant of the fast type .
the change may cause the heat instability and affect the net charge of the variant subunit having #resulted in an electrophoretic ldh-b subunit variant of the fast type .
the change may cause the heat instability and affect the net charge of the variant subunit that will finally #result in an electrophoretic ldh-b subunit variant of the fast type .
the change may cause the heat instability and affect the net charge of the variant subunit which can finally #result in an electrophoretic ldh-b subunit variant of the fast type .
the change may cause the heat instability and affect the net charge of the variant subunit which finally #resulted in an electrophoretic ldh-b subunit variant of the fast type .
the change may cause the heat instability and affect the net charge of the variant subunit which finally #results in an electrophoretic ldh-b subunit variant of the fast type .
the change may cause the heat instability and affect the net charge of the variant subunit which has been shown to finally #result in an electrophoretic ldh-b subunit variant of the fast type .
the change may cause the heat instability and affect the net charge of the variant subunit which is able to finally #result in an electrophoretic ldh-b subunit variant of the fast type .
the change may cause the heat instability and affect the net charge of the variant subunit which may have finally #resulted in an electrophoretic ldh-b subunit variant of the fast type .
two are missense mutations in exon 2 (g339d and r340c) , and the other three alterations (a nonsense mutation , a frameshift , and a splicing mutation) have been shown to #result in truncated nonfunctional proteins .
two are missense mutations in exon 2 (g339d and r340c) , and the other three alterations (a nonsense mutation , a frameshift , and a splicing mutation) have the ability to #result in truncated nonfunctional proteins .
two are missense mutations in exon 2 (g339d and r340c) , and the other three alterations (a nonsense mutation , a frameshift , and a splicing mutation) have the probability of #resulting in truncated nonfunctional proteins .
two are missense mutations in exon 2 (g339d and r340c) , and the other three alterations (a nonsense mutation , a frameshift , and a splicing mutation) may have #resulted in truncated nonfunctional proteins .
two are missense mutations in exon 2 (g339d and r340c) , and the other three alterations (a nonsense mutation , a frameshift , and a splicing mutation) may #result in truncated nonfunctional proteins .
two are missense mutations in exon 2 (g339d and r340c) , and the other three alterations (a nonsense mutation , a frameshift , and a splicing mutation) #resulted in truncated nonfunctional proteins .
two are missense mutations in exon 2 (g339d and r340c) , and the other three alterations (a nonsense mutation , a frameshift , and a splicing mutation) will #result in truncated nonfunctional proteins .
we show that the negative effect of the cpxa mutation on biofilm formation can #result from a decreased transcription of the curlin encoding csga gene .
we show that the negative effect of the cpxa mutation on biofilm formation is able to #result from a decreased transcription of the curlin encoding csga gene .
we show that the negative effect of the cpxa mutation on biofilm formation may #result from a decreased transcription of the curlin encoding csga gene .
we show that the negative effect of the cpxa mutation on biofilm formation #results from a decreased transcription of the curlin encoding csga gene .
we speculated that this is observed to be the #result of the expression of isoforms of nrf1 in mast cells .
we speculated that this is the #result of the expression of isoforms of nrf1 in mast cells .
a role for sos-1 in fgfr-mediated signaling during development hyperactive egl-15 fgf receptor signaling , conferred by either an activated egl-15 or a lf clr-1 mutation , #results in a clr phenotype .
these observations show that repression is the #result of co-operative binding of the repressor to its two sites , #resulting in the formation of a loop of dna .
both the 5 and 3 splice site mutations (1060 + 2t-->c and 678-7g-->a , respectively) #result in high proportions of mature mrnas containing introns , which has not been observed for other splicing mutations .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed a new mutation at codon 210 #resulting in the substitution of isoleucine for valine .
human mucin gene muc5b , the 10 .7-kb large central exon encodes various alternate subdomains #resulting in a super-repeat .
sequence analysis of the idhbeta gene indicates that the difference in the c-terminal 28 amino acids between beta(1) and beta(2) proteins #results from alternative splicing of a single transcript .
two are missense mutations in exon 2 (g339d and r340c) , and the other three alterations (a nonsense mutation , a frameshift , and a splicing mutation) are likely to #result in truncated nonfunctional proteins .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed of the expression of isoforms of nrf1 being able to #result in this .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed of the expression of isoforms of nrf1 being observed to #result in this .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed of the expression of isoforms of nrf1 having the ability to #result in this .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed of the expression of isoforms of nrf1 #resulting in this .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed of the expression of isoforms of nrf1 that has the ability to #result in this .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed of the expression of isoforms of nrf1 that is observed to #result in this .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed of the expression of isoforms of nrf1 that may have #resulted in this .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed of the expression of isoforms of nrf1 which has #resulted in this .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed of the expression of isoforms of nrf1 which will #result in this .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed the expression of isoforms of nrf1 being able to #result in this .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed the expression of isoforms of nrf1 being observed to #result in this .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed the expression of isoforms of nrf1 having the ability to #result in this .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed the expression of isoforms of nrf1 that is able to #result in this .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed the expression of isoforms of nrf1 that may have #resulted in this .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed the expression of isoforms of nrf1 which has #resulted in this .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed the net charge of the variant subunit being able to #result in an electrophoretic ldh-b subunit variant of the fast type .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed the net charge of the variant subunit being observed to #result in an electrophoretic ldh-b subunit variant of the fast type .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed the net charge of the variant subunit having the ability to #result in an electrophoretic ldh-b subunit variant of the fast type .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed the net charge of the variant subunit #resulting in an electrophoretic ldh-b subunit variant of the fast type .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed the net charge of the variant subunit that may have #resulted in an electrophoretic ldh-b subunit variant of the fast type .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed the net charge of the variant subunit that #resulted in an electrophoretic ldh-b subunit variant of the fast type .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed the net charge of the variant subunit which has #resulted in an electrophoretic ldh-b subunit variant of the fast type .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed the net charge of the variant subunit which will #result in an electrophoretic ldh-b subunit variant of the fast type .
the change may cause the heat instability and affect a new mutation at codon 210 being able to finally #result in the substitution of isoleucine for valine .
the change may cause the heat instability and affect a new mutation at codon 210 having finally #resulted in the substitution of isoleucine for valine .
the change may cause the heat instability and affect a new mutation at codon 210 having #resulted in the substitution of isoleucine for valine .
the change may cause the heat instability and affect a new mutation at codon 210 that has finally #resulted in the substitution of isoleucine for valine .
the change may cause the heat instability and affect a new mutation at codon 210 that has #resulted in the substitution of isoleucine for valine .
the change may cause the heat instability and affect a new mutation at codon 210 which finally #resulted in the substitution of isoleucine for valine .
the change may cause the heat instability and affect a new mutation at codon 210 which has been shown to #result in the substitution of isoleucine for valine .
the change may cause the heat instability and affect a new mutation at codon 210 which is able to finally #result in the substitution of isoleucine for valine .
the change may cause the heat instability and affect a new mutation at codon 210 which may have finally #resulted in the substitution of isoleucine for valine .
the change may cause the heat instability and affect a new mutation at codon 210 which may have #resulted in the substitution of isoleucine for valine .
the change may cause the heat instability and affect a new mutation at codon 210 which #resulted in the substitution of isoleucine for valine .
the change may cause the heat instability and affect a new mutation at codon 210 which #results in the substitution of isoleucine for valine .
the change may cause the heat instability and affect a new mutation at codon 210 , #resulting in the substitution of isoleucine for valine .
the change may cause the heat instability and affect of the expression of isoforms of nrf1 being observed to #result in this .
the change may cause the heat instability and affect of the expression of isoforms of nrf1 being shown to #result in this .
the change may cause the heat instability and affect of the expression of isoforms of nrf1 having finally #resulted in this .
the change may cause the heat instability and affect of the expression of isoforms of nrf1 that has finally #resulted in this .
the change may cause the heat instability and affect of the expression of isoforms of nrf1 that will finally #result in this .
the change may cause the heat instability and affect of the expression of isoforms of nrf1 that will #result in this .
the change may cause the heat instability and affect of the expression of isoforms of nrf1 which can #result in this .
the change may cause the heat instability and affect of the expression of isoforms of nrf1 which has been shown to finally #result in this .
the change may cause the heat instability and affect of the expression of isoforms of nrf1 which is able to finally #result in this .
the change may cause the heat instability and affect of the expression of isoforms of nrf1 which may have #resulted in this .
the change may cause the heat instability and affect of the expression of isoforms of nrf1 which #results in this .
the change may cause the heat instability and affect of the expression of isoforms of nrf1 , #resulting in this .
the change may cause the heat instability and affect the expression of isoforms of nrf1 being able to #result in this .
the change may cause the heat instability and affect the expression of isoforms of nrf1 being observed to finally #result in this .
the change may cause the heat instability and affect the expression of isoforms of nrf1 being observed to #result in this .
the change may cause the heat instability and affect the expression of isoforms of nrf1 being shown to finally #result in this .
the change may cause the heat instability and affect the expression of isoforms of nrf1 being shown to #result in this .
the change may cause the heat instability and affect the expression of isoforms of nrf1 having finally #resulted in this .
the change may cause the heat instability and affect the expression of isoforms of nrf1 which can finally #result in this .
the change may cause the heat instability and affect the expression of isoforms of nrf1 which finally #resulted in this .
the change may cause the heat instability and affect the expression of isoforms of nrf1 which is able to #result in this .
the change may cause the heat instability and affect the expression of isoforms of nrf1 which is observed to finally #result in this .
the change may cause the heat instability and affect the expression of isoforms of nrf1 which is observed to #result in this .
the change may cause the heat instability and affect the expression of isoforms of nrf1 which #resulted in this .
we speculated that an electrophoretic ldh-b subunit variant of the fast type is observed to be the #result of the net charge of the variant subunit in mast cells .
we speculated that an electrophoretic ldh-b subunit variant of the fast type may be the #result of the net charge of the variant subunit in mast cells .
we speculated that the substitution of isoleucine for valine has been shown to be the #result of a new mutation at codon 210 in mast cells .
we speculated that the substitution of isoleucine for valine is the #result of a new mutation at codon 210 in mast cells .
we speculated that the substitution of isoleucine for valine may be the #result a new mutation at codon 210 in mast cells .
a new mutation at codon 210 are able to #result in the substitution of isoleucine for valine .
a new mutation at codon 210 are observed to #result in the substitution of isoleucine for valine .
a new mutation at codon 210 can finally #result in the substitution of isoleucine for valine
a new mutation at codon 210 finally #result in the substitution of isoleucine for valine .
a new mutation at codon 210 has #resulted in the substitution of isoleucine for valine .
a new mutation at codon 210 have the ability to #result in the substitution of isoleucine for valine .
a new mutation at codon 210 may #result in the substitution of isoleucine for valine .
a new mutation at codon 210 #result in the substitution of isoleucine for valine .
of the expression of isoforms of nrf1 are able to finally #result in this .
of the expression of isoforms of nrf1 are able to #result in this .
of the expression of isoforms of nrf1 are observed to finally #result in this .
of the expression of isoforms of nrf1 are observed to #result in this .
of the expression of isoforms of nrf1 finally #result in this .
of the expression of isoforms of nrf1 has #resulted in this .
of the expression of isoforms of nrf1 may have #resulted in this .
of the expression of isoforms of nrf1 may #result in this .
of the expression of isoforms of nrf1 #result in this .
of the expression of isoforms of nrf1 #resulted in this .
of the expression of isoforms of nrf1 will #result in this .
the expression of isoforms of nrf1 are able to finally #result in this .
the expression of isoforms of nrf1 are able to #result in this .
the expression of isoforms of nrf1 finally #result in this .
the expression of isoforms of nrf1 has finally #resulted in this .
the expression of isoforms of nrf1 has #resulted in this .
the expression of isoforms of nrf1 have the ability to finally #result in this .
the expression of isoforms of nrf1 have the ability to #result in this .
the expression of isoforms of nrf1 may #result in this .
the expression of isoforms of nrf1 #result in this .
the expression of isoforms of nrf1 #resulted in this .
the expression of isoforms of nrf1 will finally #result in this .
the expression of isoforms of nrf1 will #result in this .
the net charge of the variant subunit are able to #result in an electrophoretic ldh-b subunit variant of the fast type .
the net charge of the variant subunit can finally #result in an electrophoretic ldh-b subunit variant of the fast type
the net charge of the variant subunit finally #result in an electrophoretic ldh-b subunit variant of the fast type .
the net charge of the variant subunit has finally #resulted in an electrophoretic ldh-b subunit variant of the fast type .
the net charge of the variant subunit has #resulted in an electrophoretic ldh-b subunit variant of the fast type .
the net charge of the variant subunit have the ability to finally #result in an electrophoretic ldh-b subunit variant of the fast type .
the net charge of the variant subunit have the ability to #result in an electrophoretic ldh-b subunit variant of the fast type .
the net charge of the variant subunit may have finally #resulted in an electrophoretic ldh-b subunit variant of the fast type .
the net charge of the variant subunit may have #resulted in an electrophoretic ldh-b subunit variant of the fast type .
the net charge of the variant subunit #result in an electrophoretic ldh-b subunit variant of the fast type .
the net charge of the variant subunit #resulted in an electrophoretic ldh-b subunit variant of the fast type .
the net charge of the variant subunit will finally #result in an electrophoretic ldh-b subunit variant of the fast type .
the net charge of the variant subunit will #result in an electrophoretic ldh-b subunit variant of the fast type .
a role for sos-1 in fgfr-mediated signaling during development hyperactive egl-15 fgf receptor signaling are able to #result in a clr phenotype .
a role for sos-1 in fgfr-mediated signaling during development hyperactive egl-15 fgf receptor signaling can finally #result in a clr phenotype
a role for sos-1 in fgfr-mediated signaling during development hyperactive egl-15 fgf receptor signaling can #result in a clr phenotype
a role for sos-1 in fgfr-mediated signaling during development hyperactive egl-15 fgf receptor signaling has finally #resulted in a clr phenotype .
a role for sos-1 in fgfr-mediated signaling during development hyperactive egl-15 fgf receptor signaling have the ability to finally #result in a clr phenotype .
a role for sos-1 in fgfr-mediated signaling during development hyperactive egl-15 fgf receptor signaling have the ability to #result in a clr phenotype .
a role for sos-1 in fgfr-mediated signaling during development hyperactive egl-15 fgf receptor signaling may finally #result in a clr phenotype .
a role for sos-1 in fgfr-mediated signaling during development hyperactive egl-15 fgf receptor signaling may have finally #resulted in a clr phenotype .
a role for sos-1 in fgfr-mediated signaling during development hyperactive egl-15 fgf receptor signaling may #result in a clr phenotype .
a role for sos-1 in fgfr-mediated signaling during development hyperactive egl-15 fgf receptor signaling #result in a clr phenotype .
a role for sos-1 in fgfr-mediated signaling during development hyperactive egl-15 fgf receptor signaling #resulted in a clr phenotype .
a role for sos-1 in fgfr-mediated signaling during development hyperactive egl-15 fgf receptor signaling will finally #result in a clr phenotype .
alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation may #result in mrna species with distinct 5utrs .
alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation will finally #result in mrna species with distinct 5utrs .
alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation , as our study suggested , are able to finally #result in mrna species with distinct 5utrs .
alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation , as our study suggested , are observed to finally #result in mrna species with distinct 5utrs .
alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation , as our study suggested , can finally #result in mrna species with distinct 5utrs
alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation , as our study suggested , can #result in mrna species with distinct 5utrs
alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation , as our study suggested , finally #result in mrna species with distinct 5utrs .
alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation , as our study suggested , has finally #resulted in mrna species with distinct 5utrs .
alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation , as our study suggested , may finally #result in mrna species with distinct 5utrs .
alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation , as our study suggested , may have finally #resulted in mrna species with distinct 5utrs .
alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation , as our study suggested , may #result in mrna species with distinct 5utrs .
alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation , as our study suggested , will finally #result in mrna species with distinct 5utrs .
both the 5 and 3 splice site mutations are able to finally #result in high proportions of mature mrnas containing introns .
both the 5 and 3 splice site mutations are observed to #result in high proportions of mature mrnas containing introns .
both the 5 and 3 splice site mutations can #result in high proportions of mature mrnas containing introns
both the 5 and 3 splice site mutations have the ability to #result in high proportions of mature mrnas containing introns .
both the 5 and 3 splice site mutations may have #resulted in high proportions of mature mrnas containing introns .
both the 5 and 3 splice site mutations may #result in high proportions of mature mrnas containing introns .
both the 5 and 3 splice site mutations #resulted in high proportions of mature mrnas containing introns .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed a role for sos-1 in fgfr-mediated signaling during development hyperactive egl-15 fgf receptor signaling being observed to #result in a clr phenotype .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed a role for sos-1 in fgfr-mediated signaling during development hyperactive egl-15 fgf receptor signaling having the ability to #result in a clr phenotype .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed a role for sos-1 in fgfr-mediated signaling during development hyperactive egl-15 fgf receptor signaling #resulting in a clr phenotype .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed a role for sos-1 in fgfr-mediated signaling during development hyperactive egl-15 fgf receptor signaling that has the ability to #result in a clr phenotype .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation being able to #result in mrna species with distinct 5utrs .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation having the ability to #result in mrna species with distinct 5utrs .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation #resulting in mrna species with distinct 5utrs .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation that is able to #result in mrna species with distinct 5utrs .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation that is observed to #result in mrna species with distinct 5utrs .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation that #resulted in mrna species with distinct 5utrs .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation which can #result in mrna species with distinct 5utrs .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation which will #result in mrna species with distinct 5utrs .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation , as our study suggested , having #resulted in mrna species with distinct 5utrs .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation , as our study suggested , having the ability to #result in mrna species with distinct 5utrs .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation , as our study suggested , that has the ability to #result in mrna species with distinct 5utrs .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation , as our study suggested , that is able to #result in mrna species with distinct 5utrs .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation , as our study suggested , that is observed to #result in mrna species with distinct 5utrs .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation , as our study suggested , that #resulted in mrna species with distinct 5utrs .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation , as our study suggested , which can #result in mrna species with distinct 5utrs .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation , as our study suggested , which has #resulted in mrna species with distinct 5utrs .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation , as our study suggested , which will #result in mrna species with distinct 5utrs .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed both the 5 and 3 splice site mutations being able to #result in high proportions of mature mrnas containing introns .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed both the 5 and 3 splice site mutations being observed to #result in high proportions of mature mrnas containing introns .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed both the 5 and 3 splice site mutations having #resulted in high proportions of mature mrnas containing introns .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed both the 5 and 3 splice site mutations #resulting in high proportions of mature mrnas containing introns .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed both the 5 and 3 splice site mutations that has the ability to #result in high proportions of mature mrnas containing introns .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed both the 5 and 3 splice site mutations that is observed to #result in high proportions of mature mrnas containing introns .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed both the 5 and 3 splice site mutations which has #resulted in high proportions of mature mrnas containing introns .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed both the 5 and 3 splice site mutations which #results in high proportions of mature mrnas containing introns .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed a decreased transcription of the curlin encoding csga gene being able to #result in the negative effect of the cpxa mutation .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed a decreased transcription of the curlin encoding csga gene that has the ability to #result in the negative effect of the cpxa mutation .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed a decreased transcription of the curlin encoding csga gene that is able to #result in the negative effect of the cpxa mutation .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed a decreased transcription of the curlin encoding csga gene that is observed to #result in the negative effect of the cpxa mutation .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed a decreased transcription of the curlin encoding csga gene that #resulted in the negative effect of the cpxa mutation .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed a decreased transcription of the curlin encoding csga gene which will #result in the negative effect of the cpxa mutation .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed alternative splicing of a single transcript being able to #result in the difference in the c-terminal 28 amino acids between beta(1) and beta(2) proteins .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed alternative splicing of a single transcript being observed to #result in the difference in the c-terminal 28 amino acids between beta(1) and beta(2) proteins .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed alternative splicing of a single transcript having #resulted in the difference in the c-terminal 28 amino acids between beta(1) and beta(2) proteins .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed alternative splicing of a single transcript that is able to #result in the difference in the c-terminal 28 amino acids between beta(1) and beta(2) proteins .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed alternative splicing of a single transcript that may have #resulted in the difference in the c-terminal 28 amino acids between beta(1) and beta(2) proteins .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed alternative splicing of a single transcript which has #resulted in the difference in the c-terminal 28 amino acids between beta(1) and beta(2) proteins .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed alternative splicing of a single transcript which #results in the difference in the c-terminal 28 amino acids between beta(1) and beta(2) proteins .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed of co-operative binding of the repressor being able to #result in that repression .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed of co-operative binding of the repressor being observed to #result in that repression .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed of co-operative binding of the repressor having the ability to #result in that repression .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed of co-operative binding of the repressor which has #resulted in that repression .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed of co-operative binding of the repressor which will #result in that repression .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed the other three alterations being able to #result in truncated nonfunctional proteins .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed the other three alterations having #resulted in truncated nonfunctional proteins .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed the other three alterations that has the ability to #result in truncated nonfunctional proteins .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed the other three alterations that is able to #result in truncated nonfunctional proteins .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed the other three alterations that is observed to #result in truncated nonfunctional proteins .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed the other three alterations which can #result in truncated nonfunctional proteins .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed the other three alterations which has #resulted in truncated nonfunctional proteins .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed the other three alterations which #results in truncated nonfunctional proteins .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed various alternate subdomains being able to #result in a super-repeat .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed various alternate subdomains being observed to #result in a super-repeat .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed various alternate subdomains having #resulted in a super-repeat .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed various alternate subdomains having the ability to #result in a super-repeat .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed various alternate subdomains #resulting in a super-repeat .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed various alternate subdomains that has the ability to #result in a super-repeat .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed various alternate subdomains that is able to #result in a super-repeat .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed various alternate subdomains that may have #resulted in a super-repeat .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed various alternate subdomains which has #resulted in a super-repeat .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed various alternate subdomains which #results in a super-repeat .
the change may cause the heat instability and affect a role for sos-1 in fgfr-mediated signaling during development hyperactive egl-15 fgf receptor signaling being able to finally #result in a clr phenotype .
the change may cause the heat instability and affect a role for sos-1 in fgfr-mediated signaling during development hyperactive egl-15 fgf receptor signaling being shown to finally #result in a clr phenotype .
the change may cause the heat instability and affect a role for sos-1 in fgfr-mediated signaling during development hyperactive egl-15 fgf receptor signaling being shown to #result in a clr phenotype .
the change may cause the heat instability and affect a role for sos-1 in fgfr-mediated signaling during development hyperactive egl-15 fgf receptor signaling having finally #resulted in a clr phenotype .
the change may cause the heat instability and affect a role for sos-1 in fgfr-mediated signaling during development hyperactive egl-15 fgf receptor signaling having #resulted in a clr phenotype .
the change may cause the heat instability and affect a role for sos-1 in fgfr-mediated signaling during development hyperactive egl-15 fgf receptor signaling that will finally #result in a clr phenotype .
the change may cause the heat instability and affect a role for sos-1 in fgfr-mediated signaling during development hyperactive egl-15 fgf receptor signaling that will #result in a clr phenotype .
the change may cause the heat instability and affect a role for sos-1 in fgfr-mediated signaling during development hyperactive egl-15 fgf receptor signaling which can #result in a clr phenotype .
the change may cause the heat instability and affect a role for sos-1 in fgfr-mediated signaling during development hyperactive egl-15 fgf receptor signaling which finally #resulted in a clr phenotype .
the change may cause the heat instability and affect a role for sos-1 in fgfr-mediated signaling during development hyperactive egl-15 fgf receptor signaling which has been shown to finally #result in a clr phenotype .
the change may cause the heat instability and affect a role for sos-1 in fgfr-mediated signaling during development hyperactive egl-15 fgf receptor signaling which is able to #result in a clr phenotype .
the change may cause the heat instability and affect a role for sos-1 in fgfr-mediated signaling during development hyperactive egl-15 fgf receptor signaling which is observed to finally #result in a clr phenotype .
the change may cause the heat instability and affect a role for sos-1 in fgfr-mediated signaling during development hyperactive egl-15 fgf receptor signaling which may have #resulted in a clr phenotype .
the change may cause the heat instability and affect a role for sos-1 in fgfr-mediated signaling during development hyperactive egl-15 fgf receptor signaling which #resulted in a clr phenotype .
the change may cause the heat instability and affect a role for sos-1 in fgfr-mediated signaling during development hyperactive egl-15 fgf receptor signaling , #resulting in a clr phenotype .
the change may cause the heat instability and affect alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation being shown to #result in mrna species with distinct 5utrs .
the change may cause the heat instability and affect alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation having #resulted in mrna species with distinct 5utrs .
the change may cause the heat instability and affect alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation that has #resulted in mrna species with distinct 5utrs .
the change may cause the heat instability and affect alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation that will #result in mrna species with distinct 5utrs .
the change may cause the heat instability and affect alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation which can finally #result in mrna species with distinct 5utrs .
the change may cause the heat instability and affect alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation which can #result in mrna species with distinct 5utrs .
the change may cause the heat instability and affect alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation which finally #resulted in mrna species with distinct 5utrs .
the change may cause the heat instability and affect alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation which has been shown to finally #result in mrna species with distinct 5utrs .
the change may cause the heat instability and affect alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation which has been shown to #result in mrna species with distinct 5utrs .
the change may cause the heat instability and affect alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation which is able to finally #result in mrna species with distinct 5utrs .
the change may cause the heat instability and affect alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation which is observed to #result in mrna species with distinct 5utrs .
the change may cause the heat instability and affect alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation which may have #resulted in mrna species with distinct 5utrs .
the change may cause the heat instability and affect alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation , as our study suggested , being observed to #result in mrna species with distinct 5utrs .
the change may cause the heat instability and affect alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation , as our study suggested , being shown to finally #result in mrna species with distinct 5utrs .
the change may cause the heat instability and affect alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation , as our study suggested , having finally #resulted in mrna species with distinct 5utrs .
the change may cause the heat instability and affect alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation , as our study suggested , having #resulted in mrna species with distinct 5utrs .
the change may cause the heat instability and affect alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation , as our study suggested , that has finally #resulted in mrna species with distinct 5utrs .
the change may cause the heat instability and affect alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation , as our study suggested , that will #result in mrna species with distinct 5utrs .
the change may cause the heat instability and affect alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation , as our study suggested , which can finally #result in mrna species with distinct 5utrs .
the change may cause the heat instability and affect alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation , as our study suggested , which finally #results in mrna species with distinct 5utrs .
the change may cause the heat instability and affect alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation , as our study suggested , which is able to finally #result in mrna species with distinct 5utrs .
the change may cause the heat instability and affect alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation , as our study suggested , which is able to #result in mrna species with distinct 5utrs .
the change may cause the heat instability and affect alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation , as our study suggested , which is observed to finally #result in mrna species with distinct 5utrs .
the change may cause the heat instability and affect alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation , as our study suggested , which is observed to #result in mrna species with distinct 5utrs .
the change may cause the heat instability and affect alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation , as our study suggested , which may have #resulted in mrna species with distinct 5utrs .
the change may cause the heat instability and affect alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation , as our study suggested , which #resulted in mrna species with distinct 5utrs .
the change may cause the heat instability and affect alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation , as our study suggested , which #results in mrna species with distinct 5utrs .
the change may cause the heat instability and affect alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation , #resulting in mrna species with distinct 5utrs .
the change may cause the heat instability and affect both the 5 and 3 splice site mutations being able to #result in high proportions of mature mrnas containing introns .
the change may cause the heat instability and affect both the 5 and 3 splice site mutations being observed to #result in high proportions of mature mrnas containing introns .
the change may cause the heat instability and affect both the 5 and 3 splice site mutations being shown to #result in high proportions of mature mrnas containing introns .
the change may cause the heat instability and affect both the 5 and 3 splice site mutations having finally #resulted in high proportions of mature mrnas containing introns .
the change may cause the heat instability and affect both the 5 and 3 splice site mutations that has finally #resulted in high proportions of mature mrnas containing introns .
the change may cause the heat instability and affect both the 5 and 3 splice site mutations that will finally #result in high proportions of mature mrnas containing introns .
the change may cause the heat instability and affect both the 5 and 3 splice site mutations which can finally #result in high proportions of mature mrnas containing introns .
the change may cause the heat instability and affect both the 5 and 3 splice site mutations which can #result in high proportions of mature mrnas containing introns .
the change may cause the heat instability and affect both the 5 and 3 splice site mutations which finally #resulted in high proportions of mature mrnas containing introns .
the change may cause the heat instability and affect both the 5 and 3 splice site mutations which finally #results in high proportions of mature mrnas containing introns .
the change may cause the heat instability and affect both the 5 and 3 splice site mutations which is able to #result in high proportions of mature mrnas containing introns .
the change may cause the heat instability and affect both the 5 and 3 splice site mutations which is observed to #result in high proportions of mature mrnas containing introns .
the change may cause the heat instability and affect both the 5 and 3 splice site mutations which may have finally #resulted in high proportions of mature mrnas containing introns .
the change may cause the heat instability and affect both the 5 and 3 splice site mutations , #resulting in high proportions of mature mrnas containing introns .
the change may cause the heat instability and affect a decreased transcription of the curlin encoding csga gene being observed to #result in the negative effect of the cpxa mutation .
the change may cause the heat instability and affect a decreased transcription of the curlin encoding csga gene having #resulted in the negative effect of the cpxa mutation .
the change may cause the heat instability and affect a decreased transcription of the curlin encoding csga gene that will finally #result in the negative effect of the cpxa mutation .
the change may cause the heat instability and affect a decreased transcription of the curlin encoding csga gene that will #result in the negative effect of the cpxa mutation .
the change may cause the heat instability and affect a decreased transcription of the curlin encoding csga gene which can #result in the negative effect of the cpxa mutation .
the change may cause the heat instability and affect a decreased transcription of the curlin encoding csga gene which is able to finally #result in the negative effect of the cpxa mutation .
the change may cause the heat instability and affect a decreased transcription of the curlin encoding csga gene which is able to #result in the negative effect of the cpxa mutation .
the change may cause the heat instability and affect a decreased transcription of the curlin encoding csga gene which may have #resulted in the negative effect of the cpxa mutation .
the change may cause the heat instability and affect a decreased transcription of the curlin encoding csga gene which #resulted in the negative effect of the cpxa mutation .
the change may cause the heat instability and affect a decreased transcription of the curlin encoding csga gene which #results in the negative effect of the cpxa mutation .
the change may cause the heat instability and affect a decreased transcription of the curlin encoding csga gene , #resulting in the negative effect of the cpxa mutation .
the change may cause the heat instability and affect alternative splicing of a single transcript being able to #result in the difference in the c-terminal 28 amino acids between beta(1) and beta(2) proteins .
the change may cause the heat instability and affect alternative splicing of a single transcript being shown to #result in the difference in the c-terminal 28 amino acids between beta(1) and beta(2) proteins .
the change may cause the heat instability and affect alternative splicing of a single transcript having finally #resulted in the difference in the c-terminal 28 amino acids between beta(1) and beta(2) proteins .
the change may cause the heat instability and affect alternative splicing of a single transcript having #resulted in the difference in the c-terminal 28 amino acids between beta(1) and beta(2) proteins .
the change may cause the heat instability and affect alternative splicing of a single transcript that will finally #result in the difference in the c-terminal 28 amino acids between beta(1) and beta(2) proteins .
the change may cause the heat instability and affect alternative splicing of a single transcript that will #result in the difference in the c-terminal 28 amino acids between beta(1) and beta(2) proteins .
the change may cause the heat instability and affect alternative splicing of a single transcript which can #result in the difference in the c-terminal 28 amino acids between beta(1) and beta(2) proteins .
the change may cause the heat instability and affect alternative splicing of a single transcript which finally #resulted in the difference in the c-terminal 28 amino acids between beta(1) and beta(2) proteins .
the change may cause the heat instability and affect alternative splicing of a single transcript which has been shown to #result in the difference in the c-terminal 28 amino acids between beta(1) and beta(2) proteins .
the change may cause the heat instability and affect alternative splicing of a single transcript which is able to finally #result in the difference in the c-terminal 28 amino acids between beta(1) and beta(2) proteins .
the change may cause the heat instability and affect alternative splicing of a single transcript which may have #resulted in the difference in the c-terminal 28 amino acids between beta(1) and beta(2) proteins .
the change may cause the heat instability and affect alternative splicing of a single transcript which #resulted in the difference in the c-terminal 28 amino acids between beta(1) and beta(2) proteins .
the change may cause the heat instability and affect of co-operative binding of the repressor being able to finally #result in that repression .
the change may cause the heat instability and affect of co-operative binding of the repressor that has #resulted in that repression .
the change may cause the heat instability and affect of co-operative binding of the repressor which can #result in that repression .
the change may cause the heat instability and affect of co-operative binding of the repressor which finally #resulted in that repression .
the change may cause the heat instability and affect of co-operative binding of the repressor which finally #results in that repression .
the change may cause the heat instability and affect of co-operative binding of the repressor which has been shown to finally #result in that repression .
the change may cause the heat instability and affect of co-operative binding of the repressor which is able to finally #result in that repression .
the change may cause the heat instability and affect of co-operative binding of the repressor which is observed to finally #result in that repression .
the change may cause the heat instability and affect of co-operative binding of the repressor which may have finally #resulted in that repression .
the change may cause the heat instability and affect of co-operative binding of the repressor which may have #resulted in that repression .
the change may cause the heat instability and affect the other three alterations being able to finally #result in truncated nonfunctional proteins .
the change may cause the heat instability and affect the other three alterations being able to #result in truncated nonfunctional proteins .
the change may cause the heat instability and affect the other three alterations being observed to #result in truncated nonfunctional proteins .
the change may cause the heat instability and affect the other three alterations being shown to #result in truncated nonfunctional proteins .
the change may cause the heat instability and affect the other three alterations that has #resulted in truncated nonfunctional proteins .
the change may cause the heat instability and affect the other three alterations that will finally #result in truncated nonfunctional proteins .
the change may cause the heat instability and affect the other three alterations which can finally #result in truncated nonfunctional proteins .
the change may cause the heat instability and affect the other three alterations which can #result in truncated nonfunctional proteins .
the change may cause the heat instability and affect the other three alterations which has been shown to #result in truncated nonfunctional proteins .
the change may cause the heat instability and affect the other three alterations which is observed to finally #result in truncated nonfunctional proteins .
the change may cause the heat instability and affect the other three alterations which is observed to #result in truncated nonfunctional proteins .
the change may cause the heat instability and affect the other three alterations which may have #resulted in truncated nonfunctional proteins .
the change may cause the heat instability and affect the other three alterations which #results in truncated nonfunctional proteins .
the change may cause the heat instability and affect the other three alterations , #resulting in truncated nonfunctional proteins .
the change may cause the heat instability and affect various alternate subdomains being able to #result in a super-repeat .
the change may cause the heat instability and affect various alternate subdomains being observed to #result in a super-repeat .
the change may cause the heat instability and affect various alternate subdomains being shown to #result in a super-repeat .
the change may cause the heat instability and affect various alternate subdomains having finally #resulted in a super-repeat .
the change may cause the heat instability and affect various alternate subdomains having #resulted in a super-repeat .
the change may cause the heat instability and affect various alternate subdomains that has finally #resulted in a super-repeat .
the change may cause the heat instability and affect various alternate subdomains that has #resulted in a super-repeat .
the change may cause the heat instability and affect various alternate subdomains that will finally #result in a super-repeat .
the change may cause the heat instability and affect various alternate subdomains which finally #results in a super-repeat .
the change may cause the heat instability and affect various alternate subdomains which is able to finally #result in a super-repeat .
the change may cause the heat instability and affect various alternate subdomains which is able to #result in a super-repeat .
the change may cause the heat instability and affect various alternate subdomains which is observed to finally #result in a super-repeat .
the change may cause the heat instability and affect various alternate subdomains which is observed to #result in a super-repeat .
the change may cause the heat instability and affect various alternate subdomains which may have finally #resulted in a super-repeat .
the change may cause the heat instability and affect various alternate subdomains which may have #resulted in a super-repeat .
the change may cause the heat instability and affect various alternate subdomains which #results in a super-repeat .
the change may cause the heat instability and affect various alternate subdomains , #resulting in a super-repeat .
we speculated that a super-repeat may be the #result of various alternate subdomains in mast cells .
we speculated that a super-repeat may be the #result various alternate subdomains in mast cells .
we speculated that high proportions of mature mrnas containing introns has been shown to be the #result of both the 5 and 3 splice site mutations in mast cells .
we speculated that high proportions of mature mrnas containing introns is the #result of both the 5 and 3 splice site mutations in mast cells .
we speculated that high proportions of mature mrnas containing introns may be the #result both the 5 and 3 splice site mutations in mast cells .
we speculated that mrna species with distinct 5utrs has been shown to be the #result of alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation in mast cells .
we speculated that mrna species with distinct 5utrs has been shown to be the #result of alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation , as our study suggested , in mast cells .
we speculated that mrna species with distinct 5utrs is the #result of alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation in mast cells .
we speculated that mrna species with distinct 5utrs is the #result of alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation , as our study suggested , in mast cells .
we speculated that mrna species with distinct 5utrs may be the #result alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation in mast cells .
we speculated that mrna species with distinct 5utrs may be the #result of alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation in mast cells .
we speculated that that repression is the #result of of co-operative binding of the repressor in mast cells .
we speculated that the difference in the c-terminal 28 amino acids between beta(1) and beta(2) proteins has been shown to be the #result of alternative splicing of a single transcript in mast cells .
we speculated that the difference in the c-terminal 28 amino acids between beta(1) and beta(2) proteins is observed to be the #result of alternative splicing of a single transcript in mast cells .
we speculated that the difference in the c-terminal 28 amino acids between beta(1) and beta(2) proteins is the #result of alternative splicing of a single transcript in mast cells .
we speculated that the difference in the c-terminal 28 amino acids between beta(1) and beta(2) proteins may be the #result of alternative splicing of a single transcript in mast cells .
we speculated that the negative effect of the cpxa mutation is observed to be the #result of a decreased transcription of the curlin encoding csga gene in mast cells .
we speculated that truncated nonfunctional proteins has been shown to be the #result of the other three alterations in mast cells .
we speculated that truncated nonfunctional proteins is observed to be the #result of the other three alterations in mast cells .
we speculated that truncated nonfunctional proteins is the #result of the other three alterations in mast cells .
we speculated that truncated nonfunctional proteins may be the #result of the other three alterations in mast cells .
we speculated that truncated nonfunctional proteins may be the #result the other three alterations in mast cells .
a decreased transcription of the curlin encoding csga gene are observed to finally #result in the negative effect of the cpxa mutation .
a decreased transcription of the curlin encoding csga gene can #result in the negative effect of the cpxa mutation
a decreased transcription of the curlin encoding csga gene has #resulted in the negative effect of the cpxa mutation .
a decreased transcription of the curlin encoding csga gene have the ability to finally #result in the negative effect of the cpxa mutation .
a decreased transcription of the curlin encoding csga gene may have #resulted in the negative effect of the cpxa mutation .
a decreased transcription of the curlin encoding csga gene #result in the negative effect of the cpxa mutation .
a decreased transcription of the curlin encoding csga gene #resulted in the negative effect of the cpxa mutation .
a decreased transcription of the curlin encoding csga gene will #result in the negative effect of the cpxa mutation .
alternative splicing of a single transcript are able to finally #result in the difference in the c-terminal 28 amino acids between beta(1) and beta(2) proteins .
alternative splicing of a single transcript are observed to finally #result in the difference in the c-terminal 28 amino acids between beta(1) and beta(2) proteins .
alternative splicing of a single transcript are observed to #result in the difference in the c-terminal 28 amino acids between beta(1) and beta(2) proteins .
alternative splicing of a single transcript can finally #result in the difference in the c-terminal 28 amino acids between beta(1) and beta(2) proteins
alternative splicing of a single transcript has finally #resulted in the difference in the c-terminal 28 amino acids between beta(1) and beta(2) proteins .
alternative splicing of a single transcript have the ability to finally #result in the difference in the c-terminal 28 amino acids between beta(1) and beta(2) proteins .
alternative splicing of a single transcript have the ability to #result in the difference in the c-terminal 28 amino acids between beta(1) and beta(2) proteins .
alternative splicing of a single transcript may have #resulted in the difference in the c-terminal 28 amino acids between beta(1) and beta(2) proteins .
alternative splicing of a single transcript may #result in the difference in the c-terminal 28 amino acids between beta(1) and beta(2) proteins .
of co-operative binding of the repressor are able to finally #result in that repression .
of co-operative binding of the repressor are able to #result in that repression .
of co-operative binding of the repressor are observed to #result in that repression .
of co-operative binding of the repressor has #resulted in that repression .
of co-operative binding of the repressor may have finally #resulted in that repression .
of co-operative binding of the repressor may have #resulted in that repression .
of co-operative binding of the repressor #result in that repression .
of co-operative binding of the repressor will #result in that repression .
the other three alterations are observed to finally #result in truncated nonfunctional proteins .
the other three alterations are observed to #result in truncated nonfunctional proteins .
the other three alterations can finally #result in truncated nonfunctional proteins
the other three alterations can #result in truncated nonfunctional proteins
the other three alterations finally #result in truncated nonfunctional proteins .
the other three alterations have the ability to finally #result in truncated nonfunctional proteins .
the other three alterations #resulted in truncated nonfunctional proteins .
the other three alterations will #result in truncated nonfunctional proteins .
various alternate subdomains are able to finally #result in a super-repeat .
various alternate subdomains are observed to finally #result in a super-repeat .
various alternate subdomains are observed to #result in a super-repeat .
various alternate subdomains can finally #result in a super-repeat
various alternate subdomains finally #result in a super-repeat .
various alternate subdomains has finally #resulted in a super-repeat .
various alternate subdomains will finally #result in a super-repeat .
a stop codon-containing exon (exon 4) could be finally #skipped by alternative splicing and generates a transcript that is predicted to encode a fusion protein .
a stop codon-containing exon (exon 4) is finally #skipped by alternative splicing and generates a transcript that is predicted to encode a fusion protein .
a stop codon-containing exon (exon 4) may have been finally #skipped by alternative splicing and can generate a transcript that is predicted to encode a fusion protein .
a stop codon-containing exon (exon 4) was finally #skipped by alternative splicing and generated a transcript that is predicted to encode a fusion protein .
alternative splicing can finally #skip a stop codon-containing exon (exon 4) and can generate a transcript that is predicted to encode a fusion protein .
alternative splicing finally #skipped a stop codon-containing exon (exon 4) and can generate a transcript that is predicted to encode a fusion protein .
alternative splicing finally #skips a stop codon-containing exon (exon 4) and can generate a transcript that is predicted to encode a fusion protein .
alternative splicing has finally #skipped a stop codon-containing exon (exon 4) and can generate a transcript that is predicted to encode a fusion protein .
alternative splicing has the ability to finally #skip a stop codon-containing exon (exon 4) and can generate a transcript that is predicted to encode a fusion protein .
alternative splicing is able to finally #skip a stop codon-containing exon (exon 4) and can generate a transcript that is predicted to encode a fusion protein .
direct sequencing of the paf-2 gene revealed a homozygous 1-bp insertion at nucleotide 511 (511 inst) in one patient with group c zellweger syndrome (zs) , which introduces a premature termination codon in the paf-2 gene , and , in the second patient , revealed a splice-site mutation in intron 3 (ivs3+1g-->a) being able to #skip exon 3 , an event that leads to peroxisome deficiency .
direct sequencing of the paf-2 gene revealed a homozygous 1-bp insertion at nucleotide 511 (511 inst) in one patient with group c zellweger syndrome (zs) , which introduces a premature termination codon in the paf-2 gene , and , in the second patient , revealed a splice-site mutation in intron 3 (ivs3+1g-->a) being likely to #skip exon 3 , an event that leads to peroxisome deficiency .
direct sequencing of the paf-2 gene revealed a homozygous 1-bp insertion at nucleotide 511 (511 inst) in one patient with group c zellweger syndrome (zs) , which introduces a premature termination codon in the paf-2 gene , and , in the second patient , revealed a splice-site mutation in intron 3 (ivs3+1g-->a) having been shown to #skip exon 3 , an event that leads to peroxisome deficiency .
direct sequencing of the paf-2 gene revealed a homozygous 1-bp insertion at nucleotide 511 (511 inst) in one patient with group c zellweger syndrome (zs) , which introduces a premature termination codon in the paf-2 gene , and , in the second patient , revealed a splice-site mutation in intron 3 (ivs3+1g-->a) observed to #skip exon 3 , an event that leads to peroxisome deficiency .
direct sequencing of the paf-2 gene revealed a homozygous 1-bp insertion at nucleotide 511 (511 inst) in one patient with group c zellweger syndrome (zs) , which introduces a premature termination codon in the paf-2 gene , and , in the second patient , revealed a splice-site mutation in intron 3 (ivs3+1g-->a) shown to #skip exon 3 , an event that leads to peroxisome deficiency .
direct sequencing of the paf-2 gene revealed a homozygous 1-bp insertion at nucleotide 511 (511 inst) in one patient with group c zellweger syndrome (zs) , which introduces a premature termination codon in the paf-2 gene , and , in the second patient , revealed a splice-site mutation in intron 3 (ivs3+1g-->a) , which is likely to #skip exon 3 , an event that leads to peroxisome deficiency .
direct sequencing of the paf-2 gene revealed a homozygous 1-bp insertion at nucleotide 511 (511 inst) in one patient with group c zellweger syndrome (zs) , which introduces a premature termination codon in the paf-2 gene , and , in the second patient , revealed a splice-site mutation in intron 3 (ivs3+1g-->a) , which is observed to #skip exon 3 , an event that leads to peroxisome deficiency .
direct sequencing of the paf-2 gene revealed a homozygous 1-bp insertion at nucleotide 511 (511 inst) in one patient with group c zellweger syndrome (zs) , which introduces a premature termination codon in the paf-2 gene , and , in the second patient , revealed a splice-site mutation in intron 3 (ivs3+1g-->a) , which may #skip exon 3 , an event that leads to peroxisome deficiency .
direct sequencing of the paf-2 gene revealed a homozygous 1-bp insertion at nucleotide 511 (511 inst) in one patient with group c zellweger syndrome (zs) , which introduces a premature termination codon in the paf-2 gene , and , in the second patient , revealed a splice-site mutation in intron 3 (ivs3+1g-->a) , which usually #skips exon 3 , an event that leads to peroxisome deficiency .
finally , a stop codon-containing exon (exon 4) could be #skipped by alternative splicing and generates a transcript that is predicted to encode a fusion protein .
finally , a stop codon-containing exon (exon 4) has been shown to be #skipped by alternative splicing and can generate a transcript that is predicted to encode a fusion protein .
finally , a stop codon-containing exon (exon 4) has the ability to be #skipped by alternative splicing and can generate a transcript that is predicted to encode a fusion protein .
finally , a stop codon-containing exon (exon 4) is #skipped by alternative splicing and generates a transcript that is predicted to encode a fusion protein .
finally , a stop codon-containing exon (exon 4) may have been #skipped by alternative splicing and can generate a transcript that is predicted to encode a fusion protein .
finally , a stop codon-containing exon (exon 4) was #skipped by alternative splicing and generated a transcript that is predicted to encode a fusion protein .
finally , a stop codon-containing exon (exon 4) will be #skipped by alternative splicing and can generate a transcript that is predicted to encode a fusion protein .
finally , alternative splicing can #skip a stop codon-containing exon (exon 4) and can generate a transcript that is predicted to encode a fusion protein .
finally , alternative splicing has been shown to #skip a stop codon-containing exon (exon 4) and can generate a transcript that is predicted to encode a fusion protein .
finally , alternative splicing has the ability to #skip a stop codon-containing exon (exon 4) and can generate a transcript that is predicted to encode a fusion protein .
finally , alternative splicing may have #skipped a stop codon-containing exon (exon 4) and can generate a transcript that is predicted to encode a fusion protein .
megakaryocytes undergo an endomitotic cell cycle , which consists of an s phase interrupted by a gap , during which anaphase b and cytokinesis can be #skipped by the cells .
megakaryocytes undergo an endomitotic cell cycle , which consists of an s phase interrupted by a gap , during which anaphase b and cytokinesis has been shown to be #skipped by the cells .
megakaryocytes undergo an endomitotic cell cycle , which consists of an s phase interrupted by a gap , during which anaphase b and cytokinesis have been #skipped by the cells .
megakaryocytes undergo an endomitotic cell cycle , which consists of an s phase interrupted by a gap , during which anaphase b and cytokinesis were #skipped by the cells .
megakaryocytes undergo an endomitotic cell cycle , which consists of an s phase interrupted by a gap , during which the cells enter mitosis but are likely to #skip anaphase b and cytokinesis .
megakaryocytes undergo an endomitotic cell cycle , which consists of an s phase interrupted by a gap , during which the cells enter mitosis but are observed to #skip anaphase b and cytokinesis .
megakaryocytes undergo an endomitotic cell cycle , which consists of an s phase interrupted by a gap , during which the cells enter mitosis but can #skip anaphase b and cytokinesis .
megakaryocytes undergo an endomitotic cell cycle , which consists of an s phase interrupted by a gap , during which the cells enter mitosis but have the ability to #skip anaphase b and cytokinesis .
megakaryocytes undergo an endomitotic cell cycle , which consists of an s phase interrupted by a gap , during which the cells entered mitosis but have #skipped anaphase b and cytokinesis .
the centromere has been finally #skipped on all tg autosomes as on the female xi .
the centromere has been shown to be finally #skipped on all tg autosomes as on the female xi .
the centromere has been #skipped on all tg autosomes as on the female xi .
the centromere may have been finally #skipped on all tg autosomes as on the female xi .
xist rna coated the autosome but has #skipped the xic tg , raising the possibility that x chromosome domains escape inactivation by excluding xist rna binding .
xist rna coats the autosome but has been shown to #skip the xic tg , raising the possibility that x chromosome domains escape inactivation by excluding xist rna binding .
xist rna coats the autosome but is able to #skip the xic tg , raising the possibility that x chromosome domains escape inactivation by excluding xist rna binding .
xist rna coats the autosome but , as we predicted , is able to #skip the xic tg , raising the possibility that x chromosome domains escape inactivation by excluding xist rna binding .
xist rna coats the autosome but , as we predicted , is observed to #skip the xic tg , raising the possibility that x chromosome domains escape inactivation by excluding xist rna binding .
xist rna coats the autosome but , as we predicted , will #skip the xic tg , raising the possibility that x chromosome domains escape inactivation by excluding xist rna binding .
the observation that xist rna can efficiently #skip the xic tg raises the possibility that x chromosome domains escape inactivation by excluding xist rna binding .
the observation that xist rna has efficiently #skipped the xic tg raises the possibility that x chromosome domains escape inactivation by excluding xist rna binding .
the observation that xist rna has the ability to #skip the xic tg raises the possibility that x chromosome domains escape inactivation by excluding xist rna binding .
the observation that xist rna has the probability of efficiently #skipping the xic tg raises the possibility that x chromosome domains escape inactivation by excluding xist rna binding .
the observation that xist rna has the probability of #skipping the xic tg raises the possibility that x chromosome domains escape inactivation by excluding xist rna binding .
the observation that xist rna is likely to efficiently #skip the xic tg raises the possibility that x chromosome domains escape inactivation by excluding xist rna binding .
the observation that xist rna is likely to #skip the xic tg raises the possibility that x chromosome domains escape inactivation by excluding xist rna binding .
the observation that xist rna is observed to efficiently #skip the xic tg raises the possibility that x chromosome domains escape inactivation by excluding xist rna binding .
the observation that xist rna is observed to #skip the xic tg raises the possibility that x chromosome domains escape inactivation by excluding xist rna binding .
the observation that xist rna may have efficiently #skipped the xic tg raises the possibility that x chromosome domains escape inactivation by excluding xist rna binding .
the observation that xist rna #skipped the xic tg raises the possibility that x chromosome domains escape inactivation by excluding xist rna binding .
the observation that xist rna will #skip the xic tg raises the possibility that x chromosome domains escape inactivation by excluding xist rna binding .
the observation that the xic tg has been shown to be efficiently #skipped by xist rna raises the possibility that x chromosome domains escape inactivation by excluding xist rna binding .
the observation that the xic tg has been shown to be #skipped by xist rna raises the possibility that x chromosome domains escape inactivation by excluding xist rna binding .
the observation that the xic tg has been #skipped by xist rna raises the possibility that x chromosome domains escape inactivation by excluding xist rna binding .
the observation that the xic tg has the ability to be efficiently #skipped by xist rna raises the possibility that x chromosome domains escape inactivation by excluding xist rna binding .
the observation that the xic tg has the ability to be #skipped by xist rna raises the possibility that x chromosome domains escape inactivation by excluding xist rna binding .
the observation that the xic tg is able to be efficiently #skipped by xist rna raises the possibility that x chromosome domains escape inactivation by excluding xist rna binding .
the observation that the xic tg is able to be #skipped by xist rna raises the possibility that x chromosome domains escape inactivation by excluding xist rna binding .
the observation that the xic tg is efficiently #skipped by xist rna raises the possibility that x chromosome domains escape inactivation by excluding xist rna binding .
the observation that the xic tg is likely to be efficiently #skipped by xist rna raises the possibility that x chromosome domains escape inactivation by excluding xist rna binding .
the observation that the xic tg is likely to be #skipped by xist rna raises the possibility that x chromosome domains escape inactivation by excluding xist rna binding .
the observation that the xic tg is observed to be efficiently #skipped by xist rna raises the possibility that x chromosome domains escape inactivation by excluding xist rna binding .
the observation that the xic tg is observed to be #skipped by xist rna raises the possibility that x chromosome domains escape inactivation by excluding xist rna binding .
the observation that the xic tg may have been efficiently #skipped by xist rna raises the possibility that x chromosome domains escape inactivation by excluding xist rna binding .
the observation that the xic tg may have been #skipped by xist rna raises the possibility that x chromosome domains escape inactivation by excluding xist rna binding .
the observation that the xic tg will be #skipped by xist rna raises the possibility that x chromosome domains escape inactivation by excluding xist rna binding .
a caspase-2 minigene construct could be made that is alternatively #spliced in transfected cells and nuclear extracts .
a caspase-2 minigene construct could be made that is #spliced in transfected cells and nuclear extracts .
a caspase-2 minigene construct has been shown to be made that is alternatively #spliced in transfected cells and nuclear extracts .
a caspase-2 minigene construct has been shown to be made that is #spliced in transfected cells and nuclear extracts .
a caspase-2 minigene construct has the ability to be made to be #spliced in transfected cells and nuclear extracts .
a caspase-2 minigene construct is able to be made that is alternatively #spliced in transfected cells and nuclear extracts .
a caspase-2 minigene construct is observed to be made that is #spliced in transfected cells and nuclear extracts .
a caspase-2 minigene construct may have been made that can be alternatively #spliced in transfected cells and nuclear extracts .
a caspase-2 minigene construct will be made that is alternatively #spliced in transfected cells and nuclear extracts .
a caspase-2 minigene construct will be made that is #spliced in transfected cells and nuclear extracts .
a caspase-2 minigene construct would be made that could be alternatively #spliced in transfected cells and nuclear extracts .
a pre-mrna containing mutations in se2 , however , can be alternatively #spliced predominantly using the nt 3605 3 splice site .
a pre-mrna containing mutations in se2 , however , has been alternatively #spliced predominantly using the nt 3605 3 splice site .
a pre-mrna containing mutations in se2 , however , is able to alternatively #spliced predominantly using the nt 3605 3 splice site .
a pre-mrna containing mutations in se2 , however , is alternatively #spliced predominantly using the nt 3605 3 splice site .
a pre-mrna containing mutations in se2 , however , is likely to be alternatively #spliced predominantly using the nt 3605 3 splice site .
an additional observation with the tandem repeat-containing 3? substrates was that the efficiency of bimolecular exon ligation decreased stepwise with each mutation that moved the 5?-most ag 6 nt further downstream such that rna 3i alternatively #splices only 20% as efficiently as rna 3f (fig .1 c left) .
an additional observation with the tandem repeat-containing 3? substrates was that the efficiency of bimolecular exon ligation decreased stepwise with each mutation that moved the 5?-most ag 6 nt further downstream such that rna 3i can #splice only 20% as efficiently as rna 3f (fig .1 c left) .
an additional observation with the tandem repeat-containing 3? substrates was that the efficiency of bimolecular exon ligation decreased stepwise with each mutation that moved the 5?-most ag 6 nt further downstream such that rna 3i has alternatively #spliced only 20% as efficiently as rna 3f (fig .1 c left) .
an additional observation with the tandem repeat-containing 3? substrates was that the efficiency of bimolecular exon ligation decreased stepwise with each mutation that moved the 5?-most ag 6 nt further downstream such that rna 3i has been shown to #splice only 20% as efficiently as rna 3f (fig .1 c left) .
an additional observation with the tandem repeat-containing 3? substrates was that the efficiency of bimolecular exon ligation decreased stepwise with each mutation that moved the 5?-most ag 6 nt further downstream such that rna 3i has #spliced only 20% as efficiently as rna 3f (fig .1 c left) .
an additional observation with the tandem repeat-containing 3? substrates was that the efficiency of bimolecular exon ligation decreased stepwise with each mutation that moved the 5?-most ag 6 nt further downstream such that rna 3i is able to alternatively #splice only 20% as efficiently as rna 3f (fig .1 c left) .
an additional observation with the tandem repeat-containing 3? substrates was that the efficiency of bimolecular exon ligation decreased stepwise with each mutation that moved the 5?-most ag 6 nt further downstream such that rna 3i is observed to alternatively #splice only 20% as efficiently as rna 3f (fig .1 c left) .
an additional observation with the tandem repeat-containing 3? substrates was that the efficiency of bimolecular exon ligation decreased stepwise with each mutation that moved the 5?-most ag 6 nt further downstream such that rna 3i is observed to #splice only 20% as efficiently as rna 3f (fig .1 c left) .
an additional observation with the tandem repeat-containing 3? substrates was that the efficiency of bimolecular exon ligation decreased stepwise with each mutation that moved the 5?-most ag 6 nt further downstream such that rna 3i may have alternatively #spliced only 20% as efficiently as rna 3f (fig .1 c left) .
an additional observation with the tandem repeat-containing 3? substrates was that the efficiency of bimolecular exon ligation decreased stepwise with each mutation that moved the 5?-most ag 6 nt further downstream such that rna 3i may have #spliced only 20% as efficiently as rna 3f (fig .1 c left) .
an additional observation with the tandem repeat-containing 3? substrates was that the efficiency of bimolecular exon ligation decreased stepwise with each mutation that moved the 5?-most ag 6 nt further downstream such that rna 3i #splices only 20% as efficiently as rna 3f (fig .1 c left) .
an additional observation with the tandem repeat-containing 3? substrates was that the efficiency of bimolecular exon ligation decreased stepwise with each mutation that moved the 5?-most ag 6 nt further downstream such that rna 3i will alternatively #splice only 20% as efficiently as rna 3f (fig .1 c left) .
an additional observation with the tandem repeat-containing 3? substrates was that the efficiency of bimolecular exon ligation decreased stepwise with each mutation that moved the 5?-most ag 6 nt further downstream such that rna 3i will #splice only 20% as efficiently as rna 3f (fig .1 c left) .
consequently , exon 30 with the intron has been shown to be #spliced .
consequently , exon 30 with the intron has been #spliced .
consequently , exon 30 with the intron has the ability to be #spliced .
in the remaining allelic p53 gene , there was a single-base substitution of g to t at position 1 within the #splice donor site of intron 7 , and the mutated intron cannot be properly #spliced out during the mrna maturation process .
consequently , exon 30 with the intron may have been #spliced .
in the remaining allelic p53 gene , there was a single-base substitution of g to t at position 1 within the #splice donor site of intron 7 , and the mutated intron cannot be #spliced out during the mrna maturation process .
consequently , exon 30 with the intron was #spliced .
consequently , exon 30 with the intron will be #spliced .
consequently , exon 30 with the intron , as our study suggested , can be #spliced .
consequently , exon 30 with the intron , as our study suggested , has been shown to be #spliced .
consequently , exon 30 with the intron , as our study suggested , has been #spliced .
in the remaining allelic p53 gene , there was a single-base substitution of g to t at position 1 within the #splice donor site of intron 7 , and the mutated intron has not been #spliced out during the mrna maturation process .
consequently , exon 30 with the intron , as our study suggested , is able to be #spliced .
in the remaining allelic p53 gene , there was a single-base substitution of g to t at position 1 within the #splice donor site of intron 7 , and the mutated intron is not able to be properly #spliced out during the mrna maturation process .
in the remaining allelic p53 gene , there was a single-base substitution of g to t at position 1 within the #splice donor site of intron 7 , and the mutated intron is not able to be #spliced out during the mrna maturation process .
in the remaining allelic p53 gene , there was a single-base substitution of g to t at position 1 within the #splice donor site of intron 7 , and the mutated intron is not #spliced out during the mrna maturation process .
consequently , exon 30 with the intron , as our study suggested , will be #spliced .
in the remaining allelic p53 gene , there was a single-base substitution of g to t at position 1 within the #splice donor site of intron 7 , and the mutated intron is observed not to be properly #spliced out during the mrna maturation process .
in the remaining allelic p53 gene , there was a single-base substitution of g to t at position 1 within the #splice donor site of intron 7 , and the mutated intron is observed not to be #spliced out during the mrna maturation process .
in the remaining allelic p53 gene , there was a single-base substitution of g to t at position 1 within the #splice donor site of intron 7 , and the mutated intron may not have been properly #spliced out during the mrna maturation process .
in the remaining allelic p53 gene , there was a single-base substitution of g to t at position 1 within the #splice donor site of intron 7 , and the mutated intron may not have been #spliced out during the mrna maturation process .
exons outside this size range are observed to require additional exonic and/or intronic sequences to be effectively #spliced into the mature mrna .
in the remaining allelic p53 gene , there was a single-base substitution of g to t at position 1 within the #splice donor site of intron 7 , and the mutated intron will not be properly #spliced out during the mrna maturation process .
exons outside this size range are #spliced into the mature mrna .
exons outside this size range have been effectively #spliced into the mature mrna .
it does not properly #splice out this intron and results in a substitution of the final 13 amino acids of the deduced amino acid sequence .
it does not #splice out this intron and results in a substitution of the final 13 amino acids of the deduced amino acid sequence .
exons outside this size range have required additional exonic and/or intronic sequences to be #spliced into the mature mrna .
exons outside this size range have the probability of requiring additional exonic and/or intronic sequences to be effectively #spliced into the mature mrna .
exons outside this size range have the probability of requiring additional exonic and/or intronic sequences to be #spliced into the mature mrna .
exons outside this size range may have required additional exonic and/or intronic sequences to be effectively #spliced into the mature mrna .
exons outside this size range require additional exonic and/or intronic sequences to be #spliced into the mature mrna .
exons outside this size range required additional exonic and/or intronic sequences to be #spliced into the mature mrna .
exons outside this size range were effectively #spliced into the mature mrna .
however , a pre-mrna containing mutations in se2 can be alternatively #spliced predominantly using the nt 3605 3 splice site .
however , a pre-mrna containing mutations in se2 can be #spliced predominantly using the nt 3605 3 splice site .
however , a pre-mrna containing mutations in se2 has been shown to be alternatively #spliced predominantly using the nt 3605 3 splice site .
however , a pre-mrna containing mutations in se2 has been shown to be #spliced predominantly using the nt 3605 3 splice site .
however , a pre-mrna containing mutations in se2 has the ability to be alternatively #spliced predominantly using the nt 3605 3 splice site .
however , a pre-mrna containing mutations in se2 is able to #spliced predominantly using the nt 3605 3 splice site .
however , a pre-mrna containing mutations in se2 is likely to be alternatively #spliced predominantly using the nt 3605 3 splice site .
however , a pre-mrna containing mutations in se2 is observed to be #spliced predominantly using the nt 3605 3 splice site .
however , a pre-mrna containing mutations in se2 was alternatively #spliced predominantly using the nt 3605 3 splice site .
however , a pre-mrna containing mutations in se2 was #spliced predominantly using the nt 3605 3 splice site .
however , a pre-mrna containing mutations in se2 will be alternatively #spliced predominantly using the nt 3605 3 splice site .
however , a pre-mrna containing mutations in se2 will be #spliced predominantly using the nt 3605 3 splice site .
that putative intron sequences can fail to be properly #spliced out in transcripts which spanned exon-intron boundaries is expected in antisense transcripts .
that putative intron sequences can fail to be #spliced out in transcripts which spanned exon-intron boundaries is expected in antisense transcripts .
the supt4h gene has been shown to be normally #spliced from five exons encoded by chromosome 11 .
the supt4h gene has been shown to be #spliced normally from five exons encoded by chromosome 11 .
the supt4h gene has been #spliced normally from five exons encoded by chromosome 11 .
that putative intron sequences has not been shown to be #spliced out in transcripts which spanned exon-intron boundaries is expected in antisense transcripts .
that putative intron sequences have failed to be properly #spliced out in transcripts which spanned exon-intron boundaries is expected in antisense transcripts .
the supt4h gene is able to be #spliced normally from five exons encoded by chromosome 11 .
that putative intron sequences is able to fail to be #spliced out in transcripts which spanned exon-intron boundaries is expected in antisense transcripts .
that putative intron sequences is likely to fail to be properly #spliced out in transcripts which spanned exon-intron boundaries is expected in antisense transcripts .
the supt4h gene is observed to be #spliced normally from five exons encoded by chromosome 11 .
that putative intron sequences is not observed to be properly #spliced out in transcripts which spanned exon-intron boundaries is expected in antisense transcripts .
the supt4h gene may have been #spliced normally from five exons encoded by chromosome 11 .
that putative intron sequences may fail to be properly #spliced out in transcripts which spanned exon-intron boundaries is expected in antisense transcripts .
that putative intron sequences may fail to be #spliced out in transcripts which spanned exon-intron boundaries is expected in antisense transcripts .
the supt4h gene was normally #spliced from five exons encoded by chromosome 11 .
that putative intron sequences will fail to be properly #spliced out in transcripts which spanned exon-intron boundaries is expected in antisense transcripts .
the supt4h gene will be normally #spliced from five exons encoded by chromosome 11 .
that this intron has not been properly #spliced out resulted in a substitution of the final 13 amino acids of the deduced amino acid sequence .
that this intron has not been shown to be properly #spliced out results in a substitution of the final 13 amino acids of the deduced amino acid sequence .
that this intron is not able to be properly #spliced out results in a substitution of the final 13 amino acids of the deduced amino acid sequence .
that this intron is not observed to be #spliced out results in a substitution of the final 13 amino acids of the deduced amino acid sequence .
that this intron is not properly #spliced out results in a substitution of the final 13 amino acids of the deduced amino acid sequence .
that this intron is not #spliced out results in a substitution of the final 13 amino acids of the deduced amino acid sequence .
the mouse polymeric immunoglobulin receptor gene has a 654 nt exon being able to be efficiently #spliced into the mrna .
the mouse polymeric immunoglobulin receptor gene has a 654 nt exon being #spliced efficiently into the mrna .
the mouse polymeric immunoglobulin receptor gene has a 654 nt exon having been #spliced efficiently into the mrna .
the mouse polymeric immunoglobulin receptor gene has a 654 nt exon having the ability to be efficiently #spliced into the mrna .
the mouse polymeric immunoglobulin receptor gene has a 654 nt exon observed to be efficiently #spliced into the mrna .
the mouse polymeric immunoglobulin receptor gene has a 654 nt exon observed to be #spliced efficiently into the mrna .
the mouse polymeric immunoglobulin receptor gene has a 654 nt exon shown to be efficiently #spliced into the mrna .
the mouse polymeric immunoglobulin receptor gene has a 654 nt exon that can be efficiently #spliced into the mrna .
the mouse polymeric immunoglobulin receptor gene has a 654 nt exon that has been shown to be #spliced efficiently into the mrna .
the mouse polymeric immunoglobulin receptor gene has a 654 nt exon that has been #spliced efficiently into the mrna .
virtually all genes of higher organisms have non-coding introns interspersed between the coding exons being able to be efficiently #spliced out in order to generate a mature messenger rna molecule used to encode proteins .
virtually all genes of higher organisms have non-coding introns interspersed between the coding exons being able to be #spliced out in order to generate a mature messenger rna molecule used to encode proteins .
the mouse polymeric immunoglobulin receptor gene has a 654 nt exon that may have been efficiently #spliced into the mrna .
the mouse polymeric immunoglobulin receptor gene has a 654 nt exon that may have been #spliced efficiently into the mrna .
virtually all genes of higher organisms have non-coding introns interspersed between the coding exons being #spliced out in order to generate a mature messenger rna molecule used to encode proteins .
virtually all genes of higher organisms have non-coding introns interspersed between the coding exons efficiently #spliced out in order to generate a mature messenger rna molecule used to encode proteins .
the mouse polymeric immunoglobulin receptor gene has a 654 nt exon that was #spliced efficiently into the mrna .
the mouse polymeric immunoglobulin receptor gene has a 654 nt exon that will be #spliced efficiently into the mrna .
the pre-mrnas from all of these genes are able to be #spliced with little or no exon-skipping (ref .16; also fig .1 c and data not shown) , suggesting that correct exon inclusion can be managed by the yeast gene expression machinery .
virtually all genes of higher organisms have non-coding introns interspersed between the coding exons shown to be efficiently #spliced out in order to generate a mature messenger rna molecule used to encode proteins .
the pre-mrnas from all of these genes are observed to be #spliced with little or no exon-skipping (ref .16; also fig .1 c and data not shown) , suggesting that correct exon inclusion can be managed by the yeast gene expression machinery .
the pre-mrnas from all of these genes being able to be #spliced with little or no exon-skipping (ref .16; also fig .1 c and data not shown) suggest that correct exon inclusion can be managed by the yeast gene expression machinery .
virtually all genes of higher organisms have non-coding introns interspersed between the coding exons #spliced out in order to generate a mature messenger rna molecule used to encode proteins .
the pre-mrnas from all of these genes can be #spliced with little or no exon-skipping (ref .16; also fig .1 c and data not shown) , suggesting that correct exon inclusion can be managed by the yeast gene expression machinery .
virtually all genes of higher organisms have non-coding introns interspersed between the coding exons that are able to be efficiently #spliced out in order to generate a mature messenger rna molecule used to encode proteins .
the pre-mrnas from all of these genes have been shown to be #spliced with little or no exon-skipping (ref .16; also fig .1 c and data not shown) , suggesting that correct exon inclusion can be managed by the yeast gene expression machinery .
the pre-mrnas from all of these genes have been #spliced with little or no exon-skipping (ref .16; also fig .1 c and data not shown) , suggesting that correct exon inclusion can be managed by the yeast gene expression machinery .
virtually all genes of higher organisms have non-coding introns interspersed between the coding exons that are efficiently #spliced out in order to generate a mature messenger rna molecule used to encode proteins .
the pre-mrnas from all of these genes having been #spliced with little or no exon-skipping (ref .16; also fig .1 c and data not shown) suggest that correct exon inclusion can be managed by the yeast gene expression machinery .
virtually all genes of higher organisms have non-coding introns interspersed between the coding exons that can be efficiently #spliced out in order to generate a mature messenger rna molecule used to encode proteins .
virtually all genes of higher organisms have non-coding introns interspersed between the coding exons that can be #spliced out in order to generate a mature messenger rna molecule used to encode proteins .
the pre-mrnas from all of these genes shown to be #spliced with little or no exon-skipping (ref .16; also fig .1 c and data not shown) suggest that correct exon inclusion can be managed by the yeast gene expression machinery .
the pre-mrnas from all of these genes #spliced with little or no exon-skipping (ref .16; also fig .1 c and data not shown) suggest that correct exon inclusion can be managed by the yeast gene expression machinery .
virtually all genes of higher organisms have non-coding introns interspersed between the coding exons that have been #spliced out in order to generate a mature messenger rna molecule used to encode proteins .
virtually all genes of higher organisms have non-coding introns interspersed between the coding exons that have the ability to be efficiently #spliced out in order to generate a mature messenger rna molecule used to encode proteins .
the pre-mrnas from all of these genes that are observed to be #spliced with little or no exon-skipping (ref .16; also fig .1 c and data not shown) suggest that correct exon inclusion can be managed by the yeast gene expression machinery .
virtually all genes of higher organisms have non-coding introns interspersed between the coding exons that may be efficiently #spliced out in order to generate a mature messenger rna molecule used to encode proteins .
virtually all genes of higher organisms have non-coding introns interspersed between the coding exons that may have been efficiently #spliced out in order to generate a mature messenger rna molecule used to encode proteins .
the pre-mrnas from all of these genes that have the ability to be #spliced with little or no exon-skipping (ref .16; also fig .1 c and data not shown) suggest that correct exon inclusion can be managed by the yeast gene expression machinery .
virtually all genes of higher organisms have non-coding introns interspersed between the coding exons that may have been #spliced out in order to generate a mature messenger rna molecule used to encode proteins .
the pre-mrnas from all of these genes that may have been #spliced with little or no exon-skipping (ref .16; also fig .1 c and data not shown) suggest that correct exon inclusion can be managed by the yeast gene expression machinery .
virtually all genes of higher organisms have non-coding introns interspersed between the coding exons that must be efficiently #spliced out in order to generate a mature messenger rna molecule used to encode proteins .
the pre-mrnas from all of these genes that were #spliced with little or no exon-skipping (ref .16; also fig .1 c and data not shown) suggest that correct exon inclusion can be managed by the yeast gene expression machinery .
the pre-mrnas from all of these genes that will be #spliced with little or no exon-skipping (ref .16; also fig .1 c and data not shown) suggest that correct exon inclusion can be managed by the yeast gene expression machinery .
the structure of different cdna clones indicates that usf rna can be differentially #spliced , and alternative exon usage may regulate the levels of functional usf protein .
the structure of different cdna clones indicates that usf rna has been differentially #spliced , and alternative exon usage may regulate the levels of functional usf protein .
the structure of different cdna clones indicates that usf rna has been shown to be differentially #spliced , and alternative exon usage may regulate the levels of functional usf protein .
the structure of different cdna clones indicates that usf rna has been shown to be #spliced , and alternative exon usage may regulate the levels of functional usf protein .
the structure of different cdna clones indicates that usf rna is able to be #spliced , and alternative exon usage may regulate the levels of functional usf protein .
the structure of different cdna clones indicates that usf rna may have been differentially #spliced , and alternative exon usage may regulate the levels of functional usf protein .
the structure of different cdna clones indicates that usf rna was differentially #spliced , and alternative exon usage may regulate the levels of functional usf protein .
the structure of different cdna clones indicates that usf rna will be differentially #spliced , and alternative exon usage may regulate the levels of functional usf protein .
failure to #splice out this intron resulted in a substitution of the final 13 amino acids of the deduced amino acid sequence .
the structure of different cdna clones indicates that usf rna is differentially #spliced , and alternative exon usage may regulate the levels of functional usf protein .
in the remaining allelic p53 gene , there was a single-base substitution of g to t at position 1 within the #splice donor site of intron 7 , and the mutated intron was not #spliced out during the mrna maturation process .
virtually all genes of higher organisms have non-coding introns interspersed between the coding exons that must be #spliced out in order to generate a mature messenger rna molecule used to encode proteins .
vertebrate internal exons are usually between 50 and 400 nt long; exons outside this size range may require additional exonic and/or intronic sequences to be #spliced into the mature mrna .
a caspase-2 minigene construct can be efficiently #spliced transfected cells and nuclear extracts , and the ratio of casp-2s to casp-2l mrnas produced was similar to the one observed in vivo (fig .1 c , lane 1) .
a caspase-2 minigene construct has been efficiently #spliced transfected cells and nuclear extracts , and the ratio of casp-2s to casp-2l mrnas produced was similar to the one observed in vivo (fig .1 c , lane 1) .
a caspase-2 minigene construct has been #spliced efficiently transfected cells and nuclear extracts , and the ratio of casp-2s to casp-2l mrnas produced was similar to the one observed in vivo (fig .1 c , lane 1) .
a caspase-2 minigene construct has the ability to be #spliced efficiently transfected cells and nuclear extracts , and the ratio of casp-2s to casp-2l mrnas produced was similar to the one observed in vivo (fig .1 c , lane 1) .
a caspase-2 minigene construct is able to be #spliced efficiently transfected cells and nuclear extracts , and the ratio of casp-2s to casp-2l mrnas produced was similar to the one observed in vivo (fig .1 c , lane 1) .
a caspase-2 minigene construct is efficiently #spliced transfected cells and nuclear extracts , and the ratio of casp-2s to casp-2l mrnas produced was similar to the one observed in vivo (fig .1 c , lane 1) .
a caspase-2 minigene construct is observed to be efficiently #spliced transfected cells and nuclear extracts , and the ratio of casp-2s to casp-2l mrnas produced was similar to the one observed in vivo (fig .1 c , lane 1) .
a caspase-2 minigene construct is #spliced efficiently transfected cells and nuclear extracts , and the ratio of casp-2s to casp-2l mrnas produced was similar to the one observed in vivo (fig .1 c , lane 1) .
a caspase-2 minigene construct may have been shown to be efficiently #spliced transfected cells and nuclear extracts , and the ratio of casp-2s to casp-2l mrnas produced was similar to the one observed in vivo (fig .1 c , lane 1) .
a caspase-2 minigene construct will be efficiently #spliced transfected cells and nuclear extracts , and the ratio of casp-2s to casp-2l mrnas produced was similar to the one observed in vivo (fig .1 c , lane 1) .
moreover , putative intron sequences can be #spliced out from transcripts that contain exons 15 to 24 .
moreover , putative intron sequences has been shown to be #spliced out from transcripts that contain exons 15 to 24 .
moreover , putative intron sequences has ben #spliced out from transcripts that contain exons 15 to 24 .
moreover , putative intron sequences has the ability to be efficiently #spliced out from transcripts that contain exons 15 to 24 .
moreover , putative intron sequences is efficiently #spliced out from transcripts that contain exons 15 to 24 .
moreover , putative intron sequences is observed to be efficiently #spliced out from transcripts that contain exons 15 to 24 .
moreover , putative intron sequences may have been #spliced out from transcripts that contain exons 15 to 24 .
moreover , putative intron sequences might be efficiently #spliced out from transcripts that contain exons 15 to 24 .
moreover , putative intron sequences was efficiently #spliced out from transcripts that contain exons 15 to 24 .
moreover , putative intron sequences will be #spliced out from transcripts that contain exons 15 to 24 .
the mouse polymeric immunoglobulin receptor gene has exons outside this size range being able to be efficiently #spliced into the mature mrna .
the mouse polymeric immunoglobulin receptor gene has exons outside this size range being #spliced efficiently into the mature mrna .
the mouse polymeric immunoglobulin receptor gene has exons outside this size range having been efficiently #spliced into the mature mrna .
the mouse polymeric immunoglobulin receptor gene has exons outside this size range having been #spliced efficiently into the mature mrna .
the mouse polymeric immunoglobulin receptor gene has exons outside this size range having the ability to be #spliced efficiently into the mature mrna .
the mouse polymeric immunoglobulin receptor gene has exons outside this size range observed to be efficiently #spliced into the mature mrna .
the mouse polymeric immunoglobulin receptor gene has exons outside this size range observed to be #spliced efficiently into the mature mrna .
the mouse polymeric immunoglobulin receptor gene has exons outside this size range #spliced efficiently into the mature mrna .
the mouse polymeric immunoglobulin receptor gene has exons outside this size range that has been efficiently #spliced into the mature mrna .
the mouse polymeric immunoglobulin receptor gene has exons outside this size range that has been shown to be efficiently #spliced into the mature mrna .
the mouse polymeric immunoglobulin receptor gene has exons outside this size range that has been #spliced efficiently into the mature mrna .
the mouse polymeric immunoglobulin receptor gene has exons outside this size range that is able to be #spliced efficiently into the mature mrna .
the mouse polymeric immunoglobulin receptor gene has exons outside this size range that is observed to be #spliced efficiently into the mature mrna .
the mouse polymeric immunoglobulin receptor gene has exons outside this size range that may have been efficiently #spliced into the mature mrna .
the mouse polymeric immunoglobulin receptor gene has exons outside this size range that was efficiently #spliced into the mature mrna .
the mouse polymeric immunoglobulin receptor gene has exons outside this size range that will be efficiently #spliced into the mature mrna .
we also identified usf rna differentially #spliced but containing no obvious open reading frame .
we also identified usf rna having been shown to be #spliced but containing no obvious open reading frame .
we also identified usf rna observed to be #spliced but containing no obvious open reading frame .
we also identified usf rna that are observed to be differentially #spliced but contain no obvious open reading frame .
we also identified usf rna that can be differentially #spliced but contain no obvious open reading frame .
we also identified usf rna that can be #spliced but contain no obvious open reading frame .
we also identified usf rna that could have been differentially #spliced but contained no obvious open reading frame .
we also identified usf rna that have been shown to be #spliced but contained no obvious open reading frame .
we also identified usf rna that will be #spliced but contain no obvious open reading frame .
when incubated in nuclear extracts or transfected in hela cells , the pre-mrnas from all of these genes can be #spliced predominantly following little or no exon-skipping to a level similar to that obtained with the c2 substrate (data not shown and fig .2 e , compare lane 3 to lane 1) .
when incubated in nuclear extracts or transfected in hela cells , the pre-mrnas from all of these genes has been shown to be #spliced following little or no exon-skipping to a level similar to that obtained with the c2 substrate (data not shown and fig .2 e , compare lane 3 to lane 1) .
when incubated in nuclear extracts or transfected in hela cells , the pre-mrnas from all of these genes has been shown to be #spliced predominantly following little or no exon-skipping to a level similar to that obtained with the c2 substrate (data not shown and fig .2 e , compare lane 3 to lane 1) .
when incubated in nuclear extracts or transfected in hela cells , the pre-mrnas from all of these genes has been #spliced following little or no exon-skipping to a level similar to that obtained with the c2 substrate (data not shown and fig .2 e , compare lane 3 to lane 1) .
when incubated in nuclear extracts or transfected in hela cells , the pre-mrnas from all of these genes has been #spliced predominantly following little or no exon-skipping to a level similar to that obtained with the c2 substrate (data not shown and fig .2 e , compare lane 3 to lane 1) .
when incubated in nuclear extracts or transfected in hela cells , the pre-mrnas from all of these genes has the ablity to be #spliced following little or no exon-skipping to a level similar to that obtained with the c2 substrate (data not shown and fig .2 e , compare lane 3 to lane 1) .
when incubated in nuclear extracts or transfected in hela cells , the pre-mrnas from all of these genes has the ablity to be #spliced predominantly following little or no exon-skipping to a level similar to that obtained with the c2 substrate (data not shown and fig .2 e , compare lane 3 to lane 1) .
when incubated in nuclear extracts or transfected in hela cells , the pre-mrnas from all of these genes is able to be #spliced following little or no exon-skipping to a level similar to that obtained with the c2 substrate (data not shown and fig .2 e , compare lane 3 to lane 1) .
when incubated in nuclear extracts or transfected in hela cells , the pre-mrnas from all of these genes is able to be #spliced predominantly following little or no exon-skipping to a level similar to that obtained with the c2 substrate (data not shown and fig .2 e , compare lane 3 to lane 1) .
when incubated in nuclear extracts or transfected in hela cells , the pre-mrnas from all of these genes is #spliced following little or no exon-skipping to a level similar to that obtained with the c2 substrate (data not shown and fig .2 e , compare lane 3 to lane 1) .
when incubated in nuclear extracts or transfected in hela cells , the pre-mrnas from all of these genes is #spliced predominantly following little or no exon-skipping to a level similar to that obtained with the c2 substrate (data not shown and fig .2 e , compare lane 3 to lane 1) .
when incubated in nuclear extracts or transfected in hela cells , the pre-mrnas from all of these genes may be #spliced following little or no exon-skipping to a level similar to that obtained with the c2 substrate (data not shown and fig .2 e , compare lane 3 to lane 1) .
when incubated in nuclear extracts or transfected in hela cells , the pre-mrnas from all of these genes may be #spliced predominantly following little or no exon-skipping to a level similar to that obtained with the c2 substrate (data not shown and fig .2 e , compare lane 3 to lane 1) .
when incubated in nuclear extracts or transfected in hela cells , the pre-mrnas from all of these genes may have been #spliced following little or no exon-skipping to a level similar to that obtained with the c2 substrate (data not shown and fig .2 e , compare lane 3 to lane 1) .
when incubated in nuclear extracts or transfected in hela cells , the pre-mrnas from all of these genes will be #spliced predominantly following little or no exon-skipping to a level similar to that obtained with the c2 substrate (data not shown and fig .2 e , compare lane 3 to lane 1) .
putative intron sequences has been efficiently #spliced out during transcripts .
putative intron sequences was efficiently #spliced out during transcripts .
putative intron sequences was #spliced out during transcripts .
transcripts has putative intron sequences being able to be completely #spliced out .
transcripts has putative intron sequences being able to be #spliced out .
transcripts has putative intron sequences observed to be completely #spliced out .
transcripts has putative intron sequences that has been shown to be completely #spliced out .
transcripts has putative intron sequences that has been #spliced out .
transcripts has putative intron sequences that is #spliced out .
transcripts has putative intron sequences that may have been #spliced out .
the pre-mrnas from all of these genes are #spliced with little or no exon-skipping (ref .16; also fig .1 c and data not shown) , suggesting that correct exon inclusion can be managed by the yeast gene expression machinery .
the supt4h gene are able to be #spliced with five exons encoded by chromosome 11 (ref .16; also fig .1 c and data not shown) , suggesting that correct exon inclusion can be managed by the yeast gene expression machinery .
moreover , the mutated intron has ben efficiently #spliced out from the mrna maturation process that contain exons 15 to 24 .
the supt4h gene are #spliced with five exons (ref .16; also fig .1 c and data not shown) , suggesting that correct exon inclusion can be managed by the yeast gene expression machinery .
moreover , the mutated intron has ben #spliced out from the mrna maturation process that contain exons 15 to 24 .
moreover , the mutated intron has the ability to be efficiently #spliced out from the mrna maturation process that contain exons 15 to 24 .
moreover , the mutated intron has the ability to be #spliced out from the mrna maturation process that contain exons 15 to 24 .
the supt4h gene being able to be #spliced with five exons (ref .16; also fig .1 c and data not shown) suggest that correct exon inclusion can be managed by the yeast gene expression machinery .
moreover , the mutated intron is able to be efficiently #spliced out from the mrna maturation process that contain exons 15 to 24 .
the supt4h gene can be #spliced with five exons (ref .16; also fig .1 c and data not shown) , suggesting that correct exon inclusion can be managed by the yeast gene expression machinery .
moreover , the mutated intron is able to be #spliced out from the mrna maturation process that contain exons 15 to 24 .
the supt4h gene can be #spliced with five exons encoded by chromosome 11 (ref .16; also fig .1 c and data not shown) , suggesting that correct exon inclusion can be managed by the yeast gene expression machinery .
moreover , the mutated intron is efficiently #spliced out from the mrna maturation process that contain exons 15 to 24 .
the supt4h gene have been shown to be #spliced with five exons (ref .16; also fig .1 c and data not shown) , suggesting that correct exon inclusion can be managed by the yeast gene expression machinery .
moreover , the mutated intron is observed to be #spliced out from the mrna maturation process that contain exons 15 to 24 .
moreover , the mutated intron is #spliced out from the mrna maturation process that contain exons 15 to 24 .
the supt4h gene have the ability to be #spliced with five exons (ref .16; also fig .1 c and data not shown) , suggesting that correct exon inclusion can be managed by the yeast gene expression machinery .
the supt4h gene have the ability to be #spliced with five exons encoded by chromosome 11 (ref .16; also fig .1 c and data not shown) , suggesting that correct exon inclusion can be managed by the yeast gene expression machinery .
the supt4h gene having been #spliced with five exons (ref .16; also fig .1 c and data not shown) suggest that correct exon inclusion can be managed by the yeast gene expression machinery .
the supt4h gene having been #spliced with five exons encoded by chromosome 11 (ref .16; also fig .1 c and data not shown) suggest that correct exon inclusion can be managed by the yeast gene expression machinery .
moreover , the mutated intron was efficiently #spliced out from the mrna maturation process that contain exons 15 to 24 .
the supt4h gene having the ability to be #spliced with five exons (ref .16; also fig .1 c and data not shown) suggest that correct exon inclusion can be managed by the yeast gene expression machinery .
the supt4h gene having the ability to be #spliced with five exons encoded by chromosome 11 (ref .16; also fig .1 c and data not shown) suggest that correct exon inclusion can be managed by the yeast gene expression machinery .
the supt4h gene may have been #spliced with five exons (ref .16; also fig .1 c and data not shown) , suggesting that correct exon inclusion can be managed by the yeast gene expression machinery .
moreover , the mutated intron will be #spliced out from the mrna maturation process that contain exons 15 to 24 .
that the mutated intron can fail to be properly #spliced out in the mrna maturation process which spanned exon-intron boundaries is expected in antisense transcripts .
that the mutated intron can fail to be #spliced out in the mrna maturation process which spanned exon-intron boundaries is expected in antisense transcripts .
that the mutated intron fail to be #spliced out in the mrna maturation process which spanned exon-intron boundaries is expected in antisense transcripts .
the supt4h gene shown to be #spliced with five exons encoded by chromosome 11 (ref .16; also fig .1 c and data not shown) suggest that correct exon inclusion can be managed by the yeast gene expression machinery .
that the mutated intron has not been shown to be properly #spliced out in the mrna maturation process which spanned exon-intron boundaries is expected in antisense transcripts .
that the mutated intron have failed to be #spliced out in the mrna maturation process which spanned exon-intron boundaries is expected in antisense transcripts .
the supt4h gene that are observed to be #spliced with five exons (ref .16; also fig .1 c and data not shown) suggest that correct exon inclusion can be managed by the yeast gene expression machinery .
that the mutated intron is able to fail to be properly #spliced out in the mrna maturation process which spanned exon-intron boundaries is expected in antisense transcripts .
that the mutated intron is not observed to be properly #spliced out in the mrna maturation process which spanned exon-intron boundaries is expected in antisense transcripts .
the supt4h gene that have been shown to be #spliced with five exons encoded by chromosome 11 (ref .16; also fig .1 c and data not shown) suggest that correct exon inclusion can be managed by the yeast gene expression machinery .
that the mutated intron is not observed to be #spliced out in the mrna maturation process which spanned exon-intron boundaries is expected in antisense transcripts .
that the mutated intron may fail to be #spliced out in the mrna maturation process which spanned exon-intron boundaries is expected in antisense transcripts .
that the mutated intron will fail to be properly #spliced out in the mrna maturation process which spanned exon-intron boundaries is expected in antisense transcripts .
the supt4h gene that have the ability to be #spliced with five exons encoded by chromosome 11 (ref .16; also fig .1 c and data not shown) suggest that correct exon inclusion can be managed by the yeast gene expression machinery .
the failure to #splice out the mutated intron in the mrna maturation process which spanned exon-intron boundaries is expected in antisense transcripts .
the supt4h gene that may have been #spliced with five exons encoded by chromosome 11 (ref .16; also fig .1 c and data not shown) suggest that correct exon inclusion can be managed by the yeast gene expression machinery .
the mrna maturation process has the mutated intron being able to be completely #spliced out .
the mrna maturation process has the mutated intron being able to be #spliced out .
the supt4h gene that were #spliced with five exons encoded by chromosome 11 (ref .16; also fig .1 c and data not shown) suggest that correct exon inclusion can be managed by the yeast gene expression machinery .
the supt4h gene that will be #spliced with five exons encoded by chromosome 11 (ref .16; also fig .1 c and data not shown) suggest that correct exon inclusion can be managed by the yeast gene expression machinery .
the mrna maturation process has the mutated intron having the ability to be completely #spliced out .
the supt4h gene will be #spliced with five exons (ref .16; also fig .1 c and data not shown) , suggesting that correct exon inclusion can be managed by the yeast gene expression machinery .
the structure of different cdna clones indicates that the supt4h gene can be differentially #spliced , and alternative exon usage may regulate the levels of functional usf protein .
the structure of different cdna clones indicates that the supt4h gene has been differentially #spliced , and alternative exon usage may regulate the levels of functional usf protein .
the structure of different cdna clones indicates that the supt4h gene has been shown to be differentially #spliced , and alternative exon usage may regulate the levels of functional usf protein .
the mrna maturation process has the mutated intron that has been shown to be #spliced out .
the mrna maturation process has the mutated intron that has been #spliced out .
the structure of different cdna clones indicates that the supt4h gene has the ability to be differentially #spliced , and alternative exon usage may regulate the levels of functional usf protein .
the mrna maturation process has the mutated intron that has the ability to be #spliced out .
the structure of different cdna clones indicates that the supt4h gene has the ability to be #spliced , and alternative exon usage may regulate the levels of functional usf protein .
the mrna maturation process has the mutated intron that is able to be #spliced out .
the structure of different cdna clones indicates that the supt4h gene is able to be #spliced , and alternative exon usage may regulate the levels of functional usf protein .
the mrna maturation process has the mutated intron that is completely #spliced out .
the mrna maturation process has the mutated intron that is observed to be completely #spliced out .
the structure of different cdna clones indicates that the supt4h gene is observed to be differentially #spliced , and alternative exon usage may regulate the levels of functional usf protein .
the mrna maturation process has the mutated intron that is observed to be #spliced out .
the structure of different cdna clones indicates that the supt4h gene may have been differentially #spliced , and alternative exon usage may regulate the levels of functional usf protein .
the mrna maturation process has the mutated intron that is #spliced out .
the structure of different cdna clones indicates that the supt4h gene may have been #spliced , and alternative exon usage may regulate the levels of functional usf protein .
the structure of different cdna clones indicates that the supt4h gene was #spliced , and alternative exon usage may regulate the levels of functional usf protein .
the mrna maturation process has the mutated intron that may have been #spliced out .
the structure of different cdna clones indicates that the supt4h gene will be differentially #spliced , and alternative exon usage may regulate the levels of functional usf protein .
the mutated intron has been efficiently #spliced out during the mrna maturation process .
the structure of different cdna clones indicates that the supt4h gene will be #spliced , and alternative exon usage may regulate the levels of functional usf protein .
the mutated intron has been #spliced out during the mrna maturation process .
the structure of different cdna clones indicates that a pre-mrna containing mutations in se2 can be differentially #spliced , and alternative exon usage may regulate the levels of functional usf protein .
the structure of different cdna clones indicates that a pre-mrna containing mutations in se2 can be #spliced , and alternative exon usage may regulate the levels of functional usf protein .
the structure of different cdna clones indicates that a pre-mrna containing mutations in se2 has been differentially #spliced , and alternative exon usage may regulate the levels of functional usf protein .
the structure of different cdna clones indicates that a pre-mrna containing mutations in se2 has been shown to be differentially #spliced , and alternative exon usage may regulate the levels of functional usf protein .
the mutated intron may have been #spliced out during the mrna maturation process .
the structure of different cdna clones indicates that a pre-mrna containing mutations in se2 has been shown to be #spliced , and alternative exon usage may regulate the levels of functional usf protein .
the structure of different cdna clones indicates that a pre-mrna containing mutations in se2 has been #spliced , and alternative exon usage may regulate the levels of functional usf protein .
the structure of different cdna clones indicates that a pre-mrna containing mutations in se2 has the ability to be differentially #spliced , and alternative exon usage may regulate the levels of functional usf protein .
the structure of different cdna clones indicates that a pre-mrna containing mutations in se2 is differentially #spliced , and alternative exon usage may regulate the levels of functional usf protein .
the structure of different cdna clones indicates that a pre-mrna containing mutations in se2 was differentially #spliced , and alternative exon usage may regulate the levels of functional usf protein .
the structure of different cdna clones indicates that a pre-mrna containing mutations in se2 was #spliced , and alternative exon usage may regulate the levels of functional usf protein .
the structure of different cdna clones indicates that a pre-mrna containing mutations in se2 will be differentially #spliced , and alternative exon usage may regulate the levels of functional usf protein .
the structure of different cdna clones indicates that a pre-mrna containing mutations in se2 will be #spliced , and alternative exon usage may regulate the levels of functional usf protein .
we also identified the supt4h gene having been shown to be differentially #spliced but containing no obvious open reading frame .
we also identified the supt4h gene observed to be differentially #spliced but containing no obvious open reading frame .
we also identified the supt4h gene that are able to be #spliced but contain no obvious open reading frame .
we also identified the supt4h gene that are observed to be differentially #spliced but contain no obvious open reading frame .
we also identified the supt4h gene that are observed to be #spliced but contain no obvious open reading frame .
we also identified the supt4h gene that can be differentially #spliced but contain no obvious open reading frame .
we also identified the supt4h gene that can be #spliced but contain no obvious open reading frame .
we also identified the supt4h gene that could have been #spliced but contained no obvious open reading frame .
we also identified the supt4h gene that have been differentially #spliced but contained no obvious open reading frame .
we also identified the supt4h gene that have been shown to be differentially #spliced but contained no obvious open reading frame .
we also identified the supt4h gene that have been #spliced but contained no obvious open reading frame .
we also identified the supt4h gene that may be differentially #spliced but contain no obvious open reading frame .
we also identified the supt4h gene that may be #spliced but contain no obvious open reading frame .
we also identified the supt4h gene that may have been differentially #spliced but contained no obvious open reading frame .
we also identified the supt4h gene that may have been #spliced but contained no obvious open reading frame .
we also identified the supt4h gene that were differentially #spliced but contained no obvious open reading frame .
we also identified the supt4h gene that were #spliced but contained no obvious open reading frame .
we also identified the supt4h gene that will be differentially #spliced but contain no obvious open reading frame .
we also identified the supt4h gene that will be #spliced but contain no obvious open reading frame .
we also identified a pre-mrna containing mutations in se2 being able to be differentially #spliced but containing no obvious open reading frame .
we also identified a pre-mrna containing mutations in se2 being able to be #spliced but containing no obvious open reading frame .
we also identified a pre-mrna containing mutations in se2 differentially #spliced but containing no obvious open reading frame .
we also identified a pre-mrna containing mutations in se2 observed to be differentially #spliced but containing no obvious open reading frame .
we also identified a pre-mrna containing mutations in se2 observed to be #spliced but containing no obvious open reading frame .
we also identified a pre-mrna containing mutations in se2 that are observed to be #spliced but contain no obvious open reading frame .
we also identified a pre-mrna containing mutations in se2 that are #spliced but contain no obvious open reading frame .
we also identified a pre-mrna containing mutations in se2 that can be #spliced but contain no obvious open reading frame .
we also identified a pre-mrna containing mutations in se2 that could have been #spliced but contained no obvious open reading frame .
we also identified a pre-mrna containing mutations in se2 that have been shown to be differentially #spliced but contained no obvious open reading frame .
we also identified a pre-mrna containing mutations in se2 that have been shown to be #spliced but contained no obvious open reading frame .
we also identified a pre-mrna containing mutations in se2 that have been #spliced but contained no obvious open reading frame .
we also identified a pre-mrna containing mutations in se2 that may have been #spliced but contained no obvious open reading frame .
we also identified a pre-mrna containing mutations in se2 that will be differentially #spliced but contain no obvious open reading frame .
when incubated in nuclear extracts or transfected in hela cells , the supt4h gene can be #spliced following five exons encoded by chromosome 11 to a level similar to that obtained with the c2 substrate (data not shown and fig .2 e , compare lane 3 to lane 1) .
when incubated in nuclear extracts or transfected in hela cells , the supt4h gene can be #spliced predominantly following five exons encoded by chromosome 11 to a level similar to that obtained with the c2 substrate (data not shown and fig .2 e , compare lane 3 to lane 1) .
when incubated in nuclear extracts or transfected in hela cells , the supt4h gene has been shown to be #spliced predominantly following five exons encoded by chromosome 11 to a level similar to that obtained with the c2 substrate (data not shown and fig .2 e , compare lane 3 to lane 1) .
when incubated in nuclear extracts or transfected in hela cells , the supt4h gene has been #spliced predominantly following five exons encoded by chromosome 11 to a level similar to that obtained with the c2 substrate (data not shown and fig .2 e , compare lane 3 to lane 1) .
when incubated in nuclear extracts or transfected in hela cells , the supt4h gene has the ablity to be #spliced predominantly following five exons encoded by chromosome 11 to a level similar to that obtained with the c2 substrate (data not shown and fig .2 e , compare lane 3 to lane 1) .
when incubated in nuclear extracts or transfected in hela cells , the supt4h gene is able to be #spliced following five exons encoded by chromosome 11 to a level similar to that obtained with the c2 substrate (data not shown and fig .2 e , compare lane 3 to lane 1) .
when incubated in nuclear extracts or transfected in hela cells , the supt4h gene is able to be #spliced following five exons to a level similar to that obtained with the c2 substrate (data not shown and fig .2 e , compare lane 3 to lane 1) .
when incubated in nuclear extracts or transfected in hela cells , the supt4h gene is able to be #spliced predominantly following five exons encoded by chromosome 11 to a level similar to that obtained with the c2 substrate (data not shown and fig .2 e , compare lane 3 to lane 1) .
when incubated in nuclear extracts or transfected in hela cells , the supt4h gene is able to be #spliced predominantly following five exons to a level similar to that obtained with the c2 substrate (data not shown and fig .2 e , compare lane 3 to lane 1) .
when incubated in nuclear extracts or transfected in hela cells , the supt4h gene is observed to be #spliced following five exons encoded by chromosome 11 to a level similar to that obtained with the c2 substrate (data not shown and fig .2 e , compare lane 3 to lane 1) .
when incubated in nuclear extracts or transfected in hela cells , the supt4h gene is observed to be #spliced following five exons to a level similar to that obtained with the c2 substrate (data not shown and fig .2 e , compare lane 3 to lane 1) .
when incubated in nuclear extracts or transfected in hela cells , the supt4h gene is #spliced following five exons encoded by chromosome 11 to a level similar to that obtained with the c2 substrate (data not shown and fig .2 e , compare lane 3 to lane 1) .
when incubated in nuclear extracts or transfected in hela cells , the supt4h gene may be #spliced following five exons to a level similar to that obtained with the c2 substrate (data not shown and fig .2 e , compare lane 3 to lane 1) .
when incubated in nuclear extracts or transfected in hela cells , the supt4h gene may have been #spliced following five exons encoded by chromosome 11 to a level similar to that obtained with the c2 substrate (data not shown and fig .2 e , compare lane 3 to lane 1) .
when incubated in nuclear extracts or transfected in hela cells , the supt4h gene was #spliced predominantly following five exons encoded by chromosome 11 to a level similar to that obtained with the c2 substrate (data not shown and fig .2 e , compare lane 3 to lane 1) .
when incubated in nuclear extracts or transfected in hela cells , the supt4h gene will be #spliced following five exons encoded by chromosome 11 to a level similar to that obtained with the c2 substrate (data not shown and fig .2 e , compare lane 3 to lane 1) .
when incubated in nuclear extracts or transfected in hela cells , the supt4h gene will be #spliced following five exons to a level similar to that obtained with the c2 substrate (data not shown and fig .2 e , compare lane 3 to lane 1) .
when incubated in nuclear extracts or transfected in hela cells , the supt4h gene will be #spliced predominantly following five exons to a level similar to that obtained with the c2 substrate (data not shown and fig .2 e , compare lane 3 to lane 1) .
when incubated in nuclear extracts or transfected in hela cells , a pre-mrna containing mutations in se2 has been #spliced predominantly following the nt 3605 3 splice site to a level similar to that obtained with the c2 substrate (data not shown and fig .2 e , compare lane 3 to lane 1) .
when incubated in nuclear extracts or transfected in hela cells , a pre-mrna containing mutations in se2 is able to be #spliced following the nt 3605 3 splice site to a level similar to that obtained with the c2 substrate (data not shown and fig .2 e , compare lane 3 to lane 1) .
when incubated in nuclear extracts or transfected in hela cells , a pre-mrna containing mutations in se2 is able to be #spliced predominantly following the nt 3605 3 splice site to a level similar to that obtained with the c2 substrate (data not shown and fig .2 e , compare lane 3 to lane 1) .
when incubated in nuclear extracts or transfected in hela cells , a pre-mrna containing mutations in se2 is observed to be #spliced predominantly following the nt 3605 3 splice site to a level similar to that obtained with the c2 substrate (data not shown and fig .2 e , compare lane 3 to lane 1) .
when incubated in nuclear extracts or transfected in hela cells , a pre-mrna containing mutations in se2 is #spliced predominantly following the nt 3605 3 splice site to a level similar to that obtained with the c2 substrate (data not shown and fig .2 e , compare lane 3 to lane 1) .
when incubated in nuclear extracts or transfected in hela cells , a pre-mrna containing mutations in se2 may have been #spliced following the nt 3605 3 splice site to a level similar to that obtained with the c2 substrate (data not shown and fig .2 e , compare lane 3 to lane 1) .
when incubated in nuclear extracts or transfected in hela cells , a pre-mrna containing mutations in se2 may have been #spliced predominantly following the nt 3605 3 splice site to a level similar to that obtained with the c2 substrate (data not shown and fig .2 e , compare lane 3 to lane 1) .
when incubated in nuclear extracts or transfected in hela cells , a pre-mrna containing mutations in se2 was #spliced predominantly following the nt 3605 3 splice site to a level similar to that obtained with the c2 substrate (data not shown and fig .2 e , compare lane 3 to lane 1) .
when incubated in nuclear extracts or transfected in hela cells , a pre-mrna containing mutations in se2 will be #spliced following the nt 3605 3 splice site to a level similar to that obtained with the c2 substrate (data not shown and fig .2 e , compare lane 3 to lane 1) .
when incubated in nuclear extracts or transfected in hela cells , a pre-mrna containing mutations in se2 will be #spliced predominantly following the nt 3605 3 splice site to a level similar to that obtained with the c2 substrate (data not shown and fig .2 e , compare lane 3 to lane 1) .
a pre-mrna containing mutations in se2 are able to be #spliced with the nt 3605 3 splice site (ref .16; also fig .1 c and data not shown) , suggesting that correct exon inclusion can be managed by the yeast gene expression machinery .
a pre-mrna containing mutations in se2 are observed to be #spliced with the nt 3605 3 splice site (ref .16; also fig .1 c and data not shown) , suggesting that correct exon inclusion can be managed by the yeast gene expression machinery .
a pre-mrna containing mutations in se2 can be #spliced with the nt 3605 3 splice site (ref .16; also fig .1 c and data not shown) , suggesting that correct exon inclusion can be managed by the yeast gene expression machinery .
a pre-mrna containing mutations in se2 have been #spliced with the nt 3605 3 splice site (ref .16; also fig .1 c and data not shown) , suggesting that correct exon inclusion can be managed by the yeast gene expression machinery .
a pre-mrna containing mutations in se2 have the ability to be #spliced with the nt 3605 3 splice site (ref .16; also fig .1 c and data not shown) , suggesting that correct exon inclusion can be managed by the yeast gene expression machinery .
a pre-mrna containing mutations in se2 having been #spliced with the nt 3605 3 splice site (ref .16; also fig .1 c and data not shown) suggest that correct exon inclusion can be managed by the yeast gene expression machinery .
a pre-mrna containing mutations in se2 having the ability to be #spliced with the nt 3605 3 splice site (ref .16; also fig .1 c and data not shown) suggest that correct exon inclusion can be managed by the yeast gene expression machinery .
a pre-mrna containing mutations in se2 may have been #spliced with the nt 3605 3 splice site (ref .16; also fig .1 c and data not shown) , suggesting that correct exon inclusion can be managed by the yeast gene expression machinery .
a pre-mrna containing mutations in se2 observed to be #spliced with the nt 3605 3 splice site (ref .16; also fig .1 c and data not shown) suggest that correct exon inclusion can be managed by the yeast gene expression machinery .
a pre-mrna containing mutations in se2 that are able to be #spliced with the nt 3605 3 splice site (ref .16; also fig .1 c and data not shown) suggest that correct exon inclusion can be managed by the yeast gene expression machinery .
a pre-mrna containing mutations in se2 that have been shown to be #spliced with the nt 3605 3 splice site (ref .16; also fig .1 c and data not shown) suggest that correct exon inclusion can be managed by the yeast gene expression machinery .
a pre-mrna containing mutations in se2 that have the ability to be #spliced with the nt 3605 3 splice site (ref .16; also fig .1 c and data not shown) suggest that correct exon inclusion can be managed by the yeast gene expression machinery .
a pre-mrna containing mutations in se2 that will be #spliced with the nt 3605 3 splice site (ref .16; also fig .1 c and data not shown) suggest that correct exon inclusion can be managed by the yeast gene expression machinery .
a pre-mrna containing mutations in se2 were #spliced with the nt 3605 3 splice site (ref .16; also fig .1 c and data not shown) , suggesting that correct exon inclusion can be managed by the yeast gene expression machinery .
a pre-mrna containing mutations in se2 will be #spliced with the nt 3605 3 splice site (ref .16; also fig .1 c and data not shown) , suggesting that correct exon inclusion can be managed by the yeast gene expression machinery .
however , a pre-mrna containing mutations in se2 is #spliced predominantly using the nt 3605 3 splice site .
interaction at a distance between multiple operators can divergently #transcribe glptq-glpacb operons of escherichia coli k-12s .
interaction at a distance between multiple operators can divergently #transcribe glptq-glpacb operons of escherichia coli k-12s .
interaction at a distance between multiple operators controls the adjacent and can divergently #transcribe glptq-glpacb operons of escherichia coli k-12s .
interaction at a distance between multiple operators controls the adjacent and has the ability to divergently #transcribe glptq-glpacb operons of escherichia coli k-12s .
interaction at a distance between multiple operators controls the adjacent and is able to divergently #transcribe glptq-glpacb operons of escherichia coli k-12s .
interaction at a distance between multiple operators controls the adjacent and is able to divergently #transcribe glptq-glpacb operons of escherichia coli k-12s .
interaction at a distance between multiple operators controls the adjacent and is observed to divergently #transcribe glptq-glpacb operons of escherichia coli k-12s .
interaction at a distance between multiple operators controls the adjacent and is observed to divergently #transcribe glptq-glpacb operons of escherichia coli k-12s .
interaction at a distance between multiple operators controls the adjacent and may divergently #transcribe glptq-glpacb operons of escherichia coli k-12s .
interaction at a distance between multiple operators controls the adjacent and may have divergently #transcribed glptq-glpacb operons of escherichia coli k-12s .
interaction at a distance between multiple operators controls the adjacent and will divergently #transcribe glptq-glpacb operons of escherichia coli k-12s .
interaction at a distance between multiple operators controls the adjacent , can #transcribe glptq-glpacb operons of escherichia coli k-12s .
interaction at a distance between multiple operators controls the adjacent , divergently #transcribes glptq-glpacb operons of escherichia coli k-12s .
interaction at a distance between multiple operators controls the adjacent , divergently #transcribes glptq-glpacb operons of escherichia coli k-12s .
interaction at a distance between multiple operators controls the adjacent , has been shown to divergently #transcribe glptq-glpacb operons of escherichia coli k-12s .
interaction at a distance between multiple operators controls the adjacent , has been shown to #transcribe glptq-glpacb operons of escherichia coli k-12s .
interaction at a distance between multiple operators controls the adjacent , has been shown to #transcribe glptq-glpacb operons of escherichia coli k-12s .
interaction at a distance between multiple operators controls the adjacent , has divergently #transcribed glptq-glpacb operons of escherichia coli k-12s .
interaction at a distance between multiple operators controls the adjacent , has the ability to divergently #transcribe glptq-glpacb operons of escherichia coli k-12s .
interaction at a distance between multiple operators controls the adjacent , has the ability to #transcribe glptq-glpacb operons of escherichia coli k-12s .
interaction at a distance between multiple operators controls the adjacent , has #transcribed glptq-glpacb operons of escherichia coli k-12s .
interaction at a distance between multiple operators controls the adjacent , is able to divergently #transcribe glptq-glpacb operons of escherichia coli k-12s .
interaction at a distance between multiple operators controls the adjacent , is able to #transcribe glptq-glpacb operons of escherichia coli k-12s .
interaction at a distance between multiple operators controls the adjacent , is able to #transcribe glptq-glpacb operons of escherichia coli k-12s .
interaction at a distance between multiple operators controls the adjacent , is observed to divergently #transcribe glptq-glpacb operons of escherichia coli k-12s .
interaction at a distance between multiple operators controls the adjacent , may divergently #transcribe glptq-glpacb operons of escherichia coli k-12s .
interaction at a distance between multiple operators controls the adjacent , may divergently #transcribe glptq-glpacb operons of escherichia coli k-12s .
interaction at a distance between multiple operators controls the adjacent , may have divergently #transcribed glptq-glpacb operons of escherichia coli k-12s .
interaction at a distance between multiple operators controls the adjacent , may have #transcribed glptq-glpacb operons of escherichia coli k-12s .
interaction at a distance between multiple operators controls the adjacent , may have #transcribed glptq-glpacb operons of escherichia coli k-12s .
interaction at a distance between multiple operators controls the adjacent , may #transcribe glptq-glpacb operons of escherichia coli k-12s .
interaction at a distance between multiple operators controls the adjacent , #transcribed glptq-glpacb operons of escherichia coli k-12s .
interaction at a distance between multiple operators controls the adjacent , #transcribes glptq-glpacb operons of escherichia coli k-12s .
interaction at a distance between multiple operators controls the adjacent , #transcribes glptq-glpacb operons of escherichia coli k-12s .
interaction at a distance between multiple operators controls the adjacent , will divergently #transcribe glptq-glpacb operons of escherichia coli k-12s .
interaction at a distance between multiple operators divergently #transcribes glptq-glpacb operons of escherichia coli k-12s .
interaction at a distance between multiple operators divergently #transcribes glptq-glpacb operons of escherichia coli k-12s .
interaction at a distance between multiple operators has divergently #transcribed glptq-glpacb operons of escherichia coli k-12s .
interaction at a distance between multiple operators has divergently #transcribed glptq-glpacb operons of escherichia coli k-12s .
interaction at a distance between multiple operators has the ability to divergently #transcribe glptq-glpacb operons of escherichia coli k-12s .
interaction at a distance between multiple operators may divergently #transcribe glptq-glpacb operons of escherichia coli k-12s .
interaction at a distance between multiple operators may have divergently #transcribed glptq-glpacb operons of escherichia coli k-12s .
interaction at a distance between multiple operators will divergently #transcribe glptq-glpacb operons of escherichia coli k-12s .
klk14 is approximately 5 .4 kb in length spanning seven exons and can divergently #transcribe two alternative transcripts present only in prostate (1 .5 kb) and skeletal muscle (1 .9 kb) .
klk14 is approximately 5 .4 kb in length spanning seven exons and can #transcribe two alternative transcripts present only in prostate (1 .5 kb) and skeletal muscle (1 .9 kb) .
klk14 is approximately 5 .4 kb in length spanning seven exons and can #transcribe two alternative transcripts present only in prostate (1 .5 kb) and skeletal muscle (1 .9 kb) .
klk14 is approximately 5 .4 kb in length spanning seven exons and divergently #transcribed two alternative transcripts present only in prostate (1 .5 kb) and skeletal muscle (1 .9 kb) .
klk14 is approximately 5 .4 kb in length spanning seven exons and has been shown to divergently #transcribe two alternative transcripts present only in prostate (1 .5 kb) and skeletal muscle (1 .9 kb) .
klk14 is approximately 5 .4 kb in length spanning seven exons and has divergently #transcribed two alternative transcripts present only in prostate (1 .5 kb) and skeletal muscle (1 .9 kb) .
klk14 is approximately 5 .4 kb in length spanning seven exons and has #transcribed two alternative transcripts present only in prostate (1 .5 kb) and skeletal muscle (1 .9 kb) .
klk14 is approximately 5 .4 kb in length spanning seven exons and has #transcribed two alternative transcripts present only in prostate (1 .5 kb) and skeletal muscle (1 .9 kb) .
klk14 is approximately 5 .4 kb in length spanning seven exons and is able to divergently #transcribe two alternative transcripts present only in prostate (1 .5 kb) and skeletal muscle (1 .9 kb) .
klk14 is approximately 5 .4 kb in length spanning seven exons and is able to #transcribe two alternative transcripts present only in prostate (1 .5 kb) and skeletal muscle (1 .9 kb) .
klk14 is approximately 5 .4 kb in length spanning seven exons and is able to #transcribe two alternative transcripts present only in prostate (1 .5 kb) and skeletal muscle (1 .9 kb) .
klk14 is approximately 5 .4 kb in length spanning seven exons and is observed to divergently #transcribe two alternative transcripts present only in prostate (1 .5 kb) and skeletal muscle (1 .9 kb) .
klk14 is approximately 5 .4 kb in length spanning seven exons and is observed to #transcribe two alternative transcripts present only in prostate (1 .5 kb) and skeletal muscle (1 .9 kb) .
klk14 is approximately 5 .4 kb in length spanning seven exons and is observed to #transcribe two alternative transcripts present only in prostate (1 .5 kb) and skeletal muscle (1 .9 kb) .
klk14 is approximately 5 .4 kb in length spanning seven exons and #transcribed two alternative transcripts present only in prostate (1 .5 kb) and skeletal muscle (1 .9 kb) .
klk14 is approximately 5 .4 kb in length spanning seven exons and #transcribed two alternative transcripts present only in prostate (1 .5 kb) and skeletal muscle (1 .9 kb) .
klk14 is approximately 5 .4 kb in length spanning seven exons and , by northern blot analysis , can #transcribe two alternative transcripts present only in prostate (1 .5 kb) and skeletal muscle (1 .9 kb) .
klk14 is approximately 5 .4 kb in length spanning seven exons and , by northern blot analysis , has been shown to #transcribe two alternative transcripts present only in prostate (1 .5 kb) and skeletal muscle (1 .9 kb) .
klk14 is approximately 5 .4 kb in length spanning seven exons and , by northern blot analysis , has been shown to #transcribe two alternative transcripts present only in prostate (1 .5 kb) and skeletal muscle (1 .9 kb) .
klk14 is approximately 5 .4 kb in length spanning seven exons and , by northern blot analysis , has #transcribed two alternative transcripts present only in prostate (1 .5 kb) and skeletal muscle (1 .9 kb) .
klk14 is approximately 5 .4 kb in length spanning seven exons and , by northern blot analysis , is observed to #transcribe two alternative transcripts present only in prostate (1 .5 kb) and skeletal muscle (1 .9 kb) .
klk14 is approximately 5 .4 kb in length spanning seven exons and , by northern blot analysis , is observed to #transcribe two alternative transcripts present only in prostate (1 .5 kb) and skeletal muscle (1 .9 kb) .
klk14 is approximately 5 .4 kb in length spanning seven exons and , by northern blot analysis , #transcribed two alternative transcripts present only in prostate (1 .5 kb) and skeletal muscle (1 .9 kb) .
klk14 is approximately 5 .4 kb in length spanning seven exons and , by northern blot analysis , will #transcribe two alternative transcripts present only in prostate (1 .5 kb) and skeletal muscle (1 .9 kb) .
nep-2 can #transcribe the rrn operon in the presence of the transcription factor cdf2 .
nep-2 has been shown to specifically #transcribe the rrn operon in the presence of the transcription factor cdf2 .
nep-2 has been shown to #transcribe the rrn operon in the presence of the transcription factor cdf2 .
nep-2 has the ability to specifically #transcribe the rrn operon in the presence of the transcription factor cdf2 .
nep-2 has the ability to #transcribe the rrn operon in the presence of the transcription factor cdf2 .
nep-2 has #transcribed the rrn operon in the presence of the transcription factor cdf2 .
nep-2 is able to specifically #transcribe the rrn operon in the presence of the transcription factor cdf2 .
nep-2 is believe to specifically #transcribe the rrn operon in the presence of the transcription factor cdf2 .
nep-2 is observed to specifically #transcribe the rrn operon in the presence of the transcription factor cdf2 .
nep-2 is observed to #transcribe the rrn operon in the presence of the transcription factor cdf2 .
nep-2 may have specifically #transcribed the rrn operon in the presence of the transcription factor cdf2 .
nep-2 may have #transcribed the rrn operon in the presence of the transcription factor cdf2 .
nep-2 specifically #transcribed the rrn operon in the presence of the transcription factor cdf2 .
nep-2 #transcribed the rrn operon in the presence of the transcription factor cdf2 .
nep-2 will specifically #transcribe the rrn operon in the presence of the transcription factor cdf2 .
restriction analysis of these two plasmids demonstrated that glpd and glpr are able to be divergently #transcribed .
restriction analysis of these two plasmids demonstrated that glpd and glpr are able to be divergently #transcribed .
restriction analysis of these two plasmids demonstrated that glpd and glpr are proven to be divergently #transcribed .
restriction analysis of these two plasmids demonstrated that glpd and glpr are proven to be #transcribed .
restriction analysis of these two plasmids demonstrated that glpd and glpr are proven to be #transcribed .
restriction analysis of these two plasmids demonstrated that glpd and glpr are #transcribed .
restriction analysis of these two plasmids demonstrated that glpd and glpr can be divergently #transcribed .
restriction analysis of these two plasmids demonstrated that glpd and glpr can be divergently #transcribed .
restriction analysis of these two plasmids demonstrated that glpd and glpr can be #transcribed .
restriction analysis of these two plasmids demonstrated that glpd and glpr have been divergently #transcribed .
restriction analysis of these two plasmids demonstrated that glpd and glpr have been shown to be divergently #transcribed .
restriction analysis of these two plasmids demonstrated that glpd and glpr have been #transcribed .
restriction analysis of these two plasmids demonstrated that glpd and glpr have been #transcribed .
restriction analysis of these two plasmids demonstrated that glpd and glpr may be divergently #transcribed .
restriction analysis of these two plasmids demonstrated that glpd and glpr may have been divergently #transcribed .
restriction analysis of these two plasmids demonstrated that glpd and glpr were divergently #transcribed .
restriction analysis of these two plasmids demonstrated that glpd and glpr were divergently #transcribed .
restriction analysis of these two plasmids demonstrated that glpd and glpr were #transcribed .
restriction analysis of these two plasmids demonstrated that glpd and glpr were #transcribed .
restriction analysis of these two plasmids demonstrated that glpd and glpr will be divergently #transcribed .
restriction analysis of these two plasmids demonstrated that glpd and glpr will be divergently #transcribed .
restriction analysis of these two plasmids demonstrated that glpd and glpr will be #transcribed .
restriction analysis of these two plasmids suggested that glpd and glpr are able to be #transcribed .
restriction analysis of these two plasmids suggested that glpd and glpr can be #transcribed .
restriction analysis of these two plasmids suggested that glpd and glpr have been shown to be #transcribed .
restriction analysis of these two plasmids suggested that glpd and glpr may be #transcribed .
restriction analysis of these two plasmids suggested that glpd and glpr may be #transcribed .
restriction analysis of these two plasmids suggested that glpd and glpr will be #transcribed .
restriction endonuclease cleavage analysis of these two plasmids demonstrated that glpd and glpr are proven to be divergently #transcribed .
restriction endonuclease cleavage analysis of these two plasmids demonstrated that glpd and glpr can be divergently #transcribed .
restriction endonuclease cleavage analysis of these two plasmids demonstrated that glpd and glpr have been divergently #transcribed .
restriction endonuclease cleavage analysis of these two plasmids demonstrated that glpd and glpr have been divergently #transcribed .
restriction endonuclease cleavage analysis of these two plasmids demonstrated that glpd and glpr have been shown to be divergently #transcribed .
restriction endonuclease cleavage analysis of these two plasmids demonstrated that glpd and glpr may have been divergently #transcribed .
restriction endonuclease cleavage analysis of these two plasmids demonstrated that glpd and glpr were divergently #transcribed .
subsequently , the negative-strand rnas are likely to be used as templates to #transcribe mrnas , which include a genomic-sized rna and a nested set of subgenomic mrna transcripts , all with an identical 5_ non-translated leader sequence of 72 77 nucleotides and 3_ co-terminal polyadenylated ends .
subsequently , the negative-strand rnas can be used as templates to #transcribe mrnas , which include a genomic-sized rna and a nested set of subgenomic mrna transcripts , all with an identical 5_ non-translated leader sequence of 72 77 nucleotides and 3_ co-terminal polyadenylated ends .
subsequently , the negative-strand rnas have been used as templates to #transcribe mrnas , which include a genomic-sized rna and a nested set of subgenomic mrna transcripts , all with an identical 5_ non-translated leader sequence of 72 77 nucleotides and 3_ co-terminal polyadenylated ends .
subsequently , the negative-strand rnas may be used as templates to #transcribe mrnas , which include a genomic-sized rna and a nested set of subgenomic mrna transcripts , all with an identical 5_ non-translated leader sequence of 72 77 nucleotides and 3_ co-terminal polyadenylated ends .
subsequently , the negative-strand rnas may have been used as templates to #transcribe mrnas , which include a genomic-sized rna and a nested set of subgenomic mrna transcripts , all with an identical 5_ non-translated leader sequence of 72 77 nucleotides and 3_ co-terminal polyadenylated ends .
subsequently , the negative-strand rnas may have been used as templates to #transcribe mrnas , which include a genomic-sized rna and a nested set of subgenomic mrna transcripts , all with an identical 5_ non-translated leader sequence of 72 77 nucleotides and 3_ co-terminal polyadenylated ends .
subsequently , the negative-strand rnas will be used as templates to #transcribe mrnas , which include a genomic-sized rna and a nested set of subgenomic mrna transcripts , all with an identical 5_ non-translated leader sequence of 72 77 nucleotides and 3_ co-terminal polyadenylated ends .
the 7 .5- and 3 .5-kb fzd5 mrnas are able to be #transcribed probably due to alternative splicing .
the 7 .5- and 3 .5-kb fzd5 mrnas are observed to be #transcribed probably due to alternative splicing .
the 7 .5- and 3 .5-kb fzd5 mrnas can be #transcribed probably due to alternative splicing .
the 7 .5- and 3 .5-kb fzd5 mrnas has been shown to be #transcribed probably due to alternative splicing .
the 7 .5- and 3 .5-kb fzd5 mrnas have been #transcribed probably due to alternative splicing .
the 7 .5- and 3 .5-kb fzd5 mrnas have the ability to be specifically #transcribed probably due to alternative splicing .
the 7 .5- and 3 .5-kb fzd5 mrnas have the ability to be #transcribed probably due to alternative splicing .
the 7 .5- and 3 .5-kb fzd5 mrnas may be #transcribed probably due to alternative splicing .
the 7 .5- and 3 .5-kb fzd5 mrnas may have been specifically #transcribed probably due to alternative splicing .
the 7 .5- and 3 .5-kb fzd5 mrnas will be specifically #transcribed probably due to alternative splicing .
the fnf-e2 isoform can be #transcribed from an alternative promoter located in the 3 end of the first intron and joined by alternative splicing to the second and third exons , which are shared by both rna isoforms .
the fnf-e2 isoform can be #transcribed from an alternative promoter located in the 3 end of the first intron .
the fnf-e2 isoform has been #transcribed from an alternative promoter located in the 3 end of the first intron and joined by alternative splicing to the second and third exons , which are shared by both rna isoforms .
the fnf-e2 isoform has been #transcribed from an alternative promoter located in the 3 end of the first intron .
the fnf-e2 isoform has been #transcribed from an alternative promoter located in the 3 end of the first intron .
the fnf-e2 isoform is believed to be #transcribed from an alternative promoter located in the 3 end of the first intron .
the fnf-e2 isoform is #transcribed from an alternative promoter located in the 3 end of the first intron .
the fnf-e2 isoform may be #transcribed from an alternative promoter located in the 3 end of the first intron and joined by alternative splicing to the second and third exons , which are shared by both rna isoforms .
the fnf-e2 isoform may have been #transcribed from an alternative promoter located in the 3 end of the first intron and joined by alternative splicing to the second and third exons , which are shared by both rna isoforms .
the fnf-e2 isoform may have been #transcribed from an alternative promoter located in the 3 end of the first intron .
the fnf-e2 isoform was #transcribed from an alternative promoter located in the 3 end of the first intron and joined by alternative splicing to the second and third exons , which are shared by both rna isoforms .
the fnf-e2 isoform was #transcribed from an alternative promoter located in the 3 end of the first intron and joined by alternative splicing to the second and third exons , which are shared by both rna isoforms .
the fnf-e2 isoform was #transcribed from an alternative promoter located in the 3 end of the first intron .
the fnf-e2 isoform will be #transcribed from an alternative promoter located in the 3 end of the first intron and joined by alternative splicing to the second and third exons , which are shared by both rna isoforms .
the fnf-e2 isoform will be #transcribed from an alternative promoter located in the 3 end of the first intron .
the fnf-e2 isoform , however , can be #transcribed from an alternative promoter located in the 3 end of the first intron .
the fnf-e2 isoform , however , has been proven to be #transcribed from an alternative promoter located in the 3 end of the first intron .
the fnf-e2 isoform , however , has been proven to be #transcribed from an alternative promoter located in the 3 end of the first intron .
the fnf-e2 isoform , however , has been #transcribed from an alternative promoter located in the 3 end of the first intron .
the fnf-e2 isoform , however , is believed to be #transcribed from an alternative promoter located in the 3 end of the first intron .
the fnf-e2 isoform , however , is #transcribed from an alternative promoter located in the 3 end of the first intron .
the fnf-e2 isoform , however , is #transcribed from an alternative promoter located in the 3 end of the first intron .
the fnf-e2 isoform , however , may have been #transcribed from an alternative promoter located in the 3 end of the first intron .
the fnf-e2 isoform , however , may have been #transcribed from an alternative promoter located in the 3 end of the first intron .
the fnf-e2 isoform , however , was #transcribed from an alternative promoter located in the 3 end of the first intron .
the fnf-e2 isoform , however , was #transcribed from an alternative promoter located in the 3 end of the first intron .
the fnf-e2 isoform , however , will be #transcribed from an alternative promoter located in the 3 end of the first intron .
the fhla gene resides next to the hydb gene at 59 min in the e . coli chromosome , and the two genes are able to be interestingly interestingly #transcribed in opposite directions .
the fhla gene resides next to the hydb gene at 59 min in the e . coli chromosome , and the two genes are able to be #transcribed in opposite directions .
the fhla gene resides next to the hydb gene at 59 min in the e . coli chromosome , and the two genes are observed to be interestingly interestingly #transcribed in opposite directions .
the fhla gene resides next to the hydb gene at 59 min in the e . coli chromosome , and the two genes can be interestingly interestingly #transcribed in opposite directions .
the fhla gene resides next to the hydb gene at 59 min in the e . coli chromosome , and the two genes can be #transcribed in opposite directions .
the fhla gene resides next to the hydb gene at 59 min in the e . coli chromosome , and the two genes has been interestingly interestingly #transcribed in opposite directions .
the fhla gene resides next to the hydb gene at 59 min in the e . coli chromosome , and the two genes has been #transcribed in opposite directions .
the fhla gene resides next to the hydb gene at 59 min in the e . coli chromosome , and the two genes has been #transcribed in opposite directions .
the fhla gene resides next to the hydb gene at 59 min in the e . coli chromosome , and the two genes have been shown to be interestingly interestingly #transcribed in opposite directions .
the fhla gene resides next to the hydb gene at 59 min in the e . coli chromosome , and the two genes have been shown to be #transcribed in opposite directions .
the fhla gene resides next to the hydb gene at 59 min in the e . coli chromosome , and the two genes may be interestingly interestingly #transcribed in opposite directions .
the fhla gene resides next to the hydb gene at 59 min in the e . coli chromosome , and the two genes may be #transcribed in opposite directions .
the fhla gene resides next to the hydb gene at 59 min in the e . coli chromosome , and the two genes may have been interestingly interestingly #transcribed in opposite directions .
the fhla gene resides next to the hydb gene at 59 min in the e . coli chromosome , and the two genes were #transcribed in opposite directions .
the fhla gene resides next to the hydb gene at 59 min in the e . coli chromosome , and the two genes were #transcribed in opposite directions .
the fhla gene resides next to the hydb gene at 59 min in the e . coli chromosome , and the two genes will be #transcribed in opposite directions .
the gene can be #transcribed in a large variety of organs and tissues and shows differential splicing of two exons , giving rise to at least three different transcripts .
the gene has been shown to be #transcribed in a large variety of organs and tissues and showed differential splicing of two exons , giving rise to at least three different transcripts .
the gene has been shown to be #transcribed in a large variety of organs and tissues and showed differential splicing of two exons , giving rise to at least three different transcripts .
the gene has been #transcribed in a large variety of organs and tissues and shows differential splicing of two exons , giving rise to at least three different transcripts .
the gene is likely to be #transcribed in a large variety of organs and tissues and shows differential splicing of two exons , giving rise to at least three different transcripts .
the gene is observed to be #transcribed in a large variety of organs and tissues and shows differential splicing of two exons , giving rise to at least three different transcripts .
the gene is observed to be #transcribed in a large variety of organs and tissues and shows differential splicing of two exons , giving rise to at least three different transcripts .
the gene may be #transcribed in a large variety of organs and tissues and shows differential splicing of two exons , giving rise to at least three different transcripts .
the gene may be #transcribed in a large variety of organs and tissues and shows differential splicing of two exons , giving rise to at least three different transcripts .
the gene may have been #transcribed in a large variety of organs and tissues and showed differential splicing of two exons , giving rise to at least three different transcripts .
the gene was #transcribed in a large variety of organs and tissues and showed differential splicing of two exons , giving rise to at least three different transcripts .
the gene will be #transcribed in a large variety of organs and tissues and shows differential splicing of two exons , giving rise to at least three different transcripts .
the gene , as our study predicted , has been shown to be #transcribed in a large variety of organs and tissues and showed differential splicing of two exons , giving rise to at least three different transcripts .
the gene , as our study predicted , is able to be be #transcribed in a large variety of organs and tissues and shows differential splicing of two exons , giving rise to at least three different transcripts .
the gene , as our study predicted , is likely to be #transcribed in a large variety of organs and tissues and shows differential splicing of two exons , giving rise to at least three different transcripts .
the gene , as our study predicted , is observed to be #transcribed in a large variety of organs and tissues and shows differential splicing of two exons , giving rise to at least three different transcripts .
the gene , as our study predicted , may be #transcribed in a large variety of organs and tissues and shows differential splicing of two exons , giving rise to at least three different transcripts .
the gene , as our study predicted , may have been #transcribed in a large variety of organs and tissues and showed differential splicing of two exons , giving rise to at least three different transcripts .
the gene , as our study predicted , will be #transcribed in a large variety of organs and tissues and shows differential splicing of two exons , giving rise to at least three different transcripts .
the gene , as our study predicted , will be #transcribed in a large variety of organs and tissues and shows differential splicing of two exons , giving rise to at least three different transcripts .
the negative-strand rnas , subsequently , have been chosen to be used as templates to #transcribe mrnas , which include a genomic-sized rna and a nested set of subgenomic mrna transcripts , all with an identical 5_ non-translated leader sequence of 72 77 nucleotides and 3_ co-terminal polyadenylated ends .
the negative-strand rnas , subsequently , may be used as templates to #transcribe mrnas , which include a genomic-sized rna and a nested set of subgenomic mrna transcripts , all with an identical 5_ non-translated leader sequence of 72 77 nucleotides and 3_ co-terminal polyadenylated ends .
the negative-strand rnas , subsequently , were used as templates to #transcribe mrnas , which include a genomic-sized rna and a nested set of subgenomic mrna transcripts , all with an identical 5_ non-translated leader sequence of 72 77 nucleotides and 3_ co-terminal polyadenylated ends .
the negative-strand rnas , subsequently , were used as templates to #transcribe mrnas , which include a genomic-sized rna and a nested set of subgenomic mrna transcripts , all with an identical 5_ non-translated leader sequence of 72 77 nucleotides and 3_ co-terminal polyadenylated ends .
the negative-strand rnas , subsequently , will be used as templates to #transcribe mrnas , which include a genomic-sized rna and a nested set of subgenomic mrna transcripts , all with an identical 5_ non-translated leader sequence of 72 77 nucleotides and 3_ co-terminal polyadenylated ends .
the plastid genome can be divergently #transcribed by a plastid-encoded prokaryotic-type rna polymerase (pep) and a nucleus-encoded phage-type rna polymerase (nep) .
the plastid genome can be #transcribed by a plastid-encoded prokaryotic-type rna polymerase (pep) and a nucleus-encoded phage-type rna polymerase (nep) .
the plastid genome has been shown to be divergently #transcribed by a plastid-encoded prokaryotic-type rna polymerase (pep) and a nucleus-encoded phage-type rna polymerase (nep) .
the plastid genome has been #transcribed by a plastid-encoded prokaryotic-type rna polymerase (pep) and a nucleus-encoded phage-type rna polymerase (nep) .
the plastid genome is able to be divergently #transcribed by a plastid-encoded prokaryotic-type rna polymerase (pep) and a nucleus-encoded phage-type rna polymerase (nep) .
the plastid genome is found to be #transcribed by a plastid-encoded prokaryotic-type rna polymerase (pep) and a nucleus-encoded phage-type rna polymerase (nep) .
the plastid genome is #transcribed by a plastid-encoded prokaryotic-type rna polymerase (pep) and a nucleus-encoded phage-type rna polymerase (nep) .
the plastid genome may have been #transcribed by a plastid-encoded prokaryotic-type rna polymerase (pep) and a nucleus-encoded phage-type rna polymerase (nep) .
the plastid genome will be divergently #transcribed by a plastid-encoded prokaryotic-type rna polymerase (pep) and a nucleus-encoded phage-type rna polymerase (nep) .
the ula regulon has been formed by two divergently #transcribed operons , ulag and ulaabcdef .
the ula regulon has been shown to be formed by two divergently #transcribed operons , ulag and ulaabcdef .
the ula regulon is formed by two divergently #transcribed operons , ulag and ulaabcdef .
the ula regulon may be formed by two divergently #transcribed operons , ulag and ulaabcdef .
the ula regulon may have been formed by two divergently #transcribed operons , ulag and ulaabcdef .
the ula regulon was formed by two divergently #transcribed operons , ulag and ulaabcdef .
the ula regulon will be formed by two divergently #transcribed operons , ulag and ulaabcdef .
the ula regulon will be formed by two divergently #transcribed operons , ulag and ulaabcdef .
the ula regulon , responsible for the utilization of l-ascorbate in escherichia coli , can be formed by two divergently #transcribed operons , ulag and ulaabcdef .
the ula regulon , responsible for the utilization of l-ascorbate in escherichia coli , has been formed by two divergently #transcribed operons , ulag and ulaabcdef .
the ula regulon , responsible for the utilization of l-ascorbate in escherichia coli , has been shown to be formed by two divergently #transcribed operons , ulag and ulaabcdef .
the ula regulon , responsible for the utilization of l-ascorbate in escherichia coli , is able to be formed by two divergently #transcribed operons , ulag and ulaabcdef .
the ula regulon , responsible for the utilization of l-ascorbate in escherichia coli , may have been formed by two divergently #transcribed operons , ulag and ulaabcdef .
the ula regulon , responsible for the utilization of l-ascorbate in escherichia coli , was formed by two divergently #transcribed operons , ulag and ulaabcdef .
the ula regulon , responsible for the utilization of l-ascorbate in escherichia coli , will be formed by two divergently #transcribed operons , ulag and ulaabcdef .
they also indicate that spinach harvested in march should contain preferentially nep , i .e . the enzyme being able to specifically #transcribe the rrn operon at pc .
they also indicate that spinach harvested in march should contain preferentially nep , i .e . the enzyme having specifically #transcribed the rrn operon at pc .
they also indicate that spinach harvested in march should contain preferentially nep , i .e . the enzyme observed to specifically #transcribe the rrn operon at pc .
they also indicate that spinach harvested in march should contain preferentially nep , i .e . the enzyme observed to #transcribe the rrn operon at pc .
they also indicate that spinach harvested in march should contain preferentially nep , i .e . the enzyme shown to #transcribe the rrn operon at pc .
they also indicate that spinach harvested in march should contain preferentially nep , i .e . the enzyme that can #transcribe the rrn operon at pc .
they also indicate that spinach harvested in march should contain preferentially nep , i .e . the enzyme that has been shown to specifically #transcribe the rrn operon at pc .
they also indicate that spinach harvested in march should contain preferentially nep , i .e . the enzyme that has been shown to #transcribe the rrn operon at pc .
they also indicate that spinach harvested in march should contain preferentially nep , i .e . the enzyme that has specifically #transcribed the rrn operon at pc .
they also indicate that spinach harvested in march should contain preferentially nep , i .e . the enzyme that is able to #transcribe the rrn operon at pc .
they also indicate that spinach harvested in march should contain preferentially nep , i .e . the enzyme that is observed to specifically #transcribe the rrn operon at pc .
they also indicate that spinach harvested in march should contain preferentially nep , i .e . the enzyme that may have specifically #transcribed the rrn operon at pc .
they also indicate that spinach harvested in march should contain preferentially nep , i .e . the enzyme that may have #transcribed the rrn operon at pc .
they also indicate that spinach harvested in march should contain preferentially nep , i .e . the enzyme that may specifically #transcribe the rrn operon at pc .
they also indicate that spinach harvested in march should contain preferentially nep , i .e . the enzyme that #transcribed the rrn operon at pc .
this antisense-bcma rna can be divergently #transcribed from the same locus as bcma , and exhibits mrna characteristic features , e .g .polyadenylation and splicing .
this antisense-bcma rna can be divergently #transcribed from the same locus as bcma , and exhibits mrna characteristic features , e .g .polyadenylation and splicing .
this antisense-bcma rna can be #transcribed from the same locus as bcma , and exhibits mrna characteristic features , e .g .polyadenylation and splicing .
this antisense-bcma rna has been divergently #transcribed from the same locus as bcma , and exhibits mrna characteristic features , e .g .polyadenylation and splicing .
this antisense-bcma rna has been shown to be divergently #transcribed from the same locus as bcma , and exhibits mrna characteristic features , e .g .polyadenylation and splicing .
this antisense-bcma rna has been shown to be #transcribed from the same locus as bcma , and exhibits mrna characteristic features , e .g .polyadenylation and splicing .
this antisense-bcma rna is able to be divergently #transcribed from the same locus as bcma , and exhibits mrna characteristic features , e .g .polyadenylation and splicing .
this antisense-bcma rna is observed to be #transcribed from the same locus as bcma , and exhibits mrna characteristic features , e .g .polyadenylation and splicing .
this antisense-bcma rna may be divergently #transcribed from the same locus as bcma , and exhibits mrna characteristic features , e .g .polyadenylation and splicing .
this antisense-bcma rna may be divergently #transcribed from the same locus as bcma , and exhibits mrna characteristic features , e .g .polyadenylation and splicing .
this antisense-bcma rna may be #transcribed from the same locus as bcma , and exhibits mrna characteristic features , e .g .polyadenylation and splicing .
this antisense-bcma rna may have been divergently #transcribed from the same locus as bcma , and exhibits mrna characteristic features , e .g .polyadenylation and splicing .
this antisense-bcma rna may have been divergently #transcribed from the same locus as bcma , and exhibits mrna characteristic features , e .g .polyadenylation and splicing .
this antisense-bcma rna may have been #transcribed from the same locus as bcma , and exhibits mrna characteristic features , e .g .polyadenylation and splicing .
this antisense-bcma rna was divergently #transcribed from the same locus as bcma , and exhibits mrna characteristic features , e .g .polyadenylation and splicing .
this antisense-bcma rna was divergently #transcribed from the same locus as bcma , and exhibits mrna characteristic features , e .g .polyadenylation and splicing .
this antisense-bcma rna was #transcribed from the same locus as bcma , and exhibits mrna characteristic features , e .g .polyadenylation and splicing .
this antisense-bcma rna will be divergently #transcribed from the same locus as bcma , and exhibits mrna characteristic features , e .g .polyadenylation and splicing .
this operon , activated by growth on glycolate , can be efficiently #transcribed as a single message and is under the positive control of glcc encoded by a divergent gene .
this operon , activated by growth on glycolate , has been efficiently #transcribed as a single message and is under the positive control of glcc encoded by a divergent gene .
this operon , activated by growth on glycolate , has been shown to be #transcribed as a single message and is under the positive control of glcc encoded by a divergent gene .
this operon , activated by growth on glycolate , is able to be efficiently #transcribed as a single message and is under the positive control of glcc encoded by a divergent gene .
this operon , activated by growth on glycolate , is able to be #transcribed as a single message and is under the positive control of glcc encoded by a divergent gene .
this operon , activated by growth on glycolate , is proven to be efficiently #transcribed as a single message and is under the positive control of glcc encoded by a divergent gene .
this operon , activated by growth on glycolate , may have been efficiently #transcribed as a single message and is under the positive control of glcc encoded by a divergent gene .
this operon , activated by growth on glycolate , was efficiently #transcribed as a single message and is under the positive control of glcc encoded by a divergent gene .
this operon , activated by growth on glycolate , was #transcribed as a single message and is under the positive control of glcc encoded by a divergent gene .
glptq-glpacb operons of escherichia coli k-12s are able to be divergently #transcribed by interaction at a distance between multiple operators .
glptq-glpacb operons of escherichia coli k-12s are divergently #transcribed by interaction at a distance between multiple operators .
glptq-glpacb operons of escherichia coli k-12s are observed to be divergently #transcribed by interaction at a distance between multiple operators .
glptq-glpacb operons of escherichia coli k-12s are observed to be divergently #transcribed by interaction at a distance between multiple operators .
glptq-glpacb operons of escherichia coli k-12s are observed to be #transcribed by interaction at a distance between multiple operators .
glptq-glpacb operons of escherichia coli k-12s are #transcribed by interaction at a distance between multiple operators .
glptq-glpacb operons of escherichia coli k-12s are #transcribed by interaction at a distance between multiple operators .
glptq-glpacb operons of escherichia coli k-12s can be divergently #transcribed by interaction at a distance between multiple operators .
glptq-glpacb operons of escherichia coli k-12s can be #transcribed by interaction at a distance between multiple operators .
glptq-glpacb operons of escherichia coli k-12s can be #transcribed by interaction at a distance between multiple operators .
glptq-glpacb operons of escherichia coli k-12s have been shown to be divergently #transcribed by interaction at a distance between multiple operators .
glptq-glpacb operons of escherichia coli k-12s have been shown to be #transcribed by interaction at a distance between multiple operators .
glptq-glpacb operons of escherichia coli k-12s have been #transcribed by interaction at a distance between multiple operators .
glptq-glpacb operons of escherichia coli k-12s have the ability to be #transcribed by interaction at a distance between multiple operators .
glptq-glpacb operons of escherichia coli k-12s may have been #transcribed by interaction at a distance between multiple operators .
glptq-glpacb operons of escherichia coli k-12s were divergently #transcribed by interaction at a distance between multiple operators .
glptq-glpacb operons of escherichia coli k-12s were #transcribed by interaction at a distance between multiple operators .
glptq-glpacb operons of escherichia coli k-12s were #transcribed by interaction at a distance between multiple operators .
nep-2 specifically #transcribes the rrn operon in the presence of the transcription factor cdf2 .
subsequently , the negative-strand rnas are used as templates to #transcribe mrnas , which include a genomic-sized rna and a nested set of subgenomic mrna transcripts , all with an identical 5_ non-translated leader sequence of 72 77 nucleotides and 3_ co-terminal polyadenylated ends .
the plastid genome is known to be #transcribed by a plastid-encoded prokaryotic-type rna polymerase (pep) and a nucleus-encoded phage-type rna polymerase (nep) .
they also indicate that spinach harvested in march should contain preferentially nep , i .e . the enzyme that #transcribes the rrn operon at pc .
restriction endonuclease cleavage analysis of these two plasmids demonstrated that glpd and glpr are divergently #transcribed .
restriction endonuclease cleavage analysis of these two plasmids demonstrated that glpd and glpr are divergently #transcribed .
the ula regulon , responsible for the utilization of l-ascorbate in escherichia coli , is formed by two divergently #transcribed operons , ulag and ulaabcdef .
klk14 is approximately 5 .4 kb in length spanning seven exons and , by northern blot analysis , #transcribes two alternative transcripts present only in prostate (1 .5 kb) and skeletal muscle (1 .9 kb) .
klk14 is approximately 5 .4 kb in length spanning seven exons and , by northern blot analysis , #transcribes two alternative transcripts present only in prostate (1 .5 kb) and skeletal muscle (1 .9 kb) .
the 7 .5- and 3 .5-kb fzd5 mrnas were #transcribed probably due to alternative splicing .
the gene is #transcribed in a large variety of organs and tissues and shows differential splicing of two exons , giving rise to at least three different transcripts .
this antisense-bcma rna is #transcribed from the same locus as bcma , and exhibits mrna characteristic features , e .g .polyadenylation and splicing .
interaction at a distance between multiple operators can divergently #transcribe glpd and glpr of these two plasmids .
interaction at a distance between multiple operators can divergently #transcribe glpd and glpr of these two plasmids .
interaction at a distance between multiple operators controls the adjacent and can divergently #transcribe glpd and glpr of these two plasmids .
interaction at a distance between multiple operators controls the adjacent and can divergently #transcribe glpd and glpr of these two plasmids .
interaction at a distance between multiple operators controls the adjacent and can divergently #transcribe the two genes of e . coli chromosome .
interaction at a distance between multiple operators controls the adjacent and can divergently #transcribe the two genes of e . coli chromosome .
interaction at a distance between multiple operators controls the adjacent and divergently #transcribed glpd and glpr of these two plasmids .
interaction at a distance between multiple operators controls the adjacent and divergently #transcribed glpd and glpr of these two plasmids .
interaction at a distance between multiple operators controls the adjacent and divergently #transcribed the two genes of e . coli chromosome .
interaction at a distance between multiple operators controls the adjacent and divergently #transcribes glpd and glpr of these two plasmids .
interaction at a distance between multiple operators controls the adjacent and has been shown to divergently #transcribe the two genes of e . coli chromosome .
interaction at a distance between multiple operators controls the adjacent and has divergently #transcribed the two genes of e . coli chromosome .
interaction at a distance between multiple operators controls the adjacent and has the ability to divergently #transcribe glpd and glpr of these two plasmids .
interaction at a distance between multiple operators controls the adjacent and has the ability to divergently #transcribe glpd and glpr of these two plasmids .
interaction at a distance between multiple operators controls the adjacent and has the ability to divergently #transcribe the two genes of e . coli chromosome .
interaction at a distance between multiple operators controls the adjacent and is able to divergently #transcribe glpd and glpr of these two plasmids .
interaction at a distance between multiple operators controls the adjacent and is able to divergently #transcribe glpd and glpr of these two plasmids .
interaction at a distance between multiple operators controls the adjacent and is observed to divergently #transcribe the two genes of e . coli chromosome .
interaction at a distance between multiple operators controls the adjacent and may divergently #transcribe glpd and glpr of these two plasmids .
interaction at a distance between multiple operators controls the adjacent and may divergently #transcribe glpd and glpr of these two plasmids .
interaction at a distance between multiple operators controls the adjacent and may divergently #transcribe the two genes of e . coli chromosome .
interaction at a distance between multiple operators controls the adjacent and may have divergently #transcribed the two genes of e . coli chromosome .
interaction at a distance between multiple operators controls the adjacent and will divergently #transcribe glpd and glpr of these two plasmids .
interaction at a distance between multiple operators controls the adjacent and will divergently #transcribe the two genes of e . coli chromosome .
interaction at a distance between multiple operators controls the adjacent , can divergently #transcribe glpd and glpr of these two plasmids .
interaction at a distance between multiple operators controls the adjacent , can #transcribe glpd and glpr of these two plasmids .
interaction at a distance between multiple operators controls the adjacent , can #transcribe glpd and glpr of these two plasmids .
interaction at a distance between multiple operators controls the adjacent , can #transcribe the two genes of e . coli chromosome .
interaction at a distance between multiple operators controls the adjacent , divergently #transcribed glpd and glpr of these two plasmids .
interaction at a distance between multiple operators controls the adjacent , divergently #transcribes the two genes of e . coli chromosome .
interaction at a distance between multiple operators controls the adjacent , has been shown to divergently #transcribe the two genes of e . coli chromosome .
interaction at a distance between multiple operators controls the adjacent , has been shown to #transcribe glpd and glpr of these two plasmids .
interaction at a distance between multiple operators controls the adjacent , has divergently #transcribed glpd and glpr of these two plasmids .
interaction at a distance between multiple operators controls the adjacent , has divergently #transcribed glpd and glpr of these two plasmids .
interaction at a distance between multiple operators controls the adjacent , has divergently #transcribed the two genes of e . coli chromosome .
interaction at a distance between multiple operators controls the adjacent , has the ability to divergently #transcribe the two genes of e . coli chromosome .
interaction at a distance between multiple operators controls the adjacent , has the ability to #transcribe the two genes of e . coli chromosome .
interaction at a distance between multiple operators controls the adjacent , has the ability to #transcribe the two genes of e . coli chromosome .
interaction at a distance between multiple operators controls the adjacent , has #transcribed glpd and glpr of these two plasmids .
interaction at a distance between multiple operators controls the adjacent , has #transcribed glpd and glpr of these two plasmids .
interaction at a distance between multiple operators controls the adjacent , has #transcribed the two genes of e . coli chromosome .
interaction at a distance between multiple operators controls the adjacent , is able to divergently #transcribe glpd and glpr of these two plasmids .
interaction at a distance between multiple operators controls the adjacent , is able to divergently #transcribe glpd and glpr of these two plasmids .
interaction at a distance between multiple operators controls the adjacent , is able to divergently #transcribe the two genes of e . coli chromosome .
interaction at a distance between multiple operators controls the adjacent , is able to #transcribe glpd and glpr of these two plasmids .
interaction at a distance between multiple operators controls the adjacent , is able to #transcribe the two genes of e . coli chromosome .
interaction at a distance between multiple operators controls the adjacent , is able to #transcribe the two genes of e . coli chromosome .
interaction at a distance between multiple operators controls the adjacent , is observed to divergently #transcribe glpd and glpr of these two plasmids .
interaction at a distance between multiple operators controls the adjacent , is observed to divergently #transcribe the two genes of e . coli chromosome .
interaction at a distance between multiple operators controls the adjacent , is observed to #transcribe glpd and glpr of these two plasmids .
interaction at a distance between multiple operators controls the adjacent , is observed to #transcribe the two genes of e . coli chromosome .
interaction at a distance between multiple operators controls the adjacent , may divergently #transcribe the two genes of e . coli chromosome .
interaction at a distance between multiple operators controls the adjacent , may have divergently #transcribed glpd and glpr of these two plasmids .
interaction at a distance between multiple operators controls the adjacent , may have #transcribed glpd and glpr of these two plasmids .
interaction at a distance between multiple operators controls the adjacent , may have #transcribed the two genes of e . coli chromosome .
interaction at a distance between multiple operators controls the adjacent , may #transcribe glpd and glpr of these two plasmids .
interaction at a distance between multiple operators controls the adjacent , may #transcribe the two genes of e . coli chromosome .
interaction at a distance between multiple operators controls the adjacent , may #transcribe the two genes of e . coli chromosome .
interaction at a distance between multiple operators controls the adjacent , #transcribes glpd and glpr of these two plasmids .
interaction at a distance between multiple operators controls the adjacent , will divergently #transcribe glpd and glpr of these two plasmids .
interaction at a distance between multiple operators controls the adjacent , will divergently #transcribe glpd and glpr of these two plasmids .
interaction at a distance between multiple operators controls the adjacent , will divergently #transcribe the two genes of e . coli chromosome .
interaction at a distance between multiple operators controls the adjacent , will divergently #transcribe the two genes of e . coli chromosome .
interaction at a distance between multiple operators controls the adjacent , will #transcribe glpd and glpr of these two plasmids .
interaction at a distance between multiple operators divergently #transcribed glpd and glpr of these two plasmids .
interaction at a distance between multiple operators divergently #transcribed the two genes of e . coli chromosome .
interaction at a distance between multiple operators divergently #transcribed the two genes of e . coli chromosome .
interaction at a distance between multiple operators divergently #transcribes the two genes of e . coli chromosome .
interaction at a distance between multiple operators divergently #transcribes the two genes of e . coli chromosome .
interaction at a distance between multiple operators has been shown to divergently #transcribe glpd and glpr of these two plasmids .
interaction at a distance between multiple operators has been shown to divergently #transcribe the two genes of e . coli chromosome .
interaction at a distance between multiple operators has divergently #transcribed the two genes of e . coli chromosome .
interaction at a distance between multiple operators has the ability to divergently #transcribe glpd and glpr of these two plasmids .
interaction at a distance between multiple operators has the ability to divergently #transcribe glpd and glpr of these two plasmids .
interaction at a distance between multiple operators is able to divergently #transcribe glpd and glpr of these two plasmids .
interaction at a distance between multiple operators is able to divergently #transcribe the two genes of e . coli chromosome .
interaction at a distance between multiple operators is observed to divergently #transcribe glpd and glpr of these two plasmids .
interaction at a distance between multiple operators is observed to divergently #transcribe the two genes of e . coli chromosome .
interaction at a distance between multiple operators may divergently #transcribe glpd and glpr of these two plasmids .
interaction at a distance between multiple operators may divergently #transcribe glpd and glpr of these two plasmids .
interaction at a distance between multiple operators may divergently #transcribe the two genes of e . coli chromosome .
interaction at a distance between multiple operators may have divergently #transcribed glpd and glpr of these two plasmids .
interaction at a distance between multiple operators may have divergently #transcribed the two genes of e . coli chromosome .
interaction at a distance between multiple operators will divergently #transcribe the two genes of e . coli chromosome .
restriction analysis of e . coli chromosome demonstrated that the two genes are able to be divergently #transcribed .
restriction analysis of e . coli chromosome demonstrated that the two genes are able to be divergently #transcribed .
restriction analysis of e . coli chromosome demonstrated that the two genes are able to be #transcribed .
restriction analysis of e . coli chromosome demonstrated that the two genes are divergently #transcribed .
restriction analysis of e . coli chromosome demonstrated that the two genes are proven to be divergently #transcribed .
restriction analysis of e . coli chromosome demonstrated that the two genes are proven to be #transcribed .
restriction analysis of e . coli chromosome demonstrated that the two genes are #transcribed .
restriction analysis of e . coli chromosome demonstrated that the two genes can be #transcribed .
restriction analysis of e . coli chromosome demonstrated that the two genes have been divergently #transcribed .
restriction analysis of e . coli chromosome demonstrated that the two genes have been shown to be divergently #transcribed .
restriction analysis of e . coli chromosome demonstrated that the two genes have been shown to be divergently #transcribed .
restriction analysis of e . coli chromosome demonstrated that the two genes have been shown to be #transcribed .
restriction analysis of e . coli chromosome demonstrated that the two genes have been shown to be #transcribed .
restriction analysis of e . coli chromosome demonstrated that the two genes may be divergently #transcribed .
restriction analysis of e . coli chromosome demonstrated that the two genes were #transcribed .
restriction analysis of e . coli chromosome demonstrated that the two genes will be divergently #transcribed .
restriction analysis of e . coli chromosome suggested that the two genes are proven to be #transcribed .
restriction analysis of e . coli chromosome suggested that the two genes can be #transcribed .
restriction analysis of e . coli chromosome suggested that the two genes have been shown to be #transcribed .
restriction analysis of e . coli chromosome suggested that the two genes have been #transcribed .
restriction analysis of e . coli chromosome suggested that the two genes may be #transcribed .
restriction analysis of e . coli chromosome suggested that the two genes may have been #transcribed .
restriction analysis of e . coli chromosome suggested that the two genes will be #transcribed .
restriction analysis of escherichia coli k-12s demonstrated that glptq-glpacb operons are able to be #transcribed .
restriction analysis of escherichia coli k-12s demonstrated that glptq-glpacb operons are divergently #transcribed .
restriction analysis of escherichia coli k-12s demonstrated that glptq-glpacb operons are divergently #transcribed .
restriction analysis of escherichia coli k-12s demonstrated that glptq-glpacb operons are proven to be #transcribed .
restriction analysis of escherichia coli k-12s demonstrated that glptq-glpacb operons are #transcribed .
restriction analysis of escherichia coli k-12s demonstrated that glptq-glpacb operons can be divergently #transcribed .
restriction analysis of escherichia coli k-12s demonstrated that glptq-glpacb operons have been shown to be #transcribed .
restriction analysis of escherichia coli k-12s demonstrated that glptq-glpacb operons have been #transcribed .
restriction analysis of escherichia coli k-12s demonstrated that glptq-glpacb operons may be #transcribed .
restriction analysis of escherichia coli k-12s demonstrated that glptq-glpacb operons may have been divergently #transcribed .
restriction analysis of escherichia coli k-12s demonstrated that glptq-glpacb operons may have been #transcribed .
restriction analysis of escherichia coli k-12s demonstrated that glptq-glpacb operons were divergently #transcribed .
restriction analysis of escherichia coli k-12s demonstrated that glptq-glpacb operons were divergently #transcribed .
restriction analysis of escherichia coli k-12s demonstrated that glptq-glpacb operons will be divergently #transcribed .
restriction analysis of escherichia coli k-12s demonstrated that glptq-glpacb operons will be divergently #transcribed .
restriction analysis of escherichia coli k-12s suggested that glptq-glpacb operons are able to be #transcribed .
restriction analysis of escherichia coli k-12s suggested that glptq-glpacb operons are able to be #transcribed .
restriction analysis of escherichia coli k-12s suggested that glptq-glpacb operons have been shown to be #transcribed .
restriction analysis of escherichia coli k-12s suggested that glptq-glpacb operons have been shown to be #transcribed .
restriction analysis of escherichia coli k-12s suggested that glptq-glpacb operons have been #transcribed .
restriction analysis of escherichia coli k-12s suggested that glptq-glpacb operons may be #transcribed .
restriction analysis of escherichia coli k-12s suggested that glptq-glpacb operons may be #transcribed .
restriction analysis of escherichia coli k-12s suggested that glptq-glpacb operons may have been #transcribed .
restriction analysis of escherichia coli k-12s suggested that glptq-glpacb operons may have been #transcribed .
restriction analysis of escherichia coli k-12s suggested that glptq-glpacb operons were #transcribed .
restriction analysis of escherichia coli k-12s suggested that glptq-glpacb operons will be #transcribed .
restriction endonuclease cleavage analysis of e . coli chromosome demonstrated that the two genes are able to be divergently #transcribed .
restriction endonuclease cleavage analysis of e . coli chromosome demonstrated that the two genes are proven to be divergently #transcribed .
restriction endonuclease cleavage analysis of e . coli chromosome demonstrated that the two genes can be divergently #transcribed .
restriction endonuclease cleavage analysis of e . coli chromosome demonstrated that the two genes can be divergently #transcribed .
restriction endonuclease cleavage analysis of e . coli chromosome demonstrated that the two genes have been divergently #transcribed .
restriction endonuclease cleavage analysis of e . coli chromosome demonstrated that the two genes have been divergently #transcribed .
restriction endonuclease cleavage analysis of e . coli chromosome demonstrated that the two genes may be divergently #transcribed .
restriction endonuclease cleavage analysis of e . coli chromosome demonstrated that the two genes may have been divergently #transcribed .
restriction endonuclease cleavage analysis of e . coli chromosome demonstrated that the two genes were divergently #transcribed .
restriction endonuclease cleavage analysis of escherichia coli k-12s demonstrated that glptq-glpacb operons are able to be divergently #transcribed .
restriction endonuclease cleavage analysis of escherichia coli k-12s demonstrated that glptq-glpacb operons are able to be divergently #transcribed .
restriction endonuclease cleavage analysis of escherichia coli k-12s demonstrated that glptq-glpacb operons are divergently #transcribed .
restriction endonuclease cleavage analysis of escherichia coli k-12s demonstrated that glptq-glpacb operons can be divergently #transcribed .
restriction endonuclease cleavage analysis of escherichia coli k-12s demonstrated that glptq-glpacb operons can be divergently #transcribed .
restriction endonuclease cleavage analysis of escherichia coli k-12s demonstrated that glptq-glpacb operons have been divergently #transcribed .
restriction endonuclease cleavage analysis of escherichia coli k-12s demonstrated that glptq-glpacb operons have been shown to be divergently #transcribed .
restriction endonuclease cleavage analysis of escherichia coli k-12s demonstrated that glptq-glpacb operons may be divergently #transcribed .
restriction endonuclease cleavage analysis of escherichia coli k-12s demonstrated that glptq-glpacb operons may have been divergently #transcribed .
restriction endonuclease cleavage analysis of escherichia coli k-12s demonstrated that glptq-glpacb operons were divergently #transcribed .
restriction endonuclease cleavage analysis of escherichia coli k-12s demonstrated that glptq-glpacb operons will be divergently #transcribed .
restriction endonuclease cleavage analysis of escherichia coli k-12s demonstrated that glptq-glpacb operons will be divergently #transcribed .
subsequently , ulag and ulaabcdef are likely to be used as templates to #transcribe ula regulon , which include a genomic-sized rna and a nested set of subgenomic mrna transcripts , all with an identical 5_ non-translated leader sequence of 72 77 nucleotides and 3_ co-terminal polyadenylated ends .
subsequently , ulag and ulaabcdef are selected to be used as templates to #transcribe ula regulon , which include a genomic-sized rna and a nested set of subgenomic mrna transcripts , all with an identical 5_ non-translated leader sequence of 72 77 nucleotides and 3_ co-terminal polyadenylated ends .
subsequently , ulag and ulaabcdef are used as templates to #transcribe ula regulon , which include a genomic-sized rna and a nested set of subgenomic mrna transcripts , all with an identical 5_ non-translated leader sequence of 72 77 nucleotides and 3_ co-terminal polyadenylated ends .
subsequently , ulag and ulaabcdef are used as templates to #transcribe ula regulon , which include a genomic-sized rna and a nested set of subgenomic mrna transcripts , all with an identical 5_ non-translated leader sequence of 72 77 nucleotides and 3_ co-terminal polyadenylated ends .
subsequently , ulag and ulaabcdef have been chosen to be used as templates to #transcribe ula regulon , which include a genomic-sized rna and a nested set of subgenomic mrna transcripts , all with an identical 5_ non-translated leader sequence of 72 77 nucleotides and 3_ co-terminal polyadenylated ends .
subsequently , ulag and ulaabcdef may be used as templates to #transcribe ula regulon , which include a genomic-sized rna and a nested set of subgenomic mrna transcripts , all with an identical 5_ non-translated leader sequence of 72 77 nucleotides and 3_ co-terminal polyadenylated ends .
subsequently , ulag and ulaabcdef may have been used as templates to #transcribe ula regulon , which include a genomic-sized rna and a nested set of subgenomic mrna transcripts , all with an identical 5_ non-translated leader sequence of 72 77 nucleotides and 3_ co-terminal polyadenylated ends .
subsequently , ulag and ulaabcdef may have been used as templates to #transcribe ula regulon , which include a genomic-sized rna and a nested set of subgenomic mrna transcripts , all with an identical 5_ non-translated leader sequence of 72 77 nucleotides and 3_ co-terminal polyadenylated ends .
subsequently , ulag and ulaabcdef were used as templates to #transcribe ula regulon , which include a genomic-sized rna and a nested set of subgenomic mrna transcripts , all with an identical 5_ non-translated leader sequence of 72 77 nucleotides and 3_ co-terminal polyadenylated ends .
subsequently , ulag and ulaabcdef were used as templates to #transcribe ula regulon , which include a genomic-sized rna and a nested set of subgenomic mrna transcripts , all with an identical 5_ non-translated leader sequence of 72 77 nucleotides and 3_ co-terminal polyadenylated ends .
subsequently , ulag and ulaabcdef will be used as templates to #transcribe ula regulon , which include a genomic-sized rna and a nested set of subgenomic mrna transcripts , all with an identical 5_ non-translated leader sequence of 72 77 nucleotides and 3_ co-terminal polyadenylated ends .
subsequently , ulag and ulaabcdef will be used as templates to #transcribe ula regulon , which include a genomic-sized rna and a nested set of subgenomic mrna transcripts , all with an identical 5_ non-translated leader sequence of 72 77 nucleotides and 3_ co-terminal polyadenylated ends .
the fhla gene resides next to the hydb gene at 59 min in the escherichia coli k-12s , and glptq-glpacb operons are able to be interestingly interestingly #transcribed in opposite directions .
the fhla gene resides next to the hydb gene at 59 min in the escherichia coli k-12s , and glptq-glpacb operons are observed to be interestingly interestingly #transcribed in opposite directions .
the fhla gene resides next to the hydb gene at 59 min in the escherichia coli k-12s , and glptq-glpacb operons are observed to be #transcribed in opposite directions .
the fhla gene resides next to the hydb gene at 59 min in the escherichia coli k-12s , and glptq-glpacb operons can be interestingly interestingly #transcribed in opposite directions .
the fhla gene resides next to the hydb gene at 59 min in the escherichia coli k-12s , and glptq-glpacb operons can be #transcribed in opposite directions .
the fhla gene resides next to the hydb gene at 59 min in the escherichia coli k-12s , and glptq-glpacb operons has been interestingly interestingly #transcribed in opposite directions .
the fhla gene resides next to the hydb gene at 59 min in the escherichia coli k-12s , and glptq-glpacb operons has been #transcribed in opposite directions .
the fhla gene resides next to the hydb gene at 59 min in the escherichia coli k-12s , and glptq-glpacb operons have been shown to be interestingly interestingly #transcribed in opposite directions .
the fhla gene resides next to the hydb gene at 59 min in the escherichia coli k-12s , and glptq-glpacb operons have been shown to be #transcribed in opposite directions .
the fhla gene resides next to the hydb gene at 59 min in the escherichia coli k-12s , and glptq-glpacb operons have been shown to be #transcribed in opposite directions .
the fhla gene resides next to the hydb gene at 59 min in the escherichia coli k-12s , and glptq-glpacb operons may have been #transcribed in opposite directions .
the fhla gene resides next to the hydb gene at 59 min in the escherichia coli k-12s , and glptq-glpacb operons were interestingly interestingly #transcribed in opposite directions .
the fhla gene resides next to the hydb gene at 59 min in the escherichia coli k-12s , and glptq-glpacb operons will be interestingly interestingly #transcribed in opposite directions .
the fhla gene resides next to the hydb gene at 59 min in the escherichia coli k-12s , and glptq-glpacb operons will be interestingly interestingly #transcribed in opposite directions .
the fhla gene resides next to the hydb gene at 59 min in the escherichia coli k-12s , and glptq-glpacb operons will be #transcribed in opposite directions .
the fhla gene resides next to the hydb gene at 59 min in the these two plasmids , and glpd and glpr are able to be interestingly interestingly #transcribed in opposite directions .
the fhla gene resides next to the hydb gene at 59 min in the these two plasmids , and glpd and glpr are able to be interestingly interestingly #transcribed in opposite directions .
the fhla gene resides next to the hydb gene at 59 min in the these two plasmids , and glpd and glpr are able to be #transcribed in opposite directions .
the fhla gene resides next to the hydb gene at 59 min in the these two plasmids , and glpd and glpr are able to be #transcribed in opposite directions .
the fhla gene resides next to the hydb gene at 59 min in the these two plasmids , and glpd and glpr are observed to be interestingly interestingly #transcribed in opposite directions .
the fhla gene resides next to the hydb gene at 59 min in the these two plasmids , and glpd and glpr are observed to be interestingly interestingly #transcribed in opposite directions .
the fhla gene resides next to the hydb gene at 59 min in the these two plasmids , and glpd and glpr are #transcribed in opposite directions .
the fhla gene resides next to the hydb gene at 59 min in the these two plasmids , and glpd and glpr are #transcribed in opposite directions .
the fhla gene resides next to the hydb gene at 59 min in the these two plasmids , and glpd and glpr can be #transcribed in opposite directions .
the fhla gene resides next to the hydb gene at 59 min in the these two plasmids , and glpd and glpr can be #transcribed in opposite directions .
the fhla gene resides next to the hydb gene at 59 min in the these two plasmids , and glpd and glpr has been interestingly interestingly #transcribed in opposite directions .
the fhla gene resides next to the hydb gene at 59 min in the these two plasmids , and glpd and glpr has been #transcribed in opposite directions .
the fhla gene resides next to the hydb gene at 59 min in the these two plasmids , and glpd and glpr has been #transcribed in opposite directions .
the fhla gene resides next to the hydb gene at 59 min in the these two plasmids , and glpd and glpr have been shown to be #transcribed in opposite directions .
the fhla gene resides next to the hydb gene at 59 min in the these two plasmids , and glpd and glpr may be interestingly interestingly #transcribed in opposite directions .
the fhla gene resides next to the hydb gene at 59 min in the these two plasmids , and glpd and glpr may be #transcribed in opposite directions .
the fhla gene resides next to the hydb gene at 59 min in the these two plasmids , and glpd and glpr may have been interestingly interestingly #transcribed in opposite directions .
the fhla gene resides next to the hydb gene at 59 min in the these two plasmids , and glpd and glpr may have been interestingly interestingly #transcribed in opposite directions .
the fhla gene resides next to the hydb gene at 59 min in the these two plasmids , and glpd and glpr may have been #transcribed in opposite directions .
the fhla gene resides next to the hydb gene at 59 min in the these two plasmids , and glpd and glpr may have been #transcribed in opposite directions .
the fhla gene resides next to the hydb gene at 59 min in the these two plasmids , and glpd and glpr were #transcribed in opposite directions .
the fhla gene resides next to the hydb gene at 59 min in the these two plasmids , and glpd and glpr were #transcribed in opposite directions .
the fhla gene resides next to the hydb gene at 59 min in the these two plasmids , and glpd and glpr will be interestingly interestingly #transcribed in opposite directions .
the fhla gene resides next to the hydb gene at 59 min in the these two plasmids , and glpd and glpr will be interestingly interestingly #transcribed in opposite directions .
the fhla gene resides next to the hydb gene at 59 min in the these two plasmids , and glpd and glpr will be #transcribed in opposite directions .
the mrnas can be formed by two divergently #transcribed operons , the negative-strand rnas .
the mrnas has been formed by two divergently #transcribed operons , the negative-strand rnas .
the mrnas has been shown to be formed by two divergently #transcribed operons , the negative-strand rnas .
the mrnas is formed by two divergently #transcribed operons , the negative-strand rnas .
the mrnas is observed to be formed by two divergently #transcribed operons , the negative-strand rnas .
the mrnas was formed by two divergently #transcribed operons , the negative-strand rnas .
the two alternative transcripts , responsible for the utilization of l-ascorbate in prostate (1 .5 kb) and skeletal muscle (1 .9 kb) , can be formed by two divergently #transcribed operons , klk14 .
the two alternative transcripts , responsible for the utilization of l-ascorbate in prostate (1 .5 kb) and skeletal muscle (1 .9 kb) , can be formed by two divergently #transcribed operons , klk14 .
the two alternative transcripts , responsible for the utilization of l-ascorbate in prostate (1 .5 kb) and skeletal muscle (1 .9 kb) , has been formed by two divergently #transcribed operons , klk14 .
the two alternative transcripts , responsible for the utilization of l-ascorbate in prostate (1 .5 kb) and skeletal muscle (1 .9 kb) , has been formed by two divergently #transcribed operons , klk14 .
the two alternative transcripts , responsible for the utilization of l-ascorbate in prostate (1 .5 kb) and skeletal muscle (1 .9 kb) , has been shown to be formed by two divergently #transcribed operons , klk14 .
the two alternative transcripts , responsible for the utilization of l-ascorbate in prostate (1 .5 kb) and skeletal muscle (1 .9 kb) , has been shown to be formed by two divergently #transcribed operons , klk14 .
the two alternative transcripts , responsible for the utilization of l-ascorbate in prostate (1 .5 kb) and skeletal muscle (1 .9 kb) , is observed to be formed by two divergently #transcribed operons , klk14 .
the two alternative transcripts , responsible for the utilization of l-ascorbate in prostate (1 .5 kb) and skeletal muscle (1 .9 kb) , may be formed by two divergently #transcribed operons , klk14 .
the two alternative transcripts , responsible for the utilization of l-ascorbate in prostate (1 .5 kb) and skeletal muscle (1 .9 kb) , may have been formed by two divergently #transcribed operons , klk14 .
the two alternative transcripts , responsible for the utilization of l-ascorbate in prostate (1 .5 kb) and skeletal muscle (1 .9 kb) , was formed by two divergently #transcribed operons , klk14 .
the two alternative transcripts , responsible for the utilization of l-ascorbate in prostate (1 .5 kb) and skeletal muscle (1 .9 kb) , will be formed by two divergently #transcribed operons , klk14 .
a plastid-encoded prokaryotic-type rna polymerase (pep) and a nucleus-encoded phage-type rna polymerase (nep) can specifically #transcribe the plastid genome in the presence of the transcription factor cdf2 .
a plastid-encoded prokaryotic-type rna polymerase (pep) and a nucleus-encoded phage-type rna polymerase (nep) has specifically #transcribed the plastid genome in the presence of the transcription factor cdf2 .
a plastid-encoded prokaryotic-type rna polymerase (pep) and a nucleus-encoded phage-type rna polymerase (nep) has the ability to specifically #transcribe the plastid genome in the presence of the transcription factor cdf2 .
a plastid-encoded prokaryotic-type rna polymerase (pep) and a nucleus-encoded phage-type rna polymerase (nep) has the ability to #transcribe the plastid genome in the presence of the transcription factor cdf2 .
a plastid-encoded prokaryotic-type rna polymerase (pep) and a nucleus-encoded phage-type rna polymerase (nep) has #transcribed the plastid genome in the presence of the transcription factor cdf2 .
a plastid-encoded prokaryotic-type rna polymerase (pep) and a nucleus-encoded phage-type rna polymerase (nep) is able to specifically #transcribe the plastid genome in the presence of the transcription factor cdf2 .
a plastid-encoded prokaryotic-type rna polymerase (pep) and a nucleus-encoded phage-type rna polymerase (nep) is able to #transcribe the plastid genome in the presence of the transcription factor cdf2 .
a plastid-encoded prokaryotic-type rna polymerase (pep) and a nucleus-encoded phage-type rna polymerase (nep) is believe to specifically #transcribe the plastid genome in the presence of the transcription factor cdf2 .
a plastid-encoded prokaryotic-type rna polymerase (pep) and a nucleus-encoded phage-type rna polymerase (nep) is believe to #transcribe the plastid genome in the presence of the transcription factor cdf2 .
a plastid-encoded prokaryotic-type rna polymerase (pep) and a nucleus-encoded phage-type rna polymerase (nep) is observed to #transcribe the plastid genome in the presence of the transcription factor cdf2 .
a plastid-encoded prokaryotic-type rna polymerase (pep) and a nucleus-encoded phage-type rna polymerase (nep) may have specifically #transcribed the plastid genome in the presence of the transcription factor cdf2 .
a plastid-encoded prokaryotic-type rna polymerase (pep) and a nucleus-encoded phage-type rna polymerase (nep) may have #transcribed the plastid genome in the presence of the transcription factor cdf2 .
a plastid-encoded prokaryotic-type rna polymerase (pep) and a nucleus-encoded phage-type rna polymerase (nep) may #transcribe the plastid genome in the presence of the transcription factor cdf2 .
a plastid-encoded prokaryotic-type rna polymerase (pep) and a nucleus-encoded phage-type rna polymerase (nep) #transcribed the plastid genome in the presence of the transcription factor cdf2 .
a plastid-encoded prokaryotic-type rna polymerase (pep) and a nucleus-encoded phage-type rna polymerase (nep) will #transcribe the plastid genome in the presence of the transcription factor cdf2 .
glpd and glpr of these two plasmids are able to be divergently #transcribed by interaction at a distance between multiple operators .
glpd and glpr of these two plasmids are able to be divergently #transcribed by interaction at a distance between multiple operators .
glpd and glpr of these two plasmids are able to be #transcribed by interaction at a distance between multiple operators .
glpd and glpr of these two plasmids are able to be #transcribed by interaction at a distance between multiple operators .
glpd and glpr of these two plasmids are observed to be divergently #transcribed by interaction at a distance between multiple operators .
glpd and glpr of these two plasmids can be divergently #transcribed by interaction at a distance between multiple operators .
glpd and glpr of these two plasmids have been divergently #transcribed by interaction at a distance between multiple operators .
glpd and glpr of these two plasmids have been shown to be divergently #transcribed by interaction at a distance between multiple operators .
glpd and glpr of these two plasmids have been shown to be divergently #transcribed by interaction at a distance between multiple operators .
glpd and glpr of these two plasmids have been shown to be #transcribed by interaction at a distance between multiple operators .
glpd and glpr of these two plasmids have been #transcribed by interaction at a distance between multiple operators .
glpd and glpr of these two plasmids have the ability to be divergently #transcribed by interaction at a distance between multiple operators .
glpd and glpr of these two plasmids have the ability to be #transcribed by interaction at a distance between multiple operators .
glpd and glpr of these two plasmids have the ability to be #transcribed by interaction at a distance between multiple operators .
glpd and glpr of these two plasmids may have been divergently #transcribed by interaction at a distance between multiple operators .
glpd and glpr of these two plasmids may have been #transcribed by interaction at a distance between multiple operators .
glpd and glpr of these two plasmids were divergently #transcribed by interaction at a distance between multiple operators .
glpd and glpr of these two plasmids were #transcribed by interaction at a distance between multiple operators .
the rrn operon can be divergently #transcribed by nep-2 .
the rrn operon can be #transcribed by nep-2 .
the rrn operon has been divergently #transcribed by nep-2 .
the rrn operon is able to be divergently #transcribed by nep-2 .
the rrn operon is able to be #transcribed by nep-2 .
the rrn operon is divergently #transcribed by nep-2 .
the rrn operon is found to be #transcribed by nep-2 .
the rrn operon is known to be #transcribed by nep-2 .
the rrn operon is observed to be divergently #transcribed by nep-2 .
the rrn operon may have been divergently #transcribed by nep-2 .
the rrn operon may have been #transcribed by nep-2 .
the rrn operon was divergently #transcribed by nep-2 .
the rrn operon was #transcribed by nep-2 .
the two genes of e . coli chromosome are able to be divergently #transcribed by interaction at a distance between multiple operators .
the two genes of e . coli chromosome are able to be divergently #transcribed by interaction at a distance between multiple operators .
the two genes of e . coli chromosome are able to be #transcribed by interaction at a distance between multiple operators .
the two genes of e . coli chromosome are observed to be divergently #transcribed by interaction at a distance between multiple operators .
the two genes of e . coli chromosome are observed to be divergently #transcribed by interaction at a distance between multiple operators .
the two genes of e . coli chromosome are observed to be #transcribed by interaction at a distance between multiple operators .
the two genes of e . coli chromosome are #transcribed by interaction at a distance between multiple operators .
the two genes of e . coli chromosome can be divergently #transcribed by interaction at a distance between multiple operators .
the two genes of e . coli chromosome can be #transcribed by interaction at a distance between multiple operators .
the two genes of e . coli chromosome have been shown to be divergently #transcribed by interaction at a distance between multiple operators .
the two genes of e . coli chromosome have been shown to be #transcribed by interaction at a distance between multiple operators .
the two genes of e . coli chromosome have been #transcribed by interaction at a distance between multiple operators .
the two genes of e . coli chromosome have the ability to be divergently #transcribed by interaction at a distance between multiple operators .
the two genes of e . coli chromosome have the ability to be #transcribed by interaction at a distance between multiple operators .
the two genes of e . coli chromosome have the ability to be #transcribed by interaction at a distance between multiple operators .
the two genes of e . coli chromosome may have been divergently #transcribed by interaction at a distance between multiple operators .
the two genes of e . coli chromosome may have been divergently #transcribed by interaction at a distance between multiple operators .
the two genes of e . coli chromosome may have been #transcribed by interaction at a distance between multiple operators .
the two genes of e . coli chromosome were divergently #transcribed by interaction at a distance between multiple operators .
the two genes of e . coli chromosome will be #transcribed by interaction at a distance between multiple operators .
ulag and ulaabcdef is approximately 5 .4 kb in length spanning seven exons and can divergently #transcribe ula regulon present only in escherichia coli .
ulag and ulaabcdef is approximately 5 .4 kb in length spanning seven exons and has been shown to divergently #transcribe ula regulon present only in escherichia coli .
ulag and ulaabcdef is approximately 5 .4 kb in length spanning seven exons and has been shown to #transcribe ula regulon present only in escherichia coli .
ulag and ulaabcdef is approximately 5 .4 kb in length spanning seven exons and has been shown to #transcribe ula regulon present only in escherichia coli .
ulag and ulaabcdef is approximately 5 .4 kb in length spanning seven exons and has divergently #transcribed ula regulon present only in escherichia coli .
ulag and ulaabcdef is approximately 5 .4 kb in length spanning seven exons and has the ability to #transcribe ula regulon present only in escherichia coli .
ulag and ulaabcdef is approximately 5 .4 kb in length spanning seven exons and has #transcribed ula regulon present only in escherichia coli .
ulag and ulaabcdef is approximately 5 .4 kb in length spanning seven exons and is able to divergently #transcribe ula regulon present only in escherichia coli .
ulag and ulaabcdef is approximately 5 .4 kb in length spanning seven exons and is able to #transcribe ula regulon present only in escherichia coli .
ulag and ulaabcdef is approximately 5 .4 kb in length spanning seven exons and is able to #transcribe ula regulon present only in escherichia coli .
ulag and ulaabcdef is approximately 5 .4 kb in length spanning seven exons and is observed to divergently #transcribe ula regulon present only in escherichia coli .
ulag and ulaabcdef is approximately 5 .4 kb in length spanning seven exons and is observed to #transcribe ula regulon present only in escherichia coli .
ulag and ulaabcdef is approximately 5 .4 kb in length spanning seven exons and may have divergently #transcribed ula regulon present only in escherichia coli .
ulag and ulaabcdef is approximately 5 .4 kb in length spanning seven exons and may have #transcribed ula regulon present only in escherichia coli .
ulag and ulaabcdef is approximately 5 .4 kb in length spanning seven exons and #transcribed ula regulon present only in escherichia coli .
ulag and ulaabcdef is approximately 5 .4 kb in length spanning seven exons and #transcribed ula regulon present only in escherichia coli .
ulag and ulaabcdef is approximately 5 .4 kb in length spanning seven exons and will divergently #transcribe ula regulon present only in escherichia coli .
ulag and ulaabcdef is approximately 5 .4 kb in length spanning seven exons and will #transcribe ula regulon present only in escherichia coli .
ulag and ulaabcdef is approximately 5 .4 kb in length spanning seven exons and will #transcribe ula regulon present only in escherichia coli .
ulag and ulaabcdef is approximately 5 .4 kb in length spanning seven exons and , by northern blot analysis , can #transcribe ula regulon present only in escherichia coli .
ulag and ulaabcdef is approximately 5 .4 kb in length spanning seven exons and , by northern blot analysis , has been shown to #transcribe ula regulon present only in escherichia coli .
ulag and ulaabcdef is approximately 5 .4 kb in length spanning seven exons and , by northern blot analysis , has the ability to #transcribe ula regulon present only in escherichia coli .
ulag and ulaabcdef is approximately 5 .4 kb in length spanning seven exons and , by northern blot analysis , has #transcribed ula regulon present only in escherichia coli .
ulag and ulaabcdef is approximately 5 .4 kb in length spanning seven exons and , by northern blot analysis , is able to #transcribe ula regulon present only in escherichia coli .
ulag and ulaabcdef is approximately 5 .4 kb in length spanning seven exons and , by northern blot analysis , is observed to #transcribe ula regulon present only in escherichia coli .
ulag and ulaabcdef is approximately 5 .4 kb in length spanning seven exons and , by northern blot analysis , is observed to #transcribe ula regulon present only in escherichia coli .
ulag and ulaabcdef is approximately 5 .4 kb in length spanning seven exons and , by northern blot analysis , may have #transcribed ula regulon present only in escherichia coli .
ulag and ulaabcdef is approximately 5 .4 kb in length spanning seven exons and , by northern blot analysis , may have #transcribed ula regulon present only in escherichia coli .
ulag and ulaabcdef is approximately 5 .4 kb in length spanning seven exons and , by northern blot analysis , #transcribed ula regulon present only in escherichia coli .
interaction at a distance between multiple operators can divergently #transcribe the gene , as our study predicted , of a large variety of organs and tissues .
interaction at a distance between multiple operators can divergently #transcribe the gene , as our study predicted , of a large variety of organs and tissues .
interaction at a distance between multiple operators controls the adjacent and divergently #transcribes the gene , as our study predicted , of a large variety of organs and tissues .
interaction at a distance between multiple operators controls the adjacent and has divergently #transcribed the gene , as our study predicted , of a large variety of organs and tissues .
interaction at a distance between multiple operators controls the adjacent and has the ability to divergently #transcribe the gene , as our study predicted , of a large variety of organs and tissues .
interaction at a distance between multiple operators controls the adjacent and has the ability to divergently #transcribe the gene , as our study predicted , of a large variety of organs and tissues .
interaction at a distance between multiple operators controls the adjacent and is observed to divergently #transcribe the gene , as our study predicted , of a large variety of organs and tissues .
interaction at a distance between multiple operators controls the adjacent and may have divergently #transcribed the gene , as our study predicted , of a large variety of organs and tissues .
interaction at a distance between multiple operators controls the adjacent and may have divergently #transcribed the gene , as our study predicted , of a large variety of organs and tissues .
interaction at a distance between multiple operators controls the adjacent and will divergently #transcribe the gene , as our study predicted , of a large variety of organs and tissues .
interaction at a distance between multiple operators controls the adjacent , can divergently #transcribe the gene , as our study predicted , of a large variety of organs and tissues .
interaction at a distance between multiple operators controls the adjacent , can #transcribe the gene , as our study predicted , of a large variety of organs and tissues .
interaction at a distance between multiple operators controls the adjacent , divergently #transcribed the gene , as our study predicted , of a large variety of organs and tissues .
interaction at a distance between multiple operators controls the adjacent , divergently #transcribed the gene , as our study predicted , of a large variety of organs and tissues .
interaction at a distance between multiple operators controls the adjacent , divergently #transcribes the gene , as our study predicted , of a large variety of organs and tissues .
interaction at a distance between multiple operators controls the adjacent , divergently #transcribes the gene , as our study predicted , of a large variety of organs and tissues .
interaction at a distance between multiple operators controls the adjacent , has been shown to divergently #transcribe the gene , as our study predicted , of a large variety of organs and tissues .
interaction at a distance between multiple operators controls the adjacent , has been shown to divergently #transcribe the gene , as our study predicted , of a large variety of organs and tissues .
interaction at a distance between multiple operators controls the adjacent , has been shown to #transcribe the gene , as our study predicted , of a large variety of organs and tissues .
interaction at a distance between multiple operators controls the adjacent , has divergently #transcribed the gene , as our study predicted , of a large variety of organs and tissues .
interaction at a distance between multiple operators controls the adjacent , has the ability to divergently #transcribe the gene , as our study predicted , of a large variety of organs and tissues .
interaction at a distance between multiple operators controls the adjacent , has the ability to divergently #transcribe the gene , as our study predicted , of a large variety of organs and tissues .
interaction at a distance between multiple operators controls the adjacent , has the ability to #transcribe the gene , as our study predicted , of a large variety of organs and tissues .
interaction at a distance between multiple operators controls the adjacent , has #transcribed the gene , as our study predicted , of a large variety of organs and tissues .
interaction at a distance between multiple operators controls the adjacent , has #transcribed the gene , as our study predicted , of a large variety of organs and tissues .
interaction at a distance between multiple operators controls the adjacent , is able to divergently #transcribe the gene , as our study predicted , of a large variety of organs and tissues .
interaction at a distance between multiple operators controls the adjacent , is able to #transcribe the gene , as our study predicted , of a large variety of organs and tissues .
interaction at a distance between multiple operators controls the adjacent , is observed to divergently #transcribe the gene , as our study predicted , of a large variety of organs and tissues .
interaction at a distance between multiple operators controls the adjacent , is observed to #transcribe the gene , as our study predicted , of a large variety of organs and tissues .
interaction at a distance between multiple operators controls the adjacent , may divergently #transcribe the gene , as our study predicted , of a large variety of organs and tissues .
interaction at a distance between multiple operators controls the adjacent , may have divergently #transcribed the gene , as our study predicted , of a large variety of organs and tissues .
interaction at a distance between multiple operators controls the adjacent , may have #transcribed the gene , as our study predicted , of a large variety of organs and tissues .
interaction at a distance between multiple operators controls the adjacent , may #transcribe the gene , as our study predicted , of a large variety of organs and tissues .
interaction at a distance between multiple operators controls the adjacent , #transcribed the gene , as our study predicted , of a large variety of organs and tissues .
interaction at a distance between multiple operators controls the adjacent , #transcribed the gene , as our study predicted , of a large variety of organs and tissues .
interaction at a distance between multiple operators controls the adjacent , #transcribes the gene , as our study predicted , of a large variety of organs and tissues .
interaction at a distance between multiple operators controls the adjacent , will #transcribe the gene , as our study predicted , of a large variety of organs and tissues .
interaction at a distance between multiple operators controls the adjacent , will #transcribe the gene , as our study predicted , of a large variety of organs and tissues .
interaction at a distance between multiple operators divergently #transcribes the gene , as our study predicted , of a large variety of organs and tissues .
interaction at a distance between multiple operators has been shown to divergently #transcribe the gene , as our study predicted , of a large variety of organs and tissues .
interaction at a distance between multiple operators has divergently #transcribed the gene , as our study predicted , of a large variety of organs and tissues .
interaction at a distance between multiple operators has the ability to divergently #transcribe the gene , as our study predicted , of a large variety of organs and tissues .
interaction at a distance between multiple operators is able to divergently #transcribe the gene , as our study predicted , of a large variety of organs and tissues .
interaction at a distance between multiple operators is observed to divergently #transcribe the gene , as our study predicted , of a large variety of organs and tissues .
interaction at a distance between multiple operators may divergently #transcribe the gene , as our study predicted , of a large variety of organs and tissues .
interaction at a distance between multiple operators will divergently #transcribe the gene , as our study predicted , of a large variety of organs and tissues .
restriction analysis of a large variety of organs and tissues demonstrated that the gene , as our study predicted , are able to be divergently #transcribed .
restriction analysis of a large variety of organs and tissues demonstrated that the gene , as our study predicted , are able to be divergently #transcribed .
restriction analysis of a large variety of organs and tissues demonstrated that the gene , as our study predicted , are able to be #transcribed .
restriction analysis of a large variety of organs and tissues demonstrated that the gene , as our study predicted , are divergently #transcribed .
restriction analysis of a large variety of organs and tissues demonstrated that the gene , as our study predicted , are divergently #transcribed .
restriction analysis of a large variety of organs and tissues demonstrated that the gene , as our study predicted , are proven to be divergently #transcribed .
restriction analysis of a large variety of organs and tissues demonstrated that the gene , as our study predicted , are proven to be divergently #transcribed .
restriction analysis of a large variety of organs and tissues demonstrated that the gene , as our study predicted , are proven to be #transcribed .
restriction analysis of a large variety of organs and tissues demonstrated that the gene , as our study predicted , are #transcribed .
restriction analysis of a large variety of organs and tissues demonstrated that the gene , as our study predicted , are #transcribed .
restriction analysis of a large variety of organs and tissues demonstrated that the gene , as our study predicted , can be #transcribed .
restriction analysis of a large variety of organs and tissues demonstrated that the gene , as our study predicted , have been divergently #transcribed .
restriction analysis of a large variety of organs and tissues demonstrated that the gene , as our study predicted , may be divergently #transcribed .
restriction analysis of a large variety of organs and tissues demonstrated that the gene , as our study predicted , may be divergently #transcribed .
restriction analysis of a large variety of organs and tissues demonstrated that the gene , as our study predicted , may be #transcribed .
restriction analysis of a large variety of organs and tissues demonstrated that the gene , as our study predicted , may have been #transcribed .
restriction analysis of a large variety of organs and tissues demonstrated that the gene , as our study predicted , were divergently #transcribed .
restriction analysis of a large variety of organs and tissues demonstrated that the gene , as our study predicted , were #transcribed .
restriction analysis of a large variety of organs and tissues demonstrated that the gene , as our study predicted , were #transcribed .
restriction analysis of a large variety of organs and tissues demonstrated that the gene , as our study predicted , will be divergently #transcribed .
restriction analysis of a large variety of organs and tissues demonstrated that the gene , as our study predicted , will be #transcribed .
restriction analysis of a large variety of organs and tissues demonstrated that the gene , as our study predicted , will be #transcribed .
restriction analysis of a large variety of organs and tissues suggested that the gene , as our study predicted , are able to be #transcribed .
restriction analysis of a large variety of organs and tissues suggested that the gene , as our study predicted , are able to be #transcribed .
restriction analysis of a large variety of organs and tissues suggested that the gene , as our study predicted , are proven to be #transcribed .
restriction analysis of a large variety of organs and tissues suggested that the gene , as our study predicted , can be #transcribed .
restriction analysis of a large variety of organs and tissues suggested that the gene , as our study predicted , have been shown to be #transcribed .
restriction analysis of a large variety of organs and tissues suggested that the gene , as our study predicted , have been #transcribed .
restriction analysis of a large variety of organs and tissues suggested that the gene , as our study predicted , may be #transcribed .
restriction analysis of a large variety of organs and tissues suggested that the gene , as our study predicted , may be #transcribed .
restriction analysis of a large variety of organs and tissues suggested that the gene , as our study predicted , were #transcribed .
restriction analysis of a large variety of organs and tissues suggested that the gene , as our study predicted , will be #transcribed .
restriction endonuclease cleavage analysis of a large variety of organs and tissues demonstrated that the gene , as our study predicted , are divergently #transcribed .
restriction endonuclease cleavage analysis of a large variety of organs and tissues demonstrated that the gene , as our study predicted , are proven to be divergently #transcribed .
restriction endonuclease cleavage analysis of a large variety of organs and tissues demonstrated that the gene , as our study predicted , can be divergently #transcribed .
restriction endonuclease cleavage analysis of a large variety of organs and tissues demonstrated that the gene , as our study predicted , can be divergently #transcribed .
restriction endonuclease cleavage analysis of a large variety of organs and tissues demonstrated that the gene , as our study predicted , have been shown to be divergently #transcribed .
restriction endonuclease cleavage analysis of a large variety of organs and tissues demonstrated that the gene , as our study predicted , have been shown to be divergently #transcribed .
restriction endonuclease cleavage analysis of a large variety of organs and tissues demonstrated that the gene , as our study predicted , may be divergently #transcribed .
restriction endonuclease cleavage analysis of a large variety of organs and tissues demonstrated that the gene , as our study predicted , may have been divergently #transcribed .
restriction endonuclease cleavage analysis of a large variety of organs and tissues demonstrated that the gene , as our study predicted , may have been divergently #transcribed .
restriction endonuclease cleavage analysis of a large variety of organs and tissues demonstrated that the gene , as our study predicted , will be divergently #transcribed .
the fhla gene resides next to the hydb gene at 59 min in the a large variety of organs and tissues , and the gene , as our study predicted , are able to be interestingly interestingly #transcribed in opposite directions .
the fhla gene resides next to the hydb gene at 59 min in the a large variety of organs and tissues , and the gene , as our study predicted , are able to be #transcribed in opposite directions .
the fhla gene resides next to the hydb gene at 59 min in the a large variety of organs and tissues , and the gene , as our study predicted , are observed to be interestingly interestingly #transcribed in opposite directions .
the fhla gene resides next to the hydb gene at 59 min in the a large variety of organs and tissues , and the gene , as our study predicted , are observed to be #transcribed in opposite directions .
the fhla gene resides next to the hydb gene at 59 min in the a large variety of organs and tissues , and the gene , as our study predicted , are #transcribed in opposite directions .
the fhla gene resides next to the hydb gene at 59 min in the a large variety of organs and tissues , and the gene , as our study predicted , can be interestingly interestingly #transcribed in opposite directions .
the fhla gene resides next to the hydb gene at 59 min in the a large variety of organs and tissues , and the gene , as our study predicted , can be #transcribed in opposite directions .
the fhla gene resides next to the hydb gene at 59 min in the a large variety of organs and tissues , and the gene , as our study predicted , can be #transcribed in opposite directions .
the fhla gene resides next to the hydb gene at 59 min in the a large variety of organs and tissues , and the gene , as our study predicted , has been #transcribed in opposite directions .
the fhla gene resides next to the hydb gene at 59 min in the a large variety of organs and tissues , and the gene , as our study predicted , have been shown to be interestingly interestingly #transcribed in opposite directions .
the fhla gene resides next to the hydb gene at 59 min in the a large variety of organs and tissues , and the gene , as our study predicted , have been shown to be interestingly interestingly #transcribed in opposite directions .
the fhla gene resides next to the hydb gene at 59 min in the a large variety of organs and tissues , and the gene , as our study predicted , may be interestingly interestingly #transcribed in opposite directions .
the fhla gene resides next to the hydb gene at 59 min in the a large variety of organs and tissues , and the gene , as our study predicted , may be #transcribed in opposite directions .
the fhla gene resides next to the hydb gene at 59 min in the a large variety of organs and tissues , and the gene , as our study predicted , may be #transcribed in opposite directions .
the fhla gene resides next to the hydb gene at 59 min in the a large variety of organs and tissues , and the gene , as our study predicted , were #transcribed in opposite directions .
the fhla gene resides next to the hydb gene at 59 min in the a large variety of organs and tissues , and the gene , as our study predicted , will be #transcribed in opposite directions .
the gene , as our study predicted , of a large variety of organs and tissues are able to be #transcribed by interaction at a distance between multiple operators .
the gene , as our study predicted , of a large variety of organs and tissues are observed to be divergently #transcribed by interaction at a distance between multiple operators .
the gene , as our study predicted , of a large variety of organs and tissues are #transcribed by interaction at a distance between multiple operators .
the gene , as our study predicted , of a large variety of organs and tissues can be divergently #transcribed by interaction at a distance between multiple operators .
the gene , as our study predicted , of a large variety of organs and tissues can be #transcribed by interaction at a distance between multiple operators .
the gene , as our study predicted , of a large variety of organs and tissues have been divergently #transcribed by interaction at a distance between multiple operators .
the gene , as our study predicted , of a large variety of organs and tissues have been shown to be divergently #transcribed by interaction at a distance between multiple operators .
the gene , as our study predicted , of a large variety of organs and tissues have been shown to be divergently #transcribed by interaction at a distance between multiple operators .
the gene , as our study predicted , of a large variety of organs and tissues have been shown to be #transcribed by interaction at a distance between multiple operators .
the gene , as our study predicted , of a large variety of organs and tissues have been shown to be #transcribed by interaction at a distance between multiple operators .
the gene , as our study predicted , of a large variety of organs and tissues have been #transcribed by interaction at a distance between multiple operators .
the gene , as our study predicted , of a large variety of organs and tissues have been #transcribed by interaction at a distance between multiple operators .
the gene , as our study predicted , of a large variety of organs and tissues have the ability to be divergently #transcribed by interaction at a distance between multiple operators .
the gene , as our study predicted , of a large variety of organs and tissues have the ability to be #transcribed by interaction at a distance between multiple operators .
the gene , as our study predicted , of a large variety of organs and tissues may have been divergently #transcribed by interaction at a distance between multiple operators .
the gene , as our study predicted , of a large variety of organs and tissues may have been #transcribed by interaction at a distance between multiple operators .
the gene , as our study predicted , of a large variety of organs and tissues were divergently #transcribed by interaction at a distance between multiple operators .
the gene , as our study predicted , of a large variety of organs and tissues were #transcribed by interaction at a distance between multiple operators .
the gene , as our study predicted , of a large variety of organs and tissues will be divergently #transcribed by interaction at a distance between multiple operators .
the gene , as our study predicted , of a large variety of organs and tissues will be #transcribed by interaction at a distance between multiple operators .
this antisense-bcma rna can be #transcribed from the same locus as bcma .
this antisense-bcma rna has been proven to be #transcribed from the same locus as bcma .
this antisense-bcma rna has been #transcribed from the same locus as bcma .
this antisense-bcma rna has been #transcribed from the same locus as bcma .
this antisense-bcma rna is #transcribed from the same locus as bcma .
this antisense-bcma rna may be #transcribed from the same locus as bcma .
this antisense-bcma rna was #transcribed from the same locus as bcma .
this antisense-bcma rna will be #transcribed from the same locus as bcma .
this operon can be #transcribed by glycolate .
this operon has been divergently #transcribed by glycolate .
this operon has been shown to be divergently #transcribed by glycolate .
this operon has been shown to be #transcribed by glycolate .
this operon has been #transcribed by glycolate .
this operon is divergently #transcribed by glycolate .
this operon is found to be #transcribed by glycolate .
this operon is observed to be divergently #transcribed by glycolate .
this operon is observed to be #transcribed by glycolate .
this operon may have been #transcribed by glycolate .
this operon was divergently #transcribed by glycolate .
this operon will be divergently #transcribed by glycolate .
this operon will be #transcribed by glycolate .
glycolate can specifically #transcribe this operon in the presence of the transcription factor cdf2 .
glycolate has been shown to specifically #transcribe this operon in the presence of the transcription factor cdf2 .
glycolate has the ability to #transcribe this operon in the presence of the transcription factor cdf2 .
glycolate has #transcribed this operon in the presence of the transcription factor cdf2 .
glycolate is observed to specifically #transcribe this operon in the presence of the transcription factor cdf2 .
glycolate specifically #transcribed this operon in the presence of the transcription factor cdf2 .
glycolate #transcribed this operon in the presence of the transcription factor cdf2 .
expression of recombinat proteins full-lenght and c-terminal sbp2 constructs in pask-ib7 are able to be specifically #transformed into escherichia coli bl21 (promega)
expression of recombinat proteins full-lenght and c-terminal sbp2 constructs in pask-ib7 are able to be #transformed into escherichia coli bl21 (promega)
expression of recombinat proteins full-lenght and c-terminal sbp2 constructs in pask-ib7 are likely to be #transformed into escherichia coli bl21 (promega)
expression of recombinat proteins full-lenght and c-terminal sbp2 constructs in pask-ib7 are observed to be specifically #transformed into escherichia coli bl21 (promega)
expression of recombinat proteins full-lenght and c-terminal sbp2 constructs in pask-ib7 are observed to be #transformed into escherichia coli bl21 (promega)
expression of recombinat proteins full-lenght and c-terminal sbp2 constructs in pask-ib7 are specifically #transformed into escherichia coli bl21 (promega)
expression of recombinat proteins full-lenght and c-terminal sbp2 constructs in pask-ib7 are #transformed into escherichia coli bl21 (promega)
expression of recombinat proteins full-lenght and c-terminal sbp2 constructs in pask-ib7 have been shown to be specifically #transformed into escherichia coli bl21 (promega)
expression of recombinat proteins full-lenght and c-terminal sbp2 constructs in pask-ib7 have been shown to be #transformed into escherichia coli bl21 (promega)
expression of recombinat proteins full-lenght and c-terminal sbp2 constructs in pask-ib7 have been #transformed into escherichia coli bl21 (promega)
expression of recombinat proteins full-lenght and c-terminal sbp2 constructs in pask-ib7 have the ability to be #transformed into escherichia coli bl21 (promega)
expression of recombinat proteins full-lenght and c-terminal sbp2 constructs in pask-ib7 may be specifically #transformed into escherichia coli bl21 (promega)
expression of recombinat proteins full-lenght and c-terminal sbp2 constructs in pask-ib7 may be #transformed into escherichia coli bl21 (promega)
expression of recombinat proteins full-lenght and c-terminal sbp2 constructs in pask-ib7 may have been #transformed into escherichia coli bl21 (promega)
expression of recombinat proteins full-lenght and c-terminal sbp2 constructs in pask-ib7 will be specifically #transformed into escherichia coli bl21 (promega)
expression of recombinat proteins full-lenght and c-terminal sbp2 constructs in pask-ib7 , as our study suggested , are able to be specifically #transformed into escherichia coli bl21 (promega)
expression of recombinat proteins full-lenght and c-terminal sbp2 constructs in pask-ib7 , as our study suggested , are able to be #transformed into escherichia coli bl21 (promega)
expression of recombinat proteins full-lenght and c-terminal sbp2 constructs in pask-ib7 , as our study suggested , are likely to be specifically #transformed into escherichia coli bl21 (promega)
for expression of the recombinant protein , pet28a-5 can be efficiently #transformed into escherichia coli strain bl21(de3) .
expression of recombinat proteins full-lenght and c-terminal sbp2 constructs in pask-ib7 , as our study suggested , are #transformed into escherichia coli bl21 (promega)
expression of recombinat proteins full-lenght and c-terminal sbp2 constructs in pask-ib7 , as our study suggested , have been shown to be specifically #transformed into escherichia coli bl21 (promega)
expression of recombinat proteins full-lenght and c-terminal sbp2 constructs in pask-ib7 , as our study suggested , have been shown to be #transformed into escherichia coli bl21 (promega)
for expression of the recombinant protein , pet28a-5 has been #transformed into escherichia coli strain bl21(de3) .
for expression of the recombinant protein , pet28a-5 has the ability to be #transformed into escherichia coli strain bl21(de3) .
expression of recombinat proteins full-lenght and c-terminal sbp2 constructs in pask-ib7 , as our study suggested , have been #transformed into escherichia coli bl21 (promega)
for expression of the recombinant protein , pet28a-5 is able to be efficiently #transformed into escherichia coli strain bl21(de3) .
for expression of the recombinant protein , pet28a-5 is able to be #transformed into escherichia coli strain bl21(de3) .
expression of recombinat proteins full-lenght and c-terminal sbp2 constructs in pask-ib7 , as our study suggested , have the ability to be #transformed into escherichia coli bl21 (promega)
expression of recombinat proteins full-lenght and c-terminal sbp2 constructs in pask-ib7 , as our study suggested , may be specifically #transformed into escherichia coli bl21 (promega)
for expression of the recombinant protein , pet28a-5 is likely to be efficiently #transformed into escherichia coli strain bl21(de3) .
expression of recombinat proteins full-lenght and c-terminal sbp2 constructs in pask-ib7 , as our study suggested , may be #transformed into escherichia coli bl21 (promega)
expression of recombinat proteins full-lenght and c-terminal sbp2 constructs in pask-ib7 , as our study suggested , may have been specifically #transformed into escherichia coli bl21 (promega)
for expression of the recombinant protein , pet28a-5 is observed to be #transformed into escherichia coli strain bl21(de3) .
expression of recombinat proteins full-lenght and c-terminal sbp2 constructs in pask-ib7 , as our study suggested , will be specifically #transformed into escherichia coli bl21 (promega)
for expression of the recombinant protein , pet28a-5 is #transformed into escherichia coli strain bl21(de3) .
for expression of the recombinant protein , pet28a-5 may be efficiently #transformed into escherichia coli strain bl21(de3) .
for expression of the recombinant protein , pet28a-5 may be #transformed into escherichia coli strain bl21(de3) .
for expression of the recombinant protein , pet28a-5 may have been efficiently #transformed into escherichia coli strain bl21(de3) .
for expression of the recombinant protein , pet28a-5 will be efficiently #transformed into escherichia coli strain bl21(de3) .
for expression of the recombinant protein , pet28a-5 will be #transformed into escherichia coli strain bl21(de3) .
this construct can be #transformed into the yeast strain hf7c (clontech) .
this construct has been dramatically #transformed into the yeast strain hf7c (clontech) .
this construct has been proven to be dramatically #transformed into the yeast strain hf7c (clontech) .
this construct has been shown to be dramatically #transformed into the yeast strain hf7c (clontech) .
this construct has the ability to be dramatically #transformed into the yeast strain hf7c (clontech) .
this construct is dramatically #transformed into the yeast strain hf7c (clontech) .
this construct is likely to be dramatically #transformed into the yeast strain hf7c (clontech) .
this construct may be dramatically #transformed into the yeast strain hf7c (clontech) .
this construct may be #transformed into the yeast strain hf7c (clontech) .
this construct may have been #transformed into the yeast strain hf7c (clontech) .
this construct will be #transformed into the yeast strain hf7c (clontech) .
this construct , as our study suggested , can be efficiently #transformed into the yeast strain hf7c (clontech) .
this construct , as our study suggested , can be #transformed into the yeast strain hf7c (clontech) .
this construct , as our study suggested , has been efficiently #transformed into the yeast strain hf7c (clontech) .
this construct , as our study suggested , has been shown to be efficiently #transformed into the yeast strain hf7c (clontech) .
this construct , as our study suggested , has the ability to be #transformed into the yeast strain hf7c (clontech) .
this construct , as our study suggested , is able to be efficiently #transformed into the yeast strain hf7c (clontech) .
this construct , as our study suggested , is able to be #transformed into the yeast strain hf7c (clontech) .
this construct , as our study suggested , is likely to be efficiently #transformed into the yeast strain hf7c (clontech) .
this construct , as our study suggested , is likely to be #transformed into the yeast strain hf7c (clontech) .
this construct , as our study suggested , is #transformed into the yeast strain hf7c (clontech) .
this construct , as our study suggested , will be #transformed into the yeast strain hf7c (clontech) .
pet28a-5 , for expression of the recombinant protein , can be probably #transformed into escherichia coli strain bl21(de3) .
pet28a-5 , for expression of the recombinant protein , has been shown to be probably #transformed into escherichia coli strain bl21(de3) .
pet28a-5 , for expression of the recombinant protein , has the ability to be #transformed into escherichia coli strain bl21(de3) .
the relevant dna fragments , in order to generate gst fusion proteins , are able to be completely #transformed into the bacterial strains bl21 or topp (stratagene) .
pet28a-5 , for expression of the recombinant protein , is able to be #transformed into escherichia coli strain bl21(de3) .
the relevant dna fragments , in order to generate gst fusion proteins , are cloned into pgex2t(pharmacia) and completely #transformed into the bacterial strains bl21 or topp (stratagene) .
pet28a-5 , for expression of the recombinant protein , is observed to be #transformed into escherichia coli strain bl21(de3) .
pet28a-5 , for expression of the recombinant protein , is #transformed into escherichia coli strain bl21(de3) .
the relevant dna fragments , in order to generate gst fusion proteins , are likely to be completely #transformed into the bacterial strains bl21 or topp (stratagene) .
pet28a-5 , for expression of the recombinant protein , may be #transformed into escherichia coli strain bl21(de3) .
the relevant dna fragments , in order to generate gst fusion proteins , are observed to be cloned into pgex2t(pharmacia) and completely #transformed into the bacterial strains bl21 or topp (stratagene) .
pet28a-5 , for expression of the recombinant protein , may have been probably #transformed into escherichia coli strain bl21(de3) .
pet28a-5 , for expression of the recombinant protein , will be #transformed into escherichia coli strain bl21(de3) .
the relevant dna fragments , in order to generate gst fusion proteins , can be cloned into pgex2t(pharmacia) and completely #transformed into the bacterial strains bl21 or topp (stratagene) .
the relevant dna fragments , in order to generate gst fusion proteins , can be cloned into pgex2t(pharmacia) and #transformed into the bacterial strains bl21 or topp (stratagene) .
the relevant dna fragments , in order to generate gst fusion proteins , can be completely #transformed into the bacterial strains bl21 or topp (stratagene) .
the relevant dna fragments , in order to generate gst fusion proteins , have been cloned into pgex2t(pharmacia) and completely #transformed into the bacterial strains bl21 or topp (stratagene) .
the relevant dna fragments , in order to generate gst fusion proteins , have been completely #transformed into the bacterial strains bl21 or topp (stratagene) .
the relevant dna fragments , in order to generate gst fusion proteins , have been shown to be cloned into pgex2t(pharmacia) and completely #transformed into the bacterial strains bl21 or topp (stratagene) .
the relevant dna fragments , in order to generate gst fusion proteins , have been shown to be completely #transformed into the bacterial strains bl21 or topp (stratagene) .
the relevant dna fragments , in order to generate gst fusion proteins , have been shown to be #transformed into the bacterial strains bl21 or topp (stratagene) .
the relevant dna fragments , in order to generate gst fusion proteins , may be cloned into pgex2t(pharmacia) and completely #transformed into the bacterial strains bl21 or topp (stratagene) .
the relevant dna fragments , in order to generate gst fusion proteins , may be cloned into pgex2t(pharmacia) and #transformed into the bacterial strains bl21 or topp (stratagene) .
the relevant dna fragments , in order to generate gst fusion proteins , may have been cloned into pgex2t(pharmacia) and completely #transformed into the bacterial strains bl21 or topp (stratagene) .
the relevant dna fragments , in order to generate gst fusion proteins , may have been completely #transformed into the bacterial strains bl21 or topp (stratagene) .
the relevant dna fragments , in order to generate gst fusion proteins , may have been #transformed into the bacterial strains bl21 or topp (stratagene) .
the relevant dna fragments , in order to generate gst fusion proteins , will be cloned into pgex2t(pharmacia) and #transformed into the bacterial strains bl21 or topp (stratagene) .
the relevant dna fragments , in order to generate gst fusion proteins , will be completely #transformed into the bacterial strains bl21 or topp (stratagene) .
the relevant dna fragments , in order to generate gst fusion proteins , will be #transformed into the bacterial strains bl21 or topp (stratagene) .
to generate gst fusion proteins , the relevant dna fragments are able to be cloned into pgex2t(pharmacia) and #transformed into the bacterial strains bl21 or topp (stratagene) .
to generate gst fusion proteins , the relevant dna fragments are able to be #transformed into the bacterial strains bl21 or topp (stratagene) .
to generate gst fusion proteins , the relevant dna fragments are cloned into pgex2t(pharmacia) and completely #transformed into the bacterial strains bl21 or topp (stratagene) .
to generate gst fusion proteins , the relevant dna fragments are cloned into pgex2t(pharmacia) and #transformed into the bacterial strains bl21 or topp (stratagene) .
to generate gst fusion proteins , the relevant dna fragments are likely to be cloned into pgex2t(pharmacia) and completely #transformed into the bacterial strains bl21 or topp (stratagene) .
to generate gst fusion proteins , the relevant dna fragments are observed to be cloned into pgex2t(pharmacia) and completely #transformed into the bacterial strains bl21 or topp (stratagene) .
to generate gst fusion proteins , the relevant dna fragments are observed to be completely #transformed into the bacterial strains bl21 or topp (stratagene) .
to generate gst fusion proteins , the relevant dna fragments are observed to be #transformed into the bacterial strains bl21 or topp (stratagene) .
to generate gst fusion proteins , the relevant dna fragments are #transformed into the bacterial strains bl21 or topp (stratagene) .
to generate gst fusion proteins , the relevant dna fragments can be completely #transformed into the bacterial strains bl21 or topp (stratagene) .
to generate gst fusion proteins , the relevant dna fragments have been cloned into pgex2t(pharmacia) and completely #transformed into the bacterial strains bl21 or topp (stratagene) .
to generate gst fusion proteins , the relevant dna fragments may be cloned into pgex2t(pharmacia) and completely #transformed into the bacterial strains bl21 or topp (stratagene) .
to generate gst fusion proteins , the relevant dna fragments may be cloned into pgex2t(pharmacia) and #transformed into the bacterial strains bl21 or topp (stratagene) .
to generate gst fusion proteins , the relevant dna fragments may be completely #transformed into the bacterial strains bl21 or topp (stratagene) .
to generate gst fusion proteins , the relevant dna fragments may be #transformed into the bacterial strains bl21 or topp (stratagene) .
to generate gst fusion proteins , the relevant dna fragments may have been completely #transformed into the bacterial strains bl21 or topp (stratagene) .
this construct was #transformed into the yeast strain hf7c (clontech) .
for expression of the recombinant protein , pet28a-5 was #transformed into escherichia coli strain bl21(de3) .
for expression of the recombinant protein , this construct can be efficiently #transformed into the yeast strain hf7c (clontech) .
expression of recombinat proteins full-lenght and c-terminal sbp2 constructs in pask-ib7 (bvs) can be used to completely #transform escherichia coli bl21 (promega) .
expression of recombinat proteins full-lenght and c-terminal sbp2 constructs in pask-ib7 (bvs) can be used to #transform escherichia coli bl21 (promega) .
for expression of the recombinant protein , this construct can be #transformed into the yeast strain hf7c (clontech) .
for expression of the recombinant protein , this construct has been efficiently #transformed into the yeast strain hf7c (clontech) .
expression of recombinat proteins full-lenght and c-terminal sbp2 constructs in pask-ib7 (bvs) has been shown to be used to #transform escherichia coli bl21 (promega) .
for expression of the recombinant protein , this construct has been shown to be efficiently #transformed into the yeast strain hf7c (clontech) .
for expression of the recombinant protein , this construct has been shown to be #transformed into the yeast strain hf7c (clontech) .
for expression of the recombinant protein , this construct has been #transformed into the yeast strain hf7c (clontech) .
expression of recombinat proteins full-lenght and c-terminal sbp2 constructs in pask-ib7 (bvs) has been used to #transform escherichia coli bl21 (promega) .
for expression of the recombinant protein , this construct has the ability to be #transformed into the yeast strain hf7c (clontech) .
for expression of the recombinant protein , this construct is able to be efficiently #transformed into the yeast strain hf7c (clontech) .
expression of recombinat proteins full-lenght and c-terminal sbp2 constructs in pask-ib7 (bvs) is able to be used to completely #transform escherichia coli bl21 (promega) .
expression of recombinat proteins full-lenght and c-terminal sbp2 constructs in pask-ib7 (bvs) is likely to be used to completely #transform escherichia coli bl21 (promega) .
for expression of the recombinant protein , this construct is likely to be efficiently #transformed into the yeast strain hf7c (clontech) .
expression of recombinat proteins full-lenght and c-terminal sbp2 constructs in pask-ib7 (bvs) is likely to be used to #transform escherichia coli bl21 (promega) .
expression of recombinat proteins full-lenght and c-terminal sbp2 constructs in pask-ib7 (bvs) is observed to be used to completely #transform escherichia coli bl21 (promega) .
for expression of the recombinant protein , this construct is observed to be #transformed into the yeast strain hf7c (clontech) .
expression of recombinat proteins full-lenght and c-terminal sbp2 constructs in pask-ib7 (bvs) is used to completely #transform escherichia coli bl21 (promega) .
for expression of the recombinant protein , this construct is #transformed into the yeast strain hf7c (clontech) .
expression of recombinat proteins full-lenght and c-terminal sbp2 constructs in pask-ib7 (bvs) is used to #transform escherichia coli bl21 (promega) .
for expression of the recombinant protein , this construct may be efficiently #transformed into the yeast strain hf7c (clontech) .
expression of recombinat proteins full-lenght and c-terminal sbp2 constructs in pask-ib7 (bvs) may be used to completely #transform escherichia coli bl21 (promega) .
for expression of the recombinant protein , this construct may be #transformed into the yeast strain hf7c (clontech) .
for expression of the recombinant protein , this construct may have been efficiently #transformed into the yeast strain hf7c (clontech) .
expression of recombinat proteins full-lenght and c-terminal sbp2 constructs in pask-ib7 (bvs) may have been used to completely #transform escherichia coli bl21 (promega) .
for expression of the recombinant protein , this construct may have been #transformed into the yeast strain hf7c (clontech) .
expression of recombinat proteins full-lenght and c-terminal sbp2 constructs in pask-ib7 (bvs) was used to #transform escherichia coli bl21 (promega) .
expression of recombinat proteins full-lenght and c-terminal sbp2 constructs in pask-ib7 (bvs) will be used to completely #transform escherichia coli bl21 (promega) .
expression of recombinat proteins full-lenght and c-terminal sbp2 constructs in pask-ib7 are able to be efficiently #transformed into escherichia coli bl21 (promega) and selected for by growth on plates lacking leucine and tryptophan (left panel) .
expression of recombinat proteins full-lenght and c-terminal sbp2 constructs in pask-ib7 are efficiently #transformed into escherichia coli bl21 (promega) and selected for by growth on plates lacking leucine and tryptophan (left panel) .
for expression of the recombinant protein , this construct , as our study suggested , has been shown to be efficiently #transformed into the yeast strain hf7c (clontech) .
for expression of the recombinant protein , this construct , as our study suggested , has been shown to be #transformed into the yeast strain hf7c (clontech) .
expression of recombinat proteins full-lenght and c-terminal sbp2 constructs in pask-ib7 are observed to be efficiently #transformed into escherichia coli bl21 (promega) and selected for by growth on plates lacking leucine and tryptophan (left panel) .
for expression of the recombinant protein , this construct , as our study suggested , has been #transformed into the yeast strain hf7c (clontech) .
expression of recombinat proteins full-lenght and c-terminal sbp2 constructs in pask-ib7 are observed to be #transformed into escherichia coli bl21 (promega) and selected for by growth on plates lacking leucine and tryptophan (left panel) .
for expression of the recombinant protein , this construct , as our study suggested , has the ability to be efficiently #transformed into the yeast strain hf7c (clontech) .
for expression of the recombinant protein , this construct , as our study suggested , has the ability to be #transformed into the yeast strain hf7c (clontech) .
expression of recombinat proteins full-lenght and c-terminal sbp2 constructs in pask-ib7 are #transformed into escherichia coli bl21 (promega) and selected for by growth on plates lacking leucine and tryptophan (left panel) .
for expression of the recombinant protein , this construct , as our study suggested , is able to be #transformed into the yeast strain hf7c (clontech) .
expression of recombinat proteins full-lenght and c-terminal sbp2 constructs in pask-ib7 can be #transformed into escherichia coli bl21 (promega) and selected for by growth on plates lacking leucine and tryptophan (left panel) .
expression of recombinat proteins full-lenght and c-terminal sbp2 constructs in pask-ib7 have been efficiently #transformed into escherichia coli bl21 (promega) and selected for by growth on plates lacking leucine and tryptophan (left panel) .
for expression of the recombinant protein , this construct , as our study suggested , is likely to be efficiently #transformed into the yeast strain hf7c (clontech) .
for expression of the recombinant protein , this construct , as our study suggested , is likely to be #transformed into the yeast strain hf7c (clontech) .
expression of recombinat proteins full-lenght and c-terminal sbp2 constructs in pask-ib7 have the ability to be efficiently #transformed into escherichia coli bl21 (promega) and selected for by growth on plates lacking leucine and tryptophan (left panel) .
for expression of the recombinant protein , this construct , as our study suggested , is observed to be #transformed into the yeast strain hf7c (clontech) .
for expression of the recombinant protein , this construct , as our study suggested , is #transformed into the yeast strain hf7c (clontech) .
expression of recombinat proteins full-lenght and c-terminal sbp2 constructs in pask-ib7 may have been efficiently #transformed into escherichia coli bl21 (promega) and selected for by growth on plates lacking leucine and tryptophan (left panel) .
for expression of the recombinant protein , this construct , as our study suggested , may have been efficiently #transformed into the yeast strain hf7c (clontech) .
expression of recombinat proteins full-lenght and c-terminal sbp2 constructs in pask-ib7 was #transformed into escherichia coli bl21 (promega) .
expression of recombinat proteins full-lenght and c-terminal sbp2 constructs in pask-ib7 were #transformed into escherichia coli bl21 (promega) and selected for by growth on plates lacking leucine and tryptophan (left panel) .
expression of recombinat proteins full-lenght and c-terminal sbp2 constructs in pask-ib7 will be #transformed into escherichia coli bl21 (promega) and selected for by growth on plates lacking leucine and tryptophan (left panel) .
expression of recombinat proteins full-lenght and c-terminal sbp2 constructs in pask-ib7 , as we mentioned earlier , can be used to completely #transform escherichia coli bl21 (promega) .
expression of recombinat proteins full-lenght and c-terminal sbp2 constructs in pask-ib7 , as we mentioned earlier , can be used to #transform escherichia coli bl21 (promega) .
for expression of the recombinant protein , pet28a-5 , for expression of the recombinant protein , can be #transformed into escherichia coli strain bl21(de3) .
expression of recombinat proteins full-lenght and c-terminal sbp2 constructs in pask-ib7 , as we mentioned earlier , has been shown to be used to completely #transform escherichia coli bl21 (promega) .
for expression of the recombinant protein , pet28a-5 , for expression of the recombinant protein , has been efficiently #transformed into escherichia coli strain bl21(de3) .
expression of recombinat proteins full-lenght and c-terminal sbp2 constructs in pask-ib7 , as we mentioned earlier , has been shown to be used to #transform escherichia coli bl21 (promega) .
expression of recombinat proteins full-lenght and c-terminal sbp2 constructs in pask-ib7 , as we mentioned earlier , has been used to completely #transform escherichia coli bl21 (promega) .
for expression of the recombinant protein , pet28a-5 , for expression of the recombinant protein , has been shown to be efficiently #transformed into escherichia coli strain bl21(de3) .
for expression of the recombinant protein , pet28a-5 , for expression of the recombinant protein , has been shown to be #transformed into escherichia coli strain bl21(de3) .
for expression of the recombinant protein , pet28a-5 , for expression of the recombinant protein , is able to be efficiently #transformed into escherichia coli strain bl21(de3) .
for expression of the recombinant protein , pet28a-5 , for expression of the recombinant protein , is able to be #transformed into escherichia coli strain bl21(de3) .
expression of recombinat proteins full-lenght and c-terminal sbp2 constructs in pask-ib7 , as we mentioned earlier , is likely to be used to #transform escherichia coli bl21 (promega) .
for expression of the recombinant protein , pet28a-5 , for expression of the recombinant protein , is observed to be #transformed into escherichia coli strain bl21(de3) .
expression of recombinat proteins full-lenght and c-terminal sbp2 constructs in pask-ib7 , as we mentioned earlier , may be used to completely #transform escherichia coli bl21 (promega) .
expression of recombinat proteins full-lenght and c-terminal sbp2 constructs in pask-ib7 , as we mentioned earlier , may have been used to completely #transform escherichia coli bl21 (promega) .
for expression of the recombinant protein , pet28a-5 , for expression of the recombinant protein , may have been efficiently #transformed into escherichia coli strain bl21(de3) .
expression of recombinat proteins full-lenght and c-terminal sbp2 constructs in pask-ib7 , as we mentioned earlier , may have been used to #transform escherichia coli bl21 (promega) .
for expression of the recombinant protein , pet28a-5 , for expression of the recombinant protein , was #transformed into escherichia coli strain bl21(de3) .
expression of recombinat proteins full-lenght and c-terminal sbp2 constructs in pask-ib7 , however , are able to be efficiently #transformed into escherichia coli bl21 (promega) and selected for by growth on plates lacking leucine and tryptophan (left panel) .
expression of recombinat proteins full-lenght and c-terminal sbp2 constructs in pask-ib7 , however , are efficiently #transformed into escherichia coli bl21 (promega) and selected for by growth on plates lacking leucine and tryptophan (left panel) .
this construct can be efficiently #transformed into the yeast strain hf7c (clontech) .
expression of recombinat proteins full-lenght and c-terminal sbp2 constructs in pask-ib7 , however , are likely to be efficiently #transformed into escherichia coli bl21 (promega) and selected for by growth on plates lacking leucine and tryptophan (left panel) .
expression of recombinat proteins full-lenght and c-terminal sbp2 constructs in pask-ib7 , however , are likely to be #transformed into escherichia coli bl21 (promega) and selected for by growth on plates lacking leucine and tryptophan (left panel) .
this construct has been efficiently #transformed into the yeast strain hf7c (clontech) .
expression of recombinat proteins full-lenght and c-terminal sbp2 constructs in pask-ib7 , however , are observed to be efficiently #transformed into escherichia coli bl21 (promega) and selected for by growth on plates lacking leucine and tryptophan (left panel) .
this construct has been probably #transformed into the yeast strain hf7c (clontech) .
this construct has been proven to be efficiently #transformed into the yeast strain hf7c (clontech) .
expression of recombinat proteins full-lenght and c-terminal sbp2 constructs in pask-ib7 , however , are #transformed into escherichia coli bl21 (promega) and selected for by growth on plates lacking leucine and tryptophan (left panel) .
this construct has been shown to be probably #transformed into the yeast strain hf7c (clontech) .
this construct has the ability to be efficiently #transformed into the yeast strain hf7c (clontech) .
expression of recombinat proteins full-lenght and c-terminal sbp2 constructs in pask-ib7 , however , can be #transformed into escherichia coli bl21 (promega) and selected for by growth on plates lacking leucine and tryptophan (left panel) .
this construct has the ability to be probably #transformed into the yeast strain hf7c (clontech) .
expression of recombinat proteins full-lenght and c-terminal sbp2 constructs in pask-ib7 , however , have been shown to be efficiently #transformed into escherichia coli bl21 (promega) and selected for by growth on plates lacking leucine and tryptophan (left panel) .
this construct is efficiently #transformed into the yeast strain hf7c (clontech) .
this construct is likely to be efficiently #transformed into the yeast strain hf7c (clontech) .
this construct is likely to be probably #transformed into the yeast strain hf7c (clontech) .
expression of recombinat proteins full-lenght and c-terminal sbp2 constructs in pask-ib7 , however , may have been efficiently #transformed into escherichia coli bl21 (promega) and selected for by growth on plates lacking leucine and tryptophan (left panel) .
this construct is observed to be probably #transformed into the yeast strain hf7c (clontech) .
expression of recombinat proteins full-lenght and c-terminal sbp2 constructs in pask-ib7 , however , may have been #transformed into escherichia coli bl21 (promega) and selected for by growth on plates lacking leucine and tryptophan (left panel) .
expression of recombinat proteins full-lenght and c-terminal sbp2 constructs in pask-ib7 , however , will be efficiently #transformed into escherichia coli bl21 (promega) and selected for by growth on plates lacking leucine and tryptophan (left panel) .
this construct , as our study suggested , has been dramatically #transformed into the yeast strain hf7c (clontech) .
this construct , as our study suggested , has been probably #transformed into the yeast strain hf7c (clontech) .
this construct , as our study suggested , has been proven to be dramatically #transformed into the yeast strain hf7c (clontech) .
this construct , as our study suggested , has been shown to be probably #transformed into the yeast strain hf7c (clontech) .
this construct , as our study suggested , is able to be dramatically #transformed into the yeast strain hf7c (clontech) .
this construct , as our study suggested , is likely to be probably #transformed into the yeast strain hf7c (clontech) .
this construct , as our study suggested , is observed to be dramatically #transformed into the yeast strain hf7c (clontech) .
this construct , as our study suggested , is probably #transformed into the yeast strain hf7c (clontech) .
this construct , as our study suggested , may be dramatically #transformed into the yeast strain hf7c (clontech) .
this construct , as our study suggested , may have been dramatically #transformed into the yeast strain hf7c (clontech) .
this construct , as our study suggested , will be dramatically #transformed into the yeast strain hf7c (clontech) .
this construct , as our study suggested , will be probably #transformed into the yeast strain hf7c (clontech) .
pet28a-5 can be efficiently #transformed into escherichia coli strain bl21(de3) .
pet28a-5 can be probably #transformed into escherichia coli strain bl21(de3) .
pet28a-5 has been probably #transformed into escherichia coli strain bl21(de3) .
pet28a-5 has been proven to be dramatically #transformed into escherichia coli strain bl21(de3) .
pet28a-5 has been proven to be efficiently #transformed into escherichia coli strain bl21(de3) .
pet28a-5 has been shown to be dramatically #transformed into escherichia coli strain bl21(de3) .
pet28a-5 has been shown to be probably #transformed into escherichia coli strain bl21(de3) .
pet28a-5 has been #transformed into escherichia coli strain bl21(de3) .
pet28a-5 has the ability to be #transformed into escherichia coli strain bl21(de3) .
pet28a-5 is able to be dramatically #transformed into escherichia coli strain bl21(de3) .
pet28a-5 is able to be #transformed into escherichia coli strain bl21(de3) .
pet28a-5 is dramatically #transformed into escherichia coli strain bl21(de3) .
pet28a-5 is efficiently #transformed into escherichia coli strain bl21(de3) .
pet28a-5 is likely to be dramatically #transformed into escherichia coli strain bl21(de3) .
pet28a-5 is likely to be probably #transformed into escherichia coli strain bl21(de3) .
pet28a-5 is likely to be #transformed into escherichia coli strain bl21(de3) .
pet28a-5 is observed to be dramatically #transformed into escherichia coli strain bl21(de3) .
pet28a-5 is observed to be probably #transformed into escherichia coli strain bl21(de3) .
pet28a-5 is #transformed into escherichia coli strain bl21(de3) .
pet28a-5 may be dramatically #transformed into escherichia coli strain bl21(de3) .
pet28a-5 may have been efficiently #transformed into escherichia coli strain bl21(de3) .
pet28a-5 may have been probably #transformed into escherichia coli strain bl21(de3) .
pet28a-5 will be efficiently #transformed into escherichia coli strain bl21(de3) .
pet28a-5 , for expression of the recombinant protein , can be dramatically #transformed into escherichia coli strain bl21(de3) .
pet28a-5 , for expression of the recombinant protein , has been dramatically #transformed into escherichia coli strain bl21(de3) .
pet28a-5 , for expression of the recombinant protein , has been efficiently #transformed into escherichia coli strain bl21(de3) .
pet28a-5 , for expression of the recombinant protein , has been proven to be dramatically #transformed into escherichia coli strain bl21(de3) .
pet28a-5 , for expression of the recombinant protein , has been proven to be efficiently #transformed into escherichia coli strain bl21(de3) .
pet28a-5 , for expression of the recombinant protein , has been shown to be efficiently #transformed into escherichia coli strain bl21(de3) .
pet28a-5 , for expression of the recombinant protein , is able to be dramatically #transformed into escherichia coli strain bl21(de3) .
pet28a-5 , for expression of the recombinant protein , is dramatically #transformed into escherichia coli strain bl21(de3) .
for expression of the recombinant protein , this construct was #transformed into the yeast strain hf7c (clontech) .
pet28a-5 , for expression of the recombinant protein , is likely to be dramatically #transformed into escherichia coli strain bl21(de3) .
pet28a-5 , for expression of the recombinant protein , is observed to be dramatically #transformed into escherichia coli strain bl21(de3) .
pet28a-5 , for expression of the recombinant protein , is observed to be efficiently #transformed into escherichia coli strain bl21(de3) .
pet28a-5 , for expression of the recombinant protein , may have been dramatically #transformed into escherichia coli strain bl21(de3) .
pet28a-5 , for expression of the recombinant protein , may have been efficiently #transformed into escherichia coli strain bl21(de3) .
pet28a-5 , for expression of the recombinant protein , was #transformed into escherichia coli strain bl21(de3) .
this construct (bvs) has been used to #transform the yeast strain hf7c (clontech) .
this construct (bvs) is likely to be used to completely #transform the yeast strain hf7c (clontech) .
this construct (bvs) is likely to be used to #transform the yeast strain hf7c (clontech) .
this construct (bvs) is observed to be used to completely #transform the yeast strain hf7c (clontech) .
this construct (bvs) is used to completely #transform the yeast strain hf7c (clontech) .
this construct (bvs) may have been used to #transform the yeast strain hf7c (clontech) .
this construct (bvs) was used to #transform the yeast strain hf7c (clontech) .
this construct are able to be efficiently #transformed into the yeast strain hf7c (clontech) and selected for by growth on plates lacking leucine and tryptophan (left panel) .
this construct are able to be specifically #transformed into the yeast strain hf7c (clontech)
this construct are able to be #transformed into the yeast strain hf7c (clontech) and selected for by growth on plates lacking leucine and tryptophan (left panel) .
this construct are likely to be efficiently #transformed into the yeast strain hf7c (clontech) and selected for by growth on plates lacking leucine and tryptophan (left panel) .
this construct are likely to be specifically #transformed into the yeast strain hf7c (clontech)
this construct are observed to be efficiently #transformed into the yeast strain hf7c (clontech) and selected for by growth on plates lacking leucine and tryptophan (left panel) .
this construct are observed to be specifically #transformed into the yeast strain hf7c (clontech)
this construct are observed to be #transformed into the yeast strain hf7c (clontech)
this construct are specifically #transformed into the yeast strain hf7c (clontech)
this construct are #transformed into the yeast strain hf7c (clontech) and selected for by growth on plates lacking leucine and tryptophan (left panel) .
this construct can be #transformed into the yeast strain hf7c (clontech) and selected for by growth on plates lacking leucine and tryptophan (left panel) .
this construct have been shown to be specifically #transformed into the yeast strain hf7c (clontech)
this construct have been shown to be #transformed into the yeast strain hf7c (clontech)
this construct have been shown to be #transformed into the yeast strain hf7c (clontech) and selected for by growth on plates lacking leucine and tryptophan (left panel) .
this construct have the ability to be #transformed into the yeast strain hf7c (clontech)
this construct have the ability to be #transformed into the yeast strain hf7c (clontech) and selected for by growth on plates lacking leucine and tryptophan (left panel) .
this construct may be specifically #transformed into the yeast strain hf7c (clontech)
this construct may be #transformed into the yeast strain hf7c (clontech)
this construct may have been efficiently #transformed into the yeast strain hf7c (clontech) and selected for by growth on plates lacking leucine and tryptophan (left panel) .
this construct may have been specifically #transformed into the yeast strain hf7c (clontech)
this construct may have been #transformed into the yeast strain hf7c (clontech)
this construct may have been #transformed into the yeast strain hf7c (clontech) and selected for by growth on plates lacking leucine and tryptophan (left panel) .
this construct will be efficiently #transformed into the yeast strain hf7c (clontech) and selected for by growth on plates lacking leucine and tryptophan (left panel) .
this construct will be #transformed into the yeast strain hf7c (clontech)
this construct will be #transformed into the yeast strain hf7c (clontech) and selected for by growth on plates lacking leucine and tryptophan (left panel) .
this construct , as our study suggested , are able to be #transformed into the yeast strain hf7c (clontech)
this construct , as our study suggested , are likely to be specifically #transformed into the yeast strain hf7c (clontech)
this construct , as our study suggested , are likely to be #transformed into the yeast strain hf7c (clontech)
this construct , as our study suggested , are observed to be #transformed into the yeast strain hf7c (clontech)
this construct , as our study suggested , are specifically #transformed into the yeast strain hf7c (clontech)
this construct , as our study suggested , are #transformed into the yeast strain hf7c (clontech)
this construct , as our study suggested , have been shown to be #transformed into the yeast strain hf7c (clontech)
this construct , as our study suggested , have been #transformed into the yeast strain hf7c (clontech)
this construct , as our study suggested , have the ability to be #transformed into the yeast strain hf7c (clontech)
this construct , as our study suggested , may be specifically #transformed into the yeast strain hf7c (clontech)
this construct , as our study suggested , may have been specifically #transformed into the yeast strain hf7c (clontech)
this construct , as our study suggested , will be #transformed into the yeast strain hf7c (clontech)
this construct , as we mentioned earlier , can be used to completely #transform the yeast strain hf7c (clontech) .
this construct , as we mentioned earlier , can be used to #transform the yeast strain hf7c (clontech) .
this construct , as we mentioned earlier , has been shown to be used to #transform the yeast strain hf7c (clontech) .
this construct , as we mentioned earlier , has been used to completely #transform the yeast strain hf7c (clontech) .
this construct , as we mentioned earlier , has been used to #transform the yeast strain hf7c (clontech) .
this construct , as we mentioned earlier , has the ability to be used to completely #transform the yeast strain hf7c (clontech) .
this construct , as we mentioned earlier , is able to be used to #transform the yeast strain hf7c (clontech) .
this construct , as we mentioned earlier , is likely to be used to completely #transform the yeast strain hf7c (clontech) .
this construct , as we mentioned earlier , is used to completely #transform the yeast strain hf7c (clontech) .
this construct , as we mentioned earlier , is used to #transform the yeast strain hf7c (clontech) .
this construct , as we mentioned earlier , may be used to completely #transform the yeast strain hf7c (clontech) .
this construct , as we mentioned earlier , may be used to #transform the yeast strain hf7c (clontech) .
this construct , as we mentioned earlier , may have been used to completely #transform the yeast strain hf7c (clontech) .
this construct , as we mentioned earlier , may have been used to #transform the yeast strain hf7c (clontech) .
this construct , as we mentioned earlier , will be used to #transform the yeast strain hf7c (clontech) .
this construct , however , are able to be efficiently #transformed into the yeast strain hf7c (clontech) and selected for by growth on plates lacking leucine and tryptophan (left panel) .
this construct , however , are able to be #transformed into the yeast strain hf7c (clontech) and selected for by growth on plates lacking leucine and tryptophan (left panel) .
this construct , however , are likely to be #transformed into the yeast strain hf7c (clontech) and selected for by growth on plates lacking leucine and tryptophan (left panel) .
this construct , however , are observed to be efficiently #transformed into the yeast strain hf7c (clontech) and selected for by growth on plates lacking leucine and tryptophan (left panel) .
this construct , however , are observed to be #transformed into the yeast strain hf7c (clontech) and selected for by growth on plates lacking leucine and tryptophan (left panel) .
this construct , however , are #transformed into the yeast strain hf7c (clontech) and selected for by growth on plates lacking leucine and tryptophan (left panel) .
this construct , however , can be efficiently #transformed into the yeast strain hf7c (clontech) and selected for by growth on plates lacking leucine and tryptophan (left panel) .
this construct , however , have been efficiently #transformed into the yeast strain hf7c (clontech) and selected for by growth on plates lacking leucine and tryptophan (left panel) .
this construct , however , have been shown to be #transformed into the yeast strain hf7c (clontech) and selected for by growth on plates lacking leucine and tryptophan (left panel) .
this construct , however , have the ability to be #transformed into the yeast strain hf7c (clontech) and selected for by growth on plates lacking leucine and tryptophan (left panel) .
this construct , however , may have been #transformed into the yeast strain hf7c (clontech) and selected for by growth on plates lacking leucine and tryptophan (left panel) .
this construct , however , will be efficiently #transformed into the yeast strain hf7c (clontech) and selected for by growth on plates lacking leucine and tryptophan (left panel) .
for expression of the recombinant protein , the relevant dna fragments was #transformed into the bacterial strains bl21 or topp (stratagene) .
the relevant dna fragments (bvs) has been used to completely #transform the bacterial strains bl21 or topp (stratagene) .
the relevant dna fragments (bvs) has the ability to be used to completely #transform the bacterial strains bl21 or topp (stratagene) .
the relevant dna fragments (bvs) is able to be used to completely #transform the bacterial strains bl21 or topp (stratagene) .
the relevant dna fragments (bvs) is able to be used to #transform the bacterial strains bl21 or topp (stratagene) .
the relevant dna fragments (bvs) is likely to be used to completely #transform the bacterial strains bl21 or topp (stratagene) .
the relevant dna fragments (bvs) is likely to be used to #transform the bacterial strains bl21 or topp (stratagene) .
the relevant dna fragments (bvs) is observed to be used to completely #transform the bacterial strains bl21 or topp (stratagene) .
the relevant dna fragments (bvs) is observed to be used to #transform the bacterial strains bl21 or topp (stratagene) .
the relevant dna fragments (bvs) is used to completely #transform the bacterial strains bl21 or topp (stratagene) .
the relevant dna fragments (bvs) is used to #transform the bacterial strains bl21 or topp (stratagene) .
the relevant dna fragments (bvs) was used to #transform the bacterial strains bl21 or topp (stratagene) .
the relevant dna fragments are able to be #transformed into the bacterial strains bl21 or topp (stratagene)
the relevant dna fragments are able to be #transformed into the bacterial strains bl21 or topp (stratagene) and selected for by growth on plates lacking leucine and tryptophan (left panel) .
the relevant dna fragments are efficiently #transformed into the bacterial strains bl21 or topp (stratagene) and selected for by growth on plates lacking leucine and tryptophan (left panel) .
the relevant dna fragments are likely to be efficiently #transformed into the bacterial strains bl21 or topp (stratagene) and selected for by growth on plates lacking leucine and tryptophan (left panel) .
the relevant dna fragments are likely to be specifically #transformed into the bacterial strains bl21 or topp (stratagene)
the relevant dna fragments are observed to be efficiently #transformed into the bacterial strains bl21 or topp (stratagene) and selected for by growth on plates lacking leucine and tryptophan (left panel) .
the relevant dna fragments are observed to be #transformed into the bacterial strains bl21 or topp (stratagene)
the relevant dna fragments are specifically #transformed into the bacterial strains bl21 or topp (stratagene)
the relevant dna fragments are #transformed into the bacterial strains bl21 or topp (stratagene)
the relevant dna fragments have been efficiently #transformed into the bacterial strains bl21 or topp (stratagene) and selected for by growth on plates lacking leucine and tryptophan (left panel) .
the relevant dna fragments have been shown to be efficiently #transformed into the bacterial strains bl21 or topp (stratagene) and selected for by growth on plates lacking leucine and tryptophan (left panel) .
the relevant dna fragments have been shown to be #transformed into the bacterial strains bl21 or topp (stratagene) and selected for by growth on plates lacking leucine and tryptophan (left panel) .
the relevant dna fragments have been #transformed into the bacterial strains bl21 or topp (stratagene)
the relevant dna fragments have been #transformed into the bacterial strains bl21 or topp (stratagene) and selected for by growth on plates lacking leucine and tryptophan (left panel) .
the relevant dna fragments have the ability to be efficiently #transformed into the bacterial strains bl21 or topp (stratagene) and selected for by growth on plates lacking leucine and tryptophan (left panel) .
the relevant dna fragments have the ability to be #transformed into the bacterial strains bl21 or topp (stratagene) and selected for by growth on plates lacking leucine and tryptophan (left panel) .
the relevant dna fragments may be #transformed into the bacterial strains bl21 or topp (stratagene)
the relevant dna fragments may have been #transformed into the bacterial strains bl21 or topp (stratagene)
the relevant dna fragments was #transformed into the bacterial strains bl21 or topp (stratagene) .
the relevant dna fragments were #transformed into the bacterial strains bl21 or topp (stratagene)
the relevant dna fragments were #transformed into the bacterial strains bl21 or topp (stratagene) and selected for by growth on plates lacking leucine and tryptophan (left panel) .
the relevant dna fragments will be specifically #transformed into the bacterial strains bl21 or topp (stratagene)
the relevant dna fragments , as our study suggested , are able to be specifically #transformed into the bacterial strains bl21 or topp (stratagene)
the relevant dna fragments , as our study suggested , are able to be #transformed into the bacterial strains bl21 or topp (stratagene)
the relevant dna fragments , as our study suggested , are observed to be specifically #transformed into the bacterial strains bl21 or topp (stratagene)
the relevant dna fragments , as our study suggested , have been shown to be specifically #transformed into the bacterial strains bl21 or topp (stratagene)
the relevant dna fragments , as our study suggested , have been #transformed into the bacterial strains bl21 or topp (stratagene)
the relevant dna fragments , as our study suggested , have the ability to be #transformed into the bacterial strains bl21 or topp (stratagene)
the relevant dna fragments , as our study suggested , may be specifically #transformed into the bacterial strains bl21 or topp (stratagene)
the relevant dna fragments , as our study suggested , will be specifically #transformed into the bacterial strains bl21 or topp (stratagene)
the relevant dna fragments , as our study suggested , will be #transformed into the bacterial strains bl21 or topp (stratagene)
the relevant dna fragments , as we mentioned earlier , can be used to #transform the bacterial strains bl21 or topp (stratagene) .
the relevant dna fragments , as we mentioned earlier , has been used to completely #transform the bacterial strains bl21 or topp (stratagene) .
the relevant dna fragments , as we mentioned earlier , has the ability to be used to completely #transform the bacterial strains bl21 or topp (stratagene) .
the relevant dna fragments , as we mentioned earlier , is able to be used to #transform the bacterial strains bl21 or topp (stratagene) .
the relevant dna fragments , as we mentioned earlier , is observed to be used to completely #transform the bacterial strains bl21 or topp (stratagene) .
the relevant dna fragments , as we mentioned earlier , is used to completely #transform the bacterial strains bl21 or topp (stratagene) .
the relevant dna fragments , as we mentioned earlier , may be used to completely #transform the bacterial strains bl21 or topp (stratagene) .
the relevant dna fragments , as we mentioned earlier , may be used to #transform the bacterial strains bl21 or topp (stratagene) .
the relevant dna fragments , as we mentioned earlier , may have been used to completely #transform the bacterial strains bl21 or topp (stratagene) .
the relevant dna fragments , as we mentioned earlier , may have been used to #transform the bacterial strains bl21 or topp (stratagene) .
the relevant dna fragments , as we mentioned earlier , will be used to completely #transform the bacterial strains bl21 or topp (stratagene) .
the relevant dna fragments , however , are able to be #transformed into the bacterial strains bl21 or topp (stratagene) and selected for by growth on plates lacking leucine and tryptophan (left panel) .
the relevant dna fragments , however , are likely to be #transformed into the bacterial strains bl21 or topp (stratagene) and selected for by growth on plates lacking leucine and tryptophan (left panel) .
the relevant dna fragments , however , are observed to be efficiently #transformed into the bacterial strains bl21 or topp (stratagene) and selected for by growth on plates lacking leucine and tryptophan (left panel) .
the relevant dna fragments , however , are observed to be #transformed into the bacterial strains bl21 or topp (stratagene) and selected for by growth on plates lacking leucine and tryptophan (left panel) .
the relevant dna fragments , however , can be efficiently #transformed into the bacterial strains bl21 or topp (stratagene) and selected for by growth on plates lacking leucine and tryptophan (left panel) .
the relevant dna fragments , however , have been shown to be efficiently #transformed into the bacterial strains bl21 or topp (stratagene) and selected for by growth on plates lacking leucine and tryptophan (left panel) .
the relevant dna fragments , however , have been #transformed into the bacterial strains bl21 or topp (stratagene) and selected for by growth on plates lacking leucine and tryptophan (left panel) .
the relevant dna fragments , however , have the ability to be #transformed into the bacterial strains bl21 or topp (stratagene) and selected for by growth on plates lacking leucine and tryptophan (left panel) .
the relevant dna fragments , however , may have been efficiently #transformed into the bacterial strains bl21 or topp (stratagene) and selected for by growth on plates lacking leucine and tryptophan (left panel) .
the relevant dna fragments , however , will be efficiently #transformed into the bacterial strains bl21 or topp (stratagene) and selected for by growth on plates lacking leucine and tryptophan (left panel) .
acj6 and drifter , thus , are able to #translate pn lineage information into distinct dendritic targeting specificity .
a transcript has been efficiently #translated into a c-terminal truncated protein containing the first , second and third transmembrane domains , while the splicing out of exons 3 and 4 would produce a protein with five membrane-spanning domains but lacking the third and fourth domains present in the et-ar protein .
a transcript has been shown to be efficiently #translated into a c-terminal truncated protein containing the first , second and third transmembrane domains , while the splicing out of exons 3 and 4 would produce a protein with five membrane-spanning domains but lacking the third and fourth domains present in the et-ar protein .
acj6 and drifter , thus , are likely to #translate pn lineage information into distinct dendritic targeting specificity .
a transcript is able to be efficiently #translated into a c-terminal truncated protein containing the first , second and third transmembrane domains , while the splicing out of exons 3 and 4 would produce a protein with five membrane-spanning domains but lacking the third and fourth domains present in the et-ar protein .
a transcript is likely to be efficiently #translated into a c-terminal truncated protein containing the first , second and third transmembrane domains , while the splicing out of exons 3 and 4 would produce a protein with five membrane-spanning domains but lacking the third and fourth domains present in the et-ar protein .
acj6 and drifter , thus , can efficiently #translate pn lineage information into distinct dendritic targeting specificity .
a transcript may be efficiently #translated into a c-terminal truncated protein containing the first , second and third transmembrane domains , while the splicing out of exons 3 and 4 would produce a protein with five membrane-spanning domains but lacking the third and fourth domains present in the et-ar protein .
acj6 and drifter , thus , can #translate pn lineage information into distinct dendritic targeting specificity .
acj6 and drifter , thus , efficiently #translated pn lineage information into distinct dendritic targeting specificity .
acj6 and drifter , thus , have been shown to efficiently #translate pn lineage information into distinct dendritic targeting specificity .
a transcript was efficiently #translated into a c-terminal truncated protein containing the first , second and third transmembrane domains , while the splicing out of exons 3 and 4 would produce a protein with five membrane-spanning domains but lacking the third and fourth domains present in the et-ar protein .
acj6 and drifter , thus , have the ability to efficiently #translate pn lineage information into distinct dendritic targeting specificity .
acj6 and drifter , thus , have #translated pn lineage information into distinct dendritic targeting specificity .
a transcript , as our data has shown , has been shown to be #translated into a c-terminal truncated protein containing the first , second and third transmembrane domains , while the splicing out of exons 3 and 4 would produce a protein with five membrane-spanning domains but lacking the third and fourth domains present in the et-ar protein .
acj6 and drifter , thus , may efficiently #translate pn lineage information into distinct dendritic targeting specificity .
acj6 and drifter , thus , may have efficiently #translated pn lineage information into distinct dendritic targeting specificity .
a transcript , as our data has shown , is able to be efficiently #translated into a c-terminal truncated protein containing the first , second and third transmembrane domains , while the splicing out of exons 3 and 4 would produce a protein with five membrane-spanning domains but lacking the third and fourth domains present in the et-ar protein .
acj6 and drifter , thus , may #translate pn lineage information into distinct dendritic targeting specificity .
acj6 and drifter , thus , #translated pn lineage information into distinct dendritic targeting specificity .
a transcript , as our data has shown , is likely to be efficiently #translated into a c-terminal truncated protein containing the first , second and third transmembrane domains , while the splicing out of exons 3 and 4 would produce a protein with five membrane-spanning domains but lacking the third and fourth domains present in the et-ar protein .
acj6 and drifter , thus , will #translate pn lineage information into distinct dendritic targeting specificity .
a transcript , as our data has shown , is likely to be #translated into a c-terminal truncated protein containing the first , second and third transmembrane domains , while the splicing out of exons 3 and 4 would produce a protein with five membrane-spanning domains but lacking the third and fourth domains present in the et-ar protein .
a transcript , as our data has shown , is observed to be efficiently #translated into a c-terminal truncated protein containing the first , second and third transmembrane domains , while the splicing out of exons 3 and 4 would produce a protein with five membrane-spanning domains but lacking the third and fourth domains present in the et-ar protein .
a transcript , as our data has shown , may be efficiently #translated into a c-terminal truncated protein containing the first , second and third transmembrane domains , while the splicing out of exons 3 and 4 would produce a protein with five membrane-spanning domains but lacking the third and fourth domains present in the et-ar protein .
cells are able to use signalling networks to #translate extracellular signals into specific cellular functions with high fidelity .
cells are able to use signalling networks to #translate with high fidelity extracellular signals into specific cellular functions .
cells are likely to use signalling networks to #translate extracellular signals into specific cellular functions with high fidelity .
a transcript , as our data has shown , will be #translated into a c-terminal truncated protein containing the first , second and third transmembrane domains , while the splicing out of exons 3 and 4 would produce a protein with five membrane-spanning domains but lacking the third and fourth domains present in the et-ar protein .
cells are observed to successfully #translate with high fidelity extracellular signals into specific cellular functions .
cells are observed to #translate with high fidelity extracellular signals into specific cellular functions .
cells are observed to use signalling networks to commonly #translate extracellular signals into specific cellular functions .
cells are observed to use signalling networks to #translate extracellular signals into specific cellular functions with high fidelity .
alternative splicing of exon 4 results in a transcript likely to be #translated into a c-terminal truncated protein containing the first , second and third transmembrane domains , while the splicing out of exons 3 and 4 would produce a protein with five membrane-spanning domains but lacking the third and fourth domains present in the et-ar protein .
alternative splicing of exon 4 results in a transcript observed to be #translated into a c-terminal truncated protein containing the first , second and third transmembrane domains , while the splicing out of exons 3 and 4 would produce a protein with five membrane-spanning domains but lacking the third and fourth domains present in the et-ar protein .
cells are observed to use signalling networks to #translate with high fidelity extracellular signals into specific cellular functions .
cells can successfully #translate with high fidelity extracellular signals into specific cellular functions .
alternative splicing of exon 4 results in a transcript which has been #translated into a c-terminal truncated protein containing the first , second and third transmembrane domains , while the splicing out of exons 3 and 4 would produce a protein with five membrane-spanning domains but lacking the third and fourth domains present in the et-ar protein .
alternative splicing of exon 4 results in a transcript which is able to be #translated into a c-terminal truncated protein containing the first , second and third transmembrane domains , while the splicing out of exons 3 and 4 would produce a protein with five membrane-spanning domains but lacking the third and fourth domains present in the et-ar protein .
cells have been shown to successfully #translate with high fidelity extracellular signals into specific cellular functions .
cells have been shown to use signalling networks to #translate extracellular signals into specific cellular functions with high fidelity .
alternative splicing of exon 4 results in a transcript which may be #translated into a c-terminal truncated protein containing the first , second and third transmembrane domains , while the splicing out of exons 3 and 4 would produce a protein with five membrane-spanning domains but lacking the third and fourth domains present in the et-ar protein .
cells have successfully #translated with high fidelity extracellular signals into specific cellular functions .
alternative splicing of exon 4 results in a transcript which may have been #translated into a c-terminal truncated protein containing the first , second and third transmembrane domains , while the splicing out of exons 3 and 4 would produce a protein with five membrane-spanning domains but lacking the third and fourth domains present in the et-ar protein .
cells have the ability to successfully #translate with high fidelity extracellular signals into specific cellular functions .
alternative splicing of exon 4 results in a transcript which was #translated into a c-terminal truncated protein containing the first , second and third transmembrane domains , while the splicing out of exons 3 and 4 would produce a protein with five membrane-spanning domains but lacking the third and fourth domains present in the et-ar protein .
cells have the ability to #translate with high fidelity extracellular signals into specific cellular functions .
cells have the ability to use signalling networks to commonly #translate extracellular signals into specific cellular functions .
isgf3 gamma being able to be properly #translated in vitro from recombinant clones bound dna with a specificity indistinguishable from that of isgf3 gamma purified from hela cells .
cells have the ability to use signalling networks to #translate extracellular signals into specific cellular functions with high fidelity .
isgf3 gamma observed to be properly #translated in vitro from recombinant clones bound dna with a specificity indistinguishable from that of isgf3 gamma purified from hela cells .
cells have #translated with high fidelity extracellular signals into specific cellular functions .
isgf3 gamma observed to be #translated in vitro from recombinant clones bound dna with a specificity indistinguishable from that of isgf3 gamma purified from hela cells .
cells have used signalling networks to #translate extracellular signals into specific cellular functions with high fidelity .
isgf3 gamma shown to be properly #translated in vitro from recombinant clones bound dna with a specificity indistinguishable from that of isgf3 gamma purified from hela cells .
interestingly , this reduction in liver injury can fail to #translate into improved survival .
cells have used signalling networks to #translate with high fidelity extracellular signals into specific cellular functions .
cells may have successfully #translated with high fidelity extracellular signals into specific cellular functions .
cells may have #translated with high fidelity extracellular signals into specific cellular functions .
interestingly , this reduction in liver injury fail to #translate into improved survival .
cells may successfully #translate with high fidelity extracellular signals into specific cellular functions .
isgf3 gamma that has been #translated in vitro from recombinant clones bound dna with a specificity indistinguishable from that of isgf3 gamma purified from hela cells .
cells may use signalling networks to commonly #translate extracellular signals into specific cellular functions .
interestingly , this reduction in liver injury may fail to #translate into improved survival .
cells may use signalling networks to #translate extracellular signals into specific cellular functions with high fidelity .
interestingly , this reduction in liver injury may have failed to #translate into improved survival .
cells may use signalling networks to #translate with high fidelity extracellular signals into specific cellular functions .
interestingly , this reduction in liver injury may not #translate into improved survival .
cells successfully #translate with high fidelity extracellular signals into specific cellular functions .
isgf3 gamma that is observed to be properly #translated in vitro from recombinant clones bound dna with a specificity indistinguishable from that of isgf3 gamma purified from hela cells .
cells successfully #translated with high fidelity extracellular signals into specific cellular functions .
interestingly , this reduction in liver injury will not #translate into improved survival .
cells #translate with high fidelity extracellular signals into specific cellular functions .
cells #translated with high fidelity extracellular signals into specific cellular functions .
isgf3 gamma that is #translated in vitro from recombinant clones bound dna with a specificity indistinguishable from that of isgf3 gamma purified from hela cells .
isgf3 gamma that may be properly #translated in vitro from recombinant clones bound dna with a specificity indistinguishable from that of isgf3 gamma purified from hela cells .
cells used signalling networks to #translate extracellular signals into specific cellular functions with high fidelity .
cells used signalling networks to #translate with high fidelity extracellular signals into specific cellular functions .
isgf3 gamma that was #translated in vitro from recombinant clones bound dna with a specificity indistinguishable from that of isgf3 gamma purified from hela cells .
cells will use signalling networks to #translate extracellular signals into specific cellular functions with high fidelity .
isgf3 gamma that will be properly #translated in vitro from recombinant clones bound dna with a specificity indistinguishable from that of isgf3 gamma purified from hela cells .
cells will use signalling networks to #translate with high fidelity extracellular signals into specific cellular functions .
isgf3 gamma #translated in vitro from recombinant clones bound dna with a specificity indistinguishable from that of isgf3 gamma purified from hela cells .
more than 100 proteins and polypeptides which are included in the arc/xyls family of prokaryotic positive transcriptional regulators are completely #translated from open reading frames .
more than 100 proteins and polypeptides which are included in the arc/xyls family of prokaryotic positive transcriptional regulators are likely to be completely #translated from open reading frames .
more than 100 proteins and polypeptides which are included in the arc/xyls family of prokaryotic positive transcriptional regulators are likely to be #translated from open reading frames .
more than 100 proteins and polypeptides which are included in the arc/xyls family of prokaryotic positive transcriptional regulators are observed to be #translated from open reading frames .
more than 100 proteins and polypeptides which are included in the arc/xyls family of prokaryotic positive transcriptional regulators are #translated from open reading frames .
more than 100 proteins and polypeptides which are included in the arc/xyls family of prokaryotic positive transcriptional regulators can be #translated from open reading frames .
more than 100 proteins and polypeptides which are included in the arc/xyls family of prokaryotic positive transcriptional regulators have been completely #translated from open reading frames .
cells , as our study has proven , are able to use signalling networks to #translate extracellular signals into specific cellular functions .
more than 100 proteins and polypeptides which are included in the arc/xyls family of prokaryotic positive transcriptional regulators have been shown to be #translated from open reading frames .
cells , as our study has proven , are observed to use signalling networks to #translate extracellular signals into specific cellular functions .
cells , as our study has proven , can use signalling networks to #translate extracellular signals into specific cellular functions .
more than 100 proteins and polypeptides which are included in the arc/xyls family of prokaryotic positive transcriptional regulators have the ability to be completely #translated from open reading frames .
more than 100 proteins and polypeptides which are included in the arc/xyls family of prokaryotic positive transcriptional regulators may be completely #translated from open reading frames .
more than 100 proteins and polypeptides which are included in the arc/xyls family of prokaryotic positive transcriptional regulators may be #translated from open reading frames .
more than 100 proteins and polypeptides which are included in the arc/xyls family of prokaryotic positive transcriptional regulators may have been #translated from open reading frames .
cells , as our study has proven , used signalling networks to #translate extracellular signals into specific cellular functions .
cells , as our study has proven , will use signalling networks to #translate extracellular signals into specific cellular functions .
extracellular signals are able to be #translated with high fidelity by cells into specific cellular functions .
more than 100 proteins and polypeptides which are included in the arc/xyls family of prokaryotic positive transcriptional regulators will be completely #translated from open reading frames .
extracellular signals are likely to be #translated with high fidelity by cells into specific cellular functions .
stat1 y701f which can be probably #translated in vitro can also dimerize on the lmp2 gas .
extracellular signals are likely to be #translated with high fidelity into specific cellular functions by cells .
stat1 y701f which can be #translated in vitro can also dimerize on the lmp2 gas .
extracellular signals are observed to be #translated with high fidelity by cells into specific cellular functions .
stat1 y701f which has been probably #translated in vitro can also dimerize on the lmp2 gas .
stat1 y701f which has been shown to be probably #translated in vitro can also dimerize on the lmp2 gas .
extracellular signals are #translated with high fidelity by cells into specific cellular functions .
extracellular signals can be #translated with high fidelity by cells into specific cellular functions .
stat1 y701f which is able to be probably #translated in vitro can also dimerize on the lmp2 gas .
extracellular signals can be #translated with high fidelity into specific cellular functions by cells .
stat1 y701f which is able to be #translated in vitro can also dimerize on the lmp2 gas .
extracellular signals have been shown to be #translated with high fidelity by cells into specific cellular functions .
stat1 y701f which is likely to be probably #translated in vitro can also dimerize on the lmp2 gas .
extracellular signals have been #translated with high fidelity by cells into specific cellular functions .
stat1 y701f which is observed to be probably #translated in vitro can also dimerize on the lmp2 gas .
stat1 y701f which is observed to be #translated in vitro can also dimerize on the lmp2 gas .
extracellular signals were #translated with high fidelity by cells into specific cellular functions .
extracellular signals were #translated with high fidelity into specific cellular functions by cells .
stat1 y701f which was #translated in vitro can also dimerize on the lmp2 gas .
extracellular signals will be #translated with high fidelity by cells into specific cellular functions .
extracellular signals will be #translated with high fidelity into specific cellular functions by cells .
stat1 y701f which will be #translated in vitro can also dimerize on the lmp2 gas .
extracellular signals , as our data has shown , are able to be #translated with high fidelity by cells into specific cellular functions .
stat1 , stat1 y701f , stat1 n135 , stat1 n200 and stat5/1 are able to be #translated in vitro and partially purified on heparin-agarose .
extracellular signals , as our data has shown , are able to be #translated with high fidelity into specific cellular functions by cells .
extracellular signals , as our data has shown , are likely to be #translated with high fidelity by cells into specific cellular functions .
stat1 , stat1 y701f , stat1 n135 , stat1 n200 and stat5/1 are observed to be #translated in vitro and partially purified on heparin-agarose .
extracellular signals , as our data has shown , are likely to be #translated with high fidelity into specific cellular functions by cells .
extracellular signals , as our data has shown , are observed to be #translated with high fidelity by cells into specific cellular functions .
extracellular signals , as our data has shown , are #translated with high fidelity by cells into specific cellular functions .
extracellular signals , as our data has shown , are #translated with high fidelity into specific cellular functions by cells .
stat1 , stat1 y701f , stat1 n135 , stat1 n200 and stat5/1 may be #translated in vitro and partially purified on heparin-agarose .
extracellular signals , as our data has shown , can be #translated with high fidelity into specific cellular functions by cells .
stat1 , stat1 y701f , stat1 n135 , stat1 n200 and stat5/1 may have been #translated in vitro and partially purified on heparin-agarose .
extracellular signals , as our data has shown , have been proven to be #translated with high fidelity into specific cellular functions by cells .
stat1 , stat1 y701f , stat1 n135 , stat1 n200 and stat5/1 that are able to be properly #translated in vitro are partially purified on heparin-agarose .
stat1 , stat1 y701f , stat1 n135 , stat1 n200 and stat5/1 that are able to be #translated in vitro are partially purified on heparin-agarose .
stat1 , stat1 y701f , stat1 n135 , stat1 n200 and stat5/1 that are likely to be properly #translated in vitro are partially purified on heparin-agarose .
extracellular signals , as our data has shown , have been #translated with high fidelity into specific cellular functions by cells .
stat1 , stat1 y701f , stat1 n135 , stat1 n200 and stat5/1 that are likely to be #translated in vitro are partially purified on heparin-agarose .
extracellular signals , as our data has shown , may be #translated with high fidelity by cells into specific cellular functions .
stat1 , stat1 y701f , stat1 n135 , stat1 n200 and stat5/1 that are observed to be properly #translated in vitro are partially purified on heparin-agarose .
stat1 , stat1 y701f , stat1 n135 , stat1 n200 and stat5/1 that are #translated in vitro are partially purified on heparin-agarose .
extracellular signals , as our data has shown , were #translated with high fidelity by cells into specific cellular functions .
stat1 , stat1 y701f , stat1 n135 , stat1 n200 and stat5/1 that can be #translated in vitro are partially purified on heparin-agarose .
stat1 , stat1 y701f , stat1 n135 , stat1 n200 and stat5/1 that have been properly #translated in vitro are partially purified on heparin-agarose .
stat1 , stat1 y701f , stat1 n135 , stat1 n200 and stat5/1 that have been shown to be properly #translated in vitro are partially purified on heparin-agarose .
stat1 , stat1 y701f , stat1 n135 , stat1 n200 and stat5/1 that have been shown to be #translated in vitro are partially purified on heparin-agarose .
malaria is an attractive model for the development and validation of approaches that are likely to #translate genomic information efficiently to vaccine development because of the critical need for effective anti-malarial interventions .
stat1 , stat1 y701f , stat1 n135 , stat1 n200 and stat5/1 that have the ability to be #translated in vitro are partially purified on heparin-agarose .
stat1 , stat1 y701f , stat1 n135 , stat1 n200 and stat5/1 that may be properly #translated in vitro are partially purified on heparin-agarose .
malaria is an attractive model for the development and validation of approaches that are observed to #translate genomic information to vaccine development because of the critical need for effective anti-malarial interventions .
stat1 , stat1 y701f , stat1 n135 , stat1 n200 and stat5/1 that may be #translated in vitro are partially purified on heparin-agarose .
malaria is an attractive model for the development and validation of approaches that can #translate genomic information efficiently to vaccine development because of the critical need for effective anti-malarial interventions .
stat1 , stat1 y701f , stat1 n135 , stat1 n200 and stat5/1 that may have been #translated in vitro are partially purified on heparin-agarose .
stat1 , stat1 y701f , stat1 n135 , stat1 n200 and stat5/1 that will be properly #translated in vitro are partially purified on heparin-agarose .
these changes are able to further #translate into altered expression levels and time kinetics of a number of early genes (peak expression at 2 h after stimulation) .
stat1 , stat1 y701f , stat1 n135 , stat1 n200 and stat5/1 that will be #translated in vitro are partially purified on heparin-agarose .
malaria is an attractive model for the development and validation of approaches that have the ability to #translate genomic information efficiently to vaccine development because of the critical need for effective anti-malarial interventions .
stat1 , stat1 y701f , stat1 n135 , stat1 n200 and stat5/1 will be #translated in vitro and partially purified on heparin-agarose .
malaria is an attractive model for the development and validation of approaches that have the ability to #translate genomic information to vaccine development because of the critical need for effective anti-malarial interventions .
stat1 , stat1 y701f , stat1 n135 , stat1 n200 and stat5/1 , as our data reveals , are able to be #translated in vitro and partially purified on heparin-agarose .
these changes are likely to #translate into altered expression levels and time kinetics of a number of early genes (peak expression at 2 h after stimulation) .
malaria is an attractive model for the development and validation of approaches that have #translated genomic information efficiently to vaccine development because of the critical need for effective anti-malarial interventions .
these changes are observed to further #translate into altered expression levels and time kinetics of a number of early genes (peak expression at 2 h after stimulation) .
malaria is an attractive model for the development and validation of approaches that have #translated genomic information to vaccine development because of the critical need for effective anti-malarial interventions .
stat1 , stat1 y701f , stat1 n135 , stat1 n200 and stat5/1 , as our data reveals , are observed to be #translated in vitro and partially purified on heparin-agarose .
these changes are observed to #translate into altered expression levels and time kinetics of a number of early genes (peak expression at 2 h after stimulation) .
malaria is an attractive model for the development and validation of approaches that may have #translated genomic information efficiently to vaccine development because of the critical need for effective anti-malarial interventions .
malaria is an attractive model for the development and validation of approaches that may have #translated genomic information to vaccine development because of the critical need for effective anti-malarial interventions .
these changes can #translate into altered expression levels and time kinetics of a number of early genes (peak expression at 2 h after stimulation) .
stat1 , stat1 y701f , stat1 n135 , stat1 n200 and stat5/1 , as our data reveals , have been shown to be #translated in vitro and partially purified on heparin-agarose .
malaria is an attractive model for the development and validation of approaches that may #translate genomic information to vaccine development because of the critical need for effective anti-malarial interventions .
malaria is an attractive model for the development and validation of approaches that #translate genomic information efficiently to vaccine development because of the critical need for effective anti-malarial interventions .
stat1 , stat1 y701f , stat1 n135 , stat1 n200 and stat5/1 , as our data reveals , have the ability to be #translated in vitro and partially purified on heparin-agarose .
these changes have been shown to #translate into altered expression levels and time kinetics of a number of early genes (peak expression at 2 h after stimulation) .
malaria is an attractive model for the development and validation of approaches that #translated genomic information efficiently to vaccine development because of the critical need for effective anti-malarial interventions .
stat1 , stat1 y701f , stat1 n135 , stat1 n200 and stat5/1 , as our data reveals , may have been #translated in vitro and partially purified on heparin-agarose .
these changes have the ability to further #translate into altered expression levels and time kinetics of a number of early genes (peak expression at 2 h after stimulation) .
malaria is an attractive model for the development and validation of approaches that #translated genomic information to vaccine development because of the critical need for effective anti-malarial interventions .
the arc/xyls family of prokaryotic positive transcriptional regulators includes more than 100 proteins and polypeptides being able to be #translated from open reading frames .
these changes have #translated into altered expression levels and time kinetics of a number of early genes (peak expression at 2 h after stimulation) .
malaria is an attractive model for the development and validation of approaches that will #translate genomic information to vaccine development because of the critical need for effective anti-malarial interventions .
the arc/xyls family of prokaryotic positive transcriptional regulators includes more than 100 proteins and polypeptides being likely to be #translated from open reading frames .
pn lineage information can be efficiently #translated by acj6 and drifter into distinct dendritic targeting specificity .
the arc/xyls family of prokaryotic positive transcriptional regulators includes more than 100 proteins and polypeptides observed to be #translated from open reading frames .
these changes may have #translated into altered expression levels and time kinetics of a number of early genes (peak expression at 2 h after stimulation) .
the arc/xyls family of prokaryotic positive transcriptional regulators includes more than 100 proteins and polypeptides shown to be #translated from open reading frames .
the arc/xyls family of prokaryotic positive transcriptional regulators includes more than 100 proteins and polypeptides that are able to be #translated from open reading frames .
pn lineage information has been efficiently #translated by acj6 and drifter into distinct dendritic targeting specificity .
the arc/xyls family of prokaryotic positive transcriptional regulators includes more than 100 proteins and polypeptides that are observed to be #translated from open reading frames .
these changes , as our data have shown , are able to further #translate into altered expression levels and time kinetics of a number of early genes (peak expression at 2 h after stimulation) .
these changes , as our data have shown , are able to #translate into altered expression levels and time kinetics of a number of early genes (peak expression at 2 h after stimulation) .
pn lineage information has been shown to be efficiently #translated into distinct dendritic targeting specificity by acj6 and drifter .
the arc/xyls family of prokaryotic positive transcriptional regulators includes more than 100 proteins and polypeptides that have been shown to be #translated from open reading frames .
these changes , as our data have shown , are likely to further #translate into altered expression levels and time kinetics of a number of early genes (peak expression at 2 h after stimulation) .
pn lineage information has been shown to be #translated into distinct dendritic targeting specificity by acj6 and drifter .
the arc/xyls family of prokaryotic positive transcriptional regulators includes more than 100 proteins and polypeptides that have the ability to be #translated from open reading frames .
the arc/xyls family of prokaryotic positive transcriptional regulators includes more than 100 proteins and polypeptides that may be #translated from open reading frames .
these changes , as our data have shown , are observed to #translate into altered expression levels and time kinetics of a number of early genes (peak expression at 2 h after stimulation) .
pn lineage information is able to be efficiently #translated by acj6 and drifter into distinct dendritic targeting specificity .
these changes , as our data have shown , can further #translate into altered expression levels and time kinetics of a number of early genes (peak expression at 2 h after stimulation) .
the arc/xyls family of prokaryotic positive transcriptional regulators includes more than 100 proteins and polypeptides that were #translated from open reading frames .
the arc/xyls family of prokaryotic positive transcriptional regulators includes more than 100 proteins and polypeptides that will be #translated from open reading frames .
pn lineage information is able to be #translated by acj6 and drifter into distinct dendritic targeting specificity .
these changes , as our data have shown , further #translated into altered expression levels and time kinetics of a number of early genes (peak expression at 2 h after stimulation) .
the arc/xyls family of prokaryotic positive transcriptional regulators includes more than 100 proteins and polypeptides #translated from open reading frames .
pn lineage information is able to be #translated into distinct dendritic targeting specificity by acj6 and drifter .
this mutant can be efficiently #translated in the presence of c-terminal sbp2 , and as shown in figure 6c no readthrough is detectable when the auga element is deleted , indicating that the stimulatory effect is entirely 3 utr dependent .
these changes , as our data have shown , have been shown to #translate into altered expression levels and time kinetics of a number of early genes (peak expression at 2 h after stimulation) .
pn lineage information is efficiently #translated by acj6 and drifter into distinct dendritic targeting specificity .
this mutant can be #translated in the presence of c-terminal sbp2 , and as shown in figure 6c no readthrough is detectable when the auga element is deleted , indicating that the stimulatory effect is entirely 3 utr dependent .
these changes , as our data have shown , have further #translated into altered expression levels and time kinetics of a number of early genes (peak expression at 2 h after stimulation) .
this mutant has been efficiently #translated in the presence of c-terminal sbp2 , and as shown in figure 6c no readthrough is detectable when the auga element is deleted , indicating that the stimulatory effect is entirely 3 utr dependent .
these changes , as our data have shown , have the ability to further #translate into altered expression levels and time kinetics of a number of early genes (peak expression at 2 h after stimulation) .
these changes , as our data have shown , have #translated into altered expression levels and time kinetics of a number of early genes (peak expression at 2 h after stimulation) .
these changes , as our data have shown , may further #translate into altered expression levels and time kinetics of a number of early genes (peak expression at 2 h after stimulation) .
this mutant is able to be efficiently #translated in the presence of c-terminal sbp2 , and as shown in figure 6c no readthrough is detectable when the auga element is deleted , indicating that the stimulatory effect is entirely 3 utr dependent .
these changes , as our data have shown , may have further #translated into altered expression levels and time kinetics of a number of early genes (peak expression at 2 h after stimulation) .
pn lineage information is observed to be efficiently #translated by acj6 and drifter into distinct dendritic targeting specificity .
this mutant is able to be #translated in the presence of c-terminal sbp2 , and as shown in figure 6c no readthrough is detectable when the auga element is deleted , indicating that the stimulatory effect is entirely 3 utr dependent .
these changes , as our data have shown , may have #translated into altered expression levels and time kinetics of a number of early genes (peak expression at 2 h after stimulation) .
this mutant is efficiently #translated in the presence of c-terminal sbp2 , and as shown in figure 6c no readthrough is detectable when the auga element is deleted , indicating that the stimulatory effect is entirely 3 utr dependent .
pn lineage information is observed to be #translated by acj6 and drifter into distinct dendritic targeting specificity .
these changes , as our data have shown , may #translate into altered expression levels and time kinetics of a number of early genes (peak expression at 2 h after stimulation) .
this mutant is likely to be efficiently #translated in the presence of c-terminal sbp2 , and as shown in figure 6c no readthrough is detectable when the auga element is deleted , indicating that the stimulatory effect is entirely 3 utr dependent .
pn lineage information is observed to be #translated into distinct dendritic targeting specificity by acj6 and drifter .
this mutant is likely to be #translated in the presence of c-terminal sbp2 , and as shown in figure 6c no readthrough is detectable when the auga element is deleted , indicating that the stimulatory effect is entirely 3 utr dependent .
this mutant is observed to be efficiently #translated in the presence of c-terminal sbp2 , and as shown in figure 6c no readthrough is detectable when the auga element is deleted , indicating that the stimulatory effect is entirely 3 utr dependent .
this mutant is observed to be #translated in the presence of c-terminal sbp2 , and as shown in figure 6c no readthrough is detectable when the auga element is deleted , indicating that the stimulatory effect is entirely 3 utr dependent .
pn lineage information may be efficiently #translated into distinct dendritic targeting specificity by acj6 and drifter .
this mutant may be efficiently #translated in the presence of c-terminal sbp2 , and as shown in figure 6c no readthrough is detectable when the auga element is deleted , indicating that the stimulatory effect is entirely 3 utr dependent .
this mutant may be #translated in the presence of c-terminal sbp2 , and as shown in figure 6c no readthrough is detectable when the auga element is deleted , indicating that the stimulatory effect is entirely 3 utr dependent .
this mutant may have been efficiently #translated in the presence of c-terminal sbp2 , and as shown in figure 6c no readthrough is detectable when the auga element is deleted , indicating that the stimulatory effect is entirely 3 utr dependent .
pn lineage information may have been efficiently #translated by acj6 and drifter into distinct dendritic targeting specificity .
this mutant may have been #translated in the presence of c-terminal sbp2 , and as shown in figure 6c no readthrough is detectable when the auga element is deleted , indicating that the stimulatory effect is entirely 3 utr dependent .
pn lineage information may have been #translated by acj6 and drifter into distinct dendritic targeting specificity .
this mutant will be #translated in the presence of c-terminal sbp2 , and as shown in figure 6c no readthrough is detectable when the auga element is deleted , indicating that the stimulatory effect is entirely 3 utr dependent .
pn lineage information may have been #translated into distinct dendritic targeting specificity by acj6 and drifter .
this mutant , as our study reveals , can be #translated in the presence of c-terminal sbp2 , and as shown in figure 6c no readthrough is detectable when the auga element is deleted , indicating that the stimulatory effect is entirely 3 utr dependent .
this mutant , as our study reveals , has been #translated in the presence of c-terminal sbp2 , and as shown in figure 6c no readthrough is detectable when the auga element is deleted , indicating that the stimulatory effect is entirely 3 utr dependent .
pn lineage information was #translated by acj6 and drifter into distinct dendritic targeting specificity .
pn lineage information was #translated into distinct dendritic targeting specificity by acj6 and drifter .
this mutant , as our study reveals , is likely to be #translated in the presence of c-terminal sbp2 , and as shown in figure 6c no readthrough is detectable when the auga element is deleted , indicating that the stimulatory effect is entirely 3 utr dependent .
pn lineage information will be efficiently #translated into distinct dendritic targeting specificity by acj6 and drifter .
pn lineage information will be #translated by acj6 and drifter into distinct dendritic targeting specificity .
this mutant , as our study reveals , will be #translated in the presence of c-terminal sbp2 , and as shown in figure 6c no readthrough is detectable when the auga element is deleted , indicating that the stimulatory effect is entirely 3 utr dependent .
this review examines the use of new and emerging dna , tissue , and live-cell transfection microarray technologies that are likely to be used to efficiently #translate information resulting from the completion of the human genome project .
this reduction in liver injury , as our data interestingly reveal , did not #translate into improved survival .
we also report the first definitive incorporation of sec into a selenoprotein which has been successfully #translated in reticulocyte lysates .
this reduction in liver injury , as our data interestingly reveal , has been shown to fail to #translate into improved survival .
we also report the first definitive incorporation of sec into a selenoprotein which has been #translated in reticulocyte lysates .
this review examines the use of new and emerging dna , tissue , and live-cell transfection microarray technologies that have been used to discover , validate , and #translate information resulting from the completion of the human genome project .
we also report the first definitive incorporation of sec into a selenoprotein which is able to be successfully #translated in reticulocyte lysates .
this reduction in liver injury , as our data interestingly reveal , has not #translated into improved survival .
we also report the first definitive incorporation of sec into a selenoprotein which is able to be #translated in reticulocyte lysates .
this reduction in liver injury , as our data interestingly reveal , is observed to fail to #translate into improved survival .
this review examines the use of new and emerging dna , tissue , and live-cell transfection microarray technologies that have been used to #translate information resulting from the completion of the human genome project .
this review examines the use of new and emerging dna , tissue , and live-cell transfection microarray technologies that may be used to discover , validate , and #translate information resulting from the completion of the human genome project .
we also report the first definitive incorporation of sec into a selenoprotein which is likely to be #translated in reticulocyte lysates .
this reduction in liver injury , as our data interestingly reveal , may not #translate into improved survival .
we also report the first definitive incorporation of sec into a selenoprotein which is successfully #translated in reticulocyte lysates .
this review examines the use of new and emerging dna , tissue , and live-cell transfection microarray technologies that may have been used to #translate information resulting from the completion of the human genome project .
this review examines the use of new and emerging dna , tissue , and live-cell transfection microarray technologies that would be used to discover , validate , and #translate information resulting from the completion of the human genome project .
this review examines the use of new and emerging dna , tissue , and live-cell transfection microarray technologies that would be used to efficiently #translate information resulting from the completion of the human genome project .
we also report the first definitive incorporation of sec into a selenoprotein which may have been successfully #translated in reticulocyte lysates .
we also report the first definitive incorporation of sec into a selenoprotein which was successfully #translated in reticulocyte lysates .
this review examines the use of new and emerging dna , tissue , and live-cell transfection microarray technologies that , as our study suggested , are likely to be used to efficiently #translate information resulting from the completion of the human genome project .
this review examines the use of new and emerging dna , tissue , and live-cell transfection microarray technologies that , as our study suggested , are likely to be used to #translate information resulting from the completion of the human genome project .
we also report the first definitive incorporation of sec into a selenoprotein which will be successfully #translated in reticulocyte lysates .
this review examines the use of new and emerging dna , tissue , and live-cell transfection microarray technologies that , as our study suggested , could be used to discover , validate , and #translate information resulting from the completion of the human genome project .
we also report the first definitive incorporation of sec into a selenoprotein which will be #translated in reticulocyte lysates .
this review examines the use of new and emerging dna , tissue , and live-cell transfection microarray technologies that , as our study suggested , could be used to efficiently #translate information resulting from the completion of the human genome project .
this review examines the use of new and emerging dna , tissue , and live-cell transfection microarray technologies that , as our study suggested , have been used to efficiently #translate information resulting from the completion of the human genome project .
this review examines the use of new and emerging dna , tissue , and live-cell transfection microarray technologies that , as our study suggested , have been used to #translate information resulting from the completion of the human genome project .
this review examines the use of new and emerging dna , tissue , and live-cell transfection microarray technologies that , as our study suggested , may have been used to discover , validate , and #translate information resulting from the completion of the human genome project .
this review examines the use of new and emerging dna , tissue , and live-cell transfection microarray technologies that , as our study suggested , may have been used to efficiently #translate information resulting from the completion of the human genome project .
this review examines the use of new and emerging dna , tissue , and live-cell transfection microarray technologies that , as our study suggested , may have been used to #translate information resulting from the completion of the human genome project .
this review examines the use of new and emerging dna , tissue , and live-cell transfection microarray technologies that , as our study suggested , would be used to discover , validate , and #translate information resulting from the completion of the human genome project .
this review examines the use of new and emerging dna , tissue , and live-cell transfection microarray technologies that , as our study suggested , would be used to #translate information resulting from the completion of the human genome project .
thus , acj6 and drifter are able to #translate pn lineage information into distinct dendritic targeting specificity .
thus , acj6 and drifter are likely to #translate pn lineage information into distinct dendritic targeting specificity .
thus , acj6 and drifter efficiently #translated pn lineage information into distinct dendritic targeting specificity .
thus , acj6 and drifter have been shown to #translate pn lineage information into distinct dendritic targeting specificity .
thus , acj6 and drifter have efficiently #translated pn lineage information into distinct dendritic targeting specificity .
thus , acj6 and drifter may have #translated pn lineage information into distinct dendritic targeting specificity .
thus , acj6 and drifter #translated pn lineage information into distinct dendritic targeting specificity .
thus , acj6 and drifter will efficiently #translate pn lineage information into distinct dendritic targeting specificity .
thus , acj6 and drifter will #translate pn lineage information into distinct dendritic targeting specificity .
stat1 y701f #translated in vitro can also dimerize on the lmp2 gas .
we also report the first definitive incorporation of sec into a selenoprotein #translated in reticulocyte lysates .
isgf3 gamma #translated in vitro from recombinant clones bound dna with a specificity indistinguishable from that of isgf3 gamma purified from hela cells .
alternative splicing of exon 4 results in a transcript which would be #translated into a c-terminal truncated protein containing the first , second and third transmembrane domains , while the splicing out of exons 3 and 4 would produce a protein with five membrane-spanning domains but lacking the third and fourth domains present in the et-ar protein .
interestingly , this reduction in liver injury failed to #translate into improved survival .
this review examines the use of new and emerging dna , tissue , and live-cell transfection microarray technologies that can be used to discover , validate , and #translate information resulting from the completion of the human genome project .
these changes further #translate into altered expression levels and time kinetics of a number of early genes (peak expression at 2 h after stimulation) .
acj6 and drifter are able to #translate with high fidelity pn lineage information into distinct dendritic targeting specificity .
isgf3 gamma being able to be #translated in in vitro from recombinant clones bound dna with a specificity indistinguishable clones bound dna with a specificity indistinguishable from that of isgf3 gamma purified from hela cells .
isgf3 gamma observed to be #translated in in vitro from recombinant clones bound dna with a specificity indistinguishable clones bound dna with a specificity indistinguishable from that of isgf3 gamma purified from hela cells .
isgf3 gamma properly #translated in in vitro from recombinant clones bound dna with a specificity indistinguishable clones bound dna with a specificity indistinguishable from that of isgf3 gamma purified from hela cells .
acj6 and drifter are likely to successfully #translate with high fidelity pn lineage information into distinct dendritic targeting specificity .
acj6 and drifter are likely to use signalling networks to commonly #translate pn lineage information into distinct dendritic targeting specificity .
isgf3 gamma that can be #translated in in vitro from recombinant clones bound dna with a specificity indistinguishable clones bound dna with a specificity indistinguishable from that of isgf3 gamma purified from hela cells .
isgf3 gamma that has been properly #translated in in vitro from recombinant clones bound dna with a specificity indistinguishable clones bound dna with a specificity indistinguishable from that of isgf3 gamma purified from hela cells .
acj6 and drifter are observed to successfully #translate with high fidelity pn lineage information into distinct dendritic targeting specificity .
acj6 and drifter are observed to #translate with high fidelity pn lineage information into distinct dendritic targeting specificity .
acj6 and drifter are observed to use signalling networks to #translate pn lineage information into distinct dendritic targeting specificity with high fidelity .
acj6 and drifter are observed to use signalling networks to #translate with high fidelity pn lineage information into distinct dendritic targeting specificity .
isgf3 gamma that is able to be #translated in in vitro from recombinant clones bound dna with a specificity indistinguishable clones bound dna with a specificity indistinguishable from that of isgf3 gamma purified from hela cells .
acj6 and drifter can successfully #translate with high fidelity pn lineage information into distinct dendritic targeting specificity .
acj6 and drifter can #translate with high fidelity pn lineage information into distinct dendritic targeting specificity .
isgf3 gamma that is observed to be #translated in in vitro from recombinant clones bound dna with a specificity indistinguishable clones bound dna with a specificity indistinguishable from that of isgf3 gamma purified from hela cells .
acj6 and drifter can use signalling networks to #translate with high fidelity pn lineage information into distinct dendritic targeting specificity .
isgf3 gamma that is properly #translated in in vitro from recombinant clones bound dna with a specificity indistinguishable clones bound dna with a specificity indistinguishable from that of isgf3 gamma purified from hela cells .
acj6 and drifter have been shown to successfully #translate with high fidelity pn lineage information into distinct dendritic targeting specificity .
acj6 and drifter have been shown to #translate with high fidelity pn lineage information into distinct dendritic targeting specificity .
acj6 and drifter have been shown to use signalling networks to commonly #translate pn lineage information into distinct dendritic targeting specificity .
isgf3 gamma that may have been properly #translated in in vitro from recombinant clones bound dna with a specificity indistinguishable clones bound dna with a specificity indistinguishable from that of isgf3 gamma purified from hela cells .
acj6 and drifter have been shown to use signalling networks to #translate with high fidelity pn lineage information into distinct dendritic targeting specificity .
isgf3 gamma that may have been #translated in in vitro from recombinant clones bound dna with a specificity indistinguishable clones bound dna with a specificity indistinguishable from that of isgf3 gamma purified from hela cells .
acj6 and drifter have successfully #translated with high fidelity pn lineage information into distinct dendritic targeting specificity .
isgf3 gamma that was properly #translated in in vitro from recombinant clones bound dna with a specificity indistinguishable clones bound dna with a specificity indistinguishable from that of isgf3 gamma purified from hela cells .
isgf3 gamma that will be #translated in in vitro from recombinant clones bound dna with a specificity indistinguishable clones bound dna with a specificity indistinguishable from that of isgf3 gamma purified from hela cells .
acj6 and drifter have the ability to use signalling networks to #translate pn lineage information into distinct dendritic targeting specificity with high fidelity .
isgf3 gamma #translated vitro from recombinant from that of isgf3 gamma purified from hela cells .
in reticulocyte lysates translation and partial purification of fstat1 , a selenoprotein were #translated in vitro using the t7-based coupled transcription-translation kit (promega) as per the manufacturer fs instructions .
acj6 and drifter have the ability to use signalling networks to #translate with high fidelity pn lineage information into distinct dendritic targeting specificity .
acj6 and drifter have #translated with high fidelity pn lineage information into distinct dendritic targeting specificity .
acj6 and drifter have used signalling networks to commonly #translate pn lineage information into distinct dendritic targeting specificity .
acj6 and drifter have used signalling networks to #translate pn lineage information into distinct dendritic targeting specificity with high fidelity .
stat1 y701f are able to be #translated in vitro and partially purified on heparin-agarose .
acj6 and drifter have used signalling networks to #translate with high fidelity pn lineage information into distinct dendritic targeting specificity .
stat1 y701f are observed to be #translated in vitro and partially purified on heparin-agarose .
stat1 y701f are #translated in vitro and partially purified on heparin-agarose .
acj6 and drifter may have used signalling networks to commonly #translate pn lineage information into distinct dendritic targeting specificity .
acj6 and drifter may have used signalling networks to #translate with high fidelity pn lineage information into distinct dendritic targeting specificity .
stat1 y701f have been #translated in vitro and partially purified on heparin-agarose .
stat1 y701f have the ability to be #translated in vitro and partially purified on heparin-agarose .
acj6 and drifter may #translate with high fidelity pn lineage information into distinct dendritic targeting specificity .
stat1 y701f may have been #translated in vitro and partially purified on heparin-agarose .
stat1 y701f that are able to be #translated in vitro are partially purified on heparin-agarose .
acj6 and drifter successfully #translate with high fidelity pn lineage information into distinct dendritic targeting specificity .
stat1 y701f that are likely to be properly #translated in vitro are partially purified on heparin-agarose .
stat1 y701f that are likely to be #translated in vitro are partially purified on heparin-agarose .
acj6 and drifter #translate with high fidelity pn lineage information into distinct dendritic targeting specificity .
stat1 y701f that are observed to be properly #translated in vitro are partially purified on heparin-agarose .
acj6 and drifter #translated with high fidelity pn lineage information into distinct dendritic targeting specificity .
stat1 y701f that are observed to be #translated in vitro are partially purified on heparin-agarose .
acj6 and drifter use signalling networks to #translate with high fidelity pn lineage information into distinct dendritic targeting specificity .
stat1 y701f that are properly #translated in vitro are partially purified on heparin-agarose .
stat1 y701f that are #translated in vitro are partially purified on heparin-agarose .
acj6 and drifter used signalling networks to #translate pn lineage information into distinct dendritic targeting specificity with high fidelity .
acj6 and drifter used signalling networks to #translate with high fidelity pn lineage information into distinct dendritic targeting specificity .
acj6 and drifter will successfully #translate with high fidelity pn lineage information into distinct dendritic targeting specificity .
stat1 y701f that have been properly #translated in vitro are partially purified on heparin-agarose .
stat1 y701f that have been shown to be properly #translated in vitro are partially purified on heparin-agarose .
stat1 y701f that have been shown to be #translated in vitro are partially purified on heparin-agarose .
acj6 and drifter will use signalling networks to #translate pn lineage information into distinct dendritic targeting specificity with high fidelity .
acj6 and drifter will use signalling networks to #translate with high fidelity pn lineage information into distinct dendritic targeting specificity .
acj6 and drifter , as our study has proven , are able to use signalling networks to #translate pn lineage information into distinct dendritic targeting specificity .
acj6 and drifter , as our study has proven , are likely to use signalling networks to #translate pn lineage information into distinct dendritic targeting specificity .
acj6 and drifter , as our study has proven , are observed to use signalling networks to #translate pn lineage information into distinct dendritic targeting specificity .
stat1 y701f that may be #translated in vitro are partially purified on heparin-agarose .
acj6 and drifter , as our study has proven , can use signalling networks to #translate pn lineage information into distinct dendritic targeting specificity .
stat1 y701f that may have been properly #translated in vitro are partially purified on heparin-agarose .
acj6 and drifter , as our study has proven , have been shown to use signalling networks to #translate pn lineage information into distinct dendritic targeting specificity .
stat1 y701f that may have been #translated in vitro are partially purified on heparin-agarose .
stat1 y701f that will be properly #translated in vitro are partially purified on heparin-agarose .
stat1 y701f that will be #translated in vitro are partially purified on heparin-agarose .
stat1 y701f were #translated in vitro and partially purified on heparin-agarose .
stat1 y701f , stat1 n135 , stat1 n200 and stat5/1 are #translated in vitro and partially purified on heparin-agarose .
stat1 y701f , stat1 n135 , stat1 n200 and stat5/1 may be #translated in vitro and partially purified on heparin-agarose .
stat1 y701f , stat1 n135 , stat1 n200 and stat5/1 may have been #translated in vitro and partially purified on heparin-agarose .
stat1 y701f , stat1 n135 , stat1 n200 and stat5/1 that can be properly #translated in vitro are partially purified on heparin-agarose .
stat1 y701f , stat1 n135 , stat1 n200 and stat5/1 that have been properly #translated in vitro are partially purified on heparin-agarose .
stat1 y701f , stat1 n135 , stat1 n200 and stat5/1 that have been shown to be #translated in vitro are partially purified on heparin-agarose .
stat1 y701f , stat1 n135 , stat1 n200 and stat5/1 that have been #translated in vitro are partially purified on heparin-agarose .
stat1 y701f , stat1 n135 , stat1 n200 and stat5/1 that have the ability to be properly #translated in vitro are partially purified on heparin-agarose .
stat1 y701f , stat1 n135 , stat1 n200 and stat5/1 that have the ability to be #translated in vitro are partially purified on heparin-agarose .
stat1 y701f , stat1 n135 , stat1 n200 and stat5/1 that may be properly #translated in vitro are partially purified on heparin-agarose .
stat1 y701f , stat1 n135 , stat1 n200 and stat5/1 that may have been #translated in vitro are partially purified on heparin-agarose .
stat1 y701f , stat1 n135 , stat1 n200 and stat5/1 that will be properly #translated in vitro are partially purified on heparin-agarose .
stat1 y701f , stat1 n135 , stat1 n200 and stat5/1 that will be #translated in vitro are partially purified on heparin-agarose .
stat1 y701f , stat1 n135 , stat1 n200 and stat5/1 #translated in vitro can also dimerize on the lmp2 gas .
stat1 y701f , stat1 n135 , stat1 n200 and stat5/1 were #translated in vitro and partially purified on heparin-agarose .
stat1 y701f , stat1 n135 , stat1 n200 and stat5/1 which can be probably #translated in vitro can also dimerize on the lmp2 gas .
stat1 y701f , stat1 n135 , stat1 n200 and stat5/1 which has been shown to be probably #translated in vitro can also dimerize on the lmp2 gas .
stat1 y701f , stat1 n135 , stat1 n200 and stat5/1 which has been shown to be #translated in vitro can also dimerize on the lmp2 gas .
stat1 y701f , stat1 n135 , stat1 n200 and stat5/1 which is able to be #translated in vitro can also dimerize on the lmp2 gas .
stat1 y701f , stat1 n135 , stat1 n200 and stat5/1 which is probably #translated in vitro can also dimerize on the lmp2 gas .
stat1 y701f , stat1 n135 , stat1 n200 and stat5/1 which may be #translated in vitro can also dimerize on the lmp2 gas .
stat1 y701f , stat1 n135 , stat1 n200 and stat5/1 which was probably #translated in vitro can also dimerize on the lmp2 gas .
stat1 y701f , stat1 n135 , stat1 n200 and stat5/1 which was #translated in vitro can also dimerize on the lmp2 gas .
stat1 y701f , stat1 n135 , stat1 n200 and stat5/1 which will be probably #translated in vitro can also dimerize on the lmp2 gas .
stat1 y701f , stat1 n135 , stat1 n200 and stat5/1 will be #translated in vitro and partially purified on heparin-agarose .
stat1 y701f , stat1 n135 , stat1 n200 and stat5/1 , as our data reveals , are #translated in vitro and partially purified on heparin-agarose .
stat1 y701f , as our data reveals , are able to be #translated in vitro and partially purified on heparin-agarose .
stat1 y701f , as our data reveals , have been shown to be #translated in vitro and partially purified on heparin-agarose .
in addition , our data show that this reduction in liver injury performed by these molecules/pathways in promoting cell survival or apoptosis/anoikis are likely to #translate into improved survival .
stat1 y701f , as our data reveals , have been #translated in vitro and partially purified on heparin-agarose .
stat1 y701f , as our data reveals , have the ability to be #translated in vitro and partially purified on heparin-agarose .
stat1 y701f , as our data reveals , will be #translated in vitro and partially purified on heparin-agarose .
stat1 , stat1 y701f , stat1 n135 , stat1 n200 and stat5/1 which has been probably #translated in vitro can also dimerize on the lmp2 gas .
in addition , our data show that this reduction in liver injury performed by these molecules/pathways in promoting cell survival or apoptosis/anoikis have the ability to #translate into improved survival .
in addition , our data show that this reduction in liver injury performed by these molecules/pathways in promoting cell survival or apoptosis/anoikis have #translated into improved survival .
stat1 , stat1 y701f , stat1 n135 , stat1 n200 and stat5/1 which has been shown to be #translated in vitro can also dimerize on the lmp2 gas .
cells , thus , are likely to efficiently #translate extracellular signals into specific cellular functions .
in addition , our data show that this reduction in liver injury performed by these molecules/pathways in promoting cell survival or apoptosis/anoikis may have efficiently #translated into improved survival .
in addition , our data show that this reduction in liver injury performed by these molecules/pathways in promoting cell survival or apoptosis/anoikis may have #translated into improved survival .
in addition , our data show that this reduction in liver injury performed by these molecules/pathways in promoting cell survival or apoptosis/anoikis may #translate into improved survival .
cells , thus , can efficiently #translate extracellular signals into specific cellular functions .
stat1 , stat1 y701f , stat1 n135 , stat1 n200 and stat5/1 which is likely to be #translated in vitro can also dimerize on the lmp2 gas .
cells , thus , can #translate extracellular signals into specific cellular functions .
in addition , our data show that this reduction in liver injury performed by these molecules/pathways in promoting cell survival or apoptosis/anoikis #translated into improved survival .
in addition , our data show that this reduction in liver injury performed by these molecules/pathways in promoting cell survival or apoptosis/anoikis will efficiently #translate into improved survival .
stat1 , stat1 y701f , stat1 n135 , stat1 n200 and stat5/1 which is probably #translated in vitro can also dimerize on the lmp2 gas .
in addition , our data show that this reduction in liver injury performed by these molecules/pathways in promoting cell survival or apoptosis/anoikis will #translate into improved survival .
in addition , this reduction in liver injury performed by these molecules/pathways in promoting cell survival or apoptosis/anoikis , as our data have shown , are able to efficiently #translate into improved survival .
in addition , this reduction in liver injury performed by these molecules/pathways in promoting cell survival or apoptosis/anoikis , as our data have shown , are able to #translate into improved survival .
cells , thus , have the ability to efficiently #translate extracellular signals into specific cellular functions .
stat1 , stat1 y701f , stat1 n135 , stat1 n200 and stat5/1 which may be #translated in vitro can also dimerize on the lmp2 gas .
in addition , this reduction in liver injury performed by these molecules/pathways in promoting cell survival or apoptosis/anoikis , as our data have shown , are likely to efficiently #translate into improved survival .
in addition , this reduction in liver injury performed by these molecules/pathways in promoting cell survival or apoptosis/anoikis , as our data have shown , are likely to #translate into improved survival .
cells , thus , have #translated extracellular signals into specific cellular functions .
in addition , this reduction in liver injury performed by these molecules/pathways in promoting cell survival or apoptosis/anoikis , as our data have shown , are observed to #translate into improved survival .
stat1 , stat1 y701f , stat1 n135 , stat1 n200 and stat5/1 which will be #translated in vitro can also dimerize on the lmp2 gas .
we also report the first definitive incorporation of sec into stat1 y701f #translated in vitro .
cells , thus , may #translate extracellular signals into specific cellular functions .
we also report the first definitive incorporation of sec into stat1 y701f which can be successfully #translated in vitro .
cells , thus , will #translate extracellular signals into specific cellular functions .
in addition , this reduction in liver injury performed by these molecules/pathways in promoting cell survival or apoptosis/anoikis , as our data have shown , have efficiently #translated into improved survival .
we also report the first definitive incorporation of sec into stat1 y701f which has been shown to be #translated in vitro .
thus , cells are able to efficiently #translate extracellular signals into specific cellular functions .
thus , cells are able to #translate extracellular signals into specific cellular functions .
in addition , this reduction in liver injury performed by these molecules/pathways in promoting cell survival or apoptosis/anoikis , as our data have shown , have the ability to #translate into improved survival .
we also report the first definitive incorporation of sec into stat1 y701f which is able to be successfully #translated in vitro .
in addition , this reduction in liver injury performed by these molecules/pathways in promoting cell survival or apoptosis/anoikis , as our data have shown , may efficiently #translate into improved survival .
we also report the first definitive incorporation of sec into stat1 y701f which is able to be #translated in vitro .
thus , cells are observed to efficiently #translate extracellular signals into specific cellular functions .
in addition , this reduction in liver injury performed by these molecules/pathways in promoting cell survival or apoptosis/anoikis , as our data have shown , may have efficiently #translated into improved survival .
in addition , this reduction in liver injury performed by these molecules/pathways in promoting cell survival or apoptosis/anoikis , as our data have shown , may have #translated into improved survival .
thus , cells can efficiently #translate extracellular signals into specific cellular functions .
we also report the first definitive incorporation of sec into stat1 y701f which is observed to be successfully #translated in vitro .
in addition , this reduction in liver injury performed by these molecules/pathways in promoting cell survival or apoptosis/anoikis , as our data have shown , may #translate into improved survival .
in addition , this reduction in liver injury performed by these molecules/pathways in promoting cell survival or apoptosis/anoikis , as our data have shown , #translated into improved survival .
we also report the first definitive incorporation of sec into stat1 y701f which is successfully #translated in vitro .
thus , cells have been shown to #translate extracellular signals into specific cellular functions .
thus , cells have efficiently #translated extracellular signals into specific cellular functions .
thus , cells have the ability to #translate extracellular signals into specific cellular functions .
we also report the first definitive incorporation of sec into stat1 y701f which may have been #translated in vitro .
we also report the first definitive incorporation of sec into stat1 y701f which was successfully #translated in vitro .
thus , cells may efficiently #translate extracellular signals into specific cellular functions .
we also report the first definitive incorporation of sec into stat1 y701f which will be #translated in vitro .
thus , cells may #translate extracellular signals into specific cellular functions .
we also report the first definitive incorporation of sec into stat1 y701f , stat1 n135 , stat1 n200 and stat5/1 which can be #translated in vitro .
we also report the first definitive incorporation of sec into stat1 y701f , stat1 n135 , stat1 n200 and stat5/1 which has been shown to be successfully #translated in vitro .
we also report the first definitive incorporation of sec into stat1 y701f , stat1 n135 , stat1 n200 and stat5/1 which has been successfully #translated in vitro .
we also report the first definitive incorporation of sec into stat1 y701f , stat1 n135 , stat1 n200 and stat5/1 which has been #translated in vitro .
we also report the first definitive incorporation of sec into stat1 y701f , stat1 n135 , stat1 n200 and stat5/1 which is able to be successfully #translated in vitro .
we also report the first definitive incorporation of sec into stat1 y701f , stat1 n135 , stat1 n200 and stat5/1 which is likely to be successfully #translated in vitro .
we also report the first definitive incorporation of sec into stat1 y701f , stat1 n135 , stat1 n200 and stat5/1 which is likely to be #translated in vitro .
we also report the first definitive incorporation of sec into stat1 y701f , stat1 n135 , stat1 n200 and stat5/1 which is successfully #translated in vitro .
we also report the first definitive incorporation of sec into stat1 y701f , stat1 n135 , stat1 n200 and stat5/1 which may be #translated in vitro .
we also report the first definitive incorporation of sec into stat1 y701f , stat1 n135 , stat1 n200 and stat5/1 which may have been #translated in vitro .
we also report the first definitive incorporation of sec into stat1 y701f , stat1 n135 , stat1 n200 and stat5/1 which was successfully #translated in vitro .
we also report the first definitive incorporation of sec into stat1 y701f , stat1 n135 , stat1 n200 and stat5/1 which will be successfully #translated in vitro .
we also report the first definitive incorporation of sec into stat1 y701f , stat1 n135 , stat1 n200 and stat5/1 which will be #translated in vitro .
we also report the first definitive incorporation of sec into stat1 , stat1 y701f , stat1 n135 , stat1 n200 and stat5/1 #translated in vitro .
we also report the first definitive incorporation of sec into stat1 , stat1 y701f , stat1 n135 , stat1 n200 and stat5/1 which can be #translated in vitro .
we also report the first definitive incorporation of sec into stat1 , stat1 y701f , stat1 n135 , stat1 n200 and stat5/1 which has been shown to be successfully #translated in vitro .
extracellular signals can be efficiently #translated by cells into specific cellular functions .
we also report the first definitive incorporation of sec into stat1 , stat1 y701f , stat1 n135 , stat1 n200 and stat5/1 which has been successfully #translated in vitro .
we also report the first definitive incorporation of sec into stat1 , stat1 y701f , stat1 n135 , stat1 n200 and stat5/1 which has been #translated in vitro .
we also report the first definitive incorporation of sec into stat1 , stat1 y701f , stat1 n135 , stat1 n200 and stat5/1 which is able to be #translated in vitro .
we also report the first definitive incorporation of sec into stat1 , stat1 y701f , stat1 n135 , stat1 n200 and stat5/1 which is observed to be successfully #translated in vitro .
extracellular signals can be #translated into specific cellular functions by cells .
we also report the first definitive incorporation of sec into stat1 , stat1 y701f , stat1 n135 , stat1 n200 and stat5/1 which is observed to be #translated in vitro .
we also report the first definitive incorporation of sec into stat1 , stat1 y701f , stat1 n135 , stat1 n200 and stat5/1 which is successfully #translated in vitro .
we also report the first definitive incorporation of sec into stat1 , stat1 y701f , stat1 n135 , stat1 n200 and stat5/1 which is #translated in vitro .
extracellular signals has been efficiently #translated into specific cellular functions by cells .
we also report the first definitive incorporation of sec into stat1 , stat1 y701f , stat1 n135 , stat1 n200 and stat5/1 which may have been successfully #translated in vitro .
we also report the first definitive incorporation of sec into stat1 , stat1 y701f , stat1 n135 , stat1 n200 and stat5/1 which may have been #translated in vitro .
we also report the first definitive incorporation of sec into stat1 , stat1 y701f , stat1 n135 , stat1 n200 and stat5/1 which was successfully #translated in vitro .
we also report the first definitive incorporation of sec into stat1 , stat1 y701f , stat1 n135 , stat1 n200 and stat5/1 which was #translated in vitro .
extracellular signals has been shown to be #translated by cells into specific cellular functions .
a selenoprotein are likely to be #translated in reticulocyte lysates and partially purified on heparin-agarose .
extracellular signals has been #translated by cells into specific cellular functions .
a selenoprotein are #translated in reticulocyte lysates and partially purified on heparin-agarose .
a selenoprotein have been shown to be #translated in reticulocyte lysates and partially purified on heparin-agarose .
a selenoprotein may have been #translated in reticulocyte lysates and partially purified on heparin-agarose .
extracellular signals is able to be efficiently #translated into specific cellular functions by cells .
extracellular signals is able to be #translated by cells into specific cellular functions .
a selenoprotein that are able to be #translated in reticulocyte lysates are partially purified on heparin-agarose .
extracellular signals is efficiently #translated by cells into specific cellular functions .
a selenoprotein that are observed to be #translated in reticulocyte lysates are partially purified on heparin-agarose .
a selenoprotein that are properly #translated in reticulocyte lysates are partially purified on heparin-agarose .
extracellular signals is efficiently #translated into specific cellular functions by cells .
a selenoprotein that are #translated in reticulocyte lysates are partially purified on heparin-agarose .
a selenoprotein that can be properly #translated in reticulocyte lysates are partially purified on heparin-agarose .
a selenoprotein that have been properly #translated in reticulocyte lysates are partially purified on heparin-agarose .
extracellular signals is likely to be efficiently #translated into specific cellular functions by cells .
extracellular signals is likely to be #translated by cells into specific cellular functions .
a selenoprotein that have the ability to be properly #translated in reticulocyte lysates are partially purified on heparin-agarose .
a selenoprotein that have the ability to be #translated in reticulocyte lysates are partially purified on heparin-agarose .
extracellular signals is likely to be #translated into specific cellular functions by cells .
extracellular signals is observed to be efficiently #translated by cells into specific cellular functions .
a selenoprotein that may be properly #translated in reticulocyte lysates are partially purified on heparin-agarose .
a selenoprotein that may have been #translated in reticulocyte lysates are partially purified on heparin-agarose .
a selenoprotein that will be properly #translated in reticulocyte lysates are partially purified on heparin-agarose .
a selenoprotein that will be #translated in reticulocyte lysates are partially purified on heparin-agarose .
a selenoprotein #translated in reticulocyte lysates can also dimerize on the lmp2 gas .
extracellular signals is observed to be #translated into specific cellular functions by cells .
a selenoprotein were #translated in reticulocyte lysates and partially purified on heparin-agarose .
extracellular signals is #translated by cells into specific cellular functions .
a selenoprotein which has been probably #translated in reticulocyte lysates can also dimerize on the lmp2 gas .
a selenoprotein which has been shown to be #translated in reticulocyte lysates can also dimerize on the lmp2 gas .
extracellular signals may be efficiently #translated by cells into specific cellular functions .
a selenoprotein which is able to be probably #translated in reticulocyte lysates can also dimerize on the lmp2 gas .
extracellular signals may be efficiently #translated into specific cellular functions by cells .
a selenoprotein which is able to be #translated in reticulocyte lysates can also dimerize on the lmp2 gas .
extracellular signals may have been efficiently #translated by cells into specific cellular functions .
a selenoprotein which is probably #translated in reticulocyte lysates can also dimerize on the lmp2 gas .
a selenoprotein which may be #translated in reticulocyte lysates can also dimerize on the lmp2 gas .
extracellular signals may have been efficiently #translated into specific cellular functions by cells .
a selenoprotein which was probably #translated in reticulocyte lysates can also dimerize on the lmp2 gas .
extracellular signals may have been #translated into specific cellular functions by cells .
a selenoprotein , as our data reveals , are likely to be #translated in reticulocyte lysates and partially purified on heparin-agarose .
a selenoprotein , as our data reveals , are #translated in reticulocyte lysates and partially purified on heparin-agarose .
a selenoprotein , as our data reveals , can be #translated in reticulocyte lysates and partially purified on heparin-agarose .
a selenoprotein , as our data reveals , have been #translated in reticulocyte lysates and partially purified on heparin-agarose .
extracellular signals was #translated into specific cellular functions by cells .
extracellular signals will be efficiently #translated by cells into specific cellular functions .
a selenoprotein , as our data reveals , may have been #translated in reticulocyte lysates and partially purified on heparin-agarose .
extracellular signals will be efficiently #translated into specific cellular functions by cells .
a selenoprotein , as our data reveals , will be #translated in reticulocyte lysates and partially purified on heparin-agarose .
extracellular signals will be #translated into specific cellular functions by cells .
our data show that this reduction in liver injury performed by these molecules/pathways in promoting cell survival or apoptosis/anoikis , in addition , are able to efficiently #translate into improved survival .
our data show that this reduction in liver injury performed by these molecules/pathways in promoting cell survival or apoptosis/anoikis , in addition , are able to #translate into improved survival .
our data show that this reduction in liver injury performed by these molecules/pathways in promoting cell survival or apoptosis/anoikis , in addition , are likely to #translate into improved survival .
our data show that this reduction in liver injury performed by these molecules/pathways in promoting cell survival or apoptosis/anoikis , in addition , are observed to efficiently #translate into improved survival .
our data show that this reduction in liver injury performed by these molecules/pathways in promoting cell survival or apoptosis/anoikis , in addition , are observed to #translate into improved survival .
our data show that this reduction in liver injury performed by these molecules/pathways in promoting cell survival or apoptosis/anoikis , in addition , can efficiently #translate into improved survival .
our data show that this reduction in liver injury performed by these molecules/pathways in promoting cell survival or apoptosis/anoikis , in addition , can #translate into improved survival .
our data show that this reduction in liver injury performed by these molecules/pathways in promoting cell survival or apoptosis/anoikis , in addition , have the ability to efficiently #translate into improved survival .
our data show that this reduction in liver injury performed by these molecules/pathways in promoting cell survival or apoptosis/anoikis , in addition , have the ability to #translate into improved survival .
our data show that this reduction in liver injury performed by these molecules/pathways in promoting cell survival or apoptosis/anoikis , in addition , may have efficiently #translated into improved survival .
our data show that this reduction in liver injury performed by these molecules/pathways in promoting cell survival or apoptosis/anoikis , in addition , may have #translated into improved survival .
our data show that this reduction in liver injury performed by these molecules/pathways in promoting cell survival or apoptosis/anoikis , in addition , may #translate into improved survival .
our data show that this reduction in liver injury performed by these molecules/pathways in promoting cell survival or apoptosis/anoikis , in addition , #translated into improved survival .
our data show that this reduction in liver injury performed by these molecules/pathways in promoting cell survival or apoptosis/anoikis , in addition , will efficiently #translate into improved survival .
remarkably , this reduction in liver injury are likely to #translate into improved survival .
remarkably , this reduction in liver injury are observed to #translate into improved survival .
remarkably , this reduction in liver injury can #translate into improved survival .
remarkably , this reduction in liver injury have been shown to #translate into improved survival .
remarkably , this reduction in liver injury have the ability to #translate into improved survival .
remarkably , this reduction in liver injury may #translate into improved survival .
remarkably , this reduction in liver injury #translated into improved survival .
the simple rules governing how this reduction in liver injury #translate into improved survival are found across social groups , giving social insects the potential to have a profound impact on our understanding of the interplay between network dynamics and social evolution .
under the simple governing rules found across social groups , this reduction in liver injury are able to properly #translate into improved survival , giving social insects the potential to have a profound impact on our understanding of the interplay between network dynamics and social evolution .
under the simple governing rules found across social groups , this reduction in liver injury are able to #translate into improved survival , giving social insects the potential to have a profound impact on our understanding of the interplay between network dynamics and social evolution .
under the simple governing rules found across social groups , this reduction in liver injury are likely to properly #translate into improved survival , giving social insects the potential to have a profound impact on our understanding of the interplay between network dynamics and social evolution .
under the simple governing rules found across social groups , this reduction in liver injury can properly #translate into improved survival , giving social insects the potential to have a profound impact on our understanding of the interplay between network dynamics and social evolution .
under the simple governing rules found across social groups , this reduction in liver injury can #translate into improved survival , giving social insects the potential to have a profound impact on our understanding of the interplay between network dynamics and social evolution .
under the simple governing rules found across social groups , this reduction in liver injury have been shown to #translate into improved survival , giving social insects the potential to have a profound impact on our understanding of the interplay between network dynamics and social evolution .
under the simple governing rules found across social groups , this reduction in liver injury have properly #translated into improved survival , giving social insects the potential to have a profound impact on our understanding of the interplay between network dynamics and social evolution .
under the simple governing rules found across social groups , this reduction in liver injury have the ability to #translate into improved survival , giving social insects the potential to have a profound impact on our understanding of the interplay between network dynamics and social evolution .
under the simple governing rules found across social groups , this reduction in liver injury may have #translated into improved survival , giving social insects the potential to have a profound impact on our understanding of the interplay between network dynamics and social evolution .
under the simple governing rules found across social groups , this reduction in liver injury may #translate into improved survival , giving social insects the potential to have a profound impact on our understanding of the interplay between network dynamics and social evolution .
under the simple governing rules found across social groups , this reduction in liver injury properly #translate into improved survival , giving social insects the potential to have a profound impact on our understanding of the interplay between network dynamics and social evolution .
under the simple governing rules found across social groups , this reduction in liver injury properly #translated into improved survival , giving social insects the potential to have a profound impact on our understanding of the interplay between network dynamics and social evolution .
under the simple governing rules found across social groups , this reduction in liver injury #translate into improved survival , giving social insects the potential to have a profound impact on our understanding of the interplay between network dynamics and social evolution .
under the simple governing rules found across social groups , this reduction in liver injury #translated into improved survival , giving social insects the potential to have a profound impact on our understanding of the interplay between network dynamics and social evolution .
under the simple governing rules found across social groups , this reduction in liver injury will properly #translate into improved survival , giving social insects the potential to have a profound impact on our understanding of the interplay between network dynamics and social evolution .
this reduction in liver injury can successfully #translate into improved survival , thus partly explaining the increase in power output .
this reduction in liver injury has been shown to #translate into improved survival , thus partly explaining the increase in power output .
this reduction in liver injury has successfully #translated into improved survival , thus partly explaining the increase in power output .
this reduction in liver injury has the ability to #translate into improved survival , thus partly explaining the increase in power output .
this reduction in liver injury has #translated into improved survival , thus partly explaining the increase in power output .
this reduction in liver injury is able to successfully #translate into improved survival , thus partly explaining the increase in power output .
this reduction in liver injury is likely to #translate into improved survival , thus partly explaining the increase in power output .
this reduction in liver injury may have #translated into improved survival , thus partly explaining the increase in power output .
this reduction in liver injury may #translate into improved survival , thus partly explaining the increase in power output .
this reduction in liver injury successfully #translated into improved survival , thus partly explaining the increase in power output .
this reduction in liver injury successfully #translates into improved survival , thus partly explaining the increase in power output .
this reduction in liver injury will successfully #translate into improved survival , thus partly explaining the increase in power output .
this reduction in liver injury will #translate into improved survival , thus partly explaining the increase in power output .
this reduction in liver injury , however , has been shown to #translate into improved survival , thus partly explaining the increase in power output .
this reduction in liver injury , however , has successfully #translated into improved survival , thus partly explaining the increase in power output .
this reduction in liver injury , however , has the ability to successfully #translate into improved survival , thus partly explaining the increase in power output .
this reduction in liver injury , however , is likely to successfully #translate into improved survival , thus partly explaining the increase in power output .
this reduction in liver injury , however , is observed to successfully #translate into improved survival , thus partly explaining the increase in power output .
this reduction in liver injury , however , successfully #translated into improved survival , thus partly explaining the increase in power output .
this reduction in liver injury , however , successfully #translates into improved survival , thus partly explaining the increase in power output .
this reduction in liver injury , however , will #translate into improved survival , thus partly explaining the increase in power output .
in addition , these changes performed by these molecules/pathways in promoting cell survival or apoptosis/anoikis , as our data have shown , are likely to efficiently #translate into altered expression levels and time kinetics of a number of early genes .
in addition , these changes performed by these molecules/pathways in promoting cell survival or apoptosis/anoikis , as our data have shown , are likely to #translate into altered expression levels and time kinetics of a number of early genes .
in addition , these changes performed by these molecules/pathways in promoting cell survival or apoptosis/anoikis , as our data have shown , are observed to efficiently #translate into altered expression levels and time kinetics of a number of early genes .
in addition , these changes performed by these molecules/pathways in promoting cell survival or apoptosis/anoikis , as our data have shown , are observed to #translate into altered expression levels and time kinetics of a number of early genes .
in addition , these changes performed by these molecules/pathways in promoting cell survival or apoptosis/anoikis , as our data have shown , have efficiently #translated into altered expression levels and time kinetics of a number of early genes .
in addition , these changes performed by these molecules/pathways in promoting cell survival or apoptosis/anoikis , as our data have shown , may have efficiently #translated into altered expression levels and time kinetics of a number of early genes .
in addition , these changes performed by these molecules/pathways in promoting cell survival or apoptosis/anoikis , as our data have shown , may #translate into altered expression levels and time kinetics of a number of early genes .
in addition , these changes performed by these molecules/pathways in promoting cell survival or apoptosis/anoikis , as our data have shown , #translated into altered expression levels and time kinetics of a number of early genes .
in addition , these changes performed by these molecules/pathways in promoting cell survival or apoptosis/anoikis , as our data have shown , will efficiently #translate into altered expression levels and time kinetics of a number of early genes .
in addition , our data show that these changes performed by these molecules/pathways in promoting cell survival or apoptosis/anoikis are able to efficiently #translate into altered expression levels and time kinetics of a number of early genes .
in addition , our data show that these changes performed by these molecules/pathways in promoting cell survival or apoptosis/anoikis are likely to efficiently #translate into altered expression levels and time kinetics of a number of early genes .
in addition , our data show that these changes performed by these molecules/pathways in promoting cell survival or apoptosis/anoikis are likely to #translate into altered expression levels and time kinetics of a number of early genes .
in addition , our data show that these changes performed by these molecules/pathways in promoting cell survival or apoptosis/anoikis are observed to efficiently #translate into altered expression levels and time kinetics of a number of early genes .
in addition , our data show that these changes performed by these molecules/pathways in promoting cell survival or apoptosis/anoikis are observed to #translate into altered expression levels and time kinetics of a number of early genes .
in addition , our data show that these changes performed by these molecules/pathways in promoting cell survival or apoptosis/anoikis efficiently #translated into altered expression levels and time kinetics of a number of early genes .
in addition , our data show that these changes performed by these molecules/pathways in promoting cell survival or apoptosis/anoikis have been shown to #translate into altered expression levels and time kinetics of a number of early genes .
in addition , our data show that these changes performed by these molecules/pathways in promoting cell survival or apoptosis/anoikis have efficiently #translated into altered expression levels and time kinetics of a number of early genes .
in addition , our data show that these changes performed by these molecules/pathways in promoting cell survival or apoptosis/anoikis have the ability to efficiently #translate into altered expression levels and time kinetics of a number of early genes .
in addition , our data show that these changes performed by these molecules/pathways in promoting cell survival or apoptosis/anoikis have #translated into altered expression levels and time kinetics of a number of early genes .
in addition , our data show that these changes performed by these molecules/pathways in promoting cell survival or apoptosis/anoikis may have #translated into altered expression levels and time kinetics of a number of early genes .
interestingly , these changes can fail to #translate into altered expression levels and time kinetics of a number of early genes .
interestingly , these changes fail to #translate into altered expression levels and time kinetics of a number of early genes .
interestingly , these changes failed to #translate into altered expression levels and time kinetics of a number of early genes .
interestingly , these changes has not #translated into altered expression levels and time kinetics of a number of early genes .
interestingly , these changes may have failed to #translate into altered expression levels and time kinetics of a number of early genes .
interestingly , these changes will not #translate into altered expression levels and time kinetics of a number of early genes .
our data show that these changes performed by these molecules/pathways in promoting cell survival or apoptosis/anoikis , in addition , are able to #translate into altered expression levels and time kinetics of a number of early genes .
our data show that these changes performed by these molecules/pathways in promoting cell survival or apoptosis/anoikis , in addition , are likely to #translate into altered expression levels and time kinetics of a number of early genes .
our data show that these changes performed by these molecules/pathways in promoting cell survival or apoptosis/anoikis , in addition , are observed to #translate into altered expression levels and time kinetics of a number of early genes .
our data show that these changes performed by these molecules/pathways in promoting cell survival or apoptosis/anoikis , in addition , efficiently #translated into altered expression levels and time kinetics of a number of early genes .
our data show that these changes performed by these molecules/pathways in promoting cell survival or apoptosis/anoikis , in addition , have efficiently #translated into altered expression levels and time kinetics of a number of early genes .
our data show that these changes performed by these molecules/pathways in promoting cell survival or apoptosis/anoikis , in addition , have the ability to efficiently #translate into altered expression levels and time kinetics of a number of early genes .
our data show that these changes performed by these molecules/pathways in promoting cell survival or apoptosis/anoikis , in addition , have the ability to #translate into altered expression levels and time kinetics of a number of early genes .
remarkably , these changes are likely to #translate into altered expression levels and time kinetics of a number of early genes .
remarkably , these changes are observed to #translate into altered expression levels and time kinetics of a number of early genes .
remarkably , these changes can #translate into altered expression levels and time kinetics of a number of early genes .
remarkably , these changes have the ability to #translate into altered expression levels and time kinetics of a number of early genes .
remarkably , these changes #translated into altered expression levels and time kinetics of a number of early genes .
remarkably , these changes will #translate into altered expression levels and time kinetics of a number of early genes .
the simple rules governing how these changes #translate into altered expression levels and time kinetics of a number of early genes are found across social groups , giving social insects the potential to have a profound impact on our understanding of the interplay between network dynamics and social evolution .
these changes can successfully #translate into altered expression levels and time kinetics of a number of early genes , thus partly explaining the increase in power output .
these changes has been shown to successfully #translate into altered expression levels and time kinetics of a number of early genes , thus partly explaining the increase in power output .
these changes has been shown to #translate into altered expression levels and time kinetics of a number of early genes , thus partly explaining the increase in power output .
these changes has the ability to successfully #translate into altered expression levels and time kinetics of a number of early genes , thus partly explaining the increase in power output .
these changes has the ability to #translate into altered expression levels and time kinetics of a number of early genes , thus partly explaining the increase in power output .
these changes has #translated into altered expression levels and time kinetics of a number of early genes , thus partly explaining the increase in power output .
these changes is observed to successfully #translate into altered expression levels and time kinetics of a number of early genes , thus partly explaining the increase in power output .
these changes may have successfully #translated into altered expression levels and time kinetics of a number of early genes , thus partly explaining the increase in power output .
these changes may #translate into altered expression levels and time kinetics of a number of early genes , thus partly explaining the increase in power output .
these changes , however , can #translate into altered expression levels and time kinetics of a number of early genes , thus partly explaining the increase in power output .
these changes , however , has been shown to successfully #translate into altered expression levels and time kinetics of a number of early genes , thus partly explaining the increase in power output .
these changes , however , has been shown to #translate into altered expression levels and time kinetics of a number of early genes , thus partly explaining the increase in power output .
these changes , however , has the ability to #translate into altered expression levels and time kinetics of a number of early genes , thus partly explaining the increase in power output .
these changes , however , has #translated into altered expression levels and time kinetics of a number of early genes , thus partly explaining the increase in power output .
these changes , however , is able to successfully #translate into altered expression levels and time kinetics of a number of early genes , thus partly explaining the increase in power output .
these changes , however , is observed to successfully #translate into altered expression levels and time kinetics of a number of early genes , thus partly explaining the increase in power output .
these changes , however , is observed to #translate into altered expression levels and time kinetics of a number of early genes , thus partly explaining the increase in power output .
these changes , however , may have #translated into altered expression levels and time kinetics of a number of early genes , thus partly explaining the increase in power output .
these changes , however , #translates into altered expression levels and time kinetics of a number of early genes , thus partly explaining the increase in power output .
under the simple governing rules found across social groups , these changes are able to #translate into altered expression levels and time kinetics of a number of early genes , giving social insects the potential to have a profound impact on our understanding of the interplay between network dynamics and social evolution .
under the simple governing rules found across social groups , these changes are likely to #translate into altered expression levels and time kinetics of a number of early genes , giving social insects the potential to have a profound impact on our understanding of the interplay between network dynamics and social evolution .
under the simple governing rules found across social groups , these changes are observed to properly #translate into altered expression levels and time kinetics of a number of early genes , giving social insects the potential to have a profound impact on our understanding of the interplay between network dynamics and social evolution .
under the simple governing rules found across social groups , these changes are observed to #translate into altered expression levels and time kinetics of a number of early genes , giving social insects the potential to have a profound impact on our understanding of the interplay between network dynamics and social evolution .
under the simple governing rules found across social groups , these changes have the ability to properly #translate into altered expression levels and time kinetics of a number of early genes , giving social insects the potential to have a profound impact on our understanding of the interplay between network dynamics and social evolution .
under the simple governing rules found across social groups , these changes have #translated into altered expression levels and time kinetics of a number of early genes , giving social insects the potential to have a profound impact on our understanding of the interplay between network dynamics and social evolution .
under the simple governing rules found across social groups , these changes may have properly #translated into altered expression levels and time kinetics of a number of early genes , giving social insects the potential to have a profound impact on our understanding of the interplay between network dynamics and social evolution .
under the simple governing rules found across social groups , these changes may have #translated into altered expression levels and time kinetics of a number of early genes , giving social insects the potential to have a profound impact on our understanding of the interplay between network dynamics and social evolution .
under the simple governing rules found across social groups , these changes may #translate into altered expression levels and time kinetics of a number of early genes , giving social insects the potential to have a profound impact on our understanding of the interplay between network dynamics and social evolution .
under the simple governing rules found across social groups , these changes properly #translated into altered expression levels and time kinetics of a number of early genes , giving social insects the potential to have a profound impact on our understanding of the interplay between network dynamics and social evolution .
under the simple governing rules found across social groups , these changes #translate into altered expression levels and time kinetics of a number of early genes , giving social insects the potential to have a profound impact on our understanding of the interplay between network dynamics and social evolution .
c-terminally truncated stat5a proteins likely to be remarkably #truncated at amino acids 762 or 773 had no effect on the induction of either gene .
c-terminally truncated stat5a proteins likely to be #truncated at amino acids 762 or 773 had no effect on the induction of either gene .
c-terminally truncated stat5a proteins observed to be #truncated at amino acids 762 or 773 had no effect on the induction of either gene .
c-terminally truncated stat5a proteins that are able to be remarkably #truncated at amino acids 762 or 773 had no effect on the induction of either gene .
c-terminally truncated stat5a proteins that are able to be #truncated at amino acids 762 or 773 had no effect on the induction of either gene .
c-terminally truncated stat5a proteins that are likely to be #truncated at amino acids 762 or 773 had no effect on the induction of either gene .
c-terminally truncated stat5a proteins that are observed to be #truncated at amino acids 762 or 773 had no effect on the induction of either gene .
c-terminally truncated stat5a proteins that have been shown to be remarkably #truncated at amino acids 762 or 773 had no effect on the induction of either gene .
c-terminally truncated stat5a proteins that have been shown to be #truncated at amino acids 762 or 773 had no effect on the induction of either gene .
c-terminally truncated stat5a proteins that have been #truncated at amino acids 762 or 773 had no effect on the induction of either gene .
c-terminally truncated stat5a proteins that may be remarkably #truncated at amino acids 762 or 773 had no effect on the induction of either gene .
c-terminally truncated stat5a proteins that may have been remarkably #truncated at amino acids 762 or 773 had no effect on the induction of either gene .
c-terminally truncated stat5a proteins that were #truncated at amino acids 762 or 773 had no effect on the induction of either gene .
c-terminally truncated stat5a proteins that will be remarkably #truncated at amino acids 762 or 773 had no effect on the induction of either gene .
c-terminally truncated stat5a proteins that will be #truncated at amino acids 762 or 773 had no effect on the induction of either gene .
electrophoretic mobility shift assays showed that the full-length bcl6 protein extracted from transfected cos cells and a bacterially expressed protein that can be remarkably #truncated and contains the bcl6 zinc fingers can bind specifically to dna from the u3 promoter/enhancer region of hiv-1 .
electrophoretic mobility shift assays showed that the full-length bcl6 protein extracted from transfected cos cells and a bacterially expressed protein that can be #truncated and contains the bcl6 zinc fingers can bind specifically to dna from the u3 promoter/enhancer region of hiv-1 .
electrophoretic mobility shift assays showed that the full-length bcl6 protein extracted from transfected cos cells and a bacterially expressed protein that contained the bcl6 zinc fingers and has been remarkably #truncated can bind specifically to dna from the u3 promoter/enhancer region of hiv-1 .
electrophoretic mobility shift assays showed that the full-length bcl6 protein extracted from transfected cos cells and a bacterially expressed protein that contained the bcl6 zinc fingers and has been shown to be remarkably #truncated can bind specifically to dna from the u3 promoter/enhancer region of hiv-1 .
electrophoretic mobility shift assays showed that the full-length bcl6 protein extracted from transfected cos cells and a bacterially expressed protein that contained the bcl6 zinc fingers and has been shown to be #truncated can bind specifically to dna from the u3 promoter/enhancer region of hiv-1 .
electrophoretic mobility shift assays showed that the full-length bcl6 protein extracted from transfected cos cells and a bacterially expressed protein that contained the bcl6 zinc fingers and has been #truncated can bind specifically to dna from the u3 promoter/enhancer region of hiv-1 .
electrophoretic mobility shift assays showed that the full-length bcl6 protein extracted from transfected cos cells and a bacterially expressed protein that contained the bcl6 zinc fingers and was #truncated can bind specifically to dna from the u3 promoter/enhancer region of hiv-1 .
electrophoretic mobility shift assays showed that the full-length bcl6 protein extracted from transfected cos cells and a bacterially expressed protein that contains the bcl6 zinc fingers and can be remarkably #truncated can bind specifically to dna from the u3 promoter/enhancer region of hiv-1 .
electrophoretic mobility shift assays showed that the full-length bcl6 protein extracted from transfected cos cells and a bacterially expressed protein that contains the bcl6 zinc fingers and can be #truncated can bind specifically to dna from the u3 promoter/enhancer region of hiv-1 .
electrophoretic mobility shift assays showed that the full-length bcl6 protein extracted from transfected cos cells and a bacterially expressed protein that contains the bcl6 zinc fingers and is able to be remarkably #truncated can bind specifically to dna from the u3 promoter/enhancer region of hiv-1 .
electrophoretic mobility shift assays showed that the full-length bcl6 protein extracted from transfected cos cells and a bacterially expressed protein that contains the bcl6 zinc fingers and is likely to be remarkably #truncated can bind specifically to dna from the u3 promoter/enhancer region of hiv-1 .
electrophoretic mobility shift assays showed that the full-length bcl6 protein extracted from transfected cos cells and a bacterially expressed protein that contains the bcl6 zinc fingers and is remarkably #truncated can bind specifically to dna from the u3 promoter/enhancer region of hiv-1 .
electrophoretic mobility shift assays showed that the full-length bcl6 protein extracted from transfected cos cells and a bacterially expressed protein that contains the bcl6 zinc fingers and may be #truncated can bind specifically to dna from the u3 promoter/enhancer region of hiv-1 .
electrophoretic mobility shift assays showed that the full-length bcl6 protein extracted from transfected cos cells and a bacterially expressed protein that contains the bcl6 zinc fingers and may have been #truncated can bind specifically to dna from the u3 promoter/enhancer region of hiv-1 .
electrophoretic mobility shift assays showed that the full-length bcl6 protein extracted from transfected cos cells and a bacterially expressed protein that contains the bcl6 zinc fingers and will be #truncated can bind specifically to dna from the u3 promoter/enhancer region of hiv-1 .
electrophoretic mobility shift assays showed that the full-length bcl6 protein extracted from transfected cos cells and a bacterially expressed protein that is able to be #truncated and contains the bcl6 zinc fingers can bind specifically to dna from the u3 promoter/enhancer region of hiv-1 .
electrophoretic mobility shift assays showed that the full-length bcl6 protein extracted from transfected cos cells and a bacterially expressed protein that is likely to be #truncated and contains the bcl6 zinc fingers can bind specifically to dna from the u3 promoter/enhancer region of hiv-1 .
electrophoretic mobility shift assays showed that the full-length bcl6 protein extracted from transfected cos cells and a bacterially expressed protein that is observed to be #truncated and contains the bcl6 zinc fingers can bind specifically to dna from the u3 promoter/enhancer region of hiv-1 .
electrophoretic mobility shift assays showed that the full-length bcl6 protein extracted from transfected cos cells and a bacterially expressed protein that is #truncated and contains the bcl6 zinc fingers can bind specifically to dna from the u3 promoter/enhancer region of hiv-1 .
electrophoretic mobility shift assays showed that the full-length bcl6 protein extracted from transfected cos cells and a bacterially expressed protein that may have been remarkably #truncated and contains the bcl6 zinc fingers can bind specifically to dna from the u3 promoter/enhancer region of hiv-1 .
electrophoretic mobility shift assays showed that the full-length bcl6 protein extracted from transfected cos cells and a bacterially expressed protein that may have been #truncated and contains the bcl6 zinc fingers can bind specifically to dna from the u3 promoter/enhancer region of hiv-1 .
electrophoretic mobility shift assays showed that the full-length bcl6 protein extracted from transfected cos cells and a bacterially expressed protein that was remarkably #truncated and contained the bcl6 zinc fingers can bind specifically to dna from the u3 promoter/enhancer region of hiv-1 .
electrophoretic mobility shift assays showed that the full-length bcl6 protein extracted from transfected cos cells and a bacterially expressed protein that will be #truncated and contains the bcl6 zinc fingers can bind specifically to dna from the u3 promoter/enhancer region of hiv-1 .
previous studies using wild-type encephalomyocarditis virus (emcv) and mengo virus , and variants of these viruses being able to be genetically engineered to substitute or #truncate the poly(c) tracts have produced conflicting data on the role of the poly(c) tract in the virulence of these viruses .
previous studies using wild-type encephalomyocarditis virus (emcv) and mengo virus , and variants of these viruses observed to be genetically engineered to substitute or #truncate the poly(c) tracts have produced conflicting data on the role of the poly(c) tract in the virulence of these viruses .
previous studies using wild-type encephalomyocarditis virus (emcv) and mengo virus , and variants of these viruses shown to be genetically engineered to substitute or #truncate the poly(c) tracts have produced conflicting data on the role of the poly(c) tract in the virulence of these viruses .
previous studies using wild-type encephalomyocarditis virus (emcv) and mengo virus , and variants of these viruses that are able to be genetically engineered to substitute or #truncate the poly(c) tracts have produced conflicting data on the role of the poly(c) tract in the virulence of these viruses .
previous studies using wild-type encephalomyocarditis virus (emcv) and mengo virus , and variants of these viruses that are able to be genetically engineered to #truncate or substitute the poly(c) tracts have produced conflicting data on the role of the poly(c) tract in the virulence of these viruses .
previous studies using wild-type encephalomyocarditis virus (emcv) and mengo virus , and variants of these viruses that are genetically engineered to substitute or #truncate the poly(c) tracts have produced conflicting data on the role of the poly(c) tract in the virulence of these viruses .
previous studies using wild-type encephalomyocarditis virus (emcv) and mengo virus , and variants of these viruses that can be genetically engineered to substitute or #truncate the poly(c) tracts have produced conflicting data on the role of the poly(c) tract in the virulence of these viruses .
previous studies using wild-type encephalomyocarditis virus (emcv) and mengo virus , and variants of these viruses that can be genetically engineered to #truncate or substitute the poly(c) tracts have produced conflicting data on the role of the poly(c) tract in the virulence of these viruses .
previous studies using wild-type encephalomyocarditis virus (emcv) and mengo virus , and variants of these viruses that have been shown to be genetically engineered to substitute or #truncate the poly(c) tracts have produced conflicting data on the role of the poly(c) tract in the virulence of these viruses .
previous studies using wild-type encephalomyocarditis virus (emcv) and mengo virus , and variants of these viruses that may be genetically engineered to substitute or #truncate the poly(c) tracts have produced conflicting data on the role of the poly(c) tract in the virulence of these viruses .
previous studies using wild-type encephalomyocarditis virus (emcv) and mengo virus , and variants of these viruses that may be genetically engineered to #truncate or substitute the poly(c) tracts have produced conflicting data on the role of the poly(c) tract in the virulence of these viruses .
previous studies using wild-type encephalomyocarditis virus (emcv) and mengo virus , and variants of these viruses that may have been genetically engineered to substitute or #truncate the poly(c) tracts have produced conflicting data on the role of the poly(c) tract in the virulence of these viruses .
previous studies using wild-type encephalomyocarditis virus (emcv) and mengo virus , and variants of these viruses that may have been genetically engineered to #truncate or substitute the poly(c) tracts have produced conflicting data on the role of the poly(c) tract in the virulence of these viruses .
previous studies using wild-type encephalomyocarditis virus (emcv) and mengo virus , and variants of these viruses that will be genetically engineered to substitute or #truncate the poly(c) tracts have produced conflicting data on the role of the poly(c) tract in the virulence of these viruses .
specifically , the stat5a molecule in which the c-terminus has been remarkably #truncated at amino acids 740 or 751 effectively blocked the induction of both cis and osm , whereas the c-terminal truncations at amino acids 762 or 773 had no effect on the induction of either gene .
specifically , the stat5a molecule in which the c-terminus has been shown to be remarkably #truncated at amino acids 740 or 751 effectively blocked the induction of both cis and osm , whereas the c-terminal truncations at amino acids 762 or 773 had no effect on the induction of either gene .
specifically , the stat5a molecule in which the c-terminus has the ability to be #truncated at amino acids 740 or 751 effectively blocked the induction of both cis and osm , whereas the c-terminal truncations at amino acids 762 or 773 had no effect on the induction of either gene .
specifically , the stat5a molecule in which the c-terminus is able to be #truncated at amino acids 740 or 751 effectively blocked the induction of both cis and osm , whereas the c-terminal truncations at amino acids 762 or 773 had no effect on the induction of either gene .
specifically , the stat5a molecule in which the c-terminus is likely to be remarkably #truncated at amino acids 740 or 751 effectively blocked the induction of both cis and osm , whereas the c-terminal truncations at amino acids 762 or 773 had no effect on the induction of either gene .
specifically , the stat5a molecule in which the c-terminus is likely to be #truncated at amino acids 740 or 751 effectively blocked the induction of both cis and osm , whereas the c-terminal truncations at amino acids 762 or 773 had no effect on the induction of either gene .
specifically , the stat5a molecule in which the c-terminus is remarkably #truncated at amino acids 740 or 751 effectively blocked the induction of both cis and osm , whereas the c-terminal truncations at amino acids 762 or 773 had no effect on the induction of either gene .
specifically , the stat5a molecule in which the c-terminus may be remarkably #truncated at amino acids 740 or 751 effectively blocked the induction of both cis and osm , whereas the c-terminal truncations at amino acids 762 or 773 had no effect on the induction of either gene .
specifically , the stat5a molecule in which the c-terminus may have been #truncated at amino acids 740 or 751 effectively blocked the induction of both cis and osm , whereas the c-terminal truncations at amino acids 762 or 773 had no effect on the induction of either gene .
the majority of changes have been found to #truncate the protein through nonsense mutations (32%) , insertions or deletions (29 .6%) , or splicing changes (6 .2%) , although the figures were biased by the methods employed , and , in sequenced areas , approximately 50% of all mutations were missense or in-frame .
the protein can be #truncated by the majority of changes through nonsense mutations (32%) , insertions or deletions (29 .6%) , or splicing changes (6 .2%) , although the figures were biased by the methods employed , and , in sequenced areas , approximately 50% of all mutations were missense or in-frame .
the protein has been shown to be #truncated by the majority of changes through nonsense mutations (32%) , insertions or deletions (29 .6%) , or splicing changes (6 .2%) , although the figures were biased by the methods employed , and , in sequenced areas , approximately 50% of all mutations were missense or in-frame .
the protein is likely to be #truncated by the majority of changes through nonsense mutations (32%) , insertions or deletions (29 .6%) , or splicing changes (6 .2%) , although the figures were biased by the methods employed , and , in sequenced areas , approximately 50% of all mutations were missense or in-frame .
the protein is predicted to be #truncated by the majority of changes through nonsense mutations (32%) , insertions or deletions (29 .6%) , or splicing changes (6 .2%) , although the figures were biased by the methods employed , and , in sequenced areas , approximately 50% of all mutations were missense or in-frame .
the protein is predicted to be #truncated through nonsense mutations (32%) , insertions or deletions (29 .6%) , or splicing changes (6 .2%) by the majority of changes , although the figures were biased by the methods employed , and , in sequenced areas , approximately 50% of all mutations were missense or in-frame .
the protein is #truncated by the majority of changes through nonsense mutations (32%) , insertions or deletions (29 .6%) , or splicing changes (6 .2%) , although the figures were biased by the methods employed , and , in sequenced areas , approximately 50% of all mutations were missense or in-frame .
the protein may have been #truncated by the majority of changes through nonsense mutations (32%) , insertions or deletions (29 .6%) , or splicing changes (6 .2%) , although the figures were biased by the methods employed , and , in sequenced areas , approximately 50% of all mutations were missense or in-frame .
the protein will be #truncated through nonsense mutations (32%) , insertions or deletions (29 .6%) , or splicing changes (6 .2%) by the majority of changes , although the figures were biased by the methods employed , and , in sequenced areas , approximately 50% of all mutations were missense or in-frame .
the putative resulting protein retained the region encoding the structural and functional elements of the amine oxidase but the second and fourth srcr domains are able to be #truncated and the potential bmp-1 cleavage site is not present .
the putative resulting protein retained the region encoding the structural and functional elements of the amine oxidase but the second and fourth srcr domains are #truncated and the potential bmp-1 cleavage site is not present .
the putative resulting protein retained the region encoding the structural and functional elements of the amine oxidase but the second and fourth srcr domains have been shown to be #truncated and the potential bmp-1 cleavage site has not been present .
the putative resulting protein retained the region encoding the structural and functional elements of the amine oxidase but the second and fourth srcr domains may be #truncated and the potential bmp-1 cleavage site is not present .
the putative resulting protein retained the region encoding the structural and functional elements of the amine oxidase but the second and fourth srcr domains will be #truncated and the potential bmp-1 cleavage site is not present .
therefore , to generate a comparable soluble fragment to ic1-2d/190 , pvr has also been #truncated prior to the pp-motif .
therefore , to generate a comparable soluble fragment to ic1-2d/190 , pvr is also able to be #truncated prior to the pp-motif .
therefore , to generate a comparable soluble fragment to ic1-2d/190 , pvr is also likely to be #truncated prior to the pp-motif .
therefore , to generate a comparable soluble fragment to ic1-2d/190 , pvr is also observed to be #truncated prior to the pp-motif .
therefore , to generate a comparable soluble fragment to ic1-2d/190 , pvr may also be #truncated prior to the pp-motif .
therefore , to generate a comparable soluble fragment to ic1-2d/190 , pvr may have been #truncated prior to the pp-motif .
therefore , to generate a comparable soluble fragment to ic1-2d/190 , pvr will also be #truncated prior to the pp-motif .
to generate a comparable soluble fragment to ic1-2d/190 , pvr can therefore be #truncated prior to the pp-motif .
to generate a comparable soluble fragment to ic1-2d/190 , pvr has therefore been shown to be #truncated prior to the pp-motif .
to generate a comparable soluble fragment to ic1-2d/190 , pvr is therefore able to be #truncated prior to the pp-motif .
to generate a comparable soluble fragment to ic1-2d/190 , pvr is therefore likely to be #truncated prior to the pp-motif .
to generate a comparable soluble fragment to ic1-2d/190 , pvr may therefore be #truncated prior to the pp-motif .
to generate this protein , the receptor has been #truncated prior to two consecutive proline residues (`pp-motif_) present in the junction between domains 2 and 3 (figure 1) .
to generate this protein , the receptor is able to be #truncated prior to two consecutive proline residues (`pp-motif_) present in the junction between domains 2 and 3 (figure 1) .
to generate this protein , the receptor is #truncated prior to two consecutive proline residues (`pp-motif_) present in the junction between domains 2 and 3 (figure 1) .
to generate this protein , the receptor may be #truncated prior to two consecutive proline residues (`pp-motif_) present in the junction between domains 2 and 3 (figure 1) .
to generate this protein , the receptor will be #truncated prior to two consecutive proline residues (`pp-motif_) present in the junction between domains 2 and 3 (figure 1) .
virtually all tsc1 mutations are found to dramatically #truncate the protein product .
virtually all tsc1 mutations are found to #truncate the protein product .
virtually all tsc1 mutations have been predicted to dramatically #truncate the protein product .
virtually all tsc1 mutations have the ability to #truncate the protein product .
virtually all tsc1 mutations may dramatically #truncate the protein product .
virtually all tsc1 mutations may #truncate the protein product .
virtually all tsc1 mutations #truncated the protein product .
c-terminally truncated stat5a proteins , #truncated at amino acids 762 or 773 had no effect on the induction of either gene .
to address the mechanisms of activation by crp and the rna polymerase alpha-subunit c-terminal domain (alpha-ctd) at rhasr , we tested the effects of alanine substitutions in crp activating regions 1 and 2 , overexpression of a #truncated version of alpha (alpha-delt235) , and alanine substitutions throughout alpha-ctd .
the majority of changes were predicted to #truncate the protein through nonsense mutations (32%) , insertions or deletions (29 .6%) , or splicing changes (6 .2%) , although the figures were biased by the methods employed , and , in sequenced areas , approximately 50% of all mutations were missense or in-frame .
virtually all tsc1 mutations are predicted to #truncate the protein product .
previous studies using tsc1 mutations being able to be genetically engineered to #truncate or substitute the protein product have produced conflicting data on the role of the poly(c) tract in the virulence of these viruses .
previous studies using tsc1 mutations genetically engineered to #truncate or substitute the protein product have produced conflicting data on the role of the poly(c) tract in the virulence of these viruses .
previous studies using tsc1 mutations observed to be genetically engineered to substitute or #truncate the protein product have produced conflicting data on the role of the poly(c) tract in the virulence of these viruses .
previous studies using tsc1 mutations observed to be genetically engineered to #truncate or substitute the protein product have produced conflicting data on the role of the poly(c) tract in the virulence of these viruses .
previous studies using tsc1 mutations shown to be genetically engineered to #truncate or substitute the protein product have produced conflicting data on the role of the poly(c) tract in the virulence of these viruses .
previous studies using tsc1 mutations that are able to be genetically engineered to substitute or #truncate the protein product have produced conflicting data on the role of the poly(c) tract in the virulence of these viruses .
previous studies using tsc1 mutations that are able to be genetically engineered to #truncate or substitute the protein product have produced conflicting data on the role of the poly(c) tract in the virulence of these viruses .
previous studies using tsc1 mutations that are genetically engineered to #truncate or substitute the protein product have produced conflicting data on the role of the poly(c) tract in the virulence of these viruses .
previous studies using tsc1 mutations that are observed to be genetically engineered to substitute or #truncate the protein product have produced conflicting data on the role of the poly(c) tract in the virulence of these viruses .
previous studies using tsc1 mutations that have been shown to be genetically engineered to substitute or #truncate the protein product have produced conflicting data on the role of the poly(c) tract in the virulence of these viruses .
previous studies using tsc1 mutations that may be genetically engineered to #truncate or substitute the protein product have produced conflicting data on the role of the poly(c) tract in the virulence of these viruses .
previous studies using tsc1 mutations that will be genetically engineered to #truncate or substitute the protein product have produced conflicting data on the role of the poly(c) tract in the virulence of these viruses .
virtually all wild-type encephalomyocarditis virus (emcv) and mengo virus , and variants of these viruses are able to #truncate the poly(c) tracts .
virtually all wild-type encephalomyocarditis virus (emcv) and mengo virus , and variants of these viruses are found to dramatically #truncate the poly(c) tracts .
virtually all wild-type encephalomyocarditis virus (emcv) and mengo virus , and variants of these viruses dramatically #truncate the poly(c) tracts .
virtually all wild-type encephalomyocarditis virus (emcv) and mengo virus , and variants of these viruses dramatically #truncated the poly(c) tracts .
virtually all wild-type encephalomyocarditis virus (emcv) and mengo virus , and variants of these viruses have been predicted to dramatically #truncate the poly(c) tracts .
virtually all wild-type encephalomyocarditis virus (emcv) and mengo virus , and variants of these viruses have dramatically #truncated the poly(c) tracts .
virtually all wild-type encephalomyocarditis virus (emcv) and mengo virus , and variants of these viruses have the ability to dramatically #truncate the poly(c) tracts .
virtually all wild-type encephalomyocarditis virus (emcv) and mengo virus , and variants of these viruses have #truncated the poly(c) tracts .
virtually all wild-type encephalomyocarditis virus (emcv) and mengo virus , and variants of these viruses may have dramatically #truncated the poly(c) tracts .
virtually all wild-type encephalomyocarditis virus (emcv) and mengo virus , and variants of these viruses may have #truncated the poly(c) tracts .
virtually all wild-type encephalomyocarditis virus (emcv) and mengo virus , and variants of these viruses will dramatically #truncate the poly(c) tracts .
previous studies using nonsense mutations (32%) , insertions or deletions (29 .6%) , or splicing changes (6 .2%) being able to be genetically engineered to substitute or #truncate the protein have produced conflicting data on the role of the poly(c) tract in the virulence of these viruses .
previous studies using nonsense mutations (32%) , insertions or deletions (29 .6%) , or splicing changes (6 .2%) being able to be genetically engineered to #truncate or substitute the protein have produced conflicting data on the role of the poly(c) tract in the virulence of these viruses .
previous studies using nonsense mutations (32%) , insertions or deletions (29 .6%) , or splicing changes (6 .2%) genetically engineered to #truncate or substitute the protein have produced conflicting data on the role of the poly(c) tract in the virulence of these viruses .
previous studies using nonsense mutations (32%) , insertions or deletions (29 .6%) , or splicing changes (6 .2%) observed to be genetically engineered to #truncate or substitute the protein have produced conflicting data on the role of the poly(c) tract in the virulence of these viruses .
previous studies using nonsense mutations (32%) , insertions or deletions (29 .6%) , or splicing changes (6 .2%) shown to be genetically engineered to substitute or #truncate the protein have produced conflicting data on the role of the poly(c) tract in the virulence of these viruses .
previous studies using nonsense mutations (32%) , insertions or deletions (29 .6%) , or splicing changes (6 .2%) that are able to be genetically engineered to substitute or #truncate the protein have produced conflicting data on the role of the poly(c) tract in the virulence of these viruses .
previous studies using nonsense mutations (32%) , insertions or deletions (29 .6%) , or splicing changes (6 .2%) that are able to be genetically engineered to #truncate or substitute the protein have produced conflicting data on the role of the poly(c) tract in the virulence of these viruses .
previous studies using nonsense mutations (32%) , insertions or deletions (29 .6%) , or splicing changes (6 .2%) that are genetically engineered to substitute or #truncate the protein have produced conflicting data on the role of the poly(c) tract in the virulence of these viruses .
previous studies using nonsense mutations (32%) , insertions or deletions (29 .6%) , or splicing changes (6 .2%) that are genetically engineered to #truncate or substitute the protein have produced conflicting data on the role of the poly(c) tract in the virulence of these viruses .
previous studies using nonsense mutations (32%) , insertions or deletions (29 .6%) , or splicing changes (6 .2%) that are likely to be genetically engineered to #truncate or substitute the protein have produced conflicting data on the role of the poly(c) tract in the virulence of these viruses .
previous studies using nonsense mutations (32%) , insertions or deletions (29 .6%) , or splicing changes (6 .2%) that have been shown to be genetically engineered to substitute or #truncate the protein have produced conflicting data on the role of the poly(c) tract in the virulence of these viruses .
previous studies using nonsense mutations (32%) , insertions or deletions (29 .6%) , or splicing changes (6 .2%) that may be genetically engineered to substitute or #truncate the protein have produced conflicting data on the role of the poly(c) tract in the virulence of these viruses .
previous studies using nonsense mutations (32%) , insertions or deletions (29 .6%) , or splicing changes (6 .2%) that may be genetically engineered to #truncate or substitute the protein have produced conflicting data on the role of the poly(c) tract in the virulence of these viruses .
previous studies using nonsense mutations (32%) , insertions or deletions (29 .6%) , or splicing changes (6 .2%) that may have been genetically engineered to #truncate or substitute the protein have produced conflicting data on the role of the poly(c) tract in the virulence of these viruses .
previous studies using nonsense mutations (32%) , insertions or deletions (29 .6%) , or splicing changes (6 .2%) that were genetically engineered to substitute or #truncate the protein have produced conflicting data on the role of the poly(c) tract in the virulence of these viruses .
virtually all nonsense mutations (32%) , insertions or deletions (29 .6%) , or splicing changes (6 .2%) are found to #truncate the protein .
virtually all nonsense mutations (32%) , insertions or deletions (29 .6%) , or splicing changes (6 .2%) can dramatically #truncate the protein .
virtually all nonsense mutations (32%) , insertions or deletions (29 .6%) , or splicing changes (6 .2%) dramatically #truncate the protein .
virtually all nonsense mutations (32%) , insertions or deletions (29 .6%) , or splicing changes (6 .2%) have been predicted to #truncate the protein .
virtually all nonsense mutations (32%) , insertions or deletions (29 .6%) , or splicing changes (6 .2%) have the ability to dramatically #truncate the protein .
virtually all nonsense mutations (32%) , insertions or deletions (29 .6%) , or splicing changes (6 .2%) have the ability to #truncate the protein .
virtually all nonsense mutations (32%) , insertions or deletions (29 .6%) , or splicing changes (6 .2%) may dramatically #truncate the protein .
virtually all nonsense mutations (32%) , insertions or deletions (29 .6%) , or splicing changes (6 .2%) may have dramatically #truncated the protein .
virtually all nonsense mutations (32%) , insertions or deletions (29 .6%) , or splicing changes (6 .2%) may have #truncated the protein .
virtually all nonsense mutations (32%) , insertions or deletions (29 .6%) , or splicing changes (6 .2%) may #truncate the protein .
virtually all nonsense mutations (32%) , insertions or deletions (29 .6%) , or splicing changes (6 .2%) #truncate the protein .
virtually all nonsense mutations (32%) , insertions or deletions (29 .6%) , or splicing changes (6 .2%) will dramatically #truncate the protein .
virtually all nonsense mutations (32%) , insertions or deletions (29 .6%) , or splicing changes (6 .2%) will #truncate the protein .
a g-to-a transition at the first nucleotide of intron 2 of patient 1 #abolished normal splicing .
co-administered dm , which is able to #abolish completely the cpp effect induced by morphine , had no effect on morphine-induced behavioral sensitization .
co-administered dm , which was able to #abolish completely the cpp effect induced by morphine , had no effect on morphine-induced behavioral sensitization .
disruption of rpos , mlra or csga , and the curli subunit gene #abolished ha and curli production by strain chi7122 .
furthermore , acid resistance in stationary-phase cells has been completely #abolished by the deletion of yhie , suggesting that yhie plays a critical role in stationary-phase acid resistance .
furthermore , acid resistance in stationary-phase cells is completely #abolished by the deletion of yhie , suggesting that yhie plays a critical role in stationary-phase acid resistance .
furthermore , the deletion of yhie has completely #abolished acid resistance in stationary-phase cells , suggesting that yhie plays a critical role in stationary-phase acid resistance .
furthermore , the deletion of yhie will completely #abolish acid resistance in stationary-phase cells , suggesting that yhie plays a critical role in stationary-phase acid resistance .
ha and curli production by strain chi7122 are #abolished by disruption of rpos , mlra or csga , and the curli subunit gene .
ha and curli production by strain chi7122 will be #abolished by disruption of rpos , mlra or csga , and the curli subunit gene .
however , its bcfa biosynthesis was not #abolished by this complete removal of fabd from the crude fas , but only reduced the level to 50-60% of the control level for acyl-coa primer and to 80% for alpha-keto-beta-methylvalerate primer .
however , this complete removal of fabd from the crude fas will not #abolish its bcfa biosynthesis , but only reduced the level to 50-60% of the control level for acyl-coa primer and to 80% for alpha-keto-beta-methylvalerate primer .
in addition , deletion of the distal tor box (box1) #abolished torc induction whereas the presence of a dna fragment starting three bases upstream from box1 suffices for normal torc expression .
in addition , deletion of the distal tor box (box1) can #abolish torc induction whereas the presence of a dna fragment starting three bases upstream from box1 suffices for normal torc expression .
in addition , deletion of the distal tor box (box1) has #abolished torc induction whereas the presence of a dna fragment starting three bases upstream from box1 suffices for normal torc expression .
in addition , deletion of the distal tor box (box1) is able to #abolish torc induction whereas the presence of a dna fragment starting three bases upstream from box1 suffices for normal torc expression .
in addition , deletion of the distal tor box (box1) will #abolish torc induction whereas the presence of a dna fragment starting three bases upstream from box1 suffices for normal torc expression .
normal lhx4 splicing is #abolished by this intronic mutation , which segregates in a dominant and fully penetrant manner over three generations and activates two exonic cryptic splice sites , thereby predicting two different proteins deleted in their homeodomain sequence .
normal lhx4 splicing was #abolished by this intronic mutation , which segregates in a dominant and fully penetrant manner over three generations and activates two exonic cryptic splice sites , thereby predicting two different proteins deleted in their homeodomain sequence .
normal splicing is #abolished by a g-to-a transition at the first nucleotide of intron 2 of patient 1 .
normal splicing was #abolished by a g-to-a transition at the first nucleotide of intron 2 of patient 1 .
our results showed that co-administered dm is able to #abolish completely the cpp effect induced by morphine , but had no effect on morphine-induced behavioral sensitization .
the a/t-rich mut sequence indicates that the a/t-rich element is #abolished by the mutations .
the a/t-rich mut sequence indicates that the a/t-rich element was #abolished by the mutations .
the a/t-rich mut sequence indicates that the mutations #abolished the a/t-rich element .
the cpp effect was able to be abolised by co-administered dm induced by morphine , but had no effect on morphine-induced behavioral sensitization .
the deletion of ydep , ydeo , or yhie which was induced by evga overexpression #abolish this acid resistance .
the deletion of ydep , ydeo , or yhie which was induced by evga overexpression #abolished this acid resistance .
this intronic mutation , which #abolishes normal lhx4 splicing , activates two exonic cryptic splice sites and thereby predicts two different proteins deleted in their homeodomain sequence .
noticeably , transcription at the rrn pc promoter by nep-2 is completely #abolished if cdf2-b can not bind to the template , as obtained by the mutation m1 (figure 4a , compare lanes 1 and 4; figure 4c , compare wt and m1) .
the a/t-rich mut sequence indicates the mutations introduced to #abolish the a/t-rich element .
furthermore , the deletion of yhie completely #abolished acid resistance in stationary-phase cells , suggesting that yhie plays a critical role in stationary-phase acid resistance .
in addition , deletion of the distal tor box (box1) #abolishes torc induction whereas the presence of a dna fragment starting three bases upstream from box1 suffices for normal torc expression .
this acid resistance was #abolished by deletion of ydep , ydeo , or yhie , which was induced by evga overexpression .
however , this complete removal of fabd from the crude fas did not #abolish its bcfa biosynthesis , but only reduced the level to 50-60% of the control level for acyl-coa primer and to 80% for alpha-keto-beta-methylvalerate primer .
patient 1 has a g-to-a transition at the first nucleotide of intron 2 , which #abolishes normal splicing .
this intronic mutation , which segregates in a dominant and fully penetrant manner over three generations , #abolishes normal lhx4 splicing and activates two exonic cryptic splice sites , thereby predicting two different proteins deleted in their homeodomain sequence .
furthermore , ha and curli production by strain chi7122 in stationary-phase cells has been completely #abolished by disruption of rpos , mlra or csga , and the curli subunit gene , suggesting that yhie plays a critical role in stationary-phase acid resistance .
furthermore , this acid resistance in stationary-phase cells has been completely #abolished by deletion of ydep , ydeo , or yhie , suggesting that yhie plays a critical role in stationary-phase acid resistance .
furthermore , this acid resistance in stationary-phase cells is completely #abolished by deletion of ydep , ydeo , or yhie , suggesting that yhie plays a critical role in stationary-phase acid resistance .
furthermore , deletion of the distal tor box (box1) completely #abolished torc induction in stationary-phase cells , suggesting that yhie plays a critical role in stationary-phase acid resistance .
furthermore , deletion of the distal tor box (box1) has completely #abolished torc induction in stationary-phase cells , suggesting that yhie plays a critical role in stationary-phase acid resistance .
furthermore , deletion of ydep , ydeo , or yhie has completely #abolished this acid resistance in stationary-phase cells , suggesting that yhie plays a critical role in stationary-phase acid resistance .
furthermore , deletion of ydep , ydeo , or yhie in stationary-phase cells has been completely #abolished by this acid resistance , suggesting that yhie plays a critical role in stationary-phase acid resistance .
furthermore , disruption of rpos , mlra or csga , and the curli subunit gene completely #abolishes ha and curli production by strain chi7122 in stationary-phase cells , suggesting that yhie plays a critical role in stationary-phase acid resistance .
furthermore , disruption of rpos , mlra or csga , and the curli subunit gene has completely #abolished ha and curli production by strain chi7122 in stationary-phase cells , suggesting that yhie plays a critical role in stationary-phase acid resistance .
furthermore , disruption of rpos , mlra or csga , and the curli subunit gene will completely #abolish ha and curli production by strain chi7122 in stationary-phase cells , suggesting that yhie plays a critical role in stationary-phase acid resistance .
furthermore , its bcfa biosynthesis in stationary-phase cells has been completely #abolished by this complete removal of fabd from the crude fas , suggesting that yhie plays a critical role in stationary-phase acid resistance .
furthermore , its bcfa biosynthesis in stationary-phase cells is completely #abolished by this complete removal of fabd from the crude fas , suggesting that yhie plays a critical role in stationary-phase acid resistance .
furthermore , the a/t-rich element in stationary-phase cells has been completely #abolished by the mutations , suggesting that yhie plays a critical role in stationary-phase acid resistance .
furthermore , the mutations has completely #abolished the a/t-rich element in stationary-phase cells , suggesting that yhie plays a critical role in stationary-phase acid resistance .
furthermore , the mutations will completely #abolish the a/t-rich element in stationary-phase cells , suggesting that yhie plays a critical role in stationary-phase acid resistance .
furthermore , this complete removal of fabd from the crude fas has completely #abolished its bcfa biosynthesis in stationary-phase cells , suggesting that yhie plays a critical role in stationary-phase acid resistance .
furthermore , this complete removal of fabd from the crude fas will completely #abolish its bcfa biosynthesis in stationary-phase cells , suggesting that yhie plays a critical role in stationary-phase acid resistance .
furthermore , torc induction in stationary-phase cells is completely #abolished by deletion of the distal tor box (box1) , suggesting that yhie plays a critical role in stationary-phase acid resistance .
ha and curli production by strain chi7122 has been #abolished by disruption of rpos , mlra or csga , and the curli subunit gene , which was induced by evga overexpression .
ha and curli production by strain chi7122 is #abolished by disruption of rpos , mlra or csga , and the curli subunit gene which interrupt this open reading frame .
ha and curli production by strain chi7122 is #abolished by disruption of rpos , mlra or csga , and the curli subunit gene , which was induced by evga overexpression .
ha and curli production by strain chi7122 will be #abolished by disruption of rpos , mlra or csga , and the curli subunit gene , which was induced by evga overexpression .
however , this acid resistance is not #abolished by deletion of ydep , ydeo , or yhie , but only reduced the level to 50-60% of the control level for acyl-coa primer and to 80% for alpha-keto-beta-methylvalerate primer .
however , this acid resistance was not #abolished by deletion of ydep , ydeo , or yhie , but only reduced the level to 50-60% of the control level for acyl-coa primer and to 80% for alpha-keto-beta-methylvalerate primer .
however , acid resistance is not #abolished by the deletion of yhie , but only reduced the level to 50-60% of the control level for acyl-coa primer and to 80% for alpha-keto-beta-methylvalerate primer .
however , deletion of the distal tor box (box1) does not #abolish torc induction , but only reduced the level to 50-60% of the control level for acyl-coa primer and to 80% for alpha-keto-beta-methylvalerate primer .
however , deletion of the distal tor box (box1) will not #abolish torc induction , but only reduced the level to 50-60% of the control level for acyl-coa primer and to 80% for alpha-keto-beta-methylvalerate primer .
however , deletion of ydep , ydeo , or yhie did not #abolish this acid resistance , but only reduced the level to 50-60% of the control level for acyl-coa primer and to 80% for alpha-keto-beta-methylvalerate primer .
however , deletion of ydep , ydeo , or yhie is not #abolished by this acid resistance , but only reduced the level to 50-60% of the control level for acyl-coa primer and to 80% for alpha-keto-beta-methylvalerate primer .
however , disruption of rpos , mlra or csga , and the curli subunit gene did not #abolish ha and curli production by strain chi7122 , but only reduced the level to 50-60% of the control level for acyl-coa primer and to 80% for alpha-keto-beta-methylvalerate primer .
however , disruption of rpos , mlra or csga , and the curli subunit gene will not #abolish ha and curli production by strain chi7122 , but only reduced the level to 50-60% of the control level for acyl-coa primer and to 80% for alpha-keto-beta-methylvalerate primer .
however , the a/t-rich element is not #abolished by the mutations , but only reduced the level to 50-60% of the control level for acyl-coa primer and to 80% for alpha-keto-beta-methylvalerate primer .
however , the deletion of yhie will not #abolish acid resistance , but only reduced the level to 50-60% of the control level for acyl-coa primer and to 80% for alpha-keto-beta-methylvalerate primer .
however , the mutations will not #abolish the a/t-rich element , but only reduced the level to 50-60% of the control level for acyl-coa primer and to 80% for alpha-keto-beta-methylvalerate primer .
however , torc induction is not #abolished by deletion of the distal tor box (box1) , but only reduced the level to 50-60% of the control level for acyl-coa primer and to 80% for alpha-keto-beta-methylvalerate primer .
in addition , this acid resistance #abolished deletion of ydep , ydeo , or yhie whereas the presence of a dna fragment starting three bases upstream from box1 suffices for normal torc expression .
in addition , this acid resistance #abolishes deletion of ydep , ydeo , or yhie whereas the presence of a dna fragment starting three bases upstream from box1 suffices for normal torc expression .
in addition , this acid resistance can #abolish deletion of ydep , ydeo , or yhie whereas the presence of a dna fragment starting three bases upstream from box1 suffices for normal torc expression .
in addition , this acid resistance will #abolish deletion of ydep , ydeo , or yhie whereas the presence of a dna fragment starting three bases upstream from box1 suffices for normal torc expression .
in addition , deletion of ydep , ydeo , or yhie #abolishes this acid resistance whereas the presence of a dna fragment starting three bases upstream from box1 suffices for normal torc expression .
in addition , deletion of ydep , ydeo , or yhie can #abolish this acid resistance whereas the presence of a dna fragment starting three bases upstream from box1 suffices for normal torc expression .
in addition , deletion of ydep , ydeo , or yhie will #abolish this acid resistance whereas the presence of a dna fragment starting three bases upstream from box1 suffices for normal torc expression .
in addition , disruption of rpos , mlra or csga , and the curli subunit gene #abolished ha and curli production by strain chi7122 whereas the presence of a dna fragment starting three bases upstream from box1 suffices for normal torc expression .
in addition , disruption of rpos , mlra or csga , and the curli subunit gene can #abolish ha and curli production by strain chi7122 whereas the presence of a dna fragment starting three bases upstream from box1 suffices for normal torc expression .
in addition , disruption of rpos , mlra or csga , and the curli subunit gene has #abolished ha and curli production by strain chi7122 whereas the presence of a dna fragment starting three bases upstream from box1 suffices for normal torc expression .
in addition , disruption of rpos , mlra or csga , and the curli subunit gene is able to #abolish ha and curli production by strain chi7122 whereas the presence of a dna fragment starting three bases upstream from box1 suffices for normal torc expression .
in addition , disruption of rpos , mlra or csga , and the curli subunit gene will #abolish ha and curli production by strain chi7122 whereas the presence of a dna fragment starting three bases upstream from box1 suffices for normal torc expression .
in addition , the deletion of yhie #abolishes acid resistance whereas the presence of a dna fragment starting three bases upstream from box1 suffices for normal torc expression .
in addition , the deletion of yhie can #abolish acid resistance whereas the presence of a dna fragment starting three bases upstream from box1 suffices for normal torc expression .
in addition , the deletion of yhie has #abolished acid resistance whereas the presence of a dna fragment starting three bases upstream from box1 suffices for normal torc expression .
in addition , the deletion of yhie will #abolish acid resistance whereas the presence of a dna fragment starting three bases upstream from box1 suffices for normal torc expression .
in addition , the mutations #abolished the a/t-rich element whereas the presence of a dna fragment starting three bases upstream from box1 suffices for normal torc expression .
in addition , the mutations #abolishes the a/t-rich element whereas the presence of a dna fragment starting three bases upstream from box1 suffices for normal torc expression .
in addition , the mutations can #abolish the a/t-rich element whereas the presence of a dna fragment starting three bases upstream from box1 suffices for normal torc expression .
in addition , the mutations has #abolished the a/t-rich element whereas the presence of a dna fragment starting three bases upstream from box1 suffices for normal torc expression .
in addition , the mutations is able to #abolish the a/t-rich element whereas the presence of a dna fragment starting three bases upstream from box1 suffices for normal torc expression .
in addition , the mutations will #abolish the a/t-rich element whereas the presence of a dna fragment starting three bases upstream from box1 suffices for normal torc expression .
in contrast , ha and curli production by strain chi7122 is #abolished by disruption of rpos , mlra or csga , and the curli subunit gene , whereas internal deletion of the conserved octapeptide motif (op) or the partial homeodomain (hd) of pax5 did not have any effect (figure 3b) .
in contrast , this acid resistance #abolished deletion of ydep , ydeo , or yhie , whereas internal deletion of the conserved octapeptide motif (op) or the partial homeodomain (hd) of pax5 did not have any effect (figure 3b) .
in contrast , this acid resistance can #abolish deletion of ydep , ydeo , or yhie , whereas internal deletion of the conserved octapeptide motif (op) or the partial homeodomain (hd) of pax5 did not have any effect (figure 3b) .
in contrast , acid resistance was #abolished by the deletion of yhie , whereas internal deletion of the conserved octapeptide motif (op) or the partial homeodomain (hd) of pax5 did not have any effect (figure 3b) .
in contrast , deletion of the distal tor box (box1) #abolished torc induction , whereas internal deletion of the conserved octapeptide motif (op) or the partial homeodomain (hd) of pax5 did not have any effect (figure 3b) .
in contrast , deletion of the distal tor box (box1) #abolishes torc induction , whereas internal deletion of the conserved octapeptide motif (op) or the partial homeodomain (hd) of pax5 did not have any effect (figure 3b) .
in contrast , deletion of the distal tor box (box1) can #abolish torc induction , whereas internal deletion of the conserved octapeptide motif (op) or the partial homeodomain (hd) of pax5 did not have any effect (figure 3b) .
in contrast , deletion of ydep , ydeo , or yhie #abolishes this acid resistance , whereas internal deletion of the conserved octapeptide motif (op) or the partial homeodomain (hd) of pax5 did not have any effect (figure 3b) .
in contrast , deletion of ydep , ydeo , or yhie is #abolished by this acid resistance , whereas internal deletion of the conserved octapeptide motif (op) or the partial homeodomain (hd) of pax5 did not have any effect (figure 3b) .
in contrast , deletion of ydep , ydeo , or yhie was #abolished by this acid resistance , whereas internal deletion of the conserved octapeptide motif (op) or the partial homeodomain (hd) of pax5 did not have any effect (figure 3b) .
in contrast , disruption of rpos , mlra or csga , and the curli subunit gene #abolished ha and curli production by strain chi7122 , whereas internal deletion of the conserved octapeptide motif (op) or the partial homeodomain (hd) of pax5 did not have any effect (figure 3b) .
in contrast , its bcfa biosynthesis was #abolished by this complete removal of fabd from the crude fas , whereas internal deletion of the conserved octapeptide motif (op) or the partial homeodomain (hd) of pax5 did not have any effect (figure 3b) .
in contrast , the a/t-rich element is #abolished by the mutations , whereas internal deletion of the conserved octapeptide motif (op) or the partial homeodomain (hd) of pax5 did not have any effect (figure 3b) .
in contrast , the deletion of yhie #abolished acid resistance , whereas internal deletion of the conserved octapeptide motif (op) or the partial homeodomain (hd) of pax5 did not have any effect (figure 3b) .
in contrast , the deletion of yhie #abolishes acid resistance , whereas internal deletion of the conserved octapeptide motif (op) or the partial homeodomain (hd) of pax5 did not have any effect (figure 3b) .
in contrast , the deletion of yhie can #abolish acid resistance , whereas internal deletion of the conserved octapeptide motif (op) or the partial homeodomain (hd) of pax5 did not have any effect (figure 3b) .
in contrast , the mutations can #abolish the a/t-rich element , whereas internal deletion of the conserved octapeptide motif (op) or the partial homeodomain (hd) of pax5 did not have any effect (figure 3b) .
in contrast , torc induction is #abolished by deletion of the distal tor box (box1) , whereas internal deletion of the conserved octapeptide motif (op) or the partial homeodomain (hd) of pax5 did not have any effect (figure 3b) .
the a/t-rich mut sequence indicates deletion of the distal tor box (box1) can #abolish torc induction .
the a/t-rich mut sequence indicates deletion of the distal tor box (box1) introduced to #abolish torc induction .
the a/t-rich mut sequence indicates deletion of ydep , ydeo , or yhie can #abolish this acid resistance .
the a/t-rich mut sequence indicates deletion of ydep , ydeo , or yhie introduced to #abolish this acid resistance .
the a/t-rich mut sequence indicates disruption of rpos , mlra or csga , and the curli subunit gene can #abolish ha and curli production by strain chi7122 .
the a/t-rich mut sequence indicates that ha and curli production by strain chi7122 was #abolished by disruption of rpos , mlra or csga , and the curli subunit gene .
the a/t-rich mut sequence indicates that this acid resistance #abolished deletion of ydep , ydeo , or yhie .
the a/t-rich mut sequence indicates that this acid resistance was #abolished by deletion of ydep , ydeo , or yhie .
the a/t-rich mut sequence indicates that acid resistance is #abolished by the deletion of yhie .
the a/t-rich mut sequence indicates that deletion of the distal tor box (box1) #abolish torc induction .
the a/t-rich mut sequence indicates that deletion of ydep , ydeo , or yhie #abolish this acid resistance .
the a/t-rich mut sequence indicates that deletion of ydep , ydeo , or yhie is #abolished by this acid resistance .
the a/t-rich mut sequence indicates that disruption of rpos , mlra or csga , and the curli subunit gene #abolished ha and curli production by strain chi7122 .
the a/t-rich mut sequence indicates that its bcfa biosynthesis is #abolished by this complete removal of fabd from the crude fas .
the a/t-rich mut sequence indicates that the deletion of yhie #abolished acid resistance .
the a/t-rich mut sequence indicates that this complete removal of fabd from the crude fas #abolish its bcfa biosynthesis .
the a/t-rich mut sequence indicates that torc induction was #abolished by deletion of the distal tor box (box1) .
the a/t-rich mut sequence indicates the deletion of yhie introduced to #abolish acid resistance .
the deletion of ydep , ydeo , or yhie which was induced by evga overexpression #abolish this acid resistance .
the deletion of ydep , ydeo , or yhie which was induced by evga overexpression #abolished this acid resistance .
this acid resistance #abolishes deletion of ydep , ydeo , or yhie .
this acid resistance also #abolish deletion of ydep , ydeo , or yhie associated with formate hydrogenlyase activity .
this acid resistance also #abolished deletion of ydep , ydeo , or yhie associated with formate hydrogenlyase activity .
this acid resistance being able to #abolish deletion of ydep , ydeo , or yhie interrupt this open reading frame .
this acid resistance can #abolish deletion of ydep , ydeo , or yhie .
this acid resistance can be #abolished by deletion of ydep , ydeo , or yhie .
this acid resistance has also #abolished deletion of ydep , ydeo , or yhie associated with formate hydrogenlyase activity .
this acid resistance has been #abolished by deletion of ydep , ydeo , or yhie .
this acid resistance is #abolished by deletion of ydep , ydeo , or yhie which interrupt this open reading frame .
this acid resistance promoter completely #abolished deletion of ydep , ydeo , or yhie , indicating that this element is essential for mef2 gata-4 cooperation .
this acid resistance promoter completely #abolishes deletion of ydep , ydeo , or yhie , indicating that this element is essential for mef2 gata-4 cooperation .
this acid resistance was #abolished by deletion of ydep , ydeo , or yhie which interrupt this open reading frame .
this acid resistance were #abolished by deletion of ydep , ydeo , or yhie .
this acid resistance which #abolish deletion of ydep , ydeo , or yhie interrupt this open reading frame .
this acid resistance which has #abolished deletion of ydep , ydeo , or yhie interrupt this open reading frame .
this acid resistance will #abolish deletion of ydep , ydeo , or yhie .
this acid resistance will be #abolished by deletion of ydep , ydeo , or yhie .
acid resistance can be #abolished by the deletion of yhie .
acid resistance has been #abolished by the deletion of yhie , which was induced by evga overexpression .
acid resistance has been #abolished by the deletion of yhie .
acid resistance is #abolished by the deletion of yhie which interrupt this open reading frame .
acid resistance is #abolished by the deletion of yhie , which was induced by evga overexpression .
acid resistance was #abolished by the deletion of yhie which interrupt this open reading frame .
acid resistance will be #abolished by the deletion of yhie , which was induced by evga overexpression .
acid resistance will be #abolished by the deletion of yhie .
deletion of the distal tor box (box1) also #abolish torc induction associated with formate hydrogenlyase activity .
deletion of the distal tor box (box1) also #abolished torc induction associated with formate hydrogenlyase activity .
deletion of the distal tor box (box1) can #abolish torc induction .
deletion of the distal tor box (box1) can completely #abolishes torc induction , indicating that this element is essential for mef2 gata-4 cooperation .
deletion of the distal tor box (box1) promoter completely #abolishes torc induction , indicating that this element is essential for mef2 gata-4 cooperation .
deletion of the distal tor box (box1) which #abolish torc induction interrupt this open reading frame .
deletion of the distal tor box (box1) which has #abolished torc induction interrupt this open reading frame .
deletion of the distal tor box (box1) will #abolish torc induction .
deletion of ydep , ydeo , or yhie #abolished this acid resistance .
deletion of ydep , ydeo , or yhie #abolishes this acid resistance .
deletion of ydep , ydeo , or yhie also #abolish this acid resistance associated with formate hydrogenlyase activity .
deletion of ydep , ydeo , or yhie are #abolished by this acid resistance .
deletion of ydep , ydeo , or yhie can #abolish this acid resistance .
deletion of ydep , ydeo , or yhie can completely #abolishes this acid resistance , indicating that this element is essential for mef2 gata-4 cooperation .
deletion of ydep , ydeo , or yhie has also #abolished this acid resistance associated with formate hydrogenlyase activity .
deletion of ydep , ydeo , or yhie has been #abolished by this acid resistance , which was induced by evga overexpression .
deletion of ydep , ydeo , or yhie is #abolished by this acid resistance which interrupt this open reading frame .
deletion of ydep , ydeo , or yhie is #abolished by this acid resistance , which was induced by evga overexpression .
deletion of ydep , ydeo , or yhie promoter completely #abolished this acid resistance , indicating that this element is essential for mef2 gata-4 cooperation .
deletion of ydep , ydeo , or yhie was #abolished by this acid resistance which interrupt this open reading frame .
deletion of ydep , ydeo , or yhie were #abolished by this acid resistance .
deletion of ydep , ydeo , or yhie which #abolish this acid resistance interrupt this open reading frame .
deletion of ydep , ydeo , or yhie will also #abolish this acid resistance associated with formate hydrogenlyase activity .
deletion of ydep , ydeo , or yhie will be #abolished by this acid resistance , which was induced by evga overexpression .
disruption of rpos , mlra or csga , and the curli subunit gene #abolished ha and curli production by strain chi7122 .
disruption of rpos , mlra or csga , and the curli subunit gene also #abolished ha and curli production by strain chi7122 associated with formate hydrogenlyase activity .
disruption of rpos , mlra or csga , and the curli subunit gene being able to #abolish ha and curli production by strain chi7122 interrupt this open reading frame .
disruption of rpos , mlra or csga , and the curli subunit gene can completely #abolishes ha and curli production by strain chi7122 , indicating that this element is essential for mef2 gata-4 cooperation .
disruption of rpos , mlra or csga , and the curli subunit gene has also #abolished ha and curli production by strain chi7122 associated with formate hydrogenlyase activity .
disruption of rpos , mlra or csga , and the curli subunit gene was #abolished by ha and curli production by strain chi7122 , which was induced by evga overexpression .
disruption of rpos , mlra or csga , and the curli subunit gene which #abolish ha and curli production by strain chi7122 interrupt this open reading frame .
disruption of rpos , mlra or csga , and the curli subunit gene which #abolished ha and curli production by strain chi7122 interrupt this open reading frame .
disruption of rpos , mlra or csga , and the curli subunit gene will #abolish ha and curli production by strain chi7122 .
disruption of rpos , mlra or csga , and the curli subunit gene will also #abolish ha and curli production by strain chi7122 associated with formate hydrogenlyase activity .
its bcfa biosynthesis can be #abolished by this complete removal of fabd from the crude fas .
its bcfa biosynthesis has been #abolished by this complete removal of fabd from the crude fas , which was induced by evga overexpression .
its bcfa biosynthesis was #abolished by this complete removal of fabd from the crude fas which interrupt this open reading frame .
its bcfa biosynthesis were #abolished by this complete removal of fabd from the crude fas .
its bcfa biosynthesis will be #abolished by this complete removal of fabd from the crude fas , which was induced by evga overexpression .
its bcfa biosynthesis will be #abolished by this complete removal of fabd from the crude fas .
the a/t-rich element are #abolished by the mutations .
the a/t-rich element has been #abolished by the mutations , which was induced by evga overexpression .
the a/t-rich element is #abolished by the mutations which interrupt this open reading frame .
the a/t-rich element was #abolished by the mutations which interrupt this open reading frame .
the a/t-rich element were #abolished by the mutations .
the deletion of yhie #abolished acid resistance .
the deletion of yhie being able to #abolish acid resistance interrupt this open reading frame .
the deletion of yhie can #abolish acid resistance .
the deletion of yhie can completely #abolishes acid resistance , indicating that this element is essential for mef2 gata-4 cooperation .
the deletion of yhie which #abolish acid resistance interrupt this open reading frame .
the deletion of yhie which has #abolished acid resistance interrupt this open reading frame .
the deletion of yhie will #abolish acid resistance .
the mutations #abolishes the a/t-rich element .
the mutations also #abolish the a/t-rich element associated with formate hydrogenlyase activity .
the mutations being able to #abolish the a/t-rich element interrupt this open reading frame .
the mutations has also #abolished the a/t-rich element associated with formate hydrogenlyase activity .
the mutations which #abolish the a/t-rich element interrupt this open reading frame .
the mutations which has #abolished the a/t-rich element interrupt this open reading frame .
the mutations will #abolish the a/t-rich element .
the mutations will also #abolish the a/t-rich element associated with formate hydrogenlyase activity .
this complete removal of fabd from the crude fas #abolished its bcfa biosynthesis .
this complete removal of fabd from the crude fas also #abolished its bcfa biosynthesis associated with formate hydrogenlyase activity .
this complete removal of fabd from the crude fas being able to #abolish its bcfa biosynthesis interrupt this open reading frame .
this complete removal of fabd from the crude fas can #abolish its bcfa biosynthesis .
this complete removal of fabd from the crude fas has also #abolished its bcfa biosynthesis associated with formate hydrogenlyase activity .
this complete removal of fabd from the crude fas promoter completely #abolished its bcfa biosynthesis , indicating that this element is essential for mef2 gata-4 cooperation .
this complete removal of fabd from the crude fas which #abolish its bcfa biosynthesis interrupt this open reading frame .
this complete removal of fabd from the crude fas which #abolished its bcfa biosynthesis interrupt this open reading frame .
this complete removal of fabd from the crude fas which has #abolished its bcfa biosynthesis interrupt this open reading frame .
torc induction are #abolished by deletion of the distal tor box (box1) .
torc induction has been #abolished by deletion of the distal tor box (box1) .
torc induction is #abolished by deletion of the distal tor box (box1) , which was induced by evga overexpression .
torc induction were #abolished by deletion of the distal tor box (box1) .
furthermore , this intronic mutation completely #abolished normal lhx4 splicing in stationary-phase cells , suggesting that yhie plays a critical role in stationary-phase acid resistance .
furthermore , this intronic mutation completely #abolishes normal lhx4 splicing in stationary-phase cells , suggesting that yhie plays a critical role in stationary-phase acid resistance .
furthermore , this intronic mutation has completely #abolished normal lhx4 splicing in stationary-phase cells , suggesting that yhie plays a critical role in stationary-phase acid resistance .
furthermore , this intronic mutation will completely #abolish normal lhx4 splicing in stationary-phase cells , suggesting that yhie plays a critical role in stationary-phase acid resistance .
furthermore , a g-to-a transition at the first nucleotide of intron 2 completely #abolished normal splicing in stationary-phase cells , suggesting that yhie plays a critical role in stationary-phase acid resistance .
furthermore , a g-to-a transition at the first nucleotide of intron 2 has completely #abolished normal splicing in stationary-phase cells , suggesting that yhie plays a critical role in stationary-phase acid resistance .
furthermore , co-administered dm completely #abolished the cpp effect in stationary-phase cells , suggesting that yhie plays a critical role in stationary-phase acid resistance .
furthermore , co-administered dm has completely #abolished the cpp effect in stationary-phase cells , suggesting that yhie plays a critical role in stationary-phase acid resistance .
furthermore , co-administered dm will completely #abolish the cpp effect in stationary-phase cells , suggesting that yhie plays a critical role in stationary-phase acid resistance .
furthermore , normal lhx4 splicing in stationary-phase cells has been completely #abolished by this intronic mutation , suggesting that yhie plays a critical role in stationary-phase acid resistance .
furthermore , normal splicing in stationary-phase cells has been completely #abolished by a g-to-a transition at the first nucleotide of intron 2 , suggesting that yhie plays a critical role in stationary-phase acid resistance .
furthermore , normal splicing in stationary-phase cells is completely #abolished by a g-to-a transition at the first nucleotide of intron 2 , suggesting that yhie plays a critical role in stationary-phase acid resistance .
furthermore , the cpp effect in stationary-phase cells has been completely #abolished by co-administered dm , suggesting that yhie plays a critical role in stationary-phase acid resistance .
furthermore , the cpp effect in stationary-phase cells is completely #abolished by co-administered dm , suggesting that yhie plays a critical role in stationary-phase acid resistance .
however , this intronic mutation did not #abolish normal lhx4 splicing , but only reduced the level to 50-60% of the control level for acyl-coa primer and to 80% for alpha-keto-beta-methylvalerate primer .
however , this intronic mutation will not #abolish normal lhx4 splicing , but only reduced the level to 50-60% of the control level for acyl-coa primer and to 80% for alpha-keto-beta-methylvalerate primer .
however , a g-to-a transition at the first nucleotide of intron 2 does not #abolish normal splicing , but only reduced the level to 50-60% of the control level for acyl-coa primer and to 80% for alpha-keto-beta-methylvalerate primer .
however , co-administered dm does not #abolish the cpp effect , but only reduced the level to 50-60% of the control level for acyl-coa primer and to 80% for alpha-keto-beta-methylvalerate primer .
however , normal lhx4 splicing is not #abolished by this intronic mutation , but only reduced the level to 50-60% of the control level for acyl-coa primer and to 80% for alpha-keto-beta-methylvalerate primer .
however , normal lhx4 splicing was not #abolished by this intronic mutation , but only reduced the level to 50-60% of the control level for acyl-coa primer and to 80% for alpha-keto-beta-methylvalerate primer .
however , normal splicing is not #abolished by a g-to-a transition at the first nucleotide of intron 2 , but only reduced the level to 50-60% of the control level for acyl-coa primer and to 80% for alpha-keto-beta-methylvalerate primer .
however , the cpp effect is not #abolished by co-administered dm , but only reduced the level to 50-60% of the control level for acyl-coa primer and to 80% for alpha-keto-beta-methylvalerate primer .
in addition , this intronic mutation #abolished normal lhx4 splicing whereas the presence of a dna fragment starting three bases upstream from box1 suffices for normal torc expression .
in addition , this intronic mutation can #abolish normal lhx4 splicing whereas the presence of a dna fragment starting three bases upstream from box1 suffices for normal torc expression .
in addition , this intronic mutation is able to #abolish normal lhx4 splicing whereas the presence of a dna fragment starting three bases upstream from box1 suffices for normal torc expression .
in addition , this intronic mutation will #abolish normal lhx4 splicing whereas the presence of a dna fragment starting three bases upstream from box1 suffices for normal torc expression .
in addition , a g-to-a transition at the first nucleotide of intron 2 #abolished normal splicing whereas the presence of a dna fragment starting three bases upstream from box1 suffices for normal torc expression .
in addition , a g-to-a transition at the first nucleotide of intron 2 #abolishes normal splicing whereas the presence of a dna fragment starting three bases upstream from box1 suffices for normal torc expression .
in addition , co-administered dm can #abolish the cpp effect whereas the presence of a dna fragment starting three bases upstream from box1 suffices for normal torc expression .
in addition , co-administered dm has #abolished the cpp effect whereas the presence of a dna fragment starting three bases upstream from box1 suffices for normal torc expression .
in contrast , this intronic mutation #abolishes normal lhx4 splicing , whereas internal deletion of the conserved octapeptide motif (op) or the partial homeodomain (hd) of pax5 did not have any effect (figure 3b) .
in contrast , this intronic mutation can #abolish normal lhx4 splicing , whereas internal deletion of the conserved octapeptide motif (op) or the partial homeodomain (hd) of pax5 did not have any effect (figure 3b) .
in contrast , a g-to-a transition at the first nucleotide of intron 2 #abolished normal splicing , whereas internal deletion of the conserved octapeptide motif (op) or the partial homeodomain (hd) of pax5 did not have any effect (figure 3b) .
in contrast , a g-to-a transition at the first nucleotide of intron 2 #abolishes normal splicing , whereas internal deletion of the conserved octapeptide motif (op) or the partial homeodomain (hd) of pax5 did not have any effect (figure 3b) .
in contrast , co-administered dm #abolished the cpp effect , whereas internal deletion of the conserved octapeptide motif (op) or the partial homeodomain (hd) of pax5 did not have any effect (figure 3b) .
in contrast , co-administered dm can #abolish the cpp effect , whereas internal deletion of the conserved octapeptide motif (op) or the partial homeodomain (hd) of pax5 did not have any effect (figure 3b) .
in contrast , normal lhx4 splicing is #abolished by this intronic mutation , whereas internal deletion of the conserved octapeptide motif (op) or the partial homeodomain (hd) of pax5 did not have any effect (figure 3b) .
in contrast , normal lhx4 splicing was #abolished by this intronic mutation , whereas internal deletion of the conserved octapeptide motif (op) or the partial homeodomain (hd) of pax5 did not have any effect (figure 3b) .
in contrast , normal splicing is #abolished by a g-to-a transition at the first nucleotide of intron 2 , whereas internal deletion of the conserved octapeptide motif (op) or the partial homeodomain (hd) of pax5 did not have any effect (figure 3b) .
in contrast , normal splicing was #abolished by a g-to-a transition at the first nucleotide of intron 2 , whereas internal deletion of the conserved octapeptide motif (op) or the partial homeodomain (hd) of pax5 did not have any effect (figure 3b) .
in contrast , the cpp effect is #abolished by co-administered dm , whereas internal deletion of the conserved octapeptide motif (op) or the partial homeodomain (hd) of pax5 did not have any effect (figure 3b) .
the a/t-rich mut sequence indicates this intronic mutation can #abolish normal lhx4 splicing .
the a/t-rich mut sequence indicates this intronic mutation introduced to #abolish normal lhx4 splicing .
the a/t-rich mut sequence indicates a g-to-a transition at the first nucleotide of intron 2 can #abolish normal splicing .
the a/t-rich mut sequence indicates a g-to-a transition at the first nucleotide of intron 2 introduced to #abolish normal splicing .
the a/t-rich mut sequence indicates co-administered dm can #abolish the cpp effect .
the a/t-rich mut sequence indicates that a g-to-a transition at the first nucleotide of intron 2 #abolish normal splicing .
the a/t-rich mut sequence indicates that co-administered dm #abolished the cpp effect .
the a/t-rich mut sequence indicates that normal lhx4 splicing was #abolished by this intronic mutation .
the a/t-rich mut sequence indicates that normal splicing is #abolished by a g-to-a transition at the first nucleotide of intron 2 .
the a/t-rich mut sequence indicates that normal splicing was #abolished by a g-to-a transition at the first nucleotide of intron 2 .
the a/t-rich mut sequence indicates that the cpp effect is #abolished by co-administered dm .
the a/t-rich mut sequence indicates that the cpp effect was #abolished by co-administered dm .
this intronic mutation also #abolish normal lhx4 splicing associated with formate hydrogenlyase activity .
this intronic mutation also #abolished normal lhx4 splicing associated with formate hydrogenlyase activity .
this intronic mutation being able to #abolish normal lhx4 splicing interrupt this open reading frame .
this intronic mutation can completely #abolishes normal lhx4 splicing , indicating that this element is essential for mef2 gata-4 cooperation .
this intronic mutation promoter completely #abolishes normal lhx4 splicing , indicating that this element is essential for mef2 gata-4 cooperation .
this intronic mutation which #abolished normal lhx4 splicing interrupt this open reading frame .
this intronic mutation will #abolish normal lhx4 splicing .
a g-to-a transition at the first nucleotide of intron 2 also #abolished normal splicing associated with formate hydrogenlyase activity .
a g-to-a transition at the first nucleotide of intron 2 can #abolish normal splicing .
a g-to-a transition at the first nucleotide of intron 2 was #abolished by normal splicing , which was induced by evga overexpression .
a g-to-a transition at the first nucleotide of intron 2 which #abolish normal splicing interrupt this open reading frame .
a g-to-a transition at the first nucleotide of intron 2 will #abolish normal splicing .
co-administered dm #abolished the cpp effect .
co-administered dm being able to #abolish the cpp effect interrupt this open reading frame .
co-administered dm can #abolish the cpp effect .
co-administered dm can completely #abolishes the cpp effect , indicating that this element is essential for mef2 gata-4 cooperation .
co-administered dm has also #abolished the cpp effect associated with formate hydrogenlyase activity .
co-administered dm which #abolish the cpp effect interrupt this open reading frame .
co-administered dm which #abolished the cpp effect interrupt this open reading frame .
co-administered dm which has #abolished the cpp effect interrupt this open reading frame .
co-administered dm will #abolish the cpp effect .
co-administered dm will also #abolish the cpp effect associated with formate hydrogenlyase activity .
normal lhx4 splicing are #abolished by this intronic mutation .
normal lhx4 splicing can be #abolished by this intronic mutation .
normal lhx4 splicing has been #abolished by this intronic mutation .
normal lhx4 splicing is #abolished by this intronic mutation which interrupt this open reading frame .
normal lhx4 splicing is #abolished by this intronic mutation , which was induced by evga overexpression .
normal lhx4 splicing were #abolished by this intronic mutation .
normal splicing are #abolished by a g-to-a transition at the first nucleotide of intron 2 .
normal splicing can be #abolished by a g-to-a transition at the first nucleotide of intron 2 .
normal splicing has been #abolished by a g-to-a transition at the first nucleotide of intron 2 , which was induced by evga overexpression .
normal splicing was #abolished by a g-to-a transition at the first nucleotide of intron 2 which interrupt this open reading frame .
normal splicing were #abolished by a g-to-a transition at the first nucleotide of intron 2 .
the cpp effect can be #abolished by co-administered dm .
the cpp effect is #abolished by co-administered dm which interrupt this open reading frame .
the cpp effect is #abolished by co-administered dm , which was induced by evga overexpression .
the cpp effect was #abolished by co-administered dm , which was induced by evga overexpression .
the cpp effect will be #abolished by co-administered dm , which was induced by evga overexpression .
the cpp effect will be #abolished by co-administered dm .
cytokines #altered the expression and activity of the multidrug resistance transporters in human hepatoma cell lines; analysis using rt-pcr and cdna microarrays .
cytokines can #alter the expression and activity of the multidrug resistance transporters in human hepatoma cell lines; analysis using rt-pcr and cdna microarrays .
it is believed that the molecular lesion associated with s1031 is able to #alter splicing , we looked at the sos-1 mrna produced in this mutant .
it is predicted that the molecular lesion associated with s1031 can #alter splicing , we looked at the sos-1 mrna produced in this mutant .
moreover , dam methylation inhibited binding of lrp/papi near the gatc1028 site and could #alter binding of lrp at the gatc1130 site .
moreover , dam methylation inhibits binding of lrp/papi near the gatc1028 site and can #alter binding of lrp at the gatc1130 site .
moreover , dam methylation inhibits binding of lrp/papi near the gatc1028 site and may #alter binding of lrp at the gatc1130 site .
moreover , a frur null mutation can #alter the rates of utilization of at least 36 carbon sources .
moreover , a frur null mutation could #alter the rates of utilization of at least 36 carbon sources .
moreover , a frur null mutation is able to #alter the rates of utilization of at least 36 carbon sources .
moreover , a frur null mutation may be able to #alter the rates of utilization of at least 36 carbon sources .
moreover , a frur null mutation will #alter the rates of utilization of at least 36 carbon sources .
phosphorylation of pdk1 cannot be #altered by treating the cells with insulin-like growth factor-i and four of the sites could be mutated without loss of activity .
since s1031 is a null allele , we are testing whether vulval induction can be #altered by this mutation .
since s1031 is a null allele , we are testing whether vulval induction is able to be #altered by this mutation .
since s1031 is a null allele , we are testing whether vulval induction may be #altered by this mutation .
since s1031 is a null allele , we tested whether this mutation could #alter vulval induction .
since s1031 is a null allele , we tested whether this mutation has #altered vulval induction .
since s1031 is a null allele , we tested whether this mutation was able to #alter vulval induction .
since s1031 is a null allele , we tested whether vulval induction was #altered by this mutation .
since these two bends are in opposing directions , the overall direction of the dna is not able to be #altered by them(figure 3c) .
since these two bends are in opposing directions , the overall direction of the dna will not be #altered by them(figure 3c) .
since these two bends are in opposing directions , they may not #alter the overall direction of the dna(figure 3c) .
since these two bends were in opposing directions , the overall direction of the dna could not be #altered by them(figure 3c) .
since these two bends were in opposing directions , the overall direction of the dna was not able to be #altered by them(figure 3c) .
since these two bends were in opposing directions , the overall direction of the dna was not #altered by them(figure 3c) .
since these two bends were in opposing directions , they could not #alter the overall direction of the dna(figure 3c) .
since these two bends were in opposing directions , they did not #alter the overall direction of the dna(figure 3c) .
splicing can be #altered by the molecular lesion associated with s1031 , we looked at the sos-1 mrna produced in this mutant .
splicing is able to be #altered by the molecular lesion associated with s1031 , we looked at the sos-1 mrna produced in this mutant .
splicing is predicted to be #altered by the molecular lesion associated with s1031 , we looked at the sos-1 mrna produced in this mutant .
splicing may be #altered by the molecular lesion associated with s1031 , we looked at the sos-1 mrna produced in this mutant .
the codon (ctc) normally associated with leu-93 in the transcortin polypeptide can be #altered by the mutation located within exon 2 to a codon (cac) for histidine in the variant genes .
the codon (ctc) normally associated with leu-93 in the transcortin polypeptide is able to be #altered by the mutation located within exon 2 to a codon (cac) for histidine in the variant genes .
the codon (ctc) normally associated with leu-93 in the transcortin polypeptide is #altered by the mutation located within exon 2 to a codon (cac) for histidine in the variant genes .
the codon (ctc) normally associated with leu-93 in the transcortin polypeptide will be #altered by the mutation located within exon 2 to a codon (cac) for histidine in the variant genes .
the expression and activity of the multidrug resistance transporters could be #altered by cytokines in human hepatoma cell lines; analysis using rt-pcr and cdna microarrays .
the expression and activity of the multidrug resistance transporters is able to be #altered by cytokines in human hepatoma cell lines; analysis using rt-pcr and cdna microarrays .
the expression and activity of the multidrug resistance transporters may be #altered by cytokines in human hepatoma cell lines; analysis using rt-pcr and cdna microarrays .
the expression and activity of the multidrug resistance transporters was #altered by cytokines in human hepatoma cell lines; analysis using rt-pcr and cdna microarrays .
the expression and activity of the multidrug resistance transporters will be #altered by cytokines in human hepatoma cell lines; analysis using rt-pcr and cdna microarrays .
the molecular lesion associated with s1031 is predicted to #alter splicing , we looked at the sos-1 mrna produced in this mutant .
the results provide insight into a mechanism which #alters expression of bcl-3 and leads to tumorigenic potential .
the results provide insight into a mechanism which can #alter expression of bcl-3 and may lead to tumorigenic potential .
this mutation , which #alters the codon (ctc) normally associated with leu-93 in the transcortin polypeptide to a codon (cac) for histidine in the variant genes , is located within exon 2 .
treating the cells with insulin-like growth factor-i cannot #alter phosphorylation of pdk1 and four of the sites could be mutated without loss of activity .
treating the cells with insulin-like growth factor-i does not #alter phosphorylation of pdk1 and four of the sites could be mutated without loss of activity .
treating the cells with insulin-like growth factor-i may not #alter phosphorylation of pdk1 and four of the sites could be mutated without loss of activity .
as the molecular lesion associated with s1031 is predicted to #alter splicing , we looked at the sos-1 mrna produced in this mutant .
moreover , a frur null mutation #altered the rates of utilization of at least 36 carbon sources .
the results provide insight into a mechanism whereby #altered expression of bcl-3 leads to tumorigenic potential .
cytokines #alter the expression and activity of the multidrug resistance transporters in human hepatoma cell lines; analysis using rt-pcr and cdna microarrays .
hence , glu13 indirectly affects dna-binding specificity because the overall direction of the dna are able to be #altered by these two bends .
hence , glu13 indirectly affects dna-binding specificity because the overall direction of the dna can be #altered by these two bends .
hence , glu13 indirectly affects dna-binding specificity because the overall direction of the dna is #altered by these two bends .
hence , glu13 indirectly affects dna-binding specificity because the rates of utilization of at least 36 carbon sources are able to be #altered by a frur null mutation .
hence , glu13 indirectly affects dna-binding specificity because the rates of utilization of at least 36 carbon sources can be #altered by a frur null mutation .
hence , glu13 indirectly affects dna-binding specificity because the rates of utilization of at least 36 carbon sources could be #altered by a frur null mutation .
hence , glu13 indirectly affects dna-binding specificity because the rates of utilization of at least 36 carbon sources may be #altered by a frur null mutation .
hence , glu13 indirectly affects dna-binding specificity because the rates of utilization of at least 36 carbon sources was #altered by a frur null mutation .
hence , glu13 indirectly affects dna-binding specificity because vulval induction are able to be #altered by this mutation .
hence , glu13 indirectly affects dna-binding specificity because vulval induction could be #altered by this mutation .
hence , glu13 indirectly affects dna-binding specificity because vulval induction is #altered by this mutation .
hence , glu13 indirectly affects dna-binding specificity probably because a frur null mutation may be able to subtly #alter the rates of utilization of at least 36 carbon sources .
hence , glu13 indirectly affects dna-binding specificity probably because a frur null mutation may subtly #alter the rates of utilization of at least 36 carbon sources .
hence , glu13 indirectly affects dna-binding specificity probably because these two bends can subtly #alter the overall direction of the dna .
hence , glu13 indirectly affects dna-binding specificity probably because these two bends is able to subtly #alter the overall direction of the dna .
hence , glu13 indirectly affects dna-binding specificity probably because these two bends subtly #altered the overall direction of the dna .
hence , glu13 indirectly affects dna-binding specificity probably because these two bends subtly #alters the overall direction of the dna .
hence , glu13 indirectly affects dna-binding specificity probably because this mutation can subtly #alter vulval induction .
hence , glu13 indirectly affects dna-binding specificity probably because this mutation is able to subtly #alter vulval induction .
hence , glu13 indirectly affects dna-binding specificity probably because this mutation may be able to subtly #alter vulval induction .
hence , glu13 indirectly affects dna-binding specificity probably because this mutation may subtly #alter vulval induction .
hence , glu13 indirectly affects dna-binding specificity probably because this mutation subtly #altered vulval induction .
hence , glu13 indirectly affects dna-binding specificity probably because this mutation subtly #alters vulval induction .
hence , glu13 indirectly affects dna-binding specificity probably due to a frur null mutation , which can subtly #alter the rates of utilization of at least 36 carbon sources .
hence , glu13 indirectly affects dna-binding specificity probably due to these two bends , which can subtly #alter the overall direction of the dna .
hence , glu13 indirectly affects dna-binding specificity probably due to these two bends , which may be able to subtly #alter the overall direction of the dna .
hence , glu13 indirectly affects dna-binding specificity probably due to these two bends , which subtly #altered the overall direction of the dna .
hence , glu13 indirectly affects dna-binding specificity probably due to these two bends , which was able to subtly #alter the overall direction of the dna .
hence , glu13 indirectly affects dna-binding specificity probably due to this mutation , which may subtly #alter vulval induction .
hence , glu13 indirectly affects dna-binding specificity , probably due to these two bends , which subtly #alters the the overall direction of the dna .
hence , glu13 indirectly affects dna-binding specificity , probably due to this mutation , which subtly #alters the vulval induction .
moreover , these two bends #altered the overall direction of the dna .
moreover , these two bends could #alter the overall direction of the dna .
moreover , these two bends may be able to #alter the overall direction of the dna .
moreover , these two bends will #alter the overall direction of the dna .
moreover , this mutation #altered vulval induction .
moreover , this mutation #alters vulval induction .
moreover , this mutation has #altered vulval induction .
moreover , this mutation may #alter vulval induction .
moreover , this mutation may be able to #alter vulval induction .
since a frur null mutation are in opposing directions , the rates of utilization of at least 36 carbon sources cannot be #altered by them(figure 3c) .
since a frur null mutation are in opposing directions , the rates of utilization of at least 36 carbon sources is not able to be #altered by them(figure 3c) .
since a frur null mutation are in opposing directions , the rates of utilization of at least 36 carbon sources is not #altered by them(figure 3c) .
since a frur null mutation are in opposing directions , they are not able to #alter the rates of utilization of at least 36 carbon sources(figure 3c) .
since a frur null mutation are in opposing directions , they cannot #alter the rates of utilization of at least 36 carbon sources(figure 3c) .
since a frur null mutation were in opposing directions , the rates of utilization of at least 36 carbon sources could not be #altered by them(figure 3c) .
since a frur null mutation were in opposing directions , the rates of utilization of at least 36 carbon sources was not #altered by them(figure 3c) .
since a frur null mutation were in opposing directions , they did not #alter the rates of utilization of at least 36 carbon sources(figure 3c) .
since s1031 is a null allele , we are testing whether a frur null mutation can #alter the rates of utilization of at least 36 carbon sources .
since s1031 is a null allele , we are testing whether a frur null mutation may #alter the rates of utilization of at least 36 carbon sources .
since s1031 is a null allele , we are testing whether a frur null mutation will #alter the rates of utilization of at least 36 carbon sources .
since s1031 is a null allele , we are testing whether the overall direction of the dna is #altered by these two bends .
since s1031 is a null allele , we are testing whether the rates of utilization of at least 36 carbon sources may be #altered by a frur null mutation .
since s1031 is a null allele , we are testing whether these two bends can #alter the overall direction of the dna .
since s1031 is a null allele , we are testing whether these two bends is able to #alter the overall direction of the dna .
since s1031 is a null allele , we are testing whether these two bends will #alter the overall direction of the dna .
since s1031 is a null allele , we tested whether a frur null mutation #altered the rates of utilization of at least 36 carbon sources .
since s1031 is a null allele , we tested whether a frur null mutation #alters the rates of utilization of at least 36 carbon sources .
since s1031 is a null allele , we tested whether a frur null mutation might #alter the rates of utilization of at least 36 carbon sources .
since s1031 is a null allele , we tested whether a frur null mutation was able to #alter the rates of utilization of at least 36 carbon sources .
since s1031 is a null allele , we tested whether the overall direction of the dna might be #altered by these two bends .
since s1031 is a null allele , we tested whether the overall direction of the dna was #altered by these two bends .
since s1031 is a null allele , we tested whether the rates of utilization of at least 36 carbon sources might be #altered by a frur null mutation .
since s1031 is a null allele , we tested whether the rates of utilization of at least 36 carbon sources was #altered by a frur null mutation .
since s1031 is a null allele , we tested whether these two bends #alters the overall direction of the dna .
since this mutation are in opposing directions , they are not able to #alter vulval induction(figure 3c) .
since this mutation are in opposing directions , they may not #alter vulval induction(figure 3c) .
since this mutation are in opposing directions , vulval induction cannot be #altered by them(figure 3c) .
since this mutation are in opposing directions , vulval induction will not be #altered by them(figure 3c) .
since this mutation were in opposing directions , they did not #alter vulval induction(figure 3c) .
since this mutation were in opposing directions , vulval induction could not be #altered by them(figure 3c) .
since this mutation were in opposing directions , vulval induction was not #altered by them(figure 3c) .
hence , glu13 indirectly affects dna-binding specificity because phosphorylation of pdk1 can be #altered by treating the cells with insulin-like growth factor-i .
hence , glu13 indirectly affects dna-binding specificity because phosphorylation of pdk1 could be #altered by treating the cells with insulin-like growth factor-i .
hence , glu13 indirectly affects dna-binding specificity because binding of lrp at the gatc1130 site are able to be #altered by dam methylation .
hence , glu13 indirectly affects dna-binding specificity because binding of lrp at the gatc1130 site could be #altered by dam methylation .
hence , glu13 indirectly affects dna-binding specificity because binding of lrp at the gatc1130 site is #altered by dam methylation .
hence , glu13 indirectly affects dna-binding specificity because binding of lrp at the gatc1130 site was #altered by dam methylation .
hence , glu13 indirectly affects dna-binding specificity because expression of bcl-3 can be #altered by a mechanism .
hence , glu13 indirectly affects dna-binding specificity because expression of bcl-3 could be #altered by a mechanism .
hence , glu13 indirectly affects dna-binding specificity because expression of bcl-3 may be #altered by a mechanism .
hence , glu13 indirectly affects dna-binding specificity because expression of bcl-3 was #altered by a mechanism .
hence , glu13 indirectly affects dna-binding specificity because splicing are able to be #altered by the molecular lesion associated with s1031 .
hence , glu13 indirectly affects dna-binding specificity because splicing can be #altered by the molecular lesion associated with s1031 .
hence , glu13 indirectly affects dna-binding specificity because splicing could be #altered by the molecular lesion associated with s1031 .
hence , glu13 indirectly affects dna-binding specificity probably because dam methylation is able to subtly #alter binding of lrp at the gatc1130 site .
hence , glu13 indirectly affects dna-binding specificity probably because dam methylation subtly #alters binding of lrp at the gatc1130 site .
hence , glu13 indirectly affects dna-binding specificity probably because a mechanism can subtly #alter expression of bcl-3 .
hence , glu13 indirectly affects dna-binding specificity probably because a mechanism may be able to subtly #alter expression of bcl-3 .
hence , glu13 indirectly affects dna-binding specificity probably because a mechanism may subtly #alter expression of bcl-3 .
hence , glu13 indirectly affects dna-binding specificity probably because a mechanism subtly #altered expression of bcl-3 .
hence , glu13 indirectly affects dna-binding specificity probably because a mechanism subtly #alters expression of bcl-3 .
hence , glu13 indirectly affects dna-binding specificity probably because the molecular lesion associated with s1031 can subtly #alter splicing .
hence , glu13 indirectly affects dna-binding specificity probably because the molecular lesion associated with s1031 is able to subtly #alter splicing .
hence , glu13 indirectly affects dna-binding specificity probably because the molecular lesion associated with s1031 subtly #altered splicing .
hence , glu13 indirectly affects dna-binding specificity probably because the molecular lesion associated with s1031 subtly #alters splicing .
hence , glu13 indirectly affects dna-binding specificity probably because treating the cells with insulin-like growth factor-i is able to subtly #alter phosphorylation of pdk1 .
hence , glu13 indirectly affects dna-binding specificity probably because treating the cells with insulin-like growth factor-i may be able to subtly #alter phosphorylation of pdk1 .
hence , glu13 indirectly affects dna-binding specificity probably because treating the cells with insulin-like growth factor-i may subtly #alter phosphorylation of pdk1 .
hence , glu13 indirectly affects dna-binding specificity probably because treating the cells with insulin-like growth factor-i subtly #altered phosphorylation of pdk1 .
hence , glu13 indirectly affects dna-binding specificity probably due to dam methylation , which can subtly #alter binding of lrp at the gatc1130 site .
hence , glu13 indirectly affects dna-binding specificity probably due to dam methylation , which is able to subtly #alter binding of lrp at the gatc1130 site .
hence , glu13 indirectly affects dna-binding specificity probably due to dam methylation , which may be able to subtly #alter binding of lrp at the gatc1130 site .
hence , glu13 indirectly affects dna-binding specificity probably due to dam methylation , which subtly #altered binding of lrp at the gatc1130 site .
hence , glu13 indirectly affects dna-binding specificity probably due to dam methylation , which was able to subtly #alter binding of lrp at the gatc1130 site .
hence , glu13 indirectly affects dna-binding specificity probably due to a mechanism , which may subtly #alter expression of bcl-3 .
hence , glu13 indirectly affects dna-binding specificity probably due to a mechanism , which subtly #altered expression of bcl-3 .
hence , glu13 indirectly affects dna-binding specificity probably due to a mechanism , which was able to subtly #alter expression of bcl-3 .
hence , glu13 indirectly affects dna-binding specificity probably due to the molecular lesion associated with s1031 , which can subtly #alter splicing .
hence , glu13 indirectly affects dna-binding specificity probably due to the molecular lesion associated with s1031 , which subtly #altered splicing .
hence , glu13 indirectly affects dna-binding specificity probably due to the molecular lesion associated with s1031 , which was able to subtly #alter splicing .
hence , glu13 indirectly affects dna-binding specificity probably due to treating the cells with insulin-like growth factor-i , which can subtly #alter phosphorylation of pdk1 .
hence , glu13 indirectly affects dna-binding specificity probably due to treating the cells with insulin-like growth factor-i , which may be able to subtly #alter phosphorylation of pdk1 .
hence , glu13 indirectly affects dna-binding specificity probably due to treating the cells with insulin-like growth factor-i , which may subtly #alter phosphorylation of pdk1 .
hence , glu13 indirectly affects dna-binding specificity probably due to treating the cells with insulin-like growth factor-i , which was able to subtly #alter phosphorylation of pdk1 .
hence , glu13 indirectly affects dna-binding specificity , probably due to dam methylation , which subtly #alters the binding of lrp at the gatc1130 site .
hence , glu13 indirectly affects dna-binding specificity , probably due to treating the cells with insulin-like growth factor-i , which subtly #alters the phosphorylation of pdk1 .
moreover , dam methylation #altered binding of lrp at the gatc1130 site .
moreover , dam methylation #alters binding of lrp at the gatc1130 site .
moreover , dam methylation can #alter binding of lrp at the gatc1130 site .
moreover , dam methylation may #alter binding of lrp at the gatc1130 site .
moreover , dam methylation may be able to #alter binding of lrp at the gatc1130 site .
moreover , dam methylation will be able to #alter binding of lrp at the gatc1130 site .
moreover , a mechanism can #alter expression of bcl-3 .
moreover , a mechanism could #alter expression of bcl-3 .
moreover , a mechanism is able to #alter expression of bcl-3 .
moreover , a mechanism may #alter expression of bcl-3 .
moreover , a mechanism will #alter expression of bcl-3 .
moreover , a mechanism will be able to #alter expression of bcl-3 .
moreover , the molecular lesion associated with s1031 #altered splicing .
moreover , the molecular lesion associated with s1031 #alters splicing .
moreover , the molecular lesion associated with s1031 can #alter splicing .
moreover , the molecular lesion associated with s1031 has #altered splicing .
moreover , the molecular lesion associated with s1031 is able to #alter splicing .
moreover , the molecular lesion associated with s1031 may be able to #alter splicing .
moreover , the molecular lesion associated with s1031 will #alter splicing .
moreover , the molecular lesion associated with s1031 will be able to #alter splicing .
moreover , treating the cells with insulin-like growth factor-i #altered phosphorylation of pdk1 .
moreover , treating the cells with insulin-like growth factor-i #alters phosphorylation of pdk1 .
moreover , treating the cells with insulin-like growth factor-i could #alter phosphorylation of pdk1 .
moreover , treating the cells with insulin-like growth factor-i is able to #alter phosphorylation of pdk1 .
moreover , treating the cells with insulin-like growth factor-i may be able to #alter phosphorylation of pdk1 .
moreover , treating the cells with insulin-like growth factor-i will #alter phosphorylation of pdk1 .
since dam methylation are in opposing directions , binding of lrp at the gatc1130 site is not #altered by them(figure 3c) .
since dam methylation are in opposing directions , binding of lrp at the gatc1130 site will not be #altered by them(figure 3c) .
since dam methylation are in opposing directions , they cannot #alter binding of lrp at the gatc1130 site(figure 3c) .
since dam methylation are in opposing directions , they will not #alter binding of lrp at the gatc1130 site(figure 3c) .
since dam methylation were in opposing directions , binding of lrp at the gatc1130 site was not #altered by them(figure 3c) .
since a mechanism are in opposing directions , expression of bcl-3 cannot be #altered by them(figure 3c) .
since a mechanism are in opposing directions , they cannot #alter expression of bcl-3(figure 3c) .
since a mechanism are in opposing directions , they will not #alter expression of bcl-3(figure 3c) .
since a mechanism were in opposing directions , expression of bcl-3 was not able to be #altered by them(figure 3c) .
since a mechanism were in opposing directions , expression of bcl-3 was not #altered by them(figure 3c) .
since a mechanism were in opposing directions , they could not #alter expression of bcl-3(figure 3c) .
since a mechanism were in opposing directions , they were not able to #alter expression of bcl-3(figure 3c) .
since s1031 is a null allele , we are testing whether dam methylation can #alter binding of lrp at the gatc1130 site .
since s1031 is a null allele , we are testing whether dam methylation is able to #alter binding of lrp at the gatc1130 site .
since s1031 is a null allele , we are testing whether dam methylation will #alter binding of lrp at the gatc1130 site .
since s1031 is a null allele , we are testing whether phosphorylation of pdk1 can be #altered by treating the cells with insulin-like growth factor-i .
since s1031 is a null allele , we are testing whether phosphorylation of pdk1 may be #altered by treating the cells with insulin-like growth factor-i .
since s1031 is a null allele , we are testing whether a mechanism can #alter expression of bcl-3 .
since s1031 is a null allele , we are testing whether a mechanism is able to #alter expression of bcl-3 .
since s1031 is a null allele , we are testing whether binding of lrp at the gatc1130 site is #altered by dam methylation .
since s1031 is a null allele , we are testing whether binding of lrp at the gatc1130 site may be #altered by dam methylation .
since s1031 is a null allele , we are testing whether expression of bcl-3 is #altered by a mechanism .
since s1031 is a null allele , we are testing whether splicing is able to be #altered by the molecular lesion associated with s1031 .
since s1031 is a null allele , we are testing whether splicing is #altered by the molecular lesion associated with s1031 .
since s1031 is a null allele , we are testing whether splicing may be #altered by the molecular lesion associated with s1031 .
since s1031 is a null allele , we are testing whether the molecular lesion associated with s1031 is able to #alter splicing .
since s1031 is a null allele , we are testing whether the molecular lesion associated with s1031 is going to #alter splicing .
since s1031 is a null allele , we are testing whether the molecular lesion associated with s1031 may #alter splicing .
since s1031 is a null allele , we are testing whether the molecular lesion associated with s1031 will #alter splicing .
since s1031 is a null allele , we are testing whether treating the cells with insulin-like growth factor-i is going to #alter phosphorylation of pdk1 .
since s1031 is a null allele , we are testing whether treating the cells with insulin-like growth factor-i may #alter phosphorylation of pdk1 .
since s1031 is a null allele , we tested whether dam methylation #alters binding of lrp at the gatc1130 site .
since s1031 is a null allele , we tested whether dam methylation could #alter binding of lrp at the gatc1130 site .
since s1031 is a null allele , we tested whether dam methylation might #alter binding of lrp at the gatc1130 site .
since s1031 is a null allele , we tested whether phosphorylation of pdk1 could be #altered by treating the cells with insulin-like growth factor-i .
since s1031 is a null allele , we tested whether phosphorylation of pdk1 might be #altered by treating the cells with insulin-like growth factor-i .
since s1031 is a null allele , we tested whether phosphorylation of pdk1 was able to be #altered by treating the cells with insulin-like growth factor-i .
since s1031 is a null allele , we tested whether phosphorylation of pdk1 was #altered by treating the cells with insulin-like growth factor-i .
since s1031 is a null allele , we tested whether a mechanism #altered expression of bcl-3 .
since s1031 is a null allele , we tested whether a mechanism #alters expression of bcl-3 .
since s1031 is a null allele , we tested whether a mechanism could #alter expression of bcl-3 .
since s1031 is a null allele , we tested whether a mechanism has #altered expression of bcl-3 .
since s1031 is a null allele , we tested whether a mechanism might #alter expression of bcl-3 .
since s1031 is a null allele , we tested whether binding of lrp at the gatc1130 site could be #altered by dam methylation .
since s1031 is a null allele , we tested whether binding of lrp at the gatc1130 site was able to be #altered by dam methylation .
since s1031 is a null allele , we tested whether binding of lrp at the gatc1130 site was #altered by dam methylation .
since s1031 is a null allele , we tested whether expression of bcl-3 might be #altered by a mechanism .
since s1031 is a null allele , we tested whether expression of bcl-3 was #altered by a mechanism .
since s1031 is a null allele , we tested whether splicing could be #altered by the molecular lesion associated with s1031 .
since s1031 is a null allele , we tested whether splicing might be #altered by the molecular lesion associated with s1031 .
since s1031 is a null allele , we tested whether splicing was able to be #altered by the molecular lesion associated with s1031 .
since s1031 is a null allele , we tested whether splicing was #altered by the molecular lesion associated with s1031 .
since s1031 is a null allele , we tested whether the molecular lesion associated with s1031 #altered splicing .
since s1031 is a null allele , we tested whether the molecular lesion associated with s1031 #alters splicing .
since s1031 is a null allele , we tested whether the molecular lesion associated with s1031 could #alter splicing .
since s1031 is a null allele , we tested whether the molecular lesion associated with s1031 has #altered splicing .
since s1031 is a null allele , we tested whether the molecular lesion associated with s1031 might #alter splicing .
since s1031 is a null allele , we tested whether treating the cells with insulin-like growth factor-i #alters phosphorylation of pdk1 .
since s1031 is a null allele , we tested whether treating the cells with insulin-like growth factor-i could #alter phosphorylation of pdk1 .
since s1031 is a null allele , we tested whether treating the cells with insulin-like growth factor-i might #alter phosphorylation of pdk1 .
since the molecular lesion associated with s1031 are in opposing directions , splicing is not #altered by them(figure 3c) .
since the molecular lesion associated with s1031 are in opposing directions , splicing may not be #altered by them(figure 3c) .
since the molecular lesion associated with s1031 are in opposing directions , splicing will not be #altered by them(figure 3c) .
since the molecular lesion associated with s1031 are in opposing directions , they are not able to #alter splicing(figure 3c) .
since the molecular lesion associated with s1031 were in opposing directions , splicing was not able to be #altered by them(figure 3c) .
since the molecular lesion associated with s1031 were in opposing directions , they could not #alter splicing(figure 3c) .
since the molecular lesion associated with s1031 were in opposing directions , they did not #alter splicing(figure 3c) .
since the molecular lesion associated with s1031 were in opposing directions , they were not able to #alter splicing(figure 3c) .
since treating the cells with insulin-like growth factor-i are in opposing directions , phosphorylation of pdk1 cannot be #altered by them(figure 3c) .
since treating the cells with insulin-like growth factor-i are in opposing directions , phosphorylation of pdk1 is not #altered by them(figure 3c) .
since treating the cells with insulin-like growth factor-i are in opposing directions , they cannot #alter phosphorylation of pdk1(figure 3c) .
since treating the cells with insulin-like growth factor-i are in opposing directions , they will not #alter phosphorylation of pdk1(figure 3c) .
since treating the cells with insulin-like growth factor-i were in opposing directions , phosphorylation of pdk1 was not able to be #altered by them(figure 3c) .
since treating the cells with insulin-like growth factor-i were in opposing directions , phosphorylation of pdk1 was not #altered by them(figure 3c) .
since treating the cells with insulin-like growth factor-i were in opposing directions , they could not #alter phosphorylation of pdk1(figure 3c) .
since treating the cells with insulin-like growth factor-i were in opposing directions , they did not #alter phosphorylation of pdk1(figure 3c) .
bending of 31 into the major groove over the cc and ct base pair steps #began and ended the carg-box , and 15 into the minor groove over the five central ta , aa and at base pair steps .
growth of gaal , gpi8 and gpi16 deletants , when transferred to a glucose-containing medium in order to deplete these proteins , #begins to decline at 12 , 6 and 6 h , respectively , after transfer and ceased at 24 , 12 and 12 h .
growth of gaal , gpi8 and gpi16 deletants , when transferred to a glucose-containing medium in order to deplete these proteins , can #begin to decline at 12 , 6 and 6 h , respectively , after transfer and ceased at 24 , 12 and 12 h .
bending of 31 into the major groove over the cc and ct base pair steps has #begun and ended the carg-box , and 15 into the minor groove over the five central ta , aa and at base pair steps .
growth of gaal , gpi8 and gpi16 deletants , when transferred to a glucose-containing medium in order to deplete these proteins , could have #begun to decline at 12 , 6 and 6 h , respectively , after transfer and ceased at 24 , 12 and 12 h .
bending of 31 into the major groove over the cc and ct base pair steps is able to #begin and end the carg-box , and 15 into the minor groove over the five central ta , aa and at base pair steps .
growth of gaal , gpi8 and gpi16 deletants , when transferred to a glucose-containing medium in order to deplete these proteins , is believed to #begin declining at 12 , 6 and 6 h , respectively , after transfer and ceased at 24 , 12 and 12 h .
bending of 31 into the major groove over the cc and ct base pair steps is able to promptly #begin and end the carg-box , and 15 into the minor groove over the five central ta , aa and at base pair steps .
growth of gaal , gpi8 and gpi16 deletants , when transferred to a glucose-containing medium in order to deplete these proteins , is believed to have #begun declining at 12 , 6 and 6 h , respectively , after transfer and ceased at 24 , 12 and 12 h .
bending of 31 into the major groove over the cc and ct base pair steps is assumed to have #begun and ended the carg-box , and 15 into the minor groove over the five central ta , aa and at base pair steps .
growth of gaal , gpi8 and gpi16 deletants , when transferred to a glucose-containing medium in order to deplete these proteins , may have #begun to decline at 12 , 6 and 6 h , respectively , after transfer and ceased at 24 , 12 and 12 h .
bending of 31 into the major groove over the cc and ct base pair steps is believed to have promptly #begun and ended the carg-box , and 15 into the minor groove over the five central ta , aa and at base pair steps .
bending of 31 into the major groove over the cc and ct base pair steps may #begin and end the carg-box , and 15 into the minor groove over the five central ta , aa and at base pair steps .
growth of gaal , gpi8 and gpi16 deletants , when transferred to a glucose-containing medium in order to deplete these proteins , might have #begun to decline at 12 , 6 and 6 h , respectively , after transfer and ceased at 24 , 12 and 12 h .
bending of 31 into the major groove over the cc and ct base pair steps may promptly #begin and end the carg-box , and 15 into the minor groove over the five central ta , aa and at base pair steps .
growth of gaal , gpi8 and gpi16 deletants , when transferred to a glucose-containing medium in order to deplete these proteins , was believed to #begin declining at 12 , 6 and 6 h , respectively , after transfer and ceased at 24 , 12 and 12 h .
bending of 31 into the major groove over the cc and ct base pair steps promptly #begins and ends the carg-box , and 15 into the minor groove over the five central ta , aa and at base pair steps .
growth of gaal , gpi8 and gpi16 deletants , when transferred to a glucose-containing medium in order to deplete these proteins , will #begin to decline at 12 , 6 and 6 h , respectively , after transfer and ceased at 24 , 12 and 12 h .
bending of 31 into the major groove over the cc and ct base pair steps , as our study suggested , can #begin and end the carg-box , and 15 into the minor groove over the five central ta , aa and at base pair steps .
bending of 31 into the major groove over the cc and ct base pair steps , as our study suggested , has #begun and ended the carg-box , and 15 into the minor groove over the five central ta , aa and at base pair steps .
bending of 31 into the major groove over the cc and ct base pair steps , as our study suggested , has promptly #begun and ended the carg-box , and 15 into the minor groove over the five central ta , aa and at base pair steps .
bending of 31 into the major groove over the cc and ct base pair steps , as our study suggested , is assumed to have #begun and ended the carg-box , and 15 into the minor groove over the five central ta , aa and at base pair steps .
bending of 31 into the major groove over the cc and ct base pair steps , as our study suggested , is believed to have promptly #begun and ended the carg-box , and 15 into the minor groove over the five central ta , aa and at base pair steps .
bending of 31 into the major groove over the cc and ct base pair steps , as our study suggested , may promptly #begin and end the carg-box , and 15 into the minor groove over the five central ta , aa and at base pair steps .
bending of 31 into the major groove over the cc and ct base pair steps , as our study suggested , will #begin and end the carg-box , and 15 into the minor groove over the five central ta , aa and at base pair steps .
bending of 31 into the major groove over the cc and ct base pair steps , as our study suggested , will promptly #begin and end the carg-box , and 15 into the minor groove over the five central ta , aa and at base pair steps .
on the other hand , the only transcript being believed to probably #begin at exon 1a is observed in normal cells .
on the other hand , the only transcript that #began at exon 1a was observed in normal cells .
on the other hand , the only transcript that can probably #begin at exon 1a is observed in normal cells .
on the other hand , the only transcript that has probably #begun at exon 1a was observed in normal cells .
on the other hand , the only transcript that is believed to #begin at exon 1a is observed in normal cells .
on the other hand , the only transcript that is believed to have #begun at exon 1a is observed in normal cells .
on the other hand , the only transcript that is believed to have probably #begun at exon 1a is observed in normal cells .
on the other hand , the only transcript that probably #began at exon 1a was observed in normal cells .
on the other hand , the only transcript that was able to probably #begin at exon 1a was observed in normal cells .
on the other hand , the only transcript that was believed to #begin at exon 1a is observed in normal cells .
on the other hand , the only transcript that was believed to have #begun at exon 1a is observed in normal cells .
on the other hand , the only transcript that was believed to have probably #begun at exon 1a is observed in normal cells .
on the other hand , the only transcript that was believed to probably #begin at exon 1a is observed in normal cells .
on the other hand , the only transcript which #began at exon 1a was observed in normal cells .
on the other hand , the only transcript which is able to probably #begin at exon 1a is observed in normal cells .
on the other hand , the only transcript which is believed to #begin at exon 1a is observed in normal cells .
on the other hand , the only transcript which is believed to have #begun at exon 1a is observed in normal cells .
on the other hand , the only transcript which is believed to have probably #begun at exon 1a is observed in normal cells .
on the other hand , the only transcript which is believed to probably #begin at exon 1a is observed in normal cells .
on the other hand , the only transcript which probably #began at exon 1a was observed in normal cells .
on the other hand , the only transcript which probably #begins at exon 1a is observed in normal cells .
on the other hand , the only transcript which was able to probably #begin at exon 1a was observed in normal cells .
on the other hand , the only transcript which was believed to have #begun at exon 1a is observed in normal cells .
on the other hand , the only transcript which was believed to have probably #begun at exon 1a is observed in normal cells .
on the other hand , the only transcript which was believed to probably #begin at exon 1a is observed in normal cells .
the only transcript that , on the other hand , #begins at exon 1a is observed in normal cells .
the levels of immunoreactive ib are able to promptly #begin returning to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib can #begin to return to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib can have #begun to return to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib can have promptly #begun to return to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib can promptly #begin to return to basal levels following 3-4 h exposures to poly ic .
the only transcript that , on the other hand , has probably #begun at exon 1a was observed in normal cells .
the only transcript that , on the other hand , is able to #begin at exon 1a is observed in normal cells .
the only transcript that , on the other hand , is able to probably #begin at exon 1a is observed in normal cells .
the only transcript that , on the other hand , is believed to #begin at exon 1a is observed in normal cells .
the only transcript that , on the other hand , is believed to have #begun at exon 1a is observed in normal cells .
the only transcript that , on the other hand , is believed to probably #begin at exon 1a is observed in normal cells .
the levels of immunoreactive ib have promptly #begun to return to basal levels following 3-4 h exposures to poly ic .
the only transcript that , on the other hand , probably #began at exon 1a was observed in normal cells .
the levels of immunoreactive ib is believed to #begin returning to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib is believed to have promptly #begun returning to basal levels following 3-4 h exposures to poly ic .
the only transcript that , on the other hand , was able to #begin at exon 1a was observed in normal cells .
the levels of immunoreactive ib is believed to promptly #begin returning to basal levels following 3-4 h exposures to poly ic .
the only transcript that , on the other hand , was believed to #begin at exon 1a is observed in normal cells .
the levels of immunoreactive ib may #begin to return to basal levels following 3-4 h exposures to poly ic .
the only transcript that , on the other hand , was believed to have #begun at exon 1a is observed in normal cells .
the levels of immunoreactive ib may have #begun to return to basal levels following 3-4 h exposures to poly ic .
the only transcript that , on the other hand , was believed to have probably #begun at exon 1a is observed in normal cells .
the levels of immunoreactive ib may promptly #begin to return to basal levels following 3-4 h exposures to poly ic .
the only transcript which , on the other hand , #began at exon 1a was observed in normal cells .
the only transcript which , on the other hand , can #begin at exon 1a is observed in normal cells .
the only transcript which , on the other hand , can probably #begin at exon 1a is observed in normal cells .
the levels of immunoreactive ib might promptly #begin to return to basal levels following 3-4 h exposures to poly ic .
the only transcript which , on the other hand , could #begin at exon 1a was observed in normal cells .
the levels of immunoreactive ib was able to #begin returning to basal levels following 3-4 h exposures to poly ic .
the only transcript which , on the other hand , could probably #begin at exon 1a was observed in normal cells .
the only transcript which , on the other hand , has probably #begun at exon 1a was observed in normal cells .
the levels of immunoreactive ib was believed to #begin returning to basal levels following 3-4 h exposures to poly ic .
the only transcript which , on the other hand , is able to #begin at exon 1a is observed in normal cells .
the levels of immunoreactive ib was believed to have promptly #begun returning to basal levels following 3-4 h exposures to poly ic .
the only transcript which , on the other hand , is believed to #begin at exon 1a is observed in normal cells .
the levels of immunoreactive ib will have promptly #begun to return to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib will promptly #begin to return to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib would #begin to return to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib would have #begun to return to basal levels following 3-4 h exposures to poly ic .
the only transcript which , on the other hand , was able to #begin at exon 1a was observed in normal cells .
the only transcript which , on the other hand , was able to probably #begin at exon 1a was observed in normal cells .
the only transcript which , on the other hand , was believed to #begin at exon 1a is observed in normal cells .
the only transcript which , on the other hand , was believed to have #begun at exon 1a is observed in normal cells .
the levels of immunoreactive ib , as several research works revealed , can #begin to return to basal levels following 3-4 h exposures to poly ic .
the only transcript , on the other hand , being believed to have #begun at exon 1a is observed in normal cells .
the levels of immunoreactive ib , as several research works revealed , can have promptly #begun to return to basal levels following 3-4 h exposures to poly ic .
the only transcript , on the other hand , being believed to probably #begin at exon 1a is observed in normal cells .
the levels of immunoreactive ib , as several research works revealed , could promptly #begin to return to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib , as several research works revealed , have promptly #begun to return to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib , as several research works revealed , is believed to have promptly #begun returning to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib , as several research works revealed , is believed to promptly #begin returning to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib , as several research works revealed , may #begin to return to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib , as several research works revealed , may have #begun to return to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib , as several research works revealed , might #begin to return to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib , as several research works revealed , might have #begun to return to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib , as several research works revealed , might have promptly #begun to return to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib , as several research works revealed , might promptly #begin to return to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib , as several research works revealed , promptly #began to return to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib , as several research works revealed , was able to #begin returning to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib , as several research works revealed , was able to promptly #begin returning to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib , as several research works revealed , was believed to promptly #begin returning to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib , as several research works revealed , will #begin to return to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib , as several research works revealed , will promptly #begin to return to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib , as several research works revealed , would promptly #begin to return to basal levels following 3-4 h exposures to poly ic .
when they were transferred to a glucose-containing medium in order to deplete these proteins , growth of gaal , gpi8 and gpi16 deletants could #begin to decline at 12 , 6 and 6 h , respectively , after transfer and ceased at 24 , 12 and 12 h .
when they were transferred to a glucose-containing medium in order to deplete these proteins , growth of gaal , gpi8 and gpi16 deletants is believed to #begin declining at 12 , 6 and 6 h , respectively , after transfer and ceased at 24 , 12 and 12 h .
when they were transferred to a glucose-containing medium in order to deplete these proteins , growth of gaal , gpi8 and gpi16 deletants might #begin to decline at 12 , 6 and 6 h , respectively , after transfer and ceased at 24 , 12 and 12 h .
when they were transferred to a glucose-containing medium in order to deplete these proteins , growth of gaal , gpi8 and gpi16 deletants was believed to #begin declining at 12 , 6 and 6 h , respectively , after transfer and ceased at 24 , 12 and 12 h .
when they were transferred to a glucose-containing medium in order to deplete these proteins , growth of gaal , gpi8 and gpi16 deletants was believed to have #begun declining at 12 , 6 and 6 h , respectively , after transfer and ceased at 24 , 12 and 12 h .
when they were transferred to a glucose-containing medium in order to deplete these proteins , growth of gaal , gpi8 and gpi16 deletants will #begin to decline at 12 , 6 and 6 h , respectively , after transfer and ceased at 24 , 12 and 12 h .
when they were transferred to a glucose-containing medium in order to deplete these proteins , growth of gaal , gpi8 and gpi16 deletants will have #begun to decline at 12 , 6 and 6 h , respectively , after transfer and ceased at 24 , 12 and 12 h .
when they were transferred to a glucose-containing medium in order to deplete these proteins , growth of gaal , gpi8 and gpi16 deletants would #begin to decline at 12 , 6 and 6 h , respectively , after transfer and ceased at 24 , 12 and 12 h .
both srf subunits in the ternary complex bend the two dna half sites to the same extent , resulting in bending of 31 into the major groove over the cc and ct base pair steps #beginning and ending the carg-box , and 15 into the minor groove over the five central ta , aa and at base pair steps .
when they were transferred to a glucose-containing medium in order to deplete these proteins , growth of gaal , gpi8 and gpi16 deletants #began to decline at 12 , 6 and 6 h , respectively , after transfer and ceased at 24 , 12 and 12 h .
on the other hand , the only transcript #beginning at exon 1a was observed in normal cells .
the only transcript #began at exon 1a , and continued to the c-terminus .
the only transcript #began variably at exon 1a , and continued to the c-terminus .
the only transcript #beginning variably at exon 1a will continue to the c-terminus .
the only transcript can #begin at exon 1a , and continues to the c-terminus .
the only transcript has #begun at exon 1a , and has continued to the c-terminus .
the only transcript that #began at exon 1a continued to the c-terminus .
the only transcript that #begins at exon 1a continues to the c-terminus .
the only transcript that has #begun at exon 1a has continued to the c-terminus .
the only transcript that has #begun variably at exon 1a has continued to the c-terminus .
the only transcript which #begins at exon 1a continues to the c-terminus .
the only transcript will #begin variably at exon 1a , and continues to the c-terminus .
the only transcript would #begin at exon 1a , and continued to the c-terminus .
the only transcript , as our data have shown , #began at exon 1a , and continued to the c-terminus .
the only transcript , as our data have shown , can #begin at exon 1a , and continues to the c-terminus .
the only transcript , as our data have shown , could #begin variably at exon 1a , and continued to the c-terminus .
the only transcript , as our data have shown , has #begun at exon 1a , and has continued to the c-terminus .
the only transcript , as our data have shown , is able to #begin at exon 1a , and continues to the c-terminus .
the only transcript , as our data have shown , that #began variably at exon 1a continued to the c-terminus .
the only transcript , as our data have shown , was able to #begin variably at exon 1a , and continued to the c-terminus .
the only transcript , as our data have shown , which #began at exon 1a continued to the c-terminus .
the only transcript , as our data have shown , which #begins at exon 1a continues to the c-terminus .
the only transcript , as our data have shown , which has #begun at exon 1a has continued to the c-terminus .
the only transcript , as our data have shown , will #begin at exon 1a , and continues to the c-terminus .
the only transcript , as our data have shown , would #begin at exon 1a , and continued to the c-terminus .
the only transcript , as our data have shown , would #begin variably at exon 1a , and continued to the c-terminus .
the levels of immunoreactive ib are able to #begin return to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib are able to promptly #begin return to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib #began return to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib #began returning to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib #begin to returning to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib #begin to to return to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib #beginning return to basal levels following 3-4 h exposures to poly ic can continue slowly for 33 h .
the levels of immunoreactive ib #beginning returning to basal levels following 3-4 h exposures to poly ic can continue slowly for 33 h .
the levels of immunoreactive ib #begins return to basal levels following 3-4 h exposures to poly ic , but growth continues slowly for 33 h .
the levels of immunoreactive ib #begins returning to basal levels following 3-4 h exposures to poly ic , but growth continues slowly for 33 h .
the levels of immunoreactive ib believed to #begin returning to basal levels following 3-4 h exposures to poly ic can continue slowly for 33 h .
the levels of immunoreactive ib believed to #begin to return to basal levels following 3-4 h exposures to poly ic can continue slowly for 33 h .
the levels of immunoreactive ib believed to have #begun return to basal levels following 3-4 h exposures to poly ic can continue slowly for 33 h .
the levels of immunoreactive ib believed to have #begun returning to basal levels following 3-4 h exposures to poly ic can continue slowly for 33 h .
the levels of immunoreactive ib believed to have #begun to return to basal levels following 3-4 h exposures to poly ic can continue slowly for 33 h .
the levels of immunoreactive ib believed to have probably #begun return to basal levels following 3-4 h exposures to poly ic can continue slowly for 33 h .
the levels of immunoreactive ib believed to probably #begin return to basal levels following 3-4 h exposures to poly ic can continue slowly for 33 h .
the levels of immunoreactive ib believed to probably #begin returning to basal levels following 3-4 h exposures to poly ic can continue slowly for 33 h .
the levels of immunoreactive ib can have #begun return to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib can have promptly #begun return to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib can have promptly #begun returning to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib can probably #begin return to basal levels following 3-4 h exposures to poly ic , but growth can continue slowly for 33 h .
the levels of immunoreactive ib can probably #begin returning to basal levels following 3-4 h exposures to poly ic , but growth can continue slowly for 33 h .
the levels of immunoreactive ib can promptly #begin returning to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib could #begin return to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib could have #begun return to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib could have promptly #begun return to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib could have promptly #begun returning to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib could probably #begin to return to basal levels following 3-4 h exposures to poly ic , but growth could continue slowly for 33 h .
the levels of immunoreactive ib could promptly #begin return to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib could promptly #begin returning to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib has #begun return to basal levels following 3-4 h exposures to poly ic , but growth continued slowly for 33 h .
the levels of immunoreactive ib has #begun to return to basal levels following 3-4 h exposures to poly ic , but growth continued slowly for 33 h .
the levels of immunoreactive ib has probably #begun return to basal levels following 3-4 h exposures to poly ic , but growth continued slowly for 33 h .
the levels of immunoreactive ib has probably #begun returning to basal levels following 3-4 h exposures to poly ic , but growth continued slowly for 33 h .
the levels of immunoreactive ib has probably #begun to return to basal levels following 3-4 h exposures to poly ic , but growth continued slowly for 33 h .
the levels of immunoreactive ib have #begun return to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib have #begun returning to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib is able to #begin returning to basal levels following 3-4 h exposures to poly ic , but growth can continue slowly for 33 h .
the levels of immunoreactive ib is able to probably #begin returning to basal levels following 3-4 h exposures to poly ic , but growth can continue slowly for 33 h .
the levels of immunoreactive ib is able to probably #begin to return to basal levels following 3-4 h exposures to poly ic , but growth can continue slowly for 33 h .
the levels of immunoreactive ib is believed to #begin return to basal levels following 3-4 h exposures to poly ic , but growth continues slowly for 33 h .
the levels of immunoreactive ib is believed to #begin to return to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib is believed to have #begun to return to basal levels following 3-4 h exposures to poly ic , but growth continued slowly for 33 h .
the levels of immunoreactive ib is believed to have #begun to return to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib is believed to have probably #begun return to basal levels following 3-4 h exposures to poly ic , but growth continued slowly for 33 h .
the levels of immunoreactive ib is believed to promptly #begin to return to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib may #begin return to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib may #begin returning to basal levels following 3-4 h exposures to poly ic , but growth can continue slowly for 33 h .
the levels of immunoreactive ib may have #begun return to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib may have #begun returning to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib may promptly #begin return to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib may promptly #begin returning to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib might #begin returning to basal levels following 3-4 h exposures to poly ic , but growth would continue slowly for 33 h .
the levels of immunoreactive ib might have #begun return to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib might have promptly #begun returning to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib might probably #begin returning to basal levels following 3-4 h exposures to poly ic , but growth would continue slowly for 33 h .
the levels of immunoreactive ib might promptly #begin returning to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib probably #begins returning to basal levels following 3-4 h exposures to poly ic , but growth continues slowly for 33 h .
the levels of immunoreactive ib promptly #began return to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib promptly #began returning to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib that #began return to basal levels following 3-4 h exposures to poly ic can continue slowly for 33 h .
the levels of immunoreactive ib that #begins return to basal levels following 3-4 h exposures to poly ic can continue slowly for 33 h .
the levels of immunoreactive ib that #begins returning to basal levels following 3-4 h exposures to poly ic can continue slowly for 33 h .
the levels of immunoreactive ib that #begins to return to basal levels following 3-4 h exposures to poly ic can continue slowly for 33 h .
the levels of immunoreactive ib that has #begun return to basal levels following 3-4 h exposures to poly ic can continue slowly for 33 h .
the levels of immunoreactive ib that has probably #begun return to basal levels following 3-4 h exposures to poly ic can continue slowly for 33 h .
the levels of immunoreactive ib that is believed to #begin returning to basal levels following 3-4 h exposures to poly ic can continue slowly for 33 h .
the levels of immunoreactive ib that is believed to #begin to return to basal levels following 3-4 h exposures to poly ic can continue slowly for 33 h .
the levels of immunoreactive ib that is believed to have #begun to return to basal levels following 3-4 h exposures to poly ic can continue slowly for 33 h .
the levels of immunoreactive ib that is believed to have probably #begun to return to basal levels following 3-4 h exposures to poly ic can continue slowly for 33 h .
the levels of immunoreactive ib that is believed to probably #begin return to basal levels following 3-4 h exposures to poly ic can continue slowly for 33 h .
the levels of immunoreactive ib that probably #began returning to basal levels following 3-4 h exposures to poly ic can continue slowly for 33 h .
the levels of immunoreactive ib that probably #began to return to basal levels following 3-4 h exposures to poly ic can continue slowly for 33 h .
the levels of immunoreactive ib that probably #begins return to basal levels following 3-4 h exposures to poly ic can continue slowly for 33 h .
the levels of immunoreactive ib that probably #begins to return to basal levels following 3-4 h exposures to poly ic can continue slowly for 33 h .
the levels of immunoreactive ib that was believed to #begin returning to basal levels following 3-4 h exposures to poly ic could continue slowly for 33 h .
the levels of immunoreactive ib that was believed to have #begun to return to basal levels following 3-4 h exposures to poly ic could continue slowly for 33 h .
the levels of immunoreactive ib that was believed to have probably #begun returning to basal levels following 3-4 h exposures to poly ic could continue slowly for 33 h .
the levels of immunoreactive ib that was believed to probably #begin returning to basal levels following 3-4 h exposures to poly ic could continue slowly for 33 h .
the levels of immunoreactive ib that was believed to probably #begin to return to basal levels following 3-4 h exposures to poly ic could continue slowly for 33 h .
the levels of immunoreactive ib was able to #begin returning to basal levels following 3-4 h exposures to poly ic , but growth could continue slowly for 33 h .
the levels of immunoreactive ib was able to promptly #begin to return to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib was believed to #begin returning to basal levels following 3-4 h exposures to poly ic , but growth continued slowly for 33 h .
the levels of immunoreactive ib was believed to #begin to return to basal levels following 3-4 h exposures to poly ic , but growth continued slowly for 33 h .
the levels of immunoreactive ib was believed to have #begun return to basal levels following 3-4 h exposures to poly ic , but growth continued slowly for 33 h .
the levels of immunoreactive ib was believed to have #begun return to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib was believed to have #begun returning to basal levels following 3-4 h exposures to poly ic , but growth continued slowly for 33 h .
the levels of immunoreactive ib was believed to have probably #begun returning to basal levels following 3-4 h exposures to poly ic , but growth continued slowly for 33 h .
the levels of immunoreactive ib was believed to have promptly #begun return to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib was believed to have promptly #begun to return to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib was believed to probably #begin returning to basal levels following 3-4 h exposures to poly ic , but growth continued slowly for 33 h .
the levels of immunoreactive ib was believed to probably #begin to return to basal levels following 3-4 h exposures to poly ic , but growth continued slowly for 33 h .
the levels of immunoreactive ib was believed to promptly #begin return to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib which #began return to basal levels following 3-4 h exposures to poly ic can continue slowly for 33 h .
the levels of immunoreactive ib which #began returning to basal levels following 3-4 h exposures to poly ic can continue slowly for 33 h .
the levels of immunoreactive ib which #began to return to basal levels following 3-4 h exposures to poly ic can continue slowly for 33 h .
the levels of immunoreactive ib which #begins return to basal levels following 3-4 h exposures to poly ic can continue slowly for 33 h .
the levels of immunoreactive ib which #begins to return to basal levels following 3-4 h exposures to poly ic can continue slowly for 33 h .
the levels of immunoreactive ib which has #begun to return to basal levels following 3-4 h exposures to poly ic can continue slowly for 33 h .
the levels of immunoreactive ib which has probably #begun return to basal levels following 3-4 h exposures to poly ic can continue slowly for 33 h .
the levels of immunoreactive ib which has probably #begun to return to basal levels following 3-4 h exposures to poly ic can continue slowly for 33 h .
the levels of immunoreactive ib which is believed to #begin to return to basal levels following 3-4 h exposures to poly ic can continue slowly for 33 h .
the levels of immunoreactive ib which is believed to have #begun returning to basal levels following 3-4 h exposures to poly ic can continue slowly for 33 h .
the levels of immunoreactive ib which is believed to have probably #begun returning to basal levels following 3-4 h exposures to poly ic can continue slowly for 33 h .
the levels of immunoreactive ib which is believed to have probably #begun to return to basal levels following 3-4 h exposures to poly ic can continue slowly for 33 h .
the levels of immunoreactive ib which is believed to probably #begin return to basal levels following 3-4 h exposures to poly ic can continue slowly for 33 h .
the levels of immunoreactive ib which is believed to probably #begin returning to basal levels following 3-4 h exposures to poly ic can continue slowly for 33 h .
the levels of immunoreactive ib which is believed to probably #begin to return to basal levels following 3-4 h exposures to poly ic can continue slowly for 33 h .
the levels of immunoreactive ib which probably #began return to basal levels following 3-4 h exposures to poly ic can continue slowly for 33 h .
the levels of immunoreactive ib which probably #begins to return to basal levels following 3-4 h exposures to poly ic can continue slowly for 33 h .
the levels of immunoreactive ib which was believed to #begin return to basal levels following 3-4 h exposures to poly ic could continue slowly for 33 h .
the levels of immunoreactive ib which was believed to #begin returning to basal levels following 3-4 h exposures to poly ic could continue slowly for 33 h .
the levels of immunoreactive ib which was believed to have #begun return to basal levels following 3-4 h exposures to poly ic could continue slowly for 33 h .
the levels of immunoreactive ib which was believed to have #begun to return to basal levels following 3-4 h exposures to poly ic could continue slowly for 33 h .
the levels of immunoreactive ib which was believed to have probably #begun return to basal levels following 3-4 h exposures to poly ic could continue slowly for 33 h .
the levels of immunoreactive ib which was believed to have probably #begun to return to basal levels following 3-4 h exposures to poly ic could continue slowly for 33 h .
the levels of immunoreactive ib which was believed to probably #begin returning to basal levels following 3-4 h exposures to poly ic could continue slowly for 33 h .
the levels of immunoreactive ib will #begin return to basal levels following 3-4 h exposures to poly ic , but growth will continue slowly for 33 h .
the levels of immunoreactive ib will have #begun return to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib will have #begun returning to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib will have promptly #begun return to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib will have promptly #begun returning to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib will promptly #begin return to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib will promptly #begin returning to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib would #begin return to basal levels following 3-4 h exposures to poly ic , but growth would continue slowly for 33 h .
the levels of immunoreactive ib would #begin returning to basal levels following 3-4 h exposures to poly ic , but growth would continue slowly for 33 h .
the levels of immunoreactive ib would have promptly #begun return to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib would probably #begin return to basal levels following 3-4 h exposures to poly ic , but growth would continue slowly for 33 h .
the levels of immunoreactive ib would probably #begin returning to basal levels following 3-4 h exposures to poly ic , but growth would continue slowly for 33 h .
the levels of immunoreactive ib would promptly #begin return to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib would promptly #begin returning to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib , as our study suggested , can #begin returning to basal levels following 3-4 h exposures to poly ic , but growth can continue slowly for 33 h .
the levels of immunoreactive ib , as our study suggested , can probably #begin return to basal levels following 3-4 h exposures to poly ic , but growth can continue slowly for 33 h .
the levels of immunoreactive ib , as our study suggested , can probably #begin to return to basal levels following 3-4 h exposures to poly ic , but growth can continue slowly for 33 h .
the levels of immunoreactive ib , as our study suggested , could #begin return to basal levels following 3-4 h exposures to poly ic , but growth could continue slowly for 33 h .
the levels of immunoreactive ib , as our study suggested , could #begin to return to basal levels following 3-4 h exposures to poly ic , but growth could continue slowly for 33 h .
the levels of immunoreactive ib , as our study suggested , could probably #begin return to basal levels following 3-4 h exposures to poly ic , but growth could continue slowly for 33 h .
the levels of immunoreactive ib , as our study suggested , could probably #begin returning to basal levels following 3-4 h exposures to poly ic , but growth could continue slowly for 33 h .
the levels of immunoreactive ib , as our study suggested , could probably #begin to return to basal levels following 3-4 h exposures to poly ic , but growth could continue slowly for 33 h .
the levels of immunoreactive ib , as our study suggested , has #begun returning to basal levels following 3-4 h exposures to poly ic , but growth continued slowly for 33 h .
the levels of immunoreactive ib , as our study suggested , has probably #begun returning to basal levels following 3-4 h exposures to poly ic , but growth continued slowly for 33 h .
the levels of immunoreactive ib , as our study suggested , is able to #begin return to basal levels following 3-4 h exposures to poly ic , but growth can continue slowly for 33 h .
the levels of immunoreactive ib , as our study suggested , is able to probably #begin return to basal levels following 3-4 h exposures to poly ic , but growth can continue slowly for 33 h .
the levels of immunoreactive ib , as our study suggested , is able to probably #begin to return to basal levels following 3-4 h exposures to poly ic , but growth can continue slowly for 33 h .
the levels of immunoreactive ib , as our study suggested , is believed to #begin return to basal levels following 3-4 h exposures to poly ic , but growth continues slowly for 33 h .
the levels of immunoreactive ib , as our study suggested , is believed to #begin returning to basal levels following 3-4 h exposures to poly ic , but growth continues slowly for 33 h .
the levels of immunoreactive ib , as our study suggested , is believed to have #begun return to basal levels following 3-4 h exposures to poly ic , but growth continued slowly for 33 h .
the levels of immunoreactive ib , as our study suggested , is believed to have #begun returning to basal levels following 3-4 h exposures to poly ic , but growth continued slowly for 33 h .
the levels of immunoreactive ib , as our study suggested , is believed to have #begun to return to basal levels following 3-4 h exposures to poly ic , but growth continued slowly for 33 h .
the levels of immunoreactive ib , as our study suggested , is believed to have probably #begun returning to basal levels following 3-4 h exposures to poly ic , but growth continued slowly for 33 h .
the levels of immunoreactive ib , as our study suggested , may #begin returning to basal levels following 3-4 h exposures to poly ic , but growth can continue slowly for 33 h .
the levels of immunoreactive ib , as our study suggested , might #begin returning to basal levels following 3-4 h exposures to poly ic , but growth would continue slowly for 33 h .
the levels of immunoreactive ib , as our study suggested , might #begin to return to basal levels following 3-4 h exposures to poly ic , but growth would continue slowly for 33 h .
the levels of immunoreactive ib , as our study suggested , might probably #begin returning to basal levels following 3-4 h exposures to poly ic , but growth would continue slowly for 33 h .
the levels of immunoreactive ib , as our study suggested , might probably #begin to return to basal levels following 3-4 h exposures to poly ic , but growth would continue slowly for 33 h .
the levels of immunoreactive ib , as our study suggested , probably #begins return to basal levels following 3-4 h exposures to poly ic , but growth continues slowly for 33 h .
the levels of immunoreactive ib , as our study suggested , probably #begins returning to basal levels following 3-4 h exposures to poly ic , but growth continues slowly for 33 h .
the levels of immunoreactive ib , as our study suggested , probably #begins to return to basal levels following 3-4 h exposures to poly ic , but growth continues slowly for 33 h .
the levels of immunoreactive ib , as our study suggested , was able to probably #begin return to basal levels following 3-4 h exposures to poly ic , but growth could continue slowly for 33 h .
the levels of immunoreactive ib , as our study suggested , was able to probably #begin to return to basal levels following 3-4 h exposures to poly ic , but growth could continue slowly for 33 h .
the levels of immunoreactive ib , as our study suggested , was believed to #begin return to basal levels following 3-4 h exposures to poly ic , but growth continued slowly for 33 h .
the levels of immunoreactive ib , as our study suggested , was believed to #begin returning to basal levels following 3-4 h exposures to poly ic , but growth continued slowly for 33 h .
the levels of immunoreactive ib , as our study suggested , was believed to #begin to return to basal levels following 3-4 h exposures to poly ic , but growth continued slowly for 33 h .
the levels of immunoreactive ib , as our study suggested , was believed to have #begun return to basal levels following 3-4 h exposures to poly ic , but growth continued slowly for 33 h .
the levels of immunoreactive ib , as our study suggested , was believed to have #begun returning to basal levels following 3-4 h exposures to poly ic , but growth continued slowly for 33 h .
the levels of immunoreactive ib , as our study suggested , was believed to have #begun to return to basal levels following 3-4 h exposures to poly ic , but growth continued slowly for 33 h .
the levels of immunoreactive ib , as our study suggested , was believed to have probably #begun returning to basal levels following 3-4 h exposures to poly ic , but growth continued slowly for 33 h .
the levels of immunoreactive ib , as our study suggested , was believed to have probably #begun to return to basal levels following 3-4 h exposures to poly ic , but growth continued slowly for 33 h .
the levels of immunoreactive ib , as our study suggested , was believed to probably #begin returning to basal levels following 3-4 h exposures to poly ic , but growth continued slowly for 33 h .
the levels of immunoreactive ib , as our study suggested , was believed to probably #begin to return to basal levels following 3-4 h exposures to poly ic , but growth continued slowly for 33 h .
the levels of immunoreactive ib , as our study suggested , will #begin returning to basal levels following 3-4 h exposures to poly ic , but growth will continue slowly for 33 h .
the levels of immunoreactive ib , as our study suggested , will #begin to return to basal levels following 3-4 h exposures to poly ic , but growth will continue slowly for 33 h .
the levels of immunoreactive ib , as our study suggested , will probably #begin returning to basal levels following 3-4 h exposures to poly ic , but growth will continue slowly for 33 h .
the levels of immunoreactive ib , as our study suggested , will probably #begin to return to basal levels following 3-4 h exposures to poly ic , but growth will continue slowly for 33 h .
the levels of immunoreactive ib , as our study suggested , would probably #begin to return to basal levels following 3-4 h exposures to poly ic , but growth would continue slowly for 33 h .
the levels of immunoreactive ib , as several research works revealed , are able to #begin to return to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib , as several research works revealed , #began return to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib , as several research works revealed , can #begin return to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib , as several research works revealed , can #begin returning to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib , as several research works revealed , can have #begun returning to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib , as several research works revealed , can have promptly #begun return to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib , as several research works revealed , can promptly #begin return to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib , as several research works revealed , can promptly #begin returning to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib , as several research works revealed , could #begin return to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib , as several research works revealed , could have #begun returning to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib , as several research works revealed , could promptly #begin return to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib , as several research works revealed , have #begun return to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib , as several research works revealed , have #begun returning to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib , as several research works revealed , have promptly #begun returning to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib , as several research works revealed , is believed to have #begun return to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib , as several research works revealed , is believed to have #begun to return to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib , as several research works revealed , is believed to have promptly #begun return to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib , as several research works revealed , is believed to promptly #begin to return to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib , as several research works revealed , may #begin return to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib , as several research works revealed , may #begin returning to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib , as several research works revealed , may have #begun return to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib , as several research works revealed , may have #begun returning to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib , as several research works revealed , may have promptly #begun returning to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib , as several research works revealed , may promptly #begin return to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib , as several research works revealed , might have #begun return to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib , as several research works revealed , might promptly #begin return to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib , as several research works revealed , was able to #begin to return to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib , as several research works revealed , was able to promptly #begin return to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib , as several research works revealed , was able to promptly #begin to return to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib , as several research works revealed , was believed to have #begun return to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib , as several research works revealed , was believed to have #begun to return to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib , as several research works revealed , was believed to have promptly #begun to return to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib , as several research works revealed , will have #begun return to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib , as several research works revealed , will have #begun returning to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib , as several research works revealed , will have promptly #begun returning to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib , as several research works revealed , will promptly #begin return to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib , as several research works revealed , will promptly #begin returning to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib , as several research works revealed , would #begin returning to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib , as several research works revealed , would have #begun return to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib , as several research works revealed , would have #begun returning to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib , as several research works revealed , would have promptly #begun returning to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib , as several research works revealed , would promptly #begin return to basal levels following 3-4 h exposures to poly ic .
when they were transferred to a glucose-containing medium in order to deplete these proteins , the levels of immunoreactive ib #began to to return to basal levels following 3-4 h exposures to poly ic , respectively , after transfer and ceased at 24 , 12 and 12 h .
when they were transferred to a glucose-containing medium in order to deplete these proteins , the levels of immunoreactive ib #begins to return to basal levels following 3-4 h exposures to poly ic , respectively , after transfer and ceased at 24 , 12 and 12 h .
when they were transferred to a glucose-containing medium in order to deplete these proteins , the levels of immunoreactive ib can #begin to return to basal levels following 3-4 h exposures to poly ic , respectively , after transfer and ceased at 24 , 12 and 12 h .
when they were transferred to a glucose-containing medium in order to deplete these proteins , the levels of immunoreactive ib can have #begun return to basal levels following 3-4 h exposures to poly ic , respectively , after transfer and ceased at 24 , 12 and 12 h .
when they were transferred to a glucose-containing medium in order to deplete these proteins , the levels of immunoreactive ib could #begin return to basal levels following 3-4 h exposures to poly ic , respectively , after transfer and ceased at 24 , 12 and 12 h .
when they were transferred to a glucose-containing medium in order to deplete these proteins , the levels of immunoreactive ib could have #begun to return to basal levels following 3-4 h exposures to poly ic , respectively , after transfer and ceased at 24 , 12 and 12 h .
when they were transferred to a glucose-containing medium in order to deplete these proteins , the levels of immunoreactive ib has #begun returning to basal levels following 3-4 h exposures to poly ic , respectively , after transfer and ceased at 24 , 12 and 12 h .
when they were transferred to a glucose-containing medium in order to deplete these proteins , the levels of immunoreactive ib has #begun to return to basal levels following 3-4 h exposures to poly ic , respectively , after transfer and ceased at 24 , 12 and 12 h .
when they were transferred to a glucose-containing medium in order to deplete these proteins , the levels of immunoreactive ib is able to #begin returning to basal levels following 3-4 h exposures to poly ic , respectively , after transfer and ceased at 24 , 12 and 12 h .
when they were transferred to a glucose-containing medium in order to deplete these proteins , the levels of immunoreactive ib is able to #begin to return to basal levels following 3-4 h exposures to poly ic , respectively , after transfer and ceased at 24 , 12 and 12 h .
when they were transferred to a glucose-containing medium in order to deplete these proteins , the levels of immunoreactive ib is believed to #begin return to basal levels following 3-4 h exposures to poly ic , respectively , after transfer and ceased at 24 , 12 and 12 h .
when they were transferred to a glucose-containing medium in order to deplete these proteins , the levels of immunoreactive ib is believed to #begin returning to basal levels following 3-4 h exposures to poly ic , respectively , after transfer and ceased at 24 , 12 and 12 h .
when they were transferred to a glucose-containing medium in order to deplete these proteins , the levels of immunoreactive ib is believed to #begin to return to basal levels following 3-4 h exposures to poly ic , respectively , after transfer and ceased at 24 , 12 and 12 h .
when they were transferred to a glucose-containing medium in order to deplete these proteins , the levels of immunoreactive ib is believed to have #begun returning to basal levels following 3-4 h exposures to poly ic , respectively , after transfer and ceased at 24 , 12 and 12 h .
when they were transferred to a glucose-containing medium in order to deplete these proteins , the levels of immunoreactive ib may #begin return to basal levels following 3-4 h exposures to poly ic , respectively , after transfer and ceased at 24 , 12 and 12 h .
when they were transferred to a glucose-containing medium in order to deplete these proteins , the levels of immunoreactive ib may #begin returning to basal levels following 3-4 h exposures to poly ic , respectively , after transfer and ceased at 24 , 12 and 12 h .
when they were transferred to a glucose-containing medium in order to deplete these proteins , the levels of immunoreactive ib may have #begun return to basal levels following 3-4 h exposures to poly ic , respectively , after transfer and ceased at 24 , 12 and 12 h .
when they were transferred to a glucose-containing medium in order to deplete these proteins , the levels of immunoreactive ib may have #begun returning to basal levels following 3-4 h exposures to poly ic , respectively , after transfer and ceased at 24 , 12 and 12 h .
when they were transferred to a glucose-containing medium in order to deplete these proteins , the levels of immunoreactive ib might #begin return to basal levels following 3-4 h exposures to poly ic , respectively , after transfer and ceased at 24 , 12 and 12 h .
when they were transferred to a glucose-containing medium in order to deplete these proteins , the levels of immunoreactive ib might #begin returning to basal levels following 3-4 h exposures to poly ic , respectively , after transfer and ceased at 24 , 12 and 12 h .
when they were transferred to a glucose-containing medium in order to deplete these proteins , the levels of immunoreactive ib might #begin to return to basal levels following 3-4 h exposures to poly ic , respectively , after transfer and ceased at 24 , 12 and 12 h .
when they were transferred to a glucose-containing medium in order to deplete these proteins , the levels of immunoreactive ib might have #begun return to basal levels following 3-4 h exposures to poly ic , respectively , after transfer and ceased at 24 , 12 and 12 h .
when they were transferred to a glucose-containing medium in order to deplete these proteins , the levels of immunoreactive ib was able to #begin return to basal levels following 3-4 h exposures to poly ic , respectively , after transfer and ceased at 24 , 12 and 12 h .
when they were transferred to a glucose-containing medium in order to deplete these proteins , the levels of immunoreactive ib was able to #begin to return to basal levels following 3-4 h exposures to poly ic , respectively , after transfer and ceased at 24 , 12 and 12 h .
when they were transferred to a glucose-containing medium in order to deplete these proteins , the levels of immunoreactive ib was believed to #begin to return to basal levels following 3-4 h exposures to poly ic , respectively , after transfer and ceased at 24 , 12 and 12 h .
when they were transferred to a glucose-containing medium in order to deplete these proteins , the levels of immunoreactive ib was believed to have #begun returning to basal levels following 3-4 h exposures to poly ic , respectively , after transfer and ceased at 24 , 12 and 12 h .
when they were transferred to a glucose-containing medium in order to deplete these proteins , the levels of immunoreactive ib was believed to have #begun to return to basal levels following 3-4 h exposures to poly ic , respectively , after transfer and ceased at 24 , 12 and 12 h .
when they were transferred to a glucose-containing medium in order to deplete these proteins , the levels of immunoreactive ib will #begin return to basal levels following 3-4 h exposures to poly ic , respectively , after transfer and ceased at 24 , 12 and 12 h .
when they were transferred to a glucose-containing medium in order to deplete these proteins , the levels of immunoreactive ib will #begin returning to basal levels following 3-4 h exposures to poly ic , respectively , after transfer and ceased at 24 , 12 and 12 h .
when they were transferred to a glucose-containing medium in order to deplete these proteins , the levels of immunoreactive ib will #begin to return to basal levels following 3-4 h exposures to poly ic , respectively , after transfer and ceased at 24 , 12 and 12 h .
when they were transferred to a glucose-containing medium in order to deplete these proteins , the levels of immunoreactive ib will have #begun return to basal levels following 3-4 h exposures to poly ic , respectively , after transfer and ceased at 24 , 12 and 12 h .
when they were transferred to a glucose-containing medium in order to deplete these proteins , the levels of immunoreactive ib would #begin return to basal levels following 3-4 h exposures to poly ic , respectively , after transfer and ceased at 24 , 12 and 12 h .
when they were transferred to a glucose-containing medium in order to deplete these proteins , the levels of immunoreactive ib would #begin returning to basal levels following 3-4 h exposures to poly ic , respectively , after transfer and ceased at 24 , 12 and 12 h .
when they were transferred to a glucose-containing medium in order to deplete these proteins , the levels of immunoreactive ib would have #begun returning to basal levels following 3-4 h exposures to poly ic , respectively , after transfer and ceased at 24 , 12 and 12 h .
when they were transferred to a glucose-containing medium in order to deplete these proteins , the levels of immunoreactive ib would have #begun to return to basal levels following 3-4 h exposures to poly ic , respectively , after transfer and ceased at 24 , 12 and 12 h .
when they were transferred to a glucose-containing medium in order to deplete these proteins , growth of gaal , gpi8 and gpi16 deletants #began to declining at 12 , 6 and 6 h , respectively , after transfer and ceased at 24 , 12 and 12 h .
when they were transferred to a glucose-containing medium in order to deplete these proteins , growth of gaal , gpi8 and gpi16 deletants #began to to decline at 12 , 6 and 6 h , respectively , after transfer and ceased at 24 , 12 and 12 h .
when they were transferred to a glucose-containing medium in order to deplete these proteins , growth of gaal , gpi8 and gpi16 deletants #begins decline at 12 , 6 and 6 h , respectively , after transfer and ceased at 24 , 12 and 12 h .
when they were transferred to a glucose-containing medium in order to deplete these proteins , growth of gaal , gpi8 and gpi16 deletants can have #begun decline at 12 , 6 and 6 h , respectively , after transfer and ceased at 24 , 12 and 12 h .
when they were transferred to a glucose-containing medium in order to deplete these proteins , growth of gaal , gpi8 and gpi16 deletants could #begin decline at 12 , 6 and 6 h , respectively , after transfer and ceased at 24 , 12 and 12 h .
when they were transferred to a glucose-containing medium in order to deplete these proteins , growth of gaal , gpi8 and gpi16 deletants could have #begun decline at 12 , 6 and 6 h , respectively , after transfer and ceased at 24 , 12 and 12 h .
when they were transferred to a glucose-containing medium in order to deplete these proteins , growth of gaal , gpi8 and gpi16 deletants could have #begun declining at 12 , 6 and 6 h , respectively , after transfer and ceased at 24 , 12 and 12 h .
when they were transferred to a glucose-containing medium in order to deplete these proteins , growth of gaal , gpi8 and gpi16 deletants has #begun decline at 12 , 6 and 6 h , respectively , after transfer and ceased at 24 , 12 and 12 h .
when they were transferred to a glucose-containing medium in order to deplete these proteins , growth of gaal , gpi8 and gpi16 deletants is able to #begin to decline at 12 , 6 and 6 h , respectively , after transfer and ceased at 24 , 12 and 12 h .
when they were transferred to a glucose-containing medium in order to deplete these proteins , growth of gaal , gpi8 and gpi16 deletants is believed to #begin to decline at 12 , 6 and 6 h , respectively , after transfer and ceased at 24 , 12 and 12 h .
when they were transferred to a glucose-containing medium in order to deplete these proteins , growth of gaal , gpi8 and gpi16 deletants may #begin decline at 12 , 6 and 6 h , respectively , after transfer and ceased at 24 , 12 and 12 h .
when they were transferred to a glucose-containing medium in order to deplete these proteins , growth of gaal , gpi8 and gpi16 deletants may #begin declining at 12 , 6 and 6 h , respectively , after transfer and ceased at 24 , 12 and 12 h .
when they were transferred to a glucose-containing medium in order to deplete these proteins , growth of gaal , gpi8 and gpi16 deletants may have #begun decline at 12 , 6 and 6 h , respectively , after transfer and ceased at 24 , 12 and 12 h .
when they were transferred to a glucose-containing medium in order to deplete these proteins , growth of gaal , gpi8 and gpi16 deletants may have #begun declining at 12 , 6 and 6 h , respectively , after transfer and ceased at 24 , 12 and 12 h .
when they were transferred to a glucose-containing medium in order to deplete these proteins , growth of gaal , gpi8 and gpi16 deletants might #begin decline at 12 , 6 and 6 h , respectively , after transfer and ceased at 24 , 12 and 12 h .
when they were transferred to a glucose-containing medium in order to deplete these proteins , growth of gaal , gpi8 and gpi16 deletants might #begin declining at 12 , 6 and 6 h , respectively , after transfer and ceased at 24 , 12 and 12 h .
when they were transferred to a glucose-containing medium in order to deplete these proteins , growth of gaal , gpi8 and gpi16 deletants might have #begun declining at 12 , 6 and 6 h , respectively , after transfer and ceased at 24 , 12 and 12 h .
when they were transferred to a glucose-containing medium in order to deplete these proteins , growth of gaal , gpi8 and gpi16 deletants was able to #begin decline at 12 , 6 and 6 h , respectively , after transfer and ceased at 24 , 12 and 12 h .
when they were transferred to a glucose-containing medium in order to deplete these proteins , growth of gaal , gpi8 and gpi16 deletants was able to #begin to decline at 12 , 6 and 6 h , respectively , after transfer and ceased at 24 , 12 and 12 h .
when they were transferred to a glucose-containing medium in order to deplete these proteins , growth of gaal , gpi8 and gpi16 deletants was believed to #begin to decline at 12 , 6 and 6 h , respectively , after transfer and ceased at 24 , 12 and 12 h .
when they were transferred to a glucose-containing medium in order to deplete these proteins , growth of gaal , gpi8 and gpi16 deletants was believed to have #begun decline at 12 , 6 and 6 h , respectively , after transfer and ceased at 24 , 12 and 12 h .
when they were transferred to a glucose-containing medium in order to deplete these proteins , growth of gaal , gpi8 and gpi16 deletants was believed to have #begun to decline at 12 , 6 and 6 h , respectively , after transfer and ceased at 24 , 12 and 12 h .
when they were transferred to a glucose-containing medium in order to deplete these proteins , growth of gaal , gpi8 and gpi16 deletants will #begin decline at 12 , 6 and 6 h , respectively , after transfer and ceased at 24 , 12 and 12 h .
when they were transferred to a glucose-containing medium in order to deplete these proteins , growth of gaal , gpi8 and gpi16 deletants will have #begun decline at 12 , 6 and 6 h , respectively , after transfer and ceased at 24 , 12 and 12 h .
when they were transferred to a glucose-containing medium in order to deplete these proteins , growth of gaal , gpi8 and gpi16 deletants will have #begun declining at 12 , 6 and 6 h , respectively , after transfer and ceased at 24 , 12 and 12 h .
when they were transferred to a glucose-containing medium in order to deplete these proteins , growth of gaal , gpi8 and gpi16 deletants would have #begun declining at 12 , 6 and 6 h , respectively , after transfer and ceased at 24 , 12 and 12 h .
growth of gaal , gpi8 and gpi16 deletants are able to promptly #begin decline at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants are able to promptly #begin declining at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants #began decline at 12 , 6 and 6 h , but growth continued slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants #began declining at 12 , 6 and 6 h , but growth continued slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants #began to decline at 12 , 6 and 6 h , but growth continued slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants #began to decline at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants #begin to decline at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants #begin to declining at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants #begin to to decline at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants #beginning decline at 12 , 6 and 6 h can continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants #beginning declining at 12 , 6 and 6 h can continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants #beginning to decline at 12 , 6 and 6 h can continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants #begins declining at 12 , 6 and 6 h , but growth continues slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants believed to #begin decline at 12 , 6 and 6 h can continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants believed to #begin to decline at 12 , 6 and 6 h can continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants believed to have #begun decline at 12 , 6 and 6 h can continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants believed to probably #begin to decline at 12 , 6 and 6 h can continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants can #begin decline at 12 , 6 and 6 h , but growth can continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants can #begin decline at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants can #begin to decline at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants can have #begun decline at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants can have #begun to decline at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants can have promptly #begun declining at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants can probably #begin declining at 12 , 6 and 6 h , but growth can continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants can probably #begin to decline at 12 , 6 and 6 h , but growth can continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants can promptly #begin decline at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants can promptly #begin declining at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants could #begin decline at 12 , 6 and 6 h , but growth could continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants could #begin decline at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants could #begin declining at 12 , 6 and 6 h , but growth could continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants could #begin declining at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants could #begin to decline at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants could have #begun declining at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants could have #begun to decline at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants could have promptly #begun decline at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants could have promptly #begun declining at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants could probably #begin to decline at 12 , 6 and 6 h , but growth could continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants could promptly #begin decline at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants has probably #begun to decline at 12 , 6 and 6 h , but growth continued slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants have #begun declining at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants have promptly #begun decline at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants have promptly #begun to decline at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants is able to #begin decline at 12 , 6 and 6 h , but growth can continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants is able to #begin declining at 12 , 6 and 6 h , but growth can continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants is able to #begin to decline at 12 , 6 and 6 h , but growth can continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants is able to probably #begin decline at 12 , 6 and 6 h , but growth can continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants is believed to #begin decline at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants is believed to #begin declining at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants is believed to #begin to decline at 12 , 6 and 6 h , but growth continues slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants is believed to have #begun declining at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants is believed to have probably #begun decline at 12 , 6 and 6 h , but growth continued slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants is believed to have probably #begun to decline at 12 , 6 and 6 h , but growth continued slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants is believed to probably #begin decline at 12 , 6 and 6 h , but growth continues slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants is believed to promptly #begin decline at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants is believed to promptly #begin declining at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants is believed to promptly #begin to decline at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants may have #begun declining at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants may have promptly #begun decline at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants may probably #begin declining at 12 , 6 and 6 h , but growth can continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants may probably #begin to decline at 12 , 6 and 6 h , but growth can continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants may promptly #begin decline at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants may promptly #begin declining at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants may promptly #begin to decline at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants might #begin decline at 12 , 6 and 6 h , but growth would continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants might #begin decline at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants might #begin declining at 12 , 6 and 6 h , but growth would continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants might #begin declining at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants might #begin to decline at 12 , 6 and 6 h , but growth would continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants might #begin to decline at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants might have #begun declining at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants might have promptly #begun decline at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants might have promptly #begun declining at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants might probably #begin decline at 12 , 6 and 6 h , but growth would continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants might probably #begin declining at 12 , 6 and 6 h , but growth would continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants might promptly #begin decline at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants probably #begins declining at 12 , 6 and 6 h , but growth continues slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants probably #begins to decline at 12 , 6 and 6 h , but growth continues slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants promptly #began decline at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants that #began decline at 12 , 6 and 6 h can continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants that #begins decline at 12 , 6 and 6 h can continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants that has #begun decline at 12 , 6 and 6 h can continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants that has #begun declining at 12 , 6 and 6 h can continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants that has #begun to decline at 12 , 6 and 6 h can continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants that has probably #begun decline at 12 , 6 and 6 h can continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants that has probably #begun declining at 12 , 6 and 6 h can continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants that is believed to #begin decline at 12 , 6 and 6 h can continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants that is believed to #begin declining at 12 , 6 and 6 h can continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants that is believed to #begin to decline at 12 , 6 and 6 h can continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants that is believed to have #begun decline at 12 , 6 and 6 h can continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants that is believed to have probably #begun to decline at 12 , 6 and 6 h can continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants that is believed to probably #begin decline at 12 , 6 and 6 h can continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants that is believed to probably #begin to decline at 12 , 6 and 6 h can continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants that was believed to #begin declining at 12 , 6 and 6 h could continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants that was believed to have probably #begun decline at 12 , 6 and 6 h could continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants that was believed to probably #begin declining at 12 , 6 and 6 h could continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants was able to #begin decline at 12 , 6 and 6 h , but growth could continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants was able to #begin declining at 12 , 6 and 6 h , but growth could continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants was able to #begin declining at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants was able to #begin to decline at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants was able to probably #begin declining at 12 , 6 and 6 h , but growth could continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants was able to promptly #begin decline at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants was able to promptly #begin to decline at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants was believed to #begin decline at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants was believed to #begin declining at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants was believed to #begin to decline at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants was believed to have #begun decline at 12 , 6 and 6 h , but growth continued slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants was believed to have #begun declining at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants was believed to have #begun to decline at 12 , 6 and 6 h , but growth continued slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants was believed to have probably #begun decline at 12 , 6 and 6 h , but growth continued slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants was believed to have promptly #begun declining at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants was believed to probably #begin decline at 12 , 6 and 6 h , but growth continued slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants was believed to probably #begin to decline at 12 , 6 and 6 h , but growth continued slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants was believed to promptly #begin declining at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants which #began decline at 12 , 6 and 6 h can continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants which has #begun to decline at 12 , 6 and 6 h can continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants which has probably #begun declining at 12 , 6 and 6 h can continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants which is believed to #begin declining at 12 , 6 and 6 h can continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants which is believed to have #begun decline at 12 , 6 and 6 h can continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants which is believed to have #begun declining at 12 , 6 and 6 h can continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants which is believed to have probably #begun declining at 12 , 6 and 6 h can continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants which is believed to have probably #begun to decline at 12 , 6 and 6 h can continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants which is believed to probably #begin decline at 12 , 6 and 6 h can continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants which is believed to probably #begin declining at 12 , 6 and 6 h can continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants which is believed to probably #begin to decline at 12 , 6 and 6 h can continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants which probably #began decline at 12 , 6 and 6 h can continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants which probably #began to decline at 12 , 6 and 6 h can continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants which was believed to #begin declining at 12 , 6 and 6 h could continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants which was believed to have #begun declining at 12 , 6 and 6 h could continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants which was believed to have #begun to decline at 12 , 6 and 6 h could continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants which was believed to have probably #begun decline at 12 , 6 and 6 h could continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants which was believed to have probably #begun declining at 12 , 6 and 6 h could continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants which was believed to have probably #begun to decline at 12 , 6 and 6 h could continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants which was believed to probably #begin decline at 12 , 6 and 6 h could continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants which was believed to probably #begin declining at 12 , 6 and 6 h could continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants which was believed to probably #begin to decline at 12 , 6 and 6 h could continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants will #begin decline at 12 , 6 and 6 h , but growth will continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants will #begin decline at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants will #begin declining at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants will #begin to decline at 12 , 6 and 6 h , but growth will continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants will have #begun to decline at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants will have promptly #begun declining at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants will have promptly #begun to decline at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants will probably #begin decline at 12 , 6 and 6 h , but growth will continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants will probably #begin declining at 12 , 6 and 6 h , but growth will continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants will promptly #begin decline at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants will promptly #begin declining at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants would #begin decline at 12 , 6 and 6 h , but growth would continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants would #begin decline at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants would have #begun decline at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants would have #begun declining at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants would have promptly #begun declining at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants would have promptly #begun to decline at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants would probably #begin decline at 12 , 6 and 6 h , but growth would continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants would probably #begin declining at 12 , 6 and 6 h , but growth would continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants would promptly #begin declining at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants would promptly #begin to decline at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants , as our study suggested , #begins decline at 12 , 6 and 6 h , but growth continues slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants , as our study suggested , #begins declining at 12 , 6 and 6 h , but growth continues slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants , as our study suggested , can #begin decline at 12 , 6 and 6 h , but growth can continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants , as our study suggested , can #begin declining at 12 , 6 and 6 h , but growth can continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants , as our study suggested , can probably #begin decline at 12 , 6 and 6 h , but growth can continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants , as our study suggested , can probably #begin to decline at 12 , 6 and 6 h , but growth can continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants , as our study suggested , could #begin decline at 12 , 6 and 6 h , but growth could continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants , as our study suggested , has probably #begun decline at 12 , 6 and 6 h , but growth continued slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants , as our study suggested , has probably #begun declining at 12 , 6 and 6 h , but growth continued slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants , as our study suggested , is able to #begin to decline at 12 , 6 and 6 h , but growth can continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants , as our study suggested , is able to probably #begin to decline at 12 , 6 and 6 h , but growth can continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants , as our study suggested , is believed to #begin declining at 12 , 6 and 6 h , but growth continues slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants , as our study suggested , is believed to have #begun decline at 12 , 6 and 6 h , but growth continued slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants , as our study suggested , is believed to have probably #begun declining at 12 , 6 and 6 h , but growth continued slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants , as our study suggested , is believed to probably #begin declining at 12 , 6 and 6 h , but growth continues slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants , as our study suggested , may #begin decline at 12 , 6 and 6 h , but growth can continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants , as our study suggested , may probably #begin declining at 12 , 6 and 6 h , but growth can continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants , as our study suggested , may probably #begin to decline at 12 , 6 and 6 h , but growth can continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants , as our study suggested , might #begin declining at 12 , 6 and 6 h , but growth would continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants , as our study suggested , might #begin to decline at 12 , 6 and 6 h , but growth would continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants , as our study suggested , might probably #begin decline at 12 , 6 and 6 h , but growth would continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants , as our study suggested , might probably #begin declining at 12 , 6 and 6 h , but growth would continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants , as our study suggested , was able to #begin to decline at 12 , 6 and 6 h , but growth could continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants , as our study suggested , was able to probably #begin decline at 12 , 6 and 6 h , but growth could continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants , as our study suggested , was able to probably #begin declining at 12 , 6 and 6 h , but growth could continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants , as our study suggested , was believed to #begin decline at 12 , 6 and 6 h , but growth continued slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants , as our study suggested , was believed to #begin declining at 12 , 6 and 6 h , but growth continued slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants , as our study suggested , was believed to #begin to decline at 12 , 6 and 6 h , but growth continued slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants , as our study suggested , was believed to have probably #begun declining at 12 , 6 and 6 h , but growth continued slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants , as our study suggested , was believed to probably #begin decline at 12 , 6 and 6 h , but growth continued slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants , as our study suggested , was believed to probably #begin declining at 12 , 6 and 6 h , but growth continued slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants , as our study suggested , was believed to probably #begin to decline at 12 , 6 and 6 h , but growth continued slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants , as our study suggested , will #begin declining at 12 , 6 and 6 h , but growth will continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants , as our study suggested , will #begin to decline at 12 , 6 and 6 h , but growth will continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants , as our study suggested , will probably #begin decline at 12 , 6 and 6 h , but growth will continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants , as our study suggested , would #begin declining at 12 , 6 and 6 h , but growth would continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants , as our study suggested , would #begin to decline at 12 , 6 and 6 h , but growth would continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants , as our study suggested , would probably #begin declining at 12 , 6 and 6 h , but growth would continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants , as several research works revealed , are able to #begin to decline at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants , as several research works revealed , are able to promptly #begin decline at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants , as several research works revealed , are able to promptly #begin declining at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants , as several research works revealed , are able to promptly #begin to decline at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants , as several research works revealed , #began decline at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants , as several research works revealed , #began declining at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants , as several research works revealed , #began to decline at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants , as several research works revealed , can #begin decline at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants , as several research works revealed , can have #begun decline at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants , as several research works revealed , can have #begun declining at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants , as several research works revealed , can have #begun to decline at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants , as several research works revealed , can have promptly #begun decline at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants , as several research works revealed , can have promptly #begun declining at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants , as several research works revealed , can promptly #begin decline at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants , as several research works revealed , can promptly #begin declining at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants , as several research works revealed , can promptly #begin to decline at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants , as several research works revealed , could #begin decline at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants , as several research works revealed , could #begin declining at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants , as several research works revealed , could #begin to decline at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants , as several research works revealed , could promptly #begin declining at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants , as several research works revealed , could promptly #begin to decline at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants , as several research works revealed , have promptly #begun decline at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants , as several research works revealed , have promptly #begun declining at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants , as several research works revealed , have promptly #begun to decline at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants , as several research works revealed , is believed to #begin decline at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants , as several research works revealed , is believed to have #begun to decline at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants , as several research works revealed , is believed to have promptly #begun declining at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants , as several research works revealed , is believed to promptly #begin declining at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants , as several research works revealed , is believed to promptly #begin to decline at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants , as several research works revealed , may #begin decline at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants , as several research works revealed , may have promptly #begun decline at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants , as several research works revealed , may have promptly #begun to decline at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants , as several research works revealed , may promptly #begin declining at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants , as several research works revealed , may promptly #begin to decline at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants , as several research works revealed , might #begin declining at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants , as several research works revealed , might have #begun decline at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants , as several research works revealed , might have #begun declining at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants , as several research works revealed , might have promptly #begun declining at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants , as several research works revealed , might promptly #begin decline at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants , as several research works revealed , might promptly #begin declining at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants , as several research works revealed , promptly #began decline at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants , as several research works revealed , promptly #began declining at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants , as several research works revealed , promptly #began to decline at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants , as several research works revealed , was able to #begin decline at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants , as several research works revealed , was able to promptly #begin declining at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants , as several research works revealed , was believed to #begin declining at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants , as several research works revealed , was believed to have #begun declining at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants , as several research works revealed , was believed to have promptly #begun to decline at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants , as several research works revealed , was believed to promptly #begin decline at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants , as several research works revealed , will have #begun to decline at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants , as several research works revealed , will have promptly #begun to decline at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants , as several research works revealed , will promptly #begin decline at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants , as several research works revealed , will promptly #begin declining at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants , as several research works revealed , will promptly #begin to decline at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants , as several research works revealed , would #begin decline at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants , as several research works revealed , would #begin to decline at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants , as several research works revealed , would have promptly #begun declining at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants , as several research works revealed , would promptly #begin declining at 12 , 6 and 6 h .
a downstream kinase appeared to be essential for agrin-mediated signaling , since agrin-induced achr clustering and phosphorylation were able to be #blocked by staurosporine without inhibiting musk phosphorylation (wallace , 1994; fuhrer et al . , 1997) .
a downstream kinase appeared to be essential for agrin-mediated signaling , since staurosporine could #block agrin-induced achr clustering and phosphorylation without inhibiting musk phosphorylation (wallace , 1994; fuhrer et al . , 1997) .
a downstream kinase appeared to be essential for agrin-mediated signaling , since staurosporine was able to #block agrin-induced achr clustering and phosphorylation without inhibiting musk phosphorylation (wallace , 1994; fuhrer et al . , 1997) .
a downstream kinase appeared to be essential for agrin-mediated signaling , since staurosporine was believed to have #blocked agrin-induced achr clustering and phosphorylation without inhibiting musk phosphorylation (wallace , 1994; fuhrer et al . , 1997) .
a downstream kinase appeared to be essential for agrin-mediated signaling , since staurosporine was #blocking agrin-induced achr clustering and phosphorylation without inhibiting musk phosphorylation (wallace , 1994; fuhrer et al . , 1997) .
a downstream kinase appears to be essential for agrin-mediated signaling because of staurosporines ability to #block agrin-induced achr clustering and phosphorylation without inhibiting musk phosphorylation (wallace , 1994; fuhrer et al . , 1997) .
a downstream kinase appears to be essential for agrin-mediated signaling , since agrin-induced achr clustering and phosphorylation are able to be #blocked by staurosporine without inhibiting musk phosphorylation (wallace , 1994; fuhrer et al . , 1997) .
a downstream kinase appears to be essential for agrin-mediated signaling , since agrin-induced achr clustering and phosphorylation are #blocked by staurosporine without inhibiting musk phosphorylation (wallace , 1994; fuhrer et al . , 1997) .
a downstream kinase appears to be essential for agrin-mediated signaling , since agrin-induced achr clustering and phosphorylation can be #blocked by staurosporine without inhibiting musk phosphorylation (wallace , 1994; fuhrer et al . , 1997) .
a downstream kinase appears to be essential for agrin-mediated signaling , since agrin-induced achr clustering and phosphorylation have been #blocked by staurosporine without inhibiting musk phosphorylation (wallace , 1994; fuhrer et al . , 1997) .
a downstream kinase appears to be essential for agrin-mediated signaling , since agrin-induced achr clustering and phosphorylation may be #blocked by staurosporine without inhibiting musk phosphorylation (wallace , 1994; fuhrer et al . , 1997) .
a downstream kinase appears to be essential for agrin-mediated signaling , since agrin-induced achr clustering and phosphorylation were #blocked by staurosporine without inhibiting musk phosphorylation (wallace , 1994; fuhrer et al . , 1997) .
a downstream kinase appears to be essential for agrin-mediated signaling , since staurosporine is able to #block agrin-induced achr clustering and phosphorylation without inhibiting musk phosphorylation (wallace , 1994; fuhrer et al . , 1997) .
a downstream kinase appears to be essential for agrin-mediated signaling , since staurosporine is believed to #block agrin-induced achr clustering and phosphorylation without inhibiting musk phosphorylation (wallace , 1994; fuhrer et al . , 1997) .
a downstream kinase appears to be essential for agrin-mediated signaling , since staurosporine is believed to have #blocked agrin-induced achr clustering and phosphorylation without inhibiting musk phosphorylation (wallace , 1994; fuhrer et al . , 1997) .
a downstream kinase appears to be essential for agrin-mediated signaling , since staurosporine is #blocking agrin-induced achr clustering and phosphorylation without inhibiting musk phosphorylation (wallace , 1994; fuhrer et al . , 1997) .
alanine #blocked the action of a postulated repressor .
alanine #blocks the action of a postulated repressor .
alanine can #block the action of a postulated repressor .
alanine could #block the action of a postulated repressor .
alanine could have #blocked the action of a postulated repressor .
alanine is able to #block the action of a postulated repressor .
alanine may have #blocked the action of a postulated repressor .
alanine might #block the action of a postulated repressor .
alanine might have #blocked the action of a postulated repressor .
alanine will #block the action of a postulated repressor .
both rap1 and 2 are important vaccine candidates because antibodies to rap1 are shown to #block merozoite invasion in vitro (schofield et al . , 1986; harnyuttanakorn et al . , 1992; howard et al . , 1998a) .
both rap1 and 2 are important vaccine candidates because antibodies to rap1 are shown to have #blocked merozoite invasion in vitro (schofield et al . , 1986; harnyuttanakorn et al . , 1992; howard et al . , 1998a) .
both rap1 and 2 are important vaccine candidates because antibodies to rap1 have been shown to be able to #block merozoite invasion in vitro (schofield et al . , 1986; harnyuttanakorn et al . , 1992; howard et al . , 1998a) .
both rap1 and 2 are important vaccine candidates because antibodies to rap1 have been shown to have #blocked merozoite invasion in vitro (schofield et al . , 1986; harnyuttanakorn et al . , 1992; howard et al . , 1998a) .
both rap1 and 2 are important vaccine candidates because it has been shown that antibodies to rap1 #blocked merozoite invasion in vitro (schofield et al . , 1986; harnyuttanakorn et al . , 1992; howard et al . , 1998a) .
both rap1 and 2 are important vaccine candidates because it has been shown that antibodies to rap1 can #block merozoite invasion in vitro (schofield et al . , 1986; harnyuttanakorn et al . , 1992; howard et al . , 1998a) .
both rap1 and 2 are important vaccine candidates because it has been shown that antibodies to rap1 may #block merozoite invasion in vitro (schofield et al . , 1986; harnyuttanakorn et al . , 1992; howard et al . , 1998a) .
both rap1 and 2 are important vaccine candidates because it has been shown that merozoite invasion in vitro can be #blocked by antibodies to rap1 (schofield et al . , 1986; harnyuttanakorn et al . , 1992; howard et al . , 1998a) .
both rap1 and 2 are important vaccine candidates because it has been shown that merozoite invasion in vitro has been #blocked by antibodies to rap1 (schofield et al . , 1986; harnyuttanakorn et al . , 1992; howard et al . , 1998a) .
both rap1 and 2 are important vaccine candidates because it has been shown that merozoite invasion in vitro is believed to be #blocked by antibodies to rap1 (schofield et al . , 1986; harnyuttanakorn et al . , 1992; howard et al . , 1998a) .
both rap1 and 2 are important vaccine candidates because it has been shown that merozoite invasion in vitro may be #blocked by antibodies to rap1 (schofield et al . , 1986; harnyuttanakorn et al . , 1992; howard et al . , 1998a) .
both rap1 and 2 are important vaccine candidates because it has been shown that merozoite invasion in vitro might be #blocked by antibodies to rap1 (schofield et al . , 1986; harnyuttanakorn et al . , 1992; howard et al . , 1998a) .
both rap1 and 2 are important vaccine candidates because it has been shown that merozoite invasion in vitro was believed to be #blocked by antibodies to rap1 (schofield et al . , 1986; harnyuttanakorn et al . , 1992; howard et al . , 1998a) .
both rap1 and 2 are important vaccine candidates because it has been shown that merozoite invasion in vitro was #blocked by antibodies to rap1 (schofield et al . , 1986; harnyuttanakorn et al . , 1992; howard et al . , 1998a) .
both rap1 and 2 are important vaccine candidates because it has been shown that merozoite invasion in vitro will be #blocked by antibodies to rap1 (schofield et al . , 1986; harnyuttanakorn et al . , 1992; howard et al . , 1998a) .
both rap1 and 2 are important vaccine candidates because merozoite invasion in vitro is shown to be #blocked by antibodies to rap1 (schofield et al . , 1986; harnyuttanakorn et al . , 1992; howard et al . , 1998a) .
both rap1 and 2 are important vaccine candidates because merozoite invasion in vitro was shown to have been #blocked by antibodies to rap1 (schofield et al . , 1986; harnyuttanakorn et al . , 1992; howard et al . , 1998a) .
it can #block membranes in tbst (tris-buffered saline , 0 .05% tween-20) containing 5% bovine serum albumin (for anti-phosphoryrosine blots) or skimmed milk and probed with antibodies .
it has #blocked membranes in tbst (tris-buffered saline , 0 .05% tween-20) containing 5% bovine serum albumin (for anti-phosphoryrosine blots) or skimmed milk and probed with antibodies .
it is able to #block membranes in tbst (tris-buffered saline , 0 .05% tween-20) containing 5% bovine serum albumin (for anti-phosphoryrosine blots) or skimmed milk and probed with antibodies .
it is believed to #block membranes in tbst (tris-buffered saline , 0 .05% tween-20) containing 5% bovine serum albumin (for anti-phosphoryrosine blots) or skimmed milk and probed with antibodies .
it might #block membranes in tbst (tris-buffered saline , 0 .05% tween-20) containing 5% bovine serum albumin (for anti-phosphoryrosine blots) or skimmed milk and probed with antibodies .
it would #block membranes in tbst (tris-buffered saline , 0 .05% tween-20) containing 5% bovine serum albumin (for anti-phosphoryrosine blots) or skimmed milk and probed with antibodies .
membranes are believed to be #blocked in tbst (tris-buffered saline , 0 .05% tween-20) containing 5% bovine serum albumin (for anti-phosphoryrosine blots) or skimmed milk and probed with antibodies .
membranes are #blocked in tbst (tris-buffered saline , 0 .05% tween-20) containing 5% bovine serum albumin (for anti-phosphoryrosine blots) or skimmed milk and probed with antibodies .
membranes may be #blocked in tbst (tris-buffered saline , 0 .05% tween-20) containing 5% bovine serum albumin (for anti-phosphoryrosine blots) or skimmed milk and probed with antibodies .
tagetin is more specific for distinguishing between different rna polymerases because rna polymerase during elongation can be #blocked by it (mathews and durbin , 1994) , i .e .its action is independent of different initiation factors .
tagetin is more specific for distinguishing between different rna polymerases because rna polymerase during elongation is able to be #blocked by it (mathews and durbin , 1994) , i .e .its action is independent of different initiation factors .
tagetin is more specific for distinguishing between different rna polymerases because rna polymerase during elongation is #blocked by it (mathews and durbin , 1994) , i .e .its action is independent of different initiation factors .
tagetin is more specific for distinguishing between different rna polymerases because rna polymerase during elongation was #blocked by it (mathews and durbin , 1994) , i .e .its action is independent of different initiation factors .
tagetin is more specific for distinguishing between different rna polymerases because it #blocked rna polymerase during elongation (mathews and durbin , 1994) , i .e .its action is independent of different initiation factors .
these results suggest that 14-3-3eta functions as a positive regulator in the glucocorticoid signal pathway for #blocking the degradation of gr and inducing an elevation of gr , thus enhancing the transcriptional activity of gr .
these results suggest that 14-3-3eta functions as a positive regulator in the glucocorticoid signal pathway that #blocked the degradation of gr and inducing an elevation of gr , thus enhancing the transcriptional activity of gr .
the action of a postulated repressor is #blocked by alanine .
a downstream kinase appears to be essential for agrin-mediated signaling , since staurosporine #blocks agrin-induced achr clustering and phosphorylation without inhibiting musk phosphorylation (wallace , 1994; fuhrer et al . , 1997) .
membranes were #blocked in tbst (tris-buffered saline , 0 .05% tween-20) containing 5% bovine serum albumin (for anti-phosphoryrosine blots) or skimmed milk and probed with antibodies .
tagetin is more specific for distinguishing between different rna polymerases because it #blocks rna polymerase during elongation (mathews and durbin , 1994) , i .e .its action is independent of different initiation factors .
alanine is thought to act as an inducer to #block the action of a postulated repressor .
alanine is more specific for distinguishing between different rna polymerases because it #blocked the action of a postulated repressor (mathews and durbin , 1994) , i .e .its action is independent of different initiation factors .
alanine is more specific for distinguishing between different rna polymerases because it #blocks the action of a postulated repressor (mathews and durbin , 1994) , i .e .its action is independent of different initiation factors .
alanine is more specific for distinguishing between different rna polymerases because it can #block the action of a postulated repressor (mathews and durbin , 1994) , i .e .its action is independent of different initiation factors .
alanine is more specific for distinguishing between different rna polymerases because it is able to #block the action of a postulated repressor (mathews and durbin , 1994) , i .e .its action is independent of different initiation factors .
alanine is more specific for distinguishing between different rna polymerases because it may #blocks the action of a postulated repressor (mathews and durbin , 1994) , i .e .its action is independent of different initiation factors .
both rap1 and 2 are important vaccine candidates because alanine are shown to #block the action of a postulated repressor (schofield et al . , 1986; harnyuttanakorn et al . , 1992; howard et al . , 1998a) .
both rap1 and 2 are important vaccine candidates because alanine are shown to have #blocked the action of a postulated repressor (schofield et al . , 1986; harnyuttanakorn et al . , 1992; howard et al . , 1998a) .
both rap1 and 2 are important vaccine candidates because alanine have been shown to have #blocked the action of a postulated repressor (schofield et al . , 1986; harnyuttanakorn et al . , 1992; howard et al . , 1998a) .
both rap1 and 2 are important vaccine candidates because rna polymerase during elongation is shown to be #blocked by tagetin (schofield et al . , 1986; harnyuttanakorn et al . , 1992; howard et al . , 1998a) .
both rap1 and 2 are important vaccine candidates because rna polymerase during elongation is shown to have been #blocked by tagetin (schofield et al . , 1986; harnyuttanakorn et al . , 1992; howard et al . , 1998a) .
both rap1 and 2 are important vaccine candidates because rna polymerase during elongation was shown to be #blocked by tagetin (schofield et al . , 1986; harnyuttanakorn et al . , 1992; howard et al . , 1998a) .
both rap1 and 2 are important vaccine candidates because tagetin are shown to be able to #block rna polymerase during elongation (schofield et al . , 1986; harnyuttanakorn et al . , 1992; howard et al . , 1998a) .
both rap1 and 2 are important vaccine candidates because tagetin have been shown to #block rna polymerase during elongation (schofield et al . , 1986; harnyuttanakorn et al . , 1992; howard et al . , 1998a) .
both rap1 and 2 are important vaccine candidates because tagetin have been shown to have #blocked rna polymerase during elongation (schofield et al . , 1986; harnyuttanakorn et al . , 1992; howard et al . , 1998a) .
both rap1 and 2 are important vaccine candidates because it has been shown that alanine were able to #block the action of a postulated repressor (schofield et al . , 1986; harnyuttanakorn et al . , 1992; howard et al . , 1998a) .
both rap1 and 2 are important vaccine candidates because it has been shown that rna polymerase during elongation is believed to be #blocked by tagetin (schofield et al . , 1986; harnyuttanakorn et al . , 1992; howard et al . , 1998a) .
both rap1 and 2 are important vaccine candidates because it has been shown that rna polymerase during elongation might be #blocked by tagetin (schofield et al . , 1986; harnyuttanakorn et al . , 1992; howard et al . , 1998a) .
both rap1 and 2 are important vaccine candidates because it has been shown that rna polymerase during elongation was #blocked by tagetin (schofield et al . , 1986; harnyuttanakorn et al . , 1992; howard et al . , 1998a) .
both rap1 and 2 are important vaccine candidates because it has been shown that rna polymerase during elongation will be #blocked by tagetin (schofield et al . , 1986; harnyuttanakorn et al . , 1992; howard et al . , 1998a) .
both rap1 and 2 are important vaccine candidates because it has been shown that tagetin are able to #block rna polymerase during elongation (schofield et al . , 1986; harnyuttanakorn et al . , 1992; howard et al . , 1998a) .
both rap1 and 2 are important vaccine candidates because it has been shown that tagetin #blocked rna polymerase during elongation (schofield et al . , 1986; harnyuttanakorn et al . , 1992; howard et al . , 1998a) .
both rap1 and 2 are important vaccine candidates because it has been shown that tagetin were able to #block rna polymerase during elongation (schofield et al . , 1986; harnyuttanakorn et al . , 1992; howard et al . , 1998a) .
both rap1 and 2 are important vaccine candidates because it has been shown that the action of a postulated repressor has been #blocked by alanine (schofield et al . , 1986; harnyuttanakorn et al . , 1992; howard et al . , 1998a) .
both rap1 and 2 are important vaccine candidates because it has been shown that the action of a postulated repressor is believed to be #blocked by alanine (schofield et al . , 1986; harnyuttanakorn et al . , 1992; howard et al . , 1998a) .
both rap1 and 2 are important vaccine candidates because it has been shown that the action of a postulated repressor is #blocked by alanine (schofield et al . , 1986; harnyuttanakorn et al . , 1992; howard et al . , 1998a) .
both rap1 and 2 are important vaccine candidates because it has been shown that the action of a postulated repressor might be #blocked by alanine (schofield et al . , 1986; harnyuttanakorn et al . , 1992; howard et al . , 1998a) .
both rap1 and 2 are important vaccine candidates because it has been shown that the action of a postulated repressor was believed to be #blocked by alanine (schofield et al . , 1986; harnyuttanakorn et al . , 1992; howard et al . , 1998a) .
both rap1 and 2 are important vaccine candidates because it has been shown that the action of a postulated repressor was #blocked by alanine (schofield et al . , 1986; harnyuttanakorn et al . , 1992; howard et al . , 1998a) .
both rap1 and 2 are important vaccine candidates because it has been shown that the action of a postulated repressor will be #blocked by alanine (schofield et al . , 1986; harnyuttanakorn et al . , 1992; howard et al . , 1998a) .
both rap1 and 2 are important vaccine candidates because it has been shown that the action of a postulated repressor would be #blocked by alanine (schofield et al . , 1986; harnyuttanakorn et al . , 1992; howard et al . , 1998a) .
both rap1 and 2 are important vaccine candidates because the action of a postulated repressor is shown to be #blocked by alanine (schofield et al . , 1986; harnyuttanakorn et al . , 1992; howard et al . , 1998a) .
both rap1 and 2 are important vaccine candidates because the action of a postulated repressor was shown to be #blocked by alanine (schofield et al . , 1986; harnyuttanakorn et al . , 1992; howard et al . , 1998a) .
both rap1 and 2 are important vaccine candidates because the action of a postulated repressor was shown to have been #blocked by alanine (schofield et al . , 1986; harnyuttanakorn et al . , 1992; howard et al . , 1998a) .
labeling with antibodies to the y553 phosphopeptide is specific since alanine #blocked the action of a postulated repressor .
labeling with antibodies to the y553 phosphopeptide is specific since alanine #blocks the action of a postulated repressor .
labeling with antibodies to the y553 phosphopeptide is specific since alanine can #block the action of a postulated repressor .
labeling with antibodies to the y553 phosphopeptide is specific since alanine can have #blocked the action of a postulated repressor .
labeling with antibodies to the y553 phosphopeptide is specific since alanine is able to #block the action of a postulated repressor .
labeling with antibodies to the y553 phosphopeptide is specific since alanine may #block the action of a postulated repressor .
labeling with antibodies to the y553 phosphopeptide is specific since alanine may have #blocked the action of a postulated repressor .
labeling with antibodies to the y553 phosphopeptide is specific since rna polymerase during elongation can be #blocked by tagetin .
labeling with antibodies to the y553 phosphopeptide is specific since rna polymerase during elongation is able to be #blocked by tagetin .
labeling with antibodies to the y553 phosphopeptide is specific since rna polymerase during elongation is #blocked by tagetin .
labeling with antibodies to the y553 phosphopeptide is specific since tagetin #blocks rna polymerase during elongation .
labeling with antibodies to the y553 phosphopeptide is specific since tagetin can #block rna polymerase during elongation .
labeling with antibodies to the y553 phosphopeptide is specific since tagetin can have #blocked rna polymerase during elongation .
labeling with antibodies to the y553 phosphopeptide is specific since tagetin will #block rna polymerase during elongation .
labeling with antibodies to the y553 phosphopeptide is specific since antibodies to rap1 can have #blocked merozoite invasion in vitro .
labeling with antibodies to the y553 phosphopeptide is specific since antibodies to rap1 is able to #block merozoite invasion in vitro .
labeling with antibodies to the y553 phosphopeptide is specific since antibodies to rap1 may #block merozoite invasion in vitro .
labeling with antibodies to the y553 phosphopeptide is specific since antibodies to rap1 will #block merozoite invasion in vitro .
labeling with antibodies to the y553 phosphopeptide is specific since merozoite invasion in vitro can be #blocked by antibodies to rap1 .
labeling with antibodies to the y553 phosphopeptide is specific since merozoite invasion in vitro is able to be #blocked by antibodies to rap1 .
labeling with antibodies to the y553 phosphopeptide is specific since the action of a postulated repressor is able to be #blocked by alanine .
labeling with antibodies to the y553 phosphopeptide is specific since the action of a postulated repressor is believed to be #blocked by alanine .
labeling with antibodies to the y553 phosphopeptide is specific since the action of a postulated repressor is #blocked by alanine .
labeling with antibodies to the y553 phosphopeptide was specific since alanine could #block the action of a postulated repressor .
labeling with antibodies to the y553 phosphopeptide was specific since alanine could have #blocked the action of a postulated repressor .
labeling with antibodies to the y553 phosphopeptide was specific since alanine was able to #block the action of a postulated repressor .
labeling with antibodies to the y553 phosphopeptide was specific since alanine would #block the action of a postulated repressor .
labeling with antibodies to the y553 phosphopeptide was specific since rna polymerase during elongation could be #blocked by tagetin .
labeling with antibodies to the y553 phosphopeptide was specific since rna polymerase during elongation has been #blocked by tagetin .
labeling with antibodies to the y553 phosphopeptide was specific since rna polymerase during elongation was able to be #blocked by tagetin .
labeling with antibodies to the y553 phosphopeptide was specific since tagetin might #block rna polymerase during elongation .
labeling with antibodies to the y553 phosphopeptide was specific since tagetin might have #blocked rna polymerase during elongation .
labeling with antibodies to the y553 phosphopeptide was specific since tagetin would #block rna polymerase during elongation .
labeling with antibodies to the y553 phosphopeptide was specific since antibodies to rap1 might have #blocked merozoite invasion in vitro .
labeling with antibodies to the y553 phosphopeptide was specific since antibodies to rap1 was able to #block merozoite invasion in vitro .
labeling with antibodies to the y553 phosphopeptide was specific since antibodies to rap1 would #block merozoite invasion in vitro .
labeling with antibodies to the y553 phosphopeptide was specific since merozoite invasion in vitro has been #blocked by antibodies to rap1 .
labeling with antibodies to the y553 phosphopeptide was specific since merozoite invasion in vitro was able to be #blocked by antibodies to rap1 .
labeling with antibodies to the y553 phosphopeptide was specific since merozoite invasion in vitro was believed to be #blocked by antibodies to rap1 .
labeling with antibodies to the y553 phosphopeptide was specific since the action of a postulated repressor could be #blocked by alanine .
labeling with antibodies to the y553 phosphopeptide was specific since the action of a postulated repressor has been #blocked by alanine .
pu .1 is upregulated early during commitment of multipotential progenitors to the myeloid lineages and alanine #blocks the action of a postulated repressor .
pu .1 is upregulated early during commitment of multipotential progenitors to the myeloid lineages and alanine has #blocked the action of a postulated repressor .
pu .1 is upregulated early during commitment of multipotential progenitors to the myeloid lineages and alanine is able to #block the action of a postulated repressor .
pu .1 is upregulated early during commitment of multipotential progenitors to the myeloid lineages and alanine is believed to have #blocked the action of a postulated repressor .
pu .1 is upregulated early during commitment of multipotential progenitors to the myeloid lineages and alanine is proven to #block the action of a postulated repressor .
pu .1 is upregulated early during commitment of multipotential progenitors to the myeloid lineages and alanine will #block the action of a postulated repressor .
pu .1 is upregulated early during commitment of multipotential progenitors to the myeloid lineages and rna polymerase during elongation can be #blocked by tagetin .
pu .1 is upregulated early during commitment of multipotential progenitors to the myeloid lineages and rna polymerase during elongation is #blocked by tagetin .
pu .1 is upregulated early during commitment of multipotential progenitors to the myeloid lineages and tagetin can #block rna polymerase during elongation .
pu .1 is upregulated early during commitment of multipotential progenitors to the myeloid lineages and tagetin has #blocked rna polymerase during elongation .
pu .1 is upregulated early during commitment of multipotential progenitors to the myeloid lineages and tagetin is able to #block rna polymerase during elongation .
pu .1 is upregulated early during commitment of multipotential progenitors to the myeloid lineages and tagetin is believed to #block rna polymerase during elongation .
pu .1 is upregulated early during commitment of multipotential progenitors to the myeloid lineages and tagetin is believed to have #blocked rna polymerase during elongation .
pu .1 is upregulated early during commitment of multipotential progenitors to the myeloid lineages and tagetin is proven to have #blocked rna polymerase during elongation .
pu .1 is upregulated early during commitment of multipotential progenitors to the myeloid lineages and tagetin will #block rna polymerase during elongation .
pu .1 is upregulated early during commitment of multipotential progenitors to the myeloid lineages and antibodies to rap1 #blocks merozoite invasion in vitro .
pu .1 is upregulated early during commitment of multipotential progenitors to the myeloid lineages and antibodies to rap1 can #block merozoite invasion in vitro .
pu .1 is upregulated early during commitment of multipotential progenitors to the myeloid lineages and antibodies to rap1 is believed to #block merozoite invasion in vitro .
pu .1 is upregulated early during commitment of multipotential progenitors to the myeloid lineages and antibodies to rap1 is proven to have #blocked merozoite invasion in vitro .
pu .1 is upregulated early during commitment of multipotential progenitors to the myeloid lineages and merozoite invasion in vitro is #blocked by antibodies to rap1 .
pu .1 is upregulated early during commitment of multipotential progenitors to the myeloid lineages and merozoite invasion in vitro will be #blocked by antibodies to rap1 .
pu .1 is upregulated early during commitment of multipotential progenitors to the myeloid lineages and the action of a postulated repressor is #blocked by alanine .
pu .1 is upregulated early during commitment of multipotential progenitors to the myeloid lineages and the action of a postulated repressor will be #blocked by alanine .
pu .1 was upregulated early during commitment of multipotential progenitors to the myeloid lineages and alanine #blocked the action of a postulated repressor .
pu .1 was upregulated early during commitment of multipotential progenitors to the myeloid lineages and rna polymerase during elongation has been #blocked by tagetin .
pu .1 was upregulated early during commitment of multipotential progenitors to the myeloid lineages and tagetin #blocked rna polymerase during elongation .
pu .1 was upregulated early during commitment of multipotential progenitors to the myeloid lineages and tagetin has #blocked rna polymerase during elongation .
pu .1 was upregulated early during commitment of multipotential progenitors to the myeloid lineages and merozoite invasion in vitro was #blocked by antibodies to rap1 .
pu .1 was upregulated early during commitment of multipotential progenitors to the myeloid lineages and the action of a postulated repressor has been #blocked by alanine .
pu .1 was upregulated early during commitment of multipotential progenitors to the myeloid lineages and the action of a postulated repressor was #blocked by alanine .
proteasomal inhibition can not induce any synergistic effect on the 14-3-3eta-induced increase in gr in response to glucocorticoid , and alanine can not #block the action of a postulated repressor , indicating that 14-3-3eta induces stabilization of gr .
proteasomal inhibition can not induce any synergistic effect on the 14-3-3eta-induced increase in gr in response to glucocorticoid , and alanine is not able to #block the action of a postulated repressor , indicating that 14-3-3eta induces stabilization of gr .
proteasomal inhibition can not induce any synergistic effect on the 14-3-3eta-induced increase in gr in response to glucocorticoid , and tagetin can not #block rna polymerase during elongation , indicating that 14-3-3eta induces stabilization of gr .
proteasomal inhibition can not induce any synergistic effect on the 14-3-3eta-induced increase in gr in response to glucocorticoid , and tagetin is not able to #block rna polymerase during elongation , indicating that 14-3-3eta induces stabilization of gr .
proteasomal inhibition can not induce any synergistic effect on the 14-3-3eta-induced increase in gr in response to glucocorticoid , and antibodies to rap1 can not #block merozoite invasion in vitro , indicating that 14-3-3eta induces stabilization of gr .
proteasomal inhibition did not induce any synergistic effect on the 14-3-3eta-induced increase in gr in response to glucocorticoid , and antibodies to rap1 did not #block merozoite invasion in vitro , indicating that 14-3-3eta induces stabilization of gr .
proteasomal inhibition does not induce any synergistic effect on the 14-3-3eta-induced increase in gr in response to glucocorticoid , and alanine does not #block the action of a postulated repressor , indicating that 14-3-3eta induces stabilization of gr .
proteasomal inhibition does not induce any synergistic effect on the 14-3-3eta-induced increase in gr in response to glucocorticoid , and rna polymerase during elongation is not able to be #blocked by tagetin , indicating that 14-3-3eta induces stabilization of gr .
proteasomal inhibition does not induce any synergistic effect on the 14-3-3eta-induced increase in gr in response to glucocorticoid , and rna polymerase during elongation is not #blocked by tagetin , indicating that 14-3-3eta induces stabilization of gr .
proteasomal inhibition does not induce any synergistic effect on the 14-3-3eta-induced increase in gr in response to glucocorticoid , and tagetin does not #block rna polymerase during elongation , indicating that 14-3-3eta induces stabilization of gr .
proteasomal inhibition does not induce any synergistic effect on the 14-3-3eta-induced increase in gr in response to glucocorticoid , and antibodies to rap1 does not #block merozoite invasion in vitro , indicating that 14-3-3eta induces stabilization of gr .
proteasomal inhibition does not induce any synergistic effect on the 14-3-3eta-induced increase in gr in response to glucocorticoid , and merozoite invasion in vitro can not be #blocked by antibodies to rap1 , indicating that 14-3-3eta induces stabilization of gr .
proteasomal inhibition does not induce any synergistic effect on the 14-3-3eta-induced increase in gr in response to glucocorticoid , and merozoite invasion in vitro is believed not to be #blocked by antibodies to rap1 , indicating that 14-3-3eta induces stabilization of gr .
proteasomal inhibition does not induce any synergistic effect on the 14-3-3eta-induced increase in gr in response to glucocorticoid , and merozoite invasion in vitro is not #blocked by antibodies to rap1 , indicating that 14-3-3eta induces stabilization of gr .
proteasomal inhibition does not induce any synergistic effect on the 14-3-3eta-induced increase in gr in response to glucocorticoid , and the action of a postulated repressor can not be #blocked by alanine , indicating that 14-3-3eta induces stabilization of gr .
proteasomal inhibition does not induce any synergistic effect on the 14-3-3eta-induced increase in gr in response to glucocorticoid , and the action of a postulated repressor is not #blocked by alanine , indicating that 14-3-3eta induces stabilization of gr .
proteasomal inhibition has not induced any synergistic effect on the 14-3-3eta-induced increase in gr in response to glucocorticoid , and tagetin has not #blocked rna polymerase during elongation , indicating that 14-3-3eta induces stabilization of gr .
proteasomal inhibition will not induce any synergistic effect on the 14-3-3eta-induced increase in gr in response to glucocorticoid , and alanine will not #block the action of a postulated repressor , indicating that 14-3-3eta induces stabilization of gr .
proteasomal inhibition will not induce any synergistic effect on the 14-3-3eta-induced increase in gr in response to glucocorticoid , and tagetin will not #block rna polymerase during elongation , indicating that 14-3-3eta induces stabilization of gr .
proteasomal inhibition will not induce any synergistic effect on the 14-3-3eta-induced increase in gr in response to glucocorticoid , and antibodies to rap1 will not #block merozoite invasion in vitro , indicating that 14-3-3eta induces stabilization of gr .
rna polymerase during elongation can be #blocked by tagetin .
rna polymerase during elongation has been #blocked by tagetin .
tagetin can #block rna polymerase during elongation .
tagetin can have #blocked rna polymerase during elongation .
tagetin is able to #block rna polymerase during elongation .
tagetin may #block rna polymerase during elongation .
tagetin might have #blocked rna polymerase during elongation .
tagetin was able to #block rna polymerase during elongation .
tagetin was believed to #block rna polymerase during elongation .
tagetin will #block rna polymerase during elongation .
antibodies to rap1 #blocked merozoite invasion in vitro .
antibodies to rap1 #blocks merozoite invasion in vitro .
antibodies to rap1 can have #blocked merozoite invasion in vitro .
antibodies to rap1 could have #blocked merozoite invasion in vitro .
antibodies to rap1 has #blocked merozoite invasion in vitro .
antibodies to rap1 is able to #block merozoite invasion in vitro .
antibodies to rap1 is believed to #block merozoite invasion in vitro .
antibodies to rap1 is more specific for distinguishing between different rna polymerases because it can #block merozoite invasion in vitro (mathews and durbin , 1994) , i .e .its action is independent of different initiation factors .
antibodies to rap1 is more specific for distinguishing between different rna polymerases because it may #blocks merozoite invasion in vitro (mathews and durbin , 1994) , i .e .its action is independent of different initiation factors .
antibodies to rap1 is more specific for distinguishing between different rna polymerases because merozoite invasion in vitro is able to be #blocked by it (mathews and durbin , 1994) , i .e .its action is independent of different initiation factors .
antibodies to rap1 will #block merozoite invasion in vitro .
merozoite invasion in vitro can be #blocked by antibodies to rap1 .
merozoite invasion in vitro is #blocked by antibodies to rap1 .
14-3-3eta functions can be #blocked by the degradation of gr and inducing an elevation of gr .
both rap1 and 2 are important vaccine candidates because 14-3-3eta functions is shown to be #blocked by the degradation of gr and inducing an elevation of gr (schofield et al . , 1986; harnyuttanakorn et al . , 1992; howard et al . , 1998a) .
both rap1 and 2 are important vaccine candidates because a positive regulator in the glucocorticoid signal pathway are shown to be able to #block the degradation of gr and inducing an elevation of gr (schofield et al . , 1986; harnyuttanakorn et al . , 1992; howard et al . , 1998a) .
both rap1 and 2 are important vaccine candidates because a positive regulator in the glucocorticoid signal pathway are shown to #block the degradation of gr and inducing an elevation of gr (schofield et al . , 1986; harnyuttanakorn et al . , 1992; howard et al . , 1998a) .
both rap1 and 2 are important vaccine candidates because a positive regulator in the glucocorticoid signal pathway are shown to have #blocked the degradation of gr and inducing an elevation of gr (schofield et al . , 1986; harnyuttanakorn et al . , 1992; howard et al . , 1998a) .
both rap1 and 2 are important vaccine candidates because a positive regulator in the glucocorticoid signal pathway have been shown to be able to #block the degradation of gr and inducing an elevation of gr (schofield et al . , 1986; harnyuttanakorn et al . , 1992; howard et al . , 1998a) .
both rap1 and 2 are important vaccine candidates because a positive regulator in the glucocorticoid signal pathway have been shown to #block the degradation of gr and inducing an elevation of gr (schofield et al . , 1986; harnyuttanakorn et al . , 1992; howard et al . , 1998a) .
both rap1 and 2 are important vaccine candidates because a positive regulator in the glucocorticoid signal pathway have been shown to have #blocked the degradation of gr and inducing an elevation of gr (schofield et al . , 1986; harnyuttanakorn et al . , 1992; howard et al . , 1998a) .
both rap1 and 2 are important vaccine candidates because agrin-induced achr clustering and phosphorylation was shown to be #blocked by staurosporine (schofield et al . , 1986; harnyuttanakorn et al . , 1992; howard et al . , 1998a) .
both rap1 and 2 are important vaccine candidates because it has been shown that 14-3-3eta functions can be #blocked by the degradation of gr and inducing an elevation of gr (schofield et al . , 1986; harnyuttanakorn et al . , 1992; howard et al . , 1998a) .
both rap1 and 2 are important vaccine candidates because it has been shown that 14-3-3eta functions could be #blocked by the degradation of gr and inducing an elevation of gr (schofield et al . , 1986; harnyuttanakorn et al . , 1992; howard et al . , 1998a) .
both rap1 and 2 are important vaccine candidates because it has been shown that 14-3-3eta functions has been #blocked by the degradation of gr and inducing an elevation of gr (schofield et al . , 1986; harnyuttanakorn et al . , 1992; howard et al . , 1998a) .
both rap1 and 2 are important vaccine candidates because it has been shown that 14-3-3eta functions is #blocked by the degradation of gr and inducing an elevation of gr (schofield et al . , 1986; harnyuttanakorn et al . , 1992; howard et al . , 1998a) .
both rap1 and 2 are important vaccine candidates because it has been shown that 14-3-3eta functions may be #blocked by the degradation of gr and inducing an elevation of gr (schofield et al . , 1986; harnyuttanakorn et al . , 1992; howard et al . , 1998a) .
both rap1 and 2 are important vaccine candidates because it has been shown that 14-3-3eta functions might be #blocked by the degradation of gr and inducing an elevation of gr (schofield et al . , 1986; harnyuttanakorn et al . , 1992; howard et al . , 1998a) .
both rap1 and 2 are important vaccine candidates because it has been shown that 14-3-3eta functions was believed to be #blocked by the degradation of gr and inducing an elevation of gr (schofield et al . , 1986; harnyuttanakorn et al . , 1992; howard et al . , 1998a) .
both rap1 and 2 are important vaccine candidates because it has been shown that 14-3-3eta functions was #blocked by the degradation of gr and inducing an elevation of gr (schofield et al . , 1986; harnyuttanakorn et al . , 1992; howard et al . , 1998a) .
both rap1 and 2 are important vaccine candidates because it has been shown that 14-3-3eta functions would be #blocked by the degradation of gr and inducing an elevation of gr (schofield et al . , 1986; harnyuttanakorn et al . , 1992; howard et al . , 1998a) .
both rap1 and 2 are important vaccine candidates because it has been shown that a positive regulator in the glucocorticoid signal pathway are able to #block the degradation of gr and inducing an elevation of gr (schofield et al . , 1986; harnyuttanakorn et al . , 1992; howard et al . , 1998a) .
both rap1 and 2 are important vaccine candidates because it has been shown that a positive regulator in the glucocorticoid signal pathway #block the degradation of gr and inducing an elevation of gr (schofield et al . , 1986; harnyuttanakorn et al . , 1992; howard et al . , 1998a) .
both rap1 and 2 are important vaccine candidates because it has been shown that a positive regulator in the glucocorticoid signal pathway can #block the degradation of gr and inducing an elevation of gr (schofield et al . , 1986; harnyuttanakorn et al . , 1992; howard et al . , 1998a) .
both rap1 and 2 are important vaccine candidates because it has been shown that a positive regulator in the glucocorticoid signal pathway may #block the degradation of gr and inducing an elevation of gr (schofield et al . , 1986; harnyuttanakorn et al . , 1992; howard et al . , 1998a) .
both rap1 and 2 are important vaccine candidates because it has been shown that a positive regulator in the glucocorticoid signal pathway were able to #block the degradation of gr and inducing an elevation of gr (schofield et al . , 1986; harnyuttanakorn et al . , 1992; howard et al . , 1998a) .
both rap1 and 2 are important vaccine candidates because it has been shown that agrin-induced achr clustering and phosphorylation can be #blocked by staurosporine (schofield et al . , 1986; harnyuttanakorn et al . , 1992; howard et al . , 1998a) .
both rap1 and 2 are important vaccine candidates because it has been shown that agrin-induced achr clustering and phosphorylation has been #blocked by staurosporine (schofield et al . , 1986; harnyuttanakorn et al . , 1992; howard et al . , 1998a) .
both rap1 and 2 are important vaccine candidates because it has been shown that agrin-induced achr clustering and phosphorylation is believed to be #blocked by staurosporine (schofield et al . , 1986; harnyuttanakorn et al . , 1992; howard et al . , 1998a) .
both rap1 and 2 are important vaccine candidates because it has been shown that agrin-induced achr clustering and phosphorylation is #blocked by staurosporine (schofield et al . , 1986; harnyuttanakorn et al . , 1992; howard et al . , 1998a) .
both rap1 and 2 are important vaccine candidates because it has been shown that agrin-induced achr clustering and phosphorylation might be #blocked by staurosporine (schofield et al . , 1986; harnyuttanakorn et al . , 1992; howard et al . , 1998a) .
both rap1 and 2 are important vaccine candidates because it has been shown that agrin-induced achr clustering and phosphorylation was believed to be #blocked by staurosporine (schofield et al . , 1986; harnyuttanakorn et al . , 1992; howard et al . , 1998a) .
both rap1 and 2 are important vaccine candidates because it has been shown that staurosporine are able to #block agrin-induced achr clustering and phosphorylation (schofield et al . , 1986; harnyuttanakorn et al . , 1992; howard et al . , 1998a) .
both rap1 and 2 are important vaccine candidates because it has been shown that staurosporine #blocked agrin-induced achr clustering and phosphorylation (schofield et al . , 1986; harnyuttanakorn et al . , 1992; howard et al . , 1998a) .
both rap1 and 2 are important vaccine candidates because it has been shown that staurosporine can #block agrin-induced achr clustering and phosphorylation (schofield et al . , 1986; harnyuttanakorn et al . , 1992; howard et al . , 1998a) .
both rap1 and 2 are important vaccine candidates because it has been shown that staurosporine were able to #block agrin-induced achr clustering and phosphorylation (schofield et al . , 1986; harnyuttanakorn et al . , 1992; howard et al . , 1998a) .
both rap1 and 2 are important vaccine candidates because it has been shown that the degradation of gr and inducing an elevation of gr #block 14-3-3eta functions (schofield et al . , 1986; harnyuttanakorn et al . , 1992; howard et al . , 1998a) .
both rap1 and 2 are important vaccine candidates because it has been shown that the degradation of gr and inducing an elevation of gr #blocked 14-3-3eta functions (schofield et al . , 1986; harnyuttanakorn et al . , 1992; howard et al . , 1998a) .
both rap1 and 2 are important vaccine candidates because it has been shown that the degradation of gr and inducing an elevation of gr is #blocked by a positive regulator in the glucocorticoid signal pathway (schofield et al . , 1986; harnyuttanakorn et al . , 1992; howard et al . , 1998a) .
both rap1 and 2 are important vaccine candidates because it has been shown that the degradation of gr and inducing an elevation of gr may be #blocked by a positive regulator in the glucocorticoid signal pathway (schofield et al . , 1986; harnyuttanakorn et al . , 1992; howard et al . , 1998a) .
both rap1 and 2 are important vaccine candidates because it has been shown that the degradation of gr and inducing an elevation of gr might be #blocked by a positive regulator in the glucocorticoid signal pathway (schofield et al . , 1986; harnyuttanakorn et al . , 1992; howard et al . , 1998a) .
both rap1 and 2 are important vaccine candidates because it has been shown that the degradation of gr and inducing an elevation of gr was #blocked by a positive regulator in the glucocorticoid signal pathway (schofield et al . , 1986; harnyuttanakorn et al . , 1992; howard et al . , 1998a) .
both rap1 and 2 are important vaccine candidates because staurosporine are shown to #block agrin-induced achr clustering and phosphorylation (schofield et al . , 1986; harnyuttanakorn et al . , 1992; howard et al . , 1998a) .
both rap1 and 2 are important vaccine candidates because staurosporine are shown to have #blocked agrin-induced achr clustering and phosphorylation (schofield et al . , 1986; harnyuttanakorn et al . , 1992; howard et al . , 1998a) .
both rap1 and 2 are important vaccine candidates because staurosporine have been shown to have #blocked agrin-induced achr clustering and phosphorylation (schofield et al . , 1986; harnyuttanakorn et al . , 1992; howard et al . , 1998a) .
both rap1 and 2 are important vaccine candidates because the degradation of gr and inducing an elevation of gr are shown to #block 14-3-3eta functions (schofield et al . , 1986; harnyuttanakorn et al . , 1992; howard et al . , 1998a) .
both rap1 and 2 are important vaccine candidates because the degradation of gr and inducing an elevation of gr are shown to have #blocked 14-3-3eta functions (schofield et al . , 1986; harnyuttanakorn et al . , 1992; howard et al . , 1998a) .
both rap1 and 2 are important vaccine candidates because the degradation of gr and inducing an elevation of gr have been shown to be able to #block 14-3-3eta functions (schofield et al . , 1986; harnyuttanakorn et al . , 1992; howard et al . , 1998a) .
both rap1 and 2 are important vaccine candidates because the degradation of gr and inducing an elevation of gr have been shown to #block 14-3-3eta functions (schofield et al . , 1986; harnyuttanakorn et al . , 1992; howard et al . , 1998a) .
both rap1 and 2 are important vaccine candidates because the degradation of gr and inducing an elevation of gr have been shown to have #blocked 14-3-3eta functions (schofield et al . , 1986; harnyuttanakorn et al . , 1992; howard et al . , 1998a) .
both rap1 and 2 are important vaccine candidates because the degradation of gr and inducing an elevation of gr is shown to be #blocked by a positive regulator in the glucocorticoid signal pathway (schofield et al . , 1986; harnyuttanakorn et al . , 1992; howard et al . , 1998a) .
both rap1 and 2 are important vaccine candidates because the degradation of gr and inducing an elevation of gr is shown to have been #blocked by a positive regulator in the glucocorticoid signal pathway (schofield et al . , 1986; harnyuttanakorn et al . , 1992; howard et al . , 1998a) .
labeling with antibodies to the y553 phosphopeptide is specific since 14-3-3eta functions is #blocked by the degradation of gr and inducing an elevation of gr .
labeling with antibodies to the y553 phosphopeptide is specific since a positive regulator in the glucocorticoid signal pathway #blocks the degradation of gr and inducing an elevation of gr .
labeling with antibodies to the y553 phosphopeptide is specific since a positive regulator in the glucocorticoid signal pathway can #block the degradation of gr and inducing an elevation of gr .
labeling with antibodies to the y553 phosphopeptide is specific since a positive regulator in the glucocorticoid signal pathway can have #blocked the degradation of gr and inducing an elevation of gr .
labeling with antibodies to the y553 phosphopeptide is specific since a positive regulator in the glucocorticoid signal pathway have #blocked the degradation of gr and inducing an elevation of gr .
labeling with antibodies to the y553 phosphopeptide is specific since a positive regulator in the glucocorticoid signal pathway is able to #block the degradation of gr and inducing an elevation of gr .
labeling with antibodies to the y553 phosphopeptide is specific since a positive regulator in the glucocorticoid signal pathway may #block the degradation of gr and inducing an elevation of gr .
labeling with antibodies to the y553 phosphopeptide is specific since a positive regulator in the glucocorticoid signal pathway may have #blocked the degradation of gr and inducing an elevation of gr .
labeling with antibodies to the y553 phosphopeptide is specific since a positive regulator in the glucocorticoid signal pathway will #block the degradation of gr and inducing an elevation of gr .
labeling with antibodies to the y553 phosphopeptide is specific since agrin-induced achr clustering and phosphorylation can be #blocked by staurosporine .
labeling with antibodies to the y553 phosphopeptide is specific since agrin-induced achr clustering and phosphorylation is able to be #blocked by staurosporine .
labeling with antibodies to the y553 phosphopeptide is specific since agrin-induced achr clustering and phosphorylation is #blocked by staurosporine .
labeling with antibodies to the y553 phosphopeptide is specific since staurosporine can #block agrin-induced achr clustering and phosphorylation .
labeling with antibodies to the y553 phosphopeptide is specific since staurosporine can have #blocked agrin-induced achr clustering and phosphorylation .
labeling with antibodies to the y553 phosphopeptide is specific since staurosporine have #blocked agrin-induced achr clustering and phosphorylation .
labeling with antibodies to the y553 phosphopeptide is specific since staurosporine may #block agrin-induced achr clustering and phosphorylation .
labeling with antibodies to the y553 phosphopeptide is specific since staurosporine may have #blocked agrin-induced achr clustering and phosphorylation .
labeling with antibodies to the y553 phosphopeptide is specific since staurosporine will #block agrin-induced achr clustering and phosphorylation .
labeling with antibodies to the y553 phosphopeptide is specific since the degradation of gr and inducing an elevation of gr #blocks 14-3-3eta functions .
labeling with antibodies to the y553 phosphopeptide is specific since the degradation of gr and inducing an elevation of gr have #blocked 14-3-3eta functions .
labeling with antibodies to the y553 phosphopeptide is specific since the degradation of gr and inducing an elevation of gr is able to #block 14-3-3eta functions .
labeling with antibodies to the y553 phosphopeptide is specific since the degradation of gr and inducing an elevation of gr is believed to be #blocked by a positive regulator in the glucocorticoid signal pathway .
labeling with antibodies to the y553 phosphopeptide is specific since the degradation of gr and inducing an elevation of gr may #block 14-3-3eta functions .
labeling with antibodies to the y553 phosphopeptide was specific since 14-3-3eta functions has been #blocked by the degradation of gr and inducing an elevation of gr .
labeling with antibodies to the y553 phosphopeptide was specific since 14-3-3eta functions was able to be #blocked by the degradation of gr and inducing an elevation of gr .
labeling with antibodies to the y553 phosphopeptide was specific since a positive regulator in the glucocorticoid signal pathway might have #blocked the degradation of gr and inducing an elevation of gr .
labeling with antibodies to the y553 phosphopeptide was specific since a positive regulator in the glucocorticoid signal pathway was able to #block the degradation of gr and inducing an elevation of gr .
labeling with antibodies to the y553 phosphopeptide was specific since a positive regulator in the glucocorticoid signal pathway would #block the degradation of gr and inducing an elevation of gr .
labeling with antibodies to the y553 phosphopeptide was specific since a positive regulator in the glucocorticoid signal pathway would have #blocked the degradation of gr and inducing an elevation of gr .
labeling with antibodies to the y553 phosphopeptide was specific since agrin-induced achr clustering and phosphorylation has been #blocked by staurosporine .
labeling with antibodies to the y553 phosphopeptide was specific since agrin-induced achr clustering and phosphorylation was able to be #blocked by staurosporine .
labeling with antibodies to the y553 phosphopeptide was specific since agrin-induced achr clustering and phosphorylation was #blocked by staurosporine .
labeling with antibodies to the y553 phosphopeptide was specific since staurosporine could #block agrin-induced achr clustering and phosphorylation .
labeling with antibodies to the y553 phosphopeptide was specific since staurosporine could have #blocked agrin-induced achr clustering and phosphorylation .
labeling with antibodies to the y553 phosphopeptide was specific since the degradation of gr and inducing an elevation of gr could have #blocked 14-3-3eta functions .
labeling with antibodies to the y553 phosphopeptide was specific since the degradation of gr and inducing an elevation of gr might have #blocked 14-3-3eta functions .
labeling with antibodies to the y553 phosphopeptide was specific since the degradation of gr and inducing an elevation of gr was able to be #blocked by a positive regulator in the glucocorticoid signal pathway .
labeling with antibodies to the y553 phosphopeptide was specific since the degradation of gr and inducing an elevation of gr was able to #block 14-3-3eta functions .
labeling with antibodies to the y553 phosphopeptide was specific since the degradation of gr and inducing an elevation of gr was believed to be #blocked by a positive regulator in the glucocorticoid signal pathway .
labeling with antibodies to the y553 phosphopeptide was specific since the degradation of gr and inducing an elevation of gr was #blocked by a positive regulator in the glucocorticoid signal pathway .
labeling with antibodies to the y553 phosphopeptide was specific since the degradation of gr and inducing an elevation of gr would have #blocked 14-3-3eta functions .
pu .1 is upregulated early during commitment of multipotential progenitors to the myeloid lineages and 14-3-3eta functions is believed to be #blocked by the degradation of gr and inducing an elevation of gr .
pu .1 is upregulated early during commitment of multipotential progenitors to the myeloid lineages and 14-3-3eta functions may be #blocked by the degradation of gr and inducing an elevation of gr .
pu .1 is upregulated early during commitment of multipotential progenitors to the myeloid lineages and 14-3-3eta functions will be #blocked by the degradation of gr and inducing an elevation of gr .
pu .1 is upregulated early during commitment of multipotential progenitors to the myeloid lineages and a positive regulator in the glucocorticoid signal pathway #blocks the degradation of gr and inducing an elevation of gr .
pu .1 is upregulated early during commitment of multipotential progenitors to the myeloid lineages and a positive regulator in the glucocorticoid signal pathway has #blocked the degradation of gr and inducing an elevation of gr .
pu .1 is upregulated early during commitment of multipotential progenitors to the myeloid lineages and a positive regulator in the glucocorticoid signal pathway is believed to #block the degradation of gr and inducing an elevation of gr .
pu .1 is upregulated early during commitment of multipotential progenitors to the myeloid lineages and a positive regulator in the glucocorticoid signal pathway is believed to have #blocked the degradation of gr and inducing an elevation of gr .
pu .1 is upregulated early during commitment of multipotential progenitors to the myeloid lineages and a positive regulator in the glucocorticoid signal pathway will #block the degradation of gr and inducing an elevation of gr .
pu .1 is upregulated early during commitment of multipotential progenitors to the myeloid lineages and agrin-induced achr clustering and phosphorylation is #blocked by staurosporine .
pu .1 is upregulated early during commitment of multipotential progenitors to the myeloid lineages and agrin-induced achr clustering and phosphorylation may be #blocked by staurosporine .
pu .1 is upregulated early during commitment of multipotential progenitors to the myeloid lineages and staurosporine #blocks agrin-induced achr clustering and phosphorylation .
pu .1 is upregulated early during commitment of multipotential progenitors to the myeloid lineages and staurosporine is able to #block agrin-induced achr clustering and phosphorylation .
pu .1 is upregulated early during commitment of multipotential progenitors to the myeloid lineages and staurosporine is believed to #block agrin-induced achr clustering and phosphorylation .
pu .1 is upregulated early during commitment of multipotential progenitors to the myeloid lineages and staurosporine is believed to have #blocked agrin-induced achr clustering and phosphorylation .
pu .1 is upregulated early during commitment of multipotential progenitors to the myeloid lineages and staurosporine is proven to #block agrin-induced achr clustering and phosphorylation .
pu .1 is upregulated early during commitment of multipotential progenitors to the myeloid lineages and staurosporine will #block agrin-induced achr clustering and phosphorylation .
pu .1 is upregulated early during commitment of multipotential progenitors to the myeloid lineages and the degradation of gr and inducing an elevation of gr #blocks 14-3-3eta functions .
pu .1 is upregulated early during commitment of multipotential progenitors to the myeloid lineages and the degradation of gr and inducing an elevation of gr can #block 14-3-3eta functions .
pu .1 is upregulated early during commitment of multipotential progenitors to the myeloid lineages and the degradation of gr and inducing an elevation of gr is able to #block 14-3-3eta functions .
pu .1 is upregulated early during commitment of multipotential progenitors to the myeloid lineages and the degradation of gr and inducing an elevation of gr is believed to be #blocked by a positive regulator in the glucocorticoid signal pathway .
pu .1 is upregulated early during commitment of multipotential progenitors to the myeloid lineages and the degradation of gr and inducing an elevation of gr is proven to have #blocked 14-3-3eta functions .
pu .1 is upregulated early during commitment of multipotential progenitors to the myeloid lineages and the degradation of gr and inducing an elevation of gr may be #blocked by a positive regulator in the glucocorticoid signal pathway .
pu .1 is upregulated early during commitment of multipotential progenitors to the myeloid lineages and the degradation of gr and inducing an elevation of gr will #block 14-3-3eta functions .
pu .1 was upregulated early during commitment of multipotential progenitors to the myeloid lineages and 14-3-3eta functions has been #blocked by the degradation of gr and inducing an elevation of gr .
pu .1 was upregulated early during commitment of multipotential progenitors to the myeloid lineages and a positive regulator in the glucocorticoid signal pathway #blocked the degradation of gr and inducing an elevation of gr .
pu .1 was upregulated early during commitment of multipotential progenitors to the myeloid lineages and a positive regulator in the glucocorticoid signal pathway has #blocked the degradation of gr and inducing an elevation of gr .
pu .1 was upregulated early during commitment of multipotential progenitors to the myeloid lineages and staurosporine has #blocked agrin-induced achr clustering and phosphorylation .
pu .1 was upregulated early during commitment of multipotential progenitors to the myeloid lineages and the degradation of gr and inducing an elevation of gr has #blocked 14-3-3eta functions .
proteasomal inhibition can not induce any synergistic effect on the 14-3-3eta-induced increase in gr in response to glucocorticoid , and the degradation of gr and inducing an elevation of gr can not #block 14-3-3eta functions , indicating that 14-3-3eta induces stabilization of gr .
proteasomal inhibition did not induce any synergistic effect on the 14-3-3eta-induced increase in gr in response to glucocorticoid , and staurosporine did not #block agrin-induced achr clustering and phosphorylation , indicating that 14-3-3eta induces stabilization of gr .
proteasomal inhibition does not induce any synergistic effect on the 14-3-3eta-induced increase in gr in response to glucocorticoid , and 14-3-3eta functions can not be #blocked by the degradation of gr and inducing an elevation of gr , indicating that 14-3-3eta induces stabilization of gr .
proteasomal inhibition does not induce any synergistic effect on the 14-3-3eta-induced increase in gr in response to glucocorticoid , and 14-3-3eta functions is believed not to be #blocked by the degradation of gr and inducing an elevation of gr , indicating that 14-3-3eta induces stabilization of gr .
proteasomal inhibition does not induce any synergistic effect on the 14-3-3eta-induced increase in gr in response to glucocorticoid , and 14-3-3eta functions is not #blocked by the degradation of gr and inducing an elevation of gr , indicating that 14-3-3eta induces stabilization of gr .
proteasomal inhibition does not induce any synergistic effect on the 14-3-3eta-induced increase in gr in response to glucocorticoid , and agrin-induced achr clustering and phosphorylation is not #blocked by staurosporine , indicating that 14-3-3eta induces stabilization of gr .
proteasomal inhibition does not induce any synergistic effect on the 14-3-3eta-induced increase in gr in response to glucocorticoid , and staurosporine does not #block agrin-induced achr clustering and phosphorylation , indicating that 14-3-3eta induces stabilization of gr .
proteasomal inhibition does not induce any synergistic effect on the 14-3-3eta-induced increase in gr in response to glucocorticoid , and the degradation of gr and inducing an elevation of gr can not be #blocked by a positive regulator in the glucocorticoid signal pathway , indicating that 14-3-3eta induces stabilization of gr .
proteasomal inhibition does not induce any synergistic effect on the 14-3-3eta-induced increase in gr in response to glucocorticoid , and the degradation of gr and inducing an elevation of gr is not able to be #blocked by a positive regulator in the glucocorticoid signal pathway , indicating that 14-3-3eta induces stabilization of gr .
proteasomal inhibition has not induced any synergistic effect on the 14-3-3eta-induced increase in gr in response to glucocorticoid , and staurosporine has not #blocked agrin-induced achr clustering and phosphorylation , indicating that 14-3-3eta induces stabilization of gr .
proteasomal inhibition has not induced any synergistic effect on the 14-3-3eta-induced increase in gr in response to glucocorticoid , and the degradation of gr and inducing an elevation of gr has not #blocked 14-3-3eta functions , indicating that 14-3-3eta induces stabilization of gr .
proteasomal inhibition will not induce any synergistic effect on the 14-3-3eta-induced increase in gr in response to glucocorticoid , and a positive regulator in the glucocorticoid signal pathway will not #block the degradation of gr and inducing an elevation of gr , indicating that 14-3-3eta induces stabilization of gr .
proteasomal inhibition will not induce any synergistic effect on the 14-3-3eta-induced increase in gr in response to glucocorticoid , and staurosporine will not #block agrin-induced achr clustering and phosphorylation , indicating that 14-3-3eta induces stabilization of gr .
a positive regulator in the glucocorticoid signal pathway #blocks the degradation of gr and inducing an elevation of gr .
a positive regulator in the glucocorticoid signal pathway can have #blocked the degradation of gr and inducing an elevation of gr .
a positive regulator in the glucocorticoid signal pathway could #block the degradation of gr and inducing an elevation of gr .
a positive regulator in the glucocorticoid signal pathway could have #blocked the degradation of gr and inducing an elevation of gr .
a positive regulator in the glucocorticoid signal pathway is believed to #block the degradation of gr and inducing an elevation of gr .
a positive regulator in the glucocorticoid signal pathway is more specific for distinguishing between different rna polymerases because it #blocked the degradation of gr and inducing an elevation of gr (mathews and durbin , 1994) , i .e .its action is independent of different initiation factors .
a positive regulator in the glucocorticoid signal pathway is more specific for distinguishing between different rna polymerases because it #blocks the degradation of gr and inducing an elevation of gr (mathews and durbin , 1994) , i .e .its action is independent of different initiation factors .
a positive regulator in the glucocorticoid signal pathway is more specific for distinguishing between different rna polymerases because it is able to #block the degradation of gr and inducing an elevation of gr (mathews and durbin , 1994) , i .e .its action is independent of different initiation factors .
a positive regulator in the glucocorticoid signal pathway is more specific for distinguishing between different rna polymerases because the degradation of gr and inducing an elevation of gr was #blocked by it (mathews and durbin , 1994) , i .e .its action is independent of different initiation factors .
a positive regulator in the glucocorticoid signal pathway is thought to act as an inducer to #block the degradation of gr and inducing an elevation of gr .
a positive regulator in the glucocorticoid signal pathway may have #blocked the degradation of gr and inducing an elevation of gr .
a positive regulator in the glucocorticoid signal pathway might #block the degradation of gr and inducing an elevation of gr .
a positive regulator in the glucocorticoid signal pathway might have #blocked the degradation of gr and inducing an elevation of gr .
a positive regulator in the glucocorticoid signal pathway was able to #block the degradation of gr and inducing an elevation of gr .
a positive regulator in the glucocorticoid signal pathway will #block the degradation of gr and inducing an elevation of gr .
agrin-induced achr clustering and phosphorylation has been #blocked by staurosporine .
agrin-induced achr clustering and phosphorylation was #blocked by staurosporine .
staurosporine #blocks agrin-induced achr clustering and phosphorylation .
staurosporine can have #blocked agrin-induced achr clustering and phosphorylation .
staurosporine could #block agrin-induced achr clustering and phosphorylation .
staurosporine could have #blocked agrin-induced achr clustering and phosphorylation .
staurosporine is believed to #block agrin-induced achr clustering and phosphorylation .
staurosporine is more specific for distinguishing between different rna polymerases because agrin-induced achr clustering and phosphorylation can be #blocked by it (mathews and durbin , 1994) , i .e .its action is independent of different initiation factors .
staurosporine is more specific for distinguishing between different rna polymerases because agrin-induced achr clustering and phosphorylation is able to be #blocked by it (mathews and durbin , 1994) , i .e .its action is independent of different initiation factors .
staurosporine is more specific for distinguishing between different rna polymerases because agrin-induced achr clustering and phosphorylation is #blocked by it (mathews and durbin , 1994) , i .e .its action is independent of different initiation factors .
staurosporine is more specific for distinguishing between different rna polymerases because agrin-induced achr clustering and phosphorylation was #blocked by it (mathews and durbin , 1994) , i .e .its action is independent of different initiation factors .
staurosporine is more specific for distinguishing between different rna polymerases because it #blocked agrin-induced achr clustering and phosphorylation (mathews and durbin , 1994) , i .e .its action is independent of different initiation factors .
staurosporine is more specific for distinguishing between different rna polymerases because it can #block agrin-induced achr clustering and phosphorylation (mathews and durbin , 1994) , i .e .its action is independent of different initiation factors .
staurosporine is more specific for distinguishing between different rna polymerases because it is able to #block agrin-induced achr clustering and phosphorylation (mathews and durbin , 1994) , i .e .its action is independent of different initiation factors .
staurosporine is more specific for distinguishing between different rna polymerases because it may #blocks agrin-induced achr clustering and phosphorylation (mathews and durbin , 1994) , i .e .its action is independent of different initiation factors .
staurosporine may #block agrin-induced achr clustering and phosphorylation .
staurosporine may have #blocked agrin-induced achr clustering and phosphorylation .
staurosporine might #block agrin-induced achr clustering and phosphorylation .
staurosporine might have #blocked agrin-induced achr clustering and phosphorylation .
staurosporine was believed to #block agrin-induced achr clustering and phosphorylation .
the degradation of gr and inducing an elevation of gr #blocks 14-3-3eta functions .
the degradation of gr and inducing an elevation of gr can be #blocked by a positive regulator in the glucocorticoid signal pathway .
the degradation of gr and inducing an elevation of gr can have #blocked 14-3-3eta functions .
the degradation of gr and inducing an elevation of gr could have #blocked 14-3-3eta functions .
the degradation of gr and inducing an elevation of gr is able to #block 14-3-3eta functions .
the degradation of gr and inducing an elevation of gr is believed to #block 14-3-3eta functions .
the degradation of gr and inducing an elevation of gr is more specific for distinguishing between different rna polymerases because 14-3-3eta functions can be #blocked by it (mathews and durbin , 1994) , i .e .its action is independent of different initiation factors .
the degradation of gr and inducing an elevation of gr is more specific for distinguishing between different rna polymerases because 14-3-3eta functions is #blocked by it (mathews and durbin , 1994) , i .e .its action is independent of different initiation factors .
the degradation of gr and inducing an elevation of gr is more specific for distinguishing between different rna polymerases because 14-3-3eta functions was #blocked by it (mathews and durbin , 1994) , i .e .its action is independent of different initiation factors .
the degradation of gr and inducing an elevation of gr is more specific for distinguishing between different rna polymerases because it #blocks 14-3-3eta functions (mathews and durbin , 1994) , i .e .its action is independent of different initiation factors .
the degradation of gr and inducing an elevation of gr is more specific for distinguishing between different rna polymerases because it is able to #block 14-3-3eta functions (mathews and durbin , 1994) , i .e .its action is independent of different initiation factors .
the degradation of gr and inducing an elevation of gr is more specific for distinguishing between different rna polymerases because it may #blocks 14-3-3eta functions (mathews and durbin , 1994) , i .e .its action is independent of different initiation factors .
the degradation of gr and inducing an elevation of gr may #block 14-3-3eta functions .
the degradation of gr and inducing an elevation of gr might have #blocked 14-3-3eta functions .
the degradation of gr and inducing an elevation of gr will #block 14-3-3eta functions .
the degradation of gr and inducing an elevation of gr would #block 14-3-3eta functions .
dna helicases are enzymes that are able to catalyze the unwinding of dna by disrupting the hydrogen bonding between paired bases as they progress along the dna strand in a polar fashion (either 35 or 53) , and have been shown to be involved in many essential cellular processes , including replication , transcription , dna repair and translation (for reviews see west , 1996; bird et al . , 1998; lohman et al . , 1998; hall and matson , 1999) .
dna helicases are enzymes that can catalyze the unwinding of dna by disrupting the hydrogen bonding between paired bases as they progress along the dna strand in a polar fashion (either 35 or 53) , and have been shown to be involved in many essential cellular processes , including replication , transcription , dna repair and translation (for reviews see west , 1996; bird et al . , 1998; lohman et al . , 1998; hall and matson , 1999) .
dna helicases can catalyze the unwinding of dna by disrupting the hydrogen bonding between paired bases as they progress along the dna strand in a polar fashion (either 35 or 53) , and have been shown to be involved in many essential cellular processes , including replication , transcription , dna repair and translation (for reviews see west , 1996; bird et al . , 1998; lohman et al . , 1998; hall and matson , 1999) .
dna helicases may catalyze the unwinding of dna by disrupting the hydrogen bonding between paired bases as they progress along the dna strand in a polar fashion (either 35 or 53) , and have been shown to be involved in many essential cellular processes , including replication , transcription , dna repair and translation (for reviews see west , 1996; bird et al . , 1998; lohman et al . , 1998; hall and matson , 1999) .
helicases are able to not only #catalyse the disruption of hydrogen boding between complementary regions of nucleic acids , but also move along nucleic acid strands in a polar fashion .
helicases are believed to not only #catalyse the disruption of hydrogen boding between complementary regions of nucleic acids , but also move along nucleic acid strands in a polar fashion .
helicases will not only #catalyse the disruption of hydrogen boding between complementary regions of nucleic acids , but also move along nucleic acid strands in a polar fashion .
however , rep78 and rep68 that can #catalyse the packaging reaction up to 1000-fold less efficiently posses the entire rep52 and rep40 coding regions , respectively .
however , rep78 and rep68 that #catalyse the packaging reaction up to 1000-fold less efficiently posses the entire rep52 and rep40 coding regions , respectively .
however , rep78 and rep68 that #catalysed the packaging reaction up to 1000-fold less efficiently posses the entire rep52 and rep40 coding regions , respectively .
however , rep78 and rep68 that have the ability to #catalyse the packaging reaction up to 1000-fold less efficiently posses the entire rep52 and rep40 coding regions , respectively .
however , rep78 and rep68 that may #catalyse the packaging reaction up to 1000-fold less efficiently posses the entire rep52 and rep40 coding regions , respectively .
however , rep78 and rep68 which are able to #catalyse the packaging reaction up to 1000-fold less efficiently posses the entire rep52 and rep40 coding regions , respectively .
however , rep78 and rep68 which have the ability to #catalyse the packaging reaction up to 1000-fold less efficiently posses the entire rep52 and rep40 coding regions , respectively .
however , rep78 and rep68 which may #catalyse the packaging reaction up to 1000-fold less efficiently posses the entire rep52 and rep40 coding regions , respectively .
however , it is interesting to note that rep78 and rep68 are observed to #catalyse the packaging reaction up to 1000-fold less efficiently , although they posses the entire rep52 and rep40 coding regions , respectively .
however , it is interesting to note that rep78 and rep68 are shown to #catalyse the packaging reaction up to 1000-fold less efficiently , although they posses the entire rep52 and rep40 coding regions , respectively .
however , it is interesting to note that rep78 and rep68 can #catalyse the packaging reaction up to 1000-fold less efficiently , although they posses the entire rep52 and rep40 coding regions , respectively .
however , it is interesting to note that rep78 and rep68 #catalysed the packaging reaction up to 1000-fold less efficiently , although they posses the entire rep52 and rep40 coding regions , respectively .
however , the packaging reaction has been #catalysed by rep78 and rep68 up to 1000-fold less efficiently , although they posses the entire rep52 and rep40 coding regions , respectively .
however , the packaging reaction is #catalysed by rep78 and rep68 up to 1000-fold less efficiently , although they posses the entire rep52 and rep40 coding regions , respectively .
however , the packaging reaction is observed to be #catalysed by rep78 and rep68 up to 1000-fold less efficiently , although they posses the entire rep52 and rep40 coding regions , respectively .
however , the packaging reaction was observed to be #catalysed by rep78 and rep68 up to 1000-fold less efficiently , although they posses the entire rep52 and rep40 coding regions , respectively .
the disruption of hydrogen boding between complementary regions of nucleic acids appears to be #catalysed by helicases that move along nucleic acid strands in a polar fashion .
the disruption of hydrogen boding between complementary regions of nucleic acids is believed to be #catalysed by helicases .
the disruption of hydrogen boding between complementary regions of nucleic acids is #catalysed by helicases .
the disruption of hydrogen boding between complementary regions of nucleic acids were shown to be #catalysed by helicases moving along nucleic acid strands in a polar fashion .
the disruption of hydrogen boding between complementary regions of nucleic acids will be #catalysed by helicases .
the resolution of the covalently cosed aav termini can be #catalysed by the two large virus-encoded rep proteins (rep78 and rep68) (im and muzyczka , 1990 , 1992; brister and muzyczka , 1990 , 2000) .
the resolution of the covalently cosed aav termini has been #catalysed by the two large virus-encoded rep proteins (rep78 and rep68) (im and muzyczka , 1990 , 1992; brister and muzyczka , 1990 , 2000) .
the resolution of the covalently cosed aav termini is able to be #catalysed by the two large virus-encoded rep proteins (rep78 and rep68) (im and muzyczka , 1990 , 1992; brister and muzyczka , 1990 , 2000) .
the resolution of the covalently cosed aav termini is #catalysed by the two large virus-encoded rep proteins (rep78 and rep68) (im and muzyczka , 1990 , 1992; brister and muzyczka , 1990 , 2000) .
the resolution of the covalently cosed aav termini is shown to be #catalysed by the two large virus-encoded rep proteins (rep78 and rep68) (im and muzyczka , 1990 , 1992; brister and muzyczka , 1990 , 2000) .
the resolution of the covalently cosed aav termini was believed to be #catalysed by the two large virus-encoded rep proteins (rep78 and rep68) (im and muzyczka , 1990 , 1992; brister and muzyczka , 1990 , 2000) .
the two large virus-encoded rep proteins (rep78 and rep68) are believed to #catalyse the resolution of the covalently cosed aav termini , a process that involves sequence-specific aav dna biding , strand-specific nicking and helicase activity under atp consumption (im and muzyczka , 1990 , 1992; brister and muzyczka , 1990 , 2000) .
the two large virus-encoded rep proteins (rep78 and rep68) can #catalyse the resolution of the covalently cosed aav termini , a process that involves sequence-specific aav dna biding , strand-specific nicking and helicase activity under atp consumption (im and muzyczka , 1990 , 1992; brister and muzyczka , 1990 , 2000) .
the two large virus-encoded rep proteins (rep78 and rep68) have the ability to #catalyse the resolution of the covalently cosed aav termini , a process that involves sequence-specific aav dna biding , strand-specific nicking and helicase activity under atp consumption (im and muzyczka , 1990 , 1992; brister and muzyczka , 1990 , 2000) .
the unwinding of dna is able to be #catalysed by dna helicases via disrupting the hydrogen bonding between paired bases as they progress along the dna strand in a polar fashion (either 35 or 53) , and have been shown to be involved in many essential cellular processes , including replication , transcription , dna repair and translation (for reviews see west , 1996; bird et al . , 1998; lohman et al . , 1998; hall and matson , 1999) .
the unwinding of dna is believed to be #catalysed by dna helicases via disrupting the hydrogen bonding between paired bases as they progress along the dna strand in a polar fashion (either 35 or 53) , and have been shown to be involved in many essential cellular processes , including replication , transcription , dna repair and translation (for reviews see west , 1996; bird et al . , 1998; lohman et al . , 1998; hall and matson , 1999) .
however , it is interesting to note that rep78 and rep68 #catalyse the packaging reaction up to 1000-fold less efficiently , although they posses the entire rep52 and rep40 coding regions , respectively .
the two large virus-encoded rep proteins (rep78 and rep68) #catalyse the resolution of the covalently cosed aav termini , a process that involves sequence-specific aav dna biding , strand-specific nicking and helicase activity under atp consumption (im and muzyczka , 1990 , 1992; brister and muzyczka , 1990 , 2000) .
helicases are observed to #catalyse the disruption of hydrogen boding between complementary regions of nucleic acids , a process that involves sequence-specific aav dna biding , strand-specific nicking and helicase activity under atp consumption (im and muzyczka , 1990 , 1992; brister and muzyczka , 1990 , 2000) .
helicases can #catalyse the disruption of hydrogen boding between complementary regions of nucleic acids , a process that involves sequence-specific aav dna biding , strand-specific nicking and helicase activity under atp consumption (im and muzyczka , 1990 , 1992; brister and muzyczka , 1990 , 2000) .
helicases #catalysed the disruption of hydrogen boding between complementary regions of nucleic acids , a process that involves sequence-specific aav dna biding , strand-specific nicking and helicase activity under atp consumption (im and muzyczka , 1990 , 1992; brister and muzyczka , 1990 , 2000) .
helicases have the ability to #catalyse the disruption of hydrogen boding between complementary regions of nucleic acids , a process that involves sequence-specific aav dna biding , strand-specific nicking and helicase activity under atp consumption (im and muzyczka , 1990 , 1992; brister and muzyczka , 1990 , 2000) .
helicases is able to #catalyse the disruption of hydrogen boding between complementary regions of nucleic acids , a process that involves sequence-specific aav dna biding , strand-specific nicking and helicase activity under atp consumption (im and muzyczka , 1990 , 1992; brister and muzyczka , 1990 , 2000) .
however , helicases that are able to #catalyse the disruption of hydrogen boding between complementary regions of nucleic acids up to 1000-fold less efficiently posses the entire rep52 and rep40 coding regions , respectively .
however , helicases that #catalysed the disruption of hydrogen boding between complementary regions of nucleic acids up to 1000-fold less efficiently posses the entire rep52 and rep40 coding regions , respectively .
however , helicases that may #catalyse the disruption of hydrogen boding between complementary regions of nucleic acids up to 1000-fold less efficiently posses the entire rep52 and rep40 coding regions , respectively .
however , helicases which can #catalyse the disruption of hydrogen boding between complementary regions of nucleic acids up to 1000-fold less efficiently posses the entire rep52 and rep40 coding regions , respectively .
however , helicases which #catalysed the disruption of hydrogen boding between complementary regions of nucleic acids up to 1000-fold less efficiently posses the entire rep52 and rep40 coding regions , respectively .
however , helicases which have the ability to #catalyse the disruption of hydrogen boding between complementary regions of nucleic acids up to 1000-fold less efficiently posses the entire rep52 and rep40 coding regions , respectively .
however , the two large virus-encoded rep proteins (rep78 and rep68) #catalysing the resolution of the covalently cosed aav termini up to 1000-fold less efficiently posses the entire rep52 and rep40 coding regions , respectively .
however , the two large virus-encoded rep proteins (rep78 and rep68) that are able to #catalyse the resolution of the covalently cosed aav termini up to 1000-fold less efficiently posses the entire rep52 and rep40 coding regions , respectively .
however , the two large virus-encoded rep proteins (rep78 and rep68) that have the ability to #catalyse the resolution of the covalently cosed aav termini up to 1000-fold less efficiently posses the entire rep52 and rep40 coding regions , respectively .
however , the two large virus-encoded rep proteins (rep78 and rep68) which are able to #catalyse the resolution of the covalently cosed aav termini up to 1000-fold less efficiently posses the entire rep52 and rep40 coding regions , respectively .
however , the two large virus-encoded rep proteins (rep78 and rep68) which #catalyse the resolution of the covalently cosed aav termini up to 1000-fold less efficiently posses the entire rep52 and rep40 coding regions , respectively .
however , the two large virus-encoded rep proteins (rep78 and rep68) which #catalysed the resolution of the covalently cosed aav termini up to 1000-fold less efficiently posses the entire rep52 and rep40 coding regions , respectively .
however , it is interesting to note that helicases are observed to #catalyse the disruption of hydrogen boding between complementary regions of nucleic acids up to 1000-fold less efficiently , although they posses the entire rep52 and rep40 coding regions , respectively .
however , it is interesting to note that helicases are shown to #catalyse the disruption of hydrogen boding between complementary regions of nucleic acids up to 1000-fold less efficiently , although they posses the entire rep52 and rep40 coding regions , respectively .
however , it is interesting to note that helicases can #catalyse the disruption of hydrogen boding between complementary regions of nucleic acids up to 1000-fold less efficiently , although they posses the entire rep52 and rep40 coding regions , respectively .
however , it is interesting to note that helicases #catalyse the disruption of hydrogen boding between complementary regions of nucleic acids up to 1000-fold less efficiently , although they posses the entire rep52 and rep40 coding regions , respectively .
however , it is interesting to note that the two large virus-encoded rep proteins (rep78 and rep68) are shown to #catalyse the resolution of the covalently cosed aav termini up to 1000-fold less efficiently , although they posses the entire rep52 and rep40 coding regions , respectively .
however , it is interesting to note that the two large virus-encoded rep proteins (rep78 and rep68) can #catalyse the resolution of the covalently cosed aav termini up to 1000-fold less efficiently , although they posses the entire rep52 and rep40 coding regions , respectively .
however , it is interesting to note that the two large virus-encoded rep proteins (rep78 and rep68) #catalyse the resolution of the covalently cosed aav termini up to 1000-fold less efficiently , although they posses the entire rep52 and rep40 coding regions , respectively .
however , it is interesting to note that the two large virus-encoded rep proteins (rep78 and rep68) have the ability to #catalyse the resolution of the covalently cosed aav termini up to 1000-fold less efficiently , although they posses the entire rep52 and rep40 coding regions , respectively .
however , the disruption of hydrogen boding between complementary regions of nucleic acids could be #catalysed by helicases up to 1000-fold less efficiently , although they posses the entire rep52 and rep40 coding regions , respectively .
however , the disruption of hydrogen boding between complementary regions of nucleic acids has been #catalysed by helicases up to 1000-fold less efficiently , although they posses the entire rep52 and rep40 coding regions , respectively .
however , the disruption of hydrogen boding between complementary regions of nucleic acids has the probability to be #catalysed by helicases up to 1000-fold less efficiently , although they posses the entire rep52 and rep40 coding regions , respectively .
however , the disruption of hydrogen boding between complementary regions of nucleic acids is believed to be #catalysed by helicases up to 1000-fold less efficiently , although they posses the entire rep52 and rep40 coding regions , respectively .
however , the disruption of hydrogen boding between complementary regions of nucleic acids may be #catalysed by helicases up to 1000-fold less efficiently , although they posses the entire rep52 and rep40 coding regions , respectively .
however , the disruption of hydrogen boding between complementary regions of nucleic acids was able to be #catalysed by helicases up to 1000-fold less efficiently , although they posses the entire rep52 and rep40 coding regions , respectively .
however , the disruption of hydrogen boding between complementary regions of nucleic acids will be #catalysed by helicases up to 1000-fold less efficiently , although they posses the entire rep52 and rep40 coding regions , respectively .
however , the resolution of the covalently cosed aav termini could be #catalysed by the two large virus-encoded rep proteins (rep78 and rep68) up to 1000-fold less efficiently , although they posses the entire rep52 and rep40 coding regions , respectively .
however , the resolution of the covalently cosed aav termini is able to be #catalysed by the two large virus-encoded rep proteins (rep78 and rep68) up to 1000-fold less efficiently , although they posses the entire rep52 and rep40 coding regions , respectively .
however , the resolution of the covalently cosed aav termini is #catalysed by the two large virus-encoded rep proteins (rep78 and rep68) up to 1000-fold less efficiently , although they posses the entire rep52 and rep40 coding regions , respectively .
however , the resolution of the covalently cosed aav termini is observed to be #catalysed by the two large virus-encoded rep proteins (rep78 and rep68) up to 1000-fold less efficiently , although they posses the entire rep52 and rep40 coding regions , respectively .
however , the resolution of the covalently cosed aav termini may be #catalysed by the two large virus-encoded rep proteins (rep78 and rep68) up to 1000-fold less efficiently , although they posses the entire rep52 and rep40 coding regions , respectively .
however , the resolution of the covalently cosed aav termini was able to be #catalysed by the two large virus-encoded rep proteins (rep78 and rep68) up to 1000-fold less efficiently , although they posses the entire rep52 and rep40 coding regions , respectively .
however , the resolution of the covalently cosed aav termini was #catalysed by the two large virus-encoded rep proteins (rep78 and rep68) up to 1000-fold less efficiently , although they posses the entire rep52 and rep40 coding regions , respectively .
our previous studies used in vitro hepatic microsomal preparations suggested that helicases can be most likely to #catalyse the disruption of hydrogen boding between complementary regions of nucleic acids to form the major metabolite 3-hydroxyquinine
our previous studies used in vitro hepatic microsomal preparations suggested that helicases can mostly #catalyse the disruption of hydrogen boding between complementary regions of nucleic acids to form the major metabolite 3-hydroxyquinine .
our previous studies used in vitro hepatic microsomal preparations suggested that helicases #catalysed the disruption of hydrogen boding between complementary regions of nucleic acids to form the major metabolite 3-hydroxyquinine .
our previous studies used in vitro hepatic microsomal preparations suggested that helicases #catalysing the disruption of hydrogen boding between complementary regions of nucleic acids can form the major metabolite 3-hydroxyquinine .
our previous studies used in vitro hepatic microsomal preparations suggested that helicases could mostly #catalyse the disruption of hydrogen boding between complementary regions of nucleic acids to form the major metabolite 3-hydroxyquinine .
our previous studies used in vitro hepatic microsomal preparations suggested that helicases is able to mostly #catalyse the disruption of hydrogen boding between complementary regions of nucleic acids to form the major metabolite 3-hydroxyquinine .
our previous studies used in vitro hepatic microsomal preparations suggested that helicases may mostly #catalyse the disruption of hydrogen boding between complementary regions of nucleic acids to form the major metabolite 3-hydroxyquinine .
our previous studies used in vitro hepatic microsomal preparations suggested that helicases might be most likely to #catalyse the disruption of hydrogen boding between complementary regions of nucleic acids to form the major metabolite 3-hydroxyquinine .
our previous studies used in vitro hepatic microsomal preparations suggested that helicases often #catalyses the disruption of hydrogen boding between complementary regions of nucleic acids to form the major metabolite 3-hydroxyquinine .
our previous studies used in vitro hepatic microsomal preparations suggested that helicases usually #catalyses the disruption of hydrogen boding between complementary regions of nucleic acids to form the major metabolite 3-hydroxyquinine .
our previous studies used in vitro hepatic microsomal preparations suggested that helicases was able to mostly #catalyse the disruption of hydrogen boding between complementary regions of nucleic acids to form the major metabolite 3-hydroxyquinine .
our previous studies used in vitro hepatic microsomal preparations suggested that helicases which can #catalyse the disruption of hydrogen boding between complementary regions of nucleic acids can also form the major metabolite 3-hydroxyquinine .
our previous studies used in vitro hepatic microsomal preparations suggested that helicases which could #catalyse the disruption of hydrogen boding between complementary regions of nucleic acids could also form the major metabolite 3-hydroxyquinine .
our previous studies used in vitro hepatic microsomal preparations suggested that helicases which was able to #catalyse the disruption of hydrogen boding between complementary regions of nucleic acids could form the major metabolite 3-hydroxyquinine .
our previous studies used in vitro hepatic microsomal preparations suggested that helicases would be most likely to #catalyse the disruption of hydrogen boding between complementary regions of nucleic acids to form the major metabolite 3-hydroxyquinine .
our previous studies used in vitro hepatic microsomal preparations suggested that rep78 and rep68 #catalysed the packaging reaction to form the major metabolite 3-hydroxyquinine .
our previous studies used in vitro hepatic microsomal preparations suggested that rep78 and rep68 #catalysing the packaging reaction can form the major metabolite 3-hydroxyquinine .
our previous studies used in vitro hepatic microsomal preparations suggested that rep78 and rep68 could be most likely to #catalyse the packaging reaction to form the major metabolite 3-hydroxyquinine .
our previous studies used in vitro hepatic microsomal preparations suggested that rep78 and rep68 is most likely to #catalyse the packaging reaction to form the major metabolite 3-hydroxyquinine .
our previous studies used in vitro hepatic microsomal preparations suggested that rep78 and rep68 might be most likely to #catalyse the packaging reaction to form the major metabolite 3-hydroxyquinine .
our previous studies used in vitro hepatic microsomal preparations suggested that rep78 and rep68 might mostly #catalyse the packaging reaction to form the major metabolite 3-hydroxyquinine .
our previous studies used in vitro hepatic microsomal preparations suggested that rep78 and rep68 usually #catalyses the packaging reaction to form the major metabolite 3-hydroxyquinine .
our previous studies used in vitro hepatic microsomal preparations suggested that rep78 and rep68 which could #catalyse the packaging reaction could also form the major metabolite 3-hydroxyquinine .
our previous studies used in vitro hepatic microsomal preparations suggested that rep78 and rep68 which is able to #catalyse the packaging reaction can form the major metabolite 3-hydroxyquinine .
our previous studies used in vitro hepatic microsomal preparations suggested that rep78 and rep68 which mostly #catalyses the packaging reaction can form the major metabolite 3-hydroxyquinine .
our previous studies used in vitro hepatic microsomal preparations suggested that rep78 and rep68 which was able to #catalyse the packaging reaction could form the major metabolite 3-hydroxyquinine .
our previous studies used in vitro hepatic microsomal preparations suggested that rep78 and rep68 which was most likely to #catalyse the packaging reaction can form the major metabolite 3-hydroxyquinine .
our previous studies used in vitro hepatic microsomal preparations suggested that rep78 and rep68 would be most likely to #catalyse the packaging reaction to form the major metabolite 3-hydroxyquinine .
our previous studies used in vitro hepatic microsomal preparations suggested that the two large virus-encoded rep proteins (rep78 and rep68) #catalysed the resolution of the covalently cosed aav termini to form the major metabolite 3-hydroxyquinine .
our previous studies used in vitro hepatic microsomal preparations suggested that the two large virus-encoded rep proteins (rep78 and rep68) #catalysing the resolution of the covalently cosed aav termini can form the major metabolite 3-hydroxyquinine .
our previous studies used in vitro hepatic microsomal preparations suggested that the two large virus-encoded rep proteins (rep78 and rep68) could mostly #catalyse the resolution of the covalently cosed aav termini to form the major metabolite 3-hydroxyquinine .
our previous studies used in vitro hepatic microsomal preparations suggested that the two large virus-encoded rep proteins (rep78 and rep68) is able to mostly #catalyse the resolution of the covalently cosed aav termini to form the major metabolite 3-hydroxyquinine .
our previous studies used in vitro hepatic microsomal preparations suggested that the two large virus-encoded rep proteins (rep78 and rep68) may be most likely to #catalyse the resolution of the covalently cosed aav termini to form the major metabolite 3-hydroxyquinine
our previous studies used in vitro hepatic microsomal preparations suggested that the two large virus-encoded rep proteins (rep78 and rep68) might be most likely to #catalyse the resolution of the covalently cosed aav termini to form the major metabolite 3-hydroxyquinine .
our previous studies used in vitro hepatic microsomal preparations suggested that the two large virus-encoded rep proteins (rep78 and rep68) often #catalyses the resolution of the covalently cosed aav termini to form the major metabolite 3-hydroxyquinine .
our previous studies used in vitro hepatic microsomal preparations suggested that the two large virus-encoded rep proteins (rep78 and rep68) was able to mostly #catalyse the resolution of the covalently cosed aav termini to form the major metabolite 3-hydroxyquinine .
our previous studies used in vitro hepatic microsomal preparations suggested that the two large virus-encoded rep proteins (rep78 and rep68) was most likely to #catalyse the resolution of the covalently cosed aav termini to form the major metabolite 3-hydroxyquinine
our previous studies used in vitro hepatic microsomal preparations suggested that the two large virus-encoded rep proteins (rep78 and rep68) which can #catalyse the resolution of the covalently cosed aav termini can also form the major metabolite 3-hydroxyquinine .
our previous studies used in vitro hepatic microsomal preparations suggested that the two large virus-encoded rep proteins (rep78 and rep68) which could #catalyse the resolution of the covalently cosed aav termini could also form the major metabolite 3-hydroxyquinine .
our previous studies used in vitro hepatic microsomal preparations suggested that the two large virus-encoded rep proteins (rep78 and rep68) which may #catalyse the resolution of the covalently cosed aav termini can form the major metabolite 3-hydroxyquinine .
our previous studies used in vitro hepatic microsomal preparations suggested that the two large virus-encoded rep proteins (rep78 and rep68) which was able to #catalyse the resolution of the covalently cosed aav termini could form the major metabolite 3-hydroxyquinine .
our previous studies used in vitro hepatic microsomal preparations suggested that the two large virus-encoded rep proteins (rep78 and rep68) which was most likely to #catalyse the resolution of the covalently cosed aav termini can form the major metabolite 3-hydroxyquinine .
our previous studies used in vitro hepatic microsomal preparations suggested that the two large virus-encoded rep proteins (rep78 and rep68) will be most likely to #catalyse the resolution of the covalently cosed aav termini to form the major metabolite 3-hydroxyquinine
our previous studies used in vitro hepatic microsomal preparations suggested that the two large virus-encoded rep proteins (rep78 and rep68) will mostly #catalyse the resolution of the covalently cosed aav termini to form the major metabolite 3-hydroxyquinine .
our previous studies used in vitro hepatic microsomal preparations suggested that the disruption of hydrogen boding between complementary regions of nucleic acids was mostly #catalysed by helicases to form the major metabolite 3-hydroxyquinine .
our previous studies used in vitro hepatic microsomal preparations suggested that the packaging reaction has been mostly #catalysed by rep78 and rep68 to form the major metabolite 3-hydroxyquinine .
our previous studies used in vitro hepatic microsomal preparations suggested that the packaging reaction is most likely to be #catalysed by rep78 and rep68 to form the major metabolite 3-hydroxyquinine .
our previous studies used in vitro hepatic microsomal preparations suggested that the resolution of the covalently cosed aav termini can be mostly #catalysed by the two large virus-encoded rep proteins (rep78 and rep68) to form the major metabolite 3-hydroxyquinine .
our previous studies used in vitro hepatic microsomal preparations suggested that the resolution of the covalently cosed aav termini was mostly #catalysed by the two large virus-encoded rep proteins (rep78 and rep68) to form the major metabolite 3-hydroxyquinine .
our previous studies using in vitro hepatic microsomal preparations suggested that helicases which is most likely to #catalyse the disruption of hydrogen boding between complementary regions of nucleic acids can form the major metabolite 3-hydroxyquinine .
our previous studies using in vitro hepatic microsomal preparations suggested that rep78 and rep68 which is most likely to #catalyse the packaging reaction can form the major metabolite 3-hydroxyquinine .
our previous studies using in vitro hepatic microsomal preparations suggested that the packaging reaction to form the major metabolite 3-hydroxyquinine is most likely #catalysed by rep78 and rep68 .
our previous studies using in vitro hepatic microsomal preparations suggested that the resolution of the covalently cosed aav termini to form the major metabolite 3-hydroxyquinine is most likely #catalysed by the two large virus-encoded rep proteins (rep78 and rep68) .
rep78 and rep68 are believed to not only #catalyse the packaging reaction , but also move along nucleic acid strands in a polar fashion .
rep78 and rep68 can not only #catalyse the packaging reaction , but also move along nucleic acid strands in a polar fashion .
rep78 and rep68 have the ability to #catalyse the packaging reaction , a process that involves sequence-specific aav dna biding , strand-specific nicking and helicase activity under atp consumption (im and muzyczka , 1990 , 1992; brister and muzyczka , 1990 , 2000) .
rep78 and rep68 may #catalyse the packaging reaction , a process that involves sequence-specific aav dna biding , strand-specific nicking and helicase activity under atp consumption (im and muzyczka , 1990 , 1992; brister and muzyczka , 1990 , 2000) .
rep78 and rep68 not only #catalysed the packaging reaction , but also moved along nucleic acid strands in a polar fashion .
rep78 and rep68 will not only #catalyse the packaging reaction , but also move along nucleic acid strands in a polar fashion .
the two large virus-encoded rep proteins (rep78 and rep68) are able to not only #catalyse the resolution of the covalently cosed aav termini , but also move along nucleic acid strands in a polar fashion .
the two large virus-encoded rep proteins (rep78 and rep68) are believed to not only #catalyse the resolution of the covalently cosed aav termini , but also move along nucleic acid strands in a polar fashion .
the two large virus-encoded rep proteins (rep78 and rep68) not only #catalysed the resolution of the covalently cosed aav termini , but also moved along nucleic acid strands in a polar fashion .
dna helicases are believed to #catalyse the unwinding of dna , a process that involves sequence-specific aav dna biding , strand-specific nicking and helicase activity under atp consumption (im and muzyczka , 1990 , 1992; brister and muzyczka , 1990 , 2000) .
dna helicases are observed to #catalyse the unwinding of dna , a process that involves sequence-specific aav dna biding , strand-specific nicking and helicase activity under atp consumption (im and muzyczka , 1990 , 1992; brister and muzyczka , 1990 , 2000) .
dna helicases can not only #catalyse the unwinding of dna , but also move along nucleic acid strands in a polar fashion .
dna helicases #catalyse the unwinding of dna , a process that involves sequence-specific aav dna biding , strand-specific nicking and helicase activity under atp consumption (im and muzyczka , 1990 , 1992; brister and muzyczka , 1990 , 2000) .
dna helicases have the ability to #catalyse the unwinding of dna , a process that involves sequence-specific aav dna biding , strand-specific nicking and helicase activity under atp consumption (im and muzyczka , 1990 , 1992; brister and muzyczka , 1990 , 2000) .
dna helicases will not only #catalyse the unwinding of dna , but also move along nucleic acid strands in a polar fashion .
however , dna helicases having the ability to #catalyse the unwinding of dna up to 1000-fold less efficiently posses the entire rep52 and rep40 coding regions , respectively .
however , dna helicases that may #catalyse the unwinding of dna up to 1000-fold less efficiently posses the entire rep52 and rep40 coding regions , respectively .
however , dna helicases which are able to #catalyse the unwinding of dna up to 1000-fold less efficiently posses the entire rep52 and rep40 coding regions , respectively .
however , dna helicases which #catalyse the unwinding of dna up to 1000-fold less efficiently posses the entire rep52 and rep40 coding regions , respectively .
however , it is interesting to note that dna helicases are shown to #catalyse the unwinding of dna up to 1000-fold less efficiently , although they posses the entire rep52 and rep40 coding regions , respectively .
however , the unwinding of dna is able to be #catalysed by dna helicases up to 1000-fold less efficiently , although they posses the entire rep52 and rep40 coding regions , respectively .
however , the unwinding of dna is believed to be #catalysed by dna helicases up to 1000-fold less efficiently , although they posses the entire rep52 and rep40 coding regions , respectively .
however , the unwinding of dna is observed to be #catalysed by dna helicases up to 1000-fold less efficiently , although they posses the entire rep52 and rep40 coding regions , respectively .
however , the unwinding of dna may be #catalysed by dna helicases up to 1000-fold less efficiently , although they posses the entire rep52 and rep40 coding regions , respectively .
however , the unwinding of dna might be #catalysed by dna helicases up to 1000-fold less efficiently , although they posses the entire rep52 and rep40 coding regions , respectively .
however , the unwinding of dna was #catalysed by dna helicases up to 1000-fold less efficiently , although they posses the entire rep52 and rep40 coding regions , respectively .
however , the unwinding of dna will be #catalysed by dna helicases up to 1000-fold less efficiently , although they posses the entire rep52 and rep40 coding regions , respectively .
our previous studies used in vitro hepatic microsomal preparations suggested that dna helicases often #catalyses the unwinding of dna to form the major metabolite 3-hydroxyquinine .
our previous studies used in vitro hepatic microsomal preparations suggested that dna helicases usually #catalyses the unwinding of dna to form the major metabolite 3-hydroxyquinine .
our previous studies used in vitro hepatic microsomal preparations suggested that dna helicases was able to mostly #catalyse the unwinding of dna to form the major metabolite 3-hydroxyquinine .
our previous studies used in vitro hepatic microsomal preparations suggested that dna helicases was most likely to #catalyse the unwinding of dna to form the major metabolite 3-hydroxyquinine
our previous studies used in vitro hepatic microsomal preparations suggested that dna helicases which can #catalyse the unwinding of dna can also form the major metabolite 3-hydroxyquinine .
our previous studies used in vitro hepatic microsomal preparations suggested that dna helicases which is able to #catalyse the unwinding of dna can form the major metabolite 3-hydroxyquinine .
our previous studies used in vitro hepatic microsomal preparations suggested that dna helicases which might #catalyse the unwinding of dna could form the major metabolite 3-hydroxyquinine .
our previous studies used in vitro hepatic microsomal preparations suggested that dna helicases which mostly #catalyses the unwinding of dna can form the major metabolite 3-hydroxyquinine .
our previous studies used in vitro hepatic microsomal preparations suggested that dna helicases will be most likely to #catalyse the unwinding of dna to form the major metabolite 3-hydroxyquinine
our previous studies used in vitro hepatic microsomal preparations suggested that dna helicases would be most likely to #catalyse the unwinding of dna to form the major metabolite 3-hydroxyquinine .
our previous studies used in vitro hepatic microsomal preparations suggested that dna helicases would mostly #catalyse the unwinding of dna to form the major metabolite 3-hydroxyquinine .
our previous studies used in vitro hepatic microsomal preparations suggested that the unwinding of dna has been mostly #catalysed by dna helicases to form the major metabolite 3-hydroxyquinine .
our previous studies used in vitro hepatic microsomal preparations suggested that the unwinding of dna is able to be mostly #catalysed by dna helicases to form the major metabolite 3-hydroxyquinine .
our previous studies used in vitro hepatic microsomal preparations suggested that the unwinding of dna is most likely to be #catalysed by dna helicases to form the major metabolite 3-hydroxyquinine .
our previous studies used in vitro hepatic microsomal preparations suggested that the unwinding of dna was mostly #catalysed by dna helicases to form the major metabolite 3-hydroxyquinine .
human 06-alkylguaning-dna alkyltransferase (agt) #conferring resistance to alkylation chemotherapies is therefore an active anticancer drug target .
human 06-alkylguaning-dna alkyltransferase (agt) that #conferred resistance to alkylation chemotherapies was therefore an active anticancer drug target .
human 06-alkylguaning-dna alkyltransferase (agt) that #confers resistance to alkylation chemotherapies is therefore an active anticancer drug target .
human 06-alkylguaning-dna alkyltransferase (agt) which #conferred resistance to alkylation chemotherapies was therefore an active anticancer drug target .
human 06-alkylguaning-dna alkyltransferase (agt) which #confers resistance to alkylation chemotherapies is therefore an active anticancer drug target .
human 06-alkylguaning-dna alkyltransferase (agt) which has #conferred resistance to alkylation chemotherapies was therefore an active anticancer drug target .
human 06-alkylguaning-dna alkyltransferase (agt) which is able to #confer resistance to alkylation chemotherapies was therefore an active anticancer drug target .
human 06-alkylguaning-dna alkyltransferase (agt) which is observed to #confer resistance to alkylation chemotherapies was therefore an active anticancer drug target .
human 06-alkylguaning-dna alkyltransferase (agt) which may #confer resistance to alkylation chemotherapies was therefore an active anticancer drug target .
human 06-alkylguaning-dna alkyltransferase (agt) , which directly reverses endogenous alkylation at the 06-position of guanine , #conferred resistance to alkylation chemotherapies and is therefore an active anticancer drug target .
human 06-alkylguaning-dna alkyltransferase (agt) , which directly reverses endogenous alkylation at the 06-position of guanine , is believed to #confer resistance to alkylation chemotherapies and is therefore an active anticancer drug target .
human 06-alkylguaning-dna alkyltransferase (agt) , which directly reverses endogenous alkylation at the 06-position of guanine , is observed to #confer resistance to alkylation chemotherapies and is therefore an active anticancer drug target .
human 06-alkylguaning-dna alkyltransferase (agt) , which directly reverses endogenous alkylation at the 06-position of guanine , may #confer resistance to alkylation chemotherapies and is therefore an active anticancer drug target .
human 06-alkylguaning-dna alkyltransferase (agt) , which directly reverses endogenous alkylation at the 06-position of guanine , would #confer resistance to alkylation chemotherapies and was therefore an active anticancer drug target .
in addition , evga overexpression can not #confer resistance in a tolc-deficient strain .
in addition , evga overexpression does not #confer resistance in a tolc-deficient strain .
in addition , evga overexpression is not able to #confer resistance in a tolc-deficient strain .
in addition , evga overexpression may not #confer resistance in a tolc-deficient strain .
in addition , evga overexpression might not #confer resistance in a tolc-deficient strain .
in addition , loss-of-function mutations can not have been #conferred by nonsense or frameshift alterations in the coding sequence or by splice variants , genetic screening has revealed a large number of missense codons with less obvious functional consequences .
in addition , loss-of-function mutations could not be #conferred by nonsense or frameshift alterations in the coding sequence or by splice variants , genetic screening has revealed a large number of missense codons with less obvious functional consequences .
in addition , loss-of-function mutations is believed not to be #conferred by nonsense or frameshift alterations in the coding sequence or by splice variants , genetic screening has revealed a large number of missense codons with less obvious functional consequences .
in addition , loss-of-function mutations may not be #conferred by nonsense or frameshift alterations in the coding sequence or by splice variants , genetic screening has revealed a large number of missense codons with less obvious functional consequences .
in addition , loss-of-function mutations may not have been #conferred by nonsense or frameshift alterations in the coding sequence or by splice variants , genetic screening has revealed a large number of missense codons with less obvious functional consequences .
in addition , loss-of-function mutations was believed not to be #conferred by nonsense or frameshift alterations in the coding sequence or by splice variants , genetic screening has revealed a large number of missense codons with less obvious functional consequences .
in addition , loss-of-function mutations will not have been #conferred by nonsense or frameshift alterations in the coding sequence or by splice variants , genetic screening has revealed a large number of missense codons with less obvious functional consequences .
increased agt levels parallel acquired alkylation resistance in human tumors (brent et al . , 1985; mattern et al . , 1998) , and resistance can be #conferred by transfection of agt to alkylation-sensitive cells (kaina et al . , 1991) , demonstrating the role of agt in therapeutic resistance .
increased agt levels parallel acquired alkylation resistance in human tumors (brent et al . , 1985; mattern et al . , 1998) , and resistance has been #conferred by transfection of agt to alkylation-sensitive cells (kaina et al . , 1991) , demonstrating the role of agt in therapeutic resistance .
increased agt levels parallel acquired alkylation resistance in human tumors (brent et al . , 1985; mattern et al . , 1998) , and resistance is believed to be #conferred by transfection of agt to alkylation-sensitive cells (kaina et al . , 1991) , demonstrating the role of agt in therapeutic resistance .
increased agt levels parallel acquired alkylation resistance in human tumors (brent et al . , 1985; mattern et al . , 1998) , and resistance may be #conferred by transfection of agt to alkylation-sensitive cells (kaina et al . , 1991) , demonstrating the role of agt in therapeutic resistance .
increased agt levels parallel acquired alkylation resistance in human tumors (brent et al . , 1985; mattern et al . , 1998) , and resistance may have been #conferred by transfection of agt to alkylation-sensitive cells (kaina et al . , 1991) , demonstrating the role of agt in therapeutic resistance .
increased agt levels parallel acquired alkylation resistance in human tumors (brent et al . , 1985; mattern et al . , 1998) , and resistance was believed to be #conferred by transfection of agt to alkylation-sensitive cells (kaina et al . , 1991) , demonstrating the role of agt in therapeutic resistance .
increased agt levels parallel acquired alkylation resistance in human tumors (brent et al . , 1985; mattern et al . , 1998) , and resistance was #conferred by transfection of agt to alkylation-sensitive cells (kaina et al . , 1991) , demonstrating the role of agt in therapeutic resistance .
increased agt levels parallel acquired alkylation resistance in human tumors (brent et al . , 1985; mattern et al . , 1998) , and resistance will have been #conferred by transfection of agt to alkylation-sensitive cells (kaina et al . , 1991) , demonstrating the role of agt in therapeutic resistance .
increased agt levels parallel acquired alkylation resistance in human tumors (brent et al . , 1985; mattern et al . , 1998) , and transfection of agt can #confer resistance to alkylation-sensitive cells (kaina et al . , 1991) , demonstrating the role of agt in therapeutic resistance .
increased agt levels parallel acquired alkylation resistance in human tumors (brent et al . , 1985; mattern et al . , 1998) , and transfection of agt can have #conferred resistance to alkylation-sensitive cells (kaina et al . , 1991) , demonstrating the role of agt in therapeutic resistance .
increased agt levels parallel acquired alkylation resistance in human tumors (brent et al . , 1985; mattern et al . , 1998) , and transfection of agt #conferred resistance to alkylation-sensitive cells (kaina et al . , 1991) , demonstrating the role of agt in therapeutic resistance .
increased agt levels parallel acquired alkylation resistance in human tumors (brent et al . , 1985; mattern et al . , 1998) , and transfection of agt could #confer resistance to alkylation-sensitive cells (kaina et al . , 1991) , demonstrating the role of agt in therapeutic resistance .
increased agt levels parallel acquired alkylation resistance in human tumors (brent et al . , 1985; mattern et al . , 1998) , and transfection of agt has #conferred resistance to alkylation-sensitive cells (kaina et al . , 1991) , demonstrating the role of agt in therapeutic resistance .
increased agt levels parallel acquired alkylation resistance in human tumors (brent et al . , 1985; mattern et al . , 1998) , and transfection of agt has the ability to #confer resistance to alkylation-sensitive cells (kaina et al . , 1991) , demonstrating the role of agt in therapeutic resistance .
increased agt levels parallel acquired alkylation resistance in human tumors (brent et al . , 1985; mattern et al . , 1998) , and transfection of agt is observed to #confer resistance to alkylation-sensitive cells (kaina et al . , 1991) , demonstrating the role of agt in therapeutic resistance .
increased agt levels parallel acquired alkylation resistance in human tumors (brent et al . , 1985; mattern et al . , 1998) , and transfection of agt may #confer resistance to alkylation-sensitive cells (kaina et al . , 1991) , demonstrating the role of agt in therapeutic resistance .
increased agt levels parallel acquired alkylation resistance in human tumors (brent et al . , 1985; mattern et al . , 1998) , and transfection of agt was believed to #confer resistance to alkylation-sensitive cells (kaina et al . , 1991) , demonstrating the role of agt in therapeutic resistance .
increased agt levels parallel acquired alkylation resistance in human tumors (brent et al . , 1985; mattern et al . , 1998) , and transfection of agt was observed to #confer resistance to alkylation-sensitive cells (kaina et al . , 1991) , demonstrating the role of agt in therapeutic resistance .
increased agt levels parallel acquired alkylation resistance in human tumors (brent et al . , 1985; mattern et al . , 1998) , and transfection of agt will #confer resistance to alkylation-sensitive cells (kaina et al . , 1991) , demonstrating the role of agt in therapeutic resistance .
likewise , the introduced charge of gly160his and gly160arg mutants would repel the benzyl group (figure 3b) , the 06-bg resistance can be #conferred by these mutations (xu-welliver et al . , 1999a) .
likewise , the introduced charge of gly160his and gly160arg mutants would repel the benzyl group (figure 3b) , the 06-bg resistance could be #conferred by these mutations (xu-welliver et al . , 1999a) .
likewise , the introduced charge of gly160his and gly160arg mutants would repel the benzyl group (figure 3b) , the 06-bg resistance has been #conferred by these mutations (xu-welliver et al . , 1999a) .
likewise , the introduced charge of gly160his and gly160arg mutants would repel the benzyl group (figure 3b) , the 06-bg resistance is able to be #conferred by these mutations (xu-welliver et al . , 1999a) .
likewise , the introduced charge of gly160his and gly160arg mutants would repel the benzyl group (figure 3b) , the 06-bg resistance is believed to be #conferred by these mutations (xu-welliver et al . , 1999a) .
likewise , the introduced charge of gly160his and gly160arg mutants would repel the benzyl group (figure 3b) , the 06-bg resistance is #conferred by these mutations (xu-welliver et al . , 1999a) .
likewise , the introduced charge of gly160his and gly160arg mutants would repel the benzyl group (figure 3b) , the 06-bg resistance might be #conferred by these mutations (xu-welliver et al . , 1999a) .
likewise , the introduced charge of gly160his and gly160arg mutants would repel the benzyl group (figure 3b) , the 06-bg resistance was able to be #conferred by these mutations (xu-welliver et al . , 1999a) .
likewise , the introduced charge of gly160his and gly160arg mutants would repel the benzyl group (figure 3b) , the 06-bg resistance was #conferred by these mutations (xu-welliver et al . , 1999a) .
likewise , the introduced charge of gly160his and gly160arg mutants would repel the benzyl group (figure 3b) , the 06-bg resistance will be #conferred by these mutations (xu-welliver et al . , 1999a) .
likewise , the introduced charge of gly160his and gly160arg mutants would repel the benzyl group (figure 3b) , the 06-bg resistance would be #conferred by these mutations (xu-welliver et al . , 1999a) .
likewise , the introduced charge of gly160his and gly160arg mutants would repel the benzyl group (figure 3b) , these mutations could #confer the 06-bg resistance (xu-welliver et al . , 1999a) .
likewise , the introduced charge of gly160his and gly160arg mutants would repel the benzyl group (figure 3b) , these mutations is believed to #confer the 06-bg resistance (xu-welliver et al . , 1999a) .
likewise , the introduced charge of gly160his and gly160arg mutants would repel the benzyl group (figure 3b) , these mutations may #confer the 06-bg resistance (xu-welliver et al . , 1999a) .
likewise , the introduced charge of gly160his and gly160arg mutants would repel the benzyl group (figure 3b) , these mutations was able to #confer the 06-bg resistance (xu-welliver et al . , 1999a) .
nonsense or frameshift alterations in the coding sequence or by splice variants are not able to #confer loss-of-function mutations .
nonsense or frameshift alterations in the coding sequence or by splice variants did not #confer loss-of-function mutations .
nonsense or frameshift alterations in the coding sequence or by splice variants may not #confer loss-of-function mutations .
nonsense or frameshift alterations in the coding sequence or by splice variants might not #confer loss-of-function mutations .
nonsense or frameshift alterations in the coding sequence or by splice variants were believed not to #confer loss-of-function mutations .
nonsense or frameshift alterations in the coding sequence or by splice variants will not #confer loss-of-function mutations .
resistance can have been #conferred by human 06-alkylguaning-dna alkyltransferase (agt) , which directly reverses endogenous alkylation at the 06-position of guanine , to alkylation chemotherapies .
resistance could be #conferred by human 06-alkylguaning-dna alkyltransferase (agt) , which directly reverses endogenous alkylation at the 06-position of guanine , to alkylation chemotherapies .
resistance has been #conferred by human 06-alkylguaning-dna alkyltransferase (agt) , which directly reverses endogenous alkylation at the 06-position of guanine , to alkylation chemotherapies .
resistance is #conferred by human 06-alkylguaning-dna alkyltransferase (agt) , which directly reverses endogenous alkylation at the 06-position of guanine , to alkylation chemotherapies .
resistance may have been #conferred by human 06-alkylguaning-dna alkyltransferase (agt) , which directly reverses endogenous alkylation at the 06-position of guanine , to alkylation chemotherapies .
resistance was believed to #confer by human 06-alkylguaning-dna alkyltransferase (agt) , which directly reverses endogenous alkylation at the 06-position of guanine , to alkylation chemotherapies .
resistance was #conferred by human 06-alkylguaning-dna alkyltransferase (agt) , which directly reverses endogenous alkylation at the 06-position of guanine , to alkylation chemotherapies .
specificity for either a mapk or a mapk substrate kinase (mapkap) has been #conferred by the portion of the stats .
specificity for either a mapk or a mapk substrate kinase (mapkap) may be #conferred by the portion of the stats .
specificity for either a mapk or a mapk substrate kinase (mapkap) might be #conferred by the portion of the stats .
specificity for either a mapk or a mapk substrate kinase (mapkap) was #conferred by the portion of the stats .
that the portion of the stats could #confer specificity for either a mapk or a mapk substrate kinase (mapkap) has not been determined .
that the portion of the stats has #conferred specificity for either a mapk or a mapk substrate kinase (mapkap) has not been determined .
that the portion of the stats is able to #confer specificity for either a mapk or a mapk substrate kinase (mapkap) has not been determined .
that the portion of the stats is believed to #confer specificity for either a mapk or a mapk substrate kinase (mapkap) has not been determined .
that the portion of the stats might #confer specificity for either a mapk or a mapk substrate kinase (mapkap) has not been determined .
that the portion of the stats was able to #confer specificity for either a mapk or a mapk substrate kinase (mapkap) has not been determined .
the portion of the stats #conferred specificity for either a mapk or a mapk substrate kinase (mapkap) .
resistance in a tolc-deficient strain can be #conferred by evga overexpression .
resistance in a tolc-deficient strain has been #conferred by evga overexpression .
the portion of the stats #conferring specificity for either a mapk or a mapk substrate kinase (mapkap) has not been determined .
in addition , evga overexpression did not #confer resistance in a tolc-deficient strain .
06-bg resistance in a tolc-deficient strain can be #conferred by these mutations .
06-bg resistance in a tolc-deficient strain has been #conferred by these mutations .
06-bg resistance in a tolc-deficient strain is #conferred by these mutations .
besides these side chain interactions with the 06-alkyl group , structure-based analysis of mutational data suggests that human 06-alkylguaning-dna alkyltransferase are able to #confer resistance to alkylation chemotherapies through backbone distortions .
besides these side chain interactions with the 06-alkyl group , structure-based analysis of mutational data suggests that human 06-alkylguaning-dna alkyltransferase #confer resistance to alkylation chemotherapies through backbone distortions .
besides these side chain interactions with the 06-alkyl group , structure-based analysis of mutational data suggests that human 06-alkylguaning-dna alkyltransferase could #confer resistance to alkylation chemotherapies through backbone distortions .
besides these side chain interactions with the 06-alkyl group , structure-based analysis of mutational data suggests that human 06-alkylguaning-dna alkyltransferase have the ability to #confer resistance to alkylation chemotherapies through backbone distortions .
besides these side chain interactions with the 06-alkyl group , structure-based analysis of mutational data suggests that human 06-alkylguaning-dna alkyltransferase may #confer resistance to alkylation chemotherapies through backbone distortions .
besides these side chain interactions with the 06-alkyl group , structure-based analysis of mutational data suggests that human 06-alkylguaning-dna alkyltransferase may have #conferred resistance to alkylation chemotherapies through backbone distortions .
besides these side chain interactions with the 06-alkyl group , structure-based analysis of mutational data suggests that human 06-alkylguaning-dna alkyltransferase may have the ability to #confer resistance to alkylation chemotherapies through backbone distortions .
besides these side chain interactions with the 06-alkyl group , structure-based analysis of mutational data suggests that human 06-alkylguaning-dna alkyltransferase might #confer resistance to alkylation chemotherapies through backbone distortions .
besides these side chain interactions with the 06-alkyl group , structure-based analysis of mutational data suggests that human 06-alkylguaning-dna alkyltransferase were able to #confer resistance to alkylation chemotherapies through backbone distortions .
besides these side chain interactions with the 06-alkyl group , structure-based analysis of mutational data suggests that human 06-alkylguaning-dna alkyltransferase will #confer resistance to alkylation chemotherapies through backbone distortions .
besides these side chain interactions with the 06-alkyl group , structure-based analysis of mutational data suggests that human 06-alkylguaning-dna alkyltransferase would #confer resistance to alkylation chemotherapies through backbone distortions .
besides these side chain interactions with the 06-alkyl group , structure-based analysis of mutational data suggests that human 06-alkylguaning-dna alkyltransferase would have #conferred resistance to alkylation chemotherapies through backbone distortions .
besides these side chain interactions with the 06-alkyl group , structure-based analysis of mutational data suggests that the portion of the stats are able to #confer specificity to either a mapk or a mapk substrate kinase (mapkap) through backbone distortions .
besides these side chain interactions with the 06-alkyl group , structure-based analysis of mutational data suggests that the portion of the stats are believed to #confer specificity to either a mapk or a mapk substrate kinase (mapkap) through backbone distortions .
besides these side chain interactions with the 06-alkyl group , structure-based analysis of mutational data suggests that the portion of the stats are observed to #confer specificity to either a mapk or a mapk substrate kinase (mapkap) through backbone distortions .
besides these side chain interactions with the 06-alkyl group , structure-based analysis of mutational data suggests that the portion of the stats may #confer specificity to either a mapk or a mapk substrate kinase (mapkap) through backbone distortions .
besides these side chain interactions with the 06-alkyl group , structure-based analysis of mutational data suggests that the portion of the stats will #confer specificity to either a mapk or a mapk substrate kinase (mapkap) through backbone distortions .
besides these side chain interactions with the 06-alkyl group , structure-based analysis of mutational data suggests that the portion of the stats would #confer specificity to either a mapk or a mapk substrate kinase (mapkap) through backbone distortions .
besides these side chain interactions with the 06-alkyl group , structure-based analysis of mutational data suggests that the portion of the stats would have #conferred specificity to either a mapk or a mapk substrate kinase (mapkap) through backbone distortions .
besides these side chain interactions with the 06-alkyl group , structure-based analysis of mutational data suggests that resistance can have been #conferred by transfection of agt to alkylation-sensitive cells through backbone distortions .
besides these side chain interactions with the 06-alkyl group , structure-based analysis of mutational data suggests that resistance could be #conferred by human 06-alkylguaning-dna alkyltransferase to alkylation chemotherapies through backbone distortions .
besides these side chain interactions with the 06-alkyl group , structure-based analysis of mutational data suggests that resistance could be #conferred by transfection of agt to alkylation-sensitive cells through backbone distortions .
besides these side chain interactions with the 06-alkyl group , structure-based analysis of mutational data suggests that resistance has been able to be #conferred by human 06-alkylguaning-dna alkyltransferase to alkylation chemotherapies through backbone distortions .
besides these side chain interactions with the 06-alkyl group , structure-based analysis of mutational data suggests that resistance has been able to be #conferred by transfection of agt to alkylation-sensitive cells through backbone distortions .
besides these side chain interactions with the 06-alkyl group , structure-based analysis of mutational data suggests that resistance is believed to be #conferred by human 06-alkylguaning-dna alkyltransferase to alkylation chemotherapies through backbone distortions .
besides these side chain interactions with the 06-alkyl group , structure-based analysis of mutational data suggests that resistance is believed to be #conferred by transfection of agt to alkylation-sensitive cells through backbone distortions .
besides these side chain interactions with the 06-alkyl group , structure-based analysis of mutational data suggests that resistance is believed to have been #conferred by transfection of agt to alkylation-sensitive cells through backbone distortions .
besides these side chain interactions with the 06-alkyl group , structure-based analysis of mutational data suggests that resistance is observed to be #conferred by human 06-alkylguaning-dna alkyltransferase to alkylation chemotherapies through backbone distortions .
besides these side chain interactions with the 06-alkyl group , structure-based analysis of mutational data suggests that resistance is shown to be #conferred by human 06-alkylguaning-dna alkyltransferase to alkylation chemotherapies through backbone distortions .
besides these side chain interactions with the 06-alkyl group , structure-based analysis of mutational data suggests that resistance may be #conferred by human 06-alkylguaning-dna alkyltransferase to alkylation chemotherapies through backbone distortions .
besides these side chain interactions with the 06-alkyl group , structure-based analysis of mutational data suggests that resistance may be #conferred by transfection of agt to alkylation-sensitive cells through backbone distortions .
besides these side chain interactions with the 06-alkyl group , structure-based analysis of mutational data suggests that resistance may have been #conferred by human 06-alkylguaning-dna alkyltransferase to alkylation chemotherapies through backbone distortions .
besides these side chain interactions with the 06-alkyl group , structure-based analysis of mutational data suggests that resistance might be #conferred by transfection of agt to alkylation-sensitive cells through backbone distortions .
besides these side chain interactions with the 06-alkyl group , structure-based analysis of mutational data suggests that resistance was observed to be #conferred by human 06-alkylguaning-dna alkyltransferase to alkylation chemotherapies through backbone distortions .
besides these side chain interactions with the 06-alkyl group , structure-based analysis of mutational data suggests that resistance was observed to be #conferred by transfection of agt to alkylation-sensitive cells through backbone distortions .
besides these side chain interactions with the 06-alkyl group , structure-based analysis of mutational data suggests that resistance was shown to be #conferred by human 06-alkylguaning-dna alkyltransferase to alkylation chemotherapies through backbone distortions .
besides these side chain interactions with the 06-alkyl group , structure-based analysis of mutational data suggests that resistance was shown to be #conferred by transfection of agt to alkylation-sensitive cells through backbone distortions .
besides these side chain interactions with the 06-alkyl group , structure-based analysis of mutational data suggests that resistance will be #conferred by transfection of agt to alkylation-sensitive cells through backbone distortions .
besides these side chain interactions with the 06-alkyl group , structure-based analysis of mutational data suggests that resistance will have been #conferred by human 06-alkylguaning-dna alkyltransferase to alkylation chemotherapies through backbone distortions .
besides these side chain interactions with the 06-alkyl group , structure-based analysis of mutational data suggests that resistance will have been #conferred by transfection of agt to alkylation-sensitive cells through backbone distortions .
besides these side chain interactions with the 06-alkyl group , structure-based analysis of mutational data suggests that resistance would be #conferred by transfection of agt to alkylation-sensitive cells through backbone distortions .
besides these side chain interactions with the 06-alkyl group , structure-based analysis of mutational data suggests that specificity has been #conferred by the portion of the stats to either a mapk or a mapk substrate kinase (mapkap) through backbone distortions .
besides these side chain interactions with the 06-alkyl group , structure-based analysis of mutational data suggests that specificity is able to be #conferred by the portion of the stats to either a mapk or a mapk substrate kinase (mapkap) through backbone distortions .
besides these side chain interactions with the 06-alkyl group , structure-based analysis of mutational data suggests that specificity is believed to be #conferred by the portion of the stats to either a mapk or a mapk substrate kinase (mapkap) through backbone distortions .
besides these side chain interactions with the 06-alkyl group , structure-based analysis of mutational data suggests that specificity may have been #conferred by the portion of the stats to either a mapk or a mapk substrate kinase (mapkap) through backbone distortions .
besides these side chain interactions with the 06-alkyl group , structure-based analysis of mutational data suggests that specificity might be #conferred by the portion of the stats to either a mapk or a mapk substrate kinase (mapkap) through backbone distortions .
besides these side chain interactions with the 06-alkyl group , structure-based analysis of mutational data suggests that specificity was believed to be #conferred by the portion of the stats to either a mapk or a mapk substrate kinase (mapkap) through backbone distortions .
besides these side chain interactions with the 06-alkyl group , structure-based analysis of mutational data suggests that specificity was #conferred by the portion of the stats to either a mapk or a mapk substrate kinase (mapkap) through backbone distortions .
besides these side chain interactions with the 06-alkyl group , structure-based analysis of mutational data suggests that specificity was observed to be #conferred by the portion of the stats to either a mapk or a mapk substrate kinase (mapkap) through backbone distortions .
besides these side chain interactions with the 06-alkyl group , structure-based analysis of mutational data suggests that specificity will be #conferred by the portion of the stats to either a mapk or a mapk substrate kinase (mapkap) through backbone distortions .
besides these side chain interactions with the 06-alkyl group , structure-based analysis of mutational data suggests that specificity will have been #conferred by the portion of the stats to either a mapk or a mapk substrate kinase (mapkap) through backbone distortions .
besides these side chain interactions with the 06-alkyl group , structure-based analysis of mutational data suggests that transfection of agt #conferred resistance to alkylation-sensitive cells through backbone distortions .
besides these side chain interactions with the 06-alkyl group , structure-based analysis of mutational data suggests that transfection of agt have the ability to #confer resistance to alkylation-sensitive cells through backbone distortions .
besides these side chain interactions with the 06-alkyl group , structure-based analysis of mutational data suggests that transfection of agt may #confer resistance to alkylation-sensitive cells through backbone distortions .
besides these side chain interactions with the 06-alkyl group , structure-based analysis of mutational data suggests that transfection of agt may have #conferred resistance to alkylation-sensitive cells through backbone distortions .
besides these side chain interactions with the 06-alkyl group , structure-based analysis of mutational data suggests that transfection of agt might #confer resistance to alkylation-sensitive cells through backbone distortions .
besides these side chain interactions with the 06-alkyl group , structure-based analysis of mutational data suggests that transfection of agt will #confer resistance to alkylation-sensitive cells through backbone distortions .
besides these side chain interactions with the 06-alkyl group , structure-based analysis of mutational data suggests that transfection of agt would have #conferred resistance to alkylation-sensitive cells through backbone distortions .
besides these side chain interactions with the 06-alkyl group , structure-based analysis of mutational data suggests the ability of human 06-alkylguaning-dna alkyltransferase to #confer resistance to alkylation chemotherapies through backbone distortions .
besides these side chain interactions with the 06-alkyl group , structure-based analysis of mutational data suggests the ability of the portion of the stats to #confer specificity to either a mapk or a mapk substrate kinase (mapkap) through backbone distortions .
human 06-alkylguaning-dna alkyltransferase #conferring resistance for alkylation chemotherapies has not been determined .
in addition , these mutations can not #confer 06-bg resistance in a tolc-deficient strain .
in addition , these mutations did not #confer 06-bg resistance in a tolc-deficient strain .
in addition , these mutations does not #confer 06-bg resistance in a tolc-deficient strain .
in addition , these mutations may not #confer 06-bg resistance in a tolc-deficient strain .
in addition , these mutations might not #confer 06-bg resistance in a tolc-deficient strain .
in addition , these mutations will not #confer 06-bg resistance in a tolc-deficient strain .
in itself , 06-bg resistance cannot be #conferred by these mutations .
in itself , 06-bg resistance is believed not to be #conferred by these mutations .
in itself , 06-bg resistance is not able to be #conferred by these mutations .
in itself , 06-bg resistance is not #conferred by these mutations .
in itself , 06-bg resistance may not be #conferred by these mutations .
in itself , 06-bg resistance was believed not to be #conferred by these mutations .
in itself , 06-bg resistance would not be #conferred by these mutations .
in itself , evga overexpression cannot #confer resistance .
in itself , evga overexpression could not #confer resistance .
in itself , evga overexpression did not #confer resistance .
in itself , evga overexpression is believed not to #confer resistance .
in itself , evga overexpression may not #confer resistance .
in itself , evga overexpression may not have #conferred resistance .
in itself , evga overexpression was believed not to #confer resistance .
in itself , evga overexpression was not able to #confer resistance .
in itself , evga overexpression will not #confer resistance .
in itself , evga overexpression will not have #conferred resistance .
in itself , resistance cannot be #conferred by evga overexpression .
in itself , resistance is believed not to be #conferred by evga overexpression .
in itself , resistance is not #conferred by evga overexpression .
in itself , resistance was believed not to be #conferred by evga overexpression .
in itself , resistance would not be #conferred by evga overexpression .
in itself , these mutations cannot have #conferred 06-bg resistance .
in itself , these mutations does not #confer 06-bg resistance .
in itself , these mutations is believed not to #confer 06-bg resistance .
in itself , these mutations is not able to #confer 06-bg resistance .
in itself , these mutations may not #confer 06-bg resistance .
in itself , these mutations may not have #conferred 06-bg resistance .
in itself , these mutations was not able to #confer 06-bg resistance .
in itself , these mutations would not #confer 06-bg resistance .
increased agt levels parallel acquired alkylation resistance in human tumors (brent et al . , 1985; mattern et al . , 1998) , and human 06-alkylguaning-dna alkyltransferase can #confer resistance to alkylation chemotherapies (kaina et al . , 1991) , demonstrating the role of agt in therapeutic resistance .
increased agt levels parallel acquired alkylation resistance in human tumors (brent et al . , 1985; mattern et al . , 1998) , and human 06-alkylguaning-dna alkyltransferase has the ability to #confer resistance to alkylation chemotherapies (kaina et al . , 1991) , demonstrating the role of agt in therapeutic resistance .
increased agt levels parallel acquired alkylation resistance in human tumors (brent et al . , 1985; mattern et al . , 1998) , and human 06-alkylguaning-dna alkyltransferase is able to #confer resistance to alkylation chemotherapies (kaina et al . , 1991) , demonstrating the role of agt in therapeutic resistance .
increased agt levels parallel acquired alkylation resistance in human tumors (brent et al . , 1985; mattern et al . , 1998) , and human 06-alkylguaning-dna alkyltransferase may #confer resistance to alkylation chemotherapies (kaina et al . , 1991) , demonstrating the role of agt in therapeutic resistance .
increased agt levels parallel acquired alkylation resistance in human tumors (brent et al . , 1985; mattern et al . , 1998) , and human 06-alkylguaning-dna alkyltransferase might #confer resistance to alkylation chemotherapies (kaina et al . , 1991) , demonstrating the role of agt in therapeutic resistance .
increased agt levels parallel acquired alkylation resistance in human tumors (brent et al . , 1985; mattern et al . , 1998) , and human 06-alkylguaning-dna alkyltransferase was able to #confer resistance to alkylation chemotherapies (kaina et al . , 1991) , demonstrating the role of agt in therapeutic resistance .
increased agt levels parallel acquired alkylation resistance in human tumors (brent et al . , 1985; mattern et al . , 1998) , and human 06-alkylguaning-dna alkyltransferase was observed to #confer resistance to alkylation chemotherapies (kaina et al . , 1991) , demonstrating the role of agt in therapeutic resistance .
increased agt levels parallel acquired alkylation resistance in human tumors (brent et al . , 1985; mattern et al . , 1998) , and resistance can have been #conferred by human 06-alkylguaning-dna alkyltransferase to alkylation chemotherapies (kaina et al . , 1991) , demonstrating the role of agt in therapeutic resistance .
increased agt levels parallel acquired alkylation resistance in human tumors (brent et al . , 1985; mattern et al . , 1998) , and resistance has been #conferred by human 06-alkylguaning-dna alkyltransferase to alkylation chemotherapies (kaina et al . , 1991) , demonstrating the role of agt in therapeutic resistance .
increased agt levels parallel acquired alkylation resistance in human tumors (brent et al . , 1985; mattern et al . , 1998) , and resistance is able to be #conferred by human 06-alkylguaning-dna alkyltransferase to alkylation chemotherapies (kaina et al . , 1991) , demonstrating the role of agt in therapeutic resistance .
increased agt levels parallel acquired alkylation resistance in human tumors (brent et al . , 1985; mattern et al . , 1998) , and resistance may be #conferred by human 06-alkylguaning-dna alkyltransferase to alkylation chemotherapies (kaina et al . , 1991) , demonstrating the role of agt in therapeutic resistance .
increased agt levels parallel acquired alkylation resistance in human tumors (brent et al . , 1985; mattern et al . , 1998) , and resistance may have been #conferred by human 06-alkylguaning-dna alkyltransferase to alkylation chemotherapies (kaina et al . , 1991) , demonstrating the role of agt in therapeutic resistance .
increased agt levels parallel acquired alkylation resistance in human tumors (brent et al . , 1985; mattern et al . , 1998) , and resistance might be #conferred by human 06-alkylguaning-dna alkyltransferase to alkylation chemotherapies (kaina et al . , 1991) , demonstrating the role of agt in therapeutic resistance .
increased agt levels parallel acquired alkylation resistance in human tumors (brent et al . , 1985; mattern et al . , 1998) , and resistance was able to be #conferred by human 06-alkylguaning-dna alkyltransferase to alkylation chemotherapies (kaina et al . , 1991) , demonstrating the role of agt in therapeutic resistance .
increased agt levels parallel acquired alkylation resistance in human tumors (brent et al . , 1985; mattern et al . , 1998) , and resistance was #conferred by human 06-alkylguaning-dna alkyltransferase to alkylation chemotherapies (kaina et al . , 1991) , demonstrating the role of agt in therapeutic resistance .
increased agt levels parallel acquired alkylation resistance in human tumors (brent et al . , 1985; mattern et al . , 1998) , and resistance will have been #conferred by human 06-alkylguaning-dna alkyltransferase to alkylation chemotherapies (kaina et al . , 1991) , demonstrating the role of agt in therapeutic resistance .
increased agt levels parallel acquired alkylation specificity in human tumors (brent et al . , 1985; mattern et al . , 1998) , and the portion of the stats can have #conferred resistance to either a mapk or a mapk substrate kinase (mapkap) (kaina et al . , 1991) , demonstrating the role of agt in therapeutic resistance .
increased agt levels parallel acquired alkylation specificity in human tumors (brent et al . , 1985; mattern et al . , 1998) , and the portion of the stats #conferred resistance to either a mapk or a mapk substrate kinase (mapkap) (kaina et al . , 1991) , demonstrating the role of agt in therapeutic resistance .
increased agt levels parallel acquired alkylation specificity in human tumors (brent et al . , 1985; mattern et al . , 1998) , and the portion of the stats #confers resistance to either a mapk or a mapk substrate kinase (mapkap) (kaina et al . , 1991) , demonstrating the role of agt in therapeutic resistance .
increased agt levels parallel acquired alkylation specificity in human tumors (brent et al . , 1985; mattern et al . , 1998) , and the portion of the stats may have #conferred resistance to either a mapk or a mapk substrate kinase (mapkap) (kaina et al . , 1991) , demonstrating the role of agt in therapeutic resistance .
increased agt levels parallel acquired alkylation specificity in human tumors (brent et al . , 1985; mattern et al . , 1998) , and the portion of the stats might #confer resistance to either a mapk or a mapk substrate kinase (mapkap) (kaina et al . , 1991) , demonstrating the role of agt in therapeutic resistance .
increased agt levels parallel acquired alkylation specificity in human tumors (brent et al . , 1985; mattern et al . , 1998) , and the portion of the stats will #confer resistance to either a mapk or a mapk substrate kinase (mapkap) (kaina et al . , 1991) , demonstrating the role of agt in therapeutic resistance .
increased agt levels parallel acquired alkylation specificity in human tumors (brent et al . , 1985; mattern et al . , 1998) , and resistance can be #conferred by the portion of the stats to either a mapk or a mapk substrate kinase (mapkap) (kaina et al . , 1991) , demonstrating the role of agt in therapeutic resistance .
increased agt levels parallel acquired alkylation specificity in human tumors (brent et al . , 1985; mattern et al . , 1998) , and resistance has been #conferred by the portion of the stats to either a mapk or a mapk substrate kinase (mapkap) (kaina et al . , 1991) , demonstrating the role of agt in therapeutic resistance .
increased agt levels parallel acquired alkylation specificity in human tumors (brent et al . , 1985; mattern et al . , 1998) , and resistance is able to be #conferred by the portion of the stats to either a mapk or a mapk substrate kinase (mapkap) (kaina et al . , 1991) , demonstrating the role of agt in therapeutic resistance .
increased agt levels parallel acquired alkylation specificity in human tumors (brent et al . , 1985; mattern et al . , 1998) , and resistance is #conferred by the portion of the stats to either a mapk or a mapk substrate kinase (mapkap) (kaina et al . , 1991) , demonstrating the role of agt in therapeutic resistance .
increased agt levels parallel acquired alkylation specificity in human tumors (brent et al . , 1985; mattern et al . , 1998) , and resistance was #conferred by the portion of the stats to either a mapk or a mapk substrate kinase (mapkap) (kaina et al . , 1991) , demonstrating the role of agt in therapeutic resistance .
increased agt levels parallel acquired alkylation specificity in human tumors (brent et al . , 1985; mattern et al . , 1998) , and resistance will be #conferred by the portion of the stats to either a mapk or a mapk substrate kinase (mapkap) (kaina et al . , 1991) , demonstrating the role of agt in therapeutic resistance .
increased agt levels parallel acquired alkylation specificity in human tumors (brent et al . , 1985; mattern et al . , 1998) , and resistance would be #conferred by the portion of the stats to either a mapk or a mapk substrate kinase (mapkap) (kaina et al . , 1991) , demonstrating the role of agt in therapeutic resistance .
likewise , the introduced charge of gly160his and gly160arg mutants would repel the benzyl group (figure 3b) , evga overexpression #confer the resistance (xu-welliver et al . , 1999a) .
likewise , the introduced charge of gly160his and gly160arg mutants would repel the benzyl group (figure 3b) , evga overexpression might #confer the resistance (xu-welliver et al . , 1999a) .
likewise , the introduced charge of gly160his and gly160arg mutants would repel the benzyl group (figure 3b) , evga overexpression will #confer the resistance (xu-welliver et al . , 1999a) .
likewise , the introduced charge of gly160his and gly160arg mutants would repel the benzyl group (figure 3b) , evga overexpression would #confer the resistance (xu-welliver et al . , 1999a) .
likewise , the introduced charge of gly160his and gly160arg mutants would repel the benzyl group (figure 3b) , the resistance has been #conferred by evga overexpression (xu-welliver et al . , 1999a) .
likewise , the introduced charge of gly160his and gly160arg mutants would repel the benzyl group (figure 3b) , the resistance is able to be #conferred by evga overexpression (xu-welliver et al . , 1999a) .
likewise , the introduced charge of gly160his and gly160arg mutants would repel the benzyl group (figure 3b) , the resistance may be #conferred by evga overexpression (xu-welliver et al . , 1999a) .
likewise , the introduced charge of gly160his and gly160arg mutants would repel the benzyl group (figure 3b) , the resistance was able to be #conferred by evga overexpression (xu-welliver et al . , 1999a) .
likewise , the introduced charge of gly160his and gly160arg mutants would repel the benzyl group (figure 3b) , the resistance would be #conferred by evga overexpression (xu-welliver et al . , 1999a) .
the data from the chimeras indicate that the difference is due to the absence of carboxyl sequences in alkylation chemotherapies , since human 06-alkylguaning-dna alkyltransferase could #confer resistance on stat1 .
the data from the chimeras indicate that the difference is due to the absence of carboxyl sequences in alkylation chemotherapies , since human 06-alkylguaning-dna alkyltransferase is able to #confer resistance on stat1 .
the data from the chimeras indicate that the difference is due to the absence of carboxyl sequences in alkylation chemotherapies , since human 06-alkylguaning-dna alkyltransferase may #confer resistance on stat1 .
the data from the chimeras indicate that the difference is due to the absence of carboxyl sequences in alkylation chemotherapies , since human 06-alkylguaning-dna alkyltransferase was able to #confer resistance on stat1 .
the data from the chimeras indicate that the difference is due to the absence of carboxyl sequences in alkylation chemotherapies , since resistance can be #conferred on stat1 by human 06-alkylguaning-dna alkyltransferase .
the data from the chimeras indicate that the difference is due to the absence of carboxyl sequences in alkylation chemotherapies , since resistance can have been #conferred on stat1 by human 06-alkylguaning-dna alkyltransferase .
the data from the chimeras indicate that the difference is due to the absence of carboxyl sequences in alkylation chemotherapies , since resistance is able to be #conferred on stat1 by human 06-alkylguaning-dna alkyltransferase .
the data from the chimeras indicate that the difference is due to the absence of carboxyl sequences in alkylation-sensitive cells , since resistance can be #conferred on stat1 by transfection of agt .
the data from the chimeras indicate that the difference is due to the absence of carboxyl sequences in alkylation-sensitive cells , since resistance could be #conferred on stat1 by transfection of agt .
the data from the chimeras indicate that the difference is due to the absence of carboxyl sequences in alkylation-sensitive cells , since resistance is able to be #conferred on stat1 by transfection of agt .
the data from the chimeras indicate that the difference is due to the absence of carboxyl sequences in alkylation-sensitive cells , since transfection of agt can #confer resistance on stat1 .
the data from the chimeras indicate that the difference is due to the absence of carboxyl sequences in alkylation-sensitive cells , since transfection of agt could #confer resistance on stat1 .
the data from the chimeras indicate that the difference is due to the absence of carboxyl sequences in alkylation-sensitive cells , since transfection of agt is able to #confer resistance on stat1 .
the data from the chimeras indicate that the difference is due to the absence of carboxyl sequences in alkylation-sensitive cells , since transfection of agt may #confer resistance on stat1 .
the data from the chimeras indicate that the difference is due to the absence of carboxyl sequences in alkylation-sensitive cells , since transfection of agt will #confer resistance on stat1 .
the data from the chimeras indicate that the difference is due to the absence of carboxyl sequences in either a mapk or a mapk substrate kinase (mapkap) , since the portion of the stats was able to #confer specificity on stat1 .
the data from the chimeras indicate that the difference is due to the absence of carboxyl sequences in either a mapk or a mapk substrate kinase (mapkap) , since specificity is able to be #conferred on stat1 by the portion of the stats .
the portion of the stats (agt) having #conferred specificity to either a mapk or a mapk substrate kinase (mapkap) was therefore an active anticancer drug target .
the portion of the stats (agt) that #conferred specificity to either a mapk or a mapk substrate kinase (mapkap) was therefore an active anticancer drug target .
the portion of the stats (agt) that #confers specificity to either a mapk or a mapk substrate kinase (mapkap) is therefore an active anticancer drug target .
the portion of the stats (agt) that has #conferred specificity to either a mapk or a mapk substrate kinase (mapkap) was therefore an active anticancer drug target .
the portion of the stats (agt) which #conferred specificity to either a mapk or a mapk substrate kinase (mapkap) was therefore an active anticancer drug target .
the portion of the stats (agt) which has #conferred specificity to either a mapk or a mapk substrate kinase (mapkap) was therefore an active anticancer drug target .
the portion of the stats (agt) which is able to #confer specificity to either a mapk or a mapk substrate kinase (mapkap) was therefore an active anticancer drug target .
the portion of the stats (agt) which is believed to #confer specificity to either a mapk or a mapk substrate kinase (mapkap) was therefore an active anticancer drug target .
the portion of the stats (agt) which is observed to #confer specificity to either a mapk or a mapk substrate kinase (mapkap) was therefore an active anticancer drug target .
the portion of the stats (agt) which may #confer specificity to either a mapk or a mapk substrate kinase (mapkap) was therefore an active anticancer drug target .
the portion of the stats (agt) , which directly reverses endogenous alkylation at the 06-position of guanine , can #confer specificity to either a mapk or a mapk substrate kinase (mapkap) and is therefore an active anticancer drug target .
the portion of the stats (agt) , which directly reverses endogenous alkylation at the 06-position of guanine , #conferred specificity to either a mapk or a mapk substrate kinase (mapkap) and is therefore an active anticancer drug target .
the portion of the stats (agt) , which directly reverses endogenous alkylation at the 06-position of guanine , #confers specificity to either a mapk or a mapk substrate kinase (mapkap) and is therefore an active anticancer drug target .
the portion of the stats (agt) , which directly reverses endogenous alkylation at the 06-position of guanine , could #confer specificity to either a mapk or a mapk substrate kinase (mapkap) and was therefore an active anticancer drug target .
the portion of the stats (agt) , which directly reverses endogenous alkylation at the 06-position of guanine , is believed to #confer specificity to either a mapk or a mapk substrate kinase (mapkap) and is therefore an active anticancer drug target .
the portion of the stats (agt) , which directly reverses endogenous alkylation at the 06-position of guanine , is observed to #confer specificity to either a mapk or a mapk substrate kinase (mapkap) and is therefore an active anticancer drug target .
the portion of the stats (agt) , which directly reverses endogenous alkylation at the 06-position of guanine , may #confer specificity to either a mapk or a mapk substrate kinase (mapkap) and is therefore an active anticancer drug target .
the portion of the stats (agt) , which directly reverses endogenous alkylation at the 06-position of guanine , was believed to #confer specificity to either a mapk or a mapk substrate kinase (mapkap) and was therefore an active anticancer drug target .
the portion of the stats (agt) , which directly reverses endogenous alkylation at the 06-position of guanine , was observed to #confer specificity to either a mapk or a mapk substrate kinase (mapkap) and was therefore an active anticancer drug target .
the portion of the stats (agt) , which directly reverses endogenous alkylation at the 06-position of guanine , would #confer specificity to either a mapk or a mapk substrate kinase (mapkap) and was therefore an active anticancer drug target .
transfection of agt (agt) #conferring resistance to alkylation-sensitive cells is therefore an active anticancer drug target .
transfection of agt (agt) having #conferred resistance to alkylation-sensitive cells was therefore an active anticancer drug target .
transfection of agt (agt) that #confers resistance to alkylation-sensitive cells is therefore an active anticancer drug target .
transfection of agt (agt) which can #confer resistance to alkylation-sensitive cells was therefore an active anticancer drug target .
transfection of agt (agt) which #confers resistance to alkylation-sensitive cells is therefore an active anticancer drug target .
transfection of agt (agt) which is observed to #confer resistance to alkylation-sensitive cells was therefore an active anticancer drug target .
transfection of agt (agt) , which directly reverses endogenous alkylation at the 06-position of guanine , can #confer resistance to alkylation-sensitive cells and is therefore an active anticancer drug target .
transfection of agt (agt) , which directly reverses endogenous alkylation at the 06-position of guanine , #confers resistance to alkylation-sensitive cells and is therefore an active anticancer drug target .
transfection of agt (agt) , which directly reverses endogenous alkylation at the 06-position of guanine , is able to #confer resistance to alkylation-sensitive cells and is therefore an active anticancer drug target .
transfection of agt (agt) , which directly reverses endogenous alkylation at the 06-position of guanine , is observed to #confer resistance to alkylation-sensitive cells and is therefore an active anticancer drug target .
transfection of agt (agt) , which directly reverses endogenous alkylation at the 06-position of guanine , may #confer resistance to alkylation-sensitive cells and is therefore an active anticancer drug target .
transfection of agt #conferred resistance for alkylation-sensitive cells .
transfection of agt #conferring resistance for alkylation-sensitive cells has not been determined .
transfection of agt #confers resistance for alkylation-sensitive cells .
in addition , nonsense or frameshift alterations in the coding sequence or by splice variants can not #confer loss-of-function mutations in a tolc-deficient strain .
in addition , nonsense or frameshift alterations in the coding sequence or by splice variants could not #confer loss-of-function mutations in a tolc-deficient strain .
in addition , nonsense or frameshift alterations in the coding sequence or by splice variants did not #confer loss-of-function mutations in a tolc-deficient strain .
in addition , nonsense or frameshift alterations in the coding sequence or by splice variants does not #confer loss-of-function mutations in a tolc-deficient strain .
in addition , nonsense or frameshift alterations in the coding sequence or by splice variants may not #confer loss-of-function mutations in a tolc-deficient strain .
in addition , nonsense or frameshift alterations in the coding sequence or by splice variants was not able to #confer loss-of-function mutations in a tolc-deficient strain .
in itself , loss-of-function mutations cannot be #conferred by nonsense or frameshift alterations in the coding sequence or by splice variants .
in itself , loss-of-function mutations could not be #conferred by nonsense or frameshift alterations in the coding sequence or by splice variants .
in itself , loss-of-function mutations is believed not to be #conferred by nonsense or frameshift alterations in the coding sequence or by splice variants .
in itself , loss-of-function mutations is not able to be #conferred by nonsense or frameshift alterations in the coding sequence or by splice variants .
in itself , loss-of-function mutations was believed not to be #conferred by nonsense or frameshift alterations in the coding sequence or by splice variants .
in itself , loss-of-function mutations was not able to be #conferred by nonsense or frameshift alterations in the coding sequence or by splice variants .
in itself , loss-of-function mutations was not #conferred by nonsense or frameshift alterations in the coding sequence or by splice variants .
in itself , loss-of-function mutations will not be #conferred by nonsense or frameshift alterations in the coding sequence or by splice variants .
in itself , nonsense or frameshift alterations in the coding sequence or by splice variants cannot #confer loss-of-function mutations .
in itself , nonsense or frameshift alterations in the coding sequence or by splice variants cannot have #conferred loss-of-function mutations .
in itself , nonsense or frameshift alterations in the coding sequence or by splice variants does not #confer loss-of-function mutations .
in itself , nonsense or frameshift alterations in the coding sequence or by splice variants is believed not to #confer loss-of-function mutations .
in itself , nonsense or frameshift alterations in the coding sequence or by splice variants is not able to #confer loss-of-function mutations .
in itself , nonsense or frameshift alterations in the coding sequence or by splice variants may not #confer loss-of-function mutations .
in itself , nonsense or frameshift alterations in the coding sequence or by splice variants may not have #conferred loss-of-function mutations .
in itself , nonsense or frameshift alterations in the coding sequence or by splice variants will not #confer loss-of-function mutations .
in itself , nonsense or frameshift alterations in the coding sequence or by splice variants will not have #conferred loss-of-function mutations .
in itself , nonsense or frameshift alterations in the coding sequence or by splice variants would not #confer loss-of-function mutations .
likewise , the introduced charge of gly160his and gly160arg mutants would repel the benzyl group (figure 3b) , nonsense or frameshift alterations in the coding sequence or by splice variants #conferred the loss-of-function mutations (xu-welliver et al . , 1999a) .
likewise , the introduced charge of gly160his and gly160arg mutants would repel the benzyl group (figure 3b) , nonsense or frameshift alterations in the coding sequence or by splice variants is able to #confer the loss-of-function mutations (xu-welliver et al . , 1999a) .
likewise , the introduced charge of gly160his and gly160arg mutants would repel the benzyl group (figure 3b) , nonsense or frameshift alterations in the coding sequence or by splice variants may #confer the loss-of-function mutations (xu-welliver et al . , 1999a) .
likewise , the introduced charge of gly160his and gly160arg mutants would repel the benzyl group (figure 3b) , nonsense or frameshift alterations in the coding sequence or by splice variants was able to #confer the loss-of-function mutations (xu-welliver et al . , 1999a) .
likewise , the introduced charge of gly160his and gly160arg mutants would repel the benzyl group (figure 3b) , nonsense or frameshift alterations in the coding sequence or by splice variants will #confer the loss-of-function mutations (xu-welliver et al . , 1999a) .
likewise , the introduced charge of gly160his and gly160arg mutants would repel the benzyl group (figure 3b) , nonsense or frameshift alterations in the coding sequence or by splice variants would #confer the loss-of-function mutations (xu-welliver et al . , 1999a) .
likewise , the introduced charge of gly160his and gly160arg mutants would repel the benzyl group (figure 3b) , the loss-of-function mutations could be #conferred by nonsense or frameshift alterations in the coding sequence or by splice variants (xu-welliver et al . , 1999a) .
likewise , the introduced charge of gly160his and gly160arg mutants would repel the benzyl group (figure 3b) , the loss-of-function mutations is able to be #conferred by nonsense or frameshift alterations in the coding sequence or by splice variants (xu-welliver et al . , 1999a) .
likewise , the introduced charge of gly160his and gly160arg mutants would repel the benzyl group (figure 3b) , the loss-of-function mutations is #conferred by nonsense or frameshift alterations in the coding sequence or by splice variants (xu-welliver et al . , 1999a) .
likewise , the introduced charge of gly160his and gly160arg mutants would repel the benzyl group (figure 3b) , the loss-of-function mutations may be #conferred by nonsense or frameshift alterations in the coding sequence or by splice variants (xu-welliver et al . , 1999a) .
likewise , the introduced charge of gly160his and gly160arg mutants would repel the benzyl group (figure 3b) , the loss-of-function mutations was #conferred by nonsense or frameshift alterations in the coding sequence or by splice variants (xu-welliver et al . , 1999a) .
likewise , the introduced charge of gly160his and gly160arg mutants would repel the benzyl group (figure 3b) , the loss-of-function mutations would be #conferred by nonsense or frameshift alterations in the coding sequence or by splice variants (xu-welliver et al . , 1999a) .
loss-of-function mutations in a tolc-deficient strain can be #conferred by nonsense or frameshift alterations in the coding sequence or by splice variants .
loss-of-function mutations in a tolc-deficient strain has been #conferred by nonsense or frameshift alterations in the coding sequence or by splice variants .
loss-of-function mutations in a tolc-deficient strain is able to be #conferred by nonsense or frameshift alterations in the coding sequence or by splice variants .
disruption of narl can #decrease nitrite induction of the nirb promoter whilst not suppressing induction by nitrate , suggesting that there may be a second nitrate-responsive factor .
disruption of narl can have #decreased nitrite induction of the nirb promoter whilst not suppressing induction by nitrate , suggesting that there may be a second nitrate-responsive factor .
disruption of narl has #decreased nitrite induction of the nirb promoter whilst not suppressing induction by nitrate , suggesting that there might be a second nitrate-responsive factor .
disruption of narl has the ability to #decrease nitrite induction of the nirb promoter whilst not suppressing induction by nitrate , suggesting that there may be a second nitrate-responsive factor .
disruption of narl is able to #decrease nitrite induction of the nirb promoter whilst not suppressing induction by nitrate , suggesting that there may be a second nitrate-responsive factor .
disruption of narl is shown to #decrease nitrite induction of the nirb promoter whilst not suppressing induction by nitrate , suggesting that there may be a second nitrate-responsive factor .
disruption of narl may #decrease nitrite induction of the nirb promoter whilst not suppressing induction by nitrate , suggesting that there may be a second nitrate-responsive factor .
disruption of narl was shown to #decrease nitrite induction of the nirb promoter whilst not suppressing induction by nitrate , suggesting that there might be a second nitrate-responsive factor .
if this distance of 30 amino acids is not maintained , as in human asprs chimera#1 , or in yeast lysts chimera#1 and yeast asnrs chimera#2 (figure 5b) , the binding to trna is strongly affected and the protection can have been #decreased , or even abolished in the case of human asprs chimera#1 (table) .
if this distance of 30 amino acids is not maintained , as in human asprs chimera#1 , or in yeast lysts chimera#1 and yeast asnrs chimera#2 (figure 5b) , the binding to trna is strongly affected and the protection could be #decreased , or even abolished in the case of human asprs chimera#1 (table) .
if this distance of 30 amino acids is not maintained , as in human asprs chimera#1 , or in yeast lysts chimera#1 and yeast asnrs chimera#2 (figure 5b) , the binding to trna is strongly affected and the protection had been #decreased , or even abolished in the case of human asprs chimera#1 (table) .
if this distance of 30 amino acids is not maintained , as in human asprs chimera#1 , or in yeast lysts chimera#1 and yeast asnrs chimera#2 (figure 5b) , the binding to trna is strongly affected and the protection is believed to be #decreased , or even abolished in the case of human asprs chimera#1 (table) .
if this distance of 30 amino acids is not maintained , as in human asprs chimera#1 , or in yeast lysts chimera#1 and yeast asnrs chimera#2 (figure 5b) , the binding to trna is strongly affected and the protection is shown to be #decreased , or even abolished in the case of human asprs chimera#1 (table) .
if this distance of 30 amino acids is not maintained , as in human asprs chimera#1 , or in yeast lysts chimera#1 and yeast asnrs chimera#2 (figure 5b) , the binding to trna is strongly affected and the protection may be #decreased , or even abolished in the case of human asprs chimera#1 (table) .
if this distance of 30 amino acids is not maintained , as in human asprs chimera#1 , or in yeast lysts chimera#1 and yeast asnrs chimera#2 (figure 5b) , the binding to trna is strongly affected and the protection was #decreased , or even abolished in the case of human asprs chimera#1 (table) .
if this distance of 30 amino acids is not maintained , as in human asprs chimera#1 , or in yeast lysts chimera#1 and yeast asnrs chimera#2 (figure 5b) , the binding to trna is strongly affected and the protection will have been #decreased , or even abolished in the case of human asprs chimera#1 (table) .
in brain areas of schizophrenia patients homologous to those of the nonpsychiatric subjects , the reln mrna content can be significantly #decreased (4050%; see table 2) .
in brain areas of schizophrenia patients homologous to those of the nonpsychiatric subjects , the reln mrna content could be significantly #decreased (4050%; see table 2) .
in brain areas of schizophrenia patients homologous to those of the nonpsychiatric subjects , the reln mrna content has been significantly #decreased (4050%; see table 2) .
in brain areas of schizophrenia patients homologous to those of the nonpsychiatric subjects , the reln mrna content is being significantly #decreasing (4050%; see table 2) .
in brain areas of schizophrenia patients homologous to those of the nonpsychiatric subjects , the reln mrna content may be significantly #decreased (4050%; see table 2) .
in brain areas of schizophrenia patients homologous to those of the nonpsychiatric subjects , the reln mrna content may have been significantly #decreased (4050%; see table 2) .
in brain areas of schizophrenia patients homologous to those of the nonpsychiatric subjects , the reln mrna content was being significantly #decreasing (4050%; see table 2) .
in brain areas of schizophrenia patients homologous to those of the nonpsychiatric subjects , the reln mrna content was believed to be significantly #decreased (4050%; see table 2) .
in brain areas of schizophrenia patients homologous to those of the nonpsychiatric subjects , the reln mrna content will have been significantly #decreased (4050%; see table 2) .
in contrast , only low levels of the truncated rap1 peptides are detected (consistent with that expression levels can have been lowered and methionine content can have been decreased) , and neither rap2 nor rap3 is co-immunoprecipitated in the rap1 mutants .
in contrast , only low levels of the truncated rap1 peptides are detected (consistent with that expression levels is lowered and methionine content is decreased) , and neither rap2 nor rap3 is co-immunoprecipitated in the rap1 mutants .
in contrast , only low levels of the truncated rap1 peptides are detected (consistent with that expression levels may have been lowered and methionine content may have been decreased) , and neither rap2 nor rap3 is co-immunoprecipitated in the rap1 mutants .
in contrast , only low levels of the truncated rap1 peptides have been detected (consistent with that expression levels has been lowered and methionine content has been decreased) , and neither rap2 nor rap3 has been co-immunoprecipitated in the rap1 mutants .
in contrast , only low levels of the truncated rap1 peptides were detected (consistent with that expression levels might be lowered and methionine content might be decreased) , and neither rap2 nor rap3 was co-immunoprecipitated in the rap1 mutants .
in contrast , only low levels of the truncated rap1 peptides were detected (consistent with that expression levels was able to be lowered and methionine content was able to be decreased) , and neither rap2 nor rap3 was be co-immunoprecipitated in the rap1 mutants .
in contrast , only low levels of the truncated rap1 peptides will be detected (consistent with that expression levels will be lowered and methionine content will be decreased) , and neither rap2 nor rap3 will be co-immunoprecipitated in the rap1 mutants .
lipid peroxide synthesis could be #decreased by treatment with melatonin , and permitted a recovery of both reduced glutathione and scavenger enzyme activity .
lipid peroxide synthesis is believed to be #decreased by treatment with melatonin , and permits a recovery of both reduced glutathione and scavenger enzyme activity .
lipid peroxide synthesis may be #decreased by treatment with melatonin , and permits a recovery of both reduced glutathione and scavenger enzyme activity .
lipid peroxide synthesis may have been #decreased by treatment with melatonin , and have permitted a recovery of both reduced glutathione and scavenger enzyme activity .
lipid peroxide synthesis might be #decreased by treatment with melatonin , and permitted a recovery of both reduced glutathione and scavenger enzyme activity .
lipid peroxide synthesis was able to be #decreased by treatment with melatonin , and permitted a recovery of both reduced glutathione and scavenger enzyme activity .
lipid peroxide synthesis will have been #decreased by treatment with melatonin , and have permitted a recovery of both reduced glutathione and scavenger enzyme activity .
lipid peroxide synthesis would be #decreased by treatment with melatonin , and permitted a recovery of both reduced glutathione and scavenger enzyme activity .
mef2-binding sites have been reported in several cardiac promoters and promoter activity could be #decreased by their mutation in cardiomyocytes .
mef2-binding sites have been reported in several cardiac promoters and promoter activity is able to be #decreased by their mutation in cardiomyocytes .
mef2-binding sites have been reported in several cardiac promoters and promoter activity is believed to be #decreased by their mutation in cardiomyocytes .
mef2-binding sites have been reported in several cardiac promoters and promoter activity might be #decreased by their mutation in cardiomyocytes .
mef2-binding sites have been reported in several cardiac promoters and promoter activity was #decreased by their mutation in cardiomyocytes .
mef2-binding sites have been reported in several cardiac promoters and promoter activity will be #decreased by their mutation in cardiomyocytes .
mef2-binding sites have been reported in several cardiac promoters and their mutation can #decrease promoter activity in cardiomyocytes .
mef2-binding sites have been reported in several cardiac promoters and their mutation could #decrease promoter activity in cardiomyocytes .
mef2-binding sites have been reported in several cardiac promoters and their mutation #decreased promoter activity in cardiomyocytes .
mef2-binding sites have been reported in several cardiac promoters and their mutation had the ability to #decrease promoter activity in cardiomyocytes .
mef2-binding sites have been reported in several cardiac promoters and their mutation has the ability to #decrease promoter activity in cardiomyocytes .
mef2-binding sites have been reported in several cardiac promoters and their mutation is able to #decrease promoter activity in cardiomyocytes .
mef2-binding sites have been reported in several cardiac promoters and their mutation might #decrease promoter activity in cardiomyocytes .
mef2-binding sites have been reported in several cardiac promoters and their mutation would #decrease promoter activity in cardiomyocytes .
nitrite induction of the nirb promoter can be #decreased by disruption of narl which is not suppressing induction by nitrate , suggesting that there may be a second nitrate-responsive factor .
nitrite induction of the nirb promoter can have been #decreased by disruption of narl which is not suppressing induction by nitrate , suggesting that there may be a second nitrate-responsive factor .
nitrite induction of the nirb promoter has been #decreased by disruption of narl which has not been suppressing induction by nitrate , suggesting that there may be a second nitrate-responsive factor .
nitrite induction of the nirb promoter is able to be #decreased by disruption of narl which is not suppressing induction by nitrate , suggesting that there may be a second nitrate-responsive factor .
nitrite induction of the nirb promoter is believed to be #decreased by disruption of narl which is not suppressing induction by nitrate , suggesting that there may be a second nitrate-responsive factor .
nitrite induction of the nirb promoter may be #decreased by disruption of narl which is not suppressing induction by nitrate , suggesting that there may be a second nitrate-responsive factor .
nitrite induction of the nirb promoter may have been #decreased by disruption of narl which is not suppressing induction by nitrate , suggesting that there may be a second nitrate-responsive factor .
nitrite induction of the nirb promoter was believed to be #decreased by disruption of narl which was not suppressing induction by nitrate , suggesting that there may be a second nitrate-responsive factor .
nitrite induction of the nirb promoter was shown to be #decreased by disruption of narl which was not suppressing induction by nitrate , suggesting that there may be a second nitrate-responsive factor .
nitrite induction of the nirb promoter will have been #decreased by disruption of narl which is not suppressing induction by nitrate , suggesting that there may be a second nitrate-responsive factor .
the levels of clara cell secretory protein can be #decreased in nlf from smokers , and it has also been found that nlf from smokers contained increased proportions of a truncated variant of lipocortin-1 , threee acidic forms of alpha (1)-antitrypsin , and one phosphorylated form of cystatin s .syntrophin binds to an alternatively spliced exon of dystrophin .
the levels of clara cell secretory protein can be #decreased in nlf from smokers , and it is also found that nlf from smokers contained increased proportions of a truncated variant of lipocortin-1 , threee acidic forms of alpha (1)-antitrypsin , and one phosphorylated form of cystatin s .syntrophin binds to an alternatively spliced exon of dystrophin .
the levels of clara cell secretory protein could be #decreased in nlf from smokers , and it has also been found that nlf from smokers contained increased proportions of a truncated variant of lipocortin-1 , threee acidic forms of alpha (1)-antitrypsin , and one phosphorylated form of cystatin s .syntrophin binds to an alternatively spliced exon of dystrophin .
the levels of clara cell secretory protein could be #decreased in nlf from smokers , and it was also found that nlf from smokers contained increased proportions of a truncated variant of lipocortin-1 , threee acidic forms of alpha (1)-antitrypsin , and one phosphorylated form of cystatin s .syntrophin binds to an alternatively spliced exon of dystrophin .
the levels of clara cell secretory protein is able to be #decreased in nlf from smokers , and it has also been found that nlf from smokers contained increased proportions of a truncated variant of lipocortin-1 , threee acidic forms of alpha (1)-antitrypsin , and one phosphorylated form of cystatin s .syntrophin binds to an alternatively spliced exon of dystrophin .
the levels of clara cell secretory protein is able to be #decreased in nlf from smokers , and it is also found that nlf from smokers contained increased proportions of a truncated variant of lipocortin-1 , threee acidic forms of alpha (1)-antitrypsin , and one phosphorylated form of cystatin s .syntrophin binds to an alternatively spliced exon of dystrophin .
the levels of clara cell secretory protein is believed to be #decreased in nlf from smokers , and it is also found that nlf from smokers contained increased proportions of a truncated variant of lipocortin-1 , threee acidic forms of alpha (1)-antitrypsin , and one phosphorylated form of cystatin s .syntrophin binds to an alternatively spliced exon of dystrophin .
the levels of clara cell secretory protein is #decreased in nlf from smokers , and it is also found that nlf from smokers contained increased proportions of a truncated variant of lipocortin-1 , threee acidic forms of alpha (1)-antitrypsin , and one phosphorylated form of cystatin s .syntrophin binds to an alternatively spliced exon of dystrophin .
the levels of clara cell secretory protein is shown to be #decreased in nlf from smokers , and it is also found that nlf from smokers contained increased proportions of a truncated variant of lipocortin-1 , threee acidic forms of alpha (1)-antitrypsin , and one phosphorylated form of cystatin s .syntrophin binds to an alternatively spliced exon of dystrophin .
the levels of clara cell secretory protein may have been #decreased in nlf from smokers , and it has also been found that nlf from smokers contained increased proportions of a truncated variant of lipocortin-1 , threee acidic forms of alpha (1)-antitrypsin , and one phosphorylated form of cystatin s .syntrophin binds to an alternatively spliced exon of dystrophin .
the levels of clara cell secretory protein might be #decreased in nlf from smokers , and it has also been found that nlf from smokers contained increased proportions of a truncated variant of lipocortin-1 , threee acidic forms of alpha (1)-antitrypsin , and one phosphorylated form of cystatin s .syntrophin binds to an alternatively spliced exon of dystrophin .
the levels of clara cell secretory protein might be #decreased in nlf from smokers , and it was also found that nlf from smokers contained increased proportions of a truncated variant of lipocortin-1 , threee acidic forms of alpha (1)-antitrypsin , and one phosphorylated form of cystatin s .syntrophin binds to an alternatively spliced exon of dystrophin .
the levels of clara cell secretory protein was able to be #decreased in nlf from smokers , and it has also been found that nlf from smokers contained increased proportions of a truncated variant of lipocortin-1 , threee acidic forms of alpha (1)-antitrypsin , and one phosphorylated form of cystatin s .syntrophin binds to an alternatively spliced exon of dystrophin .
the levels of clara cell secretory protein was #decreased in nlf from smokers , and it was also found that nlf from smokers contained increased proportions of a truncated variant of lipocortin-1 , threee acidic forms of alpha (1)-antitrypsin , and one phosphorylated form of cystatin s .syntrophin binds to an alternatively spliced exon of dystrophin .
the levels of clara cell secretory protein will be #decreased in nlf from smokers , and it is also found that nlf from smokers contained increased proportions of a truncated variant of lipocortin-1 , threee acidic forms of alpha (1)-antitrypsin , and one phosphorylated form of cystatin s .syntrophin binds to an alternatively spliced exon of dystrophin .
the production of c51 microcin #decreases or is absent in rpos , crp and cya mutant cells .
the production of c51 microcin had the ability to to #decrease or be absent in rpos , crp and cya mutant cells .
the production of c51 microcin is believed to #decrease or be absent in rpos , crp and cya mutant cells .
the production of c51 microcin is shown to #decrease or be absent in rpos , crp and cya mutant cells .
the production of c51 microcin may #decrease or be absent in rpos , crp and cya mutant cells .
the production of c51 microcin might #decrease or be absent in rpos , crp and cya mutant cells .
the production of c51 microcin was shown to #decrease or be absent in rpos , crp and cya mutant cells .
the production of c51 microcin will #decrease or be absent in rpos , crp and cya mutant cells .
the production of c51 microcin would #decrease or be absent in rpos , crp and cya mutant cells .
treatment with melatonin could #decrease lipid peroxide synthesis , and permitted a recovery of both reduced glutathione and scavenger enzyme activity .
treatment with melatonin is able to #decrease lipid peroxide synthesis , and permits a recovery of both reduced glutathione and scavenger enzyme activity .
treatment with melatonin is shown to #decrease lipid peroxide synthesis , and permits a recovery of both reduced glutathione and scavenger enzyme activity .
treatment with melatonin may #decrease lipid peroxide synthesis , and permits a recovery of both reduced glutathione and scavenger enzyme activity .
treatment with melatonin was able to #decrease lipid peroxide synthesis , and permitted a recovery of both reduced glutathione and scavenger enzyme activity .
treatment with melatonin will #decrease lipid peroxide synthesis , and permits a recovery of both reduced glutathione and scavenger enzyme activity .
treatment with melatonin would #decrease lipid peroxide synthesis , and permitted a recovery of both reduced glutathione and scavenger enzyme activity .
levels of clara cell have been reported in several cardiac promoters and their mutation was shown to #decrease promoter activity in cardiomyocytes .
the production of c51 microcin #decreased or was absent in rpos , crp and cya mutant cells .
treatment with melatonin #decreased lipid peroxide synthesis , and permitted a recovery of both reduced glutathione and scavenger enzyme activity .
deletion of the arca gene caused about a 2-fold increase in the ptsg expression , and disruption of narl has significantly #decreased nitrite induction of the nirb promoter .
deletion of the arca gene caused about a 2-fold increase in the ptsg expression , and disruption of narl is observed to have significantly #decreased nitrite induction of the nirb promoter .
deletion of the arca gene caused about a 2-fold increase in the ptsg expression , and disruption of narl significantly #decreased nitrite induction of the nirb promoter .
deletion of the arca gene caused about a 2-fold increase in the ptsg expression , and treatment with melatonin significantly #decreased lipid peroxide synthesis .
deletion of the arca gene caused about a 2-fold increase in the ptsg expression , and nitrite induction of the nirb promoter have been significantly #decreased by disruption of narl will significantly .
deletion of the arca gene causes about a 2-fold increase in the ptsg expression , and disruption of narl can have significantly #decreased nitrite induction of the nirb promoter .
deletion of the arca gene causes about a 2-fold increase in the ptsg expression , and disruption of narl can significantly #decrease nitrite induction of the nirb promoter .
deletion of the arca gene causes about a 2-fold increase in the ptsg expression , and disruption of narl could significantly #decrease nitrite induction of the nirb promoter .
deletion of the arca gene causes about a 2-fold increase in the ptsg expression , and disruption of narl is believed to have significantly #decreased nitrite induction of the nirb promoter .
deletion of the arca gene causes about a 2-fold increase in the ptsg expression , and disruption of narl is observed to significantly #decrease nitrite induction of the nirb promoter .
deletion of the arca gene causes about a 2-fold increase in the ptsg expression , and disruption of narl is shown to significantly #decrease nitrite induction of the nirb promoter .
deletion of the arca gene causes about a 2-fold increase in the ptsg expression , and disruption of narl may have significantly #decreased nitrite induction of the nirb promoter .
deletion of the arca gene causes about a 2-fold increase in the ptsg expression , and disruption of narl significantly #decreases nitrite induction of the nirb promoter .
deletion of the arca gene causes about a 2-fold increase in the ptsg expression , and disruption of narl was able to significantly #decrease nitrite induction of the nirb promoter .
deletion of the arca gene causes about a 2-fold increase in the ptsg expression , and disruption of narl would significantly #decrease nitrite induction of the nirb promoter .
deletion of the arca gene causes about a 2-fold increase in the ptsg expression , and treatment with melatonin can have significantly #decreased lipid peroxide synthesis .
deletion of the arca gene causes about a 2-fold increase in the ptsg expression , and treatment with melatonin could significantly #decrease lipid peroxide synthesis .
deletion of the arca gene causes about a 2-fold increase in the ptsg expression , and treatment with melatonin is believed to have significantly #decreased lipid peroxide synthesis .
deletion of the arca gene causes about a 2-fold increase in the ptsg expression , and treatment with melatonin might significantly #decrease lipid peroxide synthesis .
deletion of the arca gene causes about a 2-fold increase in the ptsg expression , and treatment with melatonin was shown to significantly #decrease lipid peroxide synthesis .
deletion of the arca gene causes about a 2-fold increase in the ptsg expression , and treatment with melatonin would significantly #decrease lipid peroxide synthesis .
deletion of the arca gene causes about a 2-fold increase in the ptsg expression , and lipid peroxide synthesis could be significantly #decreased by treatment with melatonin will significantly .
deletion of the arca gene causes about a 2-fold increase in the ptsg expression , and lipid peroxide synthesis is able to be significantly #decreased by treatment with melatonin will significantly .
deletion of the arca gene causes about a 2-fold increase in the ptsg expression , and lipid peroxide synthesis is believed to be significantly #decreased by treatment with melatonin will significantly .
deletion of the arca gene causes about a 2-fold increase in the ptsg expression , and lipid peroxide synthesis is shown to be significantly #decreased by treatment with melatonin will significantly .
deletion of the arca gene causes about a 2-fold increase in the ptsg expression , and lipid peroxide synthesis may have been significantly #decreased by treatment with melatonin will significantly .
deletion of the arca gene causes about a 2-fold increase in the ptsg expression , and lipid peroxide synthesis might be significantly #decreased by treatment with melatonin will significantly .
deletion of the arca gene causes about a 2-fold increase in the ptsg expression , and lipid peroxide synthesis was shown to be significantly #decreased by treatment with melatonin will significantly .
deletion of the arca gene causes about a 2-fold increase in the ptsg expression , and nitrite induction of the nirb promoter are significantly #decreased by disruption of narl will significantly .
deletion of the arca gene causes about a 2-fold increase in the ptsg expression , and nitrite induction of the nirb promoter can be significantly #decreased by disruption of narl will significantly .
deletion of the arca gene causes about a 2-fold increase in the ptsg expression , and nitrite induction of the nirb promoter can have been significantly #decreased by disruption of narl will significantly .
deletion of the arca gene causes about a 2-fold increase in the ptsg expression , and nitrite induction of the nirb promoter may have been significantly #decreased by disruption of narl will significantly .
deletion of the arca gene causes about a 2-fold increase in the ptsg expression , and nitrite induction of the nirb promoter might be significantly #decreased by disruption of narl will significantly .
deletion of the arca gene causes about a 2-fold increase in the ptsg expression , and nitrite induction of the nirb promoter was shown to be significantly #decreased by disruption of narl will significantly .
deletion of the arca gene causes about a 2-fold increase in the ptsg expression , and nitrite induction of the nirb promoter will be significantly #decreased by disruption of narl will significantly .
disruption of narl could #decrease nitrite induction of the nirb promoter , and permitted a recovery of both reduced glutathione and scavenger enzyme activity .
disruption of narl #decreased nitrite induction of the nirb promoter , and permitted a recovery of both reduced glutathione and scavenger enzyme activity .
disruption of narl #decreases nitrite induction of the nirb promoter , and permitted a recovery of both reduced glutathione and scavenger enzyme activity .
disruption of narl is able to #decrease nitrite induction of the nirb promoter , and permits a recovery of both reduced glutathione and scavenger enzyme activity .
disruption of narl is believed to #decrease nitrite induction of the nirb promoter , and permits a recovery of both reduced glutathione and scavenger enzyme activity .
disruption of narl is shown to #decrease nitrite induction of the nirb promoter , and permits a recovery of both reduced glutathione and scavenger enzyme activity .
disruption of narl may #decrease nitrite induction of the nirb promoter , and permits a recovery of both reduced glutathione and scavenger enzyme activity .
disruption of narl was able to #decrease nitrite induction of the nirb promoter , and permitted a recovery of both reduced glutathione and scavenger enzyme activity .
disruption of narl was believed to #decrease nitrite induction of the nirb promoter , and permitted a recovery of both reduced glutathione and scavenger enzyme activity .
disruption of narl would #decrease nitrite induction of the nirb promoter , and permitted a recovery of both reduced glutathione and scavenger enzyme activity .
in contrast , only low levels of the truncated rap1 peptides are detected (consistent with that expression levels can be lowered and the reln mrna content can be decreased) , and neither rap2 nor rap3 is co-immunoprecipitated in the rap1 mutants .
in contrast , only low levels of the truncated rap1 peptides are detected (consistent with that expression levels is able to be lowered and the reln mrna content is able to be decreased) , and neither rap2 nor rap3 is be co-immunoprecipitated in the rap1 mutants .
in contrast , only low levels of the truncated rap1 peptides are detected (consistent with that expression levels may have been lowered and the reln mrna content may have been decreased) , and neither rap2 nor rap3 is co-immunoprecipitated in the rap1 mutants .
in contrast , only low levels of the truncated rap1 peptides have been detected (consistent with that expression levels has been lowered and the reln mrna content has been decreased) , and neither rap2 nor rap3 has been co-immunoprecipitated in the rap1 mutants .
in contrast , only low levels of the truncated rap1 peptides were detected (consistent with that expression levels was lowered and the reln mrna content was decreased) , and neither rap2 nor rap3 was co-immunoprecipitated in the rap1 mutants .
treatment with melatonin can #decrease lipid peroxide synthesis whilst not suppressing induction by nitrate , suggesting that there may be a second nitrate-responsive factor .
treatment with melatonin can have #decreased lipid peroxide synthesis whilst not suppressing induction by nitrate , suggesting that there may be a second nitrate-responsive factor .
treatment with melatonin #decreases lipid peroxide synthesis whilst not suppressing induction by nitrate , suggesting that there may be a second nitrate-responsive factor .
treatment with melatonin has #decreased lipid peroxide synthesis whilst not suppressing induction by nitrate , suggesting that there might be a second nitrate-responsive factor .
treatment with melatonin has the ability to #decrease lipid peroxide synthesis whilst not suppressing induction by nitrate , suggesting that there may be a second nitrate-responsive factor .
treatment with melatonin is able to #decrease lipid peroxide synthesis whilst not suppressing induction by nitrate , suggesting that there may be a second nitrate-responsive factor .
treatment with melatonin is shown to #decrease lipid peroxide synthesis whilst not suppressing induction by nitrate , suggesting that there may be a second nitrate-responsive factor .
treatment with melatonin might #decrease lipid peroxide synthesis whilst not suppressing induction by nitrate , suggesting that there might be a second nitrate-responsive factor .
treatment with melatonin was shown to #decrease lipid peroxide synthesis whilst not suppressing induction by nitrate , suggesting that there might be a second nitrate-responsive factor .
treatment with melatonin will #decrease lipid peroxide synthesis whilst not suppressing induction by nitrate , suggesting that there may be a second nitrate-responsive factor .
treatment with melatonin would #decrease lipid peroxide synthesis whilst not suppressing induction by nitrate , suggesting that there might be a second nitrate-responsive factor .
promoter activity in cardiomyocytes can be #decreased by their mutation .
promoter activity in cardiomyocytes can have been #decreased by their mutation .
promoter activity in cardiomyocytes could be #decreased by their mutation .
promoter activity in cardiomyocytes has been #decreased by their mutation .
promoter activity in cardiomyocytes is able to be #decreased by their mutation .
promoter activity in cardiomyocytes is #decreased by their mutation .
promoter activity in cardiomyocytes was able to be #decreased by their mutation .
promoter activity in cardiomyocytes will have been #decreased by their mutation .
their mutation could #decrease promoter activity in cardiomyocytes .
their mutation #decreases promoter activity in cardiomyocytes .
their mutation has #decreased promoter activity in cardiomyocytes .
their mutation has the ability to #decrease promoter activity in cardiomyocytes .
their mutation is able to #decrease promoter activity in cardiomyocytes .
their mutation is believed to #decrease promoter activity in cardiomyocytes .
their mutation is shown to #decrease promoter activity in cardiomyocytes .
their mutation may #decrease promoter activity in cardiomyocytes .
their mutation may have #decreased promoter activity in cardiomyocytes .
their mutation might #decrease promoter activity in cardiomyocytes .
their mutation was believed to #decrease promoter activity in cardiomyocytes .
their mutation will #decrease promoter activity in cardiomyocytes .
their mutation will have #decreased promoter activity in cardiomyocytes .
their mutation would #decrease promoter activity in cardiomyocytes .
in brain areas of schizophrenia patients homologous to those of the nonpsychiatric subjects , the reln mrna content was significantly #decreased (4050%; see table 2) .
in brain areas of schizophrenia patients homologous to those of the nonpsychiatric subjects , levels of clara cell secretory protein was significantly #decreased (4050%; see table 2) .
in brain areas of schizophrenia patients homologous to those of the nonpsychiatric subjects , the protection was significantly #decreased (4050%; see table 2) .
in contrast , only low levels of the truncated rap1 peptides are detected (consistent with that expression levels can be lowered and the protection can be decreased) , and neither rap2 nor rap3 is co-immunoprecipitated in the rap1 mutants .
in contrast , only low levels of the truncated rap1 peptides are detected (consistent with that expression levels can have been lowered and levels of clara cell secretory protein can have been decreased) , and neither rap2 nor rap3 is co-immunoprecipitated in the rap1 mutants .
in contrast , only low levels of the truncated rap1 peptides are detected (consistent with that expression levels can have been lowered and the protection can have been decreased) , and neither rap2 nor rap3 is co-immunoprecipitated in the rap1 mutants .
in contrast , only low levels of the truncated rap1 peptides are detected (consistent with that expression levels is able to be lowered and levels of clara cell secretory protein is able to be decreased) , and neither rap2 nor rap3 is be co-immunoprecipitated in the rap1 mutants .
in contrast , only low levels of the truncated rap1 peptides are detected (consistent with that expression levels is able to be lowered and the protection is able to be decreased) , and neither rap2 nor rap3 is be co-immunoprecipitated in the rap1 mutants .
in contrast , only low levels of the truncated rap1 peptides are detected (consistent with that expression levels is lowered and levels of clara cell secretory protein is decreased) , and neither rap2 nor rap3 is co-immunoprecipitated in the rap1 mutants .
in contrast , only low levels of the truncated rap1 peptides are detected (consistent with that expression levels may be lowered and levels of clara cell secretory protein may be decreased) , and neither rap2 nor rap3 is co-immunoprecipitated in the rap1 mutants .
in contrast , only low levels of the truncated rap1 peptides are detected (consistent with that expression levels may be lowered and the protection may be decreased) , and neither rap2 nor rap3 is co-immunoprecipitated in the rap1 mutants .
in contrast , only low levels of the truncated rap1 peptides are detected (consistent with that expression levels may have been lowered and levels of clara cell secretory protein may have been decreased) , and neither rap2 nor rap3 is co-immunoprecipitated in the rap1 mutants .
in contrast , only low levels of the truncated rap1 peptides were detected (consistent with that expression levels might be lowered and levels of clara cell secretory protein might be decreased) , and neither rap2 nor rap3 was co-immunoprecipitated in the rap1 mutants .
in contrast , only low levels of the truncated rap1 peptides were detected (consistent with that expression levels was able to be lowered and levels of clara cell secretory protein was able to be decreased) , and neither rap2 nor rap3 was be co-immunoprecipitated in the rap1 mutants .
in contrast , only low levels of the truncated rap1 peptides were detected (consistent with that expression levels was able to be lowered and the protection was able to be decreased) , and neither rap2 nor rap3 was be co-immunoprecipitated in the rap1 mutants .
in contrast , only low levels of the truncated rap1 peptides were detected (consistent with that expression levels was lowered and levels of clara cell secretory protein was decreased) , and neither rap2 nor rap3 was co-immunoprecipitated in the rap1 mutants .
in contrast , only low levels of the truncated rap1 peptides will be detected (consistent with that expression levels will be lowered and the protection will be decreased) , and neither rap2 nor rap3 will be co-immunoprecipitated in the rap1 mutants .
in contrast , only low levels of the truncated rap1 peptides will be detected (consistent with that expression levels will have been lowered and levels of clara cell secretory protein will have been decreased) , and neither rap2 nor rap3 will be co-immunoprecipitated in the rap1 mutants .
in contrast , only low levels of the truncated rap1 peptides would be detected (consistent with that expression levels would be lowered and levels of clara cell secretory protein would be decreased) , and neither rap2 nor rap3 would be co-immunoprecipitated in the rap1 mutants .
in contrast , only low levels of the truncated rap1 peptides would be detected (consistent with that expression levels would be lowered and the protection would be decreased) , and neither rap2 nor rap3 would be co-immunoprecipitated in the rap1 mutants .
alternative mrna splicing in the coding region (encoded by exons 3-12) generates transcripts which can #delete exons 8 (75 nt) , 7+8 (156 nt) or 8+9 (168 nt) and that encode distinct protein isoforms (delta25 , delta52 and delta56 aa , respectively) .
by using homologous recombination in mouse embryonic stem cells , the headpiece domain of dematin will be #deleted to evaluate its function in vivo .
colonies of c .albicans cells being #deleted for cst20 revealed defects in the lateral formation of mycelia on synthetic solid spider media .
colonies of c .albicans cells which cst20 #deleted revealed defects in the lateral formation of mycelia on synthetic solid spider media .
however , the gata-4 mutants being able to #delete the c-terminal transactivition domain (1 332 , 201 332) were all unable to support mef2 synergy .
however , the gata-4 mutants which #deleted the c-terminal transactivition domain (1 332 , 201 332) were all unable to support mef2 synergy .
in plasmid erbb-2: s-d , the zonab binding has been #deleted , and in erbb-2: s-a the inverted ccaat box has been substituted .
in plasmid erbb-2: s-d , the zonab binding is #deleted , and in erbb-2: s-a the inverted ccaat box is substituted .
in the presence of the phage p1 cyclization recombinase cre , the transposon could #delete the ura3 , teta , and lacz genes between the two loxp sites .
in the presence of the phage p1 cyclization recombinase cre , the transposon is able to #delete the ura3 , teta , and lacz genes between the two loxp sites .
mutation of the hns gene in e . coli has resulted in strong expression of the v . fischeri lux system at low cell density even in an rpos which has #deleted strain of e . coli that emits very low levels of luminescence .
of note , the v82f mutation , which occurs adjacent to the 5 donor site of intron 4 , resulted in approximately 54% aberrantly spliced transcripts where exon 4 has been #deleted .
of note , the v82f mutation , which occurs adjacent to the 5 donor site of intron 4 , resulted in approximately 54% aberrantly spliced transcripts with exon 4 being #deleted .
of the splicing mutations , the ivs2+1 allele produced a single transcript where exon 2 can be #deleted .
of the splicing mutations , the ivs2+1 allele produced a single transcript where exon 2 has been #deleted .
of the splicing mutations , the ivs2+1 allele produced a single transcript where exon 2 was #deleted .
of the splicing mutations , the ivs9 delta a+4 allele was alternatively spliced , approximately 26% being normal transcripts and the remainder where exon 9 can be #deleted .
of the splicing mutations , the ivs9 delta a+4 allele was alternatively spliced , approximately 26% being normal transcripts and the remainder where exon 9 has been #deleted .
of the splicing mutations , the ivs9 delta a+4 allele was alternatively spliced , approximately 26% being normal transcripts and the remainder where exon 9 is #deleted .
recent experiments have provided direct evidence that antigen-loaded immature dcs are able to #delete t cells to silence them .
recent experiments have provided direct evidence that antigen-loaded immature dcs can #delete t cells to silence them .
recent experiments have provided direct evidence that antigen-loaded immature dcs #delete t cells or by expanding regulatory t cells .
recent experiments have provided direct evidence that antigen-loaded immature dcs #deleted t cells to silence them .
recent experiments have provided direct evidence that antigen-loaded immature dcs have #deleted t cells to silence them .
recent experiments have provided direct evidence that antigen-loaded immature dcs will #delete t cells to silence them .
studies with strains which are #deleted for the micf locus showed that the mara-dependent reduction of ompf required an intact micf locus .
study of the promoter-lacz gene fusions introduced into the chromosome indicated that gals expression was elevated in cells in which the normal gals gene was interrupted , but not in cells in which the galr gene has been #deleted .
the gata-4 mutants that #delete the n-terminal region (127 443 and 201 443) and the first zinc finger (242 443) were able to synergize with mef2a (figure 6a) .
the gata-4 mutants which can #delete the n-terminal region (127 443 and 201 443) and the first zinc finger (242 443) were able to synergize with mef2a (figure 6a) .
the gata-4 mutants which #delete the n-terminal region (127 443 and 201 443) and the first zinc finger (242 443) were able to synergize with mef2a (figure 6a) .
the gata-4 mutants which has #deleted the n-terminal region (127 443 and 201 443) and the first zinc finger (242 443) were able to synergize with mef2a (figure 6a) .
the gata-4 mutants with the n-terminal region (127 443 and 201 443) and the first zinc finger (242 443) #deleted were able to synergize with mef2a (figure 6a) .
the zonab binding is #deleted in plasmid erbb-2: s-d , and in erbb-2: s-a the inverted ccaat box is substituted .
the generation of replication-competent virus is considered less likely with vectors #deleting the viral transcription elements .
the generation of replication-competent virus is considered less likely with vectors that #deleted the viral transcription elements .
the generation of replication-competent virus is considered less likely with vectors which that #delete the viral transcription elements .
the propensity of isolates of the malaria parasite plasmodium falciparum #deleting a segment of chromosome 9 has provided positional information that has allowed us to identify a gene necessary for cytoadherence .
the propensity of isolates of the malaria parasite plasmodium falciparum proven to #delete a segment of chromosome 9 has provided positional information that has allowed us to identify a gene necessary for cytoadherence .
the propensity of isolates of the malaria parasite plasmodium falciparum which #delete a segment of chromosome 9 has provided positional information that has allowed us to identify a gene necessary for cytoadherence .
using homologous recombination in mouse embryonic stem cells #deletes the headpiece domain of dematin to evaluate its function in vivo .
studies with strains #deleted for the micf locus showed that the mara-dependent reduction of ompf required an intact micf locus .
study of the promoter-lacz gene fusions introduced into the chromosome indicated that gals expression was elevated in cells in which the normal gals gene was interrupted , but not in cells in which the galr gene was #deleted .
alternative mrna splicing in the coding region (encoded by exons 3-12) generates transcripts which #delete exons 8 (75 nt) , 7+8 (156 nt) or 8+9 (168 nt) and that encode distinct protein isoforms (delta25 , delta52 and delta56 aa , respectively) .
of note , the v82f mutation , which occurs adjacent to the 5 donor site of intron 4 , resulted in approximately 54% aberrantly spliced transcripts with exon 4 #deleted .
of the splicing mutations , the ivs2+1 allele produced a single transcript with exon 2 #deleted , whereas the ivs9 delta a+4 allele was alternatively spliced , approximately 26% being normal transcripts and the remainder with exon 9 #deleted .
by appropriate progenitor strains , any chromosomal region was #deleted to evaluate its function in vivo .
by appropriate progenitor strains , any chromosomal region will be #deleted to evaluate its function in vivo .
by antigen-loaded immature dcs , t cells will be #deleted to evaluate its function in vivo .
by isolates of the malaria parasite plasmodium falciparum , a segment of chromosome 9 is #deleted to evaluate its function in vivo .
by isolates of the malaria parasite plasmodium falciparum , a segment of chromosome 9 was #deleted to evaluate its function in vivo .
by isolates of the malaria parasite plasmodium falciparum , a segment of chromosome 9 will be #deleted to evaluate its function in vivo .
by micf locus , strains is #deleted to evaluate its function in vivo .
by micf locus , strains was #deleted to evaluate its function in vivo .
by the development of other immunotherapeutic agents , cytotoxic lymphocyte responses was #deleted to evaluate its function in vivo .
by the transposon , the ura3 , teta , and lacz genes between the two loxp sites was #deleted to evaluate its function in vivo .
c-terminal transactivition domain being #deleted for the gata-4 mutants revealed defects in the lateral formation of mycelia on synthetic solid spider media .
c-terminal transactivition domain #deleted for the gata-4 mutants revealed defects in the lateral formation of mycelia on synthetic solid spider media .
c-terminal transactivition domain which are #deleted for the gata-4 mutants revealed defects in the lateral formation of mycelia on synthetic solid spider media .
cst20 that can be #deleted for colonies of c .albicans cells revealed defects in the lateral formation of mycelia on synthetic solid spider media .
cst20 that #delete colonies of c .albicans cells were able to synergize with mef2a (figure 6a) .
cst20 which can #delete colonies of c .albicans cells were able to synergize with mef2a (figure 6a) .
cst20 which #delete colonies of c .albicans cells were able to synergize with mef2a (figure 6a) .
cst20 which has #deleted colonies of c .albicans cells were able to synergize with mef2a (figure 6a) .
colonies of c .albicans cells being #deleted for cst20 revealed defects in the lateral formation of mycelia on synthetic solid spider media .
colonies of c .albicans cells that are #deleted for cst20 revealed defects in the lateral formation of mycelia on synthetic solid spider media .
colonies of c .albicans cells which cst20 #deleted revealed defects in the lateral formation of mycelia on synthetic solid spider media .
colonies of c .albicans cells which are #deleted for cst20 revealed defects in the lateral formation of mycelia on synthetic solid spider media .
colonies of c .albicans cells which can #delete cst20 were able to synergize with mef2a (figure 6a) .
colonies of c .albicans cells which #deleted cst20 were able to synergize with mef2a (figure 6a) .
colonies of c .albicans cells which has #deleted cst20 were able to synergize with mef2a (figure 6a) .
d: erbb-2: s-d #deleted for mutated zonab-binding site revealed defects in the lateral formation of mycelia on synthetic solid spider media .
d: erbb-2: s-d which mutated zonab-binding site #deleted revealed defects in the lateral formation of mycelia on synthetic solid spider media .
however , cst20 that make the colonies of c .albicans cells (1 332 , 201 332) #deleted were all unable to support mef2 synergy .
however , cst20 which can #delete the colonies of c .albicans cells (1 332 , 201 332) were all unable to support mef2 synergy .
however , colonies of c .albicans cells which can #delete the cst20 (1 332 , 201 332) were all unable to support mef2 synergy .
however , colonies of c .albicans cells which #deleted the cst20 (1 332 , 201 332) were all unable to support mef2 synergy .
however , the gata-4 mutants being able to #delete the the n-terminal region and the first zinc finger (1 332 , 201 332) were all unable to support mef2 synergy .
however , the gata-4 mutants #deleting the the n-terminal region (127 443 and 201 443) and the first zinc finger (242 443) (1 332 , 201 332) were all unable to support mef2 synergy .
however , the gata-4 mutants that #delete the the n-terminal region (127 443 and 201 443) and the first zinc finger (242 443) (1 332 , 201 332) were all unable to support mef2 synergy .
however , the gata-4 mutants that #delete the the n-terminal region and the first zinc finger (1 332 , 201 332) were all unable to support mef2 synergy .
however , the gata-4 mutants that make the the n-terminal region and the first zinc finger (1 332 , 201 332) #deleted were all unable to support mef2 synergy .
however , the gata-4 mutants which #deleted the the n-terminal region and the first zinc finger (1 332 , 201 332) were all unable to support mef2 synergy .
however , mutated zonab-binding site which can #delete the d: erbb-2: s-d (1 332 , 201 332) were all unable to support mef2 synergy .
however , mutated zonab-binding site which #deleted the d: erbb-2: s-d (1 332 , 201 332) were all unable to support mef2 synergy .
however , plasmid erbb-2: s-d which #deleted the the zonab binding (1 332 , 201 332) were all unable to support mef2 synergy .
however , strains that make the micf locus (1 332 , 201 332) #deleted were all unable to support mef2 synergy .
however , strains which #deleted the micf locus (1 332 , 201 332) were all unable to support mef2 synergy .
however , vectors being able to #delete the the viral transcription elements (1 332 , 201 332) were all unable to support mef2 synergy .
however , vectors #deleting the the viral transcription elements (1 332 , 201 332) were all unable to support mef2 synergy .
however , vectors that #delete the the viral transcription elements (1 332 , 201 332) were all unable to support mef2 synergy .
however , vectors which #deleted the the viral transcription elements (1 332 , 201 332) were all unable to support mef2 synergy .
in colonies of c .albicans cells , cst20 has been #deleted , and in erbb-2: s-a the inverted ccaat box has been substituted .
in colonies of c .albicans cells , cst20 is #deleted , and in erbb-2: s-a the inverted ccaat box is substituted .
in colonies of c .albicans cells , cst20 was #deleted , and in erbb-2: s-a the inverted ccaat box was substituted .
in the gata-4 mutants , the n-terminal region (127 443 and 201 443) and the first zinc finger (242 443) is #deleted , and in erbb-2: s-a the inverted ccaat box is substituted .
in the gata-4 mutants , the n-terminal region and the first zinc finger is #deleted , and in erbb-2: s-a the inverted ccaat box is substituted .
in the gata-4 mutants , the n-terminal region and the first zinc finger was #deleted , and in erbb-2: s-a the inverted ccaat box was substituted .
in mutated zonab-binding site , d: erbb-2: s-d was #deleted , and in erbb-2: s-a the inverted ccaat box was substituted .
in strains , micf locus has been #deleted , and in erbb-2: s-a the inverted ccaat box has been substituted .
in strains , micf locus was #deleted , and in erbb-2: s-a the inverted ccaat box was substituted .
in the gata-4 mutants , c-terminal transactivition domain is #deleted , and in erbb-2: s-a the inverted ccaat box is substituted .
in the presence of the phage p1 cyclization recombinase cre , appropriate progenitor strains can #delete any chromosomal region .
in the presence of the phage p1 cyclization recombinase cre , appropriate progenitor strains could #delete any chromosomal region .
in the presence of the phage p1 cyclization recombinase cre , appropriate progenitor strains may #delete any chromosomal region .
in the presence of the phage p1 cyclization recombinase cre , antigen-loaded immature dcs can #delete t cells .
in the presence of the phage p1 cyclization recombinase cre , antigen-loaded immature dcs could #delete t cells .
in the presence of the phage p1 cyclization recombinase cre , antigen-loaded immature dcs may #delete t cells .
in the presence of the phage p1 cyclization recombinase cre , micf locus can #delete strains .
in the presence of the phage p1 cyclization recombinase cre , micf locus could #delete strains .
in the presence of the phage p1 cyclization recombinase cre , the development of other immunotherapeutic agents could #delete cytotoxic lymphocyte responses .
in the presence of the phage p1 cyclization recombinase cre , the development of other immunotherapeutic agents may #delete cytotoxic lymphocyte responses .
in vectors , the viral transcription elements has been #deleted , and in erbb-2: s-a the inverted ccaat box has been substituted .
recent experiments have provided direct evidence that appropriate progenitor strains are able to #delete any chromosomal region to silence them .
recent experiments have provided direct evidence that appropriate progenitor strains can #delete any chromosomal region to silence them .
recent experiments have provided direct evidence that appropriate progenitor strains #deleted any chromosomal region to silence them .
recent experiments have provided direct evidence that appropriate progenitor strains will #delete any chromosomal region to silence them .
recent experiments have provided direct evidence that isolates of the malaria parasite plasmodium falciparum are able to #delete a segment of chromosome 9 to silence them .
recent experiments have provided direct evidence that isolates of the malaria parasite plasmodium falciparum have #deleted a segment of chromosome 9 to silence them .
recent experiments have provided direct evidence that micf locus are able to #delete strains to silence them .
recent experiments have provided direct evidence that micf locus can #delete strains to silence them .
recent experiments have provided direct evidence that micf locus #delete strains or by expanding regulatory t cells .
recent experiments have provided direct evidence that micf locus silence strains either by #deleting them or by expanding regulatory t cells .
recent experiments have provided direct evidence that the development of other immunotherapeutic agents are able to #delete cytotoxic lymphocyte responses to silence them .
recent experiments have provided direct evidence that the development of other immunotherapeutic agents #deleted cytotoxic lymphocyte responses to silence them .
recent experiments have provided direct evidence that the development of other immunotherapeutic agents silence cytotoxic lymphocyte responses either by #deleting them or by expanding regulatory t cells .
recent experiments have provided direct evidence that the transposon silence the ura3 , teta , and lacz genes between the two loxp sites either by #deleting them or by expanding regulatory t cells .
recent experiments have provided direct evidence that the transposon will #delete the ura3 , teta , and lacz genes between the two loxp sites to silence them .
recent experiments have provided direct evidence that using homologous recombination in mouse embryonic stem cells can #delete the headpiece domain of dematin to silence them .
studies with t cells which are #deleted for the antigen-loaded immature dcs showed that the mara-dependent reduction of ompf required an intact micf locus .
studies with t cells which has been #deleted for the antigen-loaded immature dcs showed that the mara-dependent reduction of ompf required an intact micf locus .
studies with t cells which were #deleted for the antigen-loaded immature dcs showed that the mara-dependent reduction of ompf required an intact micf locus .
studies with t cells which will be #deleted for the antigen-loaded immature dcs showed that the mara-dependent reduction of ompf required an intact micf locus .
studies with the gata-4 mutants #deleted for the the n-terminal region (127 443 and 201 443) and the first zinc finger (242 443) showed that the mara-dependent reduction of ompf required an intact micf locus .
studies with a segment of chromosome 9 which are #deleted for the isolates of the malaria parasite plasmodium falciparum showed that the mara-dependent reduction of ompf required an intact micf locus .
studies with a segment of chromosome 9 which were #deleted for the isolates of the malaria parasite plasmodium falciparum showed that the mara-dependent reduction of ompf required an intact micf locus .
studies with any chromosomal region which were #deleted for the appropriate progenitor strains showed that the mara-dependent reduction of ompf required an intact micf locus .
studies with cytotoxic lymphocyte responses which are #deleted for the the development of other immunotherapeutic agents showed that the mara-dependent reduction of ompf required an intact micf locus .
studies with plasmid erbb-2: s-d #deleted for the the zonab binding showed that the mara-dependent reduction of ompf required an intact micf locus .
studies with the gata-4 mutants #deleted for the c-terminal transactivition domain showed that the mara-dependent reduction of ompf required an intact micf locus .
studies with the ura3 , teta , and lacz genes between the two loxp sites which has been #deleted for the the transposon showed that the mara-dependent reduction of ompf required an intact micf locus .
studies with the ura3 , teta , and lacz genes between the two loxp sites which will be #deleted for the the transposon showed that the mara-dependent reduction of ompf required an intact micf locus .
studies with vectors #deleted for the the viral transcription elements showed that the mara-dependent reduction of ompf required an intact micf locus .
the gata-4 mutants that #delete the n-terminal region (127 443 and 201 443) and the first zinc finger (242 443) (242 8211; 443) were able to synergize with mef2a (figure 6a) .
the gata-4 mutants that #delete the n-terminal region and the first zinc finger were able to synergize with mef2a (figure 6a) .
the generation of replication-competent virus is considered less likely with cst20 that #deleted colonies of c .albicans cells .
the generation of replication-competent virus is considered less likely with cst20 which #deleted colonies of c .albicans cells .
the generation of replication-competent virus is considered less likely with cst20 which that #delete colonies of c .albicans cells .
the generation of replication-competent virus is considered less likely with colonies of c .albicans cells that #deleted cst20 .
the generation of replication-competent virus is considered less likely with colonies of c .albicans cells which that #delete cst20 .
the generation of replication-competent virus is considered less likely with the gata-4 mutants #deleting the n-terminal region and the first zinc finger .
the generation of replication-competent virus is considered less likely with the gata-4 mutants that #delete the n-terminal region (127 443 and 201 443) and the first zinc finger (242 443) .
the generation of replication-competent virus is considered less likely with the gata-4 mutants that #deleted the n-terminal region and the first zinc finger .
the generation of replication-competent virus is considered less likely with the gata-4 mutants which #delete the n-terminal region and the first zinc finger .
the generation of replication-competent virus is considered less likely with mutated zonab-binding site #deleting d: erbb-2: s-d .
the generation of replication-competent virus is considered less likely with mutated zonab-binding site that #delete d: erbb-2: s-d .
the generation of replication-competent virus is considered less likely with mutated zonab-binding site which that #delete d: erbb-2: s-d .
the generation of replication-competent virus is considered less likely with plasmid erbb-2: s-d #deleting the zonab binding .
the generation of replication-competent virus is considered less likely with strains #deleting micf locus .
the generation of replication-competent virus is considered less likely with strains that #delete micf locus .
the generation of replication-competent virus is considered less likely with strains that #deleted micf locus .
the generation of replication-competent virus is considered less likely with the gata-4 mutants #deleting c-terminal transactivition domain .
the generation of replication-competent virus is considered less likely with the gata-4 mutants which #delete c-terminal transactivition domain .
the generation of replication-competent virus is considered less likely with the gata-4 mutants which #deleted c-terminal transactivition domain .
the generation of replication-competent virus is considered less likely with the gata-4 mutants which that #delete c-terminal transactivition domain .
the propensity of appropriate progenitor strains #deleting any chromosomal region has provided positional information that has allowed us to identify a gene necessary for cytoadherence .
the propensity of appropriate progenitor strains proven to #delete any chromosomal region has provided positional information that has allowed us to identify a gene necessary for cytoadherence .
the propensity of appropriate progenitor strains to #delete any chromosomal region has provided positional information that has allowed us to identify a gene necessary for cytoadherence .
the propensity of appropriate progenitor strains which #delete any chromosomal region has provided positional information that has allowed us to identify a gene necessary for cytoadherence .
the propensity of antigen-loaded immature dcs beleieved to #delete t cells has provided positional information that has allowed us to identify a gene necessary for cytoadherence .
the propensity of antigen-loaded immature dcs which #delete t cells has provided positional information that has allowed us to identify a gene necessary for cytoadherence .
the propensity of micf locus beleieved to #delete strains has provided positional information that has allowed us to identify a gene necessary for cytoadherence .
the propensity of micf locus to #delete strains has provided positional information that has allowed us to identify a gene necessary for cytoadherence .
the propensity of micf locus which #delete strains has provided positional information that has allowed us to identify a gene necessary for cytoadherence .
the propensity of the development of other immunotherapeutic agents proven to #delete cytotoxic lymphocyte responses has provided positional information that has allowed us to identify a gene necessary for cytoadherence .
the propensity of the development of other immunotherapeutic agents to #delete cytotoxic lymphocyte responses has provided positional information that has allowed us to identify a gene necessary for cytoadherence .
the propensity of the transposon proven to #delete the ura3 , teta , and lacz genes between the two loxp sites has provided positional information that has allowed us to identify a gene necessary for cytoadherence .
the propensity of the transposon to #delete the ura3 , teta , and lacz genes between the two loxp sites has provided positional information that has allowed us to identify a gene necessary for cytoadherence .
the propensity of the transposon which #delete the ura3 , teta , and lacz genes between the two loxp sites has provided positional information that has allowed us to identify a gene necessary for cytoadherence .
the propensity of using homologous recombination in mouse embryonic stem cells to #delete the headpiece domain of dematin has provided positional information that has allowed us to identify a gene necessary for cytoadherence .
the propensity of using homologous recombination in mouse embryonic stem cells which #delete the headpiece domain of dematin has provided positional information that has allowed us to identify a gene necessary for cytoadherence .
the reporter plasmids contained a shorter fragment of the erbb-2 promoter with a functional (d: erbb-2: s) or cst20 (colonies of c .albicans cells , being deleted; erbb-2: s-a , substitution of the inverted ccaat box) .
the reporter plasmids contained a shorter fragment of the erbb-2 promoter with a functional (d: erbb-2: s) or cst20 (colonies of c .albicans cells , deleted; erbb-2: s-a , substitution of the inverted ccaat box) .
the reporter plasmids contained a shorter fragment of the erbb-2 promoter with a functional (d: erbb-2: s) or colonies of c .albicans cells (cst20 , being deleted; erbb-2: s-a , substitution of the inverted ccaat box) .
the reporter plasmids contained a shorter fragment of the erbb-2 promoter with a functional (d: erbb-2: s) or the gata-4 mutants (the n-terminal region and the first zinc finger , being deleted; erbb-2: s-a , substitution of the inverted ccaat box) .
the reporter plasmids contained a shorter fragment of the erbb-2 promoter with a functional (d: erbb-2: s) or the gata-4 mutants (the n-terminal region and the first zinc finger , deleted; erbb-2: s-a , substitution of the inverted ccaat box) .
thus , this granule enzyme is required for the unique effects of leu-leu-ome and may provide a target for appropriate progenitor strains designed to #delete any chromosomal region .
thus , this granule enzyme is required for the unique effects of leu-leu-ome and may provide a target for appropriate progenitor strains found to #delete any chromosomal region .
thus , this granule enzyme is required for the unique effects of leu-leu-ome and may provide a target for appropriate progenitor strains proven to #delete any chromosomal region .
thus , this granule enzyme is required for the unique effects of leu-leu-ome and may provide a target for antigen-loaded immature dcs designed to #delete t cells .
thus , this granule enzyme is required for the unique effects of leu-leu-ome and may provide a target for antigen-loaded immature dcs proven to #delete t cells .
thus , this granule enzyme is required for the unique effects of leu-leu-ome and may provide a target for micf locus designed to #delete strains .
thus , this granule enzyme is required for the unique effects of leu-leu-ome and may provide a target for micf locus proven to #delete strains .
thus , this granule enzyme is required for the unique effects of leu-leu-ome and may provide a target for micf locus which are proven to #delete strains .
thus , this granule enzyme is required for the unique effects of leu-leu-ome and may provide a target for the transposon being proven to #delete the ura3 , teta , and lacz genes between the two loxp sites .
thus , this granule enzyme is required for the unique effects of leu-leu-ome and may provide a target for the transposon designed to #delete the ura3 , teta , and lacz genes between the two loxp sites .
thus , this granule enzyme is required for the unique effects of leu-leu-ome and may provide a target for the transposon proven to #delete the ura3 , teta , and lacz genes between the two loxp sites .
thus , this granule enzyme is required for the unique effects of leu-leu-ome and may provide a target for the transposon which are proven to #delete the ura3 , teta , and lacz genes between the two loxp sites .
thus , this granule enzyme is required for the unique effects of leu-leu-ome and may provide a target for using homologous recombination in mouse embryonic stem cells found to #delete the headpiece domain of dematin .
antigen-loaded immature dcs can now be constructed to #delete virtually t cells by utilizing an extensive collection of lines containing single p element insertions throughout the drosophila genome .
antigen-loaded immature dcs may now be constructed to #delete virtually t cells by utilizing an extensive collection of lines containing single p element insertions throughout the drosophila genome .
antigen-loaded immature dcs will be constructed to #delete virtually t cells by utilizing an extensive collection of lines containing single p element insertions throughout the drosophila genome .
isolates of the malaria parasite plasmodium falciparum can now be constructed to #delete virtually a segment of chromosome 9 by utilizing an extensive collection of lines containing single p element insertions throughout the drosophila genome .
isolates of the malaria parasite plasmodium falciparum will be constructed to #delete virtually a segment of chromosome 9 by utilizing an extensive collection of lines containing single p element insertions throughout the drosophila genome .
micf locus being #deleted for strains revealed defects in the lateral formation of mycelia on synthetic solid spider media .
micf locus can now be constructed to #delete virtually strains by utilizing an extensive collection of lines containing single p element insertions throughout the drosophila genome .
micf locus #deleted for strains revealed defects in the lateral formation of mycelia on synthetic solid spider media .
micf locus may now be constructed to #delete virtually strains by utilizing an extensive collection of lines containing single p element insertions throughout the drosophila genome .
micf locus that are #deleted for strains revealed defects in the lateral formation of mycelia on synthetic solid spider media .
micf locus which were #deleted for strains revealed defects in the lateral formation of mycelia on synthetic solid spider media .
micf locus will be constructed to #delete virtually strains by utilizing an extensive collection of lines containing single p element insertions throughout the drosophila genome .
mutated zonab-binding site that can be #deleted for d: erbb-2: s-d revealed defects in the lateral formation of mycelia on synthetic solid spider media .
mutated zonab-binding site that #delete d: erbb-2: s-d (242 8211; 443) were able to synergize with mef2a (figure 6a) .
mutated zonab-binding site that #delete d: erbb-2: s-d were able to synergize with mef2a (figure 6a) .
mutated zonab-binding site which can #delete d: erbb-2: s-d were able to synergize with mef2a (figure 6a) .
plasmid erbb-2: s-d which #delete the zonab binding were able to synergize with mef2a (figure 6a) .
plasmid erbb-2: s-d which #deleted the zonab binding were able to synergize with mef2a (figure 6a) .
plasmid erbb-2: s-d which has #deleted the zonab binding were able to synergize with mef2a (figure 6a) .
strains that #delete micf locus (242 8211; 443) were able to synergize with mef2a (figure 6a) .
strains which #delete micf locus were able to synergize with mef2a (figure 6a) .
strains which has #deleted micf locus were able to synergize with mef2a (figure 6a) .
the gata-4 mutants that #delete c-terminal transactivition domain were able to synergize with mef2a (figure 6a) .
the gata-4 mutants which can #delete c-terminal transactivition domain were able to synergize with mef2a (figure 6a) .
the gata-4 mutants which #delete c-terminal transactivition domain were able to synergize with mef2a (figure 6a) .
the gata-4 mutants which has #deleted c-terminal transactivition domain were able to synergize with mef2a (figure 6a) .
the n-terminal region (127 443 and 201 443) and the first zinc finger (242 443) #deleted for the gata-4 mutants revealed defects in the lateral formation of mycelia on synthetic solid spider media .
the n-terminal region (127 443 and 201 443) and the first zinc finger (242 443) which the gata-4 mutants #deleted revealed defects in the lateral formation of mycelia on synthetic solid spider media .
the n-terminal region (127 443 and 201 443) and the first zinc finger (242 443) which can be #deleted for the gata-4 mutants revealed defects in the lateral formation of mycelia on synthetic solid spider media .
the n-terminal region (127 443 and 201 443) and the first zinc finger (242 443) which were #deleted for the gata-4 mutants revealed defects in the lateral formation of mycelia on synthetic solid spider media .
the n-terminal region and the first zinc finger being #deleted for the gata-4 mutants revealed defects in the lateral formation of mycelia on synthetic solid spider media .
the n-terminal region and the first zinc finger which were #deleted for the gata-4 mutants revealed defects in the lateral formation of mycelia on synthetic solid spider media .
the zonab binding #deleted for plasmid erbb-2: s-d revealed defects in the lateral formation of mycelia on synthetic solid spider media .
the zonab binding which are #deleted for plasmid erbb-2: s-d revealed defects in the lateral formation of mycelia on synthetic solid spider media .
the zonab binding which can be #deleted for plasmid erbb-2: s-d revealed defects in the lateral formation of mycelia on synthetic solid spider media .
the zonab binding which plasmid erbb-2: s-d #deleted revealed defects in the lateral formation of mycelia on synthetic solid spider media .
the development of other immunotherapeutic agents may now be constructed to #delete virtually cytotoxic lymphocyte responses by utilizing an extensive collection of lines containing single p element insertions throughout the drosophila genome .
the development of other immunotherapeutic agents will be constructed to #delete virtually cytotoxic lymphocyte responses by utilizing an extensive collection of lines containing single p element insertions throughout the drosophila genome .
the transposon can now be constructed to #delete virtually the ura3 , teta , and lacz genes between the two loxp sites by utilizing an extensive collection of lines containing single p element insertions throughout the drosophila genome .
the transposon may now be constructed to #delete virtually the ura3 , teta , and lacz genes between the two loxp sites by utilizing an extensive collection of lines containing single p element insertions throughout the drosophila genome .
the viral transcription elements being #deleted for vectors revealed defects in the lateral formation of mycelia on synthetic solid spider media .
the viral transcription elements #deleted for vectors revealed defects in the lateral formation of mycelia on synthetic solid spider media .
the viral transcription elements that are #deleted for vectors revealed defects in the lateral formation of mycelia on synthetic solid spider media .
the viral transcription elements which are #deleted for vectors revealed defects in the lateral formation of mycelia on synthetic solid spider media .
the viral transcription elements which can be #deleted for vectors revealed defects in the lateral formation of mycelia on synthetic solid spider media .
the viral transcription elements which vectors #deleted revealed defects in the lateral formation of mycelia on synthetic solid spider media .
using homologous recombination in mouse embryonic stem cells can now be constructed to #delete virtually the headpiece domain of dematin by utilizing an extensive collection of lines containing single p element insertions throughout the drosophila genome .
using homologous recombination in mouse embryonic stem cells may now be constructed to #delete virtually the headpiece domain of dematin by utilizing an extensive collection of lines containing single p element insertions throughout the drosophila genome .
vectors that #delete the viral transcription elements (242 8211; 443) were able to synergize with mef2a (figure 6a) .
appropriate progenitor strains can now be constructed to #delete virtually any chromosomal region by utilizing an extensive collection of lines containing single p element insertions throughout the drosophila genome .
colonies of c .albicans cells #deleted for cst20 revealed defects in the lateral formation of mycelia on synthetic solid spider media .
recent experiments have provided direct evidence that antigen-loaded immature dcs silence t cells either by #deleting them or by expanding regulatory t cells .
the generation of replication-competent virus is considered less likely with vectors that #delete the viral transcription elements .
the propensity of isolates of the malaria parasite plasmodium falciparum to #delete a segment of chromosome 9 has provided positional information that has allowed us to identify a gene necessary for cytoadherence .
however , a region between the two motifs being able to #delete the an alternative spliced form of dmc1 cdna (dmc1-d) (1 332 , 201 332) were all unable to support mef2 synergy .
however , a region between the two motifs #deleting the an alternative spliced form of dmc1 cdna (dmc1-d) (1 332 , 201 332) were all unable to support mef2 synergy .
however , a region between the two motifs that #delete the an alternative spliced form of dmc1 cdna (dmc1-d) (1 332 , 201 332) were all unable to support mef2 synergy .
however , a region between the two motifs that make the an alternative spliced form of dmc1 cdna (dmc1-d) (1 332 , 201 332) #deleted were all unable to support mef2 synergy .
however , a region between the two motifs which can #delete the an alternative spliced form of dmc1 cdna (dmc1-d) (1 332 , 201 332) were all unable to support mef2 synergy .
however , a single transcript #deleting the exon 2 (1 332 , 201 332) were all unable to support mef2 synergy .
however , a single transcript that make the exon 2 (1 332 , 201 332) #deleted were all unable to support mef2 synergy .
however , a single transcript which can #delete the exon 2 (1 332 , 201 332) were all unable to support mef2 synergy .
however , aberrantly spliced transcripts being able to #delete the exon 4 (1 332 , 201 332) were all unable to support mef2 synergy .
however , aberrantly spliced transcripts #deleting the exon 4 (1 332 , 201 332) were all unable to support mef2 synergy .
however , aberrantly spliced transcripts that #delete the exon 4 (1 332 , 201 332) were all unable to support mef2 synergy .
however , rpos being able to #delete the strain of e . coli that emits very low levels of luminescence (1 332 , 201 332) were all unable to support mef2 synergy .
however , rpos #deleting the strain of e . coli that emits very low levels of luminescence (1 332 , 201 332) were all unable to support mef2 synergy .
however , rpos which can #delete the strain of e . coli that emits very low levels of luminescence (1 332 , 201 332) were all unable to support mef2 synergy .
however , rpos which #deleted the strain of e . coli that emits very low levels of luminescence (1 332 , 201 332) were all unable to support mef2 synergy .
however , strain of e . coli that emits very low levels of luminescence #deleting the rpos (1 332 , 201 332) were all unable to support mef2 synergy .
however , strain of e . coli that emits very low levels of luminescence that #delete the rpos (1 332 , 201 332) were all unable to support mef2 synergy .
however , strain of e . coli that emits very low levels of luminescence that make the rpos (1 332 , 201 332) #deleted were all unable to support mef2 synergy .
however , strain of e . coli that emits very low levels of luminescence which can #delete the rpos (1 332 , 201 332) were all unable to support mef2 synergy .
however , the remainder being able to #delete the exon 9 (1 332 , 201 332) were all unable to support mef2 synergy .
however , the remainder #deleting the exon 9 (1 332 , 201 332) were all unable to support mef2 synergy .
however , the remainder that #delete the exon 9 (1 332 , 201 332) were all unable to support mef2 synergy .
however , the remainder that make the exon 9 (1 332 , 201 332) #deleted were all unable to support mef2 synergy .
however , the remainder which #deleted the exon 9 (1 332 , 201 332) were all unable to support mef2 synergy .
however , transcripts #deleting the exons 8 (75 nt) , 7+8 (156 nt) or 8+9 (168 nt) (1 332 , 201 332) were all unable to support mef2 synergy .
however , transcripts that #delete the exons 8 (75 nt) , 7+8 (156 nt) or 8+9 (168 nt) (1 332 , 201 332) were all unable to support mef2 synergy .
however , transcripts which #deleted the exons 8 (75 nt) , 7+8 (156 nt) or 8+9 (168 nt) (1 332 , 201 332) were all unable to support mef2 synergy .
in a region between the two motifs , an alternative spliced form of dmc1 cdna (dmc1-d) is #deleted , and in erbb-2: s-a the inverted ccaat box is substituted .
in a single transcript , exon 2 was #deleted , and in erbb-2: s-a the inverted ccaat box was substituted .
in aberrantly spliced transcripts , exon 4 has been #deleted , and in erbb-2: s-a the inverted ccaat box has been substituted .
in aberrantly spliced transcripts , exon 4 is #deleted , and in erbb-2: s-a the inverted ccaat box is substituted .
in aberrantly spliced transcripts , exon 4 was #deleted , and in erbb-2: s-a the inverted ccaat box was substituted .
in rpos , strain of e . coli that emits very low levels of luminescence has been #deleted , and in erbb-2: s-a the inverted ccaat box has been substituted .
in rpos , strain of e . coli that emits very low levels of luminescence is #deleted , and in erbb-2: s-a the inverted ccaat box is substituted .
in rpos , strain of e . coli that emits very low levels of luminescence was #deleted , and in erbb-2: s-a the inverted ccaat box was substituted .
in strain of e . coli that emits very low levels of luminescence , rpos has been #deleted , and in erbb-2: s-a the inverted ccaat box has been substituted .
in strain of e . coli that emits very low levels of luminescence , rpos is #deleted , and in erbb-2: s-a the inverted ccaat box is substituted .
in the remainder , exon 9 has been #deleted , and in erbb-2: s-a the inverted ccaat box has been substituted .
in transcripts , exons 8 (75 nt) , 7+8 (156 nt) or 8+9 (168 nt) is #deleted , and in erbb-2: s-a the inverted ccaat box is substituted .
studies with aberrantly spliced transcripts #deleted for the exon 4 showed that the mara-dependent reduction of ompf required an intact micf locus .
studies with strain of e . coli that emits very low levels of luminescence #deleted for the rpos showed that the mara-dependent reduction of ompf required an intact micf locus .
studies with the remainder #deleted for the exon 9 showed that the mara-dependent reduction of ompf required an intact micf locus .
the generation of replication-competent virus is considered less likely with a region between the two motifs #deleting an alternative spliced form of dmc1 cdna (dmc1-d) .
the generation of replication-competent virus is considered less likely with a region between the two motifs that #deleted an alternative spliced form of dmc1 cdna (dmc1-d) .
the generation of replication-competent virus is considered less likely with a region between the two motifs which #delete an alternative spliced form of dmc1 cdna (dmc1-d) .
the generation of replication-competent virus is considered less likely with a region between the two motifs which #deleted an alternative spliced form of dmc1 cdna (dmc1-d) .
the generation of replication-competent virus is considered less likely with aberrantly spliced transcripts #deleting exon 4 .
the generation of replication-competent virus is considered less likely with aberrantly spliced transcripts that #deleted exon 4 .
the generation of replication-competent virus is considered less likely with aberrantly spliced transcripts which #deleted exon 4 .
the generation of replication-competent virus is considered less likely with aberrantly spliced transcripts which that #delete exon 4 .
the generation of replication-competent virus is considered less likely with rpos #deleting strain of e . coli that emits very low levels of luminescence .
the generation of replication-competent virus is considered less likely with rpos that #deleted strain of e . coli that emits very low levels of luminescence .
the generation of replication-competent virus is considered less likely with rpos which #delete strain of e . coli that emits very low levels of luminescence .
the generation of replication-competent virus is considered less likely with rpos which #deleted strain of e . coli that emits very low levels of luminescence .
the generation of replication-competent virus is considered less likely with strain of e . coli that emits very low levels of luminescence #deleting rpos .
the generation of replication-competent virus is considered less likely with strain of e . coli that emits very low levels of luminescence that #delete rpos .
the generation of replication-competent virus is considered less likely with strain of e . coli that emits very low levels of luminescence that #deleted rpos .
the generation of replication-competent virus is considered less likely with strain of e . coli that emits very low levels of luminescence which #delete rpos .
the generation of replication-competent virus is considered less likely with the remainder that #delete exon 9 .
the generation of replication-competent virus is considered less likely with the remainder which that #delete exon 9 .
the generation of replication-competent virus is considered less likely with transcripts that #delete exons 8 (75 nt) , 7+8 (156 nt) or 8+9 (168 nt) .
the generation of replication-competent virus is considered less likely with transcripts which #delete exons 8 (75 nt) , 7+8 (156 nt) or 8+9 (168 nt) .
the reporter plasmids contained a shorter fragment of the erbb-2 promoter with a functional (d: erbb-2: s) or aberrantly spliced transcripts (exon 4 , being deleted; erbb-2: s-a , substitution of the inverted ccaat box) .
the reporter plasmids contained a shorter fragment of the erbb-2 promoter with a functional (d: erbb-2: s) or rpos (strain of e . coli that emits very low levels of luminescence , deleted; erbb-2: s-a , substitution of the inverted ccaat box) .
the reporter plasmids contained a shorter fragment of the erbb-2 promoter with a functional (d: erbb-2: s) or strain of e . coli that emits very low levels of luminescence (rpos , being deleted; erbb-2: s-a , substitution of the inverted ccaat box) .
the reporter plasmids contained a shorter fragment of the erbb-2 promoter with a functional (d: erbb-2: s) or strain of e . coli that emits very low levels of luminescence (rpos , deleted; erbb-2: s-a , substitution of the inverted ccaat box) .
the reporter plasmids contained a shorter fragment of the erbb-2 promoter with a functional (d: erbb-2: s) or transcripts (exons 8 (75 nt) , 7+8 (156 nt) or 8+9 (168 nt) , being deleted; erbb-2: s-a , substitution of the inverted ccaat box) .
a region between the two motifs being #deleted for an alternative spliced form of dmc1 cdna (dmc1-d) revealed defects in the lateral formation of mycelia on synthetic solid spider media .
a region between the two motifs #deleted for an alternative spliced form of dmc1 cdna (dmc1-d) revealed defects in the lateral formation of mycelia on synthetic solid spider media .
a region between the two motifs that are #deleted for an alternative spliced form of dmc1 cdna (dmc1-d) revealed defects in the lateral formation of mycelia on synthetic solid spider media .
a region between the two motifs that can be #deleted for an alternative spliced form of dmc1 cdna (dmc1-d) revealed defects in the lateral formation of mycelia on synthetic solid spider media .
a region between the two motifs that #delete an alternative spliced form of dmc1 cdna (dmc1-d) (242 8211; 443) were able to synergize with mef2a (figure 6a) .
a region between the two motifs which an alternative spliced form of dmc1 cdna (dmc1-d) #deleted revealed defects in the lateral formation of mycelia on synthetic solid spider media .
a region between the two motifs which are #deleted for an alternative spliced form of dmc1 cdna (dmc1-d) revealed defects in the lateral formation of mycelia on synthetic solid spider media .
a region between the two motifs which were #deleted for an alternative spliced form of dmc1 cdna (dmc1-d) revealed defects in the lateral formation of mycelia on synthetic solid spider media .
a single transcript being #deleted for exon 2 revealed defects in the lateral formation of mycelia on synthetic solid spider media .
a single transcript #deleted for exon 2 revealed defects in the lateral formation of mycelia on synthetic solid spider media .
a single transcript that are #deleted for exon 2 revealed defects in the lateral formation of mycelia on synthetic solid spider media .
a single transcript which are #deleted for exon 2 revealed defects in the lateral formation of mycelia on synthetic solid spider media .
a single transcript which can be #deleted for exon 2 revealed defects in the lateral formation of mycelia on synthetic solid spider media .
a single transcript which #deleted exon 2 were able to synergize with mef2a (figure 6a) .
a single transcript which exon 2 #deleted revealed defects in the lateral formation of mycelia on synthetic solid spider media .
a single transcript which has #deleted exon 2 were able to synergize with mef2a (figure 6a) .
a single transcript with exon 2 #deleted were able to synergize with mef2a (figure 6a) .
aberrantly spliced transcripts being #deleted for exon 4 revealed defects in the lateral formation of mycelia on synthetic solid spider media .
aberrantly spliced transcripts #deleted for exon 4 revealed defects in the lateral formation of mycelia on synthetic solid spider media .
aberrantly spliced transcripts that #delete exon 4 (242 8211; 443) were able to synergize with mef2a (figure 6a) .
aberrantly spliced transcripts which can #delete exon 4 were able to synergize with mef2a (figure 6a) .
aberrantly spliced transcripts which #deleted exon 4 were able to synergize with mef2a (figure 6a) .
an alternative spliced form of dmc1 cdna (dmc1-d) #deleted for a region between the two motifs revealed defects in the lateral formation of mycelia on synthetic solid spider media .
an alternative spliced form of dmc1 cdna (dmc1-d) that are #deleted for a region between the two motifs revealed defects in the lateral formation of mycelia on synthetic solid spider media .
an alternative spliced form of dmc1 cdna (dmc1-d) which are #deleted for a region between the two motifs revealed defects in the lateral formation of mycelia on synthetic solid spider media .
an alternative spliced form of dmc1 cdna (dmc1-d) which can be #deleted for a region between the two motifs revealed defects in the lateral formation of mycelia on synthetic solid spider media .
exon 2 which a single transcript #deleted revealed defects in the lateral formation of mycelia on synthetic solid spider media .
exon 2 which are #deleted for a single transcript revealed defects in the lateral formation of mycelia on synthetic solid spider media .
exon 2 which can be #deleted for a single transcript revealed defects in the lateral formation of mycelia on synthetic solid spider media .
exon 2 which were #deleted for a single transcript revealed defects in the lateral formation of mycelia on synthetic solid spider media .
exon 4 #deleted for aberrantly spliced transcripts revealed defects in the lateral formation of mycelia on synthetic solid spider media .
exon 4 that are #deleted for aberrantly spliced transcripts revealed defects in the lateral formation of mycelia on synthetic solid spider media .
exon 4 which aberrantly spliced transcripts #deleted revealed defects in the lateral formation of mycelia on synthetic solid spider media .
exon 4 which can be #deleted for aberrantly spliced transcripts revealed defects in the lateral formation of mycelia on synthetic solid spider media .
exon 4 which were #deleted for aberrantly spliced transcripts revealed defects in the lateral formation of mycelia on synthetic solid spider media .
exon 9 which the remainder #deleted revealed defects in the lateral formation of mycelia on synthetic solid spider media .
exon 9 which were #deleted for the remainder revealed defects in the lateral formation of mycelia on synthetic solid spider media .
exons 8 (75 nt) , 7+8 (156 nt) or 8+9 (168 nt) being #deleted for transcripts revealed defects in the lateral formation of mycelia on synthetic solid spider media .
exons 8 (75 nt) , 7+8 (156 nt) or 8+9 (168 nt) that are #deleted for transcripts revealed defects in the lateral formation of mycelia on synthetic solid spider media .
exons 8 (75 nt) , 7+8 (156 nt) or 8+9 (168 nt) which are #deleted for transcripts revealed defects in the lateral formation of mycelia on synthetic solid spider media .
exons 8 (75 nt) , 7+8 (156 nt) or 8+9 (168 nt) which transcripts #deleted revealed defects in the lateral formation of mycelia on synthetic solid spider media .
exons 8 (75 nt) , 7+8 (156 nt) or 8+9 (168 nt) which were #deleted for transcripts revealed defects in the lateral formation of mycelia on synthetic solid spider media .
mutated zonab-binding site being #deleted for d: erbb-2: s-d revealed defects in the lateral formation of mycelia on synthetic solid spider media .
mutated zonab-binding site which d: erbb-2: s-d #deleted revealed defects in the lateral formation of mycelia on synthetic solid spider media .
mutated zonab-binding site which are #deleted for d: erbb-2: s-d revealed defects in the lateral formation of mycelia on synthetic solid spider media .
mutated zonab-binding site which can be #deleted for d: erbb-2: s-d revealed defects in the lateral formation of mycelia on synthetic solid spider media .
mutated zonab-binding site which were #deleted for d: erbb-2: s-d revealed defects in the lateral formation of mycelia on synthetic solid spider media .
rpos #deleted for strain of e . coli that emits very low levels of luminescence revealed defects in the lateral formation of mycelia on synthetic solid spider media .
rpos that are #deleted for strain of e . coli that emits very low levels of luminescence revealed defects in the lateral formation of mycelia on synthetic solid spider media .
rpos that can be #deleted for strain of e . coli that emits very low levels of luminescence revealed defects in the lateral formation of mycelia on synthetic solid spider media .
rpos that #delete strain of e . coli that emits very low levels of luminescence (242 8211; 443) were able to synergize with mef2a (figure 6a) .
rpos that #delete strain of e . coli that emits very low levels of luminescence were able to synergize with mef2a (figure 6a) .
rpos which #delete strain of e . coli that emits very low levels of luminescence were able to synergize with mef2a (figure 6a) .
rpos which #deleted strain of e . coli that emits very low levels of luminescence were able to synergize with mef2a (figure 6a) .
rpos which has #deleted strain of e . coli that emits very low levels of luminescence were able to synergize with mef2a (figure 6a) .
strain of e . coli that emits very low levels of luminescence being #deleted for rpos revealed defects in the lateral formation of mycelia on synthetic solid spider media .
strain of e . coli that emits very low levels of luminescence #deleted for rpos revealed defects in the lateral formation of mycelia on synthetic solid spider media .
strain of e . coli that emits very low levels of luminescence that are #deleted for rpos revealed defects in the lateral formation of mycelia on synthetic solid spider media .
strain of e . coli that emits very low levels of luminescence that #delete rpos were able to synergize with mef2a (figure 6a) .
strain of e . coli that emits very low levels of luminescence which can be #deleted for rpos revealed defects in the lateral formation of mycelia on synthetic solid spider media .
strain of e . coli that emits very low levels of luminescence which #delete rpos were able to synergize with mef2a (figure 6a) .
strain of e . coli that emits very low levels of luminescence which has #deleted rpos were able to synergize with mef2a (figure 6a) .
strain of e . coli that emits very low levels of luminescence which rpos #deleted revealed defects in the lateral formation of mycelia on synthetic solid spider media .
strain of e . coli that emits very low levels of luminescence which were #deleted for rpos revealed defects in the lateral formation of mycelia on synthetic solid spider media .
strain of e . coli that emits very low levels of luminescence with rpos #deleted were able to synergize with mef2a (figure 6a) .
the remainder #deleted for exon 9 revealed defects in the lateral formation of mycelia on synthetic solid spider media .
the remainder that can be #deleted for exon 9 revealed defects in the lateral formation of mycelia on synthetic solid spider media .
the remainder that #delete exon 9 (242 8211; 443) were able to synergize with mef2a (figure 6a) .
the remainder which are #deleted for exon 9 revealed defects in the lateral formation of mycelia on synthetic solid spider media .
the remainder which can be #deleted for exon 9 revealed defects in the lateral formation of mycelia on synthetic solid spider media .
the remainder which can #delete exon 9 were able to synergize with mef2a (figure 6a) .
the remainder which #delete exon 9 were able to synergize with mef2a (figure 6a) .
the remainder which #deleted exon 9 were able to synergize with mef2a (figure 6a) .
the remainder which has #deleted exon 9 were able to synergize with mef2a (figure 6a) .
the remainder which were #deleted for exon 9 revealed defects in the lateral formation of mycelia on synthetic solid spider media .
the remainder with exon 9 #deleted were able to synergize with mef2a (figure 6a) .
transcripts being #deleted for exons 8 (75 nt) , 7+8 (156 nt) or 8+9 (168 nt) revealed defects in the lateral formation of mycelia on synthetic solid spider media .
transcripts #deleted for exons 8 (75 nt) , 7+8 (156 nt) or 8+9 (168 nt) revealed defects in the lateral formation of mycelia on synthetic solid spider media .
transcripts that are #deleted for exons 8 (75 nt) , 7+8 (156 nt) or 8+9 (168 nt) revealed defects in the lateral formation of mycelia on synthetic solid spider media .
transcripts that #delete exons 8 (75 nt) , 7+8 (156 nt) or 8+9 (168 nt) were able to synergize with mef2a (figure 6a) .
transcripts which can #delete exons 8 (75 nt) , 7+8 (156 nt) or 8+9 (168 nt) were able to synergize with mef2a (figure 6a) .
transcripts which #delete exons 8 (75 nt) , 7+8 (156 nt) or 8+9 (168 nt) were able to synergize with mef2a (figure 6a) .
transcripts which exons 8 (75 nt) , 7+8 (156 nt) or 8+9 (168 nt) #deleted revealed defects in the lateral formation of mycelia on synthetic solid spider media .
transcripts which has #deleted exons 8 (75 nt) , 7+8 (156 nt) or 8+9 (168 nt) were able to synergize with mef2a (figure 6a) .
transcripts which were #deleted for exons 8 (75 nt) , 7+8 (156 nt) or 8+9 (168 nt) revealed defects in the lateral formation of mycelia on synthetic solid spider media .
a c-to-t transition in codon 214 creating a new rsai recognition site in exon 6 and substituting tyrosine for histidine (h214y) is identified in an asymptomatic female carrier whose son can #develop acute neonatal onset of otc deficiency .
a c-to-t transition in codon 214 creating a new rsai recognition site in exon 6 and substituting tyrosine for histidine (h214y) is identified in an asymptomatic female carrier whose son #develops acute neonatal onset of otc deficiency .
a c-to-t transition in codon 214 creating a new rsai recognition site in exon 6 and substituting tyrosine for histidine (h214y) is identified in an asymptomatic female carrier whose son has the ability to #develop acute neonatal onset of otc deficiency .
a c-to-t transition in codon 214 creating a new rsai recognition site in exon 6 and substituting tyrosine for histidine (h214y) is identified in an asymptomatic female carrier whose son is believed to #develop acute neonatal onset of otc deficiency .
a c-to-t transition in codon 214 creating a new rsai recognition site in exon 6 and substituting tyrosine for histidine (h214y) is identified in an asymptomatic female carrier whose son is found to #develop acute neonatal onset of otc deficiency .
a c-to-t transition in codon 214 creating a new rsai recognition site in exon 6 and substituting tyrosine for histidine (h214y) is identified in an asymptomatic female carrier whose son is observed to #develop acute neonatal onset of otc deficiency .
a c-to-t transition in codon 214 creating a new rsai recognition site in exon 6 and substituting tyrosine for histidine (h214y) is identified in an asymptomatic female carrier whose son is predicted to #develop acute neonatal onset of otc deficiency .
a c-to-t transition in codon 214 creating a new rsai recognition site in exon 6 and substituting tyrosine for histidine (h214y) is identified in an asymptomatic female carrier whose son may have #developed acute neonatal onset of otc deficiency .
a c-to-t transition in codon 214 creating a new rsai recognition site in exon 6 and substituting tyrosine for histidine (h214y) was identified in an asymptomatic female carrier whose son had the ability to #develop acute neonatal onset of otc deficiency .
a c-to-t transition in codon 214 creating a new rsai recognition site in exon 6 and substituting tyrosine for histidine (h214y) was identified in an asymptomatic female carrier whose son has been #developing acute neonatal onset of otc deficiency .
a c-to-t transition in codon 214 creating a new rsai recognition site in exon 6 and substituting tyrosine for histidine (h214y) was identified in an asymptomatic female carrier whose son was believed to #develop acute neonatal onset of otc deficiency .
a c-to-t transition in codon 214 creating a new rsai recognition site in exon 6 and substituting tyrosine for histidine (h214y) was identified in an asymptomatic female carrier whose son was #developing acute neonatal onset of otc deficiency .
a c-to-t transition in codon 214 creating a new rsai recognition site in exon 6 and substituting tyrosine for histidine (h214y) was identified in an asymptomatic female carrier whose son was observed to #develop acute neonatal onset of otc deficiency .
a c-to-t transition in codon 214 creating a new rsai recognition site in exon 6 and substituting tyrosine for histidine (h214y) was identified in an asymptomatic female carrier whose son was predicted to #develop acute neonatal onset of otc deficiency .
a c-to-t transition in codon 214 creating a new rsai recognition site in exon 6 and substituting tyrosine for histidine (h214y) was identified in an asymptomatic female carrier whose son was shown to #develop acute neonatal onset of otc deficiency .
a c-to-t transition in codon 214 creating a new rsai recognition site in exon 6 and substituting tyrosine for histidine (h214y) was identified in an asymptomatic female carrier whose son would #develop acute neonatal onset of otc deficiency .
spinach sown in october can have #developed into the rosette stage and grow through the end of november .
spinach sown in october #developed into the rosette stage and grew through the end of november .
spinach sown in october #developing into the rosette stage grows through the end of november .
spinach sown in october had the ability to #develop into the rosette stage and grew through the end of november .
spinach sown in october has been #developing into the rosette stage and can grow through the end of november .
spinach sown in october has #developed into the rosette stage and grown through the end of november .
spinach sown in october is able to #develop into the rosette stage and grow through the end of november .
spinach sown in october is #developing into the rosette stage and will grow through the end of november .
spinach sown in october is found to #develop into the rosette stage and grow through the end of november .
spinach sown in october may #develop into the rosette stage and grow through the end of november .
spinach sown in october may have #developed into the rosette stage and grow through the end of november .
spinach sown in october might #develop into the rosette stage and grew through the end of november .
spinach sown in october that can #develop into the rosette stage grows through the end of november .
spinach sown in october was able to #develop into the rosette stage and grew through the end of november .
spinach sown in october was shown to #develop into the rosette stage and grew through the end of november .
spinach sown in october which #develops into the rosette stage grows through the end of november .
spinach sown in october which is able to #develop into the rosette stage grows through the end of november .
spinach sown in october will #develop into the rosette stage and grow through the end of november .
spinach sown in october would #develop into the rosette stage and grew through the end of november .
to isolate cdna clones that dominantly inhibit the dna-binding activity of oct-2 , chosen as a representative factor , we are able to #develop a novel screening system .
to isolate cdna clones that dominantly inhibit the dna-binding activity of oct-2 , chosen as a representative factor , we are ready to #develop a novel screening system .
to isolate cdna clones that dominantly inhibit the dna-binding activity of oct-2 , chosen as a representative factor , we choose to #develop a novel screening system .
to isolate cdna clones that dominantly inhibit the dna-binding activity of oct-2 , chosen as a representative factor , we chose to #develop a novel screening system .
to isolate cdna clones that dominantly inhibit the dna-binding activity of oct-2 , chosen as a representative factor , we could #develop a novel screening system .
to isolate cdna clones that dominantly inhibit the dna-binding activity of oct-2 , chosen as a representative factor , we decided to #develop a novel screening system .
to isolate cdna clones that dominantly inhibit the dna-binding activity of oct-2 , chosen as a representative factor , we #develop a novel screening system .
to isolate cdna clones that dominantly inhibit the dna-binding activity of oct-2 , chosen as a representative factor , we #developed a novel screening system .
to isolate cdna clones that dominantly inhibit the dna-binding activity of oct-2 , chosen as a representative factor , we had the ability to #develop a novel screening system .
to isolate cdna clones that dominantly inhibit the dna-binding activity of oct-2 , chosen as a representative factor , we have chosen to #develop a novel screening system .
to isolate cdna clones that dominantly inhibit the dna-binding activity of oct-2 , chosen as a representative factor , we have #developed a novel screening system .
to isolate cdna clones that dominantly inhibit the dna-binding activity of oct-2 , chosen as a representative factor , we have the ability to #develop a novel screening system .
to isolate cdna clones that dominantly inhibit the dna-binding activity of oct-2 , chosen as a representative factor , we may have #developed a novel screening system .
to isolate cdna clones that dominantly inhibit the dna-binding activity of oct-2 , chosen as a representative factor , we were ready to #develop a novel screening system .
to isolate cdna clones that dominantly inhibit the dna-binding activity of oct-2 , chosen as a representative factor , we will #develop a novel screening system .
to isolate cdna clones that dominantly inhibit the dna-binding activity of oct-2 , chosen as a representative factor , we will have #developed a novel screening system .
spinach sown in october being able to #develop into he rosette stage grows through the end of november .
spinach sown in october can #develop into he rosette stage and grow through the end of november .
spinach sown in october could #develop into he rosette stage and grew through the end of november .
spinach sown in october #developed into he rosette stage and grew through the end of november .
spinach sown in october had the ability to #develop into he rosette stage and grew through the end of november .
spinach sown in october has the ability to #develop into he rosette stage and grow through the end of november .
spinach sown in october is predicted to #develop into he rosette stage and grow through the end of november .
spinach sown in october is shown to #develop into he rosette stage and grow through the end of november .
spinach sown in october might #develop into he rosette stage and grew through the end of november .
spinach sown in october was able to #develop into he rosette stage and grew through the end of november .
spinach sown in october was believed to #develop into he rosette stage and grew through the end of november .
spinach sown in october was shown to #develop into he rosette stage and grew through the end of november .
spinach sown in october which is able to #develop into he rosette stage grows through the end of november .
spinach sown in october will have #developed into he rosette stage and grow through the end of november .
a homozygous mutation having #disrupted splicing will be identified in affected siblings with classical abetalipoproteinemia .
a homozygous mutation that can #disrupt splicing which has been identified in affected siblings with classical abetalipoproteinemia .
a homozygous mutation that #disrupted splicing has been identified in affected siblings with classical abetalipoproteinemia .
arg99 and arg253 can interact with the keto groups of the go and c base pair(blue) in both sides of dsdna and #disrupt the pairing hydrogen bonds in the model .
arg99 and arg253 that interact with the keto groups of the go and c base pair(blue) in both sides of dsdna can #disrupt the pairing hydrogen bonds in the model .
quantitative single-unit electrophysiology revealed that alcohol exposure is able to #disrupt ocular dominance plasticity while preserving robust visual responses .
sequencing of cloned polymerase chain reaction amplified fragments of the amh gene revealed a 14-bp deletion in the second exon of the maternal allele; this deletion #disrupts the open reading frame .
sequencing of cloned polymerase chain reaction amplified fragments of the amh gene revealed a 14-bp deletion in the second exon of the maternal allele; this deletion has been shown to #disrupt the open reading frame .
sequencing of cloned polymerase chain reaction amplified fragments of the amh gene revealed a 14-bp deletion in the second exon of the maternal allele; this deletion has #disrupted the open reading frame .
sequencing of cloned polymerase chain reaction amplified fragments of the amh gene revealed a 14-bp deletion in the second exon of the maternal allele; this deletion is able to #disrupt the open reading frame .
the zinc finger motif , which specifically recognizes the go:c pair , is firmly fixed with respect to the c-terminal domain by the hydrogen bond network , so the lys147ala substitution has been shown to #disrupt the interaction , resulting in a drastic decrease of activity against go:c substrates .
the zinc finger motif , which specifically recognizes the go:c pair , is firmly fixed with respect to the c-terminal domain by the hydrogen bond network , so the lys147ala substitution would #disrupt the interaction , resulting in a drastic decrease of activity against go:c substrates .
these mutations may be acting in a dominant-negative fashion with the ability to #disrupt the ubiquitin-binding function , which could result in abnormal activation of the nf-kappab pathway and the subsequent activation of the osteoclasts .
this deletion has been shown to #disrupt the consensus 5 splice signal and led to exon skipping .
this deletion will have been #disrupting the consensus 5 splice signal and led to exon skipping .
treatment of the systemic inflammatory response to cpb is also confounded by the fact that inhibition of inflammation has been #disrupting protective physiologic responses or result in immunosuppression .
when both genes are #disrupted , gals expression is further elevated .
when both genes has been observed to be #disrupted , gals expression was further elevated .
when both genes were #disrupted , gals expression was further elevated .
quantitative single-unit electrophysiology revealed that alcohol exposure #disrupted ocular dominance plasticity while preserving robust visual responses .
importantly , the findings show that the arg99 and arg253 could not #disrupt the pairing hydrogen bonds in the model .
importantly , the findings show that the arg99 and arg253 did not #disrupt the pairing hydrogen bonds in the model .
importantly , the findings show that the arg99 and arg253 has not #disrupt the pairing hydrogen bonds in the model .
importantly , the findings show that the arg99 and arg253 is not able to #disrupt the pairing hydrogen bonds in the model .
importantly , the findings show that the alcohol exposure could not #disrupt ocular dominance plasticity .
importantly , the findings show that the alcohol exposure did not #disrupt ocular dominance plasticity .
importantly , the findings show that the alcohol exposure does not #disrupt ocular dominance plasticity .
importantly , the findings show that the alcohol exposure has not #disrupt ocular dominance plasticity .
importantly , the findings show that the alcohol exposure will not #disrupt ocular dominance plasticity .
importantly , the findings show that the this deletion did not #disrupt the open reading frame .
importantly , the findings show that the this deletion does not #disrupt the open reading frame .
importantly , the findings show that the this deletion has not #disrupt the open reading frame .
importantly , the findings show that the this deletion is not able to #disrupt the open reading frame .
importantly , the findings show that the this deletion will not #disrupt the open reading frame .
quantitative single-unit electrophysiology revealed that arg99 and arg253 #disrupted the pairing hydrogen bonds in the model while preserving robust visual responses .
quantitative single-unit electrophysiology revealed that arg99 and arg253 is able to #disrupt the pairing hydrogen bonds in the model while preserving robust visual responses .
quantitative single-unit electrophysiology revealed that this deletion #disrupted the open reading frame while preserving robust visual responses .
quantitative single-unit electrophysiology revealed that this deletion #disrupts the open reading frame while preserving robust visual responses .
sequencing of cloned polymerase chain reaction amplified fragments of the amh gene revealed a 14-bp deletion in the second exon of the maternal allele; arg99 and arg253 has been shown to #disrupt the pairing hydrogen bonds in the model .
sequencing of cloned polymerase chain reaction amplified fragments of the amh gene revealed a 14-bp deletion in the second exon of the maternal allele; arg99 and arg253 has #disrupted the pairing hydrogen bonds in the model .
sequencing of cloned polymerase chain reaction amplified fragments of the amh gene revealed a 14-bp deletion in the second exon of the maternal allele; alcohol exposure #disrupted ocular dominance plasticity .
sequencing of cloned polymerase chain reaction amplified fragments of the amh gene revealed a 14-bp deletion in the second exon of the maternal allele; alcohol exposure #disrupts ocular dominance plasticity .
sequencing of cloned polymerase chain reaction amplified fragments of the amh gene revealed a 14-bp deletion in the second exon of the maternal allele; alcohol exposure has been shown to #disrupt ocular dominance plasticity .
studies using polymerase chain reaction , restriction enzyme digestion (arg99 and arg253 #disrupts the pairing hydrogen bonds in the model , the arg243----his mutation , a hha i site , and the asp250----asn mutation , a taq i site) , and allele-specific oligonucleotide hybridization confirmed that the patients were indeed compound heterozygous for the respective mutations .
studies using polymerase chain reaction , restriction enzyme digestion (arg99 and arg253 which have #disrupted the pairing hydrogen bonds in the model , the arg243----his mutation , a hha i site , and the asp250----asn mutation , a taq i site) , and allele-specific oligonucleotide hybridization confirmed that the patients were indeed compound heterozygous for the respective mutations .
studies using polymerase chain reaction , restriction enzyme digestion (alcohol exposure having #disrupted ocular dominance plasticity , the arg243----his mutation , a hha i site , and the asp250----asn mutation , a taq i site) , and allele-specific oligonucleotide hybridization confirmed that the patients were indeed compound heterozygous for the respective mutations .
studies using polymerase chain reaction , restriction enzyme digestion (alcohol exposure which have #disrupted ocular dominance plasticity , the arg243----his mutation , a hha i site , and the asp250----asn mutation , a taq i site) , and allele-specific oligonucleotide hybridization confirmed that the patients were indeed compound heterozygous for the respective mutations .
studies using polymerase chain reaction , restriction enzyme digestion (this deletion #disrupts the open reading frame , the arg243----his mutation , a hha i site , and the asp250----asn mutation , a taq i site) , and allele-specific oligonucleotide hybridization confirmed that the patients were indeed compound heterozygous for the respective mutations .
studies using polymerase chain reaction , restriction enzyme digestion (this deletion having #disrupted the open reading frame , the arg243----his mutation , a hha i site , and the asp250----asn mutation , a taq i site) , and allele-specific oligonucleotide hybridization confirmed that the patients were indeed compound heterozygous for the respective mutations .
studies using polymerase chain reaction , restriction enzyme digestion (this deletion that can #disrupt the open reading frame , the arg243----his mutation , a hha i site , and the asp250----asn mutation , a taq i site) , and allele-specific oligonucleotide hybridization confirmed that the patients were indeed compound heterozygous for the respective mutations .
when both genes has been #disrupted , gals expression is further elevated .
when both genes were #disrupted , gals expression is further elevated .
alcohol exposure can interact with the keto groups of the go and c base pair(blue) in both sides of dsdna and #disrupt ocular dominance plasticity .
alcohol exposure can interact with the keto groups of the go and c base pair(blue) in both sides of dsdna to #disrupt ocular dominance plasticity .
alcohol exposure that interact with the keto groups of the go and c base pair(blue) in both sides of dsdna can #disrupt ocular dominance plasticity .
this deletion can interact with the keto groups of the go and c base pair(blue) in both sides of dsdna and #disrupt the open reading frame .
a homozygous mutation can interact with the keto groups of the go and c base pair(blue) in both sides of dsdna to #disrupt splicing .
importantly , the findings show that the a homozygous mutation did not #disrupt splicing .
importantly , the findings show that the these mutations does not #disrupt the ubiquitin-binding function .
importantly , the findings show that the these mutations is not able to #disrupt the ubiquitin-binding function .
importantly , the findings show that the this deletion does not #disrupt the consensus 5 splice signal .
importantly , the findings show that the this deletion is not able to #disrupt the consensus 5 splice signal .
importantly , the findings show that the inhibition of inflammation could not #disrupt protective physiologic responses .
importantly , the findings show that the inhibition of inflammation did not #disrupt protective physiologic responses .
importantly , the findings show that the the lys147ala substitution could not #disrupt the interaction .
importantly , the findings show that the the lys147ala substitution did not #disrupt the interaction .
importantly , the findings show that the the lys147ala substitution will not #disrupt the interaction .
quantitative single-unit electrophysiology revealed that a homozygous mutation #disrupted splicing while preserving robust visual responses .
quantitative single-unit electrophysiology revealed that a homozygous mutation has #disrupted splicing while preserving robust visual responses .
quantitative single-unit electrophysiology revealed that these mutations #disrupted the ubiquitin-binding function while preserving robust visual responses .
quantitative single-unit electrophysiology revealed that these mutations has #disrupted the ubiquitin-binding function while preserving robust visual responses .
quantitative single-unit electrophysiology revealed that this deletion #disrupted the consensus 5 splice signal while preserving robust visual responses .
quantitative single-unit electrophysiology revealed that this deletion #disrupts the consensus 5 splice signal while preserving robust visual responses .
quantitative single-unit electrophysiology revealed that this deletion has been shown to #disrupt the consensus 5 splice signal while preserving robust visual responses .
quantitative single-unit electrophysiology revealed that this deletion is able to #disrupt the consensus 5 splice signal while preserving robust visual responses .
quantitative single-unit electrophysiology revealed that inhibition of inflammation has been shown to #disrupt protective physiologic responses while preserving robust visual responses .
quantitative single-unit electrophysiology revealed that inhibition of inflammation is able to #disrupt protective physiologic responses while preserving robust visual responses .
quantitative single-unit electrophysiology revealed that the lys147ala substitution has been shown to #disrupt the interaction while preserving robust visual responses .
sequencing of cloned polymerase chain reaction amplified fragments of the amh gene revealed a 14-bp deletion in the second exon of the maternal allele; a homozygous mutation #disrupted splicing .
sequencing of cloned polymerase chain reaction amplified fragments of the amh gene revealed a 14-bp deletion in the second exon of the maternal allele; a homozygous mutation #disrupts splicing .
sequencing of cloned polymerase chain reaction amplified fragments of the amh gene revealed a 14-bp deletion in the second exon of the maternal allele; a homozygous mutation may have #disrupted splicing .
sequencing of cloned polymerase chain reaction amplified fragments of the amh gene revealed a 14-bp deletion in the second exon of the maternal allele; these mutations has #disrupted the ubiquitin-binding function .
sequencing of cloned polymerase chain reaction amplified fragments of the amh gene revealed a 14-bp deletion in the second exon of the maternal allele; these mutations is able to #disrupt the ubiquitin-binding function .
sequencing of cloned polymerase chain reaction amplified fragments of the amh gene revealed a 14-bp deletion in the second exon of the maternal allele; these mutations may have #disrupted the ubiquitin-binding function .
sequencing of cloned polymerase chain reaction amplified fragments of the amh gene revealed a 14-bp deletion in the second exon of the maternal allele; this deletion has #disrupted the consensus 5 splice signal .
sequencing of cloned polymerase chain reaction amplified fragments of the amh gene revealed a 14-bp deletion in the second exon of the maternal allele; this deletion may have #disrupted the consensus 5 splice signal .
sequencing of cloned polymerase chain reaction amplified fragments of the amh gene revealed a 14-bp deletion in the second exon of the maternal allele; inhibition of inflammation #disrupted protective physiologic responses .
sequencing of cloned polymerase chain reaction amplified fragments of the amh gene revealed a 14-bp deletion in the second exon of the maternal allele; inhibition of inflammation #disrupts protective physiologic responses .
sequencing of cloned polymerase chain reaction amplified fragments of the amh gene revealed a 14-bp deletion in the second exon of the maternal allele; inhibition of inflammation is able to #disrupt protective physiologic responses .
sequencing of cloned polymerase chain reaction amplified fragments of the amh gene revealed a 14-bp deletion in the second exon of the maternal allele; inhibition of inflammation may have #disrupted protective physiologic responses .
sequencing of cloned polymerase chain reaction amplified fragments of the amh gene revealed a 14-bp deletion in the second exon of the maternal allele; the lys147ala substitution #disrupted the interaction .
sequencing of cloned polymerase chain reaction amplified fragments of the amh gene revealed a 14-bp deletion in the second exon of the maternal allele; the lys147ala substitution #disrupts the interaction .
sequencing of cloned polymerase chain reaction amplified fragments of the amh gene revealed a 14-bp deletion in the second exon of the maternal allele; the lys147ala substitution has been shown to #disrupt the interaction .
sequencing of cloned polymerase chain reaction amplified fragments of the amh gene revealed a 14-bp deletion in the second exon of the maternal allele; the lys147ala substitution may have #disrupted the interaction .
studies using polymerase chain reaction , restriction enzyme digestion (a homozygous mutation being able to #disrupt splicing , the arg243----his mutation , a hha i site , and the asp250----asn mutation , a taq i site) , and allele-specific oligonucleotide hybridization confirmed that the patients were indeed compound heterozygous for the respective mutations .
studies using polymerase chain reaction , restriction enzyme digestion (a homozygous mutation that can #disrupt splicing , the arg243----his mutation , a hha i site , and the asp250----asn mutation , a taq i site) , and allele-specific oligonucleotide hybridization confirmed that the patients were indeed compound heterozygous for the respective mutations .
studies using polymerase chain reaction , restriction enzyme digestion (a homozygous mutation which have #disrupted splicing , the arg243----his mutation , a hha i site , and the asp250----asn mutation , a taq i site) , and allele-specific oligonucleotide hybridization confirmed that the patients were indeed compound heterozygous for the respective mutations .
studies using polymerase chain reaction , restriction enzyme digestion (these mutations #disrupts the ubiquitin-binding function , the arg243----his mutation , a hha i site , and the asp250----asn mutation , a taq i site) , and allele-specific oligonucleotide hybridization confirmed that the patients were indeed compound heterozygous for the respective mutations .
studies using polymerase chain reaction , restriction enzyme digestion (these mutations which have #disrupted the ubiquitin-binding function , the arg243----his mutation , a hha i site , and the asp250----asn mutation , a taq i site) , and allele-specific oligonucleotide hybridization confirmed that the patients were indeed compound heterozygous for the respective mutations .
studies using polymerase chain reaction , restriction enzyme digestion (this deletion being able to #disrupt the consensus 5 splice signal , the arg243----his mutation , a hha i site , and the asp250----asn mutation , a taq i site) , and allele-specific oligonucleotide hybridization confirmed that the patients were indeed compound heterozygous for the respective mutations .
studies using polymerase chain reaction , restriction enzyme digestion (this deletion #disrupts the consensus 5 splice signal , the arg243----his mutation , a hha i site , and the asp250----asn mutation , a taq i site) , and allele-specific oligonucleotide hybridization confirmed that the patients were indeed compound heterozygous for the respective mutations .
studies using polymerase chain reaction , restriction enzyme digestion (this deletion having #disrupted the consensus 5 splice signal , the arg243----his mutation , a hha i site , and the asp250----asn mutation , a taq i site) , and allele-specific oligonucleotide hybridization confirmed that the patients were indeed compound heterozygous for the respective mutations .
studies using polymerase chain reaction , restriction enzyme digestion (this deletion which have #disrupted the consensus 5 splice signal , the arg243----his mutation , a hha i site , and the asp250----asn mutation , a taq i site) , and allele-specific oligonucleotide hybridization confirmed that the patients were indeed compound heterozygous for the respective mutations .
studies using polymerase chain reaction , restriction enzyme digestion (inhibition of inflammation having #disrupted protective physiologic responses , the arg243----his mutation , a hha i site , and the asp250----asn mutation , a taq i site) , and allele-specific oligonucleotide hybridization confirmed that the patients were indeed compound heterozygous for the respective mutations .
studies using polymerase chain reaction , restriction enzyme digestion (inhibition of inflammation that can #disrupt protective physiologic responses , the arg243----his mutation , a hha i site , and the asp250----asn mutation , a taq i site) , and allele-specific oligonucleotide hybridization confirmed that the patients were indeed compound heterozygous for the respective mutations .
studies using polymerase chain reaction , restriction enzyme digestion (inhibition of inflammation which have #disrupted protective physiologic responses , the arg243----his mutation , a hha i site , and the asp250----asn mutation , a taq i site) , and allele-specific oligonucleotide hybridization confirmed that the patients were indeed compound heterozygous for the respective mutations .
studies using polymerase chain reaction , restriction enzyme digestion (the lys147ala substitution being able to #disrupt the interaction , the arg243----his mutation , a hha i site , and the asp250----asn mutation , a taq i site) , and allele-specific oligonucleotide hybridization confirmed that the patients were indeed compound heterozygous for the respective mutations .
studies using polymerase chain reaction , restriction enzyme digestion (the lys147ala substitution #disrupts the interaction , the arg243----his mutation , a hha i site , and the asp250----asn mutation , a taq i site) , and allele-specific oligonucleotide hybridization confirmed that the patients were indeed compound heterozygous for the respective mutations .
these mutations can interact with the keto groups of the go and c base pair(blue) in both sides of dsdna to #disrupt the ubiquitin-binding function .
this deletion can interact with the keto groups of the go and c base pair(blue) in both sides of dsdna and #disrupt the consensus 5 splice signal .
this deletion can interact with the keto groups of the go and c base pair(blue) in both sides of dsdna to #disrupt the consensus 5 splice signal .
inhibition of inflammation can interact with the keto groups of the go and c base pair(blue) in both sides of dsdna to #disrupt protective physiologic responses .
the lys147ala substitution can interact with the keto groups of the go and c base pair(blue) in both sides of dsdna and #disrupt the interaction .
the lys147ala substitution can interact with the keto groups of the go and c base pair(blue) in both sides of dsdna to #disrupt the interaction .
the lys147ala substitution that interact with the keto groups of the go and c base pair(blue) in both sides of dsdna can #disrupt the interaction .
a 6-bp insertion located within o2 or between ot and o1 #eliminates repression of the glptq promoter , whereas significant repression was maintained in the case of a 10-bp insertion within o2 .
a 6-bp insertion located within o2 or between ot and o1 will #eliminate repression of the glptq promoter , whereas significant repression will be maintained in the case of a 10-bp insertion within o2 .
a 6-bp insertion which #eliminated repression of the glptq promoter was located within o2 or between ot and o1 , whereas significant repression was maintained in the case of a 10-bp insertion within o2 .
an asparagine residue within a kinase domain of the product is #eliminated by a 3-bp in-frame deletion; the other two carried intronic mutations at or adjacent to the consensus dinucleotide sequences of splice-acceptor or-donor sites , which were likely to lead to aberrant splicing .
as illustrated in figure 1 , staurosporin (or genestein; data not shown) does not #eliminate the stabilization seen with mg132 .
as illustrated in figure 1 , the stabilization seen with mg132 is not #eliminated by staurosporin (or genestein; data not shown) .
as illustrated in figure 1 , the stabilization seen with mg132 will not be #eliminated by staurosporin (or genestein; data not shown) .
at a molar ratio of 5:1 , binding is completely #eliminated (figure 7) .
at a molar ratio of 5:1 , binding is observed to be completely #eliminated (figure 7) .
#eliminating all three sites makes the same high level of activation of b-raf occurs .
#eliminating any deleterious effects that might be associated with stable hoxb4 gene transfer into human cells , we took advantage of the ability of hox proteins to passively translocate through cell membranes .
exogenous h(2)o(2) was #eliminated in transgenic plants by inhibition of any one of these molecules .
one mutation can #eliminate the bamhi site in exon 7 .
one mutation would #eliminate the bamhi site in exon 7 .
one of the remaining three families carried a 3-bp in-frame deletion that #eliminates an asparagine residue within a kinase domain of the product; the other two carried intronic mutations at or adjacent to the consensus dinucleotide sequences of splice-acceptor or-donor sites , which were likely to lead to aberrant splicing .
one of the remaining three families carried a 3-bp in-frame deletion which #eliminated an asparagine residue within a kinase domain of the product; the other two carried intronic mutations at or adjacent to the consensus dinucleotide sequences of splice-acceptor or-donor sites , which were likely to lead to aberrant splicing .
secondly , sbp2 binding activity is not affected by mutations in the tetra-adenosine element in the terminal region of the phgpx 3 utr , sec incorporation is completely #eliminated by these same mutations .
secondly , sbp2 binding activity is not affected by mutations in the tetra-adenosine element in the terminal region of the phgpx 3 utr , sec incorporation was completely #eliminated by these same mutations .
secondly , sbp2 binding activity is not affected by mutations in the tetra-adenosine element in the terminal region of the phgpx 3 utr , these same mutations completely #eliminate sec incorporation .
that the inhibitory phosphorylation has been #eliminated is sufficient to confer constitutive activity upon lin-45 raf and induce multi-vulva phenotypes in c .elegans .
that the inhibitory phosphorylation is #eliminated is sufficient to confer constitutive activity upon lin-45 raf and induce multi-vulva phenotypes in c .elegans .
the bamhi site is #eliminated in exon 7 by one mutation .
the same high level of activation of b-raf occurs only when all three sites were #eliminated .
to #eliminate all three sites make the same high level of activation of b-raf occurs .
the hindiii site is #eliminated by the other in exon 11 of the phenylalanine hydroxylase gene .
the other can #eliminate the hindiii site in exon 11 of the phenylalanine hydroxylase gene .
the other #eliminated the hindiii site in exon 11 of the phenylalanine hydroxylase gene .
the other #eliminates the hindiii site in exon 11 of the phenylalanine hydroxylase gene .
the other is able to #eliminate the hindiii site in exon 11 of the phenylalanine hydroxylase gene .
the other would #eliminate the hindiii site in exon 11 of the phenylalanine hydroxylase gene .
as illustrated in figure 1 , staurosporin (or genestein; data not shown) did not #eliminate the stabilization seen with mg132 .
#eliminating the inhibitory phosphorylation or mimicking activating phosphorylation sites is sufficient to confer constitutive activity upon lin-45 raf and induce multi-vulva phenotypes in c .elegans .
a 6-bp insertion located within o2 or between ot and o1 #eliminated repression of the glptq promoter , whereas significant repression was maintained in the case of a 10-bp insertion within o2 .
one mutation #eliminates the bamhi site in exon 7 and the other #eliminates the hindiii site in exon 11 of the phenylalanine hydroxylase gene .
a 6-bp insertion can #eliminate repression of the glptq promoter while mutation at s494 has no effect (figure 2c) .
a 6-bp insertion #eliminated repression of the glptq promoter while mutation at s494 had no effect (figure 2c) .
a 6-bp insertion #eliminates repression of the glptq promoter while mutation at s494 has no effect (figure 2c) .
as illustrated in figure 1 , a molar ratio of 5:1 can not #eliminate binding .
as illustrated in figure 1 , a molar ratio of 5:1 did not #eliminate binding .
as illustrated in figure 1 , binding was not #eliminated by a molar ratio of 5:1 .
as illustrated in figure 1 , binding will not be #eliminated by a molar ratio of 5:1 .
as illustrated in figure 1 , repression of the glptq promoter was not #eliminated by a 6-bp insertion .
as illustrated in figure 1 , these same mutations can not #eliminate sec incorporation .
as illustrated in figure 1 , these same mutations did not #eliminate sec incorporation .
at a 6-bp insertion , repression of the glptq promoter can be completely #eliminated (figure 7) .
at a 6-bp insertion , repression of the glptq promoter is observed to be completely #eliminated (figure 7) .
at a 6-bp insertion , repression of the glptq promoter will be completely #eliminated (figure 7) .
at staurosporin (or genestein; data not shown) , the stabilization seen with mg132 can be completely #eliminated (figure 7) .
at staurosporin (or genestein; data not shown) , the stabilization seen with mg132 is completely #eliminated (figure 7) .
at these same mutations , sec incorporation is observed to be completely #eliminated (figure 7) .
at these same mutations , sec incorporation will be completely #eliminated (figure 7) .
in gel shift assay , a 6-bp insertion #eliminated repression of the glptq promoter .
in gel shift assay , a 6-bp insertion #eliminates repression of the glptq promoter .
in gel shift assay , a 6-bp insertion has #eliminated repression of the glptq promoter .
in gel shift assay , a 6-bp insertion will #eliminate repression of the glptq promoter .
in gel shift assay , a molar ratio of 5:1 #eliminated binding .
in gel shift assay , a molar ratio of 5:1 has #eliminated binding .
in gel shift assay , staurosporin (or genestein; data not shown) will #eliminate the stabilization seen with mg132 .
in gel shift assay , these same mutations #eliminates sec incorporation .
sec incorporation has been #eliminated by these same mutations at a 10-fold-higher concentration .
sec incorporation is #eliminated by these same mutations at a 10-fold-higher concentration .
sec incorporation was #eliminated by these same mutations at a 10-fold-higher concentration .
sec incorporation was #eliminated by these same mutations .
sec incorporation will be #eliminated by these same mutations at a 10-fold-higher concentration .
secondly , sbp2 binding activity is not affected by mutations in the tetra-adenosine element in the terminal region of the phgpx 3 utr , a molar ratio of 5:1 completely #eliminate binding .
secondly , sbp2 binding activity is not affected by mutations in the tetra-adenosine element in the terminal region of the phgpx 3 utr , binding is completely #eliminated by a molar ratio of 5:1 .
secondly , sbp2 binding activity is not affected by mutations in the tetra-adenosine element in the terminal region of the phgpx 3 utr , binding was completely #eliminated by a molar ratio of 5:1 .
secondly , sbp2 binding activity is not affected by mutations in the tetra-adenosine element in the terminal region of the phgpx 3 utr , repression of the glptq promoter is completely #eliminated by a 6-bp insertion .
secondly , sbp2 binding activity is not affected by mutations in the tetra-adenosine element in the terminal region of the phgpx 3 utr , staurosporin (or genestein; data not shown) can completely #eliminate the stabilization seen with mg132 (lesoon et al . , 1997) .
secondly , sbp2 binding activity is not affected by mutations in the tetra-adenosine element in the terminal region of the phgpx 3 utr , staurosporin (or genestein; data not shown) completely #eliminated the stabilization seen with mg132 .
secondly , sbp2 binding activity is not affected by mutations in the tetra-adenosine element in the terminal region of the phgpx 3 utr , the stabilization seen with mg132 is completely #eliminated by staurosporin (or genestein; data not shown) .
secondly , sbp2 binding activity is not affected by mutations in the tetra-adenosine element in the terminal region of the phgpx 3 utr , the stabilization seen with mg132 was completely #eliminated by staurosporin (or genestein; data not shown) .
secondly , sbp2 binding activity is not affected by mutations in the tetra-adenosine element in the terminal region of the phgpx 3 utr , yet a 6-bp insertion completely #eliminate repression of the glptq promoter (lesoon et al . , 1997) .
secondly , sbp2 binding activity is not affected by mutations in the tetra-adenosine element in the terminal region of the phgpx 3 utr , yet staurosporin (or genestein; data not shown) completely #eliminate the stabilization seen with mg132 (lesoon et al . , 1997) .
the same high level of activation of b-raf occurs only when any deleterious effects were #eliminated .
the same high level of activation of b-raf occurs only when the inhibitory phosphorylation are #eliminated .
the same high level of activation of b-raf occurs only when the inhibitory phosphorylation were #eliminated .
they establish that a 6-bp insertion , as may occur following caspase activation , can #eliminate repression of the glptq promoter required for skeletal muscle regeneration during chronic catabolic conditions .
they establish that a 6-bp insertion , as may occur following caspase activation , could #eliminate repression of the glptq promoter required for skeletal muscle regeneration during chronic catabolic conditions .
they establish that a molar ratio of 5:1 , as may occur following caspase activation , can #eliminate binding required for skeletal muscle regeneration during chronic catabolic conditions .
they establish that staurosporin (or genestein; data not shown) , as may occur following caspase activation , can #eliminate the stabilization seen with mg132 required for skeletal muscle regeneration during chronic catabolic conditions .
they establish that staurosporin (or genestein; data not shown) , as may occur following caspase activation , could #eliminate the stabilization seen with mg132 required for skeletal muscle regeneration during chronic catabolic conditions .
they establish that these same mutations , as may occur following caspase activation , can #eliminate sec incorporation required for skeletal muscle regeneration during chronic catabolic conditions .
they establish that these same mutations , as may occur following caspase activation , could #eliminate sec incorporation required for skeletal muscle regeneration during chronic catabolic conditions .
this occurs by a 6-bp insertion for #eliminating repression of the glptq promoter .
this occurs by a molar ratio of 5:1 for #eliminating binding .
this occurs by a molar ratio of 5:1 to #eliminate binding .
this occurs by these same mutations to #eliminate sec incorporation .
to #eliminate all three sites that might be associated with stable hoxb4 gene transfer into human cells , we took advantage of the ability of hox proteins to passively translocate through cell membranes .
to #eliminate any deleterious effects make the same high level of activation of b-raf occurs .
to #eliminate the inhibitory phosphorylation make the same high level of activation of b-raf occurs .
to #eliminate the inhibitory phosphorylation that might be associated with stable hoxb4 gene transfer into human cells , we took advantage of the ability of hox proteins to passively translocate through cell membranes .
a molar ratio of 5:1 at a 10-fold-higher concentration #eliminate binding .
a molar ratio of 5:1 #eliminated binding while mutation at s494 had no effect (figure 2c) .
a molar ratio of 5:1 has #eliminated binding while mutation at s494 had no effect (figure 2c) .
a molar ratio of 5:1 located within o2 or between ot and o1 #eliminates binding , whereas significant repression was maintained in the case of a 10-bp insertion within o2 .
a molar ratio of 5:1 located within o2 or between ot and o1 will #eliminate binding , whereas significant repression will be maintained in the case of a 10-bp insertion within o2 .
a molar ratio of 5:1 which #eliminates binding is located within o2 or between ot and o1 , whereas significant repression is maintained in the case of a 10-bp insertion within o2 .
binding was #eliminated by a molar ratio of 5:1 at a 10-fold-higher concentration .
binding was #eliminated by a molar ratio of 5:1 .
binding will be #eliminated by a molar ratio of 5:1 at a 10-fold-higher concentration .
repression of the glptq promoter has been #eliminated by a 6-bp insertion at a 10-fold-higher concentration .
repression of the glptq promoter is #eliminated by a 6-bp insertion at a 10-fold-higher concentration .
repression of the glptq promoter is #eliminated by a 6-bp insertion .
repression of the glptq promoter was #eliminated by a 6-bp insertion .
staurosporin (or genestein; data not shown) at a 10-fold-higher concentration #eliminate the stabilization seen with mg132 .
staurosporin (or genestein; data not shown) can #eliminate the stabilization seen with mg132 while mutation at s494 has no effect (figure 2c) .
staurosporin (or genestein; data not shown) #eliminated the stabilization seen with mg132 while mutation at s494 had no effect (figure 2c) .
staurosporin (or genestein; data not shown) located within o2 or between ot and o1 #eliminated the stabilization seen with mg132 , whereas significant repression was maintained in the case of a 10-bp insertion within o2 .
staurosporin (or genestein; data not shown) located within o2 or between ot and o1 #eliminates the stabilization seen with mg132 , whereas significant repression was maintained in the case of a 10-bp insertion within o2 .
staurosporin (or genestein; data not shown) located within o2 or between ot and o1 will #eliminate the stabilization seen with mg132 , whereas significant repression will be maintained in the case of a 10-bp insertion within o2 .
staurosporin (or genestein; data not shown) which #eliminates the stabilization seen with mg132 is located within o2 or between ot and o1 , whereas significant repression is maintained in the case of a 10-bp insertion within o2 .
the other has #eliminated the hindiii site in exon 11 of the phenylalanine hydroxylase gene .
the stabilization seen with mg132 is #eliminated by staurosporin (or genestein; data not shown) .
the stabilization seen with mg132 will be #eliminated by staurosporin (or genestein; data not shown) at a 10-fold-higher concentration .
these same mutations at a 10-fold-higher concentration #eliminated sec incorporation .
these same mutations can #eliminate sec incorporation while mutation at s494 has no effect (figure 2c) .
these same mutations #eliminated sec incorporation while mutation at s494 had no effect (figure 2c) .
these same mutations #eliminates sec incorporation while mutation at s494 has no effect (figure 2c) .
these same mutations which #eliminated sec incorporation was located within o2 or between ot and o1 , whereas significant repression was maintained in the case of a 10-bp insertion within o2 .
these same mutations which #eliminates sec incorporation is located within o2 or between ot and o1 , whereas significant repression is maintained in the case of a 10-bp insertion within o2 .
as illustrated in figure 1 , one mutation can not #eliminate the bamhi site .
as illustrated in figure 1 , one mutation did not #eliminate the bamhi site .
as illustrated in figure 1 , a 3-bp in-frame deletion can not #eliminate an asparagine residue .
as illustrated in figure 1 , a 3-bp in-frame deletion does not #eliminate an asparagine residue .
as illustrated in figure 1 , an asparagine residue is not #eliminated by a 3-bp in-frame deletion .
as illustrated in figure 1 , an asparagine residue will not be #eliminated by a 3-bp in-frame deletion .
as illustrated in figure 1 , the bamhi site was not #eliminated by one mutation .
as illustrated in figure 1 , the hindiii site was not #eliminated by the other .
as illustrated in figure 1 , the hindiii site will not be #eliminated by the other .
as illustrated in figure 1 , the other does not #eliminate the hindiii site .
at one mutation , the bamhi site can be completely #eliminated (figure 7) .
at one mutation , the bamhi site is completely #eliminated (figure 7) .
at one mutation , the bamhi site is observed to be completely #eliminated (figure 7) .
at one mutation , the bamhi site will be completely #eliminated (figure 7) .
at a 3-bp in-frame deletion , an asparagine residue is completely #eliminated (figure 7) .
at a 3-bp in-frame deletion , an asparagine residue will be completely #eliminated (figure 7) .
at the other , the hindiii site is observed to be completely #eliminated (figure 7) .
for #eliminating exogenous h(2)o(2) that might be associated with stable hoxb4 gene transfer into human cells , we took advantage of the ability of hox proteins to passively translocate through cell membranes .
in gel shift assay , one mutation #eliminates the bamhi site .
in gel shift assay , one mutation has #eliminated the bamhi site .
in gel shift assay , one mutation will #eliminate the bamhi site .
in gel shift assay , a 3-bp in-frame deletion #eliminates an asparagine residue .
in gel shift assay , the other #eliminates the hindiii site .
in gel shift assay , the other will #eliminate the hindiii site .
one mutation can #eliminate the bamhi site while mutation at s494 has no effect (figure 2c) .
one mutation #eliminated the bamhi site while mutation at s494 had no effect (figure 2c) .
one mutation located within o2 or between ot and o1 #eliminates the bamhi site , whereas significant repression was maintained in the case of a 10-bp insertion within o2 .
one mutation located within o2 or between ot and o1 has #eliminated the bamhi site , whereas significant repression was maintained in the case of a 10-bp insertion within o2 .
one mutation located within o2 or between ot and o1 will #eliminate the bamhi site , whereas significant repression will be maintained in the case of a 10-bp insertion within o2 .
one mutation which #eliminates the bamhi site is located within o2 or between ot and o1 , whereas significant repression is maintained in the case of a 10-bp insertion within o2 .
secondly , sbp2 an asparagine residue activity is not affected by mutations in the tetra-adenosine element in the terminal region of the phgpx 3 utr , a 3-bp in-frame deletion completely #eliminate binding .
secondly , sbp2 an asparagine residue activity is not affected by mutations in the tetra-adenosine element in the terminal region of the phgpx 3 utr , a 3-bp in-frame deletion completely #eliminated binding .
secondly , sbp2 an asparagine residue activity is not affected by mutations in the tetra-adenosine element in the terminal region of the phgpx 3 utr , binding is completely #eliminated by a 3-bp in-frame deletion .
secondly , sbp2 an asparagine residue activity is not affected by mutations in the tetra-adenosine element in the terminal region of the phgpx 3 utr , yet a 3-bp in-frame deletion completely #eliminate binding (lesoon et al . , 1997) .
secondly , sbp2 binding activity is not affected by mutations in the tetra-adenosine element in the terminal region of the phgpx 3 utr , one mutation can completely #eliminate the bamhi site (lesoon et al . , 1997) .
secondly , sbp2 binding activity is not affected by mutations in the tetra-adenosine element in the terminal region of the phgpx 3 utr , one mutation completely #eliminate the bamhi site .
secondly , sbp2 binding activity is not affected by mutations in the tetra-adenosine element in the terminal region of the phgpx 3 utr , one mutation completely #eliminated the bamhi site .
secondly , sbp2 binding activity is not affected by mutations in the tetra-adenosine element in the terminal region of the phgpx 3 utr , a 3-bp in-frame deletion can completely #eliminate an asparagine residue (lesoon et al . , 1997) .
secondly , sbp2 binding activity is not affected by mutations in the tetra-adenosine element in the terminal region of the phgpx 3 utr , a 3-bp in-frame deletion completely #eliminated an asparagine residue .
secondly , sbp2 binding activity is not affected by mutations in the tetra-adenosine element in the terminal region of the phgpx 3 utr , an asparagine residue is completely #eliminated by a 3-bp in-frame deletion .
secondly , sbp2 binding activity is not affected by mutations in the tetra-adenosine element in the terminal region of the phgpx 3 utr , the bamhi site is completely #eliminated by one mutation .
secondly , sbp2 binding activity is not affected by mutations in the tetra-adenosine element in the terminal region of the phgpx 3 utr , the bamhi site was completely #eliminated by one mutation .
secondly , sbp2 binding activity is not affected by mutations in the tetra-adenosine element in the terminal region of the phgpx 3 utr , the hindiii site is completely #eliminated by the other .
secondly , sbp2 binding activity is not affected by mutations in the tetra-adenosine element in the terminal region of the phgpx 3 utr , the other can completely #eliminate the hindiii site (lesoon et al . , 1997) .
secondly , sbp2 binding activity is not affected by mutations in the tetra-adenosine element in the terminal region of the phgpx 3 utr , the other completely #eliminate the hindiii site .
secondly , sbp2 binding activity is not affected by mutations in the tetra-adenosine element in the terminal region of the phgpx 3 utr , the other completely #eliminated the hindiii site .
secondly , sbp2 binding activity is not affected by mutations in the tetra-adenosine element in the terminal region of the phgpx 3 utr , yet one mutation completely #eliminate the bamhi site (lesoon et al . , 1997) .
secondly , sbp2 binding activity is not affected by mutations in the tetra-adenosine element in the terminal region of the phgpx 3 utr , yet the other completely #eliminate the hindiii site (lesoon et al . , 1997) .
secondly , sbp2 the bamhi site activity is not affected by mutations in the tetra-adenosine element in the terminal region of the phgpx 3 utr , one mutation can completely #eliminate binding (lesoon et al . , 1997) .
secondly , sbp2 the bamhi site activity is not affected by mutations in the tetra-adenosine element in the terminal region of the phgpx 3 utr , one mutation completely #eliminate binding .
secondly , sbp2 the bamhi site activity is not affected by mutations in the tetra-adenosine element in the terminal region of the phgpx 3 utr , one mutation completely #eliminated binding .
secondly , sbp2 the hindiii site activity is not affected by mutations in the tetra-adenosine element in the terminal region of the phgpx 3 utr , binding was completely #eliminated by the other .
secondly , sbp2 the hindiii site activity is not affected by mutations in the tetra-adenosine element in the terminal region of the phgpx 3 utr , the other can completely #eliminate binding (lesoon et al . , 1997) .
secondly , sbp2 the hindiii site activity is not affected by mutations in the tetra-adenosine element in the terminal region of the phgpx 3 utr , the other completely #eliminated binding .
secondly , sbp2 the hindiii site activity is not affected by mutations in the tetra-adenosine element in the terminal region of the phgpx 3 utr , yet the other completely #eliminate binding (lesoon et al . , 1997) .
the same high level of activation of b-raf occurs only when exogenous h(2)o(2) are #eliminated .
the same high level of activation of b-raf occurs only when exogenous h(2)o(2) were #eliminated .
they establish that one mutation , as may occur following caspase activation , could #eliminate the bamhi site required for skeletal muscle regeneration during chronic catabolic conditions .
they establish that a 3-bp in-frame deletion , as may occur following caspase activation , could #eliminate an asparagine residue required for skeletal muscle regeneration during chronic catabolic conditions .
they establish that the other , as may occur following caspase activation , could #eliminate the hindiii site required for skeletal muscle regeneration during chronic catabolic conditions .
this occurs by a 3-bp in-frame deletion to #eliminate an asparagine residue .
this occurs by the other to #eliminate the hindiii site .
a 3-bp in-frame deletion #eliminated an asparagine residue in a kinase domain of the product .
a 3-bp in-frame deletion #eliminates an asparagine residue in a kinase domain of the product .
a 3-bp in-frame deletion is able to #eliminate an asparagine residue in a kinase domain of the product .
a 3-bp in-frame deletion located within o2 or between ot and o1 #eliminates an asparagine residue , whereas significant repression was maintained in the case of a 10-bp insertion within o2 .
a 3-bp in-frame deletion located within o2 or between ot and o1 has #eliminated an asparagine residue , whereas significant repression was maintained in the case of a 10-bp insertion within o2 .
a 3-bp in-frame deletion located within o2 or between ot and o1 will #eliminate an asparagine residue , whereas significant repression will be maintained in the case of a 10-bp insertion within o2 .
a 3-bp in-frame deletion which #eliminated an asparagine residue was located within o2 or between ot and o1 , whereas significant repression was maintained in the case of a 10-bp insertion within o2 .
an asparagine residue is #eliminated by a 3-bp in-frame deletion .
an asparagine residue was #eliminated by a 3-bp in-frame deletion at a 10-fold-higher concentration .
an asparagine residue was #eliminated by a 3-bp in-frame deletion .
the bamhi site is #eliminated by one mutation at a 10-fold-higher concentration .
the bamhi site was #eliminated by one mutation .
the bamhi site will be #eliminated by one mutation at a 10-fold-higher concentration .
the hindiii site is #eliminated by the other .
the hindiii site will be #eliminated by the other at a 10-fold-higher concentration .
the other at a 10-fold-higher concentration #eliminated the hindiii site .
the other #eliminated the hindiii site while mutation at s494 had no effect (figure 2c) .
the other has #eliminated the hindiii site while mutation at s494 had no effect (figure 2c) .
a protein that participates in the second step of the splicing reaction has been #encoded by the prp17 gene of the yeast saccharomyces cerevisiae .
expression sbp2 northern analysis of poly (a) + rna from various tissues reveals that sbp2 is #encoded by as many as three distinct transcripts .
in this vector , the t .gondii dhfr-ts region that was shown to #encode resistance to wr99210 is excised with bamhi and kpni and replaced with human dhfr mutated .
maz has #encoded a transcription factor with dual roles in transcription initiation and termination .
maz is able to #encode a transcription factor with dual roles in transcription initiation and termination .
maz is believed to #encode a transcription factor with dual roles in transcription initiation and termination .
proteins involved in pre-mrna splicing are #encoded by a gene family including the human snrpn (small nuclear ribonucleoprotein polypeptide n) gene which maps to the smallest deletion region involved in the prader-willi syndrome (pws) within chromosome 15q11-q13 .
resistance to wr99210 has been #encoded by the t .gondii dhfr-ts region with bamhi and kpni and replaced with human dhfr mutated
resistance to wr99210 is #encoded by the t .gondii dhfr-ts region with bamhi and kpni and replaced with human dhfr mutated .
resistance to wr99210 is shown to be #encoded by the t .gondii dhfr-ts region with bamhi and kpni and replaced with human dhfr mutated
the prp17 gene of the yeast saccharomyces cerevisiae is shown to #encode a protein that participates in the second step of the splicing reaction .
the prp17 gene of the yeast saccharomyces cerevisiae may have #encoded a protein that participated in the second step of the splicing reaction .
the gene yjfq #encoded the repressor of the yjfr-x regulon (ula) , which is involved in l-ascorbate metabolism in escherichia coli .
the gene yjfq has #encoded the repressor of the yjfr-x regulon (ula) , which is involved in l-ascorbate metabolism in escherichia coli .
the gene yjfq is able to #encode the repressor of the yjfr-x regulon (ula) , which is involved in l-ascorbate metabolism in escherichia coli .
the gene yjfq is believed to have #encoded the repressor of the yjfr-x regulon (ula) , which is involved in l-ascorbate metabolism in escherichia coli .
the glp regulon of escherichia coli #encoded the proteins required for utilization of sn-glycerol 3-phosphate and its precursors .
the glp regulon of escherichia coli has #encoded the proteins required for utilization of sn-glycerol 3-phosphate and its precursors .
the glp regulon of escherichia coli may have #encoded the proteins required for utilization of sn-glycerol 3-phosphate and its precursors .
the human snrpn (small nuclear ribonucleoprotein polypeptide n) gene is one of a gene family having #encoded proteins involved in pre-mrna splicing and maps to the smallest deletion region involved in the prader-willi syndrome (pws) within chromosome 15q11-q13 .
we recently encloned murine and human cdnas #encoding cp2 , a cellular transcription factor that interacts with the alpha-globin promoter as well as with additional cellular and viral promoter elements .
we recently encloned murine and human cdnas that #encoded cp2 , a cellular transcription factor that interacts with the alpha-globin promoter as well as with additional cellular and viral promoter elements .
a transcription factor with dual roles in transcription initiation and termination has been #encoded by maz .
the proteins required for utilization of sn-glycerol 3-phosphate and its precursors have been #encoded by the glp regulon of escherichia coli .
the proteins required for utilization of sn-glycerol 3-phosphate and its precursors may be #encoded by the glp regulon of escherichia coli .
the prp17 gene of the yeast saccharomyces cerevisiae #encodes a protein that participates in the second step of the splicing reaction .
cp2 are shown to be #encoded by murine and human cdnas .
cp2 is #encoded by murine and human cdnas .
cp2 may be #encoded by murine and human cdnas .
cp2 was believed to be #encoded by murine and human cdnas .
cp2 was #encoded by murine and human cdnas .
cp2 was shown to be #encoded by murine and human cdnas .
cp2 were #encoded by murine and human cdnas .
cp2 were shown to be #encoded by murine and human cdnas .
expression the 6-pyruvoyl-tetrahydropterin synthase northern analysis of poly (a) + rna from various tissues reveals that sbp2 may be #encoded by as many as all six exons .
expression the 6-pyruvoyl-tetrahydropterin synthase northern analysis of poly (a) + rna from various tissues reveals that sbp2 was #encoded by as many as all six exons .
in plants it is estimated that all six exons are able to #encode the 6-pyruvoyl-tetrahydropterin synthase .
in plants it is estimated that all six exons #encode the 6-pyruvoyl-tetrahydropterin synthase .
in plants it is estimated that all six exons have #encoded the 6-pyruvoyl-tetrahydropterin synthase .
in plants it is estimated that the 6-pyruvoyl-tetrahydropterin synthase are #encoded by all six exons .
in plants it is estimated that the 6-pyruvoyl-tetrahydropterin synthase have been #encoded by all six exons .
in plants it is estimated that three distinct transcripts #encode sbp2 .
in plants it is estimated that three distinct transcripts may have #encoded sbp2 .
it is possible , therefore , that all six exons are involved in regulating its expression of #encoding the 6-pyruvoyl-tetrahydropterin synthase .
it is possible , therefore , that all six exons are involved in the process of #encoding the 6-pyruvoyl-tetrahydropterin synthase .
maz has been #encoding a transcription factor with dual roles in transcription initiation and termination , which is involved in l-ascorbate metabolism in escherichia coli .
maz has #encoded a transcription factor with dual roles in transcription initiation and termination , which is involved in l-ascorbate metabolism in escherichia coli .
maz is able to #encode a transcription factor with dual roles in transcription initiation and termination , which is involved in l-ascorbate metabolism in escherichia coli .
maz is believed to have #encoded a transcription factor with dual roles in transcription initiation and termination , which is involved in l-ascorbate metabolism in escherichia coli .
maz is shown to #encode a transcription factor with dual roles in transcription initiation and termination , which is involved in l-ascorbate metabolism in escherichia coli .
maz may have #encoded a transcription factor with dual roles in transcription initiation and termination .
our reseach shows that sbp2 are #encoded by three distinct transcripts .
our reseach shows that sbp2 were #encoded by three distinct transcripts .
our reseach shows that the 6-pyruvoyl-tetrahydropterin synthase are #encoded by all six exons .
our reseach shows that the 6-pyruvoyl-tetrahydropterin synthase were #encoded by all six exons .
our reseach shows that three distinct transcripts have #encoded sbp2 .
the escherichia coli yjha (renamed nanc) gene #encoded a protein of the kdgm family of outer membrane-specific channels .
the escherichia coli yjha (renamed nanc) gene has been #encoding a protein of the kdgm family of outer membrane-specific channels , which is involved in l-ascorbate metabolism in escherichia coli .
the escherichia coli yjha (renamed nanc) gene has #encoded a protein of the kdgm family of outer membrane-specific channels , which is involved in l-ascorbate metabolism in escherichia coli .
the escherichia coli yjha (renamed nanc) gene is believed to #encode a protein of the kdgm family of outer membrane-specific channels .
the escherichia coli yjha (renamed nanc) gene is believed to have #encoded a protein of the kdgm family of outer membrane-specific channels , which is involved in l-ascorbate metabolism in escherichia coli .
the escherichia coli yjha (renamed nanc) gene , which #encoded a protein of the kdgm family of outer membrane-specific channels , respectively , was affected in a reciprocal manner by the osmolarity of the growth medium .
the gene yjfq #encoded the repressor of the yjfr-x regulon (ula) .
the gene yjfq has #encoded the repressor of the yjfr-x regulon (ula) .
the gene yjfq is able to #encode the repressor of the yjfr-x regulon (ula) .
the gene yjfq is believed to #encode the repressor of the yjfr-x regulon (ula) .
the gene yjfq , #encoding the repressor of the yjfr-x regulon (ula) , respectively , is affected in a reciprocal manner by the osmolarity of the growth medium .
the gene yjfq , which #encoded the repressor of the yjfr-x regulon (ula) , respectively , was affected in a reciprocal manner by the osmolarity of the growth medium .
the glp regulon of escherichia coli #encoded the proteins required for utilization of sn-glycerol 3-phosphate and its precursors , which is involved in l-ascorbate metabolism in escherichia coli .
the glp regulon of escherichia coli has been #encoding the proteins required for utilization of sn-glycerol 3-phosphate and its precursors .
the glp regulon of escherichia coli has #encoded the proteins required for utilization of sn-glycerol 3-phosphate and its precursors , which is involved in l-ascorbate metabolism in escherichia coli .
the glp regulon of escherichia coli , which has #encoded the proteins required for utilization of sn-glycerol 3-phosphate and its precursors , respectively , was affected in a reciprocal manner by the osmolarity of the growth medium .
we recently encloned the escherichia coli yjha (renamed nanc) gene that #encoded a protein of the kdgm family of outer membrane-specific channels , a cellular transcription factor that interacts with the alpha-globin promoter as well as with additional cellular and viral promoter elements .
we recently encloned the escherichia coli yjha (renamed nanc) gene which may have #encoded a protein of the kdgm family of outer membrane-specific channels , a cellular transcription factor that interacts with the alpha-globin promoter as well as with additional cellular and viral promoter elements .
we recently encloned the gene yjfq that have #encoded the repressor of the yjfr-x regulon (ula) , a cellular transcription factor that interacts with the alpha-globin promoter as well as with additional cellular and viral promoter elements .
we recently encloned the gene yjfq which may have #encoded the repressor of the yjfr-x regulon (ula) , a cellular transcription factor that interacts with the alpha-globin promoter as well as with additional cellular and viral promoter elements .
we recently encloned the glp regulon of escherichia coli which may have #encoded the proteins required for utilization of sn-glycerol 3-phosphate and its precursors , a cellular transcription factor that interacts with the alpha-globin promoter as well as with additional cellular and viral promoter elements .
a protein of the kdgm family of outer membrane-specific channels are #encoded by the escherichia coli yjha (renamed nanc) gene .
a protein of the kdgm family of outer membrane-specific channels have been #encoded by the escherichia coli yjha (renamed nanc) gene .
a protein of the kdgm family of outer membrane-specific channels is #encoded by the escherichia coli yjha (renamed nanc) gene .
a protein of the kdgm family of outer membrane-specific channels were #encoded by the escherichia coli yjha (renamed nanc) gene .
a protein of the kdgm family of outer membrane-specific channels , a cellular transcription factor that interacts with the alpha-globin promoter as well as with additional cellular and viral promoter elements , is shown to be #encoded by the escherichia coli yjha (renamed nanc) gene which we recently encloned .
a protein of the kdgm family of outer membrane-specific channels , a cellular transcription factor that interacts with the alpha-globin promoter as well as with additional cellular and viral promoter elements , may be #encoded by the escherichia coli yjha (renamed nanc) gene which we recently encloned .
a transcription factor with dual roles in transcription initiation and termination are shown to be #encoded by maz .
a transcription factor with dual roles in transcription initiation and termination have been #encoded by maz .
a transcription factor with dual roles in transcription initiation and termination may be #encoded by maz .
a transcription factor with dual roles in transcription initiation and termination were #encoded by maz .
a transcription factor with dual roles in transcription initiation and termination were #encoded by maz .
a transcription factor with dual roles in transcription initiation and termination were shown to be #encoded by maz .
a transcription factor with dual roles in transcription initiation and termination , a cellular transcription factor that interacts with the alpha-globin promoter as well as with additional cellular and viral promoter elements , is shown to be #encoded by maz which we recently encloned .
all six exons #encodes the 6-pyruvoyl-tetrahydropterin synthase .
all six exons may #encode the 6-pyruvoyl-tetrahydropterin synthase .
all six exons , which #encode the 6-pyruvoyl-tetrahydropterin synthase , respectively , is affected in a reciprocal manner by the osmolarity of the growth medium .
murine and human cdnas #encoded cp2 , which is involved in l-ascorbate metabolism in escherichia coli .
murine and human cdnas has been #encoding cp2 , which is involved in l-ascorbate metabolism in escherichia coli .
murine and human cdnas has #encoded cp2 .
murine and human cdnas is shown to #encode cp2 , which is involved in l-ascorbate metabolism in escherichia coli .
murine and human cdnas is shown to #encode cp2 .
the proteins required for utilization of sn-glycerol 3-phosphate and its precursors are #encoded by the glp regulon of escherichia coli .
the proteins required for utilization of sn-glycerol 3-phosphate and its precursors have been #encoded by the glp regulon of escherichia coli .
the proteins required for utilization of sn-glycerol 3-phosphate and its precursors is #encoded by the glp regulon of escherichia coli .
the proteins required for utilization of sn-glycerol 3-phosphate and its precursors were #encoded by the glp regulon of escherichia coli .
the proteins required for utilization of sn-glycerol 3-phosphate and its precursors , a cellular transcription factor that interacts with the alpha-globin promoter as well as with additional cellular and viral promoter elements , is shown to be #encoded by the glp regulon of escherichia coli which we recently encloned .
the proteins required for utilization of sn-glycerol 3-phosphate and its precursors , a cellular transcription factor that interacts with the alpha-globin promoter as well as with additional cellular and viral promoter elements , may be #encoded by the glp regulon of escherichia coli which we recently encloned .
the repressor of the yjfr-x regulon (ula) are #encoded by the gene yjfq .
the repressor of the yjfr-x regulon (ula) are shown to be #encoded by the gene yjfq .
the repressor of the yjfr-x regulon (ula) has been #encoded by the gene yjfq .
the repressor of the yjfr-x regulon (ula) have been #encoded by the gene yjfq .
the repressor of the yjfr-x regulon (ula) may be #encoded by the gene yjfq .
the repressor of the yjfr-x regulon (ula) was believed to be #encoded by the gene yjfq .
the repressor of the yjfr-x regulon (ula) was shown to be #encoded by the gene yjfq .
the repressor of the yjfr-x regulon (ula) were #encoded by the gene yjfq .
the repressor of the yjfr-x regulon (ula) , a cellular transcription factor that interacts with the alpha-globin promoter as well as with additional cellular and viral promoter elements , may be #encoded by the gene yjfq which we recently encloned .
three distinct transcripts may #encode sbp2 .
compound heterozygous or homozygous mutations spread over the prp17 gene of the yeast saccharomyces cerevisiae #encoding a protein that participated in the second step of the splicing reaction cause an autosomal recessively inherited variant of hyperphenylalaninemia , mostly accompanied by a deficiency of dopamine and serotonin .
compound heterozygous or homozygous mutations spread over a pre-mrna #encoding a multipass integral membrane protein cause an autosomal recessively inherited variant of hyperphenylalaninemia , mostly accompanied by a deficiency of dopamine and serotonin .
expression a multipass integral membrane protein northern analysis of poly (a) + rna from various tissues reveals that sbp2 is #encoded by as many as a pre-mrna .
expression a multipass integral membrane protein northern analysis of poly (a) + rna from various tissues reveals that sbp2 was #encoded by as many as a pre-mrna .
expression a multipass integral membrane protein northern analysis of poly (a) + rna from various tissues shows a pre-mrna are shown to #encode sbp2 .
expression a multipass integral membrane protein northern analysis of poly (a) + rna from various tissues shows a pre-mrna are shown to have #encoded sbp2 .
expression a multipass integral membrane protein northern analysis of poly (a) + rna from various tissues shows that a pre-mrna have #encoded sbp2 .
expression a protein that participated in the second step of the splicing reaction northern analysis of poly (a) + rna from various tissues reveals that sbp2 is #encoded by as many as the prp17 gene of the yeast saccharomyces cerevisiae .
expression a protein that participated in the second step of the splicing reaction northern analysis of poly (a) + rna from various tissues reveals that sbp2 may be #encoded by as many as the prp17 gene of the yeast saccharomyces cerevisiae .
expression a protein that participated in the second step of the splicing reaction northern analysis of poly (a) + rna from various tissues reveals that sbp2 was #encoded by as many as the prp17 gene of the yeast saccharomyces cerevisiae .
expression a protein that participated in the second step of the splicing reaction northern analysis of poly (a) + rna from various tissues shows the prp17 gene of the yeast saccharomyces cerevisiae are shown to #encode sbp2 .
expression a protein that participated in the second step of the splicing reaction northern analysis of poly (a) + rna from various tissues shows that the prp17 gene of the yeast saccharomyces cerevisiae #encode sbp2 .
expression a protein that participates in the second step of the splicing reaction northern analysis of poly (a) + rna from various tissues reveals that sbp2 has been #encoded by as many as the prp17 gene of the yeast saccharomyces cerevisiae .
expression a protein that participates in the second step of the splicing reaction northern analysis of poly (a) + rna from various tissues reveals that sbp2 was #encoded by as many as the prp17 gene of the yeast saccharomyces cerevisiae .
expression a protein that participates in the second step of the splicing reaction northern analysis of poly (a) + rna from various tissues shows the prp17 gene of the yeast saccharomyces cerevisiae are shown to #encode sbp2 .
expression a protein that participates in the second step of the splicing reaction northern analysis of poly (a) + rna from various tissues shows the prp17 gene of the yeast saccharomyces cerevisiae are shown to have #encoded sbp2 .
expression a protein that participates in the second step of the splicing reaction northern analysis of poly (a) + rna from various tissues shows that the prp17 gene of the yeast saccharomyces cerevisiae have #encoded sbp2 .
expression proteins involved in pre-mrna splicing northern analysis of poly (a) + rna from various tissues reveals that sbp2 was #encoded by as many as a gene family .
expression proteins involved in pre-mrna splicing northern analysis of poly (a) + rna from various tissues shows a gene family are shown to #encode sbp2 .
expression proteins involved in pre-mrna splicing northern analysis of poly (a) + rna from various tissues shows that a gene family #encode sbp2 .
expression resistance to wr99210 northern analysis of poly (a) + rna from various tissues reveals that sbp2 has been #encoded by as many as the t .gondii dhfr-ts region .
expression resistance to wr99210 northern analysis of poly (a) + rna from various tissues reveals that sbp2 is #encoded by as many as the t .gondii dhfr-ts region .
expression resistance to wr99210 northern analysis of poly (a) + rna from various tissues shows that the t .gondii dhfr-ts region #encode sbp2 .
expression resistance to wr99210 northern analysis of poly (a) + rna from various tissues shows that the t .gondii dhfr-ts region have #encoded sbp2 .
expression resistance to wr99210 northern analysis of poly (a) + rna from various tissues shows the t .gondii dhfr-ts region are shown to #encode sbp2 .
in plants it is estimated that the prp17 gene of the yeast saccharomyces cerevisiae are able to #encode a protein that participated in the second step of the splicing reaction .
in plants it is estimated that the prp17 gene of the yeast saccharomyces cerevisiae are able to #encode a protein that participates in the second step of the splicing reaction .
in plants it is estimated that the prp17 gene of the yeast saccharomyces cerevisiae #encode a protein that participated in the second step of the splicing reaction .
in plants it is estimated that the prp17 gene of the yeast saccharomyces cerevisiae #encode a protein that participates in the second step of the splicing reaction .
in plants it is estimated that the prp17 gene of the yeast saccharomyces cerevisiae have #encoded a protein that participated in the second step of the splicing reaction .
in plants it is estimated that the prp17 gene of the yeast saccharomyces cerevisiae may have #encoded a protein that participates in the second step of the splicing reaction .
in plants it is estimated that a gene family are able to #encode proteins involved in pre-mrna splicing .
in plants it is estimated that a gene family #encode proteins involved in pre-mrna splicing .
in plants it is estimated that a gene family have #encoded proteins involved in pre-mrna splicing .
in plants it is estimated that a gene family may have #encoded proteins involved in pre-mrna splicing .
in plants it is estimated that a multipass integral membrane protein are #encoded by a pre-mrna .
in plants it is estimated that a multipass integral membrane protein have been #encoded by a pre-mrna .
in plants it is estimated that a pre-mrna are able to #encode a multipass integral membrane protein .
in plants it is estimated that a protein that participated in the second step of the splicing reaction are #encoded by the prp17 gene of the yeast saccharomyces cerevisiae .
in plants it is estimated that a protein that participated in the second step of the splicing reaction have been #encoded by the prp17 gene of the yeast saccharomyces cerevisiae .
in plants it is estimated that a protein that participates in the second step of the splicing reaction are #encoded by the prp17 gene of the yeast saccharomyces cerevisiae .
in plants it is estimated that proteins involved in pre-mrna splicing are #encoded by a gene family .
in plants it is estimated that proteins involved in pre-mrna splicing have been #encoded by a gene family .
in plants it is estimated that resistance to wr99210 have been #encoded by the t .gondii dhfr-ts region .
in plants it is estimated that the t .gondii dhfr-ts region are able to #encode resistance to wr99210 .
in plants it is estimated that the t .gondii dhfr-ts region have #encoded resistance to wr99210 .
it is possible , therefore , that the prp17 gene of the yeast saccharomyces cerevisiae are involved in #encoding a protein that participates in the second step of the splicing reaction .
it is possible , therefore , that the prp17 gene of the yeast saccharomyces cerevisiae are involved in regulating its expression of #encoding a protein that participated in the second step of the splicing reaction .
it is possible , therefore , that the prp17 gene of the yeast saccharomyces cerevisiae are involved in regulating its expression of #encoding a protein that participates in the second step of the splicing reaction .
it is possible , therefore , that the prp17 gene of the yeast saccharomyces cerevisiae are involved in the process of #encoding a protein that participated in the second step of the splicing reaction .
it is possible , therefore , that the prp17 gene of the yeast saccharomyces cerevisiae are involved in the process of #encoding a protein that participates in the second step of the splicing reaction .
it is possible , therefore , that a gene family are involved in #encoding proteins involved in pre-mrna splicing .
it is possible , therefore , that a gene family are involved in the process of #encoding proteins involved in pre-mrna splicing .
it is possible , therefore , that a pre-mrna are involved in regulating its expression of #encoding a multipass integral membrane protein .
it is possible , therefore , that a pre-mrna are involved in the process of #encoding a multipass integral membrane protein .
it is possible , therefore , that the t .gondii dhfr-ts region are involved in #encoding resistance to wr99210 .
it is possible , therefore , that the t .gondii dhfr-ts region are involved in regulating its expression of #encoding resistance to wr99210 .
our reseach shows that the prp17 gene of the yeast saccharomyces cerevisiae have #encoded a protein that participates in the second step of the splicing reaction .
our reseach shows that a multipass integral membrane protein are #encoded by a pre-mrna .
our reseach shows that a multipass integral membrane protein were #encoded by a pre-mrna .
our reseach shows that a pre-mrna have #encoded a multipass integral membrane protein .
our reseach shows that a protein that participates in the second step of the splicing reaction were #encoded by the prp17 gene of the yeast saccharomyces cerevisiae .
our reseach shows that resistance to wr99210 were #encoded by the t .gondii dhfr-ts region .
our reseach shows that the t .gondii dhfr-ts region #encode resistance to wr99210 .
our reseach shows that the t .gondii dhfr-ts region have #encoded resistance to wr99210 .
the prp17 gene of the yeast saccharomyces cerevisiae #encodes a protein that participated in the second step of the splicing reaction .
the prp17 gene of the yeast saccharomyces cerevisiae , which #encode a protein that participates in the second step of the splicing reaction , respectively , is affected in a reciprocal manner by the osmolarity of the growth medium .
we recently the prp17 gene of the yeast saccharomyces cerevisiae that #encode a protein that participated in the second step of the splicing reaction , a cellular transcription factor that interacts with the alpha-globin promoter as well as with additional cellular and viral promoter elements .
we recently the prp17 gene of the yeast saccharomyces cerevisiae that #encode a protein that participates in the second step of the splicing reaction , a cellular transcription factor that interacts with the alpha-globin promoter as well as with additional cellular and viral promoter elements .
we recently the t .gondii dhfr-ts region that #encode resistance to wr99210 , a cellular transcription factor that interacts with the alpha-globin promoter as well as with additional cellular and viral promoter elements .
a gene family , which #encode proteins involved in pre-mrna splicing , respectively , is affected in a reciprocal manner by the osmolarity of the growth medium .
a pre-mrna #encodes a multipass integral membrane protein , which is involved in l-ascorbate metabolism in escherichia coli .
a pre-mrna #encodes a multipass integral membrane protein .
a pre-mrna may #encode a multipass integral membrane protein .
the t .gondii dhfr-ts region #encodes resistance to wr99210 , which is involved in l-ascorbate metabolism in escherichia coli .
the t .gondii dhfr-ts region #encodes resistance to wr99210 .
a complementary dna clone encoding the large subunit of the essential mammalian pre-messenger rna splicing component u2 snrnp auxiliary factor(u2af65) is able to be isolated and #expressed in vitro .
a complementary dna clone encoding the large subunit of the essential mammalian pre-messenger rna splicing component u2 snrnp auxiliary factor(u2af65) is shown to be isolated and #expressed in vitro .
a complementary dna clone encoding the large subunit of the essential mammalian pre-messenger rna splicing component u2 snrnp auxiliary factor(u2af65) may have been isolated and #expressed in vitro .
a complementary dna clone encoding the large subunit of the essential mammalian pre-messenger rna splicing component u2 snrnp auxiliary factor(u2af65) will be isolated and #expressed in vitro .
bd73 messenger rna is able to be #expressed in a wide variety of tissues and cell lines .
bd73 messenger rna will be #expressed in a wide variety of tissues and cell lines .
in such cells at the cell surface , two in-frame  chain transcripts are produced , but only one has been #expressed .
in such cells at the cell surface , two in-frame  chain transcripts were produced , but it #expresses only one of them .
in such cells at the cell surface , two in-frame  chain transcripts were produced , but it has #expressed only one of them .
in such cells at the cell surface , two in-frame  chain transcripts were produced , but only one of them can be #expressed .
in such cells at the cell surface , two in-frame  chain transcripts were produced , but only one of them is observed to be #expressed .
it has been assumed that this peptide exercises its mitogenic influences through the vasopressin v1a receptor , and we have previously demonstrated that this receptor can be #expressed by classical and variant sccl .
it has been assumed that this peptide exercises its mitogenic influences through the vasopressin v1a receptor , and we have previously demonstrated that this receptor has been #expressed by classical and variant sccl .
it has been assumed that this peptide exercises its mitogenic influences through the vasopressin v1a receptor , and we have previously demonstrated that this receptor was shown to be #expressed by classical and variant sccl .
northern blot analysis reveals that bnip3alpha has been #expressed ubiquitously in most human tissues .
northern blotting and reverse transcriptase-pcr assays with oligonucleotide probes and primers specific for each transcript demonstrated that the isoform identical to ran/tc4 has been #expressed in both somatic tissues and testis , while the variant form was transcribed only in testis .
northern blotting and reverse transcriptase-pcr assays with oligonucleotide probes and primers specific for each transcript demonstrated that the isoform identical to ran/tc4 is able to be #expressed in both somatic tissues and testis , while the variant form was transcribed only in testis .
northern blotting and reverse transcriptase-pcr assays with oligonucleotide probes and primers specific for each transcript demonstrated that the isoform identical to ran/tc4 would be #expressed in both somatic tissues and testis , while the variant form was transcribed only in testis .
t cells in mice at the cell surface carrying transgenes encoding tcr  and  proteins predominantly have #expressed the transgene-encoded tcr proteins .
t cells in mice at the cell surface carrying transgenes encoding tcr  and  proteins predominantly may have #expressed the transgene-encoded tcr proteins .
the human mitochondrial transcription termination factor (mterf) cdna is cloned and #expressed in vitro , and two alternative precursors of the protein have been imported into isolated mitochondria and processed to the mature protein .
the human mitochondrial transcription termination factor (mterf) cdna was cloned and #expressed in vitro , and two alternative precursors of the protein have been imported into isolated mitochondria and processed to the mature protein .
the human mitochondrial transcription termination factor (mterf) cdna was #expressed and cloned in vitro , and two alternative precursors of the protein have been imported into isolated mitochondria and processed to the mature protein .
the human mitochondrial transcription termination factor (mterf) cdna was shown to be #expressed and cloned in vitro , and two alternative precursors of the protein have been imported into isolated mitochondria and processed to the mature protein .
the human mitochondrial transcription termination factor (mterf) cdna would be cloned and #expressed in vitro , and two alternative precursors of the protein have been imported into isolated mitochondria and processed to the mature protein .
the human mitochondrial transcription termination factor (mterf) cdna would be #expressed and cloned in vitro , and two alternative precursors of the protein have been imported into isolated mitochondria and processed to the mature protein .
the pfl operon has been #expressed at high levels anaerobically .
the pfl operon has been shown to be #expressed at high levels anaerobically .
the transgene-encoded tcr proteins may have been predominantly #expressed by t cells in mice at the cell surface .
the transgene-encoded tcr proteins were predominantly #expressed by t cells in mice at the cell surface .
the transgene-encoded tcr proteins will be predominantly #expressed by t cells in mice at the cell surface .
bd73 messenger rna is #expressed in a wide variety of tissues and cell lines .
northern blot analysis reveals that bnip3alpha is #expressed ubiquitously in most human tissues .
the pfl operon is #expressed at high levels anaerobically .
northern blotting and reverse transcriptase-pcr assays with oligonucleotide probes and primers specific for each transcript demonstrated that the isoform identical to ran/tc4 was #expressed in both somatic tissues and testis , while the variant form was transcribed only in testis .
bd73 messenger rna has been cloned and #expressed in in a wide variety of tissues and cell lines , and two alternative precursors of the protein have been imported into isolated mitochondria and processed to the mature protein .
bd73 messenger rna has been likely #expressed through +1 or -1 frameshifting by in a wide variety of tissues and cell lines .
bd73 messenger rna is able to be #expressed and cloned in in a wide variety of tissues and cell lines , and two alternative precursors of the protein have been imported into isolated mitochondria and processed to the mature protein .
bd73 messenger rna is #expressed and cloned in in a wide variety of tissues and cell lines , and two alternative precursors of the protein have been imported into isolated mitochondria and processed to the mature protein .
bd73 messenger rna is #expressed in a wide variety of tissues and cell lines .
bd73 messenger rna is likely #expressed through +1 or -1 frameshifting by in a wide variety of tissues and cell lines .
bd73 messenger rna may have been #expressed by in a wide variety of tissues and cell lines .
bd73 messenger rna may have been likely #expressed through +1 or -1 frameshifting by in a wide variety of tissues and cell lines .
bd73 messenger rna was cloned and #expressed in in a wide variety of tissues and cell lines , and two alternative precursors of the protein have been imported into isolated mitochondria and processed to the mature protein .
bd73 messenger rna was #expressed and cloned in in a wide variety of tissues and cell lines , and two alternative precursors of the protein have been imported into isolated mitochondria and processed to the mature protein .
bd73 messenger rna would be cloned and #expressed in in a wide variety of tissues and cell lines , and two alternative precursors of the protein have been imported into isolated mitochondria and processed to the mature protein .
bd73 messenger rna would be likely #expressed through +1 or -1 frameshifting by in a wide variety of tissues and cell lines .
bnip3alpha are #expressed by in most human tissues .
bnip3alpha are shown to be #expressed by in most human tissues .
bnip3alpha has been cloned and #expressed in in most human tissues , and two alternative precursors of the protein have been imported into isolated mitochondria and processed to the mature protein .
bnip3alpha has been #expressed by in most human tissues .
bnip3alpha has been likely #expressed through +1 or -1 frameshifting by in most human tissues .
bnip3alpha is able to be cloned and #expressed in in most human tissues , and two alternative precursors of the protein have been imported into isolated mitochondria and processed to the mature protein .
bnip3alpha is cloned and #expressed in in most human tissues , and two alternative precursors of the protein have been imported into isolated mitochondria and processed to the mature protein .
bnip3alpha is #expressed in most human tissues .
bnip3alpha is likely #expressed through +1 or -1 frameshifting by in most human tissues .
bnip3alpha is shown to be #expressed most human tissues .
bnip3alpha is shown to be #expressed primarily in in most human tissues and is secreted into perineuronal nets .
bnip3alpha is shown to be likely #expressed through +1 or -1 frameshifting by in most human tissues .
bnip3alpha may have been #expressed by in most human tissues .
bnip3alpha may have been #expressed most human tissues .
bnip3alpha was cloned and #expressed in in most human tissues , and two alternative precursors of the protein have been imported into isolated mitochondria and processed to the mature protein .
bnip3alpha was #expressed and cloned in in most human tissues , and two alternative precursors of the protein have been imported into isolated mitochondria and processed to the mature protein .
bnip3alpha were #expressed by in most human tissues .
bnip3alpha will be #expressed by in most human tissues .
bnip3alpha will be #expressed most human tissues .
bnip3alpha would be cloned and #expressed in in most human tissues , and two alternative precursors of the protein have been imported into isolated mitochondria and processed to the mature protein .
bnip3alpha would be #expressed and cloned in in most human tissues , and two alternative precursors of the protein have been imported into isolated mitochondria and processed to the mature protein .
in classical and variant sccl , two this receptor are produced , but only one is #expressed .
in classical and variant sccl , two this receptor are produced , but only one is shown to be #expressed .
in classical and variant sccl , two this receptor were produced , but it has #expressed only one of them .
in classical and variant sccl , two this receptor were produced , but only one is able to be #expressed .
in in a wide variety of tissues and cell lines , two bd73 messenger rna are produced , but only one has been #expressed .
in in a wide variety of tissues and cell lines , two bd73 messenger rna are produced , but only one is #expressed .
in in a wide variety of tissues and cell lines , two bd73 messenger rna were produced , but only one is able to be #expressed .
in in most human tissues , two bnip3alpha are produced , but only one is shown to be #expressed .
in in most human tissues , two bnip3alpha were produced , but only one of them can be #expressed .
in in most human tissues , two bnip3alpha were produced , but only one of them is observed to be #expressed .
in in most human tissues , two bnip3alpha were produced , but only one was #expressed .
in summary , bd73 messenger rna has been #expressed in in a wide variety of tissues and cell lines and induced by pkc , pka and erk1/2 dependent mechanisms .
in summary , bd73 messenger rna has been induced by pkc , pka and erk1/2 dependent mechanisms and #expressed in in a wide variety of tissues and cell lines .
in summary , bd73 messenger rna is able to be induced by pkc , pka and erk1/2 dependent mechanisms and #expressed in in a wide variety of tissues and cell lines .
in summary , bd73 messenger rna is #expressed in in a wide variety of tissues and cell lines and induced by pkc , pka and erk1/2 dependent mechanisms .
in summary , bd73 messenger rna was #expressed in in a wide variety of tissues and cell lines and induced by pkc , pka and erk1/2 dependent mechanisms .
in summary , bnip3alpha has been #expressed in in most human tissues and induced by pkc , pka and erk1/2 dependent mechanisms .
in summary , bnip3alpha is able to be #expressed in in most human tissues and induced by pkc , pka and erk1/2 dependent mechanisms .
in summary , bnip3alpha is #expressed in in most human tissues and induced by pkc , pka and erk1/2 dependent mechanisms .
in summary , bnip3alpha is shown to be #expressed in in most human tissues and induced by pkc , pka and erk1/2 dependent mechanisms .
in summary , bnip3alpha will be #expressed in in most human tissues and induced by pkc , pka and erk1/2 dependent mechanisms .
in summary , the human mitochondrial transcription termination factor (mterf) cdna has been #expressed in vitro and induced by pkc , pka and erk1/2 dependent mechanisms .
in summary , the human mitochondrial transcription termination factor (mterf) cdna is shown to be induced by pkc , pka and erk1/2 dependent mechanisms and #expressed in vitro .
in summary , the human mitochondrial transcription termination factor (mterf) cdna will be induced by pkc , pka and erk1/2 dependent mechanisms and #expressed in vitro .
in summary , in-frame  chain transcripts has been #expressed in such cells at the cell surface and induced by pkc , pka and erk1/2 dependent mechanisms .
in summary , in-frame  chain transcripts is #expressed in such cells at the cell surface and induced by pkc , pka and erk1/2 dependent mechanisms .
in summary , in-frame  chain transcripts is shown to be induced by pkc , pka and erk1/2 dependent mechanisms and #expressed in such cells at the cell surface .
in summary , in-frame  chain transcripts was #expressed in such cells at the cell surface and induced by pkc , pka and erk1/2 dependent mechanisms .
in summary , in-frame  chain transcripts will be #expressed in such cells at the cell surface and induced by pkc , pka and erk1/2 dependent mechanisms .
in summary , this receptor has been induced by pkc , pka and erk1/2 dependent mechanisms and #expressed in classical and variant sccl .
in summary , this receptor is able to be induced by pkc , pka and erk1/2 dependent mechanisms and #expressed in classical and variant sccl .
in summary , this receptor is shown to be #expressed in classical and variant sccl and induced by pkc , pka and erk1/2 dependent mechanisms .
in summary , this receptor will be #expressed in classical and variant sccl and induced by pkc , pka and erk1/2 dependent mechanisms .
in the cortex of adult animals , bd73 messenger rna is able to be #expressed primarily in in a wide variety of tissues and cell lines and is secreted into perineuronal nets .
in the cortex of adult animals , bd73 messenger rna is #expressed primarily in in a wide variety of tissues and cell lines and is secreted into perineuronal nets .
in the cortex of adult animals , bnip3alpha has been #expressed primarily in in most human tissues and is secreted into perineuronal nets .
in the cortex of adult animals , the human mitochondrial transcription termination factor (mterf) cdna has been #expressed primarily in vitro and is secreted into perineuronal nets .
in the cortex of adult animals , the human mitochondrial transcription termination factor (mterf) cdna was #expressed primarily in vitro and is secreted into perineuronal nets .
in the cortex of adult animals , the human mitochondrial transcription termination factor (mterf) cdna was shown to be #expressed primarily in vitro and is secreted into perineuronal nets .
in the cortex of adult animals , in-frame  chain transcripts is #expressed primarily in such cells at the cell surface and is secreted into perineuronal nets .
in the cortex of adult animals , in-frame  chain transcripts was shown to be #expressed primarily in such cells at the cell surface and is secreted into perineuronal nets .
in vitro , two the human mitochondrial transcription termination factor (mterf) cdna are produced , but only one is #expressed .
in vitro , two the human mitochondrial transcription termination factor (mterf) cdna were produced , but it has #expressed only one of them .
in vitro , two the human mitochondrial transcription termination factor (mterf) cdna were produced , but only one is able to be #expressed .
in vitro , two the human mitochondrial transcription termination factor (mterf) cdna were produced , but only one was #expressed .
it #expressed bd73 messenger rna , which was induced by pkc , pka and erk1/2 dependent mechanisms , in in a wide variety of tissues and cell lines .
it #expressed the human mitochondrial transcription termination factor (mterf) cdna , which was induced by pkc , pka and erk1/2 dependent mechanisms , in vitro .
it has been assumed that this peptide exercises its mitogenic influences through the vasopressin v1a receptor , and we have previously demonstrated that bd73 messenger rna has been #expressed by in a wide variety of tissues and cell lines .
it has been assumed that this peptide exercises its mitogenic influences through the vasopressin v1a receptor , and we have previously demonstrated that bd73 messenger rna is #expressed by in a wide variety of tissues and cell lines .
it has been assumed that this peptide exercises its mitogenic influences through the vasopressin v1a receptor , and we have previously demonstrated that bd73 messenger rna was #expressed by in a wide variety of tissues and cell lines .
it has been assumed that this peptide exercises its mitogenic influences through the vasopressin v1a receptor , and we have previously demonstrated that bnip3alpha can be #expressed by in most human tissues .
it has been assumed that this peptide exercises its mitogenic influences through the vasopressin v1a receptor , and we have previously demonstrated that bnip3alpha has been #expressed by in most human tissues .
it has been assumed that this peptide exercises its mitogenic influences through the vasopressin v1a receptor , and we have previously demonstrated that bnip3alpha may have been #expressed by in most human tissues .
it has been assumed that this peptide exercises its mitogenic influences through the vasopressin v1a receptor , and we have previously demonstrated that bnip3alpha was #expressed by in most human tissues .
it has been assumed that this peptide exercises its mitogenic influences through the vasopressin v1a receptor , and we have previously demonstrated that bnip3alpha was shown to be #expressed by in most human tissues .
it has been assumed that this peptide exercises its mitogenic influences through the vasopressin v1a receptor , and we have previously demonstrated that the human mitochondrial transcription termination factor (mterf) cdna can be #expressed by vitro .
it has been assumed that this peptide exercises its mitogenic influences through the vasopressin v1a receptor , and we have previously demonstrated that the human mitochondrial transcription termination factor (mterf) cdna has been #expressed by vitro .
it has been assumed that this peptide exercises its mitogenic influences through the vasopressin v1a receptor , and we have previously demonstrated that the human mitochondrial transcription termination factor (mterf) cdna was #expressed by vitro .
it has been assumed that this peptide exercises its mitogenic influences through the vasopressin v1a receptor , and we have previously demonstrated that in-frame  chain transcripts can be #expressed by such cells at the cell surface .
it has been assumed that this peptide exercises its mitogenic influences through the vasopressin v1a receptor , and we have previously demonstrated that in-frame  chain transcripts has been #expressed by such cells at the cell surface .
it has been assumed that this peptide exercises its mitogenic influences through the vasopressin v1a receptor , and we have previously demonstrated that in-frame  chain transcripts is #expressed by such cells at the cell surface .
it has been assumed that this peptide exercises its mitogenic influences through the vasopressin v1a receptor , and we have previously demonstrated that in-frame  chain transcripts may have been #expressed by such cells at the cell surface .
it has primarily #expressed bnip3alpha , which is secreted into perineuronal nets , in in most human tissues .
it has primarily #expressed the human mitochondrial transcription termination factor (mterf) cdna , which is secreted into perineuronal nets , in vitro .
it has primarily #expressed in-frame  chain transcripts , which is secreted into perineuronal nets , in such cells at the cell surface .
it primarily #expressed bd73 messenger rna , which was secreted into perineuronal nets , in in a wide variety of tissues and cell lines .
it primarily #expressed the human mitochondrial transcription termination factor (mterf) cdna , which was secreted into perineuronal nets , in vitro .
it primarily #expressed in-frame  chain transcripts , which was secreted into perineuronal nets , in such cells at the cell surface .
northern blot analysis reveals that bd73 messenger rna has been #expressed ubiquitously in in a wide variety of tissues and cell lines .
northern blot analysis reveals that bd73 messenger rna has been shown to be #expressed ubiquitously in in a wide variety of tissues and cell lines .
northern blot analysis reveals that the human mitochondrial transcription termination factor (mterf) cdna is #expressed ubiquitously vitro .
northern blot analysis reveals that the pfl operon has been #expressed ubiquitously in at high levels anaerobically .
northern blot analysis reveals that the pfl operon was #expressed ubiquitously in at high levels anaerobically .
northern blot analysis reveals that in-frame  chain transcripts is #expressed ubiquitously such cells at the cell surface .
rcas viruses infect only classical and variant sccl being engineered to #express ectopically this receptor , tva .
rcas viruses infect only classical and variant sccl engineered for #expressing ectopically this receptor , tva .
rcas viruses infect only in a wide variety of tissues and cell lines being engineered to #express ectopically bd73 messenger rna , tva .
rcas viruses infect only in a wide variety of tissues and cell lines being involved in #expressing ectopically bd73 messenger rna , tva .
rcas viruses infect only in a wide variety of tissues and cell lines engineered for #expressing ectopically bd73 messenger rna , tva .
rcas viruses infect only in most human tissues engineered to #express ectopically bnip3alpha , tva .
rcas viruses infect only such cells at the cell surface being engineered to #express ectopically in-frame  chain transcripts , tva .
rcas viruses infect only such cells at the cell surface engineered for #expressing ectopically in-frame  chain transcripts , tva .
rcas viruses infect only such cells at the cell surface engineered to #express ectopically in-frame  chain transcripts , tva .
rcas viruses infect only vitro being involved in #expressing ectopically the human mitochondrial transcription termination factor (mterf) cdna , tva .
rcas viruses infect only vitro engineered for #expressing ectopically the human mitochondrial transcription termination factor (mterf) cdna , tva .
rcas viruses infect only vitro engineered to #express ectopically the human mitochondrial transcription termination factor (mterf) cdna , tva .
the human mitochondrial transcription termination factor (mterf) cdna are #expressed by vitro .
the human mitochondrial transcription termination factor (mterf) cdna has been likely #expressed through +1 or -1 frameshifting by vitro .
the human mitochondrial transcription termination factor (mterf) cdna is #expressed vitro .
the human mitochondrial transcription termination factor (mterf) cdna is likely #expressed through +1 or -1 frameshifting by vitro .
the human mitochondrial transcription termination factor (mterf) cdna is shown to be likely #expressed through +1 or -1 frameshifting by vitro .
the human mitochondrial transcription termination factor (mterf) cdna may have been #expressed by vitro .
the human mitochondrial transcription termination factor (mterf) cdna were #expressed by vitro .
the human mitochondrial transcription termination factor (mterf) cdna will be #expressed by vitro .
the mechanotransduction mechanism for this signalling may directly or indirectly involve the dystrophin complex as bd73 messenger rna was not able to be #expressed in response to overload by in a wide variety of tissues and cell lines .
the mechanotransduction mechanism for this signalling may directly or indirectly involve the dystrophin complex as bnip3alpha could not to be #expressed in response to overload by in most human tissues .
the mechanotransduction mechanism for this signalling may directly or indirectly involve the dystrophin complex as bnip3alpha has been shown not to be #expressed in response to overload by in most human tissues .
the mechanotransduction mechanism for this signalling may directly or indirectly involve the dystrophin complex as bnip3alpha is unable to be #expressed in response to overload by in most human tissues .
the mechanotransduction mechanism for this signalling may directly or indirectly involve the dystrophin complex as bnip3alpha was unable to be #expressed in response to overload by in most human tissues .
the mechanotransduction mechanism for this signalling may directly or indirectly involve the dystrophin complex as the human mitochondrial transcription termination factor (mterf) cdna could not to be #expressed in response to overload by vitro .
the mechanotransduction mechanism for this signalling may directly or indirectly involve the dystrophin complex as the human mitochondrial transcription termination factor (mterf) cdna is unable to be #expressed in response to overload by vitro .
the mechanotransduction mechanism for this signalling may directly or indirectly involve the dystrophin complex as the human mitochondrial transcription termination factor (mterf) cdna was unable to be #expressed in response to overload by vitro .
the mechanotransduction mechanism for this signalling may directly or indirectly involve the dystrophin complex as classical and variant sccl , unlike normal muscle , cannot #express this receptor in response to overload .
the mechanotransduction mechanism for this signalling may directly or indirectly involve the dystrophin complex as classical and variant sccl , unlike normal muscle , was shown not to #express this receptor in response to overload
the mechanotransduction mechanism for this signalling may directly or indirectly involve the dystrophin complex as classical and variant sccl , unlike normal muscle , was unable to #express this receptor in response to overload
the mechanotransduction mechanism for this signalling may directly or indirectly involve the dystrophin complex as in a wide variety of tissues and cell lines , unlike normal muscle , does not have the ability to #express bd73 messenger rna in response to overload
the mechanotransduction mechanism for this signalling may directly or indirectly involve the dystrophin complex as in most human tissues , unlike normal muscle , does not have the ability to #express bnip3alpha in response to overload
the mechanotransduction mechanism for this signalling may directly or indirectly involve the dystrophin complex as in most human tissues , unlike normal muscle , is unable to #express bnip3alpha in response to overload .
the mechanotransduction mechanism for this signalling may directly or indirectly involve the dystrophin complex as in-frame  chain transcripts could not to be #expressed in response to overload by such cells at the cell surface .
the mechanotransduction mechanism for this signalling may directly or indirectly involve the dystrophin complex as in-frame  chain transcripts has been shown not to be #expressed in response to overload by such cells at the cell surface .
the mechanotransduction mechanism for this signalling may directly or indirectly involve the dystrophin complex as such cells at the cell surface , unlike normal muscle , does not have the ability to #express in-frame  chain transcripts in response to overload
the mechanotransduction mechanism for this signalling may directly or indirectly involve the dystrophin complex as such cells at the cell surface , unlike normal muscle , was shown not to #express in-frame  chain transcripts in response to overload
the mechanotransduction mechanism for this signalling may directly or indirectly involve the dystrophin complex as this receptor could not to be #expressed in response to overload by classical and variant sccl .
the mechanotransduction mechanism for this signalling may directly or indirectly involve the dystrophin complex as this receptor is unable to be #expressed in response to overload by classical and variant sccl .
the mechanotransduction mechanism for this signalling may directly or indirectly involve the dystrophin complex as this receptor was not able to be #expressed in response to overload by classical and variant sccl .
the mechanotransduction mechanism for this signalling may directly or indirectly involve the dystrophin complex as vitro , unlike normal muscle , was shown not to #express the human mitochondrial transcription termination factor (mterf) cdna in response to overload
the pfl operon is shown to be #expressed at high levels anaerobically .
the pfl operon was #expressed at high levels anaerobically .
this functional allelic exclusion is apparently due to control of the tcr assembly process because these classical and variant sccl are able to #express this receptor .
this functional allelic exclusion is apparently due to control of the tcr assembly process because these classical and variant sccl are involved in #expressing this receptor .
this functional allelic exclusion is apparently due to control of the tcr assembly process because these in a wide variety of tissues and cell lines are able to #express bd73 messenger rna .
this functional allelic exclusion is apparently due to control of the tcr assembly process because these in a wide variety of tissues and cell lines are #expressing bd73 messenger rna .
this functional allelic exclusion is apparently due to control of the tcr assembly process because these in a wide variety of tissues and cell lines have #expressed bd73 messenger rna .
this functional allelic exclusion is apparently due to control of the tcr assembly process because these in most human tissues #express bnip3alpha .
this functional allelic exclusion is apparently due to control of the tcr assembly process because these in most human tissues have been shown to #express bnip3alpha .
this functional allelic exclusion is apparently due to control of the tcr assembly process because these in most human tissues have #expressed bnip3alpha .
this functional allelic exclusion is apparently due to control of the tcr assembly process because these in most human tissues have the ability to #express bnip3alpha .
this functional allelic exclusion is apparently due to control of the tcr assembly process because these such cells at the cell surface are #expressing in-frame  chain transcripts .
this functional allelic exclusion is apparently due to control of the tcr assembly process because these such cells at the cell surface are involved in #expressing in-frame  chain transcripts .
this functional allelic exclusion is apparently due to control of the tcr assembly process because these such cells at the cell surface have #expressed in-frame  chain transcripts .
this functional allelic exclusion is apparently due to control of the tcr assembly process because these such cells at the cell surface have the ability to #express in-frame  chain transcripts .
this functional allelic exclusion is apparently due to control of the tcr assembly process because these vitro are able to #express the human mitochondrial transcription termination factor (mterf) cdna .
this functional allelic exclusion is apparently due to control of the tcr assembly process because these vitro are involved in #expressing the human mitochondrial transcription termination factor (mterf) cdna .
this functional allelic exclusion is apparently due to control of the tcr assembly process because these vitro #express the human mitochondrial transcription termination factor (mterf) cdna .
this functional allelic exclusion is apparently due to control of the tcr assembly process because these vitro have #expressed the human mitochondrial transcription termination factor (mterf) cdna .
classical and variant sccl are able to #express only this receptor .
in most human tissues are shown to #express only bnip3alpha .
in most human tissues have #expressed only bnip3alpha .
in-frame  chain transcripts are shown to be #expressed by such cells at the cell surface .
in-frame  chain transcripts has been cloned and #expressed in such cells at the cell surface , and two alternative precursors of the protein have been imported into isolated mitochondria and processed to the mature protein .
in-frame  chain transcripts has been #expressed primarily in such cells at the cell surface and secreted into perineuronal nets .
in-frame  chain transcripts has been likely #expressed through +1 or -1 frameshifting by such cells at the cell surface .
in-frame  chain transcripts is able to be #expressed and cloned in such cells at the cell surface , and two alternative precursors of the protein have been imported into isolated mitochondria and processed to the mature protein .
in-frame  chain transcripts is cloned and #expressed in such cells at the cell surface , and two alternative precursors of the protein have been imported into isolated mitochondria and processed to the mature protein .
in-frame  chain transcripts is #expressed and cloned in such cells at the cell surface , and two alternative precursors of the protein have been imported into isolated mitochondria and processed to the mature protein .
in-frame  chain transcripts may have been #expressed by such cells at the cell surface .
in-frame  chain transcripts may have been likely #expressed through +1 or -1 frameshifting by such cells at the cell surface .
in-frame  chain transcripts was shown to be cloned and #expressed in such cells at the cell surface , and two alternative precursors of the protein have been imported into isolated mitochondria and processed to the mature protein .
in-frame  chain transcripts will be #expressed by such cells at the cell surface .
in-frame  chain transcripts will be #expressed primarily in such cells at the cell surface and is secreted into perineuronal nets .
in-frame  chain transcripts would be cloned and #expressed in such cells at the cell surface , and two alternative precursors of the protein have been imported into isolated mitochondria and processed to the mature protein .
in-frame  chain transcripts would be likely #expressed through +1 or -1 frameshifting by such cells at the cell surface .
such cells at the cell surface are able to #express only in-frame  chain transcripts .
such cells at the cell surface are shown to #express only in-frame  chain transcripts .
such cells at the cell surface may have #expressed only in-frame  chain transcripts .
this receptor are #expressed by classical and variant sccl .
this receptor are shown to be #expressed by classical and variant sccl .
this receptor has been #expressed by classical and variant sccl .
this receptor has been #expressed primarily in classical and variant sccl and secreted into perineuronal nets .
this receptor is able to be cloned and #expressed in classical and variant sccl , and two alternative precursors of the protein have been imported into isolated mitochondria and processed to the mature protein .
this receptor is able to be #expressed and cloned in classical and variant sccl , and two alternative precursors of the protein have been imported into isolated mitochondria and processed to the mature protein .
this receptor is #expressed and cloned in classical and variant sccl , and two alternative precursors of the protein have been imported into isolated mitochondria and processed to the mature protein .
this receptor is #expressed classical and variant sccl .
this receptor may have been #expressed primarily in classical and variant sccl and secreted into perineuronal nets .
this receptor was #expressed and cloned in classical and variant sccl , and two alternative precursors of the protein have been imported into isolated mitochondria and processed to the mature protein .
this receptor were #expressed by classical and variant sccl .
this receptor will be #expressed by classical and variant sccl .
this receptor will be #expressed primarily in classical and variant sccl and is secreted into perineuronal nets .
this receptor would be cloned and #expressed in classical and variant sccl , and two alternative precursors of the protein have been imported into isolated mitochondria and processed to the mature protein .
this receptor would be likely #expressed through +1 or -1 frameshifting by classical and variant sccl .
vitro are able to #express only the human mitochondrial transcription termination factor (mterf) cdna .
vitro #express only the human mitochondrial transcription termination factor (mterf) cdna .
t cells in mice at the cell surface carrying transgenes encoding tcr  and  proteins predominantly #express the transgene-encoded tcr proteins .
a complementary dna clone has been cloned and #expressed in vitro , and two alternative precursors of the protein have been imported into isolated mitochondria and processed to the mature protein .
a complementary dna clone has been likely #expressed through +1 or -1 frameshifting by vitro .
a complementary dna clone is able to be #expressed and cloned in vitro , and two alternative precursors of the protein have been imported into isolated mitochondria and processed to the mature protein .
a complementary dna clone is cloned and #expressed in vitro , and two alternative precursors of the protein have been imported into isolated mitochondria and processed to the mature protein .
a complementary dna clone is #expressed and cloned in vitro , and two alternative precursors of the protein have been imported into isolated mitochondria and processed to the mature protein .
a complementary dna clone is #expressed vitro .
a complementary dna clone is likely #expressed through +1 or -1 frameshifting by vitro .
a complementary dna clone is shown to be #expressed primarily in vitro and is secreted into perineuronal nets .
a complementary dna clone may have been #expressed by vitro .
a complementary dna clone was shown to be cloned and #expressed in vitro , and two alternative precursors of the protein have been imported into isolated mitochondria and processed to the mature protein .
a complementary dna clone were #expressed by vitro .
a complementary dna clone will be #expressed by vitro .
a complementary dna clone will be #expressed primarily in vitro and is secreted into perineuronal nets .
a complementary dna clone would be #expressed and cloned in vitro , and two alternative precursors of the protein have been imported into isolated mitochondria and processed to the mature protein .
a complementary dna clone would be likely #expressed through +1 or -1 frameshifting by vitro .
in t cells in mice at the cell surface , two the transgene-encoded tcr proteins are produced , but only one has been #expressed .
in t cells in mice at the cell surface , two the transgene-encoded tcr proteins are produced , but only one is shown to be #expressed .
in t cells in mice at the cell surface , two the transgene-encoded tcr proteins were produced , but only one is able to be #expressed .
in t cells in mice at the cell surface , two the transgene-encoded tcr proteins were produced , but only one of them can be #expressed .
in t cells in mice at the cell surface , two the transgene-encoded tcr proteins were produced , but only one was #expressed .
in both somatic tissues and testis , two the isoform identical to ran/tc4 are produced , but only one is #expressed .
in both somatic tissues and testis , two the isoform identical to ran/tc4 were produced , but it has #expressed only one of them .
in both somatic tissues and testis , two the isoform identical to ran/tc4 were produced , but only one was #expressed .
in such cells at the cell surface , two in-frame  chain transcripts are produced , but only one is #expressed .
in such cells at the cell surface , two in-frame  chain transcripts are produced , but only one is shown to be #expressed .
in such cells at the cell surface , two in-frame  chain transcripts were produced , but only one is able to be #expressed .
in such cells at the cell surface , two in-frame  chain transcripts were produced , but only one of them can be #expressed .
in summary , a complementary dna clone has been #expressed in vitro and induced by pkc , pka and erk1/2 dependent mechanisms .
in summary , a complementary dna clone is able to be induced by pkc , pka and erk1/2 dependent mechanisms and #expressed in vitro .
in summary , a complementary dna clone was induced by pkc , pka and erk1/2 dependent mechanisms and #expressed in vitro .
in summary , the isoform identical to ran/tc4 has been #expressed in both somatic tissues and testis and induced by pkc , pka and erk1/2 dependent mechanisms .
in summary , the isoform identical to ran/tc4 has been induced by pkc , pka and erk1/2 dependent mechanisms and #expressed in both somatic tissues and testis .
in summary , the isoform identical to ran/tc4 is able to be #expressed in both somatic tissues and testis and induced by pkc , pka and erk1/2 dependent mechanisms .
in summary , the isoform identical to ran/tc4 is #expressed in both somatic tissues and testis and induced by pkc , pka and erk1/2 dependent mechanisms .
in summary , the isoform identical to ran/tc4 was #expressed in both somatic tissues and testis and induced by pkc , pka and erk1/2 dependent mechanisms .
in summary , the transgene-encoded tcr proteins has been #expressed in t cells in mice at the cell surface and induced by pkc , pka and erk1/2 dependent mechanisms .
in summary , the transgene-encoded tcr proteins is able to be #expressed in t cells in mice at the cell surface and induced by pkc , pka and erk1/2 dependent mechanisms .
in summary , the transgene-encoded tcr proteins is able to be induced by pkc , pka and erk1/2 dependent mechanisms and #expressed in t cells in mice at the cell surface .
in summary , the transgene-encoded tcr proteins is shown to be induced by pkc , pka and erk1/2 dependent mechanisms and #expressed in t cells in mice at the cell surface .
in summary , the transgene-encoded tcr proteins will be #expressed in t cells in mice at the cell surface and induced by pkc , pka and erk1/2 dependent mechanisms .
in the cortex of adult animals , a complementary dna clone is able to be #expressed primarily in vitro and is secreted into perineuronal nets .
in the cortex of adult animals , a complementary dna clone was shown to be #expressed primarily in vitro and is secreted into perineuronal nets .
in the cortex of adult animals , the isoform identical to ran/tc4 is able to be #expressed primarily in both somatic tissues and testis and is secreted into perineuronal nets .
in the cortex of adult animals , the isoform identical to ran/tc4 was shown to be #expressed primarily in both somatic tissues and testis and is secreted into perineuronal nets .
in the cortex of adult animals , the transgene-encoded tcr proteins has been #expressed primarily in t cells in mice at the cell surface and is secreted into perineuronal nets .
in the cortex of adult animals , the transgene-encoded tcr proteins is #expressed primarily in t cells in mice at the cell surface and is secreted into perineuronal nets .
in vitro , two a complementary dna clone are produced , but only one has been #expressed .
in vitro , two a complementary dna clone are produced , but only one is shown to be #expressed .
in vitro , two a complementary dna clone were produced , but it has #expressed only one of them .
in vitro , two a complementary dna clone were produced , but only one of them can be #expressed .
in vitro , two a complementary dna clone were produced , but only one was #expressed .
it #expressed a complementary dna clone , which was induced by pkc , pka and erk1/2 dependent mechanisms , in vitro .
it #expressed the isoform identical to ran/tc4 , which was induced by pkc , pka and erk1/2 dependent mechanisms , in both somatic tissues and testis .
it has been assumed that this peptide exercises its mitogenic influences through the vasopressin v1a receptor , and we have previously demonstrated that a complementary dna clone can be #expressed by vitro .
it has been assumed that this peptide exercises its mitogenic influences through the vasopressin v1a receptor , and we have previously demonstrated that a complementary dna clone has been #expressed by vitro .
it has been assumed that this peptide exercises its mitogenic influences through the vasopressin v1a receptor , and we have previously demonstrated that a complementary dna clone may have been #expressed by vitro .
it has been assumed that this peptide exercises its mitogenic influences through the vasopressin v1a receptor , and we have previously demonstrated that a complementary dna clone was able to be been #expressed by vitro .
it has been assumed that this peptide exercises its mitogenic influences through the vasopressin v1a receptor , and we have previously demonstrated that the isoform identical to ran/tc4 can be #expressed by both somatic tissues and testis .
it has been assumed that this peptide exercises its mitogenic influences through the vasopressin v1a receptor , and we have previously demonstrated that the isoform identical to ran/tc4 is #expressed by both somatic tissues and testis .
it has been assumed that this peptide exercises its mitogenic influences through the vasopressin v1a receptor , and we have previously demonstrated that the isoform identical to ran/tc4 was able to be been #expressed by both somatic tissues and testis .
it has been assumed that this peptide exercises its mitogenic influences through the vasopressin v1a receptor , and we have previously demonstrated that the isoform identical to ran/tc4 was #expressed by both somatic tissues and testis .
it has been assumed that this peptide exercises its mitogenic influences through the vasopressin v1a receptor , and we have previously demonstrated that the transgene-encoded tcr proteins is #expressed by t cells in mice at the cell surface .
it has been assumed that this peptide exercises its mitogenic influences through the vasopressin v1a receptor , and we have previously demonstrated that the transgene-encoded tcr proteins may have been #expressed by t cells in mice at the cell surface .
it has been assumed that this peptide exercises its mitogenic influences through the vasopressin v1a receptor , and we have previously demonstrated that the transgene-encoded tcr proteins was able to be been #expressed by t cells in mice at the cell surface .
it has been assumed that this peptide exercises its mitogenic influences through the vasopressin v1a receptor , and we have previously demonstrated that the transgene-encoded tcr proteins was shown to be #expressed by t cells in mice at the cell surface .
it has primarily #expressed a complementary dna clone , which is secreted into perineuronal nets , in vitro .
it has primarily #expressed the isoform identical to ran/tc4 , which is secreted into perineuronal nets , in both somatic tissues and testis .
it primarily #expressed a complementary dna clone , which was secreted into perineuronal nets , in vitro .
northern blot analysis reveals that the isoform identical to ran/tc4 is #expressed ubiquitously both somatic tissues and testis .
rcas viruses infect only t cells in mice at the cell surface being involved in #expressing ectopically the transgene-encoded tcr proteins , tva .
rcas viruses infect only t cells in mice at the cell surface engineered for #expressing ectopically the transgene-encoded tcr proteins , tva .
rcas viruses infect only both somatic tissues and testis being engineered to #express ectopically the isoform identical to ran/tc4 , tva .
rcas viruses infect only both somatic tissues and testis being involved in #expressing ectopically the isoform identical to ran/tc4 , tva .
rcas viruses infect only both somatic tissues and testis engineered for #expressing ectopically the isoform identical to ran/tc4 , tva .
rcas viruses infect only vitro being involved in #expressing ectopically a complementary dna clone , tva .
rcas viruses infect only vitro engineered for #expressing ectopically a complementary dna clone , tva .
t cells in mice at the cell surface are shown to #express only the transgene-encoded tcr proteins .
t cells in mice at the cell surface #express only the transgene-encoded tcr proteins .
t cells in mice at the cell surface may have #expressed only the transgene-encoded tcr proteins .
the mechanotransduction mechanism for this signalling may directly or indirectly involve the dystrophin complex as a complementary dna clone is unable to be #expressed in response to overload by vitro .
the mechanotransduction mechanism for this signalling may directly or indirectly involve the dystrophin complex as a complementary dna clone was not able to be #expressed in response to overload by vitro .
the mechanotransduction mechanism for this signalling may directly or indirectly involve the dystrophin complex as t cells in mice at the cell surface , unlike normal muscle , cannot #express the transgene-encoded tcr proteins in response to overload .
the mechanotransduction mechanism for this signalling may directly or indirectly involve the dystrophin complex as t cells in mice at the cell surface , unlike normal muscle , is unable to #express the transgene-encoded tcr proteins in response to overload .
the mechanotransduction mechanism for this signalling may directly or indirectly involve the dystrophin complex as t cells in mice at the cell surface , unlike normal muscle , was shown not to #express the transgene-encoded tcr proteins in response to overload
the mechanotransduction mechanism for this signalling may directly or indirectly involve the dystrophin complex as both somatic tissues and testis , unlike normal muscle , is unable to #express the isoform identical to ran/tc4 in response to overload .
the mechanotransduction mechanism for this signalling may directly or indirectly involve the dystrophin complex as both somatic tissues and testis , unlike normal muscle , was shown not to #express the isoform identical to ran/tc4 in response to overload
the mechanotransduction mechanism for this signalling may directly or indirectly involve the dystrophin complex as both somatic tissues and testis , unlike normal muscle , was unable to #express the isoform identical to ran/tc4 in response to overload
the mechanotransduction mechanism for this signalling may directly or indirectly involve the dystrophin complex as the isoform identical to ran/tc4 could not to be #expressed in response to overload by both somatic tissues and testis .
the mechanotransduction mechanism for this signalling may directly or indirectly involve the dystrophin complex as the isoform identical to ran/tc4 is unable to be #expressed in response to overload by both somatic tissues and testis .
the mechanotransduction mechanism for this signalling may directly or indirectly involve the dystrophin complex as the isoform identical to ran/tc4 was unable to be #expressed in response to overload by both somatic tissues and testis .
the mechanotransduction mechanism for this signalling may directly or indirectly involve the dystrophin complex as the transgene-encoded tcr proteins is unable to be #expressed in response to overload by t cells in mice at the cell surface .
the mechanotransduction mechanism for this signalling may directly or indirectly involve the dystrophin complex as the transgene-encoded tcr proteins was not able to be #expressed in response to overload by t cells in mice at the cell surface .
the mechanotransduction mechanism for this signalling may directly or indirectly involve the dystrophin complex as the transgene-encoded tcr proteins was unable to be #expressed in response to overload by t cells in mice at the cell surface .
the mechanotransduction mechanism for this signalling may directly or indirectly involve the dystrophin complex as vitro , unlike normal muscle , is unable to #express a complementary dna clone in response to overload .
this functional allelic exclusion is apparently due to control of the tcr assembly process because these t cells in mice at the cell surface are able to #express the transgene-encoded tcr proteins .
this functional allelic exclusion is apparently due to control of the tcr assembly process because these t cells in mice at the cell surface are #expressing the transgene-encoded tcr proteins .
this functional allelic exclusion is apparently due to control of the tcr assembly process because these t cells in mice at the cell surface are involved in #expressing the transgene-encoded tcr proteins .
this functional allelic exclusion is apparently due to control of the tcr assembly process because these t cells in mice at the cell surface have been shown to #express the transgene-encoded tcr proteins .
this functional allelic exclusion is apparently due to control of the tcr assembly process because these t cells in mice at the cell surface have #expressed the transgene-encoded tcr proteins .
this functional allelic exclusion is apparently due to control of the tcr assembly process because these both somatic tissues and testis are #expressing the isoform identical to ran/tc4 .
this functional allelic exclusion is apparently due to control of the tcr assembly process because these both somatic tissues and testis are involved in #expressing the isoform identical to ran/tc4 .
this functional allelic exclusion is apparently due to control of the tcr assembly process because these both somatic tissues and testis have been shown to #express the isoform identical to ran/tc4 .
this functional allelic exclusion is apparently due to control of the tcr assembly process because these both somatic tissues and testis have the ability to #express the isoform identical to ran/tc4 .
this functional allelic exclusion is apparently due to control of the tcr assembly process because these vitro have been shown to #express a complementary dna clone .
this functional allelic exclusion is apparently due to control of the tcr assembly process because these vitro have #expressed a complementary dna clone .
this functional allelic exclusion is apparently due to control of the tcr assembly process because these vitro have the ability to #express a complementary dna clone .
both somatic tissues and testis have #expressed only the isoform identical to ran/tc4 .
the isoform identical to ran/tc4 are #expressed by both somatic tissues and testis .
the isoform identical to ran/tc4 has been #expressed by both somatic tissues and testis .
the isoform identical to ran/tc4 has been #expressed primarily in both somatic tissues and testis and secreted into perineuronal nets .
the isoform identical to ran/tc4 is able to be cloned and #expressed in both somatic tissues and testis , and two alternative precursors of the protein have been imported into isolated mitochondria and processed to the mature protein .
the isoform identical to ran/tc4 is able to be #expressed and cloned in both somatic tissues and testis , and two alternative precursors of the protein have been imported into isolated mitochondria and processed to the mature protein .
the isoform identical to ran/tc4 is cloned and #expressed in both somatic tissues and testis , and two alternative precursors of the protein have been imported into isolated mitochondria and processed to the mature protein .
the isoform identical to ran/tc4 is #expressed both somatic tissues and testis .
the isoform identical to ran/tc4 is likely #expressed through +1 or -1 frameshifting by both somatic tissues and testis .
the isoform identical to ran/tc4 is shown to be #expressed primarily in both somatic tissues and testis and is secreted into perineuronal nets .
the isoform identical to ran/tc4 is shown to be likely #expressed through +1 or -1 frameshifting by both somatic tissues and testis .
the isoform identical to ran/tc4 may have been likely #expressed through +1 or -1 frameshifting by both somatic tissues and testis .
the isoform identical to ran/tc4 was cloned and #expressed in both somatic tissues and testis , and two alternative precursors of the protein have been imported into isolated mitochondria and processed to the mature protein .
the isoform identical to ran/tc4 was #expressed and cloned in both somatic tissues and testis , and two alternative precursors of the protein have been imported into isolated mitochondria and processed to the mature protein .
the isoform identical to ran/tc4 was shown to be cloned and #expressed in both somatic tissues and testis , and two alternative precursors of the protein have been imported into isolated mitochondria and processed to the mature protein .
the isoform identical to ran/tc4 would be likely #expressed through +1 or -1 frameshifting by both somatic tissues and testis .
the transgene-encoded tcr proteins has been likely #expressed through +1 or -1 frameshifting by t cells in mice at the cell surface .
the transgene-encoded tcr proteins is able to be cloned and #expressed in t cells in mice at the cell surface , and two alternative precursors of the protein have been imported into isolated mitochondria and processed to the mature protein .
the transgene-encoded tcr proteins is able to be #expressed and cloned in t cells in mice at the cell surface , and two alternative precursors of the protein have been imported into isolated mitochondria and processed to the mature protein .
the transgene-encoded tcr proteins is #expressed t cells in mice at the cell surface .
the transgene-encoded tcr proteins is #expressed and cloned in t cells in mice at the cell surface , and two alternative precursors of the protein have been imported into isolated mitochondria and processed to the mature protein .
the transgene-encoded tcr proteins is shown to be #expressed primarily in t cells in mice at the cell surface and is secreted into perineuronal nets .
the transgene-encoded tcr proteins may have been #expressed by t cells in mice at the cell surface .
the transgene-encoded tcr proteins will be #expressed by t cells in mice at the cell surface .
the transgene-encoded tcr proteins will be #expressed primarily in t cells in mice at the cell surface and is secreted into perineuronal nets .
the transgene-encoded tcr proteins would be cloned and #expressed in t cells in mice at the cell surface , and two alternative precursors of the protein have been imported into isolated mitochondria and processed to the mature protein .
the transgene-encoded tcr proteins would be #expressed and cloned in t cells in mice at the cell surface , and two alternative precursors of the protein have been imported into isolated mitochondria and processed to the mature protein .
the transgene-encoded tcr proteins would be likely #expressed through +1 or -1 frameshifting by t cells in mice at the cell surface .
vitro are shown to #express only a complementary dna clone .
vitro #express only a complementary dna clone .
vitro have #expressed only a complementary dna clone .
vitro may #express only a complementary dna clone .
a transcription start site is located approximately 4 kilobases 5 to the translation codon , and an rna splice of 3863 bases occurring in the 5-untranslated region #generated mature hela cell mrna .
a transcription start site is located approximately 4 kilobases 5 to the translation codon , and mature hela cell mrna has been #generated by an rna splice of 3863 bases occurring in the 5-untranslated region .
a transcription start site is located approximately 4 kilobases 5 to the translation codon , and mature hela cell mrna is #generated by an rna splice of 3863 bases occurring in the 5-untranslated region .
a transcription start site is located approximately 4 kilobases 5 to the translation codon , and mature hela cell mrna will be #generated by an rna splice of 3863 bases occurring in the 5-untranslated region .
human leukocyte antigen (hla)-g molecules have been #generated by an alternative splicing of the primary transcript of the gene and have displayed specialized function in regulating the immune response .
human leukocyte antigen (hla)-g molecules were #generated by an alternative splicing of the primary transcript of the gene and displayed specialized function in regulating the immune response .
human leukocyte antigen (hla)-g molecules will be #generated by an alternative splicing of the primary transcript of the gene and will display specialized function in regulating the immune response .
the tbc method #generated sequential overlapping fragments ( approximately 0 .4-0 .5 kb ) for each of the gene sequences , and simultaneous and sequential combinations of overlapping fragments were tested for their ability to be assembled under an array of pcr conditions .
the tbc method #generates sequential overlapping fragments ( approximately 0 .4-0 .5 kb ) for each of the gene sequences , and simultaneous and sequential combinations of overlapping fragments are tested for their ability to be assembled under an array of pcr conditions .
the bidentate rnase iii dicer #generated the 21-23 nt long mature rnas .
the bidentate rnase iii dicer #generates the 21-23 nt long mature rnas .
the bidentate rnase iii dicer has #generated the 21-23 nt long mature rnas .
the bidentate rnase iii dicer is able to #generate the 21-23 nt long mature rnas .
to analyse specifically protein expression of fhl2 in human tissues we may #generate a monoclonal antibody against fhl2 .
to analyse specifically protein expression of fhl2 in human tissues , a monoclonal antibody against fhl2 is #generated by us
to analyse specifically protein expression of fhl2 in human tissues , we #generate a monoclonal antibody against fhl2 .
to analyse specifically protein expression of fhl2 in human tissues , we will #generate a monoclonal antibody against fhl2 .
we believe this binding is found to #generate a higher order protein-dna complex within the recombinational synapse .
we believe this binding is shown to #generate a higher order protein-dna complex within the recombinational synapse .
a dnase i hypersensitive is #generated by a swi/snf-related chromatin remodeling complex , eklf coactivator-remodeling complex 1 (e-rc1) .
a swi/snf-related chromatin remodeling complex , eklf coactivator-remodeling complex 1 (e-rc1) #generate a dnase i hypersensitive .
a functional interaction surface was #generated by the ar n-terminus , because the ar n-terminuss deletion abolishes fhl2 binding .
a higher order protein-dna complex is #generated by this binding within the recombinational synapse .
an alternative splicing of the primary transcript of the gene #generates human leukocyte antigen (hla)-g molecules .
the 21-23 nt long mature rnas were #generated by the bidentate rnase iii dicer .
this binding #generates a higher order protein-dna complex within the recombinational synapse .
to analyse specifically protein expression of fhl2 in human tissues we #generated a monoclonal antibody against fhl2 .
we believe this binding is required to #generate a higher order protein-dna complex within the recombinational synapse .
we report results from preliminary transcription microarray experiments that revealed two previously unknown members of the narl regulon: the aspa gene encoding aspartate-ammonia lyase , which #generates fumarate; and the dcusr operon encoding the dicarboxylate-responsive regulatory system .
a transcription start site is located approximately 4 kilobases 5 to the translation codon , and an rna splice of 3863 bases occurs in the 5-untranslated region to #generate mature hela cell mrna .
human leukocyte antigen (hla)-g molecules are #generated by an alternative splicing of the primary transcript of the gene and display specialized function in regulating the immune response .
the tbc method was optimized to #generate sequential overlapping fragments ( approximately 0 .4-0 .5 kb ) for each of the gene sequences , and simultaneous and sequential combinations of overlapping fragments were tested for their ability to be assembled under an array of pcr conditions .
the bidentate rnase iii dicer cleaves microrna precursors to #generate the 21-23 nt long mature rnas .
although no crystal structure of the ar is available to date , one might speculate that the tbc method is either directly involved in the ar-fhl2 interaction or , alternatively , is essential for #generating sequential overlapping fragments .
although no crystal structure of the ar is available to date , one might speculate that the bidentate rnase iii dicer #generates the 21-23 nt long mature rnas .
although no crystal structure of the ar is available to date , one might speculate that the bidentate rnase iii dicer is either directly involved in the ar-fhl2 interaction or , alternatively , is essential for #generating the 21-23 nt long mature rnas .
although no crystal structure of the ar is available to date , one might speculate that a dnase i hypersensitive has been #generated by a swi/snf-related chromatin remodeling complex , eklf coactivator-remodeling complex 1 (e-rc1)
although no crystal structure of the ar is available to date , one might speculate that a dnase i hypersensitive is #generated by a swi/snf-related chromatin remodeling complex , eklf coactivator-remodeling complex 1 (e-rc1) .
although no crystal structure of the ar is available to date , one might speculate that a higher order protein-dna complex has been #generated by this binding
although no crystal structure of the ar is available to date , one might speculate that a higher order protein-dna complex was #generated by this binding .
although no crystal structure of the ar is available to date , one might speculate that a higher order protein-dna complex will be #generated by this binding .
although no crystal structure of the ar is available to date , one might speculate that a monoclonal antibody against fhl2 has been #generated by us
although no crystal structure of the ar is available to date , one might speculate that a monoclonal antibody against fhl2 has been #generated by we
although no crystal structure of the ar is available to date , one might speculate that a monoclonal antibody against fhl2 is #generated by us .
although no crystal structure of the ar is available to date , one might speculate that a monoclonal antibody against fhl2 will be #generated by we .
although no crystal structure of the ar is available to date , one might speculate that sequential overlapping fragments has been #generated by the tbc method
although no crystal structure of the ar is available to date , one might speculate that sequential overlapping fragments was #generated by the tbc method .
although no crystal structure of the ar is available to date , one might speculate that sequential overlapping fragments will be #generated by the tbc method .
although no crystal structure of the ar is available to date , one might speculate that the 21-23 nt long mature rnas is #generated by the bidentate rnase iii dicer .
although no crystal structure of the ar is available to date , one might speculate that the 21-23 nt long mature rnas was #generated by the bidentate rnase iii dicer .
although no crystal structure of the ar is available to date , one might speculate that the 21-23 nt long mature rnas will be #generated by the bidentate rnase iii dicer .
although no crystal structure of the ar is available to date , one might speculate that this binding #generated a higher order protein-dna complex .
although no crystal structure of the ar is available to date , one might speculate that us #generated a monoclonal antibody against fhl2 .
although no crystal structure of the ar is available to date , one might speculate that us #generates a monoclonal antibody against fhl2 .
although no crystal structure of the ar is available to date , one might speculate that us is either directly involved in the ar-fhl2 interaction or , alternatively , is essential for #generating a monoclonal antibody against fhl2 .
although no crystal structure of the ar is available to date , one might speculate that we #generated a monoclonal antibody against fhl2 .
in addition , there was an apparent absence of lower molecular weight fragments as evidence of the tbc method , although again the relatively small fraction involved and the possibility that degradation did not #generate sequential overlapping fragments or occured rapidly precludes any definitive conclusions
in addition , there was an apparent absence of lower molecular weight fragments as evidence of the tbc method , although again the relatively small fraction involved and the possibility that degradation does not #generate sequential overlapping fragments or occurs rapidly precludes any definitive conclusions .
in addition , there was an apparent absence of lower molecular weight fragments as evidence of the tbc method , although again the relatively small fraction involved and the possibility that sequential overlapping fragments are not #generated by degradation .
in addition , there was an apparent absence of lower molecular weight fragments as evidence of the tbc method , although again the relatively small fraction involved and the possibility that sequential overlapping fragments have not been #generated by degradation .
in addition , there was an apparent absence of lower molecular weight fragments as evidence of the bidentate rnase iii dicer , although again the relatively small fraction involved and the possibility that degradation did not #generate the 21-23 nt long mature rnas or occured rapidly precludes any definitive conclusions
in addition , there was an apparent absence of lower molecular weight fragments as evidence of the bidentate rnase iii dicer , although again the relatively small fraction involved and the possibility that degradation does not #generate the 21-23 nt long mature rnas or occurs rapidly precludes any definitive conclusions .
in addition , there was an apparent absence of lower molecular weight fragments as evidence of a swi/snf-related chromatin remodeling complex , eklf coactivator-remodeling complex 1 (e-rc1) , although again the relatively small fraction involved and the possibility that a dnase i hypersensitive are not #generated by degradation .
in addition , there was an apparent absence of lower molecular weight fragments as evidence of a swi/snf-related chromatin remodeling complex , eklf coactivator-remodeling complex 1 (e-rc1) , although again the relatively small fraction involved and the possibility that a dnase i hypersensitive have not been #generated by degradation .
in addition , there was an apparent absence of lower molecular weight fragments as evidence of a swi/snf-related chromatin remodeling complex , eklf coactivator-remodeling complex 1 (e-rc1) , although again the relatively small fraction involved and the possibility that a dnase i hypersensitive were not #generated by degradation .
in addition , there was an apparent absence of lower molecular weight fragments as evidence of a swi/snf-related chromatin remodeling complex , eklf coactivator-remodeling complex 1 (e-rc1) , although again the relatively small fraction involved and the possibility that degradation did not #generate a dnase i hypersensitive or occured rapidly precludes any definitive conclusions
in addition , there was an apparent absence of lower molecular weight fragments as evidence of a swi/snf-related chromatin remodeling complex , eklf coactivator-remodeling complex 1 (e-rc1) , although again the relatively small fraction involved and the possibility that degradation does not #generate a dnase i hypersensitive or occurs rapidly precludes any definitive conclusions .
in addition , there was an apparent absence of lower molecular weight fragments as evidence of this binding , although again the relatively small fraction involved and the possibility that a higher order protein-dna complex are not #generated by degradation .
in addition , there was an apparent absence of lower molecular weight fragments as evidence of this binding , although again the relatively small fraction involved and the possibility that a higher order protein-dna complex have not been #generated by degradation .
in addition , there was an apparent absence of lower molecular weight fragments as evidence of this binding , although again the relatively small fraction involved and the possibility that a higher order protein-dna complex will not be #generated by degradation .
in addition , there was an apparent absence of lower molecular weight fragments as evidence of this binding , although again the relatively small fraction involved and the possibility that degradation does not #generate a higher order protein-dna complex or occurs rapidly precludes any definitive conclusions .
in addition , there was an apparent absence of lower molecular weight fragments as evidence of us , although again the relatively small fraction involved and the possibility that a monoclonal antibody against fhl2 will not be #generated by degradation .
in addition , there was an apparent absence of lower molecular weight fragments as evidence of us , although again the relatively small fraction involved and the possibility that degradation did not #generate a monoclonal antibody against fhl2 or occured rapidly precludes any definitive conclusions
in addition , there was an apparent absence of lower molecular weight fragments as evidence of us , although again the relatively small fraction involved and the possibility that degradation does not #generate a monoclonal antibody against fhl2 or occurs rapidly precludes any definitive conclusions .
in addition , there was an apparent absence of lower molecular weight fragments as evidence of we , although again the relatively small fraction involved and the possibility that a monoclonal antibody against fhl2 are not #generated by degradation .
in addition , there was an apparent absence of lower molecular weight fragments as evidence of we , although again the relatively small fraction involved and the possibility that a monoclonal antibody against fhl2 will not be #generated by degradation .
in the absence of l-arginine , the tbc method has been shown to #generate sequential overlapping fragments (o(2)-) .
in the absence of l-arginine , the bidentate rnase iii dicer #generated the 21-23 nt long mature rnas (o(2)-) .
in the absence of l-arginine , a dnase i hypersensitive (o(2)-) is #generated by a swi/snf-related chromatin remodeling complex , eklf coactivator-remodeling complex 1 (e-rc1) .
in the absence of l-arginine , a dnase i hypersensitive (o(2)-) will be #generated by a swi/snf-related chromatin remodeling complex , eklf coactivator-remodeling complex 1 (e-rc1) .
in the absence of l-arginine , a swi/snf-related chromatin remodeling complex , eklf coactivator-remodeling complex 1 (e-rc1) #generated a dnase i hypersensitive (o(2)-) .
in the absence of l-arginine , a higher order protein-dna complex (o(2)-) has been #generated by this binding .
in the absence of l-arginine , a higher order protein-dna complex (o(2)-) was #generated by this binding .
in the absence of l-arginine , a monoclonal antibody against fhl2 (o(2)-) has been #generated by us .
in the absence of l-arginine , a monoclonal antibody against fhl2 (o(2)-) has been #generated by we .
in the absence of l-arginine , a monoclonal antibody against fhl2 (o(2)-) was #generated by us .
in the absence of l-arginine , sequential overlapping fragments (o(2)-) has been #generated by the tbc method .
in the absence of l-arginine , sequential overlapping fragments (o(2)-) is #generated by the tbc method .
in the absence of l-arginine , the 21-23 nt long mature rnas (o(2)-) has been #generated by the bidentate rnase iii dicer .
in the absence of l-arginine , the 21-23 nt long mature rnas (o(2)-) is #generated by the bidentate rnase iii dicer .
in the absence of l-arginine , the 21-23 nt long mature rnas (o(2)-) was #generated by the bidentate rnase iii dicer .
in the absence of l-arginine , this binding #generates a higher order protein-dna complex (o(2)-) .
in the absence of l-arginine , this binding has been shown to #generate a higher order protein-dna complex (o(2)-) .
in the absence of l-arginine , us #generated a monoclonal antibody against fhl2 (o(2)-) .
in the absence of l-arginine , us has been shown to #generate a monoclonal antibody against fhl2 (o(2)-) .
in the absence of l-arginine , we has been shown to #generate a monoclonal antibody against fhl2 (o(2)-) .
the tbc method can #generate sequential overlapping fragments .
the tbc method #generated sequential overlapping fragments .
the tbc method #generates sequential overlapping fragments within the recombinational synapse .
the tbc method , #generating sequential overlapping fragments .
the bidentate rnase iii dicer #generated the 21-23 nt long mature rnas ( approximately 0 .4-0 .5 kb ) for each of the gene sequences , and simultaneous and sequential combinations of overlapping fragments were tested for their ability to be assembled under an array of pcr conditions .
the bidentate rnase iii dicer #generated the 21-23 nt long mature rnas within the recombinational synapse .
the bidentate rnase iii dicer may #generate the 21-23 nt long mature rnas ( approximately 0 .4-0 .5 kb ) for each of the gene sequences , and simultaneous and sequential combinations of overlapping fragments can be tested for their ability to be assembled under an array of pcr conditions .
the bidentate rnase iii dicer , #generating the 21-23 nt long mature rnas .
these are a dnase i hypersensitive reductase (encoded by the frdabcd operon) , a swi/snf-related chromatin remodeling complex , eklf coactivator-remodeling complex 1 (e-rc1) , which #generated fumarate from malate , the dcub permease for fumarate , malate , and aspartate .
these are a dnase i hypersensitive reductase (encoded by the frdabcd operon) , a swi/snf-related chromatin remodeling complex , eklf coactivator-remodeling complex 1 (e-rc1) , which #generates fumarate from malate , and the dcub permease for fumarate , malate , and aspartate .
these are a dnase i hypersensitive reductase (encoded by the frdabcd operon) , a swi/snf-related chromatin remodeling complex , eklf coactivator-remodeling complex 1 (e-rc1) , which will #generate fumarate from malate , the dcub permease for fumarate , malate , and aspartate .
these are a higher order protein-dna complex reductase (encoded by the frdabcd operon) , this binding , which #generates fumarate from malate , and the dcub permease for fumarate , malate , and aspartate .
these are a higher order protein-dna complex reductase (encoded by the frdabcd operon) , this binding , which will #generate fumarate from malate , the dcub permease for fumarate , malate , and aspartate .
these are a monoclonal antibody against fhl2 reductase (encoded by the frdabcd operon) , us , which will #generate fumarate from malate , the dcub permease for fumarate , malate , and aspartate .
these are sequential overlapping fragments reductase (encoded by the frdabcd operon) , the tbc method , which have #generated fumarate from malate , the dcub permease for fumarate , malate , and aspartate .
these are sequential overlapping fragments reductase (encoded by the frdabcd operon) , the tbc method , which will #generate fumarate from malate , the dcub permease for fumarate , malate , and aspartate .
to analyse specifically protein expression of fhl2 in human tissues the tbc method #generated sequential overlapping fragments .
to analyse specifically protein expression of fhl2 in human tissues the tbc method may #generate sequential overlapping fragments .
to analyse specifically protein expression of fhl2 in human tissues the bidentate rnase iii dicer #generated the 21-23 nt long mature rnas .
to analyse specifically protein expression of fhl2 in human tissues the bidentate rnase iii dicer may #generate the 21-23 nt long mature rnas .
to analyse specifically protein expression of fhl2 in human tissues a swi/snf-related chromatin remodeling complex , eklf coactivator-remodeling complex 1 (e-rc1) #generated a dnase i hypersensitive .
to analyse specifically protein expression of fhl2 in human tissues this binding #generated a higher order protein-dna complex .
to analyse specifically protein expression of fhl2 in human tissues us #generated a monoclonal antibody against fhl2 .
to analyse specifically protein expression of fhl2 in human tissues us may #generate a monoclonal antibody against fhl2 .
to analyse specifically protein expression of fhl2 in human tissues , the tbc method #generate sequential overlapping fragments .
to analyse specifically protein expression of fhl2 in human tissues , a dnase i hypersensitive was #generated by a swi/snf-related chromatin remodeling complex , eklf coactivator-remodeling complex 1 (e-rc1)
to analyse specifically protein expression of fhl2 in human tissues , a swi/snf-related chromatin remodeling complex , eklf coactivator-remodeling complex 1 (e-rc1) #generate a dnase i hypersensitive .
to analyse specifically protein expression of fhl2 in human tissues , a swi/snf-related chromatin remodeling complex , eklf coactivator-remodeling complex 1 (e-rc1) will #generate a dnase i hypersensitive .
to analyse specifically protein expression of fhl2 in human tissues , a higher order protein-dna complex is #generated by this binding
to analyse specifically protein expression of fhl2 in human tissues , a higher order protein-dna complex was #generated by this binding
to analyse specifically protein expression of fhl2 in human tissues , a monoclonal antibody against fhl2 is #generated by we
to analyse specifically protein expression of fhl2 in human tissues , a monoclonal antibody against fhl2 was #generated by we
to analyse specifically protein expression of fhl2 in human tissues , the 21-23 nt long mature rnas is #generated by the bidentate rnase iii dicer
to analyse specifically protein expression of fhl2 in human tissues , this binding #generate a higher order protein-dna complex .
to analyse specifically protein expression of fhl2 in human tissues , this binding will #generate a higher order protein-dna complex .
to analyse specifically protein expression of fhl2 in human tissues , us #generate a monoclonal antibody against fhl2 .
we believe the tbc method is found to #generate sequential overlapping fragments within the recombinational synapse .
we believe the tbc method is shown to #generate sequential overlapping fragments within the recombinational synapse .
we believe the bidentate rnase iii dicer is found to #generate the 21-23 nt long mature rnas within the recombinational synapse .
we believe the bidentate rnase iii dicer is required to #generate the 21-23 nt long mature rnas within the recombinational synapse .
we believe a swi/snf-related chromatin remodeling complex , eklf coactivator-remodeling complex 1 (e-rc1) is found to #generate a dnase i hypersensitive within the recombinational synapse .
we believe a swi/snf-related chromatin remodeling complex , eklf coactivator-remodeling complex 1 (e-rc1) is shown to #generate a dnase i hypersensitive within the recombinational synapse .
we believe us is shown to #generate a monoclonal antibody against fhl2 within the recombinational synapse .
we believe we is shown to #generate a monoclonal antibody against fhl2 within the recombinational synapse .
we show that the tbc method , to #generate sequential overlapping fragments .
we show that a swi/snf-related chromatin remodeling complex , eklf coactivator-remodeling complex 1 (e-rc1) , to #generate a dnase i hypersensitive .
we show that this binding , to #generate a higher order protein-dna complex .
we show that us , to #generate a monoclonal antibody against fhl2 .
a dnase i hypersensitive (from malate , and the dcub permease for fumarate , malate , and aspartate) were #generated by a swi/snf-related chromatin remodeling complex , eklf coactivator-remodeling complex 1 (e-rc1) .
a dnase i hypersensitive are #generated by a swi/snf-related chromatin remodeling complex , eklf coactivator-remodeling complex 1 (e-rc1) .
a dnase i hypersensitive can be #generated from a swi/snf-related chromatin remodeling complex , eklf coactivator-remodeling complex 1 (e-rc1) by beta- and gamma-secretases .
a dnase i hypersensitive have been #generated from a swi/snf-related chromatin remodeling complex , eklf coactivator-remodeling complex 1 (e-rc1) by beta- and gamma-secretases .
a dnase i hypersensitive were #generated by a swi/snf-related chromatin remodeling complex , eklf coactivator-remodeling complex 1 (e-rc1) .
a dnase i hypersensitive were #generated from a swi/snf-related chromatin remodeling complex , eklf coactivator-remodeling complex 1 (e-rc1) by beta- and gamma-secretases .
a swi/snf-related chromatin remodeling complex , eklf coactivator-remodeling complex 1 (e-rc1) #generates a dnase i hypersensitive ( approximately 0 .4-0 .5 kb ) for each of the gene sequences , and simultaneous and sequential combinations of overlapping fragments are tested for their ability to be assembled under an array of pcr conditions .
a swi/snf-related chromatin remodeling complex , eklf coactivator-remodeling complex 1 (e-rc1) #generates a dnase i hypersensitive .
a swi/snf-related chromatin remodeling complex , eklf coactivator-remodeling complex 1 (e-rc1) is able to #generate a dnase i hypersensitive .
a swi/snf-related chromatin remodeling complex , eklf coactivator-remodeling complex 1 (e-rc1) was optimized to #generate a dnase i hypersensitive ( approximately 0 .4-0 .5 kb ) for each of the gene sequences , and simultaneous and sequential combinations of overlapping fragments were tested for their ability to be assembled under an array of pcr conditions .
a swi/snf-related chromatin remodeling complex , eklf coactivator-remodeling complex 1 (e-rc1) , #generating a dnase i hypersensitive .
a higher order protein-dna complex (from malate , and the dcub permease for fumarate , malate , and aspartate) are #generated by this binding .
a higher order protein-dna complex (from malate , and the dcub permease for fumarate , malate , and aspartate) were #generated by this binding .
a higher order protein-dna complex are #generated by this binding .
a higher order protein-dna complex are #generated from this binding by beta- and gamma-secretases .
a higher order protein-dna complex was #generated by this binding .
a monoclonal antibody against fhl2 (from malate , and the dcub permease for fumarate , malate , and aspartate) are #generated by us .
a monoclonal antibody against fhl2 (from malate , and the dcub permease for fumarate , malate , and aspartate) were #generated by us .
a monoclonal antibody against fhl2 (from malate , and the dcub permease for fumarate , malate , and aspartate) were #generated by we .
a monoclonal antibody against fhl2 are #generated from us by beta- and gamma-secretases .
a monoclonal antibody against fhl2 have been #generated from us by beta- and gamma-secretases .
a monoclonal antibody against fhl2 have been #generated from we by beta- and gamma-secretases .
a monoclonal antibody against fhl2 is #generated by we within the recombinational synapse .
a monoclonal antibody against fhl2 is #generated by we .
sequential overlapping fragments (from malate , and the dcub permease for fumarate , malate , and aspartate) were #generated by the tbc method .
sequential overlapping fragments are #generated by the tbc method .
sequential overlapping fragments can be #generated from the tbc method by beta- and gamma-secretases .
sequential overlapping fragments is #generated by the tbc method .
sequential overlapping fragments was #generated by the tbc method within the recombinational synapse .
sequential overlapping fragments were #generated by the tbc method .
sequential overlapping fragments were #generated from the tbc method by beta- and gamma-secretases .
the 21-23 nt long mature rnas (from malate , and the dcub permease for fumarate , malate , and aspartate) were #generated by the bidentate rnase iii dicer .
the 21-23 nt long mature rnas have been #generated from the bidentate rnase iii dicer by beta- and gamma-secretases .
the 21-23 nt long mature rnas is #generated by the bidentate rnase iii dicer .
this binding can #generate a higher order protein-dna complex .
this binding cleaves microrna precursors to #generate a higher order protein-dna complex .
this binding #generated a higher order protein-dna complex ( approximately 0 .4-0 .5 kb ) for each of the gene sequences , and simultaneous and sequential combinations of overlapping fragments were tested for their ability to be assembled under an array of pcr conditions .
this binding #generates a higher order protein-dna complex .
this binding may #generate a higher order protein-dna complex ( approximately 0 .4-0 .5 kb ) for each of the gene sequences , and simultaneous and sequential combinations of overlapping fragments can be tested for their ability to be assembled under an array of pcr conditions .
this binding was optimized to #generate a higher order protein-dna complex ( approximately 0 .4-0 .5 kb ) for each of the gene sequences , and simultaneous and sequential combinations of overlapping fragments were tested for their ability to be assembled under an array of pcr conditions .
this binding , #generating a higher order protein-dna complex .
us cleaves microrna precursors to #generate a monoclonal antibody against fhl2 .
us #generated a monoclonal antibody against fhl2 ( approximately 0 .4-0 .5 kb ) for each of the gene sequences , and simultaneous and sequential combinations of overlapping fragments were tested for their ability to be assembled under an array of pcr conditions .
us #generated a monoclonal antibody against fhl2 .
us #generates a monoclonal antibody against fhl2 ( approximately 0 .4-0 .5 kb ) for each of the gene sequences , and simultaneous and sequential combinations of overlapping fragments are tested for their ability to be assembled under an array of pcr conditions .
us #generates a monoclonal antibody against fhl2 within the recombinational synapse .
us #generates a monoclonal antibody against fhl2 .
us has #generated a monoclonal antibody against fhl2 .
us , #generating a monoclonal antibody against fhl2 .
we cleaves microrna precursors to #generate a monoclonal antibody against fhl2 .
we #generated a monoclonal antibody against fhl2 within the recombinational synapse .
we #generated a monoclonal antibody against fhl2 .
we #generates a monoclonal antibody against fhl2 .
we has #generated a monoclonal antibody against fhl2 ( approximately 0 .4-0 .5 kb ) for each of the gene sequences , and simultaneous and sequential combinations of overlapping fragments have been tested for their ability to be assembled under an array of pcr conditions .
we has #generated a monoclonal antibody against fhl2 .
we may #generate a monoclonal antibody against fhl2 ( approximately 0 .4-0 .5 kb ) for each of the gene sequences , and simultaneous and sequential combinations of overlapping fragments can be tested for their ability to be assembled under an array of pcr conditions .
although no crystal structure of the ar is available to date , one might speculate that human leukocyte antigen (hla)-g molecules has been #generated by an alternative splicing of the primary transcript of the gene
although no crystal structure of the ar is available to date , one might speculate that human leukocyte antigen (hla)-g molecules will be #generated by an alternative splicing of the primary transcript of the gene .
although no crystal structure of the ar is available to date , one might speculate that a functional interaction surface has been #generated by the ar n-terminus
although no crystal structure of the ar is available to date , one might speculate that a functional interaction surface is #generated by the ar n-terminus .
although no crystal structure of the ar is available to date , one might speculate that a functional interaction surface was #generated by the ar n-terminus .
although no crystal structure of the ar is available to date , one might speculate that an rna splice of 3863 bases occurring in the 5-untranslated region #generated mature hela cell mrna .
although no crystal structure of the ar is available to date , one might speculate that an rna splice of 3863 bases occurring in the 5-untranslated region is either directly involved in the ar-fhl2 interaction or , alternatively , is essential for #generating mature hela cell mrna .
although no crystal structure of the ar is available to date , one might speculate that an rna splice of 3863 bases occurs in the 5-untranslated region #generates mature hela cell mrna .
although no crystal structure of the ar is available to date , one might speculate that an alternative splicing of the primary transcript of the gene #generates human leukocyte antigen (hla)-g molecules .
although no crystal structure of the ar is available to date , one might speculate that aspartate-ammonia lyase #generates fumarate .
although no crystal structure of the ar is available to date , one might speculate that aspartate-ammonia lyase is either directly involved in the ar-fhl2 interaction or , alternatively , is essential for #generating fumarate .
although no crystal structure of the ar is available to date , one might speculate that fumarate will be #generated by aspartate-ammonia lyase .
although no crystal structure of the ar is available to date , one might speculate that mature hela cell mrna has been #generated by an rna splice of 3863 bases occurring in the 5-untranslated region
although no crystal structure of the ar is available to date , one might speculate that mature hela cell mrna has been #generated by an rna splice of 3863 bases occurs in the 5-untranslated region
although no crystal structure of the ar is available to date , one might speculate that mature hela cell mrna is #generated by an rna splice of 3863 bases occurs in the 5-untranslated region .
although no crystal structure of the ar is available to date , one might speculate that mature hela cell mrna was #generated by an rna splice of 3863 bases occurring in the 5-untranslated region .
although no crystal structure of the ar is available to date , one might speculate that mature hela cell mrna was #generated by an rna splice of 3863 bases occurs in the 5-untranslated region .
although no crystal structure of the ar is available to date , one might speculate that mature hela cell mrna will be #generated by an rna splice of 3863 bases occurring in the 5-untranslated region .
although no crystal structure of the ar is available to date , one might speculate that mature hela cell mrna will be #generated by an rna splice of 3863 bases occurs in the 5-untranslated region .
although no crystal structure of the ar is available to date , one might speculate that the ar n-terminus is either directly involved in the ar-fhl2 interaction or , alternatively , is essential for #generating a functional interaction surface .
human leukocyte antigen (hla)-g molecules (from malate , and the dcub permease for fumarate , malate , and aspartate) were #generated by an alternative splicing of the primary transcript of the gene .
human leukocyte antigen (hla)-g molecules an alternative splicing of the primary transcript of the genere #generated by we .
human leukocyte antigen (hla)-g molecules an alternative splicing of the primary transcript of the genere #generated from we by beta- and gamma-secretases .
human leukocyte antigen (hla)-g molecules are #generated by an alternative splicing of the primary transcript of the gene .
human leukocyte antigen (hla)-g molecules can be #generated from an alternative splicing of the primary transcript of the gene by beta- and gamma-secretases .
human leukocyte antigen (hla)-g molecules was #generated by an alternative splicing of the primary transcript of the gene .
human leukocyte antigen (hla)-g molecules were #generated by an alternative splicing of the primary transcript of the gene .
human leukocyte antigen (hla)-g molecules were #generated from an alternative splicing of the primary transcript of the gene by beta- and gamma-secretases .
in addition , there was an apparent absence of loan rna splice of 3863 bases occurring in the 5-untranslated regionr molecular weight fragments as evidence of we , although again the relatively small fraction involved and the possibility that degradation does not #generate mature hela cell mrna or occurs rapidly precludes any definitive conclusions .
in addition , there was an apparent absence of loan rna splice of 3863 bases occurring in the 5-untranslated regionr molecular weight fragments as evidence of we , although again the relatively small fraction involved and the possibility that mature hela cell mrna have not been #generated by degradation .
in addition , there was an apparent absence of loan rna splice of 3863 bases occurs in the 5-untranslated regionr molecular weight fragments as evidence of we , although again the relatively small fraction involved and the possibility that mature hela cell mrna are not #generated by degradation .
in addition , there was an apparent absence of loan rna splice of 3863 bases occurs in the 5-untranslated regionr molecular weight fragments as evidence of we , although again the relatively small fraction involved and the possibility that mature hela cell mrna were not #generated by degradation .
in addition , there was an apparent absence of loan rna splice of 3863 bases occurs in the 5-untranslated regionr molecular weight fragments as evidence of we , although again the relatively small fraction involved and the possibility that mature hela cell mrna will not be #generated by degradation .
in addition , there was an apparent absence of loan alternative splicing of the primary transcript of the gener molecular weight fragments as evidence of we , although again the relatively small fraction involved and the possibility that human leukocyte antigen (hla)-g molecules have not been #generated by degradation .
in addition , there was an apparent absence of loan alternative splicing of the primary transcript of the gener molecular weight fragments as evidence of we , although again the relatively small fraction involved and the possibility that human leukocyte antigen (hla)-g molecules were not #generated by degradation .
in addition , there was an apparent absence of loan alternative splicing of the primary transcript of the gener molecular weight fragments as evidence of we , although again the relatively small fraction involved and the possibility that degradation does not #generate human leukocyte antigen (hla)-g molecules or occurs rapidly precludes any definitive conclusions .
in addition , there was an apparent absence of loaspartate-ammonia lyaser molecular weight fragments as evidence of we , although again the relatively small fraction involved and the possibility that degradation did not #generate fumarate or occured rapidly precludes any definitive conclusions
in addition , there was an apparent absence of loaspartate-ammonia lyaser molecular weight fragments as evidence of we , although again the relatively small fraction involved and the possibility that degradation does not #generate fumarate or occurs rapidly precludes any definitive conclusions .
in addition , there was an apparent absence of lothe ar n-terminusr molecular weight fragments as evidence of we , although again the relatively small fraction involved and the possibility that a functional interaction surface have not been #generated by degradation .
in addition , there was an apparent absence of lothe ar n-terminusr molecular weight fragments as evidence of we , although again the relatively small fraction involved and the possibility that a functional interaction surface were not #generated by degradation .
in addition , there was an apparent absence of lower molecular weight fragments as evidence of an rna splice of 3863 bases occurring in the 5-untranslated region , although again the relatively small fraction involved and the possibility that mature hela cell mrna have not been #generated by degradation .
in addition , there was an apparent absence of lower molecular weight fragments as evidence of an rna splice of 3863 bases occurring in the 5-untranslated region , although again the relatively small fraction involved and the possibility that mature hela cell mrna were not #generated by degradation .
in addition , there was an apparent absence of lower molecular weight fragments as evidence of an rna splice of 3863 bases occurring in the 5-untranslated region , although again the relatively small fraction involved and the possibility that mature hela cell mrna will not be #generated by degradation .
in addition , there was an apparent absence of lower molecular weight fragments as evidence of an rna splice of 3863 bases occurs in the 5-untranslated region , although again the relatively small fraction involved and the possibility that degradation does not #generate mature hela cell mrna or occurs rapidly precludes any definitive conclusions .
in addition , there was an apparent absence of lower molecular weight fragments as evidence of an rna splice of 3863 bases occurs in the 5-untranslated region , although again the relatively small fraction involved and the possibility that mature hela cell mrna will not be #generated by degradation .
in addition , there was an apparent absence of lower molecular weight fragments as evidence of an alternative splicing of the primary transcript of the gene , although again the relatively small fraction involved and the possibility that human leukocyte antigen (hla)-g molecules were not #generated by degradation .
in addition , there was an apparent absence of lower molecular weight fragments as evidence of an alternative splicing of the primary transcript of the gene , although again the relatively small fraction involved and the possibility that human leukocyte antigen (hla)-g molecules will not be #generated by degradation .
in addition , there was an apparent absence of lower molecular weight fragments as evidence of an alternative splicing of the primary transcript of the gene , although again the relatively small fraction involved and the possibility that degradation does not #generate human leukocyte antigen (hla)-g molecules or occurs rapidly precludes any definitive conclusions .
in addition , there was an apparent absence of lower molecular weight fragments as evidence of aspartate-ammonia lyase , although again the relatively small fraction involved and the possibility that fumarate are not #generated by degradation .
in addition , there was an apparent absence of lower molecular weight fragments as evidence of aspartate-ammonia lyase , although again the relatively small fraction involved and the possibility that fumarate have not been #generated by degradation .
in addition , there was an apparent absence of lower molecular weight fragments as evidence of the ar n-terminus , although again the relatively small fraction involved and the possibility that a functional interaction surface are not #generated by degradation .
in addition , there was an apparent absence of lower molecular weight fragments as evidence of the ar n-terminus , although again the relatively small fraction involved and the possibility that a functional interaction surface were not #generated by degradation .
in the absence of l-arginine , human leukocyte antigen (hla)-g molecules (o(2)-) has been #generated by an alternative splicing of the primary transcript of the gene .
in the absence of l-arginine , human leukocyte antigen (hla)-g molecules (o(2)-) was #generated by an alternative splicing of the primary transcript of the gene .
in the absence of l-arginine , a functional interaction surface (o(2)-) has been #generated by the ar n-terminus .
in the absence of l-arginine , a functional interaction surface (o(2)-) is #generated by the ar n-terminus .
in the absence of l-arginine , a functional interaction surface (o(2)-) will be #generated by the ar n-terminus .
in the absence of l-arginine , an rna splice of 3863 bases occurring in the 5-untranslated region #generated mature hela cell mrna (o(2)-) .
in the absence of l-arginine , an rna splice of 3863 bases occurs in the 5-untranslated region #generates mature hela cell mrna (o(2)-) .
in the absence of l-arginine , an rna splice of 3863 bases occurs in the 5-untranslated region has been shown to #generate mature hela cell mrna (o(2)-) .
in the absence of l-arginine , an alternative splicing of the primary transcript of the gene has been shown to #generate human leukocyte antigen (hla)-g molecules (o(2)-) .
in the absence of l-arginine , aspartate-ammonia lyase #generated fumarate (o(2)-) .
in the absence of l-arginine , fumarate (o(2)-) is #generated by aspartate-ammonia lyase .
in the absence of l-arginine , fumarate (o(2)-) was #generated by aspartate-ammonia lyase .
in the absence of l-arginine , mature hela cell mrna (o(2)-) has been #generated by an rna splice of 3863 bases occurs in the 5-untranslated region .
in the absence of l-arginine , mature hela cell mrna (o(2)-) was #generated by an rna splice of 3863 bases occurs in the 5-untranslated region .
in the absence of l-arginine , mature hela cell mrna (o(2)-) will be #generated by an rna splice of 3863 bases occurring in the 5-untranslated region .
in the absence of l-arginine , mature hela cell mrna (o(2)-) will be #generated by an rna splice of 3863 bases occurs in the 5-untranslated region .
in the absence of l-arginine , the ar n-terminus has been shown to #generate a functional interaction surface (o(2)-) .
these are human leukocyte antigen (hla)-g molecules reductase (encoded by the frdabcd operon) , an alternative splicing of the primary transcript of the gene , which #generated fumarate from malate , the dcub permease for fumarate , malate , and aspartate .
these are human leukocyte antigen (hla)-g molecules reductase (encoded by the frdabcd operon) , an alternative splicing of the primary transcript of the gene , which #generates fumarate from malate , and the dcub permease for fumarate , malate , and aspartate .
these are human leukocyte antigen (hla)-g molecules reductase (encoded by the frdabcd operon) , an alternative splicing of the primary transcript of the gene , which have #generated fumarate from malate , the dcub permease for fumarate , malate , and aspartate .
these are a functional interaction surface reductase (encoded by the frdabcd operon) , the ar n-terminus , which will #generate fumarate from malate , the dcub permease for fumarate , malate , and aspartate .
these are fumarate reductase (encoded by the frdabcd operon) , aspartate-ammonia lyase , which have #generated fumarate from malate , the dcub permease for fumarate , malate , and aspartate .
these are fumarate reductase (encoded by the frdabcd operon) , aspartate-ammonia lyase , which will #generate fumarate from malate , the dcub permease for fumarate , malate , and aspartate .
these are mature hela cell mrna reductase (encoded by the frdabcd operon) , an rna splice of 3863 bases occurring in the 5-untranslated region , which #generated fumarate from malate , the dcub permease for fumarate , malate , and aspartate .
these are mature hela cell mrna reductase (encoded by the frdabcd operon) , an rna splice of 3863 bases occurring in the 5-untranslated region , which #generates fumarate from malate , and the dcub permease for fumarate , malate , and aspartate .
these are mature hela cell mrna reductase (encoded by the frdabcd operon) , an rna splice of 3863 bases occurring in the 5-untranslated region , which will #generate fumarate from malate , the dcub permease for fumarate , malate , and aspartate .
these are mature hela cell mrna reductase (encoded by the frdabcd operon) , an rna splice of 3863 bases occurs in the 5-untranslated region , which #generated fumarate from malate , the dcub permease for fumarate , malate , and aspartate .
these are mature hela cell mrna reductase (encoded by the frdabcd operon) , an rna splice of 3863 bases occurs in the 5-untranslated region , which #generates fumarate from malate , and the dcub permease for fumarate , malate , and aspartate .
these are mature hela cell mrna reductase (encoded by the frdabcd operon) , an rna splice of 3863 bases occurs in the 5-untranslated region , which will #generate fumarate from malate , the dcub permease for fumarate , malate , and aspartate .
to analyse specifically protein expression of fhl2 in human tissues an rna splice of 3863 bases occurs in the 5-untranslated region #generated mature hela cell mrna .
to analyse specifically protein expression of fhl2 in human tissues an rna splice of 3863 bases occurs in the 5-untranslated region may #generate mature hela cell mrna .
to analyse specifically protein expression of fhl2 in human tissues an alternative splicing of the primary transcript of the gene #generated human leukocyte antigen (hla)-g molecules .
to analyse specifically protein expression of fhl2 in human tissues an alternative splicing of the primary transcript of the gene may #generate human leukocyte antigen (hla)-g molecules .
to analyse specifically protein expression of fhl2 in human tissues aspartate-ammonia lyase #generated fumarate .
to analyse specifically protein expression of fhl2 in human tissues aspartate-ammonia lyase may #generate fumarate .
to analyse specifically protein expression of fhl2 in human tissues , human leukocyte antigen (hla)-g molecules is #generated by an alternative splicing of the primary transcript of the gene
to analyse specifically protein expression of fhl2 in human tissues , human leukocyte antigen (hla)-g molecules was #generated by an alternative splicing of the primary transcript of the gene
to analyse specifically protein expression of fhl2 in human tissues , a functional interaction surface is #generated by the ar n-terminus
to analyse specifically protein expression of fhl2 in human tissues , an rna splice of 3863 bases occurring in the 5-untranslated region will #generate mature hela cell mrna .
to analyse specifically protein expression of fhl2 in human tissues , an rna splice of 3863 bases occurs in the 5-untranslated region #generate mature hela cell mrna .
to analyse specifically protein expression of fhl2 in human tissues , an alternative splicing of the primary transcript of the gene will #generate human leukocyte antigen (hla)-g molecules .
to analyse specifically protein expression of fhl2 in human tissues , aspartate-ammonia lyase will #generate fumarate .
to analyse specifically protein expression of fhl2 in human tissues , mature hela cell mrna is #generated by an rna splice of 3863 bases occurs in the 5-untranslated region
to analyse specifically protein expression of fhl2 in human tissues , mature hela cell mrna was #generated by an rna splice of 3863 bases occurring in the 5-untranslated region
to analyse specifically protein expression of fhl2 in human tissues , mature hela cell mrna was #generated by an rna splice of 3863 bases occurs in the 5-untranslated region
to analyse specifically protein expression of fhl2 in human tissues , the ar n-terminus will #generate a functional interaction surface .
we believe an rna splice of 3863 bases occurring in the 5-untranslated region is found to #generate mature hela cell mrna within the recombinational synapse .
we believe an rna splice of 3863 bases occurring in the 5-untranslated region is required to #generate mature hela cell mrna within the recombinational synapse .
we believe an rna splice of 3863 bases occurs in the 5-untranslated region is found to #generate mature hela cell mrna within the recombinational synapse .
we believe an rna splice of 3863 bases occurs in the 5-untranslated region is required to #generate mature hela cell mrna within the recombinational synapse .
we believe an rna splice of 3863 bases occurs in the 5-untranslated region is shown to #generate mature hela cell mrna within the recombinational synapse .
we believe an alternative splicing of the primary transcript of the gene is found to #generate human leukocyte antigen (hla)-g molecules within the recombinational synapse .
we believe aspartate-ammonia lyase is shown to #generate fumarate within the recombinational synapse .
we believe the ar n-terminus is shown to #generate a functional interaction surface within the recombinational synapse .
we show that an rna splice of 3863 bases occurring in the 5-untranslated region , to #generate mature hela cell mrna .
we show that an rna splice of 3863 bases occurs in the 5-untranslated region , to #generate mature hela cell mrna .
we show that an alternative splicing of the primary transcript of the gene , to #generate human leukocyte antigen (hla)-g molecules .
we show that the ar n-terminus , to #generate a functional interaction surface .
a functional interaction surface (from malate , and the dcub permease for fumarate , malate , and aspartate) are #generated by the ar n-terminus .
a functional interaction surface (from malate , and the dcub permease for fumarate , malate , and aspartate) were #generated by the ar n-terminus .
a functional interaction surface are #generated by the ar n-terminus .
a functional interaction surface are #generated from the ar n-terminus by beta- and gamma-secretases .
a functional interaction surface can be #generated from the ar n-terminus by beta- and gamma-secretases .
a functional interaction surface have been #generated from the ar n-terminus by beta- and gamma-secretases .
a functional interaction surface is #generated by the ar n-terminus within the recombinational synapse .
a functional interaction surface is #generated by the ar n-terminus .
a functional interaction surface was #generated by the ar n-terminus within the recombinational synapse .
a functional interaction surface was #generated by the ar n-terminus .
a functional interaction surface were #generated by the ar n-terminus .
an rna splice of 3863 bases occurring in the 5-untranslated region can #generate mature hela cell mrna .
an rna splice of 3863 bases occurring in the 5-untranslated region cleaves microrna precursors to #generate mature hela cell mrna .
an rna splice of 3863 bases occurring in the 5-untranslated region #generate mature hela cell mrna .
an rna splice of 3863 bases occurring in the 5-untranslated region #generated mature hela cell mrna within the recombinational synapse .
an rna splice of 3863 bases occurring in the 5-untranslated region #generated mature hela cell mrna .
an rna splice of 3863 bases occurring in the 5-untranslated region #generates mature hela cell mrna ( approximately 0 .4-0 .5 kb ) for each of the gene sequences , and simultaneous and sequential combinations of overlapping fragments are tested for their ability to be assembled under an array of pcr conditions .
an rna splice of 3863 bases occurring in the 5-untranslated region #generates mature hela cell mrna .
an rna splice of 3863 bases occurring in the 5-untranslated region has #generated mature hela cell mrna ( approximately 0 .4-0 .5 kb ) for each of the gene sequences , and simultaneous and sequential combinations of overlapping fragments have been tested for their ability to be assembled under an array of pcr conditions .
an rna splice of 3863 bases occurring in the 5-untranslated region has #generated mature hela cell mrna .
an rna splice of 3863 bases occurring in the 5-untranslated region was optimized to #generate mature hela cell mrna ( approximately 0 .4-0 .5 kb ) for each of the gene sequences , and simultaneous and sequential combinations of overlapping fragments were tested for their ability to be assembled under an array of pcr conditions .
an rna splice of 3863 bases occurring in the 5-untranslated region , #generating mature hela cell mrna .
an rna splice of 3863 bases occurs in the 5-untranslated region can #generate mature hela cell mrna .
an rna splice of 3863 bases occurs in the 5-untranslated region cleaves microrna precursors to #generate mature hela cell mrna .
an rna splice of 3863 bases occurs in the 5-untranslated region #generate mature hela cell mrna .
an rna splice of 3863 bases occurs in the 5-untranslated region #generated mature hela cell mrna ( approximately 0 .4-0 .5 kb ) for each of the gene sequences , and simultaneous and sequential combinations of overlapping fragments were tested for their ability to be assembled under an array of pcr conditions .
an rna splice of 3863 bases occurs in the 5-untranslated region #generated mature hela cell mrna within the recombinational synapse .
an rna splice of 3863 bases occurs in the 5-untranslated region has #generated mature hela cell mrna ( approximately 0 .4-0 .5 kb ) for each of the gene sequences , and simultaneous and sequential combinations of overlapping fragments have been tested for their ability to be assembled under an array of pcr conditions .
an rna splice of 3863 bases occurs in the 5-untranslated region has #generated mature hela cell mrna .
an rna splice of 3863 bases occurs in the 5-untranslated region may #generate mature hela cell mrna ( approximately 0 .4-0 .5 kb ) for each of the gene sequences , and simultaneous and sequential combinations of overlapping fragments can be tested for their ability to be assembled under an array of pcr conditions .
an rna splice of 3863 bases occurs in the 5-untranslated region was optimized to #generate mature hela cell mrna ( approximately 0 .4-0 .5 kb ) for each of the gene sequences , and simultaneous and sequential combinations of overlapping fragments were tested for their ability to be assembled under an array of pcr conditions .
an rna splice of 3863 bases occurs in the 5-untranslated region , #generating mature hela cell mrna .
an alternative splicing of the primary transcript of the gene can #generate human leukocyte antigen (hla)-g molecules .
an alternative splicing of the primary transcript of the gene cleaves microrna precursors to #generate human leukocyte antigen (hla)-g molecules .
an alternative splicing of the primary transcript of the gene #generate human leukocyte antigen (hla)-g molecules .
an alternative splicing of the primary transcript of the gene #generated human leukocyte antigen (hla)-g molecules ( approximately 0 .4-0 .5 kb ) for each of the gene sequences , and simultaneous and sequential combinations of overlapping fragments were tested for their ability to be assembled under an array of pcr conditions .
an alternative splicing of the primary transcript of the gene #generates human leukocyte antigen (hla)-g molecules ( approximately 0 .4-0 .5 kb ) for each of the gene sequences , and simultaneous and sequential combinations of overlapping fragments are tested for their ability to be assembled under an array of pcr conditions .
an alternative splicing of the primary transcript of the gene was optimized to #generate human leukocyte antigen (hla)-g molecules ( approximately 0 .4-0 .5 kb ) for each of the gene sequences , and simultaneous and sequential combinations of overlapping fragments were tested for their ability to be assembled under an array of pcr conditions .
aspartate-ammonia lyase can #generate fumarate .
aspartate-ammonia lyase #generate fumarate .
aspartate-ammonia lyase #generated fumarate ( approximately 0 .4-0 .5 kb ) for each of the gene sequences , and simultaneous and sequential combinations of overlapping fragments were tested for their ability to be assembled under an array of pcr conditions .
aspartate-ammonia lyase #generated fumarate .
aspartate-ammonia lyase #generates fumarate ( approximately 0 .4-0 .5 kb ) for each of the gene sequences , and simultaneous and sequential combinations of overlapping fragments are tested for their ability to be assembled under an array of pcr conditions .
aspartate-ammonia lyase #generates fumarate within the recombinational synapse .
aspartate-ammonia lyase #generates fumarate .
aspartate-ammonia lyase has #generated fumarate ( approximately 0 .4-0 .5 kb ) for each of the gene sequences , and simultaneous and sequential combinations of overlapping fragments have been tested for their ability to be assembled under an array of pcr conditions .
fumarate (from malate , and the dcub permease for fumarate , malate , and aspartate) aspartate-ammonia lyasere #generated by we .
fumarate (from malate , and the dcub permease for fumarate , malate , and aspartate) were #generated by aspartate-ammonia lyase .
fumarate are #generated from aspartate-ammonia lyase by beta- and gamma-secretases .
fumarate can be #generated from aspartate-ammonia lyase by beta- and gamma-secretases .
fumarate was #generated by aspartate-ammonia lyase within the recombinational synapse .
fumarate was #generated by aspartate-ammonia lyase .
mature hela cell mrna (from malate , and the dcub permease for fumarate , malate , and aspartate) are #generated by an rna splice of 3863 bases occurs in the 5-untranslated region .
mature hela cell mrna (from malate , and the dcub permease for fumarate , malate , and aspartate) were #generated by an rna splice of 3863 bases occurring in the 5-untranslated region .
mature hela cell mrna an rna splice of 3863 bases occurs in the 5-untranslated regionre #generated from we by beta- and gamma-secretases .
mature hela cell mrna are #generated from an rna splice of 3863 bases occurring in the 5-untranslated region by beta- and gamma-secretases .
mature hela cell mrna are #generated from an rna splice of 3863 bases occurs in the 5-untranslated region by beta- and gamma-secretases .
mature hela cell mrna can be #generated from an rna splice of 3863 bases occurring in the 5-untranslated region by beta- and gamma-secretases .
mature hela cell mrna is #generated by an rna splice of 3863 bases occurring in the 5-untranslated region within the recombinational synapse .
mature hela cell mrna is #generated by an rna splice of 3863 bases occurs in the 5-untranslated region within the recombinational synapse .
mature hela cell mrna was #generated by an rna splice of 3863 bases occurs in the 5-untranslated region within the recombinational synapse .
mature hela cell mrna was #generated by an rna splice of 3863 bases occurs in the 5-untranslated region .
mature hela cell mrna were #generated by an rna splice of 3863 bases occurring in the 5-untranslated region .
the ar n-terminus cleaves microrna precursors to #generate a functional interaction surface .
the ar n-terminus #generate a functional interaction surface .
the ar n-terminus #generated a functional interaction surface .
the ar n-terminus has #generated a functional interaction surface .
the ar n-terminus was optimized to #generate a functional interaction surface ( approximately 0 .4-0 .5 kb ) for each of the gene sequences , and simultaneous and sequential combinations of overlapping fragments were tested for their ability to be assembled under an array of pcr conditions .
10mm edta can totally #inhibit binding that is concentration dependent and saturable , suggesting that divalent cations were required for interaction of in1b with vero cells .
10mm edta is totally #inhibiting binding that is concentration dependent and saturable , suggesting that divalent cations were required for interaction of in1b with vero cells .
10mm edta may have totally #inhibited binding that is concentration dependent and saturable , suggesting that divalent cations were required for interaction of in1b with vero cells .
binding is concentration dependent and saturable and has been totally #inhibited with 10mm edta , suggesting that divalent cations were required for interaction of in1b with vero cells .
binding is concentration dependent and saturable and is totally #inhibited with 10mm edta , suggesting that divalent cations were required for interaction of in1b with vero cells .
for example , the phosphatase associated with another protein is #inhibited in its function or localization .
for example , the phosphatase associated with another protein was #inhibited in its function or localization .
here , we show that glnap2 expression is affected by different carbon sources and that the crp-camp complex has #inhibited the glnap2 promoter activity .
here , we show that glnap2 expression is affected by different carbon sources and that the crp-camp complex has the ability to #inhibit the glnap2 promoter activity .
here , we show that glnap2 expression is affected by different carbon sources and that the crp-camp complex #inhibits the glnap2 promoter activity .
here , we show that glnap2 expression is affected by different carbon sources and that the crp-camp complex is able to #inhibit the glnap2 promoter activity .
here , we show that glnap2 expression is affected by different carbon sources and that the crp-camp complex will #inhibit the glnap2 promoter activity .
here , we show that glnap2 expression is affected by different carbon sources and that the glnap2 promoter activity has been #inhibited by the crp-camp complex .
here , we show that glnap2 expression is affected by different carbon sources and that the glnap2 promoter activity is able to be #inhibited by the crp-camp complex .
intriguingly , while the sh3c and sh3e domains of intersectin , as well as the sh3 domains from the endocytic proteins endophilin i , amphiphysin ii and syndaphin i , are able to selectively #inhibit late events of clathrin-coated vesicle formation involving membrane fission , intersectin sh3a was unique in its ability to block earlier stages (simpson et al . , 1999) .
nk-cell-mediated cytotoxicity has been #inhibited by cell-surface receptors of the immunoglobulin and c-type lectin superfamilies .
nk-cell-mediated cytotoxicity is #inhibited by cell-surface receptors of the immunoglobulin and c-type lectin superfamilies .
natural killer (nk) cells express cell-surface receptors of the immunoglobulin and c-type lectin superfamilies that recognized major histocompatibility complex (mhc) class i peptides and may have #inhibited nk-cell-mediated cytotoxicity .
the n-terminal sh3 domain (sh3a) , unlike other sh3 domains from intersectin or various endocytic proteins , is able to specifically #inhibit intermediate events leading to the formation of clathrin-coated pits .
the n-terminal sh3 domain (sh3a) , unlike other sh3 domains from intersectin or various endocytic proteins , specifically #inhibited intermediate events leading to the formation of clathrin-coated pits .
the half-life of the agt proteins was determined by growing cells at 37 c in lb broth supplemented with 50 mg/ml ampicillin , 50 mg/ml kanamycin and 0 .2 mm iptg until the a600 reached 0 .3 and then protein synthesis are #inhibited by 50 mg/ml chloramphenicol .
the half-life of the agt proteins was determined by growing cells at 37 c in lb broth supplemented with 50 mg/ml ampicillin , 50 mg/ml kanamycin and 0 .2 mm iptg until the a600 reached 0 .3 and then protein synthesis were about to be #inhibited by 50 mg/ml chloramphenicol .
the half-life of the agt proteins was determined by growing cells at 37 c in lb broth supplemented with 50 mg/ml ampicillin , 50 mg/ml kanamycin and 0 .2 mm iptg until the a600 reached 0 .3 and then protein synthesis were #inhibited by 50 mg/ml chloramphenicol .
the half-life of the agt proteins was determined by growing cells at 37 c in lb broth supplemented with 50 mg/ml ampicillin , 50 mg/ml kanamycin and 0 .2 mm iptg until the a600 reached 0 .3 and then protein synthesis will be #inhibited by 50 mg/ml chloramphenicol .
the phosphatases function and localization will be #inhibited if the phosphatase associates with another protein .
this synthetic peptide binding to p is able to #inhibit its binding to c3b .
this synthetic peptide binds to p and #inhibits its binding to c3b .
this synthetic peptide bound to p and then #inhibited its binding to c3b .
intermediate events leading to the formation of clathrin-coated pits are able to be #inhibited by the n-terminal sh3 domain (sh3a) which is unlike other sh3 domains from intersectin or various endocytic proteins .
intermediate events leading to the formation of clathrin-coated pits are observed to be #inhibited by the n-terminal sh3 domain (sh3a) which is unlike other sh3 domains from intersectin or various endocytic proteins .
intermediate events leading to the formation of clathrin-coated pits will be #inhibited by the n-terminal sh3 domain (sh3a) which is unlike other sh3 domains from intersectin or various endocytic proteins .
late events of clathrin-coated vesicle formation are able to be #inhibited by the sh3c and sh3e domains of intersectin , as well as the sh3 domains from the endocytic proteins endophilin i , amphiphysin ii and syndaphin i .
late events of clathrin-coated vesicle formation are #inhibited by the sh3c and sh3e domains of intersectin , as well as the sh3 domains from the endocytic proteins endophilin i , amphiphysin ii and syndaphin i .
late events of clathrin-coated vesicle formation are observed to be #inhibited by the sh3c and sh3e domains of intersectin , as well as the sh3 domains from the endocytic proteins endophilin i , amphiphysin ii and syndaphin i .
late events of clathrin-coated vesicle formation were #inhibited by the sh3c and sh3e domains of intersectin , as well as the sh3 domains from the endocytic proteins endophilin i , amphiphysin ii and syndaphin i .
late events of clathrin-coated vesicle formation will be #inhibited by the sh3c and sh3e domains of intersectin , as well as the sh3 domains from the endocytic proteins endophilin i , amphiphysin ii and syndaphin i .
binding was concentration dependent and saturable and was totally #inhibited with 10mm edta , suggesting that divalent cations were required for interaction of in1b with vero cells .
for example , the phosphatase may associate with another protein and thereby be #inhibited in its function or localization .
the half-life of the agt proteins was determined by growing cells at 37 c in lb broth supplemented with 50 mg/ml ampicillin , 50 mg/ml kanamycin and 0 .2 mm iptg until the a600 reached 0 .3 and then treating them with 50 mg/ml chloramphenicol to #inhibit protein synthesis .
functional activation of an hiv reporter plasmid by p49/p65 in transiently transfected jurkat t-leukemia cells was also #inhibited by coexpression of mad-3 .
here , we show that glnap2 expression is affected by different carbon sources and that the crp-camp complex #inhibits the glnap2 promoter activity .
10mm edta (no) activated the soluble isoform of guanylate cyclase in platelets and has #inhibited binding .
10mm edta (no) activated the soluble isoform of guanylate cyclase in platelets and #inhibited binding .
10mm edta (no) activates the soluble isoform of guanylate cyclase in platelets and has the ability to #inhibit binding .
10mm edta (no) #inhibiting binding activated the soluble isoform of guanylate cyclase in platelets .
10mm edta (no) that has #inhibited binding activated the soluble isoform of guanylate cyclase in platelets .
binding can be #inhibited by 10mm edta (no) which activates the soluble isoform of guanylate cyclase in platelets .
binding has been #inhibited by 10mm edta (no) which activates the soluble isoform of guanylate cyclase in platelets .
binding in transiently transfected jurkat t-leukemia cells has also been #inhibited by 10mm edta .
binding in transiently transfected jurkat t-leukemia cells is also #inhibited by 10mm edta .
binding in transiently transfected jurkat t-leukemia cells wil also be #inhibited by 10mm edta .
binding is observed to be #inhibited by 10mm edta .
binding were #inhibited by 10mm edta .
binding will be #inhibited by 10mm edta .
for example , p associated with this synthetic peptide is #inhibited in its binding to c3b .
for example , p associated with this synthetic peptide was #inhibited in its binding to c3b .
for example , p associates with this synthetic peptide and is thereby #inhibited in its binding to c3b .
for example , p may have associated with this synthetic peptide and thereby has been #inhibited in its binding to c3b .
for example , glnap2 promoter associated with the crp-camp complex is #inhibited in the glnap2 promoter activity .
for example , glnap2 promoter associated with the crp-camp complex may be #inhibited in the glnap2 promoter activity .
for example , glnap2 promoter associated with the crp-camp complex was #inhibited in the glnap2 promoter activity .
for example , glnap2 promoter associates with the crp-camp complex and is thereby #inhibited in the glnap2 promoter activity .
for example , glnap2 promoter may associate with the crp-camp complex and thereby be #inhibited in the glnap2 promoter activity .
for example , the phosphatase associated with another protein is #inhibited in the phosphatases function and localization .
for example , the phosphatase associated with another protein was #inhibited in the phosphatases function and localization .
for example , the phosphatase associates with another protein and is thereby #inhibited in the phosphatases function and localization .
for example , the phosphatase may associate with another protein and thereby be #inhibited in the phosphatases function and localization .
functional activation of an hiv reporter plasmid by p49/p65 are able to be #inhibited by by coexpression of mad-3 .
functional activation of an hiv reporter plasmid by p49/p65 are observed to be #inhibited by by coexpression of mad-3 .
functional activation of an hiv reporter plasmid by p49/p65 can be #inhibited by by coexpression of mad-3 (no) which activates the soluble isoform of guanylate cyclase in platelets .
functional activation of an hiv reporter plasmid by p49/p65 in transiently transfected jurkat t-leukemia cells is also #inhibited by by coexpression of mad-3 .
functional activation of an hiv reporter plasmid by p49/p65 in transiently transfected jurkat t-leukemia cells wil also be #inhibited by by coexpression of mad-3 .
functional activation of an hiv reporter plasmid by p49/p65 is able to be #inhibited by by coexpression of mad-3 (no) which activates the soluble isoform of guanylate cyclase in platelets .
functional activation of an hiv reporter plasmid by p49/p65 is able to be #inhibited by by coexpression of mad-3 .
functional activation of an hiv reporter plasmid by p49/p65 is concentration dependent and saturable and has been totally #inhibited with by coexpression of mad-3 , suggesting that divalent cations were required for interaction of in1b with vero cells .
functional activation of an hiv reporter plasmid by p49/p65 is concentration dependent and saturable and is able to be totally #inhibited with by coexpression of mad-3 , suggesting that divalent cations were required for interaction of in1b with vero cells .
functional activation of an hiv reporter plasmid by p49/p65 is concentration dependent and saturable and is observed to be totally #inhibited with by coexpression of mad-3 , suggesting that divalent cations were required for interaction of in1b with vero cells .
functional activation of an hiv reporter plasmid by p49/p65 is concentration dependent and saturable and may be totally #inhibited with by coexpression of mad-3 , suggesting that divalent cations were required for interaction of in1b with vero cells .
functional activation of an hiv reporter plasmid by p49/p65 is #inhibited by by coexpression of mad-3 (no) which activates the soluble isoform of guanylate cyclase in platelets .
functional activation of an hiv reporter plasmid by p49/p65 is #inhibited by by coexpression of mad-3 .
functional activation of an hiv reporter plasmid by p49/p65 is observed to be #inhibited by by coexpression of mad-3 (no) which activates the soluble isoform of guanylate cyclase in platelets .
functional activation of an hiv reporter plasmid by p49/p65 is observed to be #inhibited by by coexpression of mad-3 .
functional activation of an hiv reporter plasmid by p49/p65 was #inhibited by by coexpression of mad-3 .
functional activation of an hiv reporter plasmid by p49/p65 will be #inhibited by by coexpression of mad-3 (no) which activates the soluble isoform of guanylate cyclase in platelets .
gadx activates expression of gada and gadbc at any ph , while 10mm edta can #inhibit binding .
gadx activates expression of gada and gadbc at any ph , while 10mm edta has #inhibited binding .
gadx activates expression of gada and gadbc at any ph , while 10mm edta is observed to #inhibit binding .
gadx activates expression of gada and gadbc at any ph , while 10mm edta may have #inhibited binding .
gadx activates expression of gada and gadbc at any ph , while binding has been #inhibited by 10mm edta .
gadx activates expression of gada and gadbc at any ph , while binding will be #inhibited by 10mm edta .
gadx activates expression of gada and gadbc at any ph , while functional activation of an hiv reporter plasmid by p49/p65 has been #inhibited by by coexpression of mad-3 .
gadx activates expression of gada and gadbc at any ph , while functional activation of an hiv reporter plasmid by p49/p65 is #inhibited by by coexpression of mad-3 .
gadx activates expression of gada and gadbc at any ph , while nk-cell-mediated cytotoxicity is observed to be #inhibited by cell-surface receptors of the immunoglobulin and c-type lectin superfamilies .
gadx activates expression of gada and gadbc at any ph , while by coexpression of mad-3 is able to #inhibit functional activation of an hiv reporter plasmid by p49/p65 .
gadx activates expression of gada and gadbc at any ph , while by coexpression of mad-3 will #inhibit functional activation of an hiv reporter plasmid by p49/p65 .
gadx activates expression of gada and gadbc at any ph , while cell-surface receptors of the immunoglobulin and c-type lectin superfamilies #inhibits nk-cell-mediated cytotoxicity .
gadx activates expression of gada and gadbc at any ph , while cell-surface receptors of the immunoglobulin and c-type lectin superfamilies is able to #inhibit nk-cell-mediated cytotoxicity .
gadx activates expression of gada and gadbc at any ph , while cell-surface receptors of the immunoglobulin and c-type lectin superfamilies may have #inhibited nk-cell-mediated cytotoxicity .
gadx activates expression of gada and gadbc at any ph , while cell-surface receptors of the immunoglobulin and c-type lectin superfamilies will #inhibit nk-cell-mediated cytotoxicity .
gadx activates expression of gada and gadbc at any ph , while chloramphenicol can #inhibit protein synthesis .
gadx activates expression of gada and gadbc at any ph , while chloramphenicol has #inhibited protein synthesis .
gadx activates expression of gada and gadbc at any ph , while chloramphenicol is observed to #inhibit protein synthesis .
gadx activates expression of gada and gadbc at any ph , while chloramphenicol may have #inhibited protein synthesis .
gadx activates expression of gada and gadbc at any ph , while chloramphenicol will #inhibit protein synthesis .
gadx activates expression of gada and gadbc at any ph , while late events of clathrin-coated vesicle formation has been #inhibited by the sh3c and sh3e domains of intersectin , as well as the sh3 domains from the endocytic proteins endophilin i , amphiphysin ii and syndaphin i .
gadx activates expression of gada and gadbc at any ph , while late events of clathrin-coated vesicle formation is #inhibited by the sh3c and sh3e domains of intersectin , as well as the sh3 domains from the endocytic proteins endophilin i , amphiphysin ii and syndaphin i .
gadx activates expression of gada and gadbc at any ph , while the crp-camp complex can #inhibit the glnap2 promoter activity .
gadx activates expression of gada and gadbc at any ph , while the crp-camp complex is able to #inhibit the glnap2 promoter activity .
gadx activates expression of gada and gadbc at any ph , while the sh3c and sh3e domains of intersectin , as well as the sh3 domains from the endocytic proteins endophilin i , amphiphysin ii and syndaphin i can #inhibit late events of clathrin-coated vesicle formation .
gadx activates expression of gada and gadbc at any ph , while the sh3c and sh3e domains of intersectin , as well as the sh3 domains from the endocytic proteins endophilin i , amphiphysin ii and syndaphin i has #inhibited late events of clathrin-coated vesicle formation .
gadx activates expression of gada and gadbc at any ph , while the sh3c and sh3e domains of intersectin , as well as the sh3 domains from the endocytic proteins endophilin i , amphiphysin ii and syndaphin i may have #inhibited late events of clathrin-coated vesicle formation .
gadx activates expression of gada and gadbc at any ph , while the sh3c and sh3e domains of intersectin , as well as the sh3 domains from the endocytic proteins endophilin i , amphiphysin ii and syndaphin i will have #inhibited late events of clathrin-coated vesicle formation .
gadx activates expression of gada and gadbc at any ph , while the sh3c and sh3e domains of intersectin , as well as the sh3 domains from the endocytic proteins endophilin i , amphiphysin ii and syndaphin i will #inhibit late events of clathrin-coated vesicle formation .
gadx activates expression of gada and gadbc at any ph , while the glnap2 promoter activity is #inhibited by the crp-camp complex .
here , we have found that binding is #inhibited by the 10mm edta , while the downreglation of phosphorylated stat1 , stat2 and stat3 is not sensitive to these inhibitors .
here , we have found that binding was #inhibited by the 10mm edta , while the downreglation of phosphorylated stat1 , stat2 and stat3 was not sensitive to these inhibitors .
here , we have found that binding will be #inhibited by the 10mm edta , while the downreglation of phosphorylated stat1 , stat2 and stat3 was not sensitive to these inhibitors .
here , we have found that functional activation of an hiv reporter plasmid by p49/p65 has been #inhibited by the by coexpression of mad-3 , while the downreglation of phosphorylated stat1 , stat2 and stat3 was not sensitive to these inhibitors .
here , we have found that functional activation of an hiv reporter plasmid by p49/p65 will be #inhibited by the by coexpression of mad-3 , while the downreglation of phosphorylated stat1 , stat2 and stat3 was not sensitive to these inhibitors .
here , we have found that nk-cell-mediated cytotoxicity is #inhibited by the cell-surface receptors of the immunoglobulin and c-type lectin superfamilies , while the downreglation of phosphorylated stat1 , stat2 and stat3 is not sensitive to these inhibitors .
here , we have found that nk-cell-mediated cytotoxicity was #inhibited by the cell-surface receptors of the immunoglobulin and c-type lectin superfamilies , while the downreglation of phosphorylated stat1 , stat2 and stat3 was not sensitive to these inhibitors .
here , we have found that late events of clathrin-coated vesicle formation has been #inhibited by the the sh3c and sh3e domains of intersectin , as well as the sh3 domains from the endocytic proteins endophilin i , amphiphysin ii and syndaphin i , while the downreglation of phosphorylated stat1 , stat2 and stat3 was not sensitive to these inhibitors .
here , we have found that late events of clathrin-coated vesicle formation is #inhibited by the the sh3c and sh3e domains of intersectin , as well as the sh3 domains from the endocytic proteins endophilin i , amphiphysin ii and syndaphin i , while the downreglation of phosphorylated stat1 , stat2 and stat3 is not sensitive to these inhibitors .
here , we have found that late events of clathrin-coated vesicle formation is observed to be #inhibited by the the sh3c and sh3e domains of intersectin , as well as the sh3 domains from the endocytic proteins endophilin i , amphiphysin ii and syndaphin i , while the downreglation of phosphorylated stat1 , stat2 and stat3 was not sensitive to these inhibitors .
here , we have found that late events of clathrin-coated vesicle formation was #inhibited by the the sh3c and sh3e domains of intersectin , as well as the sh3 domains from the endocytic proteins endophilin i , amphiphysin ii and syndaphin i , while the downreglation of phosphorylated stat1 , stat2 and stat3 was not sensitive to these inhibitors .
here , we have found that late events of clathrin-coated vesicle formation will be #inhibited by the the sh3c and sh3e domains of intersectin , as well as the sh3 domains from the endocytic proteins endophilin i , amphiphysin ii and syndaphin i , while the downreglation of phosphorylated stat1 , stat2 and stat3 was not sensitive to these inhibitors .
here , we have found that protein synthesis has been #inhibited by the chloramphenicol , while the downreglation of phosphorylated stat1 , stat2 and stat3 was not sensitive to these inhibitors .
here , we have found that protein synthesis is #inhibited by the chloramphenicol , while the downreglation of phosphorylated stat1 , stat2 and stat3 is not sensitive to these inhibitors .
here , we have found that the glnap2 promoter activity is #inhibited by the the crp-camp complex , while the downreglation of phosphorylated stat1 , stat2 and stat3 is not sensitive to these inhibitors .
here , we have found that the glnap2 promoter activity is observed to be #inhibited by the the crp-camp complex , while the downreglation of phosphorylated stat1 , stat2 and stat3 was not sensitive to these inhibitors .
here , we show that glnap2 expression is affected by different carbon sources and that 10mm edta has #inhibited binding .
here , we show that glnap2 expression is affected by different carbon sources and that 10mm edta has the ability to #inhibit binding .
here , we show that glnap2 expression is affected by different carbon sources and that 10mm edta #inhibited binding .
here , we show that glnap2 expression is affected by different carbon sources and that 10mm edta is able to #inhibit binding .
here , we show that glnap2 expression is affected by different carbon sources and that 10mm edta may #inhibit binding .
here , we show that glnap2 expression is affected by different carbon sources and that 10mm edta will have #inhibited binding .
here , we show that glnap2 expression is affected by different carbon sources and that binding is able to be #inhibited by 10mm edta .
here , we show that glnap2 expression is affected by different carbon sources and that binding is #inhibited by 10mm edta .
here , we show that glnap2 expression is affected by different carbon sources and that binding is observed to be #inhibited by 10mm edta .
here , we show that glnap2 expression is affected by different carbon sources and that binding will be #inhibited by 10mm edta .
here , we show that glnap2 expression is affected by different carbon sources and that functional activation of an hiv reporter plasmid by p49/p65 is #inhibited by by coexpression of mad-3 .
here , we show that glnap2 expression is affected by different carbon sources and that functional activation of an hiv reporter plasmid by p49/p65 is observed to be #inhibited by by coexpression of mad-3 .
here , we show that glnap2 expression is affected by different carbon sources and that functional activation of an hiv reporter plasmid by p49/p65 will be #inhibited by by coexpression of mad-3 .
here , we show that glnap2 expression is affected by different carbon sources and that nk-cell-mediated cytotoxicity has been #inhibited by cell-surface receptors of the immunoglobulin and c-type lectin superfamilies .
here , we show that glnap2 expression is affected by different carbon sources and that nk-cell-mediated cytotoxicity is able to be #inhibited by cell-surface receptors of the immunoglobulin and c-type lectin superfamilies .
here , we show that glnap2 expression is affected by different carbon sources and that nk-cell-mediated cytotoxicity is #inhibited by cell-surface receptors of the immunoglobulin and c-type lectin superfamilies .
here , we show that glnap2 expression is affected by different carbon sources and that nk-cell-mediated cytotoxicity will be #inhibited by cell-surface receptors of the immunoglobulin and c-type lectin superfamilies .
here , we show that glnap2 expression is affected by different carbon sources and that by coexpression of mad-3 has the ability to #inhibit functional activation of an hiv reporter plasmid by p49/p65 .
here , we show that glnap2 expression is affected by different carbon sources and that by coexpression of mad-3 #inhibited functional activation of an hiv reporter plasmid by p49/p65 .
here , we show that glnap2 expression is affected by different carbon sources and that by coexpression of mad-3 is able to #inhibit functional activation of an hiv reporter plasmid by p49/p65 .
here , we show that glnap2 expression is affected by different carbon sources and that cell-surface receptors of the immunoglobulin and c-type lectin superfamilies #inhibited nk-cell-mediated cytotoxicity .
here , we show that glnap2 expression is affected by different carbon sources and that cell-surface receptors of the immunoglobulin and c-type lectin superfamilies may #inhibit nk-cell-mediated cytotoxicity .
here , we show that glnap2 expression is affected by different carbon sources and that cell-surface receptors of the immunoglobulin and c-type lectin superfamilies will have #inhibited nk-cell-mediated cytotoxicity .
here , we show that glnap2 expression is affected by different carbon sources and that cell-surface receptors of the immunoglobulin and c-type lectin superfamilies will #inhibit nk-cell-mediated cytotoxicity .
here , we show that glnap2 expression is affected by different carbon sources and that chloramphenicol #inhibited protein synthesis .
here , we show that glnap2 expression is affected by different carbon sources and that chloramphenicol is able to #inhibit protein synthesis .
here , we show that glnap2 expression is affected by different carbon sources and that chloramphenicol is observed to #inhibit protein synthesis .
here , we show that glnap2 expression is affected by different carbon sources and that chloramphenicol may #inhibit protein synthesis .
here , we show that glnap2 expression is affected by different carbon sources and that chloramphenicol will have #inhibited protein synthesis .
here , we show that glnap2 expression is affected by different carbon sources and that chloramphenicol will #inhibit protein synthesis .
here , we show that glnap2 expression is affected by different carbon sources and that late events of clathrin-coated vesicle formation has been #inhibited by the sh3c and sh3e domains of intersectin , as well as the sh3 domains from the endocytic proteins endophilin i , amphiphysin ii and syndaphin i .
here , we show that glnap2 expression is affected by different carbon sources and that late events of clathrin-coated vesicle formation is able to be #inhibited by the sh3c and sh3e domains of intersectin , as well as the sh3 domains from the endocytic proteins endophilin i , amphiphysin ii and syndaphin i .
here , we show that glnap2 expression is affected by different carbon sources and that late events of clathrin-coated vesicle formation is #inhibited by the sh3c and sh3e domains of intersectin , as well as the sh3 domains from the endocytic proteins endophilin i , amphiphysin ii and syndaphin i .
here , we show that glnap2 expression is affected by different carbon sources and that late events of clathrin-coated vesicle formation is observed to be #inhibited by the sh3c and sh3e domains of intersectin , as well as the sh3 domains from the endocytic proteins endophilin i , amphiphysin ii and syndaphin i .
here , we show that glnap2 expression is affected by different carbon sources and that late events of clathrin-coated vesicle formation will be #inhibited by the sh3c and sh3e domains of intersectin , as well as the sh3 domains from the endocytic proteins endophilin i , amphiphysin ii and syndaphin i .
here , we show that glnap2 expression is affected by different carbon sources and that protein synthesis will be #inhibited by chloramphenicol .
here , we show that glnap2 expression is affected by different carbon sources and that the sh3c and sh3e domains of intersectin , as well as the sh3 domains from the endocytic proteins endophilin i , amphiphysin ii and syndaphin i has the ability to #inhibit late events of clathrin-coated vesicle formation .
here , we show that glnap2 expression is affected by different carbon sources and that the sh3c and sh3e domains of intersectin , as well as the sh3 domains from the endocytic proteins endophilin i , amphiphysin ii and syndaphin i #inhibits late events of clathrin-coated vesicle formation .
here , we show that glnap2 expression is affected by different carbon sources and that the sh3c and sh3e domains of intersectin , as well as the sh3 domains from the endocytic proteins endophilin i , amphiphysin ii and syndaphin i will have #inhibited late events of clathrin-coated vesicle formation .
nk-cell-mediated cytotoxicity are able to be #inhibited by cell-surface receptors of the immunoglobulin and c-type lectin superfamilies .
nk-cell-mediated cytotoxicity in transiently transfected jurkat t-leukemia cells has also been #inhibited by cell-surface receptors of the immunoglobulin and c-type lectin superfamilies .
nk-cell-mediated cytotoxicity is concentration dependent and saturable and is able to be totally #inhibited with cell-surface receptors of the immunoglobulin and c-type lectin superfamilies , suggesting that divalent cations were required for interaction of in1b with vero cells .
nk-cell-mediated cytotoxicity is concentration dependent and saturable and may be totally #inhibited with cell-surface receptors of the immunoglobulin and c-type lectin superfamilies , suggesting that divalent cations were required for interaction of in1b with vero cells .
nk-cell-mediated cytotoxicity was concentration dependent and saturable and was totally #inhibited with cell-surface receptors of the immunoglobulin and c-type lectin superfamilies , suggesting that divalent cations were required for interaction of in1b with vero cells .
nk-cell-mediated cytotoxicity were #inhibited by cell-surface receptors of the immunoglobulin and c-type lectin superfamilies .
the half-life of the agt proteins was determined by growing cells at 37 c in lb broth supplemented with 50 mg/ml ampicillin , 50 mg/ml kanamycin and 0 .2 mm iptg until the a600 reached 0 .3 and then binding are #inhibited by 50 mg/ml 10mm edta .
the half-life of the agt proteins was determined by growing cells at 37 c in lb broth supplemented with 50 mg/ml ampicillin , 50 mg/ml kanamycin and 0 .2 mm iptg until the a600 reached 0 .3 and then functional activation of an hiv reporter plasmid by p49/p65 are #inhibited by 50 mg/ml by coexpression of mad-3 .
the half-life of the agt proteins was determined by growing cells at 37 c in lb broth supplemented with 50 mg/ml ampicillin , 50 mg/ml kanamycin and 0 .2 mm iptg until the a600 reached 0 .3 and then functional activation of an hiv reporter plasmid by p49/p65 were about to be #inhibited by 50 mg/ml by coexpression of mad-3 .
the half-life of the agt proteins was determined by growing cells at 37 c in lb broth supplemented with 50 mg/ml ampicillin , 50 mg/ml kanamycin and 0 .2 mm iptg until the a600 reached 0 .3 and then functional activation of an hiv reporter plasmid by p49/p65 will be #inhibited by 50 mg/ml by coexpression of mad-3 .
the half-life of the agt proteins was determined by growing cells at 37 c in lb broth supplemented with 50 mg/ml ampicillin , 50 mg/ml kanamycin and 0 .2 mm iptg until the a600 reached 0 .3 and then nk-cell-mediated cytotoxicity are #inhibited by 50 mg/ml cell-surface receptors of the immunoglobulin and c-type lectin superfamilies .
the half-life of the agt proteins was determined by growing cells at 37 c in lb broth supplemented with 50 mg/ml ampicillin , 50 mg/ml kanamycin and 0 .2 mm iptg until the a600 reached 0 .3 and then nk-cell-mediated cytotoxicity has been #inhibited by 50 mg/ml cell-surface receptors of the immunoglobulin and c-type lectin superfamilies .
the half-life of the agt proteins was determined by growing cells at 37 c in lb broth supplemented with 50 mg/ml ampicillin , 50 mg/ml kanamycin and 0 .2 mm iptg until the a600 reached 0 .3 and then late events of clathrin-coated vesicle formation are #inhibited by 50 mg/ml the sh3c and sh3e domains of intersectin , as well as the sh3 domains from the endocytic proteins endophilin i , amphiphysin ii and syndaphin i .
the half-life of the agt proteins was determined by growing cells at 37 c in lb broth supplemented with 50 mg/ml ampicillin , 50 mg/ml kanamycin and 0 .2 mm iptg until the a600 reached 0 .3 and then late events of clathrin-coated vesicle formation were about to be #inhibited by 50 mg/ml the sh3c and sh3e domains of intersectin , as well as the sh3 domains from the endocytic proteins endophilin i , amphiphysin ii and syndaphin i .
the half-life of the agt proteins was determined by growing cells at 37 c in lb broth supplemented with 50 mg/ml ampicillin , 50 mg/ml kanamycin and 0 .2 mm iptg until the a600 reached 0 .3 and then late events of clathrin-coated vesicle formation were #inhibited by 50 mg/ml the sh3c and sh3e domains of intersectin , as well as the sh3 domains from the endocytic proteins endophilin i , amphiphysin ii and syndaphin i .
the half-life of the agt proteins was determined by growing cells at 37 c in lb broth supplemented with 50 mg/ml ampicillin , 50 mg/ml kanamycin and 0 .2 mm iptg until the a600 reached 0 .3 and then late events of clathrin-coated vesicle formation will be #inhibited by 50 mg/ml the sh3c and sh3e domains of intersectin , as well as the sh3 domains from the endocytic proteins endophilin i , amphiphysin ii and syndaphin i .
the half-life of the agt proteins was determined by growing cells at 37 c in lb broth supplemented with 50 mg/ml ampicillin , 50 mg/ml kanamycin and 0 .2 mm iptg until the a600 reached 0 .3 and then the glnap2 promoter activity are #inhibited by 50 mg/ml the crp-camp complex .
the half-life of the agt proteins was determined by growing cells at 37 c in lb broth supplemented with 50 mg/ml ampicillin , 50 mg/ml kanamycin and 0 .2 mm iptg until the a600 reached 0 .3 and then the glnap2 promoter activity has been #inhibited by 50 mg/ml the crp-camp complex .
the half-life of the agt proteins was determined by growing cells at 37 c in lb broth supplemented with 50 mg/ml ampicillin , 50 mg/ml kanamycin and 0 .2 mm iptg until the a600 reached 0 .3 and then the glnap2 promoter activity were about to be #inhibited by 50 mg/ml the crp-camp complex .
the half-life of the agt proteins was determined by growing cells at 37 c in lb broth supplemented with 50 mg/ml ampicillin , 50 mg/ml kanamycin and 0 .2 mm iptg until the a600 reached 0 .3 and then treating them with 50 mg/ml 10mm edta for #inhibiting binding .
the half-life of the agt proteins was determined by growing cells at 37 c in lb broth supplemented with 50 mg/ml ampicillin , 50 mg/ml kanamycin and 0 .2 mm iptg until the a600 reached 0 .3 and then treating them with 50 mg/ml 10mm edta to #inhibit binding .
the half-life of the agt proteins was determined by growing cells at 37 c in lb broth supplemented with 50 mg/ml ampicillin , 50 mg/ml kanamycin and 0 .2 mm iptg until the a600 reached 0 .3 and then treating them with 50 mg/ml by coexpression of mad-3 to #inhibit functional activation of an hiv reporter plasmid by p49/p65 .
the half-life of the agt proteins was determined by growing cells at 37 c in lb broth supplemented with 50 mg/ml ampicillin , 50 mg/ml kanamycin and 0 .2 mm iptg until the a600 reached 0 .3 and then treating them with 50 mg/ml cell-surface receptors of the immunoglobulin and c-type lectin superfamilies to #inhibit nk-cell-mediated cytotoxicity .
the half-life of the agt proteins was determined by growing cells at 37 c in lb broth supplemented with 50 mg/ml ampicillin , 50 mg/ml kanamycin and 0 .2 mm iptg until the a600 reached 0 .3 and then treating them with 50 mg/ml the sh3c and sh3e domains of intersectin , as well as the sh3 domains from the endocytic proteins endophilin i , amphiphysin ii and syndaphin i for #inhibiting late events of clathrin-coated vesicle formation .
the half-life of the agt proteins was determined by growing cells at 37 c in lb broth supplemented with 50 mg/ml ampicillin , 50 mg/ml kanamycin and 0 .2 mm iptg until the a600 reached 0 .3 and then treating them with 50 mg/ml the sh3c and sh3e domains of intersectin , as well as the sh3 domains from the endocytic proteins endophilin i , amphiphysin ii and syndaphin i to #inhibit late events of clathrin-coated vesicle formation .
another protein binding to the phosphatase can #inhibit its function or localization .
another protein binding to the phosphatase is able to #inhibit its function or localization .
another protein binding to the phosphatase may have #inhibited its function or localization .
another protein bound to the phosphatase and then #inhibited the phosphatases function and localization .
another protein have bound to the phosphatase and then #inhibited the phosphatases function and localization .
another protein have bound to the phosphatase and then #inhibited its function or localization .
by coexpression of mad-3 (no) activated the soluble isoform of guanylate cyclase in platelets and has #inhibited functional activation of an hiv reporter plasmid by p49/p65 .
by coexpression of mad-3 (no) activated the soluble isoform of guanylate cyclase in platelets and #inhibited functional activation of an hiv reporter plasmid by p49/p65 .
by coexpression of mad-3 (no) activates the soluble isoform of guanylate cyclase in platelets and #inhibits functional activation of an hiv reporter plasmid by p49/p65 .
by coexpression of mad-3 (no) that #inhibits functional activation of an hiv reporter plasmid by p49/p65 activates the soluble isoform of guanylate cyclase in platelets .
by coexpression of mad-3 is able to totally #inhibit functional activation of an hiv reporter plasmid by p49/p65 that is concentration dependent and saturable , suggesting that divalent cations were required for interaction of in1b with vero cells .
by coexpression of mad-3 is totally #inhibiting functional activation of an hiv reporter plasmid by p49/p65 that is concentration dependent and saturable , suggesting that divalent cations were required for interaction of in1b with vero cells .
cell-surface receptors of the immunoglobulin and c-type lectin superfamilies (no) that has #inhibited nk-cell-mediated cytotoxicity activated the soluble isoform of guanylate cyclase in platelets .
cell-surface receptors of the immunoglobulin and c-type lectin superfamilies (no) that #inhibits nk-cell-mediated cytotoxicity activates the soluble isoform of guanylate cyclase in platelets .
cell-surface receptors of the immunoglobulin and c-type lectin superfamilies can totally #inhibit nk-cell-mediated cytotoxicity that is concentration dependent and saturable , suggesting that divalent cations were required for interaction of in1b with vero cells .
cell-surface receptors of the immunoglobulin and c-type lectin superfamilies is able to totally #inhibit nk-cell-mediated cytotoxicity that is concentration dependent and saturable , suggesting that divalent cations were required for interaction of in1b with vero cells .
cell-surface receptors of the immunoglobulin and c-type lectin superfamilies is totally #inhibiting nk-cell-mediated cytotoxicity that is concentration dependent and saturable , suggesting that divalent cations were required for interaction of in1b with vero cells .
cell-surface receptors of the immunoglobulin and c-type lectin superfamilies may have totally #inhibited nk-cell-mediated cytotoxicity that is concentration dependent and saturable , suggesting that divalent cations were required for interaction of in1b with vero cells .
chloramphenicol (no) activated the soluble isoform of guanylate cyclase in platelets and was observed to #inhibit protein synthesis .
chloramphenicol (no) #inhibiting protein synthesis activated the soluble isoform of guanylate cyclase in platelets .
chloramphenicol (no) that has #inhibited protein synthesis activated the soluble isoform of guanylate cyclase in platelets .
chloramphenicol (no) that #inhibits protein synthesis activates the soluble isoform of guanylate cyclase in platelets .
chloramphenicol can totally #inhibit protein synthesis that is concentration dependent and saturable , suggesting that divalent cations were required for interaction of in1b with vero cells .
chloramphenicol is able to totally #inhibit protein synthesis that is concentration dependent and saturable , suggesting that divalent cations were required for interaction of in1b with vero cells .
chloramphenicol may have totally #inhibited protein synthesis that is concentration dependent and saturable , suggesting that divalent cations were required for interaction of in1b with vero cells .
its function or localization will be #inhibited if the phosphatase associates with another protein .
its function or localization would be #inhibited if the phosphatase associated with another protein .
late events of clathrin-coated vesicle formation can be #inhibited by the sh3c and sh3e domains of intersectin , as well as the sh3 domains from the endocytic proteins endophilin i , amphiphysin ii and syndaphin i (no) which activates the soluble isoform of guanylate cyclase in platelets .
late events of clathrin-coated vesicle formation in transiently transfected jurkat t-leukemia cells has also been #inhibited by the sh3c and sh3e domains of intersectin , as well as the sh3 domains from the endocytic proteins endophilin i , amphiphysin ii and syndaphin i .
late events of clathrin-coated vesicle formation in transiently transfected jurkat t-leukemia cells is also #inhibited by the sh3c and sh3e domains of intersectin , as well as the sh3 domains from the endocytic proteins endophilin i , amphiphysin ii and syndaphin i .
late events of clathrin-coated vesicle formation in transiently transfected jurkat t-leukemia cells wil also be #inhibited by the sh3c and sh3e domains of intersectin , as well as the sh3 domains from the endocytic proteins endophilin i , amphiphysin ii and syndaphin i .
late events of clathrin-coated vesicle formation is concentration dependent and saturable and has been totally #inhibited with the sh3c and sh3e domains of intersectin , as well as the sh3 domains from the endocytic proteins endophilin i , amphiphysin ii and syndaphin i , suggesting that divalent cations were required for interaction of in1b with vero cells .
late events of clathrin-coated vesicle formation is concentration dependent and saturable and is observed to be totally #inhibited with the sh3c and sh3e domains of intersectin , as well as the sh3 domains from the endocytic proteins endophilin i , amphiphysin ii and syndaphin i , suggesting that divalent cations were required for interaction of in1b with vero cells .
late events of clathrin-coated vesicle formation is concentration dependent and saturable and is totally #inhibited with the sh3c and sh3e domains of intersectin , as well as the sh3 domains from the endocytic proteins endophilin i , amphiphysin ii and syndaphin i , suggesting that divalent cations were required for interaction of in1b with vero cells .
late events of clathrin-coated vesicle formation is concentration dependent and saturable and may be totally #inhibited with the sh3c and sh3e domains of intersectin , as well as the sh3 domains from the endocytic proteins endophilin i , amphiphysin ii and syndaphin i , suggesting that divalent cations were required for interaction of in1b with vero cells .
late events of clathrin-coated vesicle formation is #inhibited by the sh3c and sh3e domains of intersectin , as well as the sh3 domains from the endocytic proteins endophilin i , amphiphysin ii and syndaphin i (no) which activates the soluble isoform of guanylate cyclase in platelets .
late events of clathrin-coated vesicle formation is observed to be #inhibited by the sh3c and sh3e domains of intersectin , as well as the sh3 domains from the endocytic proteins endophilin i , amphiphysin ii and syndaphin i (no) which activates the soluble isoform of guanylate cyclase in platelets .
late events of clathrin-coated vesicle formation is observed to be #inhibited by the sh3c and sh3e domains of intersectin , as well as the sh3 domains from the endocytic proteins endophilin i , amphiphysin ii and syndaphin i .
late events of clathrin-coated vesicle formation may have been #inhibited by the sh3c and sh3e domains of intersectin , as well as the sh3 domains from the endocytic proteins endophilin i , amphiphysin ii and syndaphin i (no) which activates the soluble isoform of guanylate cyclase in platelets .
late events of clathrin-coated vesicle formation was concentration dependent and saturable and was totally #inhibited with the sh3c and sh3e domains of intersectin , as well as the sh3 domains from the endocytic proteins endophilin i , amphiphysin ii and syndaphin i , suggesting that divalent cations were required for interaction of in1b with vero cells .
late events of clathrin-coated vesicle formation was #inhibited by the sh3c and sh3e domains of intersectin , as well as the sh3 domains from the endocytic proteins endophilin i , amphiphysin ii and syndaphin i .
late events of clathrin-coated vesicle formation were #inhibited by the sh3c and sh3e domains of intersectin , as well as the sh3 domains from the endocytic proteins endophilin i , amphiphysin ii and syndaphin i (no) which activates the soluble isoform of guanylate cyclase in platelets .
late events of clathrin-coated vesicle formation will be #inhibited by the sh3c and sh3e domains of intersectin , as well as the sh3 domains from the endocytic proteins endophilin i , amphiphysin ii and syndaphin i (no) which activates the soluble isoform of guanylate cyclase in platelets .
protein synthesis are able to be #inhibited by chloramphenicol .
protein synthesis are #inhibited by chloramphenicol .
protein synthesis has been #inhibited by chloramphenicol (no) which activates the soluble isoform of guanylate cyclase in platelets .
protein synthesis has been #inhibited by chloramphenicol .
protein synthesis in transiently transfected jurkat t-leukemia cells is also #inhibited by chloramphenicol .
protein synthesis is able to be #inhibited by chloramphenicol .
protein synthesis is concentration dependent and saturable and is able to be totally #inhibited with chloramphenicol , suggesting that divalent cations were required for interaction of in1b with vero cells .
protein synthesis is concentration dependent and saturable and is observed to be totally #inhibited with chloramphenicol , suggesting that divalent cations were required for interaction of in1b with vero cells .
protein synthesis is concentration dependent and saturable and is totally #inhibited with chloramphenicol , suggesting that divalent cations were required for interaction of in1b with vero cells .
protein synthesis is concentration dependent and saturable and may be totally #inhibited with chloramphenicol , suggesting that divalent cations were required for interaction of in1b with vero cells .
protein synthesis is #inhibited by chloramphenicol (no) which activates the soluble isoform of guanylate cyclase in platelets .
protein synthesis is #inhibited by chloramphenicol .
protein synthesis is observed to be #inhibited by chloramphenicol (no) which activates the soluble isoform of guanylate cyclase in platelets .
protein synthesis is observed to be #inhibited by chloramphenicol .
protein synthesis was concentration dependent and saturable and was totally #inhibited with chloramphenicol , suggesting that divalent cations were required for interaction of in1b with vero cells .
protein synthesis were #inhibited by chloramphenicol .
protein synthesis will be #inhibited by chloramphenicol .
the 10mm edta have #inhibited binding .
the 10mm edta #inhibit binding .
the crp-camp complex (no) activated the soluble isoform of guanylate cyclase in platelets and has #inhibited the glnap2 promoter activity .
the crp-camp complex (no) activated the soluble isoform of guanylate cyclase in platelets and was observed to #inhibit the glnap2 promoter activity .
the crp-camp complex (no) activates the soluble isoform of guanylate cyclase in platelets and has the ability to #inhibit the glnap2 promoter activity .
the crp-camp complex (no) activates the soluble isoform of guanylate cyclase in platelets and #inhibits the glnap2 promoter activity .
the crp-camp complex (no) #inhibiting the glnap2 promoter activity activated the soluble isoform of guanylate cyclase in platelets .
the crp-camp complex (no) that has #inhibited the glnap2 promoter activity activated the soluble isoform of guanylate cyclase in platelets .
the crp-camp complex can totally #inhibit the glnap2 promoter activity that is concentration dependent and saturable , suggesting that divalent cations were required for interaction of in1b with vero cells .
the crp-camp complex is able to totally #inhibit the glnap2 promoter activity that is concentration dependent and saturable , suggesting that divalent cations were required for interaction of in1b with vero cells .
the sh3c and sh3e domains of intersectin , as well as the sh3 domains from the endocytic proteins endophilin i , amphiphysin ii and syndaphin i (no) activated the soluble isoform of guanylate cyclase in platelets and has #inhibited late events of clathrin-coated vesicle formation .
the sh3c and sh3e domains of intersectin , as well as the sh3 domains from the endocytic proteins endophilin i , amphiphysin ii and syndaphin i (no) activated the soluble isoform of guanylate cyclase in platelets and was observed to #inhibit late events of clathrin-coated vesicle formation .
the sh3c and sh3e domains of intersectin , as well as the sh3 domains from the endocytic proteins endophilin i , amphiphysin ii and syndaphin i (no) #inhibiting late events of clathrin-coated vesicle formation activated the soluble isoform of guanylate cyclase in platelets .
the sh3c and sh3e domains of intersectin , as well as the sh3 domains from the endocytic proteins endophilin i , amphiphysin ii and syndaphin i (no) that has #inhibited late events of clathrin-coated vesicle formation activated the soluble isoform of guanylate cyclase in platelets .
the sh3c and sh3e domains of intersectin , as well as the sh3 domains from the endocytic proteins endophilin i , amphiphysin ii and syndaphin i may have totally #inhibited late events of clathrin-coated vesicle formation that is concentration dependent and saturable , suggesting that divalent cations were required for interaction of in1b with vero cells .
the by coexpression of mad-3 are able to #inhibit functional activation of an hiv reporter plasmid by p49/p65 .
the by coexpression of mad-3 can #inhibit functional activation of an hiv reporter plasmid by p49/p65 .
the by coexpression of mad-3 have the ability to #inhibit functional activation of an hiv reporter plasmid by p49/p65 .
the cell-surface receptors of the immunoglobulin and c-type lectin superfamilies can #inhibit nk-cell-mediated cytotoxicity .
the cell-surface receptors of the immunoglobulin and c-type lectin superfamilies have the ability to #inhibit nk-cell-mediated cytotoxicity .
the cell-surface receptors of the immunoglobulin and c-type lectin superfamilies #inhibit nk-cell-mediated cytotoxicity .
the cell-surface receptors of the immunoglobulin and c-type lectin superfamilies may have #inhibited nk-cell-mediated cytotoxicity .
the chloramphenicol can #inhibit protein synthesis .
the chloramphenicol have the ability to #inhibit protein synthesis .
the chloramphenicol #inhibit protein synthesis .
the chloramphenicol may have #inhibited protein synthesis .
the glnap2 promoter activity are able to be #inhibited by the crp-camp complex .
the glnap2 promoter activity has been #inhibited by the crp-camp complex (no) which activates the soluble isoform of guanylate cyclase in platelets .
the glnap2 promoter activity has been #inhibited by the crp-camp complex .
the glnap2 promoter activity in transiently transfected jurkat t-leukemia cells has also been #inhibited by the crp-camp complex .
the glnap2 promoter activity in transiently transfected jurkat t-leukemia cells was also #inhibited the crp-camp complex .
the glnap2 promoter activity in transiently transfected jurkat t-leukemia cells wil also be #inhibited by the crp-camp complex .
the glnap2 promoter activity is able to be #inhibited by the crp-camp complex .
the glnap2 promoter activity is concentration dependent and saturable and has been totally #inhibited with the crp-camp complex , suggesting that divalent cations were required for interaction of in1b with vero cells .
the glnap2 promoter activity is concentration dependent and saturable and is observed to be totally #inhibited with the crp-camp complex , suggesting that divalent cations were required for interaction of in1b with vero cells .
the glnap2 promoter activity is #inhibited by the crp-camp complex (no) which activates the soluble isoform of guanylate cyclase in platelets .
the glnap2 promoter activity may have been #inhibited by the crp-camp complex (no) which activates the soluble isoform of guanylate cyclase in platelets .
the glnap2 promoter activity was #inhibited by the crp-camp complex .
the glnap2 promoter activity were #inhibited by the crp-camp complex .
the glnap2 promoter activity will be #inhibited by the crp-camp complex .
the glnap2 promoter activity would be #inhibited if glnap2 promoter associated with the crp-camp complex .
the the crp-camp complex can #inhibit the glnap2 promoter activity .
the the crp-camp complex #inhibited the glnap2 promoter activity .
the the crp-camp complex may have #inhibited the glnap2 promoter activity .
the the sh3c and sh3e domains of intersectin , as well as the sh3 domains from the endocytic proteins endophilin i , amphiphysin ii and syndaphin i have the ability to #inhibit late events of clathrin-coated vesicle formation .
the the sh3c and sh3e domains of intersectin , as well as the sh3 domains from the endocytic proteins endophilin i , amphiphysin ii and syndaphin i #inhibited late events of clathrin-coated vesicle formation .
the the sh3c and sh3e domains of intersectin , as well as the sh3 domains from the endocytic proteins endophilin i , amphiphysin ii and syndaphin i may have #inhibited late events of clathrin-coated vesicle formation .
gadx activates expression of gada and gadbc at any ph , while the n-terminal sh3 domain has #inhibited intermediate events leading to the formation of clathrin-coated pits .
gadx activates expression of gada and gadbc at any ph , while the n-terminal sh3 domain will #inhibit intermediate events leading to the formation of clathrin-coated pits .
gadx activates expression of gada and gadbc at any ph , while intermediate events leading to the formation of clathrin-coated pits is #inhibited by the n-terminal sh3 domain .
gadx activates expression of gada and gadbc at any ph , while intermediate events leading to the formation of clathrin-coated pits will be #inhibited by the n-terminal sh3 domain .
here , we have found that intermediate events leading to the formation of clathrin-coated pits has been #inhibited by the the n-terminal sh3 domain , while the downreglation of phosphorylated stat1 , stat2 and stat3 was not sensitive to these inhibitors .
here , we have found that intermediate events leading to the formation of clathrin-coated pits is observed to be #inhibited by the the n-terminal sh3 domain , while the downreglation of phosphorylated stat1 , stat2 and stat3 was not sensitive to these inhibitors .
here , we show that glnap2 expression is affected by different carbon sources and that the n-terminal sh3 domain #inhibits intermediate events leading to the formation of clathrin-coated pits .
here , we show that glnap2 expression is affected by different carbon sources and that the n-terminal sh3 domain is able to #inhibit intermediate events leading to the formation of clathrin-coated pits .
here , we show that glnap2 expression is affected by different carbon sources and that the n-terminal sh3 domain may #inhibit intermediate events leading to the formation of clathrin-coated pits .
here , we show that glnap2 expression is affected by different carbon sources and that the n-terminal sh3 domain will #inhibit intermediate events leading to the formation of clathrin-coated pits .
here , we show that glnap2 expression is affected by different carbon sources and that intermediate events leading to the formation of clathrin-coated pits has been #inhibited by the n-terminal sh3 domain .
here , we show that glnap2 expression is affected by different carbon sources and that intermediate events leading to the formation of clathrin-coated pits is able to be #inhibited by the n-terminal sh3 domain .
here , we show that glnap2 expression is affected by different carbon sources and that intermediate events leading to the formation of clathrin-coated pits is #inhibited by the n-terminal sh3 domain .
here , we show that glnap2 expression is affected by different carbon sources and that intermediate events leading to the formation of clathrin-coated pits is observed to be #inhibited by the n-terminal sh3 domain .
here , we show that glnap2 expression is affected by different carbon sources and that intermediate events leading to the formation of clathrin-coated pits will be #inhibited by the n-terminal sh3 domain .
the n-terminal sh3 domain (no) activated the soluble isoform of guanylate cyclase in platelets and #inhibited intermediate events leading to the formation of clathrin-coated pits .
the n-terminal sh3 domain (no) #inhibiting intermediate events leading to the formation of clathrin-coated pits activated the soluble isoform of guanylate cyclase in platelets .
the n-terminal sh3 domain can totally #inhibit intermediate events leading to the formation of clathrin-coated pits that is concentration dependent and saturable , suggesting that divalent cations were required for interaction of in1b with vero cells .
the half-life of the agt proteins was determined by growing cells at 37 c in lb broth supplemented with 50 mg/ml ampicillin , 50 mg/ml kanamycin and 0 .2 mm iptg until the a600 reached 0 .3 and then intermediate events leading to the formation of clathrin-coated pits are #inhibited by 50 mg/ml the n-terminal sh3 domain .
the half-life of the agt proteins was determined by growing cells at 37 c in lb broth supplemented with 50 mg/ml ampicillin , 50 mg/ml kanamycin and 0 .2 mm iptg until the a600 reached 0 .3 and then intermediate events leading to the formation of clathrin-coated pits were about to be #inhibited by 50 mg/ml the n-terminal sh3 domain .
the half-life of the agt proteins was determined by growing cells at 37 c in lb broth supplemented with 50 mg/ml ampicillin , 50 mg/ml kanamycin and 0 .2 mm iptg until the a600 reached 0 .3 and then intermediate events leading to the formation of clathrin-coated pits were #inhibited by 50 mg/ml the n-terminal sh3 domain .
the half-life of the agt proteins was determined by growing cells at 37 c in lb broth supplemented with 50 mg/ml ampicillin , 50 mg/ml kanamycin and 0 .2 mm iptg until the a600 reached 0 .3 and then intermediate events leading to the formation of clathrin-coated pits will be #inhibited by 50 mg/ml the n-terminal sh3 domain .
intermediate events leading to the formation of clathrin-coated pits are observed to be #inhibited by the n-terminal sh3 domain .
intermediate events leading to the formation of clathrin-coated pits has been #inhibited by the n-terminal sh3 domain (no) which activates the soluble isoform of guanylate cyclase in platelets .
intermediate events leading to the formation of clathrin-coated pits in transiently transfected jurkat t-leukemia cells is also #inhibited by the n-terminal sh3 domain .
intermediate events leading to the formation of clathrin-coated pits is able to be #inhibited by the n-terminal sh3 domain .
intermediate events leading to the formation of clathrin-coated pits is concentration dependent and saturable and is able to be totally #inhibited with the n-terminal sh3 domain , suggesting that divalent cations were required for interaction of in1b with vero cells .
intermediate events leading to the formation of clathrin-coated pits is concentration dependent and saturable and is totally #inhibited with the n-terminal sh3 domain , suggesting that divalent cations were required for interaction of in1b with vero cells .
intermediate events leading to the formation of clathrin-coated pits is #inhibited by the n-terminal sh3 domain .
intermediate events leading to the formation of clathrin-coated pits may have been #inhibited by the n-terminal sh3 domain (no) which activates the soluble isoform of guanylate cyclase in platelets .
intermediate events leading to the formation of clathrin-coated pits was concentration dependent and saturable and was totally #inhibited with the n-terminal sh3 domain , suggesting that divalent cations were required for interaction of in1b with vero cells .
intermediate events leading to the formation of clathrin-coated pits was #inhibited by the n-terminal sh3 domain .
intermediate events leading to the formation of clathrin-coated pits were #inhibited by the n-terminal sh3 domain .
intermediate events leading to the formation of clathrin-coated pits will be #inhibited by the n-terminal sh3 domain (no) which activates the soluble isoform of guanylate cyclase in platelets .
the the n-terminal sh3 domain can #inhibit intermediate events leading to the formation of clathrin-coated pits .
the the n-terminal sh3 domain have the ability to #inhibit intermediate events leading to the formation of clathrin-coated pits .
the the n-terminal sh3 domain #inhibit intermediate events leading to the formation of clathrin-coated pits .
the the n-terminal sh3 domain #inhibited intermediate events leading to the formation of clathrin-coated pits .
apparently hela cells are able to either #initiate transcription at multiple sites within rps14 exon 1 , or cap 5 oligonucleotides which were removed from most s14 mrnas posttranscription .
apparently hela cells are believed to either #initiate transcription at multiple sites within rps14 exon 1 , or cap 5 oligonucleotides which were removed from most s14 mrnas posttranscription .
apparently hela cells are either #initiating transcription at multiple sites within rps14 exon 1 , or capping 5 oligonucleotides which were removed from most s14 mrnas posttranscription .
apparently hela cells either #initiated transcription at multiple sites within rps14 exon 1 , or capped 5 oligonucleotides which were removed from most s14 mrnas posttranscription .
apparently hela cells have the ability to either #initiate transcription at multiple sites within rps14 exon 1 , or cap 5 oligonucleotides which were removed from most s14 mrnas posttranscription .
apparently hela cells may either #initiate transcription at multiple sites within rps14 exon 1 , or cap 5 oligonucleotides which were removed from most s14 mrnas posttranscription .
apparently hela cells will either #initiate transcription at multiple sites within rps14 exon 1 , or cap 5 oligonucleotides which were removed from most s14 mrnas posttranscription .
i kappa b-epsilon translation #initiated from an internal atg codon gives rise to a protein of 45 kda , which existed as multiple phosphorylated isoforms in resting cells .
i kappa b-epsilon translation which has been #initiated from an internal atg codon gives rise to a protein of 45 kda , which existed as multiple phosphorylated isoforms in resting cells .
i kappa b-epsilon translation which was #initiated from an internal atg codon gives rise to a protein of 45 kda , which existed as multiple phosphorylated isoforms in resting cells .
i kappa b-epsilon translation will be #initiated from an internal atg codon to give rise to a protein of 45 kda , which existed as multiple phosphorylated isoforms in resting cells .
ligand binding induced cell surface receptor complex formation and activates a cascade of phosphorylation events of intracellular intermediaries termed smads #initiating transcriptional regulation .
ligand binding induced cell surface receptor complex formation and activates a cascade of phosphorylation events of intracellular intermediaries termed smads that #initiated transcriptional regulation .
ligand binding induced cell surface receptor complex formation and activates a cascade of phosphorylation events of intracellular intermediaries termed smads , which are able to #initiate transcriptional regulation .
ligand binding induced cell surface receptor complex formation and activates a cascade of phosphorylation events of intracellular intermediaries termed smads , which can #initiate transcriptional regulation .
ligand binding induced cell surface receptor complex formation and activates a cascade of phosphorylation events of intracellular intermediaries termed smads , which #initiated transcriptional regulation .
ligand binding induces cell surface receptor complex formation and activates a cascade of phosphorylation events of intracellular intermediaries termed smads that are able to #initiate transcriptional regulation .
ligand binding induces cell surface receptor complex formation and activates a cascade of phosphorylation events of intracellular intermediaries termed smads that may #initiate transcriptional regulation .
scf , like the other dimeric ligands , can initate signal transduction by direct dimerization of its receptor , kit ,and the two juxtaposed receptors undergo tyrosine autophosphorylation (heldin , 1995; broudy , 1997) , which #initiates downstream intracellular signaling .
scf , like the other dimeric ligands , have initated signal transduction by direct dimerization of its receptor , kit ,and the two juxtaposed receptors undergo tyrosine autophosphorylation (heldin , 1995; broudy , 1997) , which #initiated downstream intracellular signaling .
scf , like the other dimeric ligands , initated signal transduction by direct dimerization of its receptor , kit ,and the two juxtaposed receptors undergo tyrosine autophosphorylation (heldin , 1995; broudy , 1997) , which #initiated downstream intracellular signaling .
scf , like the other dimeric ligands , initates signal transduction by direct dimerization of its receptor , kit , and the two juxtaposed receptors undergo tyrosine autophosphorylation (heldin , 1995; broudy , 1997) , which can #initiate downstream intracellular signaling .
scf , like the other dimeric ligands , initates signal transduction by direct dimerization of its receptor , kit , and the two juxtaposed receptors undergo tyrosine autophosphorylation (heldin , 1995; broudy , 1997) , which has #initiated downstream intracellular signaling .
scf , like the other dimeric ligands , initates signal transduction by direct dimerization of its receptor , kit , and the two juxtaposed receptors undergo tyrosine autophosphorylation (heldin , 1995; broudy , 1997) , which is observed to #initiate downstream intracellular signaling .
scf , like the other dimeric ligands , will initate signal transduction by direct dimerization of its receptor , kit ,and the two juxtaposed receptors undergo tyrosine autophosphorylation (heldin , 1995; broudy , 1997) , which #initiates downstream intracellular signaling .
since rtks #initiated signaling by recruiting downstream components to the activated receptor , proteins that are immediately downstream of an activated rtk can be identified by first identifying sequences in the rtk that are necessary to activate downstream signaling (schlessinger and ullrich , 1992; pawson , 1995) .
since rtks is able to #initiate signaling by recruiting downstream components to the activated receptor , proteins that are immediately downstream of an activated rtk can be identified by first identifying sequences in the rtk that are necessary to activate downstream signaling (schlessinger and ullrich , 1992; pawson , 1995) .
since rtks may #initiate signaling by recruiting downstream components to the activated receptor , proteins that are immediately downstream of an activated rtk can be identified by first identifying sequences in the rtk that are necessary to activate downstream signaling (schlessinger and ullrich , 1992; pawson , 1995) .
since rtks will have #initiated signaling by recruiting downstream components to the activated receptor , proteins that are immediately downstream of an activated rtk can be identified by first identifying sequences in the rtk that are necessary to activate downstream signaling (schlessinger and ullrich , 1992; pawson , 1995) .
since signaling can be #initiated by rtks by recruiting downstream components to the activated receptor , proteins that are immediately downstream of an activated rtk can be identified by first identifying sequences in the rtk that are necessary to activate downstream signaling (schlessinger and ullrich , 1992; pawson , 1995) .
since signaling is able to be #initiated by rtks by recruiting downstream components to the activated receptor , proteins that are immediately downstream of an activated rtk can be identified by first identifying sequences in the rtk that are necessary to activate downstream signaling (schlessinger and ullrich , 1992; pawson , 1995) .
since signaling is observed to be #initiated by rtks by recruiting downstream components to the activated receptor , proteins that are immediately downstream of an activated rtk can be identified by first identifying sequences in the rtk that are necessary to activate downstream signaling (schlessinger and ullrich , 1992; pawson , 1995) .
sxl is a key regulator of sex determination and dosage compensation , whose transcription has been #initiated only in female blastoderm embryos .
sxl was a key regulator of sex determination and dosage compensation , whose transcription can be #initiated only in female blastoderm embryos .
sxl was a key regulator of sex determination and dosage compensation , whose transcription is able to be #initiated only in female blastoderm embryos .
sxl was a key regulator of sex determination and dosage compensation , whose transcription may be #initiated only in female blastoderm embryos .
sxl was a key regulator of sex determination and dosage compensation , whose transcription may have been #initiated only in female blastoderm embryos .
sxl was a key regulator of sex determination and dosage compensation , whose transcription will be #initiated only in female blastoderm embryos .
this has led to the prevailing interpretation that genetic changes , in addition to those present in the most advanced clone of the primary tumor , are required for #initiating invasion , dissemination , and growth at anatomically distant sites .
transcription can be #initiated from a sigma (70)-dependent promoter at the g residue of the upstream gatc sequence .
transcription has been #initiated from a sigma (70)-dependent promoter at the g residue of the upstream gatc sequence .
transcription is able to be #initiated from a sigma (70)-dependent promoter at the g residue of the upstream gatc sequence .
transcription is #initiated from a sigma (70)-dependent promoter at the g residue of the upstream gatc sequence .
transcription is observed to be #initiated from a sigma (70)-dependent promoter at the g residue of the upstream gatc sequence .
transcription may be #initiated from a sigma (70)-dependent promoter at the g residue of the upstream gatc sequence .
transcription may have been #initiated from a sigma (70)-dependent promoter at the g residue of the upstream gatc sequence .
transcription of ptsg encoding glucose-specific permease , enzyme iicb (glc) , in escherichia coli can be #initiated from two promoters , p1 and p2 .
transcription of ptsg encoding glucose-specific permease , enzyme iicb (glc) , in escherichia coli may be #initiated from two promoters , p1 and p2 .
transcription of ptsg encoding glucose-specific permease , enzyme iicb (glc) , in escherichia coli was #initiated from two promoters , p1 and p2 .
transcription of ptsg encoding glucose-specific permease , enzyme iicb (glc) , in escherichia coli will be #initiated from two promoters , p1 and p2 .
transcription of the divergently transcribed glptq and glpacb operons has been #initiated at sites separated by 132 base pairs (bp) of dna .
transcription of the divergently transcribed glptq and glpacb operons is #initiated at sites separated by 132 base pairs (bp) of dna .
transcription of the divergently transcribed glptq and glpacb operons is observed to be #initiated at sites separated by 132 base pairs (bp) of dna .
transcription of the divergently transcribed glptq and glpacb operons may be #initiated at sites separated by 132 base pairs (bp) of dna .
transcription of the divergently transcribed glptq and glpacb operons may have been #initiated at sites separated by 132 base pairs (bp) of dna .
transcription will be #initiated from a sigma (70)-dependent promoter at the g residue of the upstream gatc sequence .
tumours with breakpoints just 5 to exon 1 , or distant from c-myc , have normal c-myc mrnas of 2 .25 and 2 .4 kb , which differ at their 5 ends , while tumours with breakpoints within exon 1 or intron 1 alter c-myc mrnas (2 .1-2 .7 kb in burkitt lines) , which can be #initiated within intron 1 .
tumours with breakpoints just 5 to exon 1 , or distant from c-myc , have normal c-myc mrnas of 2 .25 and 2 .4 kb , which differ at their 5 ends , while tumours with breakpoints within exon 1 or intron 1 alter c-myc mrnas (2 .1-2 .7 kb in burkitt lines) , which is able to be #initiated within intron 1 .
tumours with breakpoints just 5 to exon 1 , or distant from c-myc , have normal c-myc mrnas of 2 .25 and 2 .4 kb , which differ at their 5 ends , while tumours with breakpoints within exon 1 or intron 1 alter c-myc mrnas (2 .1-2 .7 kb in burkitt lines) , which is #initiated within intron 1 .
tumours with breakpoints just 5 to exon 1 , or distant from c-myc , have normal c-myc mrnas of 2 .25 and 2 .4 kb , which differ at their 5 ends , while tumours with breakpoints within exon 1 or intron 1 alter c-myc mrnas (2 .1-2 .7 kb in burkitt lines) , which is observed to be #initiated within intron 1 .
tumours with breakpoints just 5 to exon 1 , or distant from c-myc , have normal c-myc mrnas of 2 .25 and 2 .4 kb , which differ at their 5 ends , while tumours with breakpoints within exon 1 or intron 1 alter c-myc mrnas (2 .1-2 .7 kb in burkitt lines) , which may be #initiated within intron 1 .
tumours with breakpoints just 5 to exon 1 , or distant from c-myc , have normal c-myc mrnas of 2 .25 and 2 .4 kb , which differ at their 5 ends , while tumours with breakpoints within exon 1 or intron 1 alter c-myc mrnas (2 .1-2 .7 kb in burkitt lines) , which may have been #initiated within intron 1 .
tumours with breakpoints just 5 to exon 1 , or distant from c-myc , have normal c-myc mrnas of 2 .25 and 2 .4 kb , which differ at their 5 ends , while tumours with breakpoints within exon 1 or intron 1 alter c-myc mrnas (2 .1-2 .7 kb in burkitt lines) , which was #initiated within intron 1 .
tumours with breakpoints just 5 to exon 1 , or distant from c-myc , have normal c-myc mrnas of 2 .25 and 2 .4 kb , which differ at their 5 ends , while tumours with breakpoints within exon 1 or intron 1 alter c-myc mrnas that is able to be #initiated within intron 1 .
tumours with breakpoints just 5 to exon 1 , or distant from c-myc , have normal c-myc mrnas of 2 .25 and 2 .4 kb , which differ at their 5 ends , while tumours with breakpoints within exon 1 or intron 1 alter c-myc mrnas that is believed to be #initiated within intron 1 .
tumours with breakpoints just 5 to exon 1 , or distant from c-myc , have normal c-myc mrnas of 2 .25 and 2 .4 kb , which differ at their 5 ends , while tumours with breakpoints within exon 1 or intron 1 alter c-myc mrnas that may have been #initiated within intron 1 .
tumours with breakpoints just 5 to exon 1 , or distant from c-myc , have normal c-myc mrnas of 2 .25 and 2 .4 kb , which differ at their 5 ends , while tumours with breakpoints within exon 1 or intron 1 alter c-myc mrnas that was #initiated within intron 1 .
signal transduction can be #initiated by scf by direct dimerization of its receptor , kit ,and the two juxtaposed receptors undergo tyrosine autophosphorylation (heldin , 1995; broudy , 1997) , which #initiated downstream intracellular signaling .
signal transduction has been #initiated by scf by direct dimerization of its receptor , kit ,and the two juxtaposed receptors undergo tyrosine autophosphorylation (heldin , 1995; broudy , 1997) , which #initiated downstream intracellular signaling .
signal transduction is #initiated by scf by direct dimerization of its receptor , kit ,and the two juxtaposed receptors undergo tyrosine autophosphorylation (heldin , 1995; broudy , 1997) , which #initiated downstream intracellular signaling .
scf , like the other dimeric ligands , initates signal transduction by direct dimerization of its receptor , kit ,and the two juxtaposed receptors undergo tyrosine autophosphorylation (heldin , 1995; broudy , 1997) , which #initiates downstream intracellular signaling .
since rtks #initiate signaling by recruiting downstream components to the activated receptor , proteins that are immediately downstream of an activated rtk can be identified by first identifying sequences in the rtk that are necessary to activate downstream signaling (schlessinger and ullrich , 1992; pawson , 1995) .
sxl is a key regulator of sex determination and dosage compensation , whose transcription is #initiated only in female blastoderm embryos .
transcription of ptsg encoding glucose-specific permease , enzyme iicb (glc) , in escherichia coli is #initiated from two promoters , p1 and p2 .
transcription of the divergently transcribed glptq and glpacb operons is #initiated at sites separated by 132 base pairs (bp) of dna .
i kappa b-epsilon translation is #initiated from an internal atg codon to give rise to a protein of 45 kda , which exists as multiple phosphorylated isoforms in resting cells .
tumours with breakpoints just 5 to exon 1 , or distant from c-myc , had normal c-myc mrnas of 2 .25 and 2 .4 kb , which differ at their 5 ends , while tumours with breakpoints within exon 1 or intron 1 had altered c-myc mrnas (2 .1-2 .7 kb in burkitt lines) , #initiated within intron 1 .
i kappa b-epsilon translation can be #initiated from an internal atg codon at the g residue of the upstream gatc sequence .
i kappa b-epsilon translation has the ability to be #initiated from an internal atg codon at the g residue of the upstream gatc sequence .
i kappa b-epsilon translation will be #initiated from an internal atg codon at the g residue of the upstream gatc sequence .
ligand binding induced cell surface receptor complex formation and activates a cascade of phosphorylation events of intracellular intermediaries termed tyrosine autophosphorylation , which have #initiated downstream intracellular signaling .
ligand binding induces cell surface receptor complex formation and activates a cascade of phosphorylation events of intracellular intermediaries termed tyrosine autophosphorylation that may #initiate downstream intracellular signaling .
rtks are able to #initiate signaling by recruiting downstream components to the activated receptor , thereby raising cytosolic ca(2+) , [ca(2+)](i) .
rtks are believed to #initiate signaling by recruiting downstream components to the activated receptor , thereby raising cytosolic ca(2+) , [ca(2+)](i) .
rtks can #initiate signaling by recruiting downstream components to the activated receptor , thereby raising cytosolic ca(2+) , [ca(2+)](i) .
rtks have the ability to #initiate signaling by recruiting downstream components to the activated receptor , thereby raising cytosolic ca(2+) , [ca(2+)](i) .
rtks #initiated signaling by recruiting downstream components to the activated receptor , thereby raising cytosolic ca(2+) , [ca(2+)](i) .
rtks may have #initiated signaling by recruiting downstream components to the activated receptor , thereby raising cytosolic ca(2+) , [ca(2+)](i) .
rtks will #initiate signaling by recruiting downstream components to the activated receptor , thereby raising cytosolic ca(2+) , [ca(2+)](i) .
rtks , like the other dimeric ligands , have initated signaling recruiting downstream components to the activated receptor , kit ,and the two juxtaposed receptors undergo tyrosine autophosphorylation (heldin , 1995; broudy , 1997) , which #initiated downstream intracellular signaling .
rtks , like the other dimeric ligands , is able to initate signaling recruiting downstream components to the activated receptor , kit ,and the two juxtaposed receptors undergo tyrosine autophosphorylation (heldin , 1995; broudy , 1997) , which #initiated downstream intracellular signaling .
scf have the ability to #initiate signal transduction by by direct dimerization of its receptor , thereby raising cytosolic ca(2+) , [ca(2+)](i) .
scf #initiate signal transduction by by direct dimerization of its receptor , thereby raising cytosolic ca(2+) , [ca(2+)](i) .
scf #initiated signal transduction by by direct dimerization of its receptor , thereby raising cytosolic ca(2+) , [ca(2+)](i) .
scf may have #initiated signal transduction by by direct dimerization of its receptor , thereby raising cytosolic ca(2+) , [ca(2+)](i) .
scf will #initiate signal transduction by by direct dimerization of its receptor , thereby raising cytosolic ca(2+) , [ca(2+)](i) .
scf , like the other dimeric ligands , initates signal transduction by direct dimerization of its receptor , kit , and the two juxtaposed receptors undergo smads (heldin , 1995; broudy , 1997) , which #initiated transcriptional regulation .
scf , like the other dimeric ligands , initates signal transduction by direct dimerization of its receptor , kit , and the two juxtaposed receptors undergo smads (heldin , 1995; broudy , 1997) , which is able to #initiate transcriptional regulation .
since scf are #initiating signal transduction by by direct dimerization of its receptor , proteins that are immediately downstream of an activated rtk can be identified by first identifying sequences in the rtk that are necessary to activate downstream signaling (schlessinger and ullrich , 1992; pawson , 1995) .
since scf #initiate signal transduction by by direct dimerization of its receptor , proteins that are immediately downstream of an activated rtk can be identified by first identifying sequences in the rtk that are necessary to activate downstream signaling (schlessinger and ullrich , 1992; pawson , 1995) .
since scf is observed to #initiate signal transduction by by direct dimerization of its receptor , proteins that are immediately downstream of an activated rtk can be identified by first identifying sequences in the rtk that are necessary to activate downstream signaling (schlessinger and ullrich , 1992; pawson , 1995) .
since scf may have #initiated signal transduction by by direct dimerization of its receptor , proteins that are immediately downstream of an activated rtk can be identified by first identifying sequences in the rtk that are necessary to activate downstream signaling (schlessinger and ullrich , 1992; pawson , 1995) .
since scf will have #initiated signal transduction by by direct dimerization of its receptor , proteins that are immediately downstream of an activated rtk can be identified by first identifying sequences in the rtk that are necessary to activate downstream signaling (schlessinger and ullrich , 1992; pawson , 1995) .
since signal transduction can be #initiated by scf by by direct dimerization of its receptor , proteins that are immediately downstream of an activated rtk can be identified by first identifying sequences in the rtk that are necessary to activate downstream signaling (schlessinger and ullrich , 1992; pawson , 1995) .
since signal transduction is #initiated by scf by by direct dimerization of its receptor , proteins that are immediately downstream of an activated rtk can be identified by first identifying sequences in the rtk that are necessary to activate downstream signaling (schlessinger and ullrich , 1992; pawson , 1995) .
since signal transduction may be #initiated by scf by by direct dimerization of its receptor , proteins that are immediately downstream of an activated rtk can be identified by first identifying sequences in the rtk that are necessary to activate downstream signaling (schlessinger and ullrich , 1992; pawson , 1995) .
transcription being #initiated from a sigma (70)-dependent promoter gives rise to a protein of 45 kda , which existed as multiple phosphorylated isoforms in resting cells .
transcription has been #initiated from a sigma (70)-dependent promoter to give rise to a protein of 45 kda , which existed as multiple phosphorylated isoforms in resting cells .
transcription that is #initiated from a sigma (70)-dependent promoter gives rise to a protein of 45 kda , which existed as multiple phosphorylated isoforms in resting cells .
transcription was #initiated from a sigma (70)-dependent promoter to give rise to a protein of 45 kda , which existed as multiple phosphorylated isoforms in resting cells .
transcription which was #initiated from a sigma (70)-dependent promoter gives rise to a protein of 45 kda , which existed as multiple phosphorylated isoforms in resting cells .
downstream intracellular signaling is #initiated by tyrosine autophosphorylation , followed by phosphoryl group transfer to the regulator arca .
downstream intracellular signaling may have been #initiated by tyrosine autophosphorylation , followed by phosphoryl group transfer to the regulator arca .
transcriptional regulation could be #initiated by smads , followed by phosphoryl group transfer to the regulator arca .
transcriptional regulation has been #initiated by smads , followed by phosphoryl group transfer to the regulator arca .
transcriptional regulation is #initiated by smads , followed by phosphoryl group transfer to the regulator arca .
transcriptional regulation may have been #initiated by smads , followed by phosphoryl group transfer to the regulator arca .
ligand binding induced cell surface receptor complex formation and activates a cascade of phosphorylation events of intracellular intermediaries termed scf #initiating signal transduction .
ligand binding induced cell surface receptor complex formation and activates a cascade of phosphorylation events of intracellular intermediaries termed scf , which have #initiated signal transduction .
ligand binding induced cell surface receptor complex formation and activates a cascade of phosphorylation events of intracellular intermediaries termed scf , which #initiated signal transduction .
ligand binding induced cell surface receptor complex formation and activates a cascade of phosphorylation events of intracellular intermediaries termed scf , which may #initiate signal transduction .
ligand binding induced cell surface receptor complex formation and activates a cascade of phosphorylation events of intracellular intermediaries termed scf , which will #initiate signal transduction .
ligand binding induces cell surface receptor complex formation and activates a cascade of phosphorylation events of intracellular intermediaries termed scf that are observed to #initiate signal transduction .
ligand binding induces cell surface receptor complex formation and activates a cascade of phosphorylation events of intracellular intermediaries termed scf that have #initiated signal transduction .
scf , like the other dimeric ligands , initates signal transduction by direct dimerization of its receptor , kit , and the two juxtaposed receptors undergo scf (heldin , 1995; broudy , 1997) , which can #initiate signal transduction .
scf , like the other dimeric ligands , initates signal transduction by direct dimerization of its receptor , kit , and the two juxtaposed receptors undergo scf (heldin , 1995; broudy , 1997) , which has #initiated signal transduction .
scf , like the other dimeric ligands , initates signal transduction by direct dimerization of its receptor , kit , and the two juxtaposed receptors undergo scf (heldin , 1995; broudy , 1997) , which #initiated signal transduction .
scf , like the other dimeric ligands , initates signal transduction by direct dimerization of its receptor , kit , and the two juxtaposed receptors undergo scf (heldin , 1995; broudy , 1997) , which is able to #initiate signal transduction .
transcription of ptsg encoding glucose-specific permease can be #initiated from from two promoters , p1 and p2 at the g residue of the upstream gatc sequence .
transcription of ptsg encoding glucose-specific permease can be #initiated from from two promoters , p1 and p2 to give rise to a protein of 45 kda , which existed as multiple phosphorylated isoforms in resting cells .
transcription of ptsg encoding glucose-specific permease can be #initiated from two promoters , p1 and p2 at the g residue of the upstream gatc sequence .
transcription of ptsg encoding glucose-specific permease can be #initiated from two promoters , p1 and p2 to give rise to a protein of 45 kda , which existed as multiple phosphorylated isoforms in resting cells .
transcription of ptsg encoding glucose-specific permease has been #initiated from from two promoters , p1 and p2 at the g residue of the upstream gatc sequence .
transcription of ptsg encoding glucose-specific permease has been #initiated from from two promoters , p1 and p2 to give rise to a protein of 45 kda , which existed as multiple phosphorylated isoforms in resting cells .
transcription of ptsg encoding glucose-specific permease has been #initiated from two promoters , p1 and p2 to give rise to a protein of 45 kda , which existed as multiple phosphorylated isoforms in resting cells .
transcription of ptsg encoding glucose-specific permease has the ability to be #initiated from from two promoters , p1 and p2 at the g residue of the upstream gatc sequence .
transcription of ptsg encoding glucose-specific permease has the ability to be #initiated from two promoters , p1 and p2 at the g residue of the upstream gatc sequence .
transcription of ptsg encoding glucose-specific permease #initiated from from two promoters , p1 and p2 gives rise to a protein of 45 kda , which existed as multiple phosphorylated isoforms in resting cells .
transcription of ptsg encoding glucose-specific permease is able to be #initiated from from two promoters , p1 and p2 at the g residue of the upstream gatc sequence .
transcription of ptsg encoding glucose-specific permease is #initiated from from two promoters , p1 and p2 to give rise to a protein of 45 kda , which exists as multiple phosphorylated isoforms in resting cells .
transcription of ptsg encoding glucose-specific permease is observed to be #initiated from from two promoters , p1 and p2 to give rise to a protein of 45 kda , which existed as multiple phosphorylated isoforms in resting cells .
transcription of ptsg encoding glucose-specific permease is observed to be #initiated from two promoters , p1 and p2 to give rise to a protein of 45 kda , which existed as multiple phosphorylated isoforms in resting cells .
transcription of ptsg encoding glucose-specific permease may be #initiated from from two promoters , p1 and p2 to give rise to a protein of 45 kda , which existed as multiple phosphorylated isoforms in resting cells .
transcription of ptsg encoding glucose-specific permease may be #initiated from two promoters , p1 and p2 at the g residue of the upstream gatc sequence .
transcription of ptsg encoding glucose-specific permease may be #initiated from two promoters , p1 and p2 to give rise to a protein of 45 kda , which existed as multiple phosphorylated isoforms in resting cells .
transcription of ptsg encoding glucose-specific permease may have been #initiated from from two promoters , p1 and p2 at the g residue of the upstream gatc sequence .
transcription of ptsg encoding glucose-specific permease that is #initiated from from two promoters , p1 and p2 gives rise to a protein of 45 kda , which existed as multiple phosphorylated isoforms in resting cells .
transcription of ptsg encoding glucose-specific permease that is #initiated from two promoters , p1 and p2 gives rise to a protein of 45 kda , which existed as multiple phosphorylated isoforms in resting cells .
transcription of ptsg encoding glucose-specific permease was #initiated from two promoters , p1 and p2 at the g residue of the upstream gatc sequence .
transcription of ptsg encoding glucose-specific permease was #initiated from two promoters , p1 and p2 to give rise to a protein of 45 kda , which existed as multiple phosphorylated isoforms in resting cells .
transcription of ptsg encoding glucose-specific permease which has been #initiated from from two promoters , p1 and p2 gives rise to a protein of 45 kda , which existed as multiple phosphorylated isoforms in resting cells .
transcription of ptsg encoding glucose-specific permease which is #initiated from from two promoters , p1 and p2 gives rise to a protein of 45 kda , which existed as multiple phosphorylated isoforms in resting cells .
transcription of ptsg encoding glucose-specific permease which is #initiated from two promoters , p1 and p2 gives rise to a protein of 45 kda , which existed as multiple phosphorylated isoforms in resting cells .
transcription of ptsg encoding glucose-specific permease which was #initiated from two promoters , p1 and p2 gives rise to a protein of 45 kda , which existed as multiple phosphorylated isoforms in resting cells .
transcription of ptsg encoding glucose-specific permease will be #initiated from two promoters , p1 and p2 at the g residue of the upstream gatc sequence .
transcription of the divergently transcribed glptq and glpacb operons being #initiated from sites separated by 132 base pairs (bp) of dna gives rise to a protein of 45 kda , which existed as multiple phosphorylated isoforms in resting cells .
transcription of the divergently transcribed glptq and glpacb operons has been #initiated from sites separated by 132 base pairs (bp) of dna at the g residue of the upstream gatc sequence .
transcription of the divergently transcribed glptq and glpacb operons has been #initiated from sites separated by 132 base pairs (bp) of dna to give rise to a protein of 45 kda , which existed as multiple phosphorylated isoforms in resting cells .
transcription of the divergently transcribed glptq and glpacb operons has the ability to be #initiated from sites separated by 132 base pairs (bp) of dna at the g residue of the upstream gatc sequence .
transcription of the divergently transcribed glptq and glpacb operons is able to be #initiated from sites separated by 132 base pairs (bp) of dna at the g residue of the upstream gatc sequence .
transcription of the divergently transcribed glptq and glpacb operons is observed to be #initiated from sites separated by 132 base pairs (bp) of dna at the g residue of the upstream gatc sequence .
transcription of the divergently transcribed glptq and glpacb operons may be #initiated from sites separated by 132 base pairs (bp) of dna at the g residue of the upstream gatc sequence .
transcription of the divergently transcribed glptq and glpacb operons that is #initiated from sites separated by 132 base pairs (bp) of dna gives rise to a protein of 45 kda , which existed as multiple phosphorylated isoforms in resting cells .
transcription of the divergently transcribed glptq and glpacb operons was #initiated from sites separated by 132 base pairs (bp) of dna to give rise to a protein of 45 kda , which existed as multiple phosphorylated isoforms in resting cells .
transcription of the divergently transcribed glptq and glpacb operons which has been #initiated from sites separated by 132 base pairs (bp) of dna gives rise to a protein of 45 kda , which existed as multiple phosphorylated isoforms in resting cells .
transcription of the divergently transcribed glptq and glpacb operons which is #initiated from sites separated by 132 base pairs (bp) of dna gives rise to a protein of 45 kda , which existed as multiple phosphorylated isoforms in resting cells .
transcription of the divergently transcribed glptq and glpacb operons which may be #initiated from sites separated by 132 base pairs (bp) of dna to give rise to a protein of 45 kda , which existed as multiple phosphorylated isoforms in resting cells .
transcription of the divergently transcribed glptq and glpacb operons will be #initiated from sites separated by 132 base pairs (bp) of dna at the g residue of the upstream gatc sequence .
altered c-myc mrnas being #initiated from intron 1 gives rise to a protein of 45 kda , which existed as multiple phosphorylated isoforms in resting cells .
altered c-myc mrnas has been #initiated from intron 1 at the g residue of the upstream gatc sequence .
altered c-myc mrnas has the ability to be #initiated from intron 1 at the g residue of the upstream gatc sequence .
altered c-myc mrnas #initiated from intron 1 gives rise to a protein of 45 kda , which existed as multiple phosphorylated isoforms in resting cells .
altered c-myc mrnas may have been #initiated from intron 1 at the g residue of the upstream gatc sequence .
altered c-myc mrnas which has been #initiated from intron 1 gives rise to a protein of 45 kda , which existed as multiple phosphorylated isoforms in resting cells .
c-myc mrnas can be #initiated from intron 1 to give rise to a protein of 45 kda , which existed as multiple phosphorylated isoforms in resting cells .
c-myc mrnas has been #initiated from intron 1 at the g residue of the upstream gatc sequence .
c-myc mrnas has been #initiated from intron 1 to give rise to a protein of 45 kda , which existed as multiple phosphorylated isoforms in resting cells .
c-myc mrnas has the ability to be #initiated from intron 1 at the g residue of the upstream gatc sequence .
c-myc mrnas is #initiated from intron 1 at the g residue of the upstream gatc sequence .
c-myc mrnas is #initiated from intron 1 to give rise to a protein of 45 kda , which exists as multiple phosphorylated isoforms in resting cells .
c-myc mrnas is observed to be #initiated from intron 1 at the g residue of the upstream gatc sequence .
c-myc mrnas is observed to be #initiated from intron 1 to give rise to a protein of 45 kda , which existed as multiple phosphorylated isoforms in resting cells .
c-myc mrnas may be #initiated from intron 1 at the g residue of the upstream gatc sequence .
c-myc mrnas may have been #initiated from intron 1 at the g residue of the upstream gatc sequence .
c-myc mrnas which has been #initiated from intron 1 gives rise to a protein of 45 kda , which existed as multiple phosphorylated isoforms in resting cells .
c-myc mrnas which is #initiated from intron 1 gives rise to a protein of 45 kda , which existed as multiple phosphorylated isoforms in resting cells .
c-myc mrnas will be #initiated from intron 1 to give rise to a protein of 45 kda , which existed as multiple phosphorylated isoforms in resting cells .
signal transduction could be #initiated by scf , followed by phosphoryl group transfer to the regulator arca .
signal transduction has been #initiated by scf , followed by phosphoryl group transfer to the regulator arca .
signal transduction is able to be #initiated by scf , followed by phosphoryl group transfer to the regulator arca .
signal transduction is #initiated by scf , followed by phosphoryl group transfer to the regulator arca .
signal transduction is observed to be #initiated by scf , followed by phosphoryl group transfer to the regulator arca .
signal transduction may be #initiated by scf , followed by phosphoryl group transfer to the regulator arca .
signal transduction may have been #initiated by scf , followed by phosphoryl group transfer to the regulator arca .
signal transduction will be #initiated by scf , followed by phosphoryl group transfer to the regulator arca .
by direct sequencing of aberrant ssca conformers were revealed 15 different mutations in a total of 18 unrelated families and 13 single patients . of these , 10 were novel (7 missense mutations , 2 mutations that #lead to frameshift , and 1 mutation predicted to affect normal splicing) .
by direct sequencing of aberrant ssca conformers were revealed 15 different mutations in a total of 18 unrelated families and 13 single patients . of these , 10 were novel (7 missense mutations , 2 mutations that #led to frameshift , and 1 mutation predicted to affect normal splicing) .
by direct sequencing of aberrant ssca conformers were revealed 15 different mutations in a total of 18 unrelated families and 13 single patients . of these , 10 were novel (7 missense mutations , 2 mutations which #led to frameshift , and 1 mutation predicted to affect normal splicing) .
closer examination of the putative signal transduction pathway modulating htra transcription can #lead us to the identification of two new genes .
closer examination of the putative signal transduction pathway modulating htra transcription #leads us to the identification of two new genes .
closer examination of the putative signal transduction pathway modulating htra transcription #led us to the identification of two new genes .
closer examination of the putative signal transduction pathway modulating htra transcription will #lead us to the identification of two new genes .
cotransfection of gata-4 with mef2a , mef2c or mef2d can #lead to a synergistic 40-to 50-fold activation of the anf promoter (figure 3a) .
cotransfection of gata-4 with mef2a , mef2c or mef2d is able to #lead to a synergistic 40-to 50-fold activation of the anf promoter (figure 3a) .
cotransfection of gata-4 with mef2a , mef2c or mef2d #led to a synergistic 40-to 50-fold activation of the anf promoter (figure 3a) .
cotransfection of gata-4 with mef2a , mef2c or mef2d may #lead to a synergistic 40-to 50-fold activation of the anf promoter (figure 3a) .
in this homologous part of the genes , gpb lacks one exon due to a point mutation at the 5 splicing site of the third intron , which inactivated the 5 cleavage event of splicing and #led to ligation of the second to the fourth exon .
the mutations identified include: two frameshifts and a splice site mutation which have #led to truncated oa1 proteins; a deletion of a threonine codon at position 290; and four missense mutations , two of which involve amino acids located within putative transmembrane domains .
the splice mutation in 5 end of intron 5 can #lead to abnormal splice in exon 5 and exon 6 appears to be one of the causes of x-linked recessive adrenoleukodystrophy .
the splice mutation in 5 end of intron 5 has #led to abnormal splice in exon 5 and exon 6 appears to be one of the causes of x-linked recessive adrenoleukodystrophy .
this g:c base pair is also the strongest determinant in the sequence selection experiment #leading to the identification of the bre (lagrange et al . , 1998) .
this g:c base pair is also the strongest determinant in the sequence selection experiment which has #led to the identification of the bre (lagrange et al . , 1998) .
this has #led to a substantial diversity of nebulin and nebulette isoforms .
this is #leading to a substantial diversity of nebulin and nebulette isoforms .
this patients dna contains a c----a transversion in the splice acceptor sequence of the last intron of the only ercc-3 allele which can #lead to a 4 bp insertion in the mrna and an inactivating frameshift in the c-terminus of the protein .
this patients dna contains a c----a transversion in the splice acceptor sequence of the last intron of the only ercc-3 allele which #led to a 4 bp insertion in the mrna and an inactivating frameshift in the c-terminus of the protein .
this splice mutation in 5 end of intron 5 might has #led to abnormal splice in exon 5 and exon 6 and has brought about unstable and abnormal ald protein; the lignoceryl coa ligase could not transport very long chain fatty acids (vlcfa) into peroxisome and could not function normally; consequently , defective beta-oxidation of vlcfa in peroxisome could result in an accumulation of vlcfas in the central nervous system , adrenal gland and blood .
this splice mutation in 5 end of intron 5 might #led to abnormal splice in exon 5 and exon 6 and brought about unstable and abnormal ald protein; the lignoceryl coa ligase could not transport very long chain fatty acids (vlcfa) into peroxisome and could not function normally; consequently , defective beta-oxidation of vlcfa in peroxisome could result in an accumulation of vlcfas in the central nervous system , adrenal gland and blood .
this was caused by a point mutation (gtc----atc) at codon 383 that #led to the conservative substitution of isoleucine for valine in the putative fifth extracellular loop of the transporter .
this was caused by a point mutation (gtc----atc) at codon 383 which can #lead to the conservative substitution of isoleucine for valine in the putative fifth extracellular loop of the transporter .
this , in turn , #led to synergistic activation of the anf and other mef2 target promoters independently of the dna-binding activity of mef2 .
this , in turn , will #lead to synergistic activation of the anf and other mef2 target promoters independently of the dna-binding activity of mef2 .
we also studied in detail a complex splice site mutation , 3332dupl8bp , which #leads to an abnormal jag1 mrna , resulting in a premature stop codon .
we also studied in detail a complex splice site mutation , 3332dupl8bp , which #led to an abnormal jag1 mrna , resulting in a premature stop codon .
we also studied in detail a complex splice site mutation , 3332dupl8bp , which was found to #lead to an abnormal jag1 mrna , resulting in a premature stop codon .
we also study in detail a complex splice site mutation , 3332dupl8bp , which is believed to #lead to an abnormal jag1 mrna , resulting in a premature stop codon .
cotransfection of gata-4 with mef2a , mef2c or mef2d #leads to a synergistic 40-to 50-fold activation of the anf promoter (figure 3a) .
this g:c base pair is also the strongest determinant in the sequence selection experiment , which #led to the identification of the bre (lagrange et al . , 1998) .
this , in turn , #leads to synergistic activation of the anf and other mef2 target promoters independently of the dna-binding activity of mef2 .
in this homologous part of the genes , gpb lacks one exon due to a point mutation at the 5 splicing site of the third intron , which inactivates the 5 cleavage event of splicing and #leads to ligation of the second to the fourth exon .
the splice mutation in 5 end of intron 5 #leading to abnormal splice in exon 5 and exon 6 appears to be one of the causes of x-linked recessive adrenoleukodystrophy .
this patients dna contains a c----a transversion in the splice acceptor sequence of the last intron of the only ercc-3 allele that is detectably expressed , #leading to a 4 bp insertion in the mrna and an inactivating frameshift in the c-terminus of the protein .
this splice mutation in 5 end of intron 5 might #lead to abnormal splice in exon 5 and exon 6 and bring about unstable and abnormal ald protein; the lignoceryl coa ligase could not transport very long chain fatty acids (vlcfa) into peroxisome and could not function normally; consequently , defective beta-oxidation of vlcfa in peroxisome could result in an accumulation of vlcfas in the central nervous system , adrenal gland and blood .
this was caused by a point mutation (gtc----atc) at codon 383 , which #leads to the conservative substitution of isoleucine for valine in the putative fifth extracellular loop of the transporter .
we also studied in detail a complex splice site mutation , 3332dupl8bp , which was shown to #lead to an abnormal jag1 mrna , resulting in a premature stop codon .
7 missense mutations , 2 mutations can #lead to frameshift (figure 3a) .
7 missense mutations , 2 mutations can #lead to frameshift , an atypical form of tay-sachs disease (gm2 gangliosidosis variant ab) .
7 missense mutations , 2 mutations can #lead to frameshift .
7 missense mutations , 2 mutations can #lead us to frameshift .
7 missense mutations , 2 mutations has #led to frameshift (figure 3a) .
7 missense mutations , 2 mutations #leads to frameshift (figure 3a) .
7 missense mutations , 2 mutations #leads to frameshift , an atypical form of tay-sachs disease (gm2 gangliosidosis variant ab) .
7 missense mutations , 2 mutations #leads to frameshift .
7 missense mutations , 2 mutations #led to frameshift (figure 3a) .
7 missense mutations , 2 mutations #led to frameshift .
7 missense mutations , 2 mutations may #lead to frameshift (figure 3a) .
7 missense mutations , 2 mutations may #lead to frameshift .
7 missense mutations , 2 mutations that #leads to frameshift .
7 missense mutations , 2 mutations , but not a wild-type strain , #led to frameshift .
7 missense mutations , 2 mutations , in turn , is able to #lead to frameshift independently of the dna-binding activity of mef2 .
7 missense mutations , 2 mutations , in turn , is #leading to frameshift independently of the dna-binding activity of mef2 .
7 missense mutations , 2 mutations , in turn , #led to frameshift independently of the dna-binding activity of mef2 .
7 missense mutations , 2 mutations , in turn , will #lead to frameshift independently of the dna-binding activity of mef2 .
by direct sequencing of aberrant ssca conformers were revealed 15 different mutations in a total of 18 unrelated families and 13 single patients . of these , 10 were novel (closer examination of the putative signal transduction pathway modulating htra transcription #leading to the identification of two new genes , and 1 mutation predicted to affect normal splicing) .
by direct sequencing of aberrant ssca conformers were revealed 15 different mutations in a total of 18 unrelated families and 13 single patients . of these , 10 were novel (closer examination of the putative signal transduction pathway modulating htra transcription that #led to the identification of two new genes , and 1 mutation predicted to affect normal splicing) .
by direct sequencing of aberrant ssca conformers were revealed 15 different mutations in a total of 18 unrelated families and 13 single patients . of these , 10 were novel (cotransfection of gata-4 with mef2a , mef2c or mef2d #leading to a synergistic 40-to 50-fold activation of the anf promoter , and 1 mutation predicted to affect normal splicing) .
by direct sequencing of aberrant ssca conformers were revealed 15 different mutations in a total of 18 unrelated families and 13 single patients . of these , 10 were novel (cotransfection of gata-4 with mef2a , mef2c or mef2d that #lead to a synergistic 40-to 50-fold activation of the anf promoter , and 1 mutation predicted to affect normal splicing) .
by direct sequencing of aberrant ssca conformers were revealed 15 different mutations in a total of 18 unrelated families and 13 single patients . of these , 10 were novel (cotransfection of gata-4 with mef2a , mef2c or mef2d which #led to a synergistic 40-to 50-fold activation of the anf promoter , and 1 mutation predicted to affect normal splicing) .
by direct sequencing of aberrant ssca conformers were revealed 15 different mutations in a total of 18 unrelated families and 13 single patients . of these , 10 were novel (this that #lead to a substantial diversity of nebulin and nebulette isoforms , and 1 mutation predicted to affect normal splicing) .
by direct sequencing of aberrant ssca conformers were revealed 15 different mutations in a total of 18 unrelated families and 13 single patients . of these , 10 were novel (this that #led to a substantial diversity of nebulin and nebulette isoforms , and 1 mutation predicted to affect normal splicing) .
by direct sequencing of aberrant ssca conformers were revealed 15 different mutations in a total of 18 unrelated families and 13 single patients . of these , 10 were novel (this which #lead to synergistic activation of the anf and other mef2 target promoters , and 1 mutation predicted to affect normal splicing) .
by direct sequencing of aberrant ssca conformers were revealed 15 different mutations in a total of 18 unrelated families and 13 single patients . of these , 10 were novel (this which #led to synergistic activation of the anf and other mef2 target promoters , and 1 mutation predicted to affect normal splicing) .
by direct sequencing of aberrant ssca conformers were revealed 15 different mutations in a total of 18 unrelated families and 13 single patients . of these , 10 were novel (transduction of the mara region from a mar strain #leading to loss of ompf , and 1 mutation predicted to affect normal splicing) .
by direct sequencing of aberrant ssca conformers were revealed 15 different mutations in a total of 18 unrelated families and 13 single patients . of these , 10 were novel (transduction of the mara region from a mar strain that #led to loss of ompf , and 1 mutation predicted to affect normal splicing) .
by direct sequencing of aberrant ssca conformers were revealed 15 different mutations in a total of 18 unrelated families and 13 single patients . of these , 10 were novel (transduction of the mara region from a mar strain which #led to loss of ompf , and 1 mutation predicted to affect normal splicing) .
by direct sequencing of aberrant ssca conformers were revealed 15 different mutations in a total of 18 unrelated families and 13 single patients . of these , 10 were novel (a point mutation (gtc----atc) at codon 383 that #lead to the conservative substitution of isoleucine for valine in the putative fifth extracellular loop of the transporter , and 1 mutation predicted to affect normal splicing) .
by direct sequencing of aberrant ssca conformers were revealed 15 different mutations in a total of 18 unrelated families and 13 single patients . of these , 10 were novel (a point mutation (gtc----atc) at codon 383 that #led to the conservative substitution of isoleucine for valine in the putative fifth extracellular loop of the transporter , and 1 mutation predicted to affect normal splicing) .
by direct sequencing of aberrant ssca conformers were revealed 15 different mutations in a total of 18 unrelated families and 13 single patients . of these , 10 were novel (a point mutation (gtc----atc) at codon 383 which #lead to the conservative substitution of isoleucine for valine in the putative fifth extracellular loop of the transporter , and 1 mutation predicted to affect normal splicing) .
by direct sequencing of aberrant ssca conformers were revealed 15 different mutations in a total of 18 unrelated families and 13 single patients . of these , 10 were novel (a point mutation (gtc----atc) at codon 383 which #led to the conservative substitution of isoleucine for valine in the putative fifth extracellular loop of the transporter , and 1 mutation predicted to affect normal splicing) .
by direct sequencing of aberrant ssca conformers were revealed 15 different mutations in a total of 18 unrelated families and 13 single patients . of these , 10 were novel (the sequence selection experiment #leading to the identification of the bre , and 1 mutation predicted to affect normal splicing) .
by direct sequencing of aberrant ssca conformers were revealed 15 different mutations in a total of 18 unrelated families and 13 single patients . of these , 10 were novel (the sequence selection experiment that #lead to the identification of the bre , and 1 mutation predicted to affect normal splicing) .
by direct sequencing of aberrant ssca conformers were revealed 15 different mutations in a total of 18 unrelated families and 13 single patients . of these , 10 were novel (the sequence selection experiment that #led to the identification of the bre , and 1 mutation predicted to affect normal splicing) .
by direct sequencing of aberrant ssca conformers were revealed 15 different mutations in a total of 18 unrelated families and 13 single patients . of these , 10 were novel (the sequence selection experiment which #led to the identification of the bre , and 1 mutation predicted to affect normal splicing) .
closer examination of the putative signal transduction pathway modulating htra transcription can #lead to the identification of two new genes (figure 3a) .
closer examination of the putative signal transduction pathway modulating htra transcription can #lead to the identification of two new genes .
closer examination of the putative signal transduction pathway modulating htra transcription has #led to the identification of two new genes , an atypical form of tay-sachs disease (gm2 gangliosidosis variant ab) .
closer examination of the putative signal transduction pathway modulating htra transcription is #leading to the identification of two new genes .
closer examination of the putative signal transduction pathway modulating htra transcription #lead to the identification of two new genes .
closer examination of the putative signal transduction pathway modulating htra transcription #leads to the identification of two new genes (figure 3a) .
closer examination of the putative signal transduction pathway modulating htra transcription #leads to the identification of two new genes , an atypical form of tay-sachs disease (gm2 gangliosidosis variant ab) .
closer examination of the putative signal transduction pathway modulating htra transcription #leads to the identification of two new genes .
closer examination of the putative signal transduction pathway modulating htra transcription #led to the identification of two new genes , an atypical form of tay-sachs disease (gm2 gangliosidosis variant ab) .
closer examination of the putative signal transduction pathway modulating htra transcription #led to the identification of two new genes .
closer examination of the putative signal transduction pathway modulating htra transcription that #leads to the identification of two new genes .
closer examination of the putative signal transduction pathway modulating htra transcription , in turn , has #led to the identification of two new genes independently of the dna-binding activity of mef2 .
closer examination of the putative signal transduction pathway modulating htra transcription , in turn , is able to #lead to the identification of two new genes independently of the dna-binding activity of mef2 .
closer examination of the putative signal transduction pathway modulating htra transcription , in turn , is #leading to the identification of two new genes independently of the dna-binding activity of mef2 .
closer examination of the putative signal transduction pathway modulating htra transcription , in turn , #led to the identification of two new genes independently of the dna-binding activity of mef2 .
cotransfection of gata-4 with mef2a , mef2c or mef2d has #led to a synergistic 40-to 50-fold activation of the anf promoter , an atypical form of tay-sachs disease (gm2 gangliosidosis variant ab) .
cotransfection of gata-4 with mef2a , mef2c or mef2d has #led to a synergistic 40-to 50-fold activation of the anf promoter .
cotransfection of gata-4 with mef2a , mef2c or mef2d #lead to a synergistic 40-to 50-fold activation of the anf promoter .
cotransfection of gata-4 with mef2a , mef2c or mef2d #leads to a synergistic 40-to 50-fold activation of the anf promoter , an atypical form of tay-sachs disease (gm2 gangliosidosis variant ab) .
cotransfection of gata-4 with mef2a , mef2c or mef2d #led to a synergistic 40-to 50-fold activation of the anf promoter .
cotransfection of gata-4 with mef2a , mef2c or mef2d may #lead to a synergistic 40-to 50-fold activation of the anf promoter .
cotransfection of gata-4 with mef2a , mef2c or mef2d that #leads to a synergistic 40-to 50-fold activation of the anf promoter .
cotransfection of gata-4 with mef2a , mef2c or mef2d , but not a wild-type strain , #led to a synergistic 40-to 50-fold activation of the anf promoter .
cotransfection of gata-4 with mef2a , mef2c or mef2d , in turn , is able to #lead to a synergistic 40-to 50-fold activation of the anf promoter independently of the dna-binding activity of mef2 .
cotransfection of gata-4 with mef2a , mef2c or mef2d , in turn , will #lead to a synergistic 40-to 50-fold activation of the anf promoter independently of the dna-binding activity of mef2 .
further , experiments with an antisense-ref cdna expression vector introduced into cultured cells suggested that 7 missense mutations , 2 mutations could #lead to frameshift .
further , experiments with an antisense-ref cdna expression vector introduced into cultured cells suggested that 7 missense mutations , 2 mutations had #led to frameshift .
further , experiments with an antisense-ref cdna expression vector introduced into cultured cells suggested that 7 missense mutations , 2 mutations #led to frameshift .
further , experiments with an antisense-ref cdna expression vector introduced into cultured cells suggested that closer examination of the putative signal transduction pathway modulating htra transcription #led to the identification of two new genes .
further , experiments with an antisense-ref cdna expression vector introduced into cultured cells suggested that closer examination of the putative signal transduction pathway modulating htra transcription was able to #lead to the identification of two new genes .
further , experiments with an antisense-ref cdna expression vector introduced into cultured cells suggested that cotransfection of gata-4 with mef2a , mef2c or mef2d had #led to a synergistic 40-to 50-fold activation of the anf promoter .
further , experiments with an antisense-ref cdna expression vector introduced into cultured cells suggested that cotransfection of gata-4 with mef2a , mef2c or mef2d #led to a synergistic 40-to 50-fold activation of the anf promoter .
further , experiments with an antisense-ref cdna expression vector introduced into cultured cells suggested that this could #lead to a substantial diversity of nebulin and nebulette isoforms .
further , experiments with an antisense-ref cdna expression vector introduced into cultured cells suggested that this could #lead to synergistic activation of the anf and other mef2 target promoters .
further , experiments with an antisense-ref cdna expression vector introduced into cultured cells suggested that this was able to #lead to synergistic activation of the anf and other mef2 target promoters .
further , experiments with an antisense-ref cdna expression vector introduced into cultured cells suggested that transduction of the mara region from a mar strain was able to #lead to loss of ompf .
further , experiments with an antisense-ref cdna expression vector introduced into cultured cells suggested that a point mutation (gtc----atc) at codon 383 could #lead to the conservative substitution of isoleucine for valine in the putative fifth extracellular loop of the transporter .
further , experiments with an antisense-ref cdna expression vector introduced into cultured cells suggested that a point mutation (gtc----atc) at codon 383 #led to the conservative substitution of isoleucine for valine in the putative fifth extracellular loop of the transporter .
further , experiments with an antisense-ref cdna expression vector introduced into cultured cells suggested that a point mutation (gtc----atc) at codon 383 was able to #lead to the conservative substitution of isoleucine for valine in the putative fifth extracellular loop of the transporter .
further , experiments with an antisense-ref cdna expression vector introduced into cultured cells suggested that the sequence selection experiment #led to the identification of the bre .
further , experiments with an antisense-ref cdna expression vector introduced into cultured cells suggested that the sequence selection experiment was able to #lead to the identification of the bre .
further , experiments with an antisense-ref cdna expression vector introduced into cultured cells suggests that 7 missense mutations , 2 mutations is able to #lead to frameshift .
further , experiments with an antisense-ref cdna expression vector introduced into cultured cells suggests that closer examination of the putative signal transduction pathway modulating htra transcription is able to #lead to the identification of two new genes .
further , experiments with an antisense-ref cdna expression vector introduced into cultured cells suggests that this is able to #lead to a substantial diversity of nebulin and nebulette isoforms .
further , experiments with an antisense-ref cdna expression vector introduced into cultured cells suggests that this is able to #lead to synergistic activation of the anf and other mef2 target promoters .
further , experiments with an antisense-ref cdna expression vector introduced into cultured cells suggests that this #leads to a substantial diversity of nebulin and nebulette isoforms .
further , experiments with an antisense-ref cdna expression vector introduced into cultured cells suggests that transduction of the mara region from a mar strain is able to #lead to loss of ompf .
further , experiments with an antisense-ref cdna expression vector introduced into cultured cells suggests that a point mutation (gtc----atc) at codon 383 is able to #lead to the conservative substitution of isoleucine for valine in the putative fifth extracellular loop of the transporter .
further , experiments with an antisense-ref cdna expression vector introduced into cultured cells suggests that a point mutation (gtc----atc) at codon 383 #leads to the conservative substitution of isoleucine for valine in the putative fifth extracellular loop of the transporter .
it has been shown that this , #leading to a substantial diversity of nebulin and nebulette isoforms .
it has been shown that the sequence selection experiment , #leading to the identification of the bre .
these data suggest that 7 missense mutations , 2 mutations can #lead to frameshift that functions to stimulate phosphorylation and clustering of achrs .
these data suggest that 7 missense mutations , 2 mutations #leads to frameshift that functions to stimulate phosphorylation and clustering of achrs .
these data suggest that closer examination of the putative signal transduction pathway modulating htra transcription can #lead to the identification of two new genes that functions to stimulate phosphorylation and clustering of achrs .
these data suggest that closer examination of the putative signal transduction pathway modulating htra transcription has #led to the identification of two new genes that functions to stimulate phosphorylation and clustering of achrs .
these data suggest that cotransfection of gata-4 with mef2a , mef2c or mef2d has #led to a synergistic 40-to 50-fold activation of the anf promoter that functions to stimulate phosphorylation and clustering of achrs .
these data suggest that cotransfection of gata-4 with mef2a , mef2c or mef2d #leads to a synergistic 40-to 50-fold activation of the anf promoter that functions to stimulate phosphorylation and clustering of achrs .
these data suggest that this #leads to a substantial diversity of nebulin and nebulette isoforms that functions to stimulate phosphorylation and clustering of achrs .
these data suggest that this #leads to synergistic activation of the anf and other mef2 target promoters that functions to stimulate phosphorylation and clustering of achrs .
these data suggest that this will #lead to synergistic activation of the anf and other mef2 target promoters that functions to stimulate phosphorylation and clustering of achrs .
these data suggest that transduction of the mara region from a mar strain has #led to loss of ompf that functions to stimulate phosphorylation and clustering of achrs .
these data suggest that transduction of the mara region from a mar strain #leads to loss of ompf that functions to stimulate phosphorylation and clustering of achrs .
these data suggest that a point mutation (gtc----atc) at codon 383 can #lead to the conservative substitution of isoleucine for valine in the putative fifth extracellular loop of the transporter that functions to stimulate phosphorylation and clustering of achrs .
these data suggest that a point mutation (gtc----atc) at codon 383 will #lead to the conservative substitution of isoleucine for valine in the putative fifth extracellular loop of the transporter that functions to stimulate phosphorylation and clustering of achrs .
these data suggest that the sequence selection experiment can #lead to the identification of the bre that functions to stimulate phosphorylation and clustering of achrs .
these data suggest that the sequence selection experiment has #led to the identification of the bre that functions to stimulate phosphorylation and clustering of achrs .
these data suggest that the sequence selection experiment #leads to the identification of the bre that functions to stimulate phosphorylation and clustering of achrs .
these data suggested that 7 missense mutations , 2 mutations was able to #lead to frameshift that functions to stimulate phosphorylation and clustering of achrs .
these data suggested that closer examination of the putative signal transduction pathway modulating htra transcription was able to #lead to the identification of two new genes that functions to stimulate phosphorylation and clustering of achrs .
these data suggested that cotransfection of gata-4 with mef2a , mef2c or mef2d was able to #lead to a synergistic 40-to 50-fold activation of the anf promoter that functions to stimulate phosphorylation and clustering of achrs .
these data suggested that this #led to a substantial diversity of nebulin and nebulette isoforms that functions to stimulate phosphorylation and clustering of achrs .
these data suggested that this #led to synergistic activation of the anf and other mef2 target promoters that functions to stimulate phosphorylation and clustering of achrs .
these data suggested that this was able to #lead to a substantial diversity of nebulin and nebulette isoforms that functions to stimulate phosphorylation and clustering of achrs .
these data suggested that this was able to #lead to synergistic activation of the anf and other mef2 target promoters that functions to stimulate phosphorylation and clustering of achrs .
these data suggested that transduction of the mara region from a mar strain #led to loss of ompf that functions to stimulate phosphorylation and clustering of achrs .
these data suggested that transduction of the mara region from a mar strain was able to #lead to loss of ompf that functions to stimulate phosphorylation and clustering of achrs .
these data suggested that the sequence selection experiment was able to #lead to the identification of the bre that functions to stimulate phosphorylation and clustering of achrs .
this g:c base pair is also the strongest determinant in 7 missense mutations , 2 mutations that #leads to frameshift (lagrange et al . , 1998) .
this g:c base pair is also the strongest determinant in 7 missense mutations , 2 mutations which has #led to frameshift (lagrange et al . , 1998) .
this g:c base pair is also the strongest determinant in 7 missense mutations , 2 mutations which #leads to frameshift (lagrange et al . , 1998) .
this g:c base pair is also the strongest determinant in 7 missense mutations , 2 mutations , which #led to frameshift (lagrange et al . , 1998) .
this g:c base pair is also the strongest determinant in closer examination of the putative signal transduction pathway modulating htra transcription #leading to the identification of two new genes (lagrange et al . , 1998) .
this g:c base pair is also the strongest determinant in closer examination of the putative signal transduction pathway modulating htra transcription which has #led to the identification of two new genes (lagrange et al . , 1998) .
this g:c base pair is also the strongest determinant in closer examination of the putative signal transduction pathway modulating htra transcription which #leads to the identification of two new genes (lagrange et al . , 1998) .
this g:c base pair is also the strongest determinant in closer examination of the putative signal transduction pathway modulating htra transcription which #led to the identification of two new genes (lagrange et al . , 1998) .
this g:c base pair is also the strongest determinant in closer examination of the putative signal transduction pathway modulating htra transcription , which #led to the identification of two new genes (lagrange et al . , 1998) .
this g:c base pair is also the strongest determinant in cotransfection of gata-4 with mef2a , mef2c or mef2d #leading to a synergistic 40-to 50-fold activation of the anf promoter (lagrange et al . , 1998) .
this g:c base pair is also the strongest determinant in cotransfection of gata-4 with mef2a , mef2c or mef2d which has #led to a synergistic 40-to 50-fold activation of the anf promoter (lagrange et al . , 1998) .
this g:c base pair is also the strongest determinant in cotransfection of gata-4 with mef2a , mef2c or mef2d which #leads to a synergistic 40-to 50-fold activation of the anf promoter (lagrange et al . , 1998) .
this g:c base pair is also the strongest determinant in cotransfection of gata-4 with mef2a , mef2c or mef2d which #led to a synergistic 40-to 50-fold activation of the anf promoter (lagrange et al . , 1998) .
this g:c base pair is also the strongest determinant in this #leading to a substantial diversity of nebulin and nebulette isoforms (lagrange et al . , 1998) .
this g:c base pair is also the strongest determinant in this #leading to synergistic activation of the anf and other mef2 target promoters (lagrange et al . , 1998) .
this g:c base pair is also the strongest determinant in this which has #led to a substantial diversity of nebulin and nebulette isoforms (lagrange et al . , 1998) .
this g:c base pair is also the strongest determinant in this which has #led to synergistic activation of the anf and other mef2 target promoters (lagrange et al . , 1998) .
this g:c base pair is also the strongest determinant in this which #leads to a substantial diversity of nebulin and nebulette isoforms (lagrange et al . , 1998) .
this g:c base pair is also the strongest determinant in this which #led to a substantial diversity of nebulin and nebulette isoforms (lagrange et al . , 1998) .
this g:c base pair is also the strongest determinant in this which #led to synergistic activation of the anf and other mef2 target promoters (lagrange et al . , 1998) .
this g:c base pair is also the strongest determinant in this , which #led to synergistic activation of the anf and other mef2 target promoters (lagrange et al . , 1998) .
this g:c base pair is also the strongest determinant in transduction of the mara region from a mar strain that #leads to loss of ompf (lagrange et al . , 1998) .
this g:c base pair is also the strongest determinant in transduction of the mara region from a mar strain which has #led to loss of ompf (lagrange et al . , 1998) .
this g:c base pair is also the strongest determinant in transduction of the mara region from a mar strain which #led to loss of ompf (lagrange et al . , 1998) .
this g:c base pair is also the strongest determinant in transduction of the mara region from a mar strain , which #led to loss of ompf (lagrange et al . , 1998) .
this g:c base pair is also the strongest determinant in a point mutation (gtc----atc) at codon 383 which has #led to the conservative substitution of isoleucine for valine in the putative fifth extracellular loop of the transporter (lagrange et al . , 1998) .
this g:c base pair is also the strongest determinant in a point mutation (gtc----atc) at codon 383 which #led to the conservative substitution of isoleucine for valine in the putative fifth extracellular loop of the transporter (lagrange et al . , 1998) .
this can #lead to a substantial diversity of nebulin and nebulette isoforms (figure 3a) .
this can #lead to a substantial diversity of nebulin and nebulette isoforms , an atypical form of tay-sachs disease (gm2 gangliosidosis variant ab) .
this can #lead us to a substantial diversity of nebulin and nebulette isoforms .
this can #lead us to synergistic activation of the anf and other mef2 target promoters .
this has #led to a substantial diversity of nebulin and nebulette isoforms (figure 3a) .
this has #led to synergistic activation of the anf and other mef2 target promoters , an atypical form of tay-sachs disease (gm2 gangliosidosis variant ab) .
this has #led to synergistic activation of the anf and other mef2 target promoters .
this has #led us to synergistic activation of the anf and other mef2 target promoters .
this is able to #lead to a substantial diversity of nebulin and nebulette isoforms (figure 3a) .
this is able to #lead to synergistic activation of the anf and other mef2 target promoters (figure 3a) .
this is #leading to synergistic activation of the anf and other mef2 target promoters .
this #leads to a substantial diversity of nebulin and nebulette isoforms (figure 3a) .
this #leads us to synergistic activation of the anf and other mef2 target promoters .
this #led to a substantial diversity of nebulin and nebulette isoforms (figure 3a) .
this #led to synergistic activation of the anf and other mef2 target promoters (figure 3a) .
this #led to synergistic activation of the anf and other mef2 target promoters , an atypical form of tay-sachs disease (gm2 gangliosidosis variant ab) .
this #led us to a substantial diversity of nebulin and nebulette isoforms .
this may #lead to synergistic activation of the anf and other mef2 target promoters (figure 3a) .
this may #lead to synergistic activation of the anf and other mef2 target promoters .
this was caused by 7 missense mutations , 2 mutations #leading to frameshift .
this was caused by 7 missense mutations , 2 mutations that #led to frameshift .
this was caused by 7 missense mutations , 2 mutations which can #lead to frameshift .
this was caused by 7 missense mutations , 2 mutations , which #leads to frameshift .
this was caused by closer examination of the putative signal transduction pathway modulating htra transcription #leading to the identification of two new genes .
this was caused by closer examination of the putative signal transduction pathway modulating htra transcription that #leads to the identification of two new genes .
this was caused by closer examination of the putative signal transduction pathway modulating htra transcription that #led to the identification of two new genes .
this was caused by cotransfection of gata-4 with mef2a , mef2c or mef2d #leading to a synergistic 40-to 50-fold activation of the anf promoter .
this was caused by cotransfection of gata-4 with mef2a , mef2c or mef2d that #leads to a synergistic 40-to 50-fold activation of the anf promoter .
this was caused by cotransfection of gata-4 with mef2a , mef2c or mef2d that #led to a synergistic 40-to 50-fold activation of the anf promoter .
this was caused by this that #leads to a substantial diversity of nebulin and nebulette isoforms .
this was caused by this that #leads to synergistic activation of the anf and other mef2 target promoters .
this was caused by this that #led to a substantial diversity of nebulin and nebulette isoforms .
this was caused by this which can #lead to synergistic activation of the anf and other mef2 target promoters .
this was caused by this which has #led to synergistic activation of the anf and other mef2 target promoters .
this was caused by this , which #leads to a substantial diversity of nebulin and nebulette isoforms .
this was caused by this , which #leads to synergistic activation of the anf and other mef2 target promoters .
this was caused by transduction of the mara region from a mar strain #leading to loss of ompf .
this was caused by transduction of the mara region from a mar strain that #leads to loss of ompf .
this was caused by transduction of the mara region from a mar strain that #led to loss of ompf .
this was caused by transduction of the mara region from a mar strain which can #lead to loss of ompf .
this was caused by transduction of the mara region from a mar strain , which #leads to loss of ompf .
this was caused by the sequence selection experiment which has #led to the identification of the bre .
this , but not a wild-type strain , #led to synergistic activation of the anf and other mef2 target promoters .
this , in turn , is able to #lead to a substantial diversity of nebulin and nebulette isoforms independently of the dna-binding activity of mef2 .
this , in turn , is #leading to a substantial diversity of nebulin and nebulette isoforms independently of the dna-binding activity of mef2 .
this , in turn , #leads to a substantial diversity of nebulin and nebulette isoforms independently of the dna-binding activity of mef2 .
this , in turn , will #lead to a substantial diversity of nebulin and nebulette isoforms independently of the dna-binding activity of mef2 .
transduction of the mara region from a mar strain can #lead to loss of ompf (figure 3a) .
transduction of the mara region from a mar strain can #lead to loss of ompf , an atypical form of tay-sachs disease (gm2 gangliosidosis variant ab) .
transduction of the mara region from a mar strain can #lead us to loss of ompf .
transduction of the mara region from a mar strain has #led to loss of ompf , an atypical form of tay-sachs disease (gm2 gangliosidosis variant ab) .
transduction of the mara region from a mar strain has #led us to loss of ompf .
transduction of the mara region from a mar strain is able to #lead to loss of ompf (figure 3a) .
transduction of the mara region from a mar strain is #leading to loss of ompf , an atypical form of tay-sachs disease (gm2 gangliosidosis variant ab) .
transduction of the mara region from a mar strain is #leading to loss of ompf .
transduction of the mara region from a mar strain #lead to loss of ompf .
transduction of the mara region from a mar strain #led to loss of ompf (figure 3a) .
transduction of the mara region from a mar strain #led us to loss of ompf .
transduction of the mara region from a mar strain that #leads to loss of ompf .
transduction of the mara region from a mar strain will #lead us to loss of ompf .
transduction of the mara region from a mar strain , in turn , has #led to loss of ompf independently of the dna-binding activity of mef2 .
transduction of the mara region from a mar strain , in turn , is #leading to loss of ompf independently of the dna-binding activity of mef2 .
transduction of the mara region from a mar strain , in turn , #led to loss of ompf independently of the dna-binding activity of mef2 .
a point mutation (gtc----atc) at codon 383 can #lead to the conservative substitution of isoleucine for valine in the putative fifth extracellular loop of the transporter (figure 3a) .
a point mutation (gtc----atc) at codon 383 can #lead to the conservative substitution of isoleucine for valine in the putative fifth extracellular loop of the transporter , an atypical form of tay-sachs disease (gm2 gangliosidosis variant ab) .
a point mutation (gtc----atc) at codon 383 can #lead us to the conservative substitution of isoleucine for valine in the putative fifth extracellular loop of the transporter .
a point mutation (gtc----atc) at codon 383 has #led to the conservative substitution of isoleucine for valine in the putative fifth extracellular loop of the transporter (figure 3a) .
a point mutation (gtc----atc) at codon 383 has #led to the conservative substitution of isoleucine for valine in the putative fifth extracellular loop of the transporter .
a point mutation (gtc----atc) at codon 383 has #led us to the conservative substitution of isoleucine for valine in the putative fifth extracellular loop of the transporter .
a point mutation (gtc----atc) at codon 383 #leads to the conservative substitution of isoleucine for valine in the putative fifth extracellular loop of the transporter (figure 3a) .
a point mutation (gtc----atc) at codon 383 #leads to the conservative substitution of isoleucine for valine in the putative fifth extracellular loop of the transporter , an atypical form of tay-sachs disease (gm2 gangliosidosis variant ab) .
a point mutation (gtc----atc) at codon 383 #led to the conservative substitution of isoleucine for valine in the putative fifth extracellular loop of the transporter .
a point mutation (gtc----atc) at codon 383 #led us to the conservative substitution of isoleucine for valine in the putative fifth extracellular loop of the transporter .
a point mutation (gtc----atc) at codon 383 will #lead us to the conservative substitution of isoleucine for valine in the putative fifth extracellular loop of the transporter .
a point mutation (gtc----atc) at codon 383 , but not a wild-type strain , #led to the conservative substitution of isoleucine for valine in the putative fifth extracellular loop of the transporter .
a point mutation (gtc----atc) at codon 383 , in turn , has #led to the conservative substitution of isoleucine for valine in the putative fifth extracellular loop of the transporter independently of the dna-binding activity of mef2 .
a point mutation (gtc----atc) at codon 383 , in turn , is able to #lead to the conservative substitution of isoleucine for valine in the putative fifth extracellular loop of the transporter independently of the dna-binding activity of mef2 .
a point mutation (gtc----atc) at codon 383 , in turn , #leads to the conservative substitution of isoleucine for valine in the putative fifth extracellular loop of the transporter independently of the dna-binding activity of mef2 .
a point mutation (gtc----atc) at codon 383 , in turn , will #lead to the conservative substitution of isoleucine for valine in the putative fifth extracellular loop of the transporter independently of the dna-binding activity of mef2 .
synergistic activation of the anf and other mef2 target promoters is #led to by this .
the identification of the bre is #led to by the sequence selection experiment .
the identification of two new genes is #led to by closer examination of the putative signal transduction pathway modulating htra transcription .
the sequence selection experiment can #lead to the identification of the bre , an atypical form of tay-sachs disease (gm2 gangliosidosis variant ab) .
the sequence selection experiment has #led to the identification of the bre .
the sequence selection experiment is #leading to the identification of the bre , an atypical form of tay-sachs disease (gm2 gangliosidosis variant ab) .
the sequence selection experiment is #leading to the identification of the bre .
the sequence selection experiment #leads to the identification of the bre (figure 3a) .
the sequence selection experiment #leads to the identification of the bre , an atypical form of tay-sachs disease (gm2 gangliosidosis variant ab) .
the sequence selection experiment #leads us to the identification of the bre .
the sequence selection experiment #led to the identification of the bre (figure 3a) .
the sequence selection experiment #led to the identification of the bre , an atypical form of tay-sachs disease (gm2 gangliosidosis variant ab) .
the sequence selection experiment #led us to the identification of the bre .
the sequence selection experiment will #lead us to the identification of the bre .
the sequence selection experiment , in turn , has #led to the identification of the bre independently of the dna-binding activity of mef2 .
the sequence selection experiment , in turn , will #lead to the identification of the bre independently of the dna-binding activity of mef2 .
by direct sequencing of aberrant ssca conformers were revealed 15 different mutations in a total of 18 unrelated families and 13 single patients . of these , 10 were novel (the splice mutation in 5 end of intron 5 that #lead to abnormal splice in exon 5 and exon 6 , and 1 mutation predicted to affect normal splicing) .
by direct sequencing of aberrant ssca conformers were revealed 15 different mutations in a total of 18 unrelated families and 13 single patients . of these , 10 were novel (the splice mutation in 5 end of intron 5 that #led to abnormal splice in exon 5 and exon 6 , and 1 mutation predicted to affect normal splicing) .
by direct sequencing of aberrant ssca conformers were revealed 15 different mutations in a total of 18 unrelated families and 13 single patients . of these , 10 were novel (this splice mutation in 5 end of intron 5 #leading to abnormal splice in exon 5 and exon 6 , and 1 mutation predicted to affect normal splicing) .
by direct sequencing of aberrant ssca conformers were revealed 15 different mutations in a total of 18 unrelated families and 13 single patients . of these , 10 were novel (this splice mutation in 5 end of intron 5 that #led to abnormal splice in exon 5 and exon 6 , and 1 mutation predicted to affect normal splicing) .
by direct sequencing of aberrant ssca conformers were revealed 15 different mutations in a total of 18 unrelated families and 13 single patients . of these , 10 were novel (this splice mutation in 5 end of intron 5 which #led to abnormal splice in exon 5 and exon 6 , and 1 mutation predicted to affect normal splicing) .
by direct sequencing of aberrant ssca conformers were revealed 15 different mutations in a total of 18 unrelated families and 13 single patients . of these , 10 were novel (a c----a transversion in the splice acceptor sequence of the last intron of the only ercc-3 allele #leading to a 4 bp insertion in the mrna and an inactivating frameshift in the c-terminus of the protein , and 1 mutation predicted to affect normal splicing) .
by direct sequencing of aberrant ssca conformers were revealed 15 different mutations in a total of 18 unrelated families and 13 single patients . of these , 10 were novel (a c----a transversion in the splice acceptor sequence of the last intron of the only ercc-3 allele that #led to a 4 bp insertion in the mrna and an inactivating frameshift in the c-terminus of the protein , and 1 mutation predicted to affect normal splicing) .
by direct sequencing of aberrant ssca conformers were revealed 15 different mutations in a total of 18 unrelated families and 13 single patients . of these , 10 were novel (a c----a transversion in the splice acceptor sequence of the last intron of the only ercc-3 allele which #lead to a 4 bp insertion in the mrna and an inactivating frameshift in the c-terminus of the protein , and 1 mutation predicted to affect normal splicing) .
by direct sequencing of aberrant ssca conformers were revealed 15 different mutations in a total of 18 unrelated families and 13 single patients . of these , 10 were novel (a c----a transversion in the splice acceptor sequence of the last intron of the only ercc-3 allele which #led to a 4 bp insertion in the mrna and an inactivating frameshift in the c-terminus of the protein , and 1 mutation predicted to affect normal splicing) .
by direct sequencing of aberrant ssca conformers were revealed 15 different mutations in a total of 18 unrelated families and 13 single patients . of these , 10 were novel (a complex splice site mutation that #lead to an abnormal jag1 mrna , resulting in a premature stop codon , and 1 mutation predicted to affect normal splicing) .
by direct sequencing of aberrant ssca conformers were revealed 15 different mutations in a total of 18 unrelated families and 13 single patients . of these , 10 were novel (a complex splice site mutation that #led to an abnormal jag1 mrna , resulting in a premature stop codon , and 1 mutation predicted to affect normal splicing) .
by direct sequencing of aberrant ssca conformers were revealed 15 different mutations in a total of 18 unrelated families and 13 single patients . of these , 10 were novel (a complex splice site mutation which #led to an abnormal jag1 mrna , resulting in a premature stop codon , and 1 mutation predicted to affect normal splicing) .
by direct sequencing of aberrant ssca conformers were revealed 15 different mutations in a total of 18 unrelated families and 13 single patients . of these , 10 were novel (a point mutation at the 5 splicing site of the third intron that #led to ligation of the second to the fourth exon , and 1 mutation predicted to affect normal splicing) .
by direct sequencing of aberrant ssca conformers were revealed 15 different mutations in a total of 18 unrelated families and 13 single patients . of these , 10 were novel (a point mutation at the 5 splicing site of the third intron which #lead to ligation of the second to the fourth exon , and 1 mutation predicted to affect normal splicing) .
by direct sequencing of aberrant ssca conformers were revealed 15 different mutations in a total of 18 unrelated families and 13 single patients . of these , 10 were novel (two frameshifts and a splice site mutation #leading to truncated oa1 proteins; a deletion of a threonine codon at position 290; and four missense mutations , and 1 mutation predicted to affect normal splicing) .
by direct sequencing of aberrant ssca conformers were revealed 15 different mutations in a total of 18 unrelated families and 13 single patients . of these , 10 were novel (two frameshifts and a splice site mutation that #led to truncated oa1 proteins; a deletion of a threonine codon at position 290; and four missense mutations , and 1 mutation predicted to affect normal splicing) .
by direct sequencing of aberrant ssca conformers were revealed 15 different mutations in a total of 18 unrelated families and 13 single patients . of these , 10 were novel (two frameshifts and a splice site mutation which #led to truncated oa1 proteins; a deletion of a threonine codon at position 290; and four missense mutations , and 1 mutation predicted to affect normal splicing) .
further , experiments with an antisense-ref cdna expression vector introduced into cultured cells suggested that the splice mutation in 5 end of intron 5 had #led to abnormal splice in exon 5 and exon 6 .
further , experiments with an antisense-ref cdna expression vector introduced into cultured cells suggested that the splice mutation in 5 end of intron 5 #led to abnormal splice in exon 5 and exon 6 .
further , experiments with an antisense-ref cdna expression vector introduced into cultured cells suggested that the splice mutation in 5 end of intron 5 was able to #lead to abnormal splice in exon 5 and exon 6 .
further , experiments with an antisense-ref cdna expression vector introduced into cultured cells suggested that this splice mutation in 5 end of intron 5 had #led to abnormal splice in exon 5 and exon 6 .
further , experiments with an antisense-ref cdna expression vector introduced into cultured cells suggested that a c----a transversion in the splice acceptor sequence of the last intron of the only ercc-3 allele could #lead to a 4 bp insertion in the mrna and an inactivating frameshift in the c-terminus of the protein .
further , experiments with an antisense-ref cdna expression vector introduced into cultured cells suggested that a c----a transversion in the splice acceptor sequence of the last intron of the only ercc-3 allele was able to #lead to a 4 bp insertion in the mrna and an inactivating frameshift in the c-terminus of the protein .
further , experiments with an antisense-ref cdna expression vector introduced into cultured cells suggested that a complex splice site mutation could #lead to an abnormal jag1 mrna , resulting in a premature stop codon .
further , experiments with an antisense-ref cdna expression vector introduced into cultured cells suggested that a complex splice site mutation had #led to an abnormal jag1 mrna , resulting in a premature stop codon .
further , experiments with an antisense-ref cdna expression vector introduced into cultured cells suggested that a point mutation at the 5 splicing site of the third intron had #led to ligation of the second to the fourth exon .
further , experiments with an antisense-ref cdna expression vector introduced into cultured cells suggested that a point mutation at the 5 splicing site of the third intron was able to #lead to ligation of the second to the fourth exon .
further , experiments with an antisense-ref cdna expression vector introduced into cultured cells suggested that two frameshifts and a splice site mutation could #lead to truncated oa1 proteins; a deletion of a threonine codon at position 290; and four missense mutations .
further , experiments with an antisense-ref cdna expression vector introduced into cultured cells suggested that two frameshifts and a splice site mutation had #led to truncated oa1 proteins; a deletion of a threonine codon at position 290; and four missense mutations .
further , experiments with an antisense-ref cdna expression vector introduced into cultured cells suggested that two frameshifts and a splice site mutation #led to truncated oa1 proteins; a deletion of a threonine codon at position 290; and four missense mutations .
further , experiments with an antisense-ref cdna expression vector introduced into cultured cells suggested that two frameshifts and a splice site mutation was able to #lead to truncated oa1 proteins; a deletion of a threonine codon at position 290; and four missense mutations .
further , experiments with an antisense-ref cdna expression vector introduced into cultured cells suggests that the splice mutation in 5 end of intron 5 is able to #lead to abnormal splice in exon 5 and exon 6 .
further , experiments with an antisense-ref cdna expression vector introduced into cultured cells suggests that this splice mutation in 5 end of intron 5 #leads to abnormal splice in exon 5 and exon 6 .
further , experiments with an antisense-ref cdna expression vector introduced into cultured cells suggests that a c----a transversion in the splice acceptor sequence of the last intron of the only ercc-3 allele is able to #lead to a 4 bp insertion in the mrna and an inactivating frameshift in the c-terminus of the protein .
further , experiments with an antisense-ref cdna expression vector introduced into cultured cells suggests that a c----a transversion in the splice acceptor sequence of the last intron of the only ercc-3 allele #leads to a 4 bp insertion in the mrna and an inactivating frameshift in the c-terminus of the protein .
further , experiments with an antisense-ref cdna expression vector introduced into cultured cells suggests that a point mutation at the 5 splicing site of the third intron is able to #lead to ligation of the second to the fourth exon .
further , experiments with an antisense-ref cdna expression vector introduced into cultured cells suggests that a point mutation at the 5 splicing site of the third intron #leads to ligation of the second to the fourth exon .
it has been shown that the splice mutation in 5 end of intron 5 , #leading to abnormal splice in exon 5 and exon 6 .
it has been shown that this splice mutation in 5 end of intron 5 , #leading to abnormal splice in exon 5 and exon 6 .
the splice mutation in 5 end of intron 5 g:c base pair is also the strongest determinant in this which #leads to abnormal splice in exon 5 and exon 6 (lagrange et al . , 1998) .
the splice mutation in 5 end of intron 5 g:c base pair is also the strongest determinant in this , which #led to abnormal splice in exon 5 and exon 6 (lagrange et al . , 1998) .
the splice mutation in 5 end of intron 5 can #lead to abnormal splice in exon 5 and exon 6 .
the splice mutation in 5 end of intron 5 can #lead us to abnormal splice in exon 5 and exon 6 .
the splice mutation in 5 end of intron 5 has #led to abnormal splice in exon 5 and exon 6 (figure 3a) .
the splice mutation in 5 end of intron 5 has #led us to abnormal splice in exon 5 and exon 6 .
the splice mutation in 5 end of intron 5 is able to #lead to abnormal splice in exon 5 and exon 6 (figure 3a) .
the splice mutation in 5 end of intron 5 #leads to abnormal splice in exon 5 and exon 6 (figure 3a) .
the splice mutation in 5 end of intron 5 #leads to abnormal splice in exon 5 and exon 6 , an atypical form of tay-sachs disease (gm2 gangliosidosis variant ab) .
the splice mutation in 5 end of intron 5 #led to abnormal splice in exon 5 and exon 6 (figure 3a) .
the splice mutation in 5 end of intron 5 #led to abnormal splice in exon 5 and exon 6 , an atypical form of tay-sachs disease (gm2 gangliosidosis variant ab) .
the splice mutation in 5 end of intron 5 #led to abnormal splice in exon 5 and exon 6 .
the splice mutation in 5 end of intron 5 #led us to abnormal splice in exon 5 and exon 6 .
the splice mutation in 5 end of intron 5 may #lead to abnormal splice in exon 5 and exon 6 .
the splice mutation in 5 end of intron 5 was caused by this #leading to abnormal splice in exon 5 and exon 6 .
the splice mutation in 5 end of intron 5 was caused by this that #leads to abnormal splice in exon 5 and exon 6 .
the splice mutation in 5 end of intron 5 was caused by this that #led to abnormal splice in exon 5 and exon 6 .
the splice mutation in 5 end of intron 5 will #lead us to abnormal splice in exon 5 and exon 6 .
the splice mutation in 5 end of intron 5 , in turn , has #led to abnormal splice in exon 5 and exon 6 independently of the dna-binding activity of mef2 .
the splice mutation in 5 end of intron 5 , in turn , #leads to abnormal splice in exon 5 and exon 6 independently of the dna-binding activity of mef2 .
the splice mutation in 5 end of intron 5 , in turn , #led to abnormal splice in exon 5 and exon 6 independently of the dna-binding activity of mef2 .
the splice mutation in 5 end of intron 5 , in turn , will #lead to abnormal splice in exon 5 and exon 6 independently of the dna-binding activity of mef2 .
these data suggest that the splice mutation in 5 end of intron 5 #leads to abnormal splice in exon 5 and exon 6 that functions to stimulate phosphorylation and clustering of achrs .
these data suggest that this splice mutation in 5 end of intron 5 can #lead to abnormal splice in exon 5 and exon 6 that functions to stimulate phosphorylation and clustering of achrs .
these data suggest that this splice mutation in 5 end of intron 5 has #led to abnormal splice in exon 5 and exon 6 that functions to stimulate phosphorylation and clustering of achrs .
these data suggest that this splice mutation in 5 end of intron 5 #leads to abnormal splice in exon 5 and exon 6 that functions to stimulate phosphorylation and clustering of achrs .
these data suggest that this splice mutation in 5 end of intron 5 will #lead to abnormal splice in exon 5 and exon 6 that functions to stimulate phosphorylation and clustering of achrs .
these data suggest that a c----a transversion in the splice acceptor sequence of the last intron of the only ercc-3 allele has #led to a 4 bp insertion in the mrna and an inactivating frameshift in the c-terminus of the protein that functions to stimulate phosphorylation and clustering of achrs .
these data suggest that a c----a transversion in the splice acceptor sequence of the last intron of the only ercc-3 allele #leads to a 4 bp insertion in the mrna and an inactivating frameshift in the c-terminus of the protein that functions to stimulate phosphorylation and clustering of achrs .
these data suggest that a c----a transversion in the splice acceptor sequence of the last intron of the only ercc-3 allele will #lead to a 4 bp insertion in the mrna and an inactivating frameshift in the c-terminus of the protein that functions to stimulate phosphorylation and clustering of achrs .
these data suggest that a complex splice site mutation can #lead to an abnormal jag1 mrna , resulting in a premature stop codon that functions to stimulate phosphorylation and clustering of achrs .
these data suggest that a complex splice site mutation has #led to an abnormal jag1 mrna , resulting in a premature stop codon that functions to stimulate phosphorylation and clustering of achrs .
these data suggest that a complex splice site mutation #leads to an abnormal jag1 mrna , resulting in a premature stop codon that functions to stimulate phosphorylation and clustering of achrs .
these data suggest that a complex splice site mutation will #lead to an abnormal jag1 mrna , resulting in a premature stop codon that functions to stimulate phosphorylation and clustering of achrs .
these data suggest that two frameshifts and a splice site mutation can #lead to truncated oa1 proteins; a deletion of a threonine codon at position 290; and four missense mutations that functions to stimulate phosphorylation and clustering of achrs .
these data suggest that two frameshifts and a splice site mutation will #lead to truncated oa1 proteins; a deletion of a threonine codon at position 290; and four missense mutations that functions to stimulate phosphorylation and clustering of achrs .
these data suggested that the splice mutation in 5 end of intron 5 #led to abnormal splice in exon 5 and exon 6 that functions to stimulate phosphorylation and clustering of achrs .
these data suggested that this splice mutation in 5 end of intron 5 was able to #lead to abnormal splice in exon 5 and exon 6 that functions to stimulate phosphorylation and clustering of achrs .
these data suggested that a complex splice site mutation was able to #lead to an abnormal jag1 mrna , resulting in a premature stop codon that functions to stimulate phosphorylation and clustering of achrs .
these data suggested that a point mutation at the 5 splicing site of the third intron #led to ligation of the second to the fourth exon that functions to stimulate phosphorylation and clustering of achrs .
this g:c base pair is also the strongest determinant in the splice mutation in 5 end of intron 5 #leading to abnormal splice in exon 5 and exon 6 (lagrange et al . , 1998) .
this g:c base pair is also the strongest determinant in the splice mutation in 5 end of intron 5 that #leads to abnormal splice in exon 5 and exon 6 (lagrange et al . , 1998) .
this g:c base pair is also the strongest determinant in the splice mutation in 5 end of intron 5 which has #led to abnormal splice in exon 5 and exon 6 (lagrange et al . , 1998) .
this g:c base pair is also the strongest determinant in the splice mutation in 5 end of intron 5 which #leads to abnormal splice in exon 5 and exon 6 (lagrange et al . , 1998) .
this g:c base pair is also the strongest determinant in the splice mutation in 5 end of intron 5 which #led to abnormal splice in exon 5 and exon 6 (lagrange et al . , 1998) .
this g:c base pair is also the strongest determinant in this splice mutation in 5 end of intron 5 that #leads to abnormal splice in exon 5 and exon 6 (lagrange et al . , 1998) .
this g:c base pair is also the strongest determinant in a c----a transversion in the splice acceptor sequence of the last intron of the only ercc-3 allele #leading to a 4 bp insertion in the mrna and an inactivating frameshift in the c-terminus of the protein (lagrange et al . , 1998) .
this g:c base pair is also the strongest determinant in a c----a transversion in the splice acceptor sequence of the last intron of the only ercc-3 allele which has #led to a 4 bp insertion in the mrna and an inactivating frameshift in the c-terminus of the protein (lagrange et al . , 1998) .
this g:c base pair is also the strongest determinant in a c----a transversion in the splice acceptor sequence of the last intron of the only ercc-3 allele which #leads to a 4 bp insertion in the mrna and an inactivating frameshift in the c-terminus of the protein (lagrange et al . , 1998) .
this g:c base pair is also the strongest determinant in a c----a transversion in the splice acceptor sequence of the last intron of the only ercc-3 allele which #led to a 4 bp insertion in the mrna and an inactivating frameshift in the c-terminus of the protein (lagrange et al . , 1998) .
this g:c base pair is also the strongest determinant in a c----a transversion in the splice acceptor sequence of the last intron of the only ercc-3 allele , which #led to a 4 bp insertion in the mrna and an inactivating frameshift in the c-terminus of the protein (lagrange et al . , 1998) .
this g:c base pair is also the strongest determinant in a complex splice site mutation #leading to an abnormal jag1 mrna , resulting in a premature stop codon (lagrange et al . , 1998) .
this g:c base pair is also the strongest determinant in a complex splice site mutation which #leads to an abnormal jag1 mrna , resulting in a premature stop codon (lagrange et al . , 1998) .
this g:c base pair is also the strongest determinant in a complex splice site mutation , which #led to an abnormal jag1 mrna , resulting in a premature stop codon (lagrange et al . , 1998) .
this g:c base pair is also the strongest determinant in a point mutation at the 5 splicing site of the third intron that #leads to ligation of the second to the fourth exon (lagrange et al . , 1998) .
this g:c base pair is also the strongest determinant in a point mutation at the 5 splicing site of the third intron which has #led to ligation of the second to the fourth exon (lagrange et al . , 1998) .
this g:c base pair is also the strongest determinant in a point mutation at the 5 splicing site of the third intron which #led to ligation of the second to the fourth exon (lagrange et al . , 1998) .
this g:c base pair is also the strongest determinant in a point mutation at the 5 splicing site of the third intron , which #led to ligation of the second to the fourth exon (lagrange et al . , 1998) .
this g:c base pair is also the strongest determinant in two frameshifts and a splice site mutation #leading to truncated oa1 proteins; a deletion of a threonine codon at position 290; and four missense mutations (lagrange et al . , 1998) .
this g:c base pair is also the strongest determinant in two frameshifts and a splice site mutation which #leads to truncated oa1 proteins; a deletion of a threonine codon at position 290; and four missense mutations (lagrange et al . , 1998) .
this g:c base pair is also the strongest determinant in two frameshifts and a splice site mutation , which #led to truncated oa1 proteins; a deletion of a threonine codon at position 290; and four missense mutations (lagrange et al . , 1998) .
this splice mutation in 5 end of intron 5 g:c base pair is also the strongest determinant in this #leading to abnormal splice in exon 5 and exon 6 (lagrange et al . , 1998) .
this splice mutation in 5 end of intron 5 g:c base pair is also the strongest determinant in this that #leads to abnormal splice in exon 5 and exon 6 (lagrange et al . , 1998) .
this splice mutation in 5 end of intron 5 g:c base pair is also the strongest determinant in this which #leads to abnormal splice in exon 5 and exon 6 (lagrange et al . , 1998) .
this splice mutation in 5 end of intron 5 g:c base pair is also the strongest determinant in this , which #led to abnormal splice in exon 5 and exon 6 (lagrange et al . , 1998) .
this splice mutation in 5 end of intron 5 can #lead to abnormal splice in exon 5 and exon 6 (figure 3a) .
this splice mutation in 5 end of intron 5 can #lead to abnormal splice in exon 5 and exon 6 , an atypical form of tay-sachs disease (gm2 gangliosidosis variant ab) .
this splice mutation in 5 end of intron 5 can #lead to abnormal splice in exon 5 and exon 6 .
this splice mutation in 5 end of intron 5 can #lead us to abnormal splice in exon 5 and exon 6 .
this splice mutation in 5 end of intron 5 has #led to abnormal splice in exon 5 and exon 6 , an atypical form of tay-sachs disease (gm2 gangliosidosis variant ab) .
this splice mutation in 5 end of intron 5 has #led to abnormal splice in exon 5 and exon 6 .
this splice mutation in 5 end of intron 5 has #led us to abnormal splice in exon 5 and exon 6 .
this splice mutation in 5 end of intron 5 #lead to abnormal splice in exon 5 and exon 6 .
this splice mutation in 5 end of intron 5 #leads to abnormal splice in exon 5 and exon 6 , an atypical form of tay-sachs disease (gm2 gangliosidosis variant ab) .
this splice mutation in 5 end of intron 5 #led to abnormal splice in exon 5 and exon 6 (figure 3a) .
this splice mutation in 5 end of intron 5 #led us to abnormal splice in exon 5 and exon 6 .
this splice mutation in 5 end of intron 5 that #leads to abnormal splice in exon 5 and exon 6 .
this splice mutation in 5 end of intron 5 was caused by this that #leads to abnormal splice in exon 5 and exon 6 .
this splice mutation in 5 end of intron 5 was caused by this which has #led to abnormal splice in exon 5 and exon 6 .
this splice mutation in 5 end of intron 5 was caused by this , which #leads to abnormal splice in exon 5 and exon 6 .
this splice mutation in 5 end of intron 5 will #lead us to abnormal splice in exon 5 and exon 6 .
this splice mutation in 5 end of intron 5 , in turn , has #led to abnormal splice in exon 5 and exon 6 independently of the dna-binding activity of mef2 .
this splice mutation in 5 end of intron 5 , in turn , is able to #lead to abnormal splice in exon 5 and exon 6 independently of the dna-binding activity of mef2 .
this splice mutation in 5 end of intron 5 , in turn , is #leading to abnormal splice in exon 5 and exon 6 independently of the dna-binding activity of mef2 .
this splice mutation in 5 end of intron 5 , in turn , #leads to abnormal splice in exon 5 and exon 6 independently of the dna-binding activity of mef2 .
this splice mutation in 5 end of intron 5 , in turn , #led to abnormal splice in exon 5 and exon 6 independently of the dna-binding activity of mef2 .
this splice mutation in 5 end of intron 5 , in turn , will #lead to abnormal splice in exon 5 and exon 6 independently of the dna-binding activity of mef2 .
this was caused by the splice mutation in 5 end of intron 5 that #leads to abnormal splice in exon 5 and exon 6 .
this was caused by the splice mutation in 5 end of intron 5 that #led to abnormal splice in exon 5 and exon 6 .
this was caused by the splice mutation in 5 end of intron 5 which has #led to abnormal splice in exon 5 and exon 6 .
this was caused by the splice mutation in 5 end of intron 5 , which #leads to abnormal splice in exon 5 and exon 6 .
this was caused by this splice mutation in 5 end of intron 5 which can #lead to abnormal splice in exon 5 and exon 6 .
this was caused by this splice mutation in 5 end of intron 5 which has #led to abnormal splice in exon 5 and exon 6 .
this was caused by this splice mutation in 5 end of intron 5 , which #leads to abnormal splice in exon 5 and exon 6 .
this was caused by a c----a transversion in the splice acceptor sequence of the last intron of the only ercc-3 allele that #led to a 4 bp insertion in the mrna and an inactivating frameshift in the c-terminus of the protein .
this was caused by a c----a transversion in the splice acceptor sequence of the last intron of the only ercc-3 allele which can #lead to a 4 bp insertion in the mrna and an inactivating frameshift in the c-terminus of the protein .
this was caused by a c----a transversion in the splice acceptor sequence of the last intron of the only ercc-3 allele which has #led to a 4 bp insertion in the mrna and an inactivating frameshift in the c-terminus of the protein .
this was caused by a c----a transversion in the splice acceptor sequence of the last intron of the only ercc-3 allele , which #leads to a 4 bp insertion in the mrna and an inactivating frameshift in the c-terminus of the protein .
this was caused by a complex splice site mutation #leading to an abnormal jag1 mrna , resulting in a premature stop codon .
this was caused by a complex splice site mutation which has #led to an abnormal jag1 mrna , resulting in a premature stop codon .
this was caused by a complex splice site mutation , which #leads to an abnormal jag1 mrna , resulting in a premature stop codon .
this was caused by a point mutation at the 5 splicing site of the third intron that #led to ligation of the second to the fourth exon .
this was caused by two frameshifts and a splice site mutation #leading to truncated oa1 proteins; a deletion of a threonine codon at position 290; and four missense mutations .
this was caused by two frameshifts and a splice site mutation that #led to truncated oa1 proteins; a deletion of a threonine codon at position 290; and four missense mutations .
this was caused by two frameshifts and a splice site mutation , which #leads to truncated oa1 proteins; a deletion of a threonine codon at position 290; and four missense mutations .
a 4 bp insertion in the mrna and an inactivating frameshift in the c-terminus of the protein was #led to by a c----a transversion in the splice acceptor sequence of the last intron of the only ercc-3 allele .
a c----a transversion in the splice acceptor sequence of the last intron of the only ercc-3 allele g:c base pair is also the strongest determinant in this #leading to a 4 bp insertion in the mrna and an inactivating frameshift in the c-terminus of the protein (lagrange et al . , 1998) .
a c----a transversion in the splice acceptor sequence of the last intron of the only ercc-3 allele can #lead to a 4 bp insertion in the mrna and an inactivating frameshift in the c-terminus of the protein (figure 3a) .
a c----a transversion in the splice acceptor sequence of the last intron of the only ercc-3 allele can #lead to a 4 bp insertion in the mrna and an inactivating frameshift in the c-terminus of the protein , an atypical form of tay-sachs disease (gm2 gangliosidosis variant ab) .
a c----a transversion in the splice acceptor sequence of the last intron of the only ercc-3 allele can #lead to a 4 bp insertion in the mrna and an inactivating frameshift in the c-terminus of the protein .
a c----a transversion in the splice acceptor sequence of the last intron of the only ercc-3 allele can #lead us to a 4 bp insertion in the mrna and an inactivating frameshift in the c-terminus of the protein .
a c----a transversion in the splice acceptor sequence of the last intron of the only ercc-3 allele has #led to a 4 bp insertion in the mrna and an inactivating frameshift in the c-terminus of the protein , an atypical form of tay-sachs disease (gm2 gangliosidosis variant ab) .
a c----a transversion in the splice acceptor sequence of the last intron of the only ercc-3 allele is able to #lead to a 4 bp insertion in the mrna and an inactivating frameshift in the c-terminus of the protein (figure 3a) .
a c----a transversion in the splice acceptor sequence of the last intron of the only ercc-3 allele #lead to a 4 bp insertion in the mrna and an inactivating frameshift in the c-terminus of the protein .
a c----a transversion in the splice acceptor sequence of the last intron of the only ercc-3 allele #led to a 4 bp insertion in the mrna and an inactivating frameshift in the c-terminus of the protein (figure 3a) .
a c----a transversion in the splice acceptor sequence of the last intron of the only ercc-3 allele #led to a 4 bp insertion in the mrna and an inactivating frameshift in the c-terminus of the protein .
a c----a transversion in the splice acceptor sequence of the last intron of the only ercc-3 allele #led us to a 4 bp insertion in the mrna and an inactivating frameshift in the c-terminus of the protein .
a c----a transversion in the splice acceptor sequence of the last intron of the only ercc-3 allele was caused by this which can #lead to a 4 bp insertion in the mrna and an inactivating frameshift in the c-terminus of the protein .
a c----a transversion in the splice acceptor sequence of the last intron of the only ercc-3 allele was caused by this which has #led to a 4 bp insertion in the mrna and an inactivating frameshift in the c-terminus of the protein .
a c----a transversion in the splice acceptor sequence of the last intron of the only ercc-3 allele , in turn , is #leading to a 4 bp insertion in the mrna and an inactivating frameshift in the c-terminus of the protein independently of the dna-binding activity of mef2 .
a c----a transversion in the splice acceptor sequence of the last intron of the only ercc-3 allele , in turn , #leads to a 4 bp insertion in the mrna and an inactivating frameshift in the c-terminus of the protein independently of the dna-binding activity of mef2 .
a c----a transversion in the splice acceptor sequence of the last intron of the only ercc-3 allele , in turn , #led to a 4 bp insertion in the mrna and an inactivating frameshift in the c-terminus of the protein independently of the dna-binding activity of mef2 .
a c----a transversion in the splice acceptor sequence of the last intron of the only ercc-3 allele , in turn , will #lead to a 4 bp insertion in the mrna and an inactivating frameshift in the c-terminus of the protein independently of the dna-binding activity of mef2 .
a complex splice site mutation g:c base pair is also the strongest determinant in this #leading to an abnormal jag1 mrna , resulting in a premature stop codon (lagrange et al . , 1998) .
a complex splice site mutation g:c base pair is also the strongest determinant in this which has #led to an abnormal jag1 mrna , resulting in a premature stop codon (lagrange et al . , 1998) .
a complex splice site mutation g:c base pair is also the strongest determinant in this which #leads to an abnormal jag1 mrna , resulting in a premature stop codon (lagrange et al . , 1998) .
a complex splice site mutation g:c base pair is also the strongest determinant in this which #led to an abnormal jag1 mrna , resulting in a premature stop codon (lagrange et al . , 1998) .
a complex splice site mutation can #lead to an abnormal jag1 mrna , resulting in a premature stop codon (figure 3a) .
a complex splice site mutation has #led to an abnormal jag1 mrna , resulting in a premature stop codon (figure 3a) .
a complex splice site mutation has #led to an abnormal jag1 mrna , resulting in a premature stop codon , an atypical form of tay-sachs disease (gm2 gangliosidosis variant ab) .
a complex splice site mutation has #led us to an abnormal jag1 mrna , resulting in a premature stop codon .
a complex splice site mutation is #leading to an abnormal jag1 mrna , resulting in a premature stop codon , an atypical form of tay-sachs disease (gm2 gangliosidosis variant ab) .
a complex splice site mutation #leads to an abnormal jag1 mrna , resulting in a premature stop codon (figure 3a) .
a complex splice site mutation #leads us to an abnormal jag1 mrna , resulting in a premature stop codon .
a complex splice site mutation #led to an abnormal jag1 mrna , resulting in a premature stop codon (figure 3a) .
a complex splice site mutation #led to an abnormal jag1 mrna , resulting in a premature stop codon .
a complex splice site mutation #led us to an abnormal jag1 mrna , resulting in a premature stop codon .
a complex splice site mutation may #lead to an abnormal jag1 mrna , resulting in a premature stop codon (figure 3a) .
a complex splice site mutation was caused by this #leading to an abnormal jag1 mrna , resulting in a premature stop codon .
a complex splice site mutation was caused by this which can #lead to an abnormal jag1 mrna , resulting in a premature stop codon .
a complex splice site mutation was caused by this , which #leads to an abnormal jag1 mrna , resulting in a premature stop codon .
a complex splice site mutation will #lead us to an abnormal jag1 mrna , resulting in a premature stop codon .
a complex splice site mutation , in turn , is able to #lead to an abnormal jag1 mrna , resulting in a premature stop codon independently of the dna-binding activity of mef2 .
a complex splice site mutation , in turn , #led to an abnormal jag1 mrna , resulting in a premature stop codon independently of the dna-binding activity of mef2 .
a complex splice site mutation , in turn , will #lead to an abnormal jag1 mrna , resulting in a premature stop codon independently of the dna-binding activity of mef2 .
a point mutation at the 5 splicing site of the third intron g:c base pair is also the strongest determinant in this that #leads to ligation of the second to the fourth exon (lagrange et al . , 1998) .
a point mutation at the 5 splicing site of the third intron g:c base pair is also the strongest determinant in this which #led to ligation of the second to the fourth exon (lagrange et al . , 1998) .
a point mutation at the 5 splicing site of the third intron can #lead to ligation of the second to the fourth exon , an atypical form of tay-sachs disease (gm2 gangliosidosis variant ab) .
a point mutation at the 5 splicing site of the third intron has #led to ligation of the second to the fourth exon .
a point mutation at the 5 splicing site of the third intron has #led us to ligation of the second to the fourth exon .
a point mutation at the 5 splicing site of the third intron is able to #lead to ligation of the second to the fourth exon (figure 3a) .
a point mutation at the 5 splicing site of the third intron is #leading to ligation of the second to the fourth exon , an atypical form of tay-sachs disease (gm2 gangliosidosis variant ab) .
a point mutation at the 5 splicing site of the third intron #leads to ligation of the second to the fourth exon (figure 3a) .
a point mutation at the 5 splicing site of the third intron #leads to ligation of the second to the fourth exon , an atypical form of tay-sachs disease (gm2 gangliosidosis variant ab) .
a point mutation at the 5 splicing site of the third intron #leads to ligation of the second to the fourth exon .
a point mutation at the 5 splicing site of the third intron #led to ligation of the second to the fourth exon (figure 3a) .
a point mutation at the 5 splicing site of the third intron #led to ligation of the second to the fourth exon , an atypical form of tay-sachs disease (gm2 gangliosidosis variant ab) .
a point mutation at the 5 splicing site of the third intron #led us to ligation of the second to the fourth exon .
a point mutation at the 5 splicing site of the third intron may #lead to ligation of the second to the fourth exon (figure 3a) .
a point mutation at the 5 splicing site of the third intron may #lead to ligation of the second to the fourth exon .
a point mutation at the 5 splicing site of the third intron that #leads to ligation of the second to the fourth exon .
a point mutation at the 5 splicing site of the third intron was caused by this #leading to ligation of the second to the fourth exon .
a point mutation at the 5 splicing site of the third intron , but not a wild-type strain , #led to ligation of the second to the fourth exon .
a point mutation at the 5 splicing site of the third intron , in turn , is able to #lead to ligation of the second to the fourth exon independently of the dna-binding activity of mef2 .
a point mutation at the 5 splicing site of the third intron , in turn , is #leading to ligation of the second to the fourth exon independently of the dna-binding activity of mef2 .
a point mutation at the 5 splicing site of the third intron , in turn , #led to ligation of the second to the fourth exon independently of the dna-binding activity of mef2 .
abnormal splice in exon 5 and exon 6 is #led to by this splice mutation in 5 end of intron 5 .
abnormal splice in exon 5 and exon 6 was #led to by this splice mutation in 5 end of intron 5 .
an abnormal jag1 mrna , resulting in a premature stop codon is #led to by a complex splice site mutation .
an abnormal jag1 mrna , resulting in a premature stop codon was #led to by a complex splice site mutation .
ligation of the second to the fourth exon is #led to by a point mutation at the 5 splicing site of the third intron .
two frameshifts and a splice site mutation g:c base pair is also the strongest determinant in this #leading to truncated oa1 proteins; a deletion of a threonine codon at position 290; and four missense mutations (lagrange et al . , 1998) .
two frameshifts and a splice site mutation g:c base pair is also the strongest determinant in this that #leads to truncated oa1 proteins; a deletion of a threonine codon at position 290; and four missense mutations (lagrange et al . , 1998) .
two frameshifts and a splice site mutation g:c base pair is also the strongest determinant in this which has #led to truncated oa1 proteins; a deletion of a threonine codon at position 290; and four missense mutations (lagrange et al . , 1998) .
two frameshifts and a splice site mutation g:c base pair is also the strongest determinant in this which #led to truncated oa1 proteins; a deletion of a threonine codon at position 290; and four missense mutations (lagrange et al . , 1998) .
two frameshifts and a splice site mutation can #lead us to truncated oa1 proteins; a deletion of a threonine codon at position 290; and four missense mutations .
two frameshifts and a splice site mutation has #led to truncated oa1 proteins; a deletion of a threonine codon at position 290; and four missense mutations (figure 3a) .
two frameshifts and a splice site mutation has #led to truncated oa1 proteins; a deletion of a threonine codon at position 290; and four missense mutations , an atypical form of tay-sachs disease (gm2 gangliosidosis variant ab) .
two frameshifts and a splice site mutation has #led to truncated oa1 proteins; a deletion of a threonine codon at position 290; and four missense mutations .
two frameshifts and a splice site mutation is #leading to truncated oa1 proteins; a deletion of a threonine codon at position 290; and four missense mutations , an atypical form of tay-sachs disease (gm2 gangliosidosis variant ab) .
two frameshifts and a splice site mutation is #leading to truncated oa1 proteins; a deletion of a threonine codon at position 290; and four missense mutations .
two frameshifts and a splice site mutation #lead to truncated oa1 proteins; a deletion of a threonine codon at position 290; and four missense mutations .
two frameshifts and a splice site mutation #leads to truncated oa1 proteins; a deletion of a threonine codon at position 290; and four missense mutations (figure 3a) .
two frameshifts and a splice site mutation #leads to truncated oa1 proteins; a deletion of a threonine codon at position 290; and four missense mutations , an atypical form of tay-sachs disease (gm2 gangliosidosis variant ab) .
two frameshifts and a splice site mutation #leads us to truncated oa1 proteins; a deletion of a threonine codon at position 290; and four missense mutations .
two frameshifts and a splice site mutation #led to truncated oa1 proteins; a deletion of a threonine codon at position 290; and four missense mutations (figure 3a) .
two frameshifts and a splice site mutation #led to truncated oa1 proteins; a deletion of a threonine codon at position 290; and four missense mutations , an atypical form of tay-sachs disease (gm2 gangliosidosis variant ab) .
two frameshifts and a splice site mutation #led us to truncated oa1 proteins; a deletion of a threonine codon at position 290; and four missense mutations .
two frameshifts and a splice site mutation may #lead to truncated oa1 proteins; a deletion of a threonine codon at position 290; and four missense mutations .
two frameshifts and a splice site mutation that #leads to truncated oa1 proteins; a deletion of a threonine codon at position 290; and four missense mutations .
two frameshifts and a splice site mutation was caused by this #leading to truncated oa1 proteins; a deletion of a threonine codon at position 290; and four missense mutations .
two frameshifts and a splice site mutation was caused by this that #led to truncated oa1 proteins; a deletion of a threonine codon at position 290; and four missense mutations .
two frameshifts and a splice site mutation was caused by this which can #lead to truncated oa1 proteins; a deletion of a threonine codon at position 290; and four missense mutations .
two frameshifts and a splice site mutation was caused by this , which #leads to truncated oa1 proteins; a deletion of a threonine codon at position 290; and four missense mutations .
two frameshifts and a splice site mutation will #lead us to truncated oa1 proteins; a deletion of a threonine codon at position 290; and four missense mutations .
two frameshifts and a splice site mutation , but not a wild-type strain , #led to truncated oa1 proteins; a deletion of a threonine codon at position 290; and four missense mutations .
two frameshifts and a splice site mutation , in turn , has #led to truncated oa1 proteins; a deletion of a threonine codon at position 290; and four missense mutations independently of the dna-binding activity of mef2 .
two frameshifts and a splice site mutation , in turn , is able to #lead to truncated oa1 proteins; a deletion of a threonine codon at position 290; and four missense mutations independently of the dna-binding activity of mef2 .
a sph i cleavage site within exon 3 can be #lost in a new transthyretin variant that has been characterized .
a sph i cleavage site within exon 3 has been #lost in a new transthyretin variant that has been characterized .
a sph i cleavage site within exon 3 is #lost in a new transthyretin variant that has been characterized .
a sph i cleavage site within exon 3 is observed to be #lost in a new transthyretin variant that has been characterized .
a new transthyretin variant being able to #lose a sph i cleavage site within exon 3 has been characterized .
a new transthyretin variant observed to #lose a sph i cleavage site within exon 3 has been characterized .
a new transthyretin variant which can #lose a sph i cleavage site within exon 3 has been characterized .
gpi anchoring ability being #lost when the microsomal membranes of trypanosoma brucei were washed at high ph has been reported(sharma et al . , 2000) , whereas similar treatment of the mammalian microsomal membranes have no effect (vidugiriene and menon , 1995)
gpi anchoring ability was reported to be #lost when the microsomal membranes of trypanosoma brucei were washed at high ph (sharma et al . , 2000) , whereas similar treatment of the mammalian microsomal membranes have no effect (vidugiriene and menon , 1995)
it is reported that gpi anchoring ability is #lost when the microsomal membranes of trypanosoma brucei were washed at high ph (sharma et al . , 2000) , whereas similar treatment of the mammalian microsomal membranes have no effect (vidugiriene and menon , 1995)
it may be reported that gpi anchoring ability will be #lost when the microsomal membranes of trypanosoma brucei were washed at high ph (sharma et al . , 2000) , whereas similar treatment of the mammalian microsomal membranes had no effect (vidugiriene and menon , 1995)
it was reported that gpi anchoring ability could be #lost when the microsomal membranes of trypanosoma brucei were washed at high ph (sharma et al . , 2000) , whereas similar treatment of the mammalian microsomal membranes have no effect (vidugiriene and menon , 1995)
it was reported that gpi anchoring ability might be #lost when the microsomal membranes of trypanosoma brucei were washed at high ph (sharma et al . , 2000) , whereas similar treatment of the mammalian microsomal membranes have no effect (vidugiriene and menon , 1995)
previous studies have emphasized the high sensitivity of the n-terminal region to proteolytic cleavage , leading to truncated species that can probably #lose the first 20 70 residues but that retain enzymatic activity and dimeric structure .
previous studies have emphasized the high sensitivity of the n-terminal region to proteolytic cleavage , leading to truncated species that have the ability to #lose the first 20 70 residues but that retain enzymatic activity and dimeric structure .
stat3 is activated in v-src or v-abl-transformed cells and , along other stats , in acute t-cell leukemia cells #losing il-2 dependency (migone et al . , 1995; yu et al . , 1995) .
stat3 is activated in v-src or v-abl-transformed cells and , along other stats , in acute t-cell leukemia cells that are observed to #lose il-2 dependency (migone et al . , 1995; yu et al . , 1995) .
stat3 is activated in v-src or v-abl-transformed cells and , along other stats , in acute t-cell leukemia cells that can #lose il-2 dependency (migone et al . , 1995; yu et al . , 1995) .
stat3 is activated in v-src or v-abl-transformed cells and , along other stats , in acute t-cell leukemia cells that can probably #lose il-2 dependency (migone et al . , 1995; yu et al . , 1995) .
stat3 is activated in v-src or v-abl-transformed cells and , along other stats , in acute t-cell leukemia cells that #lost il-2 dependency (migone et al . , 1995; yu et al . , 1995) .
stat3 is activated in v-src or v-abl-transformed cells and , along other stats , in acute t-cell leukemia cells that may #lose il-2 dependency (migone et al . , 1995; yu et al . , 1995) .
stat3 is activated in v-src or v-abl-transformed cells and , along other stats , in acute t-cell leukemia cells that will #lose il-2 dependency (migone et al . , 1995; yu et al . , 1995) .
the c-terminal-deletion mutant of hnrnp a1 being able to #lose the ability to interact with the x protein and to bring it into the initiation complex results in and inhibition of mhv rna transcription and replication .
the c-terminal-deletion mutant of hnrnp a1 can probably #lose the ability to interact with the x protein and to bring it into the initiation complex , resulting in an inhibition of mhv rna transcription and replication .
the c-terminal-deletion mutant of hnrnp a1 has a high probability of #losing the ability to interact with the x protein and to bring it into the initiation complex , resulting in an inhibition of mhv rna transcription and replication .
the c-terminal-deletion mutant of hnrnp a1 has been #losing the ability to interact with the x protein and to bring it into the initiation complex , resulting in an inhibition of mhv rna transcription and replication .
the c-terminal-deletion mutant of hnrnp a1 may #lose the ability to interact with the x protein and to bring it into the initiation complex , resulting in an inhibition of mhv rna transcription and replication .
the c-terminal-deletion mutant of hnrnp a1 that can #lose the ability to interact with the x protein and to bring it into the initiation complex results in and inhibition of mhv rna transcription and replication .
the c-terminal-deletion mutant of hnrnp a1 that has #lost the ability to interact with the x protein and to bring it into the initiation complex results in and inhibition of mhv rna transcription and replication .
the c-terminal-deletion mutant of hnrnp a1 that #loses the ability to interact with the x protein and to bring it into the initiation complex results in and inhibition of mhv rna transcription and replication .
the c-terminal-deletion mutant of hnrnp a1 that may probably #lose the ability to interact with the x protein and to bring it into the initiation complex results in and inhibition of mhv rna transcription and replication .
the c-terminal-deletion mutant of hnrnp a1 will #lose the ability to interact with the x protein and to bring it into the initiation complex , resulting in an inhibition of mhv rna transcription and replication .
the c-terminal-deletion mutant of hnrnp a1 will probably #lose the ability to interact with the x protein and to bring it into the initiation complex , resulting in an inhibition of mhv rna transcription and replication .
the mice are not able to #lose weight during the treatment .
the mice cannot #lose weight during the treatment .
the mice do not have a high probability of #losing weight during the treatment .
the mice have not #lost weight during the treatment .
the mice may not have #lost weight during the treatment .
these interactions are #lost with a separation of dna-binding sites of }3 bp , as can occur for natural sre sequences , while a smaller spacing inhibits the simultaneous binding of both proteins .
these interactions are observed to be #lost with a separation of dna-binding sites of }3 bp , as can occur for natural sre sequences , while a smaller spacing inhibited the simultaneous binding of both proteins .
these interactions can probably be #lost with a separation of dna-binding sites of }3 bp , as can occur for natural sre sequences , while a smaller spacing inhibited the simultaneous binding of both proteins .
these interactions have been #lost with a separation of dna-binding sites of }3 bp , as can occur for natural sre sequences , while a smaller spacing would inhibit the simultaneous binding of both proteins .
these interactions were #lost with a separation of dna-binding sites of }3 bp , as can occur for natural sre sequences , while a smaller spacing inhibited the simultaneous binding of both proteins .
these interactions will be #lost with a separation of dna-binding sites of }3 bp , as can occur for natural sre sequences , while a smaller spacing inhibited the simultaneous binding of both proteins .
this study investigated whether informing obese individuals that they can probably #lose only modest amounts of weight would lead them to adopt more realistic weight loss expectations .
this study investigated whether informing obese individuals that they could probably #lose only modest amounts of weight would lead them to adopt more realistic weight loss expectations .
this study investigated whether informing obese individuals that they have #lost only modest amounts of weight would lead them to adopt more realistic weight loss expectations .
this study investigated whether informing obese individuals that they #lose only modest amounts of weight would lead them to adopt more realistic weight loss expectations .
this study investigated whether informing obese individuals that they #lost only modest amounts of weight would lead them to adopt more realistic weight loss expectations .
this study investigated whether informing obese individuals that they may #lose only modest amounts of weight would lead them to adopt more realistic weight loss expectations .
this study investigated whether informing obese individuals that they may probably #lose only modest amounts of weight would lead them to adopt more realistic weight loss expectations .
this study investigated whether informing obese individuals that they might #lose only modest amounts of weight would lead them to adopt more realistic weight loss expectations .
this study investigated whether informing obese individuals that they might probably #lose only modest amounts of weight would lead them to adopt more realistic weight loss expectations .
this study investigated whether informing obese individuals that they will #lose only modest amounts of weight would lead them to adopt more realistic weight loss expectations .
the ability to interact with the x protein and to bring it into the initiation complex can be #lost in the c-terminal-deletion mutant of hnrnp a1 .
the c-terminal-deletion mutant of hnrnp a1 #loses the ability to interact with the x protein and to bring it into the initiation complex , resulting in an inhibition of mhv rna transcription and replication .
these interactions would be #lost with a separation of dna-binding sites of }3 bp , as can occur for natural sre sequences , while a smaller spacing would inhibit the simultaneous binding of both proteins .
a new transthyretin variant which #lost a sph i cleavage site within exon 3 has been characterized .
a new transthyretin variant completely #loses a sph i cleavage site within exon 3 , but all show considerablegenome reduction and dependency on the nucleus to fulfill plastid functions (martin and hrrmann , 1998) .
a new transthyretin variant completely #lost a sph i cleavage site within exon 3 , but all show considerablegenome reduction and dependency on the nucleus to fulfill plastid functions (martin and hrrmann , 1998) .
a new transthyretin variant has the ability to completely #lose a sph i cleavage site within exon 3 , but all show considerablegenome reduction and dependency on the nucleus to fulfill plastid functions (martin and hrrmann , 1998) .
a new transthyretin variant is observed to completely #lose a sph i cleavage site within exon 3 , but all show considerablegenome reduction and dependency on the nucleus to fulfill plastid functions (martin and hrrmann , 1998) .
a new transthyretin variant may completely #lose a sph i cleavage site within exon 3 , but all show considerablegenome reduction and dependency on the nucleus to fulfill plastid functions (martin and hrrmann , 1998) .
a new transthyretin variant will completely #lose a sph i cleavage site within exon 3 , but all show considerablegenome reduction and dependency on the nucleus to fulfill plastid functions (martin and hrrmann , 1998) .
a new transthyretin variant will have completely #lost a sph i cleavage site within exon 3 , but all show considerablegenome reduction and dependency on the nucleus to fulfill plastid functions (martin and hrrmann , 1998) .
il-2 dependency can be #lost in acute t-cell leukemia cells that has been characterized .
il-2 dependency is able to be #lost in acute t-cell leukemia cells that has been characterized .
il-2 dependency is observed to be #lost in acute t-cell leukemia cells that has been characterized .
il-2 dependency may be #lost in acute t-cell leukemia cells that has been characterized .
il-2 dependency was #lost in acute t-cell leukemia cells that has been characterized .
stat3 is activated in v-src or v-abl-transformed cells and , along other stats , in a new transthyretin variant that are able to #lose a sph i cleavage site within exon 3 (migone et al . , 1995; yu et al . , 1995) .
stat3 is activated in v-src or v-abl-transformed cells and , along other stats , in a new transthyretin variant that can #lose a sph i cleavage site within exon 3 (migone et al . , 1995; yu et al . , 1995) .
stat3 is activated in v-src or v-abl-transformed cells and , along other stats , in a new transthyretin variant that can probably #lose a sph i cleavage site within exon 3 (migone et al . , 1995; yu et al . , 1995) .
stat3 is activated in v-src or v-abl-transformed cells and , along other stats , in a new transthyretin variant that have the ability to #lose a sph i cleavage site within exon 3 (migone et al . , 1995; yu et al . , 1995) .
stat3 is activated in v-src or v-abl-transformed cells and , along other stats , in a new transthyretin variant that may probably #lose a sph i cleavage site within exon 3 (migone et al . , 1995; yu et al . , 1995) .
stat3 is activated in v-src or v-abl-transformed cells and , along other stats , in a new transthyretin variant that will #lose a sph i cleavage site within exon 3 (migone et al . , 1995; yu et al . , 1995) .
stat3 is activated in v-src or v-abl-transformed cells and , along other stats , in a new transthyretin variant that will probably #lose a sph i cleavage site within exon 3 (migone et al . , 1995; yu et al . , 1995) .
stat3 is activated in v-src or v-abl-transformed cells and , along other stats , in a new transthyretin variant that are able to #lose a sph i cleavage site within exon 3 (migone et al . , 1995; yu et al . , 1995) .
stat3 is activated in v-src or v-abl-transformed cells and , along other stats , in a new transthyretin variant that are observed to #lose a sph i cleavage site within exon 3 (migone et al . , 1995; yu et al . , 1995) .
stat3 is activated in v-src or v-abl-transformed cells and , along other stats , in a new transthyretin variant that can #lose a sph i cleavage site within exon 3 (migone et al . , 1995; yu et al . , 1995) .
stat3 is activated in v-src or v-abl-transformed cells and , along other stats , in a new transthyretin variant that can probably #lose a sph i cleavage site within exon 3 (migone et al . , 1995; yu et al . , 1995) .
stat3 is activated in v-src or v-abl-transformed cells and , along other stats , in a new transthyretin variant that #lose a sph i cleavage site within exon 3 (migone et al . , 1995; yu et al . , 1995) .
stat3 is activated in v-src or v-abl-transformed cells and , along other stats , in a new transthyretin variant that #lost a sph i cleavage site within exon 3 (migone et al . , 1995; yu et al . , 1995) .
stat3 is activated in v-src or v-abl-transformed cells and , along other stats , in a new transthyretin variant that may #lose a sph i cleavage site within exon 3 (migone et al . , 1995; yu et al . , 1995) .
stat3 is activated in v-src or v-abl-transformed cells and , along other stats , in a new transthyretin variant that may probably #lose a sph i cleavage site within exon 3 (migone et al . , 1995; yu et al . , 1995) .
stat3 is activated in v-src or v-abl-transformed cells and , along other stats , in a new transthyretin variant that will #lose a sph i cleavage site within exon 3 (migone et al . , 1995; yu et al . , 1995) .
stat3 is activated in v-src or v-abl-transformed cells and , along other stats , in a new transthyretin variant that will probably #lose a sph i cleavage site within exon 3 (migone et al . , 1995; yu et al . , 1995) .
to this end , we made a new transthyretin variant #losing all a sph i cleavage site within exon 3 postnatally , and +/+ control mice .
to this end , we made a new transthyretin variant , which are able to #lose all a sph i cleavage site within exon 3 postnatally , and +/+ control mice .
to this end , we made a new transthyretin variant , which are observed to #lose all a sph i cleavage site within exon 3 postnatally , and +/+ control mice .
to this end , we made a new transthyretin variant , which can probably #lose all a sph i cleavage site within exon 3 postnatally , and +/+ control mice .
to this end , we made a new transthyretin variant , which has #lost all a sph i cleavage site within exon 3 postnatally , and +/+ control mice .
to this end , we made a new transthyretin variant , which have a high probability of #losing all a sph i cleavage site within exon 3 postnatally , and +/+ control mice .
to this end , we made a new transthyretin variant , which have the ability to #lose all a sph i cleavage site within exon 3 postnatally , and +/+ control mice .
to this end , we made a new transthyretin variant , which #lost all a sph i cleavage site within exon 3 postnatally , and +/+ control mice .
to this end , we made a new transthyretin variant , which might probably #lose all a sph i cleavage site within exon 3 postnatally , and +/+ control mice .
to this end , we made a new transthyretin variant , which will probably #lose all a sph i cleavage site within exon 3 postnatally , and +/+ control mice .
to this end , we made a new transthyretin variant , which would probably #lose all a sph i cleavage site within exon 3 postnatally , and +/+ control mice .
to this end , we made a new transthyretin variant , which are able to #lose all a sph i cleavage site within exon 3 postnatally , and +/+ control mice .
to this end , we made a new transthyretin variant , which can #lose all a sph i cleavage site within exon 3 postnatally , and +/+ control mice .
to this end , we made a new transthyretin variant , which has #lost all a sph i cleavage site within exon 3 postnatally , and +/+ control mice .
to this end , we made a new transthyretin variant , which have the ability to #lose all a sph i cleavage site within exon 3 postnatally , and +/+ control mice .
to this end , we made a new transthyretin variant , which #lose all a sph i cleavage site within exon 3 postnatally , and +/+ control mice .
to this end , we made a new transthyretin variant , which #lost all a sph i cleavage site within exon 3 postnatally , and +/+ control mice .
to this end , we made a new transthyretin variant , which may #lose all a sph i cleavage site within exon 3 postnatally , and +/+ control mice .
to this end , we made a new transthyretin variant , which may probably #lose all a sph i cleavage site within exon 3 postnatally , and +/+ control mice .
to this end , we made a new transthyretin variant , which might #lose all a sph i cleavage site within exon 3 postnatally , and +/+ control mice .
to this end , we made a new transthyretin variant , which will #lose all a sph i cleavage site within exon 3 postnatally , and +/+ control mice .
to this end , we made a new transthyretin variant , which will probably #lose all a sph i cleavage site within exon 3 postnatally , and +/+ control mice .
to this end , we made a new transthyretin variant , which would probably #lose all a sph i cleavage site within exon 3 postnatally , and +/+ control mice .
to this end , we made acute t-cell leukemia cells , which are able to #lose all il-2 dependency postnatally , and +/+ control mice .
to this end , we made acute t-cell leukemia cells , which can #lose all il-2 dependency postnatally , and +/+ control mice .
to this end , we made acute t-cell leukemia cells , which can probably #lose all il-2 dependency postnatally , and +/+ control mice .
to this end , we made acute t-cell leukemia cells , which could #lose all il-2 dependency postnatally , and +/+ control mice .
to this end , we made acute t-cell leukemia cells , which have the ability to #lose all il-2 dependency postnatally , and +/+ control mice .
to this end , we made acute t-cell leukemia cells , which #lost all il-2 dependency postnatally , and +/+ control mice .
to this end , we made acute t-cell leukemia cells , which may probably #lose all il-2 dependency postnatally , and +/+ control mice .
to this end , we made acute t-cell leukemia cells , which might probably #lose all il-2 dependency postnatally , and +/+ control mice .
to this end , we made acute t-cell leukemia cells , which will #lose all il-2 dependency postnatally , and +/+ control mice .
to this end , we made acute t-cell leukemia cells , which will probably #lose all il-2 dependency postnatally , and +/+ control mice .
to this end , we made acute t-cell leukemia cells , which would #lose all il-2 dependency postnatally , and +/+ control mice .
to this end , we made acute t-cell leukemia cells , which would probably #lose all il-2 dependency postnatally , and +/+ control mice .
a sph i cleavage site within exon 3 has been #lost in a new transthyretin variant that has been characterized .
a sph i cleavage site within exon 3 is observed to be #lost in a new transthyretin variant that has been characterized .
a sph i cleavage site within exon 3 may be #lost in a new transthyretin variant that has been characterized .
a new transthyretin variant being able to #lose a sph i cleavage site within exon 3 has been characterized .
a new transthyretin variant has completely #lost a sph i cleavage site within exon 3 , but all show considerablegenome reduction and dependency on the nucleus to fulfill plastid functions (martin and hrrmann , 1998) .
a new transthyretin variant has the ability to completely #lose a sph i cleavage site within exon 3 , but all show considerablegenome reduction and dependency on the nucleus to fulfill plastid functions (martin and hrrmann , 1998) .
a new transthyretin variant is completely #losing a sph i cleavage site within exon 3 , but all show considerablegenome reduction and dependency on the nucleus to fulfill plastid functions (martin and hrrmann , 1998) .
a new transthyretin variant #losing a sph i cleavage site within exon 3 has been characterized .
a new transthyretin variant which can #lose a sph i cleavage site within exon 3 has been characterized .
a new transthyretin variant which has #lost a sph i cleavage site within exon 3 has been characterized .
a new transthyretin variant which #loses a sph i cleavage site within exon 3 has been characterized .
a new transthyretin variant which #lost a sph i cleavage site within exon 3 has been characterized .
a new transthyretin variant which may #lose a sph i cleavage site within exon 3 has been characterized .
acute t-cell leukemia cells can completely #lost il-2 dependency , but all show considerablegenome reduction and dependency on the nucleus to fulfill plastid functions (martin and hrrmann , 1998) .
acute t-cell leukemia cells completely #lost il-2 dependency , but all show considerablegenome reduction and dependency on the nucleus to fulfill plastid functions (martin and hrrmann , 1998) .
acute t-cell leukemia cells has completely #lost il-2 dependency , but all show considerablegenome reduction and dependency on the nucleus to fulfill plastid functions (martin and hrrmann , 1998) .
acute t-cell leukemia cells having the ability to #lose il-2 dependency has been characterized .
acute t-cell leukemia cells is able to completely #lose il-2 dependency , but all show considerablegenome reduction and dependency on the nucleus to fulfill plastid functions (martin and hrrmann , 1998) .
acute t-cell leukemia cells is observed to completely #lose il-2 dependency , but all show considerablegenome reduction and dependency on the nucleus to fulfill plastid functions (martin and hrrmann , 1998) .
acute t-cell leukemia cells #losing il-2 dependency has been characterized .
acute t-cell leukemia cells may completely #lose il-2 dependency , but all show considerablegenome reduction and dependency on the nucleus to fulfill plastid functions (martin and hrrmann , 1998) .
acute t-cell leukemia cells which #lost il-2 dependency has been characterized .
all a sph i cleavage site within exon 3 are able to be postnatally #lost by a new transthyretin variant .
all a sph i cleavage site within exon 3 could be postnatally #lost by a new transthyretin variant .
all a sph i cleavage site within exon 3 may be postnatally #lost by a new transthyretin variant .
all a sph i cleavage site within exon 3 will be postnatally #lost by a new transthyretin variant .
all a sph i cleavage site within exon 3 would be postnatally #lost by a new transthyretin variant .
all il-2 dependency can probably be postnatally #lost by acute t-cell leukemia cells .
all il-2 dependency could be postnatally #lost by acute t-cell leukemia cells .
all il-2 dependency may be postnatally #lost by acute t-cell leukemia cells .
all il-2 dependency might probably be postnatally #lost by acute t-cell leukemia cells .
all il-2 dependency were postnatally #lost by acute t-cell leukemia cells .
all il-2 dependency would be postnatally #lost by acute t-cell leukemia cells .
all il-2 dependency would probably be postnatally #lost by acute t-cell leukemia cells .
all a sph i cleavage site within exon 3 are able to be postnatally #lost by a new transthyretin variant .
all a sph i cleavage site within exon 3 are observed to be postnatally #lost by a new transthyretin variant .
all a sph i cleavage site within exon 3 can be postnatally #lost by a new transthyretin variant .
all a sph i cleavage site within exon 3 can probably be postnatally #lost by a new transthyretin variant .
all a sph i cleavage site within exon 3 could be postnatally #lost by a new transthyretin variant .
all a sph i cleavage site within exon 3 have a high probability of being postnatally #lost by a new transthyretin variant .
all a sph i cleavage site within exon 3 may probably be postnatally #lost by a new transthyretin variant .
all a sph i cleavage site within exon 3 will be postnatally #lost by a new transthyretin variant .
all a sph i cleavage site within exon 3 will probably be postnatally #lost by a new transthyretin variant .
all a sph i cleavage site within exon 3 would be postnatally #lost by a new transthyretin variant .
all a sph i cleavage site within exon 3 would probably be postnatally #lost by a new transthyretin variant .
stat3 is activated in v-src or v-abl-transformed cells and , along other stats , in the c-terminal-deletion mutant of hnrnp a1 that are observed to #lose the ability to interact with the x protein and to bring it into the initiation complex (migone et al . , 1995; yu et al . , 1995) .
stat3 is activated in v-src or v-abl-transformed cells and , along other stats , in the c-terminal-deletion mutant of hnrnp a1 that have #lost the ability to interact with the x protein and to bring it into the initiation complex (migone et al . , 1995; yu et al . , 1995) .
stat3 is activated in v-src or v-abl-transformed cells and , along other stats , in the c-terminal-deletion mutant of hnrnp a1 that #lost the ability to interact with the x protein and to bring it into the initiation complex (migone et al . , 1995; yu et al . , 1995) .
stat3 is activated in v-src or v-abl-transformed cells and , along other stats , in the c-terminal-deletion mutant of hnrnp a1 that may probably #lose the ability to interact with the x protein and to bring it into the initiation complex (migone et al . , 1995; yu et al . , 1995) .
stat3 is activated in v-src or v-abl-transformed cells and , along other stats , in they #losing modest amounts of weight (migone et al . , 1995; yu et al . , 1995) .
stat3 is activated in v-src or v-abl-transformed cells and , along other stats , in they that are able to #lose modest amounts of weight (migone et al . , 1995; yu et al . , 1995) .
stat3 is activated in v-src or v-abl-transformed cells and , along other stats , in they that are observed to #lose modest amounts of weight (migone et al . , 1995; yu et al . , 1995) .
stat3 is activated in v-src or v-abl-transformed cells and , along other stats , in they that can probably #lose modest amounts of weight (migone et al . , 1995; yu et al . , 1995) .
stat3 is activated in v-src or v-abl-transformed cells and , along other stats , in they that have #lost modest amounts of weight (migone et al . , 1995; yu et al . , 1995) .
stat3 is activated in v-src or v-abl-transformed cells and , along other stats , in they that #lose modest amounts of weight (migone et al . , 1995; yu et al . , 1995) .
stat3 is activated in v-src or v-abl-transformed cells and , along other stats , in they that #lost modest amounts of weight (migone et al . , 1995; yu et al . , 1995) .
stat3 is activated in v-src or v-abl-transformed cells and , along other stats , in truncated species that are observed to #lose the first 20 70 residues (migone et al . , 1995; yu et al . , 1995) .
stat3 is activated in v-src or v-abl-transformed cells and , along other stats , in truncated species that can #lose the first 20 70 residues (migone et al . , 1995; yu et al . , 1995) .
stat3 is activated in v-src or v-abl-transformed cells and , along other stats , in truncated species that can probably #lose the first 20 70 residues (migone et al . , 1995; yu et al . , 1995) .
stat3 is activated in v-src or v-abl-transformed cells and , along other stats , in truncated species that have #lost the first 20 70 residues (migone et al . , 1995; yu et al . , 1995) .
stat3 is activated in v-src or v-abl-transformed cells and , along other stats , in truncated species that #lose the first 20 70 residues (migone et al . , 1995; yu et al . , 1995) .
stat3 is activated in v-src or v-abl-transformed cells and , along other stats , in truncated species that may #lose the first 20 70 residues (migone et al . , 1995; yu et al . , 1995) .
stat3 is activated in v-src or v-abl-transformed cells and , along other stats , in truncated species that may probably #lose the first 20 70 residues (migone et al . , 1995; yu et al . , 1995) .
stat3 is activated in v-src or v-abl-transformed cells and , along other stats , in truncated species that will #lose the first 20 70 residues (migone et al . , 1995; yu et al . , 1995) .
stat3 is activated in v-src or v-abl-transformed cells and , along other stats , in truncated species that will probably #lose the first 20 70 residues (migone et al . , 1995; yu et al . , 1995) .
the c-terminal-deletion mutant of hnrnp a1 has the ability to completely #lose the ability to interact with the x protein and to bring it into the initiation complex , but all show considerablegenome reduction and dependency on the nucleus to fulfill plastid functions (martin and hrrmann , 1998) .
the c-terminal-deletion mutant of hnrnp a1 is completely #losing the ability to interact with the x protein and to bring it into the initiation complex , but all show considerablegenome reduction and dependency on the nucleus to fulfill plastid functions (martin and hrrmann , 1998) .
the c-terminal-deletion mutant of hnrnp a1 is observed to completely #lose the ability to interact with the x protein and to bring it into the initiation complex , but all show considerablegenome reduction and dependency on the nucleus to fulfill plastid functions (martin and hrrmann , 1998) .
the c-terminal-deletion mutant of hnrnp a1 #losing the ability to interact with the x protein and to bring it into the initiation complex has been characterized .
the c-terminal-deletion mutant of hnrnp a1 may completely #lose the ability to interact with the x protein and to bring it into the initiation complex , but all show considerablegenome reduction and dependency on the nucleus to fulfill plastid functions (martin and hrrmann , 1998) .
the c-terminal-deletion mutant of hnrnp a1 observed to #lose the ability to interact with the x protein and to bring it into the initiation complex has been characterized .
the c-terminal-deletion mutant of hnrnp a1 which has #lost the ability to interact with the x protein and to bring it into the initiation complex has been characterized .
the c-terminal-deletion mutant of hnrnp a1 which #loses the ability to interact with the x protein and to bring it into the initiation complex has been characterized .
the c-terminal-deletion mutant of hnrnp a1 which #lost the ability to interact with the x protein and to bring it into the initiation complex has been characterized .
the c-terminal-deletion mutant of hnrnp a1 which may #lose the ability to interact with the x protein and to bring it into the initiation complex has been characterized .
to this end , we made the c-terminal-deletion mutant of hnrnp a1 , which can #lose all the ability to interact with the x protein and to bring it into the initiation complex postnatally , and +/+ control mice .
to this end , we made the c-terminal-deletion mutant of hnrnp a1 , which can probably #lose all the ability to interact with the x protein and to bring it into the initiation complex postnatally , and +/+ control mice .
to this end , we made the c-terminal-deletion mutant of hnrnp a1 , which could probably #lose all the ability to interact with the x protein and to bring it into the initiation complex postnatally , and +/+ control mice .
to this end , we made the c-terminal-deletion mutant of hnrnp a1 , which have a high probability of #losing all the ability to interact with the x protein and to bring it into the initiation complex postnatally , and +/+ control mice .
to this end , we made the c-terminal-deletion mutant of hnrnp a1 , which might #lose all the ability to interact with the x protein and to bring it into the initiation complex postnatally , and +/+ control mice .
to this end , we made the c-terminal-deletion mutant of hnrnp a1 , which might probably #lose all the ability to interact with the x protein and to bring it into the initiation complex postnatally , and +/+ control mice .
to this end , we made the c-terminal-deletion mutant of hnrnp a1 , which will #lose all the ability to interact with the x protein and to bring it into the initiation complex postnatally , and +/+ control mice .
to this end , we made the c-terminal-deletion mutant of hnrnp a1 , which would #lose all the ability to interact with the x protein and to bring it into the initiation complex postnatally , and +/+ control mice .
to this end , we made the c-terminal-deletion mutant of hnrnp a1 , which would probably #lose all the ability to interact with the x protein and to bring it into the initiation complex postnatally , and +/+ control mice .
to this end , we made they #losing all modest amounts of weight postnatally , and +/+ control mice .
to this end , we made they , which are able to #lose all modest amounts of weight postnatally , and +/+ control mice .
to this end , we made they , which are observed to #lose all modest amounts of weight postnatally , and +/+ control mice .
to this end , we made they , which can #lose all modest amounts of weight postnatally , and +/+ control mice .
to this end , we made they , which can probably #lose all modest amounts of weight postnatally , and +/+ control mice .
to this end , we made they , which has #lost all modest amounts of weight postnatally , and +/+ control mice .
to this end , we made they , which have a high probability of #losing all modest amounts of weight postnatally , and +/+ control mice .
to this end , we made they , which #lose all modest amounts of weight postnatally , and +/+ control mice .
to this end , we made they , which may #lose all modest amounts of weight postnatally , and +/+ control mice .
to this end , we made they , which might #lose all modest amounts of weight postnatally , and +/+ control mice .
to this end , we made they , which will probably #lose all modest amounts of weight postnatally , and +/+ control mice .
to this end , we made they , which would #lose all modest amounts of weight postnatally , and +/+ control mice .
to this end , we made truncated species #losing all the first 20 70 residues postnatally , and +/+ control mice .
to this end , we made truncated species , which are able to #lose all the first 20 70 residues postnatally , and +/+ control mice .
to this end , we made truncated species , which could probably #lose all the first 20 70 residues postnatally , and +/+ control mice .
to this end , we made truncated species , which #lose all the first 20 70 residues postnatally , and +/+ control mice .
to this end , we made truncated species , which might probably #lose all the first 20 70 residues postnatally , and +/+ control mice .
to this end , we made truncated species , which will #lose all the first 20 70 residues postnatally , and +/+ control mice .
to this end , we made truncated species , which will probably #lose all the first 20 70 residues postnatally , and +/+ control mice .
to this end , we made truncated species , which would probably #lose all the first 20 70 residues postnatally , and +/+ control mice .
all modest amounts of weight are able to be postnatally #lost by they .
all modest amounts of weight are postnatally #lost by they .
all modest amounts of weight can probably be postnatally #lost by they .
all modest amounts of weight could probably be postnatally #lost by they .
all modest amounts of weight may be postnatally #lost by they .
all modest amounts of weight might be postnatally #lost by they .
all modest amounts of weight will be postnatally #lost by they .
all modest amounts of weight will probably be postnatally #lost by they .
all modest amounts of weight would be postnatally #lost by they .
all the ability to interact with the x protein and to bring it into the initiation complex are able to be postnatally #lost by the c-terminal-deletion mutant of hnrnp a1 .
all the ability to interact with the x protein and to bring it into the initiation complex can be postnatally #lost by the c-terminal-deletion mutant of hnrnp a1 .
all the ability to interact with the x protein and to bring it into the initiation complex can probably be postnatally #lost by the c-terminal-deletion mutant of hnrnp a1 .
all the ability to interact with the x protein and to bring it into the initiation complex could be postnatally #lost by the c-terminal-deletion mutant of hnrnp a1 .
all the ability to interact with the x protein and to bring it into the initiation complex could probably be postnatally #lost by the c-terminal-deletion mutant of hnrnp a1 .
all the ability to interact with the x protein and to bring it into the initiation complex have a high probability of being postnatally #lost by the c-terminal-deletion mutant of hnrnp a1 .
all the ability to interact with the x protein and to bring it into the initiation complex may be postnatally #lost by the c-terminal-deletion mutant of hnrnp a1 .
all the ability to interact with the x protein and to bring it into the initiation complex might be postnatally #lost by the c-terminal-deletion mutant of hnrnp a1 .
all the ability to interact with the x protein and to bring it into the initiation complex might probably be postnatally #lost by the c-terminal-deletion mutant of hnrnp a1 .
all the ability to interact with the x protein and to bring it into the initiation complex would be postnatally #lost by the c-terminal-deletion mutant of hnrnp a1 .
all the ability to interact with the x protein and to bring it into the initiation complex would probably be postnatally #lost by the c-terminal-deletion mutant of hnrnp a1 .
all the first 20 70 residues can be postnatally #lost by truncated species .
all the first 20 70 residues can probably be postnatally #lost by truncated species .
all the first 20 70 residues could be postnatally #lost by truncated species .
all the first 20 70 residues have a high probability of being postnatally #lost by truncated species .
all the first 20 70 residues may probably be postnatally #lost by truncated species .
all the first 20 70 residues might probably be postnatally #lost by truncated species .
all the first 20 70 residues were postnatally #lost by truncated species .
all the first 20 70 residues will be postnatally #lost by truncated species .
all the first 20 70 residues will probably be postnatally #lost by truncated species .
all the first 20 70 residues would probably be postnatally #lost by truncated species .
modest amounts of weight was #lost in they that has been characterized .
the ability to interact with the x protein and to bring it into the initiation complex has been #lost in the c-terminal-deletion mutant of hnrnp a1 that has been characterized .
the ability to interact with the x protein and to bring it into the initiation complex is able to be #lost in the c-terminal-deletion mutant of hnrnp a1 that has been characterized .
the ability to interact with the x protein and to bring it into the initiation complex will be #lost in the c-terminal-deletion mutant of hnrnp a1 that has been characterized .
the first 20 70 residues has been #lost in truncated species that has been characterized .
the first 20 70 residues is able to be #lost in truncated species that has been characterized .
the first 20 70 residues is observed to be #lost in truncated species that has been characterized .
the first 20 70 residues will be #lost in truncated species that has been characterized .
they can completely #lost modest amounts of weight , but all show considerablegenome reduction and dependency on the nucleus to fulfill plastid functions (martin and hrrmann , 1998) .
they completely #lost modest amounts of weight , but all show considerablegenome reduction and dependency on the nucleus to fulfill plastid functions (martin and hrrmann , 1998) .
they having the ability to #lose modest amounts of weight has been characterized .
they is able to completely #lose modest amounts of weight , but all show considerablegenome reduction and dependency on the nucleus to fulfill plastid functions (martin and hrrmann , 1998) .
they may completely #lose modest amounts of weight , but all show considerablegenome reduction and dependency on the nucleus to fulfill plastid functions (martin and hrrmann , 1998) .
they observed to #lose modest amounts of weight has been characterized .
they which #loses modest amounts of weight has been characterized .
they will have completely #lost modest amounts of weight , but all show considerablegenome reduction and dependency on the nucleus to fulfill plastid functions (martin and hrrmann , 1998) .
truncated species can completely #lost the first 20 70 residues , but all show considerablegenome reduction and dependency on the nucleus to fulfill plastid functions (martin and hrrmann , 1998) .
truncated species completely #loses the first 20 70 residues , but all show considerablegenome reduction and dependency on the nucleus to fulfill plastid functions (martin and hrrmann , 1998) .
truncated species has completely #lost the first 20 70 residues , but all show considerablegenome reduction and dependency on the nucleus to fulfill plastid functions (martin and hrrmann , 1998) .
truncated species having the ability to #lose the first 20 70 residues has been characterized .
truncated species observed to #lose the first 20 70 residues has been characterized .
truncated species which #loses the first 20 70 residues has been characterized .
an immunopurification approach has been used to demonstrate that human rna pol iii is composed of 16 subunits apparently #modified in hela cells .
an immunopurification approach has been used to demonstrate that human rna pol iii is composed of 16 subunits being #modified in hela cells .
an immunopurification approach has been used to demonstrate that human rna pol iii is composed of 16 subunits #modified in hela cells .
an immunopurification approach has been used to demonstrate that human rna pol iii is composed of 16 subunits , some of which are able to be #modified in hela cells .
an immunopurification approach has been used to demonstrate that human rna pol iii is composed of 16 subunits , some of which can be apparently #modified in hela cells .
an immunopurification approach has been used to demonstrate that human rna pol iii is composed of 16 subunits , some of which have been apparently #modified in hela cells .
an immunopurification approach has been used to demonstrate that human rna pol iii is composed of 16 subunits , some of which have the ability to be apparently #modified in hela cells .
an immunopurification approach has been used to demonstrate that human rna pol iii is composed of 16 subunits , some of which may be apparently #modified in hela cells .
an immunopurification approach has been used to demonstrate that human rna pol iii is composed of 16 subunits , some of which might have been apparently #modified in hela cells .
an immunopurification approach has been used to demonstrate that human rna pol iii is composed of 16 subunits , some of which will be apparently #modified in hela cells .
an immunopurification approach has been used to demonstrate that some of the 16 subunits that composed human rna pol iii are apparently #modified in hela cells .
an immunopurification approach has been used to demonstrate that some of the 16 subunits that composed human rna pol iii can be apparently #modified in hela cells .
an immunopurification approach has been used to demonstrate that some of the 16 subunits that composed human rna pol iii can be #modified in hela cells .
an immunopurification approach has been used to demonstrate that some of the 16 subunits that composed human rna pol iii have been apparently #modified in hela cells .
an immunopurification approach has been used to demonstrate that some of the 16 subunits that composed human rna pol iii may be apparently #modified in hela cells .
an immunopurification approach has been used to demonstrate that some of the 16 subunits that composed human rna pol iii might have been #modified in hela cells .
an immunopurification approach has been used to demonstrate that some of the 16 subunits that composed human rna pol iii will be #modified in hela cells .
p .falciparum could be #modified genetically by transfection (crabb and cowman , 1996; crabb et al . , 1997a) to disrupt the rap1 gene .
p .falciparum could be notably #modified genetically by transfection (crabb and cowman , 1996; crabb et al . , 1997a) to disrupt the rap1 gene .
p .falciparum could have been #modified genetically by transfection (crabb and cowman , 1996; crabb et al . , 1997a) to disrupt the rap1 gene .
p .falciparum could have been notably #modified genetically by transfection (crabb and cowman , 1996; crabb et al . , 1997a) to disrupt the rap1 gene .
p .falciparum has been #modified genetically by transfection (crabb and cowman , 1996; crabb et al . , 1997a) to disrupt the rap1 gene .
p .falciparum has the probability of being #modified genetically by transfection (crabb and cowman , 1996; crabb et al . , 1997a) to disrupt the rap1 gene .
p .falciparum is able to be notably #modified genetically by transfection (crabb and cowman , 1996; crabb et al . , 1997a) to disrupt the rap1 gene .
p .falciparum is being #modified genetically by transfection (crabb and cowman , 1996; crabb et al . , 1997a) to disrupt the rap1 gene .
p .falciparum may be notably #modified genetically by transfection (crabb and cowman , 1996; crabb et al . , 1997a) to disrupt the rap1 gene .
p .falciparum may have been #modified genetically by transfection (crabb and cowman , 1996; crabb et al . , 1997a) to disrupt the rap1 gene .
p .falciparum may have been notably #modified genetically by transfection (crabb and cowman , 1996; crabb et al . , 1997a) to disrupt the rap1 gene .
p .falciparum might have been #modified genetically by transfection (crabb and cowman , 1996; crabb et al . , 1997a) to disrupt the rap1 gene .
p .falciparum might have been notably #modified genetically by transfection (crabb and cowman , 1996; crabb et al . , 1997a) to disrupt the rap1 gene .
p .falciparum was able to be #modified genetically by transfection (crabb and cowman , 1996; crabb et al . , 1997a) to disrupt the rap1 gene .
p .falciparum was able to be notably #modified genetically by transfection (crabb and cowman , 1996; crabb et al . , 1997a) to disrupt the rap1 gene .
p .falciparum was #modified genetically by transfection (crabb and cowman , 1996; crabb et al . , 1997a) to disrupt the rap1 gene .
p .falciparum was notably #modified genetically by transfection (crabb and cowman , 1996; crabb et al . , 1997a) to disrupt the rap1 gene .
p .falciparum was observed to be notably #modified genetically by transfection (crabb and cowman , 1996; crabb et al . , 1997a) to disrupt the rap1 gene .
taken together these data suggest that the sh3 acts to position the u5 region through its own association with the guk domain and that factors which are observed to #modify the binding of either u5 or sh3 to the guk domain may regulate gkap binding to the guk domain .
taken together these data suggest that the sh3 acts to position the u5 region through its own association with the guk domain and that factors which may #modify the binding of either u5 or sh3 to the guk domain may regulate gkap binding to the guk domain .
taken together these data suggest that the sh3 acts to position the u5 region through its own association with the guk domain and that factors which might have #modified the binding of either u5 or sh3 to the guk domain may regulate gkap binding to the guk domain .
taken together these data suggest that the sh3 acts to position the u5 region through its own association with the guk domain and that factors which will #modify the binding of either u5 or sh3 to the guk domain may regulate gkap binding to the guk domain .
taken together these data suggest that the binding of either u5 or sh3 to the guk domain can be #modified by factors that may regulate gkap binding to the guk domain .
taken together these data suggest that the binding of either u5 or sh3 to the guk domain could have been #modified by factors that may regulate gkap binding to the guk domain .
taken together these data suggest that the binding of either u5 or sh3 to the guk domain has the ability to be #modified by factors that may regulate gkap binding to the guk domain .
taken together these data suggest that the binding of either u5 or sh3 to the guk domain is observed to be #modified by factors that may regulate gkap binding to the guk domain .
taken together these data suggest that the binding of either u5 or sh3 to the guk domain may be #modified by factors that may regulate gkap binding to the guk domain .
taken together these data suggest that the binding of either u5 or sh3 to the guk domain might be #modified by factors that may regulate gkap binding to the guk domain .
taken together these data suggest that the binding of either u5 or sh3 to the guk domain was able to be #modified by factors that may regulate gkap binding to the guk domain .
taken together these data suggest that the binding of either u5 or sh3 to the guk domain would have been #modified by factors that may regulate gkap binding to the guk domain .
these results lead us to conclude that envz and ompr act in sequential fashion to activate porin gene expression; i .e . , envz can significantly #modify or in some way direct ompr , which in turn acts at the appropriate porin gene promoter .
these results lead us to conclude that envz and ompr act in sequential fashion to activate porin gene expression; i .e . , envz could have #modified or in some way directed ompr , which in turn acts at the appropriate porin gene promoter .
these results lead us to conclude that envz and ompr act in sequential fashion to activate porin gene expression; i .e . , envz has #modified or in some way directed ompr , which in turn acts at the appropriate porin gene promoter .
these results lead us to conclude that envz and ompr act in sequential fashion to activate porin gene expression; i .e . , envz has significantly #modified or in some way directed ompr , which in turn acts at the appropriate porin gene promoter .
these results lead us to conclude that envz and ompr act in sequential fashion to activate porin gene expression; i .e . , envz has the ability to significantly #modify or in some way direct ompr , which in turn acts at the appropriate porin gene promoter .
these results lead us to conclude that envz and ompr act in sequential fashion to activate porin gene expression; i .e . , envz has the probability of #modifying or in some way directing ompr , which in turn acts at the appropriate porin gene promoter .
these results lead us to conclude that envz and ompr act in sequential fashion to activate porin gene expression; i .e . , envz is able to #modify or in some way direct ompr , which in turn acts at the appropriate porin gene promoter .
these results lead us to conclude that envz and ompr act in sequential fashion to activate porin gene expression; i .e . , envz is #modifying or in some way directing ompr , which in turn acts at the appropriate porin gene promoter .
these results lead us to conclude that envz and ompr act in sequential fashion to activate porin gene expression; i .e . , envz is observed to #modify or in some way direct ompr , which in turn acts at the appropriate porin gene promoter .
these results lead us to conclude that envz and ompr act in sequential fashion to activate porin gene expression; i .e . , envz is observed to significantly #modify or in some way direct ompr , which in turn acts at the appropriate porin gene promoter .
these results lead us to conclude that envz and ompr act in sequential fashion to activate porin gene expression; i .e . , envz is significantly #modifying or in some way directing ompr , which in turn acts at the appropriate porin gene promoter .
these results lead us to conclude that envz and ompr act in sequential fashion to activate porin gene expression; i .e . , envz may have #modified or in some way directed ompr , which in turn acts at the appropriate porin gene promoter .
these results lead us to conclude that envz and ompr act in sequential fashion to activate porin gene expression; i .e . , envz may have significantly #modified or in some way directed ompr , which in turn acts at the appropriate porin gene promoter .
these results lead us to conclude that envz and ompr act in sequential fashion to activate porin gene expression; i .e . , envz may #modify or in some way direct ompr , which in turn acts at the appropriate porin gene promoter .
these results lead us to conclude that envz and ompr act in sequential fashion to activate porin gene expression; i .e . , envz significantly #modified or in some way directed ompr , which in turn acts at the appropriate porin gene promoter .
these results lead us to conclude that envz and ompr act in sequential fashion to activate porin gene expression; i .e . , envz will #modify or in some way direct ompr , which in turn acts at the appropriate porin gene promoter .
these results lead us to conclude that envz and ompr act in sequential fashion to activate porin gene expression; i .e . , envz would #modify or in some way direct ompr , which in turn acts at the appropriate porin gene promoter .
these results lead us to conclude that envz and ompr act in sequential fashion to activate porin gene expression; i .e . , envz would significantly #modify or in some way direct ompr , which in turn acts at the appropriate porin gene promoter .
these results lead us to conclude that envz and ompr act in sequential fashion to activate porin gene expression; i .e . , ompr , which acts at the appropriate porin gene promoter , could have been significantly #modified or in some way directed by envz .
these results lead us to conclude that envz and ompr act in sequential fashion to activate porin gene expression; i .e . , ompr , which acts at the appropriate porin gene promoter , has the probability of being significantly #modified or in some way directed by envz .
these results lead us to conclude that envz and ompr act in sequential fashion to activate porin gene expression; i .e . , ompr , which acts at the appropriate porin gene promoter , is able to be #modified or in some way directed by envz .
these results lead us to conclude that envz and ompr act in sequential fashion to activate porin gene expression; i .e . , ompr , which acts at the appropriate porin gene promoter , is able to be significantly #modified or in some way directed by envz .
these results lead us to conclude that envz and ompr act in sequential fashion to activate porin gene expression; i .e . , ompr , which acts at the appropriate porin gene promoter , is observed to be significantly #modified or in some way directed by envz .
these results lead us to conclude that envz and ompr act in sequential fashion to activate porin gene expression; i .e . , ompr , which acts at the appropriate porin gene promoter , is significantly #modified or in some way directed by envz .
these results lead us to conclude that envz and ompr act in sequential fashion to activate porin gene expression; i .e . , ompr , which acts at the appropriate porin gene promoter , may have been #modified or in some way directed by envz .
these results lead us to conclude that envz and ompr act in sequential fashion to activate porin gene expression; i .e . , ompr , which acts at the appropriate porin gene promoter , was significantly #modified or in some way directed by envz .
these results lead us to conclude that envz and ompr act in sequential fashion to activate porin gene expression; i .e . , ompr , which acts at the appropriate porin gene promoter , will be significantly #modified or in some way directed by envz .
to define the subcellular location of hvdac isoforms , hvdac genes are able to be #modified so that the encoded proteins contain cooh-terminal epitopes recognized by either of two monoclonal antibodies .
to define the subcellular location of hvdac isoforms , hvdac genes are #modified so that the encoded proteins contain cooh-terminal epitopes recognized by either of two monoclonal antibodies .
to define the subcellular location of hvdac isoforms , hvdac genes are observed to be remarkably #modified so that the encoded proteins contain cooh-terminal epitopes recognized by either of two monoclonal antibodies .
to define the subcellular location of hvdac isoforms , hvdac genes are remarkably #modified so that the encoded proteins contain cooh-terminal epitopes recognized by either of two monoclonal antibodies .
to define the subcellular location of hvdac isoforms , hvdac genes can be #modified so that the encoded proteins contain cooh-terminal epitopes recognized by either of two monoclonal antibodies .
to define the subcellular location of hvdac isoforms , hvdac genes can be remarkably #modified so that the encoded proteins contain cooh-terminal epitopes recognized by either of two monoclonal antibodies .
to define the subcellular location of hvdac isoforms , hvdac genes could have been #modified so that the encoded proteins contain cooh-terminal epitopes recognized by either of two monoclonal antibodies .
to define the subcellular location of hvdac isoforms , hvdac genes could have been remarkably #modified so that the encoded proteins contain cooh-terminal epitopes recognized by either of two monoclonal antibodies .
to define the subcellular location of hvdac isoforms , hvdac genes have the ability to be #modified so that the encoded proteins contain cooh-terminal epitopes recognized by either of two monoclonal antibodies .
to define the subcellular location of hvdac isoforms , hvdac genes may be remarkably #modified so that the encoded proteins contain cooh-terminal epitopes recognized by either of two monoclonal antibodies .
to define the subcellular location of hvdac isoforms , hvdac genes will be #modified so that the encoded proteins contain cooh-terminal epitopes recognized by either of two monoclonal antibodies .
to define the subcellular location of hvdac isoforms , hvdac genes will be remarkably #modified so that the encoded proteins contain cooh-terminal epitopes recognized by either of two monoclonal antibodies .
we have notably #modified p .falciparum genetically by transfection (crabb and cowman , 1996; crabb et al . , 1997a) to disrupt the rap1 gene .
we have the ability to #modify p .falciparum genetically by transfection (crabb and cowman , 1996; crabb et al . , 1997a) to disrupt the rap1 gene .
we have the ability to notably #modify p .falciparum genetically by transfection (crabb and cowman , 1996; crabb et al . , 1997a) to disrupt the rap1 gene .
we notably #modified p .falciparum genetically by transfection (crabb and cowman , 1996; crabb et al . , 1997a) to disrupt the rap1 gene .
we notably #modify p .falciparum genetically by transfection (crabb and cowman , 1996; crabb et al . , 1997a) to disrupt the rap1 gene .
we will notably #modify p .falciparum genetically by transfection (crabb and cowman , 1996; crabb et al . , 1997a) to disrupt the rap1 gene .
taken together these data suggest that the sh3 acts to position the u5 region through its own association with the guk domain and that factors that can #modify the binding of either u5 or sh3 to the guk domain may regulate gkap binding to the guk domain .
an immunopurification approach has been used to demonstrate that human rna pol iii is composed of 16 subunits , some of which are apparently #modified in hela cells .
these results lead us to conclude that envz and ompr act in sequential fashion to activate porin gene expression; i .e . , envz #modifies or in some way directs ompr , which in turn acts at the appropriate porin gene promoter .
an immunopurification approach has been used to demonstrate that human rna pol iii is composed of 16 some of which apparently #modified in hela cells .
an immunopurification approach has been used to demonstrate that human rna pol iii is composed of 16 some of which being #modified in hela cells .
an immunopurification approach has been used to demonstrate that human rna pol iii is composed of 16 some of which #modified in hela cells .
an immunopurification approach has been used to demonstrate that human rna pol iii is composed of 16 some of which , some of which are able to be apparently #modified in hela cells .
an immunopurification approach has been used to demonstrate that human rna pol iii is composed of 16 some of which , some of which can be apparently #modified in hela cells .
an immunopurification approach has been used to demonstrate that human rna pol iii is composed of 16 some of which , some of which have been #modified in hela cells .
an immunopurification approach has been used to demonstrate that human rna pol iii is composed of 16 some of which , some of which have the ability to be apparently #modified in hela cells .
an immunopurification approach has been used to demonstrate that human rna pol iii is composed of 16 some of which , some of which may be #modified in hela cells .
an immunopurification approach has been used to demonstrate that human rna pol iii is composed of 16 some of which , some of which might have been apparently #modified in hela cells .
an immunopurification approach has been used to demonstrate that human rna pol iii is composed of 16 some of which , some of which might have been #modified in hela cells .
an immunopurification approach has been used to demonstrate that human rna pol iii is composed of 16 some of which , some of which were #modified in hela cells .
an immunopurification approach has been used to demonstrate that human rna pol iii is composed of 16 some of which , some of which will be apparently #modified in hela cells .
an immunopurification approach has been used to demonstrate that human rna pol iii is composed of 16 subunits , subunits are apparently #modified in hela cells .
an immunopurification approach has been used to demonstrate that some of the 16 some of which that composed human rna pol iii are observed to be apparently #modified in hela cells .
an immunopurification approach has been used to demonstrate that some of the 16 some of which that composed human rna pol iii can be apparently #modified in hela cells .
an immunopurification approach has been used to demonstrate that some of the 16 some of which that composed human rna pol iii can be #modified in hela cells .
an immunopurification approach has been used to demonstrate that some of the 16 some of which that composed human rna pol iii have the ability to be apparently #modified in hela cells .
an immunopurification approach has been used to demonstrate that some of the 16 some of which that composed human rna pol iii may be apparently #modified in hela cells .
an immunopurification approach has been used to demonstrate that some of the 16 some of which that composed human rna pol iii may be #modified in hela cells .
an immunopurification approach has been used to demonstrate that some of the 16 some of which that composed human rna pol iii were apparently #modified in hela cells .
an immunopurification approach has been used to demonstrate that some of the 16 some of which that composed human rna pol iii were #modified in hela cells .
an immunopurification approach has been used to demonstrate that some of the 16 some of which that composed human rna pol iii will be #modified in hela cells .
an immunopurification approach has been used to demonstrate that human rna pol iii is composed of 16 hvdac genes being apparently #modified in hela cells .
an immunopurification approach has been used to demonstrate that human rna pol iii is composed of 16 hvdac genes , some of which can be apparently #modified in hela cells .
an immunopurification approach has been used to demonstrate that human rna pol iii is composed of 16 hvdac genes , some of which can be #modified in hela cells .
an immunopurification approach has been used to demonstrate that human rna pol iii is composed of 16 hvdac genes , some of which have the ability to be #modified in hela cells .
an immunopurification approach has been used to demonstrate that human rna pol iii is composed of 16 hvdac genes , some of which may be apparently #modified in hela cells .
an immunopurification approach has been used to demonstrate that human rna pol iii is composed of 16 hvdac genes , some of which may be #modified in hela cells .
an immunopurification approach has been used to demonstrate that human rna pol iii is composed of 16 hvdac genes , some of which might have been apparently #modified in hela cells .
an immunopurification approach has been used to demonstrate that human rna pol iii is composed of 16 hvdac genes , some of which were apparently #modified in hela cells .
an immunopurification approach has been used to demonstrate that human rna pol iii is composed of 16 hvdac genes , some of which were #modified in hela cells .
an immunopurification approach has been used to demonstrate that human rna pol iii is composed of 16 hvdac genes , some of which will be apparently #modified in hela cells .
an immunopurification approach has been used to demonstrate that human rna pol iii is composed of 16 hvdac genes , some of which will be #modified in hela cells .
an immunopurification approach has been used to demonstrate that human rna pol iii is composed of 16 hvdac genes , subunits are apparently #modified in hela cells .
an immunopurification approach has been used to demonstrate that human rna pol iii is composed of 16 p .falciparum apparently #modified in hela cells .
an immunopurification approach has been used to demonstrate that human rna pol iii is composed of 16 p .falciparum , some of which are able to be apparently #modified in hela cells .
an immunopurification approach has been used to demonstrate that human rna pol iii is composed of 16 p .falciparum , some of which are able to be #modified in hela cells .
an immunopurification approach has been used to demonstrate that human rna pol iii is composed of 16 p .falciparum , some of which are observed to be apparently #modified in hela cells .
an immunopurification approach has been used to demonstrate that human rna pol iii is composed of 16 p .falciparum , some of which can be apparently #modified in hela cells .
an immunopurification approach has been used to demonstrate that human rna pol iii is composed of 16 p .falciparum , some of which can be #modified in hela cells .
an immunopurification approach has been used to demonstrate that human rna pol iii is composed of 16 p .falciparum , some of which have been #modified in hela cells .
an immunopurification approach has been used to demonstrate that human rna pol iii is composed of 16 p .falciparum , some of which may be apparently #modified in hela cells .
an immunopurification approach has been used to demonstrate that human rna pol iii is composed of 16 p .falciparum , some of which might have been apparently #modified in hela cells .
an immunopurification approach has been used to demonstrate that human rna pol iii is composed of 16 p .falciparum , some of which might have been #modified in hela cells .
an immunopurification approach has been used to demonstrate that human rna pol iii is composed of 16 p .falciparum , some of which were apparently #modified in hela cells .
an immunopurification approach has been used to demonstrate that human rna pol iii is composed of 16 p .falciparum , some of which were #modified in hela cells .
an immunopurification approach has been used to demonstrate that human rna pol iii is composed of 16 p .falciparum , some of which will be apparently #modified in hela cells .
an immunopurification approach has been used to demonstrate that human rna pol iii is composed of 16 p .falciparum , some of which will be #modified in hela cells .
an immunopurification approach has been used to demonstrate that some of the 16 hvdac genes that composed human rna pol iii are able to be apparently #modified in hela cells .
an immunopurification approach has been used to demonstrate that some of the 16 hvdac genes that composed human rna pol iii are able to be #modified in hela cells .
an immunopurification approach has been used to demonstrate that some of the 16 hvdac genes that composed human rna pol iii are apparently #modified in hela cells .
an immunopurification approach has been used to demonstrate that some of the 16 hvdac genes that composed human rna pol iii are #modified in hela cells .
an immunopurification approach has been used to demonstrate that some of the 16 hvdac genes that composed human rna pol iii have been #modified in hela cells .
an immunopurification approach has been used to demonstrate that some of the 16 hvdac genes that composed human rna pol iii have the ability to be apparently #modified in hela cells .
an immunopurification approach has been used to demonstrate that some of the 16 hvdac genes that composed human rna pol iii might have been #modified in hela cells .
an immunopurification approach has been used to demonstrate that some of the 16 hvdac genes that composed human rna pol iii were #modified in hela cells .
an immunopurification approach has been used to demonstrate that some of the 16 hvdac genes that composed human rna pol iii will be apparently #modified in hela cells .
an immunopurification approach has been used to demonstrate that some of the 16 p .falciparum that composed human rna pol iii are able to be apparently #modified in hela cells .
an immunopurification approach has been used to demonstrate that some of the 16 p .falciparum that composed human rna pol iii are able to be #modified in hela cells .
an immunopurification approach has been used to demonstrate that some of the 16 p .falciparum that composed human rna pol iii are apparently #modified in hela cells .
an immunopurification approach has been used to demonstrate that some of the 16 p .falciparum that composed human rna pol iii are #modified in hela cells .
an immunopurification approach has been used to demonstrate that some of the 16 p .falciparum that composed human rna pol iii are observed to be #modified in hela cells .
an immunopurification approach has been used to demonstrate that some of the 16 p .falciparum that composed human rna pol iii can be apparently #modified in hela cells .
an immunopurification approach has been used to demonstrate that some of the 16 p .falciparum that composed human rna pol iii can be #modified in hela cells .
an immunopurification approach has been used to demonstrate that some of the 16 p .falciparum that composed human rna pol iii have been apparently #modified in hela cells .
an immunopurification approach has been used to demonstrate that some of the 16 p .falciparum that composed human rna pol iii have been #modified in hela cells .
an immunopurification approach has been used to demonstrate that some of the 16 p .falciparum that composed human rna pol iii have the ability to be #modified in hela cells .
an immunopurification approach has been used to demonstrate that some of the 16 p .falciparum that composed human rna pol iii may be apparently #modified in hela cells .
an immunopurification approach has been used to demonstrate that some of the 16 p .falciparum that composed human rna pol iii may be #modified in hela cells .
an immunopurification approach has been used to demonstrate that some of the 16 p .falciparum that composed human rna pol iii might have been #modified in hela cells .
an immunopurification approach has been used to demonstrate that some of the 16 p .falciparum that composed human rna pol iii were #modified in hela cells .
an immunopurification approach has been used to demonstrate that some of the 16 p .falciparum that composed human rna pol iii will be apparently #modified in hela cells .
analyses of transcription in vivo of agn-lacz with dam target sequences that are able to be #mutated support this conclusion .
analyses of transcription in vivo of agn-lacz with dam target sequences that may have been #mutated support this conclusion .
analyses of transcription in vivo of agn-lacz with dam target sequences that were #mutated support this conclusion .
analyses of transcription in vivo of agn-lacz with dam target sequences which are able to be #mutated support this conclusion .
analyses of transcription in vivo of agn-lacz with dam target sequences which are #mutated support this conclusion .
analyses of transcription in vivo of agn-lacz with dam target sequences which can be #mutated support this conclusion .
analyses of transcription in vivo of agn-lacz with #mutated dam target sequences support this conclusion .
cotransfections with plasmids expressing wt-1 , wtar (a #mutated form of wt-1) , p53 , and a #mutated form of p53 revealed a complex pattern of regulation with a 3-fold induction with wt-1 , a 7-fold induction with #mutated p53 , and a 4-fold repression with wild-type p53 .
cotransfections with plasmids expressing wt-1 , wtar (a #mutated form of wt-1) , p53 , and a #mutated form of p53 revealed a complex pattern of regulation with a 3-fold induction with wt-1 , a 7-fold induction with p53 that can be #mutated , and a 4-fold repression with wild-type p53 .
cotransfections with plasmids expressing wt-1 , wtar (a #mutated form of wt-1) , p53 , and a #mutated form of p53 revealed a complex pattern of regulation with a 3-fold induction with wt-1 , a 7-fold induction with p53 that can be remarkably #mutated , and a 4-fold repression with wild-type p53 .
cotransfections with plasmids expressing wt-1 , wtar (a #mutated form of wt-1) , p53 , and a #mutated form of p53 revealed a complex pattern of regulation with a 3-fold induction with wt-1 , a 7-fold induction with p53 that could be #mutated , and a 4-fold repression with wild-type p53 .
cotransfections with plasmids expressing wt-1 , wtar (a #mutated form of wt-1) , p53 , and a #mutated form of p53 revealed a complex pattern of regulation with a 3-fold induction with wt-1 , a 7-fold induction with p53 that has been #mutated , and a 4-fold repression with wild-type p53 .
cotransfections with plasmids expressing wt-1 , wtar (a #mutated form of wt-1) , p53 , and a #mutated form of p53 revealed a complex pattern of regulation with a 3-fold induction with wt-1 , a 7-fold induction with p53 that is believed to be remarkably #mutated , and a 4-fold repression with wild-type p53 .
cotransfections with plasmids expressing wt-1 , wtar (a #mutated form of wt-1) , p53 , and a #mutated form of p53 revealed a complex pattern of regulation with a 3-fold induction with wt-1 , a 7-fold induction with p53 that is #mutated , and a 4-fold repression with wild-type p53 .
cotransfections with plasmids expressing wt-1 , wtar (a #mutated form of wt-1) , p53 , and a #mutated form of p53 revealed a complex pattern of regulation with a 3-fold induction with wt-1 , a 7-fold induction with p53 that is observed to be remarkably #mutated , and a 4-fold repression with wild-type p53 .
cotransfections with plasmids expressing wt-1 , wtar (a #mutated form of wt-1) , p53 , and a #mutated form of p53 revealed a complex pattern of regulation with a 3-fold induction with wt-1 , a 7-fold induction with p53 that may be remarkably #mutated , and a 4-fold repression with wild-type p53 .
cotransfections with plasmids expressing wt-1 , wtar (a #mutated form of wt-1) , p53 , and a #mutated form of p53 revealed a complex pattern of regulation with a 3-fold induction with wt-1 , a 7-fold induction with p53 that might be #mutated , and a 4-fold repression with wild-type p53 .
cotransfections with plasmids expressing wt-1 , wtar (a #mutated form of wt-1) , p53 , and a #mutated form of p53 revealed a complex pattern of regulation with a 3-fold induction with wt-1 , a 7-fold induction with p53 that might be remarkably #mutated , and a 4-fold repression with wild-type p53 .
cotransfections with plasmids expressing wt-1 , wtar (a #mutated form of wt-1) , p53 , and a #mutated form of p53 revealed a complex pattern of regulation with a 3-fold induction with wt-1 , a 7-fold induction with p53 that will be #mutated , and a 4-fold repression with wild-type p53 .
cotransfections with plasmids expressing wt-1 , wtar (a #mutated form of wt-1) , p53 , and a #mutated form of p53 revealed a complex pattern of regulation with a 3-fold induction with wt-1 , a 7-fold induction with p53 that would be remarkably #mutated , and a 4-fold repression with wild-type p53 .
cotransfections with plasmids expressing wt-1 , wtar (a #mutated form of wt-1) , p53 , and a #mutated form of p53 revealed a complex pattern of regulation with a 3-fold induction with wt-1 , a 7-fold induction with p53 which could be #mutated , and a 4-fold repression with wild-type p53 .
cotransfections with plasmids expressing wt-1 , wtar (a #mutated form of wt-1) , p53 , and a #mutated form of p53 revealed a complex pattern of regulation with a 3-fold induction with wt-1 , a 7-fold induction with p53 which has the ability to be #mutated , and a 4-fold repression with wild-type p53 .
cotransfections with plasmids expressing wt-1 , wtar (a #mutated form of wt-1) , p53 , and a #mutated form of p53 revealed a complex pattern of regulation with a 3-fold induction with wt-1 , a 7-fold induction with p53 which has the ability to be remarkably #mutated , and a 4-fold repression with wild-type p53 .
cotransfections with plasmids expressing wt-1 , wtar (a #mutated form of wt-1) , p53 , and a #mutated form of p53 revealed a complex pattern of regulation with a 3-fold induction with wt-1 , a 7-fold induction with p53 which is able to be #mutated , and a 4-fold repression with wild-type p53 .
cotransfections with plasmids expressing wt-1 , wtar (a #mutated form of wt-1) , p53 , and a #mutated form of p53 revealed a complex pattern of regulation with a 3-fold induction with wt-1 , a 7-fold induction with p53 which is #mutated , and a 4-fold repression with wild-type p53 .
cotransfections with plasmids expressing wt-1 , wtar (a #mutated form of wt-1) , p53 , and a #mutated form of p53 revealed a complex pattern of regulation with a 3-fold induction with wt-1 , a 7-fold induction with p53 which might have been #mutated , and a 4-fold repression with wild-type p53 .
cotransfections with plasmids expressing wt-1 , wtar (a #mutated form of wt-1) , p53 , and a #mutated form of p53 revealed a complex pattern of regulation with a 3-fold induction with wt-1 , a 7-fold induction with p53 which might have been remarkably #mutated , and a 4-fold repression with wild-type p53 .
cotransfections with plasmids expressing wt-1 , wtar (a #mutated form of wt-1) , p53 , and a #mutated form of p53 revealed a complex pattern of regulation with a 3-fold induction with wt-1 , a 7-fold induction with p53 which will be #mutated , and a 4-fold repression with wild-type p53 .
for example , #mutating the c-terminal map kinase sites (t235 and t239) essentially leads to abolished egf-stimulated increase in phosphorylation and prevented egf-induced mobility shift (figure 5c , lanes 7 and 8) .
for example , #mutating the c-terminal map kinase sites (t235 and t239) is observed to essentially led to abolished egf-stimulated increase in phosphorylation and prevented egf-induced mobility shift (figure 5c , lanes 7 and 8) .
for example , to #mutate the c-terminal map kinase sites (t235 and t239) is observed to essentially led to abolished egf-stimulated increase in phosphorylation and prevented egf-induced mobility shift (figure 5c , lanes 7 and 8) .
for example , to #mutate the c-terminal map kinase sites (t235 and t239) may have essentially led to abolished egf-stimulated increase in phosphorylation and prevented egf-induced mobility shift (figure 5c , lanes 7 and 8) .
in cos-7 cells cotransfected with pka-calpha and sox9 expression plasmids , pka enhanced the phosphorylation of wild-type sox9 but did not affect phosphorylation of a sox9 protein in which the two pka phosphorylation sites (s (64) and s (211)) are able to be #mutated .
in cos-7 cells cotransfected with pka-calpha and sox9 expression plasmids , pka enhanced the phosphorylation of wild-type sox9 but did not affect phosphorylation of a sox9 protein in which the two pka phosphorylation sites (s (64) and s (211)) are able to be significantly #mutated .
in cos-7 cells cotransfected with pka-calpha and sox9 expression plasmids , pka enhanced the phosphorylation of wild-type sox9 but did not affect phosphorylation of a sox9 protein in which the two pka phosphorylation sites (s (64) and s (211)) could have already been #mutated .
in cos-7 cells cotransfected with pka-calpha and sox9 expression plasmids , pka enhanced the phosphorylation of wild-type sox9 but did not affect phosphorylation of a sox9 protein in which the two pka phosphorylation sites (s (64) and s (211)) have already been #mutated .
in cos-7 cells cotransfected with pka-calpha and sox9 expression plasmids , pka enhanced the phosphorylation of wild-type sox9 but did not affect phosphorylation of a sox9 protein in which the two pka phosphorylation sites (s (64) and s (211)) have already been significantly #mutated .
in cos-7 cells cotransfected with pka-calpha and sox9 expression plasmids , pka enhanced the phosphorylation of wild-type sox9 but did not affect phosphorylation of a sox9 protein in which the two pka phosphorylation sites (s (64) and s (211)) have been significantly #mutated .
in cos-7 cells cotransfected with pka-calpha and sox9 expression plasmids , pka enhanced the phosphorylation of wild-type sox9 but did not affect phosphorylation of a sox9 protein in which the two pka phosphorylation sites (s (64) and s (211)) have the ability to be significantly #mutated .
in cos-7 cells cotransfected with pka-calpha and sox9 expression plasmids , pka enhanced the phosphorylation of wild-type sox9 but did not affect phosphorylation of a sox9 protein in which the two pka phosphorylation sites (s (64) and s (211)) were significantly #mutated .
#mutating amino acids ee(437 and 438) to aa can generate the dna-binding mutant(stat5aee-aa) of stat5a .
#mutating amino acids ee(437 and 438) to aa could generate the dna-binding mutant(stat5aee-aa) of stat5a .
#mutating amino acids ee(437 and 438) to aa could have generated the dna-binding mutant(stat5aee-aa) of stat5a .
#mutating amino acids ee(437 and 438) to aa generates the dna-binding mutant(stat5aee-aa) of stat5a .
#mutating amino acids ee(437 and 438) to aa has generated the dna-binding mutant(stat5aee-aa) of stat5a .
#mutating amino acids ee(437 and 438) to aa has the ability to generate the dna-binding mutant(stat5aee-aa) of stat5a .
#mutating amino acids ee(437 and 438) to aa is able to generate the dna-binding mutant(stat5aee-aa) of stat5a .
#mutating amino acids ee(437 and 438) to aa would generate the dna-binding mutant(stat5aee-aa) of stat5a .
#mutating the c-terminal map kinase sites (t235 and t239) , for example , has essentially led to abolished egf-stimulated increase in phosphorylation and prevented egf-induced mobility shift (figure 5c , lanes 7 and 8) .
#mutating the c-terminal map kinase sites (t235 and t239) , for example , is observed to essentially led to abolished egf-stimulated increase in phosphorylation and prevented egf-induced mobility shift (figure 5c , lanes 7 and 8) .
#mutating the c-terminal map kinase sites (t235 and t239) , in contrast , essentially leads to abolished egf-stimulated increase in phosphorylation and prevented egf-induced mobility shift (figure 5c , lanes 7 and 8) .
our research has shown that #mutating the c-terminal map kinase sites (t235 and t239) has essentially led to abolished egf-stimulated increase in phosphorylation and prevented egf-induced mobility shift (figure 5c , lanes 7 and 8) .
our research has shown that #mutating the c-terminal map kinase sites (t235 and t239) is observed to essentially led to abolished egf-stimulated increase in phosphorylation and prevented egf-induced mobility shift (figure 5c , lanes 7 and 8) .
our research has shown that to #mutate the c-terminal map kinase sites (t235 and t239) has essentially led to abolished egf-stimulated increase in phosphorylation and prevented egf-induced mobility shift (figure 5c , lanes 7 and 8) .
our research has shown that to #mutate the c-terminal map kinase sites (t235 and t239) is observed to essentially led to abolished egf-stimulated increase in phosphorylation and prevented egf-induced mobility shift (figure 5c , lanes 7 and 8) .
our research has shown that to #mutate the c-terminal map kinase sites (t235 and t239) may have essentially led to abolished egf-stimulated increase in phosphorylation and prevented egf-induced mobility shift (figure 5c , lanes 7 and 8) .
rca is comprised of two major steps: (i) identifying pairs of residue positions #mutating in a coordinated manner , and (ii) using these results to identify protein regions that interact with an uncommonly high number of other residues .
rca is comprised of two major steps: (i) identifying pairs of residue positions observed to #mutate in a coordinated manner , and (ii) using these results to identify protein regions that interact with an uncommonly high number of other residues .
rca is comprised of two major steps: (i) identifying pairs of residue positions that can #mutate in a coordinated manner , and (ii) using these results to identify protein regions that interact with an uncommonly high number of other residues .
rca is comprised of two major steps: (i) identifying pairs of residue positions that has #mutated in a coordinated manner , and (ii) using these results to identify protein regions that interact with an uncommonly high number of other residues .
rca is comprised of two major steps: (i) identifying pairs of residue positions that may #mutate in a coordinated manner , and (ii) using these results to identify protein regions that interact with an uncommonly high number of other residues .
rca is comprised of two major steps: (i) identifying pairs of residue positions that might have #mutated in a coordinated manner , and (ii) using these results to identify protein regions that interact with an uncommonly high number of other residues .
rca is comprised of two major steps: (i) identifying pairs of residue positions that might #mutate in a coordinated manner , and (ii) using these results to identify protein regions that interact with an uncommonly high number of other residues .
rca is comprised of two major steps: (i) identifying pairs of residue positions that will #mutate in a coordinated manner , and (ii) using these results to identify protein regions that interact with an uncommonly high number of other residues .
rca is comprised of two major steps: (i) identifying pairs of residue positions which could #mutate in a coordinated manner , and (ii) using these results to identify protein regions which interact with an uncommonly high number of other residues .
rca is comprised of two major steps: (i) identifying pairs of residue positions which has #mutated in a coordinated manner , and (ii) using these results to identify protein regions which interact with an uncommonly high number of other residues .
rca is comprised of two major steps: (i) identifying pairs of residue positions which have the ability to #mutate in a coordinated manner , and (ii) using these results to identify protein regions which interact with an uncommonly high number of other residues .
rca is comprised of two major steps: (i) identifying pairs of residue positions which may #mutate in a coordinated manner , and (ii) using these results to identify protein regions which interact with an uncommonly high number of other residues .
rca is comprised of two major steps: (i) identifying pairs of residue positions which might have #mutated in a coordinated manner , and (ii) using these results to identify protein regions which interact with an uncommonly high number of other residues .
the dna-binding mutant(stat5aee-aa) of stat5a is generated by #mutating amino acids ee(437 and 438) to aa .
the dna-binding mutant(stat5aee-aa) of stat5a is observed to be generated by #mutating amino acids ee(437 and 438) to aa .
the gene being #mutated in variant late-infantile neuronal ceroid lipofuscinosis (cln6) and in nclf mutant mice has encoded a novel predicted transmembrane protein .
the gene having the ability to be #mutated in variant late-infantile neuronal ceroid lipofuscinosis (cln6) and in nclf mutant mice encodes a novel predicted transmembrane protein .
the gene having the ability to be #mutated in variant late-infantile neuronal ceroid lipofuscinosis (cln6) and in nclf mutant mice has encoded a novel predicted transmembrane protein .
the gene #mutated in variant late-infantile neuronal ceroid lipofuscinosis (cln6) and in nclf mutant mice encodes a novel predicted transmembrane protein .
the gene #mutated in variant late-infantile neuronal ceroid lipofuscinosis (cln6) and in nclf mutant mice has encoded a novel predicted transmembrane protein .
the gene observed to be #mutated in variant late-infantile neuronal ceroid lipofuscinosis (cln6) and in nclf mutant mice encodes a novel predicted transmembrane protein .
the gene that can be #mutated in variant late-infantile neuronal ceroid lipofuscinosis (cln6) and in nclf mutant mice encodes a novel predicted transmembrane protein .
the gene that can be #mutated in variant late-infantile neuronal ceroid lipofuscinosis (cln6) and in nclf mutant mice has encoded a novel predicted transmembrane protein .
the gene that has been #mutated in variant late-infantile neuronal ceroid lipofuscinosis (cln6) and in nclf mutant mice encodes a novel predicted transmembrane protein .
the gene that has been #mutated in variant late-infantile neuronal ceroid lipofuscinosis (cln6) and in nclf mutant mice has encoded a novel predicted transmembrane protein .
the gene that is able to be #mutated in variant late-infantile neuronal ceroid lipofuscinosis (cln6) and in nclf mutant mice encodes a novel predicted transmembrane protein .
the gene that is able to be #mutated in variant late-infantile neuronal ceroid lipofuscinosis (cln6) and in nclf mutant mice has encoded a novel predicted transmembrane protein .
the gene that is observed to be #mutated in variant late-infantile neuronal ceroid lipofuscinosis (cln6) and in nclf mutant mice has encoded a novel predicted transmembrane protein .
the gene that may have been #mutated in variant late-infantile neuronal ceroid lipofuscinosis (cln6) and in nclf mutant mice encodes a novel predicted transmembrane protein .
the gene that may have been #mutated in variant late-infantile neuronal ceroid lipofuscinosis (cln6) and in nclf mutant mice has encoded a novel predicted transmembrane protein .
the gene that was #mutated in variant late-infantile neuronal ceroid lipofuscinosis (cln6) and in nclf mutant mice has encoded a novel predicted transmembrane protein .
the gene that will be #mutated in variant late-infantile neuronal ceroid lipofuscinosis (cln6) and in nclf mutant mice encodes a novel predicted transmembrane protein .
the template fragments are #mutated by the sequence of sap97 rat , accession no .q62696 using the program swiss pdb viewer (guex and peitsch , 1997) .
the template fragments are observed to be #mutated by the sequence of sap97 rat , accession no .q62696 using the program swiss pdb viewer (guex and peitsch , 1997) .
the template fragments can be significantly #mutated by the sequence of sap97 rat , accession no .q62696 using the program swiss pdb viewer (guex and peitsch , 1997) .
the template fragments could have been significantly #mutated by the sequence of sap97 rat , accession no .q62696 using the program swiss pdb viewer (guex and peitsch , 1997) .
the template fragments have been #mutated by the sequence of sap97 rat , accession no .q62696 using the program swiss pdb viewer (guex and peitsch , 1997) .
the template fragments have been significantly #mutated by the sequence of sap97 rat , accession no .q62696 using the program swiss pdb viewer (guex and peitsch , 1997) .
the template fragments have the probability of being significantly #mutated by the sequence of sap97 rat , accession no .q62696 using the program swiss pdb viewer (guex and peitsch , 1997) .
the template fragments may be #mutated by the sequence of sap97 rat , accession no .q62696 using the program swiss pdb viewer (guex and peitsch , 1997) .
the template fragments might be #mutated by the sequence of sap97 rat , accession no .q62696 using the program swiss pdb viewer (guex and peitsch , 1997) .
the template fragments might have been significantly #mutated by the sequence of sap97 rat , accession no .q62696 using the program swiss pdb viewer (guex and peitsch , 1997) .
the template fragments will be #mutated by the sequence of sap97 rat , accession no .q62696 using the program swiss pdb viewer (guex and peitsch , 1997) .
the template fragments will be significantly #mutated by the sequence of sap97 rat , accession no .q62696 using the program swiss pdb viewer (guex and peitsch , 1997) .
this epitope , which is hla-a2 restricted , includes two amino acids being able to commonly #mutate (v82a and i84v) in the face of protease inhibitor therapy .
this epitope , which is hla-a2 restricted , includes two amino acids being able to #mutate (v82a and i84v) in the face of protease inhibitor therapy .
this epitope , which is hla-a2 restricted , includes two amino acids that are commonly #mutating (v82a and i84v) in the face of protease inhibitor therapy .
this epitope , which is hla-a2 restricted , includes two amino acids that are observed to commonly #mutate (v82a and i84v) in the face of protease inhibitor therapy .
this epitope , which is hla-a2 restricted , includes two amino acids that are observed to #mutate (v82a and i84v) in the face of protease inhibitor therapy .
this epitope , which is hla-a2 restricted , includes two amino acids that can #mutate (v82a and i84v) in the face of protease inhibitor therapy .
this epitope , which is hla-a2 restricted , includes two amino acids that could have commonly #mutated (v82a and i84v) in the face of protease inhibitor therapy .
this epitope , which is hla-a2 restricted , includes two amino acids that have commonly #mutated (v82a and i84v) in the face of protease inhibitor therapy .
this epitope , which is hla-a2 restricted , includes two amino acids that may have #mutated (v82a and i84v) in the face of protease inhibitor therapy .
this epitope , which is hla-a2 restricted , includes two amino acids that #mutated (v82a and i84v) in the face of protease inhibitor therapy .
this epitope , which is hla-a2 restricted , includes two amino acids that will commonly #mutate (v82a and i84v) in the face of protease inhibitor therapy .
this epitope , which is hla-a2 restricted , includes two amino acids that will #mutate (v82a and i84v) in the face of protease inhibitor therapy .
this epitope , which is hla-a2 restricted , includes two amino acids which are able to commonly #mutate (v82a and i84v) in the face of protease inhibitor therapy .
this epitope , which is hla-a2 restricted , includes two amino acids which are able to #mutate (v82a and i84v) in the face of protease inhibitor therapy .
this epitope , which is hla-a2 restricted , includes two amino acids which are observed to #mutate (v82a and i84v) in the face of protease inhibitor therapy .
this epitope , which is hla-a2 restricted , includes two amino acids which can commonly #mutate (v82a and i84v) in the face of protease inhibitor therapy .
this epitope , which is hla-a2 restricted , includes two amino acids which could have #mutated (v82a and i84v) in the face of protease inhibitor therapy .
this epitope , which is hla-a2 restricted , includes two amino acids which have commonly #mutated (v82a and i84v) in the face of protease inhibitor therapy .
this epitope , which is hla-a2 restricted , includes two amino acids which may have #mutated (v82a and i84v) in the face of protease inhibitor therapy .
this epitope , which is hla-a2 restricted , includes two amino acids which may #mutate (v82a and i84v) in the face of protease inhibitor therapy .
this epitope , which is hla-a2 restricted , includes two amino acids which #mutated (v82a and i84v) in the face of protease inhibitor therapy .
this epitope , which is hla-a2 restricted , includes two amino acids which will commonly #mutate (v82a and i84v) in the face of protease inhibitor therapy .
to determine how activators interact with the complex and to examine the importance of these interactions , relative to other potential targeting mechanisms , for swi/snf function , the activator-interaction domains in the complex have been identified and #mutated .
to determine how activators interact with the complex and to examine the importance of these interactions , relative to other potential targeting mechanisms , for swi/snf function , the activator-interaction domains in the complex will be identified and #mutated .
to determine how activators interact with the complex and to examine the importance of these interactions , relative to other potential targeting mechanisms , for swi/snf function , we found to identify and #mutate the activator-interaction domains in the complex .
to determine how activators interact with the complex and to examine the importance of these interactions , relative to other potential targeting mechanisms , for swi/snf function , we have identified and #mutated the activator-interaction domains in the complex .
to #mutate amino acids ee(437 and 438) to aa could generate the dna-binding mutant(stat5aee-aa) of stat5a .
to #mutate amino acids ee(437 and 438) to aa could have generated the dna-binding mutant(stat5aee-aa) of stat5a .
to #mutate amino acids ee(437 and 438) to aa generated the dna-binding mutant(stat5aee-aa) of stat5a .
to #mutate amino acids ee(437 and 438) to aa generates the dna-binding mutant(stat5aee-aa) of stat5a .
to #mutate amino acids ee(437 and 438) to aa has the ability to generate the dna-binding mutant(stat5aee-aa) of stat5a .
to #mutate amino acids ee(437 and 438) to aa is able to generate the dna-binding mutant(stat5aee-aa) of stat5a .
to #mutate amino acids ee(437 and 438) to aa will generate the dna-binding mutant(stat5aee-aa) of stat5a .
to #mutate the c-terminal map kinase sites (t235 and t239) , for example , has essentially led to abolished egf-stimulated increase in phosphorylation and prevented egf-induced mobility shift (figure 5c , lanes 7 and 8) .
to #mutate the c-terminal map kinase sites (t235 and t239) , for example , may have essentially led to abolished egf-stimulated increase in phosphorylation and prevented egf-induced mobility shift (figure 5c , lanes 7 and 8) .
to #mutate the c-terminal map kinase sites (t235 and t239) , in contrast , essentially leads to abolished egf-stimulated increase in phosphorylation and prevented egf-induced mobility shift (figure 5c , lanes 7 and 8) .
to #mutate the c-terminal map kinase sites (t235 and t239) , in contrast , has essentially led to abolished egf-stimulated increase in phosphorylation and prevented egf-induced mobility shift (figure 5c , lanes 7 and 8) .
in contrast , #mutating the c-terminal map kinase sites (t235 and t239) essentially leads to abolished egf-stimulated increase in phosphorylation and prevented egf-induced mobility shift (figure 5c , lanes 7 and 8) .
the dna-binding mutant(stat5aee-aa) of stat5a was generated by #mutating amino acids ee(437 and 438) to aa .
cotransfections with plasmids expressing wt-1 , wtar (a #mutated form of wt-1) , p53 , and a #mutated form of p53 revealed a complex pattern of regulation with a 3-fold induction with wt-1 , a 7-fold induction with #mutated p53 , and a 4-fold repression with wild-type p53 .
in cos-7 cells cotransfected with pka-calpha and sox9 expression plasmids , pka enhanced the phosphorylation of wild-type sox9 but did not affect phosphorylation of a sox9 protein in which the two pka phosphorylation sites (s (64) and s (211)) were #mutated .
rca is comprised of two major steps: (i) identifying pairs of residue positions that #mutate in a coordinated manner , and (ii) using these results to identify protein regions that interact with an uncommonly high number of other residues .
the gene #mutated in variant late-infantile neuronal ceroid lipofuscinosis (cln6) and nclf mutant mice encodes a novel predicted transmembrane protein .
this epitope , which is hla-a2 restricted , includes two amino acids that commonly #mutate (v82a and i84v) in the face of protease inhibitor therapy .
analyses of transcription in vivo of agn-lacz with the activator-interaction domains in the complex that are able to be #mutated support this conclusion .
analyses of transcription in vivo of agn-lacz with the activator-interaction domains in the complex that are #mutated support this conclusion .
analyses of transcription in vivo of agn-lacz with the activator-interaction domains in the complex which can be #mutated support this conclusion .
analyses of transcription in vivo of agn-lacz with the activator-interaction domains in the complex which have been #mutated support this conclusion .
in cos-7 cells cotransfected with pka-calpha and sox9 expression plasmids , pka enhanced the phosphorylation of wild-type sox9 but did not affect phosphorylation of a sox9 protein in which s (64) and s (211) are able to be significantly #mutated .
in cos-7 cells cotransfected with pka-calpha and sox9 expression plasmids , pka enhanced the phosphorylation of wild-type sox9 but did not affect phosphorylation of a sox9 protein in which s (64) and s (211) could have already been significantly #mutated .
in cos-7 cells cotransfected with pka-calpha and sox9 expression plasmids , pka enhanced the phosphorylation of wild-type sox9 but did not affect phosphorylation of a sox9 protein in which s (64) and s (211) could have been #mutated .
in cos-7 cells cotransfected with pka-calpha and sox9 expression plasmids , pka enhanced the phosphorylation of wild-type sox9 but did not affect phosphorylation of a sox9 protein in which s (64) and s (211) have already been significantly #mutated .
in cos-7 cells cotransfected with pka-calpha and sox9 expression plasmids , pka enhanced the phosphorylation of wild-type sox9 but did not affect phosphorylation of a sox9 protein in which s (64) and s (211) have been #mutated .
in cos-7 cells cotransfected with pka-calpha and sox9 expression plasmids , pka enhanced the phosphorylation of wild-type sox9 but did not affect phosphorylation of a sox9 protein in which s (64) and s (211) have been significantly #mutated .
in cos-7 cells cotransfected with pka-calpha and sox9 expression plasmids , pka enhanced the phosphorylation of wild-type sox9 but did not affect phosphorylation of a sox9 protein in which s (64) and s (211) were observed to be #mutated .
in cos-7 cells cotransfected with pka-calpha and sox9 expression plasmids , pka enhanced the phosphorylation of wild-type sox9 but did not affect phosphorylation of a sox9 protein in which s (64) and s (211) were observed to be significantly #mutated .
in cos-7 cells cotransfected with pka-calpha and sox9 expression plasmids , pka enhanced the phosphorylation of wild-type sox9 but did not affect phosphorylation of a the template fragments in which the sequence of sap97 rat are able to be significantly #mutated .
in cos-7 cells cotransfected with pka-calpha and sox9 expression plasmids , pka enhanced the phosphorylation of wild-type sox9 but did not affect phosphorylation of a the template fragments in which the sequence of sap97 rat are significantly #mutated .
in cos-7 cells cotransfected with pka-calpha and sox9 expression plasmids , pka enhanced the phosphorylation of wild-type sox9 but did not affect phosphorylation of a the template fragments in which the sequence of sap97 rat could have already been significantly #mutated .
in cos-7 cells cotransfected with pka-calpha and sox9 expression plasmids , pka enhanced the phosphorylation of wild-type sox9 but did not affect phosphorylation of a the template fragments in which the sequence of sap97 rat could have been #mutated .
in cos-7 cells cotransfected with pka-calpha and sox9 expression plasmids , pka enhanced the phosphorylation of wild-type sox9 but did not affect phosphorylation of a the template fragments in which the sequence of sap97 rat could have been significantly #mutated .
in cos-7 cells cotransfected with pka-calpha and sox9 expression plasmids , pka enhanced the phosphorylation of wild-type sox9 but did not affect phosphorylation of a the template fragments in which the sequence of sap97 rat have already been #mutated .
in cos-7 cells cotransfected with pka-calpha and sox9 expression plasmids , pka enhanced the phosphorylation of wild-type sox9 but did not affect phosphorylation of a the template fragments in which the sequence of sap97 rat have been significantly #mutated .
in cos-7 cells cotransfected with pka-calpha and sox9 expression plasmids , pka enhanced the phosphorylation of wild-type sox9 but did not affect phosphorylation of a the template fragments in which the sequence of sap97 rat were #mutated .
in cos-7 cells cotransfected with pka-calpha and sox9 expression plasmids , pka enhanced the phosphorylation of wild-type sox9 but did not affect phosphorylation of a the template fragments in which the sequence of sap97 rat were observed to be #mutated .
sox9 protein are able to be #mutated by s (64) and s (211) , accession no .q62696 using the program swiss pdb viewer (guex and peitsch , 1997) .
sox9 protein are #mutated by s (64) and s (211) , accession no .q62696 using the program swiss pdb viewer (guex and peitsch , 1997) .
sox9 protein are observed to be #mutated by the two pka phosphorylation sites (s (64) and s (211)) , accession no .q62696 using the program swiss pdb viewer (guex and peitsch , 1997) .
sox9 protein are observed to be significantly #mutated by s (64) and s (211) , accession no .q62696 using the program swiss pdb viewer (guex and peitsch , 1997) .
sox9 protein are observed to be significantly #mutated by the two pka phosphorylation sites (s (64) and s (211)) , accession no .q62696 using the program swiss pdb viewer (guex and peitsch , 1997) .
sox9 protein can be significantly #mutated by s (64) and s (211) , accession no .q62696 using the program swiss pdb viewer (guex and peitsch , 1997) .
sox9 protein could be #mutated by s (64) and s (211) , accession no .q62696 using the program swiss pdb viewer (guex and peitsch , 1997) .
sox9 protein could be significantly #mutated by the two pka phosphorylation sites (s (64) and s (211)) , accession no .q62696 using the program swiss pdb viewer (guex and peitsch , 1997) .
sox9 protein could have been significantly #mutated by the two pka phosphorylation sites (s (64) and s (211)) , accession no .q62696 using the program swiss pdb viewer (guex and peitsch , 1997) .
sox9 protein have been #mutated by s (64) and s (211) , accession no .q62696 using the program swiss pdb viewer (guex and peitsch , 1997) .
sox9 protein have the probability of being #mutated by s (64) and s (211) , accession no .q62696 using the program swiss pdb viewer (guex and peitsch , 1997) .
sox9 protein have the probability of being #mutated by the two pka phosphorylation sites (s (64) and s (211)) , accession no .q62696 using the program swiss pdb viewer (guex and peitsch , 1997) .
sox9 protein have the probability of being significantly #mutated by s (64) and s (211) , accession no .q62696 using the program swiss pdb viewer (guex and peitsch , 1997) .
sox9 protein have the probability of being significantly #mutated by the two pka phosphorylation sites (s (64) and s (211)) , accession no .q62696 using the program swiss pdb viewer (guex and peitsch , 1997) .
sox9 protein might be #mutated by the two pka phosphorylation sites (s (64) and s (211)) , accession no .q62696 using the program swiss pdb viewer (guex and peitsch , 1997) .
sox9 protein might be significantly #mutated by the two pka phosphorylation sites (s (64) and s (211)) , accession no .q62696 using the program swiss pdb viewer (guex and peitsch , 1997) .
sox9 protein might have been #mutated by s (64) and s (211) , accession no .q62696 using the program swiss pdb viewer (guex and peitsch , 1997) .
sox9 protein might have been significantly #mutated by s (64) and s (211) , accession no .q62696 using the program swiss pdb viewer (guex and peitsch , 1997) .
sox9 protein will be #mutated by the two pka phosphorylation sites (s (64) and s (211)) , accession no .q62696 using the program swiss pdb viewer (guex and peitsch , 1997) .
sox9 protein will be significantly #mutated by the two pka phosphorylation sites (s (64) and s (211)) , accession no .q62696 using the program swiss pdb viewer (guex and peitsch , 1997) .
sox9 protein would be #mutated by s (64) and s (211) , accession no .q62696 using the program swiss pdb viewer (guex and peitsch , 1997) .
sox9 protein would be #mutated by the two pka phosphorylation sites (s (64) and s (211)) , accession no .q62696 using the program swiss pdb viewer (guex and peitsch , 1997) .
to determine how activators interact with the complex and to examine the importance of these interactions , relative to other potential targeting mechanisms , for swi/snf function , dam target sequences have been identified and #mutated .
to determine how activators interact with the complex and to examine the importance of these interactions , relative to other potential targeting mechanisms , for swi/snf function , dam target sequences will be identified and #mutated .
to determine how activators interact with the complex and to examine the importance of these interactions , relative to other potential targeting mechanisms , for swi/snf function , we sought to identify and #mutate dam target sequences .
analyses of transcription in vivo of agn-lacz with amino acids ee(437 and 438) being #mutated support this conclusion .
analyses of transcription in vivo of agn-lacz with amino acids ee(437 and 438) #mutated support this conclusion .
analyses of transcription in vivo of agn-lacz with amino acids ee(437 and 438) that are able to be #mutated support this conclusion .
analyses of transcription in vivo of agn-lacz with amino acids ee(437 and 438) that were #mutated support this conclusion .
analyses of transcription in vivo of agn-lacz with amino acids ee(437 and 438) which are able to be #mutated support this conclusion .
analyses of transcription in vivo of agn-lacz with amino acids ee(437 and 438) which can be #mutated support this conclusion .
analyses of transcription in vivo of agn-lacz with amino acids ee(437 and 438) which may have been #mutated support this conclusion .
analyses of transcription in vivo of agn-lacz with amino acids ee(437 and 438) which were #mutated support this conclusion .
analyses of transcription in vivo of agn-lacz with gene #mutated support this conclusion .
analyses of transcription in vivo of agn-lacz with gene that are able to be #mutated support this conclusion .
analyses of transcription in vivo of agn-lacz with gene that are #mutated support this conclusion .
analyses of transcription in vivo of agn-lacz with gene that have been #mutated support this conclusion .
analyses of transcription in vivo of agn-lacz with gene that were #mutated support this conclusion .
analyses of transcription in vivo of agn-lacz with gene which are able to be #mutated support this conclusion .
analyses of transcription in vivo of agn-lacz with gene which are #mutated support this conclusion .
analyses of transcription in vivo of agn-lacz with gene which may have been #mutated support this conclusion .
analyses of transcription in vivo of agn-lacz with gene which were #mutated support this conclusion .
analyses of transcription in vivo of agn-lacz with #mutated pairs of residue positions support this conclusion .
analyses of transcription in vivo of agn-lacz with pairs of residue positions being #mutated support this conclusion .
analyses of transcription in vivo of agn-lacz with pairs of residue positions #mutated support this conclusion .
analyses of transcription in vivo of agn-lacz with pairs of residue positions that are able to be #mutated support this conclusion .
analyses of transcription in vivo of agn-lacz with pairs of residue positions which are #mutated support this conclusion .
analyses of transcription in vivo of agn-lacz with pairs of residue positions which can be #mutated support this conclusion .
analyses of transcription in vivo of agn-lacz with pairs of residue positions which may have been #mutated support this conclusion .
analyses of transcription in vivo of agn-lacz with pairs of residue positions which were #mutated support this conclusion .
to determine how activators interact with the complex and to examine the importance of these interactions , relative to other potential targeting mechanisms , for swi/snf function , amino acids ee(437 and 438) were identified and #mutated .
to determine how activators interact with the complex and to examine the importance of these interactions , relative to other potential targeting mechanisms , for swi/snf function , gene have been identified and #mutated .
to determine how activators interact with the complex and to examine the importance of these interactions , relative to other potential targeting mechanisms , for swi/snf function , pairs of residue positions were identified and #mutated .
to determine how activators interact with the complex and to examine the importance of these interactions , relative to other potential targeting mechanisms , for swi/snf function , we found to identify and #mutate amino acids ee(437 and 438) .
to determine how activators interact with the complex and to examine the importance of these interactions , relative to other potential targeting mechanisms , for swi/snf function , we have identified and #mutated amino acids ee(437 and 438) .
to determine how activators interact with the complex and to examine the importance of these interactions , relative to other potential targeting mechanisms , for swi/snf function , we have identified and #mutated gene .
to determine how activators interact with the complex and to examine the importance of these interactions , relative to other potential targeting mechanisms , for swi/snf function , we identified and #mutated amino acids ee(437 and 438) .
to determine how activators interact with the complex and to examine the importance of these interactions , relative to other potential targeting mechanisms , for swi/snf function , we identified and #mutated pairs of residue positions .
to determine how activators interact with the complex and to examine the importance of these interactions , relative to other potential targeting mechanisms , for swi/snf function , we identify and #mutate gene .
to determine how activators interact with the complex and to examine the importance of these interactions , relative to other potential targeting mechanisms , for swi/snf function , we sought to identify and #mutate pairs of residue positions .
to determine how activators interact with the complex and to examine the importance of these interactions , relative to other potential targeting mechanisms , for swi/snf function , we will identify and #mutate amino acids ee(437 and 438) .
to determine how activators interact with the complex and to examine the importance of these interactions , relative to other potential targeting mechanisms , for swi/snf function , we will identify and #mutate pairs of residue positions .
adult naive t cells , which are at rest in normal conditions , are able to #proliferate when transferred to lymphopenic hosts .
adult naive t cells , which are at rest in normal conditions , are observed to #proliferate when transferred to lymphopenic hosts .
adult naive t cells , which are at rest in normal conditions , can #proliferate strongly when transferred to lymphopenic hosts .
adult naive t cells , which are at rest in normal conditions , could have #proliferated when transferred to lymphopenic hosts .
adult naive t cells , which are at rest in normal conditions , have #proliferated when transferred to lymphopenic hosts .
adult naive t cells , which are at rest in normal conditions , have strongly #proliferated when transferred to lymphopenic hosts .
adult naive t cells , which are at rest in normal conditions , have the ability to #proliferate strongly when transferred to lymphopenic hosts .
adult naive t cells , which are at rest in normal conditions , may #proliferate strongly when transferred to lymphopenic hosts .
adult naive t cells , which are at rest in normal conditions , may #proliferate when transferred to lymphopenic hosts .
adult naive t cells , which are at rest in normal conditions , may strongly #proliferate when transferred to lymphopenic hosts .
adult naive t cells , which are at rest in normal conditions , will #proliferate strongly when transferred to lymphopenic hosts .
adult naive t cells , which are at rest in normal conditions , will #proliferate when transferred to lymphopenic hosts .
adult naive t cells , which are at rest in normal conditions , will strongly #proliferate when transferred to lymphopenic hosts .
after androgen withdrawal and antiandrogen treatment , the androgen responsive prostate cancer cells are able to cease to #proliferate and undergo apoptosis , causing tumor regression .
after androgen withdrawal and antiandrogen treatment , the androgen responsive prostate cancer cells being able to cease to #proliferate and undergo apoptosis will cause tumor regression .
after androgen withdrawal and antiandrogen treatment , the androgen responsive prostate cancer cells being observed to cease to #proliferate and undergo apoptosis will cause tumor regression .
after androgen withdrawal and antiandrogen treatment , the androgen responsive prostate cancer cells can cease to #proliferate and undergo apoptosis , causing tumor regression .
after androgen withdrawal and antiandrogen treatment , the androgen responsive prostate cancer cells ceased to #proliferate and underwent apoptosis , causing tumor regression .
after androgen withdrawal and antiandrogen treatment , the androgen responsive prostate cancer cells having ceased to #proliferate and undergo apoptosis caused tumor regression .
after androgen withdrawal and antiandrogen treatment , the androgen responsive prostate cancer cells that are able to cease to #proliferate and undergo apoptosis will cause tumor regression .
after androgen withdrawal and antiandrogen treatment , the androgen responsive prostate cancer cells that are observed to cease to #proliferate and undergo apoptosis will cause tumor regression .
after androgen withdrawal and antiandrogen treatment , the androgen responsive prostate cancer cells that will cease to #proliferate and undergo apoptosis will cause tumor regression .
cancer cells are characterized by either an increased ability for #proliferating or a diminished capacity to undergo programmed cell death .
cancer cells are characterized by either an increased ability for strong #proliferating or a diminished capacity to undergo programmed cell death .
cancer cells can be characterized by either an increased ability to #proliferate or a diminished capacity to undergo programmed cell death .
cancer cells wil be characterized by either an increased ability for #proliferating or a diminished capacity to undergo programmed cell death .
our observations illustrate that the human placenta can be endowed with the biochemical machinery to #proliferate throughout gestation , yet , there are intrinsic mechanisms that effectively circumscribe the extent and duration of trophoblast proliferation .
our observations illustrate that the human placenta has been endowed with the biochemical machinery to #proliferate indefinitely throughout gestation , yet , there are intrinsic mechanisms that effectively circumscribe the extent and duration of trophoblast proliferation .
our observations illustrate that the human placenta has been endowed with the biochemical machinery to #proliferate throughout gestation , yet , there are intrinsic mechanisms that effectively circumscribe the extent and duration of trophoblast proliferation .
our observations illustrate that the human placenta has the ability to be endowed with the biochemical machinery to #proliferate indefinitely throughout gestation , yet , there are intrinsic mechanisms that effectively circumscribe the extent and duration of trophoblast proliferation .
our observations illustrate that the human placenta has the ability to be endowed with the biochemical machinery to #proliferate throughout gestation , yet , there are intrinsic mechanisms that effectively circumscribe the extent and duration of trophoblast proliferation .
our observations illustrate that the human placenta may have been endowed with the biochemical machinery to #proliferate indefinitely throughout gestation , yet , there are intrinsic mechanisms that effectively circumscribe the extent and duration of trophoblast proliferation .
our observations illustrate that the human placenta may have been endowed with the biochemical machinery to #proliferate throughout gestation , yet , there are intrinsic mechanisms that effectively circumscribe the extent and duration of trophoblast proliferation .
our observations illustrate that the human placenta was endowed with the biochemical machinery to #proliferate throughout gestation , yet , there are intrinsic mechanisms that effectively circumscribe the extent and duration of trophoblast proliferation .
our observations illustrate that the human placenta will be endowed with the biochemical machinery to #proliferate indefinitely throughout gestation , yet , there are intrinsic mechanisms that effectively circumscribe the extent and duration of trophoblast proliferation .
our observations illustrate that the human placenta will be endowed with the biochemical machinery to #proliferate throughout gestation , yet , there are intrinsic mechanisms that effectively circumscribe the extent and duration of trophoblast proliferation .
stat5ab-/-peripheral t cells can regain the ability to #proliferate indefinitely upon introduction of full-length wild-type stat5a (figure 6b) .
stat5ab-/-peripheral t cells can regain the ability to #proliferate upon introduction of full-length wild-type stat5a (figure 6b) .
stat5ab-/-peripheral t cells have regained the ability to #proliferate indefinitely upon introduction of full-length wild-type stat5a (figure 6b) .
stat5ab-/-peripheral t cells may have regained the ability to #proliferate upon introduction of full-length wild-type stat5a (figure 6b) .
stat5ab-/-peripheral t cells regained the ability to #proliferate indefinitely upon introduction of full-length wild-type stat5a (figure 6b) .
stat5ab-/-peripheral t cells regained the ability to #proliferate upon introduction of full-length wild-type stat5a (figure 6b) .
stat5ab-/-peripheral t cells will regain the ability to #proliferate upon introduction of full-length wild-type stat5a (figure 6b) .
the ability of ebd cells being able to #proliferate in vivo was examined by injection of 3 ? 106 lvec cells into the calf muscle of 3 immunocompromised mice .
the ability of ebd cells being able to #proliferate strongly in vivo was examined by injection of 3 ? 106 lvec cells into the calf muscle of 3 immunocompromised mice .
the ability of ebd cells having strongly #proliferated in vivo was examined by injection of 3 ? 106 lvec cells into the calf muscle of 3 immunocompromised mice .
the ability of ebd cells having the ability to #proliferate strongly in vivo was examined by injection of 3 ? 106 lvec cells into the calf muscle of 3 immunocompromised mice .
the ability of ebd cells that can #proliferate in vivo was examined by injection of 3 ? 106 lvec cells into the calf muscle of 3 immunocompromised mice .
the ability of ebd cells that can #proliferate strongly in vivo was examined by injection of 3 ? 106 lvec cells into the calf muscle of 3 immunocompromised mice .
the ability of ebd cells that have strongly #proliferated in vivo was examined by injection of 3 ? 106 lvec cells into the calf muscle of 3 immunocompromised mice .
the ability of ebd cells that have the ability to #proliferate in vivo was examined by injection of 3 ? 106 lvec cells into the calf muscle of 3 immunocompromised mice .
the ability of ebd cells that have the ability to #proliferate strongly in vivo was examined by injection of 3 ? 106 lvec cells into the calf muscle of 3 immunocompromised mice .
the ability of ebd cells that is able to #proliferate strongly in vivo was examined by injection of 3 ? 106 lvec cells into the calf muscle of 3 immunocompromised mice .
the ability of ebd cells that is observed to #proliferate in vivo was examined by injection of 3 ? 106 lvec cells into the calf muscle of 3 immunocompromised mice .
the ability of ebd cells that may have #proliferated in vivo was examined by injection of 3 ? 106 lvec cells into the calf muscle of 3 immunocompromised mice .
the ability of ebd cells that may have strongly #proliferated in vivo was examined by injection of 3 ? 106 lvec cells into the calf muscle of 3 immunocompromised mice .
the ability of ebd cells that may #proliferate strongly in vivo was examined by injection of 3 ? 106 lvec cells into the calf muscle of 3 immunocompromised mice .
the ability of ebd cells that will #proliferate in vivo was examined by injection of 3 ? 106 lvec cells into the calf muscle of 3 immunocompromised mice .
the ability of ebd cells that will #proliferate strongly in vivo was examined by injection of 3 ? 106 lvec cells into the calf muscle of 3 immunocompromised mice .
stat5ab-/-peripheral t cells regain the ability to #proliferate upon introduction of full-length wild-type stat5a (figure 6b) .
adult naive t cells are able to regain the ability to #proliferate when transferred to lymphopenic hosts (figure 6b) .
adult naive t cells are observed to regain the ability to #proliferate indefinitely when transferred to lymphopenic hosts (figure 6b) .
adult naive t cells are observed to regain the ability to #proliferate when transferred to lymphopenic hosts (figure 6b) .
adult naive t cells have regained the ability to #proliferate indefinitely when transferred to lymphopenic hosts (figure 6b) .
adult naive t cells have regained the ability to #proliferate when transferred to lymphopenic hosts (figure 6b) .
adult naive t cells have the probability of regaining the ability to #proliferate indefinitely when transferred to lymphopenic hosts (figure 6b) .
adult naive t cells may have regained the ability to #proliferate when transferred to lymphopenic hosts (figure 6b) .
adult naive t cells regain the ability to #proliferate when transferred to lymphopenic hosts (figure 6b) .
adult naive t cells regained the ability to #proliferate when transferred to lymphopenic hosts (figure 6b) .
adult naive t cells will regain the ability to #proliferate indefinitely when transferred to lymphopenic hosts (figure 6b) .
adult naive t cells will regain the ability to #proliferate when transferred to lymphopenic hosts (figure 6b) .
after androgen withdrawal and antiandrogen treatment , cancer cells being able to cease to #proliferate and undergo apoptosis will cause tumor regression .
after androgen withdrawal and antiandrogen treatment , cancer cells cease to #proliferate and undergo apoptosis , causing tumor regression .
after androgen withdrawal and antiandrogen treatment , cancer cells ceased to #proliferate and underwent apoptosis , causing tumor regression .
after androgen withdrawal and antiandrogen treatment , cancer cells ceasing to #proliferate and underwent apoptosis caused tumor regression .
after androgen withdrawal and antiandrogen treatment , cancer cells having ceased to #proliferate and undergo apoptosis caused tumor regression .
after androgen withdrawal and antiandrogen treatment , cancer cells that are observed to cease to #proliferate and undergo apoptosis will cause tumor regression .
after androgen withdrawal and antiandrogen treatment , cancer cells that can cease to #proliferate and undergo apoptosis will cause tumor regression .
after androgen withdrawal and antiandrogen treatment , cancer cells that have ceased to #proliferate and undergo apoptosis caused tumor regression .
after androgen withdrawal and antiandrogen treatment , cancer cells that have the ability to cease to #proliferate and undergo apoptosis will cause tumor regression .
after androgen withdrawal and antiandrogen treatment , cancer cells that may cease to #proliferate and undergo apoptosis will cause tumor regression .
after androgen withdrawal and antiandrogen treatment , cancer cells that will cease to #proliferate and undergo apoptosis will cause tumor regression .
after androgen withdrawal and antiandrogen treatment , cancer cells will cease to #proliferate and undergo apoptosis , causing tumor regression .
our observations illustrate that adult naive t cells can be endowed with the biochemical machinery to #proliferate indefinitely when transferred to lymphopenic hosts , yet , there are intrinsic mechanisms that effectively circumscribe the extent and duration of trophoblast proliferation .
our observations illustrate that adult naive t cells has been endowed with the biochemical machinery to #proliferate when transferred to lymphopenic hosts , yet , there are intrinsic mechanisms that effectively circumscribe the extent and duration of trophoblast proliferation .
our observations illustrate that adult naive t cells has the ability to be endowed with the biochemical machinery to #proliferate indefinitely when transferred to lymphopenic hosts , yet , there are intrinsic mechanisms that effectively circumscribe the extent and duration of trophoblast proliferation .
our observations illustrate that adult naive t cells has the ability to be endowed with the biochemical machinery to #proliferate when transferred to lymphopenic hosts , yet , there are intrinsic mechanisms that effectively circumscribe the extent and duration of trophoblast proliferation .
our observations illustrate that adult naive t cells is endowed with the biochemical machinery to #proliferate indefinitely when transferred to lymphopenic hosts , yet , there are intrinsic mechanisms that effectively circumscribe the extent and duration of trophoblast proliferation .
our observations illustrate that adult naive t cells is shown to be endowed with the biochemical machinery to #proliferate indefinitely when transferred to lymphopenic hosts , yet , there are intrinsic mechanisms that effectively circumscribe the extent and duration of trophoblast proliferation .
our observations illustrate that adult naive t cells is shown to be endowed with the biochemical machinery to #proliferate when transferred to lymphopenic hosts , yet , there are intrinsic mechanisms that effectively circumscribe the extent and duration of trophoblast proliferation .
our observations illustrate that adult naive t cells may have been endowed with the biochemical machinery to #proliferate indefinitely when transferred to lymphopenic hosts , yet , there are intrinsic mechanisms that effectively circumscribe the extent and duration of trophoblast proliferation .
our observations illustrate that adult naive t cells was endowed with the biochemical machinery to #proliferate indefinitely when transferred to lymphopenic hosts , yet , there are intrinsic mechanisms that effectively circumscribe the extent and duration of trophoblast proliferation .
our observations illustrate that adult naive t cells will be endowed with the biochemical machinery to #proliferate indefinitely when transferred to lymphopenic hosts , yet , there are intrinsic mechanisms that effectively circumscribe the extent and duration of trophoblast proliferation .
our observations illustrate that stat5ab-/-peripheral t cells has been endowed with the biochemical machinery to #proliferate upon introduction of full-length wild-type stat5a , yet , there are intrinsic mechanisms that effectively circumscribe the extent and duration of trophoblast proliferation .
our observations illustrate that stat5ab-/-peripheral t cells has the ability to be endowed with the biochemical machinery to #proliferate upon introduction of full-length wild-type stat5a , yet , there are intrinsic mechanisms that effectively circumscribe the extent and duration of trophoblast proliferation .
our observations illustrate that stat5ab-/-peripheral t cells is able to be endowed with the biochemical machinery to #proliferate indefinitely upon introduction of full-length wild-type stat5a , yet , there are intrinsic mechanisms that effectively circumscribe the extent and duration of trophoblast proliferation .
our observations illustrate that stat5ab-/-peripheral t cells is able to be endowed with the biochemical machinery to #proliferate upon introduction of full-length wild-type stat5a , yet , there are intrinsic mechanisms that effectively circumscribe the extent and duration of trophoblast proliferation .
our observations illustrate that stat5ab-/-peripheral t cells is endowed with the biochemical machinery to #proliferate indefinitely upon introduction of full-length wild-type stat5a , yet , there are intrinsic mechanisms that effectively circumscribe the extent and duration of trophoblast proliferation .
our observations illustrate that stat5ab-/-peripheral t cells is shown to be endowed with the biochemical machinery to #proliferate indefinitely upon introduction of full-length wild-type stat5a , yet , there are intrinsic mechanisms that effectively circumscribe the extent and duration of trophoblast proliferation .
our observations illustrate that stat5ab-/-peripheral t cells may have been endowed with the biochemical machinery to #proliferate indefinitely upon introduction of full-length wild-type stat5a , yet , there are intrinsic mechanisms that effectively circumscribe the extent and duration of trophoblast proliferation .
our observations illustrate that stat5ab-/-peripheral t cells was endowed with the biochemical machinery to #proliferate upon introduction of full-length wild-type stat5a , yet , there are intrinsic mechanisms that effectively circumscribe the extent and duration of trophoblast proliferation .
our observations illustrate that stat5ab-/-peripheral t cells will be endowed with the biochemical machinery to #proliferate upon introduction of full-length wild-type stat5a , yet , there are intrinsic mechanisms that effectively circumscribe the extent and duration of trophoblast proliferation .
stat5ab-/-peripheral t cells , which are at rest in normal conditions , are able to #proliferate upon introduction of full-length wild-type stat5a .
stat5ab-/-peripheral t cells , which are at rest in normal conditions , can strongly #proliferate upon introduction of full-length wild-type stat5a .
stat5ab-/-peripheral t cells , which are at rest in normal conditions , could have #proliferated upon introduction of full-length wild-type stat5a .
stat5ab-/-peripheral t cells , which are at rest in normal conditions , have #proliferated upon introduction of full-length wild-type stat5a .
stat5ab-/-peripheral t cells , which are at rest in normal conditions , have strongly #proliferated upon introduction of full-length wild-type stat5a .
stat5ab-/-peripheral t cells , which are at rest in normal conditions , may #proliferate strongly upon introduction of full-length wild-type stat5a .
stat5ab-/-peripheral t cells , which are at rest in normal conditions , may strongly #proliferate upon introduction of full-length wild-type stat5a .
stat5ab-/-peripheral t cells , which are at rest in normal conditions , might have #proliferated strongly upon introduction of full-length wild-type stat5a .
stat5ab-/-peripheral t cells , which are at rest in normal conditions , might have #proliferated upon introduction of full-length wild-type stat5a .
stat5ab-/-peripheral t cells , which are at rest in normal conditions , might have strongly #proliferated upon introduction of full-length wild-type stat5a .
stat5ab-/-peripheral t cells , which are at rest in normal conditions , will #proliferate upon introduction of full-length wild-type stat5a .
stat5ab-/-peripheral t cells , which are at rest in normal conditions , will strongly #proliferate upon introduction of full-length wild-type stat5a .
treatment of adult naive t cells of different origin with the ganglioside biosynthesis inhibitors fumonisin b1 , d-threo-1-phenyl-2-decanoylamino-3-morpholino-1-propanol or d-1-threo-1-phenyl-2-hexa-decanoylamino-3-pyrrolidino-1-propanol-hcl , has impaired their capacity to #proliferate when transferred to lymphopenic hosts .
treatment of adult naive t cells of different origin with the ganglioside biosynthesis inhibitors fumonisin b1 , d-threo-1-phenyl-2-decanoylamino-3-morpholino-1-propanol or d-1-threo-1-phenyl-2-hexa-decanoylamino-3-pyrrolidino-1-propanol-hcl , has significantly impaired their capacity to #proliferate when transferred to lymphopenic hosts .
treatment of adult naive t cells of different origin with the ganglioside biosynthesis inhibitors fumonisin b1 , d-threo-1-phenyl-2-decanoylamino-3-morpholino-1-propanol or d-1-threo-1-phenyl-2-hexa-decanoylamino-3-pyrrolidino-1-propanol-hcl , has the ability to impair their capacity to #proliferate when transferred to lymphopenic hosts .
treatment of adult naive t cells of different origin with the ganglioside biosynthesis inhibitors fumonisin b1 , d-threo-1-phenyl-2-decanoylamino-3-morpholino-1-propanol or d-1-threo-1-phenyl-2-hexa-decanoylamino-3-pyrrolidino-1-propanol-hcl , impaired their capacity to #proliferate when transferred to lymphopenic hosts .
treatment of adult naive t cells of different origin with the ganglioside biosynthesis inhibitors fumonisin b1 , d-threo-1-phenyl-2-decanoylamino-3-morpholino-1-propanol or d-1-threo-1-phenyl-2-hexa-decanoylamino-3-pyrrolidino-1-propanol-hcl , is able to impair their capacity to #proliferate when transferred to lymphopenic hosts .
treatment of adult naive t cells of different origin with the ganglioside biosynthesis inhibitors fumonisin b1 , d-threo-1-phenyl-2-decanoylamino-3-morpholino-1-propanol or d-1-threo-1-phenyl-2-hexa-decanoylamino-3-pyrrolidino-1-propanol-hcl , is observed to significantly impair their capacity to #proliferate when transferred to lymphopenic hosts .
treatment of adult naive t cells of different origin with the ganglioside biosynthesis inhibitors fumonisin b1 , d-threo-1-phenyl-2-decanoylamino-3-morpholino-1-propanol or d-1-threo-1-phenyl-2-hexa-decanoylamino-3-pyrrolidino-1-propanol-hcl , will impair their capacity to #proliferate when transferred to lymphopenic hosts .
treatment of adult naive t cells of different origin with the ganglioside biosynthesis inhibitors fumonisin b1 , d-threo-1-phenyl-2-decanoylamino-3-morpholino-1-propanol or d-1-threo-1-phenyl-2-hexa-decanoylamino-3-pyrrolidino-1-propanol-hcl , will significantly impair their capacity to #proliferate when transferred to lymphopenic hosts .
treatment of stat5ab-/-peripheral t cells of different origin with the ganglioside biosynthesis inhibitors fumonisin b1 , d-threo-1-phenyl-2-decanoylamino-3-morpholino-1-propanol or d-1-threo-1-phenyl-2-hexa-decanoylamino-3-pyrrolidino-1-propanol-hcl , can significantly impair their capacity to #proliferate upon introduction of full-length wild-type stat5a .
treatment of stat5ab-/-peripheral t cells of different origin with the ganglioside biosynthesis inhibitors fumonisin b1 , d-threo-1-phenyl-2-decanoylamino-3-morpholino-1-propanol or d-1-threo-1-phenyl-2-hexa-decanoylamino-3-pyrrolidino-1-propanol-hcl , impaired their capacity to #proliferate upon introduction of full-length wild-type stat5a .
treatment of stat5ab-/-peripheral t cells of different origin with the ganglioside biosynthesis inhibitors fumonisin b1 , d-threo-1-phenyl-2-decanoylamino-3-morpholino-1-propanol or d-1-threo-1-phenyl-2-hexa-decanoylamino-3-pyrrolidino-1-propanol-hcl , is able to significantly impair their capacity to #proliferate upon introduction of full-length wild-type stat5a .
treatment of stat5ab-/-peripheral t cells of different origin with the ganglioside biosynthesis inhibitors fumonisin b1 , d-threo-1-phenyl-2-decanoylamino-3-morpholino-1-propanol or d-1-threo-1-phenyl-2-hexa-decanoylamino-3-pyrrolidino-1-propanol-hcl , is observed to significantly impair their capacity to #proliferate upon introduction of full-length wild-type stat5a .
treatment of stat5ab-/-peripheral t cells of different origin with the ganglioside biosynthesis inhibitors fumonisin b1 , d-threo-1-phenyl-2-decanoylamino-3-morpholino-1-propanol or d-1-threo-1-phenyl-2-hexa-decanoylamino-3-pyrrolidino-1-propanol-hcl , will impair their capacity to #proliferate upon introduction of full-length wild-type stat5a .
treatment of stat5ab-/-peripheral t cells of different origin with the ganglioside biosynthesis inhibitors fumonisin b1 , d-threo-1-phenyl-2-decanoylamino-3-morpholino-1-propanol or d-1-threo-1-phenyl-2-hexa-decanoylamino-3-pyrrolidino-1-propanol-hcl , will significantly impair their capacity to #proliferate upon introduction of full-length wild-type stat5a .
treatment of the human placenta of different origin with the ganglioside biosynthesis inhibitors fumonisin b1 , d-threo-1-phenyl-2-decanoylamino-3-morpholino-1-propanol or d-1-threo-1-phenyl-2-hexa-decanoylamino-3-pyrrolidino-1-propanol-hcl , has significantly impaired their capacity to #proliferate throughout gestation .
treatment of the human placenta of different origin with the ganglioside biosynthesis inhibitors fumonisin b1 , d-threo-1-phenyl-2-decanoylamino-3-morpholino-1-propanol or d-1-threo-1-phenyl-2-hexa-decanoylamino-3-pyrrolidino-1-propanol-hcl , has the ability to significantly impair their capacity to #proliferate throughout gestation .
treatment of the human placenta of different origin with the ganglioside biosynthesis inhibitors fumonisin b1 , d-threo-1-phenyl-2-decanoylamino-3-morpholino-1-propanol or d-1-threo-1-phenyl-2-hexa-decanoylamino-3-pyrrolidino-1-propanol-hcl , is observed to impair their capacity to #proliferate throughout gestation .
treatment of the human placenta of different origin with the ganglioside biosynthesis inhibitors fumonisin b1 , d-threo-1-phenyl-2-decanoylamino-3-morpholino-1-propanol or d-1-threo-1-phenyl-2-hexa-decanoylamino-3-pyrrolidino-1-propanol-hcl , is observed to significantly impair their capacity to #proliferate throughout gestation .
treatment of the human placenta of different origin with the ganglioside biosynthesis inhibitors fumonisin b1 , d-threo-1-phenyl-2-decanoylamino-3-morpholino-1-propanol or d-1-threo-1-phenyl-2-hexa-decanoylamino-3-pyrrolidino-1-propanol-hcl , will impair their capacity to #proliferate throughout gestation .
the androgen responsive prostate cancer cells are believed to be characterized by either an increased ability to strongly #proliferate or a diminished capacity to undergo programmed cell death .
the androgen responsive prostate cancer cells are characterized by either an increased ability for #proliferating or a diminished capacity to undergo programmed cell death .
the androgen responsive prostate cancer cells are characterized by either an increased ability to #proliferate or a diminished capacity to undergo programmed cell death .
the androgen responsive prostate cancer cells has been characterized by either an increased ability to #proliferate or a diminished capacity to undergo programmed cell death .
the androgen responsive prostate cancer cells has been characterized by either an increased ability to strongly #proliferate or a diminished capacity to undergo programmed cell death .
the androgen responsive prostate cancer cells may be characterized by either an increased ability to strongly #proliferate or a diminished capacity to undergo programmed cell death .
the androgen responsive prostate cancer cells was characterized by either an increased ability to #proliferate or a diminished capacity to undergo programmed cell death .
the human placenta are able to regain the ability to #proliferate indefinitely throughout gestation (figure 6b) .
the human placenta are able to regain the ability to #proliferate throughout gestation (figure 6b) .
the human placenta are observed to regain the ability to #proliferate indefinitely throughout gestation (figure 6b) .
the human placenta are observed to regain the ability to #proliferate throughout gestation (figure 6b) .
the human placenta can regain the ability to #proliferate indefinitely throughout gestation (figure 6b) .
the human placenta have regained the ability to #proliferate indefinitely throughout gestation (figure 6b) .
the human placenta have the probability of regaining the ability to #proliferate indefinitely throughout gestation (figure 6b) .
the human placenta may have regained the ability to #proliferate indefinitely throughout gestation (figure 6b) .
the human placenta may have regained the ability to #proliferate throughout gestation (figure 6b) .
the human placenta regain the ability to #proliferate throughout gestation (figure 6b) .
the human placenta regained the ability to #proliferate indefinitely throughout gestation (figure 6b) .
the human placenta regained the ability to #proliferate throughout gestation (figure 6b) .
the human placenta will regain the ability to #proliferate indefinitely throughout gestation (figure 6b) .
the human placenta , which are at rest in normal conditions , are able to #proliferate strongly throughout gestation .
the human placenta , which are at rest in normal conditions , are able to #proliferate throughout gestation .
the human placenta , which are at rest in normal conditions , are observed to #proliferate strongly throughout gestation .
the human placenta , which are at rest in normal conditions , can #proliferate throughout gestation .
the human placenta , which are at rest in normal conditions , have strongly #proliferated throughout gestation .
the human placenta , which are at rest in normal conditions , have the ability to #proliferate throughout gestation .
the human placenta , which are at rest in normal conditions , may #proliferate strongly throughout gestation .
the human placenta , which are at rest in normal conditions , may strongly #proliferate throughout gestation .
the human placenta , which are at rest in normal conditions , might have #proliferated throughout gestation .
the human placenta , which are at rest in normal conditions , might have strongly #proliferated throughout gestation .
the human placenta , which are at rest in normal conditions , #proliferate strongly throughout gestation .
the human placenta , which are at rest in normal conditions , #proliferated throughout gestation .
the human placenta , which are at rest in normal conditions , will #proliferate strongly throughout gestation .
the human placenta , which are at rest in normal conditions , will #proliferate throughout gestation .
the human placenta , which are at rest in normal conditions , will strongly #proliferate throughout gestation .
the ability of ebd cells to #proliferate in vivo was examined by injection of 3 ? 106 lvec cells into the calf muscle of 3 immunocompromised mice .
a approximately 70kd polypeptide in western blots of extraocular muscle , sternothyroid muscle , and smooth muscle has been #recognized by anti-64kd human autoantigen d1 antibodies .
a approximately 70kd polypeptide in western blots of extraocular muscle , sternothyroid muscle , and smooth muscle was #recognized by anti-64kd human autoantigen d1 antibodies .
a monoclonal antibody which has #recognized the stat1 n-terminus was purchased from transduction laboratories (lexington , ky) .
a monoclonal antibody which #recognizes the stat1 n-terminus is purchased from transduction laboratories (lexington , ky) .
affinity-purified polyclonal anti-lmp-1 antiserum #recognizes epitopes in the c-terminus of lmp-1 at a 1:200 dilution .
blots were probed with affinity-purified polyclonal anti-lmp-1 antiserum that can #recognize epitopes in the c-terminus of lmp-1 at a 1:200 dilution .
exactly how specific splice sites have been #recognized during the processing of complex precursor messenger rnas is not clear .
exactly how specific splice sites were #recognized during the processing of complex precursor messenger rnas is not clear .
exactly how specific splice sites will be #recognized during the processing of complex precursor messenger rnas is not clear .
footprinting assays have suggested that these regulators protect a stretch of up to 20 bp in the target promoters , and multiple alignments of binding sites for a number of regulators have shown that the proteins can #recognize short motifs within the protected region .
footprinting assays have suggested that these regulators protect a stretch of up to 20 bp in the target promoters , and multiple alignments of binding sites for a number of regulators have shown that the proteins has #recognized short motifs within the protected region .
individual cell clones were analyzed for stat1 expression by immunofluorescence with a monoclonal antibody which #recognized the stat1 n-terminus , and by western blotting
individual cell clones were analyzed for stat1 expression by immunofluorescence with a monoclonal antibody which #recognizes the stat1 n-terminus , and by western blotting
the narl protein also bound to these 7-2-7 sites but , unlike narp , also #recognized heptamers in other arrangements .
the narl protein has also bound to these 7-2-7 sites but , unlike narp , has also #recognized heptamers in other arrangements .
the stat1 n-terminus were #recognized by a monoclonal antibody purchasing from transduction laboratories (lexington , ky) .
the eukaryotic upstream binding factor (ubf) , has #recognized the ribosomal rna gene promoter and activated transcription mediated by rna polymerase i through cooperative interactions with the species-specific factor , sl1 .
the eukaryotic upstream binding factor (ubf) , #recognized the ribosomal rna gene promoter and activated transcription mediated by rna polymerase i through cooperative interactions with the species-specific factor , sl1 .
the eukaryotic upstream binding factor (ubf) , will #recognize the ribosomal rna gene promoter and activate transcription mediated by rna polymerase i through cooperative interactions with the species-specific factor , sl1 .
the sequence(ypydvpdya) at a 1:500 dilution is #recognized by a rat monoclonal anti-ha antibody (boehringer-ingelheim) that blots were probed with .
the two forms of stat3 (stat3fm and stat3sm) that have been #recognized by this antibody in pkr+/+mefs are indicated .
the two forms of stat3 (stat3fm and stat3sm) which were #recognized by this antibody in pkr+/+mefs are indicated .
these mutations , identified by standard methods of reverse transcription , pcr ,dideoxy-chain termination , and cycle sequencing , alter highly conserved sequences at intron/exon boundaries and cause the rna-splicing apparatus not to properly #recognize the normal splice junction .
these mutations , identified by standard methods of reverse transcription , pcr ,dideoxy-chain termination , and cycle sequencing , alter highly conserved sequences at intron/exon boundaries and make the rna-splicing apparatus not to #recognized the normal splice junction properly .
these mutations , identified by standard methods of reverse transcription , pcr ,dideoxy-chain termination , and cycle sequencing , alter highly conserved sequences at intron/exon boundaries and prevent the normal splice junction from being properly #recognized by the rna-splicing apparatus .
the ribosomal rna gene promoter is #recognized by the eukaryotic upstream binding factor (ubf) .
the ribosomal rna gene promoter was #recognized by the eukaryotic upstream binding factor (ubf) .
two sites in tsx-p2 are #recognized by the camp-crp activator complex .
a monoclonal antibody #recognizing the stat1 n-terminus was purchased from transduction laboratories (lexington , ky) .
blots were probed with a rat monoclonal anti-ha antibody (boehringer-ingelheim) that #recognizes the sequence(ypydvpdya) at a 1:500 dilution .
the two forms of stat3 (stat3fm and stat3sm) #recognized by this antibody in pkr+/+mefs are indicated .
footprinting assays have suggested that these regulators protect a stretch of up to 20 bp in the target promoters , and multiple alignments of binding sites for a number of regulators have shown that the proteins #recognize short motifs within the protected region .
the narl protein also binds to these 7-2-7 sites but , unlike narp , also #recognizes heptamers in other arrangements .
we show that the camp-crp activator complex #recognizes two sites in tsx-p2 that are separated by 33 bp : a high-affinity site (crp-1) overlaps the-35 region , and a low-affinity site (crp-2) is centered around position-74 bp .
these mutations , identified by standard methods of reverse transcription , pcr ,dideoxy-chain termination , and cycle sequencing , alter highly conserved sequences at intron/exon boundaries and prevent the rna-splicing apparatus from properly #recognizing the normal splice junction .
a monoclonal antibody also bound to these 7-2-7 sites but , unlike narp , also #recognized the stat1 n-terminus .
a monoclonal antibody are able to #recognize the stat1 n-terminus in the regulated promoters .
a monoclonal antibody can #recognize the stat1 n-terminus in the regulated promoters .
a monoclonal antibody have #recognized the stat1 n-terminus in the regulated promoters .
a monoclonal antibody #recognize the stat1 n-terminus in the regulated promoters .
a monoclonal antibody #recognized specifically the stat1 n-terminus .
a monoclonal antibody #recognized the stat1 n-terminus in the regulated promoters .
a monoclonal antibody will binds to these 7-2-7 sites but , unlike narp , will also #recognize the stat1 n-terminus .
a monoclonal antibody will #recognize the stat1 n-terminus in the regulated promoters .
anti-64kd human autoantigen d1 antibodies has also bound to these 7-2-7 sites but , unlike narp , has also #recognized a approximately 70kd polypeptide in western blots of extraocular muscle , sternothyroid muscle , and smooth muscle .
anti-64kd human autoantigen d1 antibodies #recognized a approximately 70kd polypeptide in western blots of extraocular muscle , sternothyroid muscle , and smooth muscle in the regulated promoters .
anti-64kd human autoantigen d1 antibodies #recognizing a approximately 70kd polypeptide in western blots of extraocular muscle , sternothyroid muscle , and smooth muscle was purchased from transduction laboratories (lexington , ky) .
anti-64kd human autoantigen d1 antibodies which has #recognized a approximately 70kd polypeptide in western blots of extraocular muscle , sternothyroid muscle , and smooth muscle was purchased from transduction laboratories (lexington , ky) .
anti-64kd human autoantigen d1 antibodies will binds to these 7-2-7 sites but , unlike narp , will also #recognize a approximately 70kd polypeptide in western blots of extraocular muscle , sternothyroid muscle , and smooth muscle .
blots were probed with a monoclonal antibody #recognizing the stat1 n-terminus .
blots were probed with a monoclonal antibody that can #recognize the stat1 n-terminus .
blots were probed with a monoclonal antibody that #recognized the stat1 n-terminus .
blots were probed with a monoclonal antibody that #recognizes the stat1 n-terminus .
blots were probed with a monoclonal antibody that #recognizes the the stat1 n-terminus , or with rabbit polyclonal anti-gfp or anti-rfp (clontech) antiserum at a 1:250 dilution .
blots were probed with anti-64kd human autoantigen d1 antibodies #recognizing a approximately 70kd polypeptide in western blots of extraocular muscle , sternothyroid muscle , and smooth muscle .
blots were probed with anti-64kd human autoantigen d1 antibodies that can #recognize a approximately 70kd polypeptide in western blots of extraocular muscle , sternothyroid muscle , and smooth muscle .
blots were probed with anti-64kd human autoantigen d1 antibodies that #recognizes a approximately 70kd polypeptide in western blots of extraocular muscle , sternothyroid muscle , and smooth muscle .
blots were probed with the narl protein #recognizing heptamers in other arrangements .
blots were probed with the narl protein that can #recognize heptamers in other arrangements .
blots were probed with the narl protein that #recognizes the heptamers in other arrangements , or with rabbit polyclonal anti-gfp or anti-rfp (clontech) antiserum at a 1:250 dilution .
blots were probed with a rat monoclonal anti-ha antibody (boehringer-ingelheim) that #recognized sequence(ypydvpdya) at a 1:500 dilution .
blots were probed with a rat monoclonal anti-ha antibody (boehringer-ingelheim) that #recognizes sequence(ypydvpdya) at a 1:500 dilution .
blots were probed with a monoclonal antibody that can #recognize the stat1 n-terminus .
blots were probed with a monoclonal antibody that #recognized the stat1 n-terminus .
blots were probed with a monoclonal antibody that #recognizes the stat1 n-terminus .
blots were probed with a monoclonal antibody that #recognizes the the stat1 n-terminus , or with rabbit polyclonal anti-gfp or anti-rfp (clontech) antiserum at a 1:250 dilution .
blots were probed with a monoclonal antibody that #recognizes the the stat1 n-terminus .
blots were probed with affinity-purified polyclonal anti-lmp-1 antiserum that #recognizes the epitopes in the c-terminus of lmp-1 at a 1:200 dilution , or with rabbit polyclonal anti-gfp or anti-rfp (clontech) antiserum at a 1:250 dilution .
blots were probed with affinity-purified polyclonal anti-lmp-1 antiserum that #recognizes the epitopes in the c-terminus of lmp-1 at a 1:200 dilution .
blots were probed with the camp-crp activator complex that #recognized two sites in tsx-p2 .
blots were probed with the camp-crp activator complex that #recognizes the two sites in tsx-p2 , or with rabbit polyclonal anti-gfp or anti-rfp (clontech) antiserum at a 1:250 dilution .
blots were probed with the proteins #recognizing short motifs within the protected region .
blots were probed with the proteins that #recognizes short motifs within the protected region .
blots were probed with this antibody in pkr+/+mefs #recognizing the two forms of stat3 (stat3fm and stat3sm) .
blots were probed with this antibody in pkr+/+mefs that #recognized the two forms of stat3 (stat3fm and stat3sm) .
blots were probed with this antibody in pkr+/+mefs that #recognizes the the two forms of stat3 (stat3fm and stat3sm) , or with rabbit polyclonal anti-gfp or anti-rfp (clontech) antiserum at a 1:250 dilution .
blots were probed with this antibody in pkr+/+mefs that #recognizes the the two forms of stat3 (stat3fm and stat3sm) .
footprinting assays have suggested that these regulators protect a stretch of up to 20 bp in the target promoters , and multiple alignments of binding sites for a number of regulators have shown that a monoclonal antibody are able to #recognize the stat1 n-terminus .
footprinting assays have suggested that these regulators protect a stretch of up to 20 bp in the target promoters , and multiple alignments of binding sites for a number of regulators have shown that a monoclonal antibody has #recognized the stat1 n-terminus .
footprinting assays have suggested that these regulators protect a stretch of up to 20 bp in the target promoters , and multiple alignments of binding sites for a number of regulators have shown that anti-64kd human autoantigen d1 antibodies has #recognized a approximately 70kd polypeptide in western blots of extraocular muscle , sternothyroid muscle , and smooth muscle .
footprinting assays have suggested that these regulators protect a stretch of up to 20 bp in the target promoters , and multiple alignments of binding sites for a number of regulators have shown that anti-64kd human autoantigen d1 antibodies #recognized a approximately 70kd polypeptide in western blots of extraocular muscle , sternothyroid muscle , and smooth muscle .
footprinting assays have suggested that these regulators protect a stretch of up to 20 bp in the target promoters , and multiple alignments of binding sites for a number of regulators have shown that the narl protein are able to #recognize heptamers in other arrangements .
footprinting assays have suggested that these regulators protect a stretch of up to 20 bp in the target promoters , and multiple alignments of binding sites for a number of regulators have shown that the narl protein #recognize heptamers in other arrangements .
footprinting assays have suggested that these regulators protect a stretch of up to 20 bp in the target promoters , and multiple alignments of binding sites for a number of regulators have shown that the narl protein #recognized heptamers in other arrangements .
footprinting assays have suggested that these regulators protect a stretch of up to 20 bp in the target promoters , and multiple alignments of binding sites for a number of regulators have shown that a rat monoclonal anti-ha antibody (boehringer-ingelheim) can #recognize sequence(ypydvpdya) at a 1:500 dilution .
footprinting assays have suggested that these regulators protect a stretch of up to 20 bp in the target promoters , and multiple alignments of binding sites for a number of regulators have shown that a rat monoclonal anti-ha antibody (boehringer-ingelheim) #recognized sequence(ypydvpdya) at a 1:500 dilution .
footprinting assays have suggested that these regulators protect a stretch of up to 20 bp in the target promoters , and multiple alignments of binding sites for a number of regulators have shown that a monoclonal antibody are able to #recognize the stat1 n-terminus .
footprinting assays have suggested that these regulators protect a stretch of up to 20 bp in the target promoters , and multiple alignments of binding sites for a number of regulators have shown that affinity-purified polyclonal anti-lmp-1 antiserum are able to #recognize epitopes in the c-terminus of lmp-1 at a 1:200 dilution .
footprinting assays have suggested that these regulators protect a stretch of up to 20 bp in the target promoters , and multiple alignments of binding sites for a number of regulators have shown that affinity-purified polyclonal anti-lmp-1 antiserum can #recognize epitopes in the c-terminus of lmp-1 at a 1:200 dilution .
footprinting assays have suggested that these regulators protect a stretch of up to 20 bp in the target promoters , and multiple alignments of binding sites for a number of regulators have shown that affinity-purified polyclonal anti-lmp-1 antiserum has #recognized epitopes in the c-terminus of lmp-1 at a 1:200 dilution .
footprinting assays have suggested that these regulators protect a stretch of up to 20 bp in the target promoters , and multiple alignments of binding sites for a number of regulators have shown that affinity-purified polyclonal anti-lmp-1 antiserum #recognized epitopes in the c-terminus of lmp-1 at a 1:200 dilution .
footprinting assays have suggested that these regulators protect a stretch of up to 20 bp in the target promoters , and multiple alignments of binding sites for a number of regulators have shown that the camp-crp activator complex are able to #recognize two sites in tsx-p2 .
footprinting assays have suggested that these regulators protect a stretch of up to 20 bp in the target promoters , and multiple alignments of binding sites for a number of regulators have shown that the camp-crp activator complex can #recognize two sites in tsx-p2 .
footprinting assays have suggested that these regulators protect a stretch of up to 20 bp in the target promoters , and multiple alignments of binding sites for a number of regulators have shown that the camp-crp activator complex #recognize two sites in tsx-p2 .
footprinting assays have suggested that these regulators protect a stretch of up to 20 bp in the target promoters , and multiple alignments of binding sites for a number of regulators have shown that this antibody in pkr+/+mefs #recognized the two forms of stat3 (stat3fm and stat3sm) .
individual cell clones were analyzed for stat1 expression by immunofluorescence where the two forms of stat3 (stat3fm and stat3sm) are #recognized by this antibody in pkr+/+mefs .
individual cell clones were analyzed for stat1 expression by immunofluorescence where the two forms of stat3 (stat3fm and stat3sm) were #recognized by this antibody in pkr+/+mefs .
individual cell clones were analyzed for stat1 expression by immunofluorescence where a approximately 70kd polypeptide in western blots of extraocular muscle , sternothyroid muscle , and smooth muscle are #recognized by anti-64kd human autoantigen d1 antibodies .
individual cell clones were analyzed for stat1 expression by immunofluorescence where epitopes in the c-terminus of lmp-1 at a 1:200 dilution are #recognized by affinity-purified polyclonal anti-lmp-1 antiserum .
individual cell clones were analyzed for stat1 expression by immunofluorescence where sequence(ypydvpdya) at a 1:500 dilution are #recognized by a rat monoclonal anti-ha antibody (boehringer-ingelheim) .
individual cell clones were analyzed for stat1 expression by immunofluorescence where sequence(ypydvpdya) at a 1:500 dilution were #recognized by a rat monoclonal anti-ha antibody (boehringer-ingelheim) .
individual cell clones were analyzed for stat1 expression by immunofluorescence where short motifs within the protected region are #recognized by the proteins .
individual cell clones were analyzed for stat1 expression by immunofluorescence where the stat1 n-terminus are #recognized by a monoclonal antibody .
individual cell clones were analyzed for stat1 expression by immunofluorescence where the stat1 n-terminus were #recognized by a monoclonal antibody .
individual cell clones were analyzed for stat1 expression by immunofluorescence where two sites in tsx-p2 are #recognized by the camp-crp activator complex .
individual cell clones were analyzed for stat1 expression by immunofluorescence where two sites in tsx-p2 were #recognized by the camp-crp activator complex .
individual cell clones were analyzed for stat1 expression by immunofluorescence with a monoclonal antibody which #recognized the stat1 n-terminus , and by western blotting
individual cell clones were analyzed for stat1 expression by immunofluorescence with the narl protein which #recognizes heptamers in other arrangements , and by western blotting
individual cell clones were analyzed for stat1 expression by immunofluorescence with a rat monoclonal anti-ha antibody (boehringer-ingelheim) #recognizing sequence(ypydvpdya) at a 1:500 dilution , and by western blotting .
individual cell clones were analyzed for stat1 expression by immunofluorescence with a rat monoclonal anti-ha antibody (boehringer-ingelheim) which #recognized sequence(ypydvpdya) at a 1:500 dilution , and by western blotting
individual cell clones were analyzed for stat1 expression by immunofluorescence with a rat monoclonal anti-ha antibody (boehringer-ingelheim) which #recognizes sequence(ypydvpdya) at a 1:500 dilution , and by western blotting
individual cell clones were analyzed for stat1 expression by immunofluorescence with the camp-crp activator complex #recognizing two sites in tsx-p2 , and by western blotting .
individual cell clones were analyzed for stat1 expression by immunofluorescence with the camp-crp activator complex which #recognized two sites in tsx-p2 , and by western blotting
individual cell clones were analyzed for stat1 expression by immunofluorescence with the camp-crp activator complex which #recognizes two sites in tsx-p2 , and by western blotting
individual cell clones were analyzed for stat1 expression by immunofluorescence with this antibody in pkr+/+mefs #recognizing the two forms of stat3 (stat3fm and stat3sm) , and by western blotting .
the narl protein are able to #recognize heptamers in other arrangements in the regulated promoters .
the narl protein #recognize specifically heptamers in other arrangements .
the narl protein #recognized heptamers in other arrangements in the regulated promoters .
the narl protein which has #recognized heptamers in other arrangements was purchased from transduction laboratories (lexington , ky) .
the narl protein which #recognizes heptamers in other arrangements is purchased from transduction laboratories (lexington , ky) .
the a approximately 70kd polypeptide in western blots of extraocular muscle , sternothyroid muscle , and smooth muscle is #recognized by anti-64kd human autoantigen d1 antibodies that blots were probed with .
the two forms of stat3 (stat3fm and stat3sm) are #recognized by this antibody in pkr+/+mefs .
the two forms of stat3 (stat3fm and stat3sm) , cannot be #recognized in the immunoprecipitaiton with this antibody in pkr+/+mefs as it is raised against a c-terminal region of stat3 that is missing in stat3beta .
the two forms of stat3 (stat3fm and stat3sm) , will not be #recognized in the immunoprecipitaiton with this antibody in pkr+/+mefs as it is raised against a c-terminal region of stat3 that is missing in stat3beta .
the two sites in tsx-p2 is #recognized by the camp-crp activator complex that blots were probed with .
these bands can be detected with a monoclonal antibody that #recognize the stat1 n-terminus
these bands can be detected with a monoclonal antibody which have #recognized the stat1 n-terminus
these bands can be detected with a monoclonal antibody which #recognize the stat1 n-terminus
these bands can be detected with anti-64kd human autoantigen d1 antibodies that #recognized a approximately 70kd polypeptide in western blots of extraocular muscle , sternothyroid muscle , and smooth muscle
these bands can be detected with the narl protein #recognizing heptamers in other arrangements
these bands can be detected with the narl protein that #recognize heptamers in other arrangements
these bands can be detected with the narl protein which #recognize heptamers in other arrangements
these bands can be detected with a rat monoclonal anti-ha antibody (boehringer-ingelheim) that #recognize sequence(ypydvpdya) at a 1:500 dilution
these bands can be detected with a monoclonal antibody which have #recognized the stat1 n-terminus
these bands can be detected with affinity-purified polyclonal anti-lmp-1 antiserum #recognizing epitopes in the c-terminus of lmp-1 at a 1:200 dilution
these bands can be detected with affinity-purified polyclonal anti-lmp-1 antiserum that #recognized epitopes in the c-terminus of lmp-1 at a 1:200 dilution
these bands can be detected with the camp-crp activator complex #recognizing two sites in tsx-p2
these bands can be detected with the camp-crp activator complex that #recognized two sites in tsx-p2
these bands can be detected with the camp-crp activator complex which have #recognized two sites in tsx-p2
these bands can be detected with the proteins #recognizing short motifs within the protected region
these bands can be detected with the proteins that #recognized short motifs within the protected region
these bands can be detected with the proteins which have #recognized short motifs within the protected region
these bands can be detected with the proteins which #recognize short motifs within the protected region
these bands can be detected with this antibody in pkr+/+mefs that #recognized the two forms of stat3 (stat3fm and stat3sm)
these bands can be detected with this antibody in pkr+/+mefs which #recognize the two forms of stat3 (stat3fm and stat3sm)
we show that a monoclonal antibody #recognizes the stat1 n-terminus that are separated by 33 bp : a high-affinity site (crp-1) overlaps the-35 region , and a low-affinity site (crp-2) is centered around position-74 bp .
we show that anti-64kd human autoantigen d1 antibodies has #recognized a approximately 70kd polypeptide in western blots of extraocular muscle , sternothyroid muscle , and smooth muscle that are separated by 33 bp : a high-affinity site (crp-1) overlaps the-35 region , and a low-affinity site (crp-2) is centered around position-74 bp .
we show that anti-64kd human autoantigen d1 antibodies #recognized a approximately 70kd polypeptide in western blots of extraocular muscle , sternothyroid muscle , and smooth muscle that are separated by 33 bp : a high-affinity site (crp-1) overlaps the-35 region , and a low-affinity site (crp-2) is centered around position-74 bp .
we show that anti-64kd human autoantigen d1 antibodies #recognizes a approximately 70kd polypeptide in western blots of extraocular muscle , sternothyroid muscle , and smooth muscle that are separated by 33 bp : a high-affinity site (crp-1) overlaps the-35 region , and a low-affinity site (crp-2) is centered around position-74 bp .
we show that anti-64kd human autoantigen d1 antibodies will #recognize a approximately 70kd polypeptide in western blots of extraocular muscle , sternothyroid muscle , and smooth muscle that are separated by 33 bp : a high-affinity site (crp-1) overlaps the-35 region , and a low-affinity site (crp-2) is centered around position-74 bp .
we show that the narl protein #recognized heptamers in other arrangements that are separated by 33 bp : a high-affinity site (crp-1) overlaps the-35 region , and a low-affinity site (crp-2) is centered around position-74 bp .
we show that the narl protein #recognizes heptamers in other arrangements that are separated by 33 bp : a high-affinity site (crp-1) overlaps the-35 region , and a low-affinity site (crp-2) is centered around position-74 bp .
we show that the narl protein will #recognize heptamers in other arrangements that are separated by 33 bp : a high-affinity site (crp-1) overlaps the-35 region , and a low-affinity site (crp-2) is centered around position-74 bp .
we show that a rat monoclonal anti-ha antibody (boehringer-ingelheim) has #recognized sequence(ypydvpdya) at a 1:500 dilution that are separated by 33 bp : a high-affinity site (crp-1) overlaps the-35 region , and a low-affinity site (crp-2) is centered around position-74 bp .
we show that a rat monoclonal anti-ha antibody (boehringer-ingelheim) #recognized sequence(ypydvpdya) at a 1:500 dilution that are separated by 33 bp : a high-affinity site (crp-1) overlaps the-35 region , and a low-affinity site (crp-2) is centered around position-74 bp .
we show that a rat monoclonal anti-ha antibody (boehringer-ingelheim) #recognizes sequence(ypydvpdya) at a 1:500 dilution that are separated by 33 bp : a high-affinity site (crp-1) overlaps the-35 region , and a low-affinity site (crp-2) is centered around position-74 bp .
we show that a rat monoclonal anti-ha antibody (boehringer-ingelheim) will #recognize sequence(ypydvpdya) at a 1:500 dilution that are separated by 33 bp : a high-affinity site (crp-1) overlaps the-35 region , and a low-affinity site (crp-2) is centered around position-74 bp .
we show that a monoclonal antibody will #recognize the stat1 n-terminus that are separated by 33 bp : a high-affinity site (crp-1) overlaps the-35 region , and a low-affinity site (crp-2) is centered around position-74 bp .
we show that affinity-purified polyclonal anti-lmp-1 antiserum #recognized epitopes in the c-terminus of lmp-1 at a 1:200 dilution that are separated by 33 bp : a high-affinity site (crp-1) overlaps the-35 region , and a low-affinity site (crp-2) is centered around position-74 bp .
we show that affinity-purified polyclonal anti-lmp-1 antiserum will #recognize epitopes in the c-terminus of lmp-1 at a 1:200 dilution that are separated by 33 bp : a high-affinity site (crp-1) overlaps the-35 region , and a low-affinity site (crp-2) is centered around position-74 bp .
we show that the proteins has #recognized short motifs within the protected region that are separated by 33 bp : a high-affinity site (crp-1) overlaps the-35 region , and a low-affinity site (crp-2) is centered around position-74 bp .
we show that this antibody in pkr+/+mefs #recognized the two forms of stat3 (stat3fm and stat3sm) that are separated by 33 bp : a high-affinity site (crp-1) overlaps the-35 region , and a low-affinity site (crp-2) is centered around position-74 bp .
we show that this antibody in pkr+/+mefs #recognizes the two forms of stat3 (stat3fm and stat3sm) that are separated by 33 bp : a high-affinity site (crp-1) overlaps the-35 region , and a low-affinity site (crp-2) is centered around position-74 bp .
we show that this antibody in pkr+/+mefs will #recognize the two forms of stat3 (stat3fm and stat3sm) that are separated by 33 bp : a high-affinity site (crp-1) overlaps the-35 region , and a low-affinity site (crp-2) is centered around position-74 bp .
a rat monoclonal anti-ha antibody (boehringer-ingelheim) has also bound to these 7-2-7 sites but , unlike narp , has also #recognized sequence(ypydvpdya) at a 1:500 dilution .
a rat monoclonal anti-ha antibody (boehringer-ingelheim) #recognized specifically sequence(ypydvpdya) at a 1:500 dilution .
a rat monoclonal anti-ha antibody (boehringer-ingelheim) which has #recognized sequence(ypydvpdya) at a 1:500 dilution was purchased from transduction laboratories (lexington , ky) .
a approximately 70kd polypeptide in western blots of extraocular muscle , sternothyroid muscle , and smooth muscle #recognized by anti-64kd human autoantigen d1 antibodies are indicated .
a approximately 70kd polypeptide in western blots of extraocular muscle , sternothyroid muscle , and smooth muscle that are #recognized by anti-64kd human autoantigen d1 antibodies are indicated .
a approximately 70kd polypeptide in western blots of extraocular muscle , sternothyroid muscle , and smooth muscle that have been #recognized by anti-64kd human autoantigen d1 antibodies are indicated .
a approximately 70kd polypeptide in western blots of extraocular muscle , sternothyroid muscle , and smooth muscle that will be #recognized by anti-64kd human autoantigen d1 antibodies are indicated .
a approximately 70kd polypeptide in western blots of extraocular muscle , sternothyroid muscle , and smooth muscle which can be #recognized by anti-64kd human autoantigen d1 antibodies are indicated .
a approximately 70kd polypeptide in western blots of extraocular muscle , sternothyroid muscle , and smooth muscle , cannot be #recognized in the immunoprecipitaiton with anti-64kd human autoantigen d1 antibodies as it is raised against a c-terminal region of stat3 that is missing in stat3beta .
a approximately 70kd polypeptide in western blots of extraocular muscle , sternothyroid muscle , and smooth muscle , is not #recognized in the immunoprecipitaiton with anti-64kd human autoantigen d1 antibodies as it is raised against a c-terminal region of stat3 that is missing in stat3beta .
a approximately 70kd polypeptide in western blots of extraocular muscle , sternothyroid muscle , and smooth muscle , was not #recognized in the immunoprecipitaiton with anti-64kd human autoantigen d1 antibodies as it was raised against a c-terminal region of stat3 that is missing in stat3beta .
a approximately 70kd polypeptide in western blots of extraocular muscle , sternothyroid muscle , and smooth muscle , will not be #recognized in the immunoprecipitaiton with anti-64kd human autoantigen d1 antibodies as it is raised against a c-terminal region of stat3 that is missing in stat3beta .
a monoclonal antibody also bound to these 7-2-7 sites but , unlike narp , also #recognized the stat1 n-terminus .
a monoclonal antibody are able to #recognize the stat1 n-terminus in the regulated promoters .
a monoclonal antibody can #recognize the stat1 n-terminus in the regulated promoters .
a monoclonal antibody #recognize specifically the stat1 n-terminus .
a monoclonal antibody #recognize the stat1 n-terminus in the regulated promoters .
a monoclonal antibody #recognized specifically the stat1 n-terminus .
a monoclonal antibody #recognized the stat1 n-terminus in the regulated promoters .
a monoclonal antibody #recognizing the stat1 n-terminus was purchased from transduction laboratories (lexington , ky) .
a monoclonal antibody which has #recognized the stat1 n-terminus was purchased from transduction laboratories (lexington , ky) .
a monoclonal antibody will #recognize the stat1 n-terminus in the regulated promoters .
affinity-purified polyclonal anti-lmp-1 antiserum also binds to these 7-2-7 sites but , unlike narp , also #recognizes epitopes in the c-terminus of lmp-1 at a 1:200 dilution .
affinity-purified polyclonal anti-lmp-1 antiserum are able to #recognize epitopes in the c-terminus of lmp-1 at a 1:200 dilution in the regulated promoters .
affinity-purified polyclonal anti-lmp-1 antiserum can #recognize epitopes in the c-terminus of lmp-1 at a 1:200 dilution in the regulated promoters .
affinity-purified polyclonal anti-lmp-1 antiserum have #recognized epitopes in the c-terminus of lmp-1 at a 1:200 dilution in the regulated promoters .
affinity-purified polyclonal anti-lmp-1 antiserum #recognize epitopes in the c-terminus of lmp-1 at a 1:200 dilution in the regulated promoters .
affinity-purified polyclonal anti-lmp-1 antiserum #recognized specifically epitopes in the c-terminus of lmp-1 at a 1:200 dilution .
affinity-purified polyclonal anti-lmp-1 antiserum #recognizing epitopes in the c-terminus of lmp-1 at a 1:200 dilution was purchased from transduction laboratories (lexington , ky) .
affinity-purified polyclonal anti-lmp-1 antiserum which #recognizes epitopes in the c-terminus of lmp-1 at a 1:200 dilution is purchased from transduction laboratories (lexington , ky) .
epitopes in the c-terminus of lmp-1 at a 1:200 dilution #recognized by affinity-purified polyclonal anti-lmp-1 antiserum are indicated .
epitopes in the c-terminus of lmp-1 at a 1:200 dilution that are #recognized by affinity-purified polyclonal anti-lmp-1 antiserum are indicated .
epitopes in the c-terminus of lmp-1 at a 1:200 dilution that were #recognized by affinity-purified polyclonal anti-lmp-1 antiserum are indicated .
epitopes in the c-terminus of lmp-1 at a 1:200 dilution were #recognized by affinity-purified polyclonal anti-lmp-1 antiserum .
epitopes in the c-terminus of lmp-1 at a 1:200 dilution which can be #recognized by affinity-purified polyclonal anti-lmp-1 antiserum are indicated .
epitopes in the c-terminus of lmp-1 at a 1:200 dilution , is not #recognized in the immunoprecipitaiton with affinity-purified polyclonal anti-lmp-1 antiserum as it is raised against a c-terminal region of stat3 that is missing in stat3beta .
epitopes in the c-terminus of lmp-1 at a 1:200 dilution , was not #recognized in the immunoprecipitaiton with affinity-purified polyclonal anti-lmp-1 antiserum as it was raised against a c-terminal region of stat3 that is missing in stat3beta .
heptamers in other arrangements are #recognized by the narl protein .
heptamers in other arrangements #recognized by the narl protein are indicated .
heptamers in other arrangements that have been #recognized by the narl protein are indicated .
heptamers in other arrangements that will be #recognized by the narl protein are indicated .
heptamers in other arrangements which can be #recognized by the narl protein are indicated .
heptamers in other arrangements , is not #recognized in the immunoprecipitaiton with the narl protein as it is raised against a c-terminal region of stat3 that is missing in stat3beta .
heptamers in other arrangements , will not be #recognized in the immunoprecipitaiton with the narl protein as it is raised against a c-terminal region of stat3 that is missing in stat3beta .
sequence(ypydvpdya) at a 1:500 dilution that are #recognized by a rat monoclonal anti-ha antibody (boehringer-ingelheim) are indicated .
sequence(ypydvpdya) at a 1:500 dilution that have been #recognized by a rat monoclonal anti-ha antibody (boehringer-ingelheim) are indicated .
sequence(ypydvpdya) at a 1:500 dilution that were #recognized by a rat monoclonal anti-ha antibody (boehringer-ingelheim) are indicated .
sequence(ypydvpdya) at a 1:500 dilution which can be #recognized by a rat monoclonal anti-ha antibody (boehringer-ingelheim) are indicated .
sequence(ypydvpdya) at a 1:500 dilution which were #recognized by a rat monoclonal anti-ha antibody (boehringer-ingelheim) are indicated .
sequence(ypydvpdya) at a 1:500 dilution , has not been #recognized in the immunoprecipitaiton with a rat monoclonal anti-ha antibody (boehringer-ingelheim) as it was raised against a c-terminal region of stat3 that is missing in stat3beta .
sequence(ypydvpdya) at a 1:500 dilution , was not #recognized in the immunoprecipitaiton with a rat monoclonal anti-ha antibody (boehringer-ingelheim) as it was raised against a c-terminal region of stat3 that is missing in stat3beta .
short motifs within the protected region are #recognized by the proteins .
short motifs within the protected region #recognized by the proteins are indicated .
short motifs within the protected region that are #recognized by the proteins are indicated .
short motifs within the protected region that will be #recognized by the proteins are indicated .
short motifs within the protected region which were #recognized by the proteins are indicated .
short motifs within the protected region , cannot be #recognized in the immunoprecipitaiton with the proteins as it is raised against a c-terminal region of stat3 that is missing in stat3beta .
short motifs within the protected region , has not been #recognized in the immunoprecipitaiton with the proteins as it was raised against a c-terminal region of stat3 that is missing in stat3beta .
short motifs within the protected region , was not #recognized in the immunoprecipitaiton with the proteins as it was raised against a c-terminal region of stat3 that is missing in stat3beta .
the stat1 n-terminus are #recognized by a monoclonal antibody .
the stat1 n-terminus #recognized by a monoclonal antibody are indicated .
the stat1 n-terminus that are #recognized by a monoclonal antibody are indicated .
the stat1 n-terminus that are #recognized by a monoclonal antibody are indicated .
the stat1 n-terminus that have been #recognized by a monoclonal antibody are indicated .
the stat1 n-terminus that have been #recognized by a monoclonal antibody are indicated .
the stat1 n-terminus that will be #recognized by a monoclonal antibody are indicated .
the stat1 n-terminus were #recognized by a monoclonal antibody .
the stat1 n-terminus which can be #recognized by a monoclonal antibody are indicated .
the stat1 n-terminus which were #recognized by a monoclonal antibody are indicated .
the stat1 n-terminus , cannot be #recognized in the immunoprecipitaiton with a monoclonal antibody as it is raised against a c-terminal region of stat3 that is missing in stat3beta .
the stat1 n-terminus , could not be #recognized in the immunoprecipitaiton with a monoclonal antibody as it was raised against a c-terminal region of stat3 that is missing in stat3beta .
the stat1 n-terminus , has not been #recognized in the immunoprecipitaiton with a monoclonal antibody as it was raised against a c-terminal region of stat3 that is missing in stat3beta .
the stat1 n-terminus , is not #recognized in the immunoprecipitaiton with a monoclonal antibody as it is raised against a c-terminal region of stat3 that is missing in stat3beta .
the stat1 n-terminus , is not #recognized in the immunoprecipitaiton with a monoclonal antibody as it is raised against a c-terminal region of stat3 that is missing in stat3beta .
the stat1 n-terminus , was not #recognized in the immunoprecipitaiton with a monoclonal antibody as it was raised against a c-terminal region of stat3 that is missing in stat3beta .
the camp-crp activator complex also bound to these 7-2-7 sites but , unlike narp , also #recognized two sites in tsx-p2 .
the camp-crp activator complex has also bound to these 7-2-7 sites but , unlike narp , has also #recognized two sites in tsx-p2 .
the camp-crp activator complex #recognize two sites in tsx-p2 in the regulated promoters .
the camp-crp activator complex #recognized specifically two sites in tsx-p2 .
the camp-crp activator complex #recognizing two sites in tsx-p2 was purchased from transduction laboratories (lexington , ky) .
the camp-crp activator complex which has #recognized two sites in tsx-p2 was purchased from transduction laboratories (lexington , ky) .
the camp-crp activator complex will #recognize two sites in tsx-p2 in the regulated promoters .
the proteins also binds to these 7-2-7 sites but , unlike narp , also #recognizes short motifs within the protected region .
the proteins can #recognize short motifs within the protected region in the regulated promoters .
the proteins have #recognized short motifs within the protected region in the regulated promoters .
the proteins #recognize specifically short motifs within the protected region .
the proteins #recognized short motifs within the protected region in the regulated promoters .
the proteins #recognized specifically short motifs within the protected region .
the proteins #recognizing short motifs within the protected region was purchased from transduction laboratories (lexington , ky) .
the proteins which #recognizes short motifs within the protected region is purchased from transduction laboratories (lexington , ky) .
the proteins will #recognize short motifs within the protected region in the regulated promoters .
this antibody in pkr+/+mefs also binds to these 7-2-7 sites but , unlike narp , also #recognizes the two forms of stat3 (stat3fm and stat3sm) .
this antibody in pkr+/+mefs also bound to these 7-2-7 sites but , unlike narp , also #recognized the two forms of stat3 (stat3fm and stat3sm) .
this antibody in pkr+/+mefs #recognize the two forms of stat3 (stat3fm and stat3sm) in the regulated promoters .
this antibody in pkr+/+mefs #recognized the two forms of stat3 (stat3fm and stat3sm) in the regulated promoters .
this antibody in pkr+/+mefs #recognizing the two forms of stat3 (stat3fm and stat3sm) was purchased from transduction laboratories (lexington , ky) .
this antibody in pkr+/+mefs which has #recognized the two forms of stat3 (stat3fm and stat3sm) was purchased from transduction laboratories (lexington , ky) .
this antibody in pkr+/+mefs which #recognizes the two forms of stat3 (stat3fm and stat3sm) is purchased from transduction laboratories (lexington , ky) .
two sites in tsx-p2 which can be #recognized by the camp-crp activator complex are indicated .
two sites in tsx-p2 , could not be #recognized in the immunoprecipitaiton with the camp-crp activator complex as it was raised against a c-terminal region of stat3 that is missing in stat3beta .
two sites in tsx-p2 , will not be #recognized in the immunoprecipitaiton with the camp-crp activator complex as it is raised against a c-terminal region of stat3 that is missing in stat3beta .
blots were probed with the rna-splicing apparatus #recognizing the normal splice junction .
blots were probed with the rna-splicing apparatus that can #recognize the normal splice junction .
blots were probed with the rna-splicing apparatus that #recognizes the normal splice junction .
blots were probed with the rna-splicing apparatus that #recognizes the the normal splice junction .
footprinting assays have suggested that these regulators protect a stretch of up to 20 bp in the target promoters , and multiple alignments of binding sites for a number of regulators have shown that the rna-splicing apparatus are able to #recognize the normal splice junction .
footprinting assays have suggested that these regulators protect a stretch of up to 20 bp in the target promoters , and multiple alignments of binding sites for a number of regulators have shown that the rna-splicing apparatus #recognized the normal splice junction .
individual cell clones were analyzed for stat1 expression by immunofluorescence where the normal splice junction were #recognized by the rna-splicing apparatus .
individual cell clones were analyzed for stat1 expression by immunofluorescence with the rna-splicing apparatus #recognizing the normal splice junction , and by western blotting .
individual cell clones were analyzed for stat1 expression by immunofluorescence with the rna-splicing apparatus which #recognizes the normal splice junction , and by western blotting
the the normal splice junction is #recognized by the rna-splicing apparatus that blots were probed with .
these bands can be detected with the rna-splicing apparatus which #recognize the normal splice junction
we show that the rna-splicing apparatus #recognizes the normal splice junction that are separated by 33 bp : a high-affinity site (crp-1) overlaps the-35 region , and a low-affinity site (crp-2) is centered around position-74 bp .
we show that the rna-splicing apparatus will #recognize the normal splice junction that are separated by 33 bp : a high-affinity site (crp-1) overlaps the-35 region , and a low-affinity site (crp-2) is centered around position-74 bp .
the rna-splicing apparatus also bound to these 7-2-7 sites but , unlike narp , also #recognized the normal splice junction .
the rna-splicing apparatus are able to #recognize the normal splice junction in the regulated promoters .
the rna-splicing apparatus can #recognize the normal splice junction in the regulated promoters .
the rna-splicing apparatus #recognized the normal splice junction in the regulated promoters .
the rna-splicing apparatus which has #recognized the normal splice junction was purchased from transduction laboratories (lexington , ky) .
the normal splice junction are #recognized by the rna-splicing apparatus .
the normal splice junction that are #recognized by the rna-splicing apparatus are indicated .
the normal splice junction that have been #recognized by the rna-splicing apparatus are indicated .
the normal splice junction were #recognized by the rna-splicing apparatus .
the normal splice junction which can be #recognized by the rna-splicing apparatus are indicated .
the normal splice junction which were #recognized by the rna-splicing apparatus are indicated .
the normal splice junction , will not be #recognized in the immunoprecipitaiton with the rna-splicing apparatus as it is raised against a c-terminal region of stat3 that is missing in stat3beta .
a role for sos-1 in fgfr-mediated signaling during development hyperactive egl-15 fgf receptor signaling that has #resulted in a clr phenotype is conferred by either an activated egl-15 or a lf clr-1 mutation .
a role for sos-1 in fgfr-mediated signaling during development hyperactive egl-15 fgf receptor signaling that is able to #result in a clr phenotype is conferred by either an activated egl-15 or a lf clr-1 mutation .
a role for sos-1 in fgfr-mediated signaling during development hyperactive egl-15 fgf receptor signaling that may have #resulted in a clr phenotype is conferred by either an activated egl-15 or a lf clr-1 mutation .
a role for sos-1 in fgfr-mediated signaling during development hyperactive egl-15 fgf receptor signaling that #resulted in a clr phenotype is conferred by either an activated egl-15 or a lf clr-1 mutation .
a role for sos-1 in fgfr-mediated signaling during development hyperactive egl-15 fgf receptor signaling that #results in a clr phenotype is conferred by either an activated egl-15 or a lf clr-1 mutation .
a role for sos-1 in fgfr-mediated signaling during development hyperactive egl-15 fgf receptor signaling , conferred by either an activated egl-15 or a lf clr-1 mutation , can #result in a clr phenotype .
a role for sos-1 in fgfr-mediated signaling during development hyperactive egl-15 fgf receptor signaling , conferred by either an activated egl-15 or a lf clr-1 mutation , may have #resulted in a clr phenotype .
a role for sos-1 in fgfr-mediated signaling during development hyperactive egl-15 fgf receptor signaling , conferred by either an activated egl-15 or a lf clr-1 mutation , #resulted in a clr phenotype .
a role for sos-1 in fgfr-mediated signaling during development hyperactive egl-15 fgf receptor signaling , conferred by either an activated egl-15 or a lf clr-1 mutation , will #result in a clr phenotype .
alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation are able to #result in mrna species with distinct 5utrs .
alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation have #resulted in mrna species with distinct 5utrs .
alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation #resulted in mrna species with distinct 5utrs .
alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation will #result in mrna species with distinct 5utrs .
alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation , as our study suggested , can #result in mrna species with distinct 5utrs .
alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation , as our study suggested , may have #resulted in mrna species with distinct 5utrs .
both the 5 and 3 splice site mutations (1060 + 2t-->c and 678-7g-->a , respectively) are observed to #result in high proportions of mature mrnas containing introns , which has not been observed for other splicing mutations .
both the 5 and 3 splice site mutations (1060 + 2t-->c and 678-7g-->a , respectively) can #result in high proportions of mature mrnas containing introns , which has not been observed for other splicing mutations .
both the 5 and 3 splice site mutations (1060 + 2t-->c and 678-7g-->a , respectively) has #resulted in high proportions of mature mrnas containing introns , which has not been observed for other splicing mutations .
both the 5 and 3 splice site mutations (1060 + 2t-->c and 678-7g-->a , respectively) may have #resulted in high proportions of mature mrnas containing introns , which has not been observed for other splicing mutations .
both the 5 and 3 splice site mutations (1060 + 2t-->c and 678-7g-->a , respectively) #resulted in high proportions of mature mrnas containing introns , which has not been observed for other splicing mutations .
both the 5 and 3 splice site mutations (1060 + 2t-->c and 678-7g-->a , respectively) will #result in high proportions of mature mrnas containing introns , which has not been observed for other splicing mutations .
both the 5 and 3 splice site mutations (1060 + 2t-->c and 678-7g-->a , respectively) , in contrast , are observed to #result in high proportions of mature mrnas containing introns , which has not been observed for other splicing mutations .
both the 5 and 3 splice site mutations (1060 + 2t-->c and 678-7g-->a , respectively) , in contrast , has #resulted in high proportions of mature mrnas containing introns , which has not been observed for other splicing mutations .
both the 5 and 3 splice site mutations (1060 + 2t-->c and 678-7g-->a , respectively) , in contrast , #result in high proportions of mature mrnas containing introns , which has not been observed for other splicing mutations .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed a new mutation at codon 210 being observed to #result in the substitution of isoleucine for valine .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed a new mutation at codon 210 having #resulted in the substitution of isoleucine for valine .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed a new mutation at codon 210 having the ability to #result in the substitution of isoleucine for valine .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed a new mutation at codon 210 that has the ability to #result in the substitution of isoleucine for valine .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed a new mutation at codon 210 that is observed to #result in the substitution of isoleucine for valine .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed a new mutation at codon 210 which can #result in the substitution of isoleucine for valine .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed a new mutation at codon 210 which has #resulted in the substitution of isoleucine for valine .
human mucin gene muc5b , the 10 .7-kb large central exon encodes various alternate subdomains being observed to completely #result in a super-repeat .
human mucin gene muc5b , the 10 .7-kb large central exon encodes various alternate subdomains having completely #resulted in a super-repeat .
human mucin gene muc5b , the 10 .7-kb large central exon encodes various alternate subdomains having #resulted in a super-repeat .
human mucin gene muc5b , the 10 .7-kb large central exon encodes various alternate subdomains having the ability to completely #result in a super-repeat .
human mucin gene muc5b , the 10 .7-kb large central exon encodes various alternate subdomains having the ability to #result in a super-repeat .
human mucin gene muc5b , the 10 .7-kb large central exon encodes various alternate subdomains which are able to completely #result in a super-repeat .
human mucin gene muc5b , the 10 .7-kb large central exon encodes various alternate subdomains which are observed to completely #result in a super-repeat .
human mucin gene muc5b , the 10 .7-kb large central exon encodes various alternate subdomains which are observed to #result in a super-repeat .
human mucin gene muc5b , the 10 .7-kb large central exon encodes various alternate subdomains which can completely #result in a super-repeat .
human mucin gene muc5b , the 10 .7-kb large central exon encodes various alternate subdomains which can #result in a super-repeat .
human mucin gene muc5b , the 10 .7-kb large central exon encodes various alternate subdomains which completely #resulted in a super-repeat .
human mucin gene muc5b , the 10 .7-kb large central exon encodes various alternate subdomains which have the ability to completely #result in a super-repeat .
human mucin gene muc5b , the 10 .7-kb large central exon encodes various alternate subdomains which #resulted in a super-repeat .
human mucin gene muc5b , the 10 .7-kb large central exon encodes various alternate subdomains which will #result in a super-repeat .
induction of a mutation in the laci gene can #result in the loss of transcriptional repression of the lacz gene in mutated cells .
induction of a mutation in the laci gene could have #resulted in the loss of transcriptional repression of the lacz gene in mutated cells .
induction of a mutation in the laci gene has #resulted in the loss of transcriptional repression of the lacz gene in mutated cells .
induction of a mutation in the laci gene has the ability to #result in the loss of transcriptional repression of the lacz gene in mutated cells .
induction of a mutation in the laci gene is able to #result in the loss of transcriptional repression of the lacz gene in mutated cells .
induction of a mutation in the laci gene may have #resulted in the loss of transcriptional repression of the lacz gene in mutated cells .
induction of a mutation in the laci gene #resulted in the loss of transcriptional repression of the lacz gene in mutated cells .
induction of a mutation in the laci gene #results in the loss of transcriptional repression of the lacz gene in mutated cells .
induction of a mutation in the laci gene will #result in the loss of transcriptional repression of the lacz gene in mutated cells .
induction of a mutation in the laci gene , as our study revealed , is able to #result in the loss of transcriptional repression of the lacz gene in mutated cells .
induction of a mutation in the laci gene , as our study revealed , is observed to #result in the loss of transcriptional repression of the lacz gene in mutated cells .
induction of a mutation in the laci gene , as our study revealed , may have #resulted in the loss of transcriptional repression of the lacz gene in mutated cells .
induction of a mutation in the laci gene , as our study revealed , may #result in the loss of transcriptional repression of the lacz gene in mutated cells .
mutations being able to #result in simultaneous derepression of both genes can prevent repressor binding to either site or alter the phasing of the binding sites .
mutations being observed to #result in simultaneous derepression of both genes can prevent repressor binding to either site or alter the phasing of the binding sites .
mutations having #resulted in simultaneous derepression of both genes can prevent repressor binding to either site or alter the phasing of the binding sites .
mutations #resulting in simultaneous derepression of both genes can prevent repressor binding to either site or alter the phasing of the binding sites .
mutations that are able to #result in simultaneous derepression of both genes can prevent repressor binding to either site or alter the phasing of the binding sites .
mutations that may have #resulted in simultaneous derepression of both genes can prevent repressor binding to either site or alter the phasing of the binding sites .
mutations that may #result in simultaneous derepression of both genes can prevent repressor binding to either site or alter the phasing of the binding sites .
mutations that #result in simultaneous derepression of both genes can prevent repressor binding to either site or alter the phasing of the binding sites .
mutations that #resulted in simultaneous derepression of both genes can prevent repressor binding to either site or alter the phasing of the binding sites .
mutations which prevent repressor binding to either site or alter the phasing of the binding sites have the ability to #result in simultaneous derepression of both genes .
mutations which prevent repressor binding to either site or alter the phasing of the binding sites #resulted in simultaneous derepression of both genes .
sequence analysis of the idhbeta gene indicates that the difference in the c-terminal 28 amino acids between beta(1) and beta(2) proteins can #resulted from alternative splicing of a single transcript .
sequence analysis of the idhbeta gene indicates that the difference in the c-terminal 28 amino acids between beta(1) and beta(2) proteins has been shown to #result from alternative splicing of a single transcript .
sequence analysis of the idhbeta gene indicates that the difference in the c-terminal 28 amino acids between beta(1) and beta(2) proteins has #resulted from alternative splicing of a single transcript .
sequence analysis of the idhbeta gene indicates that the difference in the c-terminal 28 amino acids between beta(1) and beta(2) proteins has the ability to #result from alternative splicing of a single transcript .
sequence analysis of the idhbeta gene indicates that the difference in the c-terminal 28 amino acids between beta(1) and beta(2) proteins may have #resulted from alternative splicing of a single transcript .
sequence analysis of the idhbeta gene indicates that the difference in the c-terminal 28 amino acids between beta(1) and beta(2) proteins #resulted from alternative splicing of a single transcript .
the change may cause the heat instability and affect the net charge of the variant subunit being able to #result in an electrophoretic ldh-b subunit variant of the fast type .
the change may cause the heat instability and affect the net charge of the variant subunit being observed to finally #result in an electrophoretic ldh-b subunit variant of the fast type .
the change may cause the heat instability and affect the net charge of the variant subunit being shown to finally #result in an electrophoretic ldh-b subunit variant of the fast type .
the change may cause the heat instability and affect the net charge of the variant subunit having #resulted in an electrophoretic ldh-b subunit variant of the fast type .
the change may cause the heat instability and affect the net charge of the variant subunit that will finally #result in an electrophoretic ldh-b subunit variant of the fast type .
the change may cause the heat instability and affect the net charge of the variant subunit which can finally #result in an electrophoretic ldh-b subunit variant of the fast type .
the change may cause the heat instability and affect the net charge of the variant subunit which finally #resulted in an electrophoretic ldh-b subunit variant of the fast type .
the change may cause the heat instability and affect the net charge of the variant subunit which finally #results in an electrophoretic ldh-b subunit variant of the fast type .
the change may cause the heat instability and affect the net charge of the variant subunit which has been shown to finally #result in an electrophoretic ldh-b subunit variant of the fast type .
the change may cause the heat instability and affect the net charge of the variant subunit which is able to finally #result in an electrophoretic ldh-b subunit variant of the fast type .
the change may cause the heat instability and affect the net charge of the variant subunit which may have finally #resulted in an electrophoretic ldh-b subunit variant of the fast type .
two are missense mutations in exon 2 (g339d and r340c) , and the other three alterations (a nonsense mutation , a frameshift , and a splicing mutation) have been shown to #result in truncated nonfunctional proteins .
two are missense mutations in exon 2 (g339d and r340c) , and the other three alterations (a nonsense mutation , a frameshift , and a splicing mutation) have the ability to #result in truncated nonfunctional proteins .
two are missense mutations in exon 2 (g339d and r340c) , and the other three alterations (a nonsense mutation , a frameshift , and a splicing mutation) have the probability of #resulting in truncated nonfunctional proteins .
two are missense mutations in exon 2 (g339d and r340c) , and the other three alterations (a nonsense mutation , a frameshift , and a splicing mutation) may have #resulted in truncated nonfunctional proteins .
two are missense mutations in exon 2 (g339d and r340c) , and the other three alterations (a nonsense mutation , a frameshift , and a splicing mutation) may #result in truncated nonfunctional proteins .
two are missense mutations in exon 2 (g339d and r340c) , and the other three alterations (a nonsense mutation , a frameshift , and a splicing mutation) #resulted in truncated nonfunctional proteins .
two are missense mutations in exon 2 (g339d and r340c) , and the other three alterations (a nonsense mutation , a frameshift , and a splicing mutation) will #result in truncated nonfunctional proteins .
we show that the negative effect of the cpxa mutation on biofilm formation can #result from a decreased transcription of the curlin encoding csga gene .
we show that the negative effect of the cpxa mutation on biofilm formation is able to #result from a decreased transcription of the curlin encoding csga gene .
we show that the negative effect of the cpxa mutation on biofilm formation may #result from a decreased transcription of the curlin encoding csga gene .
we show that the negative effect of the cpxa mutation on biofilm formation #results from a decreased transcription of the curlin encoding csga gene .
we speculated that this is observed to be the #result of the expression of isoforms of nrf1 in mast cells .
we speculated that this is the #result of the expression of isoforms of nrf1 in mast cells .
a role for sos-1 in fgfr-mediated signaling during development hyperactive egl-15 fgf receptor signaling , conferred by either an activated egl-15 or a lf clr-1 mutation , #results in a clr phenotype .
these observations show that repression is the #result of co-operative binding of the repressor to its two sites , #resulting in the formation of a loop of dna .
both the 5 and 3 splice site mutations (1060 + 2t-->c and 678-7g-->a , respectively) #result in high proportions of mature mrnas containing introns , which has not been observed for other splicing mutations .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed a new mutation at codon 210 #resulting in the substitution of isoleucine for valine .
human mucin gene muc5b , the 10 .7-kb large central exon encodes various alternate subdomains #resulting in a super-repeat .
sequence analysis of the idhbeta gene indicates that the difference in the c-terminal 28 amino acids between beta(1) and beta(2) proteins #results from alternative splicing of a single transcript .
two are missense mutations in exon 2 (g339d and r340c) , and the other three alterations (a nonsense mutation , a frameshift , and a splicing mutation) are likely to #result in truncated nonfunctional proteins .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed of the expression of isoforms of nrf1 being able to #result in this .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed of the expression of isoforms of nrf1 being observed to #result in this .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed of the expression of isoforms of nrf1 having the ability to #result in this .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed of the expression of isoforms of nrf1 #resulting in this .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed of the expression of isoforms of nrf1 that has the ability to #result in this .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed of the expression of isoforms of nrf1 that is observed to #result in this .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed of the expression of isoforms of nrf1 that may have #resulted in this .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed of the expression of isoforms of nrf1 which has #resulted in this .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed of the expression of isoforms of nrf1 which will #result in this .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed the expression of isoforms of nrf1 being able to #result in this .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed the expression of isoforms of nrf1 being observed to #result in this .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed the expression of isoforms of nrf1 having the ability to #result in this .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed the expression of isoforms of nrf1 that is able to #result in this .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed the expression of isoforms of nrf1 that may have #resulted in this .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed the expression of isoforms of nrf1 which has #resulted in this .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed the net charge of the variant subunit being able to #result in an electrophoretic ldh-b subunit variant of the fast type .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed the net charge of the variant subunit being observed to #result in an electrophoretic ldh-b subunit variant of the fast type .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed the net charge of the variant subunit having the ability to #result in an electrophoretic ldh-b subunit variant of the fast type .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed the net charge of the variant subunit #resulting in an electrophoretic ldh-b subunit variant of the fast type .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed the net charge of the variant subunit that may have #resulted in an electrophoretic ldh-b subunit variant of the fast type .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed the net charge of the variant subunit that #resulted in an electrophoretic ldh-b subunit variant of the fast type .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed the net charge of the variant subunit which has #resulted in an electrophoretic ldh-b subunit variant of the fast type .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed the net charge of the variant subunit which will #result in an electrophoretic ldh-b subunit variant of the fast type .
the change may cause the heat instability and affect a new mutation at codon 210 being able to finally #result in the substitution of isoleucine for valine .
the change may cause the heat instability and affect a new mutation at codon 210 having finally #resulted in the substitution of isoleucine for valine .
the change may cause the heat instability and affect a new mutation at codon 210 having #resulted in the substitution of isoleucine for valine .
the change may cause the heat instability and affect a new mutation at codon 210 that has finally #resulted in the substitution of isoleucine for valine .
the change may cause the heat instability and affect a new mutation at codon 210 that has #resulted in the substitution of isoleucine for valine .
the change may cause the heat instability and affect a new mutation at codon 210 which finally #resulted in the substitution of isoleucine for valine .
the change may cause the heat instability and affect a new mutation at codon 210 which has been shown to #result in the substitution of isoleucine for valine .
the change may cause the heat instability and affect a new mutation at codon 210 which is able to finally #result in the substitution of isoleucine for valine .
the change may cause the heat instability and affect a new mutation at codon 210 which may have finally #resulted in the substitution of isoleucine for valine .
the change may cause the heat instability and affect a new mutation at codon 210 which may have #resulted in the substitution of isoleucine for valine .
the change may cause the heat instability and affect a new mutation at codon 210 which #resulted in the substitution of isoleucine for valine .
the change may cause the heat instability and affect a new mutation at codon 210 which #results in the substitution of isoleucine for valine .
the change may cause the heat instability and affect a new mutation at codon 210 , #resulting in the substitution of isoleucine for valine .
the change may cause the heat instability and affect of the expression of isoforms of nrf1 being observed to #result in this .
the change may cause the heat instability and affect of the expression of isoforms of nrf1 being shown to #result in this .
the change may cause the heat instability and affect of the expression of isoforms of nrf1 having finally #resulted in this .
the change may cause the heat instability and affect of the expression of isoforms of nrf1 that has finally #resulted in this .
the change may cause the heat instability and affect of the expression of isoforms of nrf1 that will finally #result in this .
the change may cause the heat instability and affect of the expression of isoforms of nrf1 that will #result in this .
the change may cause the heat instability and affect of the expression of isoforms of nrf1 which can #result in this .
the change may cause the heat instability and affect of the expression of isoforms of nrf1 which has been shown to finally #result in this .
the change may cause the heat instability and affect of the expression of isoforms of nrf1 which is able to finally #result in this .
the change may cause the heat instability and affect of the expression of isoforms of nrf1 which may have #resulted in this .
the change may cause the heat instability and affect of the expression of isoforms of nrf1 which #results in this .
the change may cause the heat instability and affect of the expression of isoforms of nrf1 , #resulting in this .
the change may cause the heat instability and affect the expression of isoforms of nrf1 being able to #result in this .
the change may cause the heat instability and affect the expression of isoforms of nrf1 being observed to finally #result in this .
the change may cause the heat instability and affect the expression of isoforms of nrf1 being observed to #result in this .
the change may cause the heat instability and affect the expression of isoforms of nrf1 being shown to finally #result in this .
the change may cause the heat instability and affect the expression of isoforms of nrf1 being shown to #result in this .
the change may cause the heat instability and affect the expression of isoforms of nrf1 having finally #resulted in this .
the change may cause the heat instability and affect the expression of isoforms of nrf1 which can finally #result in this .
the change may cause the heat instability and affect the expression of isoforms of nrf1 which finally #resulted in this .
the change may cause the heat instability and affect the expression of isoforms of nrf1 which is able to #result in this .
the change may cause the heat instability and affect the expression of isoforms of nrf1 which is observed to finally #result in this .
the change may cause the heat instability and affect the expression of isoforms of nrf1 which is observed to #result in this .
the change may cause the heat instability and affect the expression of isoforms of nrf1 which #resulted in this .
we speculated that an electrophoretic ldh-b subunit variant of the fast type is observed to be the #result of the net charge of the variant subunit in mast cells .
we speculated that an electrophoretic ldh-b subunit variant of the fast type may be the #result of the net charge of the variant subunit in mast cells .
we speculated that the substitution of isoleucine for valine has been shown to be the #result of a new mutation at codon 210 in mast cells .
we speculated that the substitution of isoleucine for valine is the #result of a new mutation at codon 210 in mast cells .
we speculated that the substitution of isoleucine for valine may be the #result a new mutation at codon 210 in mast cells .
a new mutation at codon 210 are able to #result in the substitution of isoleucine for valine .
a new mutation at codon 210 are observed to #result in the substitution of isoleucine for valine .
a new mutation at codon 210 can finally #result in the substitution of isoleucine for valine
a new mutation at codon 210 finally #result in the substitution of isoleucine for valine .
a new mutation at codon 210 has #resulted in the substitution of isoleucine for valine .
a new mutation at codon 210 have the ability to #result in the substitution of isoleucine for valine .
a new mutation at codon 210 may #result in the substitution of isoleucine for valine .
a new mutation at codon 210 #result in the substitution of isoleucine for valine .
of the expression of isoforms of nrf1 are able to finally #result in this .
of the expression of isoforms of nrf1 are able to #result in this .
of the expression of isoforms of nrf1 are observed to finally #result in this .
of the expression of isoforms of nrf1 are observed to #result in this .
of the expression of isoforms of nrf1 finally #result in this .
of the expression of isoforms of nrf1 has #resulted in this .
of the expression of isoforms of nrf1 may have #resulted in this .
of the expression of isoforms of nrf1 may #result in this .
of the expression of isoforms of nrf1 #result in this .
of the expression of isoforms of nrf1 #resulted in this .
of the expression of isoforms of nrf1 will #result in this .
the expression of isoforms of nrf1 are able to finally #result in this .
the expression of isoforms of nrf1 are able to #result in this .
the expression of isoforms of nrf1 finally #result in this .
the expression of isoforms of nrf1 has finally #resulted in this .
the expression of isoforms of nrf1 has #resulted in this .
the expression of isoforms of nrf1 have the ability to finally #result in this .
the expression of isoforms of nrf1 have the ability to #result in this .
the expression of isoforms of nrf1 may #result in this .
the expression of isoforms of nrf1 #result in this .
the expression of isoforms of nrf1 #resulted in this .
the expression of isoforms of nrf1 will finally #result in this .
the expression of isoforms of nrf1 will #result in this .
the net charge of the variant subunit are able to #result in an electrophoretic ldh-b subunit variant of the fast type .
the net charge of the variant subunit can finally #result in an electrophoretic ldh-b subunit variant of the fast type
the net charge of the variant subunit finally #result in an electrophoretic ldh-b subunit variant of the fast type .
the net charge of the variant subunit has finally #resulted in an electrophoretic ldh-b subunit variant of the fast type .
the net charge of the variant subunit has #resulted in an electrophoretic ldh-b subunit variant of the fast type .
the net charge of the variant subunit have the ability to finally #result in an electrophoretic ldh-b subunit variant of the fast type .
the net charge of the variant subunit have the ability to #result in an electrophoretic ldh-b subunit variant of the fast type .
the net charge of the variant subunit may have finally #resulted in an electrophoretic ldh-b subunit variant of the fast type .
the net charge of the variant subunit may have #resulted in an electrophoretic ldh-b subunit variant of the fast type .
the net charge of the variant subunit #result in an electrophoretic ldh-b subunit variant of the fast type .
the net charge of the variant subunit #resulted in an electrophoretic ldh-b subunit variant of the fast type .
the net charge of the variant subunit will finally #result in an electrophoretic ldh-b subunit variant of the fast type .
the net charge of the variant subunit will #result in an electrophoretic ldh-b subunit variant of the fast type .
a role for sos-1 in fgfr-mediated signaling during development hyperactive egl-15 fgf receptor signaling are able to #result in a clr phenotype .
a role for sos-1 in fgfr-mediated signaling during development hyperactive egl-15 fgf receptor signaling can finally #result in a clr phenotype
a role for sos-1 in fgfr-mediated signaling during development hyperactive egl-15 fgf receptor signaling can #result in a clr phenotype
a role for sos-1 in fgfr-mediated signaling during development hyperactive egl-15 fgf receptor signaling has finally #resulted in a clr phenotype .
a role for sos-1 in fgfr-mediated signaling during development hyperactive egl-15 fgf receptor signaling have the ability to finally #result in a clr phenotype .
a role for sos-1 in fgfr-mediated signaling during development hyperactive egl-15 fgf receptor signaling have the ability to #result in a clr phenotype .
a role for sos-1 in fgfr-mediated signaling during development hyperactive egl-15 fgf receptor signaling may finally #result in a clr phenotype .
a role for sos-1 in fgfr-mediated signaling during development hyperactive egl-15 fgf receptor signaling may have finally #resulted in a clr phenotype .
a role for sos-1 in fgfr-mediated signaling during development hyperactive egl-15 fgf receptor signaling may #result in a clr phenotype .
a role for sos-1 in fgfr-mediated signaling during development hyperactive egl-15 fgf receptor signaling #result in a clr phenotype .
a role for sos-1 in fgfr-mediated signaling during development hyperactive egl-15 fgf receptor signaling #resulted in a clr phenotype .
a role for sos-1 in fgfr-mediated signaling during development hyperactive egl-15 fgf receptor signaling will finally #result in a clr phenotype .
alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation may #result in mrna species with distinct 5utrs .
alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation will finally #result in mrna species with distinct 5utrs .
alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation , as our study suggested , are able to finally #result in mrna species with distinct 5utrs .
alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation , as our study suggested , are observed to finally #result in mrna species with distinct 5utrs .
alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation , as our study suggested , can finally #result in mrna species with distinct 5utrs
alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation , as our study suggested , can #result in mrna species with distinct 5utrs
alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation , as our study suggested , finally #result in mrna species with distinct 5utrs .
alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation , as our study suggested , has finally #resulted in mrna species with distinct 5utrs .
alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation , as our study suggested , may finally #result in mrna species with distinct 5utrs .
alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation , as our study suggested , may have finally #resulted in mrna species with distinct 5utrs .
alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation , as our study suggested , may #result in mrna species with distinct 5utrs .
alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation , as our study suggested , will finally #result in mrna species with distinct 5utrs .
both the 5 and 3 splice site mutations are able to finally #result in high proportions of mature mrnas containing introns .
both the 5 and 3 splice site mutations are observed to #result in high proportions of mature mrnas containing introns .
both the 5 and 3 splice site mutations can #result in high proportions of mature mrnas containing introns
both the 5 and 3 splice site mutations have the ability to #result in high proportions of mature mrnas containing introns .
both the 5 and 3 splice site mutations may have #resulted in high proportions of mature mrnas containing introns .
both the 5 and 3 splice site mutations may #result in high proportions of mature mrnas containing introns .
both the 5 and 3 splice site mutations #resulted in high proportions of mature mrnas containing introns .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed a role for sos-1 in fgfr-mediated signaling during development hyperactive egl-15 fgf receptor signaling being observed to #result in a clr phenotype .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed a role for sos-1 in fgfr-mediated signaling during development hyperactive egl-15 fgf receptor signaling having the ability to #result in a clr phenotype .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed a role for sos-1 in fgfr-mediated signaling during development hyperactive egl-15 fgf receptor signaling #resulting in a clr phenotype .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed a role for sos-1 in fgfr-mediated signaling during development hyperactive egl-15 fgf receptor signaling that has the ability to #result in a clr phenotype .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation being able to #result in mrna species with distinct 5utrs .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation having the ability to #result in mrna species with distinct 5utrs .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation #resulting in mrna species with distinct 5utrs .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation that is able to #result in mrna species with distinct 5utrs .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation that is observed to #result in mrna species with distinct 5utrs .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation that #resulted in mrna species with distinct 5utrs .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation which can #result in mrna species with distinct 5utrs .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation which will #result in mrna species with distinct 5utrs .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation , as our study suggested , having #resulted in mrna species with distinct 5utrs .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation , as our study suggested , having the ability to #result in mrna species with distinct 5utrs .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation , as our study suggested , that has the ability to #result in mrna species with distinct 5utrs .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation , as our study suggested , that is able to #result in mrna species with distinct 5utrs .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation , as our study suggested , that is observed to #result in mrna species with distinct 5utrs .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation , as our study suggested , that #resulted in mrna species with distinct 5utrs .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation , as our study suggested , which can #result in mrna species with distinct 5utrs .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation , as our study suggested , which has #resulted in mrna species with distinct 5utrs .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation , as our study suggested , which will #result in mrna species with distinct 5utrs .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed both the 5 and 3 splice site mutations being able to #result in high proportions of mature mrnas containing introns .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed both the 5 and 3 splice site mutations being observed to #result in high proportions of mature mrnas containing introns .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed both the 5 and 3 splice site mutations having #resulted in high proportions of mature mrnas containing introns .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed both the 5 and 3 splice site mutations #resulting in high proportions of mature mrnas containing introns .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed both the 5 and 3 splice site mutations that has the ability to #result in high proportions of mature mrnas containing introns .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed both the 5 and 3 splice site mutations that is observed to #result in high proportions of mature mrnas containing introns .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed both the 5 and 3 splice site mutations which has #resulted in high proportions of mature mrnas containing introns .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed both the 5 and 3 splice site mutations which #results in high proportions of mature mrnas containing introns .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed a decreased transcription of the curlin encoding csga gene being able to #result in the negative effect of the cpxa mutation .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed a decreased transcription of the curlin encoding csga gene that has the ability to #result in the negative effect of the cpxa mutation .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed a decreased transcription of the curlin encoding csga gene that is able to #result in the negative effect of the cpxa mutation .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed a decreased transcription of the curlin encoding csga gene that is observed to #result in the negative effect of the cpxa mutation .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed a decreased transcription of the curlin encoding csga gene that #resulted in the negative effect of the cpxa mutation .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed a decreased transcription of the curlin encoding csga gene which will #result in the negative effect of the cpxa mutation .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed alternative splicing of a single transcript being able to #result in the difference in the c-terminal 28 amino acids between beta(1) and beta(2) proteins .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed alternative splicing of a single transcript being observed to #result in the difference in the c-terminal 28 amino acids between beta(1) and beta(2) proteins .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed alternative splicing of a single transcript having #resulted in the difference in the c-terminal 28 amino acids between beta(1) and beta(2) proteins .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed alternative splicing of a single transcript that is able to #result in the difference in the c-terminal 28 amino acids between beta(1) and beta(2) proteins .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed alternative splicing of a single transcript that may have #resulted in the difference in the c-terminal 28 amino acids between beta(1) and beta(2) proteins .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed alternative splicing of a single transcript which has #resulted in the difference in the c-terminal 28 amino acids between beta(1) and beta(2) proteins .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed alternative splicing of a single transcript which #results in the difference in the c-terminal 28 amino acids between beta(1) and beta(2) proteins .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed of co-operative binding of the repressor being able to #result in that repression .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed of co-operative binding of the repressor being observed to #result in that repression .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed of co-operative binding of the repressor having the ability to #result in that repression .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed of co-operative binding of the repressor which has #resulted in that repression .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed of co-operative binding of the repressor which will #result in that repression .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed the other three alterations being able to #result in truncated nonfunctional proteins .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed the other three alterations having #resulted in truncated nonfunctional proteins .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed the other three alterations that has the ability to #result in truncated nonfunctional proteins .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed the other three alterations that is able to #result in truncated nonfunctional proteins .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed the other three alterations that is observed to #result in truncated nonfunctional proteins .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed the other three alterations which can #result in truncated nonfunctional proteins .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed the other three alterations which has #resulted in truncated nonfunctional proteins .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed the other three alterations which #results in truncated nonfunctional proteins .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed various alternate subdomains being able to #result in a super-repeat .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed various alternate subdomains being observed to #result in a super-repeat .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed various alternate subdomains having #resulted in a super-repeat .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed various alternate subdomains having the ability to #result in a super-repeat .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed various alternate subdomains #resulting in a super-repeat .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed various alternate subdomains that has the ability to #result in a super-repeat .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed various alternate subdomains that is able to #result in a super-repeat .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed various alternate subdomains that may have #resulted in a super-repeat .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed various alternate subdomains which has #resulted in a super-repeat .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed various alternate subdomains which #results in a super-repeat .
the change may cause the heat instability and affect a role for sos-1 in fgfr-mediated signaling during development hyperactive egl-15 fgf receptor signaling being able to finally #result in a clr phenotype .
the change may cause the heat instability and affect a role for sos-1 in fgfr-mediated signaling during development hyperactive egl-15 fgf receptor signaling being shown to finally #result in a clr phenotype .
the change may cause the heat instability and affect a role for sos-1 in fgfr-mediated signaling during development hyperactive egl-15 fgf receptor signaling being shown to #result in a clr phenotype .
the change may cause the heat instability and affect a role for sos-1 in fgfr-mediated signaling during development hyperactive egl-15 fgf receptor signaling having finally #resulted in a clr phenotype .
the change may cause the heat instability and affect a role for sos-1 in fgfr-mediated signaling during development hyperactive egl-15 fgf receptor signaling having #resulted in a clr phenotype .
the change may cause the heat instability and affect a role for sos-1 in fgfr-mediated signaling during development hyperactive egl-15 fgf receptor signaling that will finally #result in a clr phenotype .
the change may cause the heat instability and affect a role for sos-1 in fgfr-mediated signaling during development hyperactive egl-15 fgf receptor signaling that will #result in a clr phenotype .
the change may cause the heat instability and affect a role for sos-1 in fgfr-mediated signaling during development hyperactive egl-15 fgf receptor signaling which can #result in a clr phenotype .
the change may cause the heat instability and affect a role for sos-1 in fgfr-mediated signaling during development hyperactive egl-15 fgf receptor signaling which finally #resulted in a clr phenotype .
the change may cause the heat instability and affect a role for sos-1 in fgfr-mediated signaling during development hyperactive egl-15 fgf receptor signaling which has been shown to finally #result in a clr phenotype .
the change may cause the heat instability and affect a role for sos-1 in fgfr-mediated signaling during development hyperactive egl-15 fgf receptor signaling which is able to #result in a clr phenotype .
the change may cause the heat instability and affect a role for sos-1 in fgfr-mediated signaling during development hyperactive egl-15 fgf receptor signaling which is observed to finally #result in a clr phenotype .
the change may cause the heat instability and affect a role for sos-1 in fgfr-mediated signaling during development hyperactive egl-15 fgf receptor signaling which may have #resulted in a clr phenotype .
the change may cause the heat instability and affect a role for sos-1 in fgfr-mediated signaling during development hyperactive egl-15 fgf receptor signaling which #resulted in a clr phenotype .
the change may cause the heat instability and affect a role for sos-1 in fgfr-mediated signaling during development hyperactive egl-15 fgf receptor signaling , #resulting in a clr phenotype .
the change may cause the heat instability and affect alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation being shown to #result in mrna species with distinct 5utrs .
the change may cause the heat instability and affect alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation having #resulted in mrna species with distinct 5utrs .
the change may cause the heat instability and affect alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation that has #resulted in mrna species with distinct 5utrs .
the change may cause the heat instability and affect alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation that will #result in mrna species with distinct 5utrs .
the change may cause the heat instability and affect alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation which can finally #result in mrna species with distinct 5utrs .
the change may cause the heat instability and affect alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation which can #result in mrna species with distinct 5utrs .
the change may cause the heat instability and affect alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation which finally #resulted in mrna species with distinct 5utrs .
the change may cause the heat instability and affect alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation which has been shown to finally #result in mrna species with distinct 5utrs .
the change may cause the heat instability and affect alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation which has been shown to #result in mrna species with distinct 5utrs .
the change may cause the heat instability and affect alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation which is able to finally #result in mrna species with distinct 5utrs .
the change may cause the heat instability and affect alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation which is observed to #result in mrna species with distinct 5utrs .
the change may cause the heat instability and affect alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation which may have #resulted in mrna species with distinct 5utrs .
the change may cause the heat instability and affect alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation , as our study suggested , being observed to #result in mrna species with distinct 5utrs .
the change may cause the heat instability and affect alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation , as our study suggested , being shown to finally #result in mrna species with distinct 5utrs .
the change may cause the heat instability and affect alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation , as our study suggested , having finally #resulted in mrna species with distinct 5utrs .
the change may cause the heat instability and affect alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation , as our study suggested , having #resulted in mrna species with distinct 5utrs .
the change may cause the heat instability and affect alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation , as our study suggested , that has finally #resulted in mrna species with distinct 5utrs .
the change may cause the heat instability and affect alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation , as our study suggested , that will #result in mrna species with distinct 5utrs .
the change may cause the heat instability and affect alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation , as our study suggested , which can finally #result in mrna species with distinct 5utrs .
the change may cause the heat instability and affect alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation , as our study suggested , which finally #results in mrna species with distinct 5utrs .
the change may cause the heat instability and affect alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation , as our study suggested , which is able to finally #result in mrna species with distinct 5utrs .
the change may cause the heat instability and affect alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation , as our study suggested , which is able to #result in mrna species with distinct 5utrs .
the change may cause the heat instability and affect alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation , as our study suggested , which is observed to finally #result in mrna species with distinct 5utrs .
the change may cause the heat instability and affect alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation , as our study suggested , which is observed to #result in mrna species with distinct 5utrs .
the change may cause the heat instability and affect alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation , as our study suggested , which may have #resulted in mrna species with distinct 5utrs .
the change may cause the heat instability and affect alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation , as our study suggested , which #resulted in mrna species with distinct 5utrs .
the change may cause the heat instability and affect alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation , as our study suggested , which #results in mrna species with distinct 5utrs .
the change may cause the heat instability and affect alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation , #resulting in mrna species with distinct 5utrs .
the change may cause the heat instability and affect both the 5 and 3 splice site mutations being able to #result in high proportions of mature mrnas containing introns .
the change may cause the heat instability and affect both the 5 and 3 splice site mutations being observed to #result in high proportions of mature mrnas containing introns .
the change may cause the heat instability and affect both the 5 and 3 splice site mutations being shown to #result in high proportions of mature mrnas containing introns .
the change may cause the heat instability and affect both the 5 and 3 splice site mutations having finally #resulted in high proportions of mature mrnas containing introns .
the change may cause the heat instability and affect both the 5 and 3 splice site mutations that has finally #resulted in high proportions of mature mrnas containing introns .
the change may cause the heat instability and affect both the 5 and 3 splice site mutations that will finally #result in high proportions of mature mrnas containing introns .
the change may cause the heat instability and affect both the 5 and 3 splice site mutations which can finally #result in high proportions of mature mrnas containing introns .
the change may cause the heat instability and affect both the 5 and 3 splice site mutations which can #result in high proportions of mature mrnas containing introns .
the change may cause the heat instability and affect both the 5 and 3 splice site mutations which finally #resulted in high proportions of mature mrnas containing introns .
the change may cause the heat instability and affect both the 5 and 3 splice site mutations which finally #results in high proportions of mature mrnas containing introns .
the change may cause the heat instability and affect both the 5 and 3 splice site mutations which is able to #result in high proportions of mature mrnas containing introns .
the change may cause the heat instability and affect both the 5 and 3 splice site mutations which is observed to #result in high proportions of mature mrnas containing introns .
the change may cause the heat instability and affect both the 5 and 3 splice site mutations which may have finally #resulted in high proportions of mature mrnas containing introns .
the change may cause the heat instability and affect both the 5 and 3 splice site mutations , #resulting in high proportions of mature mrnas containing introns .
the change may cause the heat instability and affect a decreased transcription of the curlin encoding csga gene being observed to #result in the negative effect of the cpxa mutation .
the change may cause the heat instability and affect a decreased transcription of the curlin encoding csga gene having #resulted in the negative effect of the cpxa mutation .
the change may cause the heat instability and affect a decreased transcription of the curlin encoding csga gene that will finally #result in the negative effect of the cpxa mutation .
the change may cause the heat instability and affect a decreased transcription of the curlin encoding csga gene that will #result in the negative effect of the cpxa mutation .
the change may cause the heat instability and affect a decreased transcription of the curlin encoding csga gene which can #result in the negative effect of the cpxa mutation .
the change may cause the heat instability and affect a decreased transcription of the curlin encoding csga gene which is able to finally #result in the negative effect of the cpxa mutation .
the change may cause the heat instability and affect a decreased transcription of the curlin encoding csga gene which is able to #result in the negative effect of the cpxa mutation .
the change may cause the heat instability and affect a decreased transcription of the curlin encoding csga gene which may have #resulted in the negative effect of the cpxa mutation .
the change may cause the heat instability and affect a decreased transcription of the curlin encoding csga gene which #resulted in the negative effect of the cpxa mutation .
the change may cause the heat instability and affect a decreased transcription of the curlin encoding csga gene which #results in the negative effect of the cpxa mutation .
the change may cause the heat instability and affect a decreased transcription of the curlin encoding csga gene , #resulting in the negative effect of the cpxa mutation .
the change may cause the heat instability and affect alternative splicing of a single transcript being able to #result in the difference in the c-terminal 28 amino acids between beta(1) and beta(2) proteins .
the change may cause the heat instability and affect alternative splicing of a single transcript being shown to #result in the difference in the c-terminal 28 amino acids between beta(1) and beta(2) proteins .
the change may cause the heat instability and affect alternative splicing of a single transcript having finally #resulted in the difference in the c-terminal 28 amino acids between beta(1) and beta(2) proteins .
the change may cause the heat instability and affect alternative splicing of a single transcript having #resulted in the difference in the c-terminal 28 amino acids between beta(1) and beta(2) proteins .
the change may cause the heat instability and affect alternative splicing of a single transcript that will finally #result in the difference in the c-terminal 28 amino acids between beta(1) and beta(2) proteins .
the change may cause the heat instability and affect alternative splicing of a single transcript that will #result in the difference in the c-terminal 28 amino acids between beta(1) and beta(2) proteins .
the change may cause the heat instability and affect alternative splicing of a single transcript which can #result in the difference in the c-terminal 28 amino acids between beta(1) and beta(2) proteins .
the change may cause the heat instability and affect alternative splicing of a single transcript which finally #resulted in the difference in the c-terminal 28 amino acids between beta(1) and beta(2) proteins .
the change may cause the heat instability and affect alternative splicing of a single transcript which has been shown to #result in the difference in the c-terminal 28 amino acids between beta(1) and beta(2) proteins .
the change may cause the heat instability and affect alternative splicing of a single transcript which is able to finally #result in the difference in the c-terminal 28 amino acids between beta(1) and beta(2) proteins .
the change may cause the heat instability and affect alternative splicing of a single transcript which may have #resulted in the difference in the c-terminal 28 amino acids between beta(1) and beta(2) proteins .
the change may cause the heat instability and affect alternative splicing of a single transcript which #resulted in the difference in the c-terminal 28 amino acids between beta(1) and beta(2) proteins .
the change may cause the heat instability and affect of co-operative binding of the repressor being able to finally #result in that repression .
the change may cause the heat instability and affect of co-operative binding of the repressor that has #resulted in that repression .
the change may cause the heat instability and affect of co-operative binding of the repressor which can #result in that repression .
the change may cause the heat instability and affect of co-operative binding of the repressor which finally #resulted in that repression .
the change may cause the heat instability and affect of co-operative binding of the repressor which finally #results in that repression .
the change may cause the heat instability and affect of co-operative binding of the repressor which has been shown to finally #result in that repression .
the change may cause the heat instability and affect of co-operative binding of the repressor which is able to finally #result in that repression .
the change may cause the heat instability and affect of co-operative binding of the repressor which is observed to finally #result in that repression .
the change may cause the heat instability and affect of co-operative binding of the repressor which may have finally #resulted in that repression .
the change may cause the heat instability and affect of co-operative binding of the repressor which may have #resulted in that repression .
the change may cause the heat instability and affect the other three alterations being able to finally #result in truncated nonfunctional proteins .
the change may cause the heat instability and affect the other three alterations being able to #result in truncated nonfunctional proteins .
the change may cause the heat instability and affect the other three alterations being observed to #result in truncated nonfunctional proteins .
the change may cause the heat instability and affect the other three alterations being shown to #result in truncated nonfunctional proteins .
the change may cause the heat instability and affect the other three alterations that has #resulted in truncated nonfunctional proteins .
the change may cause the heat instability and affect the other three alterations that will finally #result in truncated nonfunctional proteins .
the change may cause the heat instability and affect the other three alterations which can finally #result in truncated nonfunctional proteins .
the change may cause the heat instability and affect the other three alterations which can #result in truncated nonfunctional proteins .
the change may cause the heat instability and affect the other three alterations which has been shown to #result in truncated nonfunctional proteins .
the change may cause the heat instability and affect the other three alterations which is observed to finally #result in truncated nonfunctional proteins .
the change may cause the heat instability and affect the other three alterations which is observed to #result in truncated nonfunctional proteins .
the change may cause the heat instability and affect the other three alterations which may have #resulted in truncated nonfunctional proteins .
the change may cause the heat instability and affect the other three alterations which #results in truncated nonfunctional proteins .
the change may cause the heat instability and affect the other three alterations , #resulting in truncated nonfunctional proteins .
the change may cause the heat instability and affect various alternate subdomains being able to #result in a super-repeat .
the change may cause the heat instability and affect various alternate subdomains being observed to #result in a super-repeat .
the change may cause the heat instability and affect various alternate subdomains being shown to #result in a super-repeat .
the change may cause the heat instability and affect various alternate subdomains having finally #resulted in a super-repeat .
the change may cause the heat instability and affect various alternate subdomains having #resulted in a super-repeat .
the change may cause the heat instability and affect various alternate subdomains that has finally #resulted in a super-repeat .
the change may cause the heat instability and affect various alternate subdomains that has #resulted in a super-repeat .
the change may cause the heat instability and affect various alternate subdomains that will finally #result in a super-repeat .
the change may cause the heat instability and affect various alternate subdomains which finally #results in a super-repeat .
the change may cause the heat instability and affect various alternate subdomains which is able to finally #result in a super-repeat .
the change may cause the heat instability and affect various alternate subdomains which is able to #result in a super-repeat .
the change may cause the heat instability and affect various alternate subdomains which is observed to finally #result in a super-repeat .
the change may cause the heat instability and affect various alternate subdomains which is observed to #result in a super-repeat .
the change may cause the heat instability and affect various alternate subdomains which may have finally #resulted in a super-repeat .
the change may cause the heat instability and affect various alternate subdomains which may have #resulted in a super-repeat .
the change may cause the heat instability and affect various alternate subdomains which #results in a super-repeat .
the change may cause the heat instability and affect various alternate subdomains , #resulting in a super-repeat .
we speculated that a super-repeat may be the #result of various alternate subdomains in mast cells .
we speculated that a super-repeat may be the #result various alternate subdomains in mast cells .
we speculated that high proportions of mature mrnas containing introns has been shown to be the #result of both the 5 and 3 splice site mutations in mast cells .
we speculated that high proportions of mature mrnas containing introns is the #result of both the 5 and 3 splice site mutations in mast cells .
we speculated that high proportions of mature mrnas containing introns may be the #result both the 5 and 3 splice site mutations in mast cells .
we speculated that mrna species with distinct 5utrs has been shown to be the #result of alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation in mast cells .
we speculated that mrna species with distinct 5utrs has been shown to be the #result of alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation , as our study suggested , in mast cells .
we speculated that mrna species with distinct 5utrs is the #result of alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation in mast cells .
we speculated that mrna species with distinct 5utrs is the #result of alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation , as our study suggested , in mast cells .
we speculated that mrna species with distinct 5utrs may be the #result alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation in mast cells .
we speculated that mrna species with distinct 5utrs may be the #result of alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation in mast cells .
we speculated that that repression is the #result of of co-operative binding of the repressor in mast cells .
we speculated that the difference in the c-terminal 28 amino acids between beta(1) and beta(2) proteins has been shown to be the #result of alternative splicing of a single transcript in mast cells .
we speculated that the difference in the c-terminal 28 amino acids between beta(1) and beta(2) proteins is observed to be the #result of alternative splicing of a single transcript in mast cells .
we speculated that the difference in the c-terminal 28 amino acids between beta(1) and beta(2) proteins is the #result of alternative splicing of a single transcript in mast cells .
we speculated that the difference in the c-terminal 28 amino acids between beta(1) and beta(2) proteins may be the #result of alternative splicing of a single transcript in mast cells .
we speculated that the negative effect of the cpxa mutation is observed to be the #result of a decreased transcription of the curlin encoding csga gene in mast cells .
we speculated that truncated nonfunctional proteins has been shown to be the #result of the other three alterations in mast cells .
we speculated that truncated nonfunctional proteins is observed to be the #result of the other three alterations in mast cells .
we speculated that truncated nonfunctional proteins is the #result of the other three alterations in mast cells .
we speculated that truncated nonfunctional proteins may be the #result of the other three alterations in mast cells .
we speculated that truncated nonfunctional proteins may be the #result the other three alterations in mast cells .
a decreased transcription of the curlin encoding csga gene are observed to finally #result in the negative effect of the cpxa mutation .
a decreased transcription of the curlin encoding csga gene can #result in the negative effect of the cpxa mutation
a decreased transcription of the curlin encoding csga gene has #resulted in the negative effect of the cpxa mutation .
a decreased transcription of the curlin encoding csga gene have the ability to finally #result in the negative effect of the cpxa mutation .
a decreased transcription of the curlin encoding csga gene may have #resulted in the negative effect of the cpxa mutation .
a decreased transcription of the curlin encoding csga gene #result in the negative effect of the cpxa mutation .
a decreased transcription of the curlin encoding csga gene #resulted in the negative effect of the cpxa mutation .
a decreased transcription of the curlin encoding csga gene will #result in the negative effect of the cpxa mutation .
alternative splicing of a single transcript are able to finally #result in the difference in the c-terminal 28 amino acids between beta(1) and beta(2) proteins .
alternative splicing of a single transcript are observed to finally #result in the difference in the c-terminal 28 amino acids between beta(1) and beta(2) proteins .
alternative splicing of a single transcript are observed to #result in the difference in the c-terminal 28 amino acids between beta(1) and beta(2) proteins .
alternative splicing of a single transcript can finally #result in the difference in the c-terminal 28 amino acids between beta(1) and beta(2) proteins
alternative splicing of a single transcript has finally #resulted in the difference in the c-terminal 28 amino acids between beta(1) and beta(2) proteins .
alternative splicing of a single transcript have the ability to finally #result in the difference in the c-terminal 28 amino acids between beta(1) and beta(2) proteins .
alternative splicing of a single transcript have the ability to #result in the difference in the c-terminal 28 amino acids between beta(1) and beta(2) proteins .
alternative splicing of a single transcript may have #resulted in the difference in the c-terminal 28 amino acids between beta(1) and beta(2) proteins .
alternative splicing of a single transcript may #result in the difference in the c-terminal 28 amino acids between beta(1) and beta(2) proteins .
of co-operative binding of the repressor are able to finally #result in that repression .
of co-operative binding of the repressor are able to #result in that repression .
of co-operative binding of the repressor are observed to #result in that repression .
of co-operative binding of the repressor has #resulted in that repression .
of co-operative binding of the repressor may have finally #resulted in that repression .
of co-operative binding of the repressor may have #resulted in that repression .
of co-operative binding of the repressor #result in that repression .
of co-operative binding of the repressor will #result in that repression .
the other three alterations are observed to finally #result in truncated nonfunctional proteins .
the other three alterations are observed to #result in truncated nonfunctional proteins .
the other three alterations can finally #result in truncated nonfunctional proteins
the other three alterations can #result in truncated nonfunctional proteins
the other three alterations finally #result in truncated nonfunctional proteins .
the other three alterations have the ability to finally #result in truncated nonfunctional proteins .
the other three alterations #resulted in truncated nonfunctional proteins .
the other three alterations will #result in truncated nonfunctional proteins .
various alternate subdomains are able to finally #result in a super-repeat .
various alternate subdomains are observed to finally #result in a super-repeat .
various alternate subdomains are observed to #result in a super-repeat .
various alternate subdomains can finally #result in a super-repeat
various alternate subdomains finally #result in a super-repeat .
various alternate subdomains has finally #resulted in a super-repeat .
various alternate subdomains will finally #result in a super-repeat .
a stop codon-containing exon (exon 4) could be finally #skipped by alternative splicing and generates a transcript that is predicted to encode a fusion protein .
a stop codon-containing exon (exon 4) is finally #skipped by alternative splicing and generates a transcript that is predicted to encode a fusion protein .
a stop codon-containing exon (exon 4) may have been finally #skipped by alternative splicing and can generate a transcript that is predicted to encode a fusion protein .
a stop codon-containing exon (exon 4) was finally #skipped by alternative splicing and generated a transcript that is predicted to encode a fusion protein .
alternative splicing can finally #skip a stop codon-containing exon (exon 4) and can generate a transcript that is predicted to encode a fusion protein .
alternative splicing finally #skipped a stop codon-containing exon (exon 4) and can generate a transcript that is predicted to encode a fusion protein .
alternative splicing finally #skips a stop codon-containing exon (exon 4) and can generate a transcript that is predicted to encode a fusion protein .
alternative splicing has finally #skipped a stop codon-containing exon (exon 4) and can generate a transcript that is predicted to encode a fusion protein .
alternative splicing has the ability to finally #skip a stop codon-containing exon (exon 4) and can generate a transcript that is predicted to encode a fusion protein .
alternative splicing is able to finally #skip a stop codon-containing exon (exon 4) and can generate a transcript that is predicted to encode a fusion protein .
direct sequencing of the paf-2 gene revealed a homozygous 1-bp insertion at nucleotide 511 (511 inst) in one patient with group c zellweger syndrome (zs) , which introduces a premature termination codon in the paf-2 gene , and , in the second patient , revealed a splice-site mutation in intron 3 (ivs3+1g-->a) being able to #skip exon 3 , an event that leads to peroxisome deficiency .
direct sequencing of the paf-2 gene revealed a homozygous 1-bp insertion at nucleotide 511 (511 inst) in one patient with group c zellweger syndrome (zs) , which introduces a premature termination codon in the paf-2 gene , and , in the second patient , revealed a splice-site mutation in intron 3 (ivs3+1g-->a) being likely to #skip exon 3 , an event that leads to peroxisome deficiency .
direct sequencing of the paf-2 gene revealed a homozygous 1-bp insertion at nucleotide 511 (511 inst) in one patient with group c zellweger syndrome (zs) , which introduces a premature termination codon in the paf-2 gene , and , in the second patient , revealed a splice-site mutation in intron 3 (ivs3+1g-->a) having been shown to #skip exon 3 , an event that leads to peroxisome deficiency .
direct sequencing of the paf-2 gene revealed a homozygous 1-bp insertion at nucleotide 511 (511 inst) in one patient with group c zellweger syndrome (zs) , which introduces a premature termination codon in the paf-2 gene , and , in the second patient , revealed a splice-site mutation in intron 3 (ivs3+1g-->a) observed to #skip exon 3 , an event that leads to peroxisome deficiency .
direct sequencing of the paf-2 gene revealed a homozygous 1-bp insertion at nucleotide 511 (511 inst) in one patient with group c zellweger syndrome (zs) , which introduces a premature termination codon in the paf-2 gene , and , in the second patient , revealed a splice-site mutation in intron 3 (ivs3+1g-->a) shown to #skip exon 3 , an event that leads to peroxisome deficiency .
direct sequencing of the paf-2 gene revealed a homozygous 1-bp insertion at nucleotide 511 (511 inst) in one patient with group c zellweger syndrome (zs) , which introduces a premature termination codon in the paf-2 gene , and , in the second patient , revealed a splice-site mutation in intron 3 (ivs3+1g-->a) , which is likely to #skip exon 3 , an event that leads to peroxisome deficiency .
direct sequencing of the paf-2 gene revealed a homozygous 1-bp insertion at nucleotide 511 (511 inst) in one patient with group c zellweger syndrome (zs) , which introduces a premature termination codon in the paf-2 gene , and , in the second patient , revealed a splice-site mutation in intron 3 (ivs3+1g-->a) , which is observed to #skip exon 3 , an event that leads to peroxisome deficiency .
direct sequencing of the paf-2 gene revealed a homozygous 1-bp insertion at nucleotide 511 (511 inst) in one patient with group c zellweger syndrome (zs) , which introduces a premature termination codon in the paf-2 gene , and , in the second patient , revealed a splice-site mutation in intron 3 (ivs3+1g-->a) , which may #skip exon 3 , an event that leads to peroxisome deficiency .
direct sequencing of the paf-2 gene revealed a homozygous 1-bp insertion at nucleotide 511 (511 inst) in one patient with group c zellweger syndrome (zs) , which introduces a premature termination codon in the paf-2 gene , and , in the second patient , revealed a splice-site mutation in intron 3 (ivs3+1g-->a) , which usually #skips exon 3 , an event that leads to peroxisome deficiency .
finally , a stop codon-containing exon (exon 4) could be #skipped by alternative splicing and generates a transcript that is predicted to encode a fusion protein .
finally , a stop codon-containing exon (exon 4) has been shown to be #skipped by alternative splicing and can generate a transcript that is predicted to encode a fusion protein .
finally , a stop codon-containing exon (exon 4) has the ability to be #skipped by alternative splicing and can generate a transcript that is predicted to encode a fusion protein .
finally , a stop codon-containing exon (exon 4) is #skipped by alternative splicing and generates a transcript that is predicted to encode a fusion protein .
finally , a stop codon-containing exon (exon 4) may have been #skipped by alternative splicing and can generate a transcript that is predicted to encode a fusion protein .
finally , a stop codon-containing exon (exon 4) was #skipped by alternative splicing and generated a transcript that is predicted to encode a fusion protein .
finally , a stop codon-containing exon (exon 4) will be #skipped by alternative splicing and can generate a transcript that is predicted to encode a fusion protein .
finally , alternative splicing can #skip a stop codon-containing exon (exon 4) and can generate a transcript that is predicted to encode a fusion protein .
finally , alternative splicing has been shown to #skip a stop codon-containing exon (exon 4) and can generate a transcript that is predicted to encode a fusion protein .
finally , alternative splicing has the ability to #skip a stop codon-containing exon (exon 4) and can generate a transcript that is predicted to encode a fusion protein .
finally , alternative splicing may have #skipped a stop codon-containing exon (exon 4) and can generate a transcript that is predicted to encode a fusion protein .
megakaryocytes undergo an endomitotic cell cycle , which consists of an s phase interrupted by a gap , during which anaphase b and cytokinesis can be #skipped by the cells .
megakaryocytes undergo an endomitotic cell cycle , which consists of an s phase interrupted by a gap , during which anaphase b and cytokinesis has been shown to be #skipped by the cells .
megakaryocytes undergo an endomitotic cell cycle , which consists of an s phase interrupted by a gap , during which anaphase b and cytokinesis have been #skipped by the cells .
megakaryocytes undergo an endomitotic cell cycle , which consists of an s phase interrupted by a gap , during which anaphase b and cytokinesis were #skipped by the cells .
megakaryocytes undergo an endomitotic cell cycle , which consists of an s phase interrupted by a gap , during which the cells enter mitosis but are likely to #skip anaphase b and cytokinesis .
megakaryocytes undergo an endomitotic cell cycle , which consists of an s phase interrupted by a gap , during which the cells enter mitosis but are observed to #skip anaphase b and cytokinesis .
megakaryocytes undergo an endomitotic cell cycle , which consists of an s phase interrupted by a gap , during which the cells enter mitosis but can #skip anaphase b and cytokinesis .
megakaryocytes undergo an endomitotic cell cycle , which consists of an s phase interrupted by a gap , during which the cells enter mitosis but have the ability to #skip anaphase b and cytokinesis .
megakaryocytes undergo an endomitotic cell cycle , which consists of an s phase interrupted by a gap , during which the cells entered mitosis but have #skipped anaphase b and cytokinesis .
the centromere has been finally #skipped on all tg autosomes as on the female xi .
the centromere has been shown to be finally #skipped on all tg autosomes as on the female xi .
the centromere has been #skipped on all tg autosomes as on the female xi .
the centromere may have been finally #skipped on all tg autosomes as on the female xi .
xist rna coated the autosome but has #skipped the xic tg , raising the possibility that x chromosome domains escape inactivation by excluding xist rna binding .
xist rna coats the autosome but has been shown to #skip the xic tg , raising the possibility that x chromosome domains escape inactivation by excluding xist rna binding .
xist rna coats the autosome but is able to #skip the xic tg , raising the possibility that x chromosome domains escape inactivation by excluding xist rna binding .
xist rna coats the autosome but , as we predicted , is able to #skip the xic tg , raising the possibility that x chromosome domains escape inactivation by excluding xist rna binding .
xist rna coats the autosome but , as we predicted , is observed to #skip the xic tg , raising the possibility that x chromosome domains escape inactivation by excluding xist rna binding .
xist rna coats the autosome but , as we predicted , will #skip the xic tg , raising the possibility that x chromosome domains escape inactivation by excluding xist rna binding .
the observation that xist rna can efficiently #skip the xic tg raises the possibility that x chromosome domains escape inactivation by excluding xist rna binding .
the observation that xist rna has efficiently #skipped the xic tg raises the possibility that x chromosome domains escape inactivation by excluding xist rna binding .
the observation that xist rna has the ability to #skip the xic tg raises the possibility that x chromosome domains escape inactivation by excluding xist rna binding .
the observation that xist rna has the probability of efficiently #skipping the xic tg raises the possibility that x chromosome domains escape inactivation by excluding xist rna binding .
the observation that xist rna has the probability of #skipping the xic tg raises the possibility that x chromosome domains escape inactivation by excluding xist rna binding .
the observation that xist rna is likely to efficiently #skip the xic tg raises the possibility that x chromosome domains escape inactivation by excluding xist rna binding .
the observation that xist rna is likely to #skip the xic tg raises the possibility that x chromosome domains escape inactivation by excluding xist rna binding .
the observation that xist rna is observed to efficiently #skip the xic tg raises the possibility that x chromosome domains escape inactivation by excluding xist rna binding .
the observation that xist rna is observed to #skip the xic tg raises the possibility that x chromosome domains escape inactivation by excluding xist rna binding .
the observation that xist rna may have efficiently #skipped the xic tg raises the possibility that x chromosome domains escape inactivation by excluding xist rna binding .
the observation that xist rna #skipped the xic tg raises the possibility that x chromosome domains escape inactivation by excluding xist rna binding .
the observation that xist rna will #skip the xic tg raises the possibility that x chromosome domains escape inactivation by excluding xist rna binding .
the observation that the xic tg has been shown to be efficiently #skipped by xist rna raises the possibility that x chromosome domains escape inactivation by excluding xist rna binding .
the observation that the xic tg has been shown to be #skipped by xist rna raises the possibility that x chromosome domains escape inactivation by excluding xist rna binding .
the observation that the xic tg has been #skipped by xist rna raises the possibility that x chromosome domains escape inactivation by excluding xist rna binding .
the observation that the xic tg has the ability to be efficiently #skipped by xist rna raises the possibility that x chromosome domains escape inactivation by excluding xist rna binding .
the observation that the xic tg has the ability to be #skipped by xist rna raises the possibility that x chromosome domains escape inactivation by excluding xist rna binding .
the observation that the xic tg is able to be efficiently #skipped by xist rna raises the possibility that x chromosome domains escape inactivation by excluding xist rna binding .
the observation that the xic tg is able to be #skipped by xist rna raises the possibility that x chromosome domains escape inactivation by excluding xist rna binding .
the observation that the xic tg is efficiently #skipped by xist rna raises the possibility that x chromosome domains escape inactivation by excluding xist rna binding .
the observation that the xic tg is likely to be efficiently #skipped by xist rna raises the possibility that x chromosome domains escape inactivation by excluding xist rna binding .
the observation that the xic tg is likely to be #skipped by xist rna raises the possibility that x chromosome domains escape inactivation by excluding xist rna binding .
the observation that the xic tg is observed to be efficiently #skipped by xist rna raises the possibility that x chromosome domains escape inactivation by excluding xist rna binding .
the observation that the xic tg is observed to be #skipped by xist rna raises the possibility that x chromosome domains escape inactivation by excluding xist rna binding .
the observation that the xic tg may have been efficiently #skipped by xist rna raises the possibility that x chromosome domains escape inactivation by excluding xist rna binding .
the observation that the xic tg may have been #skipped by xist rna raises the possibility that x chromosome domains escape inactivation by excluding xist rna binding .
the observation that the xic tg will be #skipped by xist rna raises the possibility that x chromosome domains escape inactivation by excluding xist rna binding .
a caspase-2 minigene construct could be made that is alternatively #spliced in transfected cells and nuclear extracts .
a caspase-2 minigene construct could be made that is #spliced in transfected cells and nuclear extracts .
a caspase-2 minigene construct has been shown to be made that is alternatively #spliced in transfected cells and nuclear extracts .
a caspase-2 minigene construct has been shown to be made that is #spliced in transfected cells and nuclear extracts .
a caspase-2 minigene construct has the ability to be made to be #spliced in transfected cells and nuclear extracts .
a caspase-2 minigene construct is able to be made that is alternatively #spliced in transfected cells and nuclear extracts .
a caspase-2 minigene construct is observed to be made that is #spliced in transfected cells and nuclear extracts .
a caspase-2 minigene construct may have been made that can be alternatively #spliced in transfected cells and nuclear extracts .
a caspase-2 minigene construct will be made that is alternatively #spliced in transfected cells and nuclear extracts .
a caspase-2 minigene construct will be made that is #spliced in transfected cells and nuclear extracts .
a caspase-2 minigene construct would be made that could be alternatively #spliced in transfected cells and nuclear extracts .
a pre-mrna containing mutations in se2 , however , can be alternatively #spliced predominantly using the nt 3605 3 splice site .
a pre-mrna containing mutations in se2 , however , has been alternatively #spliced predominantly using the nt 3605 3 splice site .
a pre-mrna containing mutations in se2 , however , is able to alternatively #spliced predominantly using the nt 3605 3 splice site .
a pre-mrna containing mutations in se2 , however , is alternatively #spliced predominantly using the nt 3605 3 splice site .
a pre-mrna containing mutations in se2 , however , is likely to be alternatively #spliced predominantly using the nt 3605 3 splice site .
an additional observation with the tandem repeat-containing 3? substrates was that the efficiency of bimolecular exon ligation decreased stepwise with each mutation that moved the 5?-most ag 6 nt further downstream such that rna 3i alternatively #splices only 20% as efficiently as rna 3f (fig .1 c left) .
an additional observation with the tandem repeat-containing 3? substrates was that the efficiency of bimolecular exon ligation decreased stepwise with each mutation that moved the 5?-most ag 6 nt further downstream such that rna 3i can #splice only 20% as efficiently as rna 3f (fig .1 c left) .
an additional observation with the tandem repeat-containing 3? substrates was that the efficiency of bimolecular exon ligation decreased stepwise with each mutation that moved the 5?-most ag 6 nt further downstream such that rna 3i has alternatively #spliced only 20% as efficiently as rna 3f (fig .1 c left) .
an additional observation with the tandem repeat-containing 3? substrates was that the efficiency of bimolecular exon ligation decreased stepwise with each mutation that moved the 5?-most ag 6 nt further downstream such that rna 3i has been shown to #splice only 20% as efficiently as rna 3f (fig .1 c left) .
an additional observation with the tandem repeat-containing 3? substrates was that the efficiency of bimolecular exon ligation decreased stepwise with each mutation that moved the 5?-most ag 6 nt further downstream such that rna 3i has #spliced only 20% as efficiently as rna 3f (fig .1 c left) .
an additional observation with the tandem repeat-containing 3? substrates was that the efficiency of bimolecular exon ligation decreased stepwise with each mutation that moved the 5?-most ag 6 nt further downstream such that rna 3i is able to alternatively #splice only 20% as efficiently as rna 3f (fig .1 c left) .
an additional observation with the tandem repeat-containing 3? substrates was that the efficiency of bimolecular exon ligation decreased stepwise with each mutation that moved the 5?-most ag 6 nt further downstream such that rna 3i is observed to alternatively #splice only 20% as efficiently as rna 3f (fig .1 c left) .
an additional observation with the tandem repeat-containing 3? substrates was that the efficiency of bimolecular exon ligation decreased stepwise with each mutation that moved the 5?-most ag 6 nt further downstream such that rna 3i is observed to #splice only 20% as efficiently as rna 3f (fig .1 c left) .
an additional observation with the tandem repeat-containing 3? substrates was that the efficiency of bimolecular exon ligation decreased stepwise with each mutation that moved the 5?-most ag 6 nt further downstream such that rna 3i may have alternatively #spliced only 20% as efficiently as rna 3f (fig .1 c left) .
an additional observation with the tandem repeat-containing 3? substrates was that the efficiency of bimolecular exon ligation decreased stepwise with each mutation that moved the 5?-most ag 6 nt further downstream such that rna 3i may have #spliced only 20% as efficiently as rna 3f (fig .1 c left) .
an additional observation with the tandem repeat-containing 3? substrates was that the efficiency of bimolecular exon ligation decreased stepwise with each mutation that moved the 5?-most ag 6 nt further downstream such that rna 3i #splices only 20% as efficiently as rna 3f (fig .1 c left) .
an additional observation with the tandem repeat-containing 3? substrates was that the efficiency of bimolecular exon ligation decreased stepwise with each mutation that moved the 5?-most ag 6 nt further downstream such that rna 3i will alternatively #splice only 20% as efficiently as rna 3f (fig .1 c left) .
an additional observation with the tandem repeat-containing 3? substrates was that the efficiency of bimolecular exon ligation decreased stepwise with each mutation that moved the 5?-most ag 6 nt further downstream such that rna 3i will #splice only 20% as efficiently as rna 3f (fig .1 c left) .
consequently , exon 30 with the intron has been shown to be #spliced .
consequently , exon 30 with the intron has been #spliced .
consequently , exon 30 with the intron has the ability to be #spliced .
in the remaining allelic p53 gene , there was a single-base substitution of g to t at position 1 within the #splice donor site of intron 7 , and the mutated intron cannot be properly #spliced out during the mrna maturation process .
consequently , exon 30 with the intron may have been #spliced .
in the remaining allelic p53 gene , there was a single-base substitution of g to t at position 1 within the #splice donor site of intron 7 , and the mutated intron cannot be #spliced out during the mrna maturation process .
consequently , exon 30 with the intron was #spliced .
consequently , exon 30 with the intron will be #spliced .
consequently , exon 30 with the intron , as our study suggested , can be #spliced .
consequently , exon 30 with the intron , as our study suggested , has been shown to be #spliced .
consequently , exon 30 with the intron , as our study suggested , has been #spliced .
in the remaining allelic p53 gene , there was a single-base substitution of g to t at position 1 within the #splice donor site of intron 7 , and the mutated intron has not been #spliced out during the mrna maturation process .
consequently , exon 30 with the intron , as our study suggested , is able to be #spliced .
in the remaining allelic p53 gene , there was a single-base substitution of g to t at position 1 within the #splice donor site of intron 7 , and the mutated intron is not able to be properly #spliced out during the mrna maturation process .
in the remaining allelic p53 gene , there was a single-base substitution of g to t at position 1 within the #splice donor site of intron 7 , and the mutated intron is not able to be #spliced out during the mrna maturation process .
in the remaining allelic p53 gene , there was a single-base substitution of g to t at position 1 within the #splice donor site of intron 7 , and the mutated intron is not #spliced out during the mrna maturation process .
consequently , exon 30 with the intron , as our study suggested , will be #spliced .
in the remaining allelic p53 gene , there was a single-base substitution of g to t at position 1 within the #splice donor site of intron 7 , and the mutated intron is observed not to be properly #spliced out during the mrna maturation process .
in the remaining allelic p53 gene , there was a single-base substitution of g to t at position 1 within the #splice donor site of intron 7 , and the mutated intron is observed not to be #spliced out during the mrna maturation process .
in the remaining allelic p53 gene , there was a single-base substitution of g to t at position 1 within the #splice donor site of intron 7 , and the mutated intron may not have been properly #spliced out during the mrna maturation process .
in the remaining allelic p53 gene , there was a single-base substitution of g to t at position 1 within the #splice donor site of intron 7 , and the mutated intron may not have been #spliced out during the mrna maturation process .
exons outside this size range are observed to require additional exonic and/or intronic sequences to be effectively #spliced into the mature mrna .
in the remaining allelic p53 gene , there was a single-base substitution of g to t at position 1 within the #splice donor site of intron 7 , and the mutated intron will not be properly #spliced out during the mrna maturation process .
exons outside this size range are #spliced into the mature mrna .
exons outside this size range have been effectively #spliced into the mature mrna .
it does not properly #splice out this intron and results in a substitution of the final 13 amino acids of the deduced amino acid sequence .
it does not #splice out this intron and results in a substitution of the final 13 amino acids of the deduced amino acid sequence .
exons outside this size range have required additional exonic and/or intronic sequences to be #spliced into the mature mrna .
exons outside this size range have the probability of requiring additional exonic and/or intronic sequences to be effectively #spliced into the mature mrna .
exons outside this size range have the probability of requiring additional exonic and/or intronic sequences to be #spliced into the mature mrna .
exons outside this size range may have required additional exonic and/or intronic sequences to be effectively #spliced into the mature mrna .
exons outside this size range require additional exonic and/or intronic sequences to be #spliced into the mature mrna .
exons outside this size range required additional exonic and/or intronic sequences to be #spliced into the mature mrna .
exons outside this size range were effectively #spliced into the mature mrna .
however , a pre-mrna containing mutations in se2 can be alternatively #spliced predominantly using the nt 3605 3 splice site .
however , a pre-mrna containing mutations in se2 can be #spliced predominantly using the nt 3605 3 splice site .
however , a pre-mrna containing mutations in se2 has been shown to be alternatively #spliced predominantly using the nt 3605 3 splice site .
however , a pre-mrna containing mutations in se2 has been shown to be #spliced predominantly using the nt 3605 3 splice site .
however , a pre-mrna containing mutations in se2 has the ability to be alternatively #spliced predominantly using the nt 3605 3 splice site .
however , a pre-mrna containing mutations in se2 is able to #spliced predominantly using the nt 3605 3 splice site .
however , a pre-mrna containing mutations in se2 is likely to be alternatively #spliced predominantly using the nt 3605 3 splice site .
however , a pre-mrna containing mutations in se2 is observed to be #spliced predominantly using the nt 3605 3 splice site .
however , a pre-mrna containing mutations in se2 was alternatively #spliced predominantly using the nt 3605 3 splice site .
however , a pre-mrna containing mutations in se2 was #spliced predominantly using the nt 3605 3 splice site .
however , a pre-mrna containing mutations in se2 will be alternatively #spliced predominantly using the nt 3605 3 splice site .
however , a pre-mrna containing mutations in se2 will be #spliced predominantly using the nt 3605 3 splice site .
that putative intron sequences can fail to be properly #spliced out in transcripts which spanned exon-intron boundaries is expected in antisense transcripts .
that putative intron sequences can fail to be #spliced out in transcripts which spanned exon-intron boundaries is expected in antisense transcripts .
the supt4h gene has been shown to be normally #spliced from five exons encoded by chromosome 11 .
the supt4h gene has been shown to be #spliced normally from five exons encoded by chromosome 11 .
the supt4h gene has been #spliced normally from five exons encoded by chromosome 11 .
that putative intron sequences has not been shown to be #spliced out in transcripts which spanned exon-intron boundaries is expected in antisense transcripts .
that putative intron sequences have failed to be properly #spliced out in transcripts which spanned exon-intron boundaries is expected in antisense transcripts .
the supt4h gene is able to be #spliced normally from five exons encoded by chromosome 11 .
that putative intron sequences is able to fail to be #spliced out in transcripts which spanned exon-intron boundaries is expected in antisense transcripts .
that putative intron sequences is likely to fail to be properly #spliced out in transcripts which spanned exon-intron boundaries is expected in antisense transcripts .
the supt4h gene is observed to be #spliced normally from five exons encoded by chromosome 11 .
that putative intron sequences is not observed to be properly #spliced out in transcripts which spanned exon-intron boundaries is expected in antisense transcripts .
the supt4h gene may have been #spliced normally from five exons encoded by chromosome 11 .
that putative intron sequences may fail to be properly #spliced out in transcripts which spanned exon-intron boundaries is expected in antisense transcripts .
that putative intron sequences may fail to be #spliced out in transcripts which spanned exon-intron boundaries is expected in antisense transcripts .
the supt4h gene was normally #spliced from five exons encoded by chromosome 11 .
that putative intron sequences will fail to be properly #spliced out in transcripts which spanned exon-intron boundaries is expected in antisense transcripts .
the supt4h gene will be normally #spliced from five exons encoded by chromosome 11 .
that this intron has not been properly #spliced out resulted in a substitution of the final 13 amino acids of the deduced amino acid sequence .
that this intron has not been shown to be properly #spliced out results in a substitution of the final 13 amino acids of the deduced amino acid sequence .
that this intron is not able to be properly #spliced out results in a substitution of the final 13 amino acids of the deduced amino acid sequence .
that this intron is not observed to be #spliced out results in a substitution of the final 13 amino acids of the deduced amino acid sequence .
that this intron is not properly #spliced out results in a substitution of the final 13 amino acids of the deduced amino acid sequence .
that this intron is not #spliced out results in a substitution of the final 13 amino acids of the deduced amino acid sequence .
the mouse polymeric immunoglobulin receptor gene has a 654 nt exon being able to be efficiently #spliced into the mrna .
the mouse polymeric immunoglobulin receptor gene has a 654 nt exon being #spliced efficiently into the mrna .
the mouse polymeric immunoglobulin receptor gene has a 654 nt exon having been #spliced efficiently into the mrna .
the mouse polymeric immunoglobulin receptor gene has a 654 nt exon having the ability to be efficiently #spliced into the mrna .
the mouse polymeric immunoglobulin receptor gene has a 654 nt exon observed to be efficiently #spliced into the mrna .
the mouse polymeric immunoglobulin receptor gene has a 654 nt exon observed to be #spliced efficiently into the mrna .
the mouse polymeric immunoglobulin receptor gene has a 654 nt exon shown to be efficiently #spliced into the mrna .
the mouse polymeric immunoglobulin receptor gene has a 654 nt exon that can be efficiently #spliced into the mrna .
the mouse polymeric immunoglobulin receptor gene has a 654 nt exon that has been shown to be #spliced efficiently into the mrna .
the mouse polymeric immunoglobulin receptor gene has a 654 nt exon that has been #spliced efficiently into the mrna .
virtually all genes of higher organisms have non-coding introns interspersed between the coding exons being able to be efficiently #spliced out in order to generate a mature messenger rna molecule used to encode proteins .
virtually all genes of higher organisms have non-coding introns interspersed between the coding exons being able to be #spliced out in order to generate a mature messenger rna molecule used to encode proteins .
the mouse polymeric immunoglobulin receptor gene has a 654 nt exon that may have been efficiently #spliced into the mrna .
the mouse polymeric immunoglobulin receptor gene has a 654 nt exon that may have been #spliced efficiently into the mrna .
virtually all genes of higher organisms have non-coding introns interspersed between the coding exons being #spliced out in order to generate a mature messenger rna molecule used to encode proteins .
virtually all genes of higher organisms have non-coding introns interspersed between the coding exons efficiently #spliced out in order to generate a mature messenger rna molecule used to encode proteins .
the mouse polymeric immunoglobulin receptor gene has a 654 nt exon that was #spliced efficiently into the mrna .
the mouse polymeric immunoglobulin receptor gene has a 654 nt exon that will be #spliced efficiently into the mrna .
the pre-mrnas from all of these genes are able to be #spliced with little or no exon-skipping (ref .16; also fig .1 c and data not shown) , suggesting that correct exon inclusion can be managed by the yeast gene expression machinery .
virtually all genes of higher organisms have non-coding introns interspersed between the coding exons shown to be efficiently #spliced out in order to generate a mature messenger rna molecule used to encode proteins .
the pre-mrnas from all of these genes are observed to be #spliced with little or no exon-skipping (ref .16; also fig .1 c and data not shown) , suggesting that correct exon inclusion can be managed by the yeast gene expression machinery .
the pre-mrnas from all of these genes being able to be #spliced with little or no exon-skipping (ref .16; also fig .1 c and data not shown) suggest that correct exon inclusion can be managed by the yeast gene expression machinery .
virtually all genes of higher organisms have non-coding introns interspersed between the coding exons #spliced out in order to generate a mature messenger rna molecule used to encode proteins .
the pre-mrnas from all of these genes can be #spliced with little or no exon-skipping (ref .16; also fig .1 c and data not shown) , suggesting that correct exon inclusion can be managed by the yeast gene expression machinery .
virtually all genes of higher organisms have non-coding introns interspersed between the coding exons that are able to be efficiently #spliced out in order to generate a mature messenger rna molecule used to encode proteins .
the pre-mrnas from all of these genes have been shown to be #spliced with little or no exon-skipping (ref .16; also fig .1 c and data not shown) , suggesting that correct exon inclusion can be managed by the yeast gene expression machinery .
the pre-mrnas from all of these genes have been #spliced with little or no exon-skipping (ref .16; also fig .1 c and data not shown) , suggesting that correct exon inclusion can be managed by the yeast gene expression machinery .
virtually all genes of higher organisms have non-coding introns interspersed between the coding exons that are efficiently #spliced out in order to generate a mature messenger rna molecule used to encode proteins .
the pre-mrnas from all of these genes having been #spliced with little or no exon-skipping (ref .16; also fig .1 c and data not shown) suggest that correct exon inclusion can be managed by the yeast gene expression machinery .
virtually all genes of higher organisms have non-coding introns interspersed between the coding exons that can be efficiently #spliced out in order to generate a mature messenger rna molecule used to encode proteins .
virtually all genes of higher organisms have non-coding introns interspersed between the coding exons that can be #spliced out in order to generate a mature messenger rna molecule used to encode proteins .
the pre-mrnas from all of these genes shown to be #spliced with little or no exon-skipping (ref .16; also fig .1 c and data not shown) suggest that correct exon inclusion can be managed by the yeast gene expression machinery .
the pre-mrnas from all of these genes #spliced with little or no exon-skipping (ref .16; also fig .1 c and data not shown) suggest that correct exon inclusion can be managed by the yeast gene expression machinery .
virtually all genes of higher organisms have non-coding introns interspersed between the coding exons that have been #spliced out in order to generate a mature messenger rna molecule used to encode proteins .
virtually all genes of higher organisms have non-coding introns interspersed between the coding exons that have the ability to be efficiently #spliced out in order to generate a mature messenger rna molecule used to encode proteins .
the pre-mrnas from all of these genes that are observed to be #spliced with little or no exon-skipping (ref .16; also fig .1 c and data not shown) suggest that correct exon inclusion can be managed by the yeast gene expression machinery .
virtually all genes of higher organisms have non-coding introns interspersed between the coding exons that may be efficiently #spliced out in order to generate a mature messenger rna molecule used to encode proteins .
virtually all genes of higher organisms have non-coding introns interspersed between the coding exons that may have been efficiently #spliced out in order to generate a mature messenger rna molecule used to encode proteins .
the pre-mrnas from all of these genes that have the ability to be #spliced with little or no exon-skipping (ref .16; also fig .1 c and data not shown) suggest that correct exon inclusion can be managed by the yeast gene expression machinery .
virtually all genes of higher organisms have non-coding introns interspersed between the coding exons that may have been #spliced out in order to generate a mature messenger rna molecule used to encode proteins .
the pre-mrnas from all of these genes that may have been #spliced with little or no exon-skipping (ref .16; also fig .1 c and data not shown) suggest that correct exon inclusion can be managed by the yeast gene expression machinery .
virtually all genes of higher organisms have non-coding introns interspersed between the coding exons that must be efficiently #spliced out in order to generate a mature messenger rna molecule used to encode proteins .
the pre-mrnas from all of these genes that were #spliced with little or no exon-skipping (ref .16; also fig .1 c and data not shown) suggest that correct exon inclusion can be managed by the yeast gene expression machinery .
the pre-mrnas from all of these genes that will be #spliced with little or no exon-skipping (ref .16; also fig .1 c and data not shown) suggest that correct exon inclusion can be managed by the yeast gene expression machinery .
the structure of different cdna clones indicates that usf rna can be differentially #spliced , and alternative exon usage may regulate the levels of functional usf protein .
the structure of different cdna clones indicates that usf rna has been differentially #spliced , and alternative exon usage may regulate the levels of functional usf protein .
the structure of different cdna clones indicates that usf rna has been shown to be differentially #spliced , and alternative exon usage may regulate the levels of functional usf protein .
the structure of different cdna clones indicates that usf rna has been shown to be #spliced , and alternative exon usage may regulate the levels of functional usf protein .
the structure of different cdna clones indicates that usf rna is able to be #spliced , and alternative exon usage may regulate the levels of functional usf protein .
the structure of different cdna clones indicates that usf rna may have been differentially #spliced , and alternative exon usage may regulate the levels of functional usf protein .
the structure of different cdna clones indicates that usf rna was differentially #spliced , and alternative exon usage may regulate the levels of functional usf protein .
the structure of different cdna clones indicates that usf rna will be differentially #spliced , and alternative exon usage may regulate the levels of functional usf protein .
failure to #splice out this intron resulted in a substitution of the final 13 amino acids of the deduced amino acid sequence .
the structure of different cdna clones indicates that usf rna is differentially #spliced , and alternative exon usage may regulate the levels of functional usf protein .
in the remaining allelic p53 gene , there was a single-base substitution of g to t at position 1 within the #splice donor site of intron 7 , and the mutated intron was not #spliced out during the mrna maturation process .
virtually all genes of higher organisms have non-coding introns interspersed between the coding exons that must be #spliced out in order to generate a mature messenger rna molecule used to encode proteins .
vertebrate internal exons are usually between 50 and 400 nt long; exons outside this size range may require additional exonic and/or intronic sequences to be #spliced into the mature mrna .
a caspase-2 minigene construct can be efficiently #spliced transfected cells and nuclear extracts , and the ratio of casp-2s to casp-2l mrnas produced was similar to the one observed in vivo (fig .1 c , lane 1) .
a caspase-2 minigene construct has been efficiently #spliced transfected cells and nuclear extracts , and the ratio of casp-2s to casp-2l mrnas produced was similar to the one observed in vivo (fig .1 c , lane 1) .
a caspase-2 minigene construct has been #spliced efficiently transfected cells and nuclear extracts , and the ratio of casp-2s to casp-2l mrnas produced was similar to the one observed in vivo (fig .1 c , lane 1) .
a caspase-2 minigene construct has the ability to be #spliced efficiently transfected cells and nuclear extracts , and the ratio of casp-2s to casp-2l mrnas produced was similar to the one observed in vivo (fig .1 c , lane 1) .
a caspase-2 minigene construct is able to be #spliced efficiently transfected cells and nuclear extracts , and the ratio of casp-2s to casp-2l mrnas produced was similar to the one observed in vivo (fig .1 c , lane 1) .
a caspase-2 minigene construct is efficiently #spliced transfected cells and nuclear extracts , and the ratio of casp-2s to casp-2l mrnas produced was similar to the one observed in vivo (fig .1 c , lane 1) .
a caspase-2 minigene construct is observed to be efficiently #spliced transfected cells and nuclear extracts , and the ratio of casp-2s to casp-2l mrnas produced was similar to the one observed in vivo (fig .1 c , lane 1) .
a caspase-2 minigene construct is #spliced efficiently transfected cells and nuclear extracts , and the ratio of casp-2s to casp-2l mrnas produced was similar to the one observed in vivo (fig .1 c , lane 1) .
a caspase-2 minigene construct may have been shown to be efficiently #spliced transfected cells and nuclear extracts , and the ratio of casp-2s to casp-2l mrnas produced was similar to the one observed in vivo (fig .1 c , lane 1) .
a caspase-2 minigene construct will be efficiently #spliced transfected cells and nuclear extracts , and the ratio of casp-2s to casp-2l mrnas produced was similar to the one observed in vivo (fig .1 c , lane 1) .
moreover , putative intron sequences can be #spliced out from transcripts that contain exons 15 to 24 .
moreover , putative intron sequences has been shown to be #spliced out from transcripts that contain exons 15 to 24 .
moreover , putative intron sequences has ben #spliced out from transcripts that contain exons 15 to 24 .
moreover , putative intron sequences has the ability to be efficiently #spliced out from transcripts that contain exons 15 to 24 .
moreover , putative intron sequences is efficiently #spliced out from transcripts that contain exons 15 to 24 .
moreover , putative intron sequences is observed to be efficiently #spliced out from transcripts that contain exons 15 to 24 .
moreover , putative intron sequences may have been #spliced out from transcripts that contain exons 15 to 24 .
moreover , putative intron sequences might be efficiently #spliced out from transcripts that contain exons 15 to 24 .
moreover , putative intron sequences was efficiently #spliced out from transcripts that contain exons 15 to 24 .
moreover , putative intron sequences will be #spliced out from transcripts that contain exons 15 to 24 .
the mouse polymeric immunoglobulin receptor gene has exons outside this size range being able to be efficiently #spliced into the mature mrna .
the mouse polymeric immunoglobulin receptor gene has exons outside this size range being #spliced efficiently into the mature mrna .
the mouse polymeric immunoglobulin receptor gene has exons outside this size range having been efficiently #spliced into the mature mrna .
the mouse polymeric immunoglobulin receptor gene has exons outside this size range having been #spliced efficiently into the mature mrna .
the mouse polymeric immunoglobulin receptor gene has exons outside this size range having the ability to be #spliced efficiently into the mature mrna .
the mouse polymeric immunoglobulin receptor gene has exons outside this size range observed to be efficiently #spliced into the mature mrna .
the mouse polymeric immunoglobulin receptor gene has exons outside this size range observed to be #spliced efficiently into the mature mrna .
the mouse polymeric immunoglobulin receptor gene has exons outside this size range #spliced efficiently into the mature mrna .
the mouse polymeric immunoglobulin receptor gene has exons outside this size range that has been efficiently #spliced into the mature mrna .
the mouse polymeric immunoglobulin receptor gene has exons outside this size range that has been shown to be efficiently #spliced into the mature mrna .
the mouse polymeric immunoglobulin receptor gene has exons outside this size range that has been #spliced efficiently into the mature mrna .
the mouse polymeric immunoglobulin receptor gene has exons outside this size range that is able to be #spliced efficiently into the mature mrna .
the mouse polymeric immunoglobulin receptor gene has exons outside this size range that is observed to be #spliced efficiently into the mature mrna .
the mouse polymeric immunoglobulin receptor gene has exons outside this size range that may have been efficiently #spliced into the mature mrna .
the mouse polymeric immunoglobulin receptor gene has exons outside this size range that was efficiently #spliced into the mature mrna .
the mouse polymeric immunoglobulin receptor gene has exons outside this size range that will be efficiently #spliced into the mature mrna .
we also identified usf rna differentially #spliced but containing no obvious open reading frame .
we also identified usf rna having been shown to be #spliced but containing no obvious open reading frame .
we also identified usf rna observed to be #spliced but containing no obvious open reading frame .
we also identified usf rna that are observed to be differentially #spliced but contain no obvious open reading frame .
we also identified usf rna that can be differentially #spliced but contain no obvious open reading frame .
we also identified usf rna that can be #spliced but contain no obvious open reading frame .
we also identified usf rna that could have been differentially #spliced but contained no obvious open reading frame .
we also identified usf rna that have been shown to be #spliced but contained no obvious open reading frame .
we also identified usf rna that will be #spliced but contain no obvious open reading frame .
when incubated in nuclear extracts or transfected in hela cells , the pre-mrnas from all of these genes can be #spliced predominantly following little or no exon-skipping to a level similar to that obtained with the c2 substrate (data not shown and fig .2 e , compare lane 3 to lane 1) .
when incubated in nuclear extracts or transfected in hela cells , the pre-mrnas from all of these genes has been shown to be #spliced following little or no exon-skipping to a level similar to that obtained with the c2 substrate (data not shown and fig .2 e , compare lane 3 to lane 1) .
when incubated in nuclear extracts or transfected in hela cells , the pre-mrnas from all of these genes has been shown to be #spliced predominantly following little or no exon-skipping to a level similar to that obtained with the c2 substrate (data not shown and fig .2 e , compare lane 3 to lane 1) .
when incubated in nuclear extracts or transfected in hela cells , the pre-mrnas from all of these genes has been #spliced following little or no exon-skipping to a level similar to that obtained with the c2 substrate (data not shown and fig .2 e , compare lane 3 to lane 1) .
when incubated in nuclear extracts or transfected in hela cells , the pre-mrnas from all of these genes has been #spliced predominantly following little or no exon-skipping to a level similar to that obtained with the c2 substrate (data not shown and fig .2 e , compare lane 3 to lane 1) .
when incubated in nuclear extracts or transfected in hela cells , the pre-mrnas from all of these genes has the ablity to be #spliced following little or no exon-skipping to a level similar to that obtained with the c2 substrate (data not shown and fig .2 e , compare lane 3 to lane 1) .
when incubated in nuclear extracts or transfected in hela cells , the pre-mrnas from all of these genes has the ablity to be #spliced predominantly following little or no exon-skipping to a level similar to that obtained with the c2 substrate (data not shown and fig .2 e , compare lane 3 to lane 1) .
when incubated in nuclear extracts or transfected in hela cells , the pre-mrnas from all of these genes is able to be #spliced following little or no exon-skipping to a level similar to that obtained with the c2 substrate (data not shown and fig .2 e , compare lane 3 to lane 1) .
when incubated in nuclear extracts or transfected in hela cells , the pre-mrnas from all of these genes is able to be #spliced predominantly following little or no exon-skipping to a level similar to that obtained with the c2 substrate (data not shown and fig .2 e , compare lane 3 to lane 1) .
when incubated in nuclear extracts or transfected in hela cells , the pre-mrnas from all of these genes is #spliced following little or no exon-skipping to a level similar to that obtained with the c2 substrate (data not shown and fig .2 e , compare lane 3 to lane 1) .
when incubated in nuclear extracts or transfected in hela cells , the pre-mrnas from all of these genes is #spliced predominantly following little or no exon-skipping to a level similar to that obtained with the c2 substrate (data not shown and fig .2 e , compare lane 3 to lane 1) .
when incubated in nuclear extracts or transfected in hela cells , the pre-mrnas from all of these genes may be #spliced following little or no exon-skipping to a level similar to that obtained with the c2 substrate (data not shown and fig .2 e , compare lane 3 to lane 1) .
when incubated in nuclear extracts or transfected in hela cells , the pre-mrnas from all of these genes may be #spliced predominantly following little or no exon-skipping to a level similar to that obtained with the c2 substrate (data not shown and fig .2 e , compare lane 3 to lane 1) .
when incubated in nuclear extracts or transfected in hela cells , the pre-mrnas from all of these genes may have been #spliced following little or no exon-skipping to a level similar to that obtained with the c2 substrate (data not shown and fig .2 e , compare lane 3 to lane 1) .
when incubated in nuclear extracts or transfected in hela cells , the pre-mrnas from all of these genes will be #spliced predominantly following little or no exon-skipping to a level similar to that obtained with the c2 substrate (data not shown and fig .2 e , compare lane 3 to lane 1) .
putative intron sequences has been efficiently #spliced out during transcripts .
putative intron sequences was efficiently #spliced out during transcripts .
putative intron sequences was #spliced out during transcripts .
transcripts has putative intron sequences being able to be completely #spliced out .
transcripts has putative intron sequences being able to be #spliced out .
transcripts has putative intron sequences observed to be completely #spliced out .
transcripts has putative intron sequences that has been shown to be completely #spliced out .
transcripts has putative intron sequences that has been #spliced out .
transcripts has putative intron sequences that is #spliced out .
transcripts has putative intron sequences that may have been #spliced out .
the pre-mrnas from all of these genes are #spliced with little or no exon-skipping (ref .16; also fig .1 c and data not shown) , suggesting that correct exon inclusion can be managed by the yeast gene expression machinery .
the supt4h gene are able to be #spliced with five exons encoded by chromosome 11 (ref .16; also fig .1 c and data not shown) , suggesting that correct exon inclusion can be managed by the yeast gene expression machinery .
moreover , the mutated intron has ben efficiently #spliced out from the mrna maturation process that contain exons 15 to 24 .
the supt4h gene are #spliced with five exons (ref .16; also fig .1 c and data not shown) , suggesting that correct exon inclusion can be managed by the yeast gene expression machinery .
moreover , the mutated intron has ben #spliced out from the mrna maturation process that contain exons 15 to 24 .
moreover , the mutated intron has the ability to be efficiently #spliced out from the mrna maturation process that contain exons 15 to 24 .
moreover , the mutated intron has the ability to be #spliced out from the mrna maturation process that contain exons 15 to 24 .
the supt4h gene being able to be #spliced with five exons (ref .16; also fig .1 c and data not shown) suggest that correct exon inclusion can be managed by the yeast gene expression machinery .
moreover , the mutated intron is able to be efficiently #spliced out from the mrna maturation process that contain exons 15 to 24 .
the supt4h gene can be #spliced with five exons (ref .16; also fig .1 c and data not shown) , suggesting that correct exon inclusion can be managed by the yeast gene expression machinery .
moreover , the mutated intron is able to be #spliced out from the mrna maturation process that contain exons 15 to 24 .
the supt4h gene can be #spliced with five exons encoded by chromosome 11 (ref .16; also fig .1 c and data not shown) , suggesting that correct exon inclusion can be managed by the yeast gene expression machinery .
moreover , the mutated intron is efficiently #spliced out from the mrna maturation process that contain exons 15 to 24 .
the supt4h gene have been shown to be #spliced with five exons (ref .16; also fig .1 c and data not shown) , suggesting that correct exon inclusion can be managed by the yeast gene expression machinery .
moreover , the mutated intron is observed to be #spliced out from the mrna maturation process that contain exons 15 to 24 .
moreover , the mutated intron is #spliced out from the mrna maturation process that contain exons 15 to 24 .
the supt4h gene have the ability to be #spliced with five exons (ref .16; also fig .1 c and data not shown) , suggesting that correct exon inclusion can be managed by the yeast gene expression machinery .
the supt4h gene have the ability to be #spliced with five exons encoded by chromosome 11 (ref .16; also fig .1 c and data not shown) , suggesting that correct exon inclusion can be managed by the yeast gene expression machinery .
the supt4h gene having been #spliced with five exons (ref .16; also fig .1 c and data not shown) suggest that correct exon inclusion can be managed by the yeast gene expression machinery .
the supt4h gene having been #spliced with five exons encoded by chromosome 11 (ref .16; also fig .1 c and data not shown) suggest that correct exon inclusion can be managed by the yeast gene expression machinery .
moreover , the mutated intron was efficiently #spliced out from the mrna maturation process that contain exons 15 to 24 .
the supt4h gene having the ability to be #spliced with five exons (ref .16; also fig .1 c and data not shown) suggest that correct exon inclusion can be managed by the yeast gene expression machinery .
the supt4h gene having the ability to be #spliced with five exons encoded by chromosome 11 (ref .16; also fig .1 c and data not shown) suggest that correct exon inclusion can be managed by the yeast gene expression machinery .
the supt4h gene may have been #spliced with five exons (ref .16; also fig .1 c and data not shown) , suggesting that correct exon inclusion can be managed by the yeast gene expression machinery .
moreover , the mutated intron will be #spliced out from the mrna maturation process that contain exons 15 to 24 .
that the mutated intron can fail to be properly #spliced out in the mrna maturation process which spanned exon-intron boundaries is expected in antisense transcripts .
that the mutated intron can fail to be #spliced out in the mrna maturation process which spanned exon-intron boundaries is expected in antisense transcripts .
that the mutated intron fail to be #spliced out in the mrna maturation process which spanned exon-intron boundaries is expected in antisense transcripts .
the supt4h gene shown to be #spliced with five exons encoded by chromosome 11 (ref .16; also fig .1 c and data not shown) suggest that correct exon inclusion can be managed by the yeast gene expression machinery .
that the mutated intron has not been shown to be properly #spliced out in the mrna maturation process which spanned exon-intron boundaries is expected in antisense transcripts .
that the mutated intron have failed to be #spliced out in the mrna maturation process which spanned exon-intron boundaries is expected in antisense transcripts .
the supt4h gene that are observed to be #spliced with five exons (ref .16; also fig .1 c and data not shown) suggest that correct exon inclusion can be managed by the yeast gene expression machinery .
that the mutated intron is able to fail to be properly #spliced out in the mrna maturation process which spanned exon-intron boundaries is expected in antisense transcripts .
that the mutated intron is not observed to be properly #spliced out in the mrna maturation process which spanned exon-intron boundaries is expected in antisense transcripts .
the supt4h gene that have been shown to be #spliced with five exons encoded by chromosome 11 (ref .16; also fig .1 c and data not shown) suggest that correct exon inclusion can be managed by the yeast gene expression machinery .
that the mutated intron is not observed to be #spliced out in the mrna maturation process which spanned exon-intron boundaries is expected in antisense transcripts .
that the mutated intron may fail to be #spliced out in the mrna maturation process which spanned exon-intron boundaries is expected in antisense transcripts .
that the mutated intron will fail to be properly #spliced out in the mrna maturation process which spanned exon-intron boundaries is expected in antisense transcripts .
the supt4h gene that have the ability to be #spliced with five exons encoded by chromosome 11 (ref .16; also fig .1 c and data not shown) suggest that correct exon inclusion can be managed by the yeast gene expression machinery .
the failure to #splice out the mutated intron in the mrna maturation process which spanned exon-intron boundaries is expected in antisense transcripts .
the supt4h gene that may have been #spliced with five exons encoded by chromosome 11 (ref .16; also fig .1 c and data not shown) suggest that correct exon inclusion can be managed by the yeast gene expression machinery .
the mrna maturation process has the mutated intron being able to be completely #spliced out .
the mrna maturation process has the mutated intron being able to be #spliced out .
the supt4h gene that were #spliced with five exons encoded by chromosome 11 (ref .16; also fig .1 c and data not shown) suggest that correct exon inclusion can be managed by the yeast gene expression machinery .
the supt4h gene that will be #spliced with five exons encoded by chromosome 11 (ref .16; also fig .1 c and data not shown) suggest that correct exon inclusion can be managed by the yeast gene expression machinery .
the mrna maturation process has the mutated intron having the ability to be completely #spliced out .
the supt4h gene will be #spliced with five exons (ref .16; also fig .1 c and data not shown) , suggesting that correct exon inclusion can be managed by the yeast gene expression machinery .
the structure of different cdna clones indicates that the supt4h gene can be differentially #spliced , and alternative exon usage may regulate the levels of functional usf protein .
the structure of different cdna clones indicates that the supt4h gene has been differentially #spliced , and alternative exon usage may regulate the levels of functional usf protein .
the structure of different cdna clones indicates that the supt4h gene has been shown to be differentially #spliced , and alternative exon usage may regulate the levels of functional usf protein .
the mrna maturation process has the mutated intron that has been shown to be #spliced out .
the mrna maturation process has the mutated intron that has been #spliced out .
the structure of different cdna clones indicates that the supt4h gene has the ability to be differentially #spliced , and alternative exon usage may regulate the levels of functional usf protein .
the mrna maturation process has the mutated intron that has the ability to be #spliced out .
the structure of different cdna clones indicates that the supt4h gene has the ability to be #spliced , and alternative exon usage may regulate the levels of functional usf protein .
the mrna maturation process has the mutated intron that is able to be #spliced out .
the structure of different cdna clones indicates that the supt4h gene is able to be #spliced , and alternative exon usage may regulate the levels of functional usf protein .
the mrna maturation process has the mutated intron that is completely #spliced out .
the mrna maturation process has the mutated intron that is observed to be completely #spliced out .
the structure of different cdna clones indicates that the supt4h gene is observed to be differentially #spliced , and alternative exon usage may regulate the levels of functional usf protein .
the mrna maturation process has the mutated intron that is observed to be #spliced out .
the structure of different cdna clones indicates that the supt4h gene may have been differentially #spliced , and alternative exon usage may regulate the levels of functional usf protein .
the mrna maturation process has the mutated intron that is #spliced out .
the structure of different cdna clones indicates that the supt4h gene may have been #spliced , and alternative exon usage may regulate the levels of functional usf protein .
the structure of different cdna clones indicates that the supt4h gene was #spliced , and alternative exon usage may regulate the levels of functional usf protein .
the mrna maturation process has the mutated intron that may have been #spliced out .
the structure of different cdna clones indicates that the supt4h gene will be differentially #spliced , and alternative exon usage may regulate the levels of functional usf protein .
the mutated intron has been efficiently #spliced out during the mrna maturation process .
the structure of different cdna clones indicates that the supt4h gene will be #spliced , and alternative exon usage may regulate the levels of functional usf protein .
the mutated intron has been #spliced out during the mrna maturation process .
the structure of different cdna clones indicates that a pre-mrna containing mutations in se2 can be differentially #spliced , and alternative exon usage may regulate the levels of functional usf protein .
the structure of different cdna clones indicates that a pre-mrna containing mutations in se2 can be #spliced , and alternative exon usage may regulate the levels of functional usf protein .
the structure of different cdna clones indicates that a pre-mrna containing mutations in se2 has been differentially #spliced , and alternative exon usage may regulate the levels of functional usf protein .
the structure of different cdna clones indicates that a pre-mrna containing mutations in se2 has been shown to be differentially #spliced , and alternative exon usage may regulate the levels of functional usf protein .
the mutated intron may have been #spliced out during the mrna maturation process .
the structure of different cdna clones indicates that a pre-mrna containing mutations in se2 has been shown to be #spliced , and alternative exon usage may regulate the levels of functional usf protein .
the structure of different cdna clones indicates that a pre-mrna containing mutations in se2 has been #spliced , and alternative exon usage may regulate the levels of functional usf protein .
the structure of different cdna clones indicates that a pre-mrna containing mutations in se2 has the ability to be differentially #spliced , and alternative exon usage may regulate the levels of functional usf protein .
the structure of different cdna clones indicates that a pre-mrna containing mutations in se2 is differentially #spliced , and alternative exon usage may regulate the levels of functional usf protein .
the structure of different cdna clones indicates that a pre-mrna containing mutations in se2 was differentially #spliced , and alternative exon usage may regulate the levels of functional usf protein .
the structure of different cdna clones indicates that a pre-mrna containing mutations in se2 was #spliced , and alternative exon usage may regulate the levels of functional usf protein .
the structure of different cdna clones indicates that a pre-mrna containing mutations in se2 will be differentially #spliced , and alternative exon usage may regulate the levels of functional usf protein .
the structure of different cdna clones indicates that a pre-mrna containing mutations in se2 will be #spliced , and alternative exon usage may regulate the levels of functional usf protein .
we also identified the supt4h gene having been shown to be differentially #spliced but containing no obvious open reading frame .
we also identified the supt4h gene observed to be differentially #spliced but containing no obvious open reading frame .
we also identified the supt4h gene that are able to be #spliced but contain no obvious open reading frame .
we also identified the supt4h gene that are observed to be differentially #spliced but contain no obvious open reading frame .
we also identified the supt4h gene that are observed to be #spliced but contain no obvious open reading frame .
we also identified the supt4h gene that can be differentially #spliced but contain no obvious open reading frame .
we also identified the supt4h gene that can be #spliced but contain no obvious open reading frame .
we also identified the supt4h gene that could have been #spliced but contained no obvious open reading frame .
we also identified the supt4h gene that have been differentially #spliced but contained no obvious open reading frame .
we also identified the supt4h gene that have been shown to be differentially #spliced but contained no obvious open reading frame .
we also identified the supt4h gene that have been #spliced but contained no obvious open reading frame .
we also identified the supt4h gene that may be differentially #spliced but contain no obvious open reading frame .
we also identified the supt4h gene that may be #spliced but contain no obvious open reading frame .
we also identified the supt4h gene that may have been differentially #spliced but contained no obvious open reading frame .
we also identified the supt4h gene that may have been #spliced but contained no obvious open reading frame .
we also identified the supt4h gene that were differentially #spliced but contained no obvious open reading frame .
we also identified the supt4h gene that were #spliced but contained no obvious open reading frame .
we also identified the supt4h gene that will be differentially #spliced but contain no obvious open reading frame .
we also identified the supt4h gene that will be #spliced but contain no obvious open reading frame .
we also identified a pre-mrna containing mutations in se2 being able to be differentially #spliced but containing no obvious open reading frame .
we also identified a pre-mrna containing mutations in se2 being able to be #spliced but containing no obvious open reading frame .
we also identified a pre-mrna containing mutations in se2 differentially #spliced but containing no obvious open reading frame .
we also identified a pre-mrna containing mutations in se2 observed to be differentially #spliced but containing no obvious open reading frame .
we also identified a pre-mrna containing mutations in se2 observed to be #spliced but containing no obvious open reading frame .
we also identified a pre-mrna containing mutations in se2 that are observed to be #spliced but contain no obvious open reading frame .
we also identified a pre-mrna containing mutations in se2 that are #spliced but contain no obvious open reading frame .
we also identified a pre-mrna containing mutations in se2 that can be #spliced but contain no obvious open reading frame .
we also identified a pre-mrna containing mutations in se2 that could have been #spliced but contained no obvious open reading frame .
we also identified a pre-mrna containing mutations in se2 that have been shown to be differentially #spliced but contained no obvious open reading frame .
we also identified a pre-mrna containing mutations in se2 that have been shown to be #spliced but contained no obvious open reading frame .
we also identified a pre-mrna containing mutations in se2 that have been #spliced but contained no obvious open reading frame .
we also identified a pre-mrna containing mutations in se2 that may have been #spliced but contained no obvious open reading frame .
we also identified a pre-mrna containing mutations in se2 that will be differentially #spliced but contain no obvious open reading frame .
when incubated in nuclear extracts or transfected in hela cells , the supt4h gene can be #spliced following five exons encoded by chromosome 11 to a level similar to that obtained with the c2 substrate (data not shown and fig .2 e , compare lane 3 to lane 1) .
when incubated in nuclear extracts or transfected in hela cells , the supt4h gene can be #spliced predominantly following five exons encoded by chromosome 11 to a level similar to that obtained with the c2 substrate (data not shown and fig .2 e , compare lane 3 to lane 1) .
when incubated in nuclear extracts or transfected in hela cells , the supt4h gene has been shown to be #spliced predominantly following five exons encoded by chromosome 11 to a level similar to that obtained with the c2 substrate (data not shown and fig .2 e , compare lane 3 to lane 1) .
when incubated in nuclear extracts or transfected in hela cells , the supt4h gene has been #spliced predominantly following five exons encoded by chromosome 11 to a level similar to that obtained with the c2 substrate (data not shown and fig .2 e , compare lane 3 to lane 1) .
when incubated in nuclear extracts or transfected in hela cells , the supt4h gene has the ablity to be #spliced predominantly following five exons encoded by chromosome 11 to a level similar to that obtained with the c2 substrate (data not shown and fig .2 e , compare lane 3 to lane 1) .
when incubated in nuclear extracts or transfected in hela cells , the supt4h gene is able to be #spliced following five exons encoded by chromosome 11 to a level similar to that obtained with the c2 substrate (data not shown and fig .2 e , compare lane 3 to lane 1) .
when incubated in nuclear extracts or transfected in hela cells , the supt4h gene is able to be #spliced following five exons to a level similar to that obtained with the c2 substrate (data not shown and fig .2 e , compare lane 3 to lane 1) .
when incubated in nuclear extracts or transfected in hela cells , the supt4h gene is able to be #spliced predominantly following five exons encoded by chromosome 11 to a level similar to that obtained with the c2 substrate (data not shown and fig .2 e , compare lane 3 to lane 1) .
when incubated in nuclear extracts or transfected in hela cells , the supt4h gene is able to be #spliced predominantly following five exons to a level similar to that obtained with the c2 substrate (data not shown and fig .2 e , compare lane 3 to lane 1) .
when incubated in nuclear extracts or transfected in hela cells , the supt4h gene is observed to be #spliced following five exons encoded by chromosome 11 to a level similar to that obtained with the c2 substrate (data not shown and fig .2 e , compare lane 3 to lane 1) .
when incubated in nuclear extracts or transfected in hela cells , the supt4h gene is observed to be #spliced following five exons to a level similar to that obtained with the c2 substrate (data not shown and fig .2 e , compare lane 3 to lane 1) .
when incubated in nuclear extracts or transfected in hela cells , the supt4h gene is #spliced following five exons encoded by chromosome 11 to a level similar to that obtained with the c2 substrate (data not shown and fig .2 e , compare lane 3 to lane 1) .
when incubated in nuclear extracts or transfected in hela cells , the supt4h gene may be #spliced following five exons to a level similar to that obtained with the c2 substrate (data not shown and fig .2 e , compare lane 3 to lane 1) .
when incubated in nuclear extracts or transfected in hela cells , the supt4h gene may have been #spliced following five exons encoded by chromosome 11 to a level similar to that obtained with the c2 substrate (data not shown and fig .2 e , compare lane 3 to lane 1) .
when incubated in nuclear extracts or transfected in hela cells , the supt4h gene was #spliced predominantly following five exons encoded by chromosome 11 to a level similar to that obtained with the c2 substrate (data not shown and fig .2 e , compare lane 3 to lane 1) .
when incubated in nuclear extracts or transfected in hela cells , the supt4h gene will be #spliced following five exons encoded by chromosome 11 to a level similar to that obtained with the c2 substrate (data not shown and fig .2 e , compare lane 3 to lane 1) .
when incubated in nuclear extracts or transfected in hela cells , the supt4h gene will be #spliced following five exons to a level similar to that obtained with the c2 substrate (data not shown and fig .2 e , compare lane 3 to lane 1) .
when incubated in nuclear extracts or transfected in hela cells , the supt4h gene will be #spliced predominantly following five exons to a level similar to that obtained with the c2 substrate (data not shown and fig .2 e , compare lane 3 to lane 1) .
when incubated in nuclear extracts or transfected in hela cells , a pre-mrna containing mutations in se2 has been #spliced predominantly following the nt 3605 3 splice site to a level similar to that obtained with the c2 substrate (data not shown and fig .2 e , compare lane 3 to lane 1) .
when incubated in nuclear extracts or transfected in hela cells , a pre-mrna containing mutations in se2 is able to be #spliced following the nt 3605 3 splice site to a level similar to that obtained with the c2 substrate (data not shown and fig .2 e , compare lane 3 to lane 1) .
when incubated in nuclear extracts or transfected in hela cells , a pre-mrna containing mutations in se2 is able to be #spliced predominantly following the nt 3605 3 splice site to a level similar to that obtained with the c2 substrate (data not shown and fig .2 e , compare lane 3 to lane 1) .
when incubated in nuclear extracts or transfected in hela cells , a pre-mrna containing mutations in se2 is observed to be #spliced predominantly following the nt 3605 3 splice site to a level similar to that obtained with the c2 substrate (data not shown and fig .2 e , compare lane 3 to lane 1) .
when incubated in nuclear extracts or transfected in hela cells , a pre-mrna containing mutations in se2 is #spliced predominantly following the nt 3605 3 splice site to a level similar to that obtained with the c2 substrate (data not shown and fig .2 e , compare lane 3 to lane 1) .
when incubated in nuclear extracts or transfected in hela cells , a pre-mrna containing mutations in se2 may have been #spliced following the nt 3605 3 splice site to a level similar to that obtained with the c2 substrate (data not shown and fig .2 e , compare lane 3 to lane 1) .
when incubated in nuclear extracts or transfected in hela cells , a pre-mrna containing mutations in se2 may have been #spliced predominantly following the nt 3605 3 splice site to a level similar to that obtained with the c2 substrate (data not shown and fig .2 e , compare lane 3 to lane 1) .
when incubated in nuclear extracts or transfected in hela cells , a pre-mrna containing mutations in se2 was #spliced predominantly following the nt 3605 3 splice site to a level similar to that obtained with the c2 substrate (data not shown and fig .2 e , compare lane 3 to lane 1) .
when incubated in nuclear extracts or transfected in hela cells , a pre-mrna containing mutations in se2 will be #spliced following the nt 3605 3 splice site to a level similar to that obtained with the c2 substrate (data not shown and fig .2 e , compare lane 3 to lane 1) .
when incubated in nuclear extracts or transfected in hela cells , a pre-mrna containing mutations in se2 will be #spliced predominantly following the nt 3605 3 splice site to a level similar to that obtained with the c2 substrate (data not shown and fig .2 e , compare lane 3 to lane 1) .
a pre-mrna containing mutations in se2 are able to be #spliced with the nt 3605 3 splice site (ref .16; also fig .1 c and data not shown) , suggesting that correct exon inclusion can be managed by the yeast gene expression machinery .
a pre-mrna containing mutations in se2 are observed to be #spliced with the nt 3605 3 splice site (ref .16; also fig .1 c and data not shown) , suggesting that correct exon inclusion can be managed by the yeast gene expression machinery .
a pre-mrna containing mutations in se2 can be #spliced with the nt 3605 3 splice site (ref .16; also fig .1 c and data not shown) , suggesting that correct exon inclusion can be managed by the yeast gene expression machinery .
a pre-mrna containing mutations in se2 have been #spliced with the nt 3605 3 splice site (ref .16; also fig .1 c and data not shown) , suggesting that correct exon inclusion can be managed by the yeast gene expression machinery .
a pre-mrna containing mutations in se2 have the ability to be #spliced with the nt 3605 3 splice site (ref .16; also fig .1 c and data not shown) , suggesting that correct exon inclusion can be managed by the yeast gene expression machinery .
a pre-mrna containing mutations in se2 having been #spliced with the nt 3605 3 splice site (ref .16; also fig .1 c and data not shown) suggest that correct exon inclusion can be managed by the yeast gene expression machinery .
a pre-mrna containing mutations in se2 having the ability to be #spliced with the nt 3605 3 splice site (ref .16; also fig .1 c and data not shown) suggest that correct exon inclusion can be managed by the yeast gene expression machinery .
a pre-mrna containing mutations in se2 may have been #spliced with the nt 3605 3 splice site (ref .16; also fig .1 c and data not shown) , suggesting that correct exon inclusion can be managed by the yeast gene expression machinery .
a pre-mrna containing mutations in se2 observed to be #spliced with the nt 3605 3 splice site (ref .16; also fig .1 c and data not shown) suggest that correct exon inclusion can be managed by the yeast gene expression machinery .
a pre-mrna containing mutations in se2 that are able to be #spliced with the nt 3605 3 splice site (ref .16; also fig .1 c and data not shown) suggest that correct exon inclusion can be managed by the yeast gene expression machinery .
a pre-mrna containing mutations in se2 that have been shown to be #spliced with the nt 3605 3 splice site (ref .16; also fig .1 c and data not shown) suggest that correct exon inclusion can be managed by the yeast gene expression machinery .
a pre-mrna containing mutations in se2 that have the ability to be #spliced with the nt 3605 3 splice site (ref .16; also fig .1 c and data not shown) suggest that correct exon inclusion can be managed by the yeast gene expression machinery .
a pre-mrna containing mutations in se2 that will be #spliced with the nt 3605 3 splice site (ref .16; also fig .1 c and data not shown) suggest that correct exon inclusion can be managed by the yeast gene expression machinery .
a pre-mrna containing mutations in se2 were #spliced with the nt 3605 3 splice site (ref .16; also fig .1 c and data not shown) , suggesting that correct exon inclusion can be managed by the yeast gene expression machinery .
a pre-mrna containing mutations in se2 will be #spliced with the nt 3605 3 splice site (ref .16; also fig .1 c and data not shown) , suggesting that correct exon inclusion can be managed by the yeast gene expression machinery .
however , a pre-mrna containing mutations in se2 is #spliced predominantly using the nt 3605 3 splice site .
interaction at a distance between multiple operators can divergently #transcribe glptq-glpacb operons of escherichia coli k-12s .
interaction at a distance between multiple operators can divergently #transcribe glptq-glpacb operons of escherichia coli k-12s .
interaction at a distance between multiple operators controls the adjacent and can divergently #transcribe glptq-glpacb operons of escherichia coli k-12s .
interaction at a distance between multiple operators controls the adjacent and has the ability to divergently #transcribe glptq-glpacb operons of escherichia coli k-12s .
interaction at a distance between multiple operators controls the adjacent and is able to divergently #transcribe glptq-glpacb operons of escherichia coli k-12s .
interaction at a distance between multiple operators controls the adjacent and is able to divergently #transcribe glptq-glpacb operons of escherichia coli k-12s .
interaction at a distance between multiple operators controls the adjacent and is observed to divergently #transcribe glptq-glpacb operons of escherichia coli k-12s .
interaction at a distance between multiple operators controls the adjacent and is observed to divergently #transcribe glptq-glpacb operons of escherichia coli k-12s .
interaction at a distance between multiple operators controls the adjacent and may divergently #transcribe glptq-glpacb operons of escherichia coli k-12s .
interaction at a distance between multiple operators controls the adjacent and may have divergently #transcribed glptq-glpacb operons of escherichia coli k-12s .
interaction at a distance between multiple operators controls the adjacent and will divergently #transcribe glptq-glpacb operons of escherichia coli k-12s .
interaction at a distance between multiple operators controls the adjacent , can #transcribe glptq-glpacb operons of escherichia coli k-12s .
interaction at a distance between multiple operators controls the adjacent , divergently #transcribes glptq-glpacb operons of escherichia coli k-12s .
interaction at a distance between multiple operators controls the adjacent , divergently #transcribes glptq-glpacb operons of escherichia coli k-12s .
interaction at a distance between multiple operators controls the adjacent , has been shown to divergently #transcribe glptq-glpacb operons of escherichia coli k-12s .
interaction at a distance between multiple operators controls the adjacent , has been shown to #transcribe glptq-glpacb operons of escherichia coli k-12s .
interaction at a distance between multiple operators controls the adjacent , has been shown to #transcribe glptq-glpacb operons of escherichia coli k-12s .
interaction at a distance between multiple operators controls the adjacent , has divergently #transcribed glptq-glpacb operons of escherichia coli k-12s .
interaction at a distance between multiple operators controls the adjacent , has the ability to divergently #transcribe glptq-glpacb operons of escherichia coli k-12s .
interaction at a distance between multiple operators controls the adjacent , has the ability to #transcribe glptq-glpacb operons of escherichia coli k-12s .
interaction at a distance between multiple operators controls the adjacent , has #transcribed glptq-glpacb operons of escherichia coli k-12s .
interaction at a distance between multiple operators controls the adjacent , is able to divergently #transcribe glptq-glpacb operons of escherichia coli k-12s .
interaction at a distance between multiple operators controls the adjacent , is able to #transcribe glptq-glpacb operons of escherichia coli k-12s .
interaction at a distance between multiple operators controls the adjacent , is able to #transcribe glptq-glpacb operons of escherichia coli k-12s .
interaction at a distance between multiple operators controls the adjacent , is observed to divergently #transcribe glptq-glpacb operons of escherichia coli k-12s .
interaction at a distance between multiple operators controls the adjacent , may divergently #transcribe glptq-glpacb operons of escherichia coli k-12s .
interaction at a distance between multiple operators controls the adjacent , may divergently #transcribe glptq-glpacb operons of escherichia coli k-12s .
interaction at a distance between multiple operators controls the adjacent , may have divergently #transcribed glptq-glpacb operons of escherichia coli k-12s .
interaction at a distance between multiple operators controls the adjacent , may have #transcribed glptq-glpacb operons of escherichia coli k-12s .
interaction at a distance between multiple operators controls the adjacent , may have #transcribed glptq-glpacb operons of escherichia coli k-12s .
interaction at a distance between multiple operators controls the adjacent , may #transcribe glptq-glpacb operons of escherichia coli k-12s .
interaction at a distance between multiple operators controls the adjacent , #transcribed glptq-glpacb operons of escherichia coli k-12s .
interaction at a distance between multiple operators controls the adjacent , #transcribes glptq-glpacb operons of escherichia coli k-12s .
interaction at a distance between multiple operators controls the adjacent , #transcribes glptq-glpacb operons of escherichia coli k-12s .
interaction at a distance between multiple operators controls the adjacent , will divergently #transcribe glptq-glpacb operons of escherichia coli k-12s .
interaction at a distance between multiple operators divergently #transcribes glptq-glpacb operons of escherichia coli k-12s .
interaction at a distance between multiple operators divergently #transcribes glptq-glpacb operons of escherichia coli k-12s .
interaction at a distance between multiple operators has divergently #transcribed glptq-glpacb operons of escherichia coli k-12s .
interaction at a distance between multiple operators has divergently #transcribed glptq-glpacb operons of escherichia coli k-12s .
interaction at a distance between multiple operators has the ability to divergently #transcribe glptq-glpacb operons of escherichia coli k-12s .
interaction at a distance between multiple operators may divergently #transcribe glptq-glpacb operons of escherichia coli k-12s .
interaction at a distance between multiple operators may have divergently #transcribed glptq-glpacb operons of escherichia coli k-12s .
interaction at a distance between multiple operators will divergently #transcribe glptq-glpacb operons of escherichia coli k-12s .
klk14 is approximately 5 .4 kb in length spanning seven exons and can divergently #transcribe two alternative transcripts present only in prostate (1 .5 kb) and skeletal muscle (1 .9 kb) .
klk14 is approximately 5 .4 kb in length spanning seven exons and can #transcribe two alternative transcripts present only in prostate (1 .5 kb) and skeletal muscle (1 .9 kb) .
klk14 is approximately 5 .4 kb in length spanning seven exons and can #transcribe two alternative transcripts present only in prostate (1 .5 kb) and skeletal muscle (1 .9 kb) .
klk14 is approximately 5 .4 kb in length spanning seven exons and divergently #transcribed two alternative transcripts present only in prostate (1 .5 kb) and skeletal muscle (1 .9 kb) .
klk14 is approximately 5 .4 kb in length spanning seven exons and has been shown to divergently #transcribe two alternative transcripts present only in prostate (1 .5 kb) and skeletal muscle (1 .9 kb) .
klk14 is approximately 5 .4 kb in length spanning seven exons and has divergently #transcribed two alternative transcripts present only in prostate (1 .5 kb) and skeletal muscle (1 .9 kb) .
klk14 is approximately 5 .4 kb in length spanning seven exons and has #transcribed two alternative transcripts present only in prostate (1 .5 kb) and skeletal muscle (1 .9 kb) .
klk14 is approximately 5 .4 kb in length spanning seven exons and has #transcribed two alternative transcripts present only in prostate (1 .5 kb) and skeletal muscle (1 .9 kb) .
klk14 is approximately 5 .4 kb in length spanning seven exons and is able to divergently #transcribe two alternative transcripts present only in prostate (1 .5 kb) and skeletal muscle (1 .9 kb) .
klk14 is approximately 5 .4 kb in length spanning seven exons and is able to #transcribe two alternative transcripts present only in prostate (1 .5 kb) and skeletal muscle (1 .9 kb) .
klk14 is approximately 5 .4 kb in length spanning seven exons and is able to #transcribe two alternative transcripts present only in prostate (1 .5 kb) and skeletal muscle (1 .9 kb) .
klk14 is approximately 5 .4 kb in length spanning seven exons and is observed to divergently #transcribe two alternative transcripts present only in prostate (1 .5 kb) and skeletal muscle (1 .9 kb) .
klk14 is approximately 5 .4 kb in length spanning seven exons and is observed to #transcribe two alternative transcripts present only in prostate (1 .5 kb) and skeletal muscle (1 .9 kb) .
klk14 is approximately 5 .4 kb in length spanning seven exons and is observed to #transcribe two alternative transcripts present only in prostate (1 .5 kb) and skeletal muscle (1 .9 kb) .
klk14 is approximately 5 .4 kb in length spanning seven exons and #transcribed two alternative transcripts present only in prostate (1 .5 kb) and skeletal muscle (1 .9 kb) .
klk14 is approximately 5 .4 kb in length spanning seven exons and #transcribed two alternative transcripts present only in prostate (1 .5 kb) and skeletal muscle (1 .9 kb) .
klk14 is approximately 5 .4 kb in length spanning seven exons and , by northern blot analysis , can #transcribe two alternative transcripts present only in prostate (1 .5 kb) and skeletal muscle (1 .9 kb) .
klk14 is approximately 5 .4 kb in length spanning seven exons and , by northern blot analysis , has been shown to #transcribe two alternative transcripts present only in prostate (1 .5 kb) and skeletal muscle (1 .9 kb) .
klk14 is approximately 5 .4 kb in length spanning seven exons and , by northern blot analysis , has been shown to #transcribe two alternative transcripts present only in prostate (1 .5 kb) and skeletal muscle (1 .9 kb) .
klk14 is approximately 5 .4 kb in length spanning seven exons and , by northern blot analysis , has #transcribed two alternative transcripts present only in prostate (1 .5 kb) and skeletal muscle (1 .9 kb) .
klk14 is approximately 5 .4 kb in length spanning seven exons and , by northern blot analysis , is observed to #transcribe two alternative transcripts present only in prostate (1 .5 kb) and skeletal muscle (1 .9 kb) .
klk14 is approximately 5 .4 kb in length spanning seven exons and , by northern blot analysis , is observed to #transcribe two alternative transcripts present only in prostate (1 .5 kb) and skeletal muscle (1 .9 kb) .
klk14 is approximately 5 .4 kb in length spanning seven exons and , by northern blot analysis , #transcribed two alternative transcripts present only in prostate (1 .5 kb) and skeletal muscle (1 .9 kb) .
klk14 is approximately 5 .4 kb in length spanning seven exons and , by northern blot analysis , will #transcribe two alternative transcripts present only in prostate (1 .5 kb) and skeletal muscle (1 .9 kb) .
nep-2 can #transcribe the rrn operon in the presence of the transcription factor cdf2 .
nep-2 has been shown to specifically #transcribe the rrn operon in the presence of the transcription factor cdf2 .
nep-2 has been shown to #transcribe the rrn operon in the presence of the transcription factor cdf2 .
nep-2 has the ability to specifically #transcribe the rrn operon in the presence of the transcription factor cdf2 .
nep-2 has the ability to #transcribe the rrn operon in the presence of the transcription factor cdf2 .
nep-2 has #transcribed the rrn operon in the presence of the transcription factor cdf2 .
nep-2 is able to specifically #transcribe the rrn operon in the presence of the transcription factor cdf2 .
nep-2 is believe to specifically #transcribe the rrn operon in the presence of the transcription factor cdf2 .
nep-2 is observed to specifically #transcribe the rrn operon in the presence of the transcription factor cdf2 .
nep-2 is observed to #transcribe the rrn operon in the presence of the transcription factor cdf2 .
nep-2 may have specifically #transcribed the rrn operon in the presence of the transcription factor cdf2 .
nep-2 may have #transcribed the rrn operon in the presence of the transcription factor cdf2 .
nep-2 specifically #transcribed the rrn operon in the presence of the transcription factor cdf2 .
nep-2 #transcribed the rrn operon in the presence of the transcription factor cdf2 .
nep-2 will specifically #transcribe the rrn operon in the presence of the transcription factor cdf2 .
restriction analysis of these two plasmids demonstrated that glpd and glpr are able to be divergently #transcribed .
restriction analysis of these two plasmids demonstrated that glpd and glpr are able to be divergently #transcribed .
restriction analysis of these two plasmids demonstrated that glpd and glpr are proven to be divergently #transcribed .
restriction analysis of these two plasmids demonstrated that glpd and glpr are proven to be #transcribed .
restriction analysis of these two plasmids demonstrated that glpd and glpr are proven to be #transcribed .
restriction analysis of these two plasmids demonstrated that glpd and glpr are #transcribed .
restriction analysis of these two plasmids demonstrated that glpd and glpr can be divergently #transcribed .
restriction analysis of these two plasmids demonstrated that glpd and glpr can be divergently #transcribed .
restriction analysis of these two plasmids demonstrated that glpd and glpr can be #transcribed .
restriction analysis of these two plasmids demonstrated that glpd and glpr have been divergently #transcribed .
restriction analysis of these two plasmids demonstrated that glpd and glpr have been shown to be divergently #transcribed .
restriction analysis of these two plasmids demonstrated that glpd and glpr have been #transcribed .
restriction analysis of these two plasmids demonstrated that glpd and glpr have been #transcribed .
restriction analysis of these two plasmids demonstrated that glpd and glpr may be divergently #transcribed .
restriction analysis of these two plasmids demonstrated that glpd and glpr may have been divergently #transcribed .
restriction analysis of these two plasmids demonstrated that glpd and glpr were divergently #transcribed .
restriction analysis of these two plasmids demonstrated that glpd and glpr were divergently #transcribed .
restriction analysis of these two plasmids demonstrated that glpd and glpr were #transcribed .
restriction analysis of these two plasmids demonstrated that glpd and glpr were #transcribed .
restriction analysis of these two plasmids demonstrated that glpd and glpr will be divergently #transcribed .
restriction analysis of these two plasmids demonstrated that glpd and glpr will be divergently #transcribed .
restriction analysis of these two plasmids demonstrated that glpd and glpr will be #transcribed .
restriction analysis of these two plasmids suggested that glpd and glpr are able to be #transcribed .
restriction analysis of these two plasmids suggested that glpd and glpr can be #transcribed .
restriction analysis of these two plasmids suggested that glpd and glpr have been shown to be #transcribed .
restriction analysis of these two plasmids suggested that glpd and glpr may be #transcribed .
restriction analysis of these two plasmids suggested that glpd and glpr may be #transcribed .
restriction analysis of these two plasmids suggested that glpd and glpr will be #transcribed .
restriction endonuclease cleavage analysis of these two plasmids demonstrated that glpd and glpr are proven to be divergently #transcribed .
restriction endonuclease cleavage analysis of these two plasmids demonstrated that glpd and glpr can be divergently #transcribed .
restriction endonuclease cleavage analysis of these two plasmids demonstrated that glpd and glpr have been divergently #transcribed .
restriction endonuclease cleavage analysis of these two plasmids demonstrated that glpd and glpr have been divergently #transcribed .
restriction endonuclease cleavage analysis of these two plasmids demonstrated that glpd and glpr have been shown to be divergently #transcribed .
restriction endonuclease cleavage analysis of these two plasmids demonstrated that glpd and glpr may have been divergently #transcribed .
restriction endonuclease cleavage analysis of these two plasmids demonstrated that glpd and glpr were divergently #transcribed .
subsequently , the negative-strand rnas are likely to be used as templates to #transcribe mrnas , which include a genomic-sized rna and a nested set of subgenomic mrna transcripts , all with an identical 5_ non-translated leader sequence of 72 77 nucleotides and 3_ co-terminal polyadenylated ends .
subsequently , the negative-strand rnas can be used as templates to #transcribe mrnas , which include a genomic-sized rna and a nested set of subgenomic mrna transcripts , all with an identical 5_ non-translated leader sequence of 72 77 nucleotides and 3_ co-terminal polyadenylated ends .
subsequently , the negative-strand rnas have been used as templates to #transcribe mrnas , which include a genomic-sized rna and a nested set of subgenomic mrna transcripts , all with an identical 5_ non-translated leader sequence of 72 77 nucleotides and 3_ co-terminal polyadenylated ends .
subsequently , the negative-strand rnas may be used as templates to #transcribe mrnas , which include a genomic-sized rna and a nested set of subgenomic mrna transcripts , all with an identical 5_ non-translated leader sequence of 72 77 nucleotides and 3_ co-terminal polyadenylated ends .
subsequently , the negative-strand rnas may have been used as templates to #transcribe mrnas , which include a genomic-sized rna and a nested set of subgenomic mrna transcripts , all with an identical 5_ non-translated leader sequence of 72 77 nucleotides and 3_ co-terminal polyadenylated ends .
subsequently , the negative-strand rnas may have been used as templates to #transcribe mrnas , which include a genomic-sized rna and a nested set of subgenomic mrna transcripts , all with an identical 5_ non-translated leader sequence of 72 77 nucleotides and 3_ co-terminal polyadenylated ends .
subsequently , the negative-strand rnas will be used as templates to #transcribe mrnas , which include a genomic-sized rna and a nested set of subgenomic mrna transcripts , all with an identical 5_ non-translated leader sequence of 72 77 nucleotides and 3_ co-terminal polyadenylated ends .
the 7 .5- and 3 .5-kb fzd5 mrnas are able to be #transcribed probably due to alternative splicing .
the 7 .5- and 3 .5-kb fzd5 mrnas are observed to be #transcribed probably due to alternative splicing .
the 7 .5- and 3 .5-kb fzd5 mrnas can be #transcribed probably due to alternative splicing .
the 7 .5- and 3 .5-kb fzd5 mrnas has been shown to be #transcribed probably due to alternative splicing .
the 7 .5- and 3 .5-kb fzd5 mrnas have been #transcribed probably due to alternative splicing .
the 7 .5- and 3 .5-kb fzd5 mrnas have the ability to be specifically #transcribed probably due to alternative splicing .
the 7 .5- and 3 .5-kb fzd5 mrnas have the ability to be #transcribed probably due to alternative splicing .
the 7 .5- and 3 .5-kb fzd5 mrnas may be #transcribed probably due to alternative splicing .
the 7 .5- and 3 .5-kb fzd5 mrnas may have been specifically #transcribed probably due to alternative splicing .
the 7 .5- and 3 .5-kb fzd5 mrnas will be specifically #transcribed probably due to alternative splicing .
the fnf-e2 isoform can be #transcribed from an alternative promoter located in the 3 end of the first intron and joined by alternative splicing to the second and third exons , which are shared by both rna isoforms .
the fnf-e2 isoform can be #transcribed from an alternative promoter located in the 3 end of the first intron .
the fnf-e2 isoform has been #transcribed from an alternative promoter located in the 3 end of the first intron and joined by alternative splicing to the second and third exons , which are shared by both rna isoforms .
the fnf-e2 isoform has been #transcribed from an alternative promoter located in the 3 end of the first intron .
the fnf-e2 isoform has been #transcribed from an alternative promoter located in the 3 end of the first intron .
the fnf-e2 isoform is believed to be #transcribed from an alternative promoter located in the 3 end of the first intron .
the fnf-e2 isoform is #transcribed from an alternative promoter located in the 3 end of the first intron .
the fnf-e2 isoform may be #transcribed from an alternative promoter located in the 3 end of the first intron and joined by alternative splicing to the second and third exons , which are shared by both rna isoforms .
the fnf-e2 isoform may have been #transcribed from an alternative promoter located in the 3 end of the first intron and joined by alternative splicing to the second and third exons , which are shared by both rna isoforms .
the fnf-e2 isoform may have been #transcribed from an alternative promoter located in the 3 end of the first intron .
the fnf-e2 isoform was #transcribed from an alternative promoter located in the 3 end of the first intron and joined by alternative splicing to the second and third exons , which are shared by both rna isoforms .
the fnf-e2 isoform was #transcribed from an alternative promoter located in the 3 end of the first intron and joined by alternative splicing to the second and third exons , which are shared by both rna isoforms .
the fnf-e2 isoform was #transcribed from an alternative promoter located in the 3 end of the first intron .
the fnf-e2 isoform will be #transcribed from an alternative promoter located in the 3 end of the first intron and joined by alternative splicing to the second and third exons , which are shared by both rna isoforms .
the fnf-e2 isoform will be #transcribed from an alternative promoter located in the 3 end of the first intron .
the fnf-e2 isoform , however , can be #transcribed from an alternative promoter located in the 3 end of the first intron .
the fnf-e2 isoform , however , has been proven to be #transcribed from an alternative promoter located in the 3 end of the first intron .
the fnf-e2 isoform , however , has been proven to be #transcribed from an alternative promoter located in the 3 end of the first intron .
the fnf-e2 isoform , however , has been #transcribed from an alternative promoter located in the 3 end of the first intron .
the fnf-e2 isoform , however , is believed to be #transcribed from an alternative promoter located in the 3 end of the first intron .
the fnf-e2 isoform , however , is #transcribed from an alternative promoter located in the 3 end of the first intron .
the fnf-e2 isoform , however , is #transcribed from an alternative promoter located in the 3 end of the first intron .
the fnf-e2 isoform , however , may have been #transcribed from an alternative promoter located in the 3 end of the first intron .
the fnf-e2 isoform , however , may have been #transcribed from an alternative promoter located in the 3 end of the first intron .
the fnf-e2 isoform , however , was #transcribed from an alternative promoter located in the 3 end of the first intron .
the fnf-e2 isoform , however , was #transcribed from an alternative promoter located in the 3 end of the first intron .
the fnf-e2 isoform , however , will be #transcribed from an alternative promoter located in the 3 end of the first intron .
the fhla gene resides next to the hydb gene at 59 min in the e . coli chromosome , and the two genes are able to be interestingly interestingly #transcribed in opposite directions .
the fhla gene resides next to the hydb gene at 59 min in the e . coli chromosome , and the two genes are able to be #transcribed in opposite directions .
the fhla gene resides next to the hydb gene at 59 min in the e . coli chromosome , and the two genes are observed to be interestingly interestingly #transcribed in opposite directions .
the fhla gene resides next to the hydb gene at 59 min in the e . coli chromosome , and the two genes can be interestingly interestingly #transcribed in opposite directions .
the fhla gene resides next to the hydb gene at 59 min in the e . coli chromosome , and the two genes can be #transcribed in opposite directions .
the fhla gene resides next to the hydb gene at 59 min in the e . coli chromosome , and the two genes has been interestingly interestingly #transcribed in opposite directions .
the fhla gene resides next to the hydb gene at 59 min in the e . coli chromosome , and the two genes has been #transcribed in opposite directions .
the fhla gene resides next to the hydb gene at 59 min in the e . coli chromosome , and the two genes has been #transcribed in opposite directions .
the fhla gene resides next to the hydb gene at 59 min in the e . coli chromosome , and the two genes have been shown to be interestingly interestingly #transcribed in opposite directions .
the fhla gene resides next to the hydb gene at 59 min in the e . coli chromosome , and the two genes have been shown to be #transcribed in opposite directions .
the fhla gene resides next to the hydb gene at 59 min in the e . coli chromosome , and the two genes may be interestingly interestingly #transcribed in opposite directions .
the fhla gene resides next to the hydb gene at 59 min in the e . coli chromosome , and the two genes may be #transcribed in opposite directions .
the fhla gene resides next to the hydb gene at 59 min in the e . coli chromosome , and the two genes may have been interestingly interestingly #transcribed in opposite directions .
the fhla gene resides next to the hydb gene at 59 min in the e . coli chromosome , and the two genes were #transcribed in opposite directions .
the fhla gene resides next to the hydb gene at 59 min in the e . coli chromosome , and the two genes were #transcribed in opposite directions .
the fhla gene resides next to the hydb gene at 59 min in the e . coli chromosome , and the two genes will be #transcribed in opposite directions .
the gene can be #transcribed in a large variety of organs and tissues and shows differential splicing of two exons , giving rise to at least three different transcripts .
the gene has been shown to be #transcribed in a large variety of organs and tissues and showed differential splicing of two exons , giving rise to at least three different transcripts .
the gene has been shown to be #transcribed in a large variety of organs and tissues and showed differential splicing of two exons , giving rise to at least three different transcripts .
the gene has been #transcribed in a large variety of organs and tissues and shows differential splicing of two exons , giving rise to at least three different transcripts .
the gene is likely to be #transcribed in a large variety of organs and tissues and shows differential splicing of two exons , giving rise to at least three different transcripts .
the gene is observed to be #transcribed in a large variety of organs and tissues and shows differential splicing of two exons , giving rise to at least three different transcripts .
the gene is observed to be #transcribed in a large variety of organs and tissues and shows differential splicing of two exons , giving rise to at least three different transcripts .
the gene may be #transcribed in a large variety of organs and tissues and shows differential splicing of two exons , giving rise to at least three different transcripts .
the gene may be #transcribed in a large variety of organs and tissues and shows differential splicing of two exons , giving rise to at least three different transcripts .
the gene may have been #transcribed in a large variety of organs and tissues and showed differential splicing of two exons , giving rise to at least three different transcripts .
the gene was #transcribed in a large variety of organs and tissues and showed differential splicing of two exons , giving rise to at least three different transcripts .
the gene will be #transcribed in a large variety of organs and tissues and shows differential splicing of two exons , giving rise to at least three different transcripts .
the gene , as our study predicted , has been shown to be #transcribed in a large variety of organs and tissues and showed differential splicing of two exons , giving rise to at least three different transcripts .
the gene , as our study predicted , is able to be be #transcribed in a large variety of organs and tissues and shows differential splicing of two exons , giving rise to at least three different transcripts .
the gene , as our study predicted , is likely to be #transcribed in a large variety of organs and tissues and shows differential splicing of two exons , giving rise to at least three different transcripts .
the gene , as our study predicted , is observed to be #transcribed in a large variety of organs and tissues and shows differential splicing of two exons , giving rise to at least three different transcripts .
the gene , as our study predicted , may be #transcribed in a large variety of organs and tissues and shows differential splicing of two exons , giving rise to at least three different transcripts .
the gene , as our study predicted , may have been #transcribed in a large variety of organs and tissues and showed differential splicing of two exons , giving rise to at least three different transcripts .
the gene , as our study predicted , will be #transcribed in a large variety of organs and tissues and shows differential splicing of two exons , giving rise to at least three different transcripts .
the gene , as our study predicted , will be #transcribed in a large variety of organs and tissues and shows differential splicing of two exons , giving rise to at least three different transcripts .
the negative-strand rnas , subsequently , have been chosen to be used as templates to #transcribe mrnas , which include a genomic-sized rna and a nested set of subgenomic mrna transcripts , all with an identical 5_ non-translated leader sequence of 72 77 nucleotides and 3_ co-terminal polyadenylated ends .
the negative-strand rnas , subsequently , may be used as templates to #transcribe mrnas , which include a genomic-sized rna and a nested set of subgenomic mrna transcripts , all with an identical 5_ non-translated leader sequence of 72 77 nucleotides and 3_ co-terminal polyadenylated ends .
the negative-strand rnas , subsequently , were used as templates to #transcribe mrnas , which include a genomic-sized rna and a nested set of subgenomic mrna transcripts , all with an identical 5_ non-translated leader sequence of 72 77 nucleotides and 3_ co-terminal polyadenylated ends .
the negative-strand rnas , subsequently , were used as templates to #transcribe mrnas , which include a genomic-sized rna and a nested set of subgenomic mrna transcripts , all with an identical 5_ non-translated leader sequence of 72 77 nucleotides and 3_ co-terminal polyadenylated ends .
the negative-strand rnas , subsequently , will be used as templates to #transcribe mrnas , which include a genomic-sized rna and a nested set of subgenomic mrna transcripts , all with an identical 5_ non-translated leader sequence of 72 77 nucleotides and 3_ co-terminal polyadenylated ends .
the plastid genome can be divergently #transcribed by a plastid-encoded prokaryotic-type rna polymerase (pep) and a nucleus-encoded phage-type rna polymerase (nep) .
the plastid genome can be #transcribed by a plastid-encoded prokaryotic-type rna polymerase (pep) and a nucleus-encoded phage-type rna polymerase (nep) .
the plastid genome has been shown to be divergently #transcribed by a plastid-encoded prokaryotic-type rna polymerase (pep) and a nucleus-encoded phage-type rna polymerase (nep) .
the plastid genome has been #transcribed by a plastid-encoded prokaryotic-type rna polymerase (pep) and a nucleus-encoded phage-type rna polymerase (nep) .
the plastid genome is able to be divergently #transcribed by a plastid-encoded prokaryotic-type rna polymerase (pep) and a nucleus-encoded phage-type rna polymerase (nep) .
the plastid genome is found to be #transcribed by a plastid-encoded prokaryotic-type rna polymerase (pep) and a nucleus-encoded phage-type rna polymerase (nep) .
the plastid genome is #transcribed by a plastid-encoded prokaryotic-type rna polymerase (pep) and a nucleus-encoded phage-type rna polymerase (nep) .
the plastid genome may have been #transcribed by a plastid-encoded prokaryotic-type rna polymerase (pep) and a nucleus-encoded phage-type rna polymerase (nep) .
the plastid genome will be divergently #transcribed by a plastid-encoded prokaryotic-type rna polymerase (pep) and a nucleus-encoded phage-type rna polymerase (nep) .
the ula regulon has been formed by two divergently #transcribed operons , ulag and ulaabcdef .
the ula regulon has been shown to be formed by two divergently #transcribed operons , ulag and ulaabcdef .
the ula regulon is formed by two divergently #transcribed operons , ulag and ulaabcdef .
the ula regulon may be formed by two divergently #transcribed operons , ulag and ulaabcdef .
the ula regulon may have been formed by two divergently #transcribed operons , ulag and ulaabcdef .
the ula regulon was formed by two divergently #transcribed operons , ulag and ulaabcdef .
the ula regulon will be formed by two divergently #transcribed operons , ulag and ulaabcdef .
the ula regulon will be formed by two divergently #transcribed operons , ulag and ulaabcdef .
the ula regulon , responsible for the utilization of l-ascorbate in escherichia coli , can be formed by two divergently #transcribed operons , ulag and ulaabcdef .
the ula regulon , responsible for the utilization of l-ascorbate in escherichia coli , has been formed by two divergently #transcribed operons , ulag and ulaabcdef .
the ula regulon , responsible for the utilization of l-ascorbate in escherichia coli , has been shown to be formed by two divergently #transcribed operons , ulag and ulaabcdef .
the ula regulon , responsible for the utilization of l-ascorbate in escherichia coli , is able to be formed by two divergently #transcribed operons , ulag and ulaabcdef .
the ula regulon , responsible for the utilization of l-ascorbate in escherichia coli , may have been formed by two divergently #transcribed operons , ulag and ulaabcdef .
the ula regulon , responsible for the utilization of l-ascorbate in escherichia coli , was formed by two divergently #transcribed operons , ulag and ulaabcdef .
the ula regulon , responsible for the utilization of l-ascorbate in escherichia coli , will be formed by two divergently #transcribed operons , ulag and ulaabcdef .
they also indicate that spinach harvested in march should contain preferentially nep , i .e . the enzyme being able to specifically #transcribe the rrn operon at pc .
they also indicate that spinach harvested in march should contain preferentially nep , i .e . the enzyme having specifically #transcribed the rrn operon at pc .
they also indicate that spinach harvested in march should contain preferentially nep , i .e . the enzyme observed to specifically #transcribe the rrn operon at pc .
they also indicate that spinach harvested in march should contain preferentially nep , i .e . the enzyme observed to #transcribe the rrn operon at pc .
they also indicate that spinach harvested in march should contain preferentially nep , i .e . the enzyme shown to #transcribe the rrn operon at pc .
they also indicate that spinach harvested in march should contain preferentially nep , i .e . the enzyme that can #transcribe the rrn operon at pc .
they also indicate that spinach harvested in march should contain preferentially nep , i .e . the enzyme that has been shown to specifically #transcribe the rrn operon at pc .
they also indicate that spinach harvested in march should contain preferentially nep , i .e . the enzyme that has been shown to #transcribe the rrn operon at pc .
they also indicate that spinach harvested in march should contain preferentially nep , i .e . the enzyme that has specifically #transcribed the rrn operon at pc .
they also indicate that spinach harvested in march should contain preferentially nep , i .e . the enzyme that is able to #transcribe the rrn operon at pc .
they also indicate that spinach harvested in march should contain preferentially nep , i .e . the enzyme that is observed to specifically #transcribe the rrn operon at pc .
they also indicate that spinach harvested in march should contain preferentially nep , i .e . the enzyme that may have specifically #transcribed the rrn operon at pc .
they also indicate that spinach harvested in march should contain preferentially nep , i .e . the enzyme that may have #transcribed the rrn operon at pc .
they also indicate that spinach harvested in march should contain preferentially nep , i .e . the enzyme that may specifically #transcribe the rrn operon at pc .
they also indicate that spinach harvested in march should contain preferentially nep , i .e . the enzyme that #transcribed the rrn operon at pc .
this antisense-bcma rna can be divergently #transcribed from the same locus as bcma , and exhibits mrna characteristic features , e .g .polyadenylation and splicing .
this antisense-bcma rna can be divergently #transcribed from the same locus as bcma , and exhibits mrna characteristic features , e .g .polyadenylation and splicing .
this antisense-bcma rna can be #transcribed from the same locus as bcma , and exhibits mrna characteristic features , e .g .polyadenylation and splicing .
this antisense-bcma rna has been divergently #transcribed from the same locus as bcma , and exhibits mrna characteristic features , e .g .polyadenylation and splicing .
this antisense-bcma rna has been shown to be divergently #transcribed from the same locus as bcma , and exhibits mrna characteristic features , e .g .polyadenylation and splicing .
this antisense-bcma rna has been shown to be #transcribed from the same locus as bcma , and exhibits mrna characteristic features , e .g .polyadenylation and splicing .
this antisense-bcma rna is able to be divergently #transcribed from the same locus as bcma , and exhibits mrna characteristic features , e .g .polyadenylation and splicing .
this antisense-bcma rna is observed to be #transcribed from the same locus as bcma , and exhibits mrna characteristic features , e .g .polyadenylation and splicing .
this antisense-bcma rna may be divergently #transcribed from the same locus as bcma , and exhibits mrna characteristic features , e .g .polyadenylation and splicing .
this antisense-bcma rna may be divergently #transcribed from the same locus as bcma , and exhibits mrna characteristic features , e .g .polyadenylation and splicing .
this antisense-bcma rna may be #transcribed from the same locus as bcma , and exhibits mrna characteristic features , e .g .polyadenylation and splicing .
this antisense-bcma rna may have been divergently #transcribed from the same locus as bcma , and exhibits mrna characteristic features , e .g .polyadenylation and splicing .
this antisense-bcma rna may have been divergently #transcribed from the same locus as bcma , and exhibits mrna characteristic features , e .g .polyadenylation and splicing .
this antisense-bcma rna may have been #transcribed from the same locus as bcma , and exhibits mrna characteristic features , e .g .polyadenylation and splicing .
this antisense-bcma rna was divergently #transcribed from the same locus as bcma , and exhibits mrna characteristic features , e .g .polyadenylation and splicing .
this antisense-bcma rna was divergently #transcribed from the same locus as bcma , and exhibits mrna characteristic features , e .g .polyadenylation and splicing .
this antisense-bcma rna was #transcribed from the same locus as bcma , and exhibits mrna characteristic features , e .g .polyadenylation and splicing .
this antisense-bcma rna will be divergently #transcribed from the same locus as bcma , and exhibits mrna characteristic features , e .g .polyadenylation and splicing .
this operon , activated by growth on glycolate , can be efficiently #transcribed as a single message and is under the positive control of glcc encoded by a divergent gene .
this operon , activated by growth on glycolate , has been efficiently #transcribed as a single message and is under the positive control of glcc encoded by a divergent gene .
this operon , activated by growth on glycolate , has been shown to be #transcribed as a single message and is under the positive control of glcc encoded by a divergent gene .
this operon , activated by growth on glycolate , is able to be efficiently #transcribed as a single message and is under the positive control of glcc encoded by a divergent gene .
this operon , activated by growth on glycolate , is able to be #transcribed as a single message and is under the positive control of glcc encoded by a divergent gene .
this operon , activated by growth on glycolate , is proven to be efficiently #transcribed as a single message and is under the positive control of glcc encoded by a divergent gene .
this operon , activated by growth on glycolate , may have been efficiently #transcribed as a single message and is under the positive control of glcc encoded by a divergent gene .
this operon , activated by growth on glycolate , was efficiently #transcribed as a single message and is under the positive control of glcc encoded by a divergent gene .
this operon , activated by growth on glycolate , was #transcribed as a single message and is under the positive control of glcc encoded by a divergent gene .
glptq-glpacb operons of escherichia coli k-12s are able to be divergently #transcribed by interaction at a distance between multiple operators .
glptq-glpacb operons of escherichia coli k-12s are divergently #transcribed by interaction at a distance between multiple operators .
glptq-glpacb operons of escherichia coli k-12s are observed to be divergently #transcribed by interaction at a distance between multiple operators .
glptq-glpacb operons of escherichia coli k-12s are observed to be divergently #transcribed by interaction at a distance between multiple operators .
glptq-glpacb operons of escherichia coli k-12s are observed to be #transcribed by interaction at a distance between multiple operators .
glptq-glpacb operons of escherichia coli k-12s are #transcribed by interaction at a distance between multiple operators .
glptq-glpacb operons of escherichia coli k-12s are #transcribed by interaction at a distance between multiple operators .
glptq-glpacb operons of escherichia coli k-12s can be divergently #transcribed by interaction at a distance between multiple operators .
glptq-glpacb operons of escherichia coli k-12s can be #transcribed by interaction at a distance between multiple operators .
glptq-glpacb operons of escherichia coli k-12s can be #transcribed by interaction at a distance between multiple operators .
glptq-glpacb operons of escherichia coli k-12s have been shown to be divergently #transcribed by interaction at a distance between multiple operators .
glptq-glpacb operons of escherichia coli k-12s have been shown to be #transcribed by interaction at a distance between multiple operators .
glptq-glpacb operons of escherichia coli k-12s have been #transcribed by interaction at a distance between multiple operators .
glptq-glpacb operons of escherichia coli k-12s have the ability to be #transcribed by interaction at a distance between multiple operators .
glptq-glpacb operons of escherichia coli k-12s may have been #transcribed by interaction at a distance between multiple operators .
glptq-glpacb operons of escherichia coli k-12s were divergently #transcribed by interaction at a distance between multiple operators .
glptq-glpacb operons of escherichia coli k-12s were #transcribed by interaction at a distance between multiple operators .
glptq-glpacb operons of escherichia coli k-12s were #transcribed by interaction at a distance between multiple operators .
nep-2 specifically #transcribes the rrn operon in the presence of the transcription factor cdf2 .
subsequently , the negative-strand rnas are used as templates to #transcribe mrnas , which include a genomic-sized rna and a nested set of subgenomic mrna transcripts , all with an identical 5_ non-translated leader sequence of 72 77 nucleotides and 3_ co-terminal polyadenylated ends .
the plastid genome is known to be #transcribed by a plastid-encoded prokaryotic-type rna polymerase (pep) and a nucleus-encoded phage-type rna polymerase (nep) .
they also indicate that spinach harvested in march should contain preferentially nep , i .e . the enzyme that #transcribes the rrn operon at pc .
restriction endonuclease cleavage analysis of these two plasmids demonstrated that glpd and glpr are divergently #transcribed .
restriction endonuclease cleavage analysis of these two plasmids demonstrated that glpd and glpr are divergently #transcribed .
the ula regulon , responsible for the utilization of l-ascorbate in escherichia coli , is formed by two divergently #transcribed operons , ulag and ulaabcdef .
klk14 is approximately 5 .4 kb in length spanning seven exons and , by northern blot analysis , #transcribes two alternative transcripts present only in prostate (1 .5 kb) and skeletal muscle (1 .9 kb) .
klk14 is approximately 5 .4 kb in length spanning seven exons and , by northern blot analysis , #transcribes two alternative transcripts present only in prostate (1 .5 kb) and skeletal muscle (1 .9 kb) .
the 7 .5- and 3 .5-kb fzd5 mrnas were #transcribed probably due to alternative splicing .
the gene is #transcribed in a large variety of organs and tissues and shows differential splicing of two exons , giving rise to at least three different transcripts .
this antisense-bcma rna is #transcribed from the same locus as bcma , and exhibits mrna characteristic features , e .g .polyadenylation and splicing .
interaction at a distance between multiple operators can divergently #transcribe glpd and glpr of these two plasmids .
interaction at a distance between multiple operators can divergently #transcribe glpd and glpr of these two plasmids .
interaction at a distance between multiple operators controls the adjacent and can divergently #transcribe glpd and glpr of these two plasmids .
interaction at a distance between multiple operators controls the adjacent and can divergently #transcribe glpd and glpr of these two plasmids .
interaction at a distance between multiple operators controls the adjacent and can divergently #transcribe the two genes of e . coli chromosome .
interaction at a distance between multiple operators controls the adjacent and can divergently #transcribe the two genes of e . coli chromosome .
interaction at a distance between multiple operators controls the adjacent and divergently #transcribed glpd and glpr of these two plasmids .
interaction at a distance between multiple operators controls the adjacent and divergently #transcribed glpd and glpr of these two plasmids .
interaction at a distance between multiple operators controls the adjacent and divergently #transcribed the two genes of e . coli chromosome .
interaction at a distance between multiple operators controls the adjacent and divergently #transcribes glpd and glpr of these two plasmids .
interaction at a distance between multiple operators controls the adjacent and has been shown to divergently #transcribe the two genes of e . coli chromosome .
interaction at a distance between multiple operators controls the adjacent and has divergently #transcribed the two genes of e . coli chromosome .
interaction at a distance between multiple operators controls the adjacent and has the ability to divergently #transcribe glpd and glpr of these two plasmids .
interaction at a distance between multiple operators controls the adjacent and has the ability to divergently #transcribe glpd and glpr of these two plasmids .
interaction at a distance between multiple operators controls the adjacent and has the ability to divergently #transcribe the two genes of e . coli chromosome .
interaction at a distance between multiple operators controls the adjacent and is able to divergently #transcribe glpd and glpr of these two plasmids .
interaction at a distance between multiple operators controls the adjacent and is able to divergently #transcribe glpd and glpr of these two plasmids .
interaction at a distance between multiple operators controls the adjacent and is observed to divergently #transcribe the two genes of e . coli chromosome .
interaction at a distance between multiple operators controls the adjacent and may divergently #transcribe glpd and glpr of these two plasmids .
interaction at a distance between multiple operators controls the adjacent and may divergently #transcribe glpd and glpr of these two plasmids .
interaction at a distance between multiple operators controls the adjacent and may divergently #transcribe the two genes of e . coli chromosome .
interaction at a distance between multiple operators controls the adjacent and may have divergently #transcribed the two genes of e . coli chromosome .
interaction at a distance between multiple operators controls the adjacent and will divergently #transcribe glpd and glpr of these two plasmids .
interaction at a distance between multiple operators controls the adjacent and will divergently #transcribe the two genes of e . coli chromosome .
interaction at a distance between multiple operators controls the adjacent , can divergently #transcribe glpd and glpr of these two plasmids .
interaction at a distance between multiple operators controls the adjacent , can #transcribe glpd and glpr of these two plasmids .
interaction at a distance between multiple operators controls the adjacent , can #transcribe glpd and glpr of these two plasmids .
interaction at a distance between multiple operators controls the adjacent , can #transcribe the two genes of e . coli chromosome .
interaction at a distance between multiple operators controls the adjacent , divergently #transcribed glpd and glpr of these two plasmids .
interaction at a distance between multiple operators controls the adjacent , divergently #transcribes the two genes of e . coli chromosome .
interaction at a distance between multiple operators controls the adjacent , has been shown to divergently #transcribe the two genes of e . coli chromosome .
interaction at a distance between multiple operators controls the adjacent , has been shown to #transcribe glpd and glpr of these two plasmids .
interaction at a distance between multiple operators controls the adjacent , has divergently #transcribed glpd and glpr of these two plasmids .
interaction at a distance between multiple operators controls the adjacent , has divergently #transcribed glpd and glpr of these two plasmids .
interaction at a distance between multiple operators controls the adjacent , has divergently #transcribed the two genes of e . coli chromosome .
interaction at a distance between multiple operators controls the adjacent , has the ability to divergently #transcribe the two genes of e . coli chromosome .
interaction at a distance between multiple operators controls the adjacent , has the ability to #transcribe the two genes of e . coli chromosome .
interaction at a distance between multiple operators controls the adjacent , has the ability to #transcribe the two genes of e . coli chromosome .
interaction at a distance between multiple operators controls the adjacent , has #transcribed glpd and glpr of these two plasmids .
interaction at a distance between multiple operators controls the adjacent , has #transcribed glpd and glpr of these two plasmids .
interaction at a distance between multiple operators controls the adjacent , has #transcribed the two genes of e . coli chromosome .
interaction at a distance between multiple operators controls the adjacent , is able to divergently #transcribe glpd and glpr of these two plasmids .
interaction at a distance between multiple operators controls the adjacent , is able to divergently #transcribe glpd and glpr of these two plasmids .
interaction at a distance between multiple operators controls the adjacent , is able to divergently #transcribe the two genes of e . coli chromosome .
interaction at a distance between multiple operators controls the adjacent , is able to #transcribe glpd and glpr of these two plasmids .
interaction at a distance between multiple operators controls the adjacent , is able to #transcribe the two genes of e . coli chromosome .
interaction at a distance between multiple operators controls the adjacent , is able to #transcribe the two genes of e . coli chromosome .
interaction at a distance between multiple operators controls the adjacent , is observed to divergently #transcribe glpd and glpr of these two plasmids .
interaction at a distance between multiple operators controls the adjacent , is observed to divergently #transcribe the two genes of e . coli chromosome .
interaction at a distance between multiple operators controls the adjacent , is observed to #transcribe glpd and glpr of these two plasmids .
interaction at a distance between multiple operators controls the adjacent , is observed to #transcribe the two genes of e . coli chromosome .
interaction at a distance between multiple operators controls the adjacent , may divergently #transcribe the two genes of e . coli chromosome .
interaction at a distance between multiple operators controls the adjacent , may have divergently #transcribed glpd and glpr of these two plasmids .
interaction at a distance between multiple operators controls the adjacent , may have #transcribed glpd and glpr of these two plasmids .
interaction at a distance between multiple operators controls the adjacent , may have #transcribed the two genes of e . coli chromosome .
interaction at a distance between multiple operators controls the adjacent , may #transcribe glpd and glpr of these two plasmids .
interaction at a distance between multiple operators controls the adjacent , may #transcribe the two genes of e . coli chromosome .
interaction at a distance between multiple operators controls the adjacent , may #transcribe the two genes of e . coli chromosome .
interaction at a distance between multiple operators controls the adjacent , #transcribes glpd and glpr of these two plasmids .
interaction at a distance between multiple operators controls the adjacent , will divergently #transcribe glpd and glpr of these two plasmids .
interaction at a distance between multiple operators controls the adjacent , will divergently #transcribe glpd and glpr of these two plasmids .
interaction at a distance between multiple operators controls the adjacent , will divergently #transcribe the two genes of e . coli chromosome .
interaction at a distance between multiple operators controls the adjacent , will divergently #transcribe the two genes of e . coli chromosome .
interaction at a distance between multiple operators controls the adjacent , will #transcribe glpd and glpr of these two plasmids .
interaction at a distance between multiple operators divergently #transcribed glpd and glpr of these two plasmids .
interaction at a distance between multiple operators divergently #transcribed the two genes of e . coli chromosome .
interaction at a distance between multiple operators divergently #transcribed the two genes of e . coli chromosome .
interaction at a distance between multiple operators divergently #transcribes the two genes of e . coli chromosome .
interaction at a distance between multiple operators divergently #transcribes the two genes of e . coli chromosome .
interaction at a distance between multiple operators has been shown to divergently #transcribe glpd and glpr of these two plasmids .
interaction at a distance between multiple operators has been shown to divergently #transcribe the two genes of e . coli chromosome .
interaction at a distance between multiple operators has divergently #transcribed the two genes of e . coli chromosome .
interaction at a distance between multiple operators has the ability to divergently #transcribe glpd and glpr of these two plasmids .
interaction at a distance between multiple operators has the ability to divergently #transcribe glpd and glpr of these two plasmids .
interaction at a distance between multiple operators is able to divergently #transcribe glpd and glpr of these two plasmids .
interaction at a distance between multiple operators is able to divergently #transcribe the two genes of e . coli chromosome .
interaction at a distance between multiple operators is observed to divergently #transcribe glpd and glpr of these two plasmids .
interaction at a distance between multiple operators is observed to divergently #transcribe the two genes of e . coli chromosome .
interaction at a distance between multiple operators may divergently #transcribe glpd and glpr of these two plasmids .
interaction at a distance between multiple operators may divergently #transcribe glpd and glpr of these two plasmids .
interaction at a distance between multiple operators may divergently #transcribe the two genes of e . coli chromosome .
interaction at a distance between multiple operators may have divergently #transcribed glpd and glpr of these two plasmids .
interaction at a distance between multiple operators may have divergently #transcribed the two genes of e . coli chromosome .
interaction at a distance between multiple operators will divergently #transcribe the two genes of e . coli chromosome .
restriction analysis of e . coli chromosome demonstrated that the two genes are able to be divergently #transcribed .
restriction analysis of e . coli chromosome demonstrated that the two genes are able to be divergently #transcribed .
restriction analysis of e . coli chromosome demonstrated that the two genes are able to be #transcribed .
restriction analysis of e . coli chromosome demonstrated that the two genes are divergently #transcribed .
restriction analysis of e . coli chromosome demonstrated that the two genes are proven to be divergently #transcribed .
restriction analysis of e . coli chromosome demonstrated that the two genes are proven to be #transcribed .
restriction analysis of e . coli chromosome demonstrated that the two genes are #transcribed .
restriction analysis of e . coli chromosome demonstrated that the two genes can be #transcribed .
restriction analysis of e . coli chromosome demonstrated that the two genes have been divergently #transcribed .
restriction analysis of e . coli chromosome demonstrated that the two genes have been shown to be divergently #transcribed .
restriction analysis of e . coli chromosome demonstrated that the two genes have been shown to be divergently #transcribed .
restriction analysis of e . coli chromosome demonstrated that the two genes have been shown to be #transcribed .
restriction analysis of e . coli chromosome demonstrated that the two genes have been shown to be #transcribed .
restriction analysis of e . coli chromosome demonstrated that the two genes may be divergently #transcribed .
restriction analysis of e . coli chromosome demonstrated that the two genes were #transcribed .
restriction analysis of e . coli chromosome demonstrated that the two genes will be divergently #transcribed .
restriction analysis of e . coli chromosome suggested that the two genes are proven to be #transcribed .
restriction analysis of e . coli chromosome suggested that the two genes can be #transcribed .
restriction analysis of e . coli chromosome suggested that the two genes have been shown to be #transcribed .
restriction analysis of e . coli chromosome suggested that the two genes have been #transcribed .
restriction analysis of e . coli chromosome suggested that the two genes may be #transcribed .
restriction analysis of e . coli chromosome suggested that the two genes may have been #transcribed .
restriction analysis of e . coli chromosome suggested that the two genes will be #transcribed .
restriction analysis of escherichia coli k-12s demonstrated that glptq-glpacb operons are able to be #transcribed .
restriction analysis of escherichia coli k-12s demonstrated that glptq-glpacb operons are divergently #transcribed .
restriction analysis of escherichia coli k-12s demonstrated that glptq-glpacb operons are divergently #transcribed .
restriction analysis of escherichia coli k-12s demonstrated that glptq-glpacb operons are proven to be #transcribed .
restriction analysis of escherichia coli k-12s demonstrated that glptq-glpacb operons are #transcribed .
restriction analysis of escherichia coli k-12s demonstrated that glptq-glpacb operons can be divergently #transcribed .
restriction analysis of escherichia coli k-12s demonstrated that glptq-glpacb operons have been shown to be #transcribed .
restriction analysis of escherichia coli k-12s demonstrated that glptq-glpacb operons have been #transcribed .
restriction analysis of escherichia coli k-12s demonstrated that glptq-glpacb operons may be #transcribed .
restriction analysis of escherichia coli k-12s demonstrated that glptq-glpacb operons may have been divergently #transcribed .
restriction analysis of escherichia coli k-12s demonstrated that glptq-glpacb operons may have been #transcribed .
restriction analysis of escherichia coli k-12s demonstrated that glptq-glpacb operons were divergently #transcribed .
restriction analysis of escherichia coli k-12s demonstrated that glptq-glpacb operons were divergently #transcribed .
restriction analysis of escherichia coli k-12s demonstrated that glptq-glpacb operons will be divergently #transcribed .
restriction analysis of escherichia coli k-12s demonstrated that glptq-glpacb operons will be divergently #transcribed .
restriction analysis of escherichia coli k-12s suggested that glptq-glpacb operons are able to be #transcribed .
restriction analysis of escherichia coli k-12s suggested that glptq-glpacb operons are able to be #transcribed .
restriction analysis of escherichia coli k-12s suggested that glptq-glpacb operons have been shown to be #transcribed .
restriction analysis of escherichia coli k-12s suggested that glptq-glpacb operons have been shown to be #transcribed .
restriction analysis of escherichia coli k-12s suggested that glptq-glpacb operons have been #transcribed .
restriction analysis of escherichia coli k-12s suggested that glptq-glpacb operons may be #transcribed .
restriction analysis of escherichia coli k-12s suggested that glptq-glpacb operons may be #transcribed .
restriction analysis of escherichia coli k-12s suggested that glptq-glpacb operons may have been #transcribed .
restriction analysis of escherichia coli k-12s suggested that glptq-glpacb operons may have been #transcribed .
restriction analysis of escherichia coli k-12s suggested that glptq-glpacb operons were #transcribed .
restriction analysis of escherichia coli k-12s suggested that glptq-glpacb operons will be #transcribed .
restriction endonuclease cleavage analysis of e . coli chromosome demonstrated that the two genes are able to be divergently #transcribed .
restriction endonuclease cleavage analysis of e . coli chromosome demonstrated that the two genes are proven to be divergently #transcribed .
restriction endonuclease cleavage analysis of e . coli chromosome demonstrated that the two genes can be divergently #transcribed .
restriction endonuclease cleavage analysis of e . coli chromosome demonstrated that the two genes can be divergently #transcribed .
restriction endonuclease cleavage analysis of e . coli chromosome demonstrated that the two genes have been divergently #transcribed .
restriction endonuclease cleavage analysis of e . coli chromosome demonstrated that the two genes have been divergently #transcribed .
restriction endonuclease cleavage analysis of e . coli chromosome demonstrated that the two genes may be divergently #transcribed .
restriction endonuclease cleavage analysis of e . coli chromosome demonstrated that the two genes may have been divergently #transcribed .
restriction endonuclease cleavage analysis of e . coli chromosome demonstrated that the two genes were divergently #transcribed .
restriction endonuclease cleavage analysis of escherichia coli k-12s demonstrated that glptq-glpacb operons are able to be divergently #transcribed .
restriction endonuclease cleavage analysis of escherichia coli k-12s demonstrated that glptq-glpacb operons are able to be divergently #transcribed .
restriction endonuclease cleavage analysis of escherichia coli k-12s demonstrated that glptq-glpacb operons are divergently #transcribed .
restriction endonuclease cleavage analysis of escherichia coli k-12s demonstrated that glptq-glpacb operons can be divergently #transcribed .
restriction endonuclease cleavage analysis of escherichia coli k-12s demonstrated that glptq-glpacb operons can be divergently #transcribed .
restriction endonuclease cleavage analysis of escherichia coli k-12s demonstrated that glptq-glpacb operons have been divergently #transcribed .
restriction endonuclease cleavage analysis of escherichia coli k-12s demonstrated that glptq-glpacb operons have been shown to be divergently #transcribed .
restriction endonuclease cleavage analysis of escherichia coli k-12s demonstrated that glptq-glpacb operons may be divergently #transcribed .
restriction endonuclease cleavage analysis of escherichia coli k-12s demonstrated that glptq-glpacb operons may have been divergently #transcribed .
restriction endonuclease cleavage analysis of escherichia coli k-12s demonstrated that glptq-glpacb operons were divergently #transcribed .
restriction endonuclease cleavage analysis of escherichia coli k-12s demonstrated that glptq-glpacb operons will be divergently #transcribed .
restriction endonuclease cleavage analysis of escherichia coli k-12s demonstrated that glptq-glpacb operons will be divergently #transcribed .
subsequently , ulag and ulaabcdef are likely to be used as templates to #transcribe ula regulon , which include a genomic-sized rna and a nested set of subgenomic mrna transcripts , all with an identical 5_ non-translated leader sequence of 72 77 nucleotides and 3_ co-terminal polyadenylated ends .
subsequently , ulag and ulaabcdef are selected to be used as templates to #transcribe ula regulon , which include a genomic-sized rna and a nested set of subgenomic mrna transcripts , all with an identical 5_ non-translated leader sequence of 72 77 nucleotides and 3_ co-terminal polyadenylated ends .
subsequently , ulag and ulaabcdef are used as templates to #transcribe ula regulon , which include a genomic-sized rna and a nested set of subgenomic mrna transcripts , all with an identical 5_ non-translated leader sequence of 72 77 nucleotides and 3_ co-terminal polyadenylated ends .
subsequently , ulag and ulaabcdef are used as templates to #transcribe ula regulon , which include a genomic-sized rna and a nested set of subgenomic mrna transcripts , all with an identical 5_ non-translated leader sequence of 72 77 nucleotides and 3_ co-terminal polyadenylated ends .
subsequently , ulag and ulaabcdef have been chosen to be used as templates to #transcribe ula regulon , which include a genomic-sized rna and a nested set of subgenomic mrna transcripts , all with an identical 5_ non-translated leader sequence of 72 77 nucleotides and 3_ co-terminal polyadenylated ends .
subsequently , ulag and ulaabcdef may be used as templates to #transcribe ula regulon , which include a genomic-sized rna and a nested set of subgenomic mrna transcripts , all with an identical 5_ non-translated leader sequence of 72 77 nucleotides and 3_ co-terminal polyadenylated ends .
subsequently , ulag and ulaabcdef may have been used as templates to #transcribe ula regulon , which include a genomic-sized rna and a nested set of subgenomic mrna transcripts , all with an identical 5_ non-translated leader sequence of 72 77 nucleotides and 3_ co-terminal polyadenylated ends .
subsequently , ulag and ulaabcdef may have been used as templates to #transcribe ula regulon , which include a genomic-sized rna and a nested set of subgenomic mrna transcripts , all with an identical 5_ non-translated leader sequence of 72 77 nucleotides and 3_ co-terminal polyadenylated ends .
subsequently , ulag and ulaabcdef were used as templates to #transcribe ula regulon , which include a genomic-sized rna and a nested set of subgenomic mrna transcripts , all with an identical 5_ non-translated leader sequence of 72 77 nucleotides and 3_ co-terminal polyadenylated ends .
subsequently , ulag and ulaabcdef were used as templates to #transcribe ula regulon , which include a genomic-sized rna and a nested set of subgenomic mrna transcripts , all with an identical 5_ non-translated leader sequence of 72 77 nucleotides and 3_ co-terminal polyadenylated ends .
subsequently , ulag and ulaabcdef will be used as templates to #transcribe ula regulon , which include a genomic-sized rna and a nested set of subgenomic mrna transcripts , all with an identical 5_ non-translated leader sequence of 72 77 nucleotides and 3_ co-terminal polyadenylated ends .
subsequently , ulag and ulaabcdef will be used as templates to #transcribe ula regulon , which include a genomic-sized rna and a nested set of subgenomic mrna transcripts , all with an identical 5_ non-translated leader sequence of 72 77 nucleotides and 3_ co-terminal polyadenylated ends .
the fhla gene resides next to the hydb gene at 59 min in the escherichia coli k-12s , and glptq-glpacb operons are able to be interestingly interestingly #transcribed in opposite directions .
the fhla gene resides next to the hydb gene at 59 min in the escherichia coli k-12s , and glptq-glpacb operons are observed to be interestingly interestingly #transcribed in opposite directions .
the fhla gene resides next to the hydb gene at 59 min in the escherichia coli k-12s , and glptq-glpacb operons are observed to be #transcribed in opposite directions .
the fhla gene resides next to the hydb gene at 59 min in the escherichia coli k-12s , and glptq-glpacb operons can be interestingly interestingly #transcribed in opposite directions .
the fhla gene resides next to the hydb gene at 59 min in the escherichia coli k-12s , and glptq-glpacb operons can be #transcribed in opposite directions .
the fhla gene resides next to the hydb gene at 59 min in the escherichia coli k-12s , and glptq-glpacb operons has been interestingly interestingly #transcribed in opposite directions .
the fhla gene resides next to the hydb gene at 59 min in the escherichia coli k-12s , and glptq-glpacb operons has been #transcribed in opposite directions .
the fhla gene resides next to the hydb gene at 59 min in the escherichia coli k-12s , and glptq-glpacb operons have been shown to be interestingly interestingly #transcribed in opposite directions .
the fhla gene resides next to the hydb gene at 59 min in the escherichia coli k-12s , and glptq-glpacb operons have been shown to be #transcribed in opposite directions .
the fhla gene resides next to the hydb gene at 59 min in the escherichia coli k-12s , and glptq-glpacb operons have been shown to be #transcribed in opposite directions .
the fhla gene resides next to the hydb gene at 59 min in the escherichia coli k-12s , and glptq-glpacb operons may have been #transcribed in opposite directions .
the fhla gene resides next to the hydb gene at 59 min in the escherichia coli k-12s , and glptq-glpacb operons were interestingly interestingly #transcribed in opposite directions .
the fhla gene resides next to the hydb gene at 59 min in the escherichia coli k-12s , and glptq-glpacb operons will be interestingly interestingly #transcribed in opposite directions .
the fhla gene resides next to the hydb gene at 59 min in the escherichia coli k-12s , and glptq-glpacb operons will be interestingly interestingly #transcribed in opposite directions .
the fhla gene resides next to the hydb gene at 59 min in the escherichia coli k-12s , and glptq-glpacb operons will be #transcribed in opposite directions .
the fhla gene resides next to the hydb gene at 59 min in the these two plasmids , and glpd and glpr are able to be interestingly interestingly #transcribed in opposite directions .
the fhla gene resides next to the hydb gene at 59 min in the these two plasmids , and glpd and glpr are able to be interestingly interestingly #transcribed in opposite directions .
the fhla gene resides next to the hydb gene at 59 min in the these two plasmids , and glpd and glpr are able to be #transcribed in opposite directions .
the fhla gene resides next to the hydb gene at 59 min in the these two plasmids , and glpd and glpr are able to be #transcribed in opposite directions .
the fhla gene resides next to the hydb gene at 59 min in the these two plasmids , and glpd and glpr are observed to be interestingly interestingly #transcribed in opposite directions .
the fhla gene resides next to the hydb gene at 59 min in the these two plasmids , and glpd and glpr are observed to be interestingly interestingly #transcribed in opposite directions .
the fhla gene resides next to the hydb gene at 59 min in the these two plasmids , and glpd and glpr are #transcribed in opposite directions .
the fhla gene resides next to the hydb gene at 59 min in the these two plasmids , and glpd and glpr are #transcribed in opposite directions .
the fhla gene resides next to the hydb gene at 59 min in the these two plasmids , and glpd and glpr can be #transcribed in opposite directions .
the fhla gene resides next to the hydb gene at 59 min in the these two plasmids , and glpd and glpr can be #transcribed in opposite directions .
the fhla gene resides next to the hydb gene at 59 min in the these two plasmids , and glpd and glpr has been interestingly interestingly #transcribed in opposite directions .
the fhla gene resides next to the hydb gene at 59 min in the these two plasmids , and glpd and glpr has been #transcribed in opposite directions .
the fhla gene resides next to the hydb gene at 59 min in the these two plasmids , and glpd and glpr has been #transcribed in opposite directions .
the fhla gene resides next to the hydb gene at 59 min in the these two plasmids , and glpd and glpr have been shown to be #transcribed in opposite directions .
the fhla gene resides next to the hydb gene at 59 min in the these two plasmids , and glpd and glpr may be interestingly interestingly #transcribed in opposite directions .
the fhla gene resides next to the hydb gene at 59 min in the these two plasmids , and glpd and glpr may be #transcribed in opposite directions .
the fhla gene resides next to the hydb gene at 59 min in the these two plasmids , and glpd and glpr may have been interestingly interestingly #transcribed in opposite directions .
the fhla gene resides next to the hydb gene at 59 min in the these two plasmids , and glpd and glpr may have been interestingly interestingly #transcribed in opposite directions .
the fhla gene resides next to the hydb gene at 59 min in the these two plasmids , and glpd and glpr may have been #transcribed in opposite directions .
the fhla gene resides next to the hydb gene at 59 min in the these two plasmids , and glpd and glpr may have been #transcribed in opposite directions .
the fhla gene resides next to the hydb gene at 59 min in the these two plasmids , and glpd and glpr were #transcribed in opposite directions .
the fhla gene resides next to the hydb gene at 59 min in the these two plasmids , and glpd and glpr were #transcribed in opposite directions .
the fhla gene resides next to the hydb gene at 59 min in the these two plasmids , and glpd and glpr will be interestingly interestingly #transcribed in opposite directions .
the fhla gene resides next to the hydb gene at 59 min in the these two plasmids , and glpd and glpr will be interestingly interestingly #transcribed in opposite directions .
the fhla gene resides next to the hydb gene at 59 min in the these two plasmids , and glpd and glpr will be #transcribed in opposite directions .
the mrnas can be formed by two divergently #transcribed operons , the negative-strand rnas .
the mrnas has been formed by two divergently #transcribed operons , the negative-strand rnas .
the mrnas has been shown to be formed by two divergently #transcribed operons , the negative-strand rnas .
the mrnas is formed by two divergently #transcribed operons , the negative-strand rnas .
the mrnas is observed to be formed by two divergently #transcribed operons , the negative-strand rnas .
the mrnas was formed by two divergently #transcribed operons , the negative-strand rnas .
the two alternative transcripts , responsible for the utilization of l-ascorbate in prostate (1 .5 kb) and skeletal muscle (1 .9 kb) , can be formed by two divergently #transcribed operons , klk14 .
the two alternative transcripts , responsible for the utilization of l-ascorbate in prostate (1 .5 kb) and skeletal muscle (1 .9 kb) , can be formed by two divergently #transcribed operons , klk14 .
the two alternative transcripts , responsible for the utilization of l-ascorbate in prostate (1 .5 kb) and skeletal muscle (1 .9 kb) , has been formed by two divergently #transcribed operons , klk14 .
the two alternative transcripts , responsible for the utilization of l-ascorbate in prostate (1 .5 kb) and skeletal muscle (1 .9 kb) , has been formed by two divergently #transcribed operons , klk14 .
the two alternative transcripts , responsible for the utilization of l-ascorbate in prostate (1 .5 kb) and skeletal muscle (1 .9 kb) , has been shown to be formed by two divergently #transcribed operons , klk14 .
the two alternative transcripts , responsible for the utilization of l-ascorbate in prostate (1 .5 kb) and skeletal muscle (1 .9 kb) , has been shown to be formed by two divergently #transcribed operons , klk14 .
the two alternative transcripts , responsible for the utilization of l-ascorbate in prostate (1 .5 kb) and skeletal muscle (1 .9 kb) , is observed to be formed by two divergently #transcribed operons , klk14 .
the two alternative transcripts , responsible for the utilization of l-ascorbate in prostate (1 .5 kb) and skeletal muscle (1 .9 kb) , may be formed by two divergently #transcribed operons , klk14 .
the two alternative transcripts , responsible for the utilization of l-ascorbate in prostate (1 .5 kb) and skeletal muscle (1 .9 kb) , may have been formed by two divergently #transcribed operons , klk14 .
the two alternative transcripts , responsible for the utilization of l-ascorbate in prostate (1 .5 kb) and skeletal muscle (1 .9 kb) , was formed by two divergently #transcribed operons , klk14 .
the two alternative transcripts , responsible for the utilization of l-ascorbate in prostate (1 .5 kb) and skeletal muscle (1 .9 kb) , will be formed by two divergently #transcribed operons , klk14 .
a plastid-encoded prokaryotic-type rna polymerase (pep) and a nucleus-encoded phage-type rna polymerase (nep) can specifically #transcribe the plastid genome in the presence of the transcription factor cdf2 .
a plastid-encoded prokaryotic-type rna polymerase (pep) and a nucleus-encoded phage-type rna polymerase (nep) has specifically #transcribed the plastid genome in the presence of the transcription factor cdf2 .
a plastid-encoded prokaryotic-type rna polymerase (pep) and a nucleus-encoded phage-type rna polymerase (nep) has the ability to specifically #transcribe the plastid genome in the presence of the transcription factor cdf2 .
a plastid-encoded prokaryotic-type rna polymerase (pep) and a nucleus-encoded phage-type rna polymerase (nep) has the ability to #transcribe the plastid genome in the presence of the transcription factor cdf2 .
a plastid-encoded prokaryotic-type rna polymerase (pep) and a nucleus-encoded phage-type rna polymerase (nep) has #transcribed the plastid genome in the presence of the transcription factor cdf2 .
a plastid-encoded prokaryotic-type rna polymerase (pep) and a nucleus-encoded phage-type rna polymerase (nep) is able to specifically #transcribe the plastid genome in the presence of the transcription factor cdf2 .
a plastid-encoded prokaryotic-type rna polymerase (pep) and a nucleus-encoded phage-type rna polymerase (nep) is able to #transcribe the plastid genome in the presence of the transcription factor cdf2 .
a plastid-encoded prokaryotic-type rna polymerase (pep) and a nucleus-encoded phage-type rna polymerase (nep) is believe to specifically #transcribe the plastid genome in the presence of the transcription factor cdf2 .
a plastid-encoded prokaryotic-type rna polymerase (pep) and a nucleus-encoded phage-type rna polymerase (nep) is believe to #transcribe the plastid genome in the presence of the transcription factor cdf2 .
a plastid-encoded prokaryotic-type rna polymerase (pep) and a nucleus-encoded phage-type rna polymerase (nep) is observed to #transcribe the plastid genome in the presence of the transcription factor cdf2 .
a plastid-encoded prokaryotic-type rna polymerase (pep) and a nucleus-encoded phage-type rna polymerase (nep) may have specifically #transcribed the plastid genome in the presence of the transcription factor cdf2 .
a plastid-encoded prokaryotic-type rna polymerase (pep) and a nucleus-encoded phage-type rna polymerase (nep) may have #transcribed the plastid genome in the presence of the transcription factor cdf2 .
a plastid-encoded prokaryotic-type rna polymerase (pep) and a nucleus-encoded phage-type rna polymerase (nep) may #transcribe the plastid genome in the presence of the transcription factor cdf2 .
a plastid-encoded prokaryotic-type rna polymerase (pep) and a nucleus-encoded phage-type rna polymerase (nep) #transcribed the plastid genome in the presence of the transcription factor cdf2 .
a plastid-encoded prokaryotic-type rna polymerase (pep) and a nucleus-encoded phage-type rna polymerase (nep) will #transcribe the plastid genome in the presence of the transcription factor cdf2 .
glpd and glpr of these two plasmids are able to be divergently #transcribed by interaction at a distance between multiple operators .
glpd and glpr of these two plasmids are able to be divergently #transcribed by interaction at a distance between multiple operators .
glpd and glpr of these two plasmids are able to be #transcribed by interaction at a distance between multiple operators .
glpd and glpr of these two plasmids are able to be #transcribed by interaction at a distance between multiple operators .
glpd and glpr of these two plasmids are observed to be divergently #transcribed by interaction at a distance between multiple operators .
glpd and glpr of these two plasmids can be divergently #transcribed by interaction at a distance between multiple operators .
glpd and glpr of these two plasmids have been divergently #transcribed by interaction at a distance between multiple operators .
glpd and glpr of these two plasmids have been shown to be divergently #transcribed by interaction at a distance between multiple operators .
glpd and glpr of these two plasmids have been shown to be divergently #transcribed by interaction at a distance between multiple operators .
glpd and glpr of these two plasmids have been shown to be #transcribed by interaction at a distance between multiple operators .
glpd and glpr of these two plasmids have been #transcribed by interaction at a distance between multiple operators .
glpd and glpr of these two plasmids have the ability to be divergently #transcribed by interaction at a distance between multiple operators .
glpd and glpr of these two plasmids have the ability to be #transcribed by interaction at a distance between multiple operators .
glpd and glpr of these two plasmids have the ability to be #transcribed by interaction at a distance between multiple operators .
glpd and glpr of these two plasmids may have been divergently #transcribed by interaction at a distance between multiple operators .
glpd and glpr of these two plasmids may have been #transcribed by interaction at a distance between multiple operators .
glpd and glpr of these two plasmids were divergently #transcribed by interaction at a distance between multiple operators .
glpd and glpr of these two plasmids were #transcribed by interaction at a distance between multiple operators .
the rrn operon can be divergently #transcribed by nep-2 .
the rrn operon can be #transcribed by nep-2 .
the rrn operon has been divergently #transcribed by nep-2 .
the rrn operon is able to be divergently #transcribed by nep-2 .
the rrn operon is able to be #transcribed by nep-2 .
the rrn operon is divergently #transcribed by nep-2 .
the rrn operon is found to be #transcribed by nep-2 .
the rrn operon is known to be #transcribed by nep-2 .
the rrn operon is observed to be divergently #transcribed by nep-2 .
the rrn operon may have been divergently #transcribed by nep-2 .
the rrn operon may have been #transcribed by nep-2 .
the rrn operon was divergently #transcribed by nep-2 .
the rrn operon was #transcribed by nep-2 .
the two genes of e . coli chromosome are able to be divergently #transcribed by interaction at a distance between multiple operators .
the two genes of e . coli chromosome are able to be divergently #transcribed by interaction at a distance between multiple operators .
the two genes of e . coli chromosome are able to be #transcribed by interaction at a distance between multiple operators .
the two genes of e . coli chromosome are observed to be divergently #transcribed by interaction at a distance between multiple operators .
the two genes of e . coli chromosome are observed to be divergently #transcribed by interaction at a distance between multiple operators .
the two genes of e . coli chromosome are observed to be #transcribed by interaction at a distance between multiple operators .
the two genes of e . coli chromosome are #transcribed by interaction at a distance between multiple operators .
the two genes of e . coli chromosome can be divergently #transcribed by interaction at a distance between multiple operators .
the two genes of e . coli chromosome can be #transcribed by interaction at a distance between multiple operators .
the two genes of e . coli chromosome have been shown to be divergently #transcribed by interaction at a distance between multiple operators .
the two genes of e . coli chromosome have been shown to be #transcribed by interaction at a distance between multiple operators .
the two genes of e . coli chromosome have been #transcribed by interaction at a distance between multiple operators .
the two genes of e . coli chromosome have the ability to be divergently #transcribed by interaction at a distance between multiple operators .
the two genes of e . coli chromosome have the ability to be #transcribed by interaction at a distance between multiple operators .
the two genes of e . coli chromosome have the ability to be #transcribed by interaction at a distance between multiple operators .
the two genes of e . coli chromosome may have been divergently #transcribed by interaction at a distance between multiple operators .
the two genes of e . coli chromosome may have been divergently #transcribed by interaction at a distance between multiple operators .
the two genes of e . coli chromosome may have been #transcribed by interaction at a distance between multiple operators .
the two genes of e . coli chromosome were divergently #transcribed by interaction at a distance between multiple operators .
the two genes of e . coli chromosome will be #transcribed by interaction at a distance between multiple operators .
ulag and ulaabcdef is approximately 5 .4 kb in length spanning seven exons and can divergently #transcribe ula regulon present only in escherichia coli .
ulag and ulaabcdef is approximately 5 .4 kb in length spanning seven exons and has been shown to divergently #transcribe ula regulon present only in escherichia coli .
ulag and ulaabcdef is approximately 5 .4 kb in length spanning seven exons and has been shown to #transcribe ula regulon present only in escherichia coli .
ulag and ulaabcdef is approximately 5 .4 kb in length spanning seven exons and has been shown to #transcribe ula regulon present only in escherichia coli .
ulag and ulaabcdef is approximately 5 .4 kb in length spanning seven exons and has divergently #transcribed ula regulon present only in escherichia coli .
ulag and ulaabcdef is approximately 5 .4 kb in length spanning seven exons and has the ability to #transcribe ula regulon present only in escherichia coli .
ulag and ulaabcdef is approximately 5 .4 kb in length spanning seven exons and has #transcribed ula regulon present only in escherichia coli .
ulag and ulaabcdef is approximately 5 .4 kb in length spanning seven exons and is able to divergently #transcribe ula regulon present only in escherichia coli .
ulag and ulaabcdef is approximately 5 .4 kb in length spanning seven exons and is able to #transcribe ula regulon present only in escherichia coli .
ulag and ulaabcdef is approximately 5 .4 kb in length spanning seven exons and is able to #transcribe ula regulon present only in escherichia coli .
ulag and ulaabcdef is approximately 5 .4 kb in length spanning seven exons and is observed to divergently #transcribe ula regulon present only in escherichia coli .
ulag and ulaabcdef is approximately 5 .4 kb in length spanning seven exons and is observed to #transcribe ula regulon present only in escherichia coli .
ulag and ulaabcdef is approximately 5 .4 kb in length spanning seven exons and may have divergently #transcribed ula regulon present only in escherichia coli .
ulag and ulaabcdef is approximately 5 .4 kb in length spanning seven exons and may have #transcribed ula regulon present only in escherichia coli .
ulag and ulaabcdef is approximately 5 .4 kb in length spanning seven exons and #transcribed ula regulon present only in escherichia coli .
ulag and ulaabcdef is approximately 5 .4 kb in length spanning seven exons and #transcribed ula regulon present only in escherichia coli .
ulag and ulaabcdef is approximately 5 .4 kb in length spanning seven exons and will divergently #transcribe ula regulon present only in escherichia coli .
ulag and ulaabcdef is approximately 5 .4 kb in length spanning seven exons and will #transcribe ula regulon present only in escherichia coli .
ulag and ulaabcdef is approximately 5 .4 kb in length spanning seven exons and will #transcribe ula regulon present only in escherichia coli .
ulag and ulaabcdef is approximately 5 .4 kb in length spanning seven exons and , by northern blot analysis , can #transcribe ula regulon present only in escherichia coli .
ulag and ulaabcdef is approximately 5 .4 kb in length spanning seven exons and , by northern blot analysis , has been shown to #transcribe ula regulon present only in escherichia coli .
ulag and ulaabcdef is approximately 5 .4 kb in length spanning seven exons and , by northern blot analysis , has the ability to #transcribe ula regulon present only in escherichia coli .
ulag and ulaabcdef is approximately 5 .4 kb in length spanning seven exons and , by northern blot analysis , has #transcribed ula regulon present only in escherichia coli .
ulag and ulaabcdef is approximately 5 .4 kb in length spanning seven exons and , by northern blot analysis , is able to #transcribe ula regulon present only in escherichia coli .
ulag and ulaabcdef is approximately 5 .4 kb in length spanning seven exons and , by northern blot analysis , is observed to #transcribe ula regulon present only in escherichia coli .
ulag and ulaabcdef is approximately 5 .4 kb in length spanning seven exons and , by northern blot analysis , is observed to #transcribe ula regulon present only in escherichia coli .
ulag and ulaabcdef is approximately 5 .4 kb in length spanning seven exons and , by northern blot analysis , may have #transcribed ula regulon present only in escherichia coli .
ulag and ulaabcdef is approximately 5 .4 kb in length spanning seven exons and , by northern blot analysis , may have #transcribed ula regulon present only in escherichia coli .
ulag and ulaabcdef is approximately 5 .4 kb in length spanning seven exons and , by northern blot analysis , #transcribed ula regulon present only in escherichia coli .
interaction at a distance between multiple operators can divergently #transcribe the gene , as our study predicted , of a large variety of organs and tissues .
interaction at a distance between multiple operators can divergently #transcribe the gene , as our study predicted , of a large variety of organs and tissues .
interaction at a distance between multiple operators controls the adjacent and divergently #transcribes the gene , as our study predicted , of a large variety of organs and tissues .
interaction at a distance between multiple operators controls the adjacent and has divergently #transcribed the gene , as our study predicted , of a large variety of organs and tissues .
interaction at a distance between multiple operators controls the adjacent and has the ability to divergently #transcribe the gene , as our study predicted , of a large variety of organs and tissues .
interaction at a distance between multiple operators controls the adjacent and has the ability to divergently #transcribe the gene , as our study predicted , of a large variety of organs and tissues .
interaction at a distance between multiple operators controls the adjacent and is observed to divergently #transcribe the gene , as our study predicted , of a large variety of organs and tissues .
interaction at a distance between multiple operators controls the adjacent and may have divergently #transcribed the gene , as our study predicted , of a large variety of organs and tissues .
interaction at a distance between multiple operators controls the adjacent and may have divergently #transcribed the gene , as our study predicted , of a large variety of organs and tissues .
interaction at a distance between multiple operators controls the adjacent and will divergently #transcribe the gene , as our study predicted , of a large variety of organs and tissues .
interaction at a distance between multiple operators controls the adjacent , can divergently #transcribe the gene , as our study predicted , of a large variety of organs and tissues .
interaction at a distance between multiple operators controls the adjacent , can #transcribe the gene , as our study predicted , of a large variety of organs and tissues .
interaction at a distance between multiple operators controls the adjacent , divergently #transcribed the gene , as our study predicted , of a large variety of organs and tissues .
interaction at a distance between multiple operators controls the adjacent , divergently #transcribed the gene , as our study predicted , of a large variety of organs and tissues .
interaction at a distance between multiple operators controls the adjacent , divergently #transcribes the gene , as our study predicted , of a large variety of organs and tissues .
interaction at a distance between multiple operators controls the adjacent , divergently #transcribes the gene , as our study predicted , of a large variety of organs and tissues .
interaction at a distance between multiple operators controls the adjacent , has been shown to divergently #transcribe the gene , as our study predicted , of a large variety of organs and tissues .
interaction at a distance between multiple operators controls the adjacent , has been shown to divergently #transcribe the gene , as our study predicted , of a large variety of organs and tissues .
interaction at a distance between multiple operators controls the adjacent , has been shown to #transcribe the gene , as our study predicted , of a large variety of organs and tissues .
interaction at a distance between multiple operators controls the adjacent , has divergently #transcribed the gene , as our study predicted , of a large variety of organs and tissues .
interaction at a distance between multiple operators controls the adjacent , has the ability to divergently #transcribe the gene , as our study predicted , of a large variety of organs and tissues .
interaction at a distance between multiple operators controls the adjacent , has the ability to divergently #transcribe the gene , as our study predicted , of a large variety of organs and tissues .
interaction at a distance between multiple operators controls the adjacent , has the ability to #transcribe the gene , as our study predicted , of a large variety of organs and tissues .
interaction at a distance between multiple operators controls the adjacent , has #transcribed the gene , as our study predicted , of a large variety of organs and tissues .
interaction at a distance between multiple operators controls the adjacent , has #transcribed the gene , as our study predicted , of a large variety of organs and tissues .
interaction at a distance between multiple operators controls the adjacent , is able to divergently #transcribe the gene , as our study predicted , of a large variety of organs and tissues .
interaction at a distance between multiple operators controls the adjacent , is able to #transcribe the gene , as our study predicted , of a large variety of organs and tissues .
interaction at a distance between multiple operators controls the adjacent , is observed to divergently #transcribe the gene , as our study predicted , of a large variety of organs and tissues .
interaction at a distance between multiple operators controls the adjacent , is observed to #transcribe the gene , as our study predicted , of a large variety of organs and tissues .
interaction at a distance between multiple operators controls the adjacent , may divergently #transcribe the gene , as our study predicted , of a large variety of organs and tissues .
interaction at a distance between multiple operators controls the adjacent , may have divergently #transcribed the gene , as our study predicted , of a large variety of organs and tissues .
interaction at a distance between multiple operators controls the adjacent , may have #transcribed the gene , as our study predicted , of a large variety of organs and tissues .
interaction at a distance between multiple operators controls the adjacent , may #transcribe the gene , as our study predicted , of a large variety of organs and tissues .
interaction at a distance between multiple operators controls the adjacent , #transcribed the gene , as our study predicted , of a large variety of organs and tissues .
interaction at a distance between multiple operators controls the adjacent , #transcribed the gene , as our study predicted , of a large variety of organs and tissues .
interaction at a distance between multiple operators controls the adjacent , #transcribes the gene , as our study predicted , of a large variety of organs and tissues .
interaction at a distance between multiple operators controls the adjacent , will #transcribe the gene , as our study predicted , of a large variety of organs and tissues .
interaction at a distance between multiple operators controls the adjacent , will #transcribe the gene , as our study predicted , of a large variety of organs and tissues .
interaction at a distance between multiple operators divergently #transcribes the gene , as our study predicted , of a large variety of organs and tissues .
interaction at a distance between multiple operators has been shown to divergently #transcribe the gene , as our study predicted , of a large variety of organs and tissues .
interaction at a distance between multiple operators has divergently #transcribed the gene , as our study predicted , of a large variety of organs and tissues .
interaction at a distance between multiple operators has the ability to divergently #transcribe the gene , as our study predicted , of a large variety of organs and tissues .
interaction at a distance between multiple operators is able to divergently #transcribe the gene , as our study predicted , of a large variety of organs and tissues .
interaction at a distance between multiple operators is observed to divergently #transcribe the gene , as our study predicted , of a large variety of organs and tissues .
interaction at a distance between multiple operators may divergently #transcribe the gene , as our study predicted , of a large variety of organs and tissues .
interaction at a distance between multiple operators will divergently #transcribe the gene , as our study predicted , of a large variety of organs and tissues .
restriction analysis of a large variety of organs and tissues demonstrated that the gene , as our study predicted , are able to be divergently #transcribed .
restriction analysis of a large variety of organs and tissues demonstrated that the gene , as our study predicted , are able to be divergently #transcribed .
restriction analysis of a large variety of organs and tissues demonstrated that the gene , as our study predicted , are able to be #transcribed .
restriction analysis of a large variety of organs and tissues demonstrated that the gene , as our study predicted , are divergently #transcribed .
restriction analysis of a large variety of organs and tissues demonstrated that the gene , as our study predicted , are divergently #transcribed .
restriction analysis of a large variety of organs and tissues demonstrated that the gene , as our study predicted , are proven to be divergently #transcribed .
restriction analysis of a large variety of organs and tissues demonstrated that the gene , as our study predicted , are proven to be divergently #transcribed .
restriction analysis of a large variety of organs and tissues demonstrated that the gene , as our study predicted , are proven to be #transcribed .
restriction analysis of a large variety of organs and tissues demonstrated that the gene , as our study predicted , are #transcribed .
restriction analysis of a large variety of organs and tissues demonstrated that the gene , as our study predicted , are #transcribed .
restriction analysis of a large variety of organs and tissues demonstrated that the gene , as our study predicted , can be #transcribed .
restriction analysis of a large variety of organs and tissues demonstrated that the gene , as our study predicted , have been divergently #transcribed .
restriction analysis of a large variety of organs and tissues demonstrated that the gene , as our study predicted , may be divergently #transcribed .
restriction analysis of a large variety of organs and tissues demonstrated that the gene , as our study predicted , may be divergently #transcribed .
restriction analysis of a large variety of organs and tissues demonstrated that the gene , as our study predicted , may be #transcribed .
restriction analysis of a large variety of organs and tissues demonstrated that the gene , as our study predicted , may have been #transcribed .
restriction analysis of a large variety of organs and tissues demonstrated that the gene , as our study predicted , were divergently #transcribed .
restriction analysis of a large variety of organs and tissues demonstrated that the gene , as our study predicted , were #transcribed .
restriction analysis of a large variety of organs and tissues demonstrated that the gene , as our study predicted , were #transcribed .
restriction analysis of a large variety of organs and tissues demonstrated that the gene , as our study predicted , will be divergently #transcribed .
restriction analysis of a large variety of organs and tissues demonstrated that the gene , as our study predicted , will be #transcribed .
restriction analysis of a large variety of organs and tissues demonstrated that the gene , as our study predicted , will be #transcribed .
restriction analysis of a large variety of organs and tissues suggested that the gene , as our study predicted , are able to be #transcribed .
restriction analysis of a large variety of organs and tissues suggested that the gene , as our study predicted , are able to be #transcribed .
restriction analysis of a large variety of organs and tissues suggested that the gene , as our study predicted , are proven to be #transcribed .
restriction analysis of a large variety of organs and tissues suggested that the gene , as our study predicted , can be #transcribed .
restriction analysis of a large variety of organs and tissues suggested that the gene , as our study predicted , have been shown to be #transcribed .
restriction analysis of a large variety of organs and tissues suggested that the gene , as our study predicted , have been #transcribed .
restriction analysis of a large variety of organs and tissues suggested that the gene , as our study predicted , may be #transcribed .
restriction analysis of a large variety of organs and tissues suggested that the gene , as our study predicted , may be #transcribed .
restriction analysis of a large variety of organs and tissues suggested that the gene , as our study predicted , were #transcribed .
restriction analysis of a large variety of organs and tissues suggested that the gene , as our study predicted , will be #transcribed .
restriction endonuclease cleavage analysis of a large variety of organs and tissues demonstrated that the gene , as our study predicted , are divergently #transcribed .
restriction endonuclease cleavage analysis of a large variety of organs and tissues demonstrated that the gene , as our study predicted , are proven to be divergently #transcribed .
restriction endonuclease cleavage analysis of a large variety of organs and tissues demonstrated that the gene , as our study predicted , can be divergently #transcribed .
restriction endonuclease cleavage analysis of a large variety of organs and tissues demonstrated that the gene , as our study predicted , can be divergently #transcribed .
restriction endonuclease cleavage analysis of a large variety of organs and tissues demonstrated that the gene , as our study predicted , have been shown to be divergently #transcribed .
restriction endonuclease cleavage analysis of a large variety of organs and tissues demonstrated that the gene , as our study predicted , have been shown to be divergently #transcribed .
restriction endonuclease cleavage analysis of a large variety of organs and tissues demonstrated that the gene , as our study predicted , may be divergently #transcribed .
restriction endonuclease cleavage analysis of a large variety of organs and tissues demonstrated that the gene , as our study predicted , may have been divergently #transcribed .
restriction endonuclease cleavage analysis of a large variety of organs and tissues demonstrated that the gene , as our study predicted , may have been divergently #transcribed .
restriction endonuclease cleavage analysis of a large variety of organs and tissues demonstrated that the gene , as our study predicted , will be divergently #transcribed .
the fhla gene resides next to the hydb gene at 59 min in the a large variety of organs and tissues , and the gene , as our study predicted , are able to be interestingly interestingly #transcribed in opposite directions .
the fhla gene resides next to the hydb gene at 59 min in the a large variety of organs and tissues , and the gene , as our study predicted , are able to be #transcribed in opposite directions .
the fhla gene resides next to the hydb gene at 59 min in the a large variety of organs and tissues , and the gene , as our study predicted , are observed to be interestingly interestingly #transcribed in opposite directions .
the fhla gene resides next to the hydb gene at 59 min in the a large variety of organs and tissues , and the gene , as our study predicted , are observed to be #transcribed in opposite directions .
the fhla gene resides next to the hydb gene at 59 min in the a large variety of organs and tissues , and the gene , as our study predicted , are #transcribed in opposite directions .
the fhla gene resides next to the hydb gene at 59 min in the a large variety of organs and tissues , and the gene , as our study predicted , can be interestingly interestingly #transcribed in opposite directions .
the fhla gene resides next to the hydb gene at 59 min in the a large variety of organs and tissues , and the gene , as our study predicted , can be #transcribed in opposite directions .
the fhla gene resides next to the hydb gene at 59 min in the a large variety of organs and tissues , and the gene , as our study predicted , can be #transcribed in opposite directions .
the fhla gene resides next to the hydb gene at 59 min in the a large variety of organs and tissues , and the gene , as our study predicted , has been #transcribed in opposite directions .
the fhla gene resides next to the hydb gene at 59 min in the a large variety of organs and tissues , and the gene , as our study predicted , have been shown to be interestingly interestingly #transcribed in opposite directions .
the fhla gene resides next to the hydb gene at 59 min in the a large variety of organs and tissues , and the gene , as our study predicted , have been shown to be interestingly interestingly #transcribed in opposite directions .
the fhla gene resides next to the hydb gene at 59 min in the a large variety of organs and tissues , and the gene , as our study predicted , may be interestingly interestingly #transcribed in opposite directions .
the fhla gene resides next to the hydb gene at 59 min in the a large variety of organs and tissues , and the gene , as our study predicted , may be #transcribed in opposite directions .
the fhla gene resides next to the hydb gene at 59 min in the a large variety of organs and tissues , and the gene , as our study predicted , may be #transcribed in opposite directions .
the fhla gene resides next to the hydb gene at 59 min in the a large variety of organs and tissues , and the gene , as our study predicted , were #transcribed in opposite directions .
the fhla gene resides next to the hydb gene at 59 min in the a large variety of organs and tissues , and the gene , as our study predicted , will be #transcribed in opposite directions .
the gene , as our study predicted , of a large variety of organs and tissues are able to be #transcribed by interaction at a distance between multiple operators .
the gene , as our study predicted , of a large variety of organs and tissues are observed to be divergently #transcribed by interaction at a distance between multiple operators .
the gene , as our study predicted , of a large variety of organs and tissues are #transcribed by interaction at a distance between multiple operators .
the gene , as our study predicted , of a large variety of organs and tissues can be divergently #transcribed by interaction at a distance between multiple operators .
the gene , as our study predicted , of a large variety of organs and tissues can be #transcribed by interaction at a distance between multiple operators .
the gene , as our study predicted , of a large variety of organs and tissues have been divergently #transcribed by interaction at a distance between multiple operators .
the gene , as our study predicted , of a large variety of organs and tissues have been shown to be divergently #transcribed by interaction at a distance between multiple operators .
the gene , as our study predicted , of a large variety of organs and tissues have been shown to be divergently #transcribed by interaction at a distance between multiple operators .
the gene , as our study predicted , of a large variety of organs and tissues have been shown to be #transcribed by interaction at a distance between multiple operators .
the gene , as our study predicted , of a large variety of organs and tissues have been shown to be #transcribed by interaction at a distance between multiple operators .
the gene , as our study predicted , of a large variety of organs and tissues have been #transcribed by interaction at a distance between multiple operators .
the gene , as our study predicted , of a large variety of organs and tissues have been #transcribed by interaction at a distance between multiple operators .
the gene , as our study predicted , of a large variety of organs and tissues have the ability to be divergently #transcribed by interaction at a distance between multiple operators .
the gene , as our study predicted , of a large variety of organs and tissues have the ability to be #transcribed by interaction at a distance between multiple operators .
the gene , as our study predicted , of a large variety of organs and tissues may have been divergently #transcribed by interaction at a distance between multiple operators .
the gene , as our study predicted , of a large variety of organs and tissues may have been #transcribed by interaction at a distance between multiple operators .
the gene , as our study predicted , of a large variety of organs and tissues were divergently #transcribed by interaction at a distance between multiple operators .
the gene , as our study predicted , of a large variety of organs and tissues were #transcribed by interaction at a distance between multiple operators .
the gene , as our study predicted , of a large variety of organs and tissues will be divergently #transcribed by interaction at a distance between multiple operators .
the gene , as our study predicted , of a large variety of organs and tissues will be #transcribed by interaction at a distance between multiple operators .
this antisense-bcma rna can be #transcribed from the same locus as bcma .
this antisense-bcma rna has been proven to be #transcribed from the same locus as bcma .
this antisense-bcma rna has been #transcribed from the same locus as bcma .
this antisense-bcma rna has been #transcribed from the same locus as bcma .
this antisense-bcma rna is #transcribed from the same locus as bcma .
this antisense-bcma rna may be #transcribed from the same locus as bcma .
this antisense-bcma rna was #transcribed from the same locus as bcma .
this antisense-bcma rna will be #transcribed from the same locus as bcma .
this operon can be #transcribed by glycolate .
this operon has been divergently #transcribed by glycolate .
this operon has been shown to be divergently #transcribed by glycolate .
this operon has been shown to be #transcribed by glycolate .
this operon has been #transcribed by glycolate .
this operon is divergently #transcribed by glycolate .
this operon is found to be #transcribed by glycolate .
this operon is observed to be divergently #transcribed by glycolate .
this operon is observed to be #transcribed by glycolate .
this operon may have been #transcribed by glycolate .
this operon was divergently #transcribed by glycolate .
this operon will be divergently #transcribed by glycolate .
this operon will be #transcribed by glycolate .
glycolate can specifically #transcribe this operon in the presence of the transcription factor cdf2 .
glycolate has been shown to specifically #transcribe this operon in the presence of the transcription factor cdf2 .
glycolate has the ability to #transcribe this operon in the presence of the transcription factor cdf2 .
glycolate has #transcribed this operon in the presence of the transcription factor cdf2 .
glycolate is observed to specifically #transcribe this operon in the presence of the transcription factor cdf2 .
glycolate specifically #transcribed this operon in the presence of the transcription factor cdf2 .
glycolate #transcribed this operon in the presence of the transcription factor cdf2 .
expression of recombinat proteins full-lenght and c-terminal sbp2 constructs in pask-ib7 are able to be specifically #transformed into escherichia coli bl21 (promega)
expression of recombinat proteins full-lenght and c-terminal sbp2 constructs in pask-ib7 are able to be #transformed into escherichia coli bl21 (promega)
expression of recombinat proteins full-lenght and c-terminal sbp2 constructs in pask-ib7 are likely to be #transformed into escherichia coli bl21 (promega)
expression of recombinat proteins full-lenght and c-terminal sbp2 constructs in pask-ib7 are observed to be specifically #transformed into escherichia coli bl21 (promega)
expression of recombinat proteins full-lenght and c-terminal sbp2 constructs in pask-ib7 are observed to be #transformed into escherichia coli bl21 (promega)
expression of recombinat proteins full-lenght and c-terminal sbp2 constructs in pask-ib7 are specifically #transformed into escherichia coli bl21 (promega)
expression of recombinat proteins full-lenght and c-terminal sbp2 constructs in pask-ib7 are #transformed into escherichia coli bl21 (promega)
expression of recombinat proteins full-lenght and c-terminal sbp2 constructs in pask-ib7 have been shown to be specifically #transformed into escherichia coli bl21 (promega)
expression of recombinat proteins full-lenght and c-terminal sbp2 constructs in pask-ib7 have been shown to be #transformed into escherichia coli bl21 (promega)
expression of recombinat proteins full-lenght and c-terminal sbp2 constructs in pask-ib7 have been #transformed into escherichia coli bl21 (promega)
expression of recombinat proteins full-lenght and c-terminal sbp2 constructs in pask-ib7 have the ability to be #transformed into escherichia coli bl21 (promega)
expression of recombinat proteins full-lenght and c-terminal sbp2 constructs in pask-ib7 may be specifically #transformed into escherichia coli bl21 (promega)
expression of recombinat proteins full-lenght and c-terminal sbp2 constructs in pask-ib7 may be #transformed into escherichia coli bl21 (promega)
expression of recombinat proteins full-lenght and c-terminal sbp2 constructs in pask-ib7 may have been #transformed into escherichia coli bl21 (promega)
expression of recombinat proteins full-lenght and c-terminal sbp2 constructs in pask-ib7 will be specifically #transformed into escherichia coli bl21 (promega)
expression of recombinat proteins full-lenght and c-terminal sbp2 constructs in pask-ib7 , as our study suggested , are able to be specifically #transformed into escherichia coli bl21 (promega)
expression of recombinat proteins full-lenght and c-terminal sbp2 constructs in pask-ib7 , as our study suggested , are able to be #transformed into escherichia coli bl21 (promega)
expression of recombinat proteins full-lenght and c-terminal sbp2 constructs in pask-ib7 , as our study suggested , are likely to be specifically #transformed into escherichia coli bl21 (promega)
for expression of the recombinant protein , pet28a-5 can be efficiently #transformed into escherichia coli strain bl21(de3) .
expression of recombinat proteins full-lenght and c-terminal sbp2 constructs in pask-ib7 , as our study suggested , are #transformed into escherichia coli bl21 (promega)
expression of recombinat proteins full-lenght and c-terminal sbp2 constructs in pask-ib7 , as our study suggested , have been shown to be specifically #transformed into escherichia coli bl21 (promega)
expression of recombinat proteins full-lenght and c-terminal sbp2 constructs in pask-ib7 , as our study suggested , have been shown to be #transformed into escherichia coli bl21 (promega)
for expression of the recombinant protein , pet28a-5 has been #transformed into escherichia coli strain bl21(de3) .
for expression of the recombinant protein , pet28a-5 has the ability to be #transformed into escherichia coli strain bl21(de3) .
expression of recombinat proteins full-lenght and c-terminal sbp2 constructs in pask-ib7 , as our study suggested , have been #transformed into escherichia coli bl21 (promega)
for expression of the recombinant protein , pet28a-5 is able to be efficiently #transformed into escherichia coli strain bl21(de3) .
for expression of the recombinant protein , pet28a-5 is able to be #transformed into escherichia coli strain bl21(de3) .
expression of recombinat proteins full-lenght and c-terminal sbp2 constructs in pask-ib7 , as our study suggested , have the ability to be #transformed into escherichia coli bl21 (promega)
expression of recombinat proteins full-lenght and c-terminal sbp2 constructs in pask-ib7 , as our study suggested , may be specifically #transformed into escherichia coli bl21 (promega)
for expression of the recombinant protein , pet28a-5 is likely to be efficiently #transformed into escherichia coli strain bl21(de3) .
expression of recombinat proteins full-lenght and c-terminal sbp2 constructs in pask-ib7 , as our study suggested , may be #transformed into escherichia coli bl21 (promega)
expression of recombinat proteins full-lenght and c-terminal sbp2 constructs in pask-ib7 , as our study suggested , may have been specifically #transformed into escherichia coli bl21 (promega)
for expression of the recombinant protein , pet28a-5 is observed to be #transformed into escherichia coli strain bl21(de3) .
expression of recombinat proteins full-lenght and c-terminal sbp2 constructs in pask-ib7 , as our study suggested , will be specifically #transformed into escherichia coli bl21 (promega)
for expression of the recombinant protein , pet28a-5 is #transformed into escherichia coli strain bl21(de3) .
for expression of the recombinant protein , pet28a-5 may be efficiently #transformed into escherichia coli strain bl21(de3) .
for expression of the recombinant protein , pet28a-5 may be #transformed into escherichia coli strain bl21(de3) .
for expression of the recombinant protein , pet28a-5 may have been efficiently #transformed into escherichia coli strain bl21(de3) .
for expression of the recombinant protein , pet28a-5 will be efficiently #transformed into escherichia coli strain bl21(de3) .
for expression of the recombinant protein , pet28a-5 will be #transformed into escherichia coli strain bl21(de3) .
this construct can be #transformed into the yeast strain hf7c (clontech) .
this construct has been dramatically #transformed into the yeast strain hf7c (clontech) .
this construct has been proven to be dramatically #transformed into the yeast strain hf7c (clontech) .
this construct has been shown to be dramatically #transformed into the yeast strain hf7c (clontech) .
this construct has the ability to be dramatically #transformed into the yeast strain hf7c (clontech) .
this construct is dramatically #transformed into the yeast strain hf7c (clontech) .
this construct is likely to be dramatically #transformed into the yeast strain hf7c (clontech) .
this construct may be dramatically #transformed into the yeast strain hf7c (clontech) .
this construct may be #transformed into the yeast strain hf7c (clontech) .
this construct may have been #transformed into the yeast strain hf7c (clontech) .
this construct will be #transformed into the yeast strain hf7c (clontech) .
this construct , as our study suggested , can be efficiently #transformed into the yeast strain hf7c (clontech) .
this construct , as our study suggested , can be #transformed into the yeast strain hf7c (clontech) .
this construct , as our study suggested , has been efficiently #transformed into the yeast strain hf7c (clontech) .
this construct , as our study suggested , has been shown to be efficiently #transformed into the yeast strain hf7c (clontech) .
this construct , as our study suggested , has the ability to be #transformed into the yeast strain hf7c (clontech) .
this construct , as our study suggested , is able to be efficiently #transformed into the yeast strain hf7c (clontech) .
this construct , as our study suggested , is able to be #transformed into the yeast strain hf7c (clontech) .
this construct , as our study suggested , is likely to be efficiently #transformed into the yeast strain hf7c (clontech) .
this construct , as our study suggested , is likely to be #transformed into the yeast strain hf7c (clontech) .
this construct , as our study suggested , is #transformed into the yeast strain hf7c (clontech) .
this construct , as our study suggested , will be #transformed into the yeast strain hf7c (clontech) .
pet28a-5 , for expression of the recombinant protein , can be probably #transformed into escherichia coli strain bl21(de3) .
pet28a-5 , for expression of the recombinant protein , has been shown to be probably #transformed into escherichia coli strain bl21(de3) .
pet28a-5 , for expression of the recombinant protein , has the ability to be #transformed into escherichia coli strain bl21(de3) .
the relevant dna fragments , in order to generate gst fusion proteins , are able to be completely #transformed into the bacterial strains bl21 or topp (stratagene) .
pet28a-5 , for expression of the recombinant protein , is able to be #transformed into escherichia coli strain bl21(de3) .
the relevant dna fragments , in order to generate gst fusion proteins , are cloned into pgex2t(pharmacia) and completely #transformed into the bacterial strains bl21 or topp (stratagene) .
pet28a-5 , for expression of the recombinant protein , is observed to be #transformed into escherichia coli strain bl21(de3) .
pet28a-5 , for expression of the recombinant protein , is #transformed into escherichia coli strain bl21(de3) .
the relevant dna fragments , in order to generate gst fusion proteins , are likely to be completely #transformed into the bacterial strains bl21 or topp (stratagene) .
pet28a-5 , for expression of the recombinant protein , may be #transformed into escherichia coli strain bl21(de3) .
the relevant dna fragments , in order to generate gst fusion proteins , are observed to be cloned into pgex2t(pharmacia) and completely #transformed into the bacterial strains bl21 or topp (stratagene) .
pet28a-5 , for expression of the recombinant protein , may have been probably #transformed into escherichia coli strain bl21(de3) .
pet28a-5 , for expression of the recombinant protein , will be #transformed into escherichia coli strain bl21(de3) .
the relevant dna fragments , in order to generate gst fusion proteins , can be cloned into pgex2t(pharmacia) and completely #transformed into the bacterial strains bl21 or topp (stratagene) .
the relevant dna fragments , in order to generate gst fusion proteins , can be cloned into pgex2t(pharmacia) and #transformed into the bacterial strains bl21 or topp (stratagene) .
the relevant dna fragments , in order to generate gst fusion proteins , can be completely #transformed into the bacterial strains bl21 or topp (stratagene) .
the relevant dna fragments , in order to generate gst fusion proteins , have been cloned into pgex2t(pharmacia) and completely #transformed into the bacterial strains bl21 or topp (stratagene) .
the relevant dna fragments , in order to generate gst fusion proteins , have been completely #transformed into the bacterial strains bl21 or topp (stratagene) .
the relevant dna fragments , in order to generate gst fusion proteins , have been shown to be cloned into pgex2t(pharmacia) and completely #transformed into the bacterial strains bl21 or topp (stratagene) .
the relevant dna fragments , in order to generate gst fusion proteins , have been shown to be completely #transformed into the bacterial strains bl21 or topp (stratagene) .
the relevant dna fragments , in order to generate gst fusion proteins , have been shown to be #transformed into the bacterial strains bl21 or topp (stratagene) .
the relevant dna fragments , in order to generate gst fusion proteins , may be cloned into pgex2t(pharmacia) and completely #transformed into the bacterial strains bl21 or topp (stratagene) .
the relevant dna fragments , in order to generate gst fusion proteins , may be cloned into pgex2t(pharmacia) and #transformed into the bacterial strains bl21 or topp (stratagene) .
the relevant dna fragments , in order to generate gst fusion proteins , may have been cloned into pgex2t(pharmacia) and completely #transformed into the bacterial strains bl21 or topp (stratagene) .
the relevant dna fragments , in order to generate gst fusion proteins , may have been completely #transformed into the bacterial strains bl21 or topp (stratagene) .
the relevant dna fragments , in order to generate gst fusion proteins , may have been #transformed into the bacterial strains bl21 or topp (stratagene) .
the relevant dna fragments , in order to generate gst fusion proteins , will be cloned into pgex2t(pharmacia) and #transformed into the bacterial strains bl21 or topp (stratagene) .
the relevant dna fragments , in order to generate gst fusion proteins , will be completely #transformed into the bacterial strains bl21 or topp (stratagene) .
the relevant dna fragments , in order to generate gst fusion proteins , will be #transformed into the bacterial strains bl21 or topp (stratagene) .
to generate gst fusion proteins , the relevant dna fragments are able to be cloned into pgex2t(pharmacia) and #transformed into the bacterial strains bl21 or topp (stratagene) .
to generate gst fusion proteins , the relevant dna fragments are able to be #transformed into the bacterial strains bl21 or topp (stratagene) .
to generate gst fusion proteins , the relevant dna fragments are cloned into pgex2t(pharmacia) and completely #transformed into the bacterial strains bl21 or topp (stratagene) .
to generate gst fusion proteins , the relevant dna fragments are cloned into pgex2t(pharmacia) and #transformed into the bacterial strains bl21 or topp (stratagene) .
to generate gst fusion proteins , the relevant dna fragments are likely to be cloned into pgex2t(pharmacia) and completely #transformed into the bacterial strains bl21 or topp (stratagene) .
to generate gst fusion proteins , the relevant dna fragments are observed to be cloned into pgex2t(pharmacia) and completely #transformed into the bacterial strains bl21 or topp (stratagene) .
to generate gst fusion proteins , the relevant dna fragments are observed to be completely #transformed into the bacterial strains bl21 or topp (stratagene) .
to generate gst fusion proteins , the relevant dna fragments are observed to be #transformed into the bacterial strains bl21 or topp (stratagene) .
to generate gst fusion proteins , the relevant dna fragments are #transformed into the bacterial strains bl21 or topp (stratagene) .
to generate gst fusion proteins , the relevant dna fragments can be completely #transformed into the bacterial strains bl21 or topp (stratagene) .
to generate gst fusion proteins , the relevant dna fragments have been cloned into pgex2t(pharmacia) and completely #transformed into the bacterial strains bl21 or topp (stratagene) .
to generate gst fusion proteins , the relevant dna fragments may be cloned into pgex2t(pharmacia) and completely #transformed into the bacterial strains bl21 or topp (stratagene) .
to generate gst fusion proteins , the relevant dna fragments may be cloned into pgex2t(pharmacia) and #transformed into the bacterial strains bl21 or topp (stratagene) .
to generate gst fusion proteins , the relevant dna fragments may be completely #transformed into the bacterial strains bl21 or topp (stratagene) .
to generate gst fusion proteins , the relevant dna fragments may be #transformed into the bacterial strains bl21 or topp (stratagene) .
to generate gst fusion proteins , the relevant dna fragments may have been completely #transformed into the bacterial strains bl21 or topp (stratagene) .
this construct was #transformed into the yeast strain hf7c (clontech) .
for expression of the recombinant protein , pet28a-5 was #transformed into escherichia coli strain bl21(de3) .
for expression of the recombinant protein , this construct can be efficiently #transformed into the yeast strain hf7c (clontech) .
expression of recombinat proteins full-lenght and c-terminal sbp2 constructs in pask-ib7 (bvs) can be used to completely #transform escherichia coli bl21 (promega) .
expression of recombinat proteins full-lenght and c-terminal sbp2 constructs in pask-ib7 (bvs) can be used to #transform escherichia coli bl21 (promega) .
for expression of the recombinant protein , this construct can be #transformed into the yeast strain hf7c (clontech) .
for expression of the recombinant protein , this construct has been efficiently #transformed into the yeast strain hf7c (clontech) .
expression of recombinat proteins full-lenght and c-terminal sbp2 constructs in pask-ib7 (bvs) has been shown to be used to #transform escherichia coli bl21 (promega) .
for expression of the recombinant protein , this construct has been shown to be efficiently #transformed into the yeast strain hf7c (clontech) .
for expression of the recombinant protein , this construct has been shown to be #transformed into the yeast strain hf7c (clontech) .
for expression of the recombinant protein , this construct has been #transformed into the yeast strain hf7c (clontech) .
expression of recombinat proteins full-lenght and c-terminal sbp2 constructs in pask-ib7 (bvs) has been used to #transform escherichia coli bl21 (promega) .
for expression of the recombinant protein , this construct has the ability to be #transformed into the yeast strain hf7c (clontech) .
for expression of the recombinant protein , this construct is able to be efficiently #transformed into the yeast strain hf7c (clontech) .
expression of recombinat proteins full-lenght and c-terminal sbp2 constructs in pask-ib7 (bvs) is able to be used to completely #transform escherichia coli bl21 (promega) .
expression of recombinat proteins full-lenght and c-terminal sbp2 constructs in pask-ib7 (bvs) is likely to be used to completely #transform escherichia coli bl21 (promega) .
for expression of the recombinant protein , this construct is likely to be efficiently #transformed into the yeast strain hf7c (clontech) .
expression of recombinat proteins full-lenght and c-terminal sbp2 constructs in pask-ib7 (bvs) is likely to be used to #transform escherichia coli bl21 (promega) .
expression of recombinat proteins full-lenght and c-terminal sbp2 constructs in pask-ib7 (bvs) is observed to be used to completely #transform escherichia coli bl21 (promega) .
for expression of the recombinant protein , this construct is observed to be #transformed into the yeast strain hf7c (clontech) .
expression of recombinat proteins full-lenght and c-terminal sbp2 constructs in pask-ib7 (bvs) is used to completely #transform escherichia coli bl21 (promega) .
for expression of the recombinant protein , this construct is #transformed into the yeast strain hf7c (clontech) .
expression of recombinat proteins full-lenght and c-terminal sbp2 constructs in pask-ib7 (bvs) is used to #transform escherichia coli bl21 (promega) .
for expression of the recombinant protein , this construct may be efficiently #transformed into the yeast strain hf7c (clontech) .
expression of recombinat proteins full-lenght and c-terminal sbp2 constructs in pask-ib7 (bvs) may be used to completely #transform escherichia coli bl21 (promega) .
for expression of the recombinant protein , this construct may be #transformed into the yeast strain hf7c (clontech) .
for expression of the recombinant protein , this construct may have been efficiently #transformed into the yeast strain hf7c (clontech) .
expression of recombinat proteins full-lenght and c-terminal sbp2 constructs in pask-ib7 (bvs) may have been used to completely #transform escherichia coli bl21 (promega) .
for expression of the recombinant protein , this construct may have been #transformed into the yeast strain hf7c (clontech) .
expression of recombinat proteins full-lenght and c-terminal sbp2 constructs in pask-ib7 (bvs) was used to #transform escherichia coli bl21 (promega) .
expression of recombinat proteins full-lenght and c-terminal sbp2 constructs in pask-ib7 (bvs) will be used to completely #transform escherichia coli bl21 (promega) .
expression of recombinat proteins full-lenght and c-terminal sbp2 constructs in pask-ib7 are able to be efficiently #transformed into escherichia coli bl21 (promega) and selected for by growth on plates lacking leucine and tryptophan (left panel) .
expression of recombinat proteins full-lenght and c-terminal sbp2 constructs in pask-ib7 are efficiently #transformed into escherichia coli bl21 (promega) and selected for by growth on plates lacking leucine and tryptophan (left panel) .
for expression of the recombinant protein , this construct , as our study suggested , has been shown to be efficiently #transformed into the yeast strain hf7c (clontech) .
for expression of the recombinant protein , this construct , as our study suggested , has been shown to be #transformed into the yeast strain hf7c (clontech) .
expression of recombinat proteins full-lenght and c-terminal sbp2 constructs in pask-ib7 are observed to be efficiently #transformed into escherichia coli bl21 (promega) and selected for by growth on plates lacking leucine and tryptophan (left panel) .
for expression of the recombinant protein , this construct , as our study suggested , has been #transformed into the yeast strain hf7c (clontech) .
expression of recombinat proteins full-lenght and c-terminal sbp2 constructs in pask-ib7 are observed to be #transformed into escherichia coli bl21 (promega) and selected for by growth on plates lacking leucine and tryptophan (left panel) .
for expression of the recombinant protein , this construct , as our study suggested , has the ability to be efficiently #transformed into the yeast strain hf7c (clontech) .
for expression of the recombinant protein , this construct , as our study suggested , has the ability to be #transformed into the yeast strain hf7c (clontech) .
expression of recombinat proteins full-lenght and c-terminal sbp2 constructs in pask-ib7 are #transformed into escherichia coli bl21 (promega) and selected for by growth on plates lacking leucine and tryptophan (left panel) .
for expression of the recombinant protein , this construct , as our study suggested , is able to be #transformed into the yeast strain hf7c (clontech) .
expression of recombinat proteins full-lenght and c-terminal sbp2 constructs in pask-ib7 can be #transformed into escherichia coli bl21 (promega) and selected for by growth on plates lacking leucine and tryptophan (left panel) .
expression of recombinat proteins full-lenght and c-terminal sbp2 constructs in pask-ib7 have been efficiently #transformed into escherichia coli bl21 (promega) and selected for by growth on plates lacking leucine and tryptophan (left panel) .
for expression of the recombinant protein , this construct , as our study suggested , is likely to be efficiently #transformed into the yeast strain hf7c (clontech) .
for expression of the recombinant protein , this construct , as our study suggested , is likely to be #transformed into the yeast strain hf7c (clontech) .
expression of recombinat proteins full-lenght and c-terminal sbp2 constructs in pask-ib7 have the ability to be efficiently #transformed into escherichia coli bl21 (promega) and selected for by growth on plates lacking leucine and tryptophan (left panel) .
for expression of the recombinant protein , this construct , as our study suggested , is observed to be #transformed into the yeast strain hf7c (clontech) .
for expression of the recombinant protein , this construct , as our study suggested , is #transformed into the yeast strain hf7c (clontech) .
expression of recombinat proteins full-lenght and c-terminal sbp2 constructs in pask-ib7 may have been efficiently #transformed into escherichia coli bl21 (promega) and selected for by growth on plates lacking leucine and tryptophan (left panel) .
for expression of the recombinant protein , this construct , as our study suggested , may have been efficiently #transformed into the yeast strain hf7c (clontech) .
expression of recombinat proteins full-lenght and c-terminal sbp2 constructs in pask-ib7 was #transformed into escherichia coli bl21 (promega) .
expression of recombinat proteins full-lenght and c-terminal sbp2 constructs in pask-ib7 were #transformed into escherichia coli bl21 (promega) and selected for by growth on plates lacking leucine and tryptophan (left panel) .
expression of recombinat proteins full-lenght and c-terminal sbp2 constructs in pask-ib7 will be #transformed into escherichia coli bl21 (promega) and selected for by growth on plates lacking leucine and tryptophan (left panel) .
expression of recombinat proteins full-lenght and c-terminal sbp2 constructs in pask-ib7 , as we mentioned earlier , can be used to completely #transform escherichia coli bl21 (promega) .
expression of recombinat proteins full-lenght and c-terminal sbp2 constructs in pask-ib7 , as we mentioned earlier , can be used to #transform escherichia coli bl21 (promega) .
for expression of the recombinant protein , pet28a-5 , for expression of the recombinant protein , can be #transformed into escherichia coli strain bl21(de3) .
expression of recombinat proteins full-lenght and c-terminal sbp2 constructs in pask-ib7 , as we mentioned earlier , has been shown to be used to completely #transform escherichia coli bl21 (promega) .
for expression of the recombinant protein , pet28a-5 , for expression of the recombinant protein , has been efficiently #transformed into escherichia coli strain bl21(de3) .
expression of recombinat proteins full-lenght and c-terminal sbp2 constructs in pask-ib7 , as we mentioned earlier , has been shown to be used to #transform escherichia coli bl21 (promega) .
expression of recombinat proteins full-lenght and c-terminal sbp2 constructs in pask-ib7 , as we mentioned earlier , has been used to completely #transform escherichia coli bl21 (promega) .
for expression of the recombinant protein , pet28a-5 , for expression of the recombinant protein , has been shown to be efficiently #transformed into escherichia coli strain bl21(de3) .
for expression of the recombinant protein , pet28a-5 , for expression of the recombinant protein , has been shown to be #transformed into escherichia coli strain bl21(de3) .
for expression of the recombinant protein , pet28a-5 , for expression of the recombinant protein , is able to be efficiently #transformed into escherichia coli strain bl21(de3) .
for expression of the recombinant protein , pet28a-5 , for expression of the recombinant protein , is able to be #transformed into escherichia coli strain bl21(de3) .
expression of recombinat proteins full-lenght and c-terminal sbp2 constructs in pask-ib7 , as we mentioned earlier , is likely to be used to #transform escherichia coli bl21 (promega) .
for expression of the recombinant protein , pet28a-5 , for expression of the recombinant protein , is observed to be #transformed into escherichia coli strain bl21(de3) .
expression of recombinat proteins full-lenght and c-terminal sbp2 constructs in pask-ib7 , as we mentioned earlier , may be used to completely #transform escherichia coli bl21 (promega) .
expression of recombinat proteins full-lenght and c-terminal sbp2 constructs in pask-ib7 , as we mentioned earlier , may have been used to completely #transform escherichia coli bl21 (promega) .
for expression of the recombinant protein , pet28a-5 , for expression of the recombinant protein , may have been efficiently #transformed into escherichia coli strain bl21(de3) .
expression of recombinat proteins full-lenght and c-terminal sbp2 constructs in pask-ib7 , as we mentioned earlier , may have been used to #transform escherichia coli bl21 (promega) .
for expression of the recombinant protein , pet28a-5 , for expression of the recombinant protein , was #transformed into escherichia coli strain bl21(de3) .
expression of recombinat proteins full-lenght and c-terminal sbp2 constructs in pask-ib7 , however , are able to be efficiently #transformed into escherichia coli bl21 (promega) and selected for by growth on plates lacking leucine and tryptophan (left panel) .
expression of recombinat proteins full-lenght and c-terminal sbp2 constructs in pask-ib7 , however , are efficiently #transformed into escherichia coli bl21 (promega) and selected for by growth on plates lacking leucine and tryptophan (left panel) .
this construct can be efficiently #transformed into the yeast strain hf7c (clontech) .
expression of recombinat proteins full-lenght and c-terminal sbp2 constructs in pask-ib7 , however , are likely to be efficiently #transformed into escherichia coli bl21 (promega) and selected for by growth on plates lacking leucine and tryptophan (left panel) .
expression of recombinat proteins full-lenght and c-terminal sbp2 constructs in pask-ib7 , however , are likely to be #transformed into escherichia coli bl21 (promega) and selected for by growth on plates lacking leucine and tryptophan (left panel) .
this construct has been efficiently #transformed into the yeast strain hf7c (clontech) .
expression of recombinat proteins full-lenght and c-terminal sbp2 constructs in pask-ib7 , however , are observed to be efficiently #transformed into escherichia coli bl21 (promega) and selected for by growth on plates lacking leucine and tryptophan (left panel) .
this construct has been probably #transformed into the yeast strain hf7c (clontech) .
this construct has been proven to be efficiently #transformed into the yeast strain hf7c (clontech) .
expression of recombinat proteins full-lenght and c-terminal sbp2 constructs in pask-ib7 , however , are #transformed into escherichia coli bl21 (promega) and selected for by growth on plates lacking leucine and tryptophan (left panel) .
this construct has been shown to be probably #transformed into the yeast strain hf7c (clontech) .
this construct has the ability to be efficiently #transformed into the yeast strain hf7c (clontech) .
expression of recombinat proteins full-lenght and c-terminal sbp2 constructs in pask-ib7 , however , can be #transformed into escherichia coli bl21 (promega) and selected for by growth on plates lacking leucine and tryptophan (left panel) .
this construct has the ability to be probably #transformed into the yeast strain hf7c (clontech) .
expression of recombinat proteins full-lenght and c-terminal sbp2 constructs in pask-ib7 , however , have been shown to be efficiently #transformed into escherichia coli bl21 (promega) and selected for by growth on plates lacking leucine and tryptophan (left panel) .
this construct is efficiently #transformed into the yeast strain hf7c (clontech) .
this construct is likely to be efficiently #transformed into the yeast strain hf7c (clontech) .
this construct is likely to be probably #transformed into the yeast strain hf7c (clontech) .
expression of recombinat proteins full-lenght and c-terminal sbp2 constructs in pask-ib7 , however , may have been efficiently #transformed into escherichia coli bl21 (promega) and selected for by growth on plates lacking leucine and tryptophan (left panel) .
this construct is observed to be probably #transformed into the yeast strain hf7c (clontech) .
expression of recombinat proteins full-lenght and c-terminal sbp2 constructs in pask-ib7 , however , may have been #transformed into escherichia coli bl21 (promega) and selected for by growth on plates lacking leucine and tryptophan (left panel) .
expression of recombinat proteins full-lenght and c-terminal sbp2 constructs in pask-ib7 , however , will be efficiently #transformed into escherichia coli bl21 (promega) and selected for by growth on plates lacking leucine and tryptophan (left panel) .
this construct , as our study suggested , has been dramatically #transformed into the yeast strain hf7c (clontech) .
this construct , as our study suggested , has been probably #transformed into the yeast strain hf7c (clontech) .
this construct , as our study suggested , has been proven to be dramatically #transformed into the yeast strain hf7c (clontech) .
this construct , as our study suggested , has been shown to be probably #transformed into the yeast strain hf7c (clontech) .
this construct , as our study suggested , is able to be dramatically #transformed into the yeast strain hf7c (clontech) .
this construct , as our study suggested , is likely to be probably #transformed into the yeast strain hf7c (clontech) .
this construct , as our study suggested , is observed to be dramatically #transformed into the yeast strain hf7c (clontech) .
this construct , as our study suggested , is probably #transformed into the yeast strain hf7c (clontech) .
this construct , as our study suggested , may be dramatically #transformed into the yeast strain hf7c (clontech) .
this construct , as our study suggested , may have been dramatically #transformed into the yeast strain hf7c (clontech) .
this construct , as our study suggested , will be dramatically #transformed into the yeast strain hf7c (clontech) .
this construct , as our study suggested , will be probably #transformed into the yeast strain hf7c (clontech) .
pet28a-5 can be efficiently #transformed into escherichia coli strain bl21(de3) .
pet28a-5 can be probably #transformed into escherichia coli strain bl21(de3) .
pet28a-5 has been probably #transformed into escherichia coli strain bl21(de3) .
pet28a-5 has been proven to be dramatically #transformed into escherichia coli strain bl21(de3) .
pet28a-5 has been proven to be efficiently #transformed into escherichia coli strain bl21(de3) .
pet28a-5 has been shown to be dramatically #transformed into escherichia coli strain bl21(de3) .
pet28a-5 has been shown to be probably #transformed into escherichia coli strain bl21(de3) .
pet28a-5 has been #transformed into escherichia coli strain bl21(de3) .
pet28a-5 has the ability to be #transformed into escherichia coli strain bl21(de3) .
pet28a-5 is able to be dramatically #transformed into escherichia coli strain bl21(de3) .
pet28a-5 is able to be #transformed into escherichia coli strain bl21(de3) .
pet28a-5 is dramatically #transformed into escherichia coli strain bl21(de3) .
pet28a-5 is efficiently #transformed into escherichia coli strain bl21(de3) .
pet28a-5 is likely to be dramatically #transformed into escherichia coli strain bl21(de3) .
pet28a-5 is likely to be probably #transformed into escherichia coli strain bl21(de3) .
pet28a-5 is likely to be #transformed into escherichia coli strain bl21(de3) .
pet28a-5 is observed to be dramatically #transformed into escherichia coli strain bl21(de3) .
pet28a-5 is observed to be probably #transformed into escherichia coli strain bl21(de3) .
pet28a-5 is #transformed into escherichia coli strain bl21(de3) .
pet28a-5 may be dramatically #transformed into escherichia coli strain bl21(de3) .
pet28a-5 may have been efficiently #transformed into escherichia coli strain bl21(de3) .
pet28a-5 may have been probably #transformed into escherichia coli strain bl21(de3) .
pet28a-5 will be efficiently #transformed into escherichia coli strain bl21(de3) .
pet28a-5 , for expression of the recombinant protein , can be dramatically #transformed into escherichia coli strain bl21(de3) .
pet28a-5 , for expression of the recombinant protein , has been dramatically #transformed into escherichia coli strain bl21(de3) .
pet28a-5 , for expression of the recombinant protein , has been efficiently #transformed into escherichia coli strain bl21(de3) .
pet28a-5 , for expression of the recombinant protein , has been proven to be dramatically #transformed into escherichia coli strain bl21(de3) .
pet28a-5 , for expression of the recombinant protein , has been proven to be efficiently #transformed into escherichia coli strain bl21(de3) .
pet28a-5 , for expression of the recombinant protein , has been shown to be efficiently #transformed into escherichia coli strain bl21(de3) .
pet28a-5 , for expression of the recombinant protein , is able to be dramatically #transformed into escherichia coli strain bl21(de3) .
pet28a-5 , for expression of the recombinant protein , is dramatically #transformed into escherichia coli strain bl21(de3) .
for expression of the recombinant protein , this construct was #transformed into the yeast strain hf7c (clontech) .
pet28a-5 , for expression of the recombinant protein , is likely to be dramatically #transformed into escherichia coli strain bl21(de3) .
pet28a-5 , for expression of the recombinant protein , is observed to be dramatically #transformed into escherichia coli strain bl21(de3) .
pet28a-5 , for expression of the recombinant protein , is observed to be efficiently #transformed into escherichia coli strain bl21(de3) .
pet28a-5 , for expression of the recombinant protein , may have been dramatically #transformed into escherichia coli strain bl21(de3) .
pet28a-5 , for expression of the recombinant protein , may have been efficiently #transformed into escherichia coli strain bl21(de3) .
pet28a-5 , for expression of the recombinant protein , was #transformed into escherichia coli strain bl21(de3) .
this construct (bvs) has been used to #transform the yeast strain hf7c (clontech) .
this construct (bvs) is likely to be used to completely #transform the yeast strain hf7c (clontech) .
this construct (bvs) is likely to be used to #transform the yeast strain hf7c (clontech) .
this construct (bvs) is observed to be used to completely #transform the yeast strain hf7c (clontech) .
this construct (bvs) is used to completely #transform the yeast strain hf7c (clontech) .
this construct (bvs) may have been used to #transform the yeast strain hf7c (clontech) .
this construct (bvs) was used to #transform the yeast strain hf7c (clontech) .
this construct are able to be efficiently #transformed into the yeast strain hf7c (clontech) and selected for by growth on plates lacking leucine and tryptophan (left panel) .
this construct are able to be specifically #transformed into the yeast strain hf7c (clontech)
this construct are able to be #transformed into the yeast strain hf7c (clontech) and selected for by growth on plates lacking leucine and tryptophan (left panel) .
this construct are likely to be efficiently #transformed into the yeast strain hf7c (clontech) and selected for by growth on plates lacking leucine and tryptophan (left panel) .
this construct are likely to be specifically #transformed into the yeast strain hf7c (clontech)
this construct are observed to be efficiently #transformed into the yeast strain hf7c (clontech) and selected for by growth on plates lacking leucine and tryptophan (left panel) .
this construct are observed to be specifically #transformed into the yeast strain hf7c (clontech)
this construct are observed to be #transformed into the yeast strain hf7c (clontech)
this construct are specifically #transformed into the yeast strain hf7c (clontech)
this construct are #transformed into the yeast strain hf7c (clontech) and selected for by growth on plates lacking leucine and tryptophan (left panel) .
this construct can be #transformed into the yeast strain hf7c (clontech) and selected for by growth on plates lacking leucine and tryptophan (left panel) .
this construct have been shown to be specifically #transformed into the yeast strain hf7c (clontech)
this construct have been shown to be #transformed into the yeast strain hf7c (clontech)
this construct have been shown to be #transformed into the yeast strain hf7c (clontech) and selected for by growth on plates lacking leucine and tryptophan (left panel) .
this construct have the ability to be #transformed into the yeast strain hf7c (clontech)
this construct have the ability to be #transformed into the yeast strain hf7c (clontech) and selected for by growth on plates lacking leucine and tryptophan (left panel) .
this construct may be specifically #transformed into the yeast strain hf7c (clontech)
this construct may be #transformed into the yeast strain hf7c (clontech)
this construct may have been efficiently #transformed into the yeast strain hf7c (clontech) and selected for by growth on plates lacking leucine and tryptophan (left panel) .
this construct may have been specifically #transformed into the yeast strain hf7c (clontech)
this construct may have been #transformed into the yeast strain hf7c (clontech)
this construct may have been #transformed into the yeast strain hf7c (clontech) and selected for by growth on plates lacking leucine and tryptophan (left panel) .
this construct will be efficiently #transformed into the yeast strain hf7c (clontech) and selected for by growth on plates lacking leucine and tryptophan (left panel) .
this construct will be #transformed into the yeast strain hf7c (clontech)
this construct will be #transformed into the yeast strain hf7c (clontech) and selected for by growth on plates lacking leucine and tryptophan (left panel) .
this construct , as our study suggested , are able to be #transformed into the yeast strain hf7c (clontech)
this construct , as our study suggested , are likely to be specifically #transformed into the yeast strain hf7c (clontech)
this construct , as our study suggested , are likely to be #transformed into the yeast strain hf7c (clontech)
this construct , as our study suggested , are observed to be #transformed into the yeast strain hf7c (clontech)
this construct , as our study suggested , are specifically #transformed into the yeast strain hf7c (clontech)
this construct , as our study suggested , are #transformed into the yeast strain hf7c (clontech)
this construct , as our study suggested , have been shown to be #transformed into the yeast strain hf7c (clontech)
this construct , as our study suggested , have been #transformed into the yeast strain hf7c (clontech)
this construct , as our study suggested , have the ability to be #transformed into the yeast strain hf7c (clontech)
this construct , as our study suggested , may be specifically #transformed into the yeast strain hf7c (clontech)
this construct , as our study suggested , may have been specifically #transformed into the yeast strain hf7c (clontech)
this construct , as our study suggested , will be #transformed into the yeast strain hf7c (clontech)
this construct , as we mentioned earlier , can be used to completely #transform the yeast strain hf7c (clontech) .
this construct , as we mentioned earlier , can be used to #transform the yeast strain hf7c (clontech) .
this construct , as we mentioned earlier , has been shown to be used to #transform the yeast strain hf7c (clontech) .
this construct , as we mentioned earlier , has been used to completely #transform the yeast strain hf7c (clontech) .
this construct , as we mentioned earlier , has been used to #transform the yeast strain hf7c (clontech) .
this construct , as we mentioned earlier , has the ability to be used to completely #transform the yeast strain hf7c (clontech) .
this construct , as we mentioned earlier , is able to be used to #transform the yeast strain hf7c (clontech) .
this construct , as we mentioned earlier , is likely to be used to completely #transform the yeast strain hf7c (clontech) .
this construct , as we mentioned earlier , is used to completely #transform the yeast strain hf7c (clontech) .
this construct , as we mentioned earlier , is used to #transform the yeast strain hf7c (clontech) .
this construct , as we mentioned earlier , may be used to completely #transform the yeast strain hf7c (clontech) .
this construct , as we mentioned earlier , may be used to #transform the yeast strain hf7c (clontech) .
this construct , as we mentioned earlier , may have been used to completely #transform the yeast strain hf7c (clontech) .
this construct , as we mentioned earlier , may have been used to #transform the yeast strain hf7c (clontech) .
this construct , as we mentioned earlier , will be used to #transform the yeast strain hf7c (clontech) .
this construct , however , are able to be efficiently #transformed into the yeast strain hf7c (clontech) and selected for by growth on plates lacking leucine and tryptophan (left panel) .
this construct , however , are able to be #transformed into the yeast strain hf7c (clontech) and selected for by growth on plates lacking leucine and tryptophan (left panel) .
this construct , however , are likely to be #transformed into the yeast strain hf7c (clontech) and selected for by growth on plates lacking leucine and tryptophan (left panel) .
this construct , however , are observed to be efficiently #transformed into the yeast strain hf7c (clontech) and selected for by growth on plates lacking leucine and tryptophan (left panel) .
this construct , however , are observed to be #transformed into the yeast strain hf7c (clontech) and selected for by growth on plates lacking leucine and tryptophan (left panel) .
this construct , however , are #transformed into the yeast strain hf7c (clontech) and selected for by growth on plates lacking leucine and tryptophan (left panel) .
this construct , however , can be efficiently #transformed into the yeast strain hf7c (clontech) and selected for by growth on plates lacking leucine and tryptophan (left panel) .
this construct , however , have been efficiently #transformed into the yeast strain hf7c (clontech) and selected for by growth on plates lacking leucine and tryptophan (left panel) .
this construct , however , have been shown to be #transformed into the yeast strain hf7c (clontech) and selected for by growth on plates lacking leucine and tryptophan (left panel) .
this construct , however , have the ability to be #transformed into the yeast strain hf7c (clontech) and selected for by growth on plates lacking leucine and tryptophan (left panel) .
this construct , however , may have been #transformed into the yeast strain hf7c (clontech) and selected for by growth on plates lacking leucine and tryptophan (left panel) .
this construct , however , will be efficiently #transformed into the yeast strain hf7c (clontech) and selected for by growth on plates lacking leucine and tryptophan (left panel) .
for expression of the recombinant protein , the relevant dna fragments was #transformed into the bacterial strains bl21 or topp (stratagene) .
the relevant dna fragments (bvs) has been used to completely #transform the bacterial strains bl21 or topp (stratagene) .
the relevant dna fragments (bvs) has the ability to be used to completely #transform the bacterial strains bl21 or topp (stratagene) .
the relevant dna fragments (bvs) is able to be used to completely #transform the bacterial strains bl21 or topp (stratagene) .
the relevant dna fragments (bvs) is able to be used to #transform the bacterial strains bl21 or topp (stratagene) .
the relevant dna fragments (bvs) is likely to be used to completely #transform the bacterial strains bl21 or topp (stratagene) .
the relevant dna fragments (bvs) is likely to be used to #transform the bacterial strains bl21 or topp (stratagene) .
the relevant dna fragments (bvs) is observed to be used to completely #transform the bacterial strains bl21 or topp (stratagene) .
the relevant dna fragments (bvs) is observed to be used to #transform the bacterial strains bl21 or topp (stratagene) .
the relevant dna fragments (bvs) is used to completely #transform the bacterial strains bl21 or topp (stratagene) .
the relevant dna fragments (bvs) is used to #transform the bacterial strains bl21 or topp (stratagene) .
the relevant dna fragments (bvs) was used to #transform the bacterial strains bl21 or topp (stratagene) .
the relevant dna fragments are able to be #transformed into the bacterial strains bl21 or topp (stratagene)
the relevant dna fragments are able to be #transformed into the bacterial strains bl21 or topp (stratagene) and selected for by growth on plates lacking leucine and tryptophan (left panel) .
the relevant dna fragments are efficiently #transformed into the bacterial strains bl21 or topp (stratagene) and selected for by growth on plates lacking leucine and tryptophan (left panel) .
the relevant dna fragments are likely to be efficiently #transformed into the bacterial strains bl21 or topp (stratagene) and selected for by growth on plates lacking leucine and tryptophan (left panel) .
the relevant dna fragments are likely to be specifically #transformed into the bacterial strains bl21 or topp (stratagene)
the relevant dna fragments are observed to be efficiently #transformed into the bacterial strains bl21 or topp (stratagene) and selected for by growth on plates lacking leucine and tryptophan (left panel) .
the relevant dna fragments are observed to be #transformed into the bacterial strains bl21 or topp (stratagene)
the relevant dna fragments are specifically #transformed into the bacterial strains bl21 or topp (stratagene)
the relevant dna fragments are #transformed into the bacterial strains bl21 or topp (stratagene)
the relevant dna fragments have been efficiently #transformed into the bacterial strains bl21 or topp (stratagene) and selected for by growth on plates lacking leucine and tryptophan (left panel) .
the relevant dna fragments have been shown to be efficiently #transformed into the bacterial strains bl21 or topp (stratagene) and selected for by growth on plates lacking leucine and tryptophan (left panel) .
the relevant dna fragments have been shown to be #transformed into the bacterial strains bl21 or topp (stratagene) and selected for by growth on plates lacking leucine and tryptophan (left panel) .
the relevant dna fragments have been #transformed into the bacterial strains bl21 or topp (stratagene)
the relevant dna fragments have been #transformed into the bacterial strains bl21 or topp (stratagene) and selected for by growth on plates lacking leucine and tryptophan (left panel) .
the relevant dna fragments have the ability to be efficiently #transformed into the bacterial strains bl21 or topp (stratagene) and selected for by growth on plates lacking leucine and tryptophan (left panel) .
the relevant dna fragments have the ability to be #transformed into the bacterial strains bl21 or topp (stratagene) and selected for by growth on plates lacking leucine and tryptophan (left panel) .
the relevant dna fragments may be #transformed into the bacterial strains bl21 or topp (stratagene)
the relevant dna fragments may have been #transformed into the bacterial strains bl21 or topp (stratagene)
the relevant dna fragments was #transformed into the bacterial strains bl21 or topp (stratagene) .
the relevant dna fragments were #transformed into the bacterial strains bl21 or topp (stratagene)
the relevant dna fragments were #transformed into the bacterial strains bl21 or topp (stratagene) and selected for by growth on plates lacking leucine and tryptophan (left panel) .
the relevant dna fragments will be specifically #transformed into the bacterial strains bl21 or topp (stratagene)
the relevant dna fragments , as our study suggested , are able to be specifically #transformed into the bacterial strains bl21 or topp (stratagene)
the relevant dna fragments , as our study suggested , are able to be #transformed into the bacterial strains bl21 or topp (stratagene)
the relevant dna fragments , as our study suggested , are observed to be specifically #transformed into the bacterial strains bl21 or topp (stratagene)
the relevant dna fragments , as our study suggested , have been shown to be specifically #transformed into the bacterial strains bl21 or topp (stratagene)
the relevant dna fragments , as our study suggested , have been #transformed into the bacterial strains bl21 or topp (stratagene)
the relevant dna fragments , as our study suggested , have the ability to be #transformed into the bacterial strains bl21 or topp (stratagene)
the relevant dna fragments , as our study suggested , may be specifically #transformed into the bacterial strains bl21 or topp (stratagene)
the relevant dna fragments , as our study suggested , will be specifically #transformed into the bacterial strains bl21 or topp (stratagene)
the relevant dna fragments , as our study suggested , will be #transformed into the bacterial strains bl21 or topp (stratagene)
the relevant dna fragments , as we mentioned earlier , can be used to #transform the bacterial strains bl21 or topp (stratagene) .
the relevant dna fragments , as we mentioned earlier , has been used to completely #transform the bacterial strains bl21 or topp (stratagene) .
the relevant dna fragments , as we mentioned earlier , has the ability to be used to completely #transform the bacterial strains bl21 or topp (stratagene) .
the relevant dna fragments , as we mentioned earlier , is able to be used to #transform the bacterial strains bl21 or topp (stratagene) .
the relevant dna fragments , as we mentioned earlier , is observed to be used to completely #transform the bacterial strains bl21 or topp (stratagene) .
the relevant dna fragments , as we mentioned earlier , is used to completely #transform the bacterial strains bl21 or topp (stratagene) .
the relevant dna fragments , as we mentioned earlier , may be used to completely #transform the bacterial strains bl21 or topp (stratagene) .
the relevant dna fragments , as we mentioned earlier , may be used to #transform the bacterial strains bl21 or topp (stratagene) .
the relevant dna fragments , as we mentioned earlier , may have been used to completely #transform the bacterial strains bl21 or topp (stratagene) .
the relevant dna fragments , as we mentioned earlier , may have been used to #transform the bacterial strains bl21 or topp (stratagene) .
the relevant dna fragments , as we mentioned earlier , will be used to completely #transform the bacterial strains bl21 or topp (stratagene) .
the relevant dna fragments , however , are able to be #transformed into the bacterial strains bl21 or topp (stratagene) and selected for by growth on plates lacking leucine and tryptophan (left panel) .
the relevant dna fragments , however , are likely to be #transformed into the bacterial strains bl21 or topp (stratagene) and selected for by growth on plates lacking leucine and tryptophan (left panel) .
the relevant dna fragments , however , are observed to be efficiently #transformed into the bacterial strains bl21 or topp (stratagene) and selected for by growth on plates lacking leucine and tryptophan (left panel) .
the relevant dna fragments , however , are observed to be #transformed into the bacterial strains bl21 or topp (stratagene) and selected for by growth on plates lacking leucine and tryptophan (left panel) .
the relevant dna fragments , however , can be efficiently #transformed into the bacterial strains bl21 or topp (stratagene) and selected for by growth on plates lacking leucine and tryptophan (left panel) .
the relevant dna fragments , however , have been shown to be efficiently #transformed into the bacterial strains bl21 or topp (stratagene) and selected for by growth on plates lacking leucine and tryptophan (left panel) .
the relevant dna fragments , however , have been #transformed into the bacterial strains bl21 or topp (stratagene) and selected for by growth on plates lacking leucine and tryptophan (left panel) .
the relevant dna fragments , however , have the ability to be #transformed into the bacterial strains bl21 or topp (stratagene) and selected for by growth on plates lacking leucine and tryptophan (left panel) .
the relevant dna fragments , however , may have been efficiently #transformed into the bacterial strains bl21 or topp (stratagene) and selected for by growth on plates lacking leucine and tryptophan (left panel) .
the relevant dna fragments , however , will be efficiently #transformed into the bacterial strains bl21 or topp (stratagene) and selected for by growth on plates lacking leucine and tryptophan (left panel) .
acj6 and drifter , thus , are able to #translate pn lineage information into distinct dendritic targeting specificity .
a transcript has been efficiently #translated into a c-terminal truncated protein containing the first , second and third transmembrane domains , while the splicing out of exons 3 and 4 would produce a protein with five membrane-spanning domains but lacking the third and fourth domains present in the et-ar protein .
a transcript has been shown to be efficiently #translated into a c-terminal truncated protein containing the first , second and third transmembrane domains , while the splicing out of exons 3 and 4 would produce a protein with five membrane-spanning domains but lacking the third and fourth domains present in the et-ar protein .
acj6 and drifter , thus , are likely to #translate pn lineage information into distinct dendritic targeting specificity .
a transcript is able to be efficiently #translated into a c-terminal truncated protein containing the first , second and third transmembrane domains , while the splicing out of exons 3 and 4 would produce a protein with five membrane-spanning domains but lacking the third and fourth domains present in the et-ar protein .
a transcript is likely to be efficiently #translated into a c-terminal truncated protein containing the first , second and third transmembrane domains , while the splicing out of exons 3 and 4 would produce a protein with five membrane-spanning domains but lacking the third and fourth domains present in the et-ar protein .
acj6 and drifter , thus , can efficiently #translate pn lineage information into distinct dendritic targeting specificity .
a transcript may be efficiently #translated into a c-terminal truncated protein containing the first , second and third transmembrane domains , while the splicing out of exons 3 and 4 would produce a protein with five membrane-spanning domains but lacking the third and fourth domains present in the et-ar protein .
acj6 and drifter , thus , can #translate pn lineage information into distinct dendritic targeting specificity .
acj6 and drifter , thus , efficiently #translated pn lineage information into distinct dendritic targeting specificity .
acj6 and drifter , thus , have been shown to efficiently #translate pn lineage information into distinct dendritic targeting specificity .
a transcript was efficiently #translated into a c-terminal truncated protein containing the first , second and third transmembrane domains , while the splicing out of exons 3 and 4 would produce a protein with five membrane-spanning domains but lacking the third and fourth domains present in the et-ar protein .
acj6 and drifter , thus , have the ability to efficiently #translate pn lineage information into distinct dendritic targeting specificity .
acj6 and drifter , thus , have #translated pn lineage information into distinct dendritic targeting specificity .
a transcript , as our data has shown , has been shown to be #translated into a c-terminal truncated protein containing the first , second and third transmembrane domains , while the splicing out of exons 3 and 4 would produce a protein with five membrane-spanning domains but lacking the third and fourth domains present in the et-ar protein .
acj6 and drifter , thus , may efficiently #translate pn lineage information into distinct dendritic targeting specificity .
acj6 and drifter , thus , may have efficiently #translated pn lineage information into distinct dendritic targeting specificity .
a transcript , as our data has shown , is able to be efficiently #translated into a c-terminal truncated protein containing the first , second and third transmembrane domains , while the splicing out of exons 3 and 4 would produce a protein with five membrane-spanning domains but lacking the third and fourth domains present in the et-ar protein .
acj6 and drifter , thus , may #translate pn lineage information into distinct dendritic targeting specificity .
acj6 and drifter , thus , #translated pn lineage information into distinct dendritic targeting specificity .
a transcript , as our data has shown , is likely to be efficiently #translated into a c-terminal truncated protein containing the first , second and third transmembrane domains , while the splicing out of exons 3 and 4 would produce a protein with five membrane-spanning domains but lacking the third and fourth domains present in the et-ar protein .
acj6 and drifter , thus , will #translate pn lineage information into distinct dendritic targeting specificity .
a transcript , as our data has shown , is likely to be #translated into a c-terminal truncated protein containing the first , second and third transmembrane domains , while the splicing out of exons 3 and 4 would produce a protein with five membrane-spanning domains but lacking the third and fourth domains present in the et-ar protein .
a transcript , as our data has shown , is observed to be efficiently #translated into a c-terminal truncated protein containing the first , second and third transmembrane domains , while the splicing out of exons 3 and 4 would produce a protein with five membrane-spanning domains but lacking the third and fourth domains present in the et-ar protein .
a transcript , as our data has shown , may be efficiently #translated into a c-terminal truncated protein containing the first , second and third transmembrane domains , while the splicing out of exons 3 and 4 would produce a protein with five membrane-spanning domains but lacking the third and fourth domains present in the et-ar protein .
cells are able to use signalling networks to #translate extracellular signals into specific cellular functions with high fidelity .
cells are able to use signalling networks to #translate with high fidelity extracellular signals into specific cellular functions .
cells are likely to use signalling networks to #translate extracellular signals into specific cellular functions with high fidelity .
a transcript , as our data has shown , will be #translated into a c-terminal truncated protein containing the first , second and third transmembrane domains , while the splicing out of exons 3 and 4 would produce a protein with five membrane-spanning domains but lacking the third and fourth domains present in the et-ar protein .
cells are observed to successfully #translate with high fidelity extracellular signals into specific cellular functions .
cells are observed to #translate with high fidelity extracellular signals into specific cellular functions .
cells are observed to use signalling networks to commonly #translate extracellular signals into specific cellular functions .
cells are observed to use signalling networks to #translate extracellular signals into specific cellular functions with high fidelity .
alternative splicing of exon 4 results in a transcript likely to be #translated into a c-terminal truncated protein containing the first , second and third transmembrane domains , while the splicing out of exons 3 and 4 would produce a protein with five membrane-spanning domains but lacking the third and fourth domains present in the et-ar protein .
alternative splicing of exon 4 results in a transcript observed to be #translated into a c-terminal truncated protein containing the first , second and third transmembrane domains , while the splicing out of exons 3 and 4 would produce a protein with five membrane-spanning domains but lacking the third and fourth domains present in the et-ar protein .
cells are observed to use signalling networks to #translate with high fidelity extracellular signals into specific cellular functions .
cells can successfully #translate with high fidelity extracellular signals into specific cellular functions .
alternative splicing of exon 4 results in a transcript which has been #translated into a c-terminal truncated protein containing the first , second and third transmembrane domains , while the splicing out of exons 3 and 4 would produce a protein with five membrane-spanning domains but lacking the third and fourth domains present in the et-ar protein .
alternative splicing of exon 4 results in a transcript which is able to be #translated into a c-terminal truncated protein containing the first , second and third transmembrane domains , while the splicing out of exons 3 and 4 would produce a protein with five membrane-spanning domains but lacking the third and fourth domains present in the et-ar protein .
cells have been shown to successfully #translate with high fidelity extracellular signals into specific cellular functions .
cells have been shown to use signalling networks to #translate extracellular signals into specific cellular functions with high fidelity .
alternative splicing of exon 4 results in a transcript which may be #translated into a c-terminal truncated protein containing the first , second and third transmembrane domains , while the splicing out of exons 3 and 4 would produce a protein with five membrane-spanning domains but lacking the third and fourth domains present in the et-ar protein .
cells have successfully #translated with high fidelity extracellular signals into specific cellular functions .
alternative splicing of exon 4 results in a transcript which may have been #translated into a c-terminal truncated protein containing the first , second and third transmembrane domains , while the splicing out of exons 3 and 4 would produce a protein with five membrane-spanning domains but lacking the third and fourth domains present in the et-ar protein .
cells have the ability to successfully #translate with high fidelity extracellular signals into specific cellular functions .
alternative splicing of exon 4 results in a transcript which was #translated into a c-terminal truncated protein containing the first , second and third transmembrane domains , while the splicing out of exons 3 and 4 would produce a protein with five membrane-spanning domains but lacking the third and fourth domains present in the et-ar protein .
cells have the ability to #translate with high fidelity extracellular signals into specific cellular functions .
cells have the ability to use signalling networks to commonly #translate extracellular signals into specific cellular functions .
isgf3 gamma being able to be properly #translated in vitro from recombinant clones bound dna with a specificity indistinguishable from that of isgf3 gamma purified from hela cells .
cells have the ability to use signalling networks to #translate extracellular signals into specific cellular functions with high fidelity .
isgf3 gamma observed to be properly #translated in vitro from recombinant clones bound dna with a specificity indistinguishable from that of isgf3 gamma purified from hela cells .
cells have #translated with high fidelity extracellular signals into specific cellular functions .
isgf3 gamma observed to be #translated in vitro from recombinant clones bound dna with a specificity indistinguishable from that of isgf3 gamma purified from hela cells .
cells have used signalling networks to #translate extracellular signals into specific cellular functions with high fidelity .
isgf3 gamma shown to be properly #translated in vitro from recombinant clones bound dna with a specificity indistinguishable from that of isgf3 gamma purified from hela cells .
interestingly , this reduction in liver injury can fail to #translate into improved survival .
cells have used signalling networks to #translate with high fidelity extracellular signals into specific cellular functions .
cells may have successfully #translated with high fidelity extracellular signals into specific cellular functions .
cells may have #translated with high fidelity extracellular signals into specific cellular functions .
interestingly , this reduction in liver injury fail to #translate into improved survival .
cells may successfully #translate with high fidelity extracellular signals into specific cellular functions .
isgf3 gamma that has been #translated in vitro from recombinant clones bound dna with a specificity indistinguishable from that of isgf3 gamma purified from hela cells .
cells may use signalling networks to commonly #translate extracellular signals into specific cellular functions .
interestingly , this reduction in liver injury may fail to #translate into improved survival .
cells may use signalling networks to #translate extracellular signals into specific cellular functions with high fidelity .
interestingly , this reduction in liver injury may have failed to #translate into improved survival .
cells may use signalling networks to #translate with high fidelity extracellular signals into specific cellular functions .
interestingly , this reduction in liver injury may not #translate into improved survival .
cells successfully #translate with high fidelity extracellular signals into specific cellular functions .
isgf3 gamma that is observed to be properly #translated in vitro from recombinant clones bound dna with a specificity indistinguishable from that of isgf3 gamma purified from hela cells .
cells successfully #translated with high fidelity extracellular signals into specific cellular functions .
interestingly , this reduction in liver injury will not #translate into improved survival .
cells #translate with high fidelity extracellular signals into specific cellular functions .
cells #translated with high fidelity extracellular signals into specific cellular functions .
isgf3 gamma that is #translated in vitro from recombinant clones bound dna with a specificity indistinguishable from that of isgf3 gamma purified from hela cells .
isgf3 gamma that may be properly #translated in vitro from recombinant clones bound dna with a specificity indistinguishable from that of isgf3 gamma purified from hela cells .
cells used signalling networks to #translate extracellular signals into specific cellular functions with high fidelity .
cells used signalling networks to #translate with high fidelity extracellular signals into specific cellular functions .
isgf3 gamma that was #translated in vitro from recombinant clones bound dna with a specificity indistinguishable from that of isgf3 gamma purified from hela cells .
cells will use signalling networks to #translate extracellular signals into specific cellular functions with high fidelity .
isgf3 gamma that will be properly #translated in vitro from recombinant clones bound dna with a specificity indistinguishable from that of isgf3 gamma purified from hela cells .
cells will use signalling networks to #translate with high fidelity extracellular signals into specific cellular functions .
isgf3 gamma #translated in vitro from recombinant clones bound dna with a specificity indistinguishable from that of isgf3 gamma purified from hela cells .
more than 100 proteins and polypeptides which are included in the arc/xyls family of prokaryotic positive transcriptional regulators are completely #translated from open reading frames .
more than 100 proteins and polypeptides which are included in the arc/xyls family of prokaryotic positive transcriptional regulators are likely to be completely #translated from open reading frames .
more than 100 proteins and polypeptides which are included in the arc/xyls family of prokaryotic positive transcriptional regulators are likely to be #translated from open reading frames .
more than 100 proteins and polypeptides which are included in the arc/xyls family of prokaryotic positive transcriptional regulators are observed to be #translated from open reading frames .
more than 100 proteins and polypeptides which are included in the arc/xyls family of prokaryotic positive transcriptional regulators are #translated from open reading frames .
more than 100 proteins and polypeptides which are included in the arc/xyls family of prokaryotic positive transcriptional regulators can be #translated from open reading frames .
more than 100 proteins and polypeptides which are included in the arc/xyls family of prokaryotic positive transcriptional regulators have been completely #translated from open reading frames .
cells , as our study has proven , are able to use signalling networks to #translate extracellular signals into specific cellular functions .
more than 100 proteins and polypeptides which are included in the arc/xyls family of prokaryotic positive transcriptional regulators have been shown to be #translated from open reading frames .
cells , as our study has proven , are observed to use signalling networks to #translate extracellular signals into specific cellular functions .
cells , as our study has proven , can use signalling networks to #translate extracellular signals into specific cellular functions .
more than 100 proteins and polypeptides which are included in the arc/xyls family of prokaryotic positive transcriptional regulators have the ability to be completely #translated from open reading frames .
more than 100 proteins and polypeptides which are included in the arc/xyls family of prokaryotic positive transcriptional regulators may be completely #translated from open reading frames .
more than 100 proteins and polypeptides which are included in the arc/xyls family of prokaryotic positive transcriptional regulators may be #translated from open reading frames .
more than 100 proteins and polypeptides which are included in the arc/xyls family of prokaryotic positive transcriptional regulators may have been #translated from open reading frames .
cells , as our study has proven , used signalling networks to #translate extracellular signals into specific cellular functions .
cells , as our study has proven , will use signalling networks to #translate extracellular signals into specific cellular functions .
extracellular signals are able to be #translated with high fidelity by cells into specific cellular functions .
more than 100 proteins and polypeptides which are included in the arc/xyls family of prokaryotic positive transcriptional regulators will be completely #translated from open reading frames .
extracellular signals are likely to be #translated with high fidelity by cells into specific cellular functions .
stat1 y701f which can be probably #translated in vitro can also dimerize on the lmp2 gas .
extracellular signals are likely to be #translated with high fidelity into specific cellular functions by cells .
stat1 y701f which can be #translated in vitro can also dimerize on the lmp2 gas .
extracellular signals are observed to be #translated with high fidelity by cells into specific cellular functions .
stat1 y701f which has been probably #translated in vitro can also dimerize on the lmp2 gas .
stat1 y701f which has been shown to be probably #translated in vitro can also dimerize on the lmp2 gas .
extracellular signals are #translated with high fidelity by cells into specific cellular functions .
extracellular signals can be #translated with high fidelity by cells into specific cellular functions .
stat1 y701f which is able to be probably #translated in vitro can also dimerize on the lmp2 gas .
extracellular signals can be #translated with high fidelity into specific cellular functions by cells .
stat1 y701f which is able to be #translated in vitro can also dimerize on the lmp2 gas .
extracellular signals have been shown to be #translated with high fidelity by cells into specific cellular functions .
stat1 y701f which is likely to be probably #translated in vitro can also dimerize on the lmp2 gas .
extracellular signals have been #translated with high fidelity by cells into specific cellular functions .
stat1 y701f which is observed to be probably #translated in vitro can also dimerize on the lmp2 gas .
stat1 y701f which is observed to be #translated in vitro can also dimerize on the lmp2 gas .
extracellular signals were #translated with high fidelity by cells into specific cellular functions .
extracellular signals were #translated with high fidelity into specific cellular functions by cells .
stat1 y701f which was #translated in vitro can also dimerize on the lmp2 gas .
extracellular signals will be #translated with high fidelity by cells into specific cellular functions .
extracellular signals will be #translated with high fidelity into specific cellular functions by cells .
stat1 y701f which will be #translated in vitro can also dimerize on the lmp2 gas .
extracellular signals , as our data has shown , are able to be #translated with high fidelity by cells into specific cellular functions .
stat1 , stat1 y701f , stat1 n135 , stat1 n200 and stat5/1 are able to be #translated in vitro and partially purified on heparin-agarose .
extracellular signals , as our data has shown , are able to be #translated with high fidelity into specific cellular functions by cells .
extracellular signals , as our data has shown , are likely to be #translated with high fidelity by cells into specific cellular functions .
stat1 , stat1 y701f , stat1 n135 , stat1 n200 and stat5/1 are observed to be #translated in vitro and partially purified on heparin-agarose .
extracellular signals , as our data has shown , are likely to be #translated with high fidelity into specific cellular functions by cells .
extracellular signals , as our data has shown , are observed to be #translated with high fidelity by cells into specific cellular functions .
extracellular signals , as our data has shown , are #translated with high fidelity by cells into specific cellular functions .
extracellular signals , as our data has shown , are #translated with high fidelity into specific cellular functions by cells .
stat1 , stat1 y701f , stat1 n135 , stat1 n200 and stat5/1 may be #translated in vitro and partially purified on heparin-agarose .
extracellular signals , as our data has shown , can be #translated with high fidelity into specific cellular functions by cells .
stat1 , stat1 y701f , stat1 n135 , stat1 n200 and stat5/1 may have been #translated in vitro and partially purified on heparin-agarose .
extracellular signals , as our data has shown , have been proven to be #translated with high fidelity into specific cellular functions by cells .
stat1 , stat1 y701f , stat1 n135 , stat1 n200 and stat5/1 that are able to be properly #translated in vitro are partially purified on heparin-agarose .
stat1 , stat1 y701f , stat1 n135 , stat1 n200 and stat5/1 that are able to be #translated in vitro are partially purified on heparin-agarose .
stat1 , stat1 y701f , stat1 n135 , stat1 n200 and stat5/1 that are likely to be properly #translated in vitro are partially purified on heparin-agarose .
extracellular signals , as our data has shown , have been #translated with high fidelity into specific cellular functions by cells .
stat1 , stat1 y701f , stat1 n135 , stat1 n200 and stat5/1 that are likely to be #translated in vitro are partially purified on heparin-agarose .
extracellular signals , as our data has shown , may be #translated with high fidelity by cells into specific cellular functions .
stat1 , stat1 y701f , stat1 n135 , stat1 n200 and stat5/1 that are observed to be properly #translated in vitro are partially purified on heparin-agarose .
stat1 , stat1 y701f , stat1 n135 , stat1 n200 and stat5/1 that are #translated in vitro are partially purified on heparin-agarose .
extracellular signals , as our data has shown , were #translated with high fidelity by cells into specific cellular functions .
stat1 , stat1 y701f , stat1 n135 , stat1 n200 and stat5/1 that can be #translated in vitro are partially purified on heparin-agarose .
stat1 , stat1 y701f , stat1 n135 , stat1 n200 and stat5/1 that have been properly #translated in vitro are partially purified on heparin-agarose .
stat1 , stat1 y701f , stat1 n135 , stat1 n200 and stat5/1 that have been shown to be properly #translated in vitro are partially purified on heparin-agarose .
stat1 , stat1 y701f , stat1 n135 , stat1 n200 and stat5/1 that have been shown to be #translated in vitro are partially purified on heparin-agarose .
malaria is an attractive model for the development and validation of approaches that are likely to #translate genomic information efficiently to vaccine development because of the critical need for effective anti-malarial interventions .
stat1 , stat1 y701f , stat1 n135 , stat1 n200 and stat5/1 that have the ability to be #translated in vitro are partially purified on heparin-agarose .
stat1 , stat1 y701f , stat1 n135 , stat1 n200 and stat5/1 that may be properly #translated in vitro are partially purified on heparin-agarose .
malaria is an attractive model for the development and validation of approaches that are observed to #translate genomic information to vaccine development because of the critical need for effective anti-malarial interventions .
stat1 , stat1 y701f , stat1 n135 , stat1 n200 and stat5/1 that may be #translated in vitro are partially purified on heparin-agarose .
malaria is an attractive model for the development and validation of approaches that can #translate genomic information efficiently to vaccine development because of the critical need for effective anti-malarial interventions .
stat1 , stat1 y701f , stat1 n135 , stat1 n200 and stat5/1 that may have been #translated in vitro are partially purified on heparin-agarose .
stat1 , stat1 y701f , stat1 n135 , stat1 n200 and stat5/1 that will be properly #translated in vitro are partially purified on heparin-agarose .
these changes are able to further #translate into altered expression levels and time kinetics of a number of early genes (peak expression at 2 h after stimulation) .
stat1 , stat1 y701f , stat1 n135 , stat1 n200 and stat5/1 that will be #translated in vitro are partially purified on heparin-agarose .
malaria is an attractive model for the development and validation of approaches that have the ability to #translate genomic information efficiently to vaccine development because of the critical need for effective anti-malarial interventions .
stat1 , stat1 y701f , stat1 n135 , stat1 n200 and stat5/1 will be #translated in vitro and partially purified on heparin-agarose .
malaria is an attractive model for the development and validation of approaches that have the ability to #translate genomic information to vaccine development because of the critical need for effective anti-malarial interventions .
stat1 , stat1 y701f , stat1 n135 , stat1 n200 and stat5/1 , as our data reveals , are able to be #translated in vitro and partially purified on heparin-agarose .
these changes are likely to #translate into altered expression levels and time kinetics of a number of early genes (peak expression at 2 h after stimulation) .
malaria is an attractive model for the development and validation of approaches that have #translated genomic information efficiently to vaccine development because of the critical need for effective anti-malarial interventions .
these changes are observed to further #translate into altered expression levels and time kinetics of a number of early genes (peak expression at 2 h after stimulation) .
malaria is an attractive model for the development and validation of approaches that have #translated genomic information to vaccine development because of the critical need for effective anti-malarial interventions .
stat1 , stat1 y701f , stat1 n135 , stat1 n200 and stat5/1 , as our data reveals , are observed to be #translated in vitro and partially purified on heparin-agarose .
these changes are observed to #translate into altered expression levels and time kinetics of a number of early genes (peak expression at 2 h after stimulation) .
malaria is an attractive model for the development and validation of approaches that may have #translated genomic information efficiently to vaccine development because of the critical need for effective anti-malarial interventions .
malaria is an attractive model for the development and validation of approaches that may have #translated genomic information to vaccine development because of the critical need for effective anti-malarial interventions .
these changes can #translate into altered expression levels and time kinetics of a number of early genes (peak expression at 2 h after stimulation) .
stat1 , stat1 y701f , stat1 n135 , stat1 n200 and stat5/1 , as our data reveals , have been shown to be #translated in vitro and partially purified on heparin-agarose .
malaria is an attractive model for the development and validation of approaches that may #translate genomic information to vaccine development because of the critical need for effective anti-malarial interventions .
malaria is an attractive model for the development and validation of approaches that #translate genomic information efficiently to vaccine development because of the critical need for effective anti-malarial interventions .
stat1 , stat1 y701f , stat1 n135 , stat1 n200 and stat5/1 , as our data reveals , have the ability to be #translated in vitro and partially purified on heparin-agarose .
these changes have been shown to #translate into altered expression levels and time kinetics of a number of early genes (peak expression at 2 h after stimulation) .
malaria is an attractive model for the development and validation of approaches that #translated genomic information efficiently to vaccine development because of the critical need for effective anti-malarial interventions .
stat1 , stat1 y701f , stat1 n135 , stat1 n200 and stat5/1 , as our data reveals , may have been #translated in vitro and partially purified on heparin-agarose .
these changes have the ability to further #translate into altered expression levels and time kinetics of a number of early genes (peak expression at 2 h after stimulation) .
malaria is an attractive model for the development and validation of approaches that #translated genomic information to vaccine development because of the critical need for effective anti-malarial interventions .
the arc/xyls family of prokaryotic positive transcriptional regulators includes more than 100 proteins and polypeptides being able to be #translated from open reading frames .
these changes have #translated into altered expression levels and time kinetics of a number of early genes (peak expression at 2 h after stimulation) .
malaria is an attractive model for the development and validation of approaches that will #translate genomic information to vaccine development because of the critical need for effective anti-malarial interventions .
the arc/xyls family of prokaryotic positive transcriptional regulators includes more than 100 proteins and polypeptides being likely to be #translated from open reading frames .
pn lineage information can be efficiently #translated by acj6 and drifter into distinct dendritic targeting specificity .
the arc/xyls family of prokaryotic positive transcriptional regulators includes more than 100 proteins and polypeptides observed to be #translated from open reading frames .
these changes may have #translated into altered expression levels and time kinetics of a number of early genes (peak expression at 2 h after stimulation) .
the arc/xyls family of prokaryotic positive transcriptional regulators includes more than 100 proteins and polypeptides shown to be #translated from open reading frames .
the arc/xyls family of prokaryotic positive transcriptional regulators includes more than 100 proteins and polypeptides that are able to be #translated from open reading frames .
pn lineage information has been efficiently #translated by acj6 and drifter into distinct dendritic targeting specificity .
the arc/xyls family of prokaryotic positive transcriptional regulators includes more than 100 proteins and polypeptides that are observed to be #translated from open reading frames .
these changes , as our data have shown , are able to further #translate into altered expression levels and time kinetics of a number of early genes (peak expression at 2 h after stimulation) .
these changes , as our data have shown , are able to #translate into altered expression levels and time kinetics of a number of early genes (peak expression at 2 h after stimulation) .
pn lineage information has been shown to be efficiently #translated into distinct dendritic targeting specificity by acj6 and drifter .
the arc/xyls family of prokaryotic positive transcriptional regulators includes more than 100 proteins and polypeptides that have been shown to be #translated from open reading frames .
these changes , as our data have shown , are likely to further #translate into altered expression levels and time kinetics of a number of early genes (peak expression at 2 h after stimulation) .
pn lineage information has been shown to be #translated into distinct dendritic targeting specificity by acj6 and drifter .
the arc/xyls family of prokaryotic positive transcriptional regulators includes more than 100 proteins and polypeptides that have the ability to be #translated from open reading frames .
the arc/xyls family of prokaryotic positive transcriptional regulators includes more than 100 proteins and polypeptides that may be #translated from open reading frames .
these changes , as our data have shown , are observed to #translate into altered expression levels and time kinetics of a number of early genes (peak expression at 2 h after stimulation) .
pn lineage information is able to be efficiently #translated by acj6 and drifter into distinct dendritic targeting specificity .
these changes , as our data have shown , can further #translate into altered expression levels and time kinetics of a number of early genes (peak expression at 2 h after stimulation) .
the arc/xyls family of prokaryotic positive transcriptional regulators includes more than 100 proteins and polypeptides that were #translated from open reading frames .
the arc/xyls family of prokaryotic positive transcriptional regulators includes more than 100 proteins and polypeptides that will be #translated from open reading frames .
pn lineage information is able to be #translated by acj6 and drifter into distinct dendritic targeting specificity .
these changes , as our data have shown , further #translated into altered expression levels and time kinetics of a number of early genes (peak expression at 2 h after stimulation) .
the arc/xyls family of prokaryotic positive transcriptional regulators includes more than 100 proteins and polypeptides #translated from open reading frames .
pn lineage information is able to be #translated into distinct dendritic targeting specificity by acj6 and drifter .
this mutant can be efficiently #translated in the presence of c-terminal sbp2 , and as shown in figure 6c no readthrough is detectable when the auga element is deleted , indicating that the stimulatory effect is entirely 3 utr dependent .
these changes , as our data have shown , have been shown to #translate into altered expression levels and time kinetics of a number of early genes (peak expression at 2 h after stimulation) .
pn lineage information is efficiently #translated by acj6 and drifter into distinct dendritic targeting specificity .
this mutant can be #translated in the presence of c-terminal sbp2 , and as shown in figure 6c no readthrough is detectable when the auga element is deleted , indicating that the stimulatory effect is entirely 3 utr dependent .
these changes , as our data have shown , have further #translated into altered expression levels and time kinetics of a number of early genes (peak expression at 2 h after stimulation) .
this mutant has been efficiently #translated in the presence of c-terminal sbp2 , and as shown in figure 6c no readthrough is detectable when the auga element is deleted , indicating that the stimulatory effect is entirely 3 utr dependent .
these changes , as our data have shown , have the ability to further #translate into altered expression levels and time kinetics of a number of early genes (peak expression at 2 h after stimulation) .
these changes , as our data have shown , have #translated into altered expression levels and time kinetics of a number of early genes (peak expression at 2 h after stimulation) .
these changes , as our data have shown , may further #translate into altered expression levels and time kinetics of a number of early genes (peak expression at 2 h after stimulation) .
this mutant is able to be efficiently #translated in the presence of c-terminal sbp2 , and as shown in figure 6c no readthrough is detectable when the auga element is deleted , indicating that the stimulatory effect is entirely 3 utr dependent .
these changes , as our data have shown , may have further #translated into altered expression levels and time kinetics of a number of early genes (peak expression at 2 h after stimulation) .
pn lineage information is observed to be efficiently #translated by acj6 and drifter into distinct dendritic targeting specificity .
this mutant is able to be #translated in the presence of c-terminal sbp2 , and as shown in figure 6c no readthrough is detectable when the auga element is deleted , indicating that the stimulatory effect is entirely 3 utr dependent .
these changes , as our data have shown , may have #translated into altered expression levels and time kinetics of a number of early genes (peak expression at 2 h after stimulation) .
this mutant is efficiently #translated in the presence of c-terminal sbp2 , and as shown in figure 6c no readthrough is detectable when the auga element is deleted , indicating that the stimulatory effect is entirely 3 utr dependent .
pn lineage information is observed to be #translated by acj6 and drifter into distinct dendritic targeting specificity .
these changes , as our data have shown , may #translate into altered expression levels and time kinetics of a number of early genes (peak expression at 2 h after stimulation) .
this mutant is likely to be efficiently #translated in the presence of c-terminal sbp2 , and as shown in figure 6c no readthrough is detectable when the auga element is deleted , indicating that the stimulatory effect is entirely 3 utr dependent .
pn lineage information is observed to be #translated into distinct dendritic targeting specificity by acj6 and drifter .
this mutant is likely to be #translated in the presence of c-terminal sbp2 , and as shown in figure 6c no readthrough is detectable when the auga element is deleted , indicating that the stimulatory effect is entirely 3 utr dependent .
this mutant is observed to be efficiently #translated in the presence of c-terminal sbp2 , and as shown in figure 6c no readthrough is detectable when the auga element is deleted , indicating that the stimulatory effect is entirely 3 utr dependent .
this mutant is observed to be #translated in the presence of c-terminal sbp2 , and as shown in figure 6c no readthrough is detectable when the auga element is deleted , indicating that the stimulatory effect is entirely 3 utr dependent .
pn lineage information may be efficiently #translated into distinct dendritic targeting specificity by acj6 and drifter .
this mutant may be efficiently #translated in the presence of c-terminal sbp2 , and as shown in figure 6c no readthrough is detectable when the auga element is deleted , indicating that the stimulatory effect is entirely 3 utr dependent .
this mutant may be #translated in the presence of c-terminal sbp2 , and as shown in figure 6c no readthrough is detectable when the auga element is deleted , indicating that the stimulatory effect is entirely 3 utr dependent .
this mutant may have been efficiently #translated in the presence of c-terminal sbp2 , and as shown in figure 6c no readthrough is detectable when the auga element is deleted , indicating that the stimulatory effect is entirely 3 utr dependent .
pn lineage information may have been efficiently #translated by acj6 and drifter into distinct dendritic targeting specificity .
this mutant may have been #translated in the presence of c-terminal sbp2 , and as shown in figure 6c no readthrough is detectable when the auga element is deleted , indicating that the stimulatory effect is entirely 3 utr dependent .
pn lineage information may have been #translated by acj6 and drifter into distinct dendritic targeting specificity .
this mutant will be #translated in the presence of c-terminal sbp2 , and as shown in figure 6c no readthrough is detectable when the auga element is deleted , indicating that the stimulatory effect is entirely 3 utr dependent .
pn lineage information may have been #translated into distinct dendritic targeting specificity by acj6 and drifter .
this mutant , as our study reveals , can be #translated in the presence of c-terminal sbp2 , and as shown in figure 6c no readthrough is detectable when the auga element is deleted , indicating that the stimulatory effect is entirely 3 utr dependent .
this mutant , as our study reveals , has been #translated in the presence of c-terminal sbp2 , and as shown in figure 6c no readthrough is detectable when the auga element is deleted , indicating that the stimulatory effect is entirely 3 utr dependent .
pn lineage information was #translated by acj6 and drifter into distinct dendritic targeting specificity .
pn lineage information was #translated into distinct dendritic targeting specificity by acj6 and drifter .
this mutant , as our study reveals , is likely to be #translated in the presence of c-terminal sbp2 , and as shown in figure 6c no readthrough is detectable when the auga element is deleted , indicating that the stimulatory effect is entirely 3 utr dependent .
pn lineage information will be efficiently #translated into distinct dendritic targeting specificity by acj6 and drifter .
pn lineage information will be #translated by acj6 and drifter into distinct dendritic targeting specificity .
this mutant , as our study reveals , will be #translated in the presence of c-terminal sbp2 , and as shown in figure 6c no readthrough is detectable when the auga element is deleted , indicating that the stimulatory effect is entirely 3 utr dependent .
this review examines the use of new and emerging dna , tissue , and live-cell transfection microarray technologies that are likely to be used to efficiently #translate information resulting from the completion of the human genome project .
this reduction in liver injury , as our data interestingly reveal , did not #translate into improved survival .
we also report the first definitive incorporation of sec into a selenoprotein which has been successfully #translated in reticulocyte lysates .
this reduction in liver injury , as our data interestingly reveal , has been shown to fail to #translate into improved survival .
we also report the first definitive incorporation of sec into a selenoprotein which has been #translated in reticulocyte lysates .
this review examines the use of new and emerging dna , tissue , and live-cell transfection microarray technologies that have been used to discover , validate , and #translate information resulting from the completion of the human genome project .
we also report the first definitive incorporation of sec into a selenoprotein which is able to be successfully #translated in reticulocyte lysates .
this reduction in liver injury , as our data interestingly reveal , has not #translated into improved survival .
we also report the first definitive incorporation of sec into a selenoprotein which is able to be #translated in reticulocyte lysates .
this reduction in liver injury , as our data interestingly reveal , is observed to fail to #translate into improved survival .
this review examines the use of new and emerging dna , tissue , and live-cell transfection microarray technologies that have been used to #translate information resulting from the completion of the human genome project .
this review examines the use of new and emerging dna , tissue , and live-cell transfection microarray technologies that may be used to discover , validate , and #translate information resulting from the completion of the human genome project .
we also report the first definitive incorporation of sec into a selenoprotein which is likely to be #translated in reticulocyte lysates .
this reduction in liver injury , as our data interestingly reveal , may not #translate into improved survival .
we also report the first definitive incorporation of sec into a selenoprotein which is successfully #translated in reticulocyte lysates .
this review examines the use of new and emerging dna , tissue , and live-cell transfection microarray technologies that may have been used to #translate information resulting from the completion of the human genome project .
this review examines the use of new and emerging dna , tissue , and live-cell transfection microarray technologies that would be used to discover , validate , and #translate information resulting from the completion of the human genome project .
this review examines the use of new and emerging dna , tissue , and live-cell transfection microarray technologies that would be used to efficiently #translate information resulting from the completion of the human genome project .
we also report the first definitive incorporation of sec into a selenoprotein which may have been successfully #translated in reticulocyte lysates .
we also report the first definitive incorporation of sec into a selenoprotein which was successfully #translated in reticulocyte lysates .
this review examines the use of new and emerging dna , tissue , and live-cell transfection microarray technologies that , as our study suggested , are likely to be used to efficiently #translate information resulting from the completion of the human genome project .
this review examines the use of new and emerging dna , tissue , and live-cell transfection microarray technologies that , as our study suggested , are likely to be used to #translate information resulting from the completion of the human genome project .
we also report the first definitive incorporation of sec into a selenoprotein which will be successfully #translated in reticulocyte lysates .
this review examines the use of new and emerging dna , tissue , and live-cell transfection microarray technologies that , as our study suggested , could be used to discover , validate , and #translate information resulting from the completion of the human genome project .
we also report the first definitive incorporation of sec into a selenoprotein which will be #translated in reticulocyte lysates .
this review examines the use of new and emerging dna , tissue , and live-cell transfection microarray technologies that , as our study suggested , could be used to efficiently #translate information resulting from the completion of the human genome project .
this review examines the use of new and emerging dna , tissue , and live-cell transfection microarray technologies that , as our study suggested , have been used to efficiently #translate information resulting from the completion of the human genome project .
this review examines the use of new and emerging dna , tissue , and live-cell transfection microarray technologies that , as our study suggested , have been used to #translate information resulting from the completion of the human genome project .
this review examines the use of new and emerging dna , tissue , and live-cell transfection microarray technologies that , as our study suggested , may have been used to discover , validate , and #translate information resulting from the completion of the human genome project .
this review examines the use of new and emerging dna , tissue , and live-cell transfection microarray technologies that , as our study suggested , may have been used to efficiently #translate information resulting from the completion of the human genome project .
this review examines the use of new and emerging dna , tissue , and live-cell transfection microarray technologies that , as our study suggested , may have been used to #translate information resulting from the completion of the human genome project .
this review examines the use of new and emerging dna , tissue , and live-cell transfection microarray technologies that , as our study suggested , would be used to discover , validate , and #translate information resulting from the completion of the human genome project .
this review examines the use of new and emerging dna , tissue , and live-cell transfection microarray technologies that , as our study suggested , would be used to #translate information resulting from the completion of the human genome project .
thus , acj6 and drifter are able to #translate pn lineage information into distinct dendritic targeting specificity .
thus , acj6 and drifter are likely to #translate pn lineage information into distinct dendritic targeting specificity .
thus , acj6 and drifter efficiently #translated pn lineage information into distinct dendritic targeting specificity .
thus , acj6 and drifter have been shown to #translate pn lineage information into distinct dendritic targeting specificity .
thus , acj6 and drifter have efficiently #translated pn lineage information into distinct dendritic targeting specificity .
thus , acj6 and drifter may have #translated pn lineage information into distinct dendritic targeting specificity .
thus , acj6 and drifter #translated pn lineage information into distinct dendritic targeting specificity .
thus , acj6 and drifter will efficiently #translate pn lineage information into distinct dendritic targeting specificity .
thus , acj6 and drifter will #translate pn lineage information into distinct dendritic targeting specificity .
stat1 y701f #translated in vitro can also dimerize on the lmp2 gas .
we also report the first definitive incorporation of sec into a selenoprotein #translated in reticulocyte lysates .
isgf3 gamma #translated in vitro from recombinant clones bound dna with a specificity indistinguishable from that of isgf3 gamma purified from hela cells .
alternative splicing of exon 4 results in a transcript which would be #translated into a c-terminal truncated protein containing the first , second and third transmembrane domains , while the splicing out of exons 3 and 4 would produce a protein with five membrane-spanning domains but lacking the third and fourth domains present in the et-ar protein .
interestingly , this reduction in liver injury failed to #translate into improved survival .
this review examines the use of new and emerging dna , tissue , and live-cell transfection microarray technologies that can be used to discover , validate , and #translate information resulting from the completion of the human genome project .
these changes further #translate into altered expression levels and time kinetics of a number of early genes (peak expression at 2 h after stimulation) .
acj6 and drifter are able to #translate with high fidelity pn lineage information into distinct dendritic targeting specificity .
isgf3 gamma being able to be #translated in in vitro from recombinant clones bound dna with a specificity indistinguishable clones bound dna with a specificity indistinguishable from that of isgf3 gamma purified from hela cells .
isgf3 gamma observed to be #translated in in vitro from recombinant clones bound dna with a specificity indistinguishable clones bound dna with a specificity indistinguishable from that of isgf3 gamma purified from hela cells .
isgf3 gamma properly #translated in in vitro from recombinant clones bound dna with a specificity indistinguishable clones bound dna with a specificity indistinguishable from that of isgf3 gamma purified from hela cells .
acj6 and drifter are likely to successfully #translate with high fidelity pn lineage information into distinct dendritic targeting specificity .
acj6 and drifter are likely to use signalling networks to commonly #translate pn lineage information into distinct dendritic targeting specificity .
isgf3 gamma that can be #translated in in vitro from recombinant clones bound dna with a specificity indistinguishable clones bound dna with a specificity indistinguishable from that of isgf3 gamma purified from hela cells .
isgf3 gamma that has been properly #translated in in vitro from recombinant clones bound dna with a specificity indistinguishable clones bound dna with a specificity indistinguishable from that of isgf3 gamma purified from hela cells .
acj6 and drifter are observed to successfully #translate with high fidelity pn lineage information into distinct dendritic targeting specificity .
acj6 and drifter are observed to #translate with high fidelity pn lineage information into distinct dendritic targeting specificity .
acj6 and drifter are observed to use signalling networks to #translate pn lineage information into distinct dendritic targeting specificity with high fidelity .
acj6 and drifter are observed to use signalling networks to #translate with high fidelity pn lineage information into distinct dendritic targeting specificity .
isgf3 gamma that is able to be #translated in in vitro from recombinant clones bound dna with a specificity indistinguishable clones bound dna with a specificity indistinguishable from that of isgf3 gamma purified from hela cells .
acj6 and drifter can successfully #translate with high fidelity pn lineage information into distinct dendritic targeting specificity .
acj6 and drifter can #translate with high fidelity pn lineage information into distinct dendritic targeting specificity .
isgf3 gamma that is observed to be #translated in in vitro from recombinant clones bound dna with a specificity indistinguishable clones bound dna with a specificity indistinguishable from that of isgf3 gamma purified from hela cells .
acj6 and drifter can use signalling networks to #translate with high fidelity pn lineage information into distinct dendritic targeting specificity .
isgf3 gamma that is properly #translated in in vitro from recombinant clones bound dna with a specificity indistinguishable clones bound dna with a specificity indistinguishable from that of isgf3 gamma purified from hela cells .
acj6 and drifter have been shown to successfully #translate with high fidelity pn lineage information into distinct dendritic targeting specificity .
acj6 and drifter have been shown to #translate with high fidelity pn lineage information into distinct dendritic targeting specificity .
acj6 and drifter have been shown to use signalling networks to commonly #translate pn lineage information into distinct dendritic targeting specificity .
isgf3 gamma that may have been properly #translated in in vitro from recombinant clones bound dna with a specificity indistinguishable clones bound dna with a specificity indistinguishable from that of isgf3 gamma purified from hela cells .
acj6 and drifter have been shown to use signalling networks to #translate with high fidelity pn lineage information into distinct dendritic targeting specificity .
isgf3 gamma that may have been #translated in in vitro from recombinant clones bound dna with a specificity indistinguishable clones bound dna with a specificity indistinguishable from that of isgf3 gamma purified from hela cells .
acj6 and drifter have successfully #translated with high fidelity pn lineage information into distinct dendritic targeting specificity .
isgf3 gamma that was properly #translated in in vitro from recombinant clones bound dna with a specificity indistinguishable clones bound dna with a specificity indistinguishable from that of isgf3 gamma purified from hela cells .
isgf3 gamma that will be #translated in in vitro from recombinant clones bound dna with a specificity indistinguishable clones bound dna with a specificity indistinguishable from that of isgf3 gamma purified from hela cells .
acj6 and drifter have the ability to use signalling networks to #translate pn lineage information into distinct dendritic targeting specificity with high fidelity .
isgf3 gamma #translated vitro from recombinant from that of isgf3 gamma purified from hela cells .
in reticulocyte lysates translation and partial purification of fstat1 , a selenoprotein were #translated in vitro using the t7-based coupled transcription-translation kit (promega) as per the manufacturer fs instructions .
acj6 and drifter have the ability to use signalling networks to #translate with high fidelity pn lineage information into distinct dendritic targeting specificity .
acj6 and drifter have #translated with high fidelity pn lineage information into distinct dendritic targeting specificity .
acj6 and drifter have used signalling networks to commonly #translate pn lineage information into distinct dendritic targeting specificity .
acj6 and drifter have used signalling networks to #translate pn lineage information into distinct dendritic targeting specificity with high fidelity .
stat1 y701f are able to be #translated in vitro and partially purified on heparin-agarose .
acj6 and drifter have used signalling networks to #translate with high fidelity pn lineage information into distinct dendritic targeting specificity .
stat1 y701f are observed to be #translated in vitro and partially purified on heparin-agarose .
stat1 y701f are #translated in vitro and partially purified on heparin-agarose .
acj6 and drifter may have used signalling networks to commonly #translate pn lineage information into distinct dendritic targeting specificity .
acj6 and drifter may have used signalling networks to #translate with high fidelity pn lineage information into distinct dendritic targeting specificity .
stat1 y701f have been #translated in vitro and partially purified on heparin-agarose .
stat1 y701f have the ability to be #translated in vitro and partially purified on heparin-agarose .
acj6 and drifter may #translate with high fidelity pn lineage information into distinct dendritic targeting specificity .
stat1 y701f may have been #translated in vitro and partially purified on heparin-agarose .
stat1 y701f that are able to be #translated in vitro are partially purified on heparin-agarose .
acj6 and drifter successfully #translate with high fidelity pn lineage information into distinct dendritic targeting specificity .
stat1 y701f that are likely to be properly #translated in vitro are partially purified on heparin-agarose .
stat1 y701f that are likely to be #translated in vitro are partially purified on heparin-agarose .
acj6 and drifter #translate with high fidelity pn lineage information into distinct dendritic targeting specificity .
stat1 y701f that are observed to be properly #translated in vitro are partially purified on heparin-agarose .
acj6 and drifter #translated with high fidelity pn lineage information into distinct dendritic targeting specificity .
stat1 y701f that are observed to be #translated in vitro are partially purified on heparin-agarose .
acj6 and drifter use signalling networks to #translate with high fidelity pn lineage information into distinct dendritic targeting specificity .
stat1 y701f that are properly #translated in vitro are partially purified on heparin-agarose .
stat1 y701f that are #translated in vitro are partially purified on heparin-agarose .
acj6 and drifter used signalling networks to #translate pn lineage information into distinct dendritic targeting specificity with high fidelity .
acj6 and drifter used signalling networks to #translate with high fidelity pn lineage information into distinct dendritic targeting specificity .
acj6 and drifter will successfully #translate with high fidelity pn lineage information into distinct dendritic targeting specificity .
stat1 y701f that have been properly #translated in vitro are partially purified on heparin-agarose .
stat1 y701f that have been shown to be properly #translated in vitro are partially purified on heparin-agarose .
stat1 y701f that have been shown to be #translated in vitro are partially purified on heparin-agarose .
acj6 and drifter will use signalling networks to #translate pn lineage information into distinct dendritic targeting specificity with high fidelity .
acj6 and drifter will use signalling networks to #translate with high fidelity pn lineage information into distinct dendritic targeting specificity .
acj6 and drifter , as our study has proven , are able to use signalling networks to #translate pn lineage information into distinct dendritic targeting specificity .
acj6 and drifter , as our study has proven , are likely to use signalling networks to #translate pn lineage information into distinct dendritic targeting specificity .
acj6 and drifter , as our study has proven , are observed to use signalling networks to #translate pn lineage information into distinct dendritic targeting specificity .
stat1 y701f that may be #translated in vitro are partially purified on heparin-agarose .
acj6 and drifter , as our study has proven , can use signalling networks to #translate pn lineage information into distinct dendritic targeting specificity .
stat1 y701f that may have been properly #translated in vitro are partially purified on heparin-agarose .
acj6 and drifter , as our study has proven , have been shown to use signalling networks to #translate pn lineage information into distinct dendritic targeting specificity .
stat1 y701f that may have been #translated in vitro are partially purified on heparin-agarose .
stat1 y701f that will be properly #translated in vitro are partially purified on heparin-agarose .
stat1 y701f that will be #translated in vitro are partially purified on heparin-agarose .
stat1 y701f were #translated in vitro and partially purified on heparin-agarose .
stat1 y701f , stat1 n135 , stat1 n200 and stat5/1 are #translated in vitro and partially purified on heparin-agarose .
stat1 y701f , stat1 n135 , stat1 n200 and stat5/1 may be #translated in vitro and partially purified on heparin-agarose .
stat1 y701f , stat1 n135 , stat1 n200 and stat5/1 may have been #translated in vitro and partially purified on heparin-agarose .
stat1 y701f , stat1 n135 , stat1 n200 and stat5/1 that can be properly #translated in vitro are partially purified on heparin-agarose .
stat1 y701f , stat1 n135 , stat1 n200 and stat5/1 that have been properly #translated in vitro are partially purified on heparin-agarose .
stat1 y701f , stat1 n135 , stat1 n200 and stat5/1 that have been shown to be #translated in vitro are partially purified on heparin-agarose .
stat1 y701f , stat1 n135 , stat1 n200 and stat5/1 that have been #translated in vitro are partially purified on heparin-agarose .
stat1 y701f , stat1 n135 , stat1 n200 and stat5/1 that have the ability to be properly #translated in vitro are partially purified on heparin-agarose .
stat1 y701f , stat1 n135 , stat1 n200 and stat5/1 that have the ability to be #translated in vitro are partially purified on heparin-agarose .
stat1 y701f , stat1 n135 , stat1 n200 and stat5/1 that may be properly #translated in vitro are partially purified on heparin-agarose .
stat1 y701f , stat1 n135 , stat1 n200 and stat5/1 that may have been #translated in vitro are partially purified on heparin-agarose .
stat1 y701f , stat1 n135 , stat1 n200 and stat5/1 that will be properly #translated in vitro are partially purified on heparin-agarose .
stat1 y701f , stat1 n135 , stat1 n200 and stat5/1 that will be #translated in vitro are partially purified on heparin-agarose .
stat1 y701f , stat1 n135 , stat1 n200 and stat5/1 #translated in vitro can also dimerize on the lmp2 gas .
stat1 y701f , stat1 n135 , stat1 n200 and stat5/1 were #translated in vitro and partially purified on heparin-agarose .
stat1 y701f , stat1 n135 , stat1 n200 and stat5/1 which can be probably #translated in vitro can also dimerize on the lmp2 gas .
stat1 y701f , stat1 n135 , stat1 n200 and stat5/1 which has been shown to be probably #translated in vitro can also dimerize on the lmp2 gas .
stat1 y701f , stat1 n135 , stat1 n200 and stat5/1 which has been shown to be #translated in vitro can also dimerize on the lmp2 gas .
stat1 y701f , stat1 n135 , stat1 n200 and stat5/1 which is able to be #translated in vitro can also dimerize on the lmp2 gas .
stat1 y701f , stat1 n135 , stat1 n200 and stat5/1 which is probably #translated in vitro can also dimerize on the lmp2 gas .
stat1 y701f , stat1 n135 , stat1 n200 and stat5/1 which may be #translated in vitro can also dimerize on the lmp2 gas .
stat1 y701f , stat1 n135 , stat1 n200 and stat5/1 which was probably #translated in vitro can also dimerize on the lmp2 gas .
stat1 y701f , stat1 n135 , stat1 n200 and stat5/1 which was #translated in vitro can also dimerize on the lmp2 gas .
stat1 y701f , stat1 n135 , stat1 n200 and stat5/1 which will be probably #translated in vitro can also dimerize on the lmp2 gas .
stat1 y701f , stat1 n135 , stat1 n200 and stat5/1 will be #translated in vitro and partially purified on heparin-agarose .
stat1 y701f , stat1 n135 , stat1 n200 and stat5/1 , as our data reveals , are #translated in vitro and partially purified on heparin-agarose .
stat1 y701f , as our data reveals , are able to be #translated in vitro and partially purified on heparin-agarose .
stat1 y701f , as our data reveals , have been shown to be #translated in vitro and partially purified on heparin-agarose .
in addition , our data show that this reduction in liver injury performed by these molecules/pathways in promoting cell survival or apoptosis/anoikis are likely to #translate into improved survival .
stat1 y701f , as our data reveals , have been #translated in vitro and partially purified on heparin-agarose .
stat1 y701f , as our data reveals , have the ability to be #translated in vitro and partially purified on heparin-agarose .
stat1 y701f , as our data reveals , will be #translated in vitro and partially purified on heparin-agarose .
stat1 , stat1 y701f , stat1 n135 , stat1 n200 and stat5/1 which has been probably #translated in vitro can also dimerize on the lmp2 gas .
in addition , our data show that this reduction in liver injury performed by these molecules/pathways in promoting cell survival or apoptosis/anoikis have the ability to #translate into improved survival .
in addition , our data show that this reduction in liver injury performed by these molecules/pathways in promoting cell survival or apoptosis/anoikis have #translated into improved survival .
stat1 , stat1 y701f , stat1 n135 , stat1 n200 and stat5/1 which has been shown to be #translated in vitro can also dimerize on the lmp2 gas .
cells , thus , are likely to efficiently #translate extracellular signals into specific cellular functions .
in addition , our data show that this reduction in liver injury performed by these molecules/pathways in promoting cell survival or apoptosis/anoikis may have efficiently #translated into improved survival .
in addition , our data show that this reduction in liver injury performed by these molecules/pathways in promoting cell survival or apoptosis/anoikis may have #translated into improved survival .
in addition , our data show that this reduction in liver injury performed by these molecules/pathways in promoting cell survival or apoptosis/anoikis may #translate into improved survival .
cells , thus , can efficiently #translate extracellular signals into specific cellular functions .
stat1 , stat1 y701f , stat1 n135 , stat1 n200 and stat5/1 which is likely to be #translated in vitro can also dimerize on the lmp2 gas .
cells , thus , can #translate extracellular signals into specific cellular functions .
in addition , our data show that this reduction in liver injury performed by these molecules/pathways in promoting cell survival or apoptosis/anoikis #translated into improved survival .
in addition , our data show that this reduction in liver injury performed by these molecules/pathways in promoting cell survival or apoptosis/anoikis will efficiently #translate into improved survival .
stat1 , stat1 y701f , stat1 n135 , stat1 n200 and stat5/1 which is probably #translated in vitro can also dimerize on the lmp2 gas .
in addition , our data show that this reduction in liver injury performed by these molecules/pathways in promoting cell survival or apoptosis/anoikis will #translate into improved survival .
in addition , this reduction in liver injury performed by these molecules/pathways in promoting cell survival or apoptosis/anoikis , as our data have shown , are able to efficiently #translate into improved survival .
in addition , this reduction in liver injury performed by these molecules/pathways in promoting cell survival or apoptosis/anoikis , as our data have shown , are able to #translate into improved survival .
cells , thus , have the ability to efficiently #translate extracellular signals into specific cellular functions .
stat1 , stat1 y701f , stat1 n135 , stat1 n200 and stat5/1 which may be #translated in vitro can also dimerize on the lmp2 gas .
in addition , this reduction in liver injury performed by these molecules/pathways in promoting cell survival or apoptosis/anoikis , as our data have shown , are likely to efficiently #translate into improved survival .
in addition , this reduction in liver injury performed by these molecules/pathways in promoting cell survival or apoptosis/anoikis , as our data have shown , are likely to #translate into improved survival .
cells , thus , have #translated extracellular signals into specific cellular functions .
in addition , this reduction in liver injury performed by these molecules/pathways in promoting cell survival or apoptosis/anoikis , as our data have shown , are observed to #translate into improved survival .
stat1 , stat1 y701f , stat1 n135 , stat1 n200 and stat5/1 which will be #translated in vitro can also dimerize on the lmp2 gas .
we also report the first definitive incorporation of sec into stat1 y701f #translated in vitro .
cells , thus , may #translate extracellular signals into specific cellular functions .
we also report the first definitive incorporation of sec into stat1 y701f which can be successfully #translated in vitro .
cells , thus , will #translate extracellular signals into specific cellular functions .
in addition , this reduction in liver injury performed by these molecules/pathways in promoting cell survival or apoptosis/anoikis , as our data have shown , have efficiently #translated into improved survival .
we also report the first definitive incorporation of sec into stat1 y701f which has been shown to be #translated in vitro .
thus , cells are able to efficiently #translate extracellular signals into specific cellular functions .
thus , cells are able to #translate extracellular signals into specific cellular functions .
in addition , this reduction in liver injury performed by these molecules/pathways in promoting cell survival or apoptosis/anoikis , as our data have shown , have the ability to #translate into improved survival .
we also report the first definitive incorporation of sec into stat1 y701f which is able to be successfully #translated in vitro .
in addition , this reduction in liver injury performed by these molecules/pathways in promoting cell survival or apoptosis/anoikis , as our data have shown , may efficiently #translate into improved survival .
we also report the first definitive incorporation of sec into stat1 y701f which is able to be #translated in vitro .
thus , cells are observed to efficiently #translate extracellular signals into specific cellular functions .
in addition , this reduction in liver injury performed by these molecules/pathways in promoting cell survival or apoptosis/anoikis , as our data have shown , may have efficiently #translated into improved survival .
in addition , this reduction in liver injury performed by these molecules/pathways in promoting cell survival or apoptosis/anoikis , as our data have shown , may have #translated into improved survival .
thus , cells can efficiently #translate extracellular signals into specific cellular functions .
we also report the first definitive incorporation of sec into stat1 y701f which is observed to be successfully #translated in vitro .
in addition , this reduction in liver injury performed by these molecules/pathways in promoting cell survival or apoptosis/anoikis , as our data have shown , may #translate into improved survival .
in addition , this reduction in liver injury performed by these molecules/pathways in promoting cell survival or apoptosis/anoikis , as our data have shown , #translated into improved survival .
we also report the first definitive incorporation of sec into stat1 y701f which is successfully #translated in vitro .
thus , cells have been shown to #translate extracellular signals into specific cellular functions .
thus , cells have efficiently #translated extracellular signals into specific cellular functions .
thus , cells have the ability to #translate extracellular signals into specific cellular functions .
we also report the first definitive incorporation of sec into stat1 y701f which may have been #translated in vitro .
we also report the first definitive incorporation of sec into stat1 y701f which was successfully #translated in vitro .
thus , cells may efficiently #translate extracellular signals into specific cellular functions .
we also report the first definitive incorporation of sec into stat1 y701f which will be #translated in vitro .
thus , cells may #translate extracellular signals into specific cellular functions .
we also report the first definitive incorporation of sec into stat1 y701f , stat1 n135 , stat1 n200 and stat5/1 which can be #translated in vitro .
we also report the first definitive incorporation of sec into stat1 y701f , stat1 n135 , stat1 n200 and stat5/1 which has been shown to be successfully #translated in vitro .
we also report the first definitive incorporation of sec into stat1 y701f , stat1 n135 , stat1 n200 and stat5/1 which has been successfully #translated in vitro .
we also report the first definitive incorporation of sec into stat1 y701f , stat1 n135 , stat1 n200 and stat5/1 which has been #translated in vitro .
we also report the first definitive incorporation of sec into stat1 y701f , stat1 n135 , stat1 n200 and stat5/1 which is able to be successfully #translated in vitro .
we also report the first definitive incorporation of sec into stat1 y701f , stat1 n135 , stat1 n200 and stat5/1 which is likely to be successfully #translated in vitro .
we also report the first definitive incorporation of sec into stat1 y701f , stat1 n135 , stat1 n200 and stat5/1 which is likely to be #translated in vitro .
we also report the first definitive incorporation of sec into stat1 y701f , stat1 n135 , stat1 n200 and stat5/1 which is successfully #translated in vitro .
we also report the first definitive incorporation of sec into stat1 y701f , stat1 n135 , stat1 n200 and stat5/1 which may be #translated in vitro .
we also report the first definitive incorporation of sec into stat1 y701f , stat1 n135 , stat1 n200 and stat5/1 which may have been #translated in vitro .
we also report the first definitive incorporation of sec into stat1 y701f , stat1 n135 , stat1 n200 and stat5/1 which was successfully #translated in vitro .
we also report the first definitive incorporation of sec into stat1 y701f , stat1 n135 , stat1 n200 and stat5/1 which will be successfully #translated in vitro .
we also report the first definitive incorporation of sec into stat1 y701f , stat1 n135 , stat1 n200 and stat5/1 which will be #translated in vitro .
we also report the first definitive incorporation of sec into stat1 , stat1 y701f , stat1 n135 , stat1 n200 and stat5/1 #translated in vitro .
we also report the first definitive incorporation of sec into stat1 , stat1 y701f , stat1 n135 , stat1 n200 and stat5/1 which can be #translated in vitro .
we also report the first definitive incorporation of sec into stat1 , stat1 y701f , stat1 n135 , stat1 n200 and stat5/1 which has been shown to be successfully #translated in vitro .
extracellular signals can be efficiently #translated by cells into specific cellular functions .
we also report the first definitive incorporation of sec into stat1 , stat1 y701f , stat1 n135 , stat1 n200 and stat5/1 which has been successfully #translated in vitro .
we also report the first definitive incorporation of sec into stat1 , stat1 y701f , stat1 n135 , stat1 n200 and stat5/1 which has been #translated in vitro .
we also report the first definitive incorporation of sec into stat1 , stat1 y701f , stat1 n135 , stat1 n200 and stat5/1 which is able to be #translated in vitro .
we also report the first definitive incorporation of sec into stat1 , stat1 y701f , stat1 n135 , stat1 n200 and stat5/1 which is observed to be successfully #translated in vitro .
extracellular signals can be #translated into specific cellular functions by cells .
we also report the first definitive incorporation of sec into stat1 , stat1 y701f , stat1 n135 , stat1 n200 and stat5/1 which is observed to be #translated in vitro .
we also report the first definitive incorporation of sec into stat1 , stat1 y701f , stat1 n135 , stat1 n200 and stat5/1 which is successfully #translated in vitro .
we also report the first definitive incorporation of sec into stat1 , stat1 y701f , stat1 n135 , stat1 n200 and stat5/1 which is #translated in vitro .
extracellular signals has been efficiently #translated into specific cellular functions by cells .
we also report the first definitive incorporation of sec into stat1 , stat1 y701f , stat1 n135 , stat1 n200 and stat5/1 which may have been successfully #translated in vitro .
we also report the first definitive incorporation of sec into stat1 , stat1 y701f , stat1 n135 , stat1 n200 and stat5/1 which may have been #translated in vitro .
we also report the first definitive incorporation of sec into stat1 , stat1 y701f , stat1 n135 , stat1 n200 and stat5/1 which was successfully #translated in vitro .
we also report the first definitive incorporation of sec into stat1 , stat1 y701f , stat1 n135 , stat1 n200 and stat5/1 which was #translated in vitro .
extracellular signals has been shown to be #translated by cells into specific cellular functions .
a selenoprotein are likely to be #translated in reticulocyte lysates and partially purified on heparin-agarose .
extracellular signals has been #translated by cells into specific cellular functions .
a selenoprotein are #translated in reticulocyte lysates and partially purified on heparin-agarose .
a selenoprotein have been shown to be #translated in reticulocyte lysates and partially purified on heparin-agarose .
a selenoprotein may have been #translated in reticulocyte lysates and partially purified on heparin-agarose .
extracellular signals is able to be efficiently #translated into specific cellular functions by cells .
extracellular signals is able to be #translated by cells into specific cellular functions .
a selenoprotein that are able to be #translated in reticulocyte lysates are partially purified on heparin-agarose .
extracellular signals is efficiently #translated by cells into specific cellular functions .
a selenoprotein that are observed to be #translated in reticulocyte lysates are partially purified on heparin-agarose .
a selenoprotein that are properly #translated in reticulocyte lysates are partially purified on heparin-agarose .
extracellular signals is efficiently #translated into specific cellular functions by cells .
a selenoprotein that are #translated in reticulocyte lysates are partially purified on heparin-agarose .
a selenoprotein that can be properly #translated in reticulocyte lysates are partially purified on heparin-agarose .
a selenoprotein that have been properly #translated in reticulocyte lysates are partially purified on heparin-agarose .
extracellular signals is likely to be efficiently #translated into specific cellular functions by cells .
extracellular signals is likely to be #translated by cells into specific cellular functions .
a selenoprotein that have the ability to be properly #translated in reticulocyte lysates are partially purified on heparin-agarose .
a selenoprotein that have the ability to be #translated in reticulocyte lysates are partially purified on heparin-agarose .
extracellular signals is likely to be #translated into specific cellular functions by cells .
extracellular signals is observed to be efficiently #translated by cells into specific cellular functions .
a selenoprotein that may be properly #translated in reticulocyte lysates are partially purified on heparin-agarose .
a selenoprotein that may have been #translated in reticulocyte lysates are partially purified on heparin-agarose .
a selenoprotein that will be properly #translated in reticulocyte lysates are partially purified on heparin-agarose .
a selenoprotein that will be #translated in reticulocyte lysates are partially purified on heparin-agarose .
a selenoprotein #translated in reticulocyte lysates can also dimerize on the lmp2 gas .
extracellular signals is observed to be #translated into specific cellular functions by cells .
a selenoprotein were #translated in reticulocyte lysates and partially purified on heparin-agarose .
extracellular signals is #translated by cells into specific cellular functions .
a selenoprotein which has been probably #translated in reticulocyte lysates can also dimerize on the lmp2 gas .
a selenoprotein which has been shown to be #translated in reticulocyte lysates can also dimerize on the lmp2 gas .
extracellular signals may be efficiently #translated by cells into specific cellular functions .
a selenoprotein which is able to be probably #translated in reticulocyte lysates can also dimerize on the lmp2 gas .
extracellular signals may be efficiently #translated into specific cellular functions by cells .
a selenoprotein which is able to be #translated in reticulocyte lysates can also dimerize on the lmp2 gas .
extracellular signals may have been efficiently #translated by cells into specific cellular functions .
a selenoprotein which is probably #translated in reticulocyte lysates can also dimerize on the lmp2 gas .
a selenoprotein which may be #translated in reticulocyte lysates can also dimerize on the lmp2 gas .
extracellular signals may have been efficiently #translated into specific cellular functions by cells .
a selenoprotein which was probably #translated in reticulocyte lysates can also dimerize on the lmp2 gas .
extracellular signals may have been #translated into specific cellular functions by cells .
a selenoprotein , as our data reveals , are likely to be #translated in reticulocyte lysates and partially purified on heparin-agarose .
a selenoprotein , as our data reveals , are #translated in reticulocyte lysates and partially purified on heparin-agarose .
a selenoprotein , as our data reveals , can be #translated in reticulocyte lysates and partially purified on heparin-agarose .
a selenoprotein , as our data reveals , have been #translated in reticulocyte lysates and partially purified on heparin-agarose .
extracellular signals was #translated into specific cellular functions by cells .
extracellular signals will be efficiently #translated by cells into specific cellular functions .
a selenoprotein , as our data reveals , may have been #translated in reticulocyte lysates and partially purified on heparin-agarose .
extracellular signals will be efficiently #translated into specific cellular functions by cells .
a selenoprotein , as our data reveals , will be #translated in reticulocyte lysates and partially purified on heparin-agarose .
extracellular signals will be #translated into specific cellular functions by cells .
our data show that this reduction in liver injury performed by these molecules/pathways in promoting cell survival or apoptosis/anoikis , in addition , are able to efficiently #translate into improved survival .
our data show that this reduction in liver injury performed by these molecules/pathways in promoting cell survival or apoptosis/anoikis , in addition , are able to #translate into improved survival .
our data show that this reduction in liver injury performed by these molecules/pathways in promoting cell survival or apoptosis/anoikis , in addition , are likely to #translate into improved survival .
our data show that this reduction in liver injury performed by these molecules/pathways in promoting cell survival or apoptosis/anoikis , in addition , are observed to efficiently #translate into improved survival .
our data show that this reduction in liver injury performed by these molecules/pathways in promoting cell survival or apoptosis/anoikis , in addition , are observed to #translate into improved survival .
our data show that this reduction in liver injury performed by these molecules/pathways in promoting cell survival or apoptosis/anoikis , in addition , can efficiently #translate into improved survival .
our data show that this reduction in liver injury performed by these molecules/pathways in promoting cell survival or apoptosis/anoikis , in addition , can #translate into improved survival .
our data show that this reduction in liver injury performed by these molecules/pathways in promoting cell survival or apoptosis/anoikis , in addition , have the ability to efficiently #translate into improved survival .
our data show that this reduction in liver injury performed by these molecules/pathways in promoting cell survival or apoptosis/anoikis , in addition , have the ability to #translate into improved survival .
our data show that this reduction in liver injury performed by these molecules/pathways in promoting cell survival or apoptosis/anoikis , in addition , may have efficiently #translated into improved survival .
our data show that this reduction in liver injury performed by these molecules/pathways in promoting cell survival or apoptosis/anoikis , in addition , may have #translated into improved survival .
our data show that this reduction in liver injury performed by these molecules/pathways in promoting cell survival or apoptosis/anoikis , in addition , may #translate into improved survival .
our data show that this reduction in liver injury performed by these molecules/pathways in promoting cell survival or apoptosis/anoikis , in addition , #translated into improved survival .
our data show that this reduction in liver injury performed by these molecules/pathways in promoting cell survival or apoptosis/anoikis , in addition , will efficiently #translate into improved survival .
remarkably , this reduction in liver injury are likely to #translate into improved survival .
remarkably , this reduction in liver injury are observed to #translate into improved survival .
remarkably , this reduction in liver injury can #translate into improved survival .
remarkably , this reduction in liver injury have been shown to #translate into improved survival .
remarkably , this reduction in liver injury have the ability to #translate into improved survival .
remarkably , this reduction in liver injury may #translate into improved survival .
remarkably , this reduction in liver injury #translated into improved survival .
the simple rules governing how this reduction in liver injury #translate into improved survival are found across social groups , giving social insects the potential to have a profound impact on our understanding of the interplay between network dynamics and social evolution .
under the simple governing rules found across social groups , this reduction in liver injury are able to properly #translate into improved survival , giving social insects the potential to have a profound impact on our understanding of the interplay between network dynamics and social evolution .
under the simple governing rules found across social groups , this reduction in liver injury are able to #translate into improved survival , giving social insects the potential to have a profound impact on our understanding of the interplay between network dynamics and social evolution .
under the simple governing rules found across social groups , this reduction in liver injury are likely to properly #translate into improved survival , giving social insects the potential to have a profound impact on our understanding of the interplay between network dynamics and social evolution .
under the simple governing rules found across social groups , this reduction in liver injury can properly #translate into improved survival , giving social insects the potential to have a profound impact on our understanding of the interplay between network dynamics and social evolution .
under the simple governing rules found across social groups , this reduction in liver injury can #translate into improved survival , giving social insects the potential to have a profound impact on our understanding of the interplay between network dynamics and social evolution .
under the simple governing rules found across social groups , this reduction in liver injury have been shown to #translate into improved survival , giving social insects the potential to have a profound impact on our understanding of the interplay between network dynamics and social evolution .
under the simple governing rules found across social groups , this reduction in liver injury have properly #translated into improved survival , giving social insects the potential to have a profound impact on our understanding of the interplay between network dynamics and social evolution .
under the simple governing rules found across social groups , this reduction in liver injury have the ability to #translate into improved survival , giving social insects the potential to have a profound impact on our understanding of the interplay between network dynamics and social evolution .
under the simple governing rules found across social groups , this reduction in liver injury may have #translated into improved survival , giving social insects the potential to have a profound impact on our understanding of the interplay between network dynamics and social evolution .
under the simple governing rules found across social groups , this reduction in liver injury may #translate into improved survival , giving social insects the potential to have a profound impact on our understanding of the interplay between network dynamics and social evolution .
under the simple governing rules found across social groups , this reduction in liver injury properly #translate into improved survival , giving social insects the potential to have a profound impact on our understanding of the interplay between network dynamics and social evolution .
under the simple governing rules found across social groups , this reduction in liver injury properly #translated into improved survival , giving social insects the potential to have a profound impact on our understanding of the interplay between network dynamics and social evolution .
under the simple governing rules found across social groups , this reduction in liver injury #translate into improved survival , giving social insects the potential to have a profound impact on our understanding of the interplay between network dynamics and social evolution .
under the simple governing rules found across social groups , this reduction in liver injury #translated into improved survival , giving social insects the potential to have a profound impact on our understanding of the interplay between network dynamics and social evolution .
under the simple governing rules found across social groups , this reduction in liver injury will properly #translate into improved survival , giving social insects the potential to have a profound impact on our understanding of the interplay between network dynamics and social evolution .
this reduction in liver injury can successfully #translate into improved survival , thus partly explaining the increase in power output .
this reduction in liver injury has been shown to #translate into improved survival , thus partly explaining the increase in power output .
this reduction in liver injury has successfully #translated into improved survival , thus partly explaining the increase in power output .
this reduction in liver injury has the ability to #translate into improved survival , thus partly explaining the increase in power output .
this reduction in liver injury has #translated into improved survival , thus partly explaining the increase in power output .
this reduction in liver injury is able to successfully #translate into improved survival , thus partly explaining the increase in power output .
this reduction in liver injury is likely to #translate into improved survival , thus partly explaining the increase in power output .
this reduction in liver injury may have #translated into improved survival , thus partly explaining the increase in power output .
this reduction in liver injury may #translate into improved survival , thus partly explaining the increase in power output .
this reduction in liver injury successfully #translated into improved survival , thus partly explaining the increase in power output .
this reduction in liver injury successfully #translates into improved survival , thus partly explaining the increase in power output .
this reduction in liver injury will successfully #translate into improved survival , thus partly explaining the increase in power output .
this reduction in liver injury will #translate into improved survival , thus partly explaining the increase in power output .
this reduction in liver injury , however , has been shown to #translate into improved survival , thus partly explaining the increase in power output .
this reduction in liver injury , however , has successfully #translated into improved survival , thus partly explaining the increase in power output .
this reduction in liver injury , however , has the ability to successfully #translate into improved survival , thus partly explaining the increase in power output .
this reduction in liver injury , however , is likely to successfully #translate into improved survival , thus partly explaining the increase in power output .
this reduction in liver injury , however , is observed to successfully #translate into improved survival , thus partly explaining the increase in power output .
this reduction in liver injury , however , successfully #translated into improved survival , thus partly explaining the increase in power output .
this reduction in liver injury , however , successfully #translates into improved survival , thus partly explaining the increase in power output .
this reduction in liver injury , however , will #translate into improved survival , thus partly explaining the increase in power output .
in addition , these changes performed by these molecules/pathways in promoting cell survival or apoptosis/anoikis , as our data have shown , are likely to efficiently #translate into altered expression levels and time kinetics of a number of early genes .
in addition , these changes performed by these molecules/pathways in promoting cell survival or apoptosis/anoikis , as our data have shown , are likely to #translate into altered expression levels and time kinetics of a number of early genes .
in addition , these changes performed by these molecules/pathways in promoting cell survival or apoptosis/anoikis , as our data have shown , are observed to efficiently #translate into altered expression levels and time kinetics of a number of early genes .
in addition , these changes performed by these molecules/pathways in promoting cell survival or apoptosis/anoikis , as our data have shown , are observed to #translate into altered expression levels and time kinetics of a number of early genes .
in addition , these changes performed by these molecules/pathways in promoting cell survival or apoptosis/anoikis , as our data have shown , have efficiently #translated into altered expression levels and time kinetics of a number of early genes .
in addition , these changes performed by these molecules/pathways in promoting cell survival or apoptosis/anoikis , as our data have shown , may have efficiently #translated into altered expression levels and time kinetics of a number of early genes .
in addition , these changes performed by these molecules/pathways in promoting cell survival or apoptosis/anoikis , as our data have shown , may #translate into altered expression levels and time kinetics of a number of early genes .
in addition , these changes performed by these molecules/pathways in promoting cell survival or apoptosis/anoikis , as our data have shown , #translated into altered expression levels and time kinetics of a number of early genes .
in addition , these changes performed by these molecules/pathways in promoting cell survival or apoptosis/anoikis , as our data have shown , will efficiently #translate into altered expression levels and time kinetics of a number of early genes .
in addition , our data show that these changes performed by these molecules/pathways in promoting cell survival or apoptosis/anoikis are able to efficiently #translate into altered expression levels and time kinetics of a number of early genes .
in addition , our data show that these changes performed by these molecules/pathways in promoting cell survival or apoptosis/anoikis are likely to efficiently #translate into altered expression levels and time kinetics of a number of early genes .
in addition , our data show that these changes performed by these molecules/pathways in promoting cell survival or apoptosis/anoikis are likely to #translate into altered expression levels and time kinetics of a number of early genes .
in addition , our data show that these changes performed by these molecules/pathways in promoting cell survival or apoptosis/anoikis are observed to efficiently #translate into altered expression levels and time kinetics of a number of early genes .
in addition , our data show that these changes performed by these molecules/pathways in promoting cell survival or apoptosis/anoikis are observed to #translate into altered expression levels and time kinetics of a number of early genes .
in addition , our data show that these changes performed by these molecules/pathways in promoting cell survival or apoptosis/anoikis efficiently #translated into altered expression levels and time kinetics of a number of early genes .
in addition , our data show that these changes performed by these molecules/pathways in promoting cell survival or apoptosis/anoikis have been shown to #translate into altered expression levels and time kinetics of a number of early genes .
in addition , our data show that these changes performed by these molecules/pathways in promoting cell survival or apoptosis/anoikis have efficiently #translated into altered expression levels and time kinetics of a number of early genes .
in addition , our data show that these changes performed by these molecules/pathways in promoting cell survival or apoptosis/anoikis have the ability to efficiently #translate into altered expression levels and time kinetics of a number of early genes .
in addition , our data show that these changes performed by these molecules/pathways in promoting cell survival or apoptosis/anoikis have #translated into altered expression levels and time kinetics of a number of early genes .
in addition , our data show that these changes performed by these molecules/pathways in promoting cell survival or apoptosis/anoikis may have #translated into altered expression levels and time kinetics of a number of early genes .
interestingly , these changes can fail to #translate into altered expression levels and time kinetics of a number of early genes .
interestingly , these changes fail to #translate into altered expression levels and time kinetics of a number of early genes .
interestingly , these changes failed to #translate into altered expression levels and time kinetics of a number of early genes .
interestingly , these changes has not #translated into altered expression levels and time kinetics of a number of early genes .
interestingly , these changes may have failed to #translate into altered expression levels and time kinetics of a number of early genes .
interestingly , these changes will not #translate into altered expression levels and time kinetics of a number of early genes .
our data show that these changes performed by these molecules/pathways in promoting cell survival or apoptosis/anoikis , in addition , are able to #translate into altered expression levels and time kinetics of a number of early genes .
our data show that these changes performed by these molecules/pathways in promoting cell survival or apoptosis/anoikis , in addition , are likely to #translate into altered expression levels and time kinetics of a number of early genes .
our data show that these changes performed by these molecules/pathways in promoting cell survival or apoptosis/anoikis , in addition , are observed to #translate into altered expression levels and time kinetics of a number of early genes .
our data show that these changes performed by these molecules/pathways in promoting cell survival or apoptosis/anoikis , in addition , efficiently #translated into altered expression levels and time kinetics of a number of early genes .
our data show that these changes performed by these molecules/pathways in promoting cell survival or apoptosis/anoikis , in addition , have efficiently #translated into altered expression levels and time kinetics of a number of early genes .
our data show that these changes performed by these molecules/pathways in promoting cell survival or apoptosis/anoikis , in addition , have the ability to efficiently #translate into altered expression levels and time kinetics of a number of early genes .
our data show that these changes performed by these molecules/pathways in promoting cell survival or apoptosis/anoikis , in addition , have the ability to #translate into altered expression levels and time kinetics of a number of early genes .
remarkably , these changes are likely to #translate into altered expression levels and time kinetics of a number of early genes .
remarkably , these changes are observed to #translate into altered expression levels and time kinetics of a number of early genes .
remarkably , these changes can #translate into altered expression levels and time kinetics of a number of early genes .
remarkably , these changes have the ability to #translate into altered expression levels and time kinetics of a number of early genes .
remarkably , these changes #translated into altered expression levels and time kinetics of a number of early genes .
remarkably , these changes will #translate into altered expression levels and time kinetics of a number of early genes .
the simple rules governing how these changes #translate into altered expression levels and time kinetics of a number of early genes are found across social groups , giving social insects the potential to have a profound impact on our understanding of the interplay between network dynamics and social evolution .
these changes can successfully #translate into altered expression levels and time kinetics of a number of early genes , thus partly explaining the increase in power output .
these changes has been shown to successfully #translate into altered expression levels and time kinetics of a number of early genes , thus partly explaining the increase in power output .
these changes has been shown to #translate into altered expression levels and time kinetics of a number of early genes , thus partly explaining the increase in power output .
these changes has the ability to successfully #translate into altered expression levels and time kinetics of a number of early genes , thus partly explaining the increase in power output .
these changes has the ability to #translate into altered expression levels and time kinetics of a number of early genes , thus partly explaining the increase in power output .
these changes has #translated into altered expression levels and time kinetics of a number of early genes , thus partly explaining the increase in power output .
these changes is observed to successfully #translate into altered expression levels and time kinetics of a number of early genes , thus partly explaining the increase in power output .
these changes may have successfully #translated into altered expression levels and time kinetics of a number of early genes , thus partly explaining the increase in power output .
these changes may #translate into altered expression levels and time kinetics of a number of early genes , thus partly explaining the increase in power output .
these changes , however , can #translate into altered expression levels and time kinetics of a number of early genes , thus partly explaining the increase in power output .
these changes , however , has been shown to successfully #translate into altered expression levels and time kinetics of a number of early genes , thus partly explaining the increase in power output .
these changes , however , has been shown to #translate into altered expression levels and time kinetics of a number of early genes , thus partly explaining the increase in power output .
these changes , however , has the ability to #translate into altered expression levels and time kinetics of a number of early genes , thus partly explaining the increase in power output .
these changes , however , has #translated into altered expression levels and time kinetics of a number of early genes , thus partly explaining the increase in power output .
these changes , however , is able to successfully #translate into altered expression levels and time kinetics of a number of early genes , thus partly explaining the increase in power output .
these changes , however , is observed to successfully #translate into altered expression levels and time kinetics of a number of early genes , thus partly explaining the increase in power output .
these changes , however , is observed to #translate into altered expression levels and time kinetics of a number of early genes , thus partly explaining the increase in power output .
these changes , however , may have #translated into altered expression levels and time kinetics of a number of early genes , thus partly explaining the increase in power output .
these changes , however , #translates into altered expression levels and time kinetics of a number of early genes , thus partly explaining the increase in power output .
under the simple governing rules found across social groups , these changes are able to #translate into altered expression levels and time kinetics of a number of early genes , giving social insects the potential to have a profound impact on our understanding of the interplay between network dynamics and social evolution .
under the simple governing rules found across social groups , these changes are likely to #translate into altered expression levels and time kinetics of a number of early genes , giving social insects the potential to have a profound impact on our understanding of the interplay between network dynamics and social evolution .
under the simple governing rules found across social groups , these changes are observed to properly #translate into altered expression levels and time kinetics of a number of early genes , giving social insects the potential to have a profound impact on our understanding of the interplay between network dynamics and social evolution .
under the simple governing rules found across social groups , these changes are observed to #translate into altered expression levels and time kinetics of a number of early genes , giving social insects the potential to have a profound impact on our understanding of the interplay between network dynamics and social evolution .
under the simple governing rules found across social groups , these changes have the ability to properly #translate into altered expression levels and time kinetics of a number of early genes , giving social insects the potential to have a profound impact on our understanding of the interplay between network dynamics and social evolution .
under the simple governing rules found across social groups , these changes have #translated into altered expression levels and time kinetics of a number of early genes , giving social insects the potential to have a profound impact on our understanding of the interplay between network dynamics and social evolution .
under the simple governing rules found across social groups , these changes may have properly #translated into altered expression levels and time kinetics of a number of early genes , giving social insects the potential to have a profound impact on our understanding of the interplay between network dynamics and social evolution .
under the simple governing rules found across social groups , these changes may have #translated into altered expression levels and time kinetics of a number of early genes , giving social insects the potential to have a profound impact on our understanding of the interplay between network dynamics and social evolution .
under the simple governing rules found across social groups , these changes may #translate into altered expression levels and time kinetics of a number of early genes , giving social insects the potential to have a profound impact on our understanding of the interplay between network dynamics and social evolution .
under the simple governing rules found across social groups , these changes properly #translated into altered expression levels and time kinetics of a number of early genes , giving social insects the potential to have a profound impact on our understanding of the interplay between network dynamics and social evolution .
under the simple governing rules found across social groups , these changes #translate into altered expression levels and time kinetics of a number of early genes , giving social insects the potential to have a profound impact on our understanding of the interplay between network dynamics and social evolution .
c-terminally truncated stat5a proteins likely to be remarkably #truncated at amino acids 762 or 773 had no effect on the induction of either gene .
c-terminally truncated stat5a proteins likely to be #truncated at amino acids 762 or 773 had no effect on the induction of either gene .
c-terminally truncated stat5a proteins observed to be #truncated at amino acids 762 or 773 had no effect on the induction of either gene .
c-terminally truncated stat5a proteins that are able to be remarkably #truncated at amino acids 762 or 773 had no effect on the induction of either gene .
c-terminally truncated stat5a proteins that are able to be #truncated at amino acids 762 or 773 had no effect on the induction of either gene .
c-terminally truncated stat5a proteins that are likely to be #truncated at amino acids 762 or 773 had no effect on the induction of either gene .
c-terminally truncated stat5a proteins that are observed to be #truncated at amino acids 762 or 773 had no effect on the induction of either gene .
c-terminally truncated stat5a proteins that have been shown to be remarkably #truncated at amino acids 762 or 773 had no effect on the induction of either gene .
c-terminally truncated stat5a proteins that have been shown to be #truncated at amino acids 762 or 773 had no effect on the induction of either gene .
c-terminally truncated stat5a proteins that have been #truncated at amino acids 762 or 773 had no effect on the induction of either gene .
c-terminally truncated stat5a proteins that may be remarkably #truncated at amino acids 762 or 773 had no effect on the induction of either gene .
c-terminally truncated stat5a proteins that may have been remarkably #truncated at amino acids 762 or 773 had no effect on the induction of either gene .
c-terminally truncated stat5a proteins that were #truncated at amino acids 762 or 773 had no effect on the induction of either gene .
c-terminally truncated stat5a proteins that will be remarkably #truncated at amino acids 762 or 773 had no effect on the induction of either gene .
c-terminally truncated stat5a proteins that will be #truncated at amino acids 762 or 773 had no effect on the induction of either gene .
electrophoretic mobility shift assays showed that the full-length bcl6 protein extracted from transfected cos cells and a bacterially expressed protein that can be remarkably #truncated and contains the bcl6 zinc fingers can bind specifically to dna from the u3 promoter/enhancer region of hiv-1 .
electrophoretic mobility shift assays showed that the full-length bcl6 protein extracted from transfected cos cells and a bacterially expressed protein that can be #truncated and contains the bcl6 zinc fingers can bind specifically to dna from the u3 promoter/enhancer region of hiv-1 .
electrophoretic mobility shift assays showed that the full-length bcl6 protein extracted from transfected cos cells and a bacterially expressed protein that contained the bcl6 zinc fingers and has been remarkably #truncated can bind specifically to dna from the u3 promoter/enhancer region of hiv-1 .
electrophoretic mobility shift assays showed that the full-length bcl6 protein extracted from transfected cos cells and a bacterially expressed protein that contained the bcl6 zinc fingers and has been shown to be remarkably #truncated can bind specifically to dna from the u3 promoter/enhancer region of hiv-1 .
electrophoretic mobility shift assays showed that the full-length bcl6 protein extracted from transfected cos cells and a bacterially expressed protein that contained the bcl6 zinc fingers and has been shown to be #truncated can bind specifically to dna from the u3 promoter/enhancer region of hiv-1 .
electrophoretic mobility shift assays showed that the full-length bcl6 protein extracted from transfected cos cells and a bacterially expressed protein that contained the bcl6 zinc fingers and has been #truncated can bind specifically to dna from the u3 promoter/enhancer region of hiv-1 .
electrophoretic mobility shift assays showed that the full-length bcl6 protein extracted from transfected cos cells and a bacterially expressed protein that contained the bcl6 zinc fingers and was #truncated can bind specifically to dna from the u3 promoter/enhancer region of hiv-1 .
electrophoretic mobility shift assays showed that the full-length bcl6 protein extracted from transfected cos cells and a bacterially expressed protein that contains the bcl6 zinc fingers and can be remarkably #truncated can bind specifically to dna from the u3 promoter/enhancer region of hiv-1 .
electrophoretic mobility shift assays showed that the full-length bcl6 protein extracted from transfected cos cells and a bacterially expressed protein that contains the bcl6 zinc fingers and can be #truncated can bind specifically to dna from the u3 promoter/enhancer region of hiv-1 .
electrophoretic mobility shift assays showed that the full-length bcl6 protein extracted from transfected cos cells and a bacterially expressed protein that contains the bcl6 zinc fingers and is able to be remarkably #truncated can bind specifically to dna from the u3 promoter/enhancer region of hiv-1 .
electrophoretic mobility shift assays showed that the full-length bcl6 protein extracted from transfected cos cells and a bacterially expressed protein that contains the bcl6 zinc fingers and is likely to be remarkably #truncated can bind specifically to dna from the u3 promoter/enhancer region of hiv-1 .
electrophoretic mobility shift assays showed that the full-length bcl6 protein extracted from transfected cos cells and a bacterially expressed protein that contains the bcl6 zinc fingers and is remarkably #truncated can bind specifically to dna from the u3 promoter/enhancer region of hiv-1 .
electrophoretic mobility shift assays showed that the full-length bcl6 protein extracted from transfected cos cells and a bacterially expressed protein that contains the bcl6 zinc fingers and may be #truncated can bind specifically to dna from the u3 promoter/enhancer region of hiv-1 .
electrophoretic mobility shift assays showed that the full-length bcl6 protein extracted from transfected cos cells and a bacterially expressed protein that contains the bcl6 zinc fingers and may have been #truncated can bind specifically to dna from the u3 promoter/enhancer region of hiv-1 .
electrophoretic mobility shift assays showed that the full-length bcl6 protein extracted from transfected cos cells and a bacterially expressed protein that contains the bcl6 zinc fingers and will be #truncated can bind specifically to dna from the u3 promoter/enhancer region of hiv-1 .
electrophoretic mobility shift assays showed that the full-length bcl6 protein extracted from transfected cos cells and a bacterially expressed protein that is able to be #truncated and contains the bcl6 zinc fingers can bind specifically to dna from the u3 promoter/enhancer region of hiv-1 .
electrophoretic mobility shift assays showed that the full-length bcl6 protein extracted from transfected cos cells and a bacterially expressed protein that is likely to be #truncated and contains the bcl6 zinc fingers can bind specifically to dna from the u3 promoter/enhancer region of hiv-1 .
electrophoretic mobility shift assays showed that the full-length bcl6 protein extracted from transfected cos cells and a bacterially expressed protein that is observed to be #truncated and contains the bcl6 zinc fingers can bind specifically to dna from the u3 promoter/enhancer region of hiv-1 .
electrophoretic mobility shift assays showed that the full-length bcl6 protein extracted from transfected cos cells and a bacterially expressed protein that is #truncated and contains the bcl6 zinc fingers can bind specifically to dna from the u3 promoter/enhancer region of hiv-1 .
electrophoretic mobility shift assays showed that the full-length bcl6 protein extracted from transfected cos cells and a bacterially expressed protein that may have been remarkably #truncated and contains the bcl6 zinc fingers can bind specifically to dna from the u3 promoter/enhancer region of hiv-1 .
electrophoretic mobility shift assays showed that the full-length bcl6 protein extracted from transfected cos cells and a bacterially expressed protein that may have been #truncated and contains the bcl6 zinc fingers can bind specifically to dna from the u3 promoter/enhancer region of hiv-1 .
electrophoretic mobility shift assays showed that the full-length bcl6 protein extracted from transfected cos cells and a bacterially expressed protein that was remarkably #truncated and contained the bcl6 zinc fingers can bind specifically to dna from the u3 promoter/enhancer region of hiv-1 .
electrophoretic mobility shift assays showed that the full-length bcl6 protein extracted from transfected cos cells and a bacterially expressed protein that will be #truncated and contains the bcl6 zinc fingers can bind specifically to dna from the u3 promoter/enhancer region of hiv-1 .
previous studies using wild-type encephalomyocarditis virus (emcv) and mengo virus , and variants of these viruses being able to be genetically engineered to substitute or #truncate the poly(c) tracts have produced conflicting data on the role of the poly(c) tract in the virulence of these viruses .
previous studies using wild-type encephalomyocarditis virus (emcv) and mengo virus , and variants of these viruses observed to be genetically engineered to substitute or #truncate the poly(c) tracts have produced conflicting data on the role of the poly(c) tract in the virulence of these viruses .
previous studies using wild-type encephalomyocarditis virus (emcv) and mengo virus , and variants of these viruses shown to be genetically engineered to substitute or #truncate the poly(c) tracts have produced conflicting data on the role of the poly(c) tract in the virulence of these viruses .
previous studies using wild-type encephalomyocarditis virus (emcv) and mengo virus , and variants of these viruses that are able to be genetically engineered to substitute or #truncate the poly(c) tracts have produced conflicting data on the role of the poly(c) tract in the virulence of these viruses .
previous studies using wild-type encephalomyocarditis virus (emcv) and mengo virus , and variants of these viruses that are able to be genetically engineered to #truncate or substitute the poly(c) tracts have produced conflicting data on the role of the poly(c) tract in the virulence of these viruses .
previous studies using wild-type encephalomyocarditis virus (emcv) and mengo virus , and variants of these viruses that are genetically engineered to substitute or #truncate the poly(c) tracts have produced conflicting data on the role of the poly(c) tract in the virulence of these viruses .
previous studies using wild-type encephalomyocarditis virus (emcv) and mengo virus , and variants of these viruses that can be genetically engineered to substitute or #truncate the poly(c) tracts have produced conflicting data on the role of the poly(c) tract in the virulence of these viruses .
previous studies using wild-type encephalomyocarditis virus (emcv) and mengo virus , and variants of these viruses that can be genetically engineered to #truncate or substitute the poly(c) tracts have produced conflicting data on the role of the poly(c) tract in the virulence of these viruses .
previous studies using wild-type encephalomyocarditis virus (emcv) and mengo virus , and variants of these viruses that have been shown to be genetically engineered to substitute or #truncate the poly(c) tracts have produced conflicting data on the role of the poly(c) tract in the virulence of these viruses .
previous studies using wild-type encephalomyocarditis virus (emcv) and mengo virus , and variants of these viruses that may be genetically engineered to substitute or #truncate the poly(c) tracts have produced conflicting data on the role of the poly(c) tract in the virulence of these viruses .
previous studies using wild-type encephalomyocarditis virus (emcv) and mengo virus , and variants of these viruses that may be genetically engineered to #truncate or substitute the poly(c) tracts have produced conflicting data on the role of the poly(c) tract in the virulence of these viruses .
previous studies using wild-type encephalomyocarditis virus (emcv) and mengo virus , and variants of these viruses that may have been genetically engineered to substitute or #truncate the poly(c) tracts have produced conflicting data on the role of the poly(c) tract in the virulence of these viruses .
previous studies using wild-type encephalomyocarditis virus (emcv) and mengo virus , and variants of these viruses that may have been genetically engineered to #truncate or substitute the poly(c) tracts have produced conflicting data on the role of the poly(c) tract in the virulence of these viruses .
previous studies using wild-type encephalomyocarditis virus (emcv) and mengo virus , and variants of these viruses that will be genetically engineered to substitute or #truncate the poly(c) tracts have produced conflicting data on the role of the poly(c) tract in the virulence of these viruses .
specifically , the stat5a molecule in which the c-terminus has been remarkably #truncated at amino acids 740 or 751 effectively blocked the induction of both cis and osm , whereas the c-terminal truncations at amino acids 762 or 773 had no effect on the induction of either gene .
specifically , the stat5a molecule in which the c-terminus has been shown to be remarkably #truncated at amino acids 740 or 751 effectively blocked the induction of both cis and osm , whereas the c-terminal truncations at amino acids 762 or 773 had no effect on the induction of either gene .
specifically , the stat5a molecule in which the c-terminus has the ability to be #truncated at amino acids 740 or 751 effectively blocked the induction of both cis and osm , whereas the c-terminal truncations at amino acids 762 or 773 had no effect on the induction of either gene .
specifically , the stat5a molecule in which the c-terminus is able to be #truncated at amino acids 740 or 751 effectively blocked the induction of both cis and osm , whereas the c-terminal truncations at amino acids 762 or 773 had no effect on the induction of either gene .
specifically , the stat5a molecule in which the c-terminus is likely to be remarkably #truncated at amino acids 740 or 751 effectively blocked the induction of both cis and osm , whereas the c-terminal truncations at amino acids 762 or 773 had no effect on the induction of either gene .
specifically , the stat5a molecule in which the c-terminus is likely to be #truncated at amino acids 740 or 751 effectively blocked the induction of both cis and osm , whereas the c-terminal truncations at amino acids 762 or 773 had no effect on the induction of either gene .
specifically , the stat5a molecule in which the c-terminus is remarkably #truncated at amino acids 740 or 751 effectively blocked the induction of both cis and osm , whereas the c-terminal truncations at amino acids 762 or 773 had no effect on the induction of either gene .
specifically , the stat5a molecule in which the c-terminus may be remarkably #truncated at amino acids 740 or 751 effectively blocked the induction of both cis and osm , whereas the c-terminal truncations at amino acids 762 or 773 had no effect on the induction of either gene .
specifically , the stat5a molecule in which the c-terminus may have been #truncated at amino acids 740 or 751 effectively blocked the induction of both cis and osm , whereas the c-terminal truncations at amino acids 762 or 773 had no effect on the induction of either gene .
the majority of changes have been found to #truncate the protein through nonsense mutations (32%) , insertions or deletions (29 .6%) , or splicing changes (6 .2%) , although the figures were biased by the methods employed , and , in sequenced areas , approximately 50% of all mutations were missense or in-frame .
the protein can be #truncated by the majority of changes through nonsense mutations (32%) , insertions or deletions (29 .6%) , or splicing changes (6 .2%) , although the figures were biased by the methods employed , and , in sequenced areas , approximately 50% of all mutations were missense or in-frame .
the protein has been shown to be #truncated by the majority of changes through nonsense mutations (32%) , insertions or deletions (29 .6%) , or splicing changes (6 .2%) , although the figures were biased by the methods employed , and , in sequenced areas , approximately 50% of all mutations were missense or in-frame .
the protein is likely to be #truncated by the majority of changes through nonsense mutations (32%) , insertions or deletions (29 .6%) , or splicing changes (6 .2%) , although the figures were biased by the methods employed , and , in sequenced areas , approximately 50% of all mutations were missense or in-frame .
the protein is predicted to be #truncated by the majority of changes through nonsense mutations (32%) , insertions or deletions (29 .6%) , or splicing changes (6 .2%) , although the figures were biased by the methods employed , and , in sequenced areas , approximately 50% of all mutations were missense or in-frame .
the protein is predicted to be #truncated through nonsense mutations (32%) , insertions or deletions (29 .6%) , or splicing changes (6 .2%) by the majority of changes , although the figures were biased by the methods employed , and , in sequenced areas , approximately 50% of all mutations were missense or in-frame .
the protein is #truncated by the majority of changes through nonsense mutations (32%) , insertions or deletions (29 .6%) , or splicing changes (6 .2%) , although the figures were biased by the methods employed , and , in sequenced areas , approximately 50% of all mutations were missense or in-frame .
the protein may have been #truncated by the majority of changes through nonsense mutations (32%) , insertions or deletions (29 .6%) , or splicing changes (6 .2%) , although the figures were biased by the methods employed , and , in sequenced areas , approximately 50% of all mutations were missense or in-frame .
the protein will be #truncated through nonsense mutations (32%) , insertions or deletions (29 .6%) , or splicing changes (6 .2%) by the majority of changes , although the figures were biased by the methods employed , and , in sequenced areas , approximately 50% of all mutations were missense or in-frame .
the putative resulting protein retained the region encoding the structural and functional elements of the amine oxidase but the second and fourth srcr domains are able to be #truncated and the potential bmp-1 cleavage site is not present .
the putative resulting protein retained the region encoding the structural and functional elements of the amine oxidase but the second and fourth srcr domains are #truncated and the potential bmp-1 cleavage site is not present .
the putative resulting protein retained the region encoding the structural and functional elements of the amine oxidase but the second and fourth srcr domains have been shown to be #truncated and the potential bmp-1 cleavage site has not been present .
the putative resulting protein retained the region encoding the structural and functional elements of the amine oxidase but the second and fourth srcr domains may be #truncated and the potential bmp-1 cleavage site is not present .
the putative resulting protein retained the region encoding the structural and functional elements of the amine oxidase but the second and fourth srcr domains will be #truncated and the potential bmp-1 cleavage site is not present .
therefore , to generate a comparable soluble fragment to ic1-2d/190 , pvr has also been #truncated prior to the pp-motif .
therefore , to generate a comparable soluble fragment to ic1-2d/190 , pvr is also able to be #truncated prior to the pp-motif .
therefore , to generate a comparable soluble fragment to ic1-2d/190 , pvr is also likely to be #truncated prior to the pp-motif .
therefore , to generate a comparable soluble fragment to ic1-2d/190 , pvr is also observed to be #truncated prior to the pp-motif .
therefore , to generate a comparable soluble fragment to ic1-2d/190 , pvr may also be #truncated prior to the pp-motif .
therefore , to generate a comparable soluble fragment to ic1-2d/190 , pvr may have been #truncated prior to the pp-motif .
therefore , to generate a comparable soluble fragment to ic1-2d/190 , pvr will also be #truncated prior to the pp-motif .
to generate a comparable soluble fragment to ic1-2d/190 , pvr can therefore be #truncated prior to the pp-motif .
to generate a comparable soluble fragment to ic1-2d/190 , pvr has therefore been shown to be #truncated prior to the pp-motif .
to generate a comparable soluble fragment to ic1-2d/190 , pvr is therefore able to be #truncated prior to the pp-motif .
to generate a comparable soluble fragment to ic1-2d/190 , pvr is therefore likely to be #truncated prior to the pp-motif .
to generate a comparable soluble fragment to ic1-2d/190 , pvr may therefore be #truncated prior to the pp-motif .
to generate this protein , the receptor has been #truncated prior to two consecutive proline residues (`pp-motif_) present in the junction between domains 2 and 3 (figure 1) .
to generate this protein , the receptor is able to be #truncated prior to two consecutive proline residues (`pp-motif_) present in the junction between domains 2 and 3 (figure 1) .
to generate this protein , the receptor is #truncated prior to two consecutive proline residues (`pp-motif_) present in the junction between domains 2 and 3 (figure 1) .
to generate this protein , the receptor may be #truncated prior to two consecutive proline residues (`pp-motif_) present in the junction between domains 2 and 3 (figure 1) .
to generate this protein , the receptor will be #truncated prior to two consecutive proline residues (`pp-motif_) present in the junction between domains 2 and 3 (figure 1) .
virtually all tsc1 mutations are found to dramatically #truncate the protein product .
virtually all tsc1 mutations are found to #truncate the protein product .
virtually all tsc1 mutations have been predicted to dramatically #truncate the protein product .
virtually all tsc1 mutations have the ability to #truncate the protein product .
virtually all tsc1 mutations may dramatically #truncate the protein product .
virtually all tsc1 mutations may #truncate the protein product .
virtually all tsc1 mutations #truncated the protein product .
c-terminally truncated stat5a proteins , #truncated at amino acids 762 or 773 had no effect on the induction of either gene .
to address the mechanisms of activation by crp and the rna polymerase alpha-subunit c-terminal domain (alpha-ctd) at rhasr , we tested the effects of alanine substitutions in crp activating regions 1 and 2 , overexpression of a #truncated version of alpha (alpha-delt235) , and alanine substitutions throughout alpha-ctd .
the majority of changes were predicted to #truncate the protein through nonsense mutations (32%) , insertions or deletions (29 .6%) , or splicing changes (6 .2%) , although the figures were biased by the methods employed , and , in sequenced areas , approximately 50% of all mutations were missense or in-frame .
virtually all tsc1 mutations are predicted to #truncate the protein product .
previous studies using tsc1 mutations being able to be genetically engineered to #truncate or substitute the protein product have produced conflicting data on the role of the poly(c) tract in the virulence of these viruses .
previous studies using tsc1 mutations genetically engineered to #truncate or substitute the protein product have produced conflicting data on the role of the poly(c) tract in the virulence of these viruses .
previous studies using tsc1 mutations observed to be genetically engineered to substitute or #truncate the protein product have produced conflicting data on the role of the poly(c) tract in the virulence of these viruses .
previous studies using tsc1 mutations observed to be genetically engineered to #truncate or substitute the protein product have produced conflicting data on the role of the poly(c) tract in the virulence of these viruses .
previous studies using tsc1 mutations shown to be genetically engineered to #truncate or substitute the protein product have produced conflicting data on the role of the poly(c) tract in the virulence of these viruses .
previous studies using tsc1 mutations that are able to be genetically engineered to substitute or #truncate the protein product have produced conflicting data on the role of the poly(c) tract in the virulence of these viruses .
previous studies using tsc1 mutations that are able to be genetically engineered to #truncate or substitute the protein product have produced conflicting data on the role of the poly(c) tract in the virulence of these viruses .
previous studies using tsc1 mutations that are genetically engineered to #truncate or substitute the protein product have produced conflicting data on the role of the poly(c) tract in the virulence of these viruses .
previous studies using tsc1 mutations that are observed to be genetically engineered to substitute or #truncate the protein product have produced conflicting data on the role of the poly(c) tract in the virulence of these viruses .
previous studies using tsc1 mutations that have been shown to be genetically engineered to substitute or #truncate the protein product have produced conflicting data on the role of the poly(c) tract in the virulence of these viruses .
previous studies using tsc1 mutations that may be genetically engineered to #truncate or substitute the protein product have produced conflicting data on the role of the poly(c) tract in the virulence of these viruses .
previous studies using tsc1 mutations that will be genetically engineered to #truncate or substitute the protein product have produced conflicting data on the role of the poly(c) tract in the virulence of these viruses .
virtually all wild-type encephalomyocarditis virus (emcv) and mengo virus , and variants of these viruses are able to #truncate the poly(c) tracts .
virtually all wild-type encephalomyocarditis virus (emcv) and mengo virus , and variants of these viruses are found to dramatically #truncate the poly(c) tracts .
virtually all wild-type encephalomyocarditis virus (emcv) and mengo virus , and variants of these viruses dramatically #truncate the poly(c) tracts .
virtually all wild-type encephalomyocarditis virus (emcv) and mengo virus , and variants of these viruses dramatically #truncated the poly(c) tracts .
virtually all wild-type encephalomyocarditis virus (emcv) and mengo virus , and variants of these viruses have been predicted to dramatically #truncate the poly(c) tracts .
virtually all wild-type encephalomyocarditis virus (emcv) and mengo virus , and variants of these viruses have dramatically #truncated the poly(c) tracts .
virtually all wild-type encephalomyocarditis virus (emcv) and mengo virus , and variants of these viruses have the ability to dramatically #truncate the poly(c) tracts .
virtually all wild-type encephalomyocarditis virus (emcv) and mengo virus , and variants of these viruses have #truncated the poly(c) tracts .
virtually all wild-type encephalomyocarditis virus (emcv) and mengo virus , and variants of these viruses may have dramatically #truncated the poly(c) tracts .
virtually all wild-type encephalomyocarditis virus (emcv) and mengo virus , and variants of these viruses may have #truncated the poly(c) tracts .
virtually all wild-type encephalomyocarditis virus (emcv) and mengo virus , and variants of these viruses will dramatically #truncate the poly(c) tracts .
previous studies using nonsense mutations (32%) , insertions or deletions (29 .6%) , or splicing changes (6 .2%) being able to be genetically engineered to substitute or #truncate the protein have produced conflicting data on the role of the poly(c) tract in the virulence of these viruses .
previous studies using nonsense mutations (32%) , insertions or deletions (29 .6%) , or splicing changes (6 .2%) being able to be genetically engineered to #truncate or substitute the protein have produced conflicting data on the role of the poly(c) tract in the virulence of these viruses .
previous studies using nonsense mutations (32%) , insertions or deletions (29 .6%) , or splicing changes (6 .2%) genetically engineered to #truncate or substitute the protein have produced conflicting data on the role of the poly(c) tract in the virulence of these viruses .
previous studies using nonsense mutations (32%) , insertions or deletions (29 .6%) , or splicing changes (6 .2%) observed to be genetically engineered to #truncate or substitute the protein have produced conflicting data on the role of the poly(c) tract in the virulence of these viruses .
previous studies using nonsense mutations (32%) , insertions or deletions (29 .6%) , or splicing changes (6 .2%) shown to be genetically engineered to substitute or #truncate the protein have produced conflicting data on the role of the poly(c) tract in the virulence of these viruses .
previous studies using nonsense mutations (32%) , insertions or deletions (29 .6%) , or splicing changes (6 .2%) that are able to be genetically engineered to substitute or #truncate the protein have produced conflicting data on the role of the poly(c) tract in the virulence of these viruses .
previous studies using nonsense mutations (32%) , insertions or deletions (29 .6%) , or splicing changes (6 .2%) that are able to be genetically engineered to #truncate or substitute the protein have produced conflicting data on the role of the poly(c) tract in the virulence of these viruses .
previous studies using nonsense mutations (32%) , insertions or deletions (29 .6%) , or splicing changes (6 .2%) that are genetically engineered to substitute or #truncate the protein have produced conflicting data on the role of the poly(c) tract in the virulence of these viruses .
previous studies using nonsense mutations (32%) , insertions or deletions (29 .6%) , or splicing changes (6 .2%) that are genetically engineered to #truncate or substitute the protein have produced conflicting data on the role of the poly(c) tract in the virulence of these viruses .
previous studies using nonsense mutations (32%) , insertions or deletions (29 .6%) , or splicing changes (6 .2%) that are likely to be genetically engineered to #truncate or substitute the protein have produced conflicting data on the role of the poly(c) tract in the virulence of these viruses .
previous studies using nonsense mutations (32%) , insertions or deletions (29 .6%) , or splicing changes (6 .2%) that have been shown to be genetically engineered to substitute or #truncate the protein have produced conflicting data on the role of the poly(c) tract in the virulence of these viruses .
previous studies using nonsense mutations (32%) , insertions or deletions (29 .6%) , or splicing changes (6 .2%) that may be genetically engineered to substitute or #truncate the protein have produced conflicting data on the role of the poly(c) tract in the virulence of these viruses .
previous studies using nonsense mutations (32%) , insertions or deletions (29 .6%) , or splicing changes (6 .2%) that may be genetically engineered to #truncate or substitute the protein have produced conflicting data on the role of the poly(c) tract in the virulence of these viruses .
previous studies using nonsense mutations (32%) , insertions or deletions (29 .6%) , or splicing changes (6 .2%) that may have been genetically engineered to #truncate or substitute the protein have produced conflicting data on the role of the poly(c) tract in the virulence of these viruses .
previous studies using nonsense mutations (32%) , insertions or deletions (29 .6%) , or splicing changes (6 .2%) that were genetically engineered to substitute or #truncate the protein have produced conflicting data on the role of the poly(c) tract in the virulence of these viruses .
virtually all nonsense mutations (32%) , insertions or deletions (29 .6%) , or splicing changes (6 .2%) are found to #truncate the protein .
virtually all nonsense mutations (32%) , insertions or deletions (29 .6%) , or splicing changes (6 .2%) can dramatically #truncate the protein .
virtually all nonsense mutations (32%) , insertions or deletions (29 .6%) , or splicing changes (6 .2%) dramatically #truncate the protein .
virtually all nonsense mutations (32%) , insertions or deletions (29 .6%) , or splicing changes (6 .2%) have been predicted to #truncate the protein .
virtually all nonsense mutations (32%) , insertions or deletions (29 .6%) , or splicing changes (6 .2%) have the ability to dramatically #truncate the protein .
virtually all nonsense mutations (32%) , insertions or deletions (29 .6%) , or splicing changes (6 .2%) have the ability to #truncate the protein .
virtually all nonsense mutations (32%) , insertions or deletions (29 .6%) , or splicing changes (6 .2%) may dramatically #truncate the protein .
virtually all nonsense mutations (32%) , insertions or deletions (29 .6%) , or splicing changes (6 .2%) may have dramatically #truncated the protein .
virtually all nonsense mutations (32%) , insertions or deletions (29 .6%) , or splicing changes (6 .2%) may have #truncated the protein .
virtually all nonsense mutations (32%) , insertions or deletions (29 .6%) , or splicing changes (6 .2%) may #truncate the protein .
virtually all nonsense mutations (32%) , insertions or deletions (29 .6%) , or splicing changes (6 .2%) #truncate the protein .
virtually all nonsense mutations (32%) , insertions or deletions (29 .6%) , or splicing changes (6 .2%) will dramatically #truncate the protein .
virtually all nonsense mutations (32%) , insertions or deletions (29 .6%) , or splicing changes (6 .2%) will #truncate the protein .
